PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Uozumi, H; Hiroi, Y; Zou, YZ; Takimoto, E; Toko, H; Niu, P; Shimoyama, M; Yazaki, Y; Nagai, R; Komuro, I				Uozumi, H; Hiroi, Y; Zou, YZ; Takimoto, E; Toko, H; Niu, P; Shimoyama, M; Yazaki, Y; Nagai, R; Komuro, I			gp130 plays a critical role in pressure overload-induced cardiac hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LEUKEMIA INHIBITORY FACTOR; MYOCARDIAL-CELL HYPERTROPHY; MECHANICAL-STRESS; GENE-EXPRESSION; HEART-CELLS; CARDIOMYOCYTE HYPERTROPHY; INTERLEUKIN-6 FAMILY; SIGNAL TRANSDUCER; RAT-HEART	gp130, a common receptor for the interleukin 6 family, plays pivotal roles in growth and survival of cardiac myocytes. In the present study, we examined the role of gp130 in pressure overload-induced cardiac hypertrophy using transgenic (TG) mice, which express a dominant negative mutant of gp130 in the heart under the control of a myosin heavy chain promoter. TG mice were apparently healthy and fertile. There were no differences in body weight and heart weight between TG mice and littermate wild type (WT) mice. Pressure overload-induced increases in the heart weight/body weight ratio, ventricular wall thickness, and cross-sectional areas of cardiac myocytes were significantly smaller in TG mice than in WT mice, Northern blot analysis revealed that pressure overload-induced up-regulation of brain natriuretic factor gene and down regulation of sarcoplasmic reticulum Ca2+ ATPase 2 gene were attenuated in TG mice. Pressure overload activated ERKs and STAT3 in the heart of WT mice, whereas pressure overload-induced activation of STAT3, but not of ERKs, was suppressed in TG mice. These results suggest that gp130 plays a critical role in pressure overload-induced cardiac hypertrophy possibly through the STAT3 pathway.	Chiba Univ, Sch Med, Dept Med 3, Chuo Ku, Chiba 2608670, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; Tottori Univ, Fac Med, Dept Internal Med 1, Tottori 6808550, Japan; Int Med Ctr Japan, Tokyo 1628655, Japan	Chiba University; University of Tokyo; Tottori University; National Center for Global Health & Medicine - Japan	Komuro, I (corresponding author), Chiba Univ, Sch Med, Dept Med 3, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp						BAKER KM, 1990, AM J PHYSIOL, V259, pH610, DOI 10.1152/ajpheart.1990.259.2.H610; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Ernst M, 1999, J BIOL CHEM, V274, P9729, DOI 10.1074/jbc.274.14.9729; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; HILTON DJ, 1992, TRENDS BIOCHEM SCI, V17, P72, DOI 10.1016/0968-0004(92)90505-4; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Kodama H, 1997, CIRC RES, V81, P656; KOJIMA M, 1994, CIRCULATION, V89, P2204, DOI 10.1161/01.CIR.89.5.2204; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Kumanogoh A, 1997, P NATL ACAD SCI USA, V94, P2478, DOI 10.1073/pnas.94.6.2478; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; YAMAZAKI T, 1995, CIRC RES, V77, P258, DOI 10.1161/01.RES.77.2.258; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	32	61	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23115	23119		10.1074/jbc.M100814200	http://dx.doi.org/10.1074/jbc.M100814200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11262406	hybrid			2022-12-27	WOS:000169412700151
J	Akiba, S; Hatazawa, R; Ono, K; Kitatani, K; Hayama, M; Sato, T				Akiba, S; Hatazawa, R; Ono, K; Kitatani, K; Hayama, M; Sato, T			Secretory phospholipase A(2) mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A(2) expression in rat gastric epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; MESANGIAL CELLS; FACTOR-ALPHA; GROUP IIA; MUCOSAL CELLS; CYCLOOXYGENASE-2; INDUCTION; PROTEIN; INHIBITION; ACTIVATION	Transforming growth factor (TGF)-alpha and interleukin (IL)-1 beta are responsible for the healing of gastric lesions through, in part, prostaglandin (PG) generation. We examined the contribution of cytosolic and secretory phospholipase A(2)s (cPLA(2) and sPLA(2)) to the PC generation by rat gastric epithelial cells in response to both stimuli. Stimulation with TGF-alpha for 24 h increased cPLA(2) and cyclooxygenase (COX)-2 markedly, PGE(2) slightly, and type IIA sPLA(2) and COX-1 not at all, whereas IL-1 beta increased sPLA(2) only. Both stimuli synergistically increased PGE(2), sPLA(2), and the two COXs but not cPLA(2). The onset of the PGE(2) generation paralleled the sPLA(2) release but was apparently preceded by increases in cPLA(2) and the two COXs, The increase in PGE(2) was impaired by inhibitors for sPLA(2) and COX-2 but not COX-1. cPLA(2) inhibitors suppressed PGE(2) generation by TGF-alpha alone but not augmentation of PGE(2) generation or sPLA(2) release by IL-1 beta in combination with TGF-alpha. Furthermore, despite an increase in cPLA(2) including its phosphorylated form (phosphoserine), A23187-induced arachidonic acid liberation was impaired in the TGF-alpha/ IL-1 beta -stimulated cells, in which p11, a putative cPLA(2) inhibitory molecule, was also increased and co-immunoprecipitated with cPLA(2). These results suggest that synergistic stimulation of sPLA(2) and COX-2 expression by TGF-alpha and IL-1 beta results in an increase in PGE(2).(.) Presumably, the preceding cPLA(2) expression is not involved in the PGE(2) generation, because of impairment of its hydrolytic activity in the stimulated cells.	Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashima Ku, Kyoto 6078414, Japan	Kyoto Pharmaceutical University	Akiba, S (corresponding author), Kyoto Pharmaceut Univ, Dept Pathol Biochem, Yamashima Ku, Kyoto 6078414, Japan.		Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135				Akiba S, 2000, BRIT J PHARMACOL, V131, P1004, DOI 10.1038/sj.bjp.0703637; Akiba S, 1997, J BIOCHEM-TOKYO, V122, P859; Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Bamba H, 1998, BIOCHEM BIOPH RES CO, V245, P567, DOI 10.1006/bbrc.1998.8436; BARNARD JA, 1995, GASTROENTEROLOGY, V108, P564, DOI 10.1016/0016-5085(95)90087-X; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Brzozowski T, 1999, EUR J PHARMACOL, V385, P47, DOI 10.1016/S0014-2999(99)00681-0; Ciardiello F, 1998, CLIN CANCER RES, V4, P821; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Diaz-Cazorla M, 1999, EUR J BIOCHEM, V260, P268, DOI 10.1046/j.1432-1327.1999.00144.x; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Hayama M, 2000, EUR J PHARMACOL, V390, P37, DOI 10.1016/S0014-2999(99)00913-9; Hayama M, 1997, J BIOCHEM-TOKYO, V122, P1196; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Huwiler A, 1997, BBA-LIPID LIPID MET, V1348, P257, DOI 10.1016/S0005-2760(97)00073-8; Jacques C, 1997, J CLIN INVEST, V99, P1864, DOI 10.1172/JCI119353; Jones MK, 1999, FASEB J, V13, P2186, DOI 10.1096/fasebj.13.15.2186; Kobayashi I, 1996, IN VITRO CELL DEV-AN, V32, P259; Kobayashi K, 1995, J CLIN GASTROENTEROL, V21, pS12; Kobayashi O, 1996, J GASTROEN HEPATOL, V11, P129, DOI 10.1111/j.1440-1746.1996.tb00049.x; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; Konturek PC, 1998, EUR J PHARMACOL, V342, P55, DOI 10.1016/S0014-2999(97)01408-8; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Lenferink AEG, 1998, BIOCHEM J, V336, P147, DOI 10.1042/bj3360147; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; NAKANO O, 1995, DIGEST DIS SCI, V40, P1679, DOI 10.1007/BF02212688; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; PFEILSCHIFTER J, 1993, J CLIN INVEST, V92, P2516, DOI 10.1172/JCI116860; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; ROBERT A, 1991, LIFE SCI, V48, P123, DOI 10.1016/0024-3205(91)90405-Z; Rutten MJ, 1996, AM J PHYSIOL-GASTR L, V270, pG604, DOI 10.1152/ajpgi.1996.270.4.G604; Sasaki E, 1998, J CLIN GASTROENTEROL, V27, pS21, DOI 10.1097/00004836-199800001-00005; Sawaoka H, 1999, PROSTAG LEUKOTR ESS, V61, P315, DOI 10.1054/plef.1999.0106; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Takahashi M, 1996, J CLIN INVEST, V98, P2604, DOI 10.1172/JCI119080; TAKAHASHI M, 1995, J CLIN INVEST, V95, P1994, DOI 10.1172/JCI117884; Thomas G, 2000, J BIOL CHEM, V275, P10876, DOI 10.1074/jbc.275.15.10876; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202; Yokota Y, 1999, BBA-MOL CELL BIOL L, V1438, P213, DOI 10.1016/S1388-1981(99)00053-0; Yucel-Lindberg T, 1999, BIOCHEM BIOPH RES CO, V257, P528, DOI 10.1006/bbrc.1999.0523	57	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21854	21862		10.1074/jbc.M010201200	http://dx.doi.org/10.1074/jbc.M010201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274144	hybrid			2022-12-27	WOS:000169297900137
J	Speina, E; Ciesla, JM; Wojcik, J; Bajek, M; Kusmierek, JT; Tudek, B				Speina, E; Ciesla, JM; Wojcik, J; Bajek, M; Kusmierek, JT; Tudek, B			The pyrimidine ring-opened derivative of 1,N-6-ethenoadenine is excised from DNA by the Escherichia coli Fpg and Nth proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; LIPID-PEROXIDATION; ENDONUCLEASE-III; REPAIR; SPECTROSCOPY; GLYCOSYLASE; SENSITIVITY; PARAMETERS; ADDUCTS; LESIONS	It was previously shown that 1,N-6-ethenoadenine (epsilonA) in DNA rearranges into a pyrimidine ring-opened derivative of 20-fold higher mutagenic potency in Escherichia coli (AB1157 lac Delta U169) than the parental epsilonA (Basu, A. K,, Wood, M. L,, Niedernhofer, L. J,, Ramos, L, A., and Essigmann, J, M, (1993) Biochemistry 32, 12793-12801), We have found that at pH 7.0, the stability of the N-glycosidic bond in epsilon dA is 20-fold lower than in dA, In alkaline conditions, but also at neutrality, epsilon dA depurinates or converts into products: epsilon dA --> B --> C --> D, Compound B is a product of water molecule addition to the C(2)-N(3) bond, which is in equilibrium with a product of N(1)- C(2) bond rupture in epsilon dA, Compound C is a deformylated derivative of ring-opened compound B, which further depurinates yielding compound D, Ethenoadenine degradation products are not recognized by human N-alkylpurine-DNA glycosylase, which repairs epsilonA. Product B is excised from oligodeoxynucleotides by E, coli formamidopyrimidine-DNA glycosylase (Fpg) and endonuclease III (Nth), Repair by the Fpg protein is as efficient as that of 7,8-dihydro-8-oxoguanine when the excised base is paired with dT and dC but is less favorable when paired with dC: and dA, Ethenoadenine rearrangement products are formed in oligodeoxynucleotides also at neutral pH at the rate of about 23% per week at 37 degreesC, and therefore they may contribute to epsilonA mutations.	Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Tudek, B (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	tudek@ibb.waw.pl	Speina, Elzbieta/ABB-3371-2021	Wojcik, Jacek/0000-0002-7685-3515; Elzbieta, Speina/0000-0002-0734-9390; Ciesla, Jaroslaw/0000-0003-0695-7201				AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Barbin A, 1999, IARC SCI PUBL, P303; BARRIO JR, 1972, BIOCHEM BIOPH RES CO, V46, P597, DOI 10.1016/S0006-291X(72)80181-5; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; BARTSCH H, 1994, DRUG METAB REV, V26, P349, DOI 10.3109/03602539409029802; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Dizdaroglu M, 2000, BIOCHEMISTRY-US, V39, P5586, DOI 10.1021/bi9927787; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; Duarte V, 2000, NUCLEIC ACIDS RES, V28, P1555, DOI 10.1093/nar/28.7.1555; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Graziewicz MA, 1999, MUTAT RES-DNA REPAIR, V434, P41, DOI 10.1016/S0921-8777(99)00012-9; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; HOFFMAN RE, 1988, MAGN RESON CHEM, V26, P523, DOI 10.1002/mrc.1260260617; Jurado J, 1998, BIOCHEMISTRY-US, V37, P7757, DOI 10.1021/bi972982z; KAMINSKI ZW, 1987, COMPUT METH PROG BIO, V24, P41, DOI 10.1016/0169-2607(87)90064-2; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KONTAXIS G, 1994, J MAGN RESON SER A, V111, P70, DOI 10.1006/jmra.1994.1227; KRONBERG L, 1992, CHEM RES TOXICOL, V5, P852, DOI 10.1021/tx00030a019; KUSMIEREK JT, 1989, CHEM RES TOXICOL, V2, P230, DOI 10.1021/tx00010a003; LAVAL J, 1990, MUTAT RES, V233, P73, DOI 10.1016/0027-5107(90)90152-T; LEE H, 1971, BIOCHIM BIOPHYS ACTA, V242, P519, DOI 10.1016/0005-2744(71)90144-6; Levine RL, 2000, CANCER RES, V60, P4098; Moriya M, 1999, IARC SCI PUBL, P263; Nair J, 1998, CANCER EPIDEM BIOMAR, V7, P435; Nair J, 1996, CANCER RES, V56, P1267; Nair J, 1999, IARC SCI PUBL, P55; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SINGER B, 1983, MOL BIOL MUTAGENS CA, P15; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Swenberg JA, 1999, IARC SCI PUBL, P29; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TSOU KC, 1974, NUCLEIC ACIDS RES, V1, P531, DOI 10.1093/nar/1.4.531; Tudek B, 1999, ACTA BIOCHIM POL, V46, P785, DOI 10.18388/abp.1999_4151; YIP K F, 1973, Tetrahedron Letters, V33, P3087	42	25	25	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21821	21827		10.1074/jbc.M100998200	http://dx.doi.org/10.1074/jbc.M100998200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259435	hybrid			2022-12-27	WOS:000169297900133
J	Matsuno-Yagi, A; Hatefi, Y				Matsuno-Yagi, A; Hatefi, Y			Ubiquinol : cytochrome c oxidoreductase (complex III) - Effect of inhibitors on cytochrome b reduction in submitochondrial particles and the role of ubiquinone in complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; PROTONMOTIVE Q-CYCLE; MITOCHONDRIAL ELECTRON-TRANSPORT; BOVINE HEART-MITOCHONDRIA; BC(1) COMPLEX; OXIDATIVE-PHOSPHORYLATION; ETHOXYFORMIC ANHYDRIDE; RESPIRATORY-CHAIN; REDOX REACTIONS; ATP SYNTHESIS	Two sets of studies have been reported on the electron transfer pathway of complex III in bovine heart submitochondrial particles (SMP), 1) In the presence of myxothiazol, MOA-stilbene, stigmatellin, or of antimycin added to SMP pretreated with ascorbate and KCN to reduce the high potential components (iron-sulfur protein (ISP) and cytochrome c(1)) of complex III, addition of succinate reduced heme b(H) followed by a slow and partial reduction of heme b(L). Similar results were obtained when SMP were treated only with KCN or NaN3, reagents that inhibit cytochrome oxidase, not complex III. The average initial rate of b(H) reduction under these conditions was about 25-30% of the rate of b reduction by succinate in antimycin-treated SMP, where both bH and bL were concomitantly reduced. These results have been discussed in relation to the Q-cycle hypothesis and the effect of the redox state of ISP/c(1) on cytochrome b reduction by succinate, 2) Reverse electron transfer from ISP reduced with ascorbate plus phenazine methosulfate to cytochrome b was studied in SMP, ubiquinone (Q)-depleted SMP containing less than or equal to0.06 mol of Q/mol of complex III, and Q-replenished SMP, The results showed that Q was not required for electron transfer from ISP to b, a reaction that was inhibited by antimycin (also by myxothiazol or MOA-stilbene as reported elsewhere). It was also shown that antimycin did not inhibit electron transfer from b (b,) to Q, in clear contrast to the assumption of the Q-cycle hypothesis regarding the site of antimycin inhibition.	Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Hatefi, Y (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA.	hatefi@scripps.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK008126, R01DK008126] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK08126] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; CHANCE B, 1961, J BIOL CHEM, V236, P1577; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3351, DOI 10.1021/bi00128a007; DEVRIES S, 1980, FEBS LETT, V122, P143; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; ERECINSKA M, 1974, ARCH BIOCHEM BIOPHYS, V160, P412, DOI 10.1016/0003-9861(74)90415-9; Hansen KC, 2000, BBA-BIOENERGETICS, V1456, P121, DOI 10.1016/S0005-2728(99)00107-3; HATEFI Y, 1962, J BIOL CHEM, V237, P1681; HATEFI Y, 1982, BIOCHEMISTRY-US, V21, P6614, DOI 10.1021/bi00268a045; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HOWELL N, 1993, BIOCHEMISTRY-US, V32, P11162, DOI 10.1021/bi00092a028; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuno-Yagi A, 1999, J BIOL CHEM, V274, P9283, DOI 10.1074/jbc.274.14.9283; MatsunoYagi A, 1997, J BIOL CHEM, V272, P16928, DOI 10.1074/jbc.272.27.16928; MatsunoYagi A, 1996, J BIOL CHEM, V271, P6164, DOI 10.1074/jbc.271.11.6164; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; MEINHARDT SW, 1987, J BIOL CHEM, V262, P8702; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; OHNISHI T, 1994, FEBS LETT, V353, P103, DOI 10.1016/0014-5793(94)01021-8; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Sadoski RC, 2000, BIOCHEMISTRY-US, V39, P4231, DOI 10.1021/bi000003o; Snyder CH, 1999, J BIOENERG BIOMEMBR, V31, P235, DOI 10.1023/A:1005419712731; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TSAI A, 1986, BIOCHIM BIOPHYS ACTA, V852, P100, DOI 10.1016/0005-2728(86)90061-7; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YAGI T, 1982, BIOCHEMISTRY-US, V21, P4777, DOI 10.1021/bi00262a039; YU CA, 1978, BIOCHEM BIOPH RES CO, V82, P1070, DOI 10.1016/0006-291X(78)90296-6; Yu CA, 1999, J BIOENERG BIOMEMBR, V31, P167, DOI 10.1023/A:1005418325934; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	38	16	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19006	19011		10.1074/jbc.M101446200	http://dx.doi.org/10.1074/jbc.M101446200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262412	hybrid			2022-12-27	WOS:000169091000049
J	Prasad, SVN; Barak, LS; Rapacciuolo, A; Caron, MG; Rockman, HA				Prasad, SVN; Barak, LS; Rapacciuolo, A; Caron, MG; Rockman, HA			Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1 - A role in receptor sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CLATHRIN ADAPTER AP-2; ARRESTIN; GAMMA; DESENSITIZATION; TRAFFICKING; ENDOCYTOSIS; EXPRESSION; INSIGHTS; SUBUNIT	Agonist-dependent desensitization of the beta -adrenergic receptor requires translocation and activation of the beta -adrenergic receptor kinase1 by liberated G beta gamma subunits. Subsequent internalization of agonist-occupied receptors occurs as a result of the binding of beta -arrestin to the phosphorylated receptor followed by interaction with the AP2 adaptor and clathrin proteins. Receptor internalization is known to require D-3 phosphoinositides that are generated by the action of phosphoinositide 3-kinase. Phosphoinositide 3-kinases form a family of lipid kinases that couple signals via receptor tyrosine kinases and G-protein-coupled receptors, The molecular mechanism by which phosphoinositide 3-kinase acts to promote beta -adrenergic receptor internalization is not well understood. In the present investigation we demonstrate a novel finding that beta -adrenergic receptor kinase 1 and phosphoinositide 3-kinase form a cytosolic complex, which leads to beta -adrenergic receptor kinase 1-mediated translocation of phosphoinositide 3-kinase to the membrane in an agonist-dependent manner. Furthermore, agonist-induced translocation of phosphoinositide 3-kinase results in rapid interaction with the receptor, which is of functional importance, since inhibition of phosphoinositide 3-kinase activity attenuates beta -adrenergic receptor sequestration. Therefore, agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane is an important step in the process of receptor sequestration and links phosphoinositide 3-kinase to G-protein-coupled receptor activation and sequestration.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Rockman, HA (corresponding author), Duke Univ, Med Ctr, Dept Med & Cell Biol, CARL Bldg,Rm 226,DUMC 3104, Durham, NC 27710 USA.	h.rockman@duke.edu	Rapacciuolo, Antonio/AAR-8012-2020	Rapacciuolo, Antonio/0000-0002-4739-7004	NHLBI NIH HHS [HL61365, HL56687] Funding Source: Medline; NINDS NIH HHS [NS19576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056687, R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; BERS DM, 1979, BIOCHIM BIOPHYS ACTA, V555, P131, DOI 10.1016/0005-2736(79)90078-6; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rockman HA, 1996, J MOL MED-JMM, V74, P489, DOI 10.1007/BF00204974; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Sorensen SD, 1999, J PHARMACOL EXP THER, V290, P603; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; UEKI J, 1993, J APPL PHYSIOL, V75, P559, DOI 10.1152/jappl.1993.75.2.559; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	144	151	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18953	18959		10.1074/jbc.M102376200	http://dx.doi.org/10.1074/jbc.M102376200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259422	hybrid			2022-12-27	WOS:000169091000042
J	Kammerer, RA; Jaravine, VA; Frank, S; Schulthess, T; Landwehr, R; Lustig, A; Garcia-Echeverria, C; Alexandrescu, AT; Engel, J; Steinmetz, MO				Kammerer, RA; Jaravine, VA; Frank, S; Schulthess, T; Landwehr, R; Lustig, A; Garcia-Echeverria, C; Alexandrescu, AT; Engel, J; Steinmetz, MO			An intrahelical salt bridge within the trigger site stabilizes the GCN4 leucine zipper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL FORMATION; X-RAY STRUCTURE; AMINO-ACIDS; HELIX PROPENSITY; CORTEXILLIN-I; ROD DOMAIN; PEPTIDES; PROTEINS; COMPLEX; REGION	We previously reported that a helical trigger segment within the GCN4 leucine zipper monomer is indispensable for the formation of its parallel two-stranded coiled coil. Here, we demonstrate that the intrinsic secondary structure of the trigger site is largely stabilized by an intrahelical salt bridge. Removal of this surface salt bridge by a single amino acid mutation induced only minor changes in the backbone structure of the GCN4 leucine zipper dimer as verified by nuclear magnetic resonance. The mutation, however, substantially destabilized the dimeric structure. These findings support the proposed hierarchic folding mechanism of the GCN4 coiled coil in which local helix formation within the trigger segment precedes dimerization.	Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland; Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland; Novartis Pharma AG, Funct Genom Area, CH-4002 Basel, Switzerland	University of Basel; University of Basel; Novartis; Novartis	Kammerer, RA (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.		Steinmetz, Michel O/AAA-3349-2022; Jaravine, Victor/C-6957-2008	Steinmetz, Michel O/0000-0001-6157-3687; Kammerer, Richard/0000-0003-4570-5197				Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; GARCIAECHEVERRI.C, 1994, LETT PEPT SCI, V1, P255; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; KONIG P, 1993, J MOL BIOL, V233, P139, DOI 10.1006/jmbi.1993.1490; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699; Myers JK, 1999, J MOL BIOL, V289, P205, DOI 10.1006/jmbi.1999.2747; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; SAUDEK V, 1991, PROTEIN ENG, V4, P519, DOI 10.1093/protein/4.5.519; Smith JS, 1998, BIOCHEMISTRY-US, V37, P33, DOI 10.1021/bi972026h; Sosnick TR, 1996, PROTEINS, V24, P427; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; THOMPSON KS, 1993, BIOCHEMISTRY-US, V32, P5491, DOI 10.1021/bi00072a001; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539; Yang JX, 1997, PROTEIN SCI, V6, P1264, DOI 10.1002/pro.5560060614; Yu YB, 2000, J CHROMATOGR A, V890, P81, DOI 10.1016/S0021-9673(00)00472-6; Zhu H, 2000, J MOL BIOL, V300, P1377, DOI 10.1006/jmbi.2000.3936; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	32	41	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13685	13688		10.1074/jbc.M010492200	http://dx.doi.org/10.1074/jbc.M010492200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11134036	hybrid			2022-12-27	WOS:000168356600026
J	Romberg, L; Simon, M; Erickson, HP				Romberg, L; Simon, M; Erickson, HP			Polymerization of FtsZ, a bacterial homolog of tubulin - Is assembly cooperative?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; ESCHERICHIA-COLI; GTP HYDROLYSIS; DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; SELF-ASSOCIATION; BINDING-PROTEIN; ACTIN FILAMENT; RATE CONSTANTS	FtsZ is a bacterial homolog of tubulin that is essential for prokaryotic cytokinesis. In vitro, GTP induces FtsZ to assemble into straight, 6-nm-wide polymers. Here we show that the polymerization of these FtsZ filaments most closely resembles noncooperative (or "isodesmic") assembly; the polymers are single-stranded and assemble with no evidence of a nucleation phase and without a critical concentration. We have developed a model for the isodesmic polymerization that includes GTP hydrolysis in the scheme. The model can account for the lengths of the FtsZ polymers and their maximum steady state nucleotide hydrolysis rates. It predicts that unlike microtubules, FtsZ protofilaments consist of GTP bound FtsZ subunits that hydrolyze their nucleotide only slowly and are connected by high affinity longitudinal bonds with a nanomolar K-D.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Duke University; United States Department of Energy (DOE); Brookhaven National Laboratory	Romberg, L (corresponding author), Harvard Univ, Sch Med, Inst Chem & Cellular Biol, SGM 604, Boston, MA 02115 USA.				NIGMS NIH HHS [GM28553] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028553] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS ET, 1968, BIOCHEMISTRY-US, V7, P1044, DOI 10.1021/bi00843a025; Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; BAKER TS, 1978, J MOL BIOL, V123, P89, DOI 10.1016/0022-2836(78)90378-9; Boyle DS, 1997, MOL MICROBIOL, V24, P1263, DOI 10.1046/j.1365-2958.1997.4091773.x; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; Erickson HP, 1996, J CELL BIOL, V135, P5, DOI 10.1083/jcb.135.1.5; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; FRIEDEN C, 1983, BIOCHEMISTRY-US, V22, P5836, DOI 10.1021/bi00294a023; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4559, DOI 10.1021/bi00692a001; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; HIMES RH, 1977, J BIOL CHEM, V252, P6222; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Khattar MM, 1997, J BACTERIOL, V179, P784, DOI 10.1128/jb.179.3.784-793.1997; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OBRIEN ET, 1990, BIOCHEMISTRY-US, V29, P6648, DOI 10.1021/bi00480a014; OBRIEN ET, 1987, BIOCHEMISTRY-US, V26, P4148, DOI 10.1021/bi00387a061; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Palacios P, 1996, MOL MICROBIOL, V20, P1093, DOI 10.1111/j.1365-2958.1996.tb02549.x; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; REISLER E, 1970, BIOCHEMISTRY-US, V9, P3095, DOI 10.1021/bi00817a600; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; THUSIUS D, 1975, J MOL BIOL, V92, P413, DOI 10.1016/0022-2836(75)90289-2; TOBACMAN LS, 1982, J BIOL CHEM, V257, P4166; TRINCZEK B, 1993, MOL BIOL CELL, V4, P323, DOI 10.1091/mbc.4.3.323; VANHOLDE KE, 1985, PHYSICAL BIOCH, P220; VOTER WA, 1984, J BIOL CHEM, V259, P430; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	67	178	179	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11743	11753		10.1074/jbc.M009033200	http://dx.doi.org/10.1074/jbc.M009033200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152458	hybrid			2022-12-27	WOS:000168081800044
J	van den Hurk, WH; Willems, HJJ; Bloemen, M; Martens, GJM				van den Hurk, WH; Willems, HJJ; Bloemen, M; Martens, GJM			Novel frameshift mutations near short simple repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TRANSCRIPTS; SECRETION; MUTANTS; PEPTIDE	In patients with Alzheimer's disease or Down's syndrome, the cerebellar cortex exhibits protein deposits in neurofibrillary tangles and neuritic plaques. Recently, the deposits have been shown to contain protein fragments of ubiquitin-B and amyloid precursor protein (APP) with an aberrant carboxyl terminus resulting from frameshift mutations (dinucleotide deletions; Delta GU or Delta GA) in or adjacent to GAGAG motifs in their mRNAs, a process referred to as molecular misreading. We have now used a bacterial expression system with the green fluorescent protein as a reporter to screen gene transcripts from aged controls, Alzheimer's disease, and Down's syndrome for molecular misreading. Novel frameshift mutations at a number of locations in the transcripts of the ubiquitin-B and APP genes were discovered (Delta GA, DeltaG, Delta GU, Delta GG, Delta CA, Delta AU, DeltaA, Delta AA, DeltaC, DeltaU, and insertion of an A). Interestingly, most mutations were in close proximity of short simple repeats (GAGAG, GGUGGU, GAGACACACA, UCAUCAUCA, CAAACAAA, and GAAGAAGAA), demonstrating that the GAGAG motif does not constitute the only hot spot for transcriptional errors. Unlike the previously detected aberrant APP fragments, some of the novel ones have the potential to generate the neurotoxic peptide beta -amyloid, We conclude that during aging molecular misreading is a widespread phenomenon.	Univ Nijmegen, Dept Mol Anim Physiol, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen	Martens, GJM (corresponding author), Univ Nijmegen, Dept Mol Anim Physiol, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	gmart@sci.kun.nl	Martens, Gerard JM/D-1925-2010; Bloemen, Marjon/W-9393-2018					BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; EVANS DAP, 1994, P NATL ACAD SCI USA, V91, P6059, DOI 10.1073/pnas.91.13.6059; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HAASS C, 1993, J BIOL CHEM, V268, P3021; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hol EM, 1998, PROG BRAIN RES, V117, P379; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Leeuwen FW, 1998, TRENDS NEUROSCI, V21, P331, DOI 10.1016/S0166-2236(98)01280-6; VANDENHURK WH, 1999, TEC BEHAV N, V13, P863	16	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11496	11498		10.1074/jbc.M011040200	http://dx.doi.org/10.1074/jbc.M011040200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11139590	hybrid, Green Published			2022-12-27	WOS:000168081800011
J	Koroll, M; Rathjen, FG; Volkmer, H				Koroll, M; Rathjen, FG; Volkmer, H			The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-BINDING-ACTIVITY; ADHESION MOLECULE; PDZ DOMAINS; L1 FAMILY; NERVOUS-SYSTEM; AXONAL SURFACE; PROTEIN; TYROSINE; SITE; F11	Neurofascin belongs to the L1 subgroup of the immunoglobulin superfamily of cell adhesion molecules and is implicated in axonal growth and fasciculation, We used yeast two-hybrid screening to identify proteins that interact with neurofascin intracellularly and therefore might link it to trafficking, spatial targeting, or signaling pathways, Here, we demonstrate that rat syntenin-1, previously published as syntenin, mda-9, or TACIP18 in human, is a neurofascin-binding protein that exhibits a wide-spread tissue expression pattern with a relative maximum in brain. Syntenin-1 was found not to interact with other vertebrate members of the L1 subgroup such as L1 itself or NrCAM, We confirmed the specificity of the neurofascin-syntenin-1 interaction by ligand-overlay assay, surface plasmon resonance analysis, and colocalization of both proteins in heterologous cells. The COOH terminus of neurofascin was mapped to interact with the second PDZ domain of syntenin-1. Furthermore, we isolated syntenin-2 that may be expressed in two isoforms, Despite their high sequence similarity to syntenin-1, syntenin-2 alpha, which interacts with neurexin I, and syntenin-2 beta do not bind to neurofascin or several other transmembrane proteins that are binding partners of syntenin-1, Finally, we report that syntenin-1 and -2 both form homodimers and can interact with each other.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rathjen, FG (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	Rathjen@mdc-berlin.de	Volkmer, Hansjuergen/AAU-9641-2021	Volkmer, Hansjuergen/0000-0002-3867-0603				Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dubreuil RR, 1996, J CELL BIOL, V133, P647, DOI 10.1083/jcb.133.3.647; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Jefford G, 2000, J BIOL CHEM, V275, P27726; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Lambert S, 1997, J NEUROSCI, V17, P7025; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Malhotra JD, 1998, J BIOL CHEM, V273, P33354, DOI 10.1074/jbc.273.50.33354; Moulding HD, 2000, J NEUROSCI, V20, P5696, DOI 10.1523/JNEUROSCI.20-15-05696.2000; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Ren Q, 1998, J NEUROCHEM, V70, P1839; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785	46	99	106	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10646	10654		10.1074/jbc.M010647200	http://dx.doi.org/10.1074/jbc.M010647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152476	hybrid			2022-12-27	WOS:000167980900013
J	Li, RA; Ennis, IL; French, RJ; Dudley, SC; Tomaselli, GF; Marban, E				Li, RA; Ennis, IL; French, RJ; Dudley, SC; Tomaselli, GF; Marban, E			Clockwise domain arrangement of the sodium channel revealed by mu-conotoxin (GIIIA) docking orientation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE MUTAGENESIS; NA+ CHANNEL; BINDING-SITE; CONUS-GEOGRAPHUS; RAT SKELETAL; MUSCLE; PORE; RESIDUES; PEPTIDE; MUTANT	mu -Conotoxins (mu -CTXs) specifically inhibit Na+ flux by occluding the pore of voltage-gated Na+ channels. Although the three-dimensional structures of mu -CTXs are well defined, the molecular configuration of the channel receptor is much less certain; even the fundamental question of whether the four homologous Nat channel domains are arranged in a clockwise or counter-clockwise configuration remains unanswered. Residues Asp(762) and Glu(765) from domain II and Asp(1241) from domain III of rat skeletal muscle Naf channels are known to be critical for Ec-CTX binding. We probed toxin-channel interactions by determining the potency of block of wild-type, D762K, E765K, and D1241C channels by wildtype and point-mutated mu -CTXs (R1A, Q14D, K11A, K16A, and R19A). Individual interaction energies for different toxin-channel pairs were quantified from the half-blocking concentrations using mutant cycle analysis. We find that Asp(762) and Glu(765) interact strongly with Gln(14) and Arg(19) but not Arg(1) and that Asp(1241) is tightly coupled to Lys(16) but not Arg(1) or Lys(11). These newly identified toxin-channel interactions within adjacent domains, interpreted in light of the known asymmetric toxin structure, fix the orientation of the toxin with respect to the channel and reveal that the four internal domains of Na+ channels age arranged in a clockwise configuration as viewed from the extracellular surface.	Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Emory Univ, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Johns Hopkins University; University of Calgary; Emory University; Emory University	Marban, E (corresponding author), Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, 720 Rutland Ave,Ross 844, Baltimore, MD 21205 USA.		Marban, Eduardo/GWC-8514-2022; Li, Ronald/E-9833-2010; Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021	Dudley, Samuel/0000-0001-5843-5961; Ennis, Irene/0000-0003-3510-7302	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052768, R01HL064828, R01HL050411] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL-52768, R01 HL-50411, HL-64828] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; CHAHINE M, 1995, RECEPTOR CHANNEL, V3, P164; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; CHEN LQ, 1992, FEBS LETT, V309, P253, DOI 10.1016/0014-5793(92)80783-D; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; French R J, 1999, Methods Enzymol, V294, P575; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665, DOI 10.1146/annurev.bi.57.070188.003313; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN SH, 1992, PFLUG ARCH EUR J PHY, V422, P90, DOI 10.1007/BF00381519; HIDAKA Y, 1990, FEBS LETT, V264, P29, DOI 10.1016/0014-5793(90)80756-9; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Li RA, 1997, BIOPHYS J, V73, P1874, DOI 10.1016/S0006-3495(97)78218-3; Li RA, 2000, J GEN PHYSIOL, V115, P81, DOI 10.1085/jgp.115.1.81; Li RK, 2000, J BIOL CHEM, V275, P27551; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; NAKAMURA H, 1983, EXPERIENTIA, V39, P590, DOI 10.1007/BF01971110; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SATO K, 1991, J BIOL CHEM, V266, P16989; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Yamagishi T, 1997, BIOPHYS J, V73, P195, DOI 10.1016/S0006-3495(97)78060-3; YANAGAWA Y, 1986, NEUROSCI LETT, V64, P7, DOI 10.1016/0304-3940(86)90654-3	40	84	88	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11072	11077		10.1074/jbc.M010862200	http://dx.doi.org/10.1074/jbc.M010862200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154701	hybrid			2022-12-27	WOS:000167980900068
J	Anderson, JAM; Fredenburgh, JC; Stafford, AR; Guo, YS; Hirsh, J; Ghazarossian, V; Weitz, JI				Anderson, JAM; Fredenburgh, JC; Stafford, AR; Guo, YS; Hirsh, J; Ghazarossian, V; Weitz, JI			Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN; TISSUE FACTOR PATHWAY; COAGULATION-FACTOR XA; FACTOR VA BINDING; HUMAN FACTOR-IX; ACTIVE-SITE; FACTOR-VIIIA; CATALYTIC ACTIVITY; SUBSTRATE RECOGNITION; SELECTIVE-INHIBITION	In buffer systems, heparin and low molecular weight heparin (LMWH) directly inhibit the intrinsic factor X-activating complex (intrinsic tenase) but have no effect on the prothrombin-activating complex (prothrombinase). Although chemical modification of LMWH, to lower its affinity for antithrombin (LA-LMWH) has no effect on its ability to inhibit intrinsic tenase, N-desulfation of LMWH reduces its activity IS-fold, To further explore the role of sulfation, hypersulfated LA-LMWH was synthesized (sLA-LMWH), sLA-LMWH is not only a 32-fold more potent inhibitor of intrinsic tenase than LA-LMWH; it also acquires prothrombinase inhibitory activity, A direct correlation between the extent of sulfation of LA-LMWH and its inhibitory activity against intrinsic tenase and prothrombinase is observed. In plasma-based assays of tenase and prothrombinase, sLA-LMWH produces similar prolongation of clotting times in plasma depleted of antithrombin and/or heparin cofactor II as it does in control plasma. In contrast, heparin has no effect in antithrombin-depleted plasma. When the effect of sLA-LMWH on various components of tenase and prothrombinase was examined, its inhibitory activity was found to be cofactor-dependent (factors Va and VIIIa) and phospholipid-independent. These studies reveal that sLA-LMWH acts as a potent antithrombin-independent inhibitor of coagulation by attenuating intrinsic tenase and prothrombinase.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada; Vasc Therapeut Inc, Mt View, CA 94040 USA	McMaster University; McMaster University	Weitz, JI (corresponding author), Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada.		Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BAJAJ SP, 1993, METHOD ENZYMOL, V222, P96; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BARROW RT, 1994, J BIOL CHEM, V269, P26796; BARROW RT, 1994, J BIOL CHEM, V269, P593; BENEDICT CR, 1991, J CLIN INVEST, V88, P1760, DOI 10.1172/JCI115495; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; BROZE GJ, 1987, P NATL ACAD SCI USA, V84, P1886, DOI 10.1073/pnas.84.7.1886; CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152; Chang JL, 1998, J BIOL CHEM, V273, P12089, DOI 10.1074/jbc.273.20.12089; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 1999, J BIOL CHEM, V274, P15401, DOI 10.1074/jbc.274.22.15401; Feuerstein GZ, 1999, ARTERIOSCL THROM VAS, V19, P2554, DOI 10.1161/01.ATV.19.10.2554; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GROOTENHUIS PDJ, 1995, NAT STRUCT BIOL, V2, P736, DOI 10.1038/nsb0995-736; HASHIMOTO N, 1985, J BIOCHEM, V97, P1347, DOI 10.1093/oxfordjournals.jbchem.a135187; HIRSH J, 1992, BLOOD, V79, P1; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; JORDAN RE, 1980, J BIOL CHEM, V255, P73; Kolkman JA, 2000, BIOCHEMISTRY-US, V39, P7398, DOI 10.1021/bi992735q; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0; Mao SS, 1998, J BIOL CHEM, V273, P30086, DOI 10.1074/jbc.273.46.30086; Marder VJ., 1994, HEMOSTASIS THROMBOSI, P837; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2; NAGASE H, 1995, BLOOD, V85, P1527, DOI 10.1182/blood.V85.6.1527.bloodjournal8561527; Nagase H, 1997, THROMB HAEMOSTASIS, V77, P399; Nagase H, 1997, THROMB HAEMOSTASIS, V78, P864; NESHEIM ME, 1984, SURV SYN PATHOL RES, V3, P219; OLSON ST, 1991, J BIOL CHEM, V266, P6342; PEPPER DS, 1977, THROMB RES, V11, P687, DOI 10.1016/0049-3848(77)90026-3; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rudolph AE, 2000, BIOCHEMISTRY-US, V39, P2861, DOI 10.1021/bi992379b; SCHOEN P, 1990, THROMB RES, V57, P415, DOI 10.1016/0049-3848(90)90257-D; Sheehan JP, 1998, BLOOD, V92, P1617, DOI 10.1182/blood.V92.5.1617.417k13_1617_1625; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Taniuchi Y, 1998, THROMB HAEMOSTASIS, V79, P543; TUSZYNSKI GP, 1987, J BIOL CHEM, V262, P9718; VLASUK GP, 1993, THROMB HAEMOSTASIS, V70, P212; Weitz JI, 1999, CIRCULATION, V99, P682, DOI 10.1161/01.CIR.99.5.682; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Wong AG, 1997, THROMB HAEMOSTASIS, V77, P1143	57	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9755	9761		10.1074/jbc.M010048200	http://dx.doi.org/10.1074/jbc.M010048200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134031	hybrid			2022-12-27	WOS:000167996400025
J	Jensen, AA; Sheppard, PO; Jensen, LB; O'Hara, PJ; Brauner-Osborne, H				Jensen, AA; Sheppard, PO; Jensen, LB; O'Hara, PJ; Brauner-Osborne, H			Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1 - Noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; METAL-ION SITES; EXTRACELLULAR DOMAIN; LIGAND-BINDING; AGONIST-BINDING; MOLECULAR-CLONING; CA2+ RECEPTOR; EXPRESSION; SUBTYPE; REGION	The metabotropic glutamate receptors (mGluRs) belong to family C of the G-protein-coupled receptor (GPCR) superfamily. The receptors are characterized by having unusually long amino-terminal domains (ATDs), to which agonist binding has been shown to take place. Previously, we have constructed a molecular model of the ATD of mGluR1 based on a weak amino acid sequence similarity with a bacterial periplasmic binding protein. The ATD consists of two globular lobes, which are speculated to contract from an "open" to a "closed" conformation following agonist binding. In the present study, we have created a Zn2+ binding site in mGluR1b by mutating the residue Lys(260) to a histidine, Zinc acts as a noncompetitive antagonist of agonist-induced IP accumulation on the K260H mutant with an IC50 value of 2 muM, Alanine mutations of three potential "zinc coligands" in proximity to the introduced histidine in K260H knock out the ability of Zn2+ to antagonize the agonist-induced response. Zn2+ binding to K260H does not appear to affect the dimerization of the receptor, Instead, we propose that binding of zinc has introduced a structural constraint in the ATD lobe, preventing the formation of a "closed" conformation, and thus stabilizing a more or less inactive "open" form of the ATD, This study presents the first metal ion site constructed in a family C GPCR, Furthermore, it is the first time a metal ion site has been created in a region outside of the seven transmembrane regions of a GPCR and the loops connecting these. The findings offer valuable insight into the mechanism of ATD closure and family C receptor activation. Furthermore, the findings demonstrate that ATD regions other than those participating in agonist binding could be potential targets for new generations of ligands for this family of receptors.	Royal Danish Sch Pharm, Dept Med Chem, NeuroSci PharmaBiotec Res Ctr, DK-2100 Copenhagen, Denmark; Royal Danish Sch Pharm, Dept Pharmacol, NeuroSci PharmaBiotec Res Ctr, DK-2100 Copenhagen, Denmark; ZymoGenet Inc, Seattle, WA 98102 USA	Royal Danish School of Pharmacy; Royal Danish School of Pharmacy; Zymogenet Inc.	Brauner-Osborne, H (corresponding author), Royal Danish Sch Pharm, Dept Med Chem, NeuroSci PharmaBiotec Res Ctr, 2 Univ Pk, DK-2100 Copenhagen, Denmark.	hbo@dfh.dk	Bräuner-Osborne, Hans/D-7260-2011; Jensen, Anders/AAJ-3335-2020	Bräuner-Osborne, Hans/0000-0001-9495-7388; Jensen, Anders/0000-0002-7927-5052				Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Annoura H, 1996, BIOORG MED CHEM LETT, V6, P763, DOI 10.1016/0960-894X(96)00104-7; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brauner-Osborne H, 1999, NEUROREPORT, V10, P3923; Brown EM, 1999, AM J MED, V106, P238, DOI 10.1016/S0002-9343(98)00418-5; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P57, DOI 10.1093/protein/4.1.57; Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; Doherty AJ, 1999, BIOCHEM J, V341, P415, DOI 10.1042/0264-6021:3410415; Elling CE, 1997, ANN NY ACAD SCI, V814, P142, DOI 10.1111/j.1749-6632.1997.tb46152.x; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; Elling CE, 1997, FOLD DES, V2, pS76, DOI 10.1016/S1359-0278(97)00068-0; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; IPPOLITO JA, 1994, BIOCHEMISTRY-US, V33, P15241, DOI 10.1021/bi00255a004; Jensen AA, 2000, EUR J PHARMACOL, V397, P247, DOI 10.1016/S0014-2999(00)00283-1; Jensen AA, 2000, J BIOL CHEM, V275, P29547, DOI 10.1074/jbc.M910023199; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; Kolczewski S, 1999, BIOORG MED CHEM LETT, V9, P2173, DOI 10.1016/S0960-894X(99)00346-7; Lesburg CA, 1997, BIOCHEMISTRY-US, V36, P15780, DOI 10.1021/bi971296x; Litschig S, 1999, MOL PHARMACOL, V55, P453; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lu ZL, 2000, J BIOL CHEM, V275, P5682, DOI 10.1074/jbc.275.8.5682; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; MCGRATH ME, 1993, BIOCHEMISTRY-US, V32, P1914, DOI 10.1021/bi00059a005; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pin JP, 1999, EUR J PHARMACOL, V375, P277, DOI 10.1016/S0014-2999(99)00258-7; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Ray K, 2000, J BIOL CHEM, V275, P34245, DOI 10.1074/jbc.M005581200; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; REGAN L, 1993, ANNU REV BIOPH BIOM, V22, P257, DOI 10.1146/annurev.bb.22.060193.001353; REGAN L, 1995, TRENDS BIOCHEM SCI, V20, P280, DOI 10.1016/S0968-0004(00)89044-1; REID SNM, 1995, J COMP NEUROL, V355, P470, DOI 10.1002/cne.903550311; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Romano C, 1999, NEUROPHARMACOLOGY, V38, pA37; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; Tones MA, 1995, NEUROREPORT, V7, P117, DOI 10.1097/00001756-199512290-00028; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Varney MA, 1999, J PHARMACOL EXP THER, V290, P170; Wichmann J, 1999, BIOORG MED CHEM LETT, V9, P1573, DOI 10.1016/S0960-894X(99)00227-9	61	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10110	10118		10.1074/jbc.M007220200	http://dx.doi.org/10.1074/jbc.M007220200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133983	hybrid			2022-12-27	WOS:000167996400071
J	Korolkova, YV; Kozlov, SA; Lipkin, AV; Pluzhnikov, KA; Hadley, JK; Filippov, AK; Brown, DA; Angelo, K; Strobaek, D; Jespersen, T; Olesen, SP; Jensen, BS; Grishin, EV				Korolkova, YV; Kozlov, SA; Lipkin, AV; Pluzhnikov, KA; Hadley, JK; Filippov, AK; Brown, DA; Angelo, K; Strobaek, D; Jespersen, T; Olesen, SP; Jensen, BS; Grishin, EV			An ERG channel inhibitor from the scorpion Buthus eupeus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+-CHANNEL; 3-DIMENSIONAL STRUCTURE; POTASSIUM CHANNELS; FUNCTIONAL EXPRESSION; CHARYBDOTOXIN; TOXIN; PEPTIDE; PURIFICATION; RECEPTOR; BLOCKER	The isolation of the peptide inhibitor of M-type K+ current, BeKm-1, from the venom of the Central Asian scorpion Buthus eupeus has been described previously (Fillipov A. K,, Kozlov, S, A, Pluzhnikov, K. A., Grishin, E. V., and Brown, D, A (1996) FEBS Lett, 384, 277-280). Here we report the cloning, expression, and selectivity of BeKm-1. A full-length cDNA of 365 nucleotides encoding the precursor of BeKm-1 was isolated using the rapid amplification of cDNA ends polymerase chain reaction technique from mRNA obtained from scorpion telsons, Sequence analysis of the cDNA revealed that the precursor contains a signal peptide of 21 amino acid residues. The mature toxin consists of 36 amino acid residues. BeKm-1 belongs to the family of scorpion venom potassium channel blockers and represents a new subgroup of these toxins. The recombinant BeKm-1 was produced as a Protein A fusion product in the periplasm of Escherichia coli. After cleavage and high performance liquid chromatography purification, recombinant BeKm-1 displayed the same properties as the native toxin, Three BeKm-1 mutants (R27K, F32K, and R27K/F32K) were generated, purified, and characterized. Recombinant wild-type BeKm-1 and the three mutants partly inhibited the native M-like current in NG108-15 at 100 nM. The effect of the recombinant BeKm-1 on different K+ channels was also studied. BeKm-1 inhibited hERG1 channels with an IC50 of 3.3 nM, but had no effect at 100 nM on hEAG, hSK1, rSK2, hIK, hBK, KCNQ1/KCNE1, KCNQ2/KCNQ3, KCNQ4 channels, and minimal effect on rELK1. Thus, BeKm-1 was shown to be a novel specific blocker of hERG1 potassium channels.	Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark; NeuroSearch AS, DK-2750 Ballerup, Denmark	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of London; University College London; University of Copenhagen	Korolkova, YV (corresponding author), Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10,GSP-7, Moscow 117997, Russia.	july@ibch.ru	Jespersen, Thomas/G-4860-2011; Olesen, Søren-Peter/B-9621-2012; Kozlov, Sergey A/D-1548-2012; Olesen, Søren P/H-4206-2011; Lipkin, Alexey V/F-9028-2014; Brown, David A/J-9019-2012	Jespersen, Thomas/0000-0001-6575-360X; Kozlov, Sergey A/0000-0002-0242-4240; Olesen, Søren P/0000-0002-4381-5192; Lipkin, Alexey V/0000-0001-7624-8529; 				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; BouhaoualaZahar B, 1996, EUR J BIOCHEM, V238, P653, DOI 10.1111/j.1432-1033.1996.0653w.x; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Christie MJ, 1995, CLIN EXP PHARMACOL P, V22, P944, DOI 10.1111/j.1440-1681.1995.tb02331.x; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; FERNANDEZ I, 1994, BIOCHEMISTRY-US, V33, P14256, DOI 10.1021/bi00251a038; Filippov AK, 1996, FEBS LETT, V384, P277, DOI 10.1016/0014-5793(96)00333-X; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; HARVEY AL, 1995, TOXICON, V33, P425, DOI 10.1016/0041-0101(94)00181-7; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8151, DOI 10.1021/bi00150a006; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; KAWASAKI I, 1972, ANAL BIOCHEM, V48, P546, DOI 10.1016/0003-2697(72)90110-8; Kharrat R, 1996, EUR J BIOCHEM, V242, P491, DOI 10.1111/j.1432-1033.1996.0491r.x; KIYATKIN N, 1993, EUR J BIOCHEM, V213, P121, DOI 10.1111/j.1432-1033.1993.tb17741.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legros C, 1997, FEBS LETT, V417, P123, DOI 10.1016/S0014-5793(97)01177-0; Legros C, 1996, FEBS LETT, V390, P81, DOI 10.1016/0014-5793(96)00616-3; Legros C, 1997, FEBS LETT, V402, P45, DOI 10.1016/S0014-5793(96)01492-5; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; Meves H, 1999, BRIT J PHARMACOL, V127, P1213, DOI 10.1038/sj.bjp.0702642; MIHAILOVA AG, 1999, FEBS LETT, V442, P226; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; Olamendi-Portugal T, 1998, TOXICON, V36, P759, DOI 10.1016/S0041-0101(97)00163-3; OlamendiPortugal T, 1996, BIOCHEM J, V315, P977, DOI 10.1042/bj3150977; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; Rowan EG, 1996, BRAZ J MED BIOL RES, V29, P1765; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selyanko AA, 1999, J NEUROSCI, V19, P7742; SMITH C, 1986, J BIOL CHEM, V261, P4607; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stansfeld C, 1997, TRENDS NEUROSCI, V20, P13, DOI 10.1016/S0166-2236(96)20058-X; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890	57	81	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9868	9876		10.1074/jbc.M005973200	http://dx.doi.org/10.1074/jbc.M005973200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136720	hybrid			2022-12-27	WOS:000167996400040
J	Till, JH; Ablooglu, AJ; Frankel, M; Bishop, SM; Kohanski, RA; Hubbard, SR				Till, JH; Ablooglu, AJ; Frankel, M; Bishop, SM; Kohanski, RA; Hubbard, SR			Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase - Insights into kinase mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; DOMAIN; AUTOPHOSPHORYLATION; SRC; PHOSPHORYLATION; INHIBITOR; COMPLEX; FAMILY	The tyrosine kinase domain of the insulin receptor is subject to autoinhibition in the unphosphorylated basal state via steric interactions involving the activation loop. A mutation in the activation loop designed to relieve autoinhibition, Asp-1161 --> Ala, substantially increases the ability of the unphosphorylated kinase to bind ATP. The crystal structure of this mutant in complex with an ATP analog has been determined at 2.4-Angstrom resolution. The structure shows that the active site is unobstructed, but the end of the activation loop is disordered and therefore the binding site for peptide substrates is not fully formed. In addition, Phe-1151 of the protein kinase-conserved DFG motif, at the beginning of the activation loop, hinders closure of the catalytic cleft and proper positioning of alpha -helix C for catalysis, These results, together with viscometric kinetic measurements, suggest that peptide substrate binding induces a reconfiguration of the unphosphorylated activation loop prior to the catalytic step. The crystallographic and solution studies provide new insights into the mechanism by which the activation loop controls phosphoryl transfer as catalyzed by the insulin receptor.	CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York University; New York University	Kohanski, RA (corresponding author), CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA.			Hubbard, Stevan/0000-0002-2707-9383	NIDDK NIH HHS [DK52916, DK50074] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050074, R01DK052916] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Bishop SM, 1999, BIOCHEMISTRY-US, V38, P3079, DOI 10.1021/bi982546s; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann AD, 1997, BIOCHEMISTRY-US, V36, P7681, DOI 10.1021/bi970170x; CHLEBOWSKI JF, 1974, J BIOL CHEM, V249, P7192; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Frankel M, 1999, PROTEIN SCI, V8, P2158, DOI 10.1110/ps.8.10.2158; Grace MR, 1997, BIOCHEMISTRY-US, V36, P1874, DOI 10.1021/bi962138t; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHANSKI RA, 1993, BIOCHEMISTRY-US, V32, P5773, DOI 10.1021/bi00073a008; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; STAUBS PA, 1994, J BIOL CHEM, V269, P27186; TAVARE JM, 1988, BIOCHEM J, V253, P783, DOI 10.1042/bj2530783; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P1533, DOI 10.1021/bi952435i; WEI L, 1995, J BIOL CHEM, V270, P8122, DOI 10.1074/jbc.270.14.8122; White MF, 1998, CURR TOP MICROBIOL, V228, P179; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	40	54	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10049	10055		10.1074/jbc.M010161200	http://dx.doi.org/10.1074/jbc.M010161200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124964	hybrid			2022-12-27	WOS:000167996400064
J	Kenny, MK; Mendez, F; Sandigursky, M; Kureekattil, RP; Goldman, JD; Franklin, WA; Bases, R				Kenny, MK; Mendez, F; Sandigursky, M; Kureekattil, RP; Goldman, JD; Franklin, WA; Bases, R			Heat shock protein 70 binds to human apurinic/apyrimidinic endonuclease and stimulates endonuclease activity at abasic sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC ENDONUCLEASE; NUCLEOTIDE EXCISION-REPAIR; NITRIC-OXIDE; RESISTANCE; CELLS; SUBSTRATE	The interaction of human heat shock protein 70 (HSP70) with human apurinic/apyrimidinic endonuclease (HAP1) was demonstrated by coimmunoprecipitation. A combination of HSP70 and HAP1 also caused a shift in the electrophoretic mobility of a DNA fragment containing an apurinic/apyrimidinic site. The functional consequence of the HSP70/HAP1 interaction was a 10-100-fold enhancement of endonuclease activity at abasic sites. The physical and functional interaction between HSP70 and HAP1 did not require the addition of ATP. The association of HSP70 and a key base excision repair enzyme suggests a role for heat shock proteins in promoting base excision repair. These findings provide a possible mechanism by which HSP70 protects cells against oxidative stress.	Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bases, R (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, 111 E 210 St, Bronx, NY 10467 USA.				NCI NIH HHS [P30 CA 13330, CA 71612, CA 52025] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052025, P30CA013330, R29CA052025, R29CA071612] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLMANN K, 1995, J CLIN INVEST, V95, P2840, DOI 10.1172/JCI117989; Burkart V, 2000, J BIOL CHEM, V275, P19521, DOI 10.1074/jbc.M002265200; Chow KC, 2000, FEBS LETT, V478, P133, DOI 10.1016/S0014-5793(00)01822-6; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; FEIGE U, 1994, EXPERIENTIA, V50, P979, DOI 10.1007/BF01923452; Fujihara SM, 1999, EMBO J, V18, P411, DOI 10.1093/emboj/18.2.411; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GUNTHER E, 1994, EXPERIENTIA, V50, P981; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mendez F, 2000, RADIAT RES, V153, P186, DOI 10.1667/0033-7587(2000)153[0186:HSPAWB]2.0.CO;2; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Zou Y, 1998, J BIOL CHEM, V273, P12887, DOI 10.1074/jbc.273.21.12887	13	54	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9532	9536		10.1074/jbc.M009297200	http://dx.doi.org/10.1074/jbc.M009297200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11133992	hybrid			2022-12-27	WOS:000167607700120
J	Potter, LR; Hunter, T				Potter, LR; Hunter, T			Guanylyl cyclase-linked natriuretic peptide receptors: Structure and regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; STIMULATED CGMP ACCUMULATION; FACTOR-R1 RECEPTOR; EXTRACELLULAR DOMAIN; ANP RECEPTOR; BINDING; ACTIVATION; MECHANISM; PHOSPHORYLATION; GLYCOSYLATION		Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 356, St Paul, MN 55108 USA; Salk Inst Biol Studies, Mol Biol & Virol Lab, San Diego, CA 92186 USA	University of Minnesota System; University of Minnesota Twin Cities; Salk Institute	Potter, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 356, 1479 Gortner Ave, St Paul, MN 55108 USA.	Potter@tc.umn.edu			NATIONAL CANCER INSTITUTE [F32CA067452] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA067452] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Chrisman TD, 1999, J BIOL CHEM, V274, P4293, DOI 10.1074/jbc.274.7.4293; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DELEAN A, 1986, LIFE SCI, V39, P1109, DOI 10.1016/0024-3205(86)90203-1; DUDA T, 1990, MOL CELL BIOCHEM, V93, P179; Fenrick R, 1997, MOL CELL BIOCHEM, V173, P25, DOI 10.1023/A:1006855522272; Fenrick R, 1996, MOL CELL BIOCHEM, V165, P103, DOI 10.1007/BF00229471; Foster DC, 1998, J BIOL CHEM, V273, P16311, DOI 10.1074/jbc.273.26.16311; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; GORACZNIAK RM, 1992, BIOCHEM J, V282, P533, DOI 10.1042/bj2820533; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; HENRY JP, 1956, CIRC RES, V4, P85, DOI 10.1161/01.RES.4.1.85; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; JAISWAL RK, 1992, BIOCHEM BIOPH RES CO, V182, P395, DOI 10.1016/S0006-291X(05)80158-5; JEWETT JRS, 1993, EMBO J, V12, P769, DOI 10.1002/j.1460-2075.1993.tb05711.x; KAWABE J, 1992, BIOCHIM BIOPHYS ACTA, V1175, P81, DOI 10.1016/0167-4889(92)90012-Z; KISCH B, 1956, Exp Med Surg, V14, P99; Kitano K, 1996, J IMMUNOL METHODS, V194, P147, DOI 10.1016/0022-1759(96)00075-0; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KUNO T, 1986, J BIOL CHEM, V261, P5817; KUROSE H, 1987, FEBS LETT, V219, P375, DOI 10.1016/0014-5793(87)80256-9; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; LAROSE L, 1991, BIOCHEMISTRY-US, V30, P8990, DOI 10.1021/bi00101a012; Levin ER, 1998, NEW ENGL J MED, V339, P321; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1992, J BIOL CHEM, V267, P21691; Lucas KA, 2000, PHARMACOL REV, V52, P375; MAACK T, 1992, ANNU REV PHYSIOL, V54, P11, DOI 10.1146/annurev.physiol.54.1.11; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; MELOCHE S, 1988, BIOCHEMISTRY-US, V27, P8151, DOI 10.1021/bi00421a025; Misono KS, 2000, CIRC RES, V86, P1135; Misono KS, 1999, BIOCHEMISTRY-US, V38, P516, DOI 10.1021/bi982127v; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Miyagi M, 2000, BBA-PROTEIN STRUCT M, V1478, P30, DOI 10.1016/S0167-4838(00)00002-9; NAMBI P, 1986, P NATL ACAD SCI USA, V83, P8492, DOI 10.1073/pnas.83.22.8492; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; SCHIFFRIN EL, 1991, AM J PHYSIOL, V260, pH58, DOI 10.1152/ajpheart.1991.260.1.H58; SMITH JB, 1987, AM J PHYSIOL, V253, pC147, DOI 10.1152/ajpcell.1987.253.1.C147; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Wong SKF, 1995, J BIOL CHEM, V270, P30818, DOI 10.1074/jbc.270.51.30818; YASUNARI K, 1992, HYPERTENSION, V19, P314, DOI 10.1161/01.HYP.19.4.314	59	160	167	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6057	6060		10.1074/jbc.R000033200	http://dx.doi.org/10.1074/jbc.R000033200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11152699	hybrid			2022-12-27	WOS:000167261000001
J	Skeel, A; Leonard, EJ				Skeel, A; Leonard, EJ			alpha(1)-antichymotrypsin is the human plasma inhibitor of macrophage ectoenzymes that cleave pro-macrophage stimulating protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HUMAN CATHEPSIN-G; TYROSINE KINASE; PROTEOLYTIC CLEAVAGE; GENE-PRODUCT; RECEPTOR; ACTIVATION; EXPRESSION; ALPHA-1-ANTICHYMOTRYPSIN; IDENTIFICATION	Macrophage stimulating protein (MSP) is secreted as 78-kDa single chain pro-MSP, which is converted to biologically active, disulfide-linked alpha beta chain MSP by cleavage at Arg(483)-Val(484) Murine resident peritoneal macrophages have two cell surface proteolytic activities that cleave pro-MSP. One is a pro-MSP convertase, which cleaves pro-MSP to active MSP; the other degrades pro-MSP, The degrading protease is inhibited by soybean trypsin inhibitor or by low concentrations of blood plasma, which allows the convertase to cleave pro-MSP to MSP. Using pro-MSP cleavage as the assay, we purified the inhibitor from human plasma. The bulk of the plasma protein was removed by salting out and by isoelectric precipitation of albumin. Highly purified inhibitor was then obtained in three steps: dye-ligand binding and elution, ion exchange chromatography, and high performance liquid chromatography gel filtration. After SDS-polyacrylamide gel electrophoresis and transfer to a polyvinylidene membrane, N-terminal sequencing of the product identified it as alpha (1)-antichymotrypsin, The mean concentration of alpha (1)-antichymotrypsin in human plasma is 7 muM. At this concentration, alpha (1)-antichymotrypsin inhibits both macrophage enzymes. A concentration of 0.4 muM, which is in the expected concentration range in extracellular fluid, preferentially inhibits the degrading enzyme, which allows for cleavage to active MSP by the pro-MSP convertase.	NCI, Immunopathol Sect, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Leonard, EJ (corresponding author), NCI, Immunopathol Sect, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA.	leonarde@mail.ncifcrf.gov						AVRIL LE, 1994, FEBS LETT, V345, P81, DOI 10.1016/0014-5793(94)00410-2; BERNINGER RW, 1985, J MED, V16, P101; BOSTERLING B, 1981, BIOCHIM BIOPHYS ACTA, V657, P58, DOI 10.1016/0005-2744(81)90130-3; CORRELL PH, 1997, GENES FUNCTION, V1, P1; Danilkovitch A, 1999, J LEUKOCYTE BIOL, V65, P345, DOI 10.1002/jlb.65.3.345; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; FRANCIS CW, 1990, HEMATOLOGY, P1313; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; IWAMA A, 1995, BLOOD, V86, P3394, DOI 10.1182/blood.V86.9.3394.bloodjournal8693394; LEONARD EJ, 1976, EXP CELL RES, V102, P434, DOI 10.1016/0014-4827(76)90065-3; Leonard EJ, 1997, CIBA F SYMP, V212, P183; LEONARD EJ, 1999, ADV CANCER RES, P139; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nanney LB, 1998, J INVEST DERMATOL, V111, P573, DOI 10.1046/j.1523-1747.1998.00332.x; PARK CH, 1986, BIOCHEMISTRY-US, V25, P3977, DOI 10.1021/bi00362a001; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; RONSIN C, 1993, ONCOGENE, V8, P1195; SKEEL A, 1991, J EXP MED, V173, P1227, DOI 10.1084/jem.173.5.1227; SOTTRUPJENSEN L, 1975, P NATL ACAD SCI USA, V72, P2577, DOI 10.1073/pnas.72.7.2577; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; TRAVIS J, 1978, BIOCHEMISTRY-US, V17, P5647, DOI 10.1021/bi00619a010; WANG MH, 1994, J BIOL CHEM, V269, P14027; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WANG MH, 1993, J LEUKOCYTE BIOL, V54, P289, DOI 10.1002/jlb.54.4.289; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; WANG MH, 1994, J BIOL CHEM, V269, P3436; WUN TC, 1982, J BIOL CHEM, V257, P7262; Yoshikawa W, 1999, ARCH BIOCHEM BIOPHYS, V363, P356, DOI 10.1006/abbi.1998.1090; YOSHIMURA T, 1993, J BIOL CHEM, V268, P15461	30	10	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21932	21937		10.1074/jbc.M100652200	http://dx.doi.org/10.1074/jbc.M100652200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274154	hybrid			2022-12-27	WOS:000169297900147
J	Yan, C; Naltner, A; Conkright, J; Ghaffari, M				Yan, C; Naltner, A; Conkright, J; Ghaffari, M			Protein-protein interaction of retinoic acid receptor alpha and thyroid transcription factor-1 in respiratory epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B GENE; ACTIVATION; LUNG; COACTIVATOR; EXPRESSION; PROMOTER; BINDING; ORGANOGENESIS; STIMULATION; TIF2	Surfactant protein B (SP-B) is a 79-amino acid peptide critical to postnatal respiratory adaptation and is developmentally regulated. Previous studies demonstrated that retinoic acid receptors (RARs) and thyroid transcription factor 1 (TTF-1) stimulated SP-B gene expression in respiratory epithelial cells. Clustered retinoic acid-responsive element and TTF-1 binding sites were identified in the enhancer region of the SP-B gene and were required for retinoic acid stimulation of the human SP-B (hSP-B) promoter. In addition, RAR and TTF-1 were colocalized in mouse bronchiolar and alveolar type II epithelial cells, the cellular site of SP-B synthesis. In the present studies, RAR and TTF-1 were colocalized in the nucleus of H441 cells. RAR and TTF-1 synergistically stimulated the hSP-B promoter in H441 cells. Direct protein-protein interactions between RAR and TTF-1 were demonstrated by the glutathione S-transferase pull-down assay and the mammalian cell two hybrid assay. Truncation/deletion studies showed that the RAR-TTF-1 interaction was mediated through the RAR DNA binding domain (DBD) and the TTF-1 homeodomain, RAR DBD greatly enhanced TTF-1 homeodomain DNA binding activity to a hSP-B enhancer oligonucleotide, in which retinoic acid-responsive element and TTF-1 DNA binding sites overlap. Chromatin immunoprecipitation assay demonstrated that retinoic acid treatment of H441 cells greatly stimulated both RAR and TTF-1 DNA binding to the hSP-B enhancer region in H441 cells. These findings support a model in which RAR/retinoid X receptor, TTF-1, and coactivators (p160 members and CBP) form an enhanceosome in the enhancer region of the hSP-B gene.	Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yan, C (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Cong.Yan@chmcc.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056387, R01HL061803, P50HL056387] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akinbi HT, 1997, J BIOL CHEM, V272, P9640; Bogue CW, 1996, AM J PHYSIOL-LUNG C, V271, pL862, DOI 10.1152/ajplung.1996.271.5.L862; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Clark JC, 1997, AM J RESP CELL MOL, V16, P46, DOI 10.1165/ajrcmb.16.1.8998078; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; George TN, 1997, PEDIATR RES, V41, P692, DOI 10.1203/00006450-199705000-00015; George TN, 1998, AM J PHYSIOL-LUNG C, V274, pL560, DOI 10.1152/ajplung.1998.274.4.L560; Ghaffari M, 1997, BIOCHEM J, V328, P757, DOI 10.1042/bj3280757; Ghaffari M, 1999, AM J PHYSIOL-LUNG C, V276, pL398, DOI 10.1152/ajplung.1999.276.3.L398; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; METZLER MD, 1993, ENDOCRINOLOGY, V133, P1990, DOI 10.1210/en.133.5.1990; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Naltner A, 2000, AM J PHYSIOL-LUNG C, V279, pL1066, DOI 10.1152/ajplung.2000.279.6.L1066; ONATE SA, 1995, SCIENCE, V270, P1354; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Yan C, 1998, AM J PHYSIOL-LUNG C, V275, pL239, DOI 10.1152/ajplung.1998.275.2.L239; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; YANG N, 1991, P NATL ACAD SCI USA, V88, P3559, DOI 10.1073/pnas.88.9.3559	32	47	48	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21686	21691		10.1074/jbc.M011378200	http://dx.doi.org/10.1074/jbc.M011378200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274148	hybrid			2022-12-27	WOS:000169297900118
J	LaMonica, R; Kocer, SS; Nazarova, J; Dowling, W; Geimonen, E; Shaw, RD; Mackow, ER				LaMonica, R; Kocer, SS; Nazarova, J; Dowling, W; Geimonen, E; Shaw, RD; Mackow, ER			VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kappa B to effect rotavirus-specific cellular responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; ALPHA-INDUCED ACTIVATION; DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; TERMINAL KINASE; TNF-ALPHA; C-JUN; CYTOPLASMIC DOMAIN	Rotaviruses rapidly activate NF-kappaB and induce the secretion of selected chemokines after infection. The ability of rotavirus particles lacking genomic RNA to activate NF-kappaB suggested that rotavirus proteins direct cell signaling responses. We identified conserved TNFR-associated factor (TRAF) binding motifs within the rotavirus capsid protein VP4 and its N-terminal VP8* cleavage product. TRAFs (-1, -2, and -3) are bound by the rhesus rotavirus VP8* protein through three discrete TRAF binding domains. Expression of VP4 or VP8* from rhesus or human rotaviruses induced a 5-7-fold increase in NF-kappaB activity and synergistically enhanced TRAF2-mediated NF-kappaB activation. Mutagenesis of VP8* TRAF binding motifs abolished VP8* binding to TRAFs and the ability of the protein to activate NF-kappaB. Expression of pathway-specific dominant negative (DN) inhibitors DN-TRAF2 or DN-NF-kappaB-inducing kinase also abolished VP8*-, VP4-, or rotavirus-mediated NF-kappaB activation. These findings demonstrate that rotavirus primarily activates NF-kappaB through a TRAF2-NF-kappaB-inducing kinase signaling pathway and that VP4 and VP8* proteins direct pathway activation through interactions with cellular TRAFs, In contrast, transcriptional responses from AP-1 reporters were inhibited 5-fold by VP8* and were not activated by rotavirus infection, suggesting the differential regulation of TRAF2 signaling responses by VP8*. VP8* blocked JNK activation directed by TRAF2 or TRAF5 but had no effect on JNK activation directed by TRAF6 or MEKK1, This establishes that fully cytoplasmic rotaviruses selectively engage signaling pathways, which regulate cellular transcriptional responses. These findings also demonstrate that TRAF2 interactions can disengage JNK signaling from NF-kappaB activation and thereby provide a new means for TRAF2 interactions to determine pathway-specific responses.	SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Mol Cell Biol Program, Stony Brook, NY 11794 USA; Vet Adm Med Ctr, Northport, NY 11768 USA; Walter Reed Army Inst Res, Dept Retrovirol, Rockville, MD 20850 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Mackow, ER (corresponding author), SUNY Stony Brook, Dept Med, HSC T17,Rm 60, Stony Brook, NY 11794 USA.	EMackow@mail.som.sunysb.edu			NIAID NIH HHS [AI42150, AI31016, AI44917] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031016, R03AI042150, R01AI044917] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Ansieau S, 1996, P NATL ACAD SCI USA, V93, P14053, DOI 10.1073/pnas.93.24.14053; Awane M, 1999, J IMMUNOL, V162, P5337; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Benya RV, 1998, ANN NY ACAD SCI, V863, P64, DOI 10.1111/j.1749-6632.1998.tb10684.x; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Casola A, 1998, GASTROENTEROLOGY, V114, P947, DOI 10.1016/S0016-5085(98)70314-2; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Denisova E, 1999, J VIROL, V73, P3147, DOI 10.1128/JVI.73.4.3147-3153.1999; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587; ESTES MK, 1996, VIROLOGY, P1329; FINKEL T, 1993, J BIOL CHEM, V268, P5; FIORE L, 1991, VIROLOGY, V181, P553, DOI 10.1016/0042-6822(91)90888-I; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gravestein LA, 1998, EUR J IMMUNOL, V28, P2208, DOI 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L; Hecht G, 1999, J CLIN INVEST, V104, P253, DOI 10.1172/JCI6373; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Jobin C, 1997, J IMMUNOL, V158, P226; Jobin C, 1999, J IMMUNOL, V162, P4447; Jobin C, 1998, J IMMUNOL, V160, P410; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KALJOT KT, 1988, J VIROL, V62, P1136, DOI 10.1128/JVI.62.4.1136-1144.1988; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; MACKOW ER, 1990, P NATL ACAD SCI USA, V87, P518, DOI 10.1073/pnas.87.2.518; MACKOW ER, 1986, P NATL ACAD SCI USA, V85, P645; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mankertz J, 2000, J CELL SCI, V113, P2085; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Miller WE, 1998, MOL CELL BIOL, V18, P2835, DOI 10.1128/MCB.18.5.2835; Neurath MF, 2000, CHIRURG, V71, P30; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Obert G, 2000, J VIROL, V74, P4645, DOI 10.1128/JVI.74.10.4645-4651.2000; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; PRASAD BVV, 1990, NATURE, V343, P476, DOI 10.1038/343476a0; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rollo EE, 1999, J IMMUNOL, V163, P4442; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Ruiz MC, 1996, J VIROL, V70, P4877, DOI 10.1128/JVI.70.8.4877-4883.1996; Sato K, 1999, J IMMUNOL, V162, P3865; Schmitz H, 1999, J CELL SCI, V112, P137; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; SHAW RD, 1986, VIROLOGY, V155, P434, DOI 10.1016/0042-6822(86)90205-9; Sheth R, 1996, VIROLOGY, V221, P251, DOI 10.1006/viro.1996.0374; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Shrivastava A, 1998, J VIROL, V72, P9722, DOI 10.1128/JVI.72.12.9722-9728.1998; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sutherland CL, 1999, J IMMUNOL, V162, P4720; SUZUKI H, 1985, ARCH VIROL, V85, P25, DOI 10.1007/BF01317003; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Warzocha K, 1998, LEUKEMIA LYMPHOMA, V29, P81, DOI 10.3109/10428199809058384; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; YAN MH, 1994, NATURE, V372, P798; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	80	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19889	19896		10.1074/jbc.M100499200	http://dx.doi.org/10.1074/jbc.M100499200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262403	hybrid			2022-12-27	WOS:000169135100029
J	Pienimaki, JP; Rilla, K; Fulop, C; Sironen, RK; Karvinen, S; Pasonen, S; Lammi, MJ; Tammi, R; Hascall, VC; Tammi, MI				Pienimaki, JP; Rilla, K; Fulop, C; Sironen, RK; Karvinen, S; Pasonen, S; Lammi, MJ; Tammi, R; Hascall, VC; Tammi, MI			Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNOVIAL LINING CELLS; SKIN ORGAN-CULTURE; FACTOR RECEPTOR; CYTOKINE REGULATION; MOLECULAR-CLONING; MESSENGER-RNA; EXPRESSION; FIBROBLASTS; METABOLISM; MIGRATION	Hyaluronan is an abundant and rapidly turned over matrix molecule between the vital cell layers of the epidermis. In this study, epidermal growth factor (EGF) induced a coat of hyaluronan and a 3-5-fold increase in its rate of synthesis in a rat epidermal keratinocyte cell line that has retained its ability for differentiation. EGF also increased hyaluronan in perinuclear vesicles, suggesting concurrent enhancement in its endocytosis. Cell-associated hyaluronan was most abundant in elongated cells that were stimulated to migrate by EGF, as determined in vitro in a wound healing assay. Large fluctuations in the pool size of UDP-N-acetylglucosamine, the metabolic precursor of hyaluronan, correlated with medium glucose concentrations but not with EGF. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed no increase in hyaluronan synthases 1 and 3 (Has1 and Has3), whereas Has2 mRNA increased 23-fold in less than 2 h following the introduction of EGF, as estimated by quantitative RT-PCR with a truncated Has2 mRNA internal standard. The average level of Has2 mRNA increased from similar to6 copied cell in cultures before change of fresh medium, up to similar to 54 copies/cell after 6 h in EGF-containing medium. A control medium with 10% serum caused a maximum level of similar to 21 copies/cell at 6 h. The change in the Has2 mRNA levels and the stimulation of hyaluronan synthesis followed a similar temporal pattern, reaching a maximum level at 6 h and declining toward 24 h, a finding in line with a predominantly Has2-dependent hyaluronan synthesis and its transcriptional regulation.	Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland; Lerner Res Inst, Dept Biomed Engn, Connect Tissue Biol Sect, Cleveland, OH 44195 USA	University of Eastern Finland; Cleveland Clinic Foundation	Tammi, MI (corresponding author), Univ Kuopio, Dept Anat, POB 1627, FIN-70211 Kuopio, Finland.	markku.tammi@uku.fi	Lammi, Mikko/B-9291-2008; Tammi, Markku/AAQ-7878-2021	Lammi, Mikko/0000-0002-6181-9904; Rilla, Kirsi/0000-0002-7862-5727				AGREN UM, 1995, J CELL PHYSIOL, V164, P240, DOI 10.1002/jcp.1041640204; Anttila MA, 2000, CANCER RES, V60, P150; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Carley William W., 1996, Microcirculation (Philadelphia), V3, P359, DOI 10.3109/10739689609148308; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Ellis I, 1997, DEVELOPMENT, V124, P1593; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Feusi E, 1999, NEPHRON, V83, P66, DOI 10.1159/000045475; Fulop C, 1997, ARCH BIOCHEM BIOPHYS, V337, P261, DOI 10.1006/abbi.1996.9793; Hall CL, 1996, ONCOGENE, V13, P2213; HAMERMAN D, 1984, P SOC EXP BIOL MED, V177, P205; HAUBECK HD, 1995, ARTHRITIS RHEUM-US, V38, P669, DOI 10.1002/art.1780380515; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Ichikawa T, 1999, J INVEST DERMATOL, V113, P935, DOI 10.1046/j.1523-1747.1999.00804.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kawakami M, 1998, ANN RHEUM DIS, V57, P602, DOI 10.1136/ard.57.10.602; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Knudson W, 1996, AM J PATHOL, V148, P1721; Kolettas E, 1998, ANTICANCER RES, V18, P385; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; LICHTNER RB, 1995, ONCOGENE, V10, P1823; MACCALLUM D K, 1990, Skin Pharmacology, V3, P86; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N; MIDURA RJ, 1994, GLYCOBIOLOGY, V4, P333, DOI 10.1093/glycob/4.3.333; Nishida Y, 2000, ARTHRITIS RHEUM-US, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; Ropponen K, 1998, CANCER RES, V58, P342; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; STOSCHECK CM, 1992, J INVEST DERMATOL, V99, P645, DOI 10.1111/1523-1747.ep12668143; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; TAMMI R, 1989, J INVEST DERMATOL, V92, P326, DOI 10.1111/1523-1747.ep12277125; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; TAMMI R, 1990, ARCH ORAL BIOL, V35, P219, DOI 10.1016/0003-9969(90)90058-I; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Tiedemann K, 1997, MATRIX BIOL, V15, P469, DOI 10.1016/S0945-053X(97)90020-2; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Tzahar E, 1998, BBA-REV CANCER, V1377, pM25, DOI 10.1016/S0304-419X(97)00032-2; vanderHeyden MAG, 1997, EXP CELL RES, V234, P521, DOI 10.1006/excr.1997.3661; Wang C, 1996, AM J PATHOL, V148, P1861; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; Yung S, 2000, KIDNEY INT, V58, P1953, DOI 10.1111/j.1523-1755.2000.00367.x; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091	61	163	170	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20428	20435		10.1074/jbc.M007601200	http://dx.doi.org/10.1074/jbc.M007601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262389	hybrid			2022-12-27	WOS:000169135100102
J	Pettersson, PL; Mannervik, B				Pettersson, PL; Mannervik, B			The role of glutathione in the isomerization of Delta(5)-androstene-3,17-dione catalyzed by human glutathione transferase A1-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; ACTIVE-SITE; BINDING-SITE; DELTA-5-3-KETOSTEROID ISOMERASE; HETEROLOGOUS EXPRESSION; CRYSTAL-STRUCTURES; DRUG-RESISTANCE; PHAGE DISPLAY; MU-CLASS; RAT	Human glutathione transferase (GS'P') A1-1 efficiently catalyzes the isomerization of Delta (5)-androstene-3,17-dione (AD) into Delta (4)-androstene-3,17-dione. High activity requires glutathione, but enzymatic catalysis occurs also in the absence of this cofactor. Glutathione alone shows a limited catalytic effect. S-Alkylglutathione derivatives do not promote the reaction, and the pH dependence of the isomerization indicates that the glutathione thiolate serves as a base in the catalytic mechanism. Mutation of the active-site Tyr(9) into Phe significantly decreases the steady-state kinetic parameters, alters their pH dependence, and increases the pK(a) value of the enzyme-bound glutathione thiol. Thus, Tyr(9) promotes the reaction via its phenolic hydroxyl group in protonated form. GST A2-2 has a catalytic efficiency with AD 100-fold lower than the homologous GST A1-1. Another Alpha class enzyme, GST A4-4, is 1000-fold less active than GST A1-1. The Y9F mutant of GST A1-1 is more efficient than GST A2-2 and GST A4-4, both having a glutathione cofactor and an active-site Tyr(9) residue. The active sites of GST A2-2 and GST A1-1 differ by only four amino acid residues, suggesting that proper orientation of AD in relation to the thiolate of glutathione is crucial for high catalytic efficiency in the isomerization reaction. The GST A1-1-catalyzed steroid isomerization provides a complement to the previously described isomerase activity of 3 beta -hydroxysteroid dehydrogenase.	Uppsala Univ, Biomed Ctr, Dept Biochem, SE-75123 Uppsala, Sweden	Uppsala University	Mannervik, B (corresponding author), Uppsala Univ, Biomed Ctr, Dept Biochem, Box 576, SE-75123 Uppsala, Sweden.							Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; BARDSLEY WG, 1995, COMPUT CHEM, V19, P75, DOI 10.1016/0097-8485(95)00007-F; Barycki JJ, 1997, ARCH BIOCHEM BIOPHYS, V345, P16, DOI 10.1006/abbi.1997.0244; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BENSON AM, 1976, BIOCHEM BIOPH RES CO, V69, P1073, DOI 10.1016/0006-291X(76)90482-4; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BROTHERS PN, 1995, BIOCHEMISTRY-US, V34, P15453, DOI 10.1021/bi00047a009; CLARKE TR, 1993, ENDOCRINOLOGY, V132, P1971, DOI 10.1210/en.132.5.1971; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Fersht A., 1999, STRUCTURE MECH PROTE, P114; FERSHT A, 1999, STRUCTURE MECH PROTE, P178; FORD HC, 1974, J BIOL CHEM, V249, P1363; Gustafsson A, 1999, J MOL BIOL, V288, P787, DOI 10.1006/jmbi.1999.2712; Gustafsson A, 1999, BIOCHEMISTRY-US, V38, P16268, DOI 10.1021/bi991482y; Hansson LO, 1997, BIOCHEMISTRY-US, V36, P11252, DOI 10.1021/bi9702952; Hansson LO, 1999, J MOL BIOL, V287, P265, DOI 10.1006/jmbi.1999.2607; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ji XH, 1996, P NATL ACAD SCI USA, V93, P8208, DOI 10.1073/pnas.93.16.8208; KULIOPULOS A, 1987, BIOCHEMISTRY-US, V26, P3927, DOI 10.1021/bi00387a028; LIU SX, 1992, J BIOL CHEM, V267, P4296; LUUTHE V, 1991, BIOCHEMISTRY-US, V30, P8861; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Massiah MA, 1998, BIOCHEMISTRY-US, V37, P14701, DOI 10.1021/bi981447b; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; MEYER DJ, 1995, BIOCHEM J, V311, P739, DOI 10.1042/bj3110739; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; RHOADS DM, 1987, BIOCHEM BIOPH RES CO, V145, P474, DOI 10.1016/0006-291X(87)91345-3; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; SAMUELS LT, 1951, SCIENCE, V113, P490, DOI 10.1126/science.113.2939.490; SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STENBERG G, 1992, BIOCHEM J, V284, P313, DOI 10.1042/bj2840313; STENBERG G, 1991, FEBS LETT, V293, P153, DOI 10.1016/0014-5793(91)81174-7; STENBERG G, 1992, PROTEIN EXPRES PURIF, V3, P80, DOI 10.1016/1046-5928(92)90060-A; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; TEW KD, 1994, CANCER RES, V54, P4313; Thomas JL, 1998, J STEROID BIOCHEM, V66, P327, DOI 10.1016/S0960-0760(98)00058-2; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Thornburg LD, 1998, BIOCHEMISTRY-US, V37, P10499, DOI 10.1021/bi980099a; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; VANOMMEN B, 1990, BIOCHEM J, V269, P609, DOI 10.1042/bj2690609; Wang JB, 2000, J BIOL CHEM, V275, P5493, DOI 10.1074/jbc.275.8.5493; WIDERSTEN M, 1994, BIOCHEMISTRY-US, V33, P11717, DOI 10.1021/bi00205a007; WIDERSTEN M, 1995, J MOL BIOL, V250, P115, DOI 10.1006/jmbi.1995.0362; Widersten M, 1996, BIOCHEMISTRY-US, V35, P7731, DOI 10.1021/bi9601619; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8	56	43	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11698	11704		10.1074/jbc.M009146200	http://dx.doi.org/10.1074/jbc.M009146200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152686	hybrid			2022-12-27	WOS:000168081800038
J	Benjannet, S; Elagoz, A; Wickham, L; Mamarbachi, M; Munzer, JS; Basak, A; Lazure, C; Cromlish, JA; Sisodia, S; Checler, F; Chretien, M; Seidah, NG				Benjannet, S; Elagoz, A; Wickham, L; Mamarbachi, M; Munzer, JS; Basak, A; Lazure, C; Cromlish, JA; Sisodia, S; Checler, F; Chretien, M; Seidah, NG			Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding - The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PROPROTEIN CONVERTASE; IN-VITRO; ASPARTYL PROTEASE; HUMAN BRAIN; CLEAVAGE; FURIN; BACE; IDENTIFICATION	Processing of the beta -amyloid precursor protein (beta APP) by beta- and gamma -secretases generates the amyloidogenic peptide A beta, a major factor in the etiology of Alzheimer's disease. Following the recent identification of the beta -secretase beta -amyloid-converting enzyme (BACE), we herein investigate its zymogen processing, molecular properties, and cellular trafficking. Our data show that among the proprotein convertase family members, furin is the major converting enzyme of pro-BACE into BACE within the trans-Golgi network of HK293 cells. While we demonstrate that; the 24-amino acid prosegment is required for the efficient exit of pro-BACE from the endoplasmic reticulum, it may not play a strong inhibitory role since we observe that pro-BACE can produce significant quantities of the Swedish mutant beta APP(sw) beta -secretase product C99, BACE is palmitoylated at three Cys residues within its transmembrane/cytosolic tail and is sulfated at mature N-glycosylated moieties, Data with three different antibodies show that a small fraction of membrane-bound BACE is shed into the medium and that the extent of ectodomain shedding is palmitoylation-dependent. Overexpression of full-length BACE causes a significant increase in the production of C99 and a decrease in the alpha -secretase product APPs alpha. Although there is little increase in the generation of A beta by full-length BACE, overexpression of either a soluble form of BACE (equivalent to the shed form) or one lacking the prosegment leads to enhanced A beta levels. These findings suggest that the shedding of BACE may play a role in the amyloidogenic processing of beta APP.	Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Ottawa Hosp, Loeb Hlth Res Inst, Dis Aging Unit, Ottawa, ON K1Y 4K9, Canada; Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Chicago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Seidah, NG (corresponding author), Clin Res Inst Montreal, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.		Seidah, Nabil/I-3596-2013; Checler, Frederic/C-1241-2009	Seidah, Nabil/0000-0001-6503-9342; Checler, Frederic/0000-0003-2098-1750; CHRETIEN, Michel/0000-0002-8588-4460				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Karaivanova VK, 1998, BIOCHEM J, V329, P511; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Mercure C, 1996, HYPERTENSION, V28, P840, DOI 10.1161/01.HYP.28.5.840; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rigot V, 1999, EUR J BIOCHEM, V261, P659, DOI 10.1046/j.1432-1327.1999.00300.x; ROMPAEY LV, 1997, BIOCHEM J, V326, P507; Sauder JM, 2000, J MOL BIOL, V300, P241, DOI 10.1006/jmbi.2000.3860; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Van Gassen G, 2000, NEUROBIOL DIS, V7, P135, DOI 10.1006/nbdi.2000.0306; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	48	265	272	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10879	10887		10.1074/jbc.M009899200	http://dx.doi.org/10.1074/jbc.M009899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152688	hybrid			2022-12-27	WOS:000167980900044
J	Otsuka, F; Yamamoto, S; Erickson, GF; Shimasaki, S				Otsuka, F; Yamamoto, S; Erickson, GF; Shimasaki, S			Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; RAT GRANULOSA-CELLS; MESSENGER-RIBONUCLEIC-ACID; CHAIN CLEAVAGE CYTOCHROME-P-450; MOUSE OOCYTES; INDEPENDENT REGULATION; MAMMALIAN OVARY; HOMOLOG GDF-9B; OVULATION RATE; CUMULUS CELLS	We have recently reported that oocyte-derived bone morphogenetic protein-15 (BMP-15) can directly modulate follicle-stimulating hormone (FSH) action in rat granulosa cells. Here, we investigate underlying mechanisms of this BMP-15 effect. Treatment with BMP-15 alone exerted no significant effect on the basal expression of mRNAs encoding steroidogenic acute regulatory protein, P450 side chain cleavage enzyme, P450 aromatase, 3 beta -hydroxysteroid dehydrogenase, luteinization hormone receptor, and inhibin/activin subunits. However, BMP-15 markedly inhibited the FSH-induced increases in these messages. In striking contrast, BMP-15 did not change the forskolin-induced levels of these transcripts, Thus, the inhibitory effect of BMP-15 on FSH action must be upstream of cAMP signaling. We next examined changes in FSH receptor mRNA expression. Interestingly, BMP-15 severely reduced the levels of FSH receptor mRNA in both basal and FSH-stimulated cells. To determine whether this effect was at the level of FSH function, we investigated the effect of BMP-15 on FSH bioactivity, Consistent with the mRNA data, BMP-15 inhibited the biological response of FSH, but not that of forskolin. Based on these results, we propose that BMP-15 is an important determinant of FSH action through its ability to inhibit FSH receptor expression. Because FSH plays an essential role in follicle growth and development, our findings could have new implications for understanding how oocyte growth factors contribute to folliculogenesis.	Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Shimasaki, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Reprod Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sshimasaki@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NICHD NIH HHS [U54HD12303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Ariyoshi N, 1998, J BIOL CHEM, V273, P7610, DOI 10.1074/jbc.273.13.7610; BACICH DJ, 1994, ENDOCRINOLOGY, V135, P735, DOI 10.1210/en.135.2.735; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; CANIPARI R, 1995, DEV BIOL, V167, P371, DOI 10.1006/dbio.1995.1031; CHAN YL, 1987, J BIOL CHEM, V262, P1111; DAVIS GH, 1992, BIOL REPROD, V46, P636, DOI 10.1095/biolreprod46.4.636; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Elvin JA, 2000, P NATL ACAD SCI USA, V97, P10288, DOI 10.1073/pnas.180295197; Elvin JA, 2000, MOL CELL ENDOCRINOL, V159, P1, DOI 10.1016/S0303-7207(99)00185-9; Eppig JJ, 1997, BIOL REPROD, V56, P976, DOI 10.1095/biolreprod56.4.976; Eppig John J., 1997, Human Reproduction (Oxford), V12, P127; Erickson GF, 2000, TRENDS ENDOCRIN MET, V11, P193, DOI 10.1016/S1043-2760(00)00249-6; ERICKSON GF, 1978, ENDOCRINOLOGY, V102, P1275, DOI 10.1210/endo-102-4-1275; ERICKSON GF, 1983, MOL CELL ENDOCRINOL, V29, P21, DOI 10.1016/0303-7207(83)90003-5; ESCH FS, 1987, MOL ENDOCRINOL, V1, P388, DOI 10.1210/mend-1-5-388; Findlay JK, 1999, TRENDS ENDOCRIN MET, V10, P183, DOI 10.1016/S1043-2760(98)00144-1; FITZPATRICK SL, 1991, ENDOCRINOLOGY, V129, P1452, DOI 10.1210/endo-129-3-1452; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GHERSEVICH S, 1994, ENDOCRINOLOGY, V135, P1963, DOI 10.1210/en.135.5.1963; GOLDSCHMIT D, 1989, ENDOCRINOLOGY, V124, P369, DOI 10.1210/endo-124-1-369; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; HICKEY GJ, 1990, MOL ENDOCRINOL, V4, P3, DOI 10.1210/mend-4-1-3; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; Jaatinen R, 1999, MOL CELL ENDOCRINOL, V156, P189, DOI 10.1016/S0303-7207(99)00100-8; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 1998, ENDOCRINOLOGY, V139, P3289, DOI 10.1210/en.139.7.3289; LACHANCE Y, 1990, J BIOL CHEM, V265, P20469; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; Minegishi T, 2000, BIOL REPROD, V62, P325, DOI 10.1095/biolreprod62.2.325; MIURA R, 1994, BIOCHEM J, V299, P561, DOI 10.1042/bj2990561; OONK RB, 1989, J BIOL CHEM, V264, P21934; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; RICHARDS JS, 1995, RECENT PROG HORM RES, V50, P223; SALUSTRI A, 1990, J BIOL CHEM, V265, P19517; SHACKELL GH, 1993, BIOL REPROD, V48, P1150, DOI 10.1095/biolreprod48.5.1150; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; STEELE GL, 1993, OVARY, P113; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; TILLY JL, 1992, ENDOCRINOLOGY, V130, P1296, DOI 10.1210/en.130.3.1296; TSAIMORRIS CH, 1991, J BIOL CHEM, V266, P11355; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; VANDERHYDEN BC, 1992, BIOL REPROD, V46, P1196, DOI 10.1095/biolreprod46.6.1196; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370	53	228	258	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11387	11392		10.1074/jbc.M010043200	http://dx.doi.org/10.1074/jbc.M010043200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154695	hybrid			2022-12-27	WOS:000167980900110
J	Yan, C; Luo, HL; Lee, JD; Abe, JI; Berk, BC				Yan, C; Luo, HL; Lee, JD; Abe, JI; Berk, BC			Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE-1 BMK1; MAP KINASE KINASE; PROTEIN-KINASE; ENDOTHELIAL-CELLS; SHEAR-STRESS; NUCLEAR TRANSLOCATION; SENSITIVE KINASE; TYROSINE KINASES; GROWTH-FACTOR; SIGNAL	The mitogen-activated protein kinases (MAPKs) play important roles in regulation of cell growth and survival. Human MAPK 5 (ERK5) or Big MAP kinase 1 (BMK1) is a recently cloned member of the MAPK family. To identify ERK5-related kinases, we searched the GenBank(TM) expressed sequence tag (EST) data base for mouse cDNAs with homology to human ERK5. A full-length mouse cDNA that was highly homologous to the human ERK5 was identified. Further analysis of ERK5 polymerase chain reaction products generated from mouse embryo cDNA yielded three mouse ERK5 cDNAs (mERK5a, mERK5b, and mERK5c). Sequence analysis showed that these cDNAs are alternative splice products of the mouse ERK5 gene. Interestingly, expressed mERK5b and mERK5c act as dominant negative inhibitors based on inhibition of mERK5a kinase activity and mERK5a-mediated MEF2C transactivation. However, the physiological significance of mERK5b and mERK5c is not fully understood. Further investigation using these mouse ERK5 splice variants and other constructed mutants identified functional roles of several regions of mERK5, which-appear to be important for protein-protein interaction and intracellular localization. Specifically, we found that the long C-terminal tail, which contains a putative nuclear localization signal, is not required for activation and kinase activity but is responsible for the activation of nuclear transcription factor MEF2C due to nuclear targeting. In addition, the N-terminal domain spanning amino acids (aa) 1-77 is important for cytoplasmic targeting; the domain from aa 78 to 139 is required for association with the upstream kinase MEK5; and the domain from aa 140-406 is necessary for oligomerization. Taken together, these observations indicate that ERK5 is regulated by distinct mechanisms determined by its unique structure and presumably the presence of multiple splice variants.	Univ Rochester, Sch Med & Dent, Cardiovasc Res Ctr, Rochester, NY 14642 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Rochester; University of Washington; University of Washington Seattle; Scripps Research Institute	Berk, BC (corresponding author), Univ Rochester, Sch Med & Dent, Cardiovasc Res Ctr, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.			Yan, Chen/0000-0002-1397-6358; Berk, Bradford/0000-0002-2767-4115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049192, P01HL018645, T32HL007828] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18645, HL49192, T32HL07828] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Abe MK, 1999, MOL CELL BIOL, V19, P1301; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; Cuppen E, 1997, J BIOL CHEM, V272, P30215, DOI 10.1074/jbc.272.48.30215; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mazaki Y, 1998, J BIOL CHEM, V273, P22435, DOI 10.1074/jbc.273.35.22435; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; PLATH K, 1994, BIOCHEM BIOPH RES CO, V203, P1188, DOI 10.1006/bbrc.1994.2308; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Takahashi M, 1996, J CLIN INVEST, V98, P2623, DOI 10.1172/JCI119083; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	32	126	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10870	10878		10.1074/jbc.M009286200	http://dx.doi.org/10.1074/jbc.M009286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139578	hybrid			2022-12-27	WOS:000167980900043
J	Gupta, M; Kogut, P; Davis, FJ; Belaguli, NS; Schwartz, RJ; Gupta, MP				Gupta, M; Kogut, P; Davis, FJ; Belaguli, NS; Schwartz, RJ; Gupta, MP			Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTIN GENE; MUSCLE-SPECIFIC TRANSCRIPTION; HEAVY-CHAIN GENE; M-CAT ELEMENTS; FACTOR-I; INDUCIBLE EXPRESSION; PROMOTER ELEMENTS; CARDIAC MYOCYTES; XENOPUS-EMBRYOS; FACTOR RTEF-1	Serum response factor is a MADS box transcription factor that binds to consensus sequences CC(A/T)(6)GG found in the promoter region of several serum-inducible and muscle-specific genes. In skeletal myocytes serum response factor (SRF) has been shown to heterodimerize with the myogenic basic helix-loop-helix family of factors, related to MyoD, for control of muscle gene regulation. Here we report that SRF binds to another myogenic factor, TEF-1, that has been implicated in the regulation of a variety of cardiac muscle genes. By using different biochemical assays such as affinity precipitation of protein, GST-pulldown assay, and coimmunoprecipitation of proteins, we show that SRF binds to TEF-1 both in in vitro and in vivo assay conditions. A strong interaction of SRF with TEF-1 was seen even when one protein was denatured and immobilized on nitrocellulose membrane, indicating a direct and stable interaction between SRF and TEF-1, which occurs without a cofactor. This interaction is mediated through the C-terminal subdomain of MADS box of SRF encompassing amino acids 204-244 and the putative 2nd and 3rd alpha -helix/beta -sheet configuration of the TEA/ATTS DNA-binding domain of TEF-1, In the transient transfection assay, a positive cooperative effect of SRF and TEF-1 was observed when DNA-binding sites for both factors, serum response element and M-CAT respectively, were intact; mutation of either site abolished their synergistic effect. Similarly, an SRF mutant, SRFpm-1, defective in DNA binding failed to collaborate with TEF-1 for gene regulation, indicating that the synergistic trans-activation function of SRF and TEF-1 occurs via their binding to cognate DNA-binding sites. Our results demonstrate a novel association between SRF and TEF-1 for cardiac muscle gene regulation and disclose a general mechanism by which these two super families of factors are likely to control diversified biological functions.	Univ Illinois, Heart Inst Children, Chicago, IL 60612 USA; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Dept Surg, Div Cardiac & Thorac, Chicago, IL 60637 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Baylor College of Medicine	Gupta, MP (corresponding author), Univ Chicago, Dept Surg Cardiac & Thorac, MC 834-4648, Chicago, IL 60637 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068083] Funding Source: NIH RePORTER; NHLBI NIH HHS [R0-1 HL-68083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Berger LC, 1996, J VIROL, V70, P1203, DOI 10.1128/JVI.70.2.1203-1212.1996; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Butler AJ, 1999, MOL CELL BIOL, V19, P296; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Carson JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1624, DOI 10.1152/ajpcell.1996.270.6.C1624; CHAMBERS AE, 1994, GENE DEV, V8, P1324, DOI 10.1101/gad.8.11.1324; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eadara JK, 1996, VIROLOGY, V223, P120, DOI 10.1006/viro.1996.0461; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; Groisman R, 1996, J BIOL CHEM, V271, P5258; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; Gupta MP, 1997, MOL CELL BIOL, V17, P3924, DOI 10.1128/MCB.17.7.3924; GUPTA MP, 1994, J BIOL CHEM, V269, P29677; Gupta MP, 2000, NUCLEIC ACIDS RES, V28, P3168, DOI 10.1093/nar/28.16.3168; Hautmann MB, 1997, CIRC RES, V81, P600, DOI 10.1161/01.RES.81.4.600; Hines WA, 1999, MOL CELL BIOL, V19, P1841; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Jiang SW, 1996, J BIOL CHEM, V271, P9510, DOI 10.1074/jbc.271.16.9510; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Koo HM, 1996, CIRCULATION, V94, P1322; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MELIN F, 1993, EMBO J, V12, P4657, DOI 10.1002/j.1460-2075.1993.tb06154.x; METZLER DE, 1977, BIOCH CHEM REACTIONS, P75; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; NATESAN S, 1995, MOL CELL BIOL, V15, P5979; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; SHAW PE, 1992, EMBO J, V11, P3011, DOI 10.1002/j.1460-2075.1992.tb05371.x; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; TAYLOR M, 1989, DEVELOPMENT, V106, P67; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; VANDROMME M, 1992, J CELL BIOL, V118, P1489, DOI 10.1083/jcb.118.6.1489; VINCENT CK, 1993, MOL CELL BIOL, V13, P1264, DOI 10.1128/MCB.13.2.1264; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	57	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10413	10422		10.1074/jbc.M008625200	http://dx.doi.org/10.1074/jbc.M008625200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136726	hybrid			2022-12-27	WOS:000167996400108
J	Li, BM; Comai, L				Li, BM; Comai, L			Requirements for the nucleolytic processing of DNA ends by the Werner syndrome protein-Ku70/80 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; KU PROTEIN; CATALYTIC SUBUNIT; SYNDROME GENE; HELICASE; EXONUCLEASE; BINDING; CELLS; LOCALIZATION	Werner syndrome (WS) is an inherited disease characterized by premature onset of aging, increased cancer incidence, and genomic instability. The WS gene encodes a protein with helicase and exonuclease activities. Our previous studies indicated that the Werner syndrome protein (WRN) interacts with Ku, a heterodimeric factor of 70- and 80-kDa subunits implicated in the repair of double strand DNA breaks, Moreover, we demonstrated that Ku70/80 strongly stimulates and alters WRN exonuclease activity. In this report, we investigate further the association between WRN and Ku70/ 80. First, using various WRN deletion mutants we show that 50 amino acids at the amino terminus are required and sufficient to interact with Ku70/80. In addition, our data indicate that the region of Ku80 between amino acids 215 and 276 is necessary for binding to WRN, Then, we show that the amino-terminal region of WRN from amino acid 1 to 388, which comprise the exonuclease domain, can be efficiently stimulated by Ku to degrade DNA substrates, indicating that the helicase domain and the carboxyl-terminal tail are not required for the stimulatory process. Finally, using gel shift assays, we demonstrate that Ku recruits WRN to DNA, Taken together, these results suggest that Ku-mediated activation of WRN exonuclease activity may play an important role in a cellular pathway that requires processing of DNA ends.	Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Comai, L (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, 2011 Zonal Ave,HMR-509, Los Angeles, CA 90033 USA.		Comai, Lucio/L-5905-2019; Comai, Lucio/H-9524-2019	Comai, Lucio/0000-0003-3109-1841; 				Bachant JB, 1999, NATURE, V398, P757, DOI 10.1038/19641; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Cooper MP, 2000, GENE DEV, V14, P907; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dyer CAE, 1998, AGE AGEING, V27, P73, DOI 10.1093/ageing/27.1.73; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GEBHART E, 1988, HUM GENET, V80, P135, DOI 10.1007/BF00702855; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Matsumoto T, 1997, NAT GENET, V16, P335, DOI 10.1038/ng0897-335; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ochem AE, 1997, J BIOL CHEM, V272, P29919, DOI 10.1074/jbc.272.47.29919; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; RUNGER TM, 1994, J INVEST DERMATOL, V102, P45, DOI 10.1111/1523-1747.ep12371730; SALK D, 1985, ADV EXP MED BIOL, V190, P541; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	51	86	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9896	9902		10.1074/jbc.M008575200	http://dx.doi.org/10.1074/jbc.M008575200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152456	hybrid			2022-12-27	WOS:000167996400044
J	Peron, P; Rahmani, M; Zagar, Y; Durand-Schneider, AM; Lardeux, B; Bernuau, D				Peron, P; Rahmani, M; Zagar, Y; Durand-Schneider, AM; Lardeux, B; Bernuau, D			Potentiation of smad transactivation by jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes - Role of phosphatidylinositol 8-kinase-induced AP-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-TRANSFORMATION; INDUCED APOPTOSIS; KINASE PATHWAY; DNA-SYNTHESIS; TRANSCRIPTION; 3-KINASE; BINDING; FAMILY; IDENTIFICATION; SUPERFAMILY	Cross-talk between Smad and mitogen-activated protein kinase pathways has been described recently, and evidence for Smad cooperation with AP-1 is emerging. Here we report that epidermal growth factor (EGF) potentializes transforming growth factor beta (TGF-beta)-induced Smad3 transactivation in rat hepatocytes, an effect abrogated by TAM-67, a dominant negative mutant of AP-1, Antisense transfection experiments indicated that c-Jun and JunB were involved in the synergistic effect, and endogenous c-Jun physically associated with Smad3 during a combined EGF/TGF-beta treatment, We next investigated which signaling pathway transduced by EGF was responsible for the jun-induced synergism. Whereas inhibition of JNK had no effect, inhibition of the phosphatidylinositol-3 ' kinase (PI3-kinase) pathway by LY294002 or by expression of a dominant negative mutant of PI3-kinase reduced EGF/TGF-beta -induced Smad3 transcriptional activity. Transfection of an activated Has with a mutation enabling the activation of the PI3-kinase pathway alone mimicked the EGF/TGF-beta potentiation of Smad3 transactivation, and TAM-67 abolished this effect, suggesting that the PI3 -kinase pathway stimulates Smad3 via AP-1 stimulation. The EGF/TGF-beta -induced activation of Smad3 correlated with PI3-kinase and p38-dependent but not JNK-dependent phosphorylation of c-Jun, Since potentiation of a Smad-binding element-driven gene was also induced by EGF/TGF-beta treatment, this novel mechanism of Jun/Smad cooperation might be crucial for diversifying TGF-P responses.	Univ Paris 07, Fac Med Xavier Bichat, INSERM Unite 327, Biol Cellulaire Lab, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bernuau, D (corresponding author), Univ Paris 07, Fac Med Xavier Bichat, INSERM Unite 327, Biol Cellulaire Lab, F-75018 Paris, France.	bernuau@bichat.inserm.fr		Rahmani, Mohamed/0000-0002-3992-8039				Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; BALAVOINE S, 1990, EUR J BIOCHEM, V189, P617, DOI 10.1111/j.1432-1033.1990.tb15530.x; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; CARR BI, 1986, CANCER RES, V46, P2330; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Huang CS, 1997, J BIOL CHEM, V272, P4187, DOI 10.1074/jbc.272.7.4187; Huang CS, 1996, MOL CELL BIOL, V16, P6427; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Krymskaya VP, 1997, AM J PHYSIOL-LUNG C, V273, pL1220, DOI 10.1152/ajplung.1997.273.6.L1220; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Le Cam A, 1995, Methods Mol Biol, V48, P141; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCMAHON JB, 1986, CANCER RES, V46, P4665; Nadori F, 1997, HEPATOLOGY, V26, P1477; NAKAMURA T, 1985, BIOCHEM BIOPH RES CO, V133, P1042, DOI 10.1016/0006-291X(85)91241-0; Osborn MT, 1999, BIOTECHNIQUES, V27, P887, DOI 10.2144/99275bm02; Roberts RA, 2000, HEPATOLOGY, V31, P420, DOI 10.1002/hep.510310223; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; WANG SR, 1985, IN VITRO CELL DEV B, V21, P526; Wong C, 1999, MOL CELL BIOL, V19, P1821; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	51	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10524	10531		10.1074/jbc.M005919200	http://dx.doi.org/10.1074/jbc.M005919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134003	hybrid			2022-12-27	WOS:000167996400121
J	Liao, HJ; Ji, QS; Carpenter, G				Liao, HJ; Ji, QS; Carpenter, G			Phospholipase C-gamma 1 is required for the induction of immediate early genes by platelet-derived growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-GAMMA; FACTOR RECEPTOR; PHOSPHORYLATION SITES; BETA-RECEPTOR; SIGNAL; CELL; IDENTIFICATION; MESSENGER; PATHWAYS; TERMINUS	To explore the functional role of phospholipase C-gamma1 (PLC-gamma1) in the induction of immediate early genes (IEGs), we have examined the influence of PLcg1 gene disruption on the expression of 14 IEG mRNAs induced by platelet-derived growth factor (PDGF). Plcg1-null embryos were used to produce immortalized fibroblasts genetically deficient in PLC-gamma1 (Null cells), and retroviral infection of those cells was used to derive PLC-gamma1 re-expressing cells (Null+ cells). In terms of PDGF activation of PDGF receptor tyrosine phosphorylation as well as the mitogen-activated protein kinases Erk1 and Erk2, Null and Null+ cells responded equivalently. However, the PDGF-dependent expression of all IEG mRNAs was diminished in cells lacking PLC-gamma1. The expression of FIC, COX-2, KC, JE, and c-fos mRNAs were most strongly compromised, as the stimulation of these genes was reduced by more than 90% in cells lacking PLC-gamma1, The combination of PIMA and ionomycin, downstream analogs of PLC activation, did provoke expression of mRNAs for these IEGs in the Null cells. We conclude that PLC-gamma1 is necessary for the maximal expression of many PDGF-induced IEGs and is essential for significant induction of at least five IEGs.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	graham.carpenter@mcmail.vanderbilt.edu			NCI NIH HHS [CA75195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Ji QS, 1999, MOL CELL BIOL, V19, P4961; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; KASHISHIAN A, 1993, MOL BIOL CELL, V4, P49, DOI 10.1091/mbc.4.1.49; LAROSE L, 1993, ONCOGENE, V8, P2493; Montmayeur JP, 1997, J BIOL CHEM, V272, P32670, DOI 10.1074/jbc.272.51.32670; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590	25	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8627	8630		10.1074/jbc.C100030200	http://dx.doi.org/10.1074/jbc.C100030200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254653	hybrid			2022-12-27	WOS:000167607700002
J	Ren, XY; Kasir, J; Rahamimoff, H				Ren, XY; Kasir, J; Rahamimoff, H			The transport activity of the Na+-Ca2+ exchanger NCX1 expressed in HEK 293 cells is sensitive to covalent modification of intracellular cysteine residues by sulfhydryl reagents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; SINGLE CYSTEINE; TOPOLOGY; MUTANTS; CLONING; REGION; RBE-1; MODEL; SITE	Membrane permeable N-ethylmaleimide (NEM) and (2-aminoethyl)methanethiosulfonatehydrobromide (MTSEA) inhibited the rat brain Na+-Ca2+ exchanger RBE-2 (NCX1.5) expressed in HEK 293 cells in a dose dependent manner. 50% inhibition was obtained at 1 mM MTSEA and 1.65 mM NEM, External application of membrane impermeable [2-(trimethylammonium)ethyl]methanethiosulfonatebromide (MTSET) and sodium(2-sulfonatoethyl)methanethiosulfonate (MTSES) did not inhibit the transport activity in whole cells, Following reconstitution, however, of RBE-2 transfected, cell proteins into proteoliposomes, external application of MTSET and MTSES led to decrease in transport activity to 42.7 (S.D. = 9.1) and 51% (S.D. = 10.14), respectively. Similar results were obtained also when the rat heart isoform RHE-1 (NCX1.1) or the rat brain isoform RBE-1 (NCX1.4) was expressed. NEM and MTSEA inhibited Na+ gradient-dependent Ca2+ uptake also in HEK 293 cells expressing RBE-2/C14A/C20S/C122S/C780S (numbering corresponds to RBE-2), a mutant in which all putative extracellular cysteines were exchanged. To study the accessibility of different cysteines to covalent modification, surface biotinylation of cells expressing the wild type exchanger and its mutants was carried out using 3-(N-maleimidylpropionyl)biocytin. Surface biotinylation revealed immunoreactive protein derived from the wild type Na+-Ca2+ exchanger only if the transfected cells were exposed to the reducing agent Tris(2-carboxyethyl)phosphine. No reduction was needed when the single cysteine mutants of RBE-2, C14A, C20S, and C780S, were expressed. Treatment of the cells expressing these mutants with MTSET before biotinylation, led to a decrease in the amount of exchanger protein that was revealed. No immunoreactive protein was detected when the quadruple mutant RBE-2, C14A/C20S/C122S/C780S, was biotinylated, suggesting that no additional cysteines are accessible directly from the extracellular face of the membrane. Permeabilizing the cells expressing RBE-2/C14A/C20S/C122S/C780S with streptolysin O resulted in biotinylation of the exchanger protein. Its amount decreased if exposure to NEM preceded streptolysin O treatment. Our results suggest that Na+-Ca2+ exchange activity is inhibited by covalent modification with sulfhydryl reagents of cysteine residues that are accessible from the cytoplasmic face of the membrane.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Rahamimoff, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.	Hannah@cc.huji.ac.il						BARZILAI A, 1987, BIOCHEMISTRY-US, V26, P6113, DOI 10.1021/bi00393a025; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; DIPOLO R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P75, DOI 10.1016/0005-2736(93)90383-B; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; FURMAN I, 1995, J BIOL CHEM, V270, P19120, DOI 10.1074/jbc.270.32.19120; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Harlow E., 1988, ANTIBODIES LAB MANUA; HAZAMA S, 1983, Hokkaido Journal of Medical Science, V58, P354; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Kasir J, 1999, J BIOL CHEM, V274, P24873, DOI 10.1074/jbc.274.35.24873; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; LOW W, 1993, FEBS LETT, V316, P63, DOI 10.1016/0014-5793(93)81737-K; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; ORLICKY J, 1987, GEN PHYSIOL BIOPHYS, V6, P155; PIERCE GN, 1986, J MEMBRANE BIOL, V94, P217, DOI 10.1007/BF01869717; Ren X, 1999, NEUROSCI LETT, pS34; Ruegg U T, 1977, Methods Enzymol, V47, P111; Santacruz-Toloza L, 2000, J BIOL CHEM, V275, P182, DOI 10.1074/jbc.275.1.182; Shafer DE, 2000, ANAL BIOCHEM, V282, P161, DOI 10.1006/abio.2000.4609; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942	25	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9572	9579		10.1074/jbc.M007823200	http://dx.doi.org/10.1074/jbc.M007823200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134012	hybrid			2022-12-27	WOS:000167607700126
J	Gao, TY; Cuadra, AE; Ma, H; Bunemann, M; Gerhardstein, BL; Cheng, T; Ten Eick, R; Hosey, MM				Gao, TY; Cuadra, AE; Ma, H; Bunemann, M; Gerhardstein, BL; Cheng, T; Ten Eick, R; Hosey, MM			C-terminal fragments of the alpha(1C) (Ca(v)1.2) subunit associate with and regulate L-type calcium channels containing C-terminal-truncated alpha(1C) subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CLASS-C; 2 SIZE FORMS; CA2+ CHANNELS; MEDIATED PHOSPHORYLATION; TRANSFECTED CELLS; ALPHA-1 SUBUNIT; BETA-SUBUNIT; DIHYDROPYRIDINE; IDENTIFICATION; PROTEINS	L-type Ca2+ channels in native tissues have been found to contain a pore-forming alpha (1) subunit that is often truncated at the C terminus. However, the C terminus contains many important domains that regulate channel function. To test the hypothesis that C-terminal fragments may associate with and regulate C-terminal-truncated alpha (1C) (Ca(V)1.2) subunits, we performed electrophysiological and biochemical experiment, In tsA201 cells expressing either wild type or C-terminal-truncated alpha (1C) subunits in combination with a beta (2a) subunit, truncation of the alpha (1C) subunit by as little as 147 amino acids led to a 10-15-fold increase in currents compared with those obtained from control, full-length alpha (1C) subunits, Dialysis of cells expressing the truncated alpha (1C) subunits with C-terminal fragments applied through the patch pipette reconstituted the inhibition of the channels seen with full-length alpha (1C) Subunits. In addition, C-terminal deletion mutants containing a tethered C terminus also exhibited the C-terminal-induced inhibition. Immunoprecipitation assays demonstrated the association of the C-terminal fragments with truncated alpha (1C) subunits, In addition, glutathione S-transferase pull-down assays demonstrated that the C-terminal inhibitory fragment could associate with at least two domains within the C terminus. The results support the hypothesis the C-terminal fragments of the alpha (1C) subunit can associate with C-terminal-truncated alpha (1C) subunits and inhibit the currents through L-type Ca2+ channels.	Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University	Ten Eick, R (corresponding author), Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 303 E Chicago Ave S215, Chicago, IL 60611 USA.				NHLBI NIH HHS [HL23306] Funding Source: Medline; NIDDK NIH HHS [T32-DK07169] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023306, R01HL023306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRAWLEY RM, 1992, J BIOL CHEM, V267, P18218; BROWN KC, 1995, BIOCHEMISTRY-US, V34, P4733, DOI 10.1021/bi00014a030; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; CHANG FC, 1988, J BIOL CHEM, V263, P18929; CHEUNG W Y, 1982, Journal of Cyclic Nucleotide Research, V7, P71; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; De Waard M, 1996, Ion Channels, V4, P41; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HELL JW, 1993, J BIOL CHEM, V268, P19451; Hosey MM, 1996, TRENDS CARDIOVAS MED, V6, P265, DOI 10.1016/S1050-1738(96)00109-0; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Puri TS, 1997, BIOCHEMISTRY-US, V36, P9605, DOI 10.1021/bi970500d; PURI TS, 1998, THESIS NW U; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; WEI XY, 1994, J BIOL CHEM, V269, P1635	27	99	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21089	21097		10.1074/jbc.M008000200	http://dx.doi.org/10.1074/jbc.M008000200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274161	hybrid			2022-12-27	WOS:000169297900041
J	Li, JP; Gong, F; El Darwish, K; Jalkanen, M; Lindahl, U				Li, JP; Gong, F; El Darwish, K; Jalkanen, M; Lindahl, U			Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-DEACETYLASE/N-SULFOTRANSFERASE; HEPARIN/HEPARAN SULFATE; MOLECULAR-CLONING; MAST-CELLS; INSITU HYBRIDIZATION; CHONDROITIN SULFATE; EXPRESSION; MICE; MOUSE; 2-SULFOTRANSFERASE	The murine gene for the glucuronyl C5-epimerase involved in heparan sulfate biosynthesis was cloned, using a previously isolated bovine lung cDNA fragment (Li, J.-P., Hagner-McWhirter, A. Kjellen, L., Palgi, J., Jalkanen, M., and Lindahl, U. (1997) J. Biol. Chem. 272, 28158-28163) as probe. The similar to 11-kilobase pair mouse gene contains 3 exons from the first ATG to stop codon and is localized to chromosome 9. Southern analysis of the genomic DNA and chromosome mapping suggested the occurrence of a single epimerase gene. Based on the genomic sequence, a mouse liver cDNA was isolated that encodes a 618-amino acid residue protein, thus extending by 174 N terminal residues the sequence deduced from the (incomplete) bovine cDNA. Comparison of murine, bovine, and human epimerase cDNA structures indicated 96-99% identity at the amino acid level. A cDNA identical to the mouse liver species was demonstrated in mouse mast cells committed to heparin biosynthesis. These findings suggest that the iduronic acid residues in heparin and heparan sulfate, despite different structural contexts, are generated by the same C5-epimerase enzyme. The catalytic activity of the recombinant full-length mouse liver epimerase, expressed in insect cells, was found to be >2 orders of magnitude higher than that of the previously cloned, smaller bovine recombinant protein. The similar to 52-kDa, similarly highly active, enzyme originally purified from bovine liver (Campbell, P., Hannesson, H. H., Sandback, D., Roden, L., Lindahl, U., and Li, J.-P. (1994) J. Biol. Chem. 269, 26953-26958) was found to be associated with an 22-kDa peptide generated by a single proteolytic cleavage of the full-sized protein.	Uppsala Univ, Dept Med Biochem & Microbiol, Ctr Biomed, SE-75123 Uppsala, Sweden; BioTie Therapies Corp, Turku Technol Ctr, FIN-20520 Turku, Finland	Uppsala University	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Ctr Biomed, Box 852, SE-75123 Uppsala, Sweden.							Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; BERNFIELD M, 1992, ANN REV CELL BIOL, V8, P333; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; CASU B, 2001, IN PRESS ADV CARBOHY; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; FURTH J, 1957, P SOC EXP BIOL MED, V95, P824; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JACOBSSON KG, 1985, J BIOL CHEM, V260, P2154; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; LIDHOLT K, 1995, BIOCHEM J, V311, P233, DOI 10.1042/bj3110233; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LYON M, 1994, J BIOL CHEM, V269, P11216; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; RONG J, 2001, IN PRESS BIOCHEMISTR; Rong JH, 2000, BIOCHEM J, V346, P463, DOI 10.1042/0264-6021:3460463; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sambrook J., 2002, MOL CLONING LAB MANU; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170	38	53	64	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20069	20077		10.1074/jbc.M011783200	http://dx.doi.org/10.1074/jbc.M011783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274177	hybrid			2022-12-27	WOS:000169135100054
J	Park, K; Verchere, CB				Park, K; Verchere, CB			Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide - Implications for islet amyloid formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; ALZHEIMERS-DISEASE; IN-VITRO; SECRETORY GRANULES; APOLIPOPROTEIN-E; BETA-CELLS; A-BETA; SULFATE PROTEOGLYCANS; PRECURSOR PROTEIN; PANCREATIC-ISLETS	Islet amyloid deposits are a characteristic pathologic lesion of the pancreas in type 2 diabetes and are composed primarily of the islet beta cell peptide islet amyloid polypeptide (IAPP or amylin) as well as the basement membrane heparan sulfate proteoglycan perlecan. Impaired processing of the IAPP precursor has been implicated in the mechanism of islet amyloid formation. The Nand C-terminal cleavage sites where pro-LAPP is processed by prohormone convertases contain a series of basic amino acid residues that we hypothesized may interact with heparan sulfate proteoglycans. This possibility was tested using affinity chromatography by applying synthetic fragments of pro-IAPP to heparin-agarose and heparan sulfate-Sepharose. An N-terminal human pro-IAPP fragment (residues 1-30) was retained by both heparin-agarose and heparan sulfate-Sepharose, eluting at 0.18 M NaCl at pH 7.5. Substitution of alanine residues for two basic residues in the N-terminal cleavage site abolished heparin and heparan sulfate binding activity. At pH 5.5, the affinity of the wild-type peptide for heparin/heparan sulfate was increased, implying a role far histidine residues at positions 6 and 28 of pro-IAPP. A C-terminal pro-IAPP fragment (residues 41-67) had no specific affinity for either heparin or heparan sulfate, and the N- or C-terminal fragments had only weak affinity for chondroitin sulfate. These data suggest that monomeric N-terminal human pro-IAPP contains a heparin binding domain that is lost during normal processing of pro-IAPP.	Univ British Columbia, British Columbia Res Inst Childrens & Womens Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada	University of British Columbia	Verchere, CB (corresponding author), Univ British Columbia, British Columbia Res Inst Childrens & Womens Hlth, Dept Pathol & Lab Med, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.							Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; ANCSIN JB, 2001, IN PRESS METHODS MOL; BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Charge SBP, 1996, J PATHOL, V179, P443; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; CLARK A, 1989, CELL TISSUE RES, V257, P179; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DEKONING EJP, 1994, P NATL ACAD SCI USA, V91, P8467, DOI 10.1073/pnas.91.18.8467; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; HALBAN PA, 1994, BIOCHEM J, V299, P1; Higham CE, 2000, EUR J BIOCHEM, V267, P4998, DOI 10.1046/j.1432-1327.2000.01548.x; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Hou X, 1999, DIABETOLOGIA, V42, P188, DOI 10.1007/s001250051138; Inoue S, 1996, LAB INVEST, V74, P670; JI ZS, 1993, J BIOL CHEM, V268, P10160; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; KANATSUKA A, 1989, FEBS LETT, V259, P199, DOI 10.1016/0014-5793(89)81527-3; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Kudva YC, 1998, BIOCHEM J, V331, P809, DOI 10.1042/bj3310809; Larson JL, 2000, PROTEIN SCI, V9, P427; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; OGAWA A, 1990, J CLIN INVEST, V85, P973, DOI 10.1172/JCI114528; Passafaro M, 1996, J BIOL CHEM, V271, P30096, DOI 10.1074/jbc.271.47.30096; PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Verchere CB, 2000, DIABETES, V49, P1477, DOI 10.2337/diabetes.49.9.1477; Wang J, 2001, DIABETES, V50, P534, DOI 10.2337/diabetes.50.3.534; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; WESTERMARK P, 1987, AM J PATHOL, V127, P414; WESTERMARK P, 1989, DIABETES RES CLIN PR, V7, P219, DOI 10.1016/0168-8227(89)90008-9; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	53	84	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16611	16616		10.1074/jbc.M008423200	http://dx.doi.org/10.1074/jbc.M008423200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11145957	hybrid			2022-12-27	WOS:000168730400004
J	van der Wal, J; Habets, R; Varnai, P; Balla, T; Jalink, K				van der Wal, J; Habets, R; Varnai, P; Balla, T; Jalink, K			Monitoring agonist-induced phospholipase C activation in live cells by fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ADRENAL GLOMERULOSA CELLS; INOSITOL 1,4,5-TRISPHOSPHATE; LYSOPHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; NEUROKININ RECEPTORS; NEURITE RETRACTION; CA2+ OSCILLATIONS; PLASMA-MEMBRANE; LIVING CELLS	Agonist-induced intracellular Ca2+ signals following phospholipase C (PLC) activation display a variety of patterns, including transient, sustained, and oscillatory behavior. These Ca2+ changes have been well characterized, but detailed kinetic analyses of PLC activation in single living cells is lacking, due to the absence of suitable indicators for use in vivo. Recently, green fluorescent protein-tagged pleckstrin homology domains have been employed to monitor PLC activation in single cells, based on (confocal) imaging of their fluorescence translocation from the membrane to the cytosol that occurs upon hydrolysis of phosphatidylinositol bisphosphate, Here we describe fluorescence resonance energy transfer between pleckstrin homology domains of PLC delta1 tagged with cyan and yellow fluorescent proteins as a sensitive readout of phosphatidylinositol bisphosphate metabolism for use both in cell populations and in single cells. Fluorescence resonance energy transfer requires significantly less excitation intensity, enabling prolonged and fast data acquisition without the cell damage that limits confocal experiments. It also allows experiments on motile or extremely flat cells, and can be scaled to record from cell populations as well as single neurites, Characterization of responses to various agonists by this method reveals that stimuli that elicit very similar Ca2+ mobilization responses can exhibit widely different kinetics of PLC activation, and that the latter appears to follow receptor activation more faithfully than the cytosolic Ca2+ transient.	Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; NIH, Endocrinol & Reprod Res Branch, Bethesda, MD 20892 USA	Netherlands Cancer Institute; National Institutes of Health (NIH) - USA	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.			Jalink, Kees/0000-0001-7019-3440; Balla, Tamas/0000-0002-9077-3335	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBLAS J, 1995, J BIOL CHEM, V270, P8944, DOI 10.1074/jbc.270.15.8944; ALBLAS J, 1993, J BIOL CHEM, V268, P22235; Alblas J, 1996, EMBO J, V15, P3351, DOI 10.1002/j.1460-2075.1996.tb00700.x; BALLA T, 1994, J BIOL CHEM, V269, P16101; CHAU LY, 1993, J NEUROCHEM, V60, P454, DOI 10.1111/j.1471-4159.1993.tb03172.x; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Dupont G, 1998, BIOESSAYS, V20, P607, DOI 10.1002/(SICI)1521-1878(199808)20:8<607::AID-BIES2>3.3.CO;2-2; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; HUNYADY L, 1991, J BIOL CHEM, V266, P2783; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lankiewicz L, 1997, ACTA BIOCHIM POL, V44, P477, DOI 10.18388/abp.1997_4398; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MIYAWAKI A, 2000, IN PRESS CALCIUM SIG, P3; MYERS DE, 1989, CELL SIGNAL, V1, P335, DOI 10.1016/0898-6568(89)90052-1; Paltauf-Doburzynska J, 2000, J PHYSIOL-LONDON, V524, P701, DOI 10.1111/j.1469-7793.2000.00701.x; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STEPHENS L, 1993, BIOCHEM J, V296, P481, DOI 10.1042/bj2960481; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TILLY BC, 1990, BIOCHEM J, V266, P235, DOI 10.1042/bj2660235; TILLY BC, 1988, BIOCHEM J, V252, P857, DOI 10.1042/bj2520857; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WIJELATH ES, 1988, BIOCHEM BIOPH RES CO, V152, P392, DOI 10.1016/S0006-291X(88)80726-5; Zhang CY, 1996, MOL PHARMACOL, V50, P864; Zhu DM, 2000, J BIOL CHEM, V275, P6063, DOI 10.1074/jbc.275.9.6063	37	204	212	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15337	15344		10.1074/jbc.M007194200	http://dx.doi.org/10.1074/jbc.M007194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11152673	hybrid			2022-12-27	WOS:000168528800108
J	Low, WK; Lin, QS; Stathakis, C; Miao, M; Fletcher, GL; Hew, CL				Low, WK; Lin, QS; Stathakis, C; Miao, M; Fletcher, GL; Hew, CL			Isolation and characterization of skin-type, type I antifreeze polypeptides from the longhorn sculpin, Myoxocephalus octodecemspinosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WINTER FLOUNDER; SHORTHORN SCULPIN; PROTEIN; ICE; OCTODECIMSPINOSIS; EXPRESSION; GLYCOPROTEINS; CONSERVATION; MECHANISMS; EVOLUTION	The antifreeze polypeptides (AFPs) are found in several marine fish and have been grouped into four distinct biochemical classes (type I-IV), Recently, the new subclass of skin-type, type I AFPs that are produced intracellularly as mature polypeptides have been identified in the winter flounder (Pleuronectes americanus) and the shorthorn sculpin (Myoxocephalus scorpius). This study demonstrates the presence of skin-type AFPs in the longhorn sculpin (Myoxocephalus octodecemspinosus), which produces type IV serum AFPs. Using polymerase chain reaction-based methods, a clone that encoded for a type I AFP was identified. The clone lacked a signal sequence, indicating that the mature polypeptide is produced in the cytosol, A recombinant protein was produced in Escherichia coli and antifreeze activity was characterized, Four individual Ala-rich polypeptides with antifreeze activity mere isolated from the skin tissue. One polypeptide was completely sequenced by tandem MS. This study provides the first evidence of a fish species that produces two different biochemical classes of antifreeze proteins (type I and type IV), and enforces the notion that skin-type AFPs are a widespread biological phenomenon in fish.	Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Hosp Sick Children, Div Struct Biol & Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada	National University of Singapore; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Memorial University Newfoundland	Hew, CL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore.		Lin, Qingsong/H-9794-2012; Hew, Choy Leong/I-1501-2012	Lin, Qingsong/0000-0001-9117-8514; Hew, Choy Leong/0000-0002-9441-0064				Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; CHAKRABARTTY A, 1991, EUR J BIOCHEM, V202, P1057, DOI 10.1111/j.1432-1033.1991.tb16470.x; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11313; CHAKRABARTTY A, 1988, CAN J ZOOL, V66, P403, DOI 10.1139/z88-057; Cheng AL, 1997, BIOPHYS J, V73, P2851, DOI 10.1016/S0006-3495(97)78315-2; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; DAVIES PL, 1992, GENE, V112, P171, DOI 10.1016/0378-1119(92)90373-W; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; Deng GJ, 1998, BBA-PROTEIN STRUCT M, V1388, P305, DOI 10.1016/S0167-4838(98)00180-0; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; DEVRIES AL, 1983, ANNU REV PHYSIOL, V45, P245, DOI 10.1146/annurev.ph.45.030183.001333; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; FEENEY RE, 1986, ANNU REV BIOPHYS BIO, V15, P59; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; Hays LM, 1996, P NATL ACAD SCI USA, V93, P6835, DOI 10.1073/pnas.93.13.6835; HEW CL, 1980, CAN J BIOCHEM CELL B, V58, P377, DOI 10.1139/o80-049; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; HEW CL, 1992, EUR J BIOCHEM, V203, P33, DOI 10.1111/j.1432-1033.1992.tb19824.x; Lin GS, 1999, FEBS LETT, V453, P331, DOI 10.1016/S0014-5793(99)00752-8; Lin QS, 1999, EUR J BIOCHEM, V264, P49, DOI 10.1046/j.1432-1327.1999.00569.x; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Low WK, 1998, J BIOL CHEM, V273, P23098, DOI 10.1074/jbc.273.36.23098; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; WEN DY, 1992, J BIOL CHEM, V267, P14102; YANG DSC, 1988, NATURE, V333, P232, DOI 10.1038/333232a0; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhao ZH, 1998, BBA-PROTEIN STRUCT M, V1382, P177, DOI 10.1016/S0167-4838(97)00197-0	29	23	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11582	11589		10.1074/jbc.M009293200	http://dx.doi.org/10.1074/jbc.M009293200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11136728	hybrid			2022-12-27	WOS:000168081800024
J	Surtees, JA; Funnell, BE				Surtees, JA; Funnell, BE			The DNA binding domains of P1 ParB and the architecture of the P1 plasmid partition complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; PROTEIN SECONDARY STRUCTURE; BACTERIAL PLASMIDS; CHROMOSOME; SPECIFICITY; SITE; ORGANIZATION; LOCALIZATION; RECOGNITION; SPORULATION	Stable maintenance of P1 plasmids in Escherichia coli is mediated by a high affinity nucleoprotein complex called the partition complex, which consists of ParB and the E. coli integration host factor (IHF) bound specifically to the P1 parS site. IHF strongly stimulates ParB binding to parS, and the minimal partition complex contains a single dimer of ParB, To examine the architecture of the partition complex, we have investigated the DNA binding activity of various ParB fragments. Gel mobility shift and DNase I protection assays showed that the first 141 residues of ParB are dispensable for the formation of the minimal, high affinity partition complex. A fragment missing only the last 16 amino acids of ParB bound specifically to parS, but binding was weak and was no longer stimulated by IHF. The ability of IHF to stimulate ParB binding to parS correlated with the ability of ParB to dimerize via its C terminus. Using full and partial parS sites, we show that two regions of ParB, one in the center and the other near the C terminus of the protein, interact with distinct sequences within parS. Based on these data, we have proposed a model of how the ParB dimer binds parS to form the minimal partition complex.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto	Funnell, BE (corresponding author), Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada.			Funnell, Barbara/0000-0002-1828-6567				ABELES AL, 1985, J MOL BIOL, V185, P261, DOI 10.1016/0022-2836(85)90402-4; Bouet JY, 2000, J BIOL CHEM, V275, P8213, DOI 10.1074/jbc.275.11.8213; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; DAVIS MA, 1990, EMBO J, V9, P991, DOI 10.1002/j.1460-2075.1990.tb08201.x; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; DAVIS MA, 1988, EMBO J, V7, P1881, DOI 10.1002/j.1460-2075.1988.tb03021.x; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; FUNNELL BE, 1988, J BACTERIOL, V170, P954, DOI 10.1128/JB.170.2.954-960.1988; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; FUNNELL BE, 1994, BIOCHIMIE, V76, P924, DOI 10.1016/0300-9084(94)90017-5; Gal-Mor O, 1998, GENE, V217, P83, DOI 10.1016/S0378-1119(98)00357-6; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; HAYES F, 1993, P NATL ACAD SCI USA, V90, P9228, DOI 10.1073/pnas.90.19.9228; HAYES F, 1994, J MOL BIOL, V243, P190, DOI 10.1006/jmbi.1994.1646; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; MARTIN KA, 1991, J BACTERIOL, V173, P3630, DOI 10.1128/JB.173.12.3630-3634.1991; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; MORI H, 1989, J BIOL CHEM, V264, P15535; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Radnedge L, 1998, EMBO J, V17, P6076, DOI 10.1093/emboj/17.20.6076; Radnedge L, 1996, EMBO J, V15, P1155, DOI 10.1002/j.1460-2075.1996.tb00454.x; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sambrook J., 2002, MOL CLONING LAB MANU; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Surtees JA, 1999, J BACTERIOL, V181, P5898, DOI 10.1128/JB.181.19.5898-5908.1999; WILLIAMS DR, 1992, J GEN MICROBIOL, V138, P1; Youngren B, 2000, J BACTERIOL, V182, P3924, DOI 10.1128/JB.182.14.3924-3928.2000	37	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12385	12394		10.1074/jbc.M009370200	http://dx.doi.org/10.1074/jbc.M009370200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11150297	hybrid			2022-12-27	WOS:000168081800126
J	Verine, A; Le Petit-Thevenin, J; Panicot-Dubois, L; Valette, A; Lombardo, D				Verine, A; Le Petit-Thevenin, J; Panicot-Dubois, L; Valette, A; Lombardo, D			Phosphorylation of the oncofetal variant of the human bile salt-dependent lipase - Identification of phosphorylation site and relation with secretion process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL ESTER LIPASE; PANCREATIC CHOLESTEROL ESTERASE; MOLECULAR-CLONING; STIMULATED LIPASE; CDNA CLONING; CELLS; HYDROLASE; PURIFICATION; PROTEIN; LYSOPHOSPHOLIPASE	In this paper, we report, for the first time, the localization of the phosphorylation site of the fetoacinar pancreatic protein (FAPP), which is an oncofetal variant of the pancreatic bile salt-dependent lipase. Using Chinese hamster ovary (CHO) cells transfected with the cDNA encoding FAPP, we radiolabeled the enzyme with P-32, and then the protein was purified by affinity chromatography on cholate-immobilized Sepharose column and submitted to a CNBr hydrolysis. Analysis of peptides by high pressure liquid chromatography, associated with the radioactivity profile, revealed that the phosphorylation site is located at threonine 340, Site-specific mutagenesis experiments, in which the threonine was replaced by an alanine residue, were used to invalidate the phosphorylation of FAPP and to study the influence of the modification on the activity and secretion of the enzyme. These studies showed that CHO cells, transfected with the mutated cDNA of FAPP, kept all of their ability to synthesize the protein, but the loss of the phosphorylation motif prevented the release of the protein in the extracellular compartment, However, the mutated enzyme, which was sequestrated in the transfected CHO cells, remains active on bile salt-dependent lipase substrates.	Fac Med Marseille, INSERM, U260, F-13385 Marseille 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Verine, A (corresponding author), Fac Med Marseille, INSERM, U260, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.		Panicot-Dubois, Laurence/E-3030-2016	Panicot-Dubois, Laurence/0000-0003-0848-5009				ABOUAKIL N, 1988, BIOCHIM BIOPHYS ACTA, V961, P299, DOI 10.1016/0005-2760(88)90077-X; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; BRUNEAU N, 1995, EUR J BIOCHEM, V233, P209, DOI 10.1111/j.1432-1033.1995.209_1.x; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Caillol N, 2000, J CELL BIOCHEM, V79, P628, DOI 10.1002/1097-4644(20001215)79:4<628::AID-JCB120>3.0.CO;2-T; COLWELL NS, 1993, BIOCHIM BIOPHYS ACTA, V1172, P175, DOI 10.1016/0167-4781(93)90288-O; ESCRIBANO MJ, 1989, J BIOL CHEM, V264, P21865; GJELLESVIK DR, 1992, BIOCHIM BIOPHYS ACTA, V1124, P123, DOI 10.1016/0005-2760(92)90088-D; GOLDBERG E, 1972, J BIOL CHEM, V247, P2044; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; KYGER EM, 1989, BIOCHEM BIOPH RES CO, V164, P1302, DOI 10.1016/0006-291X(89)91811-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Petit-Thevenin J, 2001, BBA-MOL CELL BIOL L, V1530, P184, DOI 10.1016/S1388-1981(00)00181-5; LINDSTROM MB, 1988, BIOCHIM BIOPHYS ACTA, V959, P178, DOI 10.1016/0005-2760(88)90029-X; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Madeyski K, 1999, GENE, V239, P273, DOI 10.1016/S0378-1119(99)00410-2; MAS E, 1993, BIOCHEM J, V289, P609, DOI 10.1042/bj2890609; MIRALLES F, 1993, EUR J CELL BIOL, V60, P115; Panicot L, 1999, GLYCOBIOLOGY, V9, P935, DOI 10.1093/glycob/9.9.935; Pasqualini E, 1997, BIOCHEM J, V327, P527, DOI 10.1042/bj3270527; Pasqualini E, 1998, J BIOL CHEM, V273, P28208, DOI 10.1074/jbc.273.43.28208; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; REICHSTEINER M, 1996, TRENDS BIOCHEM SCI, V21, P267; REUE K, 1991, J LIPID RES, V32, P267; Sbarra V, 1998, BBA-LIPID LIPID MET, V1393, P80, DOI 10.1016/S0005-2760(98)00067-8; SHAMIR R, 1995, BIOCHEMISTRY-US, V34, P6351, DOI 10.1021/bi00019a013; SUGO T, 1993, EUR J BIOCHEM, V216, P799, DOI 10.1111/j.1432-1033.1993.tb18200.x; Verine A, 1999, BIOCHEM J, V342, P179, DOI 10.1042/0264-6021:3420179; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743	32	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12356	12361		10.1074/jbc.M008658200	http://dx.doi.org/10.1074/jbc.M008658200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11148205	hybrid			2022-12-27	WOS:000168081800122
J	Baumann, CT; Maruvada, P; Hager, GL; Yen, PM				Baumann, CT; Maruvada, P; Hager, GL; Yen, PM			Nuclear cytoplasmic shuttling by thyroid hormone receptors - Multiple protein interactions are required for nuclear retention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-DEPENDENT DEGRADATION; HUMAN ESTROGEN-RECEPTOR; RETINOIC ACID RECEPTOR; GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; LIVING CELLS; HISTONE ACETYLTRANSFERASE; MEDIATED PROTEOLYSIS; ANDROGEN RECEPTOR; BINDING DOMAIN	In this report, we have studied the intracellular dynamics and distribution of the thyroid hormone receptor-beta (TR beta) in living cells, utilizing fusions to the green fluorescent protein. Wild-type TB beta was mostly nuclear in both the absence and presence of triiodothyronine; however, triiodothyronine induced a nuclear reorganization of TR beta. By mutating defined regions of TR beta, we found that both nuclear corepressor and retinoid X receptor are involved in maintaining the unliganded receptor within the nucleus. A TR beta mutant defective in DNA binding had only a slightly altered nuclear/cytoplasmic distribution compared with wild-type TR beta; thus, site-specific DNA binding is not essential for maintaining TR beta within the nucleus. Both AT beta depletion studies and heterokaryon analysis demonstrated that TR beta rapidly shuttles between the nuclear and the cytoplasmic compartments. Cotransfection of nuclear corepressor and retinoid X receptor markedly decreased the shuttling by maintaining unliganded TR beta within the nucleus. In summary, our findings demonstrate that TR beta rapidly shuttles between the nucleus and the cytoplasm and that protein-protein interactions of TR beta with various cofactors, rather than specific DNA interactions, play the predominant role in determining the intracellular distribution of the receptor.	NCI, Lab Recept Biol & Gene Express, Bethesda, MD 20892 USA; NIDDKD, Mol Regulat & Neuroendocrinol Sect, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hager, GL (corresponding author), NCI, Lab Recept Biol & Gene Express, 41 Lib Dr,Bldg 41,Rm B602, Bethesda, MD 20892 USA.		Yen, Paul M/V-9857-2019	Yen, Paul/0000-0002-3790-8114	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; Baumann CT, 1999, CELL BIOCHEM BIOPHYS, V31, P119, DOI 10.1007/BF02738167; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; GANNON F, 1976, STEROIDS, V28, P669, DOI 10.1016/0039-128X(76)90008-8; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; GOVINDAN MV, 1980, EXP CELL RES, V127, P293, DOI 10.1016/0014-4827(80)90435-8; GOVINDAN MV, 1985, NUCLEIC ACIDS RES, V13, P8293, DOI 10.1093/nar/13.23.8293; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; HOUSLEY PR, 1990, J BIOL CHEM, V265, P12778; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Koenig RJ, 1998, THYROID, V8, P703, DOI 10.1089/thy.1998.8.703; LEFEBVRE P, 1988, BIOCHEMISTRY-US, V27, P9186, DOI 10.1021/bi00426a017; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Liu Y, 1998, MOL ENDOCRINOL, V12, P34, DOI 10.1210/mend.12.1.0046; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nickerson JA, 1995, INT REV CYTOL, V162A, P67; OPPENHEIMER JH, 1975, ENDOCR RES COMMUN, V2, P309, DOI 10.1080/07435807509089004; PAPAMICHAIL M, 1980, EXP CELL RES, V125, P490, DOI 10.1016/0014-4827(80)90144-5; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, P69; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; SAMUELS HH, 1973, SCIENCE, V181, P1253, DOI 10.1126/science.181.4106.1253; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; SPINDLER BJ, 1975, J BIOL CHEM, V250, P4113; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; SUGAWARA A, 1994, J BIOL CHEM, V269, P433; Syvala H, 1998, LIFE SCI, V63, P1505, DOI 10.1016/S0024-3205(98)00417-2; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Ting YT, 1997, J BIOL CHEM, V272, P4129, DOI 10.1074/jbc.272.7.4129; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; VANSTEENSEL B, 1995, J CELL BIOCHEM, V57, P465, DOI 10.1002/jcb.240570312; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; YEN PM, 1995, ENDOCRINOLOGY, V136, P2845, DOI 10.1210/en.136.7.2845; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zamir I, 1997, P NATL ACAD SCI USA, V94, P14400, DOI 10.1073/pnas.94.26.14400; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	57	113	116	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11237	11245		10.1074/jbc.M011112200	http://dx.doi.org/10.1074/jbc.M011112200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152480	hybrid			2022-12-27	WOS:000167980900089
J	Damia, G; Sanchez, Y; Erba, E; Broggini, M				Damia, G; Sanchez, Y; Erba, E; Broggini, M			DNA damage induces p53-dependent down-regulation of hCHK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; CHECKPOINT PATHWAY; PROTEIN-KINASE; FISSION YEAST; P53; CHK1; PHOSPHORYLATION; CDC25; CDS1; REPLICATION	The levels of the human checkpoint gene hCHK1 were measured in human cancer cells growing in vitro after treatment with the DNA damaging agent cis-dichlorodiammine platinum(II) (DDP), Treatment of human cancer cell lines with DDP induced a decrease in the hCHK1 protein levels starting 6 h after treatment, with a further decline at 24 and 48 h, A similar decrease in the levels of hCHK1 was found at the mRNA level by using Northern blot analysis. By using isogenic cell systems in which p53 was disrupted either by transfection with HPV-EG or by targeted homologous recombination, we found that the DNA damage-induced down-regulation of hCHK1 was only observable in wild type p53-expressing cells, with only a minor decline in the hCHK1 levels observable 48 h after treatment in cells with disrupted p53, Similarly, treatment of mutant p53-expressing human cancer cell lines with DDP did not result in changes in the levels of hCHK1. The p53-dependent down-regulation of hCHK1 is likely to be at transcriptional levels, as suggested by the lack of down-regulation of the hCHK1 when transfected under the control of a heterologous viral promoter. In addition, p53 is able to downregulate the luciferase activity under the control of the 5' flanking region of the hCHK1 gene. The data suggest a strict link between p53 and hCHK1 governing the activation and repression of the G(2) checkpoint in which both proteins participate.	Mario Negri Inst Pharmacol Res, Dept Oncol, Mol Pharmacol Unit, I-20157 Milan, Italy; Univ Cincinnati, Dept Mol Genet, Cincinnati, OH 45267 USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University System of Ohio; University of Cincinnati	Damia, G (corresponding author), Mario Negri Inst Pharmacol Res, Dept Oncol, Mol Pharmacol Unit, Via Eritrea 62, I-20157 Milan, Italy.		damia, giovanna/AAB-1428-2020; broggini, massimo/AAA-6460-2020	damia, giovanna/0000-0001-9749-434X; BROGGINI, MASSIMO/0000-0002-8138-9358				ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; BROGGINI M, 1991, CANCER RES, V51, P199; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chehab NH, 2000, GENE DEV, V14, P278; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; EL DW, 1993, CELL, V75, P817; FAN SJ, 1995, CANCER RES, V55, P1649; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Ko LJ, 1996, GENE DEV, V56, P2649; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Oren M., 1996, BIOCHIM BIOPHYS ACTA, V1288, P13, DOI DOI 10.1016/S0304-419X(96)00030-3; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Piwnica-Worms H, 1999, NATURE, V401, P535, DOI 10.1038/44029; Poon RYC, 1997, CANCER RES, V57, P5168; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Suganuma M, 1999, CANCER RES, V59, P5887; Tominaga K, 1999, J BIOL CHEM, V274, P31463, DOI 10.1074/jbc.274.44.31463; Vikhanskaya F, 1999, CLIN CANCER RES, V5, P937; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	39	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10641	10645		10.1074/jbc.M007178200	http://dx.doi.org/10.1074/jbc.M007178200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152453	hybrid			2022-12-27	WOS:000167980900012
J	Mills, KV; Paulus, H				Mills, KV; Paulus, H			Reversible inhibition of protein splicing by zinc ion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SPLIT INTEIN; DNAE GENE; IN-VITRO; MECHANISM	Protein splicing involves the self-catalyzed excision of a protein-splicing element, the intein, from flanking polypeptides, the exteins, which are concomitantly joined by a peptide bond. Taking advantage of recently developed in vitro systems in which protein splicing occurs in trans to assay for protein-splicing inhibitors, we discovered that low concentrations of Zn2+ inhibited splicing mediated both by the RecA intein from Mycobacterium tuberculosis and by the naturally split DnaE intein from Synechocystis sp. PCC6803. Inhibition by Zn2+ was also observed with a cis-splicing system involving the RecA intein. In all experimental systems used, inhibition by Zn2+ could be completely reversed by the addition of EDTA. Zinc ion also inhibited hydroxylamine-dependent N-terminal cleavage of the RecA intein. All other divalent transition metal ions tested were less effective as inhibitors than Zn2+. The reversible inhibition by Zn2+ should be useful in studies of the mechanism of protein splicing and allow structural studies of unmodified protein-splicing precursors.	Boston Biomed Res Inst, Watertown, MA 02742 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Boston Biomedical Research Institute; Harvard University; Harvard University; Harvard Medical School	Paulus, H (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02742 USA.	paulus@bbri.org	Wood, David W/B-2992-2012		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055875] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11301] Funding Source: Medline; NIGMS NIH HHS [R01 GM55875] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLEMAN JE, 1961, J BIOL CHEM, V236, P2244; DZELZKALNS VA, 1986, J BACTERIOL, V165, P964, DOI 10.1128/jb.165.3.964-971.1986; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; KASAHARA M, 1974, J BIOCHEM, V76, P967; Lew BM, 1998, J BIOL CHEM, V273, P15887, DOI 10.1074/jbc.273.26.15887; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Paul-Soto R, 1999, BIOCHEMISTRY-US, V38, P16500, DOI 10.1021/bi9911381; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Shingledecker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P138, DOI 10.1006/abbi.1999.1645; Shingledecker K, 1998, GENE, V207, P187, DOI 10.1016/S0378-1119(97)00624-0; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; SPENCER P, 1993, BIOCHEM J, V290, P279, DOI 10.1042/bj2900279; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Zhao SM, 2000, J BACTERIOL, V182, P1053, DOI 10.1128/JB.182.4.1053-1061.2000	21	54	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10832	10838		10.1074/jbc.M011149200	http://dx.doi.org/10.1074/jbc.M011149200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152694	hybrid			2022-12-27	WOS:000167980900038
J	White, WH; Gunyuzlu, PL; Toyn, JH				White, WH; Gunyuzlu, PL; Toyn, JH			Saccharomyces cerevisiae is capable of de novo pantothenic acid biosynthesis involving a novel pathway of beta-alanine production from spermine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE-B; ESCHERICHIA-COLI; CANDIDA-ALBICANS; BINDING SITE; YEAST; GENE; RESISTANCE; CLONING; ENCODES; IDENTIFICATION	Pantothenic acid and beta -alanine are metabolic intermediates in coenzyme A biosynthesis, Using a functional screen in the yeast Saccharomyces cerevisiae, a putative amine oxidase, encoded by FMS1, was found to be rate-limiting for beta -alanine and pantothenic acid biosynthesis. Overexpression of FMS1 caused excess pantothenic acid to be excreted into the medium, whereas deletion mutants required beta -alanine or pantothenic acid for growth. Furthermore, yeast genes ECM31 and YIL145c, which both have structural homology to genes of the bacterial pantothenic acid pathway, were also required for pantothenic acid biosynthesis. The homology of FMS1 to FAD-containing amine oxidases and its role in beta -alanine biosynthesis suggested that its substrates are polyamines. Indeed, we found that all the enzymes of the polyamine pathway in yeast are necessary for beta -alanine biosynthesis; spe1 Delta, spe2 Delta, spe3 Delta, and spe4 Delta are all beta -alanine auxotrophs, Thus, contrary to previous reports, yeast is naturally capable of pantothenic acid biosynthesis, and the beta -alanine is derived from methionine via a pathway involving spermine. These findings should facilitate the identification of further enzymes and biochemical pathways involved in polyamine degradation and pantothenic acid biosynthesis in S. cerevisiae and raise questions about these pathways in other organisms.	Dupont Pharmaceut Co, Expt Stn, Dept Appl Biotechnol, Wilmington, DE 19880 USA	DuPont	Toyn, JH (corresponding author), Dupont Pharmaceut Co, Expt Stn, Dept Appl Biotechnol, E336-239A,Rte 141 & Henry Clay Rd, Wilmington, DE 19880 USA.							BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Genschel U, 1999, BIOCHEM J, V341, P669, DOI 10.1042/0264-6021:3410669; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Glansdorff N, 1996, ESCHERICHIA COLI SAL, P408; Gunyuzlu PL, 2000, MOL BIOTECHNOL, V15, P29, DOI 10.1385/MB:15:1:29; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Jackowski S., 1996, ESCHERICHIA COLI SAL, P687; Joets J, 1996, CURR GENET, V30, P115, DOI 10.1007/s002940050109; Kurtov D, 1999, MOL GEN GENET, V262, P115, DOI 10.1007/s004380051065; KWAN SW, 1995, ARCH BIOCHEM BIOPHYS, V316, P385, DOI 10.1006/abbi.1995.1051; LARGE PJ, 1992, FEMS MICROBIOL LETT, V88, P249, DOI 10.1111/j.1574-6968.1992.tb04991.x; Leonian LH, 1942, AM J BOT, V29, P459, DOI 10.2307/2437311; Lussier M, 1997, GENETICS, V147, P435; MALLOY PJ, 1993, P NATL ACAD SCI USA, V90, P1902, DOI 10.1073/pnas.90.5.1902; MANIVASAKAM P, 1995, NUCLEIC ACIDS RES, V23, P2799, DOI 10.1093/nar/23.14.2799; Marcireau C, 1996, YEAST, V12, P531, DOI 10.1002/(SICI)1097-0061(199605)12:6<531::AID-YEA934>3.3.CO;2-5; PADMANABHAN R, 1972, ARCH BIOCHEM BIOPHYS, V150, P531, DOI 10.1016/0003-9861(72)90071-9; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; Sambrook J., 2002, MOL CLONING LAB MANU; Sherman F., 1986, METHODS YEAST GENETI; SLOTNICK IJ, 1957, J BACTERIOL, V74, P122, DOI 10.1128/JB.74.2.122-125.1957; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; ZHOU BP, 1995, J BIOL CHEM, V270, P23653, DOI 10.1074/jbc.270.40.23653; Zhou BP, 1998, J BIOL CHEM, V273, P14862, DOI 10.1074/jbc.273.24.14862	35	113	121	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10794	10800		10.1074/jbc.M009804200	http://dx.doi.org/10.1074/jbc.M009804200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154694	hybrid			2022-12-27	WOS:000167980900033
J	Bardwell, AJ; Flatauer, LJ; Matsukuma, K; Thorner, J; Bardwell, L				Bardwell, AJ; Flatauer, LJ; Matsukuma, K; Thorner, J; Bardwell, L			A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE RESPONSE PATHWAY; YEAST SACCHAROMYCES-CEREVISIAE; ANTHRAX LETHAL FACTOR; C-JUN; SUBSTRATE-SPECIFICITY; TRANSDUCTION PATHWAY; TRANSCRIPTION FACTOR; MUTATIONAL ANALYSIS; FILAMENTOUS-GROWTH; STRUCTURAL BASIS	The recognition of mitogen-activated protein kinases (MAPKs) by their upstream activators, MAPK/ERK kinases (MEKs), is crucial for the effective and accurate transmission of many signals. We demonstrated previously that the yeast MAPKs Kss1 and Fus3 bind with high affinity to the N terminus of the MEK Ste7, and proposed that a conserved motif in Ste7, the MAPK-docking site, mediates this interaction. Here we show that the corresponding sequences in human MEK1 and MEK2 are necessary and sufficient for the direct binding of the MAPKs ERK1 and ERK2, Mutations in MEK1, MEK2, or Ste7 that altered conserved residues in the docking site diminished binding of the cognate MAPKs, Furthermore, short peptides corresponding to the docking sites in these MEKs inhibited MEK1-mediated phosphorylation of ERK2 in vitro. In yeast cells, docking-defective alleles of Ste7 were modestly compromised in their ability to transmit the mating pheromone signal. This deficiency was dramatically enhanced when the ability of the Ste5 scaffold protein to associate with components of the MAPK cascade was also compromised. Thus, both the MEK-MAPK docking interaction and binding to the Ste5 scaffold make mutually reinforcing contributions to the efficiency of signaling by this MAPK cascade in vivo.	Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Irvine; University of California System; University of California Berkeley	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019; THORNER, Jeremy/O-6132-2019	Bardwell, Lee/0000-0002-2393-8363; THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841, R01GM060366] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060366-01, GM21841, R01 GM060366, GM60366, R01 GM021841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; CHOI KY, 1994, CELL, V78, P499; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; CREIGTON TE, 1993, PROTEIN STRUCTURES M; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Elion EA, 1998, SCIENCE, V281, P1625, DOI 10.1126/science.281.5383.1625; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; GIBBS JB, 1994, CELL, V79, P193, DOI 10.1016/0092-8674(94)90189-9; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; HASSON MS, 1994, MOL CELL BIOL, V14, P1054, DOI 10.1128/MCB.14.2.1054; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jiang Y, 1997, J BIOL CHEM, V272, P11096; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Karandikar M, 1999, CELL CALCIUM, V26, P219, DOI 10.1054/ceca.1999.0074; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; Kieran MW, 1999, ONCOGENE, V18, P6647, DOI 10.1038/sj.onc.1203057; Kolman MF, 1997, J BIOL CHEM, V272, P16904, DOI 10.1074/jbc.272.27.16904; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; PRINTEN JA, 1994, GENETICS, V138, P609; Prowse CN, 2000, BIOCHEMISTRY-US, V39, P6258, DOI 10.1021/bi000277b; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SEGER R, 1992, J BIOL CHEM, V267, P14373; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; SIKORSKI RS, 1989, GENETICS, V122, P19; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Tsunoda S, 1998, CURR OPIN GENET DEV, V8, P419, DOI 10.1016/S0959-437X(98)80112-3; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; YASHAR B, 1995, MOL CELL BIOL, V15, P6545; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	87	137	140	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10374	10386		10.1074/jbc.M010271200	http://dx.doi.org/10.1074/jbc.M010271200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134045	Green Accepted, hybrid			2022-12-27	WOS:000167996400104
J	Lee, YS; Han, JS; Jeon, Y; Hwang, DS				Lee, YS; Han, JS; Jeon, Y; Hwang, DS			The arc two-component signal transduction system inhibits in vitro Escherichia coli chromosomal initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; REPLICATION ORIGIN; DNA-REPLICATION; TRANSCRIPTIONAL ACTIVATION; ENZYMATIC REPLICATION; MEDIATING REPRESSION; REGULATORY SYSTEM; AEROBIC PATHWAYS; GENE-EXPRESSION; PROTEIN BINDS	Under anaerobic growth conditions, Escherichia coli operates a two-component signal transduction system, termed Are, that consists of ArcB protein, a transmembrane sensor kinase and ArcA protein, the cognate response regulator. In response to low oxygen levels, autophosphorylated ArcB phosphorylates ArcA, and the resulting phosphorylated ArcA (ArcA-P) functions as a transcriptional regulator of the genes necessary to maintain anaerobic growth. Under anaerobic conditions, cells maintain a slow growth rate, suggesting that the initiation of chromosomal replication is regulated to reduce the initiation frequency. DNase I footprinting experiments revealed that ArcA-P binds to the left region of the chromosomal origin, oriC, ArcA-P did not affect the in vitro replication of plasmid DNA containing the ColE1 origin nor the in vitro replication of viral DNAs; however, ArcA-P specifically inhibited in vitro E, coli chromosomal replication. This inhibition was caused by the prevention of open complex formation, a necessary step in the initiation of chromosomal replication. Our in vitro results suggest that the Are two-component system participates in regulating chromosomal initiation under anaerobic growth conditions.	Seoul Natl Univ, Inst Mol Biol & Genet, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU)	Hwang, DS (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Sch Biol Sci, Seoul 151742, South Korea.	dshwang@plaza.snu.ac.kr						ASAI T, 1990, EMBO J, V9, P4065, DOI 10.1002/j.1460-2075.1990.tb07628.x; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; BEYERSMANN D, 1974, J BACTERIOL, V118, P783, DOI 10.1128/JB.118.3.783-789.1974; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; Colloms SD, 1998, MOL MICROBIOL, V28, P521, DOI 10.1046/j.1365-2958.1998.00812.x; DRAPAL N, 1995, MOL MICROBIOL, V16, P597, DOI 10.1111/j.1365-2958.1995.tb02422.x; FULLER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5817, DOI 10.1073/pnas.80.19.5817; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HWANG DS, 1992, J BIOL CHEM, V267, P23087; HWANG DS, 1990, CELL, V63, P325, DOI 10.1016/0092-8674(90)90165-B; HWANG DS, 1988, J BIOL CHEM, V263, P10625; HWANG DS, 1992, J BIOL CHEM, V267, P23083; IUCHI S, 1989, J BACTERIOL, V171, P868, DOI 10.1128/jb.171.2.868-873.1989; IUCHI S, 1989, J BACTERIOL, V171, P2889, DOI 10.1128/jb.171.5.2889-2893.1989; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1994, J BACTERIOL, V176, P1695, DOI 10.1128/jb.176.6.1695-1701.1994; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KAGUNI JM, 1982, NATURE, V296, P623, DOI 10.1038/296623a0; KORNBERG A, 1992, DNA REPLICATION, P521; Lee YS, 1996, MOL MICROBIOL, V19, P389, DOI 10.1046/j.1365-2958.1996.485902.x; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; LYNCH AS, 1996, ESCHERICHIA COLI SAL, V1, P1526; McGuire AM, 1999, MOL MICROBIOL, V32, P219, DOI 10.1046/j.1365-2958.1999.01347.x; MESSER W, 1996, ESCHERICHIA COLI SAL, V2, P1579; NINFA AJ, 1996, ESCHERICHIA COLI SAL, V1, P1246; Nystrom T, 1996, EMBO J, V15, P3219, DOI 10.1002/j.1460-2075.1996.tb00686.x; OKA A, 1980, MOL GEN GENET, V178, P9, DOI 10.1007/BF00267207; Parkinson J.S., 1995, 2 COMPONENT SIGNAL T, P9; Pellicer MT, 1999, J BIOL CHEM, V274, P1745, DOI 10.1074/jbc.274.3.1745; POLACZEK P, 1990, New Biologist, V2, P265; Sambrook J., 2002, MOL CLONING LAB MANU; SAWERS G, 1992, J BACTERIOL, V174, P3474, DOI 10.1128/JB.174.11.3474-3478.1992; SILVERMAN PM, 1991, J MOL BIOL, V218, P119, DOI 10.1016/0022-2836(91)90878-A; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Strohmaier H, 1998, J MOL BIOL, V277, P309, DOI 10.1006/jmbi.1997.1598; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x; Torheim NK, 1999, EMBO J, V18, P4882, DOI 10.1093/emboj/18.17.4882; VERMA M, 1989, MOL GEN GENET, V216, P446, DOI 10.1007/BF00334389; VONMEYENBURG K, 1987, ESCHERICHIA COLI SAL, V2, P1555; YUNG BYM, 1989, J BIOL CHEM, V264, P6146; ZYSKIND JW, 1983, P NATL ACAD SCI-BIOL, V80, P1164, DOI 10.1073/pnas.80.5.1164	52	36	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9917	9923		10.1074/jbc.M008629200	http://dx.doi.org/10.1074/jbc.M008629200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133990	hybrid			2022-12-27	WOS:000167996400047
J	Prevot, D; Morel, AP; Voeltzel, T; Rostan, MC; Rimokh, R; Magaud, JP; Corbo, L				Prevot, D; Morel, AP; Voeltzel, T; Rostan, MC; Rimokh, R; Magaud, JP; Corbo, L			Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex - Involvement in estrogen receptor alpha signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; NEURONAL PC12 CELLS; NERVE GROWTH-FACTOR; NUCLEAR RECEPTOR; REGULATORY COMPLEX; TOB/BTG1 FAMILY; CYCLIN D1; GENE; EXPRESSION; PC3	We have reported previously the physical interaction of B-cell translocation gene proteins (BTG)1 and BTG2 with the mouse protein CAF1 (CCR4-associated factor 1) and suggested that these proteins may participate, through their association with CAF1, in transcription regulation. Here we describe the in vitro and in vivo association of these proteins with hPOP2, the human paralog of hCAF1, The physical and functional relationships between the BTG proteins and their partners hCAF1 and hPOP2 were investigated to find out how these interactions affect cellular processes, and in particular transcription regulation. We defined their interaction regions and examined their expression in various human tissues. We also show functional data indicating their involvement in estrogen receptor a (ER alpha)-mediated transcription regulation. We found that BTG1 and BTG2, probably through their interaction with CAF1 via a CCR4-like complex, can play both positive or negative roles in regulating the ER alpha function. In addition, our results indicate that two LXXLL motifs, referred to as nuclear receptor boxes, present in both BTG1 and BTG2, are involved in the regulation of ER alpha -mediated activation.	Ctr Leon Berard, INSERM, U453, F-69373 Lyon 08, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Corbo, L (corresponding author), Ctr Leon Berard, INSERM, U453, 28 Rue Laennec, F-69373 Lyon 08, France.		Rimokh, Ruth/G-7506-2014					Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Bai YL, 1999, MOL CELL BIOL, V19, P6642; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bogdan JA, 1998, BIOCHEM J, V336, P471, DOI 10.1042/bj3360471; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Fidler C, 1999, GENOMICS, V56, P134, DOI 10.1006/geno.1998.5687; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Levy A, 1999, GENE CHROMOSOME CANC, V24, P42, DOI 10.1002/(SICI)1098-2264(199901)24:1<42::AID-GCC6>3.0.CO;2-F; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Malatesta P, 2000, MECH DEVELOP, V90, P17, DOI 10.1016/S0925-4773(99)00224-5; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuda S, 1996, ONCOGENE, V12, P705; MESNER PW, 1995, J NEUROSCI, V15, P7357; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Pineau P, 1999, ONCOGENE, V18, P3127, DOI 10.1038/sj.onc.1202648; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; RIMOKH R, 1991, GENE CHROMOSOME CANC, V3, P24, DOI 10.1002/gcc.2870030106; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436; Wang SL, 1997, DEV BIOL, V188, P322, DOI 10.1006/dbio.1997.8655; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	39	110	115	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9640	9648		10.1074/jbc.M008201200	http://dx.doi.org/10.1074/jbc.M008201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136725	hybrid			2022-12-27	WOS:000167996400010
J	Shieh, HL; Chen, Y; Brown, CR; Chiang, HL				Shieh, HL; Chen, Y; Brown, CR; Chiang, HL			Biochemical analysis of fructose-1,6-bisphosphatase import into vacuole import and degradation vesicles reveals a role for UBC1 in vesicle biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; PLASMA-MEMBRANE PROTEINS; SACCHAROMYCES-CEREVISIAE; PEROXISOME DEGRADATION; PROTEASOME PATHWAY; YEAST VACUOLE; H+-ATPASE; CYTOPLASM; ENDOCYTOSIS; GLUCOSE	When Saccharomyces cerevisiae are shifted from medium containing poor carbon sources to medium containing fresh glucose, the key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is imported into Vid (vacuole import and degradation) vesicles and then to the vacuole for degradation. Here, we show that FBPase import is independent of vacuole functions and proteasome degradation, However, FBPase import required the ubiquitin-conjugating enzyme Ubc1p, A strain containing a deletion of the UBC1 gene exhibited defective FBPase import. Furthermore, FBPase import was inhibited when cells overexpressed the K48R/K63R ubiquitin mutant that fails to form multiubiquitin chains. The defects in FBPase import seen for the Delta ubc1 and the K48R/K63R mutants were attributed to the Vid vesicle fraction. In the Delta ubc1 mutant, the level of the Vid vesicle-specific marker Vid24p was reduced in the vesicle fraction, suggesting that UBC1 is required for either Vid vesicle production or Vid24p binding to Vid vesicles. However, the K48R/K63R mutant did not prevent Vid24p binding to Vid vesicles, indicating that ubiquitin chain formation is dispensable for Vid24p binding to these structures. Our results support the findings that ubiquitin conjugation and ubiquitin chain formation play important roles in a number of cellular processes including organelle biogenesis.	Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.				NIGMS NIH HHS [R01GM59480] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Drose S, 1997, J EXP BIOL, V200, P1; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GANCEDO C, 1971, J BACTERIOL, V107, P401, DOI 10.1128/JB.107.2.401-405.1971; GRAHAM TR, 1993, EMBO J, V12, P869, DOI 10.1002/j.1460-2075.1993.tb05727.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoffman M, 1996, GENETICS, V143, P1555; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hutchins MU, 1999, J CELL SCI, V112, P4079; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Jiang Y, 1998, EMBO J, V17, P6942, DOI 10.1093/emboj/17.23.6942; JONES EW, 1991, J BIOL CHEM, V266, P7963; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; KANE PM, 1992, J BIOL CHEM, V267, P447; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Klionsky DJ, 1998, J BIOL CHEM, V273, P10807, DOI 10.1074/jbc.273.18.10807; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nakamura N, 1997, J BIOCHEM, V121, P338; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Scott SV, 1997, TRENDS CELL BIOL, V7, P225, DOI 10.1016/S0962-8924(97)01050-7; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353; Zoladek T, 1997, GENETICS, V145, P595	54	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10398	10406		10.1074/jbc.M001767200	http://dx.doi.org/10.1074/jbc.M001767200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134048	hybrid			2022-12-27	WOS:000167996400106
J	Gautam, A; Bastia, D				Gautam, A; Bastia, D			A replication terminus located at or near a replication checkpoint of Bacillus subtilis functions independently of stringent control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; ESCHERICHIA-COLI; RNA-POLYMERASE; PROTEIN; FORK; TERMINATION; IDENTIFICATION; CONTRAHELICASE; MODULATION; MECHANISM	We have examined a replication terminus (omega L1) located on the left arm of the chromosome of Bacillus subtilis and within the yxcC gene and at or near the left replication checkpoint that is activated under stringent conditions. The psi L1 sequence appears to bind to two dimers of the replication terminator protein (RTP) rather weakly and seems to possess overlapping core and auxiliary sites that have some sequence similarities with normal Ter sites. Surprisingly, the asymmetrical, isolated psi L1 site arrested replication forks in vivo in both orientations and independent of stringent control. In vitro, the sequence arrested DnaB helicase in both orientations, albeit more weakly than the normal Ter1 terminus, The key points of mechanistic interest that emerge from the present work are: (i) strong binding of a Ter (psi L1) sequence to RTP did not appear to be essential for fork arrest and (ii) polarity of fork arrest could not be correlated in this case with just symmetrical protein-DNA interaction at the core and auxiliary sites of psi L1. On the basis of the result it would appear that the weak RTP-L1Ter interaction cannot by itself account for fork arrest, thus suggesting a role for DnaB-RTP interaction.	Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University	Bastia, D (corresponding author), Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA.							Autret S, 1999, MOL MICROBIOL, V31, P1665, DOI 10.1046/j.1365-2958.1999.01299.x; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BUSSIERE DE, 1995, CELL, V80, P651; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; CARRIGAN CM, 1991, J MOL BIOL, V222, P197, DOI 10.1016/0022-2836(91)90206-L; CASHEL M, 1997, ESCHERICHIA COLI SAL, V2, P1410; Chatterji D, 1998, GENES CELLS, V3, P279, DOI 10.1046/j.1365-2443.1998.00190.x; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; LEVINE A, 1995, MOL MICROBIOL, V15, P287, DOI 10.1111/j.1365-2958.1995.tb02243.x; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; Manna AC, 1996, P NATL ACAD SCI USA, V93, P3253, DOI 10.1073/pnas.93.8.3253; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Meijer WJJ, 1996, MOL MICROBIOL, V19, P1295, DOI 10.1111/j.1365-2958.1996.tb02474.x; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; SAHOO T, 1995, EMBO J, V14, P619, DOI 10.1002/j.1460-2075.1995.tb07038.x; SEROR SJ, 1986, NATURE, V321, P709, DOI 10.1038/321709a0; SMITH MT, 1992, J MOL BIOL, V227, P648, DOI 10.1016/0022-2836(92)90214-5; SZALEWSKAPALASZ A, 1994, EMBO J, V13, P5779, DOI 10.1002/j.1460-2075.1994.tb06916.x; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445	20	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8771	8777		10.1074/jbc.M009538200	http://dx.doi.org/10.1074/jbc.M009538200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11124956	hybrid			2022-12-27	WOS:000167607700022
J	Leeb-Lundberg, LMF; Kang, DS; Lamb, DS; Lamb, ME; Fathy, DB				Leeb-Lundberg, LMF; Kang, DS; Lamb, DS; Lamb, ME; Fathy, DB			The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity - Roles of residues in the fourth intracellular and third transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KININ B-1 RECEPTOR; PROTEIN-COUPLED RECEPTOR; HUMAN LUNG FIBROBLASTS; SMOOTH-MUSCLE CELLS; ALTERED FREQUENCY; INVERSE AGONISTS; HORMONE RECEPTOR; CARBOXYL TAIL; B2; ACTIVATION	The B1 bradykinin (BK) receptor (B1R) is a seven-transmembrane domain, G protein-coupled receptor that is induced by injury and important in inflammation and nociception. Here, we show that the human B1R exhibits a high level of ligand-independent, constitutive activity. Constitutive activity was identified by the increase in basal cellular phosphoinositide hydrolysis as a function of the density of the receptors in transiently transfected HEK293 cells. Several B1R peptide antagonists were neutral antagonists or very weakly efficacious inverse agonists, Constitutive B1R activity was further increased by alanine mutation of Asn(121) in the third transmembrane domain of the receptor (B1A(121)). This mutant resembled the agonist preferred receptor state since it also exhibited increased agonist affinity and decreased agonist responsiveness. A dramatic loss of constitutive activity occurred when the fourth intracellular C-terminal domain (IC-IV) of the human B2 BK receptor subtype (B2R), which exhibits minimal constitutive activity, was substituted in either B1R or B1A121 to make B1(B2ICIV) and B1(B2ICIV)A(121), respectively. Activity was partially recovered by subsequent alanine mutation of a cluster of two serines and two threonines in IC-IV of either B1(B2ICIV) or B1(B2ICIV)A121, a cluster that is important for B2R desensitization. The ligand-independent, constitutive activity of B1R therefore depends on epitopes in both transmembrane and intracellular domains. We propose that the activity is primarily due to the lack of critical epitopes in IC-IV that regulate such activity.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Leeb-Lundberg, LMF (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, Mail Code 7760,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041659, R01GM041659] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Austin CE, 1997, J BIOL CHEM, V272, P11420; Bachvarov DR, 1998, J AM SOC NEPHROL, V9, P598; Bachvarov DR, 1998, GASTROENTEROLOGY, V115, P1045, DOI 10.1016/S0016-5085(98)70071-X; BASCANDS JL, 1993, AM J PHYSIOL, V264, pF548, DOI 10.1152/ajprenal.1993.264.3.F548; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blaukat A, 1999, BIOCHEMISTRY-US, V38, P1300, DOI 10.1021/bi981727r; Claeysen S, 1999, MOL PHARMACOL, V55, P910; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COUGHLIN SR, 1994, CURR OPIN CELL BIOL, V6, P191, DOI 10.1016/0955-0674(94)90135-X; DAVIS AJ, 1994, BRIT J PHARMACOL, V113, P63, DOI 10.1111/j.1476-5381.1994.tb16174.x; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Dray A, 1997, CAN J PHYSIOL PHARM, V75, P704, DOI 10.1139/cjpp-75-6-704; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; FARMER SG, 1991, AGENTS ACTIONS, V34, P191, DOI 10.1007/BF01993275; Fathy DB, 1999, J BIOL CHEM, V274, P29603, DOI 10.1074/jbc.274.42.29603; Fathy DB, 1998, J BIOL CHEM, V273, P12210, DOI 10.1074/jbc.273.20.12210; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; Hasegawa H, 1996, J BIOL CHEM, V271, P1857, DOI 10.1074/jbc.271.4.1857; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Kenakin T, 1996, PHARMACOL REV, V48, P413; LAUE L, 1995, P NATL ACAD SCI USA, V92, P1906, DOI 10.1073/pnas.92.6.1906; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P25970; Marceau F, 1998, PHARMACOL REV, V50, P357; Marie J, 1999, MOL PHARMACOL, V55, P92, DOI 10.1124/mol.55.1.92; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; Mathis SA, 1996, MOL PHARMACOL, V50, P128; MATUSLEIBOVITCH N, 1995, J BIOL CHEM, V270, P1041, DOI 10.1074/jbc.270.3.1041; MENKE JG, 1994, J BIOL CHEM, V269, P21588; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Perez DM, 1996, MOL PHARMACOL, V49, P112; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Phagoo SB, 1999, MOL PHARMACOL, V56, P325, DOI 10.1124/mol.56.2.325; Pizard A, 1999, J BIOL CHEM, V274, P12738, DOI 10.1074/jbc.274.18.12738; PROUD D, 1988, ANNU REV IMMUNOL, V6, P49, DOI 10.1146/annurev.iy.06.040188.000405; Regoli D, 2000, P NATL ACAD SCI USA, V97, P7676, DOI 10.1073/pnas.150233397; REGOLI D, 1980, PHARMACOL REV, V32, P1; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Scheer A, 1997, J RECEPT SIGNAL TR R, V17, P57, DOI 10.3109/10799899709036594; STERANKA LR, 1988, P NATL ACAD SCI USA, V85, P3245, DOI 10.1073/pnas.85.9.3245; WARD PE, 1991, BRADYKININ ANTAGONIS, P147	42	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8785	8792		10.1074/jbc.M007396200	http://dx.doi.org/10.1074/jbc.M007396200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134011	hybrid			2022-12-27	WOS:000167607700024
J	de Pouplana, LR; Schimmel, P				de Pouplana, LR; Schimmel, P			Operational RNA code for amino acids in relation to genetic code in evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SPECIES-SPECIFIC AMINOACYLATION; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; ACCEPTOR STEM; MICROHELIX AMINOACYLATION; ENZYMATIC AMINOACYLATION; THERMUS-THERMOPHILUS; TERTIARY STRUCTURE; SINGLE NUCLEOTIDE; MAJOR DETERMINANT		Scripps Res Inst, Dept Mol Biol & Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol & Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	de Pouplana, Lluis Ribas/AAA-4738-2019	de Pouplana, Lluis Ribas/0000-0002-2087-0359	PHS HHS [23562] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander RW, 1998, P NATL ACAD SCI USA, V95, P12214, DOI 10.1073/pnas.95.21.12214; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; BEDOUELLE H, 1990, BIOCHIMIE, V72, P589, DOI 10.1016/0300-9084(90)90122-W; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; BROWN JR, 1995, P NATL ACAD SCI USA, V92, P2441, DOI 10.1073/pnas.92.7.2441; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P55, DOI 10.1111/j.1749-6632.1987.tb40597.x; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; de Duve C, 1991, BLUEPRINT CELL NATUR; de Pouplana LR, 1998, P NATL ACAD SCI USA, V95, P11295, DOI 10.1073/pnas.95.19.11295; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Di Giulio M, 1997, J MOL EVOL, V45, P571, DOI 10.1007/PL00006261; DICK TP, 1995, J MOL EVOL, V41, P1; Doolittle RF, 1998, CURR OPIN GENET DEV, V8, P630, DOI 10.1016/S0959-437X(98)80030-0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Felden B, 1998, P NATL ACAD SCI USA, V95, P10431, DOI 10.1073/pnas.95.18.10431; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; Freeland SJ, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01531-5; FRUGIER M, 1992, P NATL ACAD SCI USA, V89, P3990, DOI 10.1073/pnas.89.9.3990; FRUGIER M, 1994, EMBO J, V13, P2218, DOI 10.1002/j.1460-2075.1994.tb06499.x; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HAMANN CS, 1995, BIOCHEMISTRY-US, V34, P6527, DOI 10.1021/bi00019a034; Heckl M, 1998, FEBS LETT, V427, P315, DOI 10.1016/S0014-5793(98)00435-9; HIPPS D, 1995, P NATL ACAD SCI USA, V92, P5550, DOI 10.1073/pnas.92.12.5550; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; LAMOUR V, 1994, P NATL ACAD SCI USA, V91, P8670, DOI 10.1073/pnas.91.18.8670; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; Lechler A, 1997, NUCLEIC ACIDS RES, V25, P2737, DOI 10.1093/nar/25.14.2737; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; MARTINIS SA, 1993, J BIOL CHEM, V268, P6069; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, V1, P887; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; MOLLER W, 1992, J MOL EVOL, V34, P471, DOI 10.1007/BF00160461; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Musier-Forsyth K, 1999, ACCOUNTS CHEM RES, V32, P368, DOI 10.1021/ar970148w; MUSIERFORSYTH K, 1995, J AM CHEM SOC, V117, P7253, DOI 10.1021/ja00132a029; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; NAGEL GM, 1995, J MOL EVOL, V40, P487; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; Nair S, 1997, J MOL BIOL, V269, P1, DOI 10.1006/jmbi.1997.1025; Noller H.F., 1993, RNA WORLD, P137; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; NUREKI O, 1993, TRANSLATION APPARATU; PARK SJ, 1988, J BIOL CHEM, V263, P16527; PUTZ J, 1991, SCIENCE, V252, P1696, DOI 10.1126/science.2047878; QUINN CL, 1995, BIOCHEMISTRY-US, V34, P12489, DOI 10.1021/bi00039a001; RIPMASTER TL, 1995, P NATL ACAD SCI USA, V92, P4932, DOI 10.1073/pnas.92.11.4932; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rodin S, 1996, P NATL ACAD SCI USA, V93, P4537, DOI 10.1073/pnas.93.10.4537; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUDINGER J, 1992, NUCLEIC ACIDS RES, V20, P1865, DOI 10.1093/nar/20.8.1865; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Saks ME, 1996, EMBO J, V15, P2843, DOI 10.1002/j.1460-2075.1996.tb00645.x; SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844; SAMPSON JR, 1993, NUCLEIC ACIDS RES, V21, P4467, DOI 10.1093/nar/21.19.4467; Schimmel P, 1999, P NATL ACAD SCI USA, V96, P327, DOI 10.1073/pnas.96.2.327; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Schmitt E, 1998, EMBO J, V17, P5227, DOI 10.1093/emboj/17.17.5227; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; SHIBA K, 1994, J BIOL CHEM, V269, P30049; SHIBA K, 1995, BIOCHEMISTRY-US, V34, P10340, DOI 10.1021/bi00033a004; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Weiner AM, 1999, BIOL BULL, V196, P327, DOI 10.2307/1542962; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	76	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6881	6884		10.1074/jbc.R000032200	http://dx.doi.org/10.1074/jbc.R000032200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11238440	hybrid			2022-12-27	WOS:000167442900001
J	Baumann, CA; Brady, MJ; Saltiel, AR				Baumann, CA; Brady, MJ; Saltiel, AR			Activation of glycogen synthase by insulin in 3T3-L1 adipocytes involves c-Cbl-associating protein (CAP)-dependent and CAP-independent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT; RAT ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; HORMONAL-STIMULATION; KINASE INHIBITION; POTENTIAL ROLE; TRANSLOCATION; CELLS; DEPHOSPHORYLATION	In adipose and muscle, insulin stimulates glucose uptake and glycogen synthase activity. Phosphatidylinositol 3-kinase (PI3K) activation is necessary but not sufficient for these metabolic actions of insulin. The insulin stimulated translocation of phospho c-Cbl to lipid rafts, via its association with CAP, comprises a second pathway regulating GLUT4 translocation. In 3T3-L1 adipocytes, overexpression of a dominant negative CAP mutant (CAP Delta SH3) completely blocked the insulin-stimulated glucose transport and glycogen synthesis but only partially inhibited glycogen synthase activation. In contrast, CAP Delta SH3 expression did not affect glycogen synthase activation by insulin in the absence of extracellular glucose. Moreover, CAP Delta SH3 has no effect on the PI3K dependent activation of protein phosphatase-l or phosphorylation of glycogen synthase kinase-3. These results indicate blockade of the c-Cbl/CAP pathway directly inhibits insulin-stimulated glucose uptake, which results in secondary inhibition of glycogen synthase activation and glycogen synthesis.	Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Physiol, Ann Arbor, MI 48109 USA; Pfizer Global Res & Dev, Dept Cell Biol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pfizer	Saltiel, AR (corresponding author), Univ Michigan, Med Ctr, Dept Med, MSRB I,Rm 4520,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.		Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828				Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Brady MJ, 1999, TRENDS ENDOCRIN MET, V10, P408, DOI 10.1016/S1043-2760(99)00201-5; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; Brady MJ, 1998, J BIOL CHEM, V273, P14063, DOI 10.1074/jbc.273.23.14063; Cadefau J, 1997, BIOCHEM J, V322, P745, DOI 10.1042/bj3220745; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; FERNANDEZNOVELL JM, 1992, BIOCHEM J, V288, P497, DOI 10.1042/bj2880497; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hurel SJ, 1996, BIOCHEM J, V320, P871, DOI 10.1042/bj3200871; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; LAWRENCE JC, 1978, J BIOL CHEM, V253, P2104; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LAWRENCE JC, 1984, J BIOL CHEM, V259, P7975; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; NIELSEN JN, 2001, IN PRESS J PHYSL; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; SAKAUE H, 1995, J BIOL CHEM, V270, P11304, DOI 10.1074/jbc.270.19.11304; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442	29	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6065	6068		10.1074/jbc.C000856200	http://dx.doi.org/10.1074/jbc.C000856200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11222622	hybrid			2022-12-27	WOS:000167261000003
J	Caltagirone, A; Weiss, G; Pantopoulos, K				Caltagirone, A; Weiss, G; Pantopoulos, K			Modulation of cellular iron metabolism by hydrogen peroxide - Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS LEADS; CITRIC-ACID CYCLE; REGULATORY PROTEINS; NITRIC-OXIDE; TRANSLATIONAL REGULATION; MITOCHONDRIAL ACONITASE; MOLECULAR CONTROL; TRANSFERRIN; FERRITIN; TRANSPORTER	Cellular iron uptake and storage are coordinately controlled by binding of iron-regulatory proteins (IRP), IRP1 and IRP2, to iron-responsive elements (IREs) within the mRNAs encoding transferrin receptor (TfR) and ferritin. Under conditions of iron starvation, both IRP1 and IRP2 bind with high affinity to cognate IREs, thus stabilizing TfR and inhibiting translation of ferritin mRNAs, The IRE/IRP regulatory system receives additional input by oxidative stress in the form of H2O2 that leads to rapid activation of IRP1. Here we show that treating murine B6 fibroblasts with a pulse of 100 muM H2O2 for 1 h is sufficient to alter critical parameters of iron homeostasis in a time-dependent manner. First, this stimulus inhibits ferritin synthesis for at least 8 h, leading to a significant (50%) reduction of cellular ferritin content. Second, treatment with H2O2 induces a similar to4-fold increase in TfR mRNA levels within 2-6 h, and subsequent accumulation of newly synthesized protein after 4 h, This is associated with a profound increase in the cell surface expression of TfR, enhanced binding to fluorescein-tagged transferrin, and stimulation of transferrin-mediated iron uptake into cells, Under these conditions, no significant alterations are observed in the levels of mitochondrial aconitase and the (D) under bar ivalent (M) under bar etal (T) under bar ransporter DMT1, although both are encoded by two as yet lesser characterized IRE-containing mRNAs, Finally. H2O2-treated cells display an increased capacity to sequester Fe-59 in ferritin, despite a reduction in the ferritin pool, which results in a rearrangement of Fe-59 intracellular distribution. Our data suggest that H2O2 regulates cellular iron acquisition and intracellular iron distribution by both IRP1-dependent and -independent mechanisms.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Fac Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; Univ Innsbruck Hosp, Dept Internal Med, A-6020 Innsbruck, Austria	Lady Davis Institute; McGill University; McGill University; Medical University of Innsbruck	Pantopoulos, K (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	kastas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057; Weiss, Guenter/0000-0003-0709-2158				Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; BALLA G, 1992, J BIOL CHEM, V267, P18148; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Busfield SJ, 1997, EUR J BIOCHEM, V249, P77, DOI 10.1111/j.1432-1033.1997.t01-1-00077.x; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CHAN RYY, 1994, EUR J BIOCHEM, V220, P683, DOI 10.1111/j.1432-1033.1994.tb18669.x; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hanson ES, 1999, GENE EXPRESSION, V7, P367; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; IHARA K, 1984, J BIOL CHEM, V259, P278; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; MALORNI W, 1993, J CELL SCI, V106, P309; Malorni W, 1998, EXP CELL RES, V241, P102, DOI 10.1006/excr.1998.4020; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Mulero V, 1999, BLOOD, V94, P2383, DOI 10.1182/blood.V94.7.2383.419k20_2383_2389; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; PANTOPOULOS K, 1995, RNA, V1, P155; PANTOPOULOS K, 2000, NITRIC OXIDE, P293; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Ponka P, 1997, BLOOD, V89, P1; Rouault TA, 2000, COLD SPRING HARBOR M, V39, P655; Schalinske KL, 1998, J BIOL CHEM, V273, P3740, DOI 10.1074/jbc.273.6.3740; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; THEIL EC, 1999, INORGANIC BIOCH REGU, P187; TORRES M, 2000, NITRIC OXIDE BIOL PA, P329; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; VILE GF, 1993, J BIOL CHEM, V268, P14678; Wardrop SL, 1999, EUR J BIOCHEM, V263, P41, DOI 10.1046/j.1432-1327.1999.00447.x; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Weiss G, 1997, BLOOD, V89, P680, DOI 10.1182/blood.V89.2.680; Zhang L, 2000, BIOCHEM J, V349, P289, DOI 10.1042/0264-6021:3490289; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0	55	97	101	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19738	19745		10.1074/jbc.M100245200	http://dx.doi.org/10.1074/jbc.M100245200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264285	hybrid			2022-12-27	WOS:000169135100010
J	Gourley, DG; Schuttelkopf, AW; Anderson, LA; Price, NC; Boxer, DH; Hunter, WN				Gourley, DG; Schuttelkopf, AW; Anderson, LA; Price, NC; Boxer, DH; Hunter, WN			Oxyanion binding alters conformation and quaternary structure of the C-terminal domain of the transcriptional regulator ModE - Implications for molybdate-dependent regulation, signaling, storage, and transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN; MOLYBDENUM; MODABCD; OPERON; PROGRAM; REFINEMENT; REPRESSOR; DNA	The molybdate-dependent transcriptional regulator ModE of Escherichia coli functions as a sensor of intracellular molybdate concentration and a regulator for the transcription of several operons that control the uptake and utilization of molybdenum. We present two high-resolution crystal structures of the C-terminal oxyanion-binding domain in complex with molybdate and tungstate. The ligands bind between subunits at the dimerization interface, and analysis reveals that oxyanion selectivity is determined primarily by size. The relevance of the structures is indicated by fluorescence measurements, which show that the oxyanion binding properties of the C-terminal domain of ModE are similar to those of the full-length protein. Comparisons with the apoprotein structure have identified structural rearrangements that occur on binding oxyanion. This molybdate-dependent conformational switch promotes a change in shape and alterations to the surface of the protein and may provide the signal for recruitment of other proteins to construct the machinery for transcription. Sequence and structure-based comparisons lead to a classification of molybdate-binding proteins.	Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Univ Stirling, Dept Biol Sci, Stirling FK9 4LA, Scotland	University of Dundee; University of Stirling	Hunter, WN (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019					Anderson LA, 2000, J BACTERIOL, V182, P7035, DOI 10.1128/JB.182.24.7035-7043.2000; Anderson LA, 1997, EUR J BIOCHEM, V246, P119, DOI 10.1111/j.1432-1033.1997.00119.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; DEAN DA, 1990, J BIOL CHEM, V265, P21005; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grunden AM, 1999, J BIOL CHEM, V274, P24308, DOI 10.1074/jbc.274.34.24308; Grunden AM, 1997, ARCH MICROBIOL, V168, P345, DOI 10.1007/s002030050508; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; HINTON SM, 1986, NUCLEIC ACIDS RES, V14, P9371, DOI 10.1093/nar/14.23.9371; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Lawson DM, 1997, J CHEM SOC DALTON, P3981, DOI 10.1039/a704006g; McNicholas PM, 1997, MOL MICROBIOL, V23, P515, DOI 10.1046/j.1365-2958.1997.d01-1864.x; McNicholas PM, 1998, J BACTERIOL, V180, P4638, DOI 10.1128/JB.180.17.4638-4643.1998; McNicholas PM, 1998, MOL MICROBIOL, V27, P197, DOI 10.1046/j.1365-2958.1998.00675.x; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAU RN, 1998, IRON RELATED TRANSIT, P217; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; RECH S, 1995, J BACTERIOL, V177, P1023, DOI 10.1128/jb.177.4.1023-1029.1995; Self WT, 1999, MICROBIOL-UK, V145, P41, DOI 10.1099/13500872-145-1-41; Wagner UG, 2000, STRUCTURE, V8, P1127, DOI 10.1016/S0969-2126(00)00525-6; Walkenhorst HM, 1995, MICROBIOL RES, V150, P347	35	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20641	20647		10.1074/jbc.M100919200	http://dx.doi.org/10.1074/jbc.M100919200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259434	hybrid			2022-12-27	WOS:000169135100130
J	Huang, P; Liu, J; Di, AK; Robinson, NC; Musch, MW; Kaetzel, MA; Nelson, DJ				Huang, P; Liu, J; Di, AK; Robinson, NC; Musch, MW; Kaetzel, MA; Nelson, DJ			Regulation of human CLC-3 channels by multifunctional Ca2+/calmodulin-dependent protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CONDUCTANCE; AIRWAY EPITHELIAL-CELLS; MOLECULAR-IDENTIFICATION; ANNEXIN-IV; CALCIUM; EXPRESSION; MEMBRANE; VOLUME; LOCALIZATION; INHIBITOR	The multifunctional calcium/calmodulin-dependent protein kinase II, CaMKII, has been shown to regulate chloride movement and cellular function in both excitable and non-excitable cells. We show that the plasma membrane expression of a member of the CIC family of Cl- channels, human CLC-3 (hCLC-3), a 90-kDa protein, is regulated by CaMKII, We cloned the full-length hCLC-3 gene from the human colonic tumor cell line T84, previously shown to express a CaMKII-activated Cl- conductance (I-Cl,I-CaMKII), and transfected this gene into the mammalian epithelial cell line tsA, which lacks endogenous expression of I-Cl,I-CaMKII. Biotinylation experiments demonstrated plasma membrane expression of hCLC-3 in the stably transfected cells. In whole cell patch clamp experiments, autonomously active CaMKII was introduced into tsA cells stably transfected with hCLC-3 via the patch pipette, Cells transfected with the hCLC-3 gene showed a 22-fold increase in current density over cells expressing the vector alone. Kinase-de pendent current expression was abolished in the presence of the autocamtide-2-related inhibitory peptide, a specific inhibitor of CaMKII, A mutation of glycine 280 to glutamic acid in the conserved motif in the putative pore region of the channel changed anion selectivity from I- > Cl- to Cl- > I-. These results indicate that hCLC-3 encodes a Cl- channel that is regulated by CaMKII-dependent phosphorylation.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, IBD Res Ctr, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	University of Chicago; University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,MC 0926, Chicago, IL 60637 USA.				NIDDK NIH HHS [DK46433, DK-42086] Funding Source: Medline; NIGMS NIH HHS [GM36823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046433, P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; CHAN HC, 1992, AM J PHYSIOL, V262, pC1273, DOI 10.1152/ajpcell.1992.262.5.C1273; CHAN HC, 1994, J BIOL CHEM, V269, P32464; CHAO AC, 1995, J CLIN INVEST, V96, P1794, DOI 10.1172/JCI118225; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; HOLEVINSKY KO, 1994, J MEMBRANE BIOL, V140, P13; Ishida A, 1998, FEBS LETT, V427, P115, DOI 10.1016/S0014-5793(98)00405-0; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; KAETZEL MA, 1994, J BIOL CHEM, V269, P5297; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Merlin D, 1998, AM J PHYSIOL-CELL PH, V275, pC484, DOI 10.1152/ajpcell.1998.275.2.C484; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; Okada Y, 1998, J GEN PHYSIOL, V112, P365, DOI 10.1085/jgp.112.3.365; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WORRELL RT, 1991, AM J PHYSIOL, V260, pC877, DOI 10.1152/ajpcell.1991.260.4.C877; Xie WW, 1998, J PHYSIOL-LONDON, V510, P661, DOI 10.1111/j.1469-7793.1998.661bj.x; Xie WW, 1996, J BIOL CHEM, V271, P14092, DOI 10.1074/jbc.271.24.14092	27	138	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20093	20100		10.1074/jbc.M009376200	http://dx.doi.org/10.1074/jbc.M009376200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274166	hybrid			2022-12-27	WOS:000169135100057
J	Swayze, RD; Braun, AP				Swayze, RD; Braun, AP			A catalytically inactive mutant of type I cGMP-dependent protein kinase prevents enhancement of large conductance, calcium-sensitive K+ channels by sodium nitroprusside and cGMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CYCLIC GUANOSINE-MONOPHOSPHATE; ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE; TYROSINE KINASE; BKCA CHANNELS; CA CHANNEL; PHOSPHORYLATION; ARTERY; MECHANISM	The activation of large conductance, calcium-sensitive K+ (BKCa) channels by the nitric oxide (NO)/cyclic GMP (cGMP) signaling pathway appears to be an important cellular mechanism contributing to the relaxation of smooth muscle. In HEK 293 cells transiently transfected with BKCa channels, we observed that the NO donor sodium nitroprusside and the membrane-permeable analog of cGMP, dibutyryl cGMP, were both able to enhance BKCa channel activity 4-5-fold in cell-attached membrane patches. This enhancement correlated with an endogenous cGMP-dependent protein kinase activity and the presence of the alpha isoform of type I cGMP-dependent protein kinase (cGKI). We observed that cotransfection of cells with BKCa channels and a catalytically inactive ("dead") mutant of human cGKI alpha prevented enhancement of BKCa channel in response to either sodium nitroprusside or dibutyryl cGMP in a dominant negative fashion. In contrast, expression of wild-type cGKI alpha supported enhancement of channel activity by these two agents. Importantly, both endogenous and expressed forms of cGKI alpha were found to associate with BKCa channel protein, as demonstrated by a reciprocal co-immunoprecipitation strategy. In vitro, cGKI alpha was able to directly phosphorylate immunoprecipitated BKCa channels, suggesting that cGKI alpha -dendent phosphorylation of BKCa channels in situ may be responsible for the observed enhancement of channel activity. In summary, our data demonstrate that cGKI alpha alone is sufficient to promote the enhancement of BKCa channels in situ after activation of the NO/cGMP signaling pathway.	Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary	Braun, AP (corresponding author), Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.			Swayze, Richard/0000-0003-0692-5648				Abderrahmane A, 1998, AM J RESP CELL MOL, V19, P485, DOI 10.1165/ajrcmb.19.3.2996; ALIOUA A, 1995, AM J PHYSIOL-LUNG C, V268, pL1057, DOI 10.1152/ajplung.1995.268.6.L1057; Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; BIALECKI RA, 1995, AM J PHYSIOL, V268, P152; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DINERMAN JL, 1994, NEUROPHARMACOLOGY, V33, P1245, DOI 10.1016/0028-3908(94)90023-X; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FEELISCH M, 1998, PFLUEGERS ARCH, V58, P113; Francis S H, 1994, Adv Pharmacol, V26, P115, DOI 10.1016/S1054-3589(08)60053-8; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; FURCHGOTT RF, 1984, ANNU REV PHARMACOL, V24, P175, DOI 10.1146/annurev.pa.24.040184.001135; GEORGE MJ, 1995, J INVEST MED, V43, P451; GLASS DB, 1982, J BIOL CHEM, V257, P1196; Haburcak M, 1997, CELL CALCIUM, V21, P291, DOI 10.1016/S0143-4160(97)90117-2; Han GC, 1999, J CARDIOVASC PHARM, V34, P619, DOI 10.1097/00005344-199911000-00001; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu XQ, 1998, J BIOL CHEM, V273, P5337, DOI 10.1074/jbc.273.9.5337; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li PL, 1998, HYPERTENSION, V31, P303, DOI 10.1161/01.HYP.31.1.303; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu G, 1998, AM J PHYSIOL-GASTR L, V274, pG848, DOI 10.1152/ajpgi.1998.274.5.G848; McDonald L J, 1995, Adv Pharmacol, V34, P263; Mistry DK, 1998, BRIT J PHARMACOL, V124, P1131, DOI 10.1038/sj.bjp.0701940; Murad F, 1987, Prog Clin Biol Res, V249, P65; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Peng W, 1996, J APPL PHYSIOL, V81, P1264, DOI 10.1152/jappl.1996.81.3.1264; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; SHEPPARD D, 1994, AM J RESP CELL MOL, V11, P1; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Sperelakis N, 1994, Adv Pharmacol, V26, P217, DOI 10.1016/S1054-3589(08)60056-3; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stockand JD, 1996, AM J PHYSIOL-CELL PH, V271, pC1669, DOI 10.1152/ajpcell.1996.271.5.C1669; Stockand JD, 1996, AM J PHYSIOL-CELL PH, V270, pC1773, DOI 10.1152/ajpcell.1996.270.6.C1773; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG J, 1999, J NEUROSCI, V19, P1; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; WOLFE L, 1987, J BIOL CHEM, V262, P16906; Yamakage M, 1996, AM J PHYSIOL-LUNG C, V270, pL338, DOI 10.1152/ajplung.1996.270.3.L338; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zanzinger J, 1996, PFLUG ARCH EUR J PHY, V432, P671, DOI 10.1007/s004240050184	58	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19729	19737		10.1074/jbc.M005711200	http://dx.doi.org/10.1074/jbc.M005711200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262387	hybrid			2022-12-27	WOS:000169135100009
J	Urnov, FD; Wolffe, AP				Urnov, FD; Wolffe, AP			An array of positioned nucleosomes potentiates thyroid hormone receptor action in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SEQUENCE SPECIFICITY; XENOPUS HSP70 PROMOTER; IN-VIVO; GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR; MESSENGER-RNA; AMPHIBIAN METAMORPHOSIS; ANDROGEN RECEPTOR; RESPONSE ELEMENT; BETA GENE	The assembly of the genome into chromatin imposes a poorly understood set of rules and constraints on action by regulatory factors. We investigated the role played by chromatin infrastructure in enabling an acute response of the Xenopus TR betaA gene to thyroid hormone receptor (TR), an extensively studied member of the nuclear hormone receptor superfamily, We found that in addition to the known TR response element (TRE) in the promoter, full range regulation required an upstream enhancer that contained multiple nonconsensus TREs and augmented ligand action at high receptor levels. An array of translationally positioned nucleosomes formed over the TR betaA locus in vivo; unliganded TR engaged this array in linker DNA between two nucleosomes and via TREs on the surface of histone octamers, Remarkably, assembly of enhancer DNA into mature chromatin potentiated binding by TR to its target response elements and enabled a greater range of regulation by TR than was observed on immature chromatin templates. Because assembly of enhancer DNA into chromatin increased TR binding to the nonconsensus TREs, we hypothesize that chromatin disruption targeted by liganded TR to the enhancer may lead to receptor release from the template and to an attenuation of response to hormone.	Sangamo Biosci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; NICHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA	Sangamo Therapeutics, Inc.; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Urnov, FD (corresponding author), Sangamo Biosci, Point Richmond Tech Ctr, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA.	furnov@sangamo.com						Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BARTON MC, 1988, P NATL ACAD SCI USA, V85, P7119, DOI 10.1073/pnas.85.19.7119; Belikov S, 2000, EMBO J, V19, P1023, DOI 10.1093/emboj/19.5.1023; BROWN DD, 1995, RECENT PROG HORM RES, V50, P309; CARTWRIGHT IL, 1983, P NATL ACAD SCI-BIOL, V80, P3213, DOI 10.1073/pnas.80.11.3213; CARTWRIGHT IL, 1989, METHOD ENZYMOL, V170, P359; CHEN HW, 1993, MOL CELL BIOL, V13, P2366, DOI 10.1128/MCB.13.4.2366; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DU ZJ, 1995, BIOTECHNIQUES, V18, P376; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EISEN LP, 1988, J BIOL CHEM, V263, P12044; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; FONDELL JD, 1993, GENE DEV, V7, P1400, DOI 10.1101/gad.7.7b.1400; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fragoso G, 1997, METHODS, V11, P246, DOI 10.1006/meth.1996.0411; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Hager GL, 2001, PROG NUCLEIC ACID RE, V66, P279; Harbers M, 1998, J STEROID BIOCHEM, V67, P181, DOI 10.1016/S0960-0760(98)00100-9; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; JONES DH, 1991, BIOTECHNIQUES, V10, P62; KALINYAK JE, 1987, J BIOL CHEM, V262, P10441; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Landsberger N, 1997, EMBO J, V16, P4361, DOI 10.1093/emboj/16.14.4361; LEFSTIN JA, 1994, GENE DEV, V8, P2842, DOI 10.1101/gad.8.23.2842; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Li Q, 1999, EMBO J, V18, P5634, DOI 10.1093/emboj/18.20.5634; LIN MC, 1993, J STEROID BIOCHEM, V45, P333; Liu Z, 1999, P NATL ACAD SCI USA, V96, P9485, DOI 10.1073/pnas.96.17.9485; LU Q, 1995, EMBO J, V14, P4738, DOI 10.1002/j.1460-2075.1995.tb00155.x; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; OLLINGWOOD TN, 1999, J MOL ENDOCRINOL, V23, P255; Olson DP, 1998, J BIOL CHEM, V273, P3375, DOI 10.1074/jbc.273.6.3375; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PTASHNE M, 1992, GENETIC SWITCH PHAGE, P16; RANJAN M, 1994, J BIOL CHEM, V269, P24699; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; SAMUELS HH, 1982, RECENT PROG HORM RES, V38, P557; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Sewack GF, 2001, MOL CELL BIOL, V21, P1404, DOI 10.1128/MCB.21.4.1404-1415.2001; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHI YB, 1992, J BIOL CHEM, V267, P733; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Tata JR, 1999, BIOCHIMIE, V81, P359, DOI 10.1016/S0300-9084(99)80082-0; Tata JR, 2000, INSECT BIOCHEM MOLEC, V30, P645, DOI 10.1016/S0965-1748(00)00035-7; THOMAS GH, 1988, EMBO J, V7, P2191, DOI 10.1002/j.1460-2075.1988.tb03058.x; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tse C, 1998, P NATL ACAD SCI USA, V95, P12169, DOI 10.1073/pnas.95.21.12169; Urnov FD, 2000, EMBO J, V19, P4074, DOI 10.1093/emboj/19.15.4074; Verreault A, 2000, GENE DEV, V14, P1430; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; WOLFFE A, 1998, CHROMATIN STRUCTURE, P240; WONG CW, 1995, MOL ENDOCRINOL, V9, P551, DOI 10.1210/me.9.5.551; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1998, EMBO J, V17, P520, DOI 10.1093/emboj/17.2.520; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Wong JM, 1997, EMBO J, V16, P7130, DOI 10.1093/emboj/16.23.7130; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3; ZARET KS, 1992, P NATL ACAD SCI USA, V89, P6540, DOI 10.1073/pnas.89.14.6540; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	86	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19753	19761		10.1074/jbc.M100924200	http://dx.doi.org/10.1074/jbc.M100924200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274156	hybrid			2022-12-27	WOS:000169135100012
J	Gong, Y; Kim, SO; Felez, J; Grella, DK; Castellino, FJ; Miles, LA				Gong, Y; Kim, SO; Felez, J; Grella, DK; Castellino, FJ; Miles, LA			Conversion of glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING SITES; NATIVE GLU; UROKINASE; RECEPTOR; DOMAINS; MECHANISM; CHAIN	When Glu-plasminogen is bound to cells, plasmin (Pm) formation by plasminogen (Pg) activators is markedly enhanced compared with the reaction in solution. It is not known whether the direct activation of Glu-Pg by Pg activators is promoted on the cell surface or whether plasminolytic conversion of Glu-Pg to the more readily activated Lys-Pg is necessary for enhanced Pm formation on the cell surface. To distinguish between these potential mechanisms, we tested whether Pm formation on the cell. surface could be stimulated in the absence of conversion of Glu-Pg to Lys-Pg, Rates of activation of Glu-Pg, Lys-Pg, and a mutant Glu-Pg, [D646E]Glu-Pg, by either tissue Pg activator (t-PA) or urokinase (u-PA) were compared when these Pg forms were either bound to human umbilical vein endothelial cells (HUVEC) or in solution. ([D646E]Glu-Pg can be cleaved at the Arg(561)-Val(562) bond by Pg activators but does not possess Pm activity subsequent to this cleavage because of the mutation of Asp(646) Of the serine protease catalytic triad,) Glu-Pg activation by t-PA was enhanced on HUVEC compared with the solution phase by 13-fold. In contrast, much less enhancement of Pg activation was observed with [D646E]Glu-Pg (similar to2-fold), Although the extent of activation of Lys-Pg on cells was similar to that of Glu-Pg, the cells afforded minimal enhancement of Lys-Pg activation compared with the solution phase (1.3-fold). Similar results were obtained when u-PA was used as activator. When Glu-Pg was bound to the cell in the presence of either t-PA or u-PA, conversion to Lys-Pg was observed, but conversion of ([D646E]Glu-Pg to ([D646E]Lys-Pg was not detected, consistent with the conversion of Glu-Pg to Lys-Pg being necessary for optimal enhancement of Pg activation on cell surfaces. Furthermore, we found that conversion of [D646E]Glu-Pg to [D646E]Lys-Pg by exogenous Pm was markedly enhanced (similar to 20-fold) on the HUVEC surface, suggesting that the stimulation of the conversion of Glu-Pg to Lys-Pg is a key mechanism by which cells enhance Pg activation.	Scripps Res Inst, La Jolla, CA 92037 USA; Univ Notre Dame, Notre Dame, IN 46556 USA; Inst Recerca Oncol, Barcelona 08907, Spain	Scripps Research Institute; University of Notre Dame	Miles, LA (corresponding author), Scripps Res Inst, CVN 26,10550 N Torey Pines Rd, La Jolla, CA 92037 USA.	lmiles@scripps.edu			NHLBI NIH HHS [HL31950, HL45934, HL38272, HL13423] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038272, R01HL013423, R37HL013423, P01HL031950, R01HL045934, R29HL038272] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; BEEBE D, 1989, BLOOD, V74, P1116; BEEBE DP, 1987, THROMB RES, V46, P241, DOI 10.1016/0049-3848(87)90286-6; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; DUVALJOBE C, 1994, J BIOL CHEM, V269, P21353; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Felez J, 1996, THROMB HAEMOSTASIS, V76, P577; FELEZ J, 1991, BLOOD, V78, P2318; FUKAO H, 1992, BIOCHEM BIOPH RES CO, V187, P956, DOI 10.1016/0006-291X(92)91290-7; GONZALEZGRONOW M, 1991, ARCH BIOCHEM BIOPHYS, V286, P625, DOI 10.1016/0003-9861(91)90090-6; HAJJAR KA, 1987, J CLIN INVEST, V80, P1712, DOI 10.1172/JCI113262; HAJJAR KA, 1990, J BIOL CHEM, V265, P2908; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HAJJAR KA, 1988, J CLIN INVEST, V82, P1769, DOI 10.1172/JCI113790; HAJJAR KA, 1986, CIRCULATION, V74, P233; HORREVOETS AJG, 1995, J BIOL CHEM, V270, P15770, DOI 10.1074/jbc.270.26.15770; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Longstaff C, 1999, BLOOD, V93, P3839, DOI 10.1182/blood.V93.11.3839.411k08_3839_3846; Lopez-Alemany R., 1996, Fibrinolysis, V10, P5; LOSCALZO J, 1987, J CLIN INVEST, V79, P1749, DOI 10.1172/JCI113015; MARKUS G, 1978, J BIOL CHEM, V253, P733; MARKUS G, 1979, J BIOL CHEM, V254, P1211; MENHART N, 1995, BIOCHEMISTRY-US, V34, P1482, DOI 10.1021/bi00005a003; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1988, BLOOD, V72, P628; MILES LA, 1988, J BIOL CHEM, V263, P11928; RAMAKRISHNAN V, 1990, J BIOL CHEM, V265, P2755; RIJKEN DC, 1982, J BIOL CHEM, V257, P2920; RUSSELL ME, 1990, J BIOL CHEM, V265, P2569; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Sinniger V, 1999, J BIOL CHEM, V274, P12414, DOI 10.1074/jbc.274.18.12414; STRICKER RB, 1986, BLOOD, V68, P275; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; WIMAN B, 1973, EUR J BIOCHEM, V39, P1, DOI 10.1111/j.1432-1033.1973.tb03096.x; WIMAN B, 1973, EUR J BIOCHEM, V36, P25, DOI 10.1111/j.1432-1033.1973.tb02880.x	36	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19078	19083		10.1074/jbc.M101387200	http://dx.doi.org/10.1074/jbc.M101387200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11264290	hybrid			2022-12-27	WOS:000169091000060
J	Melen, K; Kinnunen, L; Julkunen, I				Melen, K; Kinnunen, L; Julkunen, I			Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; HUMAN MXB PROTEIN; DNA-BINDING; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ALPHA; TRANSLOCATION; LOCALIZATION; ACTIVATOR	Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors, which mediate interferon (IFN), interleukin, and some growth factor and peptide hormone signaling in cells, IFN stimulation results in tyrosine phosphorylation, dimerization, and nuclear import of STATs. In response to IFN-gamma stimulation, STAT1 forms homodimers, whereas IFN-alpha induction results in the formation of STAT1.STAT2 heterodimers, which assemble with p48 protein in the nucleus. Phosphorylation as such is not sufficient to target STATs into the nucleus; rather, the dimerization triggered by phosphorylation is essential. Although IFN-induced nuclear import of STATs is mediated by the importin/Ran transport system, no classic nuclear localization signal (NLS) has been found in STATs. In the three-dimensional structure of STAT1, we observed a structural arginine/lysine-rich element within the DNA-binding domain of the molecule. We created a series of point mutations in these elements of STAT1 and STAT2 and showed by transient transfection/IFN stimulation assay that this site is essential for the nuclear import of both STAT1 and STAT2. The results suggest that two arginine/lysine-rich elements, one in each STAT monomer, are required for IFN-induced nuclear import of STAT dimers, import-defective STAT1 and STAT2 proteins were readily phosphorylated and dimerized, but they functioned as dominant negative molecules inhibiting the nuclear import of heterologous STAT protein.	Natl Publ Hlth Inst, Dept Microbiol, Lab Viral & Mol Immunol, FIN-00300 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Melen, K (corresponding author), Natl Publ Hlth Inst, Dept Microbiol, Lab Viral & Mol Immunol, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	krister.melen@ktl.fi	Kinnunen, Leena/B-7059-2012	Kinnunen, Leena/0000-0001-8739-4812				ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; CANTELL K, 1986, METHOD ENZYMOL, V119, P54; Cantell K, 1981, Methods Enzymol, V78, P29; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; Koster M, 1999, EUR J BIOCHEM, V260, P137, DOI 10.1046/j.1432-1327.1999.00149.x; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lackmann M, 1998, GROWTH FACTORS, V16, P39, DOI 10.3109/08977199809017490; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehtonen A, 1997, J IMMUNOL, V159, P794; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Melen K, 1997, J BIOL CHEM, V272, P32353, DOI 10.1074/jbc.272.51.32353; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Milocco LH, 1999, MOL CELL BIOL, V19, P2913; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MORIN N, 1989, MOL CELL BIOL, V9, P4372, DOI 10.1128/MCB.9.10.4372; Mowen K, 1998, J BIOL CHEM, V273, P30073, DOI 10.1074/jbc.273.46.30073; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Subramaniam PS, 2000, J CELL SCI, V113, P2771; Summers M., 1986, TEX AGR EXP STN B, V1555, P1; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x	49	105	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16447	16455		10.1074/jbc.M008821200	http://dx.doi.org/10.1074/jbc.M008821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11150296	hybrid			2022-12-27	WOS:000168623100117
J	Ivanov, KI; Puustinen, P; Merits, A; Saarma, M; Makinen, K				Ivanov, KI; Puustinen, P; Merits, A; Saarma, M; Makinen, K			Phosphorylation down-regulates the RNA binding function of the coat protein of potato virus A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO MOSAIC-VIRUS; CELL-TO-CELL; MOVEMENT PROTEIN; NONTOXIC CONCENTRATIONS; ETCH POTYVIRUS; NUCLEIC-ACIDS; VIRAL-RNA; TRANSPORT; PLANTS; TRAFFICKING	Plant viruses encode movement proteins (MPs) to facilitate transport of their genomes from infected into neighboring healthy cells through plasmodesmata, Growing evidence suggests that specific phosphorylation events can regulate MP functions. The coat protein (CP) of potato virus A (PVA; genus Potyvirus) is a multifunctional protein involved both in virion assembly and virus movement. Labeling of PVA-infected tobacco leaves with [P-33]orthophosphate demonstrated that PVA CP is phosphorylated in vivo. Competition assays established that PVA CP and the well characterized 30-kDa MP of tobacco mosaic virus (genus Tobamovirus) are phosphorylated in vitro by the same Ser/Thr kinase activity from tobacco leaves. This activity exhibits a strong preference for Mn2+ over Mg2+, can be inhibited by micromolar concentrations of Zn2+ and Cd2+, and is not Ca2+-dependent. Tryptic phosphopeptide mapping revealed that PVA CP was phosphorylated by this protein kinase activity on multiple sites. In contrast, PVA CP was not phosphorylated when packaged into virions, suggesting that the phosphorylation sites are located within the RNA binding domain and not exposed on the surface of the virion. Furthermore, two independent experimental approaches demonstrated that the RNA binding function of PVA CP is strongly inhibited by phosphorylation, From these findings, we suggest that protein phosphorylation represents a possible mechanism regulating formation and/or stability of viral ribonucleoproteins in planta.	Univ Helsinki, Viikki Bioctr, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Makinen, K (corresponding author), Univ Helsinki, Viikki Bioctr, Inst Biotechnol, POB 56, FIN-00014 Helsinki, Finland.		Mäkinen, Kristiina M/C-8650-2012; Ivanov, Konstantin/C-4644-2015; Merits, Andres/H-3125-2015	Mäkinen, Kristiina M/0000-0001-8233-8942; Ivanov, Konstantin/0000-0001-9198-5674; Merits, Andres/0000-0001-8193-0071				ATKINS D, 1991, J GEN VIROL, V72, P2831, DOI 10.1099/0022-1317-72-11-2831; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Citovsky V, 1998, PLANT J, V16, P13, DOI 10.1046/j.1365-313x.1998.00263.x; CITOVSKY V, 1990, CELL, V60, P637, DOI 10.1016/0092-8674(90)90667-4; CITOVSKY V, 1992, PLANT CELL, V4, P397, DOI 10.1105/tpc.4.4.397; CITOVSKY V, 1991, BIOESSAYS, V13, P373, DOI 10.1002/bies.950130802; CITOVSKY V, 1993, GENE DEV, V7, P904, DOI 10.1101/gad.7.5.904; Cruz SS, 1999, TRENDS MICROBIOL, V7, P237, DOI 10.1016/S0966-842X(99)01508-5; Daros JA, 1997, VIROLOGY, V237, P327, DOI 10.1006/viro.1997.8802; DOLJA VV, 1994, EMBO J, V13, P1482, DOI 10.1002/j.1460-2075.1994.tb06403.x; Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7; Ghoshroy S, 1998, PLANT J, V13, P591, DOI 10.1046/j.1365-313X.1998.00061.x; HALEY A, 1995, PLANT J, V8, P715, DOI 10.1046/j.1365-313X.1995.08050715.x; HAMMOND J, 1988, J VIROL METHODS, V20, P203, DOI 10.1016/0166-0934(88)90124-3; HUGHES RK, 1995, MOL PLANT MICROBE IN, V8, P658, DOI 10.1094/MPMI-8-0658; IVANOV KI, 1994, FEBS LETT, V346, P217, DOI 10.1016/0014-5793(94)00477-3; Karpova OV, 1997, VIROLOGY, V230, P11, DOI 10.1006/viro.1997.8472; Karpova OV, 1999, VIROLOGY, V261, P20, DOI 10.1006/viro.1999.9842; Kawakami S, 1999, J VIROL, V73, P6831, DOI 10.1128/JVI.73.8.6831-6840.1999; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazarowitz SG, 1999, PLANT CELL, V11, P535, DOI 10.1105/tpc.11.4.535; Lee JY, 2000, PLANTA, V210, P177, DOI 10.1007/PL00008124; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; MCDONALD JG, 1977, J GEN VIROL, V35, P251, DOI 10.1099/0022-1317-35-2-251; Merits A, 1998, J GEN VIROL, V79, P3123, DOI 10.1099/0022-1317-79-12-3123; Oparka KJ, 1999, CELL, V97, P743, DOI 10.1016/S0092-8674(00)80786-2; PUURAND U, 1992, VIRUS RES, V23, P99, DOI 10.1016/0168-1702(92)90070-P; Revers F, 1999, MOL PLANT MICROBE IN, V12, P367, DOI 10.1094/MPMI.1999.12.5.367; Seron K, 1996, VIROLOGY, V219, P274, DOI 10.1006/viro.1996.0246; SHUKLA DD, 1994, POTYVIRIDAE, P124; Sokolova M, 1997, FEBS LETT, V400, P201, DOI 10.1016/S0014-5793(96)01380-4; Sun GQ, 1997, BIOCHEMISTRY-US, V36, P2139, DOI 10.1021/bi962291n; Sun GQ, 1999, BIOCHEMISTRY-US, V38, P5659, DOI 10.1021/bi982793w; Vihinen H, 2000, J BIOL CHEM, V275, P27775; Waigmann E, 2000, EMBO J, V19, P4875, DOI 10.1093/emboj/19.18.4875; WATANABE Y, 1992, FEBS LETT, V313, P181, DOI 10.1016/0014-5793(92)81440-W; ZAWORSKI PG, 1988, ANAL BIOCHEM, V173, P440, DOI 10.1016/0003-2697(88)90211-4	40	70	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13530	13540		10.1074/jbc.M009551200	http://dx.doi.org/10.1074/jbc.M009551200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11152464	hybrid			2022-12-27	WOS:000168356600006
J	Hagen, KD; Meeks, JC				Hagen, KD; Meeks, JC			The unique cyanobacterial protein OpcA is an allosteric effector of glucose-6-phosphate dehydrogenase in Nostoc punctiforme ATCC 29133	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN ATCC-29133; ANABAENA SP PCC-7120; ELECTRON DONATION; REDOX MODULATION; HETEROCYSTS; LIGHT; NITROGENASE; THIOREDOXIN; FERREDOXIN; EXPRESSION	Glucose-6-phosphate dehydrogenase (G6PD), encoded by zwf, is essential for nitrogen fixation and dark heterotrophic growth of the cyanobacterium Nostoc punctiforme ATCC 29133, In N. punctiforme, zwf is part of a four-gene operon transcribed in the order fbp-tal-zwf-opcA, Genetic analyses indicated that opcA is required for G6PD activity. To define the role of opcA, the synthesis, aggregation state, and activity of G6PD in N. punctiforme strains expressing different amounts of G6PD and/or OpcA were examined. A single tetrameric form of G6PD was consistently observed for all strains, as well as for recombinant N. punctiforme His-G6PD purified from Escherichia coli, regardless of the quantity of OpcA present. However, His-G6PD and the G6PD of strain UCD 351, which lacks OpcA, had low affinities for glucose 6-phosphate (G6P) substrate (K-m (app) = 65 and 85 mM, respectively) relative to wild-type N. punctiforme G6PD (K-m (app) = 0.5 mM). Near wild-type affinities for G6P were observed for these enzymes when saturating amounts of His-OpcA- or OpcA-containing extract were added. Kinetic studies were consistent with OpcA acting as an allosteric activator of G6PD. A role in redox modulation of G6PD activity was also indicated, because thioredoxin-mediated inactivation and reactivation of His-G6PD occurred only when His-OpcA was present.	Univ Calif Davis, Microbiol Sect, Div Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Meeks, JC (corresponding author), Univ Calif Davis, Microbiol Sect, Div Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	jcmeeks@ucdavis.edu		Hagen, Kari/0000-0001-9673-2481				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APTE SK, 1978, PROC R SOC SER B-BIO, V200, P1, DOI 10.1098/rspb.1978.0001; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; BOTHE H, 1988, METHOD ENZYMOL, V167, P496; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; CAMPBELL EL, 1992, J GEN MICROBIOL, V138, P473, DOI 10.1099/00221287-138-3-473; COHEN MF, 1994, MICROBIOL-SGM, V140, P3233, DOI 10.1099/13500872-140-12-3233; COSSAR JD, 1984, J GEN MICROBIOL, V130, P991; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Gleason FK, 1996, ARCH BIOCHEM BIOPHYS, V334, P277, DOI 10.1006/abbi.1996.0456; Hanson TE, 1998, MICROBIOL-SGM, V144, P1537, DOI 10.1099/00221287-144-6-1537; Harlow E., 1988, ANTIBODIES LAB MANUA; Levy H R, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P97; NEWMAN J, 1995, FEMS MICROBIOL LETT, V133, P187, DOI 10.1111/j.1574-6968.1995.tb07882.x; RIPPKA R, 1992, PASTURE CULTURE COLL; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAEFFER F, 1978, ARCH MICROBIOL, V116, P9, DOI 10.1007/BF00408728; SCHEIBE R, 1989, ARCH BIOCHEM BIOPHYS, V274, P290, DOI 10.1016/0003-9861(89)90441-4; SCHEIBE R, 1990, BOT ACTA, V103, P327, DOI 10.1111/j.1438-8677.1990.tb00170.x; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Summers ML, 1996, MOL MICROBIOL, V22, P473, DOI 10.1046/j.1365-2958.1996.1371502.x; SUMMERS ML, 1995, THESIS U CALIFORNIA; Sundaram S, 1998, MICROBIOL-SGM, V144, P1549, DOI 10.1099/00221287-144-6-1549; UDVARDY J, 1984, J BACTERIOL, V157, P681, DOI 10.1128/JB.157.2.681-683.1984; UDVARDY J, 1983, FEBS LETT, V152, P97, DOI 10.1016/0014-5793(83)80490-6; Wenderoth I, 1997, J BIOL CHEM, V272, P26985, DOI 10.1074/jbc.272.43.26985; Wendt UK, 1999, PLANT MOL BIOL, V40, P487, DOI 10.1023/A:1006257230779; WINKENBACH F, 1973, PLANT PHYSIOL, V52, P480, DOI 10.1104/pp.52.5.480	30	39	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11477	11486		10.1074/jbc.M010472200	http://dx.doi.org/10.1074/jbc.M010472200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152472	hybrid			2022-12-27	WOS:000168081800009
J	Venhudova, G; Canals, F; Querol, E; Aviles, FX				Venhudova, G; Canals, F; Querol, E; Aviles, FX			Mutations in the N- and C-terminal tails of potato carboxypeptidase inhibitor influence its oxidative refolding process at the reshuffling stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE FOLDING PATHWAY; EPIDERMAL GROWTH-FACTOR; TRYPSIN-INHIBITOR; METALLOCARBOXYPEPTIDASE INHIBITOR; GENE-EXPRESSION; PROTEIN; STABILITY; MECHANISM; SEQUENCES; COMPLEX	A comparative study of the oxidative refolding for nine selected potato carboxypeptidase inhibitor (PCI) mutants was carried out using the disulfide quenching approach. The mutations were performed at the N- and C-terminal tails of PCI outside its disulfide stabilized central core. The differences between the refolding of wild type and mutant proteins were observed in the second phase of the refolding process, the reshuffling of disulfide bridges, although the first phase, nonspecific packing, was not greatly affected by the mutations. Point mutations at the C-tail or deletion of up to three C-terminal residues of PCI resulted in a lower efficiency of the reshuffling process. In the case of the mutants lacking five N-terminal or four or five C-terminal residues, no "native-like" form was observed after the refolding process. On the other hand, the double mutant G35P/P36G did not attain a native-like form either, al though one slightly more stable species was observed after being submitted to refolding, The disulfide pairing of this species is different from that of the wtPCI native form. The differences between the refolding process of wild type and mutant forms are interpreted in the light of the new view of protein folding. The results of the present study support the hypothesis that the refolding of this small disulfide-rich protein, and others, is driven by noncovalent interactions at the reshuffling stage. It is also shown that the interactions established between the N- and C-tail residues and the core of PCI are important for the proper refolding of the protein.	Univ Autonoma Barcelona, Inst Biol Fonamental, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biol Fonamental, E-08193 Barcelona, Spain.		Avilés, Francesc Xavier/A-2664-2015; Aviles, Francesc Xavier/F-3482-2019	Avilés, Francesc Xavier/0000-0002-1399-6789; Aviles, Francesc Xavier/0000-0002-1399-6789				Adler A J, 1973, Methods Enzymol, V27, P675; BALDWIN RL, 1994, NATURE, V369, P183, DOI 10.1038/369183a0; Blanco-Aparicio C, 1998, J BIOL CHEM, V273, P12370, DOI 10.1074/jbc.273.20.12370; CHANG JY, 1995, J BIOL CHEM, V270, P9207, DOI 10.1074/jbc.270.16.9207; Chang JY, 2000, J BIOL CHEM, V275, P8287, DOI 10.1074/jbc.275.12.8287; CHANG JY, 1994, J BIOL CHEM, V269, P22087; Chang JY, 1997, J BIOL CHEM, V272, P69; Chang JY, 1996, BIOCHEMISTRY-US, V35, P11702, DOI 10.1021/bi9606915; Chang JY, 2000, J BIOL CHEM, V275, P14205, DOI 10.1074/jbc.275.19.14205; CHATRENET B, 1993, J BIOL CHEM, V268, P20988; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; Creighton T E, 1986, Methods Enzymol, V131, P83; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; Creighton Thomas E., 1992, P301; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; GAY GD, 1995, J MOL BIOL, V254, P968, DOI 10.1006/jmbi.1995.0669; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; HASS GM, 1980, BIOCHEM BIOPH RES CO, V97, P1481, DOI 10.1016/S0006-291X(80)80032-5; HASS GM, 1976, BIOCHEMISTRY-US, V15, P93, DOI 10.1021/bi00646a015; HASS GM, 1981, METHOD ENZYMOL, V80, P778; Klement P, 1999, BLOOD, V94, P2735, DOI 10.1182/blood.V94.8.2735.420k30_2735_2743; LIN SL, 1995, NAT STRUCT BIOL, V2, P835, DOI 10.1038/nsb1095-835; LING MH, 1993, J BIOL CHEM, V268, P810; Marino-Buslje C, 2000, EUR J BIOCHEM, V267, P1502, DOI 10.1046/j.1432-1327.2000.01150.x; MARTINEAU B, 1991, MOL GEN GENET, V228, P281, DOI 10.1007/BF00282477; Mas JM, 1998, J MOL BIOL, V284, P541, DOI 10.1006/jmbi.1998.2194; MOLINA MA, 1992, GENE, V116, P129, DOI 10.1016/0378-1119(92)90508-M; MOLINA MA, 1994, J BIOL CHEM, V269, P21467; Otlewski J, 1996, ACTA BIOCHIM POL, V43, P431; PriceCarter M, 1996, BIOCHEMISTRY-US, V35, P15547, DOI 10.1021/bi9615755; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; ROLKA K, 1992, BIOL CHEM H-S, V373, P1055, DOI 10.1515/bchm3.1992.373.2.1055; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Villanueva J, 1998, FEBS LETT, V440, P175, DOI 10.1016/S0014-5793(98)01447-1; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Wu J, 1997, PROTEIN SCI, V6, P391	36	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11683	11690		10.1074/jbc.M007927200	http://dx.doi.org/10.1074/jbc.M007927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152676	hybrid			2022-12-27	WOS:000168081800036
J	Zanassi, P; Paolillo, M; Feliciello, A; Avvedimento, EV; Gallo, V; Schinelli, S				Zanassi, P; Paolillo, M; Feliciello, A; Avvedimento, EV; Gallo, V; Schinelli, S			cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; C-FOS TRANSCRIPTION; MAP KINASE; CYCLIC-AMP; B-RAF; MEMBRANE DEPOLARIZATION; CREB PHOSPHORYLATION; RYANODINE RECEPTOR; GENE-EXPRESSION; ACTIVATION	Activation of the cAMP dependent protein kinase A (PKA) pathway may induce cAMP-response element-binding protein (CREB) phosphorylation either directly or via cross-talk mechanisms with other signal transduction pathways. In this study, we have investigated in striatal primary cultures the mechanism by which activation of the cAMP/PKA-dependent pathway leads to CREB phosphorylation via the extracellular signal-regulated kinase (ERK) dependent pathway. We have found that PKA-induced CREB phosphorylation and CREB-dependent transcription are mediated by calcium (Ca2+) release from intracellular stores and are blocked by inhibitors of the protein kinase C and ERK pathways. This mechanism appears to be mediated by the small G-protein Rap1, whose activation appears to be primed by PKA-induced Ca2+ release but not further induced by direct or indirect PKA- or protein kinase C-dependent phosphorylation. These results suggest that, in striatal neurons, intracellular Ca2+ release, Rap1, and ERK pathway play a crucial role in the PKA induced CREB phosphorylation and CREB-dependent transcription.	Univ Pavia, Fac Farm, Dipartimento Farmacol Sperimentale & Applicata, I-27100 Pavia, Italy; CNR, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Univ Catanzaro, Fac Med Catanzaro, Dipartimento Med Sperimentale, I-88100 Catanzaro, Italy; NICHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Schinelli, S (corresponding author), Univ Pavia, Fac Farm, Dipartimento Farmacol Sperimentale & Applicata, 14 Viale Taramelli, I-27100 Pavia, Italy.	schnll@unipv.it	Paolillo, Mayra/N-2615-2015	Paolillo, Mayra/0000-0002-7751-3336; Feliciello, Antonio/0000-0002-7932-2170				Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; BURT DR, 1977, SCIENCE, V196, P327, DOI 10.1126/science.847477; Das S, 1997, SYNAPSE, V25, P227; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; Paolillo M, 1999, J BIOL CHEM, V274, P6546, DOI 10.1074/jbc.274.10.6546; Paolillo M, 1998, EUR J NEUROSCI, V10, P1937, DOI 10.1046/j.1460-9568.1998.00203.x; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Roberson ED, 1999, J NEUROSCI, V19, P4337; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SCHINELLI S, 1994, MOL BRAIN RES, V21, P162, DOI 10.1016/0169-328X(94)90389-1; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; YOSHIDA A, 1992, J NEUROSCI, V12, P1094	38	137	138	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11487	11495		10.1074/jbc.M007631200	http://dx.doi.org/10.1074/jbc.M007631200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11139572	hybrid			2022-12-27	WOS:000168081800010
J	Cessna, SG; Low, PS				Cessna, SG; Low, PS			An apoplastic Ca2+ sensor regulates internal Ca2+ release in aequorin-transformed tobacco cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOOSMOTIC SHOCK; CALCIUM; RECEPTOR; FLUXES; STORES; KINASE; SIGNAL	Removal of Ca2+ from tobacco suspension cell medium has two immediate effects on cytosolic Ca2+ fluxes: (i) externally derived Ca2+ influx (occurring in response to cold shock or hypo osmotic shock) is inhibited, and (ii) organellar Ca2+ release (induced by a fungally derived defense elicitor, caffeine, or hypo-osmotic shock) is elevated. We show here that the enhanced release of internal Ca2+ is Likely due to increased discharge from a caffeine-sensitive store in response to a signal transduced from an extracellular Ca2+ sensor. Thus, chelation of extracellular Ca2+ in the absence of any other stimulus directly activates release of intracellular Ca2+ into the cytosol, Evidence that this chelator-activated Ca2+ flux is dependent on a signaling pathway includes its abrogation by prior treatment with caffeine, and its inhibition by protein kinase inhibitors (K252a and staurosporine) and anion channel blockers (niflumate and anthracene-9-carboxylate). An unexpected characteristic of tobacco cell adaptation to low external Ca2+ was the emergence of a new Ca2+ compartment that was inaccessible to external EGTA, yet responsive to the usual stimulants of extracellular Ca2+ entry. Thus, cells that are exposed to EGTA for 20 min lose sensitivity to caffeine and defense elicitors, indicating that their intracellular Ca2+ pools have been depleted, Surprisingly, these same cells simultaneously regain their ability to respond to stimuli that usually activate extracellular Ca2+ influx even though all external Ca2+ is chelated, Because this gradual restoration of Ca2+ influx can be inhibited by the same kinase inhibitors that block EGTA-activated Ca2+ release, we propose that chelator-activated Ca2+ release from internal stores leads to deposition of this Ca2+ into a novel EGTA- and caffeine-insensitive compartment that can subsequently be activated by stimulants of extracellular Ca2+ entry.	Purdue Univ, Dept Chem, W Lafayette, IN 47904 USA; Purdue Univ, Biochem & Mol Biol Program, W Lafayette, IN 47904 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Low, PS (corresponding author), Purdue Univ, Dept Chem, 1393 Brown Bldg, W Lafayette, IN 47904 USA.			Cessna, Stephen/0000-0001-7233-8711; Low, Philip/0000-0001-9042-5528				ALLEN DG, 1977, SCIENCE, V195, P996, DOI 10.1126/science.841325; ALLISON JD, 1995, SSSA SPEC PUBL, V42, P241; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Cessna SG, 1998, J BIOL CHEM, V273, P27286, DOI 10.1074/jbc.273.42.27286; CESSNA SG, 2001, IN PRESS PLANTA; Chandra S, 1997, J BIOL CHEM, V272, P28274, DOI 10.1074/jbc.272.45.28274; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; McGehee DS, 1997, J PHYSIOL-LONDON, V502, P31, DOI 10.1111/j.1469-7793.1997.031bl.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Riccardi D, 1999, CELL CALCIUM, V26, P77, DOI 10.1054/ceca.1999.0066; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Takahashi K, 1997, PLANT PHYSIOL, V113, P587, DOI 10.1104/pp.113.2.587; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Tibbits CW, 1998, CARBOHYD RES, V310, P101, DOI 10.1016/S0008-6215(98)00172-4; Xu HX, 1998, PLANT CELL, V10, P585, DOI 10.1105/tpc.10.4.585; Yamaguchi T, 2000, ADV PHARMACOL, V47, P209	24	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10655	10662		10.1074/jbc.M006989200	http://dx.doi.org/10.1074/jbc.M006989200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139570	hybrid			2022-12-27	WOS:000167980900014
J	Verde, I; Pahlke, G; Salanova, M; Zhang, G; Wang, S; Coletti, D; Onuffer, J; Jin, SLC; Conti, M				Verde, I; Pahlke, G; Salanova, M; Zhang, G; Wang, S; Coletti, D; Onuffer, J; Jin, SLC; Conti, M			Myomegalin is a novel protein of the Golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A; SUBCELLULAR-LOCALIZATION; CENTROSOMAL PROTEIN; SKELETAL-MUSCLE; GENE; IDENTIFICATION; ACTIVATION; VESICLES; DOMAIN; AMP	Subcellular targeting of the components of the cAMP-dependent pathway is thought to be essential for intracellular signaling. Here we have identified a novel protein, named myomegalin, that interacts with the cyclic nucleotide phosphodiesterase PDE4D, thereby targeting it to particulate structures. Myomegalin is a large 2,324-amino acid protein mostly composed of alpha -helical and coiled coil structures, with domains shared with microtubule-associated proteins, and a leucine zipper identical to that found in the Drosophila centrosomin. Transcripts of 7.5-8 kilobases were present in most tissues, whereas a short mRNA of 2.4 kilobases was detected only in rat testis. A third splicing variant was expressed predominantly in rat heart. Antibodies against the deduced sequence recognized particulate myomegalin proteins of 62 kDa in testis and 230-250 kDa in heart and skeletal muscle. Immunocytochemistry and transfection studies demonstrate colocalization of PDE4D and myomegalin in the Golgi/centrosomal area of cultured cells, and in sarcomeric structures of skeletal muscle. Myomegalin expressed in COS-7 cells coimmunoprecipitated with PDE4D3 and sequestered it to particulate structures. These findings indicate that myomegalin is a novel protein that functions as an anchor to localize components of the cAMP-dependent pathway to the Golgi/centrosomal region of the cell.	Stanford Univ, Sch Med, Div Reprod Biol, Dept Gynecol & Obstet, Stanford, CA 94305 USA; Berlex Biosci, Dept Immunol, Richmond, CA 94804 USA	Stanford University	Conti, M (corresponding author), Stanford Univ, Sch Med, Div Reprod Biol, Dept Gynecol & Obstet, Stanford, CA 94305 USA.	marco.conti@stanford.edu	Pinheiro, Maísa/E-7424-2012; Coletti, Dario/CAG-9308-2022; Coletti, Dario/U-2219-2018; Verde, Ignacio/M-3991-2013	Verde, Ignacio/0000-0003-3492-5725; Wang, Sonya/0000-0003-4429-0508; Coletti, Dario/0000-0001-7373-1953	NICHD NIH HHS [R01-HD20788] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BLOODGOOD RA, 1992, BIOL CELL, V76, P291, DOI 10.1016/0248-4900(92)90431-Y; Bolger GB, 1997, BIOCHEM J, V328, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; DECAMILLI P, 1986, J CELL BIOL, V103, P189, DOI 10.1083/jcb.103.1.189; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HEUER JG, 1995, DEVELOPMENT, V121, P3861; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; Jilling T, 1996, J BIOL CHEM, V271, P4381; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; JOSWIG G, 1991, J CELL SCI, V98, P37; KERYER G, 1993, EXP CELL RES, V204, P230, DOI 10.1006/excr.1993.1029; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Li KJ, 1998, J CELL BIOL, V141, P455, DOI 10.1083/jcb.141.2.455; Lim J, 1999, J BIOL CHEM, V274, P19677, DOI 10.1074/jbc.274.28.19677; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Megraw TL, 1999, DEVELOPMENT, V126, P2829; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Muniz M, 1997, P NATL ACAD SCI USA, V94, P14461, DOI 10.1073/pnas.94.26.14461; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Petzelt C, 1997, J CELL SCI, V110, P2573; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pryzwansky Katherine B., 1998, Cell Biochemistry and Biophysics, V28, P251, DOI 10.1007/BF02737813; Reilein AR, 1998, J CELL BIOL, V142, P803, DOI 10.1083/jcb.142.3.803; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Salanova M, 1999, ENDOCRINOLOGY, V140, P2297, DOI 10.1210/en.140.5.2297; Scholler JK, 1997, DNA CELL BIOL, V16, P515, DOI 10.1089/dna.1997.16.515; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511	47	156	161	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11189	11198		10.1074/jbc.M006546200	http://dx.doi.org/10.1074/jbc.M006546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134006	hybrid, Green Published			2022-12-27	WOS:000167980900082
J	Yokoyama, T; Kimura, KM; Ushiki, Y; Yamada, S; Morooka, A; Nakashiba, T; Sassa, T; Itohara, S				Yokoyama, T; Kimura, KM; Ushiki, Y; Yamada, S; Morooka, A; Nakashiba, T; Sassa, T; Itohara, S			In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; PRP 27-30; SCRAPIE; MICE; EXPRESSION; CELLS; GENE; BINDING; COPPER	The central event in prion disease is thought to be conformational conversion of the cellular isoform of prion protein (PrPC) to the insoluble isoform PrPSc. We generated polyclonal and monoclonal antibodies by immunizing PrPC-null mice with native PrPC. All seven monoclonal antibodies (mAbs) immunoprecipitated PrPC, but they immunoprecipitated PrPSc weakly or not at all, thereby indicating preferential reactivities to PrPC in solution. Immunoprecipitation using these mAbs revealed a marked loss of PrPC in brains at the terminal stage of illness. Histoblot analyses using these polyclonal antibodies in combination of pretreatment of blots dissociated PrPC and PrPSc in situ and consistently demonstrated the decrease of PrPC at regions where PrPSc accumulated. interestingly, same mAbs showed immunohistochemical reactivities to abnormal isoforms. One group of mAbs showed reactivity to materials that accumulated in astrocytes, while the other group did so to amorphous plaques in neuropil. Epitope mapping indicated that single mAbs have reactivities to multiple epitopes, thus implying dual specificities. This suggests the importance of octarepeats as a part of PrPC-specific conformation. Our observations support the notion that loss of function of PrPC may partly underlie the pathogenesis of prion diseases. The conversion of PrPC to PrPSc may involve multiple steps at different sites.	Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; Nippi Res Inst Biomatrix, Tokyo 1208601, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; RIKEN; Kyoto University	Itohara, S (corresponding author), Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan.		SASSA, Takayuki/B-2519-2012; Itohara, Shigeyoshi/I-8769-2012	SASSA, Takayuki/0000-0003-3145-9829; Itohara, Shigeyoshi/0000-0002-2410-9989				CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; INUMARU S, 1991, VIRUS RES, V21, P123; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; McKenzie D, 1998, J BIOL CHEM, V273, P25545, DOI 10.1074/jbc.273.40.25545; Nishida N, 1999, LAB INVEST, V79, P689; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WHITTINGTON MA, 1995, NAT GENET, V9, P197, DOI 10.1038/ng0295-197; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172, DOI 10.1128/CDLI.2.2.172-176.1995; YOKOYAMA WM, 1991, CURRENT PROTOCOLS IM, V1; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	32	101	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11265	11271		10.1074/jbc.M008734200	http://dx.doi.org/10.1074/jbc.M008734200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152682	hybrid			2022-12-27	WOS:000167980900093
J	Gowri, PM; Ganguly, TC; Cao, JS; Devalaraja, MN; Groner, B; Vore, M				Gowri, PM; Ganguly, TC; Cao, JS; Devalaraja, MN; Groner, B; Vore, M			Conversion of threonine 757 to valine enhances stat5a transactivation potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE STIMULATION; MAMMARY EPITHELIAL-CELLS; DNA-BINDING; RAT-LIVER; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; SIGNAL TRANSDUCER; PROTEIN-KINASE; GENE PROMOTER; FACTOR-I	The growth hormone family of cytokines transduces intracellular signals through the Jak2-Stat5 pathway to activate the transcription of target genes. Amino acids within the C termini of Stats constitute the transactivation domain but also regulate the time course of tyrosine phosphorylation and extent of DNA binding. We mutated Thr(757) in the C-terminal of Stat5a (Thr-Stat5) to Val (Val-Stat5) and Asp (Asp-Stat5) and examined the effect on nuclear translocation, DNA binding. and prolactin-induced transcriptional activation of a Stat5-responsive luciferase reporter gene. Val-Stat5 produced a 5-fold higher increase in transcriptional activity relative to Thr-Stat5; Asp-Stat5 produced a similar response to Thr-Stat5. The increased transactivation was ligand induced and was not due to differences in basal expression of Val-Stat5 or to a constitutively activated Stat5 protein. Similar rates of loss of DNA binding ability and phosphorylation of Val- and Thr-Stat5 were observed following a single pulse of prolactin, indicating that the dephosphorylation pathways were unaltered. The serine-threonine kinase inhibitor H7 inhibited the transactivation potential of Thr-, Val-, and Asp-Stat5 to a similar extent, eliminating phosphorylation of Thr757 as a regulatory mechanism. The results suggest that Thr757 modulates the transactivation potential of Stat5 by a mechanism(s) that is dependent on the formation of Stat5 dimers and/or their nuclear translocation.	Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; Georg Speyer Haus, D-60596 Frankfurt, Germany	University of Kentucky	Vore, M (corresponding author), Univ Kentucky, Grad Ctr Toxicol, 306 Hlth Sci Res Bldg, Lexington, KY 40536 USA.		Vore, Mary/E-2177-2012					AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; BURDON TG, 1994, MOL ENDOCRINOL, V8, P1528, DOI 10.1210/me.8.11.1528; Callus BA, 2000, J BIOL CHEM, V275, P16954, DOI 10.1074/jbc.M909976199; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Galsgaard ED, 1996, MOL ENDOCRINOL, V10, P652, DOI 10.1210/me.10.6.652; Ganguly TC, 1997, J CLIN INVEST, V99, P2906, DOI 10.1172/JCI119485; Gebert CA, 1997, MOL ENDOCRINOL, V11, P400, DOI 10.1210/me.11.4.400; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GRONER B, 1995, CURR OPIN GENET DEV, V5, P587, DOI 10.1016/0959-437X(95)80027-1; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; KAZANSKY AV, 1995, MOL ENDOCRINOL, V9, P1598, DOI 10.1210/me.9.11.1598; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kirken RA, 1997, J BIOL CHEM, V272, P14098, DOI 10.1074/jbc.272.22.14098; Kordula T, 1996, J BIOL CHEM, V271, P6752, DOI 10.1074/jbc.271.12.6752; LI S, 1995, MOL CELL BIOL, V15, P2063; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARINI F, 1993, NUCLEIC ACIDS RES, V21, P2277, DOI 10.1093/nar/21.9.2277; Milocco LH, 1999, MOL CELL BIOL, V19, P2913; MORRIGL R, 1997, MOL CELL BIOL, V17, P3663; MORRIGL R, 1996, MOL CELL BIOL, V16, P5691; OBrien ML, 1996, CARCINOGENESIS, V17, P185, DOI 10.1093/carcin/17.2.185; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; Starr R, 1999, BIOESSAYS, V21, P47, DOI 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Wang DM, 1996, MOL CELL BIOL, V16, P6141; Wartmann M, 1996, J BIOL CHEM, V271, P31863, DOI 10.1074/jbc.271.50.31863; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794	38	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10485	10491		10.1074/jbc.M007156200	http://dx.doi.org/10.1074/jbc.M007156200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133982	hybrid			2022-12-27	WOS:000167996400116
J	Sayeski, PP; Ali, MS; Frank, SJ; Bernstein, KE				Sayeski, PP; Ali, MS; Frank, SJ; Bernstein, KE			The angotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif (YRFRR)-Y-231	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-II; AT(1) RECEPTOR; TYROSINE KINASE; CARDIAC MYOCYTES; RNA-POLYMERASE; N-TERMINUS; CELLS; DOMAIN; PATHWAY; PHOSPHORYLATION	In response to angiotensin II, Jak2 autophosphorylates and binds the angiotensin II AT(1) receptor. By studying a variety of Jak2 deletion proteins, we now show that the Jak2 protein motif (YRFRR)-Y-231 is required for the co-association of this kinase with the AT(1) receptor. We also used a full-length Jak2 protein containing a (231)FAAAA amino acid substitution. Although this protein still autophosphorylated in response to angiotensin II, it did not co-associate with the AT(1) receptor. This uncoupling indicates that AT(1)/Jak2 co-association is not necessary for angiotensin II-induced Jak2 autophosphorylation and that Jak2 autophosphorylation per se is insufficient for AT, receptor co-association, In response to angiotensin II, the Jak2-(231)FAAAA mutant will tyrosine phosphorylate Stat1. However, in the absence of AT(1)/Jak2 co-association, Stat1 did not translocate into the cell nucleus and failed to mediate gene transcription. This notable result indicates that Stat1 tyrosine phosphorylation alone is insufficient for Stat1 nuclear translocation. In summary, we now show that, although Jak2-mediated tyrosine phosphorylation of Stat1 is independent of receptor co-association, Jak2-mediated recruitment of Stat1 to the AT, receptor is critical for Stat1 nuclear translocation and subsequent gene transcription.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Univ Alabama, Div Endocrinol & Metab, Dept Med, Birmingham, AL 35294 USA	Emory University; University of Alabama System; University of Alabama Birmingham	Bernstein, KE (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 1639 Pierce Dr,7107 WWB, Atlanta, GA 30322 USA.			Bernstein, Kenneth/0000-0001-8097-3272	NHLBI NIH HHS [HL47035, F32-HL09678, HL61710] Funding Source: Medline; NIDDK NIH HHS [DK44280, DK39777, T32-DK07298, DK45215, DK51445] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047035, R01HL061710, F32HL009678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039777, R01DK039777, R01DK051445, P50DK045215, R01DK044280] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; Ali MS, 1998, BIOCHEM BIOPH RES CO, V249, P672, DOI 10.1006/bbrc.1998.9054; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BHAT GJ, 1995, J BIOL CHEM, V270, P19059, DOI 10.1074/jbc.270.32.19059; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; Cacalano NA, 1999, EMBO J, V18, P1549, DOI 10.1093/emboj/18.6.1549; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; DAMELL JE, 1997, SCIENCE, V277, P1630; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; FRANK SJ, 1995, J BIOL CHEM, V270, P14766; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; McWhinney CD, 1997, J MOL CELL CARDIOL, V29, P2513, DOI 10.1006/jmcc.1997.0489; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; Sakai I, 1997, J BIOL CHEM, V272, P12350, DOI 10.1074/jbc.272.19.12350; Sayeski PP, 1999, J BIOL CHEM, V274, P33131, DOI 10.1074/jbc.274.46.33131; Sayeski PP, 1997, NUCLEIC ACIDS RES, V25, P1458, DOI 10.1093/nar/25.7.1458; Sayeski PP, 1998, REGUL PEPTIDES, V78, P19, DOI 10.1016/S0167-0115(98)00137-2; Sayeski PP, 1999, CIRC RES, V84, P1332, DOI 10.1161/01.RES.84.11.1332; Sayeski PP, 1998, CIRC RES, V82, P1279, DOI 10.1161/01.RES.82.12.1279; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SHIN TH, 1994, MOL ENDOCRINOL, V8, P704, DOI 10.1210/me.8.6.704; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Yi WS, 1996, MOL ENDOCRINOL, V10, P1425, DOI 10.1210/me.10.11.1425; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; ZHAO YM, 1995, J BIOL CHEM, V270, P13814, DOI 10.1074/jbc.270.23.13814	34	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10556	10563		10.1074/jbc.M008856200	http://dx.doi.org/10.1074/jbc.M008856200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152457	hybrid			2022-12-27	WOS:000167996400125
J	Inagaki, S; Ohoka, Y; Sugimoto, H; Fujioka, S; Amazaki, M; Kurinami, H; Miyazaki, N; Tohyama, M; Furuyama, T				Inagaki, S; Ohoka, Y; Sugimoto, H; Fujioka, S; Amazaki, M; Kurinami, H; Miyazaki, N; Tohyama, M; Furuyama, T			Sema4C, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; PDZ-DOMAIN; AXON GUIDANCE; SIGNALING COMPLEXES; NEURITE OUTGROWTH; FAMILY; RECEPTOR; IDENTIFICATION; GENES; BRAIN	Semaphorins are known to act as chemorepulsive molecules that guide axons during neural development. Sema4C, a group 4 semaphorin, is a transmembrane semaphorin of unknown function. The cytoplasmic domain of Sema4C contains a proline-rich region that may interact with some signaling proteins. In this study, we demonstrate that Sema4C is enriched in the adult mouse brain and associated with PSD-95 isoforms containing PDZ (PSD-95/DLG/ZO-1) domains, such as PSD-95/SAP90, PSD-93/chapsin110, and SAP97/DLG-1, which are concentrated in the post-synaptic density of the brain. In the neocortex, S4C is enriched in the synaptic vesicle fraction and Triton X-100 insoluble post-synaptic density fraction. Immunostaining for Sema4C overlaps that for PSD-95 in superficial layers I-IV of the neocortex. In neocortical culture, S4C is colocalized with PSD-95 in neurons, with a dot-like pattern along the neurites. Sema4C thus may function in the cortical neurons as a hi-directional transmembrane ligand through interacting with PSD-95.	Osaka Univ, Fac Med, Sch Allied Hlth Sci, Neurobiol Grp, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Inagaki, S (corresponding author), Osaka Univ, Fac Med, Sch Allied Hlth Sci, Neurobiol Grp, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.			Furuyama, Tatsuo/0000-0001-7349-103X				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cai HB, 1999, J NEUROSCI, V19, P6519; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Elhabazi A, 1997, J BIOL CHEM, V272, P23515, DOI 10.1074/jbc.272.38.23515; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Goslin  K., 1991, CULTURING NERVE CELL, P339; Hata Y, 1996, J NEUROSCI, V16, P2488; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; INAGAKI S, 1991, BRAIN RES, V541, P354, DOI 10.1016/0006-8993(91)91038-3; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P396, DOI 10.1006/bbrc.1996.1367; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kobayashi H, 1997, J NEUROSCI, V17, P8339; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyazaki N, 1999, NEUROSCI RES, V33, P269, DOI 10.1016/S0168-0102(99)00015-2; Miyazaki N, 1999, NEUROSCIENCE, V93, P401, DOI 10.1016/S0306-4522(99)00134-7; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PONGTING CP, 1997, BIOESSAYS, V19, P469; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Sambrook J., 2002, MOL CLONING LAB MANU; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yagi T, 2000, GENE DEV, V14, P1169; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	52	55	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9174	9181		10.1074/jbc.M009051200	http://dx.doi.org/10.1074/jbc.M009051200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134026	hybrid			2022-12-27	WOS:000167607700075
J	Dashti, SR; Efimova, T; Eckert, RL				Dashti, SR; Efimova, T; Eckert, RL			MEK7-dependent activation of p38 MAP kinase in keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; SIGNAL-TRANSDUCTION PATHWAY; DISTAL REGULATORY REGION; JUN NH2-TERMINAL KINASE; PROTEIN-KINASE; CELL-DIFFERENTIATION; CROSS-LINKING; DNA-BINDING; IN-VITRO; TRANSCRIPTION	Previous studies suggest that a PKC/Ras/MEKK1 cascade regulates involucrin (hINV) gene expression in human epidermal keratinocytes. MEK7, which is expressed in epidermis, has been identified as a member of this cascade (Efimova, T., LaCelle, P., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395 and Efimova, T., and Eckert, R. L. (2000) J. Biol. Chem. 275, 1601-1607). However, the kinase that functions downstream of MEK7 has not been identified. Our present studies show that MEK7 expression in keratinocytes markedly activates p38 alpha and modestly activates JNK. Activation of p38 MAPK by MEK7 is a novel finding, as previous reports have assigned MEK7 as a JNK regulator. We also demonstrate that this regulation is physiologically important, as the p38 alpha- and JNK-dependent activities regulate hINV promoter activity and expression of the endogenous hINV gene.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem Reprod Biol Dermatol & Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Eckert, RL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Rm E532,2109 Adelbert Rd, Cleveland, OH 44106 USA.			Dashti, Shervin/0000-0002-1552-9738; Efimova, Tatiana/0000-0002-9869-1545				Alonso G, 2000, J BIOL CHEM, V275, P40641, DOI 10.1074/jbc.M007835200; Balasubramanian S, 2000, BIOCHEM J, V350, P791, DOI 10.1042/0264-6021:3500791; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Green H, 1980, Harvey Lect, V74, P101; GRUDA MC, 1994, ONCOGENE, V9, P2537; Hale KK, 1999, J IMMUNOL, V162, P4246; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hu MCT, 1999, J BIOL CHEM, V274, P7095, DOI 10.1074/jbc.274.11.7095; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Vuong H, 2000, J BIOL CHEM, V275, P32250, DOI 10.1074/jbc.M005227200; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	37	49	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					8059	8063		10.1074/jbc.C000862200	http://dx.doi.org/10.1074/jbc.C000862200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244091	hybrid			2022-12-27	WOS:000167474900055
J	Vijaykumar, M; Naik, RS; Gowda, DC				Vijaykumar, M; Naik, RS; Gowda, DC			Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-alpha secretion by macrophages is mediated without membrane insertion or endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; MANNOSE RECEPTOR; SIGNAL-TRANSDUCTION; TRYPANOSOMA-CRUZI; ANCHORS; BIOSYNTHESIS; EXPRESSION; PHAGOCYTOSIS; ACTIVATION	The glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are believed to contribute to the pathogenesis of malaria by inducing the secretion of proinflammatory cytokines by macrophages, Previous studies have shown that P, falciparum GPIs elicit toxic immune responses by protein tyrosine kinase (PTK)- and protein kinase C (PKC)-mediated cell signaling pathways, which are activated by the carbohydrate and acyl moieties of the intact GPIs, respectively. In this study, we show that induction of TNF-alpha by P, falciparum GPIs in macrophages is mediated by the recognition of the distal fourth mannose residue. This event is critical but not sufficient for the productive cell signaling; interaction by the acylglycerol moisty of GPIs is also required. These novel interactions are coupled to previously demonstrated PTK and PKC pathways, since the specific inhibitors of these kinases effectively blocked the GPI-induced TMF-alpha: production. Surprisingly, sn-2 lyso-GPIs were also able to elicit TNF-alpha secretion. Contrary to the prevailing notion, GPIs are neither inserted to the plasma membranes nor endocytosized, Thus, this study defines the GPI structural requirements and reveals a novel mechanism for the outside-in activation of cell signaling by P, falciparum GPIs in inducing proinflammatory responses.	Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA	Georgetown University	Gowda, DC (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, 3900 Reservoir Rd NW, Washington, DC 20007 USA.		Vijay-Kumar, Matam/Q-8988-2019		NIAID NIH HHS [AI41139] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Camargo MM, 1997, J IMMUNOL, V158, P5890; DRICKAMER K, 1994, MOL GLYCOBIOLOGY, P51; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; Ferguson MAJ, 1999, BBA-MOL BASIS DIS, V1455, P327, DOI 10.1016/S0925-4439(99)00058-7; Field MC, 1997, GLYCOBIOLOGY, V7, P161, DOI 10.1093/glycob/7.2.161-d; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; HERBERT E, 2000, BIOSCIENCE REP, V20, P213; Ilangumaran S, 1996, TRENDS CELL BIOL, V6, P163, DOI 10.1016/0962-8924(96)20012-1; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MENON AK, 1994, METHOD ENZYMOL, V230, P418; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Milne KG, 1999, J BIOL CHEM, V274, P1465, DOI 10.1074/jbc.274.3.1465; Murai M, 1996, IMMUNOLOGY, V89, P436, DOI 10.1046/j.1365-2567.1996.d01-765.x; MURAI M, 1995, J LEUKOCYTE BIOL, V57, P687, DOI 10.1002/jlb.57.4.687; Naik RS, 2000, J BIOL CHEM, V275, P24506, DOI 10.1074/jbc.M002151200; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; Pereira-Chioccola VL, 1999, BIOCHEM SOC T, V27, P516, DOI 10.1042/bst0270516; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Rowe JA, 1998, MOL BIOCHEM PARASIT, V92, P177, DOI 10.1016/S0166-6851(97)00237-5; Schofield L, 1996, J IMMUNOL, V156, P1886; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tachado SD, 1996, J IMMUNOL, V156, P1897; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Voth BR, 1998, MOL BIOCHEM PARASIT, V93, P31, DOI 10.1016/S0166-6851(98)00013-9; ZHANG F, 1992, P NATL ACAD SCI USA, V89, P5231, DOI 10.1073/pnas.89.12.5231	31	41	44	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6909	6912		10.1074/jbc.C100007200	http://dx.doi.org/10.1074/jbc.C100007200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11152670	hybrid			2022-12-27	WOS:000167442900008
J	Moriwaki, Y; Begum, NA; Kobayashi, M; Matsumoto, M; Toyoshima, K; Seya, T				Moriwaki, Y; Begum, NA; Kobayashi, M; Matsumoto, M; Toyoshima, K; Seya, T			Mycobacterium bovis bacillus Calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-ANCHOR PROTEINS; RING FINGER DOMAIN; DIFFERENTIAL DISPLAY; MOLECULAR-CLONING; INNATE IMMUNITY; MDCK CELLS; APOPTOSIS; IDENTIFICATION; ORIENTATION; MONOCYTES	LITAF and PIG7 encode an identical protein, and they have recently been reported as lipopolysaccharide and p53-inducible genes, respectively. By using the differential display approach, we identified a Mycobacterium bovis BCG cell wall skeleton (BCG-CWS)-inducible gene fragment from human monocytes, showing no homology to any reported gene. Full-length cloning of this fragment reveals the following. 1) The differential display product represents the incomplete 3'-untranslated region of LITAF/PIG7. 2) The coding region of the transcript differs from LITAF/PIG7 due to an absence of a single guanine residue, resulting in a potential translational frameshift. 3) The newly coded protein turns out to be 86% identical and 90% similar to an estrogen-inducible rat gene, EET-1. Repeated analysis, expressed sequence tag search, comparison with homologues, and genome sequence analysis confirmed the absence of the single guanine residue. One interesting feature of this protein is that it possesses the RING domain signature and is predicted to be localized in the nucleus. However, detailed analysis together with experimental evidence suggests it is neither a RING family member nor a nuclear protein. Comparison of a total collection of 18 proteins from various species indicates that proteins of this family are small in size and mainly conserved at the C-terminal domain with a unique motif, We characterize this novel protein as an unglycosylated small integral membrane protein of the lysosome/late endosome (SIMPLE) whose expression is elicited in monocytes by live and heat-killed BCG, BCG cell wall complex, lipopolysaccharide, and tumor necrosis factor-cu. To our knowledge this is the first report of pathogen-associated molecular pattern (PAMP)induced differential expression of a lysosomal membrane protein presumably involved in apoptosis.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka 537, Japan; Nara Inst Sci & Technol, Dept Mol Immunol, Nara 6310101, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Nara Institute of Science & Technology	Seya, T (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka 537, Japan.		Seya, Tsukasa/A-4336-2012; 美佐子, 松本/A-4497-2012	Moriwaki, Yasuhiro/0000-0001-9533-0421				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Asano H, 1993, DNA Seq, V3, P369, DOI 10.3109/10425179309020838; Begum NA, 1999, BIOCHEM BIOPH RES CO, V256, P325, DOI 10.1006/bbrc.1999.0329; BEGUM NA, 1995, HEPATOLOGY, V22, P1447, DOI 10.1002/hep.1840220518; Bhalla K, 1999, J HUM GENET, V44, P383, DOI 10.1007/s100380050183; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Capone MC, 1996, J IMMUNOL, V157, P969; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Chan JYH, 2001, J BIOL CHEM, V276, P2139, DOI 10.1074/jbc.M007965200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P102; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo Ana Maria, 1998, Frontiers in Bioscience, V3, pD25; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Everett LM, 1997, ENDOCRINOLOGY, V138, P3836, DOI 10.1210/en.138.9.3836; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HAYASHI A, 1994, P JPN ACAD B-PHYS, V70, P205, DOI 10.2183/pjab.70.205; Hayashi A, 1998, P JPN ACAD B-PHYS, V74, P50, DOI 10.2183/pjab.74.50; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; Hu G, 1999, MOL CELL BIOL, V19, P724; HURWITZ A, 1992, MOL CELL ENDOCRINOL, V84, pC19, DOI 10.1016/0303-7207(92)90063-C; Ihrke G, 2000, BIOCHEM J, V345, P287, DOI 10.1042/0264-6021:3450287; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; KOKEN MHM, 1995, CR ACAD SCI III-VIE, V318, P733; Kremer L, 1997, EUR J IMMUNOL, V27, P2450, DOI 10.1002/eji.1830270945; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lai ZH, 1998, BIOCHEMISTRY-US, V37, P17005, DOI 10.1021/bi980596r; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Mao M, 1998, P NATL ACAD SCI USA, V95, P8175, DOI 10.1073/pnas.95.14.8175; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rojas M, 1999, J IMMUNOL, V162, P6122; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Salamonsen LA, 1999, BEST PRACT RES CL OB, V13, P161, DOI 10.1053/beog.1999.0015; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Seya T, 2000, ADV EXP MED BIOL, V465, P229; Simmen T, 1999, J CELL SCI, V112, P45; Stenmark H, 1999, J CELL SCI, V112, P4175; TAKASHIBA S, 1995, INFECT IMMUN, V63, P1529, DOI 10.1128/IAI.63.4.1529-1534.1995; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Tranque P, 1996, P NATL ACAD SCI USA, V93, P3105, DOI 10.1073/pnas.93.7.3105; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	64	77	85	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23065	23076		10.1074/jbc.M011660200	http://dx.doi.org/10.1074/jbc.M011660200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11274176	hybrid			2022-12-27	WOS:000169412700144
J	Lovshin, J; Estall, J; Yusta, B; Brown, TJ; Drucker, DJ				Lovshin, J; Estall, J; Yusta, B; Brown, TJ; Drucker, DJ			Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC EXPRESSION; GENE-EXPRESSION; FOOD-INTAKE; RAT-BRAIN; LITHIUM-CHLORIDE; BODY-WEIGHT; NEUROENDOCRINE FUNCTION; PEPTIDE-1-(7-36) AMIDE; INTEROCEPTIVE STRESS; GLUCOSE-TOLERANCE	Glucagon-like peptide-2 (GLP-2) regulates energy homeostasis via effects on nutrient absorption and maintenance of gut mucosal epithelial integrity. The biological actions of GLP-2 in the central nervous system (CNS) remain poorly understood. We studied the sites of endogenous GLP-2 receptor (GLP-2R) expression, the localization of transgenic LacZ expression under the control of the mouse GLP-2R promoter, and the actions of GLP-2 in the murine CNS, GLP-2R expression was detected in multiple extrahypothalamic regions of the mouse and rat CNS, including cell groups in the cerebellum, medulla, amygdala, hippocampus, dentate gyrus, pens, cerebral cortex, and pituitary, A 1.5-kilobase fragment of the mouse GLP-2R promoter directed LacZ expression to the gastrointestinal tract and CNS regions in the mouse that exhibited endogenous GLP-2R expression, including the cerebellum, amygdala, hippocampus, and dentate gyrus, Intracerebroventricular injection of GLP-2 significantly inhibited food intake during dark-phase feeding in wild-type mice. Disruption of glucagonlike peptide-1 receptor (GLP-1R) signaling with the antagonist exendin-(9-39) in wild-type mice or genetically in GLP-1R(-/-) mice significantly potentiated the anorectic actions of GLP-2, These findings illustrate that CNS GLP-2R expression is not restricted to hypothalamic nuclei and demonstrate that the anorectic effects of GLP-2 are transient and modulated by the presence or absence of GLP-1R signaling in vivo.	Toronto Gen Hosp, Banting & Best Diabet Ctr, Dept Med, Toronto, ON M5G 2C4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Div Reprod Sci, Toronto, ON M5G 1Y5, Canada; Univ Toronto, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Drucker, DJ (corresponding author), Toronto Gen Hosp, Banting & Best Diabet Ctr, Dept Med, 101 Coll St,CCRW3-845, Toronto, ON M5G 2C4, Canada.		Drucker, Daniel J/A-4092-2010; Brown, Theodore J./E-2192-2013	Brown, Theodore J./0000-0002-3074-4516; Estall, Jennifer/0000-0002-9838-1440				Alavi K, 2000, J PEDIATR SURG, V35, P847, DOI 10.1053/jpsu.2000.6861; Alvarez E, 1996, J NEUROCHEM, V66, P920; Beak SA, 1998, J CLIN INVEST, V101, P1334, DOI 10.1172/JCI610; Beak SA, 1996, ENDOCRINOLOGY, V137, P4130, DOI 10.1210/en.137.10.4130; Benjamin MA, 2000, GUT, V47, P112, DOI 10.1136/gut.47.1.112; Boushey RP, 1999, AM J PHYSIOL-ENDOC M, V277, pE937, DOI 10.1152/ajpendo.1999.277.5.E937; Boylan MO, 1997, J BIOL CHEM, V272, P17438, DOI 10.1074/jbc.272.28.17438; CAMPOS RV, 1994, ENDOCRINOLOGY, V134, P2156, DOI 10.1210/en.134.5.2156; Cheeseman CI, 1996, AM J PHYSIOL-GASTR L, V271, pG477, DOI 10.1152/ajpgi.1996.271.3.G477; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DaCambra MP, 2000, BIOCHEMISTRY-US, V39, P8888, DOI 10.1021/bi000497p; Donahey JCK, 1998, BRAIN RES, V779, P75, DOI 10.1016/S0006-8993(97)01057-3; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; Drucker DJ, 2001, ENDOCRINOLOGY, V142, P521, DOI 10.1210/en.142.2.521; Drucker DJ, 1999, AM J PHYSIOL-GASTR L, V276, pG79, DOI 10.1152/ajpgi.1999.276.1.G79; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Drucker DJ, 1997, NAT BIOTECHNOL, V15, P673, DOI 10.1038/nbt0797-673; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Dusing MR, 2000, AM J PHYSIOL-GASTR L, V279, pG1080, DOI 10.1152/ajpgi.2000.279.5.G1080; FRANKLIN KBJ, 1997, MOUSE BRAIN STEROTAX; Galehshahi FS, 1998, FEBS LETT, V436, P163, DOI 10.1016/S0014-5793(98)01116-8; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; HAN VKM, 1986, J NEUROSCI RES, V16, P97, DOI 10.1002/jnr.490160110; Holst JJ, 1999, TRENDS ENDOCRIN MET, V10, P229, DOI 10.1016/S1043-2760(99)00157-5; HOOSEIN NM, 1984, FEBS LETT, V178, P83, DOI 10.1016/0014-5793(84)81245-4; Jin TR, 1996, MOL CELL BIOL, V16, P19; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; LankatButtgereit B, 1997, PEPTIDES, V18, P617, DOI 10.1016/S0196-9781(97)00001-6; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Larsen PJ, 1997, ENDOCRINOLOGY, V138, P4445, DOI 10.1210/en.138.10.4445; MacLusky NJ, 2000, ENDOCRINOLOGY, V141, P752, DOI 10.1210/en.141.2.752; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Munroe DG, 1999, P NATL ACAD SCI USA, V96, P1569, DOI 10.1073/pnas.96.4.1569; Oka JI, 2000, BRAIN RES, V878, P194, DOI 10.1016/S0006-8993(00)02741-4; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Portois L, 1999, J BIOL CHEM, V274, P8181, DOI 10.1074/jbc.274.12.8181; Prasad R, 2000, J PEDIATR SURG, V35, P357, DOI 10.1016/S0022-3468(00)90040-X; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR1537, DOI 10.1152/ajpregu.1999.277.5.R1537; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Scrocchi LA, 1998, ENDOCRINOLOGY, V139, P3127, DOI 10.1210/en.139.7.3127; Seeley RJ, 2000, J NEUROSCI, V20, P1616; Seeley RJ, 2000, ENDOCRINOLOGY, V141, P473, DOI 10.1210/en.141.2.473; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Sivarajah P, 2001, COMP BIOCHEM PHYS B, V128, P517, DOI 10.1016/S1096-4959(00)00355-9; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thiele TE, 1997, AM J PHYSIOL-REG I, V272, pR726, DOI 10.1152/ajpregu.1997.272.2.R726; Thiele TE, 1998, BRAIN RES, V801, P164, DOI 10.1016/S0006-8993(98)00584-8; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Tsai CH, 1997, AM J PHYSIOL-GASTR L, V272, pG662, DOI 10.1152/ajpgi.1997.272.3.G662; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; van Dijk G, 1999, NEUROPEPTIDES, V33, P406; WHITE RB, 2000, 82 ANN M END SOC JUN, P271; Wildhage I, 1999, ENDOCRINOLOGY, V140, P624, DOI 10.1210/en.140.2.624; Wojdemann M, 1999, J CLIN ENDOCR METAB, V84, P2513, DOI 10.1210/jc.84.7.2513; Wojdemann M, 1998, SCAND J GASTROENTERO, V33, P828; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 1999, J BIOL CHEM, V274, P30459, DOI 10.1074/jbc.274.43.30459; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489	67	89	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21489	21499		10.1074/jbc.M009382200	http://dx.doi.org/10.1074/jbc.M009382200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262390	hybrid			2022-12-27	WOS:000169297900093
J	Schneider, C; Tallman, KA; Porter, NA; Brash, AR				Schneider, C; Tallman, KA; Porter, NA; Brash, AR			Two distinct pathways of formation of 4-hydroxynonenal - Mechanisms of nonenzymatic transformation of the 9-and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; METHYL LINOLEATE; ALDEHYDES; IDENTIFICATION; LIPOXYGENASE; PRODUCT; HYDROPEROXIDES; AUTOXIDATION; SPECIFICITY; OXYGENATION	The mechanism of formation of 4-hydroxy-2E-nonenal (4-HNE) has been a matter of debate since it was discovered as a major cytotoxic product of lipid peroxidation in 1980, Recent evidence points to 4-hydroperoxy-2E-nonenal (4-HPNE) as the immediate precursor of 4-HNE (Lee, S, H., and Blair, I. A. (2000) Chem. Res. Toxicol. 13, 698-702; Noordermeer, M. A., Feussner, I., Kolbe, A., Veldink, G. A., and Vliegenthart, J. F. G. (2800) Biochem, Biophys, Res. Commun, 277, 112-116), and a pathway via 9-hydroperoxylinoleic acid and 3Z-nonenal is recognized in plant extracts. Using the 9- and 13-hydroperoxides of linoleic acid as starting material, we find that two distinct mechanisms lead tea the formation of 4-H(P)NE and the corresponding 4-hydro(pero)xyalkenal that retains the original carboxyl group (9-hydroperoxy-12-oxo-10E-dodecsnoic acid), Chiral analysis revealed that 4-HPNE formed from 13S-hydroperoxy-9Z,11E-octadecadienoic acid (13S-HPODE) retains >90% S configuration, whereas it is nearly racemic from 9S-hydroperoxy-10E,12Z-octadecadienoic acid (9S-HPODE), 9-Hydroperoxy-12-oxo-10E-dodecenoic acid is >90% S when derived from 9S-HPODE and almost racemic from 13S-HPODE, Through analysis of intermediates and products, we provide evidence that (i) allylic hydrogen abstraction at C-8 of 13S-HPODE leads to a 10,13-dihydroperoxide that undergoes cleavage between C-9 and C-10 to give 4S-HPNE, whereas direct Hock cleavage of the 13S-HPODE gives 12-oxo-9Z-dodecenoic acid, which oxygenates to racemic 9-hydroperoxy-12-oxo-10E-dodecenoic acid; by contrast, (ii) 9S-HPODE cleaves directly to 3Z-nonenal as a precursor of racemic 4-HPNE, whereas allylic hydrogen abstraction at C-14 and oxygenation to a 9,12-dihydroperoxide leads to chiral 9S-hydroperoxy-12-oxo-10E-dodecenoic acid. Our results distinguish two major pathways to the formation of 4-HNE that should apply also to other fatty acid hydroperoxides. Slight (similar to 10%) differences in the observed chiralities from those predicted in the above mechanisms suggest the existence of additional routes to the 4-hydroxyalkenals.	Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave & Pierce, Nashville, TN 37232 USA.	alan.brash@mcmail.vanderbilt.edu			NIGMS NIH HHS [GM-53638, GM-15431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, R01GM053638, P01GM015431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; BENEDETTI A, 1982, BIOCHIM BIOPHYS ACTA, V711, P345, DOI 10.1016/0005-2760(82)90044-3; Bowry VW, 1999, ACCOUNTS CHEM RES, V32, P27, DOI 10.1021/ar950059o; Brash AR, 2000, LIPIDS, V35, P947, DOI 10.1007/s11745-000-0604-0; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; COREY EJ, 1987, TETRAHEDRON LETT, V28, P5391, DOI 10.1016/S0040-4039(00)96736-4; ESTERBAUER H, 1986, BIOCHIM BIOPHYS ACTA, V876, P154, DOI 10.1016/0005-2760(86)90329-2; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAZIO VM, 1993, MOL ASPECTS MED, V14, P217, DOI 10.1016/0098-2997(93)90008-2; FRIMER AA, 1979, CHEM REV, V79, P359, DOI 10.1021/cr60321a001; GARDNER HW, 1993, J BIOL CHEM, V268, P6971; Gardner HW, 1998, PLANT PHYSIOL, V116, P1359, DOI 10.1104/pp.116.4.1359; GARDNER HW, 1984, LIPIDS, V19, P294, DOI 10.1007/BF02534458; Gardner HW, 1998, LIPIDS, V33, P745, DOI 10.1007/s11745-998-0265-z; HAMBERG M, 1983, BIOCHIM BIOPHYS ACTA, V752, P191, DOI 10.1016/0005-2760(83)90112-1; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; INGRAM CD, 1988, LIPIDS, V23, P340, DOI 10.1007/BF02537345; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MATTHEW JA, 1977, LIPIDS, V12, P324, DOI 10.1007/BF02533358; Nair J, 1999, MUTAT RES-FUND MOL M, V424, P59, DOI 10.1016/S0027-5107(99)00008-1; Noordermeer MA, 2000, BIOCHEM BIOPH RES CO, V277, P112, DOI 10.1006/bbrc.2000.3641; PORTER NA, 1980, J AM CHEM SOC, V102, P5597, DOI 10.1021/ja00537a032; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; Schneider C, 1997, CHIRALITY, V9, P563, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<563::AID-CHIR25>3.0.CO;2-L; Silverstein R.M., 1981, SPECTROMETRIC IDENTI, P181; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218	30	266	271	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20831	20838		10.1074/jbc.M101821200	http://dx.doi.org/10.1074/jbc.M101821200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259420	hybrid			2022-12-27	WOS:000169297900008
J	Piek, E; Ju, WJ; Heyer, J; Escalante-Alcalde, D; Stewart, CL; Weinstein, M; Deng, CX; Kucherlapati, R; Bottinger, EP; Roberts, AB				Piek, E; Ju, WJ; Heyer, J; Escalante-Alcalde, D; Stewart, CL; Weinstein, M; Deng, CX; Kucherlapati, R; Bottinger, EP; Roberts, AB			Functional characterization of transforming growth factor beta signaling in Smad2-and Smad3-deficient fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TARGETED DISRUPTION; IV COLLAGENASE; SMAD7 PROMOTER; CELL-LINES; FACTOR-SS; PATHWAY; GENE; ACTIVIN; BINDING	A prominent pathway of transforming growth factor (TGF)-beta signaling involves receptor-dependent phosphorylation of Smad2 and Smad3, which then translocate to the nucleus to activate transcription of target genes. To investigate the relative importance of these two Smad proteins in TGF-beta1 signal transduction, we have utilized a loss of function approach, based on analysis of the effects of TGF-beta1 on fibroblasts derived from mouse embryos deficient in Smad2 (S2KO) or Smad3 (S3KO). TGF-beta1 caused 50% inhibition of cellular proliferation in wild-type fibroblasts as assessed by [H-3]thymidine incorporation, whereas the growth of S2KO or S3KO cells was only weakly inhibited by TGF-beta1. Lack of Smad2 or Smad3 expression did not affect TGF-1 beta -induced fibronectin synthesis but resulted in markedly suppressed induction of plasminogen activator inhibitor-1 by TGF-beta1. Moreover, TGF-beta1-mediated induction of matrix metalloproteinase-a was selectively dependent on Smad2, whereas induction of c-fos, Smad7, and TGF-beta1 autoinduction relied on expression of Smad3. Investigation of transcriptional activation of TGF-beta -sensitive reporter genes in the different fibroblasts showed that activation of the (Smad binding element)(4)-Lux reporter by TGF-beta1 was dependent on expression of Smad3, but not Smad2, whereas activation of the activin response element-Lux reporter was strongly suppressed in S2KO fibroblasts but, on the contrary, enhanced in S3KO cells. Our findings indicate specific roles for Smad2 and Smad3 in TGF-beta1 signaling.	NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; NCI, Canc & Dev Biol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Piek, E (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bldg 41,Rm C629,41 Lib Dr,MSC-5055, Bethesda, MD 20892 USA.		deng, chuxia/N-6713-2016; Kucherlapati, Raju/ABC-8807-2021	Escalante-Alcalde, Diana/0000-0003-0325-6602; Ju, Wenjun/0000-0002-9136-8454	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056077, Z01DK056001, ZIADK056001] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-56077-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai T, 1998, CANCER LETT, V122, P157, DOI 10.1016/S0304-3835(97)00384-4; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Blain SW, 2000, J BIOL CHEM, V275, P32066, DOI 10.1074/jbc.M006496200; BROWN PD, 1990, CANCER RES, V50, P6184; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; Datto MB, 1999, MOL CELL BIOL, V19, P2495; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; GLICK AB, 1994, GENE DEV, V8, P2429, DOI 10.1101/gad.8.20.2429; Hata A, 1998, MOL MED TODAY, V4, P257, DOI 10.1016/S1357-4310(98)01247-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagarajan RP, 1999, J BIOL CHEM, V274, P31229, DOI 10.1074/jbc.274.44.31229; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; PIEK E, 2001, IN PRESS ADV CANC RE; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Riggins GJ, 1997, CANCER RES, V57, P2578; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Takenoshita S, 1998, GENOMICS, V48, P1, DOI 10.1006/geno.1997.5149; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	45	344	360	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19945	19953		10.1074/jbc.M102382200	http://dx.doi.org/10.1074/jbc.M102382200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262418	hybrid			2022-12-27	WOS:000169135100036
J	Heiden, MGV; Li, XX; Gottleib, E; Hill, RB; Thompson, CB; Colombini, M				Heiden, MGV; Li, XX; Gottleib, E; Hill, RB; Thompson, CB; Colombini, M			Bcl-x(L) promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROSPORA-CRASSA; CYTOCHROME-C; ION-CHANNEL; VDAC; PERMEABILITY; APOPTOSIS; PORIN; RESPIRATION; TRANSPORT; PREVENTS	The diffusion of metabolites across the outer mitochondrial membrane is essential for coupled cellular respiration. The outer membrane of mitochondria isolated from growth factor-deprived cells is impaired in its ability to exchange metabolic anions, When added to mitochondria, recombinant Bcl-x(L) restores metabolite exchange across the outer membrane without inducing the loss of cytochrome c from the intermembrane space. Restoration of outer membrane permeability to anionic metabolites does not occur directly through Bcl-x(L) ion channels. Instead, recombinant Bcl-x(L) maintains the outer mitochondrial membrane channel, VDAC, in an open configuration. Consistent with these findings, when ADP-induced oxidative phosphorylation is limited by exogenous beta -NADH, recombinant Bcl-x(L) can sustain outer mitochondrial membrane permeability to ADP. beta -NADH limits respiration by promoting the closed configuration of VDAC. Together these results demonstrate that following an apoptotic signal, Bcl-x(L) can maintain metabolite exchange across the outer mitochondrial membrane by inhibiting VDAC closure.	Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University System of Maryland; University of Maryland College Park	Thompson, CB (corresponding author), Abramson Family Canc Res Inst, 450 BRBII 421 Curie Blvd, Philadelphia, PA 19104 USA.		Gottlieb, Eyal/G-6450-2010; Colombini, Marco/A-1540-2014	Gottlieb, Eyal/0000-0002-9770-0956; Hill, Blake/0000-0001-6228-3905				ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1987, METHOD ENZYMOL, V148, P465; COLOMBINI M, 1980, J MEMBRANE BIOL, V53, P79, DOI 10.1007/BF01870576; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; FINKELSTEIN A, 1981, J MEMBRANE BIOL, V59, P155, DOI 10.1007/BF01875422; FREITAG H, 1983, METHOD ENZYMOL, V97, P286; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Lam M, 1998, J BIOL CHEM, V273, P17307, DOI 10.1074/jbc.273.28.17307; LEE AC, 1994, J BIOL CHEM, V269, P30974; Lee An-Chin, 1997, Methods in Cell Science, V19, P71, DOI 10.1023/A:1009761922055; Lemeshko SV, 2000, BIOPHYS J, V79, P2785, DOI 10.1016/S0006-3495(00)76518-0; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MANNELLA CA, 1992, TRENDS BIOCHEM SCI, V17, P315, DOI 10.1016/0968-0004(92)90444-E; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; PARSONS DF, 1966, ANN NY ACAD SCI, V137, P643, DOI 10.1111/j.1749-6632.1966.tb50188.x; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Vander Heiden MG, 1999, MOL CELL, V3, P159; ZIZI M, 1994, J BIOL CHEM, V269, P1614	32	318	326	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19414	19419		10.1074/jbc.M101590200	http://dx.doi.org/10.1074/jbc.M101590200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259441	hybrid			2022-12-27	WOS:000169091000103
J	Hanson, MN; Schoenberg, DR				Hanson, MN; Schoenberg, DR			Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; BINDING PROTEIN; CODING REGION; ENDONUCLEOLYTIC CLEAVAGE; 3'-UNTRANSLATED REGION; XENOPUS LIVER; IN-VITRO; DESTABILIZATION; PURIFICATION; TRANSLATION	Previous work from this laboratory identified a polysome-associated endonuclease whose activation by estrogen correlates with the coordinate destabilization of serum protein mRNAs. This enzyme, named polysomal ribonuclease 1, or PMR-1, is a novel member of the peroxidase gene family. A characteristic feature of PMR-1 is its ability to generate in vitro degradation intermediates by cleaving within overlapping APyrUGA elements in the 5'-coding region of albumin mRNA. The current study sought to determine whether the in vivo destabilization of albumin mRNA following estrogen administration involves the generation of decay intermediates that could be identified as products of PMR-1 cleavage. A sensitive ligation-mediated polymerase chain reaction technique was developed to identify labile decay intermediates, and its validity in identifying PMR-1-generated decay intermediates of albumin mRNA was confirmed by primer extension experiments performed with liver RNA that was isolated from estrogen-treated frogs or digested in vitro with the purified endonuclease. Ligation-mediated polymerase chain reaction was also used to identify decay intermediates from the 3'-end of albumin mRNA, and as a final proof of principle it was employed to identify in vivo decay intermediates of the c-myc coding region instability determinant corresponding to sites of in vitro cleavage by a polysome-associated endonuclease.	Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA	Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University; Ohio State University	Hanson, MN (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 1645 Neil Ave, Columbus, OH 43210 USA.		Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038277] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038277, R01 GM038277-14, GM38277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BINDER R, 1989, J BIOL CHEM, V264, P16910; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Chernokalskaya E, 1997, NUCLEIC ACIDS RES, V25, P735, DOI 10.1093/nar/25.4.735; Chernokalskaya E, 1998, RNA, V4, P1537, DOI 10.1017/S1355838298980451; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; CUNNINGHAM KS, 2001, RIBONUCLEASE; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dodson RE, 1997, J BIOL CHEM, V272, P12249, DOI 10.1074/jbc.272.19.12249; DOMPENCIEL RE, 1995, J BIOL CHEM, V270, P6108, DOI 10.1074/jbc.270.11.6108; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jo H, 1998, METHODS, V16, P365, DOI 10.1006/meth.1998.0691; Lee CH, 1998, J BIOL CHEM, V273, P25261, DOI 10.1074/jbc.273.39.25261; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; NIELSEN DA, 1990, MOL CELL BIOL, V10, P371, DOI 10.1128/MCB.10.1.371; PASTORI RL, 1991, BIOCHEMISTRY-US, V30, P10490, DOI 10.1021/bi00107a018; PASTORI RL, 1991, MOL ENDOCRINOL, V5, P461, DOI 10.1210/mend-5-4-461; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Rao MN, 1996, NUCLEIC ACIDS RES, V24, P4078, DOI 10.1093/nar/24.20.4078; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schoenberg DR, 1999, METHODS, V17, P60, DOI 10.1006/meth.1998.0708; SCHOENBERG DR, 1997, MRNA METABOLISM POST, P217; THARUN S, 1997, MRNA METABOLISM POST, P181; van Dijk EL, 2000, J MOL BIOL, V300, P449, DOI 10.1006/jmbi.2000.3856; VANDIJK EL, 1998, RNA, V4, P1632; Wang ZR, 2000, EMBO J, V19, P295, DOI 10.1093/emboj/19.2.295	30	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12331	12337		10.1074/jbc.M010483200	http://dx.doi.org/10.1074/jbc.M010483200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152474	hybrid, Green Accepted			2022-12-27	WOS:000168081800119
J	Hansen, CH; Wittstock, U; Olsen, CE; Hick, AJ; Pickett, JA; Halkier, BA				Hansen, CH; Wittstock, U; Olsen, CE; Hick, AJ; Pickett, JA; Halkier, BA			Cytochrome P450CYP79F1 from Arabidopsis catalyzes the conversion of dihomomethionine and trihomomethionine to the corresponding aldoximes in the biosynthesis of aliphatic glucosinolates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPE BRASSICA-NAPUS; ESCHERICHIA-COLI; CYANOGENIC GLUCOSIDES; SORGHUM-BICOLOR; ENZYMES; EXPRESSION; THALIANA; PLANTS; TRANSFORMATION; METABOLISM	Glucosinolates are natural plant products that have received rising attention due to their role in interactions between pests and crop plants and as chemical protectors against cancer. Glucosinolates are derived from amino acids and have aldoximes as intermediates. We report that cytochrome P450 CYP79F1 catalyzes aldoxime:formation in the biosynthesis of aliphatic glucosinolates in Arabidopsis thaliana. Using recombinant CYP79F1 functionally expressed in Escherichia coli, we show that both dihomomethionine and trihomomethionine are metabolized by CYP79F1 resulting in the formation of 5-methylthiopentanaldoxime and 6-methylthiohexanaldoxime, respectively. 5-methylthiopentanaldoxime is the precursor of the major glucosinolates in leaves of A. thaliana, i.e. 4-methylthiobutylglucosinolate and 4-methylsulfinylbutylglucosinolate, and a variety of other glucosinolates in Brassica sp, Transgenic A. thaliana with cosuppression of CYP79F1 have a reduced content of aliphatic glucosinolates and a highly increased level of dihomomethionine and trihomomethionine. The transgenic plants have a morphological phenotype showing loss of apical dominance and formation of multiple axillary shoots. Our data provide the first evidence that a cytochrome P450 catalyzes the N-hydroxylation of chain-elongated methionine homologues to the corresponding aldoximes in the biosynthesis of aliphatic glucosinolates.	Royal Vet & Agr Univ, Plant Biochem Lab, Dept Plant Biol, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Dept Chem, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol, DK-1871 Frederiksberg C, Denmark; Rothamsted Expt Stn, Harpenden AL5 2JQ, Herts, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Halkier, BA (corresponding author), Royal Vet & Agr Univ, Plant Biochem Lab, Dept Plant Biol, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	halkier@biobase.dk	Olsen, Carl E/H-3031-2014; Halkier, Barbara A/H-3196-2014	Olsen, Carl E/0000-0002-2275-0596; Halkier, Barbara A/0000-0002-3742-702X; Wittstock, Ute/0000-0002-0914-8453				Andersen MD, 2000, J BIOL CHEM, V275, P1966, DOI 10.1074/jbc.275.3.1966; [Anonymous], 1988, ACS SYM SER; Ausubel F., 1999, CURRENT PROTOCOLS MO; Bak S, 1999, PLANT J, V20, P663, DOI 10.1046/j.1365-313X.1999.00642.x; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; BENNETT R, 1993, PLANT PHYSIOL, V102, P1307, DOI 10.1104/pp.102.4.1307; BENNETT R, 1995, PLANTA, V196, P239, DOI 10.1007/BF00201380; Bennett RN, 1997, PLANT PHYSIOL, V114, P1283, DOI 10.1104/pp.114.4.1283; BUCHNER R, 1987, GLUCOSINOLATES RAPES, P155; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAWSON GW, 1993, J BIOL CHEM, V268, P27154; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; GIOVANELLI J, 1985, PLANT PHYSIOL, V78, P555, DOI 10.1104/pp.78.3.555; Graser G, 2000, ARCH BIOCHEM BIOPHYS, V378, P411, DOI 10.1006/abbi.2000.1812; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halkier BA, 1999, NATURALLY OCCURRING GLYCOSIDES, P193; HALKIER BA, 1995, ARCH BIOCHEM BIOPHYS, V322, P369, DOI 10.1006/abbi.1995.1477; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; HOGGE LR, 1988, J CHROMATOGR SCI, V26, P551, DOI 10.1093/chromsci/26.11.551; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Kim J, 2000, PLANT SCI, V151, P9, DOI 10.1016/S0168-9452(99)00188-0; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nielsen JS, 2000, PLANT PHYSIOL, V122, P1311, DOI 10.1104/pp.122.4.1311; OMURA T, 1964, J BIOL CHEM, V239, P2370; PORTER TD, 1991, METHOD ENZYMOL, V206, P108; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rodman JE, 1998, AM J BOT, V85, P997, DOI 10.2307/2446366; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; ROSSITER JT, 1990, PHYTOCHEMISTRY, V29, P2509, DOI 10.1016/0031-9422(90)85177-H; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	37	118	131	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11078	11085		10.1074/jbc.M010123200	http://dx.doi.org/10.1074/jbc.M010123200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11133994	hybrid			2022-12-27	WOS:000167980900069
J	Holmes, A; Abraham, DJ; Sa, S; Xu, SW; Black, CM; Leask, A				Holmes, A; Abraham, DJ; Sa, S; Xu, SW; Black, CM; Leask, A			CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; FACTOR GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; TGF-BETA; SYSTEMIC-SCLEROSIS; INDUCED PHOSPHORYLATION; COLLAGEN-SYNTHESIS; SKIN FIBROBLASTS; TISSUE-SECTIONS; MESSENGER-RNA	In normal adult fibroblasts, transforming growth factor-beta (TGF beta) induces the expression of connective tissue growth:factor (CTGF). CTGF independently promotes fibroblast proliferation and matrix deposition, and in acute models of fibrosis promotes cell proliferation and collagen deposition acting synergistically with TGF-beta, In contrast to normal fibroblasts, fibroblasts cultured from fibrotic tissues express high basal levels of CTGF, even in the absence of added TGF beta, Induction of transcription by TGF beta requires the action of SMAD proteins. In this report we have investigated the role of SMADs in the TGF beta -induction of CTGF in normal fibroblasts and in the elevated levels of CTGF expression found in dermal fibroblasts cultured from lesional areas of patients with scleroderma, a progressive fibrotic disorder that can affect all organs of the body. We have identified a functional SMAD binding site in the CTGF promoter. TGF beta -induction of CTGF is dependent on SMAD3 and SMAD4:but not SMAD2 and is p300-independent, However, mutation of the SMAD binding site does not reduce the high level of CTGF promoter activity observed in dermal fibroblasts cultured from lesional areas of scleroderma patients, Conversely, the previously termed TGF beta RE in the CTGF promoter is required for basal CTGF promoter activity in normal fibroblasts and for the:elevated level of CTGF promoter activity in scleroderma fibroblasts, Thus, the maintenance of the fibrotic phenotype in scleroderma fibroblasts, as visualized by: excess CTGF expression, appears to be independent of SMAD-dependent TGF beta signaling. Furthermore, given CTGF's activities, the high level of CTGF expression observed in scleroderma lesions may contribute to the excessive scarring observed in this disorder.	FibroGen Inc, San Francisco, CA 94080 USA; UCL Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London NW3 2PF, England	FibroGen; University of London; University College London; UCL Medical School	Leask, A (corresponding author), FibroGen Inc, 225 Gateway Blvd, San Francisco, CA 94080 USA.	aleask@fibrogen.com	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015		NIAMS NIH HHS [AR45879] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045879] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bitzer M, 2000, GENE DEV, V14, P187; BLACK CM, 1998, OXFORD TXB RHEUMATOL, P771; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; DEGUCHI Y, 1992, ANN RHEUM DIS, V51, P362, DOI 10.1136/ard.51.3.362; di Mola FF, 1999, ANN SURG, V230, P63, DOI 10.1097/00000658-199907000-00010; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; HAYASAKA A, 1991, J HEPATOL, V13, P328, DOI 10.1016/0168-8278(91)90077-O; HIGLEY H, 1994, ARTHRITIS RHEUM, V37, P278, DOI 10.1002/art.1780370218; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; McCartney-Francis N L, 1998, Int Rev Immunol, V16, P553, DOI 10.3109/08830189809043009; MCWHIRTER A, 1994, LAB INVEST, V71, P885; MORELAND LW, 1992, AM J MED, V93, P628, DOI 10.1016/0002-9343(92)90195-H; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; NEEDLEMAN BW, 1990, ARTHRITIS RHEUM, V33, P650, DOI 10.1002/art.1780330507; PELTONEN J, 1990, ARTHRITIS RHEUM-US, V33, P1829, DOI 10.1002/art.1780331211; Querfeld C, 1999, J DERMATOL SCI, V21, P13, DOI 10.1016/S0923-1811(99)00008-0; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; Sato S, 2000, J RHEUMATOL, V27, P149; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Shimo T, 1998, J BIOCHEM-TOKYO, V124, P130, DOI 10.1093/oxfordjournals.jbchem.a022071; SMITH EA, 1990, J INVEST DERMATOL, V95, pS125, DOI 10.1111/1523-1747.ep12874998; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	57	353	382	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10594	10601		10.1074/jbc.M010149200	http://dx.doi.org/10.1074/jbc.M010149200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152469	hybrid			2022-12-27	WOS:000167980900005
J	Ahn, C; Morris, NR				Ahn, C; Morris, NR			NUDF, a fungal homolog of the human LIS1 protein, functions as a dimer in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LISSENCEPHALY GENE-PRODUCT; ASPERGILLUS-NIDULANS; CYTOPLASMIC DYNEIN; NUCLEAR MIGRATION; NEURONAL MIGRATION; DYNACTIN COMPLEX; HEAVY-CHAIN; NEUROSPORA; INTERACTS; MOVEMENT	The NUDF protein is required for nuclear migration through the mycelium of the filamentous fungus Aspergillus nidulans, It is of particular interest, because it closely resembles a human protein, LIS1, that is required for development of the cerebral cortex. Both are similar to 50-kDa proteins with a short N-terminal predicted coiled coil and seven WD-40 domains in the C-terminal half of the molecule. They also interact with homologous proteins, suggesting that they may have similar biochemical functions. Here we describe the purification to homogeneity of NUDF protein in a single step from a cell-free extract of A. nidulans. We demonstrate that NUDF is a homodimer, that its dimerization occurs via the N-terminal coiled coil region of the molecule, and that it must be a dimer to support the growth of A. nidulans.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Morris, NR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.				NIGMS NIH HHS [GM52309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052309] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; KIM JS, 1993, PROTEIN SCI, V2, P348; Kitagawa M, 2000, FEBS LETT, V479, P57, DOI 10.1016/S0014-5793(00)01856-1; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Liu Z, 1999, DEVELOPMENT, V126, P4477; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Tinsley JH, 1996, MOL BIOL CELL, V7, P731, DOI 10.1091/mbc.7.5.731; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; Xiang X, 1999, CURR OPIN MICROBIOL, V2, P636, DOI 10.1016/S1369-5274(99)00034-X; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100	26	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9903	9909		10.1074/jbc.M010233200	http://dx.doi.org/10.1074/jbc.M010233200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134054	hybrid			2022-12-27	WOS:000167996400045
J	Kakizawa, T; Miyamoto, T; Ichikawa, K; Takeda, T; Suzuki, S; Mori, J; Kumagai, M; Yamashita, K; Hashizume, K				Kakizawa, T; Miyamoto, T; Ichikawa, K; Takeda, T; Suzuki, S; Mori, J; Kumagai, M; Yamashita, K; Hashizume, K			Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; ACUTE MYELOID-LEUKEMIA; POU DOMAIN; GLUCOCORTICOID-RECEPTOR; FUSION PARTNER; N-COR; OCT-1; COACTIVATOR; BINDING; SMRT	Octamer transcription factor-1 (Oct-l) is a member of the POU (Pit-l, Oct-1, unc-86) family of transcription factors and is involved in the transcriptional regulation of a variety of gene expressions related to cell cycle regulation, development, and hormonal signals. It has been shown that Oct-1 acts not only as a transcriptional activator but also as a transcriptional repressor for certain genes. The mechanism of the repressive function of Oct-1 has not been well understood. Here we demonstrate by using the glutathione S-transferase pull-down assays and coimmunoprecipitation assays that the POU domain of Oct-1 directly interacts with a silencing mediator for retinoid and thyroid hormone receptors (SMRT). The interaction surfaces are located in the C-terminal region of SMRT, which are different from previously described silencing domains I and II or receptor interacting domains I and II. In transient transfection assays in COS1 cells, overexpression of SMRT attenuated the augmentation of Oct-1 transcriptional activity by OBF-1/OCA-B, activator for Oct-1. In pull-down assays, increasing amounts of SMRT could compete the binding of OCA-B to Oct-1 POU domain. The activity of Oct-1 could be determined by a regulated balance between SMRT and OCA-B, Furthermore, cotransfected unliganded thyroid hormone receptor enhanced the transactivation by Oct-1, and addition of 3,3',5-tri-iodo-L-thyronine obliterated the stimulatory effects. Consequently, in the presence of cotransfected thyroid hormone receptor, the octamer response element acts as an element negatively regulated by 3,3',5-tri-iodo-L-thyronine. The results suggest that the transcriptional activity of Oct-1 can be modulated by interaction through its POU domain by a silencing mediator SMRT resulting in the cross-talk between Oct-1 and nuclear receptors.	Shinshu Univ, Sch Med, Dept Agingn Med & Geriatr, Matsumoto, Nagano 3908621, Japan	Shinshu University	Miyamoto, T (corresponding author), Shinshu Univ, Sch Med, Dept Agingn Med & Geriatr, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	miyamoto@hsp.md.shinshu-u.ac.jp						Asahara H, 1999, MOL CELL BIOL, V19, P8219; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; COENJAERTS FEJ, 1994, EMBO J, V13, P5401, DOI 10.1002/j.1460-2075.1994.tb06875.x; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Kakizawa T, 1999, J BIOL CHEM, V274, P19103, DOI 10.1074/jbc.274.27.19103; KUTOH E, 1992, MOL CELL BIOL, V12, P4960, DOI 10.1128/MCB.12.11.4960; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; MIYAMOTO T, 1991, ENDOCRINOLOGY, V129, P907, DOI 10.1210/endo-129-2-907; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NAKAI A, 1988, MOL ENDOCRINOL, V2, P1087, DOI 10.1210/mend-2-11-1087; NAKSHATRI H, 1995, J BIOL CHEM, V270, P19613, DOI 10.1074/jbc.270.33.19613; Prefontaine GG, 1999, J BIOL CHEM, V274, P26713, DOI 10.1074/jbc.274.38.26713; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; Schwachtgen JL, 1998, BLOOD, V92, P1247, DOI 10.1182/blood.V92.4.1247.416k08_1247_1258; Shah PC, 1997, EMBO J, V16, P7105, DOI 10.1093/emboj/16.23.7105; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Subramaniam N, 1998, J BIOL CHEM, V273, P23567, DOI 10.1074/jbc.273.36.23567; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x; ZWILLING S, 1994, NUCLEIC ACIDS RES, V22, P1655, DOI 10.1093/nar/22.9.1655	38	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9720	9725		10.1074/jbc.M008531200	http://dx.doi.org/10.1074/jbc.M008531200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134019	hybrid			2022-12-27	WOS:000167996400020
J	Kasahara, M; Unno, T; Yashiro, K; Ohmori, M				Kasahara, M; Unno, T; Yashiro, K; Ohmori, M			CyaG, a novel cyanobacterial adenylyl cyclase and a possible ancestor of mammalian guanylyl cyclases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; SPIRULINA-PLATENSIS; RETGC-1; GENE; PROTEINS; DIMERIZATION; ACTIVATION; SEQUENCES; MUTATION; ENCODES	A novel gene encoding an adenylyl cyclase, designated cyaG, was identified in the filamentous cyanobacterium Spirulina platensis, The predicted amino acid sequence of the C-terminal region of cyaG was similar to the catalytic domains of Class III adenylyl and guanylyl cyclases, The N-terminal region next to the catalytic domain of CyaG was similar to the dimerization domain, which is highly conserved among guanylyl cyclases. As a whole, CyaG is more closely related to guanylyl cyclases than to adenylyl cyclases in its primary structure. The catalytic domain of CyaG was expressed in Escherichia coli and partially purified. CyaG showed adenylyl cyclase (but not guanylyl cyclase) activity. By site-directed mutagenesis of three amino acid residues (Lys(533), Ile(603), and Asp(605)) within the purine ring recognition site of CyaG to Glu, Arg, and Cys, respectively, CyaG was transformed to a guanylyl cyclase that produced cGMP instead of cAMP. Thus having properties of both cyclases, CyaG may therefore represent a critical position in the evolution of Class III adenylyl and guanylyl cyclases.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 153, Japan	University of Tokyo	Ohmori, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, 4-6-1 Komaba, Tokyo 153, Japan.	cohmori@mail.ecc.u-tokyo.ac.jp						BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; DANCHIN A, 1993, ADV SEC MESS PHOSPH, V27, P109; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; DE RE, 1973, BIOCHEM BIOPH RES CO, V55, P758; DEV IK, 1990, J BIOENERG BIOMEMBR, V22, P271, DOI 10.1007/BF00763168; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Kasahara M, 1999, J BIOL CHEM, V274, P15167, DOI 10.1074/jbc.274.21.15167; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; Linder JU, 1999, EMBO J, V18, P4222, DOI 10.1093/emboj/18.15.4222; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LONDOS C, 1977, J BIOL CHEM, V252, P5957; MACKLE MM, 1994, J BACTERIOL, V176, P1857, DOI 10.1128/jb.176.7.1857-1864.1994; Perrault I, 1998, AM J HUM GENET, V63, P651, DOI 10.1086/301985; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yashiro K, 1996, PLANT MOL BIOL, V31, P175, DOI 10.1007/BF00020618; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	30	30	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10564	10569		10.1074/jbc.M008006200	http://dx.doi.org/10.1074/jbc.M008006200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134014	hybrid			2022-12-27	WOS:000167996400126
J	Lins, L; Couvineau, A; Rouyer-Fessard, C; Nicole, P; Maoret, JJ; Benhamed, M; Brasseur, R; Thomas, A; Laburthe, M				Lins, L; Couvineau, A; Rouyer-Fessard, C; Nicole, P; Maoret, JJ; Benhamed, M; Brasseur, R; Thomas, A; Laburthe, M			The human VPAC(1) receptor - Three-dimensional model and mutagenesis of the N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CONSTITUTIVE ACTIVATION; ADENYLATE-CYCLASE; VIP; RESIDUES; SECRETIN; FAMILY; GLUCAGON; HORMONE; BINDING	The human VPAC(1), receptor for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide belongs to the class II family of G-protein-coupled receptors with seven transmembrane segments. Like for all class II receptors, the extracellular N-terminal domain of the human VPAC(1), receptor plays a predominant role in peptide ligand recognition. To determine the three-dimensional structure of this N-terninal domain (residues 1-144), the Protein Data Bank (PDB) was screened for a homologous protein. A subdomain of yeast lipase B was found to have 27% sequence identity and 50% sequence homology with the N-terminal domain (8-117) of the VPAC(1), receptor together with a good alignment of the hydrophobic clusters. A model of the N-terminal domain of VPAC(1), receptor was thus constructed by homology, It indicated the presence of a putative signal sequence in the N-terminal extremity. Moreover, residues (Glu(36) Trp(67) Asp(68), Trp(73), and Gly(109)) which were shown tb be crucial for VIP binding are gathered around a groove that is essentially negatively charged. New putatively important residues for VIP binding were suggested from the model analysis. Site-directed mutagenesis and stable transfection of mutants in CHO cells indicated that Pro(74), Pro(87), Phe(90), and Trp(110) are indeed important for VIP binding and activation of adenylyl cyclase activation, Combination of molecular modeling and directed mutagenesis provided the first partial three-dimensional structure of a VIP-binding domain, constituted of an electronegative groove with an outspanning tryptophan shell at one end, in the N-terminal extracellular region of the human VPAC(1), receptor.	Univ Paris 07, INSERM, U410, F-75018 Paris, France; Fac Univ Gembloux, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Liege	Laburthe, M (corresponding author), Univ Paris 07, INSERM, U410, F-75018 Paris, France.	laburthe@bichat.inserm.fr	couvineau, alain/T-3466-2019; LINS, LAURENCE/Y-1661-2019; couvineau, alain/G-3641-2013; LABURTHE, Marc/C-1875-2012	couvineau, alain/0000-0003-2912-5168; LINS, LAURENCE/0000-0001-7772-6748; couvineau, alain/0000-0003-2912-5168; 				BRADFORD M, 1979, ANAL BIOCHEM, V78, P248; CHOU PY, 1977, J MOL BIOL, V115, P135, DOI 10.1016/0022-2836(77)90094-8; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Couvineau A, 1996, J BIOL CHEM, V271, P12795, DOI 10.1074/jbc.271.22.12795; COUVINEAU A, 1994, BIOCHEM BIOPH RES CO, V200, P769, DOI 10.1006/bbrc.1994.1517; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Du K, 1997, BIOCHEM BIOPH RES CO, V230, P289, DOI 10.1006/bbrc.1996.5949; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gaudin P, 1998, J BIOL CHEM, V273, P4990, DOI 10.1074/jbc.273.9.4990; GAUDIN P, 1995, BIOCHEM BIOPH RES CO, V211, P901, DOI 10.1006/bbrc.1995.1897; Gaudin P, 1999, BIOCHEM BIOPH RES CO, V254, P15, DOI 10.1006/bbrc.1998.9883; Gozes I, 1999, CURR MED CHEM, V6, P1019; Jin L, 2000, J BIOL CHEM, V275, P27238; KUDSEN SM, 1997, FEBS LETT, V412, P141; LABURTHE M, 1987, J BIOL CHEM, V262, P10180; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 1999, CONT ENDOCRINOL, V8, P125; LABURTHE M, 1986, MOL PHARMACOL, V29, P23; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nicole P, 2000, BIOCHEM BIOPH RES CO, V276, P654, DOI 10.1006/bbrc.2000.3375; Nicole P, 1998, J PHARMACOL EXP THER, V284, P744; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; NISHIO M, 1998, CH PI INTERACTION EV, P175; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAHMAN M, 1994, J MOL GRAPHICS, V12, P212, DOI 10.1016/0263-7855(94)80090-1; SAID SI, 1991, TRENDS ENDOCRIN MET, V2, P107, DOI 10.1016/S1043-2760(05)80006-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3	33	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10153	10160		10.1074/jbc.M009730200	http://dx.doi.org/10.1074/jbc.M009730200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124960	hybrid			2022-12-27	WOS:000167996400076
J	Matsuo, Y; Akiyama, N; Nakamura, H; Yodoi, J; Noda, M; Kizaka-Kondoh, S				Matsuo, Y; Akiyama, N; Nakamura, H; Yodoi, J; Noda, M; Kizaka-Kondoh, S			Identification of a novel thioredoxin-related transmembrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BREFELDIN-A; DISULFIDE-ISOMERASE; REDOX REGULATION; QUALITY-CONTROL; GROWTH-FACTOR; CLONING; ER; REDUCTION; APOPTOSIS	We recently identified a series of transforming growth factor-beta -responsive genes in A549 human adenocarcinoma cell line by a gene trap screening method. Here we report the molecular cloning and characterization of one of these genes, designated TMX, that encodes a novel protein of 280 amino acid residues. The TMX protein possesses an N-terminal signal peptide followed by one thioredoxin (Trx)-like domain with a unique active site sequence, Cys-Pro-Ala-Cys, and a potential transmembrane domain. There are putative TMX homologs with identical active site sequences in the Caenorhabditis elegans and Drosophila genomes, Using recombinant proteins expressed in Escherichia coli, we demonstrated the activity of the Trx domain of TMX to cleave the interchain disulfide bridges in insulin in vitro, The TMX transcript is widely expressed in normal human tissues, and subcellular fractionation and immunostaining for an epitope-tagged TMX protein suggest that TMX is predominantly localized in the endoplasmic reticulum (ER), When TMX was expressed in HEK293 cells, it significantly suppressed the apoptosis induced by brefeldin A, an inhibitor of ER-Golgi transport. This activity was abolished when two Cys residues in the active site sequence were mutated to Ser, suggesting that the Trx-like activity of TMX may help relieve ER stress caused by brefeldin A.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Inst Virus Res, Dept Biol Responses, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp	Kondoh, Shinae/C-6937-2015; Kondoh, Shinae/AAF-8745-2020	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782; Matsuo, Yoshiyuki/0000-0002-3183-4871				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Akiyama N, 2000, MOL CELL BIOL, V20, P3266, DOI 10.1128/MCB.20.9.3266-3273.2000; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Guo H, 1998, EXP CELL RES, V245, P57, DOI 10.1006/excr.1998.4235; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOIZUMI K, 1976, J BIOCHEM-TOKYO, V79, P739, DOI 10.1093/oxfordjournals.jbchem.a131126; Kondoh G, 1999, FEBS LETT, V458, P299, DOI 10.1016/S0014-5793(99)01172-2; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Li Q, 1998, VIROLOGY, V252, P28, DOI 10.1006/viro.1998.9417; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MITSUI A, 1992, BIOCHEM BIOPH RES CO, V186, P1220, DOI 10.1016/S0006-291X(05)81536-0; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NAKAMURA H, 1998, CURR TREND IMMUNOL, V1, P133; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	48	90	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10032	10038		10.1074/jbc.M011037200	http://dx.doi.org/10.1074/jbc.M011037200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152479	Green Submitted, hybrid			2022-12-27	WOS:000167996400062
J	Scheiner, S; Kar, T; Gu, YL				Scheiner, S; Kar, T; Gu, YL			Strength of the (CH)-H-alpha center dot center dot O hydrogen bond of amino acid residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOT-O INTERACTIONS; NUCLEAR-MAGNETIC-RESONANCE; AB-INITIO CALCULATIONS; C-H...N INTERACTIONS; NMR CHEMICAL-SHIFT; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC EVIDENCE; INTERACTION ENERGIES; BASIS-SETS; H-BOND	Although the peptide (CH)-H-alpha group has historically not been thought to form hydrogen bonds within proteins, ab initio quantum calculations show it to be a potent proton donor. Its binding energy to a water molecule lies in the range between 1.9 and 2.5 kcal/mol for nonpolar and polar amino acids; the hydrogen bond (H-bond) involving the charged lysine residue is even stronger than a conventional OH . .O interaction. The preferred H-bond lengths are quite uniform, about 3.32 Angstrom. Formation of each interaction results in a downfield shift of the bridging hydrogen's chemical shift and a blue shift in the (CH)-H-alpha stretching frequency, potential diagnostics of the presence of such an H-bond within a protein.	Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Scheiner, S (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	scheiner@cc.usu.edu	Scheiner, Steve/AAY-8761-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057936] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57936] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADCOCK JL, 1995, J ORG CHEM, V60, P1999, DOI 10.1021/jo00112a021; Afonin AV, 1999, CAN J CHEM, V77, P416, DOI 10.1139/cjc-77-4-416; ALKORTA I, 1995, J PHYS CHEM-US, V99, P6457, DOI 10.1021/j100017a026; Alkorta I, 2000, J FLUORINE CHEM, V101, P233, DOI 10.1016/S0022-1139(99)00164-5; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Auffinger P, 1997, J MOL BIOL, V274, P54, DOI 10.1006/jmbi.1997.1370; Bedell BL, 1999, J PHYS CHEM A, V103, P4572, DOI 10.1021/jp990493y; Bella J, 1996, J MOL BIOL, V264, P734, DOI 10.1006/jmbi.1996.0673; Berger I, 1996, P NATL ACAD SCI USA, V93, P12116, DOI 10.1073/pnas.93.22.12116; BERKOVITCHYELLIN Z, 1984, ACTA CRYSTALLOGR B, V40, P159, DOI 10.1107/S0108768184001919; Biswas R, 1997, J MOL BIOL, V270, P511, DOI 10.1006/jmbi.1997.1118; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brandl M, 1999, THEOR CHEM ACC, V101, P103, DOI 10.1007/s002140050415; Chakrabarti P, 1998, J MOL BIOL, V284, P867, DOI 10.1006/jmbi.1998.2199; Cubero E, 1999, CHEM PHYS LETT, V310, P445, DOI 10.1016/S0009-2614(99)00831-3; Cubero E, 1999, J PHYS CHEM A, V103, P6394, DOI 10.1021/jp990258f; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Desiraju G.R., 1999, WEAK HYDROGEN BOND S, p[29, 293]; Desiraju GR, 1997, SCIENCE, V278, P404, DOI 10.1126/science.278.5337.404; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; Fabiola GF, 1997, ACTA CRYSTALLOGR D, V53, P316, DOI 10.1107/S0907444997000383; Frisch M. J., 1998, GAUSSIAN 98; Giribet CG, 1996, J CHEM SOC FARADAY T, V92, P3029, DOI 10.1039/ft9969203029; GLUSKER JP, 1995, ACTA CRYSTALLOGR D, V51, P418, DOI 10.1107/S0907444995003313; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Gu YL, 1999, J AM CHEM SOC, V121, P9411, DOI 10.1021/ja991795g; Harakas G, 1998, J AM CHEM SOC, V120, P6405, DOI 10.1021/ja9803411; Hartmann M, 2000, J PHYS CHEM A, V104, P968, DOI 10.1021/jp992234e; Hobza P, 1999, CHEM PHYS LETT, V303, P447, DOI 10.1016/S0009-2614(99)00217-1; Hobza P, 1999, CHEM PHYS LETT, V299, P180, DOI 10.1016/S0009-2614(98)01264-0; Hobza P, 1998, J PHYS CHEM A, V102, P2501, DOI 10.1021/jp973374w; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; JEFFREY GA, 1982, INT J BIOL MACROMOL, V4, P173, DOI 10.1016/0141-8130(82)90048-4; Karger N, 1999, J PHYS CHEM A, V103, P8672, DOI 10.1021/jp990908f; Kim KS, 1997, J AM CHEM SOC, V119, P12952, DOI 10.1021/ja971836d; Kuduva SS, 1999, J AM CHEM SOC, V121, P1936, DOI 10.1021/ja981967u; LEONARD GA, 1995, ACTA CRYSTALLOGR D, V51, P136, DOI 10.1107/S0907444994004713; LI C, 1983, J CHEM SOC PERK T 1, P2193, DOI 10.1039/p19830002193; Mandel-Gutfreund Y, 1998, J MOL BIOL, V277, P1129, DOI 10.1006/jmbi.1998.1660; Meadows ES, 2000, J AM CHEM SOC, V122, P3325, DOI 10.1021/ja9940672; Mizuno K, 1998, J CHEM PHYS, V109, P9502, DOI 10.1063/1.477612; Musah RA, 1997, J AM CHEM SOC, V119, P9083, DOI 10.1021/ja9716766; NEUHEUSER T, 1994, J PHYS CHEM-US, V98, P6459, DOI 10.1021/j100077a007; Novoa JJ, 1997, CHEM PHYS LETT, V266, P23, DOI 10.1016/S0009-2614(96)01514-X; Novoa JJ, 1996, CHEM PHYS LETT, V251, P33, DOI 10.1016/0009-2614(96)00036-X; NOVOA JJ, 1991, J CHEM PHYS, V95, P5179, DOI 10.1063/1.461686; PASCARD C, 1995, ACTA CRYSTALLOGR D, V51, P407, DOI 10.1107/S0907444994014526; Peralta JE, 1999, J MOL STRUC-THEOCHEM, V491, P23, DOI 10.1016/S0166-1280(99)00027-5; PINCHAS S, 1963, J PHYS CHEM-US, V67, P1862, DOI 10.1021/j100803a030; PINCHAS S, 1955, ANAL CHEM, V27, P2, DOI 10.1021/ac60097a002; Rivelino R, 2000, CHEM PHYS LETT, V322, P207, DOI 10.1016/S0009-2614(00)00412-7; ROVIRA MC, 1995, CHEM PHYS, V200, P319, DOI 10.1016/0301-0104(95)00210-3; RUBIN J, 1972, BIOCHEMISTRY-US, V11, P3112, DOI 10.1021/bi00766a027; SAENGER W, 1973, ANGEW CHEM INT EDIT, V12, P591, DOI 10.1002/anie.197305911; SAMMES MP, 1976, J CHEM SOC PERK T 2, P1130, DOI 10.1039/p29760001130; SATONAKA H, 1988, B CHEM SOC JPN, V61, P2031, DOI 10.1246/bcsj.61.2031; Scheiner S, 2000, ADV MOL STRUCT RES, V6, P159; Scheiner S, 2000, J MOL STRUC-THEOCHEM, V500, P441, DOI 10.1016/S0166-1280(00)00375-4; SCHEINER S, 1994, ANNU REV PHYS CHEM, V45, P23; Scheiner S, 1997, T PHYS CHEM SER; SLASINSKI FM, 1976, J ORG CHEM, V41, P2693, DOI 10.1021/jo00878a007; SMITH DA, 1994, ACS SYM SER, V569, P82; Sponer J, 2000, J PHYS CHEM A, V104, P4592, DOI 10.1021/jp9943880; STEINER T, 1992, J AM CHEM SOC, V114, P10146, DOI 10.1021/ja00052a009; STEINER T, 1993, J AM CHEM SOC, V115, P4540, DOI 10.1021/ja00064a016; STEINER T, 1995, J CHEM SOC PERK T 2, P1315, DOI 10.1039/p29950001315; Steiner T, 2000, J PHYS CHEM A, V104, P433, DOI 10.1021/jp993179c; SUSSMAN JL, 1972, J MOL BIOL, V66, P403, DOI 10.1016/0022-2836(72)90423-8; SZCZESNIAK MM, 1993, J CHEM PHYS, V98, P3078, DOI 10.1063/1.465050; Takahara PM, 1996, J AM CHEM SOC, V118, P12309, DOI 10.1021/ja9625079; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; TURI L, 1993, J PHYS CHEM-US, V97, P12197, DOI 10.1021/j100149a017; Vargas R, 2000, J AM CHEM SOC, V122, P4750, DOI 10.1021/ja993600a; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Wahl MC, 1996, NAT STRUCT BIOL, V3, P24, DOI 10.1038/nsb0196-24; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Wu DY, 1999, J MOL STRUC-THEOCHEM, V459, P171, DOI 10.1016/S0166-1280(98)00273-5; Yoshida H, 1997, J PHYS CHEM A, V101, P1731, DOI 10.1021/jp9624010; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	82	260	265	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9832	9837		10.1074/jbc.M010770200	http://dx.doi.org/10.1074/jbc.M010770200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152477	hybrid			2022-12-27	WOS:000167996400035
J	Yoshikawa, M; Iwasaki, H; Shinagawa, H				Yoshikawa, M; Iwasaki, H; Shinagawa, H			Evidence that phenylalanine 69 in Escherichia coli RuvC resolvase forms a stacking interaction during binding and destabilization of a holliday junction DNA substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PROTEIN MUTS; HOMOLOGOUS RECOMBINATION; RNA-POLYMERASE; RESOLUTION; ENDONUCLEASE; CLEAVAGE; IDENTIFICATION; SPECIFICITY; MUTATIONS; MISMATCH	Escherichia coli RuvC resolvase is a specific endonuclease that recognizes and cleaves Holliday junctions formed during homologous recombination and recombinational repair. This study examines the phenotype of RuvC mutants with amino acid substitutions at phenylalanine 69 (F69L, F69Y, F69W, and F69A), a catalytically important residue that faces the catalytic center of the enzyme, F69Y, but not the other three mutants, almost fully complements the UV sensitivity of a Delta ruvC strain and substantially resolves synthetic Holliday junctions in vitro, In the presence of 100 mM NaCl, RuvC F69A and F69L are defective in junction binding, but F69Y and F69W retain near wild-type binding activity during a gel shift binding assay. KMnO4 was used to probe synthetic Holliday junction DNA in a complex with wild-type and mutant RuvC; F69A and F69L did not induce disruption of base pairing at the crossover to the same extent as wild-type RuvC, Thus, the aromatic ring of Phe-69 is involved in DNA binding, probably via a stacking interaction with a nucleotide base, and this interaction may induce a structural change in junction DNA that is required to form a catalytically competent complex.	Osaka Univ, Res Inst Microbial Dis, Dept Mol Microbiol, Suita, Osaka 565, Japan; Japan Sci & Technol Corp, PRESTO, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Microbiol, Suita, Osaka 565, Japan.	iwasaki@biken.osaka-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873				ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BENNETT RJ, 1995, P NATL ACAD SCI USA, V92, P5635, DOI 10.1073/pnas.92.12.5635; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; BENSON F, 1991, MOL GEN GENET, V225, P266, DOI 10.1007/BF00269858; BUCKLE M, 1991, METHOD ENZYMOL, V208, P236; CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653; DUCKETT DR, 1990, EMBO J, V9, P583, DOI 10.1002/j.1460-2075.1990.tb08146.x; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Hagan NFP, 1998, J MOL BIOL, V281, P17, DOI 10.1006/jmbi.1998.1934; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Ichiyanagi K, 1998, GENES CELLS, V3, P575, DOI 10.1046/j.1365-2443.1998.00213.x; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LLOYD RG, 1984, MOL GEN GENET, V194, P303, DOI 10.1007/BF00383532; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SAITO A, 1995, P NATL ACAD SCI USA, V92, P7470, DOI 10.1073/pnas.92.16.7470; Sha RJ, 2000, BIOCHEMISTRY-US, V39, P11982, DOI 10.1021/bi001037z; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHIDA T, 1996, J BIOL CHEM, V42, P26105; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKAHAGI M, 1994, J BIOL CHEM, V269, P15132; TAKAHAGI M, 1991, J BACTERIOL, V173, P5747, DOI 10.1128/jb.173.18.5747-5753.1991; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Yoshikawa M, 2000, GENES CELLS, V5, P803, DOI 10.1046/j.1365-2443.2000.00371.x	33	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10432	10436		10.1074/jbc.M010138200	http://dx.doi.org/10.1074/jbc.M010138200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152689	hybrid			2022-12-27	WOS:000167996400110
J	Zhang, XT; Cui, ZF; Miyakawa, T; Moye-Rowley, WS				Zhang, XT; Cui, ZF; Miyakawa, T; Moye-Rowley, WS			Cross-talk between transcriptional regulators of multidrug resistance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLEIOTROPIC DRUG-RESISTANCE; TRANSPORTER-ENCODING GENE; 4-NITROQUINOLINE N-OXIDE; YEAST; EXPRESSION; PDR1; ACTIVATION; PRODUCT; MUTANTS; DOMAIN	Multiple or pleiotropic drug resistance often arises in the yeast Saccharomyces cerevisiae due to genetic alterations of the functional state of the Cys(6)-Zn(II)(2) transcription factors Pdr1p and Pdr3p, Single amino acid substitutions give rise to hyperactive forms of these regulatory proteins, which in turn cause overproduction of downstream target genes that directly mediate multidrug resistance. Previous work has identified a novel Cys(6)-Zn(II)(2) transcription factor designated Yrr1p as mutant forms of this protein confer high level resistance to the cell cycle inhibitor reveromycin A and DNA damaging agent 4-nitroquinoline-N-oxide. In the present study, we demonstrate that Yrr1p also mediates oligomycin resistance through activation of the ATP-binding cassette transporter-encoding gene YOR1, Additionally, insertion of triplicated copies of the hemagglutinin epitope in the C-terminal region of Yrr1p causes the protein to behave as a hyperactive regulator of transcription. We have found that YRR1 expression is both controlled in a. Pdr1p/Pdr3p-dependent- manner and autoregulated. Chromatin immunoprecipitation experiments also show that Yrr1p associates with target prometers in vivo, Together these data argue that the signal generated by activation of Pdr1p and/or Pdr3p can be amplified through the action of these transcriptional regulatory proteins on downstream target genes, like YRR1, that also encode transcription factors.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA; Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398526, Japan	University of Iowa; University of Iowa; Hiroshima University	Moye-Rowley, WS (corresponding author), Univ Iowa, Dept Physiol & Biophys, 5-612 Bowen Sci Bldg, Iowa City, IA 52242 USA.		Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120	NIGMS NIH HHS [GM49825] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALZI E, 1987, J BIOL CHEM, V262, P16871; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; BALZI E, 1994, J BIOL CHEM, V269, P2206; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Coleman ST, 1997, J BIOL CHEM, V272, P23224, DOI 10.1074/jbc.272.37.23224; Cui Z, 1998, MOL MICROBIOL, V29, P1307, DOI 10.1046/j.1365-2958.1998.01027.x; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; Cui ZF, 1999, BIOSCI BIOTECH BIOCH, V63, P162, DOI 10.1271/bbb.63.162; DELAHODDE A, 1995, MOL CELL BIOL, V15, P4043; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; DEXTER D, 1994, GENETICS, V136, P505; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hach A, 1999, MOL CELL BIOL, V19, P4324; Hallstrom TC, 2000, MOL MICROBIOL, V36, P402, DOI 10.1046/j.1365-2958.2000.01858.x; Hallstrom TC, 2000, J BIOL CHEM, V275, P37347, DOI 10.1074/jbc.M007338200; Hallstrom TC, 1998, J BIOL CHEM, V273, P2098, DOI 10.1074/jbc.273.4.2098; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Nourani A, 1997, MOL GEN GENET, V256, P397, DOI 10.1007/s004380050583; ONeill LP, 1996, METHOD ENZYMOL, V274, P189; RANK GH, 1976, MOL GEN GENET, V144, P281, DOI 10.1007/BF00341726; Sherman F, 1979, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; STONE G, 1993, EMBO J, V12, P1375, DOI 10.1002/j.1460-2075.1993.tb05782.x; Wang D, 1999, J BIOL CHEM, V274, P19017, DOI 10.1074/jbc.274.27.19017	35	39	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8812	8819		10.1074/jbc.M010686200	http://dx.doi.org/10.1074/jbc.M010686200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134057	hybrid			2022-12-27	WOS:000167607700028
J	Rieske, P; Pongubala, JMR				Rieske, P; Pongubala, JMR			AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; NF-KAPPA-B; STIMULATING FACTOR-RECEPTOR; NORMAL MYELOID DEVELOPMENT; ACTIVATED PROTEIN-KINASES; REGULATORY FACTOR FAMILY; IMMUNOGLOBULIN-KAPPA; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SOMATIC HYPERMUTATION	Signal transduction by the antigen receptor complexes is critical for developmental progression of B-lymphocytes, which are defined by assembly and sequential expression of immunoglobulin genes, which in turn are regulated by the enhancer elements. Although proximal antigen-receptor signal transduction pathways are well defined, the precise nuclear factors targeted by these signals remained unknown. Previous studies have demonstrated that tissue-restricted transcription factors including PU.1 and PU.1 interaction partner (PIP) function synergistically with c-Fos plus c-Jun to stimulate the kappa E3'-enhancer in 3T3 cells. In this study, we demonstrate that the functional synergy between these factors is enhanced in response to mitogen-activated protein kinase kinase kinase, in 3T3 cells, where the enhancer is inactive. However in S194 plasmacytoma cells, mitogen-activated protein kinase kinase kinase was able to stimulate the activity of PU.1 but unable to induce the kappa E3'-enhancer activity. We have found that Ras-phosphoinositide 3-kinase-dependent externally regulated kinase, AKT, induces kappa E3'-enhancer activity in both pre-B and plasmacytoma cells. AKT stimulation of the kappa E3'-enhancer is primarily due to PU.1 induction and is independent of PU.1 interaction with PIP. Activation of AKT had no effect on the expression levels of PU.1 or its protein-protein interaction with PIP. Using a series of deletion constructs, we have determined that the PU.1 acid-rich (amino acids 33-74) transactivation domain is necessary for AKT-mediated induction. Substitution analyses within this region indicate that phosphorylation of Ser(41) is necessary to respond to AKT. Consistent with these studies, ligation of antigen receptors in A20 B cells mimics AKT activation of PU.1. Taken together, these results provide evidence that PU.1 is induced by AKT signal in a phosphoinositide 3-kinase-dependent manner, leading to inducible or constitutive activation of its target genes.	MCP Hahnemann Univ, Sch Med, Dept Biochem, Philadelphia, PA 19102 USA	Drexel University	Pongubala, JMR (corresponding author), MCP Hahnemann Univ, Sch Med, Dept Biochem, 245 N 15th St, Philadelphia, PA 19102 USA.		Rieske, Piotr/M-4821-2015	Rieske, Piotr/0000-0002-2970-0970	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046308] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 46308] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURAS JA, 1995, MOL IMMUNOL, V32, P541, DOI 10.1016/0161-5890(95)00018-A; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHEN HM, 1993, J BIOL CHEM, V268, P8230; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; DEL PL, 1997, SCIENCE, V278, P687; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gold MR, 2000, IMMUNOL REV, V176, P47; Gong SC, 1996, J EXP MED, V184, P2079, DOI 10.1084/jem.184.6.2079; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; Heydemann A, 1996, MOL CELL BIOL, V16, P1676; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Inaba T, 1996, MOL CELL BIOL, V16, P2264; Kim BC, 1999, J BIOL CHEM, V274, P24372, DOI 10.1074/jbc.274.34.24372; Kim YM, 1999, J IMMUNOL, V163, P2000; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Ozes ON, 1999, NATURE, V401, P82; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Perkel JM, 1998, J IMMUNOL, V160, P241; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; RAYGALLET D, 1995, ONCOGENE, V11, P303; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; ROSMARIN AG, 1995, P NATL ACAD SCI USA, V92, P801, DOI 10.1073/pnas.92.3.801; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Ying H, 1998, J IMMUNOL, V160, P2287; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	87	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					8460	8468		10.1074/jbc.M007482200	http://dx.doi.org/10.1074/jbc.M007482200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11133986	hybrid			2022-12-27	WOS:000167474900106
J	Watanabe, N; Che, FS; Iwano, M; Takayama, S; Yoshida, S; Isogai, A				Watanabe, N; Che, FS; Iwano, M; Takayama, S; Yoshida, S; Isogai, A			Dual targeting of spinach protoporphyrinogen oxidase II to mitochondria and chloroplasts by alternative use of two in-frame initiation codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; GENE; PURIFICATION; FERROCHELATASE; LOCALIZATION; HERBICIDES; SEQUENCE; PROTEIN; CLONING; ENZYMES	Protoporphyrinogen oxidase (Protox) is the final enzyme in the common pathway of chlorophyll and heme biosynthesis. Two Protox isoenzymes have been described in tobacco, a plastidic and a mitachondrial form. We isolated and sequenced spinach Protox cDNA, which encodes a homolog of tobacco mitochondrial Protox (Protox II). Alignment of the deduced amino acid sequence between Protox II and other tobacco mitochondrial Protox homologs revealed a 26-amino acid N-terminal extension unique to the spinach enzyme. Immunoblot analysis of spinach leaf extract detected two proteins with apparent molecular masses of 57 and 55 kDa in chloroplasts and mitochondria, respectively. In vitro translation experiments indicated that two translation products (59 and 55 kDa) are produced from Protox II mRNA, using two in-frame initiation codons. Transport experiments using green fluorescent protein-fused Protox II suggested that the larger and smaller translation products (Protox IIL and IIS) target exclusively to chloroplasts and mitochondria, respectively.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Inst Phys & Chem Res, Plant Funct Lab, Wako, Saitama 3510198, Japan	Nara Institute of Science & Technology; RIKEN	Che, FS (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Takayama 8916-5, Nara 6300101, Japan.		Isogai, Akira/O-8897-2017	Isogai, Akira/0000-0001-8095-0441				Akashi K, 1998, FEBS LETT, V431, P39, DOI 10.1016/S0014-5793(98)00717-0; AMAYA Y, 1988, J BIOL CHEM, V263, P14463; Camadro JM, 1996, J BIOL CHEM, V271, P9120, DOI 10.1074/jbc.271.15.9120; CAMADRO JM, 1994, J BIOL CHEM, V269, P32085; Camadro JM, 1999, PEROXIDIZING HERBICIDES, P245; Che FS, 2000, PLANT PHYSIOL, V124, P59, DOI 10.1104/pp.124.1.59; Dailey H. A., 1990, BIOSYNTHESIS HEME CH, P123; DAILEY HA, 1987, BIOCHEMISTRY-US, V26, P2697, DOI 10.1021/bi00384a007; Dailey TA, 1995, ARCH BIOCHEM BIOPHYS, V324, P379, DOI 10.1006/abbi.1995.0051; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; DUKE SO, 1994, ACS SYM SER, V559, P191; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; GRASER E, 1998, PLANT MOL BIOL, V36, P311; Gualberto JM, 1995, METHOD CELL BIOL, V50, P161, DOI 10.1016/S0091-679X(08)61029-8; HANSSON M, 1994, J BACTERIOL, V176, P5962, DOI 10.1128/jb.176.19.5962-5970.1994; ICHINOSE K, 1995, J PLANT PHYSIOL, V146, P693, DOI 10.1016/S0176-1617(11)81935-8; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; JOYARD J, 1991, EUR J BIOCHEM, V199, P489, DOI 10.1111/j.1432-1033.1991.tb16148.x; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lermontova I, 1997, P NATL ACAD SCI USA, V94, P8895, DOI 10.1073/pnas.94.16.8895; MATRINGE M, 1994, J BIOL CHEM, V269, P15010; Mireau H, 1996, PLANT CELL, V8, P1027, DOI 10.1105/tpc.8.6.1027; NHISHIMURA K, 1995, J BIOL CHEM, V270, P8076; Reinbothe S, 1996, EUR J BIOCHEM, V237, P323, DOI 10.1111/j.1432-1033.1996.00323.x; Roper JM, 1997, EUR J BIOCHEM, V246, P32, DOI 10.1111/j.1432-1033.1997.t01-1-00032.x; SASARMAN A, 1993, CAN J MICROBIOL, V39, P1155, DOI 10.1139/m93-174; Scharfe C, 1999, NUCLEIC ACIDS RES, V27, P153, DOI 10.1093/nar/27.1.153; SIEPKER LJ, 1987, BIOCHIM BIOPHYS ACTA, V913, P349, DOI 10.1016/0167-4838(87)90146-4; Silva-Filho MC, 1996, PLANT MOL BIOL, V30, P769, DOI 10.1007/BF00019010; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; TAKETANI S, 1995, EUR J BIOCHEM, V230, P760, DOI 10.1111/j.1432-1033.1995.0760h.x; VOLRASH SL, 1997, Patent No. 973201; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WALKER CJ, 1995, PHYSIOL PLANTARUM, V94, P419, DOI 10.1111/j.1399-3054.1995.tb00948.x; Wang G, 1999, NUCLEIC ACIDS RES, V27, P2806, DOI 10.1093/nar/27.13.2806; Watanabe N, 1998, PLANT PHYSIOL, V118, P751, DOI 10.1104/pp.118.3.751; Watanabe N, 2000, PLANT CELL PHYSIOL, V41, P889, DOI 10.1093/pcp/pcd007; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	41	119	132	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20474	20481		10.1074/jbc.M101140200	http://dx.doi.org/10.1074/jbc.M101140200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274159	hybrid			2022-12-27	WOS:000169135100108
J	Sheng, YH; Reddel, SW; Herzog, H; Wang, YX; Brighton, T; France, MP; Robertson, SA; Krilis, SA				Sheng, YH; Reddel, SW; Herzog, H; Wang, YX; Brighton, T; France, MP; Robertson, SA; Krilis, SA			Impaired thrombin generation in beta(2)-glycoprotein I null mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; BETA-2-GLYCOPROTEIN-I; ANTICOAGULANT; INHIBITOR; BINDING	Autoimmune antibodies to beta (2)-glycoprotein I (beta 2GPI) have been proposed to be clinically relevant because of their strong association with thrombosis, miscarriage, and thrombocytopenia, By using a homologous recombination approach, beta 2GPI-null mice were generated to begin to understand the physiologic and pathologic role of this prominent plasma protein in mammals. When beta 2GPI heterozygotes on a 129/Sv/C57BL/6 mixed genetic background were intercrossed, only 8.9% of the resulting 336 offspring possessed both disrupted alleles, These data suggest that beta 2GPI plays a beneficial role in implantation and/or fetal development in at least some mouse strains. Although those beta 2GPI-null mice that were born appeared to be relatively normal anatomically and histologically, subsequent analysis revealed that they possessed an impaired in vitro ability to generate thrombin relative to wild type mice. Thus, beta 2GPI also appears to play an important role in thrombin-mediated coagulation.	Univ New S Wales, Dept Immunol Allergy & Infect Dis, St George Hosp, Kogarah, NSW 2217, Australia; Univ New S Wales, Dept Med, St George Hosp, Kogarah, NSW 2217, Australia; Univ New S Wales, Dept Haematol, St George Hosp, Kogarah, NSW 2217, Australia; St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; Univ Sydney, Dept Vet Anat & Pathol, Sydney, NSW 2006, Australia; Univ Adelaide, Dept Obstet & Gynaecol, Adelaide, SA 5005, Australia; Univ Adelaide, Reprod Med Unit, Adelaide, SA 5005, Australia	St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Sydney; University of Adelaide; University of Adelaide	Krilis, SA (corresponding author), Univ New S Wales, Dept Immunol Allergy & Infect Dis, St George Hosp, South St, Kogarah, NSW 2217, Australia.	s.krilis@unsw.edu.au	Robertson, Sarah A/C-8182-2009; sheng, yong H/C-5052-2013; Herzog, Herbert/B-8294-2008	Robertson, Sarah A/0000-0002-9967-0084; sheng, yong H/0000-0002-4623-9098; Reddel, Stephen/0000-0002-0169-3350				Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; BANCSI LFJMM, 1992, THROMB HAEMOSTASIS, V67, P649; Del Papa N, 1998, J IMMUNOL, V160, P5572; EXNER T, 1978, BRIT J HAEMATOL, V40, P143, DOI 10.1111/j.1365-2141.1978.tb03648.x; GINSBERG JS, 1993, BLOOD, V81, P2958; HANLY JG, 1998, LUPUS, V7, P219; HOEG JM, 1985, ATHEROSCLEROSIS, V55, P25, DOI 10.1016/0021-9150(85)90163-7; Kandiah DA, 1998, ADV IMMUNOL, V70, P507, DOI 10.1016/S0065-2776(08)60393-4; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Matsuura E, 1998, LUPUS, V7, pS135, DOI 10.1177/096120339800700230; Mori T, 1996, THROMB HAEMOSTASIS, V75, P49; NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9; POLTZ E, 1979, FEBS LETT, V102, P183; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; SCHOUSBOE I, 1985, BLOOD, V66, P1086; Sheng YH, 1997, GENOMICS, V41, P128, DOI 10.1006/geno.1997.4610; THIAGARAJAN P, 1980, J CLIN INVEST, V66, P397, DOI 10.1172/JCI109869; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	20	67	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13817	13821		10.1074/jbc.M010990200	http://dx.doi.org/10.1074/jbc.M010990200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11145969	hybrid			2022-12-27	WOS:000168356600045
J	Innamorati, G; Le Gouill, C; Balamotis, M; Birnbaumer, M				Innamorati, G; Le Gouill, C; Balamotis, M; Birnbaumer, M			The long and the short cycle - Alternative intracellular routes for trafficking of G-protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V2 VASOPRESSIN RECEPTOR; INDUCED INTERNALIZATION; TRANSFERRIN RECEPTOR; MEDIATED ENDOCYTOSIS; PHOSPHORYLATION; CELLS; RESENSITIZATION; COMPLEXES; ENDOSOMES; PATHWAYS	The C terminus of the human V2 vasopressin receptor contains multiple phosphorylation sites including a cluster of amino acids that when phosphorylated prevents the return of the internalized receptor to the cell surface. To identify the step where the recycling process was interrupted, the trafficking of the V2 receptor was compared with that of the recycling Via receptor after exposure to ligand, Initially, both receptors internalized in small peripheral endosomes, but a physical separation of their endocytic pathways was subsequently detected. The Via receptor remained evenly distributed throughout the cytosol, whereas the V2 receptor accumulated in a large aggregation of vesicles in the proximity of the nucleus where it colocalized with the transferrin receptor and Rab11, a small GTP-binding protein that is concentrated in the perinuclear recycling compartment; only marginal colocalization of Rab11 with the Via receptor was observed. Thus, the V2 receptor was sequestered in the perinuclear recycling compartment, Targeting to the perinuclear recycling compartment was determined by the receptor subtype and not by the inability to recycle, since the mutation S363A in the phosphorylation-dependent retention signal generated a Va receptor that was recycled via the same compartment, The perinuclear recycling compartment was enriched in p-arrestin after internalization of either wild type V2 receptor or its recycling mutant, indicating that long term interaction between the receptors and arrestin was not responsible for the intracellular retention. Thus, the fully phosphorylated retention domain overrides the natural tendency of the V2 receptor to recycle and, by preventing its exit from the perinuclear recycling compartment, interrupts its transit via the "long cycle." The data suggest that the inactivation of the domain, possibly by dephosphorylation, triggers the return of the receptor from the perinuclear compartment to the plasma membrane.	Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Birnbaumer, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.		Innamorati, Giulio/GVU-1941-2022; Innamorati, Giulio/AAR-6314-2020	Innamorati, Giulio/0000-0003-0123-8777	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041244] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-41-244] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; GORBULEV V, 1993, EUR J BIOCHEM, V215, P1, DOI 10.1111/j.1432-1033.1993.tb18000.x; Hasbi A, 2000, J PHARMACOL EXP THER, V293, P237; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; Innamorati G, 1998, J BIOL CHEM, V273, P7155, DOI 10.1074/jbc.273.12.7155; Innamorati G, 1996, MOL PHARMACOL, V50, P467; Innamorati G, 1997, J BIOL CHEM, V272, P2486; Innamorati G, 1999, J RECEPT SIGNAL TR R, V19, P315, DOI 10.3109/10799899909036654; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Krisch B, 1998, J HISTOCHEM CYTOCHEM, V46, P1233, DOI 10.1177/002215549804601103; Krueger KM, 1997, J BIOL CHEM, V272, P5; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; LUTZ W, 1990, P NATL ACAD SCI USA, V87, P6507, DOI 10.1073/pnas.87.17.6507; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Morrison KJ, 1996, MOL PHARMACOL, V50, P692; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; Pfeiffer R, 1998, EXP CELL RES, V244, P327, DOI 10.1006/excr.1998.4159; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; RAPOSO G, 1989, EUR J CELL BIOL, V50, P340; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; TOOZE J, 1992, J CELL BIOL, V118, P813, DOI 10.1083/jcb.118.4.813; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trischler M, 1999, J CELL SCI, V112, P4773; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Zhang J, 1997, RECEPTOR CHANNEL, V5, P193	37	133	133	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13096	13103		10.1074/jbc.M009780200	http://dx.doi.org/10.1074/jbc.M009780200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11150299	hybrid			2022-12-27	WOS:000168198600089
J	Kresse, H; Seidler, DG; Muller, M; Breuer, E; Hausser, H; Roughley, PJ; Schonherr, E				Kresse, H; Seidler, DG; Muller, M; Breuer, E; Hausser, H; Roughley, PJ; Schonherr, E			Different usage of the glycosaminoglycan attachment sites of biglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; DERMATAN SULFATE PROTEOGLYCAN; CORE PROTEIN; DECORIN; IDENTIFICATION; SEQUENCE; THROMBOMODULIN; GLYCOSYLATION; PURIFICATION; RECOGNITION	Biglycan is a member of the small leucine-rich proteoglycan family. Its core protein comprises two chondroitin/dermatan sulfate attachment sites on serine 42 and serine 47, respectively, which are the fifth and tenth amino add residues, respectively, after removal of the prepro peptide. Because the regulation of glycosaminoglycan chain assembly is not fully understood and because of the in vivo existence of monoglycanated biglycan, mutant core proteins were stably expressed in human 293 and Chinese hamster ovary cells in which i) either one or both serine residues were converted into alanine or threonine residues, ii) the number of acidic amino acids N-terminal of the respective serine residues was altered, and iii) a hexapeptide was inserted between the mutated site 1 and the unaltered site 2, Labeling experiments with [S-35]sulfate and [S-35]methionine indicated that serine 42 was almost fully used as the glycosaminoglycan attachment site regardless of whether site 2 was available or not for chain assembly. In contrast, substitution of site 2 was greatly influenced by the presence or absence of serine 42, although additional mutations demonstrated a direct influence of the amino acid sequence between the two sites. When site 2 was not substituted with a glycosaminoglycan chain, there was also no assembly of the linkage region. These results indicate that xylosyltransferase is the rate-limiting enzyme in glycosaminoglycan chain assembly and implicate a cooperative effect on the xylosyl transfer to site 2 by xylosylation of site 1, which probably becomes manifest before the removal of the propeptide. It is shown additionally that biglycan expressed in 293 cells may still contain the propeptide sequence and may carry heparan sulfate chains as well as sulfated N-linked oligosaccharides.	Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada	University of Munster; McGill University	Kresse, H (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	kresse@uni-muenster.de						ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; Blaschke UK, 1996, J BIOL CHEM, V271, P30347, DOI 10.1074/jbc.271.48.30347; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Brinkmann T, 1997, J BIOL CHEM, V272, P11171; Dolan M, 1997, J BIOL CHEM, V272, P4316, DOI 10.1074/jbc.272.7.4316; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; FISHER LW, 1987, J BIOL CHEM, V262, P9702; FISHER LW, 1989, J BIOL CHEM, V264, P4571; GERLITZ B, 1993, BIOCHEM J, V295, P131, DOI 10.1042/bj2950131; HAUSSER H, 1989, BIOCHEM J, V263, P137, DOI 10.1042/bj2630137; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; Hausser H, 1999, BIOCHEM J, V344, P827, DOI 10.1042/0264-6021:3440827; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hocking AM, 1996, J BIOL CHEM, V271, P19571, DOI 10.1074/jbc.271.32.19571; HUBER S, 1988, J BIOL CHEM, V263, P752; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JOHNSTONE B, 1993, BIOCHEM J, V292, P661, DOI 10.1042/bj2920661; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Krishnan P, 1999, J BIOL CHEM, V274, P10945, DOI 10.1074/jbc.274.16.10945; LIN JH, 1994, J BIOL CHEM, V269, P25021; LOHMANDER LS, 1989, J BIOL CHEM, V264, P18775; MANN DM, 1990, J BIOL CHEM, V265, P5317; MARCUM JA, 1991, BIOCHEM BIOPH RES CO, V175, P706, DOI 10.1016/0006-291X(91)91623-K; MINTZ KP, 1994, J BIOL CHEM, V269, P4845; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; NEAME PJ, 1989, J BIOL CHEM, V264, P8653; Pfeil U, 2000, GLYCOBIOLOGY, V10, P803, DOI 10.1093/glycob/10.8.803; RAUCH U, 1988, BIOL CHEM H-S, V369, P595, DOI 10.1515/bchm3.1988.369.2.595; ROUGHLEY PJ, 1993, BIOCHEM J, V295, P421, DOI 10.1042/bj2950421; ROUGHLEY PJ, 1996, BIOCHEM J, V318, P979; SCHONHERR E, 1993, BIOCHEM J, V290, P893, DOI 10.1042/bj2900893; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; WONGPALMS S, 1995, ARCH BIOCHEM BIOPHYS, V319, P383, DOI 10.1006/abbi.1995.1308	41	30	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13411	13416		10.1074/jbc.M009321200	http://dx.doi.org/10.1074/jbc.M009321200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11145959	hybrid			2022-12-27	WOS:000168198600129
J	Bernard-Pierrot, I; Delbe, J; Caruelle, D; Barritault, D; Courty, J; Milhiet, PE				Bernard-Pierrot, I; Delbe, J; Caruelle, D; Barritault, D; Courty, J; Milhiet, PE			The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE HB-GAM; NIH 3T3 CELLS; NEURITE OUTGROWTH; BINDING-PROTEIN; PLEIOTROPHIN; PURIFICATION; EXPRESSION; RECEPTOR; MIDKINE; HARP	Heparin affin regulatory peptide (HARP) is a 18-kDa heparin-binding polypeptide that is highly expressed in developing tissues and in several primary human tumors. It seems to play a key role in cellular growth and differentiation. In vitro, HARP displays mitogenic, angiogenic, and neurite outgrowth activities. It is a secreted protein that is organized in two beta -sheet domains, each domain containing a cluster of basic residues. To assess determinants involved in the biological activities of HARP, C-terminally truncated proteins were produced in Chinese hamster ovary-K1 cells and tested for their mitogenic, tumor formation in nude mice and neurite outgrowth activities. Our data clearly indicate that the residues 111-136 of the lysine-rich C-terminal domain are involved in the mitogenic and tumor formation activities of HARP. Correlatively, no signal transduction was detected using the corresponding mutant, suggesting the absence of HARP binding to its high affinity receptor. However, this C-terminal domain of HARP is not involved in the neurite outgrowth activity. We also demonstrate that HARP signal peptide cleavage could led to two maturated forms that are both but differentially mitogenic.	Univ Paris 12, Lab Rech Croissance Cellulaire Reparat & Regener, CNRS, UPRESA 7053, F-94010 Creteil, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Courty, J (corresponding author), Univ Paris 12, Lab Rech Croissance Cellulaire Reparat & Regener, CNRS, UPRESA 7053, Ave Gen de Gaulle, F-94010 Creteil, France.	Courty@univ-paris12.fr	Courty, Jose/Q-3702-2018; Delbe, Jean/R-3680-2018					Bernard-Pierrot I, 1999, BIOCHEM BIOPH RES CO, V266, P437, DOI 10.1006/bbrc.1999.1835; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Choudhuri R, 1997, CANCER RES, V57, P1814; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; COURTY J, 2000, HEPARIN AFIN REGULAT, P145; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; DELBE J, 1995, J CELL PHYSIOL, V164, P47, DOI 10.1002/jcp.1041640107; Delbe J, 1999, PATHOL BIOL, V47, P352; FABRI L, 1992, BIOCHEM INT, V28, P1; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; KOJIMA S, 1995, BIOCHEM BIOPH RES CO, V206, P468, DOI 10.1006/bbrc.1995.1066; KUO MD, 1992, BIOCHEM BIOPH RES CO, V182, P188, DOI 10.1016/S0006-291X(05)80129-9; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Laaroubi Khalid, 1995, Progress in Growth Factor Research, V6, P25; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; LI YS, 1993, BIOCHEM BIOPH RES CO, V195, P1089, DOI 10.1006/bbrc.1993.2156; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; PALERMO DP, 1991, J BIOTECHNOL, V19, P35, DOI 10.1016/0168-1656(91)90073-5; Papadimitriou E, 2000, BIOCHEM BIOPH RES CO, V274, P242, DOI 10.1006/bbrc.2000.3126; RAULAIS D, 1991, BIOCHEM BIOPH RES CO, V174, P708, DOI 10.1016/0006-291X(91)91475-R; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Sato H, 1999, EXP CELL RES, V246, P152, DOI 10.1006/excr.1998.4304; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; TAKAMATSU H, 1992, BIOCHEM BIOPH RES CO, V185, P224, DOI 10.1016/S0006-291X(05)80979-9; Vacherot F, 1999, J BIOL CHEM, V274, P7741, DOI 10.1074/jbc.274.12.7741; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Zhang N, 1999, P NATL ACAD SCI USA, V96, P6734, DOI 10.1073/pnas.96.12.6734; Zhang N, 1999, J BIOL CHEM, V274, P12959, DOI 10.1074/jbc.274.19.12959	34	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12228	12234		10.1074/jbc.M010913200	http://dx.doi.org/10.1074/jbc.M010913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11150308	hybrid			2022-12-27	WOS:000168081800106
J	James, IE; Marquis, RW; Blake, SM; Hwang, SM; Gress, CJ; Ru, Y; Zembryki, D; Yamashita, DS; McQueney, MS; Tomaszek, TA; Oh, HJ; Gowen, M; Veber, DF; Lark, MW				James, IE; Marquis, RW; Blake, SM; Hwang, SM; Gress, CJ; Ru, Y; Zembryki, D; Yamashita, DS; McQueney, MS; Tomaszek, TA; Oh, HJ; Gowen, M; Veber, DF; Lark, MW			Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-RESORPTION; IN-VITRO; MOLECULAR-CLONING; OSTEOPETROSIS; TISSUE; ASSAY; MICE; VIVO	Cathepsins K and L are related cysteine proteases that have been proposed to play important roles in osteoclast-mediated bone resorption, To further examine the putative role of cathepsin L in bone resorption, we have evaluated selective and potent inhibitors of human cathepsin L and cathepsin K in an in vitro assay of human osteoclastic resorption and an in situ assay of osteoclast cathepsin activity, The potent selective cathepsin L inhibitors (K-i = 0.0099, 0.034, and 0.27 nM) were inactive in both the in situ cytochemical assay (IC50 > 1 muM) and the osteoclast-mediated bone resorption assay (IC50 > 300 nM). Conversely, the cathepsin K selective inhibitor was potently active in both the cytochemical (IC50 = 63 nM) and resorption (IC50 = 71 nM) assays. A recently reported dipeptide aldehyde with activity against cathepsins L (K-i = 0.052 mM) and K (K-i = 1.57 nM) was also active in both assays (IC50 = 110 and 115 nM, respectively) These data confirm that cathepsin K and not cathepsin L is the major protease responsible for human osteoclastic bone resorption.	SmithKline Beecham Pharmaceut, Dept Bone & Cartilage Biol, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Med Chem, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Prot Biochem, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Mech Enzymol, King Of Prussia, PA 19406 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	James, IE (corresponding author), SmithKline Beecham Pharmaceut, Dept Bone & Cartilage Biol, 709 Swedeland Rd,POB 1539, King Of Prussia, PA 19406 USA.							BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; DODDS RA, 1998, METHODS BONE BIOL, P198; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; ELMORE SM, 1966, AM J MED, V40, P273, DOI 10.1016/0002-9343(66)90108-2; Foged NT, 1996, J BONE MINER RES, V11, P226; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; HART KA, 1996, J BONE MINER RES, V11, pS181; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; James IE, 1999, J BONE MINER RES, V14, P1562, DOI 10.1359/jbmr.1999.14.9.1562; James IE, 1996, J BONE MINER RES, V11, P1608; KAHN AJ, 1975, NATURE, V258, P325, DOI 10.1038/258325a0; MEREDITH SC, 1978, J BONE JOINT SURG AM, V60, P1122, DOI 10.2106/00004623-197860080-00023; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Thompson SK, 1997, P NATL ACAD SCI USA, V94, P14249, DOI 10.1073/pnas.94.26.14249; VERBER DF, 2000, PEPTIDES NEW MILLENI, P453; Votta BJ, 1997, J BONE MINER RES, V12, P1396, DOI 10.1359/jbmr.1997.12.9.1396; WALKER DG, 1973, SCIENCE, V180, P275; Woo JT, 1996, EUR J PHARMACOL, V300, P131, DOI 10.1016/0014-2999(95)00858-6; Yasuma T, 1998, J MED CHEM, V41, P4301, DOI 10.1021/jm9803065	21	37	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11507	11511		10.1074/jbc.M010684200	http://dx.doi.org/10.1074/jbc.M010684200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11148212	hybrid			2022-12-27	WOS:000168081800013
J	Schillace, RV; Voltz, JW; Sim, ATR; Shenolikar, S; Scott, JD				Schillace, RV; Voltz, JW; Sim, ATR; Shenolikar, S; Scott, JD			Multiple interactions within the AKAP220 signaling complex contribute to protein phosphatase 1 regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ANCHORING PROTEIN; RABBIT SKELETAL-MUSCLE; CATALYTIC SUBUNIT; MOLECULAR-CLONING; PHOSPHOPROTEIN PHOSPHATASE; TARGETING SUBUNITS; MYOSIN PHOSPHATASE; SCAFFOLD PROTEIN; SMOOTH-MUSCLE; BINDING MOTIF	The phosphorylation status of cellular proteins is controlled by the opposing actions of protein kinases and phosphatases. Compartmentalization of these enzymes is critical for spatial and temporal control of these phosphorylation/dephosphorylation events. We previously reported that a 220-kDa A-kinase anchoring protein (AKAP220) coordinates the location of the cAMP-dependent protein kinase (PKA) and the type 1 protein phosphatase catalytic subunit (PP1c) (Schillace, R. V., and Scott, J. D. (1999) Curr. Biol. 9, 321-324). We now demonstrate that an AKAP220 fragment is a competitive inhibitor of PP1c activity (K-i = 2.9 +/- 0.7 muM). Mapping studies and activity measurements indicate that several protein-protein interactions act synergistically to inhibit PP1. A consensus targeting motif, between residues 1195 and 1198 (Lys-Val-Gln-Phe), binds but does not affect enzyme activity, whereas determinants between residues 1711 and 1901 inhibit the phosphatase. Analysis of truncated PP1c and chimeric PP1/2A catalytic subunits suggests that AKAP220 inhibits the phosphatase in a manner distinct from all known PP1 inhibitors and toxins. Intermolecular interactions within the AKAP220 signaling complex further contribute to PP1 inhibition as addition of the PKA regulatory subunit (RII) enhances phosphatase inhibition. These experiments indicate that regulation of PP1 activity by AKAP220 involves a complex network of intra- and intermolecular interactions.	Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97201 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Newcastle, Fac Med & Hlth Sci, Sch Biomed Sci, Discipline Med Biochem, Newcastle, NSW 2308, Australia	Howard Hughes Medical Institute; Oregon Health & Science University; Duke University; University of Newcastle	Scott, JD (corresponding author), Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, MRB 322,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052054, P01DK044239] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52054, DK44239] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; BOLLEN M, 1994, FEBS LETT, V344, P196, DOI 10.1016/0014-5793(94)00391-2; Campos M, 1996, J BIOL CHEM, V271, P28478, DOI 10.1074/jbc.271.45.28478; CARR DW, 1991, J BIOL CHEM, V266, P14188; CAUDWELL FB, 1986, FEBS LETT, V194, P85, DOI 10.1016/0014-5793(86)80056-4; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COGHLAN VM, 1995, BIOCHEM SOC T, V23, P591; COHEN P, 1989, J BIOL CHEM, V264, P21435; Colbran RJ, 1997, J NEUROCHEM, V69, P920; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Connor JH, 1999, J BIOL CHEM, V274, P22366, DOI 10.1074/jbc.274.32.22366; Connor JH, 2000, J BIOL CHEM, V275, P18670, DOI 10.1074/jbc.M909312199; DENT P, 1992, EUR J BIOCHEM, V210, P1037, DOI 10.1111/j.1432-1033.1992.tb17509.x; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; FAUX MC, 1996, CELL, V70, P8; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; HELPS NR, 1995, FEBS LETT, V377, P395; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; HUBBARD MJ, 1990, EUR J BIOCHEM, V189, P243, DOI 10.1111/j.1432-1033.1990.tb15483.x; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Johnson DF, 1996, EUR J BIOCHEM, V239, P317, DOI 10.1111/j.1432-1033.1996.0317u.x; JURGENSEN SR, 1985, P NATL ACAD SCI USA, V82, P7565, DOI 10.1073/pnas.82.22.7565; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; KHATRA BS, 1985, BIOCHEM BIOPH RES CO, V130, P567, DOI 10.1016/0006-291X(85)90454-1; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KREBS EG, 1985, BIOCHEM SOC T, V13, P813, DOI 10.1042/bst0130813; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Lin JW, 1998, J NEUROSCI, V18, P2017; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PARK IK, 1994, J BIOL CHEM, V269, P28919; PARK IK, 1994, J BIOL CHEM, V269, P944; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; RENOUF S, 1995, FEBS LETT, V375, P75, DOI 10.1016/0014-5793(95)01180-M; Schillace RV, 1999, J CLIN INVEST, V103, P761, DOI 10.1172/JCI6491; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Snyder GL, 1998, J NEUROSCI, V18, P10297; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Van Eynde A, 1995, J BIOL CHEM, V270, P28068, DOI 10.1074/jbc.270.47.28068; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yang J, 2000, J BIOL CHEM, V275, P22635, DOI 10.1074/jbc.M003082200; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	67	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12128	12134		10.1074/jbc.M010398200	http://dx.doi.org/10.1074/jbc.M010398200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152471	hybrid			2022-12-27	WOS:000168081800093
J	Scorrano, L; Penzo, D; Petronilli, V; Pagano, F; Bernardi, P				Scorrano, L; Penzo, D; Petronilli, V; Pagano, F; Bernardi, P			Arachidonic acid causes cell death through the mitochondrial permeability transition - Implications for tumor necrosis factor-alpha apoptotic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; CYTOCHROME-C RELEASE; 2 SEPARATE SITES; CYCLOSPORINE-A; FATTY-ACIDS; GD3 GANGLIOSIDE; OXIDATIVE-PHOSPHORYLATION; MEMBRANE DEPOLARIZATION; PYRIDINE-NUCLEOTIDES; DEPENDENT ACTIVATION	We have investigated the effects of arachidonic and palmitic acids in isolated rat liver mitochondria and in rat hepatoma MH1C1 cells. We show that both compounds induce the mitochondrial permeability transition (PT). At variance from palmitic acid, however, arachidonic acid causes a PT at concentrations that do not cause PT-independent depolarization or respiratory inhibition, suggesting a specific effect on the PT pore. When added to intact MH1C1 cells, arachidonic acid but not palmitic acid caused a mitochondrial PT in situ that was accompanied by cytochrome c release and rapidly followed by cell death. All these effects of arachidonic acid could be prevented by cyclosporin A but not by the phospholipase A(2) inhibitor aristolochic acid. In contrast, tumor necrosis factor alpha caused phospholipid hydrolysis, induction of the PT, cytochrome c release, and cell death that could be inhibited by both cyclosporin A and aristolochic acid. These findings suggest that arachidonic acid produced by cytosolic phospholipase A(2) may be a mediator of tumor necrosis factor alpha cytotoxicity in situ through induction of the mitochondrial PT.	Dept Biomed Sci, CNR, Unit Study Biomembranes, Padua, Italy; Univ Padua, Dept Urol, I-35121 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua	Bernardi, P (corresponding author), Dipartimento Sci Biomed Sperimentali, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@civ.bio.unipd.it	Scorrano, Luca/A-6652-2008; Petronilli, Valeria/C-3558-2015; Scorrano, Luca/K-3967-2019; Bernardi, Paolo/C-3656-2008	Scorrano, Luca/0000-0002-8515-8928; Petronilli, Valeria/0000-0003-4026-6404; Scorrano, Luca/0000-0002-8515-8928; Bernardi, Paolo/0000-0001-9187-3736	Telethon [1141] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; COSTANTINI P, 1995, TOXICOLOGY, V99, P77, DOI 10.1016/0300-483X(94)02997-9; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Eriksson O, 1998, J BIOL CHEM, V273, P12669, DOI 10.1074/jbc.273.20.12669; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; GUTKNECHT J, 1988, J MEMBRANE BIOL, V106, P83, DOI 10.1007/BF01871769; HILLERED L, 1988, J NEUROSCI RES, V19, P94, DOI 10.1002/jnr.490190113; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Jayadev S, 1997, J BIOL CHEM, V272, P17196, DOI 10.1074/jbc.272.27.17196; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; LUVISETTO S, 1990, J BIOENERG BIOMEMBR, V22, P635, DOI 10.1007/BF00809068; MCGEERUSSELL SM, 1970, BRAIN RES, V20, P193, DOI 10.1016/0006-8993(70)90288-X; MUTCH DG, 1992, CANCER RES, V52, P866; NEALE ML, 1988, IMMUNOLOGY, V64, P81; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Rial E, 2001, BBA-BIOENERGETICS, V1504, P70, DOI 10.1016/S0005-2728(00)00240-1; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; ROTTENBERG H, 1986, BIOCHEMISTRY-US, V25, P1747, DOI 10.1021/bi00355a045; SCHOLEFIELD PG, 1956, CAN J BIOCHEM PHYS, V34, P1227; Schonfeld P, 1997, FEBS LETT, V420, P167, DOI 10.1016/S0014-5793(97)01511-1; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tafani M, 2000, AM J PATHOL, V156, P2111, DOI 10.1016/S0002-9440(10)65082-1; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wieckowski MR, 1998, FEBS LETT, V423, P339, DOI 10.1016/S0014-5793(98)00118-5; Wissing D, 1997, P NATL ACAD SCI USA, V94, P5073, DOI 10.1073/pnas.94.10.5073; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; YOSHIDA S, 1983, J NEUROCHEM, V40, P1278, DOI 10.1111/j.1471-4159.1983.tb13567.x	58	253	258	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12035	12040		10.1074/jbc.M010603200	http://dx.doi.org/10.1074/jbc.M010603200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134037	hybrid			2022-12-27	WOS:000168081800081
J	Churchill, GC; Galione, A				Churchill, GC; Galione, A			Prolonged inactivation of nicotinic acid adenine dinucleotide phosphate-induced Ca2+ release mediates a spatiotemporal Ca2+ memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; INOSITOL TRISPHOSPHATE; CALCIUM-RELEASE; PYRIDINE-NUCLEOTIDE; NAADP; MICROSOMES	Although numerous extracellular stimuli are coupled to increases in intracellular Ca2+, different stimuli are thought to achieve specificity by eliciting different spatiotemporal Ca2+ increases. We investigated the effect of nicotinic acid adenine dinucleotide phosphate (NAADP) inactivation on spatiotemporal Ca2+ signals in intact sea urchin eggs. The photorelease of NAADP but not inositol 1,4,5-trisphosphate or cyclic ADP-ribose resulted in self-inactivation. When NAADP was released first locally and subsequently globally, the spatial pattern of the first response shaped that of the second. Specifically, the local release of NAADP created a Ca2+ gradient that was reversed during the subsequent global release of NAADP. Neither cyclic ADP-ribose nor inositol 1,4,5-trisphosphate showed a similar effect. In contrast to homogenates, NAADP inactivation was reversible in intact eggs with resensitization occurring in similar to 20 min. Because initial NAADP responses affect later responses, NAADP can serve as a mechanism for a Ca2+ memory that has both spatial and temporal components. This NAADP-mediated Ca2+ memory provides a novel mechanism for cells to control spatiotemporal Ca2+ increases.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.		Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646				Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Chini EN, 1996, BIOCHEM J, V316, P709, DOI 10.1042/bj3160709; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; Genazzani AA, 1997, TRENDS PHARMACOL SCI, V18, P108, DOI 10.1016/S0165-6147(96)01036-X; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Navazio L, 2000, P NATL ACAD SCI USA, V97, P8693, DOI 10.1073/pnas.140217897; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725	18	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11223	11225		10.1074/jbc.M009335200	http://dx.doi.org/10.1074/jbc.M009335200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139579	hybrid			2022-12-27	WOS:000167980900086
J	Gu, BJ; Zhang, WY; Worthington, RA; Sluyter, R; Dao-Ung, P; Petrou, S; Barden, JA; Wiley, JS				Gu, BJ; Zhang, WY; Worthington, RA; Sluyter, R; Dao-Ung, P; Petrou, S; Barden, JA; Wiley, JS			A Glu-496 to Ala polymorphism leads to loss of function of the human P2X(7) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVITY; NUCLEOTIDE RECEPTOR; EXTRACELLULAR ATP; HUMAN-LYMPHOCYTES; XENOPUS-OOCYTES; PURINERGIC RECEPTORS; HUMAN MACROPHAGES; DENDRITIC CELLS; ION CHANNELS; ACTIVATION	P2X(7) receptor is a ligand-gated cation-selective channel that mediates ATP-induced apoptosis of cells of the immune system. We and others have shown that P2X(7) is nonfunctional both in lymphocytes and monocytes from some subjects. To study a possible genetic basis we sequenced DNA coding for the carboxyl-terminal tail of P2X(7). In 9 of 45 normal subjects a heterozygous nucleotide substitution (1513A-->C) was found, whereas 1 subject carried the homozygous substitution that codes for glutamic acid to alanine at amino acid position 496. Surface expression of P2X(7) on lymphocytes was not affected by this E496A polymorphism, demonstrated both by confocal microscopy and immunofluorescent staining. Monocytes and lymphocytes from the E496A homozygote subject expressed nonfunctional receptor, whereas heterozygotes showed P2X(7) function that was half that of germline P2X(7). Results of transfection experiments showed that the mutant P2X(7) receptor was nonfunctional when expressed at low receptor density but regained function at a high receptor density. This density dependence of mutant P2X(7) function was also seen on differentiation of fresh monocytes to macrophages with interferon-gamma, which up-regulated mutant P2X(7) and partially restored its function. P2X(7)-mediated apoptosis of lymphocytes was impaired in homozygous mutant P2X(7) compared with germline (8.6 versus 35.2%). The data suggest that the glutamic acid at position 496 is required for optimal assembly of the P2X(7) receptor.	Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Anat & Histol, Sydney, NSW 2006, Australia; Univ Melbourne, Dept Physiol, Melbourne, Vic 3050, Australia	University of Sydney; University of Sydney; University of Melbourne	Wiley, JS (corresponding author), Nepean Hosp, Clin Sci Bldg, Penrith, NSW 2750, Australia.		Petrou, Steven/M-8332-2013; Sluyter, Ronald/B-5798-2009	Sluyter, Ronald/0000-0003-4909-686X; Petrou, Steven/0000-0002-4960-6375; Gu, Ben/0000-0001-5500-4453; Wiley, James/0000-0001-9421-4154				Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Chessell IP, 1998, BRIT J PHARMACOL, V124, P1314, DOI 10.1038/sj.bjp.0701958; Chused TM, 1996, J IMMUNOL, V157, P1371; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; ELMOATASSIM C, 1992, J BIOL CHEM, V267, P23664; Fernando KC, 1999, ARCH BIOCHEM BIOPHYS, V362, P197, DOI 10.1006/abbi.1998.1045; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Gargett CE, 1996, BIOCHEM J, V313, P529, DOI 10.1042/bj3130529; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; HICKMAN SE, 1994, BLOOD, V84, P2452; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Humphreys BD, 1996, J IMMUNOL, V157, P5627; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; KUSNER DJ, 1994, BIOCHEM J, V304, P485, DOI 10.1042/bj3040485; Kusner DJ, 2000, J IMMUNOL, V164, P379, DOI 10.4049/jimmunol.164.1.379; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; Li GH, 2000, J BIOL CHEM, V275, P29107, DOI 10.1074/jbc.M910277199; Nagy PV, 2000, IMMUNOL LETT, V72, P23, DOI 10.1016/S0165-2478(00)00168-1; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; NUTTLE LC, 1994, J BIOL CHEM, V269, P13988; PENG L, 1998, CHIN MED J, V78, P508; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Sharma N, 2000, KIDNEY INT, V57, P803, DOI 10.1046/j.1523-1755.2000.00918.x; Sikora A, 1999, J IMMUNOL, V163, P558; Small KM, 2000, J BIOL CHEM, V275, P38518, DOI 10.1074/jbc.M004550200; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; TATHAM PER, 1990, J GEN PHYSIOL, V95, P459, DOI 10.1085/jgp.95.3.459; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	41	261	280	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11135	11142		10.1074/jbc.M010353200	http://dx.doi.org/10.1074/jbc.M010353200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150303	Green Published			2022-12-27	WOS:000167980900075
J	Nishimori, S; Tanaka, Y; Chiba, T; Fujii, M; Imamura, T; Miyazono, K; Ogasawara, T; Kawaguchi, H; Igarashi, T; Fujita, T; Tanaka, K; Toyoshima, H				Nishimori, S; Tanaka, Y; Chiba, T; Fujii, M; Imamura, T; Miyazono, K; Ogasawara, T; Kawaguchi, H; Igarashi, T; Fujita, T; Tanaka, K; Toyoshima, H			Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; FACTOR-BETA; I RECEPTORS; DIFFERENTIATION; PROTEINS; DEGRADATION; KINASE; PROLIFERATION; INHIBITORS; PATHWAY	Cyclin-dependent kinase inhibitory proteins (CKIs) are negative regulators of the cell cycle. Of all CKls, only p57(Kip2) plays an essential role(s) that other CKIs cannot compensate for in embryonic development. Recently, we found that p57(Kip2) is degraded through the ubiquitin-proteasome pathway in osteoblastic cells stimulated to proliferation by transforming growth factor (TGF)-beta1 (Urano, T., Yashiroda, H., Muraoka, RI., Tanaka, K., Hosoi, T.:, Inoue, S., Ouchi, Y., and Toyoshima, H. (1999) J. Biol, Chem. 274, 12197-12200). We report here that TGF-beta1-induced p57(Kip2) proteolysis is mediated through transcription by the Smad pathway. When the constitutively active form of the TGF-beta type I receptor ALK-5(TD) was ectopically expressed in osteoblastic cells, p57(Kip2) that had been accumulated by serum starvation causing the cell-cycle arrest was rapidly degraded in a manner analogous to TGF-beta1 stimulation. Moreover, Smad2 or Smad3 with Smad4 enhanced the proteolytic pathway of p57(Kip2). Th, degradation of p57(Kip2) evoked by TGF-beta1 was blocked by forced expression of an inhibitory Smad called Smad7 or by the addition of actinomycin D or alpha -amanitin. These results indicate that accelerated degradation of p57(Kip2) by TGF-beta1/Smad signaling is mediated through a newly synthesized factor(s) that modifies p57(Kip2) or the ubiquitin-proteasome pathway.	Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Inst Med Sci, Dept Tumor Biochem, Bunkyo Ku, Tokyo 1138613, Japan; Univ Tokyo, Branch Hosp, Dept Internal Med, Bunkyo Ku, Tokyo 1128688, Japan; Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Bunkyo Ku, Tokyo 1138655, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Ogasawara, Toru/I-1629-2014	Ogasawara, Toru/0000-0002-2996-081X				Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Hannigan M, 1998, BIOCHEM BIOPH RES CO, V246, P55, DOI 10.1006/bbrc.1998.8570; Harper JW, 1999, NAT CELL BIOL, V1, pE5, DOI 10.1038/8952; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Urano T, 1999, J BIOL CHEM, V274, P12197, DOI 10.1074/jbc.274.18.12197; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	33	51	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10700	10705		10.1074/jbc.M007499200	http://dx.doi.org/10.1074/jbc.M007499200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152674	hybrid			2022-12-27	WOS:000167980900020
J	Brieba, LG; Gopal, V; Sousa, R				Brieba, LG; Gopal, V; Sousa, R			Scanning mutagenesis reveals roles for helix N of the bacteriophage T7 RNA polymerase thumb subdomain in transcription complex stability, pausing, and termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; KINETIC MECHANISM; CRYSTAL-STRUCTURE; ELONGATION; INITIATION; LYSOZYME; BINDING; MUTANT; SITE; CONFORMATIONS	Deletions within the thumb subdomain (residues 335-408) of T7 RNA polymerase decrease elongation complex stability and processivity, but the structure of a T7RNAP initial transcription complex containing a 3-nucleotide RNA reveals no interactions between the thumb and the RNA or DNA. Modeling of a longer RNA in this structure, using a T7DNAP-primer-template structure as a guide, suggests that the phosphate ribose backbone of the RNA contacts a stretch of mostly positively charged side chains between residues 385 and 395 of helix N of the thumb. Scanning mutagenesis of this region reveals that alanine substitutions of Arg(391), Ser(393), and Arg(394) destabilize elongation complexes and that substitutions at 393 and 394 increase termination of transcripts 5 or more bases in length. The alpha -carbons of all 3 of these residues lie on the side of helix N, which faces into the template-binding cleft of the RNA polymerase, and modeling suggests that they can contact the RNA 4-5 bases away from the 3 ' -end. Alanine substitutions of other residues within 385-395 do not have marked effects on transcription complex stability, but alanine substitutions of Asp(388) and Tyr(385) reduce pausing and termination at the T7 concatemer junction , Both of these side chains lie on the outer side of helix N, pointing away from the template binding cleft. The thumb subdomain of T7RNAP therefore has roles both in transcription complex stabilization and in pausing and termination at the T7 concatemer junction.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.		Brieba, Luis/I-8447-2016	Brieba, Luis/0000-0002-6073-5207; Sousa, Rui/0000-0003-4314-121X	NIGMS NIH HHS [R01 GM052522, GM 52522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; BONNER G, 1994, J BIOL CHEM, V269, P25129; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DZANTIEV L, 2000, BIOCHEMISTRY-US, V39, P536; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; He B, 1998, J BIOL CHEM, V273, P18802, DOI 10.1074/jbc.273.30.18802; Huang JB, 1999, J MOL BIOL, V293, P457, DOI 10.1006/jmbi.1999.3135; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; JENG ST, 1990, J BIOL CHEM, V265, P3823; JENG ST, 1992, J BIOL CHEM, V267, P19306; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Lyakhov DL, 1997, J MOL BIOL, V269, P28, DOI 10.1006/jmbi.1997.1015; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MCALLISTER WT, 1997, MECH TRANSCRIPTION N, V11, P16; MENTESANAS PE, 2000, J MOL BIOL, V302; Mote J, 1998, J BIOL CHEM, V273, P16843, DOI 10.1074/jbc.273.27.16843; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; MUNOZ V, 1995, CURR OPIN BIOTECH, V6, P382, DOI 10.1016/0958-1669(95)80066-2; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; SOUSA R, 1994, J MOL BIOL, V244, P6, DOI 10.1006/jmbi.1994.1699; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TEMIAKOV D, 2000, IN PRESS P NATL ACAD; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Villemain J, 1998, J MOL BIOL, V281, P793, DOI 10.1006/jmbi.1998.1989; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358	43	20	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10306	10313		10.1074/jbc.M009866200	http://dx.doi.org/10.1074/jbc.M009866200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124963	hybrid			2022-12-27	WOS:000167996400096
J	Haynes, LP; Evans, GJO; Morgan, A; Burgoyne, RD				Haynes, LP; Evans, GJO; Morgan, A; Burgoyne, RD			A direct inhibitory role for the Rab3-specific effector, Noc2, in Ca2+-regulated exocytosis in neuroendocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; REGULATED EXOCYTOSIS; PC12 CELLS; NSEC-1 MUNC-18; RAB PROTEINS; GTPASE RAB3A; ALPHA-SNAP; BINDING; RABPHILIN-3A; SECRETION	Rab proteins comprise a family of GTPases, conserved from yeast to mammals, which are integral components of membrane trafficking pathways. Rab3A is a neural/neuroendocrine-specific member of the Rab family involved in Ca2+-regulated exocytosis, where it functions in an inhibitory capacity controlling recruitment of secretory vesicles into a releasable pool at the plasma membrane. The effector by which Rab3A exerts its inhibitory effect is unclear as the Rab3A effecters Rabphilin and RIM have been excluded from for this role. One putative Rab3A effector in dense-core granule exocytosis is the cytosolic zinc finger protein, Noc2, We have established that overexpression of Noc2 in PC12 cells has a direct inhibitory effect upon Ca2+-triggered exocytosis in permeabilized cells. We demonstrate specific nucleotide-dependent binding of Noc2 to Rab3A and show that the inhibition of exocytosis is dependent upon this interaction since Rab3A binding-deficient mutants of Noc2 do not inhibit exocytosis, We propose that Noc2 may be a negative effector for Rab3A in regulated exocytosis of dense-core granules from endocrine eels.	Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burgoyne, RD (corresponding author), Univ Liverpool, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	burgoyne@liverpool.ac.uk	Burgoyne, Robert/C-6706-2008; Morgan, Alan/AAI-8875-2020; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387; Evans, Gareth John Owen/0000-0003-2573-7001; Morgan, Alan/0000-0002-0346-1289				Arribas M, 1997, EUR J CELL BIOL, V74, P209; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Calakos N, 1996, PHYSIOL REV, V76, P1; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Chung SH, 1997, J NEUROCHEM, V69, P164; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DARCHEN F, 1995, J CELL SCI, V108, P1639; Doussau F, 1998, J NEUROSCI, V18, P3147; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fisher RJ, 1999, PFLUG ARCH EUR J PHY, V437, P754, DOI 10.1007/s004240050842; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Graham ME, 1997, MOL BIOL CELL, V8, P431, DOI 10.1091/mbc.8.3.431; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Graham ME, 1997, J NEUROCHEM, V69, P2369; Haynes LP, 1999, BIOCHEM J, V342, P707, DOI 10.1042/0264-6021:3420707; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Joberty G, 1999, J CELL SCI, V112, P3579; Johannes L, 1998, J NEUROCHEM, V71, P1127; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; MCKIERNAN CJ, 1993, J BIOL CHEM, V268, P24449; Nonet ML, 1997, J NEUROSCI, V17, P8061; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Regazzi R, 1996, J CELL SCI, V109, P2265; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Steel GJ, 1997, BIOCHEM J, V325, P511, DOI 10.1042/bj3250511; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WICK PF, 1993, J BIOL CHEM, V268, P10983; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164	51	45	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9726	9732		10.1074/jbc.M006959200	http://dx.doi.org/10.1074/jbc.M006959200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134008	hybrid			2022-12-27	WOS:000167996400021
J	Mongiat, M; Otto, J; Oldershaw, R; Ferrer, F; Sato, JD; Iozzo, RV				Mongiat, M; Otto, J; Oldershaw, R; Ferrer, F; Sato, JD; Iozzo, RV			Fibroblast growth factor-binding protein is a novel partner for perlecan protein core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DENSITY-LIPOPROTEIN-RECEPTOR; CELL-ADHESION MOLECULES; COLLAGEN TYPE-IV; BASEMENT-MEMBRANES; DOMAIN-III; STRUCTURAL CHARACTERIZATION; 2-HYBRID SYSTEM; GLOBULAR DOMAIN; TUMOR-GROWTH	Perlecan, a widespread heparan sulfate proteoglycan, functions as a bioactive reservoir for growth factors by stabilizing them against misfolding or proteolysis. These factors, chiefly members of the fibroblast growth factor (FGF) gene family, are coupled to the N-terminal heparan sulfate chains, which augment high affinity binding and receptor activation. However, rather little is known about biological partners of the protein core. The major goal of this study was to identify novel proteins that interact with the protein core of perlecan. Using the yeast two-hybrid system and domain III of perlecan as bait, we screened similar to0.5 10(6) cDNA clones from a keratinocyte library and identified a strongly interactive clone. This cDNA corresponded to FGF-binding protein (FGF-BP), a secreted protein previously shown to bind acidic and basic FGF and to modulate their activities. Using a panel of deletion mutants, FGF-BP binding was localized to the second EGF repeat of domain III, a region very close to the binding site for FGF7. FGF-BP could be coimmunoprecipitated with an antibody against perlecan and bound in solution to recombinant domain III-alkaline phosphatase fusion protein. Immunohistochemical analyses revealed colocalization of FGF-BP and perlecan in the pericellular stroma of various squamous cell carcinomas suggesting a potential in vivo interaction. Thus, FGF-BP should be considered a novel biological ligand for perlecan, an interaction that could influence cancer growth and tissue remodeling.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Amer Type Culture Collect, Div Cell Mol & Dev Biol, Manassas, VA 20110 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Cellular Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 249,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.		Mongiat, Maurizio/H-8297-2018; Iozzo, Renato/AAS-1980-2020	Mongiat, Maurizio/0000-0001-6509-0068; Iozzo, Renato/0000-0002-5908-5112	NCI NIH HHS [R01 CA47282, R01 CA39481] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Aho S, 1998, MATRIX BIOL, V17, P401, DOI 10.1016/S0945-053X(98)90100-7; Aigner A, 2000, GROWTH FACTORS, V18, P51, DOI 10.3109/08977190009003233; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; BATTAGLIA C, 1993, EUR J CELL BIOL, V61, P92; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHAKRAVARTI S, 1995, J BIOL CHEM, V270, P404, DOI 10.1074/jbc.270.1.404; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Couchman JR, 1996, J BIOL CHEM, V271, P9595, DOI 10.1074/jbc.271.16.9595; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; CZUBAYKO F, 1994, J BIOL CHEM, V269, P28243; DUNLEVY JR, 2000, PROTEOGLYCANS STRUCT, P275; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gohring W, 1998, EUR J BIOCHEM, V255, P60, DOI 10.1046/j.1432-1327.1998.2550060.x; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; HEREMANS A, 1990, J BIOL CHEM, V265, P8716; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; ISEMURA M, 1987, J BIOL CHEM, V262, P8926; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Joseph SJ, 1996, DEVELOPMENT, V122, P3443; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kurtz A, 1997, ONCOGENE, V14, P2671, DOI 10.1038/sj.onc.1201117; Lametsch R, 2000, J BIOL CHEM, V275, P19469, DOI 10.1074/jbc.M002550200; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; LiaudetCoopman EDE, 1996, J BIOL CHEM, V271, P21303, DOI 10.1074/jbc.271.35.21303; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Mathiak M, 1997, CANCER RES, V57, P2130; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; NOONAN DM, 1993, KIDNEY INT, V43, P53, DOI 10.1038/ki.1993.10; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Okamoto T, 1996, IN VITRO CELL DEV-AN, V32, P69; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Rak J, 1997, NAT MED, V3, P1083, DOI 10.1038/nm1097-1083; REINHARDT D, 1993, J BIOL CHEM, V268, P10881; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x; Schulze B, 1996, MATRIX BIOL, V15, P349, DOI 10.1016/S0945-053X(96)90138-9; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; TIMAR J, 1992, AM J PATHOL, V141, P467; VIGNY M, 1988, J CELL PHYSIOL, V137, P321, DOI 10.1002/jcp.1041370216; Villar MJ, 1999, J CELL BIOCHEM, V75, P665, DOI 10.1002/(SICI)1097-4644(19991215)75:4<665::AID-JCB12>3.0.CO;2-S; Wang XC, 1998, BIOCHEM MOL BIOL INT, V46, P81; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; WU DQ, 1991, J BIOL CHEM, V266, P16778; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668	75	113	122	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10263	10271		10.1074/jbc.M011493200	http://dx.doi.org/10.1074/jbc.M011493200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11148217	hybrid			2022-12-27	WOS:000167996400091
J	Shi, XP; Chen, E; Yin, KC; Na, S; Garsky, VM; Lai, MT; Li, YM; Platchek, M; Register, RB; Sardana, MK; Tang, MJ; Thiebeau, J; Wood, T; Shafer, JA; Gardell, SJ				Shi, XP; Chen, E; Yin, KC; Na, S; Garsky, VM; Lai, MT; Li, YM; Platchek, M; Register, RB; Sardana, MK; Tang, MJ; Thiebeau, J; Wood, T; Shafer, JA; Gardell, SJ			The Pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PEPSTATIN-AFFINITY-CHROMATOGRAPHY; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; PROCATHEPSIN-D; CLEAVAGE; MATURATION; INTERMEDIATE; PURIFICATION; PROPEPTIDE	beta -Secretase (BACE) is a membrane-bound aspartyl protease that cleaves the amyloid precursor protein to generate the N terminus of the amyloid P peptide. PACE is expressed as a precursor protein containing Pre, Pro, protease, transmembrane, and cytosolic domains. A soluble PACE derivative (PreProBACE460) that is truncated between the protease and transmembrane domains was produced by baculovirus-mediated expression. ProBACE460 was purified from conditioned media of infected insect cells using immobilized concanavalin A and immobilized PACE inhibitor, P10-P4 ' Stat(Val), Furin cleaves ProBACE460 between the Pro and protease regions to generate mature BACE460. The k(cat)/K-m of ProBACE460 when assayed with a polypeptide substrate is only 2.3-fold less than that of BACE460, This finding and the similar inhibitory potency of P10-P4 ' Stat(Val) for ProBACE460 and BACE460 suggest that the Pro domain has little effect on the PACE active site. Exposure of ProBACE460 to guanidine denaturation/renaturation results in a 7-fold higher recovery of PACE activity than when BACE460 is similarly treated. The presence of free PACE Pro peptide during renaturation of BACE460 but not ProBACE460 increases recovery of activity. These findings show that the Pro domain in ProBACE460 does not suppress activity as in a strict zymogen but does appear to facilitate proper folding of an active protease domain.	Merck Res Labs, Dept Biol Chem, W Point, PA 19486 USA; Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA	Merck & Company; Merck & Company	Gardell, SJ (corresponding author), Merck Res Labs, Dept Biol Chem, WP42-213, W Point, PA 19486 USA.							Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; CONNER GE, 1989, BIOCHEM J, V263, P601, DOI 10.1042/bj2630601; EDALJI R, 1991, J PROTEIN CHEM, V10, P403, DOI 10.1007/BF01025254; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; Ermolieff J, 2000, BIOCHEMISTRY-US, V39, P12450, DOI 10.1021/bi001494f; ESUMI H, 1978, FEBS LETT, V86, P33, DOI 10.1016/0014-5793(78)80092-1; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; FUSEK M, 1991, FEBS LETT, V287, P160, DOI 10.1016/0014-5793(91)80040-A; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Khan AR, 1998, PROTEIN SCI, V7, P815; Laprise MH, 1998, BIOTECHNOL BIOENG, V58, P85, DOI 10.1002/(SICI)1097-0290(19980405)58:1<85::AID-BIT9>3.0.CO;2-Q; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; ROEBROEK AJM, 1995, DNA CELL BIOL, V14, P223, DOI 10.1089/dna.1995.14.223; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; YAMSHCHIKOV GV, 1995, VIROLOGY, V214, P50, DOI 10.1006/viro.1995.9955; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	27	122	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10366	10373		10.1074/jbc.M009200200	http://dx.doi.org/10.1074/jbc.M009200200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11266439	hybrid			2022-12-27	WOS:000167996400103
J	Tian, B; Mathews, MB				Tian, B; Mathews, MB			Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON ACTION; MUTATIONAL ANALYSIS; MOLECULAR-BASIS; MESSENGER-RNA; IN-VIVO; DOMAIN; ACTIVATION; DIMERIZATION; MECHANISM; LOCALIZATION	The interferon-inducible double-stranded RNA (dsRNA)-activated protein kinase PKR is regulated by dsRNAs that interact with the two dsRNA-binding motifs (dsRBMs) in its N terminus. The dsRBM is a conserved protein motif found in many proteins from most organisms. In this study, we investigated the biochemical functions and cytological activities of the two PKR dsRBMs (dsRBM1 and dsRBM2) and the cooperation between them. We found that dsRBM1 has a higher affinity for binding to dsRNA than dsRBM2, In addition, dsRBM1 has RNA-annealing activity that is not displayed by dsRBM2, Both dsRBMs have an intrinsic ability to dimerize (dsRBM2) or multimerize (dsRBM1), Binding to dsRNA inhibits oligomerization of dsRBM1 but not dsRBM2 and strongly inhibits the dimerization of the intact PKR N terminus (p20) containing both dsRBMs, dsRBM1, like p20, activates reporter gene expression in transfection assays, and it plays a determinative role in localizing PKR to the nucleolus and cytoplasm of the cell. Thus, dsRBM2 has weak or no activity in dsRNA binding, stimulation of gene expression, and PKR localization, but it strongly enhances these functions of dsRBM1 when contained in p20. However, dsRBM2 does not enhance the annealing activity of dsRBM1, This study shows that the dsRBMs of PKR possess distinct properties and that some, but not all, of the functions of the enzyme depend on cooperation between the two motifs.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mathews, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	mathews@umdnj.edu		Tian, Bin/0000-0001-8903-8256	NIAID NIH HHS [AI34552] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Besse S, 1998, EXP CELL RES, V239, P379, DOI 10.1006/excr.1997.3908; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; Brooks R, 1998, FEBS LETT, V434, P121, DOI 10.1016/S0014-5793(98)00963-6; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Circle DA, 1997, RNA, V3, P438; CLEMENS MJ, 1994, BIOCHIMIE, V76, P770, DOI 10.1016/0300-9084(94)90081-7; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; GREEN SR, 1995, MOL CELL BIOL, V15, P358, DOI 10.1128/MCB.15.1.358; Gunnery S, 1998, METHODS, V15, P189, DOI 10.1006/meth.1998.0623; Hitti E, 1998, NUCLEIC ACIDS RES, V26, P4382, DOI 10.1093/nar/26.19.4382; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; JIMENEZGARCIA LF, 1993, J CELL SCI, V106, P11; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Krovat BC, 1996, J BIOL CHEM, V271, P28112, DOI 10.1074/jbc.271.45.28112; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MCCORMACK SJ, 1994, VIROLOGY, V198, P92, DOI 10.1006/viro.1994.1011; MCCORMACK SJ, 1995, VIROLOGY, V206, P511, DOI 10.1016/S0042-6822(95)80067-0; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Melville MW, 2000, CELL MOL LIFE SCI, V57, P311, DOI 10.1007/PL00000692; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Ortega LG, 1996, VIROLOGY, V215, P31, DOI 10.1006/viro.1996.0004; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, MOL CELL BIOL, V18, P7009, DOI 10.1128/MCB.18.12.7009; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pe'ery T, 2000, COLD SPRING HARBOR M, V39, P371; Raine DA, 1998, FEBS LETT, V436, P343, DOI 10.1016/S0014-5793(98)01163-6; RendeFournier R, 1997, VIROLOGY, V238, P410, DOI 10.1006/viro.1997.8824; Robertson HD, 1996, BIOCHIMIE, V78, P909, DOI 10.1016/S0300-9084(97)86712-0; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; SCHMEDT C, 1995, J MOL BIOL, V249, P29, DOI 10.1006/jmbi.1995.0278; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Zhang SS, 1999, J CELL SCI, V112, P2693; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434	59	75	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9936	9944		10.1074/jbc.M007328200	http://dx.doi.org/10.1074/jbc.M007328200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134010	hybrid			2022-12-27	WOS:000167996400050
J	Guittaut, M; Charpentier, S; Normand, T; Dubois, M; Raimond, J; Legrand, A				Guittaut, M; Charpentier, S; Normand, T; Dubois, M; Raimond, J; Legrand, A			Identification of an internal gene to the human galectin-3 gene with two different overlapping reading frames that do not encode galectin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE TRANSLATION INITIATION; CARBOHYDRATE-BINDING PROTEIN-35; HUMAN MOLYBDOPTERIN SYNTHASE; III COLLAGEN GENE; MESSENGER-RNA; BICISTRONIC TRANSCRIPT; DISTINCT FORMS; EXPRESSION; CELLS; GROWTH	We previously reported that alternative transcripts were initiated within the second intron of the human Galectin-3 gene (LGALS3), We now demonstrate that these transcripts arise from an internal gene embedded within LGALS3 and named galig (Galectin-3 internal gene). Tissue-specific expression of galig was assayed by screening of several human tissues. Contrary to LGALS3, galig appears to be tightly regulated and principally activated in leukocytes from peripheral blood. Cloning and characterization of galig transcripts revealed that they contain two out-of-frame overlapping open-reading frames (ORFs). Transfection of expression vectors encoding enhanced green fluorescent protein (EGFP) chimeras indicated that both ORFs could be translated in proteins unrelated to Galectin-3. The ORF1 polypeptide targets EGFP to cytosol and nucleus whereas ORF2 targets EGFP to mitochondria. These results revealed the exceptional genetic organization of the LGALS3 locus.	Univ Orleans, CNRS, UPR4301, Ctr Biophys Mol, F-45071 Orleans 02, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans	Legrand, A (corresponding author), Univ Orleans, CNRS, UPR4301, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans 02, France.		Guittaut, Michael/ABE-4274-2021	Guittaut, Michael/0000-0001-9540-5593				AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; AOKI M, 1993, J BIOL CHEM, V268, P22723; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; BAO Q, 1995, J CELL SCI, V108, P2791; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BENNETT VD, 1990, J BIOL CHEM, V265, P2223; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FOWLIS D, 1995, DEV DYNAM, V203, P241, DOI 10.1002/aja.1002030211; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; HAMANN KK, 1991, EXP CELL RES, V196, P82, DOI 10.1016/0014-4827(91)90458-7; Horwich A, 1990, CURR OPIN CELL BIOL, V2, P625, DOI 10.1016/0955-0674(90)90103-L; HSU DK, 1992, J BIOL CHEM, V267, P14167; Kadrofske MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7, DOI 10.1006/abbi.1997.0447; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; LABARRIERE N, 1995, J BIOL CHEM, V270, P19205, DOI 10.1074/jbc.270.33.19205; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LEGRAND A, 1991, AM J PATHOL, V139, P629; NAH HD, 1994, J BIOL CHEM, V269, P16443; NANGIAMAKKER P, 1993, CANCER RES, V53, P5033; Okazaki S, 1998, BIOCHEM BIOPH RES CO, V250, P347, DOI 10.1006/bbrc.1998.9331; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; QUELLE DE, 1995, CELL, V83, P993; RAIMOND J, 1995, FEBS LETT, V363, P165, DOI 10.1016/0014-5793(95)00310-6; Ritchie H, 1997, BIOCHEM BIOPH RES CO, V231, P425, DOI 10.1006/bbrc.1997.6126; Sloan J, 1999, NUCLEIC ACIDS RES, V27, P854, DOI 10.1093/nar/27.3.854; Stallmeyer B, 1999, AM J HUM GENET, V64, P698, DOI 10.1086/302295; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; VOSS JW, 1991, J BIOL CHEM, V266, P12832; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Zhang YJ, 1997, NUCLEIC ACIDS RES, V25, P2470, DOI 10.1093/nar/25.12.2470	37	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 26	2001	276	4					2652	2657		10.1074/jbc.M002523200	http://dx.doi.org/10.1074/jbc.M002523200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	398YV	11160123	hybrid			2022-12-27	WOS:000166784800050
J	Pecci, A; Viegas, LR; Baranao, JL; Beato, M				Pecci, A; Viegas, LR; Baranao, JL; Beato, M			Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; GLUCOCORTICOID RECEPTOR; IN-VIVO; APOPTOSIS; RNA; BCL-X(L); STAT5; DEXAMETHASONE; MITOCHONDRIA; INDUCTION	Differential splicing from the bcl-X gene generates several isoforms with opposite effects on the apoptotic response. To explore the mechanism controlling the balance between the various isoforms, we have characterized the 5' region of the mouse bcl-X gene. We identified three new promoters in addition to the two previously described (Grillot, D. A, M., G.-G., Ekhterae, D., Duan, L., Inohara, N., Ohta, S., Seldin, M. F., and Nunez, G. (1997) J. Immunol. 158, 4750-4757). These five promoters (P1-P5) would give rise to at least five mRNAs with different 5'-untranslated region, all sharing the same translation initiation site. Except for the product of the most proximal promoter (P1), the other mRNAs are generated by alternative splicing of noncoding exons to a common acceptor site located in the first translated exon. Reverse transcriptase-polymerase chain reaction, primer extension, and RNase protection assays demonstrate a tissue-specific pattern of promoter usage. P1 and P2 are active in all tissues analyzed, whereas the other three promoter show tissue-specific activities. P3 is active in spleen, liver, and kidney, P4 is active in uterus and spleen, and P5 is active in spleen, liver, brain, and thymus, We present evidence suggesting that promoter selection influences the outcome of the splice process. Transcripts from P1 generate mainly the mRNA for the long isoform Bcl-X-L, whereas transcripts from P2 generate mRNAs for the isoforms Bcl-X-L, Bcl-X-S, and Bcl-X-gamma and transcripts from P3 yield mainly mRNAs for the isoform Bcl-X-gamma. Our results suggest a key role of promoter choice in determining alternative splicing and, thus, the balance of Bcl-X isoforms.	Inst Mol Biol & Tumorforsch, D-35033 Marburg, Germany; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Beato, M (corresponding author), Inst Mol Biol & Tumorforsch, D-35033 Marburg, Germany.		Beato, Miguel/B-5564-2015	Beato, Miguel/0000-0002-2878-2222				BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Chang TC, 1997, FEBS LETT, V415, P11, DOI 10.1016/S0014-5793(97)01083-1; Chen F, 1999, J BIOL CHEM, V274, P35591, DOI 10.1074/jbc.274.50.35591; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; FANG W, 1994, J IMMUNOL, V153, P4388; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; JacobsHelber SM, 1997, J BIOL CHEM, V272, P6850, DOI 10.1074/jbc.272.11.6850; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; MacCarthy-Morrogh L, 2000, ONCOGENE, V19, P5534, DOI 10.1038/sj.onc.1203949; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pecci A, 1997, J BIOL CHEM, V272, P11791, DOI 10.1074/jbc.272.18.11791; SAKAMOTO T, 1995, BIOCHEM BIOPH RES CO, V215, P511, DOI 10.1006/bbrc.1995.2494; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Yamamoto M, 1998, HEPATOLOGY, V27, P959, DOI 10.1002/hep.510270410; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	36	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21062	21069		10.1074/jbc.M008665200	http://dx.doi.org/10.1074/jbc.M008665200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274164	hybrid			2022-12-27	WOS:000169297900037
J	Hou, YM; Chang, V; Capper, AB; Taussig, R; Gautam, N				Hou, YM; Chang, V; Capper, AB; Taussig, R; Gautam, N			G protein beta subunit types differentially interact with a muscarinic receptor but not adenylyl cyclase type II or phospholipase C-beta 2/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEINS; GAMMA-SUBUNITS; MOLECULAR-CLONING; SF9 CELLS; C BETA-2; ACTIVATION; RECONSTITUTION; PURIFICATION; TRANSDUCIN; EFFECTORS	In comparison with the alpha subunit of G proteins, the role of the beta subunit in signaling is less well understood. During the regulation of effecters by the beta gamma complex, it is known that the beta subunit contacts effecters directly, whereas the role of the beta subunit is undefined in receptor-G protein interaction, Among the five G protein beta subunits known, the beta (4) subunit type is the least studied. me compared the ability of beta gamma complexes containing beta (4) and the well characterized beta (1) to stimulate three different effecters: phospholipase C-beta2, phospholipase C-beta3, and adenylyl cyclase type II. beta (4)gamma (2) and beta (1)gamma (2) activated all three of these effecters: with equal efficacy. However, nucleotide exchange in a G protein constituting alpha (o)beta (4)gamma (2) mas stimulated significantly more by the M2 muscarinic receptor compared with alpha (o)beta (1)gamma (2). Because alpha (o) forms heterotrimers with beta (4)gamma (2) and beta (1)gamma (2) equally well, these results show that the beta subunit type plays a direct role in the receptor activation of a G protein.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan	Gautam, N (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.				NIGMS NIH HHS [GM53645, R01 GM046963, R01 GM053645, GM46963] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053645] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano T, 1999, J BIOL CHEM, V274, P21425, DOI 10.1074/jbc.274.30.21425; Azpiazu I, 1999, J BIOL CHEM, V274, P35305, DOI 10.1074/jbc.274.50.35305; AZPIAZU I, 2001, IN PRESS METHODS ENZ; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Figler RA, 1997, BIOCHEMISTRY-US, V36, P16288, DOI 10.1021/bi972000q; FONG HKW, 1987, P NATL ACAD SCI USA, V84, P3792, DOI 10.1073/pnas.84.11.3792; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; GIERSCHIK P, 1994, METHOD ENZYMOL, V238, P181; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hayashi MK, 1996, J BIOCHEM, V120, P1232; Hou YM, 2000, J BIOL CHEM, V275, P38961, DOI 10.1074/jbc.C000604200; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEE E, 1994, METHOD ENZYMOL, V237, P146; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Myung CS, 2000, P NATL ACAD SCI USA, V97, P9311, DOI 10.1073/pnas.97.16.9311; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; PRONIN AN, 1994, METHOD ENZYMOL, V237, P482; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Taylor JM, 1996, J BIOL CHEM, V271, P3336; VONWEIZSACKER E, 1992, BIOCHEM BIOPH RES CO, V183, P350, DOI 10.1016/0006-291X(92)91650-F; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Weng GZ, 1996, J BIOL CHEM, V271, P26445, DOI 10.1074/jbc.271.43.26445; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Yan K, 1997, J BIOL CHEM, V272, P2056; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597; ZHANG S, 1996, J BIOL CHEM, V271, P2028; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575	50	35	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19982	19988		10.1074/jbc.M010424200	http://dx.doi.org/10.1074/jbc.M010424200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262394	hybrid			2022-12-27	WOS:000169135100041
J	Habelhah, H; Shah, K; Huang, L; Burlingame, AL; Shokat, KM; Ronai, Z				Habelhah, H; Shah, K; Huang, L; Burlingame, AL; Shokat, KM; Ronai, Z			Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RIBONUCLEOPROTEIN-K; ACTIVATED PROTEIN-KINASE; UNNATURAL NUCLEOTIDE SPECIFICITY; HNRNP-K; MAP KINASES; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; TYROSINE KINASE; DNA-BINDING; PHOSPHORYLATION	Modification of the ATP pocket on protein kinases allows selective use of an ATP analogue that exhibits high affinity for the altered kinases. Using this approach, we altered the ATP-binding site on JNK and identified N-6-(2-phenythyl)-ATP, a modified form of ATP that exhibits high specificity and affinity for the modified, but not the wild type form, of JNK. Using modified JNK and its ATP analogue enables the detection of novel JNK substrates. Among substrates identified using this approach is heterogeneous nuclear ribonucleoprotein K, which is involved in transcription and post-transcriptional mRNA metabolism. The newly identified substrate can be phosphorylated by JNK on amino acids 216 and 353, which contribute to heterogeneous nuclear ribonucleoprotein K mediated transcriptional activities.	CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Ronai, Z (corresponding author), CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, 1425 Madison Ave,Rm 15-20, New York, NY 10029 USA.		Huang, Lan/C-3618-2011	Habelhah, Hasem/0000-0003-4097-1007; RONAI, ZEEV/0000-0002-3859-0400	NCI NIH HHS [CA70731, CA59008] Funding Source: Medline; NCRR NIH HHS [RR01614] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADLER V, 1992, J BIOL CHEM, V267, P17001; ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BSTELO X, 1995, MOL CELL BIOL, V15, P1324; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; CHENG JT, 1993, MOL CELL BIOL, V13, P801, DOI 10.1128/MCB.13.2.801; CHOU SY, 1992, MOL BIOL CELL, V3, P1117, DOI 10.1091/mbc.3.10.1117; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; FUCHS SY, 1998, GENE DEV, V12, P2543; FUCHS SY, 1996, ONCOGENE, V13, P1529; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Hovemann BT, 2000, GENE, V245, P127, DOI 10.1016/S0378-1119(00)00027-5; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lee MH, 1996, J BIOL CHEM, V271, P3420; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Moriguchi T, 1996, Adv Pharmacol, V36, P121, DOI 10.1016/S1054-3589(08)60579-7; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; SETH A, 1992, J BIOL CHEM, V267, P24796; SEUNINGEN I, 1995, J BIOL CHEM, V270, P26976; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; TRIER M, 1994, CELL, V78, P787; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	68	106	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18090	18095		10.1074/jbc.M011396200	http://dx.doi.org/10.1074/jbc.M011396200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11259409	hybrid			2022-12-27	WOS:000168866500064
J	Oishi, K; Takahashi, M; Mukai, H; Banno, Y; Nakashima, S; Kanaho, Y; Nozawa, Y; Ono, Y				Oishi, K; Takahashi, M; Mukai, H; Banno, Y; Nakashima, S; Kanaho, Y; Nozawa, Y; Ono, Y			PKN regulates phospholipase D1 through direct interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ADP-RIBOSYLATION-FACTOR; AMINO-TERMINAL REGION; ZIPPER-LIKE SEQUENCES; TRANSCRIPTION FACTOR; POTENTIAL EFFECTOR; PUTATIVE TARGET; RAT-LIVER; D DEFINES; ACTIVATION	The association of phospholipase (PLD)-1 with protein kinase C-related protein kinases, PKN alpha and PKN beta, was analyzed. PLD1 interacted with PKN alpha and PKN beta in COS-7 cells transiently transfected with PLD1 and PKN alpha or PKN beta expression constructs. The interactions between endogenous PLD1 and PKN alpha or PKN beta were confirmed by co-immunoprecipitation from mammalian cells. In vitro binding studies using the deletion mutants of PLD1 indicated that PKN alpha directly bound to residues 228-598 of PLD1 and that PKN beta interacted with residues 1-228 and 228-598 of PLD1. PKN alpha stimulated the activity of PLD1 in the presence of phosphatidylinositol 4,5-bisphosphate in vitro, whereas PKN beta had a modest effect on the stimulation of PLD1 activity. The stimulation of PLD1 activity by PKN alpha was slightly enhanced by the addition of arachidonic acid. These results suggest that the PKN family functions as a novel intracellular player of PLD1 signaling pathway.	Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Gifu Univ, Sch Med, Dept Biochem, Gifu 5008076, Japan; Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Tokyo 1138613, Japan; Gifu Int Inst Biotechnol, Dept Environm Cell Responses, Gifu 5050116, Japan; Inst Appl Biochem, Gifu 5050116, Japan	Kobe University; Kobe University; Gifu University; Tokyo Metropolitan Institute of Medical Science	Ono, Y (corresponding author), Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan.	yonodayo@kobe-u.ac.jp	Takahashi, Mikiko/AAH-2345-2019	Mukai, Hideyuki/0000-0002-0167-8695				Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Banno Y, 1999, J BIOL CHEM, V274, P27385, DOI 10.1074/jbc.274.39.27385; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Katayama K, 1998, BIOCHEM J, V329, P647, DOI 10.1042/bj3290647; Kawamata T, 1998, J NEUROSCI, V18, P7402; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kim Y, 1999, BIOCHEMISTRY-US, V38, P10344, DOI 10.1021/bi990579h; KITAGAWA M, 1995, BIOCHEM J, V310, P657, DOI 10.1042/bj3100657; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Mukai H, 1996, J BIOL CHEM, V271, P9816, DOI 10.1074/jbc.271.16.9816; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V204, P348, DOI 10.1006/bbrc.1994.2466; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Oishi K, 1999, BIOCHEM BIOPH RES CO, V261, P808, DOI 10.1006/bbrc.1999.1116; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Shibata H, 1996, FEBS LETT, V385, P221, DOI 10.1016/0014-5793(96)00385-7; Shibata H, 1999, MOL BRAIN RES, V74, P126, DOI 10.1016/S0169-328X(99)00273-9; Singer WD, 1996, J BIOL CHEM, V271, P4504; Steed PM, 1998, FASEB J, V12, P1309, DOI 10.1096/fasebj.12.13.1309; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Sung TC, 1999, J BIOL CHEM, V274, P3659, DOI 10.1074/jbc.274.6.3659; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Takanaga H, 1998, EXP CELL RES, V241, P363, DOI 10.1006/excr.1998.4060; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476; Yu WP, 1997, J BIOL CHEM, V272, P10030	39	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18096	18101		10.1074/jbc.M010646200	http://dx.doi.org/10.1074/jbc.M010646200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11259428	hybrid			2022-12-27	WOS:000168866500065
J	Wehrle-Haller, B; Imhof, BA				Wehrle-Haller, B; Imhof, BA			Stem cell factor presentation to c-kit - Identification of a basolateral targeting domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; POLARIZED EPITHELIAL-CELLS; TRANS-GOLGI NETWORK; LEUCINE-BASED MOTIF; MDCK CELLS; DI-LEUCINE; CYTOPLASMIC DOMAIN; MONOCLONAL-ANTIBODY; STEEL(17H) MICE; SORTING SIGNAL	Stem cell factor (also known as mast cell growth factor and kit-ligand) is a transmembrane growth factor with a highly conserved cytoplasmic domain. Basolateral membrane expression in epithelia and persistent cell surface exposure of stem cell factor are required for complete biological activity in pigmentation, fertility, learning, and hematopoiesis. Here we show by site-directed mutagenesis that the cytoplasmic domain of stem cell factor contains a monomeric leucine-dependent basolateral targeting signal. N-terminal to this motif, a cluster of acidic amino acids serves to increase the efficiency of basolateral sorting mediated by the leucine residue. Hence, basolateral targeting of stem cell factor requires a mono-leucine determinant assisted by a cluster of acidic amino acids. This mono-leucine determinant is functionally conserved in colony-stimulating factor-1, a transmembrane growth factor related to stem cell factor. Furthermore, this leucine motif is not capable of inducing endocytosis, allowing for persistent cell surface expression of stem cell factor. In contrast, the mutated cytoplasmic tail found in the stem cell factor mutant Mgf(SI17H) induces constitutive endocytosis by a motif that is related to signals for endocytosis and lysosomal targeting. Our findings therefore present monoleucines as a novel type of protein sorting motif for transmembrane growth factors.	Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland	University of Geneva	Wehrle-Haller, B (corresponding author), Ctr Med Univ Geneva, Dept Pathol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Bernhard.Wehrle-Haller@medecine.unige.ch						AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832; Briley GP, 1997, MOL BIOL CELL, V8, P1619, DOI 10.1091/mbc.8.8.1619; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DOVER GA, 1991, CELL, V65, P9, DOI 10.1016/0092-8674(91)90401-J; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IMHOF BA, 1983, CELL, V35, P667, DOI 10.1016/0092-8674(83)90099-5; Kapur R, 1999, BLOOD, V94, P1915; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; Parichy DM, 1999, DEV GENES EVOL, V209, P349, DOI 10.1007/s004270050263; PAWSON T, 1990, TRENDS GENET, V6, P350, DOI 10.1016/0168-9525(90)90276-C; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Reich V, 1996, J CELL SCI, V109, P2133; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Simmen T, 1999, MOL CELL BIOL, V19, P3136; Simmen T, 1999, J CELL SCI, V112, P45; Simonsen A, 1997, J CELL SCI, V110, P597; Simonsen A, 1998, EUR J CELL BIOL, V76, P25, DOI 10.1016/S0171-9335(98)80014-9; Tajima Y, 1998, J EXP MED, V187, P1451, DOI 10.1084/jem.187.9.1451; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wehrle-Haller B, 1999, DEV BIOL, V210, P71, DOI 10.1006/dbio.1999.9260; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296	40	38	40	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12667	12674		10.1074/jbc.M008357200	http://dx.doi.org/10.1074/jbc.M008357200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152680	hybrid			2022-12-27	WOS:000168198600028
J	Craig, JC; Schumacher, MA; Mansoor, SE; Farrens, DL; Brennan, RG; Goodman, RH				Craig, JC; Schumacher, MA; Mansoor, SE; Farrens, DL; Brennan, RG; Goodman, RH			Consensus and variant cAMP-regulated enhancers have distinct CREB-binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGION LEUCINE-ZIPPER; C-FOS TRANSCRIPTION; DNA-BINDING; RESPONSIVE ELEMENT; CRYSTAL-STRUCTURE; PROTEIN CREB; BASIC REGION; PHOSPHORYLATION; GCN4; DIMERIZATION	Recent determination of the cAMP response element-binding protein (CREB) basic leucine zipper (bZIP) consensus CRE crystal structure revealed key dimerization and DNA binding features that are conserved among members of the CREB/CREM/ATF-1 family of transcription factors. Dimerization appeared to be mediated by a Tyr(307)-Glu(312) interhelical hydrogen bond and a Glu(319)- Arg(314) electrostatic interaction. An unexpected hexahydrated Mg2+ ion was centered above the CRE in the dimer cavity. In the present study, we related these features to CREB dimerization and DNA binding. A Y307F substitution reduced dimer stability and DNA binding affinity, whereas a Y307R mutation produced a stabilizing effect. Mutation of Glu(319) to Ala or Lys attenuated dimerization and DNA binding. Mg2+ ions enhanced the binding affinity of wild-type CREB to the palindromic CRE by similar to 20-fold but did not do so for divergent CREs, Similarly, mutation of Lys(304), which mediates the CREB interaction with the hydrated Mg2+, blocked CREB binding to the palindromic but not the variant CRE sequences. The distinct binding characteristics of the K304A mutants to the consensus and variant CRE sequences indicate that CREB binding to these elements is differentially regulated by Mg2+ ions, We suggest that CREB binds the consensus and variant CRE sequences through fundamentally distinct mechanisms.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	goodmanr@ohsu.edu		Brennan, Richard/0000-0001-7647-485X				BENBROOK DM, 1990, ONCOGENE, V5, P295; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; ELLENBERGER T, 1994, CURR OPIN STRUC BIOL, V4, P12, DOI 10.1016/S0959-440X(94)90054-X; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fass DM, 2001, J BIOL CHEM, V276, P2992, DOI 10.1074/jbc.M008274200; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Kato H, 1998, BRAIN RES, V779, P329, DOI 10.1016/S0006-8993(97)01232-8; KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/jmbi.1995.0645; KERPPOLA T, 1995, NATURE, V373, P199, DOI 10.1038/373199a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; LORIAUX MM, 1994, J BIOL CHEM, V269, P28839; Lundblad JR, 1998, J BIOL CHEM, V273, P19251, DOI 10.1074/jbc.273.30.19251; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; ROSS JBA, 1999, TOPICS FLUORESCENCE, P1; SANTIAGORIVERA ZI, 1993, PROTEIN SCI, V2, P1461, DOI 10.1002/pro.5560020910; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; SELLERS JW, 1990, MOL CELL BIOL, V10, P5077, DOI 10.1128/MCB.10.10.5077; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHORT ML, 1991, NUCLEIC ACIDS RES, V19, P4290, DOI 10.1093/nar/19.15.4290; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; YUN Y, 1990, MOL ENDOCRINOL, V4, P931, DOI 10.1210/mend-4-6-931	35	58	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11719	11728		10.1074/jbc.M010263200	http://dx.doi.org/10.1074/jbc.M010263200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134034	hybrid			2022-12-27	WOS:000168081800041
J	Heimpel, S; Basset, G; Odoy, S; Klingenberg, M				Heimpel, S; Basset, G; Odoy, S; Klingenberg, M			Expression of the mitochondrial ADP/ATP carrier in Escherichia coli - Renaturation, reconstitution, and the effect of mutations on 10 positive residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP CARRIER; ADENINE-NUCLEOTIDE CARRIER; 6 ARGININE MUTATIONS; SACCHAROMYCES-CEREVISIAE; TRANSPORT PROTEIN; BACTERIAL EXPRESSION; UNCOUPLING PROTEIN; YEAST; TRANSLOCATOR; SEQUENCE	Previously, the role of residues in the ADP/ATP carrier (AAC) from Saccharomyces cerevisiae has been studied by mutagenesis, but the dependence of mitochondrial biogenesis on functional AAC impedes segregation of the mutational effects on transport and biogenesis. Unlike other mitochondrial carriers, expression of the AAC from yeast or mammalians in Escherichia coli encountered difficulties because of disparate codon usage. Here we introduce the AAC from Neurospora crassa in E. coli, where it is accumulated in inclusion bodies and establish the reconstitution conditions. AAC expressed with heat shock vector gave higher activity than with pET-3a, Transport activity was absolutely dependent on cardiolipin. The 10 single mutations of intrahelical positive residues and of the matrix repeat (+X+) motif resulted in lower activity, except of R245A. R143A had decreased sensitivity toward carboxyatractylate. The ATP-linked exchange is generally more affected than ADP exchange. This reflects a charge network that propagates positive charge defects to ATP(4-) more strongly than to ADP(3-) transport. Comparison to the homologous mutants of yeast AAC2 permits attribution of the roles of these residues more to ADP/ATP transport or to AAC import into mitochondria.	Univ Munich, Inst Phys Biochem, D-80336 Munich, Germany	University of Munich	Klingenberg, M (corresponding author), Univ Munich, Inst Phys Biochem, Schillerstr 44, D-80336 Munich, Germany.							AQUILA H, 1978, EUR J BIOCHEM, V85, P549, DOI 10.1111/j.1432-1033.1978.tb12270.x; ARENDS H, 1984, EMBO J, V3, P377, DOI 10.1002/j.1460-2075.1984.tb01815.x; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3826; BOGNER W, 1986, EUR J BIOCHEM, V161, P611, DOI 10.1111/j.1432-1033.1986.tb10485.x; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; CLELAND JL, 1992, BIO-TECHNOL, V10, P1013, DOI 10.1038/nbt0992-1013; DREES M, 1988, BIOCHEMISTRY-US, V27, P8584, DOI 10.1021/bi00423a012; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; ERDELT H, 1972, EUR J BIOCHEM, V30, P107, DOI 10.1111/j.1432-1033.1972.tb02077.x; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; FRANKEL S, 1991, P NATL ACAD SCI USA, V88, P1192, DOI 10.1073/pnas.88.4.1192; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KLINGENBERG M, 1973, EUR J BIOCHEM, V38, P346, DOI 10.1111/j.1432-1033.1973.tb03067.x; Klingenberg M, 1995, METHOD ENZYMOL, V260, P369, DOI 10.1016/0076-6879(95)60151-1; KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511; Klingenberg M, 1976, ENZYMES BIOLOGICAL M, V3, P383; KLINGENBERG M, 1991, STUDY ENZYMES, V2, P367; KLINGENBERG M, 1987, ADV MEMBRANE BIOCH B, P389; KNIRSCH M, 1989, FEBS LETT, V244, P427, DOI 10.1016/0014-5793(89)80577-0; KRAMER R, 1977, FEBS LETT, V82, P363, DOI 10.1016/0014-5793(77)80622-4; KRAMER R, 1984, BIOCHIM BIOPHYS ACTA, V765, P353, DOI 10.1016/0005-2728(84)90176-2; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; LASVARENNE JB, 1984, J MOL BIOL, V180, P549; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; MAHLKE K, 1991, THESIS U MUNICH MUNI; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; Muller V, 1996, BIOCHEMISTRY-US, V35, P16132, DOI 10.1021/bi960667r; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; NELSON DR, 1993, J MOL BIOL, V230, P1171, DOI 10.1006/jmbi.1993.1234; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nelson DR, 1996, BBA-BIOENERGETICS, V1275, P133, DOI 10.1016/0005-2728(96)00063-1; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x; WELLS MA, 1969, METHOD ENZYMOL, V14, P178; WINKLER E, 1992, EUR J BIOCHEM, V207, P135, DOI 10.1111/j.1432-1033.1992.tb17030.x; WOHLRAB H, 1994, BIOCHEMISTRY-US, V33, P9371, DOI 10.1021/bi00198a001	44	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11499	11506		10.1074/jbc.M010586200	http://dx.doi.org/10.1074/jbc.M010586200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11136735	hybrid			2022-12-27	WOS:000168081800012
J	Petronilli, V; Penzo, D; Scorrano, L; Bernardi, P; Di Lisa, F				Petronilli, V; Penzo, D; Scorrano, L; Bernardi, P; Di Lisa, F			The mitochondrial permeability transition, release of cytochrome c and cell death - Correlation with the duration of pore openings in situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-INDUCED MEMBRANE TRANSITION; CYCLOSPORINE-A; MEDIATED APOPTOSIS; INTACT-CELLS; ACTIVATION; CHANNEL; BAX; HEPATOCYTES; MODULATION; INDUCTION	We investigated the relationship between opening of the permeability transition pore (PTP), mitochondrial depolarization, cytochrome c release, and occurrence of cell death in rat hepatoma MH1C1 cells. Treatment with arachidonic acid or A23187 induces PTP opening in situ with similar kinetics, as assessed by the calcein loading-Co2+ quenching technique (Petronilli, V., Miotto, G., Canton, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1999) Biophys, J. 76, 725-734), Yet depolarization, as assessed from the changes of mitochondrial tetramethylrhodamine methyl ester (TMRM) fluorescence, is rapid and extensive with arachidonic acid and slow and partial with A23187. Cyclosporin A-inhibitable release of cytochrome c and cell death correlate with the changes of TMRM fluorescence but not with those of calcein fluorescence. Since pore opening must be accompanied by depolarization, we conclude that short PTP openings are detected only by trapped calcein and may have little impact on cell viability, while changes of TMRM distribution require longer PTP openings, which cause release of cytochrome c and may result in cell death. Modulation of the open time appears to be the key element in determining the outcome of stimuli that converge on the PTP.	Univ Padua, Dept Biomed Sci, CNR, Unit Study Biomembranes, I-35100 Padua, Italy; Univ Padua, Dept Biol Chem, I-35100 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua	Petronilli, V (corresponding author), Univ Padua, Dept Biomed Sci, CNR, Unit Study Biomembranes, Viale Giuseppe Colombo 3, I-35100 Padua, Italy.		Scorrano, Luca/A-6652-2008; Bernardi, Paolo/C-3656-2008; Scorrano, Luca/K-3967-2019; Petronilli, Valeria/C-3558-2015	Scorrano, Luca/0000-0002-8515-8928; Bernardi, Paolo/0000-0001-9187-3736; Scorrano, Luca/0000-0002-8515-8928; Petronilli, Valeria/0000-0003-4026-6404; Di Lisa, Fabio/0000-0001-9757-8818	Telethon [1141] Funding Source: Medline	Telethon(Fondazione Telethon)		Adachi S, 1998, J BIOL CHEM, V273, P19892, DOI 10.1074/jbc.273.31.19892; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rottenberg H, 1998, BBA-MOL CELL RES, V1404, P393, DOI 10.1016/S0167-4889(98)00088-3; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2000, GENE DEV, V14, P2060; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	43	403	421	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12030	12034		10.1074/jbc.M010604200	http://dx.doi.org/10.1074/jbc.M010604200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134038	hybrid			2022-12-27	WOS:000168081800080
J	Quijano, C; Hernandez-Saavedra, D; Castro, L; McCord, JM; Freeman, BA; Radi, R				Quijano, C; Hernandez-Saavedra, D; Castro, L; McCord, JM; Freeman, BA; Radi, R			Reaction of peroxynitrite with Mn-superoxide dismutase - Role of the metal center in decomposition kinetics and nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; ESCHERICHIA-COLI; PROSTACYCLIN SYNTHASE; TYROSINE NITRATION; MANGANESE; INACTIVATION; OXIDATION; PURIFICATION; EXPRESSION; RADICALS	Manganese superoxide dismutase (Mn-SOD), a critical mitochondrial antioxidant enzyme, becomes inactivated and nitrated in vitro and potentially in vivo by peroxynitrite. Since peroxynitrite readily reacts with transition metal centers, we assessed the role of the manganese ion in the reaction between peroxynitrite and Mn-SOD. Peroxynitrite reacts with human recombinant and Escherichia coli Mn-SOD with a second order rate constant of 1.0 +/- 0.2 x 10(5) and 1.4 +/- 0.2 x 105 M-1 s(-1) at pH 7.47 and 37 degreesC, respectively. The E. coli apoenzyme, obtained by removing the manganese ion from the active site, presents a rate constant < 10(4) M-1 s(-1) for the reaction with peroxynitrite, whereas that of the manganese-reconstituted apoenzyme (apo/Mn) was comparable to that of the holoenzyme. Peroxynitrite-dependent nitration of 4-hydroxyphenylacetic acid was increased 21% by Mn-SOD. The apo/Mn also promoted nitration, but the ape and the zinc-substituted apoenzyme (apo/Zn) enzymes did not. The extent of tyrosine nitration in the enzyme was also affected by the presence and nature (i.e. manganese or zinc) of the metal center in the active site. For comparative purposes, we also studied the reaction of peroxynitrite with low molecular weight complexes of manganese and zinc with tetrakis-(4-benzoic acid) porphyrin (tbap). Mn(tbap) reacts with peroxynitrite with a rate constant of 6.8 +/- 0.1 x 10(4) M-1 s(-1) and maximally increases nitration yields by 350%. Zn(tbap), on the other hand, affords protection against nitration. Our results indicate that the manganese ion in Mn-SOD plays an important role in the decomposition kinetics of peroxynitrite and in peroxynitrite-dependent nitration of self and remote tyrosine residues.	Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; Univ Colorado, Webb Waring Lung Inst, Denver, CO 80262 USA; Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Ctr Free Rad Res, Birmingham, AL 35233 USA	Universidad de la Republica, Uruguay; University of Colorado System; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Av Gen Flores 2125, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy	McCord, Joe/GWU-8607-2022; Hernandez-Saavedra, Daniel/AGO-1286-2022; Freeman, Bruce A/H-9342-2012	Hernandez-Saavedra, Daniel/0000-0003-1449-944X	FIC NIH HHS [R03-TW0099] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; BECK Y, 1987, NUCLEIC ACIDS RES, V15, P9076, DOI 10.1093/nar/15.21.9076; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221; BEYER WF, 1989, BIOCHEMISTRY-US, V28, P4403, DOI 10.1021/bi00436a042; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; Brito C, 1999, J IMMUNOL, V162, P3356; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; COTTON FA, 1988, QUIMIKCA INORGANIC A; Crapo J D, 1978, Methods Enzymol, V53, P382; Crow JP, 1999, ARCH BIOCHEM BIOPHYS, V371, P41, DOI 10.1006/abbi.1999.1414; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V328, P208, DOI 10.1006/abbi.1996.0162; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Ferrer-Sueta G, 1997, CHEM RES TOXICOL, V10, P1338, DOI 10.1021/tx970116h; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; FLORE L, 1987, METHOD ENZYMOL, V105, P93; FLORIS R, 1993, EUR J BIOCHEM, V215, P767, DOI 10.1111/j.1432-1033.1993.tb18091.x; Gao BF, 1996, GENE, V176, P269, DOI 10.1016/0378-1119(96)00246-6; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; GROVES JT, 1995, J AM CHEM SOC, V117, P9578, DOI 10.1021/ja00142a032; HO YS, 1988, FEBS LETT, V229, P256, DOI 10.1016/0014-5793(88)81136-0; HUGH, 1968, J CHEM SOC, P450; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KRALL J, 1988, J BIOL CHEM, V263, P1910; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu RG, 2000, FREE RADICAL BIO MED, V28, P1197, DOI 10.1016/S0891-5849(00)00237-9; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; MARKLUND S, 1978, INT J BIOCHEM, V9, P299, DOI 10.1016/0020-711X(78)90101-5; MARRES CAM, 1985, EUR J BIOCHEM, V147, P153, DOI 10.1111/j.1432-1033.1985.tb08731.x; MATSUDA Y, 1990, EUR J BIOCHEM, V194, P713, DOI 10.1111/j.1432-1033.1990.tb19461.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Omar B, 1991, OXIDATIVE STRESS OXI, P493; OSE DE, 1976, J BIOL CHEM, V251, P1217; OSE DE, 1979, ARCH BIOCHEM BIOPHYS, V194, P360, DOI 10.1016/0003-9861(79)90628-3; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Ramezanian MS, 1996, CHEM RES TOXICOL, V9, P232, DOI 10.1021/tx950135w; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; THOMSON L, 1995, ARCH BIOCHEM BIOPHYS, V319, P491, DOI 10.1006/abbi.1995.1321; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; WEISIGER RA, 1973, J BIOL CHEM, V248, P3582; WENDEL A, 1991, OXIDATIVE STRESS OXI, P585; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	60	165	176	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11631	11638		10.1074/jbc.M009429200	http://dx.doi.org/10.1074/jbc.M009429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152462	hybrid			2022-12-27	WOS:000168081800030
J	Zoraghi, R; Kunz, S; Gong, KW; Seebeck, T				Zoraghi, R; Kunz, S; Gong, KW; Seebeck, T			Characterization of TbPDE2A, a novel cyclic nucleotide-specific phosphodiesterase from the protozoan parasite Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CGMP-SPECIFIC PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE; AMP PHOSPHODIESTERASE; AFRICAN TRYPANOSOMES; ADENYLATE-CYCLASE; MOLECULAR-CLONING; GENE FAMILY; EXPRESSION; BINDING; DIFFERENTIATION	This study reports the identification and characterization of a cAMP-specific phosphodiesterase from the parasitic hemoflagellate Trypanosoma brucei, TbPDE2A is a class I phosphodiesterase, Its catalytic domain exhibits 30-40% sequence identity with those of all 11 mammalian phosphodiesterase (PDE) families, as well as with PDE2 from Saccharomyces cerevisiae, dunce from Drosophila melanogaster, and regA from Dictyostelium discoideum. The overall structure of TbPDE2A resembles that of human PDE11A in that its N-terminal region contains a single GAF domain. This domain is very similar to those of the mammalian PDE2, -5, -6, -10, and -11, where it constitutes a potential cGMP binding site. TbPDE2A can be expressed in S. cerevisiae, and it complements an S, cerevisiae PDE deletion strain. Recombinant TbPDE2A is specific for cAMP, with a K-m of similar to2 muM. It is entirely resistant to the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine, but it is sensitive to trequinsin, dipyridamole, sildenafil, and ethaverine with IC50 values of 5.4, 5.9, 9.4, and 14.2 muM, respectively. All four compounds inhibit proliferation of bloodstream form trypanosomes in culture, indicating that TbPDE2A is an essential enzyme.	Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	University of Bern	Seebeck, T (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	thomas.seebeck@izb.unibe.ch						Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; ALEXANDRE S, 1990, MOL BIOCHEM PARASIT, V43, P279, DOI 10.1016/0166-6851(90)90152-C; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Atienza JM, 1998, METHODS, V14, P35, DOI 10.1006/meth.1997.0563; Barnette M S, 1999, Prog Drug Res, V53, P193; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bielekova B, 2000, J IMMUNOL, V164, P1117, DOI 10.4049/jimmunol.164.2.1117; BODLEY AL, 1995, J INFECT DIS, V172, P1157, DOI 10.1093/infdis/172.4.1157; BRUN R, 1979, ACTA TROP, V36, P289; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; Clayton C, 1998, MOL BIOCHEM PARASIT, V97, P221, DOI 10.1016/S0166-6851(98)00115-7; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; Doherty AM, 1999, CURR OPIN CHEM BIOL, V3, P466, DOI 10.1016/S1367-5931(99)80068-4; DRYIA TP, 1996, NAT GENET, V13, P358; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; HESSE F, 1995, MOL BIOCHEM PARASIT, V70, P157, DOI 10.1016/0166-6851(95)00027-X; HOYER LL, 1994, MICROBIOL-UK, V140, P1533, DOI 10.1099/13500872-140-7-1533; Jacobitz S, 1997, MOL PHARMACOL, V51, P999, DOI 10.1124/mol.51.6.999; KIELY PDW, 1995, EUR J IMMUNOL, V25, P2899, DOI 10.1002/eji.1830251029; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; Langtry HD, 1999, DRUGS, V57, P967, DOI 10.2165/00003495-199957060-00015; McAllisterLucas LM, 1995, J BIOL CHEM, V270, P30671, DOI 10.1074/jbc.270.51.30671; Moreland RB, 1998, LIFE SCI, V62, pPL309, DOI 10.1016/S0024-3205(98)00158-1; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MURPHY NB, 1987, J MOL BIOL, V195, P855, DOI 10.1016/0022-2836(87)90490-6; Naula C, 2000, PARASITOL TODAY, V16, P35, DOI 10.1016/S0169-4758(99)01582-3; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; PAVETO C, 1995, J BIOL CHEM, V270, P16576, DOI 10.1074/jbc.270.28.16576; Pays Etienne, 1997, P199; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; PILLAI R, 1993, P NATL ACAD SCI USA, V90, P11970, DOI 10.1073/pnas.90.24.11970; Rascon A, 2000, MOL BIOCHEM PARASIT, V106, P283, DOI 10.1016/S0166-6851(99)00224-8; REED SL, 1985, INFECT IMMUN, V49, P844, DOI 10.1128/IAI.49.3.844-847.1985; Rieckmann P, 1996, J NEUROIMMUNOL, V64, P193, DOI 10.1016/0165-5728(95)00176-X; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; SCHILLING RJ, 1994, ANAL BIOCHEM, V216, P154, DOI 10.1006/abio.1994.1019; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; SEEBECK T, 1999, NOVA ACT LEOPOLD, V78, P227; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Spina D, 1998, ADV PHARMACOL, V44, P33, DOI 10.1016/S1054-3589(08)60125-8; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; Valverde D, 1996, HUM GENET, V97, P35; Vassella E, 1997, J CELL SCI, V110, P2661; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; WALTER RD, 1982, MOL BIOCHEM PARASIT, V6, P287, DOI 10.1016/0166-6851(82)90061-5; WANG Y, 1991, MOL PHARMACOL, V40, P750; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822	54	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11559	11566		10.1074/jbc.M005419200	http://dx.doi.org/10.1074/jbc.M005419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134002	hybrid			2022-12-27	WOS:000168081800021
J	Ghosh, AK; Yuan, WH; Mori, Y; Chen, SJ; Varga, J				Ghosh, AK; Yuan, WH; Mori, Y; Chen, SJ; Varga, J			Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta - Integration at the level of p300/CBP transcriptional coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKIN FIBROBLASTS; NECROSIS-FACTOR-ALPHA; ACTIVATOR INHIBITOR-1 GENE; HUMAN DERMAL FIBROBLASTS; CBP-INDUCED STIMULATION; TGF-BETA; SMAD PROTEINS; MESSENGER-RNA; SIGNALING PATHWAYS; COL1A2 PROMOTER	Among the extracellular signals that modulate the synthesis of collagen, transforming growth factor-beta (TGF-beta) and interferon-gamma (IFN-gamma) are preeminent. These two cytokines exert antagonistic effects on fibroblasts, and play important roles in the physiologic regulation of extracellular matrix turnover. We have shown previously that in normal skin fibroblasts, TGF-beta positively regulates alpha2(I) procollagen gene (COL1A2) promoter activity through the cellular Smad signal transduction pathway. In contrast, IFN-gamma activates Stat1 alpha, down-regulates COL1A2 transcription, and abrogates its stimulation induced by TGF-beta, The level of integration of the two pathways mediating antagonistic collagen regulation is unknown. We now report that IFN-gamma abrogates TGF-beta -stimulated COL1A2 transcription in fibroblasts by inhibiting Smad activities. IFN-gamma appears to induce competition between activated Stat1 alpha and Smad3 for interaction with limiting amounts of cellular p300/CBP, Overexpression of p300 restored COL1A2 stimulation by TGF-beta in the presence of IFN-gamma, and potentiated IFN-beta -dependent positive transcriptional responses. In contrast to fibroblasts, in U4A cells lacking Jak1 and consequently unable to activate Stat1 alpha -mediated responses, IFN-gamma failed to repress TGF-beta -induced transcription. These results indicate that as essential coactivators for both Smad3 and Stat1 alpha, nuclear p300/CBP integrate signals that positively or negatively regulate COL1A2 transcription. The findings implicate a novel mechanism to account for antagonistic interaction of Smad and Jak-Stat pathways in regulation of target genes. In fibroblasts responding to cytokines with opposing effects on collagen transcription, the relative levels of cellular coactivators, and their interaction with regulated transcription factors, may govern the net effect.	Univ Illinois, Coll Med, Rheumatol Sect, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Varga, J (corresponding author), Univ Illinois, Coll Med, Rheumatol Sect, M-C 733,1158 Mol Biol Res Bldg,900 S Ashland Ave, Chicago, IL 60607 USA.				NIAMS NIH HHS [AR42309, AR46390] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR046390, R01AR042309] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bannister AJ, 1995, ONCOGENE, V11, P2509; BAUVOIS B, 1992, J IMMUNOL, V148, P3912; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bitzer M, 2000, GENE DEV, V14, P187; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Higashi K, 1998, MATRIX BIOL, V16, P447, DOI 10.1016/S0945-053X(98)90016-6; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MOSES H, 1992, J IMMUNOL, V148, P3642; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; VARGA J, 1990, EUR J CLIN INVEST, V20, P487, DOI 10.1111/j.1365-2362.1990.tb01915.x; Venkataraman C, 1999, J IMMUNOL, V162, P4053; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yuan WH, 1999, J CELL PHYSIOL, V179, P97, DOI 10.1002/(SICI)1097-4652(199904)179:1<97::AID-JCP12>3.3.CO;2-5; Yuan WH, 1998, J CELL PHYSIOL, V177, P174, DOI 10.1002/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D; YUFIT T, 1995, J INVEST DERMATOL, V105, P388, DOI 10.1111/1523-1747.ep12320990; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	69	199	217	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11041	11048		10.1074/jbc.M004709200	http://dx.doi.org/10.1074/jbc.M004709200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134049	hybrid, Green Submitted			2022-12-27	WOS:000167980900064
J	Hung, HL; Kim, AY; Hong, W; Rakowski, C; Blobel, GA				Hung, HL; Kim, AY; Hong, W; Rakowski, C; Blobel, GA			Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; TRANSCRIPTION FACTOR GATA-1; PORPHOBILINOGEN DEAMINASE GENE; HEMATOPOIETIC TRANSCRIPTION; IN-VITRO; HISTONE ACETYLTRANSFERASES; CHROMATIN STRUCTURE; ERYTHROID-CELLS; WW DOMAINS	The hematopoietic transcription factor NF-E2 is an important regulator of erythroid and megakaryocytic gene expression, The transcription cofactor cAMP-response element-binding protein (CREB)-binding protein (CEP) has previously been implicated in mediating NF-E2 function. In this report, we examined the role of CBP, a coactivator with intrinsic acetyltransferase activity, in the regulation of NF-E2, We found that both the hematopoietic-specific subunit of NF-E2, p45, and the widely expressed small subunit, MafG, interact with CBP in vitro and in vivo. CBP acetylates MafG;, but not p45, predominantly in the basic region of MafG. Immunoprecipitation experiments with anti acetyl lysine antibodies demonstrate that MafG is acetylated in vivo in erythroid cells. Transfection experiments further show that CBP stimulates MafG acetylation in intact cells in an E1A sensitive manner. Acetylation of MafG augments DNA binding activity of NF-E2, and mutations at the major acetylation sites markedly reduce DNA binding and transcriptional activation by NF-E2. Together, these results suggest that recruitment of CBP by NF-E2 to specific erythroid/megakaryocytic promoters might regulate transcription by at least two mechanisms involving both modification of chromatin structure and modulation of transcription factor activity.	Childrens Hosp Philadelphia, Abramson Pediat Res Ctr 316A, Div Hematol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Blobel, GA (corresponding author), Childrens Hosp Philadelphia, Abramson Pediat Res Ctr 316A, Div Hematol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [1RO1DK54937, 1F32DK10027] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054937, F32DK010027] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amrolia PJ, 1997, P NATL ACAD SCI USA, V94, P10051, DOI 10.1073/pnas.94.19.10051; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; Blank V, 1997, BLOOD, V89, P3925, DOI 10.1182/blood.V89.11.3925; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Cheng XB, 1997, MOL CELL BIOL, V17, P1407, DOI 10.1128/MCB.17.3.1407; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Elnitski L, 1997, J BIOL CHEM, V272, P369; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Forsberg EC, 1999, J BIOL CHEM, V274, P26850, DOI 10.1074/jbc.274.38.26850; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Gong QH, 1996, MOL CELL BIOL, V16, P6055; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hung HL, 1999, MOL CELL BIOL, V19, P3496; IGARASHI K, 1995, J BIOL CHEM, V270, P7615, DOI 10.1074/jbc.270.13.7615; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Liu L, 1999, MOL CELL BIOL, V19, P1202; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mosser EA, 1998, BIOCHEMISTRY-US, V37, P13686, DOI 10.1021/bi981310l; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schubeler D, 2000, GENE DEV, V14, P940; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	48	71	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10715	10721		10.1074/jbc.M007846200	http://dx.doi.org/10.1074/jbc.M007846200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154691	hybrid			2022-12-27	WOS:000167980900022
J	Mirnikjoo, B; Brown, SE; Kim, HFS; Marangell, LB; Sweatt, JD; Weeber, EJ				Mirnikjoo, B; Brown, SE; Kim, HFS; Marangell, LB; Sweatt, JD; Weeber, EJ			Protein kinase inhibition by omega-3 fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; AGE-RELATED-CHANGES; DOCOSAHEXAENOIC ACID; ELECTROCONVULSIVE SHOCK; EICOSAPENTAENOIC ACID; LEARNING-ABILITY; BIPOLAR DISORDER; RAT HIPPOCAMPUS; CYCLIC-AMP; BRAIN	Recent data suggest that omega -3 fatty acids may be effective in epilepsy, cardiovascular disorders, arthritis, and as mood stabilizers for bipolar disorder; however, the mechanism of action of these compounds is unknown. Based oh earlier studies implicating omega -3 fatty acids as inhibitors of protein kinase C activity in intact cells, we hypothesized that omega -3 fatty acids may act through direct inhibition of second messenger-regulated kinases and sought to determine whether the omega -3 double bond might uniquely confer pharmacologic efficacy and potency for fatty acids of this type. In our studies we observed that omega -3 fatty acids inhibited the in vitro activities of cAMP-dependent protein kinase, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and the mitogen-activated protein kinase (MAPK), Our results with a series of long-chain fatty acid structural homologs suggest an important role for the omega -3 double bond in conferring inhibitory efficacy. To assess whether omega -3 fatty acids were capable of inhibiting protein kinases in living neurons, we evaluated their effect on signal transduction pathways in the hippocampus. We found that omega -3 fatty acids could prevent serotonin receptor-induced MAPK activation in hippocampal slice preparations, In addition, we evaluated the effect of omega -3 fatty acids on hippocampal long-term potentiation, a form of synaptic plasticity known to be dependent on protein kinase activation. We observed that omega -3 fatty acids blocked long-term potentiation induction without inhibiting basal synaptic transmission. Overall, our results from both in vitro and live cell preparations suggest that inhibition of second messenger-regulated protein kinases is one locus of action of omega -3 fatty acids.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Weeber, EJ (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.	eweeber@cns.bcm.tmc.edu	Weeber, Edwin J/A-5396-2012	Sweatt, J. David/0000-0003-3567-485X				ANDERSON GJ, 1990, PEDIATR RES, V27, P89, DOI 10.1203/00006450-199001000-00023; Bazan N G, 1989, Prog Clin Biol Res, V312, P95; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BAZAN NG, 1970, LIFE SCI, V9, P501, DOI 10.1016/0024-3205(70)90205-5; BAZAN NG, 1990, UPSALA J MED SCI, P97; BOURRE JM, 1990, BIOCHIM BIOPHYS ACTA, V1043, P149, DOI 10.1016/0005-2760(90)90288-9; Chen HM, 1999, INVEST OPHTH VIS SCI, V40, P2418; CHENG G, 1994, BRAIN RES, V646, P230, DOI 10.1016/0006-8993(94)90083-3; Delion S, 1997, J LIPID RES, V38, P680; Engler MB, 1999, AM J HYPERTENS, V12, P1225, DOI 10.1016/S0895-7061(99)90060-2; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; HARDY SJ, 1994, J NEUROCHEM, V62, P1546; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hilty DM, 2000, J NEUROPSYCH CLIN N, V12, P283, DOI 10.1176/appi.neuropsych.12.2.283-a; HOLIAN O, 1992, ANTICANCER RES, V12, P975; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; INAGAKI M, 1986, MOL PHARMACOL, V29, P577; Itokazu N, 2000, BRAIN RES, V862, P211, DOI 10.1016/S0006-8993(00)02129-6; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McGahon B, 1997, NEUROSCIENCE, V81, P9, DOI 10.1016/S0306-4522(97)00116-4; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Nanjo A, 1999, J NUTR SCI VITAMINOL, V45, P633, DOI 10.3177/jnsv.45.633; NISHIKAWA M, 1994, J PHYSIOL-LONDON, V475, P83, DOI 10.1113/jphysiol.1994.sp020051; PEPE S, 1994, P NATL ACAD SCI USA, V91, P8832, DOI 10.1073/pnas.91.19.8832; POLING JS, 1995, MOL PHARMACOL, V47, P381; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; Richardson AJ, 1999, INT J PSYCHOPHYSIOL, V34, P333, DOI 10.1016/S0167-8760(99)00090-2; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; SPEIZER LA, 1991, AM J PHYSIOL, V261, pE109, DOI 10.1152/ajpendo.1991.261.1.E109; Stoll AL, 1999, ARCH GEN PSYCHIAT, V56, P407, DOI 10.1001/archpsyc.56.5.407; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TAYLOR SS, 1993, RECEPTOR, V3, P165; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6; Young C, 1998, NEUROSCI LETT, V247, P198, DOI 10.1016/S0304-3940(98)00272-9; Young G, 1998, MED PEDIATR ONCOL, V30, P117, DOI 10.1002/(SICI)1096-911X(199802)30:2<117::AID-MPO9>3.0.CO;2-L; Zimmer L, 2000, J LIPID RES, V41, P32	42	136	143	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10888	10896		10.1074/jbc.M008150200	http://dx.doi.org/10.1074/jbc.M008150200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152679	hybrid			2022-12-27	WOS:000167980900045
J	Hunsucker, SA; Spychala, J; Mitchell, BS				Hunsucker, SA; Spychala, J; Mitchell, BS			Human cytosolic 5 '-nucleotidase I - Characterization and role in nucleoside analog resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE FORMATION; CELL-LINES; SOLUBLE 5'-NUCLEOTIDASE; PIGEON HEART; CANCER CELL; RAT-HEART; NUCLEOTIDE; AMP; PURIFICATION; GEMCITABINE	Nucleoside analogs are important in the treatment of hematologic malignancies, solid tumors, and viral infections. Their metabolism to the triphosphate form is central to their chemotherapeutic efficacy. Although the nucleoside kinases responsible for the phosphorylation of these compounds have been well described, the nucleotidases that may mediate drug resistance through dephosphorylation remain obscure, We have cloned and characterized a novel human cytosolic 5 ' -nucleotidase (cN-I) that potentially may have an important role in nucleoside analog metabolism. It is expressed at a high level in skeletal and heart muscle, at an intermediate level in pancreas and brain, and at a low level in kidney, testis, and uterus, The recombinant cN-I showed high affinity toward dCMP and lower affinity toward AMP and IMP, ADP was necessary for maximal catalytic activity. Expression of cN-I in Jurkat and HEK 293 cells conferred resistance to 2-chloro-2 ' -deoxyadenosine, with a 49-fold increase in the IC50 in HEK 293 and a greater than 400-fold increase in the IC50 in Jurkat cells. Expression of cN-I also conferred a 22-fold increase in the IC50 to 2 ' ,3 ' -difluorodeoxycytidine in HEK 293 cells and an 82-fold increase in the IC50 to 2 ' ,3 ' -dideoxycytidine in Jurkat cells. These data indicate that cN-I may play an important role in the regulation of physiological pyrimidine nucleotide pools and may also alter the therapeutic efficacy of certain nucleoside analogs.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Spychala, J (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA.			Hunsucker, Sally/0000-0002-7034-7355	NATIONAL CANCER INSTITUTE [R01CA034085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER; NCI NIH HHS [2R01CA034085-18] Funding Source: Medline; NIGMS NIH HHS [5T32GM07040-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Brito RA, 1999, ONCOLOGY-BASEL, V57, P2, DOI 10.1159/000055262; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; CARSON DA, 1991, BIOCHIM BIOPHYS ACTA, V1091, P22, DOI 10.1016/0167-4889(91)90216-K; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; DARVISH A, 1993, AM J PHYSIOL, V264, pH1528; Garvey EP, 1998, BIOCHEMISTRY-US, V37, P9043, DOI 10.1021/bi980209d; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; Grant S, 1998, ADV CANCER RES, V72, P197; Hapke DM, 1996, CANCER RES, V56, P2343; HE MX, 1992, J MOL CELL CARDIOL, V24, P79, DOI 10.1016/0022-2828(92)91161-W; HEADRICK JP, 1989, BIOCHEM J, V261, P541, DOI 10.1042/bj2610541; JENNINGS RB, 1985, ANNU REV PHYSIOL, V47, P727, DOI 10.1146/annurev.ph.47.030185.003455; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; MARSZALEK J, 1989, COMPUT APPL BIOSCI, V5, P239; MULLANE K, 1995, J MOL CELL CARDIOL, V27, P1041, DOI 10.1016/0022-2828(95)90073-X; NEWBY AC, 1988, BIOCHEM J, V253, P123, DOI 10.1042/bj2530123; NEWBY AC, 1984, TRENDS BIOCHEM SCI, V9, P42, DOI 10.1016/0968-0004(84)90176-2; OKA J, 1994, BIOCHEM BIOPH RES CO, V205, P917, DOI 10.1006/bbrc.1994.2752; PLAGEMANN PGW, 1989, MOL PHARMACOL, V36, P185; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; Rofstad EK, 2000, INT J RADIAT BIOL, V76, P589, DOI 10.1080/095530000138259; Sala-Newby GB, 1999, J BIOL CHEM, V274, P17789, DOI 10.1074/jbc.274.25.17789; Sala-Newby GB, 2000, J BIOL CHEM, V275, P11666, DOI 10.1074/jbc.275.16.11666; Schirmer M, 1998, EXP HEMATOL, V26, P1223; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Skladanowski AC, 1996, AM J PHYSIOL-HEART C, V270, pH1493, DOI 10.1152/ajpheart.1996.270.4.H1493; SKLADANOWSKI AC, 1990, BIOCHEM J, V268, P117, DOI 10.1042/bj2680117; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; TRUONG VL, 1988, BIOCHEM J, V253, P117, DOI 10.1042/bj2530117; van Moorsel CJA, 1999, BRIT J CANCER, V80, P981, DOI 10.1038/sj.bjc.6690452; YAMAZAKI Y, 1991, BIOCHEMISTRY-US, V30, P1503, DOI 10.1021/bi00220a009	36	95	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10498	10504		10.1074/jbc.M011218200	http://dx.doi.org/10.1074/jbc.M011218200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133996	hybrid			2022-12-27	WOS:000167996400118
J	Xiong, GM; Maser, E				Xiong, GM; Maser, E			Regulation of the steroid-inducible 3 alpha-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PSEUDOMONAS-TESTOSTERONI; MOLECULAR-CLONING; DELTA-5-3-KETOSTEROID ISOMERASE; ANTIBIOTIC-RESISTANCE; TYROSINE RESIDUES; EXPRESSION; PROTEIN; OVEREXPRESSION; SUPERFAMILY	The Comamonas testosteroni 3 alpha -hydroxysteroid dehydrogenase/carbonyl reductase gene (hsdA) codes for an adaptive enzyme in the degradation of steroid compounds. However, no information was available on the molecular regulation of steroid-inducible genes nor on the mechanism of steroid signaling in procaryotes. We, therefore, investigated the cis- and trans-acting elements of hsdA expression to infer the mechanism of its molecular regulation by steroids. The gene was localized on a 5.257-kilobase EcoRI fragment of C, testosteroni chromosomal DNA. The promoter was characterized, and the transcriptional start site was identified. Two palindromic operator domains were found upstream of hsdA, A new gene coding for a trans-acting negative regulator (repressor A, RepA) of hsdA expression was characterized. The specific interaction between RepA, testosterone, and the operator domain is demonstrated. From our results we conclude that hsdA is under negative transcriptional control by an adjacent gene product (RepA), Accordingly, induction of hsdA by steroids in fact is a derepression, where steroidal inducers bind to the repressor, thereby preventing its binding to the hsdA operator.	Univ Marburg, Sch Med, Dept Pharmacol & Toxicol, D-35033 Marburg, Germany	Philipps University Marburg	Maser, E (corresponding author), Univ Marburg, Sch Med, Dept Pharmacol & Toxicol, Karl von Frisch Str 1, D-35033 Marburg, Germany.							Arai H, 1999, MOL MICROBIOL, V33, P1132, DOI 10.1046/j.1365-2958.1999.01554.x; BAKER ME, 1995, P SOC EXP BIOL MED, V208, P131; BAKER ME, 1992, CAN J MICROBIOL, V38, P541, DOI 10.1139/m92-089; BARBARO DJ, 1987, REV INFECT DIS, V9, P124; CHENG KC, 1991, MOL ENDOCRINOL, V5, P823, DOI 10.1210/mend-5-6-823; COULTER AW, 1968, J BIOL CHEM, V243, P3238; Florin C, 1996, J BACTERIOL, V178, P3322, DOI 10.1128/jb.178.11.3322-3330.1996; FUJITA Y, 1987, P NATL ACAD SCI USA, V84, P4524, DOI 10.1073/pnas.84.13.4524; GARCIAVALDES E, 1988, APPL ENVIRON MICROB, V54, P2478; GENTIRAIMONDI S, 1991, GENE, V105, P43, DOI 10.1016/0378-1119(91)90512-A; GENUS JMC, 1977, PHYTOCHEMISTRY, V17, P1; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KULIOPULOS A, 1987, P NATL ACAD SCI USA, V84, P8893, DOI 10.1073/pnas.84.24.8893; LENARD J, 1992, TRENDS BIOCHEM SCI, V17, P147, DOI 10.1016/0968-0004(92)90323-2; LEPPIK RA, 1987, BIOCHEM J, V423, P15; LI YK, 1993, BIOCHEMISTRY-US, V32, P1816, DOI 10.1021/bi00058a016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD IA, 1976, BIOCHIM BIOPHYS ACTA, V450, P142, DOI 10.1016/0005-2760(76)90086-2; MACDONALD IA, 1979, APPL ENVIRON MICROB, V37, P992, DOI 10.1128/AEM.37.5.992-1000.1979; MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990; MARCUS PI, 1956, J BIOL CHEM, V218, P661; MASER E, 1992, FEBS LETT, V297, P196, DOI 10.1016/0014-5793(92)80359-O; Mobus E, 1998, J BIOL CHEM, V273, P30888, DOI 10.1074/jbc.273.47.30888; Mobus E, 1997, J BACTERIOL, V179, P5951; Mobus E, 1999, ADV EXP MED BIOL, V463, P395; MOLNAR I, 1995, MOL MICROBIOL, V15, P895, DOI 10.1111/j.1365-2958.1995.tb02359.x; OPPERMANN UCT, 1993, ADV EXP MED BIOL, V328, P379; Oppermann UCT, 1996, J STEROID BIOCHEM, V58, P217, DOI 10.1016/0960-0760(96)00021-0; Oppermann UCT, 1996, EUR J BIOCHEM, V241, P744, DOI 10.1111/j.1432-1033.1996.00744.x; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; PLESIAT P, 1991, J BACTERIOL, V173, P7219, DOI 10.1128/jb.173.22.7219-7227.1991; Sambrook J., 2002, MOL CLONING LAB MANU; SUZUKI K, 1993, GENE, V130, P137, DOI 10.1016/0378-1119(93)90357-9; TALALAY P, 1952, NATURE, V170, P620, DOI 10.1038/170620a0; THOMAS JE, 1989, J STEROID BIOCHEM, V32, P27, DOI 10.1016/0022-4731(89)90009-5; TOMKINS GM, 1956, J BIOL CHEM, V218, P437; UWAJIMA T, 1978, AGR BIOL CHEM TOKYO, V42, P1577, DOI 10.1080/00021369.1978.10863207; WATANABE M, 1979, J STEROID BIOCHEM, V10, P207, DOI 10.1016/0022-4731(79)90237-1; WU PG, 1994, BIOCHEMISTRY-US, V33, P7415, DOI 10.1021/bi00189a048; XIONG GM, 1992, EUR J BIOCHEM, V204, P789, DOI 10.1111/j.1432-1033.1992.tb16696.x	44	54	60	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9961	9970		10.1074/jbc.M010962200	http://dx.doi.org/10.1074/jbc.M010962200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139589	hybrid			2022-12-27	WOS:000167996400053
J	Russnak, R; Konczal, D; McIntire, SL				Russnak, R; Konczal, D; McIntire, SL			A family of yeast proteins mediating bidirectional vacuolar amino acid transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR GABA TRANSPORTER; SACCHAROMYCES-CEREVISIAE; MEMBRANE-VESICLES; SYSTEM-A; GLUTAMINE TRANSPORTER; ACTIVE-TRANSPORT; THYROID-CELLS; CLONING; TYROSINE; IDENTIFICATION	Seven genes in Saccharomyces cerevisiae are predicted to code for membrane-spanning proteins (designated AVT1-7) that are related to the neuronal gamma -aminobutyric acid-glycine vesicular transporters. We have now demonstrated that four of these proteins mediate amino acid transport in vacuoles, One protein, AVT1, is required for the vacuolar uptake of large neutral amino acids including tyrosine, glutamine, asparagine, isoleucine, and leucine, Three proteins, AVT3, AVT4, and AVT6, are involved in amino acid efflux from the vacuole and, as such, are the first to be shown directly to transport compounds from the lumen of an acidic intracellular organelle, This function is consistent with the role of the vacuole in protein degradation, whereby accumulated amino acids are exported to the cytosol, Protein AVT6 is responsible for the efflux of aspartate and glutamate, an activity that would account for their exclusion from vacuoles in vivo. Transport by AVT1 and AVT6 requires ATP for function and is abolished in the presence of nigericin, indicating that the same pH gradient can drive amino acid transport in opposing directions. Efflux of tyrosine and other large neutral amino acids by the two closely related proteins, AVT3 and AVT4, is similar in terms of substrate specificity to transport system h described in mammalian lysosomes and melanosomes. These findings suggest that yeast AVT transporter function has been conserved to control amino acid flux in vacuolar-like organelles.	Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Gallo Ctr, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Russnak, R (corresponding author), Univ Calif San Francisco, Dept Neurol, Sch Med, 505 Parnassus Ave,M798, San Francisco, CA 94143 USA.	russnak@itsa.ucsf.edu						Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; ANDRE B, 1993, MOL GEN GENET, V237, P17; ANDRE B, 1990, NUCLEIC ACIDS RES, V18, P3049, DOI 10.1093/nar/18.10.3049; BERNAR J, 1986, J BIOL CHEM, V261, P7107; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; COLLARINI EJ, 1989, BIOCHIM BIOPHYS ACTA, V987, P139, DOI 10.1016/0005-2736(89)90536-1; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; HARPER GS, 1988, J BIOL CHEM, V263, P9320; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Masson J, 1999, PHARMACOL REV, V51, P439; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E; Potterf SB, 1996, J BIOL CHEM, V271, P4002; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; SATO T, 1984, J BIOL CHEM, V259, P1505; SATO T, 1984, J BIOL CHEM, V259, P1509; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; WIEMKEN A, 1974, ARCH MICROBIOL, V101, P45, DOI 10.1007/BF00455924; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	31	132	145	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23849	23857		10.1074/jbc.M008028200	http://dx.doi.org/10.1074/jbc.M008028200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11274162	hybrid			2022-12-27	WOS:000169531100084
J	Cuddeback, SM; Yamaguchi, H; Komatsu, K; Miyashita, T; Yamada, M; Wu, C; Singh, S; Wang, HG				Cuddeback, SM; Yamaguchi, H; Komatsu, K; Miyashita, T; Yamada, M; Wu, C; Singh, S; Wang, HG			Molecular cloning and characterization of Bif-1 - A novel Src homology 3 domain-containing protein that associates with Bax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PROGRAMMED CELL-DEATH; BCL-2 FAMILY MEMBERS; PROMOTES APOPTOSIS; MITOCHONDRIA; SURVIVAL; HETERODIMERIZES; TRANSLOCATION; DIMERIZATION; EXPRESSION	Bax is a proapoptotic member of the Bcl-2 protein family that commits the cell to undergo programmed cell death in response to apoptotic stimuli. To gain further insights into Bax mechanisms, we have identified a novel Bax-binding protein, termed Bif-1, by using a yeast two-hybrid cloning technique. Bif-1 is an evolutionarily conserved cytoplasmic protein that contains a predicted Src homology 3 (SH3) domain located near its C terminus but shares no significant homology with members of the Bcl-2 family. A Northern blot analysis indicates that Bif-1 is expressed in most tissues with abundant expression in heart and skeletal muscle. Bif-1 is capable of interacting with Bax as demonstrated by yeast two-hybrid, coimmunoprecipitation, and immunofluorescence studies. Induction of apoptosis in murine pre-B hematopoietic cells FL5.12 by interleukin-3 withdrawal results in increased association of Bax with Bif-1, which is accompanied by a conformational change in the Bax protein. Overexpression of Bif-1 promotes Bax conformational change, caspase activation, and apoptotic cell death in FL5.12 cells following interleukin-3 deprivation. Bif-1 thus represents a new type of regulator of Bax-mediated signaling pathways for apoptosis.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Pharmacol & Therapeut, Drug Discovery Progam, Tampa, FL 33612 USA; Imgenex Corp, San Diego, CA 92121 USA; Natl Childrens Med Res Ctr, Dept Genet, Tokyo 154, Japan	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; National Center for Child Health & Development - Japan	Wang, HG (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Pharmacol & Therapeut, Drug Discovery Progam, 12902 Magnolia Dr, Tampa, FL 33612 USA.		Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Wu, Chun-Fang/0000-0002-4973-2021				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; KORSMEYER SJ, 1999, CANCER RES, V59, P1693; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MORTON CJ, 1994, CURR BIOL, V4, P615, DOI 10.1016/S0960-9822(00)00134-2; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nishita M, 1998, EXP CELL RES, V244, P357, DOI 10.1006/excr.1998.4203; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reed J C, 1996, Behring Inst Mitt, P72; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WANG HG, 1995, J CELL BIOL, V129, P1103, DOI 10.1083/jcb.129.4.1103; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	36	134	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20559	20565		10.1074/jbc.M101527200	http://dx.doi.org/10.1074/jbc.M101527200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259440	hybrid			2022-12-27	WOS:000169135100119
J	Howe, LR; Crawford, HC; Subbaramaiah, K; Hassell, JA; Dannenberg, AJ; Brown, AMC				Howe, LR; Crawford, HC; Subbaramaiah, K; Hassell, JA; Dannenberg, AJ; Brown, AMC			PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; BETA-CATENIN; COLON-CANCER; PHYSICALLY INTERACT; SYNTHASE-2 GENE; NUCLEAR-FACTOR; CYCLIN D1; PROTEIN	The inducible prostaglandin synthase cyclooxygenase-2 (COX-2) is aberrantly expressed in intestinal tumors resulting from APC mutation, and is also transcriptionally upregulated in mouse mammary epithehial cells in response to Wnt1 expression. beta -Catenin stabilization is a consequence of both APC mutation and Wnt signaling. We have previously observed coordinate regulation of the matrilysin promoter by beta -catenin and Ets family transcription factors of the PEA3 subfamily. Here we show that while beta -catenin only weakly activates the COX-2 promoter, PEA3 family transcription factors are potent activators of COX-2 transcription. Consistent with this, PEA3 is up-regulated in Wnt1-expressing mouse mammary epithelial cells, and PEA3 factors are highly expressed in tumors from Wnt1 transgenic mice, in which Cox-2 is also up-regulated. Promoter mapping experiments suggest that the NF-PLG site in the COX-2 promoter is important for mediating PEA3 responsiveness. The NF-IL6 site is also important for COX-2 transcription in some colorectal cancer lines (Shao, J., Sheng, H., Inoue, H., Morrow, J. D., and DuBois, R. N. (2000) J, Biol; Chem 275, 33951-33956), and PEA3 factors are highly expressed in colorectal cancer cell lines. Therefore, we speculate that PEA3 factors may contribute to the upregulation of COX-2 expression resulting from both APC mutation and Wnt1 expression.	Rockefeller Univ, Strang Canc Res Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell Biol & Anat, New York, NY 10021 USA; Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L86 4K1, Canada	Rockefeller University; Cornell University; Vanderbilt University; Cornell University; McMaster University	Howe, LR (corresponding author), Rockefeller Univ, Strang Canc Res Lab, 1230 York Ave,Box 231, New York, NY 10021 USA.	lrhowe@med.cornell.edu	Crawford, Howard/A-2874-2008	Howe, Louise/0000-0002-1468-7136	NCI NIH HHS [R01 CA047207, CA47207, CA89578] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA047207, R01CA047207, R01CA089578] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Boolbol SK, 1996, CANCER RES, V56, P2556; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chan G, 1999, CANCER RES, V59, P991; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Dale TC, 1998, BIOCHEM J, V329, P209; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; Gallet A, 1998, CURR BIOL, V8, P893, DOI 10.1016/S0960-9822(07)00369-7; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Haertel-Wiesmann M, 2000, J BIOL CHEM, V275, P32046, DOI 10.1074/jbc.M000074200; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Harris RE, 2000, CANCER RES, V60, P2101; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hida T, 1998, CANCER RES, V58, P3761; Howe LR, 1999, CANCER RES, V59, P1572; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; KARGMAN SL, 1995, CANCER RES, V55, P2556; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LIU CH, 2001, IN PRESS J BIOL CHEM, V276; Majima M, 1997, JPN J PHARMACOL, V75, P105, DOI 10.1254/jjp.75.105; Masferrer JL, 2000, CANCER RES, V60, P1306; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Parrett ML, 1997, INT J ONCOL, V10, P503; Polakis P, 2000, GENE DEV, V14, P1837; Reddy BS, 2000, CANCER RES, V60, P293; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; Ristimaki A, 1997, CANCER RES, V57, P1276; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; SANO H, 1995, CANCER RES, V55, P3785; Seed MP, 1997, CANCER RES, V57, P1625; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TIANO H, 1997, P AM ASSOC CANC RES, V38, P1727; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Williams CS, 1996, GASTROENTEROLOGY, V111, P1134, DOI 10.1016/S0016-5085(96)70083-5; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Wolff H, 1998, CANCER RES, V58, P4997; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Xu LF, 2000, GENE DEV, V14, P585; Yamada M, 1999, CURR EYE RES, V19, P300, DOI 10.1076/ceyr.19.4.300.5301; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	66	104	108	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20108	20115		10.1074/jbc.M010692200	http://dx.doi.org/10.1074/jbc.M010692200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274170	hybrid			2022-12-27	WOS:000169135100059
J	Morris, CA; Tobacman, LS; Homsher, E				Morris, CA; Tobacman, LS; Homsher, E			Modulation of contractile activation in skeletal muscle by a calcium-insensitive troponin C mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN FILAMENT ACTIVATION; ACTOMYOSIN ATPASE ACTIVITY; FORCE GENERATION; TENSION DEVELOPMENT; MYOSIN SUBFRAGMENT-1; INORGANIC-PHOSPHATE; MEDIATED REGULATION; ISOMETRIC FORCE; FIBERS; BINDING	Calcium controls the level of muscle activation via interactions with the troponin complex. Replacement of the native, skeletal calcium-binding subunit of troponin, troponin C, with mixtures of functional cardiac and mutant cardiac troponin C insensitive to calcium and permanently inactive provides a novel method to alter the number of myosin cross-bridges capable of binding to the actin filament. Extraction of skeletal troponin C and replacement with functional and mutant cardiac troponin C were used to evaluate the relationship between the extent of thin filament activation (fractional calcium binding), isometric force, and the rate of force generation in muscle fibers independent of the calcium concentration. The experiments showed a direct, linear relationship between force and the number of cross-bridges attaching to the thin filament. Further, above 35% maximal isometric activation, following partial replacement with mixtures of cardiac and mutant troponin C, the rate of force generation was independent of the number of actin sites available for cross-bridge interaction at saturating calcium concentrations. This contrasts with the marked decrease in the rate of force generation when force was reduced by decreasing the calcium concentration. The results are consistent with hypotheses proposing that calcium controls the transition between weakly and strongly bound cross-bridge states.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52252 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52252 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa; University of Iowa	Morris, CA (corresponding author), Univ Penn, Penn Muscle Inst, Dept Physiol, Philadelphia, PA 19104 USA.				NHLBI NIH HHS [HL38834] Funding Source: Medline; NIAMS NIH HHS [AR-30988] Funding Source: Medline; NIGMS NIH HHS [GM08496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038834, R01HL038834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030988] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Araujo A, 1996, BIOPHYS J, V70, P2316, DOI 10.1016/S0006-3495(96)79797-7; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; BRANDT PW, 1984, J MOL BIOL, V180, P379, DOI 10.1016/S0022-2836(84)80010-8; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Butters CA, 1997, J BIOL CHEM, V272, P13196, DOI 10.1074/jbc.272.20.13196; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHALOVICH JM, 1992, PHARMACOL THERAPEUT, V55, P95, DOI 10.1016/0163-7258(92)90013-P; CHASE PB, 1994, BIOPHYS J, V67, P1994, DOI 10.1016/S0006-3495(94)80682-4; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FORTUNE NS, 1994, J PHYSIOL-LONDON, V474, P283, DOI 10.1113/jphysiol.1994.sp020021; GIULIAN GG, 1983, ANAL BIOCHEM, V129, P277, DOI 10.1016/0003-2697(83)90551-1; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRABAREK Z, 1983, J BIOL CHEM, V258, P4098; GREASER ML, 1973, J BIOL CHEM, V248, P2125; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; Huynh Q, 1996, BIOPHYS J, V70, P1447, DOI 10.1016/S0006-3495(96)79704-7; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MEHEGAN JP, 1991, J BIOL CHEM, V266, P966; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; METZGER JM, 1990, SCIENCE, V247, P1088, DOI 10.1126/science.2309121; METZGER JM, 1991, J GEN PHYSIOL, V98, P233, DOI 10.1085/jgp.98.2.233; MILLAR NC, 1990, J BIOL CHEM, V265, P20234; Morris CA, 1998, BIOPHYS J, V74, pA347; MOSS RL, 1986, J BIOL CHEM, V261, P6096; MOSS RL, 1986, J GEN PHYSIOL, V87, P761, DOI 10.1085/jgp.87.5.761; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; Tesi C, 2000, BIOPHYS J, V78, P3081, DOI 10.1016/S0006-3495(00)76845-7; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VIBERT P, 1997, J MOL BIOL, V265, P8; Wahr PA, 1999, BIOPHYS J, V76, P2166, DOI 10.1016/S0006-3495(99)77371-6; WALKER JW, 1992, J BIOL CHEM, V267, P2459; WOLFF MR, 1995, CIRC RES, V76, P154, DOI 10.1161/01.RES.76.1.154; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; YATES LD, 1993, J MUSCLE RES CELL M, V14, P392, DOI 10.1007/BF00121290	45	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20245	20251		10.1074/jbc.M007371200	http://dx.doi.org/10.1074/jbc.M007371200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262388	hybrid			2022-12-27	WOS:000169135100079
J	Tan, JEL; Wong, SC; Gan, SKE; Xu, SL; Lam, KP				Tan, JEL; Wong, SC; Gan, SKE; Xu, SL; Lam, KP			The adaptor protein BLNK is required for B cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; X-LINKED AGAMMAGLOBULINEMIA; MEDIATED ACTIVATION; PHOSPHOLIPASE C-GAMMA-2; CUTTING EDGE; BCL-X; SIGNAL-TRANSDUCTION; SH2 DOMAIN; EXPRESSION; MICE	B lymphocytes lacking the adaptor protein B cell linker (BLNK) do not proliferate in response to B cell antigen receptor (BCR) engagement. We demonstrate here that BCR-activated BLNK-/- B cells fail to enter the cell cycle, and this is due to their inability to induce the expression of the cell cycle regulatory proteins such as cyclin D2 and cyclin-dependent kinase 4. BCR-stimulated BLNK-/- B cells also do not up-regulate the cell survival protein Bcl-x(L), which may be necessary for the cells to complete the cell cycle. In addition, BLNK-/- B cells exhibit a high rate of spontaneous apoptosis in culture. Examination of the various BCR-activated signaling pathways in mouse BLNK-/- B cells reveals the intact activation of Akt and mitogen-activated protein kinases but the impaired activation of nuclear factor (NF)-kappaB that is known to regulate genes involved in cell proliferation and survival. The inability to activate NF-kappaB in BCR-stimulated BLNK-/- B cells is due to a failure to induce the degradation of the inhibitory kappaB protein. In all these aspects, BLNK-/- B cells resemble xid B cells that have a mutation in Bruton's tyrosine kinase (Btk). Recently, phospholipase C (PLC)-gamma2 has also been demonstrated to be essential for NF-kappaB activation. Since BLNK has been shown separately to interact with both Btk and PLC-gamma2, our finding of normal Btk but impaired PLC-gamma2 activation in BCR-stimulated BLMK-/- B cells strongly suggests that BLNK orchestrates the formation of a Btk-PLC-gamma2 signaling axis that regulates NF-kappaB activation. Taken together, the NF-kappaB activation defect may be sufficient to explain the similar defects in BCR-induced B cell proliferation and T cell-independent immune responses in BLNK-/-, Btk(-/-), and PLC-gamma2(-/-) mice.	Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lam, KP (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.		Gan, Samuel Ken-En/AAL-4290-2021; Lam, Kong-Peng/G-5374-2012	Gan, Samuel Ken-En/0000-0001-9936-5090; Lam, Kong-Peng/0000-0002-1316-4333				Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Brorson K, 1997, J IMMUNOL, V159, P135; Buhl AM, 1999, J IMMUNOL, V162, P4438; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; Choi MSK, 1996, EUR J IMMUNOL, V26, P676, DOI 10.1002/eji.1830260325; Craxton A, 1999, ADV IMMUNOL, V73, P79, DOI 10.1016/S0065-2776(08)60786-5; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reed SI, 1997, CANCER SURV, V29, P7; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Snapper CM, 1996, J IMMUNOL, V156, P183; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Solvason N, 1998, J EXP MED, V187, P1081, DOI 10.1084/jem.187.7.1081; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tanguay DA, 1996, J IMMUNOL, V156, P539; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Xu SL, 2000, J IMMUNOL, V165, P4153, DOI 10.4049/jimmunol.165.8.4153	52	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20055	20063		10.1074/jbc.M010800200	http://dx.doi.org/10.1074/jbc.M010800200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274146	hybrid			2022-12-27	WOS:000169135100052
J	Ridgeway, AG; Skerjanc, IS				Ridgeway, AG; Skerjanc, IS			Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER FACTOR 2C; EYES-ABSENT GENE; SINE-OCULIS; MUSCLE DIFFERENTIATION; CUBITUS-INTERRUPTUS; OTHERS EXPRESSION; VERTEBRATE MUSCLE; SONIC HEDGEHOG; TARGET GENES; NEURAL-TUBE	Pax3 is a paired box transcription factor expressed during somitogenesis that has been implicated in initiating the expression of the myogenic regulatory factors during myogenesis. We find that Pax3 is necessary and sufficient to induce myogenesis in pluripotent stem cells. Pax3 induced the expression of the transcription factor Six1, its cofactor Eya2, and the transcription factor Mox1 prior to inducing the expression of MyoD and myogenin. Overexpression of a dominant negative Pax3, engineered by fusing the active transcriptional repression domain of mouse EN-2 in place of the Pax3 transcriptional activation domain, completely abolished skeletal myogenesis without inhibiting cardiogenesis. Expression of the dominant negative Pax3 resulted in a loss of expression of Six1, Eya2, and endogenous Pax3 as well as a down-regulation in the expression of Mox1. No effect was found on the expression of Gli2. These results indicate that Pax3 activity is essential for skeletal muscle development, the expression of Six1 and Eya2, and is involved in regulating its own expression. In summary, the combined approach of expressing both a wild type and dominant negative transcription factor in stem cells has identified a cascade of transcriptional events controlled by Pax3 that are necessary and sufficient for skeletal myogenesis.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Skerjanc, IS (corresponding author), Univ Western Ontario, Dept Biochem, Med Sci Bldg, London, ON N6A 5C1, Canada.	skerjanc@julian.uwo.ca	Skerjanc, Ilona/AAN-3318-2020					ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; BOBER E, 1994, DEVELOPMENT, V120, P603; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1998, DEVELOPMENT, V125, P777; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BUFFINGER N, 1995, DEV BIOL, V169, P96, DOI 10.1006/dbio.1995.1130; BUFFINGER N, 1994, DEVELOPMENT, V120, P1443; Candia AF, 1996, INT J DEV BIOL, V40, P1179; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Cossu G, 1996, DEVELOPMENT, V122, P429; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Currie PD, 1998, MECH DEVELOP, V73, P3, DOI 10.1016/S0925-4773(98)00036-7; Daston G, 1996, DEVELOPMENT, V122, P1017; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Fraisier C, 1998, GENE THER, V5, P946, DOI 10.1038/sj.gt.3300676; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Gofflot F, 1997, DEV DYNAM, V210, P431, DOI 10.1002/(SICI)1097-0177(199712)210:4<431::AID-AJA7>3.0.CO;2-H; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; GOULDING M, 1994, DEVELOPMENT, V120, P957; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Halder G, 1998, DEVELOPMENT, V125, P2181; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Lyon JJ, 1996, GENE, V182, P123, DOI 10.1016/S0378-1119(96)00531-8; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MANSOURI A, 1994, J CELL SCI, P35; MARDON G, 1994, DEVELOPMENT, V120, P3473; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P529, DOI 10.1007/BF02255843; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; Montross WT, 2000, J CELL SCI, V113, P1759; MUNSTERBERG AE, 1995, DEVELOPMENT, V121, P651; Ohto H, 1999, MOL CELL BIOL, V19, P6815; OLIVER G, 1995, DEVELOPMENT, V121, P693; Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Ridgeway AG, 1999, FEBS LETT, V456, P399, DOI 10.1016/S0014-5793(99)00993-X; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RUDNICKI MA, 1990, DEV BIOL, V138, P348, DOI 10.1016/0012-1606(90)90202-T; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SCHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574, DOI 10.1093/nar/22.22.4574; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SERIKAKU MA, 1994, GENETICS, V138, P1137; Shen WP, 1997, DEVELOPMENT, V124, P45; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Smith ST, 1996, DEVELOPMENT, V122, P3141; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Tajbakhsh S, 1997, CURR OPIN GENET DEV, V7, P634, DOI 10.1016/S0959-437X(97)80011-1; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; WILLISON K, 1990, TRENDS GENET, V6, P104, DOI 10.1016/0168-9525(90)90106-G; Wilton S, 1999, IN VITRO CELL DEV-AN, V35, P175; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xu PX, 1997, DEVELOPMENT, V124, P219	84	112	118	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19033	19039		10.1074/jbc.M011491200	http://dx.doi.org/10.1074/jbc.M011491200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262400	hybrid			2022-12-27	WOS:000169091000053
J	Swank, DM; Bartoo, ML; Knowles, AF; Iliffe, C; Bernstein, SI; Molloy, JE; Sparrow, JC				Swank, DM; Bartoo, ML; Knowles, AF; Iliffe, C; Bernstein, SI; Molloy, JE; Sparrow, JC			Alternative exon-encoded regions of Drosophila myosin heavy chain modulate ATPase rates and actin sliding velocity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MYOSIN; INDIRECT FLIGHT-MUSCLE; VITRO MOTILITY ASSAY; SMOOTH-MUSCLE; LIGHT-CHAIN; MOTOR DOMAIN; IN-VITRO; SHORTENING VELOCITY; FUNCTIONAL DOMAINS; INVITRO MOTILITY	To investigate the molecular functions of the regions encoded by alternative exons from the single Drosophila myosin heavy chain gene, we made the first kinetic measurements of two muscle myosin isoforms that differ in all alternative regions. Myosin was purified from the indirect flight muscles of wild-type and transgenic flies expressing a major embryonic isoform. The in vitro actin sliding velocity on the flight muscle isoform (6.4 mum.s(-1) at 22 degreesC) is among the fastest reported for a type II myosin and was g-fold faster than with the embryonic isoform. With smooth muscle tropomyosin bound to actin, the actin sliding velocity on the embryonic isoform increased 6-fold, whereas that on the flight muscle myosin slightly decreased. No difference in the step sizes of Drosophila and rabbit skeletal myosins were found using optical tweezers, suggesting that the slower in vitro velocity with the embryonic isoform is due to altered kinetics. Basal ATPase rates for flight muscle myosin are higher than those of embryonic and rabbit myosin. These differences explain why the embryonic myosin cannot functionally substitute in vivo for the native flight muscle isoform, and demonstrate that one or more of the five myosin heavy chain alternative exons must influence Drosophila myosin kinetics.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; San Diego State Univ, Dept Chem, San Diego, CA 92182 USA; Univ York, Dept Biol, York YO1 5YW, N Yorkshire, England	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; University of York - UK	Swank, DM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	dswank@sciences.sdsu.edu		Bernstein, Sanford/0000-0001-7094-5390; Molloy, Justin/0000-0002-8307-2450	NIGMS NIH HHS [GM32443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BERNSTEIN SI, 1983, NATURE, V302, P393, DOI 10.1038/302393a0; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bing W, 1998, J BIOL CHEM, V273, P15016, DOI 10.1074/jbc.273.24.15016; Bobkov AA, 1996, P NATL ACAD SCI USA, V93, P2285, DOI 10.1073/pnas.93.6.2285; BULLARD B, 1973, BIOCHEM J, V135, P277, DOI 10.1042/bj1350277; Chan WP, 1996, J EXP BIOL, V199, P2767; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; Dickinson MH, 1997, BIOPHYS J, V73, P3122, DOI 10.1016/S0006-3495(97)78338-3; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FALKENTHAL S, 1985, P NATL ACAD SCI USA, V82, P449, DOI 10.1073/pnas.82.2.449; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GEORGE EL, 1989, MOL CELL BIOL, V9, P2957, DOI 10.1128/MCB.9.7.2957; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREENE LE, 1978, P NATL ACAD SCI USA, V75, P54, DOI 10.1073/pnas.75.1.54; HASTINGS GA, 1991, J CELL BIOL, V114, P263, DOI 10.1083/jcb.114.2.263; HOMSHER E, 1992, AM J PHYSIOL, V262, P714; HYNES TR, 1987, CELL, V48, P953, DOI 10.1016/0092-8674(87)90704-5; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; KRONERT WA, 1991, EMBO J, V10, P2479, DOI 10.1002/j.1460-2075.1991.tb07787.x; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; LEHMAN W, 1974, J GEN PHYSIOL, V63, P553, DOI 10.1085/jgp.63.5.553; LEVINE JD, 1973, P NATL ACAD SCI USA, V70, P1050, DOI 10.1073/pnas.70.4.1050; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; LOWEY S, 1993, J BIOL CHEM, V268, P20414; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; MILLER RC, 1993, J MUSCLE RES CELL M, V14, P85, DOI 10.1007/BF00132183; Molloy J. E., 1995, Biophysical Journal, V68, P298; MOLLOY JE, 1987, NATURE, V328, P449, DOI 10.1038/328449a0; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Moore JR, 2000, BIOPHYS J, V78, P1431, DOI 10.1016/S0006-3495(00)76696-3; MOSS RL, 1986, J PHYSIOL-LONDON, V377, P487, DOI 10.1113/jphysiol.1986.sp016199; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PECKHAM M, 1990, J MUSCLE RES CELL M, V11, P203, DOI 10.1007/BF01843574; PULLMAN ME, 1967, METHOD ENZYMOL, V10, P57; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Razzaq A, 1999, J BIOL CHEM, V274, P28321, DOI 10.1074/jbc.274.40.28321; ROOT DD, 1994, BIOCHEMISTRY-US, V33, P12581, DOI 10.1021/bi00208a008; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; ROZEK CE, 1983, CELL, V32, P23, DOI 10.1016/0092-8674(83)90493-2; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Schmitz S, 2000, J MOL BIOL, V295, P1201, DOI 10.1006/jmbi.1999.3407; SELLERS JR, 1993, METHOD CELL BIOL, V39, P23, DOI 10.1016/S0091-679X(08)60159-4; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; TAKAHASHI S, 1987, ZOOL SCI, V4, P833; TAKAHASHI S, 1990, COMP BIOCHEM PHYS B, V95, P183, DOI 10.1016/0305-0491(90)90268-X; TAKIGUCHI K, 1990, J BIOCHEM-TOKYO, V107, P671, DOI 10.1093/oxfordjournals.jbchem.a123106; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Thedinga E, 1999, J MUSCLE RES CELL M, V20, P785, DOI 10.1023/A:1005658825375; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WANG F, 1993, BIOPHYS J, V64, pA359; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; WHITE DCS, 1986, J MUSCLE RES CELL M, V7, P179, DOI 10.1007/BF01753419; Zhang SX, 2001, MECH DEVELOP, V101, P35, DOI 10.1016/S0925-4773(00)00549-9	63	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15117	15124		10.1074/jbc.M008379200	http://dx.doi.org/10.1074/jbc.M008379200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11134017	hybrid			2022-12-27	WOS:000168528800079
J	Duan, RQ; Xie, W; Burghardt, RC; Safe, S				Duan, RQ; Xie, W; Burghardt, RC; Safe, S			Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; TERNARY COMPLEX FACTORS; C-FOS TRANSCRIPTION; PROTEIN-KINASE-C; GROWTH FACTOR-I; SIGNAL-TRANSDUCTION; CROSS-TALK; PROTOONCOGENE EXPRESSION; CELLULAR PROLIFERATION; GENE-TRANSCRIPTION	17 beta -Estradiol (E2) induces c-fos protooncogene expression in MCF-7 human breast cancer cells, and deletion analysis of the c-fas promoter showed that the serum response element (SRE) at -325 to -296 was E2-responsive. The mechanism of ligand-activated estrogen receptor alpha (ER alpha)-dependent activation of gene expression through the SRE was determined by mutational analysis of the promoter, analysis of mitogen-activated protein kinase (MAPK) pathway activation by E2, and transforming growth factor alpha (TGF-alpha) as a positive control. In addition, ER alpha -negative MDA-MB-231 breast cancer and Chinese hamster ovary cells were used as reference cell lines, The results showed that transcriptional activation of the SRE by E2 was due to ER alpha activation of the MAPK pathway and increased binding of the serum response factor and Elk-1 to the SRE. Subsequent studies with dominant negative Elk-1, wild type, and variant GAL4-Elk-1. fusion proteins confirmed that phosphorylation of Elk-1 at serines 383 and 389 in the C-terminal region of Elk-1 is an important downstream target associated with activation of an SRE by E2. Both E2 (ER alpha -dependent) and,growth factors (ER alpha -independent) activated the SRE in breast cancer cells via the Ras/MAPK pathway; however, in ER-negative CHO cells that do not express a receptor for TGF-alpha, only hormone-induced activation was observed in cells transfected with ER alpha.	Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	xu, huanfang/I-4315-2012; Burghardt, Robert C./AAF-4847-2021	Burghardt, Robert C./0000-0003-1021-8444	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009253, P30ES009106] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES09253, ES09106] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Bonapace IM, 1996, ONCOGENE, V12, P753; CANDELIERE GA, 1991, MOL ENDOCRINOL, V5, P1780, DOI 10.1210/mend-5-12-1780; Candeliere GA, 1996, MOL CELL BIOL, V16, P584; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen DS, 1999, MOL CELL BIOL, V19, P1002; CHO H, 1993, MOL ENDOCRINOL, V7, P441, DOI 10.1210/me.7.3.441; COHEN D R, 1989, Critical Reviews in Oncogenesis, V1, P65; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Curran T, 1988, ONCOGENE HDB, P307; Darnell JE, 1996, RECENT PROG HORM RES, V51, P391; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; DICKSON RB, 1991, BREAST, P363; DICKSON RB, 1988, BREAST CANCER CELLUL, P119; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; ETHIER SP, 1995, J NATL CANCER I, V87, P964, DOI 10.1093/jnci/87.13.964; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; INCE BA, 1994, MOL ENDOCRINOL, V8, P1397, DOI 10.1210/me.8.10.1397; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kato S, 1998, ONCOLOGY-BASEL, V55, P5, DOI 10.1159/000055253; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; LIPPMAN ME, 1989, RECENT PROG HORM RES, V45, P383; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Marino M, 1998, BIOCHEM BIOPH RES CO, V245, P254, DOI 10.1006/bbrc.1998.8413; MCDONNELL SE, 1990, MOL CELL BIOL, V10, P4284, DOI 10.1128/MCB.10.8.4284; MEYER DJ, 1993, P NATL ACAD SCI USA, V90, P6721, DOI 10.1073/pnas.90.14.6721; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; MULLER R, 1985, BIOCHIM BIOPHYS ACTA, V823, P207; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; Shaul PW, 1999, STEROIDS, V64, P28, DOI 10.1016/S0039-128X(98)00105-6; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Treisman R, 1990, Semin Cancer Biol, V1, P47; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VANDERBURG B, 1991, J STEROID BIOCHEM, V40, P215, DOI 10.1016/0960-0760(91)90185-8; VANDERBURG B, 1990, MOL ENDOCRINOL, V4, P1720, DOI 10.1210/mend-4-11-1720; VANDERBURG B, 1989, MOL CELL ENDOCRINOL, V64, P223, DOI 10.1016/0303-7207(89)90149-4; Wang Y, 1998, CELL GROWTH DIFFER, V9, P513; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; WEISZ A, 1993, CRIT REV ONCOGENESIS, V4, P361; WILDING G, 1988, CANCER RES, V48, P802	64	124	130	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11590	11598		10.1074/jbc.M005492200	http://dx.doi.org/10.1074/jbc.M005492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11145955	hybrid			2022-12-27	WOS:000168081800025
J	Park, KM; Chen, A; Bonventre, JV				Park, KM; Chen, A; Bonventre, JV			Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; INDUCED CELL-DEATH; PROTEIN-KINASE; HEAT-SHOCK; C-JUN; REPERFUSION INJURY; SIGNAL-TRANSDUCTION; PROXIMAL TUBULES; RAT-KIDNEY; STRESS	MAPK activities, including JNK, p38, and ERK, are markedly enhanced after ischemia in vivo and chemical anoxia in vitro. The relative extent of JNK, p38, or ERK activation has been proposed to determine cell fate after injury. A mouse model was established in which prior exposure to ischemia protected against a second ischemic insult imposed 8 or 15 days later, In contrast to what was observed after 30 min of bilateral ischemia, when a second period of ischemia of 30- or 35-min duration was imposed 8 days later, there was no subsequent increase in plasma creatinine, decrease in glomerular filtration rate, or increase in fractional excretion of sodium. A shorter period of prior ischemia (15 min) was partially protective against subsequent ischemic injury 8 days later. Unilateral ischemia was also protective against a subsequent ischemic insult to the same kidney, revealing that systemic uremia is not necessary for protection. The ischemia-related activation of JNK and p38 and outer medullary vascular congestion were markedly mitigated by prior exposure to ischemia, whereas preconditioning had no effect on post-ischemic activation of ERK1/2. The phosphorylation of MKK7, MKK4, and MKK3/6, upstream activators of JNK and p38, was markedly reduced by ischemic preconditioning, whereas the post-ischemic phosphorylation of MEK1/2, the upstream activator of ERK1/2, was unaffected by preconditioning. Pre- and post-ischemic HSP-25 levels were much higher in the preconditioned kidney. In summary, post-ischemic JNK and p38 (but not ERK1/2) activation was markedly reduced in a model of kidney ischemic preconditioning that was established in the mouse. The reduction in JNK and p38 activation can be accounted for by reduced activation of upstream MAPK kinases. The post-ischemic activation patterns of MAPKs may explain the remarkable protection against ischemic injury observed in this model.	Massachusetts Gen Hosp E, Med Serv, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Bonventre, JV (corresponding author), Massachusetts Gen Hosp E, Med Serv, Suite 4002,149 13th St, Charlestown, MA 02129 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, R37DK039773, R01DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS010828, P50NS010828] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38452, DK39773] Funding Source: Medline; NINDS NIH HHS [NS10828] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbate M, 1999, AM J PHYSIOL-RENAL, V277, pF454, DOI 10.1152/ajprenal.1999.277.3.F454; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bogoyevitch MA, 1996, CIRC RES, V79, P162, DOI 10.1161/01.RES.79.2.162; Brown D, 1997, AM J PHYSIOL-RENAL, V273, pF1003, DOI 10.1152/ajprenal.1997.273.6.F1003; Cochrane J, 1999, RENAL FAILURE, V21, P135, DOI 10.3109/08860229909066978; Conger J, 1997, Adv Ren Replace Ther, V4, P25; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FINN WF, 1984, J LAB CLIN MED, V103, P193; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; HONDA N, 1987, KIDNEY INT, V31, P1233, DOI 10.1038/ki.1987.136; Huot J, 1996, CANCER RES, V56, P273; Islam CF, 1997, BRIT J UROL, V79, P842, DOI 10.1046/j.1464-410X.1997.00209.x; Jefayri MK, 2000, BJU INT, V85, P1007, DOI 10.1046/j.1464-410x.2000.00678.x; Lee HT, 2000, AM J PHYSIOL-RENAL, V278, pF380, DOI 10.1152/ajprenal.2000.278.3.F380; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Meng XZ, 1999, ANN NY ACAD SCI, V874, P69, DOI 10.1111/j.1749-6632.1999.tb09226.x; MOLITORIS BA, 1992, AM J PHYSIOL, V263, pF488, DOI 10.1152/ajprenal.1992.263.3.F488; Nakano A, 2000, CIRC RES, V86, P144, DOI 10.1161/01.RES.86.2.144; POMBO CM, 1994, J BIOL CHEM, V269, P26545; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Safirstein R, 1998, SEMIN NEPHROL, V18, P519; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; Schwarz ER, 1997, CURR OPIN CARDIOL, V12, P475, DOI 10.1097/00001573-199712050-00007; Smoyer WE, 2000, J AM SOC NEPHROL, V11, P211, DOI 10.1681/ASN.V112211; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; ZAGER RA, 1985, AM J PHYSIOL, V249, pF148, DOI 10.1152/ajprenal.1985.249.1.F148; ZAGER RA, 1994, KIDNEY INT, V45, P1760, DOI 10.1038/ki.1994.229; ZAGER RA, 1995, KIDNEY INT, V47, P628, DOI 10.1038/ki.1995.80; ZAGER RA, 1995, LAB INVEST, V72, P592; ZAGER RA, 1984, KIDNEY INT, V26, P689, DOI 10.1038/ki.1984.204	38	258	269	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11870	11876		10.1074/jbc.M007518200	http://dx.doi.org/10.1074/jbc.M007518200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11150293	hybrid			2022-12-27	WOS:000168081800060
J	Swain, JF; Gierasch, LM				Swain, JF; Gierasch, LM			Signal peptides bind and aggregate RNA - An alternative explanation for GTPase inhibition in the signal recognition particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE-RICH DOMAIN; ESCHERICHIA-COLI SRP; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; PROTEIN TRANSLOCATION; SEQUENCE RECOGNITION; SECONDARY STRUCTURE; TARGETING PATHWAYS; MEMBRANE-PROTEIN; INVIVO FUNCTION	N-terminal signal sequences can direct nascent protein chains to the inner membrane of prokaryotes and the endoplasmic reticulum of eukaryotes by interacting with the signal recognition particle. In this study, we show that isolated peptides corresponding to several bacterial signal sequences inhibit the GTPase activity of the Escherichia coli signal recognition particle, as previously reported (Miller, J. D., Bernstein, H. D., and Waiter, P. (1994) Nature 367, 657-659), but not by the direct mechanism proposed. Instead, isolated signal peptides bind nonspecifically to the RNA component and aggregate the entire signal recognition particle, leading to a loss of its intrinsic GTPase activity. Surprisingly, only "functional" peptide sequences aggregate RNA;the peptides in general use as "nonfunctional" negative controls (e.g. those with deletions or charged substitutions within the hydrophobic core), are sufficiently different in physical character that they do not aggregate RNA and thus have no effect on the GTPase activity of the signal recognition particle. We propose that the reported effect of functional signal peptides on the GTPase activity of the signal recognition particle is an artifact of the high peptide concentrations and low salt conditions used in these in vitro studies and that signal sequences at the N terminus of nascent chains in vivo do not exhibit this activity.	Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Gierasch, Lila M/D-1494-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019573, R01GM034962] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM34962, F32 GM19573] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; BATENBURG AM, 1988, BIOCHEMISTRY-US, V27, P5678, DOI 10.1021/bi00415a043; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Bernstein HD, 1998, CURR BIOL, V8, pR715, DOI 10.1016/S0960-9822(98)70456-7; BIANCHI F, 1994, BIOCHEM BIOPH RES CO, V201, P1197, DOI 10.1006/bbrc.1994.1832; BRIGGS MS, 1985, SCIENCE, V228, P1096, DOI 10.1126/science.3158076; CARLSON JH, 1993, J BACTERIOL, V175, P3327, DOI 10.1128/jb.175.11.3327-3334.1993; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; EMR SD, 1983, P NATL ACAD SCI-BIOL, V80, P4599, DOI 10.1073/pnas.80.15.4599; FIDELIO GD, 1987, BIOCHEM J, V244, P295, DOI 10.1042/bj2440295; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; HIGH S, 1991, J CELL BIOL, V113, P229, DOI 10.1083/jcb.113.2.229; HOYT DW, 1991, BIOCHEMISTRY-US, V30, P10155, DOI 10.1021/bi00106a012; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; JONES JD, 1994, BIOPHYS J, V67, P1534, DOI 10.1016/S0006-3495(94)80627-7; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Saenger W., 1984, PRINCIPLES NUCL ACID, P399; SHINNAR AE, 1984, J AM CHEM SOC, V106, P5006, DOI 10.1021/ja00329a063; SUAU P, 1977, J MOL BIOL, V117, P909, DOI 10.1016/S0022-2836(77)80005-3; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WANG ZL, 1993, BIOCHEMISTRY-US, V32, P13991, DOI 10.1021/bi00213a032; WARRANT RW, 1978, NATURE, V271, P130, DOI 10.1038/271130a0; Zheng N, 1997, MOL CELL, V1, P79, DOI 10.1016/S1097-2765(00)80009-X; Zheng T, 1999, J BIOL CHEM, V274, P36623, DOI 10.1074/jbc.274.51.36623; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x; [No title captured]	39	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12222	12227		10.1074/jbc.M011128200	http://dx.doi.org/10.1074/jbc.M011128200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11148214	hybrid			2022-12-27	WOS:000168081800105
J	Zhang, YN; Wang, PG; Brew, K				Zhang, YN; Wang, PG; Brew, K			Specificity and mechanism of metal ion activation in UDP-galactose :beta-Galactoside-alpha-1,3-galactosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ALPHA-GALACTOSYL EPITOPES; PURPLE ACID-PHOSPHATASE; STRUCTURE PREDICTION; HUMAN ALPHA-1,3-FUCOSYL-TRANSFERASE-V; CHEMOENZYMATIC SYNTHESIS; HOMOLOGOUS SEQUENCES; CIRCULAR-DICHROISM; EXPRESSION CLONING; RECOMBINANT ENZYME	UDP-galactose:beta -galactosyl-alpha1,3-galactosyltransferase (alpha 3GT) catalyzes the synthesis of galactosyl-alpha -1,3-beta -galactosyl structures in mammalian glycoconjugates. In humans the gene for a3GT is inactivated, and its product, the alpha -Gal epitope, is the target of a large fraction of natural antibodies. alpha 3GT is a member of a family of metal-dependent-retaining glycosyltransferases that includes the histo blood group A and B enzymes. Mn2+ activates the catalytic domain of alpha 3GT (alpha 3GTcd), but the affinity reported for this ion is very low relative to physiological levels. Enzyme activity over a wide range of metal ion concentrations indicates a dependence on Mn2+ binding to two sites. At physiological metal ion concentrations, Zn2+ gives higher levels of activity and may be the natural cofactor. To determine the role of the cation, metal activation was perturbed by substituting Co2+ and Zn2+ for Mn2+ and by mutagenesis of a conserved (DVD151)-V-149 sequence motif that is considered to act in cation binding in many glycosyltransferases. The aspartates of this motif were found to be essential for activity, and the kinetic properties of a Val(150) to Ala mutant with reduced activity were determined. The results indicate that the cofactor is involved in binding UDP-galactose and has a crucial influence on catalytic efficiency for galactose transfer and for the low endogenous UDP-galactose hydrolase activity. It may therefore interact with one or more phosphates of UDP-galactose in the Michaelis complex and in the transition state for cleavage of the UDP to galactose bond. The DXD motif conserved in many glycosyltransferases appears to have a key role in metal-mediated donor substrate binding and phosphate-sugar bond cleavage.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	University of Miami; Wayne State University	Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.		Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032; 	NIGMS NIH HHS [GM 58773] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058773] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BLANKEN WM, 1985, J BIOL CHEM, V260, P2927; Breton C, 1998, J BIOCHEM, V123, P1000; BURGNER JW, 1984, BIOCHEMISTRY-US, V23, P3636, DOI 10.1021/bi00311a010; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; CASEY CE, 1985, AM J CLIN NUTR, V41, P1193, DOI 10.1093/ajcn/41.6.1193; COLLINS BH, 1995, J IMMUNOL, V154, P5500; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P129; DiFrancesco V, 1996, PROTEIN SCI, V5, P106; Fang JW, 1998, J AM CHEM SOC, V120, P6635, DOI 10.1021/ja9808898; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Haslam DB, 1996, P NATL ACAD SCI USA, V93, P10697, DOI 10.1073/pnas.93.20.10697; Hayashi T, 1997, BIOORGAN MED CHEM, V5, P497, DOI 10.1016/S0968-0896(96)00263-5; HENION TR, 1994, GLYCOBIOLOGY, V4, P193, DOI 10.1093/glycob/4.2.193; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Imberty A, 1999, GLYCOBIOLOGY, V9, P713, DOI 10.1093/glycob/9.7.713; JOZIASSE DH, 1990, EUR J BIOCHEM, V191, P75, DOI 10.1111/j.1432-1033.1990.tb19095.x; JOZIASSE DH, 1989, J BIOL CHEM, V264, P14290; KHATRA BS, 1974, EUR J BIOCHEM, V44, P537, DOI 10.1111/j.1432-1033.1974.tb03513.x; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KIM SC, 1988, ARCH BIOCHEM BIOPHYS, V267, P54, DOI 10.1016/0003-9861(88)90007-0; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; POWELL JT, 1976, J BIOL CHEM, V251, P3645; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; STRAHAN KM, 1995, IMMUNOGENETICS, V41, P101, DOI 10.1007/BF00182319; STRATER N, 1995, SCIENCE, V268, P1489, DOI 10.1126/science.7770774; SUERBAUM H, 1993, EUR J BIOCHEM, V214, P313, DOI 10.1111/j.1432-1033.1993.tb17926.x; VANDENEIJNDEN DH, 1983, EUR J BIOCHEM, V134, P523; VINCENT JB, 1992, BIOCHEMISTRY-US, V31, P3033, DOI 10.1021/bi00127a001; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Walker KW, 1998, PROTEIN SCI, V7, P2684, DOI 10.1002/pro.5560071224; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; WITSELL DL, 1990, J BIOL CHEM, V265, P15731; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zhang YN, 1999, GLYCOBIOLOGY, V9, P815, DOI 10.1093/glycob/9.8.815	48	48	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11567	11574		10.1074/jbc.M006530200	http://dx.doi.org/10.1074/jbc.M006530200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11133981	hybrid			2022-12-27	WOS:000168081800022
J	Emoto, M; Langille, SE; Czech, MP				Emoto, M; Langille, SE; Czech, MP			A role for kinesin in insulin-stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT TRAFFICKING; VESICLE TRAFFICKING; ORGANELLE MOVEMENT; RAT ADIPOCYTES; TAU-PROTEIN; ACTIN; MOTILITY; OVEREXPRESSION; MICROTUBULES	Insulin regulates glucose uptake in adipocytes and muscle by stimulating the movement of sequestered glucose transporter 4 (GLUT4) proteins from intracellular membranes to the cell surface. Here we report that optimal insulin-mediated GLUT4 translocation is dependent upon both microtubule and actin-based cytoskeletal structures in cultured adipocytes, Depolymerization of microtubules and F-actin in 3T3-L1 adipocytes causes the dispersion of perinuclear GLUT4-containing membranes and abolishes insulin action on GLUT4 movements to the plasma membrane. Furthermore, heterologous expression in 3T3-L1 adipocytes of the microtubule-binding protein hTau40, which impairs kinesin motors that move toward the plus ends of microtubules, markedly delayed the appearance of GLUT4 at the plasma membrane in response to insulin, The hTau40 protein had no detectable effect on microtubule structure or perinuclear GLUT4 localization under these conditions. These results are consistent with the hypothesis that both the actin and microtubule-based cytoskeleton, as well as a kinesin motor, direct the translocation of GLUT4 to the plasma membrane in response to insulin.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			NIDDK NIH HHS [DK30898] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J BIOL CHEM, V268, P9187; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HARING HU, 1979, FEBS LETT, V105, P329, DOI 10.1016/0014-5793(79)80641-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Khayat ZA, 2000, J CELL SCI, V113, P279; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OKADA T, 1994, J BIOL CHEM, V269, P3568; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Reilein AR, 1998, J CELL BIOL, V142, P803, DOI 10.1083/jcb.142.3.803; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Trinczek B, 1999, J CELL SCI, V112, P2355; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; YANG J, 1993, J BIOL CHEM, V268, P4600	32	85	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10677	10682		10.1074/jbc.M010785200	http://dx.doi.org/10.1074/jbc.M010785200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145966	hybrid			2022-12-27	WOS:000167980900017
J	Akiyoshi, Y; Clayton, J; Phan, L; Yamamoto, M; Hinnebusch, AG; Watanabe, Y; Asano, K				Akiyoshi, Y; Clayton, J; Phan, L; Yamamoto, M; Hinnebusch, AG; Watanabe, Y; Asano, K			Fission yeast homolog of murine int-6 protein, encoded by mouse mammary tumor virus integration site, is associated with the conserved core subunits of eukaryotic translation initiation factor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD-REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; FACTOR EIF-3; RNA-BINDING; CELL-PROLIFERATION; COMPLEX-FORMATION; NUCLEAR-BODIES; WHEAT-GERM; GENE	The murine int-6 locus, identified as a frequent integration site of mouse mammary tumor viruses, encodes the 48-kDa eIF3e subunit of translation initiation factor eIF3, Previous studies indicated that the catalytically active core of budding yeast eIF3 consists of five subunits, all conserved in eukaryotes, but does not contain a protein closely related to eIF3e/Int-6, Whereas the budding yeast genome does not encode a protein closely related to murine Int-6, fission yeast does encode an Int-6 ortholog, designated here Int6, We found that fission yeast Int6/eIF3e is a cytoplasmic protein associated with 40 S ribosomes, FLAG epitope-tagged Tif35,a putative core eIF3g subunit, copurified with Int6 and all five orthologs of core eIF3 subunits, An int6 deletion (int6 Delta) mutant was viable but grew slowly in minimal medium. This slow growth phenotype was accompanied by a reduction in the amount of polyribosomes engaged in translation and was complemented by expression of human Int-6 protein. These findings support the idea that human and Schizosaccharomyces pombe Int-6 homologs are involved in translation. Interestingly, haploid int6 Delta cells showed unequal nuclear partitioning, possibly because of a defect in tubulin function, and diploid int6 Delta cells formed abnormal spores. We propose that Int6 is not an essential subunit of eIF3 but might be involved in regulating the activity of eIF3 for translation of specific mRNAs in S. pombe.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; NICHD, Lab Eukaryot Gene Regulat, NIH, Bethesda, MD 20892 USA; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Japan Science & Technology Agency (JST)	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.			Watanabe, Yoshinori/0000-0002-5488-4812	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001004] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; BENNE R, 1978, J BIOL CHEM, V253, P3078; Block KL, 1998, J BIOL CHEM, V273, P31901, DOI 10.1074/jbc.273.48.31901; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; BUSCHMAN JL, 1993, MOL CELL BIOL, V13, P4618; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; CHECKLEY JW, 1981, J BIOL CHEM, V256, P1582; Chen CR, 1999, P NATL ACAD SCI USA, V96, P517, DOI 10.1073/pnas.96.2.517; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; DANAIE P, 1995, J BIOL CHEM, V270, P4288, DOI 10.1074/jbc.270.9.4288; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Greenberg JR, 1998, J BIOL CHEM, V273, P23485, DOI 10.1074/jbc.273.36.23485; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hanachi P, 1999, J BIOL CHEM, V274, P8546, DOI 10.1074/jbc.274.13.8546; HANICJOYCE PJ, 1987, J BIOL CHEM, V262, P2845; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; Humphrey T, 1998, GENETICS, V148, P1731; Kondoh H, 2000, GENES CELLS, V5, P525, DOI 10.1046/j.1365-2443.2000.00344.x; Kovarik P, 1998, CURR GENET, V33, P100, DOI 10.1007/s002940050314; LAUER SJ, 1985, BIOCHEMISTRY-US, V24, P2924, DOI 10.1021/bi00333a016; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Morris-Desbois C, 1999, J CELL SCI, V112, P3331; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Naranda T, 1997, MOL CELL BIOL, V17, P145, DOI 10.1128/MCB.17.1.145; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; TRACHSEL H, 1979, BIOCHIM BIOPHYS ACTA, V565, P305, DOI 10.1016/0005-2787(79)90207-7; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	43	47	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10056	10062		10.1074/jbc.M010188200	http://dx.doi.org/10.1074/jbc.M010188200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134033	hybrid			2022-12-27	WOS:000167996400065
J	Gao, Y; Wells, L; Comer, FI; Parker, GJ; Hart, GW				Gao, Y; Wells, L; Comer, FI; Parker, GJ; Hart, GW			Dynamic O-glycosylation of nuclear and cytosolic proteins - Cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; INSULIN-RESISTANCE; D-GLUCOSAMINIDASE; SKELETAL-MUSCLE; RAT-BRAIN; LOCALIZATION; PHOSPHORYLATION; PURIFICATION; ACETYLHEXOSAMINIDASES; AMIDOTRANSFERASE	Dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) on Ser/Thr residues is ubiquitous in higher eukaryotes and is analogous to protein phosphorylation, The enzyme for the addition of this modification, O-GlcNAc transferase, has been cloned from several species. Here, we have cloned a human brain O-GlcNAcase that cleaves O-GlcNAc off proteins. The cloned cDNA encodes a polypeptide of 916 amino acids with a predicted molecular mass of 103 kDa and a pi value of 4.63, but the protein migrates as a 130-kDa band on SDS-polyacrylamide gel electrophoresis. The cloned O-GlcNAcase has a pH optimum of 5.5-7.0 and is inhibited by GlcNAc but not by GalNAc, p-Nitrophenyl (pNP)-beta -GlcNAc, but not pNP-beta -GalNAc or pNP-alpha -GlcNAc, is a substrate. The cloned enzyme cleaves GlcNAc, but not GalNAc, from glycopeptides. Cell fractionation suggests that the overexpressed protein is mostly localized in the cytoplasm, It therefore has all the expected characteristics of O-GlcNAcase and is distinct from lysosomal hexosaminidases, Northern blots show that the transcript is expressed in every human tissue examined but is the highest in the brain, placenta, and pancreas. An understanding of O-GlcNAc dynamics and O-GlcNAcase may be key to elucidating the relationships between O-phosphate and O-GlcNAc and to the understanding of the molecular mechanisms of diseases such as diabetes, cancer, and neurodegeneration.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Utah, Dept Internal Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84132 USA	Johns Hopkins University; Utah System of Higher Education; University of Utah	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363; Hart, Gerald/0000-0001-7812-4351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NICHD NIH HHS [HD13563] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Cooksey RC, 1999, ENDOCRINOLOGY, V140, P1151, DOI 10.1210/en.140.3.1151; DONG DLY, 1993, J BIOL CHEM, V268, P16679; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; EMILIANI C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P265, DOI 10.1016/0167-4838(90)90024-A; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; GRIFFITH LS, 1995, J NEUROSCI RES, V41, P270, DOI 10.1002/jnr.490410214; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; IZUMI T, 1980, BIOCHIM BIOPHYS ACTA, V615, P402, DOI 10.1016/0005-2744(80)90507-0; IZUMI T, 1983, J BIOL CHEM, V258, P6991; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jiang MS, 1997, J BIOL CHEM, V272, P2421; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KUSTERMANNKUHN B, 1983, HUM GENET, V65, P172, DOI 10.1007/BF00286657; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lubas WA, 1997, J BIOL CHEM, V272, P9316; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OVERDIJK B, 1981, BIOCHIM BIOPHYS ACTA, V659, P255, DOI 10.1016/0005-2744(81)90052-8; OVERDIJK B, 1975, BIOCHEM J, V151, P257, DOI 10.1042/bj1510257; POENARU L, 1973, BIOMED EXPRESS, V19, P538; REASON AJ, 1992, J BIOL CHEM, V267, P16911; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Snow DM, 1998, INT REV CYTOL, V181, P43, DOI 10.1016/S0074-7696(08)60416-7; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Yao PJ, 1998, J NEUROSCI, V18, P2399; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0	45	496	526	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9838	9845		10.1074/jbc.M010420200	http://dx.doi.org/10.1074/jbc.M010420200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11148210	hybrid			2022-12-27	WOS:000167996400036
J	Lee, DK; Duan, HO; Chang, CS				Lee, DK; Duan, HO; Chang, CS			Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATION; COACTIVATOR; KINASE; TERMINATION; SEQUENCE; PROTEIN; CLONING; DOMAIN; TFIIB	Androgen receptor (AR) may communicate with the general transcription machinery on the core promoter to exert its function as a transcriptional modulator. Our previous report demonstrated that the AR interacted with transcription factor IIH (TFIIH) under physiological conditions and that overexpression of Cdk-activating kinase, the kinase moiety of TFIIH, enhanced AR-mediated transcription in prostate cancer cells. In an effort to further dissect the mechanisms implicated in AR transactivation, we report here that AR interacts with PITALRE, a kinase subunit of positive elongation factor b (P-TEFb), Cotransfection of the plasmid encoding the mutant PITALRE (mtPITALRE), defective in its RNA polymerase II COOH-terminal domain (CTD)-kinase activity, resulted in preferential inhibition of AR-mediated transactivation. Indeed, AR transactivation in PC-3 cells was preferentially inhibited at the low concentration of 5,6-dicloro-1-beta -D-ribofuranosylbenzimida-zole (DRB), a CTD kinase inhibitor. These results suggest that CTD phosphorylation may play an important role in AR-mediated transcription. Furthermore, a nuclear run-on transcription assay of the prostate-specific antigen gene, an androgen-inducible gene, showed that transcription efficiency of the distal region of the gene was enhanced upon androgen induction. Taken together, our reports suggest that AR interacts with TFIIH and P-TEFb and enhances the elongation stage of transcription.	Univ Rochester, Med Ctr, Dept Pathol Urol Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol Urol Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	chang@urmc.rochester.edu			NCI NIH HHS [CA55639, CA71570] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055639, R29CA055639] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; BLANCO JCG, 1995, P NATL ACAD SCI USA, V92, P1535, DOI 10.1073/pnas.92.5.1535; Blau J, 1996, MOL CELL BIOL, V16, P2044; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRASER NW, 1979, P NATL ACAD SCI USA, V76, P2571, DOI 10.1073/pnas.76.6.2571; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; HADZIC E, 1995, MOL CELL BIOL, V15, P4507; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Kang HY, 1999, J BIOL CHEM, V274, P8570, DOI 10.1074/jbc.274.13.8570; KELLY JJ, 1991, NUCLEIC ACIDS RES, V19, P6799, DOI 10.1093/nar/19.24.6799; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Malik S, 1996, MOL CELL BIOL, V16, P1824; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; McEwan IJ, 1997, P NATL ACAD SCI USA, V94, P8485, DOI 10.1073/pnas.94.16.8485; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TAMM I, 1979, P NATL ACAD SCI USA, V76, P5750, DOI 10.1073/pnas.76.11.5750; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yankulov KY, 1996, MOL CELL BIOL, V16, P3291; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974; ZANDOMENI R, 1984, J BIOL CHEM, V259, P4804; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	38	106	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9978	9984		10.1074/jbc.M002285200	http://dx.doi.org/10.1074/jbc.M002285200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11266437	hybrid			2022-12-27	WOS:000167996400055
J	Yu, LC; Twu, YC; Chang, CY; Lin, M				Yu, LC; Twu, YC; Chang, CY; Lin, M			Molecular basis of the Kell-null phenotype - A mutation at the splice site of human Kel gene abolishes the expression of Kell blood group antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP PROTEIN; GROUP SYSTEM; DISEASE; XK; IDENTIFICATION; ANTIBODIES; DEFICIENCY; COLLAGEN; VARIANT	The Kell blood group system is polymorphic, and 23 antigens have been defined to date. The Kell antigens are located on a single red cell transmembrane glyco-protein, encoded by the 19 exons of the KEL gene. The different Kell phenotypes result from point mutations leading to amino acid changes in the Kell glycoprotein. An unusual phenotype, which is defined as the complete lack of all of the Kell antigens, has been identified and designated as the Kell-null or Ko phenotype, The coding region of the KEL gene of the Ko individual showed a normal KEL2/KEL4/KEL7 gene sequence; nevertheless, a G to C mutation at the splice donor site (5' splice site) of intron 3 was found to be present as a homozygote in the individual. The mutation destroys the conserved GT sequence of the splice donor site. Reverse transcription-polymerase chain reaction analysis showed the absence of the complete KEL mRNA. Instead, a major transcript with the exon 3 region skipped was found. The exon 3 of the KEL gene encodes the transmembrane domain of the Kell glycoprotein, and a transcript without exon 3 is predicted to have a premature stop codon that abolishes the translation of C-terminal segment. The segment contains all of the known positions responsible for characterizing different Kell antigens, and this explains the lack of all Kell antigens in Ko red cells.	Mackay Mem Hosp, Transfus Med Lab, Dept Med Res, Tamsui 251, Taipei, Taiwan; Mackay Mem Hosp, Immunohematol Reference Lab, Tamsui 251, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital	Lin, M (corresponding author), Mackay Mem Hosp, Transfus Med Lab, Dept Med Res, 45 Ming San Rd, Tamsui 251, Taipei, Taiwan.	marilin@ms2.mmh.org.tw						CHOWN B, 1957, NATURE, V180, P711, DOI 10.1038/180711a0; Condino-Neto A, 2000, BLOOD, V95, P3548, DOI 10.1182/blood.V95.11.3548.011k36_3548_3554; COOMBS RRA, 1946, LANCET, V250, P264; DANIELS G, 1995, HUMAN BLOOD GROUPS; Harteveld CL, 2000, BRIT J HAEMATOL, V110, P694, DOI 10.1046/j.1365-2141.2000.02225.x; ISSITT PD, 1998, APPL BLOOD GROUP SER, P609; JABER A, 1991, BRIT J HAEMATOL, V79, P311, DOI 10.1111/j.1365-2141.1991.tb04539.x; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEE S, 1995, BLOOD, V85, P1364, DOI 10.1182/blood.V85.5.1364.bloodjournal8551364; Lee S, 2000, SEMIN HEMATOL, V37, P113, DOI 10.1016/S0037-1963(00)90036-2; Lee S, 1999, BLOOD, V94, P1440, DOI 10.1182/blood.V94.4.1440.416k01_1440_1450; Lee S, 1997, TRANSFUSION, V37, P1117, DOI 10.1046/j.1537-2995.1997.37111298088039.x; Lee S, 1997, VOX SANG, V73, P1, DOI 10.1046/j.1423-0410.1997.7310001.x; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; LEE S, 1995, TRANSFUSION, V35, P822, DOI 10.1046/j.1537-2995.1995.351096026362.x; Lee S, 1996, TRANSFUSION, V36, P490, DOI 10.1046/j.1537-2995.1996.36696269505.x; Lee S, 2000, TRANSFUS MED REV, V14, P93, DOI 10.1016/S0887-7963(00)80001-2; LEE SH, 1995, BLOOD, V85, P912, DOI 10.1182/blood.V85.4.912.bloodjournal854912; LEVINE P, 1949, SCIENCE, V109, P464, DOI 10.1126/science.109.2836.464; McVey JH, 1998, BLOOD, V92, P920, DOI 10.1182/blood.V92.3.920.415a18_920_926; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Okubo M, 2000, AM J MED GENET, V93, P211, DOI 10.1002/1096-8628(20000731)93:3<211::AID-AJMG10>3.0.CO;2-Z; REDMAN CM, 1986, J BIOL CHEM, V261, P9521; REDMAN CM, 1988, BRIT J HAEMATOL, V68, P131, DOI 10.1111/j.1365-2141.1988.tb04191.x; Redman Colvin M., 1995, V6, P227; REID ME, 1997, BLOOD GROUP ANTIGEN, P175; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Russo D, 2000, BLOOD, V96, P340, DOI 10.1182/blood.V96.1.340.013k45_340_346; Russo D, 1999, BBA-BIOMEMBRANES, V1461, P10, DOI 10.1016/S0005-2736(99)00148-0; Russo D, 1998, J BIOL CHEM, V273, P13950, DOI 10.1074/jbc.273.22.13950; SCHENKELBRUNNER H, 2000, HUMAN BLOOD GROUPS C, P485; Schwarze U, 1999, AM J HUM GENET, V65, P336, DOI 10.1086/302512; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; UCHIKAWA M, 2000, VOX SANG, V78, P11; Wagner T, 2000, NEW ENGL J MED, V343, P72, DOI 10.1056/NEJM200007063430120; Winberg JO, 1997, HUM MOL GENET, V6, P1125, DOI 10.1093/hmg/6.7.1125; Wyatt J, 2000, THROMB HAEMOSTASIS, V84, P449; Yazdanbakhsh K, 1999, BLOOD, V94, P310, DOI 10.1182/blood.V94.1.310.413k12_310_318	39	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10247	10252		10.1074/jbc.M009879200	http://dx.doi.org/10.1074/jbc.M009879200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134029	hybrid			2022-12-27	WOS:000167996400089
J	Lehrman, MA				Lehrman, MA			Oligosaccharide-based information in endoplasmic reticulum quality control and other biological systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNFOLDED PROTEIN RESPONSE; CIS-ISOPRENYLTRANSFERASE ACTIVITY; MOLECULAR CHAPERONE; N-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; LINKED GLYCOSYLATION; CALNEXIN; ER; GLYCOPROTEIN; BIOSYNTHESIS		Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lehrman, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mlehrm@mednet.swmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R56GM038545] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38545] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BANERJEE DK, 1981, BIOCHEMISTRY-US, V20, P1561, DOI 10.1021/bi00509a024; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Cacan R, 2000, GLYCOBIOLOGY, V10, P645, DOI 10.1093/glycob/10.7.645; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Chung DH, 2000, J BIOL CHEM, V275, P4981, DOI 10.1074/jbc.275.7.4981; CRICK DC, 1994, J BIOL CHEM, V269, P10559; CRICK DC, 1994, J NEUROCHEM, V62, P247; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Etzler ME, 1998, J CELL BIOCHEM, P123; Etzler ME, 1999, P NATL ACAD SCI USA, V96, P5856, DOI 10.1073/pnas.96.10.5856; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HASSID WZ, 1957, CARBOHYDRATES CHEM B, P478; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HUBBARD SC, 1979, J BIOL CHEM, V254, P4568; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kean EL, 1999, J BIOL CHEM, V274, P34072, DOI 10.1074/jbc.274.48.34072; KEAN EL, 1985, J BIOL CHEM, V260, P2561; KEAN EL, 1994, BIOCHEMISTRY-US, V33, P10508, DOI 10.1021/bi00200a036; Konrad M, 1996, BIOCHEM J, V316, P575, DOI 10.1042/bj3160575; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; LEHRMAN MA, 1989, J BIOL CHEM, V264, P1584; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; PARODI AJ, 1983, J BIOL CHEM, V258, P8260; Patil AR, 2000, J BIOL CHEM, V275, P24348, DOI 10.1074/jbc.M003102200; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; POUYSSEGUR J, 1977, CELL, V11, P941, DOI 10.1016/0092-8674(77)90305-1; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wang J, 2000, BIOCHEMISTRY-US, V39, P8993, DOI 10.1021/bi000027v; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zuber C, 2000, MOL BIOL CELL, V11, P4227, DOI 10.1091/mbc.11.12.4227	73	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8623	8626		10.1074/jbc.R100002200	http://dx.doi.org/10.1074/jbc.R100002200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254652	hybrid			2022-12-27	WOS:000167607700001
J	Tam, WF; Sen, RJ				Tam, WF; Sen, RJ			I kappa B family members function by different mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; REL PROTEINS; ALPHA; LOCALIZATION; IMPORT; SEQUENCES; COMPLEXES; PATHWAY; MICE	The I kappaB family of proteins regulates NF-kappaB-dependent transcription by inhibiting DNA binding and localizing these factors to the cell cytoplasm, I kappaB alpha does this by shifting the balance between nuclear import of Rel proteins and their export from the nucleus. Here we show that, unlike I kappaB alpha, I kappaB beta and I kappaB beta appear to sequester p65 or c-Rel in the cytoplasm by inhibiting nuclear import. Furthermore, because I kappaB beta does not undergo nucleocytoplasmic shuttling, it cannot remove nuclear proteins like I kappaB alpha does. We conclude that the mechanism of action differs among I kappaB family members.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Sen, RJ (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.							BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Foo SY, 1999, TRENDS GENET, V15, P229; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Klement JF, 1996, MOL CELL BIOL, V16, P2341; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	19	91	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7701	7704		10.1074/jbc.C000916200	http://dx.doi.org/10.1074/jbc.C000916200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11152669	hybrid			2022-12-27	WOS:000167474900004
J	Li, YQ; Kuwahara, H; Ren, J; Wen, GY; Kufe, D				Li, YQ; Kuwahara, H; Ren, J; Wen, GY; Kufe, D			The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR LEF-1; TUMOR-SUPPRESSOR PROTEIN; MONOCLONAL-ANTIBODY DF3; CELL-CELL ADHESION; GROWTH-FACTOR; HUMAN CANCER; RECEPTOR; REACTIVITY; BINDING; COMPLEXES	The DF3/MUC1 mucin-like glycoprotein is aberrantly overexpressed in most human carcinomas. The cytoplasmic domain of MUC1 interacts with glycogen synthase kinase 3 beta (GSK3 beta) and thereby decreases binding of MUC1 and beta -catenin. The present studies demonstrate that MUC1 associates with the c-Src tyrosine kinase. c-Src phosphorylates the MUC1 cytoplasmic domain at a YEKV motif located between sites involved in interactions with GSK3 beta and beta -catenin. The results demonstrate that the c-Src SH2 domain binds directly to pYEKV and inhibits the interaction between MUC1 and GSK3 beta. Moreover and in contrast to GSK3 beta, in vitro and in vivo studies demonstrate that c-Src-mediated phosphorylation of MUC1 increases binding of MUC1 and beta -catenin. The findings support a novel role for c-Src in regulating interactions of MUC1 with GSK3 beta and beta -catenin.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R21CA087421] Funding Source: NIH RePORTER; NCI NIH HHS [CA87421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; FRIEDMAN EL, 1986, CANCER RES, V46, P5189; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Holmes TC, 1996, J NEUROSCI, V16, P1581; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAWANISHI J, 1995, MOL CELL BIOL, V15, P1175; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LIGHTENBERG M, 1992, CANCER RES, V52, P223; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MALARKEY K, 1995, BIOCHEM J, V309, P361, DOI 10.1042/bj3090361; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; PEREY L, 1992, CANCER RES, V52, P2563; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; vanHoek ML, 1997, BIOCHEM J, V326, P271, DOI 10.1042/bj3260271; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	198	221	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6061	6064		10.1074/jbc.C000754200	http://dx.doi.org/10.1074/jbc.C000754200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11152665	hybrid			2022-12-27	WOS:000167261000002
J	Mukherjee, S; Casanova, JE; Hunzicker-Dunn, M				Mukherjee, S; Casanova, JE; Hunzicker-Dunn, M			Desensitization of the luteinizing hormone/choriogonadotropin receptor in ovarian follicular membranes is inhibited by catalytically inactive ARNO(+)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLECKSTRIN-HOMOLOGY DOMAINS; ADP-RIBOSYLATION FACTOR-6; ADENYLYL CYCLASE; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; HORMONE; CELLS; BETA; ARF	We have investigated the participation of endogenous ADP-ribosylation factor (ARF) nucleotide-binding site opener (ARNO) in desensitization of the luteinizing hormone/choriogonadotropin (LH/CG) receptor, independent of receptor internalization, using a cell-free plasma membrane model. We recently showed that the addition of recombinant ARNO promotes binding of beta -arrestin1 to the third intracellular (3i) loop of the active LH/CG receptor, thereby reducing the ability of the receptor to activate the stimulatory G protein and signal to adenylyl cyclase. In the present report we determined whether ARNO is detectable in follicular membranes and whether the catalytically inactive E156K ARNO mutant, containing a mutation in the Sec7 domain, can act in a dominant negative manner to block LH/CG receptor desensitization. Results show that ARNO is readily detected in follicular membranes and that levels of membrane-associated ARNO increase with follicular maturation. The addition of catalytically inactive E156K ARNO blocks both the release of beta -arrestin1 from its membrane docking site, based on Western blot analysis, and development of LH/CG receptor desensitization. We also investigated whether a point mutation in the pleckstrin homology (PH) domain of ARNO (R280D), which blocks binding of phosphoinositides like phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 4,5-bisphosphate (PIP2) but not catalytic activity, disrupts LH/CG receptor desensitization. R280D ARNO neither promotes nor inhibits LH/CG receptor desensitization, consistent with a requirement of the PH domain of ARNO for its association with the plasma membrane. LH/CG receptor activation of ARNO is not mediated by activation of phosphatidylinositol 3-kinase (PI 3-kinase) or by G protein beta gamma subunits. Taken together, these results suggest that LH/CG receptor promotes beta -arrestin1 release from its membrane docking site to bind to the 3i loop of the LH/CG receptor via activation of membrane delimited endogenous ARNO. As ARNO activation is independent of PI 3-kinase and G beta gamma, our results are consistent with a role for PIP2 in receptor-stimulated ARNO activation.	Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	Northwestern University; University of Virginia	Hunzicker-Dunn, M (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032991] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 32991] Funding Source: Medline; NICHD NIH HHS [R01 HD/DK 38060] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BENDER FE, 1982, STAT METHODS FOOD AG; BOCKAERT J, 1976, J BIOL CHEM, V251, P2653; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; CHANNING CP, 1974, BIOL REPROD, V10, P179, DOI 10.1095/biolreprod10.2.179; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cullen PJ, 2000, CURR BIOL, V10, pR876, DOI 10.1016/S0960-9822(00)00818-6; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; DIMINO MJ, 1987, BIOL REPROD, V36, P97, DOI 10.1095/biolreprod36.1.97; EKSTROM RC, 1989, ENDOCRINOLOGY, V125, P2470, DOI 10.1210/endo-125-5-2470; EKSTROM RC, 1989, ENDOCRINOLOGY, V124, P956, DOI 10.1210/endo-124-2-956; EZRA E, 1980, J BIOL CHEM, V255, P653; EZRA E, 1981, J BIOL CHEM, V256, P5377; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; HSUEH AJW, 1984, ENDOCR REV, V5, P76, DOI 10.1210/edrv-5-1-76; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; KHARLUND JK, 1998, J BIOL CHEM, V273, P1859; Kim HS, 1998, FEBS LETT, V433, P312, DOI 10.1016/S0014-5793(98)00937-5; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mukherjee S, 1999, J BIOL CHEM, V274, P12984, DOI 10.1074/jbc.274.19.12984; Mukherjee S, 1999, P NATL ACAD SCI USA, V96, P493, DOI 10.1073/pnas.96.2.493; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Rajagopalan-Gupta RM, 1999, ENDOCRINOLOGY, V140, P1612, DOI 10.1210/en.140.4.1612; RajagopalanGupta RM, 1997, MOL ENDOCRINOL, V11, P538, DOI 10.1210/me.11.5.538; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2	41	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6524	6528		10.1074/jbc.C000725200	http://dx.doi.org/10.1074/jbc.C000725200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11139567	hybrid			2022-12-27	WOS:000167261000061
J	Isoyama, T; Murayama, A; Nomoto, A; Kuge, S				Isoyama, T; Murayama, A; Nomoto, A; Kuge, S			Nuclear import of the yeast AP-1-like transcription factor Yap1p is mediated by transport receptor Pse1p, and this import step is not affected by oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; LOCALIZATION SIGNALS; BINDING PROTEIN; EXPORT SIGNALS; DNA-BINDING; RAN-GTPASE; CRM1; RNA; PHOSPHORYLATION	The yeast AP-1-like transcription factor, Yap1p, is essential for the oxidative stress response in budding yeast. Yap1p is located predominantly in the cytoplasm; however, upon imposition of oxidative stress, Yap1p concentrates in the nucleus and activates target genes. Yap1p is constitutively transported in and out of the nucleus. Oxidative stress inhibits the Crm1p/Xpo1p-dependent nuclear export step, resulting in nuclear accumulation of Yap1p, In this study, we examined the mechanism for Yap1p nuclear import, and determined whether the import step is affected by oxidative stress. The nuclear accumulation of Yap1p required the activity of the small GTPase, Ran/Gsp1p. Under conditions in pse1-1 cells carrying a temperature-sensitive mutation of the importin beta family member PSE1/KAP121, nuclear translocation of Yap1p was inhibited dramatically. In an in vitro assay, we showed that Yap1p could directly bind to Pse1p and that this interaction was dissociated by Ran-GTP. These results indicate that Pse1p is the nuclear import receptor for Yap1p, In addition to Pse1p, we suggest that Kap123p, which is homologous to Pse1p, has a minor effect on the nuclear import of Yap1p. Furthermore, we identified the nuclear localization signal of Yap1p and demonstrated that the nuclear import of Yap1p was not affected by oxidative stress.	Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kuge, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Aoba Ku, Aza Aoba, Sendai, Miyagi 9808578, Japan.							Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; AUSUBEL I, 2000, CURRENT PROTOCOLS MO, V3; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Ghaffari M, 1997, BIOCHEM J, V328, P757, DOI 10.1042/bj3280757; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Isoyama T, 1999, J GEN VIROL, V80, P2319, DOI 10.1099/0022-1317-80-9-2319; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Moede T, 1999, FEBS LETT, V461, P229, DOI 10.1016/S0014-5793(99)01446-5; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Shiroki K, 1999, J VIROL, V73, P2193, DOI 10.1128/JVI.73.3.2193-2200.1999; SIKORSKI RS, 1989, GENETICS, V122, P19; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Turpin P, 1999, FEBS LETT, V452, P82, DOI 10.1016/S0014-5793(99)00533-5; VANDROMME M, 1995, P NATL ACAD SCI USA, V92, P4646, DOI 10.1073/pnas.92.10.4646; Williams SC, 1997, GENE EXPRESSION, V6, P371; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Wozniak RW, 1998, TRENDS CELL BIOL, V8, P184, DOI 10.1016/S0962-8924(98)01248-3; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x	48	55	60	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21863	21869		10.1074/jbc.M009258200	http://dx.doi.org/10.1074/jbc.M009258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274141	hybrid			2022-12-27	WOS:000169297900138
J	Tugores, A; Le, J; Sorokina, I; Snijders, AJ; Duyao, M; Reddy, PS; Carlee, L; Ronshaugen, M; Mushegian, A; Watanaskul, T; Chu, S; Buckler, A; Emtage, S; McCormick, MK				Tugores, A; Le, J; Sorokina, I; Snijders, AJ; Duyao, M; Reddy, PS; Carlee, L; Ronshaugen, M; Mushegian, A; Watanaskul, T; Chu, S; Buckler, A; Emtage, S; McCormick, MK			The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE MATRILYSIN; REGULATES EXPRESSION; II RECEPTOR; GENE; DROSOPHILA; PATHWAY; KINASE; DIFFERENTIATION; TEL; FAMILY	Exon trapping and cDNA selection procedures were used to search for novel genes at human chromosome 11p13, a region previously associated with loss of heterozygosity in epithelial carcinomas. Using these approaches, we found the ESE-2 and ESE-3 genes, coding for ETS domain-containing transcription factors. These genes lie in close proximity to the catalase gene within a similar to 200-kilobase genomic interval. ESE-3 mRNA is widely expressed in human tissues with high epithelial content, and immunohistochemical analysis with a newly generated monoclonal antibody revealed that ESE-3 is a nuclear protein expressed exclusively in differentiated epithelial cells and that it is absent in the epithelial carcinomas tested. In transient transfections, ESE-3 behaves as a repressor of the Ras- or phorbol ester-induced transcriptional activation of a subset of promoters that contain ETS and AP-1 binding sites. ESE-3-mediated repression is sequence- and context-dependent and depends both on the presence of high affinity ESE-3 binding sites in combination with AP-1 cis-elements and the arrangement of these sites within a given promoter. We propose that ESE-3 might be an important determinant in the control of epithelial differentiation, as a modulator of the nuclear response to mitogen-activated protein kinase signaling cascades.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Axys Pharmaceut Inc, S San Francisco, CA 94080 USA	University of California System; University of California San Diego	Tugores, A (corresponding author), Univ Calif San Diego, Dept Biol, 9500 Gilman Dr,0349, La Jolla, CA 92093 USA.		Tugores, Antonio/AAE-7939-2021; Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225; Ronshaugen, Matthew/0000-0001-5326-5924; Tugores, Antonio/0000-0002-1849-9239; Sorokina, Irina/0000-0003-1531-1832				Albagli O, 1996, MECH DEVELOP, V59, P29, DOI 10.1016/0925-4773(96)00568-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; Brembeck FH, 2000, ONCOGENE, V19, P1941, DOI 10.1038/sj.onc.1203441; BROOKSWILSON AR, 2000, Patent No. 6087485; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chang J, 2000, ONCOGENE, V19, P151, DOI 10.1038/sj.onc.1203252; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; EVANS GA, 1989, P NATL ACAD SCI USA, V83, P7821; Fischer DF, 1999, GENOMICS, V55, P88, DOI 10.1006/geno.1998.5622; FONG KM, 1994, GENE CHROMOSOME CANC, V10, P183, DOI 10.1002/gcc.2870100306; Foos G, 1998, J BIOL CHEM, V273, P18871, DOI 10.1074/jbc.273.30.18871; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Gabay L, 1996, DEVELOPMENT, V122, P3355; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GALANG CK, 1994, ONCOGENE, V9, P2913; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Harlow E., 1988, ANTIBODIES LAB MANUA; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kleinbaum LA, 1999, BIOCHEM BIOPH RES CO, V264, P119, DOI 10.1006/bbrc.1999.1493; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; Poirel H, 2000, ONCOGENE, V19, P4802, DOI 10.1038/sj.onc.1203830; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; Rogge R, 1995, DEVELOPMENT, V121, P3947; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V105, P190, DOI 10.1111/1523-1747.ep12317104; Sark MWJ, 1998, J BIOL CHEM, V273, P24683, DOI 10.1074/jbc.273.38.24683; SCHOLZ H, 1993, GENETICS, V135, P455; SETH A, 1994, ONCOGENE, V9, P469; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Shipman R, 1998, INT J ONCOL, V12, P107; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TUGORES A, 1992, JIMMUNOL, V269, P30789; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; XIA X, 2000, DAMBE DATA ANAL MOL; Yang XMJ, 1999, AM J SURG PATHOL, V23, P147, DOI 10.1097/00000478-199902000-00002; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198	69	64	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20397	20406		10.1074/jbc.M010930200	http://dx.doi.org/10.1074/jbc.M010930200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259407	hybrid			2022-12-27	WOS:000169135100098
J	Young, JI; Smith, JR				Young, JI; Smith, JR			DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; CANCER-CELLS; METHYLATION; TELOMERASE; SENESCENCE; EXPRESSION; TRANSFORMATION; DEMETHYLATION; ACETYLATION; CULTURE	Maintenance of methylation patterns in the mammalian genome by DNA (cytosine-5) methyltransferases (DNAMeTase) is required for normal cell and tissue function, Inhibition of DNAMeTase in cultured cells induces the expression of p21, a cyclin-dependent kinase (Cdk) inhibitor critical for cells to enter replicative senescence, We investigated the effects of DNAMeTase inhibition in normal human fibroblasts and found that it induces an irreversible growth arrest. Cells arrested by DNAMeTase inhibition became enlarged and had a flat morphology, exhibited an increased expression of collagenase and p21, and the DNA synthesis block could be overcome by the introduction of the SV40 large T antigen, all characteristics of senescent cells. In contrast, normal human fibroblasts lacking a functional p21 gene fail to undergo cell cycle arrest following DNAMeTase inhibition, indicating that p21 is an essential component of this arrest. Furthermore, DNAMeTase activity was reduced as cells approached the end of their proliferative potential. These data suggest that DNAMeTase could be an integral part of the mechanisms by which cells count the number of cell divisions completed and initiate a signaling cascade that ultimately results in the senescent phenotype.	Baylor Coll Med, Roy M & Phyllis Gough Huffington Ctr Aging, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Roy M & Phyllis Gough Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Roy M & Phyllis Gough Huffington Ctr Aging, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Young, JI (corresponding author), Baylor Coll Med, Roy M & Phyllis Gough Huffington Ctr Aging, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.				NIA NIH HHS [P01 AG 13663] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG013663] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS RLP, 1979, BIOCHIM BIOPHYS ACTA, V561, P345, DOI 10.1016/0005-2787(79)90143-6; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; FAIRWEATHER DS, 1987, EXP CELL RES, V168, P153, DOI 10.1016/0014-4827(87)90424-1; Fournel M, 1999, J BIOL CHEM, V274, P24250, DOI 10.1074/jbc.274.34.24250; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GORMAN SD, 1985, J CELL PHYSIOL, V125, P122, DOI 10.1002/jcp.1041250116; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; HORNSBY PJ, 1992, MUTAT RES, V275, P13, DOI 10.1016/0921-8734(92)90004-9; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; JONES PA, 1983, RECENT RES CANCER, V84, P202; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; PEREIRASMITH OM, 1982, SOMAT CELL GENET, V8, P731, DOI 10.1007/BF01543015; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; ROBERTSON KD, 2000, J BIOL CHEM, V25, P338; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Young J, 2000, EXP GERONTOL, V35, P23, DOI 10.1016/S0531-5565(99)00076-5; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	42	57	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19610	19616		10.1074/jbc.M009470200	http://dx.doi.org/10.1074/jbc.M009470200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259405	hybrid			2022-12-27	WOS:000169091000126
J	Aguilar, RC; Boehm, M; Gorshkova, I; Crouch, RJ; Tomita, K; Saito, T; Ohno, H; Bonifacino, JS				Aguilar, RC; Boehm, M; Gorshkova, I; Crouch, RJ; Tomita, K; Saito, T; Ohno, H; Bonifacino, JS			Signal-binding specificity of the mu 4 subunit of the adaptor protein complex AP-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; SORTING SIGNALS; MEDIUM CHAINS; CLATHRIN; DISTINCT; RECOGNITION; TGN38; REQUIREMENTS; TRANSPORT; SEQUENCE	The medium (p) chains of the adaptor protein (AP) complexes AP-1, AP-2, and AP-3 recognize distinct subsets of tyrosine-based (YXX phi) sorting signals found within the cytoplasmic domains of integral membrane proteins. Here, we describe the signal-binding specificity and affinity of the medium subunit mu4 of the recently described adaptor protein complex AP-4. To elucidate the determinants of specificity, we screened a two-hybrid combinatorial peptide library using mu4 as a selector protein. Statistical analyses of the results revealed that mu4 prefers aspartic acid at position Y+1, proline or arginine at Y+2, and phenylalanine at Y-1 and Y+3 (phi). In addition, we examined the interaction of mu4 with naturally occurring YXX phi signals by both two-hybrid and in vitro binding analyses. These experiments showed that mu4 recognized the tyrosine signal from the human lysosomal protein LAMP-2, HTGYEQF. Using surface plasmon resonance measurements, we determined the apparent dissociation constant for the mu4-YXX phi interaction to be in the micromolar range. To gain insight into a possible role of AP-4 in intracellular trafficking, we constructed a Tac chimera bearing a mu4-specific YXX phi signal. This chimera was targeted to the endosomal-lysosomal system without being internalized from the plasma membrane.	NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; Chiba Univ, Grad Sch Med, Dept Mol Genet, Chuo Ku, Chiba 2608670, Japan; Kanazawa Univ, Canc Res Inst, Div Mol Membrane Biol, Kanazawa, Ishikawa 9200934, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chiba University; Kanazawa University	Bonifacino, JS (corresponding author), NICHD, Cell Biol & Metab Branch, NIH, Bldg 18T,Rm 101, Bethesda, MD 20892 USA.		Ohno, Hiroshi/L-7899-2014; Saito, Takashi/C-9684-2009	Ohno, Hiroshi/0000-0001-8776-9661; Saito, Takashi/0000-0001-9495-3547; Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068, ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607, Z01HD000068] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGUILAR RC, 1997, J BIOL CHEM, V272, P2760; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 1996, P ASSOC AM PHYSICIAN, V108, P285; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mullins C, 2000, MOL GEN GENET, V263, P1003, DOI 10.1007/PL00008688; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Shim J, 2000, MOL BIOL CELL, V11, P2743, DOI 10.1091/mbc.11.8.2743; Stephens DJ, 1997, J BIOL CHEM, V272, P14104, DOI 10.1074/jbc.272.22.14104; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Storch S, 2001, J BIOL CHEM, V276, P4298, DOI 10.1074/jbc.M005548200; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Wang XL, 1997, FEBS LETT, V402, P57, DOI 10.1016/S0014-5793(96)01500-1	34	103	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13145	13152		10.1074/jbc.M010591200	http://dx.doi.org/10.1074/jbc.M010591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11139587	hybrid			2022-12-27	WOS:000168198600095
J	Kuo, YM; Kokjohn, TA; Beach, TG; Sue, LI; Brune, D; Lopez, JC; Kalback, WM; Abramowski, D; Sturchler-Pierrat, C; Staufenbiel, M; Roher, AE				Kuo, YM; Kokjohn, TA; Beach, TG; Sue, LI; Brune, D; Lopez, JC; Kalback, WM; Abramowski, D; Sturchler-Pierrat, C; Staufenbiel, M; Roher, AE			Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; MASS-SPECTROMETRY; PEPTIDE VARIANTS; CORE PROTEIN; MICE; DEPOSITION; PRESENILIN-1; COMPONENT; PATHOLOGY; FRAGMENT	We have undertaken an integrated chemical and morphological comparison of the amyloid-beta (A beta) molecules and the amyloid plaques present in the brains of APP23 transgenic (tg) mice and human Alzheimer's disease (AD) patients. Despite an apparent overall structural resemblance to AD pathology, our detailed chemical analyses revealed that although the amyloid plaques characteristic of AD contain cores that are highly resistant to chemical and physical disruption, the tg mice produced amyloid cores that were completely soluble in buffers containing SDS, A beta chemical alterations account for the extreme stability of AD plaque core amyloid. The corresponding lack of post-translational modifications such as N-terminal degradation, isomerization, racemization, pyroglutamyl formation, oxidation, and covalently linked dimers in tg mouse A beta provides an explanation for the differences in solubility between human AD and the APP23 tg mouse plaques. We hypothesize either that insufficient time is available for A beta structural modifications or that the complex species-specific environment of the human disease is not precisely replicated in the tg mice. The appraisal of therapeutic agents or protocols in these animal models must be judged in the context of the lack of complete equivalence between the transgenic mouse plaques and the human AD lesions.	Sun Hlth Res Inst, Longtime Ctr Mol Biol & Genet, Sun City, AZ 85351 USA; Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ 85351 USA; Novartis Pharma Inc, CH-4002 Basel, Switzerland; Arizona State Univ, Dept Biochem & Chem, Tempe, AZ 85287 USA; Midwestern Univ, Dept Microbiol, Glendale, AZ 85308 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Novartis; Arizona State University; Arizona State University-Tempe; Midwestern University	Roher, AE (corresponding author), Sun Hlth Res Inst, Longtime Ctr Mol Biol & Genet, 10515 W Santa Fe Dr, Sun City, AZ 85351 USA.		Kuo, Yu-Min/A-9050-2013	Kuo, Yu-Min/0000-0003-4867-2482				Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brun A., 1983, ALZHEIMERS DISEASE S, P37; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Fukuchi K, 1996, AM J PATHOL, V149, P219; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gouras GK, 1998, J NEUROCHEM, V71, P1920; GOWING E, 1994, J BIOL CHEM, V269, P10987; HIGGINS LS, 1995, P NATL ACAD SCI USA, V92, P4402, DOI 10.1073/pnas.92.10.4402; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Lalowski M, 1996, J BIOL CHEM, V271, P33623, DOI 10.1074/jbc.271.52.33623; Li QX, 1999, J NEUROCHEM, V72, P2479, DOI 10.1046/j.1471-4159.1999.0722479.x; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; ROHER AE, 1988, J CELL BIOL, V107, P2703, DOI 10.1083/jcb.107.6.2703; ROHER AE, 2000, CEREBRAL AMYLOID ANG, P157; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Szendrei GI, 1996, INT J PEPT PROT RES, V47, P289; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Terry Robert D., 1994, P179; TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; WISNIEWSKI HM, 1983, ALZHEIMERS DISEASE S, P57	43	212	228	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12991	12998		10.1074/jbc.M007859200	http://dx.doi.org/10.1074/jbc.M007859200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152675	hybrid			2022-12-27	WOS:000168198600076
J	Cruz, WS; Kwon, G; Marshall, CA; McDaniel, ML; Semenkovich, CF				Cruz, WS; Kwon, G; Marshall, CA; McDaniel, ML; Semenkovich, CF			Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells - A potential link between insulin resistance and beta-cell dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FATTY-ACID CYCLE; PROTEIN-KINASE-C; ENZYME-ACTIVITY; DEVELOPMENTAL REGULATION; HEPATIC LIPASE; OBESE RATS; SECRETION; EXPRESSION; ADIPOCYTES	Lipoprotein lipase (LpL) provides tissues with triglyceride-derived fatty acids. Fatty acids affect beta -cell function, and LpL overexpression decreases insulin secretion in cell lines, but whether LpL is regulated in beta -cells is unknown. To test the hypothesis that glucose and insulin regulate LpL activity in beta -cells, we studied pancreatic islets and INS-1 cells. Acute exposure of beta -cells to physiological concentrations of glucose stimulated both total cellular LpL activity and heparin-releasable LpL activity. Glucose had no effect on total LpL protein mass but instead promoted the appearance of LpL protein in a heparin-releasable fraction, suggesting that glucose stimulates the translocation of LpL hom intracellular to extracellular sites in beta -cells. The induction of heparin-releasable LpL activity was unaffected by treatment with diazoxide, an inhibitor of insulin exocytosis that does not alter glucose metabolism but was blocked by conditions that inhibit glucose metabolism. In vitro hyperinsulinemia had no effect; on LpL activity in the presence of low concentrations of glucose but increased LpL activity in the presence of 20 mM glucose. Using dual-laser confocal microscopy, we detected intracellular LpL in vesicles distinct from those containing insulin. LpL was also detected at the cell surface and was displaced from this site by heparin in dispersed islets and INS-1 cells. These results show that glucose metabolism controls the trafficking of LpL activity in beta -cells independent of insulin secretion. They suggest that hyperglycemia and hyperinsulinemia associated with insulin resistance may contribute to progressive beta -cell dysfunction by increasing LpL-mediated delivery of lipid to islets.	Washington Univ, Sch Med, Div Atherosclerosis Nutr & Lipid Res, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Atherosclerosis Nutr & Lipid Res, Dept Med, Campus Box 8046,660 S Euclid Ave, St Louis, MO 63110 USA.			Semenkovich, Clay/0000-0003-1163-1871	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK006181, R56DK006181, R01DK053198, T32DK007296] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58427] Funding Source: Medline; NIDDK NIH HHS [T32 DK07296, DK53198, DK56341, DK06181] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BASSO L V, 1970, Journal of Clinical Investigation, V49, P537, DOI 10.1172/JCI106264; BEHR SR, 1986, BIOCHIM BIOPHYS ACTA, V889, P346, DOI 10.1016/0167-4889(86)90197-7; BENGTSSON G, 1982, FEBS LETT, V147, P183, DOI 10.1016/0014-5793(82)81038-7; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P549, DOI 10.1111/j.1432-1033.1980.tb04602.x; BENGTSSON G, 1983, BIOCHIM BIOPHYS ACTA, V751, P254, DOI 10.1016/0005-2760(83)90180-7; BENZEEV O, 1994, J LIPID RES, V35, P1511; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; CAMPILLO JE, 1979, DIABETOLOGIA, V16, P267, DOI 10.1007/BF01221954; COLEMAN T, 1995, J BIOL CHEM, V270, P12518, DOI 10.1074/jbc.270.21.12518; CORNELIUS P, 1988, BIOCHEM J, V249, P765, DOI 10.1042/bj2490765; CRESPIN SR, 1969, J CLIN INVEST, V48, P1934, DOI 10.1172/JCI106160; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Ewart HS, 1999, BIOCHEM J, V340, P485, DOI 10.1042/0264-6021:3400485; Ewart HS, 1999, CAN J PHYSIOL PHARM, V77, P571, DOI 10.1139/cjpp-77-8-571; Goldberg IJ, 1996, J LIPID RES, V37, P693; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; KERN PA, 1987, DIABETES, V36, P1238, DOI 10.2337/diabetes.36.11.1238; Kraemer FB, 1998, METABOLISM, V47, P555, DOI 10.1016/S0026-0495(98)90239-6; Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702; LARNKJAER A, 1995, BIOCHEM J, V307, P205, DOI 10.1042/bj3070205; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; Marshall BA, 1999, J BIOL CHEM, V274, P27426, DOI 10.1074/jbc.274.39.27426; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; MONTAGUE W, 1968, NATURE, V217, P853, DOI 10.1038/217853a0; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; ONG JM, 1989, J BIOL CHEM, V264, P3177; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Ranganathan G, 1999, J BIOL CHEM, V274, P9122, DOI 10.1074/jbc.274.13.9122; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Sartippour MR, 1998, DIABETES, V47, P431, DOI 10.2337/diabetes.47.3.431; Sartippour MR, 2000, DIABETES, V49, P597, DOI 10.2337/diabetes.49.4.597; SEIP RL, 1995, AM J PHYSIOL-ENDOC M, V268, pE229, DOI 10.1152/ajpendo.1995.268.2.E229; SEMB H, 1987, BIOCHIM BIOPHYS ACTA, V921, P104, DOI 10.1016/0005-2760(87)90176-7; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; Semenkovich CF, 1998, J LIPID RES, V39, P1141; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; SEMENKOVICH CF, 1990, J BIOL CHEM, V265, P5429; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; SINGHBIST A, 1994, BIOCHEM BIOPH RES CO, V202, P838, DOI 10.1006/bbrc.1994.2006; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; TAVANGAR K, 1992, AM J PHYSIOL, V262, pE330, DOI 10.1152/ajpendo.1992.262.3.E330; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; Yaney GC, 2000, ENDOCRINOLOGY, V141, P1989, DOI 10.1210/en.141.6.1989; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	51	42	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12162	12168		10.1074/jbc.M010707200	http://dx.doi.org/10.1074/jbc.M010707200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11154699	hybrid			2022-12-27	WOS:000168081800098
J	Deak, PM; Wolf, DH				Deak, PM; Wolf, DH			Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; PROTEASOME PATHWAY; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SACCHAROMYCES-CEREVISIAE; UNCONVENTIONAL ROUTE; SECRETORY PATHWAY; RING-H2 FINGER; ER DEGRADATION; FAMILIAR FATE; IN-VIVO	The endoplasmic reticulum contains a protein quality control system that discovers malfolded or unassembled secretory proteins and subjects them to degradation in the cytosol, This requires retrograde transport of the respective proteins from the endoplasmic reticulum back to the cytosol via the Sec61 translocon. In addition, a fully competent ubiquitination machinery and the 26 S proteasome are necessary for retrotranslocation and degradation. Ubiquitination of mutated and malfolded proteins of the endoplasmic reticulum is dependent mainly on the ubiquitin conjugating enzyme Ubc7p. In addition, several new membrane components of the endoplasmic reticulum are required for degradation. Here we present the topology of the previously discovered RING-MS finger protein Der3/Hrd1p, one of the new components of the endoplasmic reticulum membrane. The protein spans the membrane six times. The amino terminus and the carboxyl terminus containing the RING finger domain face the cytoplasm. Altogether, RING finger-dependent ubiquitination of malfolded carboxypeptidase yscY in vivo, as well as of Der3/Hrd1p itself in vitro and RING finger dependent binding of Ubc7p, uncovers Der3/Hrd1p as the ubiquitin-protein ligase (E3) of the endoplasmic reticulum-associated protein degradation process.	Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@po.uni-stuttgart.de						[Anonymous], 1991, Methods Enzymol, V194, P1; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1999, FEBS LETT, V448, P244, DOI 10.1016/S0014-5793(99)00362-2; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FRANZUSOFF A, 1991, METHOD ENZYMOL, V194, P662; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; McCracken AA, 1998, ADV MOL CEL, V27, P165, DOI 10.1016/S1569-2558(08)60461-0; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; SIKORSKI RS, 1989, GENETICS, V122, P19; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	41	143	147	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10663	10669		10.1074/jbc.M008608200	http://dx.doi.org/10.1074/jbc.M008608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139575	hybrid			2022-12-27	WOS:000167980900015
J	Medvedev, AV; Snedden, SK; Raimbault, S; Ricquier, D; Collins, S				Medvedev, AV; Snedden, SK; Raimbault, S; Ricquier, D; Collins, S			Transcriptional regulation of the mouse uncoupling protein-2 gene - Double E-Box motif is required for peroxisome proliferator-activated receptor-gamma-dependent activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; FATTY-ACIDS; PPAR-GAMMA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; IN-VIVO; GLUCOSE REGULATION; STEROL REGULATION; RESPONSE ELEMENT; SYNTHASE GENE	Uncoupling protein-2 (UCP2) is present in many tissues with relevance to fuel metabolism, and its expression is increased in fat and muscle in response to elevated circulating free fatty acids resulting from fasting and high fat feeding. We proposed a role for peroxisome proliferator-activated receptor-gamma (PPAR gamma) as a mediator of these physiological changes in UCP2, because thiazolidinediones also increase expression of UCP2 in these cell types (1), To determine the molecular basis for this regulation, we isolated the 7.3-kilobase promoter region of the mouse UCP2 gene. The -7.3-kilobase/+12-base pair fragment activates transcription of a reporter gene by 50-100-fold. Deletion and point mutation analysis, coupled with gel shift assays, indicate the presence of a 43-base pair enhancer (-86/-44) that is responsible for the majority of both basal and PPAR gamma -dependent transcriptional activity. The distal (-86/-76) part of the enhancer specifically binds Sp1, Sp2, and Sp3 and is indistinguishable from a consensus Sp1 element in competition experiments. Point mutation in this sequence reduces basal activity by 75%. A second region (-74/-66) is identical to the sterol response element consensus and specifically binds ADD1/SREBP1. However, deletion of this sequence does not affect basal transcriptional activity or the response to PPAR gamma, The proximal portion of the enhancer contains a direct repeat of two E-Box motifs, which contributes most strongly to basal and PPAR gamma -dependent transcription of the UCP2 promoter. Deletion of this region results in a 10-20-fold reduction of transcriptional activity and complete loss of PPAR gamma responsiveness. Point mutations in either E-Box, but not in the spacer region between them, eliminate the stimulatory response to PPAR gamma, However, gel shift assays show that PPAR gamma does not bind to this region. Taken together, these data indicate that PPAR gamma activates the UCP2 gene indirectly by altering the activity or expression of other transcription factors that bind to the UCP2 promoter.	Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; CNRS, Ctr Rech Endocrinol Mol & Dev, UPR 9078, F-92190 Meudon, France	Duke University; Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS)	Collins, S (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Box 3557, Durham, NC 27710 USA.			Medvedev, Alexander/0000-0001-6983-1687	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK009812, R01DK054024] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK54024, F31-DK09812] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnone MI, 1997, DEVELOPMENT, V124, P1851; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Austin S, 1998, CELL GROWTH DIFFER, V9, P267; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; Brun RP, 1997, CURR OPIN LIPIDOL, V8, P212, DOI 10.1097/00041433-199708000-00004; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; MIYAMOTO NG, 1987, NUCLEIC ACIDS RES, V15, P9095, DOI 10.1093/nar/15.21.9095; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Pecqueur C, 1999, BIOCHEM BIOPH RES CO, V255, P40, DOI 10.1006/bbrc.1998.0146; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosen ED, 2000, GENE DEV, V14, P1293; Samec S, 1999, DIABETES, V48, P436, DOI 10.2337/diabetes.48.2.436; Samec S, 1998, DIABETES, V47, P1693, DOI 10.2337/diabetes.47.11.1693; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230	45	90	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10817	10823		10.1074/jbc.M010587200	http://dx.doi.org/10.1074/jbc.M010587200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150307	hybrid			2022-12-27	WOS:000167980900036
J	Rho, J; Choi, S; Seong, YR; Cho, WK; Kim, SH; Im, DS				Rho, J; Choi, S; Seong, YR; Cho, WK; Kim, SH; Im, DS			PRMT5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; MYELIN BASIC-PROTEIN; N-METHYLTRANSFERASE; DEPENDENT METHYLTRANSFERASES; SUBSTRATE-SPECIFICITY; FISSION YEAST; NS3 PROTEIN; IN-VIVO; IDENTIFICATION; DOMAIN	We found that JBP1, known as a human homolog (Skb1Hs) of Skb1 of fission yeast, interacts with NS3 of the hepatitis C virus in a yeast two-hybrid screen. Amino acid sequence analysis revealed that Skb1Hs/JBP1 contains conserved motifs of S-adenosyl-L-methionine-dependent protein-arginine methyltransferases (PRMTs). Here, we demonstrate that Skb1Hs/JBP1, named PRMT5, is a distinct member of the PRMT family. Recombinant PRMT5 protein purified from human cells methylated myelin basic protein, histone, and the amino terminus of fibrillarin fused to glutathione S-transferase. Myelin basic protein methylated by PRMT5 contained monomethylated and dimethylated arginine residues. Recombinant glutathione S-transferase-PRMT5 protein expressed in Escherichia coli also contained the catalytic activity. Sedimentation analysis of purified PRMT5 on a sucrose density gradient indicated that PRMT5 formed distinct homooligomeric complexes, including a dimer and tetramer, that comigrated with the enzyme activity. The PRMT5 homo-oligomers were dissociated into a monomer in the presence of a reducing agent, whereas a monomer, dimer, and multimer were detected in the absence or at low concentrations of a reducing agent. The results indicate that both covalent linkage by a disulfide bond and noncovalent association are involved in the formation of PRMT5 homo oligomers. Western blot analysis of sedimentation fractions suggests that endogenous PRMT5 is present as a homo-oligomer in a 293T cell extract, PRMT5 appears to have lower specific enzyme activity than PRMT1. Although PRMT1 is known to be mainly located in the nucleus, human PRMT5 is predominantly localized in the cytoplasm.	Korea Res Inst Biosci & Biotechnol, Cell Biol Lab, Taejon 305333, South Korea; Korea Basic Sci Inst, Biomol Res Team, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Basic Science Institute (KBSI)	Im, DS (corresponding author), Korea Res Inst Biosci & Biotechnol, Cell Biol Lab, Taejon 305333, South Korea.	imdongsu@mail.kribb.re.kr		Rho, Jaerang/0000-0002-0019-4939				Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Fujita T, 1996, BIOCHEM BIOPH RES CO, V229, P825, DOI 10.1006/bbrc.1996.1887; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HEINE MA, 1993, MOL BIOL CELL, V4, P1189, DOI 10.1091/mbc.4.11.1189; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Katsanis N, 1997, MAMM GENOME, V8, P526, DOI 10.1007/s003359900491; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kim S, 1997, INT J BIOCHEM CELL B, V29, P743, DOI 10.1016/S1357-2725(97)00009-5; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPEYRE B, 1985, NUCLEIC ACIDS RES, V13, P5805, DOI 10.1093/nar/13.16.5805; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Muramatsu S, 1997, J VIROL, V71, P4954, DOI 10.1128/JVI.71.7.4954-4961.1997; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; PAIK WK, 1968, J BIOL CHEM, V243, P2108; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; RAWAL N, 1994, BIOCHEM J, V300, P483, DOI 10.1042/bj3000483; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; STONER GL, 1984, J NEUROCHEM, V43, P433, DOI 10.1111/j.1471-4159.1984.tb00919.x; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; WINSTONLA, 1996, CELL SIGNAL, V7, P739	54	119	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11393	11401		10.1074/jbc.M008660200	http://dx.doi.org/10.1074/jbc.M008660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152681	hybrid			2022-12-27	WOS:000167980900111
J	Amir-Ahmady, B; Salati, LM				Amir-Ahmady, B; Salati, LM			Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; RNA-POLYMERASE-II; NUCLEAR POSTTRANSCRIPTIONAL MECHANISM; MITOTIC APPARATUS PROTEIN; ACETYL-COA CARBOXYLASE; S14 GENE-TRANSCRIPTION; MESSENGER-RNA; RAT-LIVER; THYROID-HORMONE; SPLICING COMPLEXES	Expression of glucose-6-phosphate dehydrogenase (G6PD) gene during starvation and refeeding is regulated by a posttranscriptional mechanism occurring in the nucleus. The amount of G6PD mRNA at different stages of processing was measured in RNA isolated from the nuclear matrix fraction of mouse liver. This nuclear fraction contains nascent transcripts and RNA undergoing processing. Using a ribonuclease protection assay with probes that cross an exon-intron boundary in the G6PD transcript, the abundance of mRNAs that contain the intron (unspliced) and without the intron (spliced) was measured. Refeeding resulted in 6- and 8-fold increases in abundance of G6PD unspliced and spliced RNA respectively, in the nuclear matrix fraction. However, the amount of G6PD unspliced RNA was at most 15% of the amount of spliced RNA. During refeeding, G6PD spliced RNA accumulated at a rate significantly greater than unspliced RNA. Further, the amount of partially spliced RNA exceeded the amount of unspliced RNA indicating that the enhanced accumulation occurs early in processing, Starvation and refeeding did not regulate either the rate of polyadenylation or the length of the poly(A) tail. Thus, the G6PD gene is regulated during refeeding by enhanced efficiency of splicing of its RNA and this processing protects the mRNA from decay, a novel mechanism for nutritional regulation of gene expression.	W Virginia Univ, Hlth Sci Ctr, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Salati, LM (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.				NIDDK NIH HHS [R01 DK046897, DK46897] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046897, R29DK046897, R56DK046897] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoniou M, 1998, NUCLEIC ACIDS RES, V26, P721, DOI 10.1093/nar/26.3.721; BERDANIER CD, 1979, J NUTR, V109, P1766, DOI 10.1093/jn/109.10.1766; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; BEREZNEY R, 1977, J CELL BIOL, V73, P616, DOI 10.1083/jcb.73.3.616; BLAKE WL, 1990, J NUTR, V120, P1727, DOI 10.1093/jn/120.12.1727; BLENCOWE BJ, 1994, J CELL BIOL, V127, P593, DOI 10.1083/jcb.127.3.593; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BURMEISTER LA, 1991, J BIOL CHEM, V266, P22905; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIEJEK EM, 1982, BIOCHEMISTRY-US, V21, P4945, DOI 10.1021/bi00263a018; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; DOZIN B, 1986, P NATL ACAD SCI USA, V83, P4705, DOI 10.1073/pnas.83.13.4705; EHRETSMANN CP, 1995, MOL CELL ENDOCRINOL, V110, P185, DOI 10.1016/0303-7207(95)03531-B; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; ELMeskini R, 1997, ENDOCRINOLOGY, V138, P379, DOI 10.1210/en.138.1.379; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; GEREZ L, 1995, J BIOL CHEM, V270, P19569, DOI 10.1074/jbc.270.33.19569; GLOCK GE, 1955, BIOCHEM J, V61, P390, DOI 10.1042/bj0610390; GLOCK GE, 1954, BIOCHEM J, V56, P171, DOI 10.1042/bj0560171; Goethe R, 1998, J IMMUNOL, V160, P4970; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; GOZUKARA EM, 1972, BIOCHIM BIOPHYS ACTA, V286, P155, DOI 10.1016/0304-4165(72)90101-8; Grillasca JP, 1997, FEBS LETT, V401, P38, DOI 10.1016/S0014-5793(96)01433-0; HAMBLIN PS, 1989, J BIOL CHEM, V264, P21646; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hillgartner FB, 1996, BIOCHEM J, V319, P263, DOI 10.1042/bj3190263; Hirose Y, 2000, GENE DEV, V14, P1415; Hodge DL, 1997, ARCH BIOCHEM BIOPHYS, V348, P303, DOI 10.1006/abbi.1997.0373; JUMP DB, 1990, J BIOL CHEM, V265, P3474; JUMP DB, 1993, P NATL ACAD SCI USA, V90, P8454, DOI 10.1073/pnas.90.18.8454; JUMP DB, 1994, J LIPID RES, V35, P1076; KALLAJOKI M, 1991, EMBO J, V10, P3351, DOI 10.1002/j.1460-2075.1991.tb04899.x; KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x; KILEDJIAN M, 1991, J BIOL CHEM, V266, P4207; KIM KS, 1992, BIOCHEM BIOPH RES CO, V189, P264, DOI 10.1016/0006-291X(92)91553-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; LIAW CW, 1984, J BIOL CHEM, V259, P7253; MAEKAWA T, 1991, EUR J CELL BIOL, V54, P255; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Mortillaro MJ, 1996, P NATL ACAD SCI USA, V93, P8253, DOI 10.1073/pnas.93.16.8253; MURPHY D, 1992, MOL CELL BIOL, V12, P2624, DOI 10.1128/MCB.12.6.2624; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; Nickerson JA, 1995, INT REV CYTOL, V162A, P67; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Porter D, 1997, ANAL BIOCHEM, V247, P279, DOI 10.1006/abio.1997.2059; PROSTKO CR, 1989, BIOCHEM J, V258, P295, DOI 10.1042/bj2580295; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1969; SCHRODER HC, 1987, J BIOL CHEM, V262, P8917; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Stabile LP, 1998, J LIPID RES, V39, P1951; Stabile LP, 1996, ARCH BIOCHEM BIOPHYS, V332, P269, DOI 10.1006/abbi.1996.0342; STAPLETON SR, 1990, J BIOL CHEM, V265, P18442; SUN JM, 1994, J CELL BIOCHEM, V55, P252, DOI 10.1002/jcb.240550212; TANG TK, 1994, J CELL SCI, V107, P1389; TANG TK, 1993, J CELL SCI, V104, P249; TEPPERMAN HM, 1964, AM J PHYSIOL, V206, P357, DOI 10.1152/ajplegacy.1964.206.2.357; TOUSSON A, 1991, J CELL BIOL, V112, P427, DOI 10.1083/jcb.112.3.427; Walker JD, 1996, ENDOCRINOLOGY, V137, P2293, DOI 10.1210/en.137.6.2293; WAN KM, 1994, P NATL ACAD SCI USA, V91, P594, DOI 10.1073/pnas.91.2.594; WATANABE A, 1973, ARCH BIOCHEM BIOPHYS, V158, P43, DOI 10.1016/0003-9861(73)90595-X; WINBERRY L, 1977, J BIOL CHEM, V252, P7796; WOLFE RG, 1978, J NUTR, V108, P1708, DOI 10.1093/jn/108.10.1708; ZEITLIN S, 1987, MOL CELL BIOL, V7, P111, DOI 10.1128/MCB.7.1.111; ZENG CQ, 1994, P NATL ACAD SCI USA, V91, P1505, DOI 10.1073/pnas.91.4.1505; ZENG CQ, 1994, CELL MOTIL CYTOSKEL, V29, P167, DOI 10.1002/cm.970290208; Zhang J, 1996, RNA, V2, P235; ZHOU H, 1994, J BIOL CHEM, V269, P22433; Zollo M, 1993, DNA Seq, V3, P319, DOI 10.3109/10425179309020830	78	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10514	10523		10.1074/jbc.M010535200	http://dx.doi.org/10.1074/jbc.M010535200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124967	Green Published, hybrid			2022-12-27	WOS:000167996400120
J	Hanson, PK; Nichols, JW				Hanson, PK; Nichols, JW			Energy-dependent flip of fluorescence-labeled phospholipids is regulated by nutrient starvation and transcription factors, PDR1 and PDR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE MEMBRANE; PLASMA-MEMBRANE; TRANSBILAYER MOVEMENT; SACCHAROMYCES-CEREVISIAE; ASYMMETRIC DISTRIBUTION; MULTIDRUG-RESISTANCE; MAMMALIAN-CELLS; BLOOD-CELLS; RED-CELL; YEAST	The yeast Saccharomyces cerevisiae readily accumulates short-chain, fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-labebd phosphatidylcholine and phosphatidylethanolamine at the nuclear envelope/endoplasmic reticulum and mitochondria. The net intracellular accumulation reflects the sum of their inwardly and outwardly directed transbilayer translocation across the plasma membrane (flip and flop, respectively). The rate of flop is negligible in energy-depleted cells as well as at low temperature (2 degreesC), Although flip is reduced at 2 degreesC, it can still be measured by now cytometry, allowing the rate of flip, independent of flop, to be characterized at this temperature. Flip requires the energy of the plasma membrane proton electrochemical gradient and is down-regulated as cells pass through the diauxic shift and enter stationary phase. Furthermore, drug-resistant, gain-of-function mutations in the transcription factors, PDR1 and PDR3, result in a dramatic downregulation of flip in addition to their already established up-regulation of flop. These results imply that down-regulation of the NBD-phospholipid flip pathway is a physiological response to environmental stress.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Nichols, JW (corresponding author), Emory Univ, Sch Med, Dept Physiol, 1648 Pierce Dr, Atlanta, GA 30322 USA.	wnichols@physio.emory.edu		Hanson, Pamela/0000-0002-9312-1682	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R21GM052410] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52410, GM08367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BRETSCHER MS, 1972, J MOL BIOL, V71, P523, DOI 10.1016/0022-2828(72)90028-4; CONNOR J, 1987, BIOCHEMISTRY-US, V26, P5099, DOI 10.1021/bi00390a031; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; DEVAUX PF, 1994, CHEM PHYS LIPIDS, V73, P107, DOI 10.1016/0009-3084(94)90177-5; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; JULIEN M, 1993, EXP CELL RES, V208, P387, DOI 10.1006/excr.1993.1260; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Mahe Y, 1996, MOL MICROBIOL, V20, P109, DOI 10.1111/j.1365-2958.1996.tb02493.x; Marx U, 1999, EUR J BIOCHEM, V263, P254, DOI 10.1046/j.1432-1327.1999.00497.x; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; MORROT G, 1990, FEBS LETT, V266, P29, DOI 10.1016/0014-5793(90)81498-D; MULLER K, 1994, BIOCHEMISTRY-US, V33, P9968; Muller P, 1996, HEPATOLOGY, V24, P1497; NOLAN JP, 1995, BIOCHEMISTRY-US, V34, P3907, DOI 10.1021/bi00012a006; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; Pomorski T, 1996, J CELL SCI, V109, P687; Pomorski T, 1999, BIOCHEMISTRY-US, V38, P142, DOI 10.1021/bi981244n; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x; RIEZMAN H, 1986, TRENDS BIOCHEM SCI, V11, P325, DOI 10.1016/0968-0004(86)90290-2; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; ROSING J, 1985, BLOOD, V65, P1557, DOI 10.1182/blood.V65.6.1557.bloodjournal6561557; SCHROIT AJ, 1987, BIOCHEMISTRY-US, V26, P1812, DOI 10.1021/bi00381a004; SCHROIT AJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P313, DOI 10.1016/0304-4157(91)90019-S; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SHERMAN F, 1986, METHODS YEAST GENETI, P181; Siegmund A, 1998, J BIOL CHEM, V273, P34399, DOI 10.1074/jbc.273.51.34399; SLEIGHT RG, 1989, J CELL SCI, V93, P363; SLEIGHT RG, 1985, J BIOL CHEM, V260, P1146; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; TILLEY L, 1986, FEBS LETT, V194, P21, DOI 10.1016/0014-5793(86)80044-8; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; ZACHOWSKI A, 1987, BIOCHIM BIOPHYS ACTA, V897, P197, DOI 10.1016/0005-2736(87)90328-2; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZIMMERMAN ML, 1993, BIOCHEMISTRY-US, V32, P12257, DOI 10.1021/bi00096a040; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	59	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9861	9867		10.1074/jbc.M009065200	http://dx.doi.org/10.1074/jbc.M009065200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136727	hybrid			2022-12-27	WOS:000167996400039
J	Lemmens, R; Larsson, O; Berggren, PO; Islam, MS				Lemmens, R; Larsson, O; Berggren, PO; Islam, MS			Ca2+-induced Ca2+ release from the endoplasmic reticulum amplifies the Ca2+ signal mediated by activation of voltage-gated L-type Ca2+ channels in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ADRENAL GLOMERULOSA CELLS; PHOSPHOLIPASE-C ACTIVITY; CYCLIC ADP-RIBOSE; RYANODINE RECEPTOR; CALCIUM-RELEASE; CATION SENSITIVITY; RINM5F CELLS; THAPSIGARGIN; ISLETS	Stimulus-secretion coupling in pancreatic beta -cells involves membrane depolarization and Ca2+ entry through voltage-gated L-type Ca2+ channels, which is one determinant of increases in the cytoplasmic free Ca2+ concentration ([Ca2+](i)). We investigated how the endoplasmic reticulum (ER)-associated Ca2+ apparatus further modifies this Ca2+ signal. When fura-2-loaded mouse beta -cells were depolarized by KCI in the presence of 3 mM glucose, [Ca2+](i) increased to a peak in two phases. The second phase of the [Ca2+](i) increase was abolished when ER Ca2+ stores were depleted by thapsigargin, The steady-state [Ca2+]i measured at 300 s of depolarization was higher in control cells compared with cells in which the ER Ca2+ pools were depleted. The amount of Ca2+ presented to the cytoplasm during depolarization as estimated from the integral of the increment in [Ca2+](i) over time (integral Delta [Ca2+](i)dt) was similar to 30% higher compared with that in the Ca pool-depleted cells. neothapsigargin, an inactive analog, did not affect [Ca2+](i) response. Using Sr2+ in the extracellular medium and exploiting the differences in the fluorescence properties of Ca2+- and Sr2+-bound fluo-3, we found that the incoming Sr2+ triggered Ca2+ release from the ER, Depolarization-induced [Ca2+](i) response was not altered by U73122, an inhibitor of phosphatidylinositol-specific phospholipase C, suggesting that stimulation of the enzyme by Ca2+ is not essential for amplification of Ca2+ signaling, [Ca2+](i) response was enhanced when cells were depolarized in the presence of 3 mM glucose, forskolin, and caffeine, suggesting involvement of ryanodine receptors in the amplification process. Pretreatment with ryanodine (100 muM) diminished the second phase of the depolarization-induced increase in [Ca2+](i). We conclude that Ca2+ entry through L-type voltage-gated Ca2+ channels triggers Ca2+ release from the ER and that such a process amplifies depolarization-induced Ca2+ signaling in beta -cells.	Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med, Endocrine & Diabet Unit,Karolinska Hosp, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Islam, MS (corresponding author), Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med, Endocrine & Diabet Unit,Karolinska Hosp, S-17176 Stockholm, Sweden.		Islam, Shahidul/K-3295-2019	Islam, Shahidul/0000-0002-9016-1881; Berggren, Per-Olof/0000-0001-8991-413X				ANDERSEN A, 1994, ACTA CHEM SCAND, V48, P340, DOI 10.3891/acta.chem.scand.48-0340; BALLA T, 1994, J BIOL CHEM, V269, P16101; BECKER PL, 1989, SCIENCE, V244, P211, DOI 10.1126/science.2704996; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Bird GSJ, 1997, CELL CALCIUM, V21, P253, DOI 10.1016/S0143-4160(97)90049-X; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; DUARTE CB, 1993, EUR J PHARM-MOLEC PH, V244, P259, DOI 10.1016/0922-4106(93)90151-X; EVTODIENKO YV, 1994, CELL CALCIUM, V15, P143, DOI 10.1016/0143-4160(94)90053-1; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEDESKOV CJ, 1991, MOL CELL ENDOCRINOL, V78, P187, DOI 10.1016/0303-7207(91)90122-9; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; ISLAM MS, 1992, FEBS LETT, V296, P287, DOI 10.1016/0014-5793(92)80306-2; ISLAM MS, 1995, BIOCHEM J, V306, P679, DOI 10.1042/bj3060679; Islam MS, 1997, BIOCHEM J, V321, P347, DOI 10.1042/bj3210347; ISLAM MS, 1993, BIOCHEM J, V293, P423, DOI 10.1042/bj2930423; ISLAM MS, 1993, SCIENCE, V262, P584, DOI 10.1126/science.8211188; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; ISLAM MS, 1994, THESIS KAROLINSKA I; Lee B, 1998, J MOL ENDOCRINOL, V21, P31, DOI 10.1677/jme.0.0210031; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Missiaen L, 1998, J BIOL CHEM, V273, P8983, DOI 10.1074/jbc.273.15.8983; MONTAGUE W, 1985, BIOCHEM J, V227, P483, DOI 10.1042/bj2270483; POWIS G, 1992, CANCER RES, V52, P2835; ROSSIER MF, 1993, BIOCHEM J, V296, P309, DOI 10.1042/bj2960309; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; TAYLOR CW, 1986, BIOCHEM J, V238, P765, DOI 10.1042/bj2380765; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Velez P, 1997, BIOPHYS J, V72, pTH157; WALENGA R, 1980, J BIOL CHEM, V255, P6024; Zawalich WS, 1997, AM J PHYSIOL-ENDOC M, V272, pE671, DOI 10.1152/ajpendo.1997.272.4.E671; ZAWALICH WS, 1995, ENDOCRINOLOGY, V136, P4903, DOI 10.1210/en.136.11.4903	40	75	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9971	9977		10.1074/jbc.M009463200	http://dx.doi.org/10.1074/jbc.M009463200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139580	hybrid			2022-12-27	WOS:000167996400054
J	Mark, BL; Vocadlo, DJ; Knapp, S; Triggs-Raine, BL; Withers, SG; James, MNG				Mark, BL; Vocadlo, DJ; Knapp, S; Triggs-Raine, BL; Withers, SG; James, MNG			Crystallographic evidence for substrate-assisted catalysis in a bacterial beta-hexosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAY-SACHS-DISEASE; ACID-SEQUENCE SIMILARITIES; ELECTRON-DENSITY MAPS; GLYCOSYL HYDROLASES; STREPTOMYCES-PLICATUS; ACTIVE-SITE; MECHANISMS; CLASSIFICATION; CHITOBIASE; HYDROLYSIS	beta -Hexosaminidase, a family 20 glycosyl hydrolase, catalyzes the removal of beta -1,4-linked N-acetylhexosamine residues from oligosaccharides and their conjugates, Heritable deficiency of this enzyme results in various forms of GalNAc-beta (1,4)-[N-acetylneuraminic acid (2,3)]-Gal-beta (1,4)-Glc-ceramide gangliosidosis, including Tay-Sachs disease. We have determined the x-ray crystal structure of a P-hexosaminidase from Streptomyces plicatus to 2.2 Angstrom resolution (Protein Data Bank code 1HP4), P-Hexosaminidases are believed to use a substrate-assisted catalytic mechanism that generates a cyclic oxazolinium ion intermediate. We have solved and refined a complex between the cyclic intermediate analogue N-acethlglucosamine-thiazoline and beta -hexosaminidase from S, plicatus to 2.1 Angstrom resolution (Protein Data Bank code 1HP5), Difference Fourier analysis revealed the pyranose ring of N-acetylglucosamine-thiazoline bound in the enzyme active site with a conformation close to that of a C-4(1) chair. A tryptophan-lined hydrophobic pocket envelops the thiazoline ring, protecting it from solvolysis at the iminium ion carbon. Within this pocket, Tyr(393) and Asp(313) appear important for positioning the 2-acetamido group of the substrate for nucleophilic attack at the anomeric center and for dispersing the positive charge distributed into the oxazolinium ring upon cyclization, This complex provides decisive structural evidence for substrate-assisted catalysis and the formation of a covalent, cyclic intermediate in family 20 beta -hexosaminidases.	Univ Alberta, Dept Biochem, MRC, Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Rutgers State Univ, Dept Chem, New Brunswick, NJ 08903 USA; Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada	University of Alberta; University of British Columbia; Rutgers State University New Brunswick; University of Manitoba	James, MNG (corresponding author), Univ Alberta, Dept Biochem, MRC, Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada.		Withers, Stephen G/I-7229-2019; Vocadlo, David J/E-5508-2014; Triggs-Raine, Barbara/AAF-6209-2021	Withers, Stephen G/0000-0002-6722-5701; Vocadlo, David J/0000-0001-6897-5558; Triggs-Raine, Barbara/0000-0003-4719-6779; Mark, Brian/0000-0002-7344-1355				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BROWN CA, 1989, J BIOL CHEM, V264, P21705; BROWN CA, 1993, AM J HUM GENET, V53, P497; Brunger A. T., 1993, XPLOR SYSTEM XRAY CR; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao ZM, 1997, J BIOL CHEM, V272, P14975, DOI 10.1074/jbc.272.23.14975; CHURCH WB, 1992, J MOL BIOL, V227, P577, DOI 10.1016/0022-2836(92)90911-3; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fernandes MJG, 1997, J BIOL CHEM, V272, P814, DOI 10.1074/jbc.272.2.814; Gravel R. A., 1995, METABOLIC BASIS INHE, P1807; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hou YM, 2000, BIOCHEMISTRY-US, V39, P6219, DOI 10.1021/bi992464j; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIRBY AJ, 1984, ACCOUNTS CHEM RES, V17, P305, DOI 10.1021/ar00105a002; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAI ECK, 1994, BIOCHEMISTRY-US, V33, P14743, DOI 10.1021/bi00253a012; LEGLER G, 1992, CARBOHYD RES, V233, P113, DOI 10.1016/S0008-6215(00)90924-8; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pennybacker M, 1997, J BIOL CHEM, V272, P8002, DOI 10.1074/jbc.272.12.8002; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; ROBBINS PW, 1992, GENE, V111, P69, DOI 10.1016/0378-1119(92)90604-N; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2475, DOI 10.1016/S0040-4039(00)84560-8; Sambrook J., 2002, MOL CLONING LAB MANU; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; TANAKA A, 1990, AM J HUM GENET, V46, P329; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	50	227	246	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10330	10337		10.1074/jbc.M011067200	http://dx.doi.org/10.1074/jbc.M011067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124970	hybrid			2022-12-27	WOS:000167996400099
J	Xing, HR; Kolesnick, R				Xing, HR; Kolesnick, R			Kinase suppressor of ras signals through Thr(269) of c-Raf-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-KINASE; EPIDERMAL GROWTH-FACTOR; SERINE THREONINE KINASE; PDGF BETA-RECEPTOR; KSR-1 GENE ENCODES; RAF-1 KINASE; TYROSINE PHOSPHORYLATION; A431 CELLS; MAP KINASE; PLASMA-MEMBRANE	We recently established a two-stage in vitro assay for KSR kinase activity in which KSR never comes in contact with any recombinant kinase other than c-Raf-l and defined the epidermal growth factor (EGF) as a potent activator of KSR kinase activity (Xing, H, R,, Lozano, J,, and Kolesnick, R, (2000) J, BioL Chem. 275, 17276-17280), That study, however, did not address the mechanism of c-Raf-l stimulation by activated KSR, Here we show that phosphorylation of c-Raf-l on Thr(269) by KSR is necessary for optimal activation in response to EGF stimulation. In vitro, KSR specifically phosphorylated c-Raf-l on threonine residues during the first stage of the two-stage kinase assay. Using purified wild-type and mutant c-Raf-l proteins, we demonstrate that Th-269 is, the major c-Raf-l site phosphorylated by KSR in vitro and that phosphorylation of this site is essential for c-Raf-l activation by KSR, KSR acts via transphosphorylation, not by increasing c-Raf-l autophosphorylation, as kinase-inactive c-Raf-1(K375M) served as an equally effective KSR substrate. In vivo, low physiologic doses of EGF (0.001-0.1 ng/ml) stimulated KSR activation and induced Thr(269) phosphorylation and activation of c-Raf-l, Low dose EGF did not induce serine or tyrosine phosphorylation of c-Raf-l, High dose EGF (10-100 ng/ml) induced no additional Thr(269) phosphorylation, but rather increased c-Raf-l phosphorylation on serine residues and Tyr(340)/Tyr(341). A Raf-l mutant with valine substituted for Thr(269) was unresponsive to low dose EGF, but was serine- and Tyr(340)/Try(341)-phosphorylated and partially activated at high dose EGF. This study shows that Thr(269) is the major c-Raf-l site phosphorylated by KSR, Furthermore, phosphorylation of this site is essential for c-Raf-l activation by KSR in vitro and for optimal c-Raf-l activation in response to physiologic EGF stimulation in vivo.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, Sloan Kettering Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA042385] Funding Source: NIH RePORTER; NCI NIH HHS [CA42385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADUNYAH SE, 1995, BIOCHEM BIOPH RES CO, V206, P103, DOI 10.1006/bbrc.1995.1015; Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; BEIMLING P, 1994, BIOCHEM BIOPH RES CO, V204, P841, DOI 10.1006/bbrc.1994.2536; Cacace AM, 1999, MOL CELL BIOL, V19, P229; CARROLL MP, 1990, J BIOL CHEM, V265, P19812; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CHAJRY N, 1994, BIOCHEM BIOPH RES CO, V203, P984, DOI 10.1006/bbrc.1994.2279; Chajry N, 1996, EUR J BIOCHEM, V235, P97, DOI 10.1111/j.1432-1033.1996.00097.x; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DENT P, 1995, MOL CELL BIOL, V15, P4125; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; DENT P, 1994, P NATL ACAD SCI USA, V91, P9544, DOI 10.1073/pnas.91.20.9544; DENT P, 1994, BIOCHEM J, V303, P105, DOI 10.1042/bj3030105; Dent P, 1996, J BIOL CHEM, V271, P3119, DOI 10.1074/jbc.271.6.3119; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; DOWNWARD J, 1995, CELL, V83, P831, DOI 10.1016/0092-8674(95)90198-1; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; IZUMI T, 1991, J BIOL CHEM, V266, P7933; Jakus J, 1996, ONCOGENE, V12, P2369; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAWAMOTO T, 1984, J BIOL CHEM, V259, P7761; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MAGNUSON NS, 1994, SEMIN CANCER BIOL, V5, P247; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MOODIE SA, 1994, TRENDS GENET, V10, P44, DOI 10.1016/0168-9525(94)90147-3; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; MORRISON DK, 1990, CANCER CELL-MON REV, V2, P377; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Silvy M, 1998, ENDOCRINOLOGY, V139, P2382, DOI 10.1210/en.139.5.2382; SOLER C, 1994, ONCOGENE, V9, P2207; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; Stewart S, 1999, MOL CELL BIOL, V19, P5523; STORM SM, 1990, ONCOGENE, V5, P345; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Tebar F, 2000, ENDOCRINOLOGY, V141, P876, DOI 10.1210/en.141.3.876; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Toyoda M, 1998, BIOCHEM BIOPH RES CO, V250, P430, DOI 10.1006/bbrc.1998.9332; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; Xing HR, 2000, J BIOL CHEM, V275, P17276, DOI 10.1074/jbc.C900989199; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	60	53	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9733	9741		10.1074/jbc.M008096200	http://dx.doi.org/10.1074/jbc.M008096200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134016	hybrid			2022-12-27	WOS:000167996400022
J	Gardner, RG; Shan, H; Matsuda, SPT; Hampton, RY				Gardner, RG; Shan, H; Matsuda, SPT; Hampton, RY			An oxysterol-derived positive signal for 3-hydroxy-3-methylglutaryl-CoA reductase degradation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; HMG-COA REDUCTASE; 2,3-OXIDOSQUALENE-LANOSTEROL CYCLASE INHIBITOR; STEROL-ENHANCED DEGRADATION; RETICULUM MEMBRANE-PROTEIN; GREEN FLUORESCENT PROTEIN; REGULATED DEGRADATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL-BIOSYNTHESIS	Sterol synthesis by the mevalonate pathway is modulated, in part, through feedback-regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR). In mammals, both a non-sterol isoprenoid signal derived from farnesyl diphosphate (FPP) and a sterol-derived signal appear to act together to positively regulate the rate of HMGR degradation. Although the nature and number of sterol-derived signals are not clear, there is growing evidence that oxysterols can serve in this capacity. In yeast, a similar non-sterol isoprenoid signal generated from FPP acts to positively regulate HMGR degradation, but the existence of any sterol-derived signal has thus far not been revealed. We now demonstrate, through the use of genetic and pharmacological manipulation of oxidosqualene-lanosterol cyclase, that an oxysterol-derived signal positively regulated HMGR degradation in yeast. The oxysterol-derived signal acted by specifically modulating HMGR stability, not endoplasmic reticulum-associated degradation in general. Direct biochemical labeling of mevalonate pathway products confirmed that oxysterols were produced endogenously in yeast and that their levels varied appropriately in response to genetic or pharmacological manipulations that altered HMGR stability. Genetic manipulation of oxidosqualene-lanosterol cyclase did result in the buildup of detectable levels of 24,25-oxidolanosterol by gas chromatography, gas chromatography-mass spectroscopy, and MMR analyses, whereas no detectable amounts were observed in wild-type cells or cells with squalene epoxidase down-regulated. In contrast to mammalian cells, the yeast oxysterol-derived signal was not required for HMGR degradation in yeast, Rather, the function of this second signal was to enhance the ability of the FPP-derived signal to promote HMGR degradation. Thus, although differences do exist, both yeast and mammalian cells employ a similar strategy of multiinput regulation of HMGR degradation.	Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, Dept Chem, Houston, TX 77005 USA	University of California System; University of California San Diego; Rice University; Rice University	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.			Gardner, Richard/0000-0003-2162-6275	NHLBI NIH HHS [HL49122] Funding Source: Medline; NIDDK NIH HHS [DK5199601] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAI M, 1992, BIOCHEM BIOPH RES CO, V185, P323, DOI 10.1016/S0006-291X(05)90003-X; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; BOUTAUD O, 1992, BIOCHEM BIOPH RES CO, V188, P898, DOI 10.1016/0006-291X(92)91140-L; BRADFUTE DL, 1994, J BIOL CHEM, V269, P6645; BRODERICK G, 1991, NEUROUROL URODYNAM, V10, P507, DOI 10.1002/nau.1930100507; CHEREST H, 1985, GENE, V34, P269; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; CHUN KT, 1990, J BIOL CHEM, V265, P22004; CORRELL CC, 1994, J BIOL CHEM, V269, P17390; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; DOLLIS D, 1994, BIOCHEM PHARMACOL, V48, P49, DOI 10.1016/0006-2952(94)90222-4; Du EZ, 1999, J BIOL CHEM, V274, P1856, DOI 10.1074/jbc.274.3.1856; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; FIELD RB, 1979, LIPIDS, V14, P741, DOI 10.1007/BF02533900; FIELD RB, 1977, ARCH BIOCHEM BIOPHYS, V180, P465, DOI 10.1016/0003-9861(77)90061-3; FUNG B, 1976, BIOCHEM PHARMACOL, V25, P1249, DOI 10.1016/0006-2952(76)90086-1; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; KUMAGAI H, 1995, J BIOL CHEM, V270, P19107, DOI 10.1074/jbc.270.32.19107; Lopez D, 1997, ARCH BIOCHEM BIOPHYS, V343, P118, DOI 10.1006/abbi.1997.0162; Mark M, 1996, J LIPID RES, V37, P148; Meigs TE, 1997, ARCH BIOCHEM BIOPHYS, V345, P1, DOI 10.1006/abbi.1997.0200; Meigs TE, 1996, J BIOL CHEM, V271, P7916, DOI 10.1074/jbc.271.14.7916; MEIGS TE, 1992, J BIOL CHEM, V267, P13547; Morand OH, 1997, J LIPID RES, V38, P373; MOUNTAIN HA, 1991, YEAST, V7, P781, DOI 10.1002/yea.320070804; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; NI Y, 1993, TETRAHEDRON LETT, V34, P3687, DOI 10.1016/S0040-4039(00)79201-X; PANINI SR, 1986, J LIPID RES, V27, P1190; PANINI SR, 1992, J BIOL CHEM, V267, P12647; Peffley DM, 1997, ARCH BIOCHEM BIOPHYS, V337, P251, DOI 10.1006/abbi.1996.9796; Peffley DM, 1998, BIOCHEM PHARMACOL, V56, P439, DOI 10.1016/S0006-2952(98)00083-5; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; RYDER NS, 1989, CLIN EXP DERMATOL, V14, P98, DOI 10.1111/j.1365-2230.1989.tb00900.x; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836	52	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8681	8694		10.1074/jbc.M007888200	http://dx.doi.org/10.1074/jbc.M007888200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134013	hybrid			2022-12-27	WOS:000167607700011
J	Iwasaki, K; Morimatsu, M; Inanami, O; Uchida, E; Syuto, B; Kuwabara, M; Niiyama, M				Iwasaki, K; Morimatsu, M; Inanami, O; Uchida, E; Syuto, B; Kuwabara, M; Niiyama, M			Isolation, characterization, and cDNA cloning of chicken turpentine-induced protein, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE NADPH OXIDASE; MOLECULAR-CLONING; FREE-RADICALS; HUMAN-NEUTROPHILS; LYMPHOCYTES-T; CELL-SURFACE; ACTIVATION; CONTAINS; DOMAIN; DIFFERENTIATION	Acute-phase serum proteins were induced by administrating a chicken with turpentine oil. One of these proteins was a new protein that appeared in front of albumin in polyacrylamide disc gel electrophoresis using a 4.5-16% gel. To purify this protein, turpentine-administrated chicken serum was fractionated by ammonium sulfate precipitation at 50% saturation, and the supernatant fraction was chromatographed on a DEAE-Toyopearl 650S column. The purified protein is a mannose-glycoprotein, and its N-terminal sequence, determined by the Edoman method, is not homologous from that of other reported acute-phase proteins. An analysis of physiological function with two different test systems, chemiluminescence measurement and electron spin resonance spectroscopy, showed that the purified protein has antioxidant, activity and inhibits superoxide (O-2(radical anion)) mediated by activation of the receptor. In support of these results, the complete amino acid sequence of 18-B is homologous to the scavenger receptor cysteine-rich (SRCR) family of proteins that participate in the regulation of leukocyte function. 18-B is composed of four SRCR domains, which is different from the previously characterized SRCR family of proteins such as Sp alpha, CD6, and CD163. These findings indicate that turpentine-induced 18-B, a new member of scavenger receptor cysteine-rich family, may be implicated in regulation of cell function in a manner of inhibition of the overproduction of the reactive oxygen species.	Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Internal Med 2, Ebetsu, Hokkaido 0698501, Japan; Iwate Univ, Fac Agr, Dept Vet Physiol, Morioka, Iwate 0208550, Japan; Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Med, Sapporo, Hokkaido 0600818, Japan	Rakuno Gakuen University; Iwate University; Hokkaido University	Niiyama, M (corresponding author), Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Internal Med 2, Ebetsu, Hokkaido 0698501, Japan.		Inanami, Osamu/A-5197-2012; Morimatsu, Masami/A-6698-2012	Inanami, Osamu/0000-0001-7895-3918; Morimatsu, Masami/0000-0003-0740-0157				AMRANI DL, 1986, BIOCHEM J, V238, P365, DOI 10.1042/bj2380365; ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BRITIGAN BE, 1987, J LEUKOCYTE BIOL, V41, P349, DOI 10.1002/jlb.41.4.349; BRITIGAN BE, 1986, J BIOL CHEM, V261, P4426; Chamulitrat W, 1999, FREE RADICAL BIO MED, V27, P411, DOI 10.1016/S0891-5849(99)00088-X; Cheng H, 1996, ANAT REC, V244, P327; DELERS E, 1983, COMP BIOCH PHYSL, V74, P619; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FELGENHAUER K, 1970, Clinica Chimica Acta, V27, P305, DOI 10.1016/0009-8981(70)90349-9; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; GRIENINGER G, 1989, ANN NY ACAD SCI, V557, P257; GRIENINGER G, 1986, J BIOL CHEM, V261, P5719; HALLQUIST NA, 1994, COMP BIOCHEM PHYS B, V108, P375, DOI 10.1016/0305-0491(94)90089-2; HUANG HJS, 1987, P NATL ACAD SCI USA, V84, P204, DOI 10.1073/pnas.84.1.204; Inanami O, 1998, ARCH BIOCHEM BIOPHYS, V350, P36, DOI 10.1006/abbi.1997.0484; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; JAIN NK, 1982, VET REC, V110, P421, DOI 10.1136/vr.110.18.421; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; KLASING KC, 1991, POULTRY SCI, V70, P1176, DOI 10.3382/ps.0701176; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PATTERSON LT, 1965, TEX REP BIOL MED, V23, P600; SINHA BK, 1987, RES VET SCI, V42, P365, DOI 10.1016/S0034-5288(18)30720-3; SYUTO B, 1981, JPN J VET SCI, V43, P71; Takito J, 1999, AM J PHYSIOL-RENAL, V277, pF277, DOI 10.1152/ajprenal.1999.277.2.F277; THIES ES, 1983, AM J VET RES, V44, P288; TOHJO H, 1995, POULTRY SCI, V74, P648, DOI 10.3382/ps.0740648; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URBAN J, 1979, J BIOL CHEM, V254, P565; VAN DE VELDE H, 1991, NATURE, V351, P662; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; WHITNEY GS, 1995, J BIOL CHEM, V270, P18187, DOI 10.1074/jbc.270.31.18187; WIJNGAARD PLJ, 1992, J IMMUNOL, V149, P3273; Yamamori T, 2000, FEBS LETT, V467, P253, DOI 10.1016/S0014-5793(00)01167-4	40	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9400	9405		10.1074/jbc.M011713200	http://dx.doi.org/10.1074/jbc.M011713200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11136738	hybrid			2022-12-27	WOS:000167607700104
J	Wilson, GM; Sutphen, K; Chuang, KY; Brewer, G				Wilson, GM; Sutphen, K; Chuang, KY; Brewer, G			Folding of A+U-rich RNA elements modulates AUF1 binding - Potential roles in regulation of mRNA turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; RECEPTOR MESSENGER-RNA; IN-VITRO SYSTEM; FLUORESCENCE ANISOTROPY; HAIRPIN RIBOZYME; MAMMALIAN-CELLS; RIBOSOMAL-RNA; STABILITY; PROTEIN; DECAY	In mammals, A+U-rich elements (AREs) are potent cis-acting determinants of rapid cytoplasmic mRNA turnover. Recognition of these sequences by AUF1 is associated with acceleration of mRNA decay, likely involving recruitment or assembly of multi-subunit transacting complexes. Previously, we demonstrated that AUF1 deletion mutants formed tetramers on U-rich RNA substrates by sequential addition of protein dimers (Wilson, G. M., Sun, Y., Lu, H,, and Brewer, G, (1999) J, Biol. Chem. 274, 33374-33381). Here, we show that binding of the full-length p37 isoform of AUF1 to these RNAs proceeds via a similar mechanism, allowing delineation of equilibrium binding constants for both stages of tetramer assembly. However, association of AUF1 with the ARE from tumor necrosis factor (TNF alpha) mRNA was significantly inhibited by magnesium ions. Further fluorescence and hydrodynamic experiments indicated that Mg2+ induced or stabilized a conformational change in the TNF alpha ARE. Based on the solution of parameters describing both the protein-RNA and Mg2+-RNA equilibria, we present a dynamic, global equilibrium binding model describing the relationship between Mg2+ and AUF1 binding to the TNF alpha ARE. These studies provide the first evidence that some AREs may adopt higher order RNA structures that regulate their interaction with traits-acting factors and indicate that mRNA structural remodeling has the potential to modulate the turnover rates of some ARE-containing mRNAs.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wilson, GM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA.	wilsongm@umdnj.edu; brewerga@umdnj.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507	NCI NIH HHS [R01 CA 52443] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; Blyn LB, 2000, NUCLEIC ACIDS RES, V28, P1778, DOI 10.1093/nar/28.8.1778; Brewer G, 1999, J BIOL CHEM, V274, P16174, DOI 10.1074/jbc.274.23.16174; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Brewer G, 1998, J BIOL CHEM, V273, P34770, DOI 10.1074/jbc.273.52.34770; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; Buzby JS, 1996, BLOOD, V88, P2889, DOI 10.1182/blood.V88.8.2889.bloodjournal8882889; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DeMaria CT, 1997, J BIOL CHEM, V272, P27635, DOI 10.1074/jbc.272.44.27635; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; FASMAN GD, 1976, CRC HDB BIOCH MOL BI, P589; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Gluick TC, 1997, J MOL BIOL, V270, P451, DOI 10.1006/jmbi.1997.1119; Gonzalez RL, 1999, J MOL BIOL, V289, P1267, DOI 10.1006/jmbi.1999.2841; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; JAMESON DM, 1995, METHOD ENZYMOL, V246, P283; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Misra VK, 2000, J MOL BIOL, V299, P813, DOI 10.1006/jmbi.2000.3769; Nair TM, 2000, NUCLEIC ACIDS RES, V28, P1935, DOI 10.1093/nar/28.9.1935; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; Pande A, 1996, J BIOL CHEM, V271, P8493, DOI 10.1074/jbc.271.14.8493; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; Qin PZF, 1999, METHODS, V18, P60, DOI 10.1006/meth.1999.0757; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; ROSS HJ, 1991, BLOOD, V77, P1787; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Serebrov V, 1998, NUCLEIC ACIDS RES, V26, P2723, DOI 10.1093/nar/26.11.2723; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Tholanikunnel BG, 1997, J BIOL CHEM, V272, P11471; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Walter F, 1998, RNA, V4, P719, DOI 10.1017/S135583829898030X; Walter F, 1998, BIOCHEMISTRY-US, V37, P17629, DOI 10.1021/bi9821115; Walter NG, 1998, EMBO J, V17, P2378, DOI 10.1093/emboj/17.8.2378; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Xiong Y, 2000, RNA, V6, P1316, DOI 10.1017/S135583820000090X; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yu YT, 1999, METHODS, V18, P13, DOI 10.1006/meth.1999.0752; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	56	61	63	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8695	8704		10.1074/jbc.M009848200	http://dx.doi.org/10.1074/jbc.M009848200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11124962	hybrid			2022-12-27	WOS:000167607700012
J	Wooten, MW; Seibenhener, ML; Mamidipudi, V; Diaz-Meco, MT; Barker, PA; Moscat, J				Wooten, MW; Seibenhener, ML; Mamidipudi, V; Diaz-Meco, MT; Barker, PA; Moscat, J			The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappa B activation by nerve growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; NEUROTROPHIN RECEPTOR; SIGNAL-TRANSDUCTION; SURVIVAL; APOPTOSIS; PKC; DIFFERENTIATION; ISOFORMS; PATHWAY; FAMILY	Nerve growth factor (NGF) binding to both p75 and TrkA neurotrophin receptors activates the transcription factor nuclear factor kappaB (NF-kappaB). Here we show that the atypical protein kinase C-interacting protein, p62, which binds TRAF6, selectively interacts with TrkA but not p75. In contrast, TRAF6 interacts with p75 but not TrkA. We demonstrate the formation of a TRAF6-p62 complex that serves as a bridge linking both p75 and TrkA signaling. Of functional relevance, transfection of antisense p62-enhanced p75-mediated cell death and diminished NGF-induced differentiation occur through a mechanism involving inhibition of IKK activity. These findings reveal a new function for p62 as a common platform for communication of both p75-TRAF6 and TrkA signals. Moreover, we demonstrated that p62 serves as a scaffold for activation of the NF-kappaB pathway, which mediates NGF survival and differentiation responses.	Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, Auburn, AL 36849 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada	Auburn University System; Auburn University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); McGill University	Wooten, MW (corresponding author), Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, 331 Funchess Hall, Auburn, AL 36849 USA.		Moscat, Jorge/A-7011-2009	Diaz-Meco, Maria/0000-0003-0147-0998				Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; Feng ZW, 1999, J BIOL CHEM, V274, P30341, DOI 10.1074/jbc.274.43.30341; Foehr ED, 2000, J NEUROSCI, V20, P7556; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Jiang H, 1999, J BIOL CHEM, V274, P26209, DOI 10.1074/jbc.274.37.26209; Kaplan DR, 1998, PROG BRAIN RES, V117, P35; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Li QT, 2000, GENE DEV, V14, P1729; Lomaga MA, 2000, J NEUROSCI, V20, P7384; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Wooten MW, 1999, J NEUROSCI RES, V58, P607, DOI 10.1002/(SICI)1097-4547(19991201)58:5<607::AID-JNR1>3.0.CO;2-M; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202	21	144	158	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7709	7712		10.1074/jbc.C000869200	http://dx.doi.org/10.1074/jbc.C000869200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244088	hybrid			2022-12-27	WOS:000167474900006
J	Sun, RG; Chen, XM; Yang, VW				Sun, RG; Chen, XM; Yang, VW			Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; TRANSCRIPTION FACTOR; BIOLOGICAL ASSAYS; EPITHELIAL-CELLS; NUCLEAR PROTEINS; GENE; EXPRESSION; GROWTH; FINGER; FAMILY	Intestinal-enriched Kruppel-like factor (IKLF or KLF5) belongs to the family of mammalian Kruppel-like transcription factors. Previous studies indicate that expression of IKLF is enriched in the proliferating crypt epithelial cells of the intestinal tract. However, the biological function of IKLF is unknown. In the current study, we have shown that the level of IKLF mRNA was nearly undetectable in serum-deprived NIH3T3 fibroblasts but became acutely and significantly increased upon the addition of fetal bovine serum or the phorbol ester, PMA. This induction required protein synthesis because it was prevented by cycloheximide. Transfection of IKLF into NIH3T3 cells resulted in the formation of foci in a manner similar to that caused by the activated Ha-ras oncogene. Constitutive expression of IKLF in transfected NIH3T3 cells significantly increased the rate of proliferation when compared with cells transfected with an empty vector. The growth of IKLF-transfected cells was no longer inhibited by cell-cell contact or by low serum content. Moreover, these cells proliferated in an anchorage-independent fashion. We conclude that IKLF encodes a delayed early response gene product that positively regulates cellular proliferation and may give rise to a transformed phenotype when overexpressed.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yang, VW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Ross 918,720 Rutland Ave, Baltimore, MD 21205 USA.				NCI NIH HHS [R01 CA084197-02, CA84197, R01 CA084197] Funding Source: Medline; NIDDK NIH HHS [DK52230, R01 DK052230-04, R01 DK052230] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052230] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Hoshino Y, 2000, CIRCULATION, V102, P2528, DOI 10.1161/01.CIR.102.20.2528; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Ogata T, 2000, J THORAC CARDIOV SUR, V119, P983, DOI 10.1016/S0022-5223(00)70093-6; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; White JA, 1997, GENOMICS, V45, P468, DOI 10.1006/geno.1997.4979; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41	27	135	143	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6897	6900		10.1074/jbc.C000870200	http://dx.doi.org/10.1074/jbc.C000870200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11152667	Green Accepted, hybrid			2022-12-27	WOS:000167442900005
J	Llull, D; Garcia, E; Lopez, R				Llull, D; Garcia, E; Lopez, R			Tts, a processive beta-glucosyltransferase of Streptococcus pneumoniae, directs the synthesis of the branched type 37 capsular polysaccharide in pneumococcus and other gram-positive species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN SYNTHASE; BACILLUS-SUBTILIS; GENETIC-TRANSFORMATION; CELLULOSE BIOSYNTHESIS; ESCHERICHIA-COLI; HIGHER-PLANTS; GALU GENE; IDENTIFICATION; GLYCOSYLTRANSFERASES; TRANSFERASE	The type 37 capsule of Streptococcus pneumoniae is a homopolysaccharide built up from repeating units of [beta -D-Glcp-(1-->2)]-beta -D-Glcp-(1-->3). The elements governing the expression of the tts gene, coding for the glucosyltransferase involved in the synthesis off the type 37 pneumococcal capsular polysaccharide, have been studied. Primer extension analysis and functional tests demonstrated the presence of four new transcriptional start points upstream of the previously reported tts promoter (ttsp), Most interesting, three of these transcriptional start points are located in a RUP element thought to be involved in recombinational events (Oggioni, M. R., and Claverys, J. P. (1999) Microbiology 145, 2647-2653). Transformation experiments using either a recombinant plasmid containing the whole transcriptional unit of tts or chromosomal DNA from a type 37 pneumococcus showed that tts is the only gene required to drive the biosynthesis of a type 37 capsule in S, pneumoniae and other Gram-positive bacteria, namely Streptococcus oralis, Streptococcus gordonii, and Bacillus subtilis. The Tts synthase was overproduced in S, pneumoniae and purified as a membrane-associated enzyme. These membrane preparations used UDP-Glc as substrate to catalyze the synthesis of a high molecular weight polysaccharide immunologically identical to the type 37 capsule. In addition, UDP-Gal was also a substrate to produce type 37 polysaccharide since a strong UDF-Glc-4'-epimerase activity is associated to the membrane fraction of S, pneumoniae, These results indicated that Tts has a dual biochemical activity that leads to the synthesis of the branched type 37 polysaccharide.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia, E (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	e.garcia@cib.csic.es		Partearroyo Lacaba, Olvido/0000-0002-1692-4481				Adeyeye A, 1988, CARBOHYD RES, V180, P295, DOI 10.1016/0008-6215(88)80086-7; ALLEN PZ, 1988, MOL IMMUNOL, V25, P1011, DOI 10.1016/0161-5890(88)90008-9; Arrecubieta C, 1996, J EXP MED, V184, P449, DOI 10.1084/jem.184.2.449; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RM, 2000, PLANT PHYSIOL BIOCH, V38, P57, DOI 10.1016/S0981-9428(00)00168-6; Bulone V, 1999, PHYTOCHEMISTRY, V50, P9, DOI 10.1016/S0031-9422(98)00494-4; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CANOSI U, 1981, MOL GEN GENET, V181, P434, DOI 10.1007/BF00428732; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; DeAngelis PL, 1999, CELL MOL LIFE SCI, V56, P670, DOI 10.1007/s000180050461; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; DIAZ E, 1990, GENE, V90, P163, DOI 10.1016/0378-1119(90)90455-Z; DISTLER J, 1964, P NATL ACAD SCI USA, V48, P2187; Dowson CG, 1997, J APPL MICROBIOL, V83, pS42, DOI 10.1046/j.1365-2672.83.s1.5.x; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; GARCIA E, 1993, MOL GEN GENET, V239, P188; GARCIA E, 1985, FEMS MICROBIOL LETT, V29, P77; Garcia E, 2000, RES MICROBIOL, V151, P429, DOI 10.1016/S0923-2508(00)00173-X; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; GUIDOLIN A, 1994, INFECT IMMUN, V62, P5384, DOI 10.1128/IAI.62.12.5384-5396.1994; HANSEN SA, 1975, J CHROMATOGR, V107, P224, DOI 10.1016/S0021-9673(00)82770-3; HEIDELBERGER M, 1983, INFECT IMMUN, V41, P1234, DOI 10.1128/IAI.41.3.1234-1244.1983; Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Herbert D., 1971, METHODS MICROBIOLOGY, V5, P290, DOI [DOI 10.1016/S0580-9517(08)70641-X, 10.1007/978-3-030-30515-4_14]; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Kolkman MAB, 1998, J BIOCHEM, V123, P937; Kolkman MAB, 1996, J BACTERIOL, V178, P3736, DOI 10.1128/jb.178.13.3736-3741.1996; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Llull D, 1998, BBA-GENE STRUCT EXPR, V1443, P217, DOI 10.1016/S0167-4781(98)00213-9; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mollerach M, 2000, GENE, V260, P77, DOI 10.1016/S0378-1119(00)00468-6; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; POZZI G, 1990, RES MICROBIOL, V141, P659, DOI 10.1016/0923-2508(90)90060-4; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; Roy AB, 1999, BIOCHEM J, V344, P185, DOI 10.1042/0264-6021:3440185; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; Saxena IM, 1997, CELLULOSE, V4, P33, DOI 10.1023/A:1018411101036; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; SIEWERT G, 1967, P NATL ACAD SCI USA, V57, P767, DOI 10.1073/pnas.57.3.767; STOOLMILLER AC, 1969, J BIOL CHEM, V244, P236; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; YASBIN RE, 1975, J BACTERIOL, V121, P296, DOI 10.1128/JB.121.1.296-304.1975	57	58	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21053	21061		10.1074/jbc.M010287200	http://dx.doi.org/10.1074/jbc.M010287200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11264282	hybrid			2022-12-27	WOS:000169297900036
J	Prinetti, A; Chigorno, V; Prioni, S; Loberto, N; Marano, N; Tettamanti, G; Sonnino, S				Prinetti, A; Chigorno, V; Prioni, S; Loberto, N; Marano, N; Tettamanti, G; Sonnino, S			Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN-LAYER CHROMATOGRAPHY; EXOGENOUS GANGLIOSIDE GM1; LONG-TERM POTENTIATION; CAVEOLAE-LIKE DOMAINS; SIGNAL-TRANSDUCTION; NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; NEUROBLASTOMA-CELLS; NEURITE OUTGROWTH; MASS-SPECTROMETRY	In the present paper, we report on the properties of sphingolipid-enriched domains of rat cerebellar granule cells in culture at different stages of neuronal development. The major lipid components of these domains were glycerophospholipids and cholesterol, Glycerophospholipids were 45-75% and cholesterol 15-45% of total lipids of the domains. This corresponded to 5-17% of total cell glycerophospholipids and 15-45% of total cell cholesterol, Phosphatidylcholine, mainly dipalmitoylphosphatidylcholine, was 66-85% of all the glycerophospholipids associated with these domains. Consequently, the palmitoyl residue was significantly enriched in the domains. The surface occupied by these structures increased during development. 40-70% of cell sphingolipids segregated in sphingolipid-enriched membrane domains, with the maximum ganglioside density in fully differentiated neurons. A high content of ceramide was found in the domains of aging neurons. Then, the sphingolipid/glycerophospholipid molar ratio was more than doubled during the initial stage of development, whereas the cholesterol/glycerophospholipid molar ratio gradually decreased during in vitro differentiation. Phosphorylated phosphoinositides, which were scant in the domains of undifferentiated cells, dramatically increased during differentiation and aging in culture. Proteins were minor components of the domains (0.1-2.8% of all domain components). Phosphotyrosine-containing proteins were selectively recovered in the sphingolipid-enriched domain. Among these, Src family protein-tyrosine kinases, known to participate to the process of neuronal differentiation, were associated with the sphingolipid-enriched domains in a way specific for the type of kinase and for the developmental stage of the cell. Proteins belonging to other signaling pathways, such as phosphoinositide 3-kinase and its downstream target, Akt, were not associated with the domains.	Univ Milan, Sch Med, Study Ctr Funct Biochem Brain Lipids, Dept Med Chem & Biochem,LITA, I-20090 Milan, Italy; St Lawrence Univ, Dept Chem, Canton, NY 13617 USA	University of Milan; Saint Lawrence University	Sonnino, S (corresponding author), Univ Milan, Sch Med, Study Ctr Funct Biochem Brain Lipids, Dept Med Chem & Biochem,LITA, Via Fratelli Cervi 93, I-20090 Milan, Italy.	Sandro.Sonnino@unimi.it	Sonnino, Sandro/R-4154-2017; Prinetti, Alessandro/R-4206-2017	Sonnino, Sandro/0000-0001-8180-5908; Prinetti, Alessandro/0000-0003-0252-2593				BALAZS R, 1988, DEV BRAIN RES, V40, P269, DOI 10.1016/0165-3806(88)90139-3; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; BJELFMAN C, 1990, MOL CELL BIOL, V10, P361, DOI 10.1128/MCB.10.1.361; BRAVO R, 1984, 2 DIMENSIONAL GEL EL, P3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BURGOYNE RD, 1988, BRAIN RES REV, V13, P77, DOI 10.1016/0165-0173(88)90006-9; CARTER HE, 1961, J LIPID RES, V2, P228; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; CHAKRABORTY M, 1993, BRAIN RES, V625, P197, DOI 10.1016/0006-8993(93)91059-2; Chester MA, 1997, PURE APPL CHEM, V69, P2475, DOI 10.1351/pac199769122475; Chigorno V, 1997, J LIPID RES, V38, P1163; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Farooqui AA, 1995, BRAIN RES REV, V21, P152, DOI 10.1016/0165-0173(95)00008-9; FRIES E, 1988, BIOCHEM INT, V16, P737; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Ishitani R, 1996, J NEUROCHEM, V66, P928; *IUPAC IUBMB JOINT, 1998, PURE APPL CHEM, V312, P167; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; KEFALAS P, 1995, INT J BIOCHEM CELL B, V27, P551, DOI 10.1016/1357-2725(95)00024-J; KERWIN JL, 1994, J LIPID RES, V35, P1102; KINGSBURY AE, 1985, DEV BRAIN RES, V17, P17, DOI 10.1016/0165-3806(85)90128-2; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; LEDEEN RW, 1992, TRENDS GLYCOSCI GLYC, V4, P174; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; Masserini M, 1999, J NEUROCHEM, V73, P1, DOI 10.1046/j.1471-4159.1999.0730001.x; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; MELLSTROM K, 1987, MOL CELL BIOL, V7, P4178, DOI 10.1128/MCB.7.12.4178; MEYERSON G, 1993, FEBS LETT, V332, P27, DOI 10.1016/0014-5793(93)80475-A; PARTRIDGE SM, 1948, BIOCHEM J, V42, P238, DOI 10.1042/bj0420238; Pomeroy SL, 2000, MENT RETARD DEV D R, V6, P41; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; Prinetti A, 2000, GLYCOCONJUGATE J, V17, P223, DOI 10.1023/A:1026545424720; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; RIBONI L, 1992, FEBS LETT, V300, P188, DOI 10.1016/0014-5793(92)80193-K; RIBONI L, 1990, NEUROCHEM RES, V15, P1175, DOI 10.1007/BF01208577; RIBONI L, 1993, FEBS LETT, V322, P257, DOI 10.1016/0014-5793(93)81582-K; SARAFIAN T, 1990, J NEUROCHEM, V55, P913, DOI 10.1111/j.1471-4159.1990.tb04578.x; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SINGER HS, 1994, CURR OPIN NEUROL, V7, P153, DOI 10.1097/00019052-199404000-00012; SONNINO S, 1983, ANAL BIOCHEM, V128, P104, DOI 10.1016/0003-2697(83)90350-0; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TAKI T, 1994, ANAL BIOCHEM, V223, P232, DOI 10.1006/abio.1994.1579; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Tettamanti G, 1996, J LIPID MEDIAT CELL, V14, P263, DOI 10.1016/0929-7855(96)00535-4; THANGNIPON W, 1992, NEUROCHEM RES, V17, P45, DOI 10.1007/BF00966864; THANGNIPON W, 1983, DEV BRAIN RES, V11, P177, DOI 10.1016/0165-3806(83)90215-8; TOYOKUNI T, 1991, J LABELLED COMPD RAD, V29, P567, DOI 10.1002/jlcr.2580290508; VALSECCHI M, 1993, J NEUROCHEM, V60, P193, DOI 10.1111/j.1471-4159.1993.tb05837.x; VASKOVSKY VE, 1968, J LIPID RES, V9, P396; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Yates AJ, 1998, ANN NY ACAD SCI, V845, P57, DOI 10.1111/j.1749-6632.1998.tb09662.x	65	145	150	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21136	21145		10.1074/jbc.M010666200	http://dx.doi.org/10.1074/jbc.M010666200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11264283	hybrid			2022-12-27	WOS:000169297900047
J	Sivaram, MVS; Sudha, R; Roy, RP				Sivaram, MVS; Sudha, R; Roy, RP			A role for the alpha 113 (GH1) amino acid residue in the polymerization of sickle hemoglobin - Evaluation of its inhibitory strength and interaction linkage with two fiber contact sites (alpha 16/23) located in the AB region of the alpha-chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFINED CRYSTAL-STRUCTURE; DEOXYHEMOGLOBIN-S; BETA-CHAIN; CELL HEMOGLOBIN; 3-DIMENSIONAL RECONSTRUCTION; SEMISYNTHESIS; RESOLUTION	A cluster of amino acid residues located in the AB-GH region of the alpha -chain are shown in intra-double strand axial interactions of the hemoglobin S (HbS) polymer. However, alpha Leu-113 (GH1) located in the periphery is not implicated in any interactions by either crystal structure or models of the fiber, and its role in HbS polymerization has not been explored by solution experiments. We have constructed HbS Twin Peaks (beta Glu-6-->Val, alpha Leu-113-->His) to ascertain the hitherto unknown role of the alpha 113 site in the polymerization process. The structural and functional behavior of HbS Twin Peaks was comparable with HbS. HbS Twin Peaks polymerized with a slower rate compared with HbS, and its polymer solubility (C-sat) was found to be about 1.8-fold higher than HbS, To further authenticate the participation of the alpha 113 site in the polymerization process as well as to evaluate its relative inhibitory strength, we constructed HbS tetramers in which the alpha 113 mutation was coupled individually with two established fiber contact sites (alpha 16 and alpha 23) located in the AB region of the alpha -chain: HbS(alpha Lys-16-->Gln, alpha Leu-113-->His), HbS(alpha Glu-23-->Gln, alpha Leu-113-->His). The single mutants at alpha 16/alpha 23 sites were also engineered as controls. The C-sat values of the HbS point mutants involving sites alpha 16 or alpha 23 were higher than HbS but markedly lower as compared with HbS Twin Peaks. In contrast, C-sat values of both double mutants were comparable with or higher than that of HbS Twin Peaks, The demonstration of the inhibitory effect of alpha 113 mutation alone or in combination with other sites, in quantitative terms, unequivocally establishes a role for this site in HbS gelation, These results have implications for development of a more accurate model of the fiber that could serve as a blueprint for therapeutic intervention.	Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Roy, RP (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	rproy@nii.res.in						ADACHI K, 1979, J BIOL CHEM, V254, P7765; ADACHI K, 1995, PROTEIN SCI, V4, P1272, DOI 10.1002/pro.5560040703; ADACHI K, 1979, J BIOL CHEM, V254, P4079; BENESCH RE, 1982, NATURE, V299, P231, DOI 10.1038/299231a0; BENESCH RE, 1977, NATURE, V269, P772, DOI 10.1038/269772a0; BENESCH RE, 1976, NATURE, V260, P219, DOI 10.1038/260219a0; Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; BRIEHL RW, 1970, J BIOL CHEM, V245, P544; Bucci E, 1981, Methods Enzymol, V76, P97; CRETEGNY I, 1993, J MOL BIOL, V230, P733, DOI 10.1006/jmbi.1993.1195; DYKES G, 1978, NATURE, V272, P506, DOI 10.1038/272506a0; DYKES GW, 1979, J MOL BIOL, V130, P451, DOI 10.1016/0022-2836(79)90434-0; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; GUIS M, 1985, HEMOGLOBIN, V9, P175, DOI 10.3109/03630268508996999; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; HIMANEN JP, 1995, J BIOL CHEM, V270, P13885, DOI 10.1074/jbc.270.23.13885; Himanen JP, 1996, J BIOL CHEM, V271, P25152, DOI 10.1074/jbc.271.41.25152; Himanen JP, 1997, BLOOD, V89, P4196, DOI 10.1182/blood.V89.11.4196; Ho C, 1996, J MOL BIOL, V263, P475, DOI 10.1006/jmbi.1996.0590; IMAI K, 1989, J BIOL CHEM, V264, P11174; IMAI K, 1973, BIOCHEMISTRY-US, V12, P128, DOI 10.1021/bi00725a021; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; KRAUS LM, 1966, BIOCHEMISTRY-US, V5, P3701, DOI 10.1021/bi00875a046; Li XF, 1997, BLOOD, V90, P4620, DOI 10.1182/blood.V90.11.4620.4620_4620_4627; LIANG CC, 1982, HEMOGLOBIN, V6, P629; MAITA T, 1984, J BIOCHEM-TOKYO, V95, P805, DOI 10.1093/oxfordjournals.jbchem.a134672; MANNING JM, 1991, ADV ENZYMOL RAMB, V64, P55; Manning JM, 1998, J BIOL CHEM, V273, P19359, DOI 10.1074/jbc.273.31.19359; Nacharaju P, 1997, J BIOL CHEM, V272, P27869, DOI 10.1074/jbc.272.44.27869; Nagel R. L., 1978, BIOCH CLIN ASPECTS H, P195; NAGEL RL, 1980, NATURE, V283, P832, DOI 10.1038/283832a0; PADLAN EA, 1985, J BIOL CHEM, V260, P8272; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; RAO MJ, 1995, J BIOL CHEM, V270, P19250, DOI 10.1074/jbc.270.33.19250; Rao MJ, 2000, J MOL BIOL, V300, P1389, DOI 10.1006/jmbi.2000.3898; RHODA MD, 1984, BIOCHIM BIOPHYS ACTA, V786, P62, DOI 10.1016/0167-4838(84)90154-7; ROY RP, 1993, J BIOL CHEM, V268, P16406; ROY RP, 1994, METHOD ENZYMOL, V231, P194; WATOWICH SJ, 1989, J MOL BIOL, V209, P821, DOI 10.1016/0022-2836(89)90610-4; WATOWICH SJ, 1993, J STRUCT BIOL, V111, P161, DOI 10.1006/jsbi.1993.1047	41	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18209	18215		10.1074/jbc.M101788200	http://dx.doi.org/10.1074/jbc.M101788200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11259442	hybrid			2022-12-27	WOS:000168866500080
J	Klein, ATJ; Barnett, P; Bottger, G; Konings, D; Tabak, HF; Distel, B				Klein, ATJ; Barnett, P; Bottger, G; Konings, D; Tabak, HF; Distel, B			Recognition of peroxisomal targeting signal type 1 by the import receptor Pex5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN PEX13P; TETRATRICOPEPTIDE REPEAT-DOMAIN; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; 3-KETOACYL-COA THIOLASE; DNA-POLYMERASE; SH3 DOMAIN; TPR DOMAIN; YEAST; IDENTIFICATION	We have studied how Pex5p recognizes peroxisomal targeting signal type I (PTS1)-containing proteins. A randomly mutagenized pex5 library was screened in a two-hybrid setup for mutations that disrupted the interaction with the PTS1 protein Mdh3p or for suppressor mutations that could restore the interaction with Mdh3p containing a mutation in its PTS1. All mutations localized in the tetratricopeptide repeat (TPR) domain of Pex5p. The Pex5p TPR domain was modeled based on the crystal structure of a related TPR protein. Mapping of the mutations on this structural model revealed that some of the loss-of-interaction mutations consisted of substitutions in alpha -helices of TPRs with bulky amino acids, probably resulting in local misfolding and thereby indirectly preventing binding of PTS1 proteins. The other loss-of-interaction mutations and most suppressor mutations localized in short, exposed, intra-repeat loops of TPR2, TPR3, and TPR6, which are predicted to mediate direct interaction with PTS1 amino acids. Additional site-directed mutants at conserved positions in intra-repeat loops underscored the importance of the loops of TPR2 and TPR3 for PTS1 interaction. Based on the mutational analysis and the structural model, we put forward a model as to how PTS1 proteins are selected by Pex5p.	Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.		Barnett, Phil/F-6153-2011	Barnett, Phil/0000-0001-7420-6106				Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Eckert K A, 1991, PCR Methods Appl, V1, P17; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Gatto GJ, 2000, PROTEINS, V38, P241, DOI 10.1002/(SICI)1097-0134(20000215)38:3<241::AID-PROT1>3.0.CO;2-1; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; Kunau WH, 1998, CURR OPIN MICROBIOL, V1, P232, DOI 10.1016/S1369-5274(98)80016-7; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Miller J.H., 1972, EXPT MOL GENETICS; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Sambrook J., 2002, MOL CLONING LAB MANU; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Szilard RK, 2000, BIOCHEM J, V346, P177, DOI 10.1042/0264-6021:3460177; Tabak HF, 1995, COLD SPRING HARB SYM, V60, P649, DOI 10.1101/SQB.1995.060.01.069; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P526; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	51	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15034	15041		10.1074/jbc.M010776200	http://dx.doi.org/10.1074/jbc.M010776200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11154700	hybrid			2022-12-27	WOS:000168528800069
J	Bonini, MG; Augusto, O				Bonini, MG; Augusto, O			Carbon dioxide stimulates the production of thiyl, sulfinyl, and disulfide radical anion from thiol oxidation by peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON OXIDATION; BOVINE SERUM-ALBUMIN; NITRIC-OXIDE; SPIN-TRAP; MEDIATED OXIDATION; TYROSINE NITRATION; PULSE-RADIOLYSIS; DECOMPOSITION; GLUTATHIONE; RESONANCE	Reaction of peroxynitrite with the biological ubiquitous CO2 produces about 35% yields of two relatively strong one-electron oxidants, CO3. and (NO2)-N-.,, but the remaining of peroxynitrite is isomerized to the innocuous nitrate. Partial oxidant deactivation may confound interpretation of the effects of HCO3-/CO2 on the oxidation of targets that react with peroxynitrite by both one- and two-electron mechanisms. Thiols are example of such targets, and previous studies have reported that HCO3-/ CO, partially inhibits GSH oxidation by peroxynitrite at pH 7,4. To differentiate the effects of HCO3-/CO2 on twoand one-electron thiol oxidation, we monitored GSH, cysteine, and albumin oxidation by peroxynitrite at pH 5.4 and 7.4 by thiol disappearance, oxygen consumption, fast flow EPR, and EPR spin trapping. Our results demonstrate that HCO3-/CO2 diverts thiol oxidation by peroxynitrite from two- to one-electron mechanisms particularly at neutral pH. At acid pH values, thiol oxidation to free radicals predominates even in the absence of HCO3-/CO2. In addition to the previously characterized thiyl radicals (RS'), we also characterized radicals derived from them such as the corresponding sulfinyl (RSO.) and disulfide anion radical (RSSR.-) of both GSH and cysteine, Thiyl, RSO. and RSSR.- are reactive radicals that may contribute to the biodamaging and bioregulatory actions of peroxynitrite.	Univ Sao Paulo, Inst Quim, Dept Quim, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Augusto, Ohara/D-3839-2012	Augusto, Ohara/0000-0002-7220-4286				Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; Balazy M, 1998, J BIOL CHEM, V273, P32009, DOI 10.1074/jbc.273.48.32009; Barton J.P., 1970, INT J RADIAT PHYS CH, V2, P159; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bisby RH, 1998, J CHEM SOC FARADAY T, V94, P2069, DOI 10.1039/a801239c; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; Borg D.C., 1976, FREE RADICALS BIOL, P69; CHEN SN, 1975, RADIAT RES, V62, P18, DOI 10.2307/3574180; CHEN SN, 1973, RADIAT RES, V56, P40, DOI 10.2307/3573789; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; DAVIES MJ, 1993, FREE RADICAL RES COM, V18, P353, DOI 10.3109/10715769309147502; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FORNI LG, 1996, J CHEM SOC P2, P1; Gatti RM, 1998, ARCH BIOCHEM BIOPHYS, V349, P36, DOI 10.1006/abbi.1997.0451; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Gerasimov OV, 1999, INORG CHEM, V38, P4317, DOI 10.1021/ic990384y; GILBERT BC, 1972, J CHEM SOC PERK T 2, P1272, DOI 10.1039/p29720001272; GILBERT BC, 1975, J CHEM SOC PERK T 2, P892, DOI 10.1039/p29750000892; Giorgio S, 1998, INFECT IMMUN, V66, P807, DOI 10.1128/IAI.66.2.807-814.1998; Goldstein S, 1999, J AM CHEM SOC, V121, P2444, DOI 10.1021/ja9822254; GOLSTEIN S, 2000, J BIOL CHEM, V275, P3031; GRACEFFA P, 1983, ARCH BIOCHEM BIOPHYS, V225, P802, DOI 10.1016/0003-9861(83)90092-9; Groves JT, 1999, CURR OPIN CHEM BIOL, V3, P226, DOI 10.1016/S1367-5931(99)80036-2; Hodges GR, 1999, J AM CHEM SOC, V121, P10695, DOI 10.1021/ja991077u; HOFFMAN MZ, 1973, J PHYS CHEM-US, V77, P990, DOI 10.1021/j100627a005; HUIE RE, 1991, RADIAT PHYS CHEM, V38, P477; Hurst JK, 1999, ACCOUNTS CHEM RES, V32, P520, DOI 10.1021/ar9703488; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Karoui H, 1996, J BIOL CHEM, V271, P6000, DOI 10.1074/jbc.271.11.6000; Kirsch M, 2000, J BIOL CHEM, V275, P16702, DOI 10.1074/jbc.M909228199; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Kuhn DM, 1999, J NEUROSCI, V19, P10289; Kuhn DM, 1999, J BIOL CHEM, V274, P29726, DOI 10.1074/jbc.274.42.29726; Lehnig M, 1999, ARCH BIOCHEM BIOPHYS, V368, P303, DOI 10.1006/abbi.1999.1268; LI ASW, 1988, J MAGN RESON, V79, P140, DOI 10.1016/0022-2364(88)90329-0; Lymar SV, 2000, RADIAT PHYS CHEM, V59, P387, DOI 10.1016/S0969-806X(00)00277-2; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; Lymar SV, 1998, INORG CHEM, V37, P294, DOI 10.1021/ic970946i; Merenyi G, 1998, CHEM RES TOXICOL, V11, P712, DOI 10.1021/tx980043h; MISIK V, 1993, FREE RADICAL BIO MED, V15, P611, DOI 10.1016/0891-5849(93)90164-P; NUCIFORA G, 1972, RADIAT RES, V49, P96, DOI 10.2307/3573375; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pietraforte D, 1997, BIOCHEM J, V321, P743, DOI 10.1042/bj3210743; PRUTZ WA, 1989, INT J RADIAT BIOL, V55, P539, DOI 10.1080/09553008914550591; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; QUINTILIANI M, 1977, INT J RADIAT BIOL, V32, P195, DOI 10.1080/09553007714550891; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 1996, CHEM RES TOXICOL, V9, P828, DOI 10.1021/tx950176s; RADI R, 1990, METHOD ENZYMOL, V269, P354; RAO DNR, 1990, J BIOL CHEM, V265, P844; Richeson CE, 1998, J AM CHEM SOC, V120, P7211, DOI 10.1021/ja980871x; Santos CXC, 2000, ARCH BIOCHEM BIOPHYS, V377, P146, DOI 10.1006/abbi.2000.1751; Scorza G, 1998, BIOCHEM J, V329, P405, DOI 10.1042/bj3290405; SEALY RC, 1985, J AM CHEM SOC, V107, P3401, DOI 10.1021/ja00298a001; SEVILLA MD, 1987, BIOCHEM BIOPH RES CO, V144, P1037, DOI 10.1016/S0006-291X(87)80068-2; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; van der Vliet A, 1998, J BIOL CHEM, V273, P30255, DOI 10.1074/jbc.273.46.30255; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863; ZHAO R, 1994, J AM CHEM SOC, V116, P12010, DOI 10.1021/ja00105a048	65	148	148	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9749	9754		10.1074/jbc.M008456200	http://dx.doi.org/10.1074/jbc.M008456200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134018	hybrid			2022-12-27	WOS:000167996400024
J	Chen, SC; Yen, CH; Yeh, MS; Huang, CJ; Liu, TY				Chen, SC; Yen, CH; Yeh, MS; Huang, CJ; Liu, TY			Biochemical properties and cDNa cloning of two new lectins from the plasma of Tachypleus tridentatus - Tachypleus plasma lectin 1 and 2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; HORSESHOE-CRAB HEMOLYMPH; INNATE IMMUNITY; LIMULUS-POLYPHEMUS; INHIBITORY-ACTIVITY; BINDING PROTEIN; PURIFICATION; LIPOPOLYSACCHARIDE; AMEBOCYTES; SYSTEM	A Sepharose CL-4B-binding protein, Tachypleus plasma lectin 1 (TPL-1), and a lipopolysaccharide (LPS)binding protein, Tachypleus plasma lectin-2 (TPL-2), have been isolated from the plasma of Tachypleus tri-dentatus and biochemically characterized, Each protein is coded by a homologous family of multigenes, TPL-1 binds to Sepharose CL-4B and was eluted with buffer containing 0.4 M GlcNAc, The deduced amino acid sequence of TPL-1 consisted of 232 amino acids with an N-glycosylation site, Asn-Gly-Ser at residues 74-76. It shares a 65% sequence identity and similar internal repeats of about 20 amino acid motifs with tachylectin-1. Tachylectin-1 was identified as a lipopolysaccharideagarose binding nonglycosylated protein from the amebocytes of T, tridentatus, TPL-8 was eluted from the LPS-Sepbarose CL-4B affinity column in buffer containing 0.4 M GlcNAc and 2 M KCI, The deduced amino acid sequence of TPL-2 consisted of 128 amino acids with an N-glycosylation site, Asn-Cys-Thr, at positions 3-5, It shares an 80% sequence identity with tachylectin-3, isolated from the amebocytes of T, tridentatus, TPL-2 purified by LPS-affinity column from the plasma predominantly exists as a dimer of a glycoprotein with an apparent molecular mass of 36 kDa, Tachylectin-3 is an intracellular nonglycosylated protein that also exists as a dimer in solution with an apparent molecular mass of 29 kDa, It recognizes Gram-negative bacteria through the 0-antigen of LPS, Western blot analyses showed that, in the plasma, TPL-1 and TPL-2 exist predominantly as oligomers with molecular masses above 60 kDa, They both bind to Gram-positive and Gram-negative bacteria, and this binding is inhibited by GlcNAc, Possible binding site of TPL-1 and TPL-8 to the bacteria could be at the NAc moiety of GlcNAc-MurNAc of the peptidoglycan, The physiological function of TPL-1 and TPL-2 is most likely related to their ability to form a cluster of interlocking molecules to immobilize and entrap invading organisms.	Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan	Liu, TY (corresponding author), OriGene Technol Inc, 6 Taft Ct,Suite 300, Rockville, MD 20850 USA.	dliu@origene.com						Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; ENGHILD JJ, 1990, BIOCHEMISTRY-US, V29, P10070, DOI 10.1021/bi00495a009; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FORTESDIAS CL, 1993, COMP BIOCHEM PHYS B, V105, P79, DOI 10.1016/0305-0491(93)90171-Z; FREUDENBERG MA, 1989, INFECTION, V17, P322, DOI 10.1007/BF01650719; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; HONG TH, 1989, J IMMUNOL METHODS, V120, P151, DOI 10.1016/0022-1759(89)90236-6; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Iwaki D, 1999, EUR J BIOCHEM, V264, P314, DOI 10.1046/j.1432-1327.1999.00588.x; Iwanaga S, 1998, J BIOCHEM, V123, P1; KAPITANY RA, 1973, ANAL BIOCHEM, V56, P361, DOI 10.1016/0003-2697(73)90202-9; Kawabata S, 1999, DEV COMP IMMUNOL, V23, P391, DOI 10.1016/S0145-305X(99)00019-1; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LIU T, 1991, J BIOL CHEM, V266, P14813; MANIATIS T, 1982, MOL CLONING LABORATO, P280; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MINETTI CASA, 1991, J BIOL CHEM, V266, P20773; MURER EH, 1975, J CELL PHYSIOL, V86, P533, DOI 10.1002/jcp.1040860310; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nagai T, 1999, J BIOL CHEM, V274, P37673, DOI 10.1074/jbc.274.53.37673; NGUYEN NY, 1986, J BIOL CHEM, V261, P450; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; PORATH J, 1971, J CHROMATOGR, V60, P167, DOI 10.1016/S0021-9673(00)95547-X; ROBEY FA, 1981, J BIOL CHEM, V256, P969; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612	31	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9631	9639		10.1074/jbc.M008414200	http://dx.doi.org/10.1074/jbc.M008414200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133989	hybrid, Green Published			2022-12-27	WOS:000167996400009
J	Komatsu, M; Tanida, I; Ueno, T; Ohsumi, M; Ohsumi, Y; Kominami, E				Komatsu, M; Tanida, I; Ueno, T; Ohsumi, M; Ohsumi, Y; Kominami, E			The C-terminal region of an Apg7p/Cvt2p is required for homodimerization and is essential for its E1 activity and E1-E2 complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; PROTEIN CONJUGATION SYSTEM; SACCHAROMYCES-CEREVISIAE; AUTOPHAGIC PROCESS; TARGETING PATHWAY; YEAST VACUOLE; CYTOPLASM; GENE; DEGRADATION; MECHANISMS	Apg7p/Cvt2p, a protein-activating enzyme, is essential for both the Apg12p-Apg5p conjugation system and the Apg8p membrane targeting in autophagy and cytoplasm-to-vacuole targeting in the yeast Saccharomyces cerevisiae, Similar to the ubiquitin-conjugating system, both Apg12p and Apg8p are activated by Apg7p, an El-like enzyme. Apg12p is then transferred to Apg10p, an E2-like enzyme, and conjugated with Apg5p, whereas Apg8p is transferred to Apg3p, another E2-like enzyme, followed by conjugation with phosphatidylethanoiamine. Evidence is presented here that Apg7p forms a homodimer with two active-site cysteine residues via the C-terminal region, The dimerization of Apg7p is independent of the other Apg proteins and facilitated by overexpressed Apg12p, The C-terminal 123 amino acids of Apg7p (residues 508 to 630 out of 630 amino acids) are sufficient for its dimerization, where there is neither an ATP binding domain nor an active-site cysteine essential for its El activity, The deletion of its carboxyl 40 amino acids (residues 591-630 out of 630 amino acids) results in several defects of not only Apg7p dimerization but also interactions with two substrates, Apg12p and Apg8p and Apg12p-Apg5p conjugation, whereas the mutant Apg7p contains both an ATP binding domain and an active-site cysteine. Furthermore, the carboxyl 40 amino acids of Apg7p are also essential for the interaction of Apg7p with Apg3p to form the E1-E2 complex for Apg8p. These results suggest that Apg7p forms a homodimer via the C-terminal region and that the C-terminal region is essential for both the activity of the El enzyme for Apg12p and Apg8p as well as the formation of an E1-E2 complex for Apg8p.	Juntendo Univ, Sch Med, Dept Biochem, Tokyo 1138421, Japan; Teikyo Univ Sci & Technol, Dept Biosci, Yamanashi 4090193, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448501, Japan	Juntendo University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kominami, E (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo 1138421, Japan.		Komatsu, Masaaki/B-8321-2011; Ohsumi, Yoshinori/C-6449-2009; Kominami, Eiki/D-3802-2009; Tanida, Isei/C-8277-2009	Komatsu, Masaaki/0000-0001-7672-7722; Ohsumi, Yoshinori/0000-0003-2384-2166; Tanida, Isei/0000-0001-8999-3990				Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; James P, 1996, GENETICS, V144, P1425; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaiser C., 1994, METHODS YEAST GENETI; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; SIKORSKI RS, 1989, GENETICS, V122, P19; Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353	50	76	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9846	9854		10.1074/jbc.M007737200	http://dx.doi.org/10.1074/jbc.M007737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139573	hybrid			2022-12-27	WOS:000167996400037
J	Schroder, NW; Pfeil, D; Opitz, B; Michelsen, KS; Amberger, J; Zahringer, U; Gobel, UB; Schumann, RR				Schroder, NW; Pfeil, D; Opitz, B; Michelsen, KS; Amberger, J; Zahringer, U; Gobel, UB; Schumann, RR			Activation of mitogen-activated protein kinases p42/44, p38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; BORRELIA-BURGDORFERI LIPOPROTEINS; LIPOPOLYSACCHARIDE-BINDING-PROTEIN; NECROTIZING ULCERATIVE GINGIVITIS; BACTERIAL LIPOPOLYSACCHARIDE; MAP KINASE; TYROSINE PHOSPHORYLATION; CUTTING EDGE; PERIODONTAL-DISEASE; MONOKINE PRODUCTION	We have shown previously that phenol/water extracts derived from two novel Treponema species, Treponema maltophilum, and Treponema brennaborense, resembling lipoteichoic acid (LTA), induce cytokines in mononuclear cells. This response was lipopolysaccharide binding-protein (LBP)-dependent and involved Toll-like receptors (TLRs), Here we show that secretion of tumor necrosis factor-alpha induced by Treponema culture supernatants and extracted LTA was paralleled by an LBP-dependent phosphorylation of mitogen-activated protein kinases (MAPKs) p42 and p44, and p38, as well as the stress-activated protein kinases c-Jun N-terminal kinases 1 and 2, Phosphorylation of p42/44 correlated with an increase of activity, and tumor necrosis factor-cu levels were significantly reduced by addition of inhibitors of p42/44 and p38, PD 98059 and SE 203580, respectively. Treponeme LTA differed from bacterial lipopolysaccharide regarding time course of p42/44 phosphorylation, exhibiting a prolonged activation of MAPKs. Furthermore, MAPK activation and cytokine induction failed to be strictly correlated. Involvement of TLR-4 for phosphorylation of p42/44 was shown employing the neutralizing anti-murine TLR-4 antibody MTS 510, In TLR-2-negative U373 cells, the compounds studied differed regarding MAPK activation with T. maltophilum leading to a stronger activation, In summary, the data presented here show that treponeme LTA are able to activate the MAPK and stress-activated protein kinase pathway involving LBP and TLR-4.	Humboldt Univ, Fak Med, Klinikum Charite, Inst Mikrobiol & Hyg, D-10117 Berlin, Germany; Forschungsinst Borstel, Labor Immunchem, D-23845 Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel	Schumann, RR (corresponding author), Humboldt Univ, Fak Med, Klinikum Charite, Inst Mikrobiol & Hyg, Dorotheenstr 96, D-10117 Berlin, Germany.			Opitz, Bastian/0000-0003-1276-836X				Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; BHAKDI S, 1991, INFECT IMMUN, V59, P4614, DOI 10.1128/IAI.59.12.4614-4620.1991; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; CHOI BK, 1994, INFECT IMMUN, V62, P1889, DOI 10.1128/IAI.62.5.1889-1895.1994; Choi BK, 1997, INT J SYST BACTERIOL, V47, P175, DOI 10.1099/00207713-47-1-175; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DING A, 1993, J IMMUNOL, V151, P5596; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FREED E, 1994, COLD SPRING HARB SYM, V59, P187, DOI 10.1101/SQB.1994.059.01.023; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; GENG Y, 1994, P NATL ACAD SCI USA, V91, P8602, DOI 10.1073/pnas.91.18.8602; GEPPERT TD, 1994, MOL MED, V1, P93; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HAN JH, 1995, BBA-MOL CELL RES, V1265, P224, DOI 10.1016/0167-4889(95)00002-A; HARDY PH, 1983, P SOC EXP BIOL MED, V174, P47; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoshino K, 1999, J IMMUNOL, V162, P3749; KELLER R, 1992, INFECT IMMUN, V60, P3664, DOI 10.1128/IAI.60.9.3664-3672.1992; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; LIU MK, 1994, J IMMUNOL, V153, P2642; LUKEHART SA, 1994, HARRISONS PRINCIPLES, P726; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Means TK, 1999, J IMMUNOL, V163, P6748; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Nocton J J, 1995, Adv Intern Med, V40, P69; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; OFFENBACHER S, 1993, J PERIODONTOL, V64, P432, DOI 10.1902/jop.1993.64.5s.432; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RADOLF JD, 1991, J IMMUNOL, V147, P1968; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REIMANN T, 1994, J IMMUNOL, V153, P5740; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; RIVIERE GR, 1991, NEW ENGL J MED, V325, P539, DOI 10.1056/NEJM199108223250803; RIVIERE GR, 1991, INFECT IMMUN, V59, P2653, DOI 10.1128/IAI.59.8.2653-2657.1991; Rosen G, 1999, INFECT IMMUN, V67, P1180, DOI 10.1128/IAI.67.3.1180-1186.1999; Sanghera JS, 1996, J IMMUNOL, V156, P4457; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SCHUMANN RR, 1994, MED MICROBIOL IMMUN, V183, P279; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; SEGER R, 1992, J BIOL CHEM, V267, P14373; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SHAPIRA L, 1994, ORAL MICROBIOL IMMUN, V9, P112, DOI 10.1111/j.1399-302X.1994.tb00044.x; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WEIDEMANN B, 1994, INFECT IMMUN, V62, P4709, DOI 10.1128/IAI.62.11.4709-4715.1994; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wyss C, 1996, INT J SYST BACTERIOL, V46, P745, DOI 10.1099/00207713-46-3-745; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	70	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9713	9719		10.1074/jbc.M008954200	http://dx.doi.org/10.1074/jbc.M008954200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134043	hybrid			2022-12-27	WOS:000167996400019
J	Meijers, R; Morris, RJ; Adolph, HW; Merli, A; Lamzin, VS; Cedergren-Zeppezauer, ES				Meijers, R; Morris, RJ; Adolph, HW; Merli, A; Lamzin, VS; Cedergren-Zeppezauer, ES			On the enzymatic activation of NADH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ALCOHOL-DEHYDROGENASE; HORSE LIVER; SUBSTITUTED COBALT(II); COORDINATION GEOMETRY; PROTEIN CONFORMATION; BINDING; MECHANISM; ISOZYMES; CRYSTALLINE; RESOLUTION	Atomic (1 Angstrom) resolution x-ray structures of horse liver alcohol dehydrogenase in complex with NADH revealed the formation of an adduct in the active site between a metal-bound water and NADH. Furthermore, a pronounced distortion of the pyridine ring of NADH was observed, A series of quantum chemical calculations on the water-nicotinamide adduct showed that the puckering of the pyridine ring in the crystal structures can only be reproduced when the water is considered a hydroxide ion, These observations provide fundamental insight into the enzymatic activation of NADH for hydride transfer.	DESY, European Mol Biol Lab, D-22603 Hamburg, Germany; Univ Saarlandes, Fachrichtung 124, D-66041 Saarbrucken, Germany; Univ Parma, Inst Sci Biochim, I-43000 Parma, Italy; Univ Lund, Kemicentrum, S-22100 Lund, Sweden	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Saarland University; University of Parma; Lund University	Lamzin, VS (corresponding author), DESY, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany.		Adolph, Hans W/A-2104-2008; Meijers, Rob/D-5521-2011	Morris, Richard/0000-0003-3080-2613; Lamzin, Victor/0000-0002-6058-7793; Meijers, Rob/0000-0003-2872-6279				Adolph HW, 1997, BIOCHEMISTRY-US, V36, P8743, DOI 10.1021/bi970398k; AL-KARADAGHI S, 1994, ACTA CRYSTALLOGR D, V50, P793, DOI 10.1107/S0907444994005263; ALMARSSON O, 1993, J AM CHEM SOC, V115, P2125, DOI 10.1021/ja00059a005; Bader R. F. W., 1990, QUANTUM THEORY; BERTINI I, 1986, ZINC ENZYMES, P377; BURKE JR, 1993, BIOCHEMISTRY-US, V32, P13220, DOI 10.1021/bi00211a034; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Dauter Z, 1997, CURR OPIN STRUC BIOL, V7, P681, DOI 10.1016/S0959-440X(97)80078-4; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DUNN MF, 1982, BIOCHEMISTRY-US, V21, P354, DOI 10.1021/bi00531a024; DWORSCHACK RT, 1977, BIOCHEMISTRY-US, V16, P111, DOI 10.1021/bi00620a018; Eklund H., 1987, BIOL MACROMOL, V3, P73; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERSHT A, 1999, STRUCTURE MECHANISM, P460; Foglio MH, 1999, BBA-PROTEIN STRUCT M, V1432, P239, DOI 10.1016/S0167-4838(99)00104-1; HEMMINGSEN L, 1995, BIOCHEMISTRY-US, V34, P7145, DOI 10.1021/bi00021a028; Hemmingsen L, 1996, EUR J BIOCHEM, V241, P546, DOI 10.1111/j.1432-1033.1996.00546.x; HUBATSCH I, 1995, J CHROMATOGR A, V711, P105, DOI 10.1016/0021-9673(95)00227-E; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; KVASSMAN J, 1980, EUR J BIOCHEM, V103, P565, DOI 10.1111/j.1432-1033.1980.tb05981.x; LOEWUS FA, 1953, J AM CHEM SOC, V75, P5018, DOI 10.1021/ja01116a039; MAHLER HR, 1957, J AM CHEM SOC, V79, P1159, DOI 10.1021/ja01562a035; Mantle D., 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P235; MARET W, 1979, EUR J BIOCHEM, V98, P501, DOI 10.1111/j.1432-1033.1979.tb13211.x; MARET W, 1989, BIOCHEMISTRY-US, V28, P9944, DOI 10.1021/bi00452a011; Merli A, 1996, J BIOL CHEM, V271, P9177, DOI 10.1074/jbc.271.16.9177; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Northrop DB, 2000, BIOPHYS J, V79, P1621, DOI 10.1016/S0006-3495(00)76412-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SLOAN DL, 1975, BIOCHEMISTRY-US, V14, P1998, DOI 10.1021/bi00680a030	36	99	99	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9316	9321		10.1074/jbc.M010870200	http://dx.doi.org/10.1074/jbc.M010870200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134046	hybrid			2022-12-27	WOS:000167607700093
J	Nakatsukasa, K; Nishikawa, S; Hosokawa, N; Nagata, K; Endo, T				Nakatsukasa, K; Nishikawa, S; Hosokawa, N; Nagata, K; Endo, T			Mnl1p, an alpha-mannosidase-like protein in yeast Saccharomyces cerevisiae, is required for endoplasmic reticulum-associated degradation of glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PATHWAY; QUALITY-CONTROL; GENE DELETION; PROTEASOME; ER; MEMBRANE; GLYCOSYLATION; TRANSLOCATION; BIOSYNTHESIS; TRANSPORT	The endoplasmic reticulum (ER) has a mechanism to block the exit of misfolded or unassembled proteins from the ER for the downstream organelles in the secretory pathway. Misfolded proteins retained in the ER are subjected to proteasome-dependent degradation in the cytosol when they cannot achieve correct folding and/or assembly within an appropriate time window. Although specific mannose trimming of the protein-bound oligosaccharide is essential for the degradation of misfolded glycoproteins, the precise mechanism for this recognition remains obscure. Here we report a new alpha -mannosidase-like protein, Mnl1p (mannosidase-like protein), in the yeast ER. Mnl1p is unlikely to exhibit alpha1,2-mannosidase activity, because it lacks cysteine residues that are essential for alpha1,2-mannosidase. However deletion of the MNL1 gene causes retardation of the degradation of misfolded carboxypeptidase Y, but not of the unglycosylated mutant form of the yeast alpha -mating pheromone. Possible roles of Mnl1p in the degradation and in the ER-retention of misfolded glycoproteins are discussed.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama, Japan	Nagoya University; Kyoto University; Japan Science & Technology Agency (JST)	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.							BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HEMMINGS BA, 1981, P NATL ACAD SCI-BIOL, V78, P435, DOI 10.1073/pnas.78.1.435; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HOSOKAWA N, 2001, IN PRESS EMBO REP; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Lipari F, 1996, J BIOL CHEM, V271, P27615, DOI 10.1074/jbc.271.44.27615; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; NISHIKAWA S, 1994, MOL BIOL CELL, V5, P1129, DOI 10.1091/mbc.5.10.1129; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; NISHIKAWA S, 1991, BIOCHIM BIOPHYS ACTA, V1093, P135, DOI 10.1016/0167-4889(91)90114-D; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; QADOTA H, 1992, YEAST, V8, P735, DOI 10.1002/yea.320080906; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Romisch K, 1999, J CELL SCI, V112, P4185; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; SU K, 1993, J BIOL CHEM, V268, P14301; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	34	145	148	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8635	8638		10.1074/jbc.C100023200	http://dx.doi.org/10.1074/jbc.C100023200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254655	hybrid			2022-12-27	WOS:000167607700004
J	Zang, MW; Waelde, CA; Xiang, XQ; Rana, A; Wen, R; Luo, ZJ				Zang, MW; Waelde, CA; Xiang, XQ; Rana, A; Wen, R; Luo, ZJ			Microtubule integrity regulates pak leading to ras-independent activation of Raf-1 - Insights into mechanisms of Raf-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; BINDING; SERINE; IDENTIFICATION; C-RAF-1; ASSOCIATION; DEFINITION	Growth factors activate Raf-1 by engaging a complex program, which requires Res binding, membrane recruitment, and phosphorylation of Raf-1, The present study employs the microtubule-depolymerizing drug nocodazole as an alternative approach to explore the mechanisms of Raf activation, Incubation of cells with nocodazole leads to activation of Pak1/2, kinases downstream of small GTPases Rac/Cdc42, which. have been previously indicated to phosphorylate Raf-1 Ser(338). No- codazole-induced stimulation of Raf-1 is augmented by co-expression of small GTPases Rac/Cdc42 and Pak1/2. Dominant negative mutants of these proteins block activation of Raf-1 by nocodazole, but not by epidermal growth factor (EGF), Thus, our studies define Rac/ Cdc42/Pak as a module upstream of Raf-1 during its activation by microtubule disruption. Although it is Res-independent, nocodazole-induced activation of Raf-1 appears to involve the amino-terminal regulatory region in which the integrity of the Ras binding domain is required. Surprisingly, the Raf zinc finger mutation (C165S/C168S) causes a robust activation of Raf-1 by nocodazole, whereas it diminishes Res-dependent activation of Raf-1, We also show that mutation of residues Ser(338) to Ala or Tyr(340)-Tyr(341) to Phe-Phe immediately amino-terminal to the catalytic domain abrogates activation of both the wild type and zinc finger mutant Raf by both EGF/4 beta- 12-O-tetradecanoylphorbol- 13-acetate and nocodazole. Finally, an in vitro kinase assay demonstrates that the zinc finger mutant serves as a better substrate of Pak1 than the wild type Raf-l, Collectively, our results indicate that 1) the zinc finger exerts an inhibitory effect on Raf-1 activation, probably by preventing phosphorylation of (SSYY341)-S-338; 2) such inhibition is first overcome by an unknown factor binding in place of Ras-GTP to the amino-terminal regulatory region in response to nocodazole; and 3) EGF and nocodazole utilize different kinases to phosphorylate Ser338, an event crucial for Raf activation.	Boston Univ, Sch Med, Evans Dept Med, Diabet & Metab Res Unit,Endocrinol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Med Serv, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania	Luo, ZJ (corresponding author), Boston Univ, Sch Med, Evans Dept Med, Diabet & Metab Res Unit,Endocrinol Sect, 650 Albany St,Rm 820, Boston, MA 02118 USA.	zluo@medicine.bu.edu	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Zang, Mengwei/0000-0002-2502-2586	NIGMS NIH HHS [GM 57959] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057959] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Best A, 1996, J BIOL CHEM, V271, P3756; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Jelinek T, 1996, MOL CELL BIOL, V16, P1027; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; Laird AD, 1999, J BIOL CHEM, V274, P4430, DOI 10.1074/jbc.274.7.4430; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; RAPP UR, 1988, ONCOGENE HDB, P213; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rommel C, 1996, ONCOGENE, V12, P609; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; TURNER BC, 1993, P NATL ACAD SCI USA, V90, P5544, DOI 10.1073/pnas.90.12.5544; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Ziogas A, 1998, J BIOL CHEM, V273, P24108, DOI 10.1074/jbc.273.37.24108	52	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25157	25165		10.1074/jbc.M100152200	http://dx.doi.org/10.1074/jbc.M100152200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11274179	hybrid			2022-12-27	WOS:000169800700098
J	Paukert, M; Osteroth, R; Geisler, HS; Brandle, U; Glowatzki, E; Ruppersberg, JP; Grunder, S				Paukert, M; Osteroth, R; Geisler, HS; Brandle, U; Glowatzki, E; Ruppersberg, JP; Grunder, S			Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL DORSAL-HORN; SUBSTANCE-P; ACTIVATED CURRENTS; SENSORY NEURONS; CELL-TYPE; RECEPTOR; PAIN; DESENSITIZATION; SENSITIZATION; LOCALIZATION	The P2X(3) receptor is an ATP-gated ion channel predominantly expressed in nociceptive neurons from the dorsal root ganglion, P2X(3) receptor channels are highly expressed in sensory neurons and probably contribute to the sensation of pain. Kinetics of P2X(3) currents are characterized by rapid desensitization (<100 ms) and slow recovery (>20 s). Thus, any mechanism modulating rate of desensitization and/or recovery may have profound effect on susceptibility of nociceptive neurons expressing P2X(3) to ATP, Here we show that currents mediated by P2X(3) receptor channels and the heteromeric channel P2X(2/3) composed of P2X(2) and P2X(3) subunits are potentiated by the neuropeptides substance P and bradykinin, which are known to modulate pain perception. The effect is mediated by the respective neuropeptide receptors, can be mimicked by phorbol ester and blocked by inhibitors of protein kinases, Together with data from site-directed mutagenesis our results suggest that inflammatory mediators sensitize nociceptors through phosphorylation of P2X(3) and P2X(2/3) ion channels or associated proteins.	Dept Otolaryngol, Div Sensory Biophys, D-72076 Tubingen, Germany; Dept Physiol 2, D-72076 Tubingen, Germany		Grunder, S (corresponding author), Dept Otolaryngol, Div Sensory Biophys, Rontgenweg 11, D-72076 Tubingen, Germany.	stefan.gruender@uni-tuebingen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Glowatzki, Elisabeth/0000-0003-3135-658X				Bland-Ward PA, 2000, J AUTONOM NERV SYST, V81, P146, DOI 10.1016/S0165-1838(00)00122-3; BlandWard PA, 1997, BRIT J PHARMACOL, V122, P365, DOI 10.1038/sj.bjp.0701371; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V347, P255, DOI 10.1113/jphysiol.1984.sp015065; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Collo G, 1996, J NEUROSCI, V16, P2495; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; DRAY A, 1982, NEUROSCI LETT, V33, P61, DOI 10.1016/0304-3940(82)90130-6; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Hamilton SG, 1999, BRIT J PHARMACOL, V126, P326, DOI 10.1038/sj.bjp.0702258; HOKFELT T, 1975, SCIENCE, V190, P889, DOI 10.1126/science.242075; Hu HZ, 1997, NEUROSCIENCE, V77, P535, DOI 10.1016/S0306-4522(96)00451-4; Hu HZ, 1996, BRAIN RES, V739, P163, DOI 10.1016/S0006-8993(96)00821-9; KANGRGA I, 1990, J NEUROSCI, V10, P2026; King BF, 1996, J PHYSIOL-LONDON, V494, P17, DOI 10.1113/jphysiol.1996.sp021472; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Li CY, 1999, NEUROSCI LETT, V263, P57, DOI 10.1016/S0304-3940(99)00114-7; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; MCCARTHY PW, 1989, NEUROSCIENCE, V28, P745, DOI 10.1016/0306-4522(89)90019-5; MCGUIRK SM, 1992, NEUROSCIENCE, V49, P117, DOI 10.1016/0306-4522(92)90079-H; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Stanfa LC, 2000, BRIT J PHARMACOL, V129, P351, DOI 10.1038/sj.bjp.0703047; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Tsuda M, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0007.2000; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vulchanova L, 1998, EUR J NEUROSCI, V10, P3470, DOI 10.1046/j.1460-9568.1998.00355.x; Woolf CJ, 1998, NEURON, V20, P1063, DOI 10.1016/S0896-6273(00)80487-0; Xiang ZH, 1998, NEUROSCI LETT, V256, P105, DOI 10.1016/S0304-3940(98)00774-5	44	112	121	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21077	21082		10.1074/jbc.M101465200	http://dx.doi.org/10.1074/jbc.M101465200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11264291	hybrid			2022-12-27	WOS:000169297900039
J	Tartare-Deckert, S; Monthouel, MN; Charvet, C; Foucault, I; Van Obberghen, E; Bernard, A; Altman, A; Deckert, M				Tartare-Deckert, S; Monthouel, MN; Charvet, C; Foucault, I; Van Obberghen, E; Bernard, A; Altman, A; Deckert, M			Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE SELECTION; SIGNALING PATHWAY; TYROSINE KINASE; CBL-B; RECEPTOR; FAMILY; SLP-76; PROTEINS; PHOSPHORYLATION; MEDIATE	Vav1 and Vav2 are members of the Dbl family of guanine nucleotide exchange factors for the Rho family of small GTPases. Although the role of Vav1 during lymphocyte development and activation is well characterized, the function of Vav2 is still unclear. In this study, we compared the signaling pathways regulated by Vav1 and Vav2 following engagement of the T cell receptor (TCR). We show that Vav2 is tyrosine-phosphorylated upon TCR stimulation and by co-expressed Src and Syk family kinases, Using glutathione S-transferase fusion proteins, we observed that the Src homology 2 domain of Vav2 binds tyrosine-phosphorylated proteins from TCR-stimulated Jurkat T cell lysates, including c-Cbl and SLP-76, Like Vav1, Vav2 cooperated with TCR stimulation to increase extracellular signal-regulated kinase activation and to promote c-fos serum response element transcriptional activity. Moreover, both proteins displayed a similar action in increasing the expression of the early activation marker CD69 in Jurkat T cells. However, in contrast to Vav1, Vav2 dramatically suppressed TCR signals leading to nuclear factor of activated T cells (NF-AT)dependent transcription and induction of the interleukin-a promoter. Vav2 appears to act upstream of the phosphatase calcineurin because a constitutively active form of calcineurin rescued the effect of Vav2 by restoring TCR-induced NF-AT activation. Interestingly, the Dbl homology and Src homology 2 domains of Vav2 were necessary for its inhibitory effect on NF-AT activation and far induction of serum response element transcriptional activity. Taken together, our results indicate that Vav1 and Vav2 exert overlapping but nonidentical functions in T cells. The negative regulatory pathway elicited by Vav2 might play an important role in regulating lymphocyte activation processes.	Hop Archet, INSERM, U343, F-06202 Nice 3, France; Fac Med, INSERM, U145, F-06107 Nice 2, France; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; La Jolla Institute for Immunology	Deckert, M (corresponding author), Hop Archet, INSERM, U343, IFR50, F-06202 Nice 3, France.	deckert@unice.fr	Deckert, Marcel/M-4998-2016; TARTARE-DECKERT, Sophie/P-6057-2015; Deckert, Marcel/T-3566-2019	TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Deckert, Marcel/0000-0003-2094-559X	NIGMS NIH HHS [GM50819] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050819] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Altman A, 1999, ADV IMMUNOL, V72, P1, DOI 10.1016/S0065-2776(08)60017-6; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Collins TL, 1997, IMMUNOL TODAY, V18, P221; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FISHWICK DAT, 1995, EUR J IMMUNOL, V25, P3215; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Hehner SP, 2000, J IMMUNOL, V164, P3829, DOI 10.4049/jimmunol.164.7.3829; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Marengere LEM, 1997, J IMMUNOL, V159, P70; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Musci MA, 1997, J IMMUNOL, V159, P1639; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; SawkaVerhelle D, 1997, J BIOL CHEM, V272, P16414, DOI 10.1074/jbc.272.26.16414; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schuebel KE, 1996, ONCOGENE, V13, P363; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	53	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20849	20857		10.1074/jbc.M010588200	http://dx.doi.org/10.1074/jbc.M010588200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262396	hybrid			2022-12-27	WOS:000169297900010
J	Long, AD; Mangalam, HJ; Chan, BYP; Tolleri, L; Hatfield, GW; Baldi, P				Long, AD; Mangalam, HJ; Chan, BYP; Tolleri, L; Hatfield, GW; Baldi, P			Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework - Analysis of global gene expression in Escherichia coli K12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDNA FILTER ANALYSIS; QUANTITATIVE HYBRIDIZATION; PATTERNS; ARRAYS; SCALE	We describe statistical methods based on the t test that can be conveniently used on high density array data to test for statistically significant differences between treatments. These t tests employ either the observed variance among replicates within treatments or a Bayesian estimate of the variance among replicates within treatments based on a prior estimate obtained from a local estimate of the standard deviation. The Bayesian prior allows statistical inference to be made from microarray data even when experiments are only replicated at nominal levels. We apply these new statistical tests to a data set that examined differential gene expression patterns in IHF+ and IHF- Escherichia coli cells (Arfin, S, M., Long, A. D., Ito, E. T., Tolleri, L., Riehle, M. M., Paegle, E. S., and Hatfield, G. W. (2000) J, Biol. Chem, 275, 29672-29684), These analyses identify a more biologically reasonable set of candidate genes than those identified using statistical tests not incorporating a Bayesian prior. We also show that statistical tests based on analysis of variance and a Bayesian prior identify genes that are up or down-regulated following an experimental manipulation more reliably than approaches based only on a t test or fold change. All the described tests are implemented in a simple-to-use web interface called Cyber-T that is located on the University of California at Irvine genomics web site.	Univ Calif Irvine, Sch Biol Sci, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Engn, Dept Chem & Biochem Engn, Irvine, CA 92697 USA; Natl Ctr Genome Resources, Santa Fe, NM USA; Tacg Informat, Irvine, CA 92612 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Center for Genome Resources (NCGR)	Long, AD (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.			Chan, Bob/0000-0002-8616-9565; Long, Tony/0000-0002-5007-8514	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058564] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55073, GM-58564] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arfin SM, 2000, J BIOL CHEM, V275, P29672, DOI 10.1074/jbc.M002247200; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baldi P., 1998, PHYS TODAY, DOI DOI 10.1063/1.1537915; BOX GEP, 1992, BAYESIAN INFERENCE S, P92; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; NGUYEN C, 1995, GENOMICS, V29, P207, DOI 10.1006/geno.1995.1233; Pietu G, 1996, GENOME RES, V6, P492, DOI 10.1101/gr.6.6.492; Rovere P, 1997, ADV EXP MED BIOL, V417, P467; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; SOKAL RR, 1995, BIOMETRY, P219; SPECTOR P, 1994, INTRO S S PLUS, P131; TAKAHASHI N, 1995, GENE, V164, P219, DOI 10.1016/0378-1119(95)00396-N; ZHAO ND, 1995, GENE, V156, P207, DOI 10.1016/0378-1119(95)00023-Y	22	296	305	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19937	19944		10.1074/jbc.M010192200	http://dx.doi.org/10.1074/jbc.M010192200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259426	hybrid			2022-12-27	WOS:000169135100035
J	Luo, DL; Broad, LM; Bird, GS; Putney, JW				Luo, DL; Broad, LM; Bird, GS; Putney, JW			Mutual antagonism of calcium entry by capacitative and arachidonic acid-mediated calcium entry pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACRIMAL ACINAR-CELLS; CA2+ ENTRY; INOSITOL TRISPHOSPHATE; CATION CHANNELS; HEK293 CELLS; RECEPTOR; RELEASE; MECHANISM; INHIBITION; ACTIVATION	In nonexcitable cells, the predominant mechanism for regulated entry of Ca2+ is capacitative calcium entry, whereby depletion of intracellular Ca2+ stores signals the activation of plasma membrane calcium channels, A number of other regulated Ca2+ entry pathways occur in specific cell types, however, and it is not know to what degree the different pathways interact when present in the same cell. In this study, we have examined the interaction between capacitative calcium entry and arachidonic acid-activated calcium entry, which co-exist in HEK293 cells. These two pathways exhibit mutual antagonism. That is, capacitative calcium entry is potently inhibited by arachidonic acid, and arachidonic acid-activated entry is inhibited by the pre-activation of capacitative calcium entry with thapsigargin. In the latter case, the inhibition does not seem to result from a direct action of thapsigargin, inhibition of endoplasmic reticulum Ca2+ pumps, depletion of Ca2+ stores, or entry of Ca2+ through capacitative calcium entry channels. Rather, it seems that a discrete step in the pathway signaling capacitative calcium entry interacts with and inhibits the arachidonic acid pathway, The findings reveal a novel process of mutual antagonism between two distinct calcium entry pathways. This mutual antagonism may provide an important protective mechanism for the cell, guarding against toxic Ca2+ overload.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Bird, Gary/AAI-8186-2021; Putney, James W/F-7247-2019	Bird, Gary/0000-0003-1389-8748; Putney, James W/0000-0002-3379-4789	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090087, ZIAES090087] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AlonsoTorre SR, 1997, BBA-BIOMEMBRANES, V1328, P207, DOI 10.1016/S0005-2736(97)00094-1; Barritt GJ, 1999, BIOCHEM J, V337, P153, DOI 10.1042/0264-6021:3370153; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bird GSJ, 1996, J BIOL CHEM, V271, P6766, DOI 10.1074/jbc.271.12.6766; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Clementi E, 1996, CELL CALCIUM, V19, P269, DOI 10.1016/S0143-4160(96)90068-8; Gamberucci A, 1997, CELL CALCIUM, V21, P375, DOI 10.1016/S0143-4160(97)90031-2; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hsu AL, 2000, J BIOL CHEM, V275, P16242, DOI 10.1074/jbc.M002077200; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, BIOESSAYS, V21, P38; SASAKI T, 1990, FEBS LETT, V264, P130, DOI 10.1016/0014-5793(90)80782-E; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 1998, J BIOL CHEM, V273, P32636, DOI 10.1074/jbc.273.49.32636; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	30	64	68	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20186	20189		10.1074/jbc.M100327200	http://dx.doi.org/10.1074/jbc.M100327200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274150	hybrid			2022-12-27	WOS:000169135100070
J	Rogers, RJ; Monnier, JM; Nick, HS				Rogers, RJ; Monnier, JM; Nick, HS			Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1 beta utilizes an alternative pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-SUPEROXIDE-DISMUTASE; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CYTOSOLIC PHOSPHOLIPASE A(2); OXYGEN SPECIES PRODUCTION; FREE-RADICAL PRODUCTION; ENDOTHELIAL-CELLS; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; ARACHIDONIC-ACID	Mitochondrial levels of the anti-oxidant enzyme, manganese superoxide dismutase (MnSOD), are dramatically elevated in response to stimulation with tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and lipopolysaccharide (LPS). However, the precise intracellular signaling pathways responsible for this inducible expression are poorly understood. MnSOD expression in pulmonary epithelial and endothelial cells, treated with inflammatory mediators and various inhibitors, was studied by Northern analysis. The mitochondrial electron transport chain inhibitors, antimycin A and myxothiazol, selectively blocked TNF-alpha -inducible expression of MnSOD but not that of IL-1 beta or LPS, indicating different signaling pathways. N-Acetylcysteine could reliably decrease inducible MnSOD expression by TNF-alpha, but not IL-1, linking reactive oxygen species (ROS) to the TNF-alpha signaling pathway. Elevated levels of arachidonic acid have been demonstrated previously to generate mitochondrial ROS. A specific cytoplasmic phospholipase A(2) inhibitor reduced stimulated MnSOD expression by TNF-alpha, but not by IL-1 beta, further supporting the role of ROS. Other investigators have shown that MnSOD expression may be regulated by NF-kappaB. Our results with a specific inhibitory kappa -kinase inhibitor indicate that NF-kappaB modulates IL-1 beta signaling but not the TNF-alpha pathway. Thus, we have demonstrated that although inducible MnSOD transcription may appear similar at the messenger RNA level, the intracellular signaling pathways are differentially regulated.	Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nick, HS (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Box 100244, Gainesville, FL 32610 USA.							Arai T, 1998, BIOCHEM J, V331, P853, DOI 10.1042/bj3310853; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BEYER RE, 1990, FREE RADICAL BIO MED, V8, P545, DOI 10.1016/0891-5849(90)90154-B; BONDY SC, 1995, FEBS LETT, V375, P53, DOI 10.1016/0014-5793(95)01173-C; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; De Keulenaer GW, 2000, ARTERIOSCL THROM VAS, V20, P385, DOI 10.1161/01.ATV.20.2.385; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376, DOI 10.1210/endo-129-5-2376; EASTGATE J, 1993, BLOOD, V81, P639; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; FENG L, 1995, J CLIN INVEST, V95, P1669, DOI 10.1172/JCI117842; FREEMAN BA, 1982, LAB INVEST, V47, P412; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Goossens V, 1996, J BIOL CHEM, V271, P192, DOI 10.1074/jbc.271.1.192; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HANSBERG W, 1993, FREE RADICAL BIO MED, V14, P287, DOI 10.1016/0891-5849(93)90025-P; Henry Y, 1999, CELL MOL LIFE SCI, V55, P1003, DOI 10.1007/s000180050351; HOWELL N, 1983, SOMAT CELL GENET, V9, P143, DOI 10.1007/BF01543174; HURT J, 1992, NUCLEIC ACIDS RES, V20, P2985, DOI 10.1093/nar/20.12.2985; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES S, 1997, WORKING PAPERS LIT, V1, P17; Kinnula VL, 1998, CANCER LETT, V125, P191, DOI 10.1016/S0304-3835(97)00511-9; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KRAMER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5807, DOI 10.1073/pnas.80.19.5807; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Kuo SY, 1999, J BIOL CHEM, V274, P3345, DOI 10.1074/jbc.274.6.3345; LAMBOWITZ AM, 1983, NATURE, V303, P806, DOI 10.1038/303806a0; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; Li Q, 1997, J BIOL CHEM, V272, P2404, DOI 10.1074/jbc.272.4.2404; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; REMACLE J, 1995, MUTAT RES-DNAGING G, V316, P103, DOI 10.1016/0921-8734(95)90004-7; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZALCAZAR JA, 1995, J BIOL CHEM, V270, P23944, DOI 10.1074/jbc.270.41.23944; SanchezAlcazar JA, 1997, J BIOL CHEM, V272, P30167, DOI 10.1074/jbc.272.48.30167; Schmidt KN, 1996, ADV EXP MED BIOL, V387, P63; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; Surpin M, 1997, ESSAYS BIOCHEM, V32, P113; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; THIERBACH G, 1981, BIOCHIM BIOPHYS ACTA, V638, P282, DOI 10.1016/0005-2728(81)90238-3; VALENTINE JF, 1992, GASTROENTEROLOGY, V103, P905, DOI 10.1016/0016-5085(92)90024-S; VISNER GA, 1991, AM J PHYSIOL, V260, pL444, DOI 10.1152/ajplung.1991.260.6.L444; VISNER GA, 1990, J BIOL CHEM, V265, P2856; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; WARNER BB, 1991, AM J PHYSIOL, V260, pL296, DOI 10.1152/ajplung.1991.260.4.L296; Warner BB, 1996, AM J PHYSIOL-LUNG C, V271, pL150, DOI 10.1152/ajplung.1996.271.1.L150; WISPE JR, 1992, J BIOL CHEM, V267, P23937; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200	65	73	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20419	20427		10.1074/jbc.M008915200	http://dx.doi.org/10.1074/jbc.M008915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264281	hybrid			2022-12-27	WOS:000169135100101
J	Pages, C; Daviaud, D; An, SZ; Krief, S; Lafontan, M; Valet, P; Saulnier-Blache, JS				Pages, C; Daviaud, D; An, SZ; Krief, S; Lafontan, M; Valet, P; Saulnier-Blache, JS			Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-CLONING; XENOPUS OOCYTES; GROWTH-FACTORS; MEDIATOR; IDENTIFICATION; EXPRESSION; ADIPOCYTES; EDG-1; CELLS	EDG-2, EDG-4, EDG-7, and PSP24 genes encode distinct lysophosphatidic acid (LPA) receptors, The aim of the present study was to determine which receptor subtype is involved in the biological responses generated by LPA in preadipocytes, Growing 3T3F442A preadipocytes express EDG-2 and EDG-4 mRNAs, with no expression of EDG-7 or PSP24 mRNAs. Quantitative reverse transcriptase-polymerase chain reaction revealed that EDG-2 transcripts were 10-fold more abundant than that of EDG-4. To determine the involvement of the EDG-2 receptor in the responses of growing preadipocytes to LPA, stable transfection of antisense EDG-2 cDNA was performed in growing 3T3F442A preadipocytes. This procedure, led to a significant and specific reduction in EDG-2 mRNA and protein. This was associated with a significant alteration in the effect of LPA on both cell proliferation and cell spreading, Finally, the differentiation of growing preadipocytes into quiescent adipocytes led to a strong reduction in the level of EDG-2 transcripts. Results demonstrate the significant contribution of the EDG-2 receptor in the biological responses generated by LPA in 3T3F442A preadipocytes.	Univ Toulouse 3, CHU Rangueil, Inst Louis Burnard, INSERM,U317, F-31403 Toulouse 04, France; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; SmithKline Beecham Labs Pharmaceut, F-35762 St Gregoire, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California San Francisco; GlaxoSmithKline	Saulnier-Blache, JS (corresponding author), Univ Toulouse 3, CHU Rangueil, Inst Louis Burnard, INSERM,U317, Batiment L3, F-31403 Toulouse 04, France.		Saulnier-Blache, Jean Sebastien/X-7729-2018; Valet, Philippe/N-7472-2017	Valet, Philippe/0000-0001-6520-7393; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723; Krief, Stephane/0000-0002-5543-731X				An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; Betuing S, 1996, ENDOCRINOLOGY, V137, P5220, DOI 10.1210/en.137.12.5220; Betuing S, 1997, BIOCHEM BIOPH RES CO, V235, P765, DOI 10.1006/bbrc.1997.6887; BOULOUMIE A, 1994, J BIOL CHEM, V269, P30254; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; Contos JJA, 2000, GENOMICS, V64, P155, DOI 10.1006/geno.2000.6122; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Gaits F, 1997, FEBS LETT, V410, P54, DOI 10.1016/S0014-5793(97)00411-0; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; GOETZL EJ, 1994, J BIOL CHEM, V269, P809; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; JALINK K, 1994, BBA-REV CANCER, V1198, P185, DOI 10.1016/0304-419X(94)90013-2; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P952, DOI 10.1006/bbrc.2000.3569; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu CH, 1997, GENOMICS, V43, P15, DOI 10.1006/geno.1997.4759; Pages C, 1999, BIOCHEM BIOPH RES CO, V265, P572, DOI 10.1006/bbrc.1999.1726; Pages C, 2000, ANN NY ACAD SCI, V905, P159; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sasagawa T, 1998, J NUTR SCI VITAMINOL, V44, P809, DOI 10.3177/jnsv.44.809; Saulnier-Blache JS, 2000, J LIPID RES, V41, P1947; TIGYI G, 1992, J BIOL CHEM, V267, P21360; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806	27	39	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11599	11605		10.1074/jbc.M010111200	http://dx.doi.org/10.1074/jbc.M010111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152468	hybrid, Green Published			2022-12-27	WOS:000168081800026
J	D'Angelo, M; Billings, PC; Pacifici, M; Leboy, PS; Kirsch, T				D'Angelo, M; Billings, PC; Pacifici, M; Leboy, PS; Kirsch, T			Authentic matrix vesicles contain active metalloproteases (MMP) - A role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; MEDIATED MINERALIZATION; NUCLEATIONAL CORE; BINDING PROTEINS; TGF-BETA; CHONDROCYTES; CARTILAGE; MECHANISMS; COLLAGEN; CULTURES	Matrix vesicles (MV) play a key role in the initiation of cartilage mineralization. Although many components in these microstructures have been identified, the specific function of each component is still poorly understood. In this study, we show that metalloproteases (MMP), MMP-2, -9, and -13 are associated with MV isolated from growth plate cartilage. In addition, we provide evidence that MV contain transforming growth factor-beta (TGF-beta) and that MV-associated MMP-13 is capable of activating latent TGF-beta. To determine whether MMPs are associated directly with MV, vesicles isolated from growth plate cartilage were sequentially treated with hyaluronidase, NaCl, and bacterial collagenase to remove matrix proteins and other components attached to their outer surface. Finally, the vesicles were incubated with detergent to rupture the MCV membrane and expose components that are inside the vesicles. Each treated MV fraction was subjected to substrate zymography, immunoblotting, and substrate activity assay. Whereas active MMP-13 was lost after combined treatment with hyaluronidase and Nacl, MMP-8 and -9 activities were still retained in the pellet fraction even after detergent treatment, suggesting that the gelatinases, MMP-2 and -9, are integral components of MV. In addition, MV contain TGF-beta in the small latent complex, and MMP-13 associated with the MV surface was responsible for activation of TGF-beta. Since the amount of TGF-beta activated by hypertrophic chondrocytes increased with mineral appearance in serum-free chondrocyte cultures, a role for active MV-associated MMPs is suggested in activation of TGF-beta seen during late chondrocyte hypertrophy and mineralization of growth plate cartilage.	Univ Penn, Sch Dent Med, Dept Biochem, Hershey, PA 17033 USA; Univ Penn, Sch Dent Med, Dept Anat & Histol, Hershey, PA 17033 USA	University of Pennsylvania; University of Pennsylvania	Kirsch, T (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Orthopaed & Rehabil, Coll Med, H089,500 Univ Dr, Hershey, PA 17033 USA.	tkirsch@psu.edu	D'Angelo, Maria Grazia/K-4685-2016; Leboy, Phoebe/A-1062-2007	D'Angelo, Maria Grazia/0000-0003-1241-4350; 	NIAMS NIH HHS [AR 46245, AR 43732, AR 40075] Funding Source: Medline; NIDCR NIH HHS [DE 11876, DE 05676] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040075, R29AR043732, R01AR046245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE011876] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; ANDERSON HC, 1969, J CELL BIOL, V41, P59, DOI 10.1083/jcb.41.1.59; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BOYAN BD, 1994, J BIOL CHEM, V269, P28374; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; DAngelo M, 1997, J BONE MINER RES, V12, P1368, DOI 10.1359/jbmr.1997.12.9.1368; DANGELO M, 1998, T 44 ANN M ORTH RES, V23, P497; DEAN DD, 1992, CALCIFIED TISSUE INT, V50, P342, DOI 10.1007/BF00301632; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; GENGE BR, 1989, J BIOL CHEM, V264, P10917; HALE JE, 1987, J BIOL CHEM, V262, P1916; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Jeffrey JJ, 1998, BIOL EXTRAC, P15; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kirsch T, 2000, J BONE MINER RES, V15, P261, DOI 10.1359/jbmr.2000.15.2.261; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Miyazono K., 1991, CIBA F SYMP, V157, P89; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Sasaki T, 1999, ANN NY ACAD SCI, V878, P347, DOI 10.1111/j.1749-6632.1999.tb07694.x; Schmitz JP, 1996, J CELL BIOCHEM, V61, P375, DOI 10.1002/(SICI)1097-4644(19960601)61:3<375::AID-JCB5>3.3.CO;2-I; SHIBATA Y, 1993, INT J BIOCHEM, V25, P239, DOI 10.1016/0020-711X(93)90012-4; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; TSCHAN T, 1990, J CELL BIOL, V111, P257, DOI 10.1083/jcb.111.1.257; WU LNY, 1993, J BIOL CHEM, V268, P25084; WU LNY, 1991, J BIOL CHEM, V266, P1195; WU LNY, 1991, J BIOL CHEM, V266, P1187; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404	32	144	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11347	11353		10.1074/jbc.M009725200	http://dx.doi.org/10.1074/jbc.M009725200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145962	hybrid			2022-12-27	WOS:000167980900104
J	Dormeyer, M; Reckenfelderbaumer, N; Ludemann, H; Krauth-Siegel, RL				Dormeyer, M; Reckenfelderbaumer, N; Ludemann, H; Krauth-Siegel, RL			Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRITHIDIA-FASCICULATA; FUNCTIONAL-CHARACTERIZATION; CYSTEINE RESIDUES; THIOREDOXIN; TRYPAREDOXIN; GLUTATHIONE; METABOLISM; CLONING; PURIFICATION	Trypanosoma brucei, the causative agent of African sleeping sickness, synthesizes deoxyribonucleotides via a classical eukaryotic class I ribonucleotide reductase, The unique thiol metabolism of trypanosomatids in which the nearly ubiquitous glutathione reductase is replaced by a trypanothione reductase prompted us to study the nature of thiols providing reducing equivalents for the parasite synthesis of DNA precursors. Here we show that the dithiol trypanothione (bis(glutathionyl)spermidine), in contrast to glutathione, is a direct reductant of T. brucei ribonucleotide reductase with a K-m value of 2 mM, This is the first example of a natural low molecular mass thiol directly delivering reducing equivalents for ribonucleotide reduction. At submillimolar concentrations, the reaction is strongly accelerated by tryparedoxin, a 16-kDa parasite protein with a WCPPC active site motif, The K-m value of T, brucei ribonucleotide reductase for T. brucei tryparedoxin is about 4 muM. The disulfide form of trypanothione is a powerful inhibitor of the tryparedoxin-mediated reaction that may represent a physiological regulation of deoxyribonucleotide synthesis by the redox state of the cell. The trypanothione/tryparedoxin system is a new system providing electrons for a class I ribonucleotide reductase, in addition to the well known thioredoxin and glutaredoxin systems described in other organisms.	Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Krauth-Siegel, RL (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	krauth-siegel@urz.uni-heidelberg.de						ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Breidbach T, 2000, FEBS LETT, V473, P212, DOI 10.1016/S0014-5793(00)01533-7; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Dormeyer M, 1997, FEBS LETT, V414, P449, DOI 10.1016/S0014-5793(97)01036-3; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Krauth-Siegel RL, 1999, PARASITOL TODAY, V15, P404, DOI 10.1016/S0169-4758(99)01516-1; KRAUTHSIEGEL RL, 1993, FEBS LETT, V317, P105, DOI 10.1016/0014-5793(93)81501-P; KrauthSiegel RL, 1996, MOL BIOCHEM PARASIT, V80, P203, DOI 10.1016/0166-6851(96)02689-8; KRAUTHSIEGEL RL, 1995, FASEB J, V9, P1138, DOI 10.1096/fasebj.9.12.7672506; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Montemartini M, 1998, BIOL CHEM, V379, P1137, DOI 10.1515/bchm.1998.379.8-9.1137; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Reckenfelderbaumer N, 2000, J BIOL CHEM, V275, P7547, DOI 10.1074/jbc.275.11.7547; Sjoberg B. M., 1995, NUCLEIC ACIDS MOL BI, V9, P192; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x	36	98	104	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10602	10606		10.1074/jbc.M010352200	http://dx.doi.org/10.1074/jbc.M010352200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150302	hybrid			2022-12-27	WOS:000167980900006
J	Fried, MG; Daugherty, MA				Fried, MG; Daugherty, MA			In vitro interaction of the Escherichia coli cyclic AMP receptor protein with the lactose repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ACTIVATOR PROTEIN; LAC REPRESSOR; DNA-BINDING; OPERATOR DNA; TRANSCRIPTION; PROMOTER; OPERON; 3',5'-MONOPHOSPHATE; EQUILIBRIUM; INDUCER	Sedimentation equilibrium studies show that the Escherichia coli cyclic AMP receptor protein (CAP) and lactose repressor associate to form a 2:1 complex in vitro. This is, to our knowledge, the first demonstration of a direct interaction of these proteins in the absence of DNA. No 1:1 complex was detected over a wide range of CAP concentrations, suggesting that binding is highly cooperative. Complex formation is stimulated by cAMP, with a net uptake of 1 equivalent of cAMP per molecule of CAP bound. Substitution of the dimeric lacI-18 mutant repressor for tetrameric wild-type repressor completely eliminates detectable binding. We therefore propose that CAP binds the cleft between dimeric units in the repressor tetramer. CAP-lac repressor interactions may play important roles in regulatory events that take place at overlapping CAP and repressor binding sites in the lactose promoter.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Fried, MG (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.							ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUTLER AP, 1977, BIOCHEMISTRY-US, V16, P4757, DOI 10.1021/bi00641a001; CHAKERIAN AE, 1992, MOL MICROBIOL, V6, P963, DOI 10.1111/j.1365-2958.1992.tb02162.x; CHEN J, 1992, J BIOL CHEM, V267, P13843; CHEN J, 1994, BIOCHEMISTRY-US, V33, P1234, DOI 10.1021/bi00171a025; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; FRIED MG, 1984, J MOL BIOL, V172, P241, DOI 10.1016/S0022-2836(84)80025-X; Fried MG, 1996, SCIENCE, V274, P1930, DOI 10.1126/science.274.5294.1930; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; HUDSON JM, 1990, J MOL BIOL, V214, P381, DOI 10.1016/0022-2836(90)90188-R; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; LEE JY, 1991, CELL, V66, P793, DOI 10.1016/0092-8674(91)90122-F; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; MAJORS J, 1977, THESIS HARVARD U; MALAN TP, 1984, CELL, V39, P173, DOI 10.1016/0092-8674(84)90203-4; McRorie D. K., 1993, SELF ASS SYSTEMS ANA; Mller-Hill B., 1996, LAC OPERON; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OGORMAN RB, 1980, J BIOL CHEM, V255, P100; REZNIKOFF WS, 1992, J BACTERIOL, V174, P655, DOI 10.1128/jb.174.3.655-658.1992; REZNIKOFF WS, 1992, MOL MICROBIOL, V6, P2419; SCHLAX PJ, 1995, J MOL BIOL, V245, P331, DOI 10.1006/jmbi.1994.0028; SCHMITZ A, 1981, NUCLEIC ACIDS RES, V9, P277, DOI 10.1093/nar/9.2.277; SOGAARDANDERSEN L, 1991, P NATL ACAD SCI USA, V88, P4921, DOI 10.1073/pnas.88.11.4921; STICKLE DF, 1994, EUR J BIOCHEM, V226, P869, DOI 10.1111/j.1432-1033.1994.00869.x; STRANEY SB, 1987, CELL, V51, P699, DOI 10.1016/0092-8674(87)90093-6; TAKAHASHI M, 1980, BIOCHEMISTRY-US, V19, P5124, DOI 10.1021/bi00563a029; Vossen KM, 1996, J MOL BIOL, V255, P44, DOI 10.1006/jmbi.1996.0005; Wyman J., 1990, BINDING LINKAGE FUNC, P63	34	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11226	11229		10.1074/jbc.M009087200	http://dx.doi.org/10.1074/jbc.M009087200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152685	hybrid			2022-12-27	WOS:000167980900087
J	Neve, EPA; Ingelman-Sundberg, M				Neve, EPA; Ingelman-Sundberg, M			Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN IMPORT; PROCESSING PEPTIDASE; RECOGNITION; LIVER; TRANSLOCATION; RETENTION; PRECURSOR; RECEPTOR; DOMAINS	Cytochrome P450 2E1 (CYP2E1) lacking the hydrophobic NH2-terminal hydrophobic transmembrane domain is specifically targeted to mitochondria, where it is processed to a soluble and catalytically active form (Delta 2E1) with a mass of about 40 kDa. Small amounts of Delta 2E1 were also observed in mitochondria isolated from rat liver, indicating that this form of CYP2E1 is also present in vivo. In the present study the mitochondrial targeting signal was identified and characterized by the use of several NH2-terminally truncated and mutated forms of CYP2E1 that were expressed in the mouse H2.35 hepatoma cell line. Two potential mitochondrial targeting sequences were identified in the NH2 terminus of CYP2E1. Deletion of the first potential mitochondrial targeting sequence located between amino acids 50 and 65, as in Delta (2-64)2E1, still resulted in mitochondrial targeting and processing, but when, in addition to the first, the second potential mitochondrial targeting sequence located between amino acids 74 and 95 was also deleted, as in Delta (2-95)2E1, the mitochondrial targeting was abolished. Mutation of the four positively charged Arg and Lys residues present in this sequence to neutral Ala residues resulted in the abrogation of mitochondrial targeting. Deletion of a hydrophobic stretch of amino acids between residues 76 and 83 also abolished mitochondrial targeting and import. Once imported in the mitochondria, these constructs were further processed to the mature protein Delta 2E1. It is concluded that mitochondrial targeting of CYP2E1 is mediated through a sequence located between residues 74 and 95 and that positively charged residues as well as a hydrophobic stretch present in the beginning of this sequence are essential for this process.	Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ingelman-Sundberg, M (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Box 210, S-17177 Stockholm, Sweden.	magnus.ingelman-sundberg@imm.ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021					Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; AHN KS, 1993, J BIOL CHEM, V268, P18726; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BOHNI PC, 1983, J BIOL CHEM, V258, P4937; Bondoc FY, 1999, BIOCHEM PHARMACOL, V58, P461, DOI 10.1016/S0006-2952(99)00111-2; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Chen Q, 1998, MOL PHARMACOL, V53, P638, DOI 10.1124/mol.53.4.638; ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225; Eliasson E, 1996, MOL PHARMACOL, V50, P573; French SW, 1997, J NUTR, V127, pS907, DOI 10.1093/jn/127.5.907S; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; INGELMANSUNDBERG M, 1993, ALCOHOL, V10, P447, DOI 10.1016/0741-8329(93)90063-T; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neve EPA, 1999, FEBS LETT, V460, P309, DOI 10.1016/S0014-5793(99)01361-7; Neve EPA, 2000, J BIOL CHEM, V275, P17130, DOI 10.1074/jbc.M000957200; Neve EPA, 1996, ARCH BIOCHEM BIOPHYS, V333, P459, DOI 10.1006/abbi.1996.0415; OGISHIMA T, 1985, J BIOCHEM, V98, P781, DOI 10.1093/oxfordjournals.jbchem.a135335; OMURA T, 1991, METHOD ENZYMOL, V206, P75; Pahan K, 1997, FREE RADICAL BIO MED, V23, P963, DOI 10.1016/S0891-5849(97)00017-8; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; PFANNER N, 1987, J BIOL CHEM, V262, P14851; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; ROISE D, 1988, J BIOL CHEM, V263, P4509; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Ronis MJJ, 1996, CYTOCHROMES P450 MET, P211; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; Schleiff E, 1999, FEBS LETT, V461, P9, DOI 10.1016/S0014-5793(99)01415-5; Szczesna-Skorupa E, 2000, ARCH BIOCHEM BIOPHYS, V374, P128, DOI 10.1006/abbi.1999.1628; Szczesna-Skorupa E, 2000, J BIOL CHEM, V275, P19409, DOI 10.1074/jbc.M002394200; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	43	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11317	11322		10.1074/jbc.M008640200	http://dx.doi.org/10.1074/jbc.M008640200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11133991	hybrid			2022-12-27	WOS:000167980900100
J	Eicken, C; Sharma, V; Klabunde, T; Owens, RT; Pikas, DS; Hook, M; Sacchettini, JC				Eicken, C; Sharma, V; Klabunde, T; Owens, RT; Pikas, DS; Hook, M; Sacchettini, JC			Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE IMMUNIZATION; ASPARTATE RECEPTOR; PROTECTIVE EPITOPE; OSPC; MICE; SEQUENCE; SPIROCHETE; EXPRESSION; CHALLENGE; INFECTION	The outer surface protein C (OspC) is one of the major host-induced antigens of Borrelia burgdorferi, the causative agent of Lyme disease. We have solved the crystal structure of recombinant OspC to a resolution of 2.5 Angstrom OspC, a largely alpha -helical protein, is a dimer with a characteristic central four-helical bundle formed by association of the two longest helices from each subunit, OspC is very different from OspA and similar to the extracellular domain of the bacterial aspartate receptor and the variant surface glycoprotein from Trypanosoma brucei, Most of the surface-exposed residues of OspC are highly variable among different OspC isolates. The membrane proximal halves of the two long alpha -helices are the only conserved regions that are solvent accessible. As vaccination with recombinant OspC has been shown to elicit a protective immune response in mice, these regions are candidates for peptide-based vaccines.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Albert B Alkek Inst Biosci & Technol, Ctr Struct Biol, Houston, TX 77030 USA; Texas A&M Univ, Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Albert B Alkek Inst Biosci & Technol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu						BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; BURMAN N, 1990, MOL MICROBIOL, V4, P1715, DOI 10.1111/j.1365-2958.1990.tb00549.x; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Gilmore RD, 1999, INFECT IMMUN, V67, P5463, DOI 10.1128/IAI.67.10.5463-5469.1999; Gilmore RD, 2000, INFECT IMMUN, V68, P411, DOI 10.1128/IAI.68.1.411-414.2000; Gilmore RD, 1996, INFECT IMMUN, V64, P2234, DOI 10.1128/IAI.64.6.2234-2239.1996; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Huang XL, 1999, J BIOMOL NMR, V14, P283, DOI 10.1023/A:1008398527355; JAURISHEIPKE S, 1993, MED MICROBIOL IMMUN, V182, P37; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Mathiesen MJ, 1998, INFECT IMMUN, V66, P4073; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PREACMURSIC V, 1992, INFECTION, V20, P342, DOI 10.1007/BF01710681; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; STEVENSON B, 1994, FEMS MICROBIOL LETT, V124, P367, DOI 10.1111/j.1574-6968.1994.tb07310.x; STEVENSON B, 1994, INFECT IMMUN, V62, P3568, DOI 10.1128/IAI.62.8.3568-3571.1994; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THEISEN M, 1993, J CLIN MICROBIOL, V31, P2570, DOI 10.1128/JCM.31.10.2570-2576.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; WILSKE B, 1986, ZBL BAKT-INT J MED M, V263, P92; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zhong WM, 1997, P NATL ACAD SCI USA, V94, P12533, DOI 10.1073/pnas.94.23.12533; Zucker WR, 2001, J BIOL CHEM, V276, P457, DOI 10.1074/jbc.M008449200; [No title captured]	41	73	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10010	10015		10.1074/jbc.M010062200	http://dx.doi.org/10.1074/jbc.M010062200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139584	hybrid			2022-12-27	WOS:000167996400059
J	Rocic, P; Lucchesi, PK				Rocic, P; Lucchesi, PK			Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin II-induced signaling in vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROTEIN-SYNTHESIS; FOCAL ADHESION KINASE; GROWTH-FACTOR; S6 KINASE; ACTIVATION; CALCIUM; P70; PHOSPHORYLATION; TRANSDUCTION; RECEPTOR	Abnormal vascular smooth muscle cell (VSMC) growth plays a key role in the pathogenesis of hypertension and atherosclerosis. Angiotensin II (Ang II) elicits a hypertrophic growth response characterized by an increase in protein synthesis in the absence of DNA synthesis and cell proliferation. Intracellular signaling mechanisms linking angiotensin type I receptor activation to protein synthesis in VSMC have not been fully characterized. The present study investigates the role of the nonreceptor proline-rich tyrosine kinase 2 (PYK2) in Ang II-induced VSMC protein synthesis and in the regulation of two signaling pathways that have been implicated in the control of protein synthesis, the extracellular signal-regulated kinase (ERK1/2) and the phosphatidylinositol 3-kinase/Akt pathways. PYK2 antisense oligonucleotides were used to down-regulate PM(2 expression in cultured VSMC. An 80% down-regulation in PYK2 expression resulted in an similar to 80% inhibition of ERK1/2 (3.8 +/- 1.3 versus 16.6 +/- 1.8), p70S6 kinase (1.03 +/- 0.03 versus 3.8 +/- 0.5), and Akt activation (3.0 +/- 0.8 versus 16.0 +/- 1.0) by Ang II. Furthermore, PYK2 down-regulation resulted in a complete inhibition of Ang II-induced VSMC protein synthesis. These data conclusively identify PYK2 as an upstream regulator of both the ERK1/2 and the phosphatidylinositol 3-kinase/Akt pathways that are involved in Ang II-induced VSMC protein synthesis.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Lucchesi, PK (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 986,1530 3rd Ave S, Birmingham, AL 35294 USA.		Lucchesi, Pamela A/E-3558-2011	Rocic, Petra/0000-0002-5781-3075	NHLBI NIH HHS [HL56046, HL63318] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056046, R01HL063318, R29HL056046] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Berk BC, 1997, CIRC RES, V80, P607, DOI 10.1161/01.RES.80.5.607; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; GIASSON E, 1995, J BIOL CHEM, V270, P5225, DOI 10.1074/jbc.270.10.5225; Govindarajan G, 2000, CIRC RES, V87, P710, DOI 10.1161/01.RES.87.8.710; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hou M, 2000, ACTA PHYSIOL SCAND, V168, P301; Huckle William R., 1994, Progress in Growth Factor Research, V5, P177, DOI 10.1016/0955-2235(94)90004-3; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; Koller E, 2000, TRENDS PHARMACOL SCI, V21, P142, DOI 10.1016/S0165-6147(00)01448-6; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Lucchesi PA, 1996, CIRC RES, V78, P962, DOI 10.1161/01.RES.78.6.962; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pratt R E, 1996, Blood Press Suppl, V2, P6; Rocic P, 2001, FASEB J, V15, pA488; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; Sabri A, 1998, CIRC RES, V83, P841, DOI 10.1161/01.RES.83.8.841; SALAZAR EP, 2001, J BIOL CHEM     0215; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Takahashi T, 1997, J BIOL CHEM, V272, P16018, DOI 10.1074/jbc.272.25.16018; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699	29	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21902	21906		10.1074/jbc.M101684200	http://dx.doi.org/10.1074/jbc.M101684200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262415	hybrid			2022-12-27	WOS:000169297900143
J	Christensen, ST; Guerra, C; Wada, Y; Valentin, T; Angeletti, RH; Satir, P; Hamasaki, T				Christensen, ST; Guerra, C; Wada, Y; Valentin, T; Angeletti, RH; Satir, P; Hamasaki, T			A regulatory light chain of ciliary outer arm dynein in Tetrahymena thermophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							22S DYNEIN; MICROTUBULE TRANSLOCATION; BEAT FREQUENCY; PARAMECIUM; PHOSPHORYLATION; MOTILITY; AXONEMES; TRANSFORMATION; MUTANTS; PROTEIN	Ciliary beat frequency is primarily regulated by outer arm dyneins (22 S dynein), Chilcote and Johnson (Chilcote, T. J., and Johnson, K. A. (1990) J. Biol Chem, 256, 17257-17266) previously studied isolated Tetrahymena 22 S dynein, identifying a protein p34, which showed cAMP-dependent phosphorylation, Here, we characterize the molecular biochemistry of p34 further, demonstrating that it is the functional ortholog of the 22 S dynein regulatory light chain, p29, in Paramecium, p34, thiophosphorylated in isolated axonemes in the presence of cAMP, co-purified with 22 S dynein and not with inner arm dynein (14 S dynein), Isolated 22 S dynein containing phosphorylated p34 showed similar to 70% increase in in vitro microtubule translocation velocity compared with its unphosphorylated counterpart. Extracted p34 rebound to isolated 22 S dynein from either Tetrahymena or Paramecium but not to 14 S dynein from either ciliate. Binding of radiolabeled p34 to 22 S dynein was competitive with p29, Phosphorylated p34 was not present in axonemes isolated from a mutant lacking outer arms. Two-dimensional gel electrophoresis followed by phosphorimaging revealed at least five phosphorylated p34-related spots, consistent with multiple phosphorylation sites in p34 or perhaps multiple isoforms of p34, These new features suggest that a class of outer arm dynein light chains including p34 regulates microtubule sliding velocity and consequently ciliary beat frequency through phosphorylation.	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Satir, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Christensen, Søren/N-3049-2014; Christensen, Søren Tvorup/ABG-6089-2020	Christensen, Søren/0000-0001-5004-304X; Christensen, Søren Tvorup/0000-0001-5004-304X	NATIONAL CANCER INSTITUTE [T32CA009475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NCI NIH HHS [CA 09475] Funding Source: Medline; NIDDK NIH HHS [DK41918] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKALOW K, 1994, J CELL BIOL, V126, P727, DOI 10.1083/jcb.126.3.727; BARKALOW K, 1994, CELL MOTIL CYTOSKEL, V27, P299, DOI 10.1002/cm.970270403; BONINI NM, 1988, J CELL BIOL, V106, P1615, DOI 10.1083/jcb.106.5.1615; BONINI NM, 1990, J CELL SCI, V95, P219; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Bruns PJ, 2000, METHOD CELL BIOL, V62, P501; CHILCOTE TJ, 1990, J BIOL CHEM, V256, P17257; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; Hamasaki T, 1995, BIOPHYS J, V69, P2569, DOI 10.1016/S0006-3495(95)80128-1; HAMASAKI T, 1991, P NATL ACAD SCI USA, V88, P7918, DOI 10.1073/pnas.88.18.7918; HAMASAKI T, 1989, CELL MOTIL CYTOSKEL, V12, P1, DOI 10.1002/cm.970120102; HAYASHI M, 1979, J BIOL CHEM, V254, P1561; HENNESSEY T, 1985, EUR J CELL BIOL, V36, P153; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; KIY T, 1992, APPL MICROBIOL BIOT, V38, P141; Lansley AB, 1999, BIOPHYS J, V77, P629, DOI 10.1016/S0006-3495(99)76919-5; LANSLEY AB, 1992, AM J PHYSIOL, V263, P232; LUDMANN SA, 1993, J EUKARYOT MICROBIOL, V40, P650, DOI 10.1111/j.1550-7408.1993.tb06123.x; MARCHESERAGONA SP, 1995, METHOD CELL BIOL, V47, P171, DOI 10.1016/S0091-679X(08)60806-7; ORIAS E, 1983, J CELL SCI, V64, P49; SALATHE M, 1993, AM J RESP CELL MOL, V9, P306, DOI 10.1165/ajrcmb/9.3.306; SATIR B, 1976, CELL BIOL INT REP, V1, P69; Satir P, 1998, EUR J PROTISTOL, V34, P267, DOI 10.1016/S0932-4739(98)80053-9; SAUVE DM, 1995, ANAL BIOCHEM, V226, P382, DOI 10.1006/abio.1995.1242; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sullivan J, 1996, J EUKARYOT MICROBIOL, V43, P5, DOI 10.1111/j.1550-7408.1996.tb02466.x; Taylor HC, 1999, CELL MOTIL CYTOSKEL, V43, P167, DOI 10.1002/(SICI)1097-0169(1999)43:2<167::AID-CM8>3.3.CO;2-H; Wang HL, 1998, CELL MOTIL CYTOSKEL, V39, P1, DOI 10.1002/(SICI)1097-0169(1998)39:1<1::AID-CM1>3.0.CO;2-B	28	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20048	20054		10.1074/jbc.M008412200	http://dx.doi.org/10.1074/jbc.M008412200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274140	hybrid			2022-12-27	WOS:000169135100051
J	Prada-Delgado, A; Carrasco-Marin, E; Bokoch, GM; Alvarez-Dominguez, C				Prada-Delgado, A; Carrasco-Marin, E; Bokoch, GM; Alvarez-Dominguez, C			Interferon-gamma listericidal action is mediated by novel Rab5a functions at the phagosomal environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; NADPH OXIDASE; MONOCYTOGENES; ACTIVATION; MATURATION; MACROPHAGES; RECEPTOR; TRAFFICKING; ENDOCYTOSIS; MODULATION	Control and clearance of Listeria monocytogenes infection is an interferon-gamma -dependent process. The listericidal mechanism of action involves activation of NADPH oxidase and inducible nitric oxide synthase to produce reactive oxygen and nitrogen intermediate radicals, respectively. Recently, we have described in a nonpathogenic model of L. monocytogenes (hemolysin negative mutant strain) that the interferon-gamma -inducible GTPase Rab5a contributed to Listeria destruction in resting macrophages. Here, we report in a pathogenic model of L. monocytogenes (hemolysin-positive strain) that Rab5a plays a central role in Listeria destruction induced by interferon-gamma and within the phagosomal environment. These findings reveal the importance of Rab5a as the responsible factor mediating the listericidal action of interferon-gamma. Active Rab5a causes remodeling of the phagosomal environment, facilitates the translocation of Rac2 to LM phagosomes, and regulates the activity of this GTPase. Rac2 activation and translocation governs the phagocyte NADPH oxidase activity and the consequent reactive oxygen intermediate production that leads to killing of the pathogen.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Scripps Res Inst, Dept Immunol IMM14R221, La Jolla, CA 92037 USA; Washington Univ, Dept Cell Biol, St Louis, MO 63110 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Scripps Research Institute; Washington University (WUSTL)	Alvarez-Dominguez, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Cantoblanco, E-28049 Madrid, Spain.	calvarez@cbm.uam.es	Marin, Eugenio Carrasco/AAG-1578-2021; Alvarez-Dominguez, Carmen/J-4675-2014	Marin, Eugenio Carrasco/0000-0002-3556-9227; Alvarez-Dominguez, Carmen/0000-0002-4585-6959	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez-Dominguez C, 2000, IMMUNOLOGY, V101, P83, DOI 10.1046/j.1365-2567.2000.00083.x; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BASTIAN NR, 1994, CURR OPIN IMMUNOL, V6, P131, DOI 10.1016/0952-7915(94)90044-2; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; BORTOLUSSI R, 1987, INFECT IMMUN, V55, P3197, DOI 10.1128/IAI.55.12.3197-3203.1987; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; HIGGINBOTHAM JN, 1992, CLIN EXP IMMUNOL, V88, P492; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; LEYVACOBIAN F, 1994, IMMUNOL LETT, V43, P29, DOI 10.1016/0165-2478(94)00146-4; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Pizarro-Cerda J, 1999, J IMMUNOL, V162, P3519; Porter S S, 1989, J Clin Anesth, V1, P170, DOI 10.1016/0952-8180(89)90037-8; PORTNOY DA, 1992, CURR OPIN IMMUNOL, V4, P20, DOI 10.1016/0952-7915(92)90118-X; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; QUINN MT, 1993, J BIOL CHEM, V268, P20983; ROSSMAN MD, 1990, CELL IMMUNOL, V126, P268, DOI 10.1016/0008-8749(90)90320-Q; Schaible UE, 1998, J IMMUNOL, V160, P1290; Searle S, 1998, J CELL SCI, V111, P2855; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Via LE, 1998, J CELL SCI, V111, P897	35	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19059	19065		10.1074/jbc.M101639200	http://dx.doi.org/10.1074/jbc.M101639200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262414	hybrid			2022-12-27	WOS:000169091000057
J	Kirkpatrick, H; Johnson, K; Laughon, A				Kirkpatrick, H; Johnson, K; Laughon, A			Repression of Dpp targets by binding of brinker to mad sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EMBRYO; TRANSCRIPTIONAL CONTROL; DECAPENTAPLEGIC GENE; MORPHOGEN GRADIENT; SMAD PROTEINS; GERM LAYERS; MEDEA; DNA; HOMOLOG; MOTHERS	Signaling by decapentaplegic (Dpp), a Drosophila member of the transforming growth factor (TGF) beta superfamily of growth factors, has recently been shown to activate targets such as vestigial (vg) indirectly through negative regulation of brinker (brk), Here we show that the Brk protein functions as a repressor by binding to Dpp response elements. The Brk DNA binding activity was localized to an amino-terminal region containing a putative homeodomain. Brk bound to a Dpp response element of the Ultrabithorax: (Ubx) midgut enhancer at a sequence that overlaps a binding site for the Smad protein, Mothers Against Dpp (Mad). Furthermore, Brk was able to compete with Mad for occupancy of this binding site. This recognition of overlapping binding sites provides a potential explanation for why the G/C-rich Mad binding site consensus differs the Smad3/Smad4 binding site consensus. We also found that the Dpp response element from Ubx was more sensitive than the vg quadrant enhancer to repression by Brk. This difference correlates with short-range activation of Ubx by Dpp in the visceral mesoderm, whereas vg exhibits a long-range response to Dpp in the wing imaginal disc, indicating that Brk binding sites may play a critical role in limiting thresholds for activation by Dpp. Finally, we provide evidence that Brk is capable of functioning as an active repressor, Thus, whereas Brk and Mad compete for regulation of Ubx and vg, Brk may regulate other Dpp targets without direct involvement of Mad.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Laughon, A (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	alaughon@facstaff.wisc.edu						Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Certel K, 2000, DEVELOPMENT, V127, P3173; Das P, 1998, DEVELOPMENT, V125, P1519; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Haerry TE, 1998, DEVELOPMENT, V125, P3977; HALDER G, 1998, GENE DEV, V12, P3815; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hudson JB, 1998, DEVELOPMENT, V125, P1407; IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Maduzia LL, 1997, BIOCHEM BIOPH RES CO, V238, P595, DOI 10.1006/bbrc.1997.7353; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MASUCCI JD, 1993, DEV BIOL, V159, P276, DOI 10.1006/dbio.1993.1240; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELSON HB, 1993, ROUX ARCH DEV BIOL, V202, P341, DOI 10.1007/BF00188733; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; PANGANIBAN GEF, 1990, DEVELOPMENT, V110, P1041; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; RAFTERY LA, 1995, GENETICS, V139, P241; Raftery LA, 1996, ANN NY ACAD SCI, V785, P318, DOI 10.1111/j.1749-6632.1996.tb56296.x; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022; THURINGER F, 1993, EMBO J, V12, P2419, DOI 10.1002/j.1460-2075.1993.tb05896.x; Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	56	64	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18216	18222		10.1074/jbc.M101365200	http://dx.doi.org/10.1074/jbc.M101365200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11262410	hybrid			2022-12-27	WOS:000168866500081
J	Crespo, NC; Ohkanda, J; Yen, TJ; Hamilton, AD; Sebti, SM				Crespo, NC; Ohkanda, J; Yen, TJ; Hamilton, AD; Sebti, SM			The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TUMOR-GROWTH; CENP-E; GERANYLGERANYLTRANSFERASE-I; TRANSFERASE INHIBITORS; MITOTIC CHECKPOINT; RAS PRENYLATION; K-RAS; PROTEIN; FARNESYLATION; KINETOCHORES	Even though farnesyltransferase inhibitors (FTIs), a novel class of therapeutic agents presently in clinical trials, have preclinically outstanding anticancer activity and impressive lack of toxicity, their mechanism of action is not well understood. To enhance our understanding of how FTIs inhibit the growth of tumors, we have investigated their effects on eel cycle progression of two human lung cancer cell lines, A-549 and Calu-1. In this report, we show in synchronized A-549 and Calu-1 cells that FTI-2153 treatment resulted in a large accumulation of cells in the mitosis phase of the cell division cycle, with some cells in the G(0)/G(1) phase. Furthermore, microtubule immunostaining and 4,6-diamidino-2-phenylindole DNA staining demonstrated that the FTI-2153-induced accumulation in mitosis is due to the inability of these cells to progress from prophase to metaphase. FTI-2153 inhibited the ability of A-549 and Calu-1 cells to form bipolar spindles and caused formation of monoasteral spindles. Furthermore, FTI-2153 induced a ring-shaped chromosome morphology and inhibited chromosome alignment. Time-lapse videomicroscopy confirmed this result by showing that FTI-2153-treated cells are unable to align their chromosomes at the metaphase plate. FTI-2153 did not affect the localization to the kinetochores of two farnesylated centromeric proteins, CENP-E and CENP-F. Thus, a mechanism by which FTIs inhibit progression through mitosis and tumor growth is by blocking bipolar spindle formation and chromosome alignment.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Oncol, Drug Discovery Program,MRC,DRDIS, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Biochem & Mol Biol, Drug Discovery Program, Tampa, FL 33612 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Yale University; Fox Chase Cancer Center	Sebti, SM (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Oncol, Drug Discovery Program,MRC,DRDIS, 12902 Magnolia Dr, Tampa, FL 33612 USA.		Ohkanda, Junko/I-6102-2019	Ohkanda, Junko/0000-0001-9663-5104; Yen, Tim/0000-0003-2159-0997	NATIONAL CANCER INSTITUTE [U19CA067771] Funding Source: NIH RePORTER; NCI NIH HHS [CA67771] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Gibbs JB, 1997, ANNU REV PHARMACOL, V37, P143, DOI 10.1146/annurev.pharmtox.37.1.143; HUANG CC, 2000, FARNESYLTRANSFERASE, P21; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; JORDAN MA, 1991, CANCER RES, V51, P2212; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Lebowitz PF, 1998, ONCOGENE, V17, P1439, DOI 10.1038/sj.onc.1202175; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; PATNAIK A, 2000, FARNESYLTRANSFERASE, P233; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sebti S. M., 2000, FARNESYLTRANSFERASE, P197; Sebti SM, 1997, PHARMACOL THERAPEUT, V74, P103, DOI 10.1016/S0163-7258(97)00014-4; SEPPLORENZINO L, 1995, CANCER RES, V55, P5302; Sun JZ, 1999, CANCER RES, V59, P4919; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Vogt A, 1996, ONCOGENE, V13, P1991; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	33	112	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16161	16167		10.1074/jbc.M006213200	http://dx.doi.org/10.1074/jbc.M006213200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11154688	hybrid			2022-12-27	WOS:000168623100080
J	Richman, JG; Brady, AE; Wang, Q; Hensel, JL; Colbran, RJ; Limbird, LE				Richman, JG; Brady, AE; Wang, Q; Hensel, JL; Colbran, RJ; Limbird, LE			Agonist-regulated interaction between alpha(2)-adrenergic receptors and spinophilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FILAMENT-BINDING PROTEIN; 3RD INTRACELLULAR LOOP; CANINE KIDNEY-CELLS; ADRENERGIC-RECEPTORS; ALPHA-2-ADRENERGIC RECEPTOR; ALPHA(2A)-ADRENERGIC RECEPTOR; BASOLATERAL MEMBRANE; COUPLED RECEPTORS; SUBTYPES	Previously, we demonstrated that the third intracellular (3i) loop of the heptahelical alpha (2A)-adrenergic receptor (alpha (2A)AAR) is critical for retention at the basolateral surface of polarized Madin-Darby canine kidney II (MDCKII) cells following their direct targeting to this surface, Findings that the 3i loops of the D-2 dopamine receptors interact with spinophilin (Smith, F. D., Oxford, G. S., and Milgram, S. L. (1999) J. Biol. Chem. 274, 19894-19900) and that spinophilin is enriched beneath the basolateral surface of polarized MDCK cells prompted us to assess whether alpha (2)AR subtypes might also interact with spinophilin. [S-35]Met-labeled 3i loops of the alpha (2A)AR (Val(217)-Ala(377)), alpha (2B)AR (Lys(210)-Trp(354)), and alpha (2C)AR (Arg(248)-Val(363)) subtypes interacted with glutathione S-transferase-spinophilin fusion proteins. These interactions could be refined to spinophilin amino acid residues 169-255, in a region between spinophilin's F-actin binding and phosphatase 1 regulatory domains. Furthermore, these interactions occur in intact cells in an agonist regulated fashion, because alpha (2A)AR and spinophilin coimmunoprecipitation from cells is enhanced by prior treatment with agonist. These findings suggest that spinophilin may contribute not only to alpha (2)AR localization but also to agonist modulation of alpha (2)AR signaling.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Limbird, LE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Rm 464, Nashville, TN 37232 USA.		Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Wang, Qin/0000-0002-1079-5914	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043879, T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037508] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43879, T32DK07563] Funding Source: Medline; NINDS NIH HHS [NS37508] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; EASON MG, 1992, J BIOL CHEM, V267, P25473; FLORDELLIS CS, 1995, J BIOL CHEM, V270, P3491, DOI 10.1074/jbc.270.8.3491; GUYER CA, 1990, J BIOL CHEM, V265, P17307; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Jinsi A, 1996, EUR J PHARMACOL, V302, P183, DOI 10.1016/0014-2999(96)00049-0; JONES SB, 1990, J PHARMACOL EXP THER, V254, P294; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KUROSE H, 1994, J BIOL CHEM, V269, P10093; LANIER SM, 1991, J BIOL CHEM, V266, P10470; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MACNULTY EE, 1992, J BIOL CHEM, V267, P2149; Mani SK, 2000, SCIENCE, V287, P1053, DOI 10.1126/science.287.5455.1053; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Olli-Lahdesmaki T, 1999, J NEUROSCI, V19, P9281; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; RICHMAN JG, 1998, AM J PHYSIOL, V43, pC654; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Saunders C, 2000, MOL PHARMACOL, V57, P44; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; SMITH SK, 1981, P NATL ACAD SCI-BIOL, V78, P4026, DOI 10.1073/pnas.78.7.4026; Snyder GL, 1998, J NEUROSCI, V18, P10297; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; VONZASTROW M, 1994, J BIOL CHEM, V269, P15448; WADE SM, 1994, MOL PHARMACOL, V45, P1191; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153	48	101	104	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15003	15008		10.1074/jbc.M011679200	http://dx.doi.org/10.1074/jbc.M011679200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11154706	hybrid			2022-12-27	WOS:000168528800065
J	Cherqui, S; Kalatzis, V; Trugnan, G; Antignac, C				Cherqui, S; Kalatzis, V; Trugnan, G; Antignac, C			The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; INTRACELLULAR TRAFFICKING; NEPHROPATHIC CYSTINOSIS; CYTOPLASMIC TAIL; TRANSPORT; ENDOCYTOSIS; DELIVERY; PROTEINS; GLYCOPROTEINS; PROTEOLYSIS	Cystinosis is a lysosomal transport disorder characterized by an accumulation of intra-lysosomal cystine, Biochemical studies showed that the lysosomal cystine transporter was distinct from the plasma membrane cystine transporters and that it exclusively transported cystine. The gene underlying cystinosis, CTNS, encodes a predicted seven-transmembrane domain protein called cystinosin, which is highly glycosylated at the N-terminal end and carries a GY-XX-Phi (where Phi is a hydrophobic residue) lysosomal-targeting motif in its carboxyl tail. We constructed cystinosin-green fluorescent protein fusion proteins to determine the subcellular localization of cystinosin in transfected cell lines and showed that cystinosin-green fluorescent protein colocalizes with lysosomal-associated membrane protein 2 (LAMP-S) to lysosomes. Deletion of the GY-XX-Phi motif resulted in a partial redirection to the plasma membrane as well as sorting to lysosomes, demonstrating that this motif is only partially responsible for the lysosomal targeting of cystinosin and suggesting the existence of a second sorting signal. A complete relocalization of cystinosin to the plasma membrane was obtained after deletion of half of the third cytoplasmic loop (amino acids 280-288) coupled with the deletion of the GY-DQ-L motif, demonstrating the presence of the second signal within this loop. Using site-directed mutagenesis studies we identified a novel conformational lysosomal-sorting motif, the core of which was delineated to YF-PQA (amino acids 281-285).	Hop Necker Enfants Malad, INSERM, U423, F-75015 Paris, France; Ctr Hosp Univ St Antoine, INSERM, U538, F-75012 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Antignac, C (corresponding author), Hop Necker Enfants Malad, INSERM, U423, 149 Rue Sevres, F-75015 Paris, France.		Kalatzis, Vasiliki/F-6170-2019; ANTIGNAC, Corinne/H-8945-2017	Kalatzis, Vasiliki/0000-0002-9626-8807; ANTIGNAC, Corinne/0000-0002-9934-4940; Cherqui, Stephanie/0000-0003-1240-5219				Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; BANNAI S, 1980, J BIOL CHEM, V255, P2372; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Calvo PA, 1999, J BIOL CHEM, V274, P12780, DOI 10.1074/jbc.274.18.12780; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Mancini GMS, 2000, J INHERIT METAB DIS, V23, P278, DOI 10.1023/A:1005640214408; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; OPRESKO LK, 1995, J BIOL CHEM, V270, P4325, DOI 10.1074/jbc.270.9.4325; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; Thoene J, 1999, MOL GENET METAB, V67, P283, DOI 10.1006/mgme.1999.2876; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955	34	97	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13314	13321		10.1074/jbc.M010562200	http://dx.doi.org/10.1074/jbc.M010562200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11150305	hybrid			2022-12-27	WOS:000168198600117
J	Ghosh, D; Sawicki, M; Lala, P; Erman, M; Pangborn, W; Eyzaguirre, J; Gutierrez, R; Jornvall, H; Thiel, DJ				Ghosh, D; Sawicki, M; Lala, P; Erman, M; Pangborn, W; Eyzaguirre, J; Gutierrez, R; Jornvall, H; Thiel, DJ			Multiple conformations of catalytic serine and histidine in acetylxylan esterase at 0.90 angstrom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING DOMAIN; X-RAY-DIFFRACTION; XYLAN ESTERASE; PENICILLIUM-PURPUROGENUM; TRICHODERMA-REESEI; SYSTEMS	Acetylxylan esterase (AXEII; 207 amino acids) from Penicillium purpurogenum has substrate specificities toward acetate esters of D-xylopyranose residues in xylan and belongs to a new class of alpha/beta hydrolases. The crystal structure of AXEII has been determined by single isomorphous replacement and anomalous scattering, and refined at 0.90- and 1.10-Angstrom resolutions with data collected at 85 K and 295 K, respectively. The tertiary structure consists of a doubly wound alpha/beta sandwich, having a central six-stranded parallel beta -sheet flanked by two parallel ol-helices on each side. The catalytic residues Ser(90), His(187), and Ap(175) are located at the C-terminal end of the sheet, an exposed region of the molecule. The serine and histidine side chains in the 295 K structure show the frequently observed conformations in which Ser(90) is trans and the hydroxyl group is in the plane of the imidazole ring of His(187), However, the structure at 85 K displays an additional conformation in which Ser(90) side-chain hydroxyl is away from the plane of the imidazole ring of His(187). The His(187) side chain forms a hydrogen bond with a sulfate ion and adopts an altered conformation. The only other known hydrolase that has a similar tertiary structure is Fusarium solani cutinase, The exposed nature of the catalytic triad suggests that AXEII is a pure esterase, i.e. an alpha/beta hydrolase with specificity for nonlipidic polar substrates.	Hauptmann Woodward Med Res Inst, Buffalo, NY 14203 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Pontificia Univ Catolica Chile, Santiago, Chile; Karolinska Inst, SE-17177 Stockholm, Sweden; Cornell High Energy Synchotron Source, Ithaca, NY 14853 USA	Hauptman Woodward Medical Research Institute; Roswell Park Cancer Institute; Pontificia Universidad Catolica de Chile; Karolinska Institutet; Cornell University	Ghosh, D (corresponding author), Hauptmann Woodward Med Res Inst, 73 High St, Buffalo, NY 14203 USA.	ghosh@hwi.buffalo.edu	Gutierrez, Rodrigo/ABA-9285-2020; Gutiérrez, Rodrigo A/C-2611-2008	Gutierrez, Rodrigo/0000-0002-5961-5005; Gutiérrez, Rodrigo A/0000-0002-5961-5005				BIELY P, 1985, FEBS LETT, V186, P80, DOI 10.1016/0014-5793(85)81343-0; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; BRUNGER AT, 1997, XPLOR MANUAL 3 8; CHRISTOV LP, 1993, ENZYME MICROB TECH, V15, P460, DOI 10.1016/0141-0229(93)90078-G; Egana L, 1996, BIOTECHNOL APPL BIOC, V24, P33; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; EYZAGUIRRE J, 1999, SPECIAL PUBLICATION, V246, P117; Ghosh D, 1999, ACTA CRYSTALLOGR D, V55, P779, DOI 10.1107/S0907444999000244; GHOSH D, 1995, STRUCTURE, V3, P279, DOI 10.1016/S0969-2126(01)00158-7; Gutierrez R, 1998, FEBS LETT, V423, P35, DOI 10.1016/S0014-5793(98)00055-6; Hakulinen N, 1998, ACTA CRYSTALLOGR D, V54, P430, DOI 10.1107/S0907444997012213; JOSELEAU JP, 1992, PROGR BIOTECHNOL, V7, P1; Longhi S, 1997, J MOL BIOL, V268, P779, DOI 10.1006/jmbi.1997.1000; MargollesClark E, 1996, EUR J BIOCHEM, V237, P553, DOI 10.1111/j.1432-1033.1996.0553p.x; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1995, HKL MANUAL; Pangborn W, 1996, PROTEINS, V24, P523, DOI 10.1002/(SICI)1097-0134(199604)24:4<523::AID-PROT13>3.0.CO;2-N; POUTANEN K, 1988, APPL MICROBIOL BIOT, V28, P419, DOI 10.1007/BF00268207; ROE SM, 1993, J MOL BIOL, V229, P419, DOI 10.1006/jmbi.1993.1043; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Sheldrick G.M., 1997, SHELX 97 MANUAL; Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011; WONG KKY, 1993, PORT PR R M, V4, P127	23	58	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11159	11166		10.1074/jbc.M008831200	http://dx.doi.org/10.1074/jbc.M008831200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134051				2022-12-27	WOS:000167980900078
J	Bleijs, DA; van Duijnhoven, GCF; van Vliet, SJ; Thijssen, JPH; Figdor, CG; van Kooyk, Y				Bleijs, DA; van Duijnhoven, GCF; van Vliet, SJ; Thijssen, JPH; Figdor, CG; van Kooyk, Y			A single amino acid in the cytoplasmic domain of the beta(2) integrin lymphocyte function-associated antigen-1 regulates avidity-dependent inside-out signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD11/CD18 LEUKOCYTE INTEGRINS; PROTEIN-KINASE-C; PHORBOL ESTER; CELL-ADHESION; CYTOSKELETAL ASSOCIATION; MONOCLONAL-ANTIBODY; ACTIN CYTOSKELETON; ALPHA-ACTININ; SMALL GTPASE; LFA-1	The leukocyte-specific beta (2) integrin lymphocyte function-associated antigen-1 (LFA-1) (alpha (L)/beta (2)) mediates activation-dependent adhesion to intercellular adhesion molecule (ICAM)-1, In leukocytes, LFA-1 requires activation by intracellular messengers to bind ICAM-1, We observed malfunctioning of LFA-1 activation in leukemic T cells and K562-transfected cells. This defective inside-out integrin activation is only restricted to beta (2) integrins, since beta (1) integrins expressed in KS62 readily respond to activation signals, such as phorbol la-myristate 13-acetate, To unravel these differences in inside-out signaling between beta (1) and beta (2) integrins, we searched for amino acids in the p, cytoplasmic domain that are critical in the activation of LFA-1, We provide evidence that substitution of a single amino acid (L732R) in the beta (2) cytoplasmic DLRE motif, creating the DRRE motif, is sufficient to completely restore PMA responsiveness of LFA-1 expressed in K562. In addition, an intact TTT motif in the C-terminal domain is necessary for the acquired PMA responsiveness. We observed that restoration of the PMA response altered neither LFA-1 affinity nor the phosphorylation status of LFA-1. In contrast, strong differences were observed in the capacity of LFA-1 to form clusters, which indicates that inside-out activation of LFA-1 strongly depends on cytoskeletal induced receptor reorganization that was induced by activation of the Ca2+-dependent protease calpain.	UMC Nijmegen, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands	Radboud University Nijmegen	van Kooyk, Y (corresponding author), UMC Nijmegen, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.		Figdor, Carl G/A-4232-2010	Figdor, Carl G/0000-0002-2366-9212; van Vliet, Sandra/0000-0003-1811-2687				ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; BEATTY PG, 1983, J IMMUNOL, V131, P2913; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FIGDOR CG, 1990, IMMUNOL TODAY, V11, P277, DOI 10.1016/0167-5699(90)90112-M; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; KEIZER GD, 1988, J IMMUNOL, V140, P1393; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; KRENSKY AM, 1983, J IMMUNOL, V131, P611; Li JX, 1996, J BIOL CHEM, V271, P12985, DOI 10.1074/jbc.271.22.12985; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lobb RR, 1995, CELL ADHES COMMUN, V3, P385, DOI 10.3109/15419069509081293; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; MARTZ E, 1987, HUM IMMUNOL, V18, P3, DOI 10.1016/0198-8859(87)90110-8; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; PARDI R, 1995, J IMMUNOL, V155, P1252; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Valmu L, 1999, EUR J IMMUNOL, V29, P2107, DOI 10.1002/(SICI)1521-4141(199907)29:07<2107::AID-IMMU2107>3.0.CO;2-T; VALMU L, 1995, J IMMUNOL, V155, P1175; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; VANKOOYK Y, 1993, J EXP MED, V177, P185, DOI 10.1084/jem.177.1.185; WACHOLTZ MC, 1989, J EXP MED, V170, P431, DOI 10.1084/jem.170.2.431; Zhou XM, 2000, J BIOL CHEM, V275, P20217, DOI 10.1074/jbc.M909129199	46	23	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10338	10346		10.1074/jbc.M008967200	http://dx.doi.org/10.1074/jbc.M008967200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134023	hybrid, Green Published			2022-12-27	WOS:000167996400100
J	Chambenoit, O; Hamon, Y; Marguet, D; Rigneault, H; Rosseneu, M; Chimini, G				Chambenoit, O; Hamon, Y; Marguet, D; Rigneault, H; Rosseneu, M; Chimini, G			Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; BINDING CASSETTE TRANSPORTER-1; DENSITY-LIPOPROTEIN DEFICIENCY; CHOLESTEROL EFFLUX; TANGIER-DISEASE; PLASMA-MEMBRANE; APOPTOTIC CELLS; GENE; MUTATIONS; CAMP	The identification of defects in ABCA1 as the molecular basis of Tangier disease has highlighted its crucial role in the loading with phospholipids and cholesterol of nascent apolipoprotein particles. Indeed the expression of ABCA1 affects apolipoprotein A-I (apoA-I)-mediated removal of lipids from cell membranes, and the possible role of ABCA1 as an apoA-I surface receptor has been recently suggested, In the present study, we have investigated the role of the ABCA1 transporter as an apoA-I receptor with the analysis of a panel of transfectants expressing functional or mutant forms of ABCA1, We provide experimental evidence that the forced expression of a functional ABCA1 transporter confers surface competence for apoA-I binding. This, however, appears to be dependent on ABCA1 function. Structurally intact but ATPase-deficient forms of the transporter fail to elicit a specific cell association of the ligand, In addition the diffusion parameters of membrane-associated apoA-I indicate an interaction with membrane lipids rather than proteins. These results do not support a direct molecular interaction between ABCA1 and apoA-I, but rather suggest that the ABCA1-induced modification of the lipid distribution in the membrane, evidenced by the phosphatidylserine exofacial flopping, generates a biophysical microenvironment required for the docking of apoA-I at the cell surface.	CNRS Marseille Luminy, Ctr Immunol, INSERM, F-13288 Marseille 09, France; Ecole Normale Super Phys Marseille, Inst Fresnel, F-13397 Marseille, France; State Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Ghent University	Chimini, G (corresponding author), CNRS Marseille Luminy, Ctr Immunol, INSERM, Parc Sci Luminy Case 906, F-13288 Marseille 09, France.		HAMON, Yannick YH/N-5372-2016; RIGNEAULT, Hervé/L-6303-2017; Marguet, Didier/B-9946-2008; HAMON, Yannick/S-3118-2019; Marguet, Didier/AGO-5421-2022	HAMON, Yannick YH/0000-0002-7636-2310; RIGNEAULT, Hervé/0000-0001-6007-0631; HAMON, Yannick/0000-0002-7636-2310; Marguet, Didier/0000-0003-3198-5095				Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Becq F, 1997, J BIOL CHEM, V272, P2695, DOI 10.1074/jbc.272.5.2695; Bergeron J, 1997, BBA-LIPID LIPID MET, V1344, P139, DOI 10.1016/S0005-2760(96)00136-1; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Ito J, 2000, J LIPID RES, V41, P894; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Lauffenburger D, 1993, RECEPTORS MODELS BIN, P9; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Peelman F, 1997, EUR J BIOCHEM, V249, P708, DOI 10.1111/j.1432-1033.1997.t01-2-00708.x; Rothblat GH, 1999, J LIPID RES, V40, P781; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; VANLOO B, 1995, J LIPID RES, V36, P1686; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Yokoyama S, 1998, BBA-LIPID LIPID MET, V1392, P1, DOI 10.1016/S0005-2760(98)00032-0	34	166	175	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9955	9960		10.1074/jbc.M010265200	http://dx.doi.org/10.1074/jbc.M010265200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11150301	hybrid			2022-12-27	WOS:000167996400052
J	Cui, Y; Konig, J; Leier, I; Buchholz, U; Keppler, D				Cui, Y; Konig, J; Leier, I; Buchholz, U; Keppler, D			Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER; SUBSTRATE-SPECIFICITY; RAT; GLUCURONIDES; POLYPEPTIDE; ALBUMIN; ACID	Bilirubin, the end product of heme catabolism, is taken up from the blood circulation into the liver. This work identifies a high-affinity transport protein mediating the uptake of bilirubin and its conjugates into human hepatocytes. Human embryonic kidney cells (HEK293) permanently expressing the recombinant organic anion-transporting polypeptide 2 (human OATP2, also known as LST-1 or OATP-C; symbol SLC21A6) showed uptake of [H-3]monoglucuronosyl bilirubin, [H-3]bisglucuronosyl bilirubin, and [H-3]sulfobromophthalein with X, values of 0,10, 0,28, and 0.14,muM, respectively. High-affinity uptake of unconjugated [H-3]bilirubin by OATP2 occurred in the presence of albumin and was not mediated by another basolateral hepatic uptake transporter, human OATP8 (symbol SLC21A8), OATP2 and OATP8 differed by their capacity to extract substrates from albumin before transport. In comparison to the high-affinity transport by OATP8, OATP8 transported [H-3]sulfobromophthalein and [H-3]monoglucuronosyl bilirubin with lower affinity, with K-m values of 3.3 and 0.5 muM. respectively. The organic anion indocyanine green potently inhibited transport mediated by OATP2, with a Ki value of 112 nM, but did not inhibit transport mediated by OATP8, Human OATP2 may play a key role in the prevention of hyperbilirubinemia by facilitating the selective entry of unconjugated bilirubin and its glucuronate conjugates into human hepatocytes.	Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Cui, Y (corresponding author), Deutsch Krebsforschungszentrum, Div Tumor Biochem, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Keppler, Dietrich/A-5528-2013; Cui, Yunhai/AAP-7670-2021	Keppler, Dietrich/0000-0003-2964-2333; Cui, Yunhai/0000-0003-4969-072X; Koenig, Joerg/0000-0001-7016-5482				Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; ARIAS IA, 1961, AM J PHYSIOL, V200, P1091, DOI 10.1152/ajplegacy.1961.200.5.1091; BLACK M, 1969, NEW ENGL J MED, V280, P1266, DOI 10.1056/NEJM196906052802303; BRODERSEN R, 1990, ACTA PAEDIATR SCAND, V79, P12, DOI 10.1111/j.1651-2227.1990.tb11323.x; Chowdhury Jayanta Roy, 1994, P471; CRAWFORD JM, 1987, J CLIN INVEST, V79, P1172, DOI 10.1172/JCI112934; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kamisako T, 1999, HEPATOLOGY, V30, P485, DOI 10.1002/hep.510300220; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; LEHMANN WD, 1984, J LABELLED COMPD RAD, V21, P455, DOI 10.1002/jlcr.2580210508; MARTIN JF, 1976, GASTROENTEROLOGY, V70, P385; Mediavilla MG, 1999, FEBS LETT, V463, P143, DOI 10.1016/S0014-5793(99)01606-3; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; OKUDA K, 1976, GUT, V17, P588, DOI 10.1136/gut.17.8.588; Pascolo L, 1996, BIOCHEM J, V316, P999, DOI 10.1042/bj3160999; SCHARSCHMIDT BF, 1975, J CLIN INVEST, V56, P1280, DOI 10.1172/JCI108204; SENAFI SB, 1994, BIOCHEM J, V303, P233, DOI 10.1042/bj3030233; WEISIGER RA, 1985, P NATL ACAD SCI USA, V82, P1563, DOI 10.1073/pnas.82.5.1563	22	374	389	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9626	9630		10.1074/jbc.M004968200	http://dx.doi.org/10.1074/jbc.M004968200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134001	hybrid			2022-12-27	WOS:000167996400008
J	Finazzi, G; Zito, F; Barbagallo, RP; Wollman, FA				Finazzi, G; Zito, F; Barbagallo, RP; Wollman, FA			Contrasted effects of inhibitors of cytochrome b(6)f complex on state transitions in Chlamydomonas reinhardtii - The role of Q(o) site occupancy in LHCII kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST PROTEIN-PHOSPHORYLATION; LIGHT ENERGY-DISTRIBUTION; BC(1) COMPLEX; CHLOROPHYLL FLUORESCENCE; DOMAIN MOVEMENT; BF COMPLEX; BINDING; PHOTOSYNTHESIS; PLASTOQUINONE; DEACTIVATION	We have investigated the relationship between the occupancy of the Q(o) site in the cytochrome b(6)f complex and the activation of the LHCII protein kinase that controls state transitions. To this aim, fluorescence emission and LHCII phosphorylation patterns were studied in whole cells of Chlamydomonas reinhardtii treated with different plastoquinone analogues. The analysis of fluorescence induction at room temperature indicates that stigmatellin consistently prevented transition to State 2, whereas 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone behaved as an inhibitor of state transitions only after the cells were preilluminated, The same effects were observed on the phosphorylation patterns of the LHCII proteins, while subunit V of the cytochrome b(6)f complex showed a different behavior. These findings are discussed on the basis of a dynamic structural model of cytochrome b(6)f that relates the activation of the LHCII kinase to the occupancy of the Q(o) site and the movement of the Rieske protein.	Univ Milan, Ctr Studio Biol Cellulare & Mol Piante, CNR, I-20133 Milan, Italy; CNRS, Inst Biol Physicochim, UPR 9050, F-75005 Paris, France; CNRS, Inst Biol Physicochim, UPR 1261, F-75005 Paris, France	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Finazzi, G (corresponding author), Univ Milan, Ctr Studio Biol Cellulare & Mol Piante, CNR, Via Celoria 26, I-20133 Milan, Italy.	giovanni.finazzi@unimi.it		Zito, Francesca/0000-0003-1783-5090				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; ALLEN JF, 1981, BIOCHIM BIOPHYS ACTA, V638, P290, DOI 10.1016/0005-2728(81)90239-5; Barbagallo RP, 1999, BIOCHEMISTRY-US, V38, P12814, DOI 10.1021/bi990424+; BENNETT J, 1991, ANNU REV PLANT PHYS, V42, P281, DOI 10.1146/annurev.pp.42.060191.001433; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Breyton C, 2000, J BIOL CHEM, V275, P13195, DOI 10.1074/jbc.275.18.13195; Brugna M, 2000, P NATL ACAD SCI USA, V97, P2069, DOI 10.1073/pnas.030539897; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Crofts AR, 1998, CURR OPIN STRUC BIOL, V8, P501, DOI 10.1016/S0959-440X(98)80129-2; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEKOUCHKOVSKY Y, 1975, BIOCHIM BIOPHYS ACTA, V376, P259, DOI 10.1016/0005-2728(75)90018-3; DELOSME R, 1994, BBA-BIOENERGETICS, V1185, P56, DOI 10.1016/0005-2728(94)90193-7; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; Elich TD, 1997, FEBS LETT, V411, P236, DOI 10.1016/S0014-5793(97)00698-4; FRANK K, 1995, PHOTOCHEM PHOTOBIOL, V61, P2, DOI 10.1111/j.1751-1097.1995.tb09237.x; Fulgosi H, 1998, EMBO J, V17, P1577, DOI 10.1093/emboj/17.6.1577; GAL A, 1990, J BIOL CHEM, V265, P19742; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hamel P, 2000, J BIOL CHEM, V275, P17072, DOI 10.1074/jbc.M001468200; HORTON P, 1981, BIOCHIM BIOPHYS ACTA, V635, P53, DOI 10.1016/0005-2728(81)90006-2; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; RICH PR, 1991, BIOCHIM BIOPHYS ACTA, V1058, P312, DOI 10.1016/S0005-2728(05)80252-X; Schoepp B, 1999, FEBS LETT, V450, P245, DOI 10.1016/S0014-5793(99)00511-6; SUEOKA N, 1965, P NATL ACAD SCI USA, V54, P1665; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; VENER AV, 1995, J BIOL CHEM, V270, P25225, DOI 10.1074/jbc.270.42.25225; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	35	61	69	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9770	9774		10.1074/jbc.M010092200	http://dx.doi.org/10.1074/jbc.M010092200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134032	hybrid			2022-12-27	WOS:000167996400027
J	Depoix, C; Delmotte, MH; Formstecher, P; Lefebvre, P				Depoix, C; Delmotte, MH; Formstecher, P; Lefebvre, P			Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; EMBRYONAL CARCINOMA-CELLS; HUMAN ESTROGEN-RECEPTOR; DNA-BINDING; X-RECEPTOR; HOMODIMER FORMATION; NUCLEAR RECEPTORS; IN-VIVO; BETA-2 PROMOTER; DIMERIZATION	Heterodimerization of retinoic acid receptors (RARs) with 9-cis-retinoic receptors (RXRs) is a prerequisite for binding of RXR.RAR dimers to DNA and for retinoic acid-induced gene regulation. Whether retinoids control RXR/RAR solution interaction remains a debated question, and we have used in vitro and in vivo protein interaction assays to investigate the role of ligand in modulating RXR/RAR interaction in the absence of DNA. Two-hybrid assay in mammalian cells demonstrated that only RAR agonists were able to increase significantly RAR interaction with RXR, whereas RAR antagonists inhibited RXR binding to RAR, Quantitative glutathione S-transferase pull-dawn assays established that there was a strict correlation between agonist binding affinity for the RAR monomer and the affinity of RXR for liganded RAR, but RAR antagonists were inactive in inducing RXR recruitment to RAR in vitro, Alteration of coactivator- or corepressor-binding interfaces of RXR or RAR did not alter ligand-enhanced dimerization. In contrast, preventing the formation of a stable holoreceptor structure upon agonist binding strongly altered RXR.RAR dimerization, Finally, we observed that RAR interaction with RXR silenced RXR ligand-dependent activation function. We propose that ligand-controlled dimerization of RAR with RXR is an important step in the RXR.RAR activation process. This interaction is dependent upon adequate remodeling of the AF-2 structure and amenable to pharmacological inhibition by structurally modified retinoids.	Fac Med Henri Warembourg, INSERM, U459, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Lefebvre, P (corresponding author), Fac Med Henri Warembourg, INSERM, U459, 1 Pl Verdun, F-59045 Lille, France.		Lefebvre, Philippe/F-2685-2010	Lefebvre, Philippe/0000-0002-9366-5129; depoix, christophe/0000-0003-2826-3075				APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; ARNOLD SF, 1995, P NATL ACAD SCI USA, V92, P7475, DOI 10.1073/pnas.92.16.7475; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Benkoussa M, 1997, RECEPT SIGNAL TRANS, V7, P257; Bhattacharyya N, 1997, MOL CELL BIOL, V17, P6481, DOI 10.1128/MCB.17.11.6481; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Collingwood TN, 1997, J BIOL CHEM, V272, P13060, DOI 10.1074/jbc.272.20.13060; Delmotte MH, 1999, J BIOL CHEM, V274, P38225, DOI 10.1074/jbc.274.53.38225; DEMARZO AM, 1991, P NATL ACAD SCI USA, V88, P72, DOI 10.1073/pnas.88.1.72; DEY A, 1994, MOL CELL BIOL, V14, P8191, DOI 10.1128/MCB.14.12.8191; Dong D, 1998, BIOCHEMISTRY-US, V37, P10691, DOI 10.1021/bi980561r; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; Dudley MW, 2000, P NATL ACAD SCI USA, V97, P3696, DOI 10.1073/pnas.040558197; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; FURLOW JD, 1993, J BIOL CHEM, V268, P12519; Glass CK, 2000, GENE DEV, V14, P121; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kakizawa T, 1997, J BIOL CHEM, V272, P23799, DOI 10.1074/jbc.272.38.23799; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; LEES JA, 1990, MOL CELL BIOL, V10, P5529, DOI 10.1128/MCB.10.10.5529; LEFEBVRE B, 1995, BIOCHEMISTRY-US, V34, P5477, DOI 10.1021/bi00016a019; Lefebvre B, 1998, MOL CELL ENDOCRINOL, V139, P161, DOI 10.1016/S0303-7207(98)00065-3; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; LEFEBVRE P, 1995, J BIOL CHEM, V270, P10806, DOI 10.1074/jbc.270.18.10806; Leonhardt SA, 1998, MOL ENDOCRINOL, V12, P1914, DOI 10.1210/me.12.12.1914; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Mouchon A, 1999, MOL CELL BIOL, V19, P3073; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Rachez C, 1996, J BIOL CHEM, V271, P17996, DOI 10.1074/jbc.271.30.17996; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tate BF, 1996, FASEB J, V10, P1524, DOI 10.1096/fasebj.10.13.8940298; Vega Diaz Barbara, 2000, Journal of Biological Chemistry, V275, P642; WANG H, 1995, J BIOL CHEM, V270, P23322, DOI 10.1074/jbc.270.40.23322; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	44	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9452	9459		10.1074/jbc.M008004200	http://dx.doi.org/10.1074/jbc.M008004200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254657	hybrid			2022-12-27	WOS:000167607700110
J	Mueller, GA; Smith, AM; Chapman, MD; Rule, GS; Benjamin, DC				Mueller, GA; Smith, AM; Chapman, MD; Rule, GS; Benjamin, DC			Hydrogen exchange nuclear magnetic resonance spectroscopy mapping of antibody epitopes on the house dust mite allergen Der p 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II DERMATOPHAGOIDES; PROTEIN ANTIGEN; P 2; IGE; MUTAGENESIS; BINDING; SURFACE	New strategies for allergen-specific immunotherapy have focused on reducing IgE reactivity of purified recombinant allergens while maintaining T-cell epitopes. Previously, we showed that disrupting the disulfide bonds of the major house dust mite allergen Der p 2 resulted in 10-100-fold less skin test reactivity in mite-allergic subjects but did not change in vitro T-cell proliferative responses. To provide a more complete picture of the antigenic surface of Der p 2, we report here the identification of three epitopes using hydrogen protection nuclear magnetic resonance spectroscopy. The epitopes are defined by monoclonal antibodies that are able to inhibit IgE antibody binding to the allergen. Each monoclonal antibody affected the amide exchange rate of 2-3 continuous residues in different regions of Der p 2. Based on these data, a number of other residues were predicted to belong to each epitope, and this prediction was tested for monoclonal antibody 7A1 by generating alanine point mutants. The results indicate that only a small number of residues within the predicted epitope are functionally important for antibody binding. The molecular definition of these three epitopes will enable us to target limited positions for mutagenesis and to expand our studies of hypoallergenic variants for immunotherapy.	Univ Virginia, Asthma & Allerg Dis Ctr, Biophys Program, Charlottesville, VA 22908 USA; Univ Virginia, Asthma & Allerg Dis Ctr, Dept Med, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Beirne B Carter Ctr Immunol, Charlottesville, VA 22908 USA; Carnegie Mellon Univ, Div Biol Sci, Pittsburgh, PA 15213 USA	University of Virginia; University of Virginia; University of Virginia; Carnegie Mellon University	Benjamin, DC (corresponding author), Univ Virginia Hlth Syst, Beirne B Carter Ctr Immunol, POB 801386, Charlottesville, VA 22908 USA.	dcb@virginia.edu	Mueller, Geoffrey A/I-2909-2017; Rule, Gordon S/Q-2422-2015	Mueller, Geoffrey A/0000-0001-8361-5323; Rule, Gordon S/0000-0002-4396-3363; Chapman, Martin/0000-0002-0845-3632	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034607, U19AI034607, R37AI020565, R01AI020565] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 34607, AI-20565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benjamin David C., 1996, Methods (Orlando), V9, P508, DOI 10.1006/meth.1996.0058; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Chua KY, 1996, CLIN EXP ALLERGY, V26, P829, DOI 10.1111/j.1365-2222.1996.tb00615.x; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Hakkaart GAJ, 1998, CLIN EXP ALLERGY, V28, P169, DOI 10.1046/j.1365-2222.1998.00205.x; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mueller GA, 1998, BIOCHEMISTRY-US, V37, P12707, DOI 10.1021/bi980578+; Mueller GA, 1997, J BIOL CHEM, V272, P26893, DOI 10.1074/jbc.272.43.26893; Nishiyama C, 1999, MOL IMMUNOL, V36, P53, DOI 10.1016/S0161-5890(98)00112-6; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; OVSYANNIKOVA IG, 1994, J ALLERGY CLIN IMMUN, V94, P537, DOI 10.1016/0091-6749(94)90211-9; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PRASAD L, 1993, J BIOL CHEM, V268, P10705; Schuurman J, 1997, J ALLERGY CLIN IMMUN, V99, P545, DOI 10.1016/S0091-6749(97)70083-6; Smith AM, 1997, CLIN EXP ALLERGY, V27, P593, DOI 10.1111/j.1365-2222.1997.tb00750.x; Smith AM, 1996, MOL IMMUNOL, V33, P399, DOI 10.1016/0161-5890(95)00150-6; SMITH AM, 1991, J IMMUNOL, V146, P1254; SMITH AM, 1999, IMMUNOTHERAPY ASTHMA; SMITHGILL SJ, 1990, FASEB J, V4, P2276; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V81, P884, DOI 10.1016/0091-6749(88)90946-3; Williams DC, 1996, J MOL BIOL, V257, P866, DOI 10.1006/jmbi.1996.0207	28	57	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9359	9365		10.1074/jbc.M010812200	http://dx.doi.org/10.1074/jbc.M010812200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134039	hybrid			2022-12-27	WOS:000167607700099
J	Cascio, M; Shenkel, S; Grodzicki, RL; Sigworth, FJ; Fox, RO				Cascio, M; Shenkel, S; Grodzicki, RL; Sigworth, FJ; Fox, RO			Functional reconstitution and characterization of recombinant human alpha(1)-glycine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PROTEIN SECONDARY STRUCTURE; HUMAN GLYCINE RECEPTOR; GATED ION CHANNELS; CIRCULAR-DICHROISM; TRANSMEMBRANE DOMAINS; CHLORIDE CONDUCTANCE; GLUTAMATE-RECEPTOR; AGONIST BINDING; BETA-ALANINE	By utilizing a baculoviral expression system described previously (Cascio, M., Schoppa, N. E., Grodzicki, R. L., Sigworth, F. J., and Fox, R. O. (1993) J. Biol. Chem. 268, 22135-22142), functional recombinant homomeric human alpha (1)-glycine receptors (GlyR) were overexpressed in insect cell culture, solubilized, purified, and reconstituted into lipid vesicles via gel filtration. Reconstituted GlyR channels were observed to retain native-like activity in single channel recordings of planar bilayers and in flux assays of small unilamellar vesicles, providing evidence that the recombinant homomeric receptor may be functionally reconstituted. This reconstitution is significant in that it indicates that the overexpressed homomeric receptor is an appropriate substrate for subsequent biophysical characterization aimed at the general elucidation of structure function, Circular dichroism spectroscopy of reconstituted GlyR indicated a low alpha -helical content and a significant fraction of polyproline structure. The small fraction of observed alpha -helix is insufficient to accommodate the four helical transmembrane domains proposed in models for this receptor. By inference, other members of the homologous ligand-gated channel superfamily, which include the ionotropic gamma -aminobutyric acid, acetylcholine, and serotonin receptors, may also be erroneously modeled, and alternate models should be considered.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas Medical Branch Galveston; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fox, RO (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 6-658 Basic Sci Bldg, Galveston, TX 77555 USA.	fox@bloch.utmb.edu			NIGMS NIH HHS [GM51911, GM55851] Funding Source: Medline; NINDS NIH HHS [NS21501] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051911, R01GM055851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021501] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Barrantes FJ, 2000, J BIOL CHEM, V275, P37333, DOI 10.1074/jbc.M005246200; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Boileau AJ, 1999, J NEUROSCI, V19, P4847; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; CASCIO M, 1993, J BIOL CHEM, V268, P22135; CASCIO M, 1995, METH NEUROSCI, V25, P175; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; Fiske CH, 1925, J BIOL CHEM, V66, P375; GARCIACALVO M, 1989, BIOCHEMISTRY-US, V28, P6405, DOI 10.1021/bi00441a037; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GORNETSCHELNOKOW U, 1994, EMBO J, V13, P338, DOI 10.1002/j.1460-2075.1994.tb06266.x; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUCHO F, 1994, TRENDS BIOCHEM SCI, V19, P383, DOI 10.1016/0968-0004(94)90116-3; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; ISHII T, 1993, J BIOL CHEM, V268, P2836; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; KUBO T, 1985, EUR J BIOCHEM, V149, P5, DOI 10.1111/j.1432-1033.1985.tb08885.x; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Leite JF, 2000, J BIOL CHEM, V275, P13683, DOI 10.1074/jbc.275.18.13683; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MAYO KH, 1991, BIOCHEMISTRY-US, V30, P8251, DOI 10.1021/bi00247a022; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MIELKE DL, 1988, J BIOL CHEM, V263, P3177; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MORR J, 1995, FEBS LETT, V368, P495, DOI 10.1016/0014-5793(95)00721-K; Niethammer M, 1996, J NEUROSCI, V16, P2157; Olsen RW, 1998, TOXICOL LETT, V101, P193, DOI 10.1016/S0378-4274(98)00185-4; Ortells MO, 1997, PROTEINS, V29, P391, DOI 10.1002/(SICI)1097-0134(199711)29:3<391::AID-PROT12>3.0.CO;2-I; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; RIQUELME G, 1990, FEBS LETT, V276, P54, DOI 10.1016/0014-5793(90)80505-D; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schertler G. F. X., 1992, CURR OPIN STRUC BIOL, V2, P534, DOI DOI 10.1016/0959-440X(92)90083-J; SCHLOSS P, 1991, J NEUROCHEM, V57, P1556, DOI 10.1111/j.1471-4159.1991.tb06351.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHENKEL S, 1989, P NATL ACAD SCI USA, V86, P9592, DOI 10.1073/pnas.86.23.9592; SKACH WR, 1993, J BIOL CHEM, V268, P6903; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WU J, 1992, ANAL BIOCHEM, V200, P359, DOI 10.1016/0003-2697(92)90479-Q; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yan D, 1999, J BIOL CHEM, V274, P5537, DOI 10.1074/jbc.274.9.5537	75	28	28	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20981	20988		10.1074/jbc.M010968200	http://dx.doi.org/10.1074/jbc.M010968200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11145968	hybrid			2022-12-27	WOS:000169297900026
J	Shinohara, M; Kodama, A; Matozaki, T; Fukuhara, A; Tachibana, K; Nakanishi, H; Takai, Y				Shinohara, M; Kodama, A; Matozaki, T; Fukuhara, A; Tachibana, K; Nakanishi, H; Takai, Y			Roles of cell-cell adhesion-dependent tyrosine phosphorylation of Gab-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN-CATENIN COMPLEX; HEPATOCYTE GROWTH-FACTOR; SRC FAMILY KINASES; SMALL G-PROTEINS; BETA-CATENIN; ALPHA-CATENIN; N-CADHERIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; EPITHELIAL MORPHOGENESIS	Gab-1 is a multiple docking protein that is tyrosine phosphorylated by receptor tyrosine kinases such as c-Met, hepatocyte growth factor/scatter factor receptor, and epidermal growth factor receptor. We have now demonstrated that cell-cell adhesion also induces marked tyrosine phosphorylation of Gab-1 and that disruption of cell-cell adhesion results in its dephosphorylation, An anti-E-cadherin antibody decreased cell-cell adhesion-dependent tyrosine phosphorylation of Gab-1, whereas the expression of E-cadherin specifically induced tyrosine phosphorylation of Gab-1, A relatively selective inhibitor of Src family kinases reduced cell-cell adhesion-dependent tyrosine phosphorylation of Gab-1, whereas expression of a dominant-negative mutant of Csk increased it. Disruption of cell-cell adhesion, which reduced tyrosine phosphorylation of Gab-1, also reduced the activation of mitogen-activated protein kinase and Akt in response to cell cell adhesion. These results indicate that E-cadherin-mediated cell-cell adhesion induces tyrosine phosphorylation by a Src family kinase of Gab-1, thereby regulating the activation of Ras/MAP kinase and phosphatidylinositol 3-kinase/Akt cascades.	Osaka Univ, Grad Sch Med, Fac Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan	Osaka University	Takai, Y (corresponding author), Osaka Univ, Grad Sch Med, Fac Med, Dept Biochem & Mol Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Nakanishi, Hiroyuki/0000-0002-9765-0266				BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lampugnani MG, 1997, J CELL SCI, V110, P2065; LEMMON MA, 2000, BIOCHEM J, V15, P1; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nieset JE, 1997, J CELL SCI, V110, P1013; OCHIAI A, 1994, BIOCHEM BIOPH RES CO, V205, P73, DOI 10.1006/bbrc.1994.2631; OKADA M, 1991, J BIOL CHEM, V266, P24249; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Polakis P, 2000, GENE DEV, V14, P1837; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; SCHLAEPFER DD, 1994, NATURE, V372, P786; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0	56	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18941	18946		10.1074/jbc.M100909200	http://dx.doi.org/10.1074/jbc.M100909200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262408	hybrid			2022-12-27	WOS:000169091000040
J	Ayvazian, L; Kerfelec, B; Granon, S; Foglizzo, E; Crenon, I; Dubois, C; Chapus, C				Ayvazian, L; Kerfelec, B; Granon, S; Foglizzo, E; Crenon, I; Dubois, C; Chapus, C			The lipase C-terminal domain - A novel unusual inhibitor of pancreatic lipase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLIPASE COMPLEX; CRYSTAL-STRUCTURE; X-RAY; COLIPASE; ACTIVATION; ABILITY	In vertebrates, dietary fat digestion mainly results from the combined effect of pancreatic lipase, colipase, and bile. It has been proposed that in vivo lipase adsorption on oil-water emulsion is mediated by a preformed lipase-colipase-mixed micelle complex. The main lipase-colipase binding site is located on the C-terminal domain of the enzyme. We report here that in vitro the isolated C-terminal domain behaves as a potent noncovalent inhibitor of lipase and that the inhibitory effect is triggered by the presence of micelles, Lipase inhibition results from the formation of a nonproductive C-terminal domain-colipase-micelle ternary complex, which competes for colipase with the active lipase-colipase-micelle ternary complex, thus diverting colipase from its lipase-anchoring function. The formation of such a complex has been evidenced by molecular sieving experiments. This nonproductive complex lowers the amount of active lipase thus reducing lipolysis, Preliminary experiments performed in rats show that the C-terminal domain also behaves as an inhibitor in vivo and thus could be considered a potential new tool for specifically reducing intestinal lipolysis.	INSERM, U476, F-13009 Marseille, France; Lab LAPHAL, F-13718 Allauch, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Chapus, C (corresponding author), INSERM, U476, 18 Ave Mozart, F-13009 Marseille, France.							ABOUSALHAM K, 1991, PROT ENG, V5, P105; Ayvazian L, 1996, PROTEIN ENG, V9, P707, DOI 10.1093/protein/9.8.707; BOUCHIER IA, 1968, LANCET, V1, P340; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; CHAPUS C, 1981, EUR J BIOCHEM, V115, P99; GUERCIOLINI R, 1997, INT J OBES S3, V21, P12; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; LAB LAPHAL, 1998, Patent No. 9830588; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON A, 1986, BIOCHIM BIOPHYS ACTA, V664, P538; LOMBARDO D, 1989, J MOL BIOL, V205, P259, DOI 10.1016/0022-2836(89)90380-X; MAHEGOUHIER N, 1988, BIOCHIM BIOPHYS ACTA, V229, P286; Pignol D, 2000, J BIOL CHEM, V275, P4220, DOI 10.1074/jbc.275.6.4220; RATHELOT J, 1981, BIOCHIMIE, V63, P227, DOI 10.1016/S0300-9084(81)80196-4; STERNBY B, 1981, COMP BIOCHEM PHYS B, V68, P15, DOI 10.1016/0305-0491(81)90173-5; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0	21	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14014	14018		10.1074/jbc.M010328200	http://dx.doi.org/10.1074/jbc.M010328200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11154696	hybrid			2022-12-27	WOS:000168356600070
J	Korschineck, I; Ziegler, S; Breuss, J; Lang, I; Lorenz, M; Kaun, C; Ambros, PF; Binder, BR				Korschineck, I; Ziegler, S; Breuss, J; Lang, I; Lorenz, M; Kaun, C; Ambros, PF; Binder, BR			Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR; ACTIVATOR INHIBITOR TYPE-1; PLASMINOGEN-ACTIVATOR; LDL RECEPTOR; ENDOTHELIAL-CELLS; MESSENGER-RNA; VLDL RECEPTOR; SH3 DOMAINS; CLONING	Novel members of the low density lipoprotein receptor family were identified in human endothelial and vascular smooth muscle cells utilizing a homology-cloning strategy. Four novel mRNA transcripts could be identified as isoforms of the apolipoprotein E receptor 2 (apoEr2): one form lacking three ligand binding repeats (nucleotides 497-883) but containing a novel ligand binding repeat adjacent to a unique cysteine-rich domain preceding the epidermal growth factor precursor domain of apoEr2, forms lacking the O -linked sugar domain, and forms containing a 59-amino acid deletion within the cytoplasmic tail. By fluorescence in situ hybridization for chromosome mapping, we could confirm that the novel alternative forms of apoEr2 are splice variants of transcripts from a single copy gene on chromosome 1p34. To analyze whether the different splice variants of apoEra mRNA are expressed in a splice variant-specific pattern, we concentrated on the central nervous system, where high expression of apoEra has been described originally. By means of splice variant-specific in situ hybridization, we could confirm that apoEra mRNA is abundantly expressed in brain tissue and, with exception of the newly identified ligand binding domain, all mRNA splice variants exhibited a similar expression pattern. The mRNA of the newly identified ligand binding domain, however, was expressed in brain only in cells of the vascular wall, confirming data from Northern blotting, where the mRNA of the newly identified ligand binding domain was found in several tissues but was absent in brain tissue.	Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; Univ Vienna, Vienna Gen Hosp, Dept Cardiol, A-1090 Vienna, Austria; St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria	University of Vienna; University of Vienna; Saint Anna Children's Hospital	Binder, BR (corresponding author), Univ Vienna, Dept Vasc Biol & Thrombosis Res, Schwarzspanierstr 17, A-1090 Vienna, Austria.		Winter, Max P/E-8456-2011; Ambros, Peter/AAA-1266-2021; Kaun, Christoph/L-7543-2015	Ambros, Peter/0000-0002-5507-7211; Kaun, Christoph/0000-0003-3873-7246; Lang, Irene/0000-0003-0485-2692; breuss, johannes/0000-0003-1312-3387				BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; BUJO H, 1995, J BIOL CHEM, V270, P23546, DOI 10.1074/jbc.270.40.23546; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Clatworthy AE, 1999, NEUROSCIENCE, V90, P903, DOI 10.1016/S0306-4522(98)00489-8; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; HAJJAR DP, 1992, FASEB J, V6, P2933, DOI 10.1096/fasebj.6.11.1644257; HEEGAARD CW, 1995, J BIOL CHEM, V270, P20855, DOI 10.1074/jbc.270.35.20855; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Sambrook J., 2002, MOL CLONING LAB MANU; Schweizer D, 1994, Methods Mol Biol, V29, P97; STRICKLAND DK, 1994, FRIBRINOLYSIS, V8, P208; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	31	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13192	13197		10.1074/jbc.M011795200	http://dx.doi.org/10.1074/jbc.M011795200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152697	hybrid			2022-12-27	WOS:000168198600101
J	Rodriguez, MS; Dargemont, C; Hay, RT				Rodriguez, MS; Dargemont, C; Hay, RT			SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NF-KAPPA-B; UBIQUITIN-RELATED MODIFIER; PORE COMPLEX; COVALENT MODIFICATION; ENZYME; PML; LOCALIZATION; DEGRADATION; RANGAP1	SUMO-1 is a small ubiquitin-related modifier that is covalently linked to many cellular protein targets. Proteins modified by SUMO-1 and the SUMO-l-activating and -conjugating enzymes are located predominantly in the nucleus. Here we define a transferable sequence containing the psi KXE motif, where psi represents a large hydrophobic amino acid, that confers the ability to be SUMO-l-modified on proteins to which it is linked. Whereas addition of short sequences from p53 and I kappaB alpha containing the psi KXE motif, to a carrier protein is sufficient for modification in vitro, modification in vivo requires the additional presence of a nuclear localization signal. Thus, protein substrates must be targeted to the nucleus to undergo SUMO-1 conjugation.	Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland; Inst Jacques Monod, Lab Transport Nucleocytoplasm, CNRS UMR 7592, F-75251 Paris 05, France	University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Hay, RT (corresponding author), Univ St Andrews, Sch Biol, Biomol Sci Bldg, St Andrews KY16 9ST, Fife, Scotland.		Hay, Ronald T/F-9338-2011; Hay, Ronald/S-3233-2019	Hay, Ronald T/0000-0001-7113-9024; Hay, Ronald/0000-0001-7113-9024				ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Duprez E, 1999, J CELL SCI, V112, P381; ERRICO A, UNPUB; Firestein R, 1998, J BIOL CHEM, V273, P5892, DOI 10.1074/jbc.273.10.5892; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hodges M, 1998, CURR BIOL, V8, pR749, DOI 10.1016/S0960-9822(07)00477-0; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson PR, 1997, TRENDS CELL BIOL, V7, P408, DOI 10.1016/S0962-8924(97)01132-X; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	43	601	626	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12654	12659		10.1074/jbc.M009476200	http://dx.doi.org/10.1074/jbc.M009476200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11124955	hybrid			2022-12-27	WOS:000168198600026
J	van Rossenberg, SMW; Sliedregt, LAJM; Autar, R; Piperi, C; Van der Merwe, AP; van Berkel, TJC; Kuiper, J; Biessen, EAL				van Rossenberg, SMW; Sliedregt, LAJM; Autar, R; Piperi, C; Van der Merwe, AP; van Berkel, TJC; Kuiper, J; Biessen, EAL			A structure-function study of ligand recognition by CD22 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC ASIALOGLYCOPROTEIN RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; ADHESION MOLECULE CD22-BETA; ACID-BINDING-SITE; SIALYL-LEWIS-X; B-CELL ANTIGEN; IMMUNOGLOBULIN SUPERFAMILY; NATURAL LIGANDS; HIGH-AFFINITY; E-SELECTIN	B-cell-specific CD22 is a member of a group of cell adhesion molecules within the immunoglobulin superfamily that display binding to glycans with terminal sialic acid residues. Binding of endogenous ligands to CD22 triggers B-cell activation and proliferation. It is therefore conceivable that high affinity ligands for CD22 may be of value as inhibitors of B-cell activation in allergy and chronic inflammation. In this study, we aimed to delineate the structural requirements for ligand binding to CD22. A library of 20 mono-, di-, and trisaccharide analogs of the basic binding motif Neu5Ac(alpha2,6)Lac was synthesized and screened for affinity for CD22 beta, In general, CD22 ligand recognition appeared to be rather tolerant with respect to structural modifications of the anomeric sugar on a mono-, di-, and trisaccharide level, although affinity was increased by the presence of a nitro aromatic group at C-2, The most potent monovalent ligand, Neu5Ac-4-nitrobenzoyl-Glc, was selected to generate multivalent ligands based on either a glutamate or Tris cluster core. All multivalent ligands displayed at least a 10-fold increased affinity for CD22 compared with the corresponding monovalent glycoside, Interestingly, a maximal gain in affinity was already obtained for bivalent ligands, regardless of the terminal glycoside, A trivalent Tris-based cluster of Neu5Ac-4-nitrobenzoyl-Glc displayed a 300-fold higher affinity compared with the basic binding motif, which makes it, to our knowledge, the most potent antagonist for CD22 yet synthesized. As our in vitro fluorescence-activated cell sorting studies demonstrated efficient cellular uptake of a CD22 substrate, the most potent ligand in this study may hold promise as a homing device for immunomodulatory compounds and cytostatics.	Leiden Univ, Sylvius Lab, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Leiden University; Leiden University - Excl LUMC; University of Oxford	van Rossenberg, SMW (corresponding author), Leiden Univ, Sylvius Lab, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, POB 9503, NL-2300 RA Leiden, Netherlands.		Van Berkel, Theo/ABD-7677-2021; Piperi, Christina/AAF-2009-2020	Piperi, Christina/0000-0002-2701-0618				ADLER P, 1995, J BIOL CHEM, V270, P5164, DOI 10.1074/jbc.270.10.5164; BIESSEN EAL, 1995, J MED CHEM, V38, P1846, DOI 10.1021/jm00011a003; BIESSEN EAL, 1995, J MED CHEM, V38, P1538, DOI 10.1021/jm00009a014; Biessen EAL, 1996, J BIOL CHEM, V271, P28024, DOI 10.1074/jbc.271.45.28024; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 1997, GLYCOCONJUGATE J, V14, P601, DOI 10.1023/A:1018588526788; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; Hayashi M, 1996, J ORG CHEM, V61, P2938, DOI 10.1021/jo960125f; Kelm S, 1998, EUR J BIOCHEM, V255, P663, DOI 10.1046/j.1432-1327.1998.2550663.x; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kelm S, 1996, GLYCOCONJUGATE J, V13, P913, DOI 10.1007/BF01053186; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; LAW CL, 1994, IMMUNOL TODAY, V15, P442, DOI 10.1016/0167-5699(94)90275-5; LAW CL, 1995, J IMMUNOL, V155, P3368; Miyauchi H, 1997, BIOORG MED CHEM LETT, V7, P989, DOI 10.1016/S0960-894X(97)00156-X; NATH D, 1995, J BIOL CHEM, V270, P26184, DOI 10.1074/jbc.270.44.26184; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; NIKRAD PV, 1993, CARBOHYD RES, V250, P145, DOI 10.1016/0008-6215(93)84162-Y; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; POWELL LD, 1993, J BIOL CHEM, V268, P7019; POWELL LD, 1995, J BIOL CHEM, V270, P7523, DOI 10.1074/jbc.270.13.7523; POWELL LD, 1994, J BIOL CHEM, V269, P10628; Ramphal JY, 1996, J MED CHEM, V39, P1357, DOI 10.1021/jm9600611; SGROI D, 1993, J BIOL CHEM, V268, P7011; Simanek EE, 1998, CHEM REV, V98, P833, DOI 10.1021/cr940226i; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Sliedregt LAJM, 2001, BIOORGAN MED CHEM, V9, P85, DOI 10.1016/S0968-0896(00)00224-8; Sliedregt LAJM, 1999, J MED CHEM, V42, P609, DOI 10.1021/jm981078h; STAMENKOVIC I, 1990, NATURE, V345, P74, DOI 10.1038/345074a0; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; TOOGOOD PL, 1991, J MED CHEM, V34, P3140; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273	34	17	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12967	12973		10.1074/jbc.M009276200	http://dx.doi.org/10.1074/jbc.M009276200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152460	hybrid			2022-12-27	WOS:000168198600073
J	Andrei-Selmer, C; Knuppel, A; Satyanarayana, C; Heese, C; Schu, PV				Andrei-Selmer, C; Knuppel, A; Satyanarayana, C; Heese, C; Schu, PV			A new class of mutants deficient in dodecamerization of aminopeptidase 1 and vacuolar transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; YEAST; CYTOPLASM; AUTOPHAGY; DEGRADATION; MECHANISM; MEMBRANE; CYTOSOL; ENZYME	Vacuolar aminopeptidase 1 is transported to the vacuole by cytoplasmic double-membrane vesicles, the nonclassic Cvt pathway The cytosolic protein dodecamerizes and is enclosed in a double-membrane vesicle, which is transported to and fuses with the vacuole releasing a single-membrane autophagic body into the vacuolar lumen. This is degraded and the precursor sequence of aminopeptidase 1 is removed. This pathway resembles autophagy, and most proteins identified to function in the Cvt pathway are also required for autophagy and vice versa. The cytosolic precursor protein and the matured vacuolar protein form a homododecameric complex, and only this complex has enzymatic activity. We developed a new genetic screen to isolate mutants in the biogenesis of vacuolar aminopeptidase 1 based on its enzymatic activity. The sensitivity of this assay made it possible for us to search for mutants under conditions where autophagy is down-regulated, and me describe two new mutants defective in the biogenesis pathway of vacuolar aminopeptidase 1. Mutants are defective in dodecamerization of pApe1p and in Cvt vesicle formation. Complex assembly and transport vesicle formation appear to be linked processes. This mechanism can control the potentially harmful cytoplasmic proteolytic activity and could be the driving force for this nonclassic mechanism of vacuolar enzyme transport.	Univ Gottingen, Dept Biochem 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Schu, PV (corresponding author), Univ Gottingen, Dept Biochem 2, Zentrum Biochem & Mol Zellbiol, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.							AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; ANDREISELMER C, 1999, THESIS U GOTTINGEN; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; CHANG YH, 1989, J BIOL CHEM, V264, P6979; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P77; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Hoffman M, 1996, GENETICS, V143, P1555; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Martinez E, 1997, J MOL BIOL, V267, P1124, DOI 10.1006/jmbi.1997.0925; Martinez E, 1999, MOL MICROBIOL, V33, P52, DOI 10.1046/j.1365-2958.1999.01446.x; METZ G, 1977, Z NATURFORSCH C, V32, P929; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Satyanarayana C, 2000, FEBS LETT, V470, P232, DOI 10.1016/S0014-5793(00)01324-7; SCHU P, 1991, EUR J BIOCHEM, V197, P1, DOI 10.1111/j.1432-1033.1991.tb15874.x; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; SEGUIREAL B, 1995, EMBO J, V14, P5476, DOI 10.1002/j.1460-2075.1995.tb00234.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TRUMBLY RJ, 1983, J BACTERIOL, V156, P36, DOI 10.1128/JB.156.1.36-48.1983; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418	28	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11606	11614		10.1074/jbc.M003846200	http://dx.doi.org/10.1074/jbc.M003846200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152450	hybrid			2022-12-27	WOS:000168081800027
J	Bischof, O; Galande, S; Farzaneh, F; Kohwi-Shigematsu, T; Campisi, J				Bischof, O; Galande, S; Farzaneh, F; Kohwi-Shigematsu, T; Campisi, J			Selective cleavage of BLM, the Bloom syndrome protein, during apoptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME GENE-PRODUCT; DNA HELICASE ACTIVITY; ESCHERICHIA-COLI; POLY(ADP-RIBOSE) POLYMERASE; PROTEOLYTIC CLEAVAGE; NUCLEAR MATRIX; CASPASES; COMPLEX; RECQ; CLONING	Bloom syndrome (BS) is an autosomal recessive disorder characterized by a high incidence of cancer and genomic instability. BLM, the protein defective in BS, is a RECQ-like helicase that is presumed to function in mammalian DNA replication, recombination, or repair. We show here that BLM, but not the related RECQ-like helicase WRN, is rapidly cleaved in cells undergoing apoptosis. BLM was cleaved to 47- and 110-kDa major fragments, with kinetics similar to the apoptotic cleavage of poly(A)DP-ribose polymerase. BLM cleavage was prevented by a caspase 3 inhibitor and did not occur in caspase 3-deficient cells. Moreover, recombinant BLM was cleaved to 47- and 110-kDa fragments by caspase 3, but not caspase 6, in vitro. The caspase 3 recognition sequence (TEVD415)-T-412 was verified by mutating aspartate 415 to glycine and showing that this mutation rendered BLM resistant to caspase 3 cleavage. Cleavage did not abolish the BM helicase activity but abolished BLM nuclear foci and the association of BLM with condensed DNA and the insoluble matrix. The results suggest that BLM, but not WRN, is an early selected target during the execution of apoptosis.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Kings Coll London, Guys Kings & St Thomas Sch Med, Rayne Inst, Dept Mol Med, London SE5 9NU, England	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of London; King's College London	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Bldg 84,Rm 144,1 Cyclotron Rd, Berkeley, CA 94720 USA.	jcampisi@lbl.gov	Bischof, Oliver/K-1548-2019; Farzaneh, Farzin/B-4902-2009	Farzaneh, Farzin/0000-0002-9275-2415	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011658] Funding Source: NIH RePORTER; NIA NIH HHS [AG11658] Funding Source: Medline; NIGMS NIH HHS [GM59901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; COMPTON DA, 1991, J CELL BIOL, V112, P1083, DOI 10.1083/jcb.112.6.1083; Cooper MP, 2000, GENE DEV, V14, P907; Creighton T. E., 1993, PROTEINS STRUCTURES; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Flygare J, 1998, FEBS LETT, V427, P247, DOI 10.1016/S0014-5793(98)00433-5; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MARTIN SJ, 1993, SCIENCE, V262, P1355; Matiba B, 1997, Semin Immunol, V9, P59, DOI 10.1006/smim.1996.0054; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Moens PB, 2000, J CELL SCI, V113, P663; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Wan KM, 1999, P NATL ACAD SCI USA, V96, P933, DOI 10.1073/pnas.96.3.933; Wang Y, 2000, GENE DEV, V14, P927; Watt PM, 1996, CURR BIOL, V6, P265, DOI 10.1016/S0960-9822(02)00474-8; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	69	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12068	12075		10.1074/jbc.M006462200	http://dx.doi.org/10.1074/jbc.M006462200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11154689	hybrid			2022-12-27	WOS:000168081800086
J	Ginger, ML; Chance, ML; Sadler, IH; Goad, LJ				Ginger, ML; Chance, ML; Sadler, IH; Goad, LJ			The biosynthetic incorporation of the intact leucine skeleton into sterol by the trypanosomatid Leishmania mexicana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SUBCELLULAR-LOCALIZATION; INTERMEDIARY METABOLISM; ENERGY-METABOLISM; AXENIC CULTURE; CARBON-SOURCES; CRUZI; PROMASTIGOTES; KETOCONAZOLE	The amino acid leucine is efficiently used by the trypanosomatid Leishmania mexicana for sterol biosynthesis. The incubation of [2-C-13]leucine with L. mexicana promastigotes in the presence of ketoconazole gave 14 alpha -methylergosta-8,24(24(1))-3 beta -ol as the major sterol, which was shown by mass spectrometry to contain up to six atoms of C-13 per molecule, C-13 NMR analysis of the 14 alpha -methylergosta-8,24(24(1))-3 beta -ol revealed that it was labeled in only six positions: C-2, C-6, C-11, C-12, C-16, and C-23, This established that the leucine skeleton is incorporated intact into the isoprenoid pathway leading to sterol; it is not converted first to acetyl CoA, as in animals and plants, with utilization of the acetyl-CoA to regenerate 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). An inhibitor of HMG-CoA synthase (L-659,699) blocked the incorporation of [1-C-14]acetate into sterol but had no inhibitory effect on (U-C-14]leucine incorporation. The HMG-CoA reductase inhibitor lovastatin inhibited promastigote growth and [U-C-14]leucine incorporation into sterol, The addition of unlabeled mevalonic acid (MVA) overcame the lovastatin inhibition of growth and also diluted the incorporation of [1-C-14]leucine into sterol. These results are compatible with two routes by which the leucine skeleton may enter intact into the isoprenoid pathway. The catabolism of leucine could generate HMG-CoA that is then directly reduced to MVA for incorporation into sterol, Alternatively, a compound produced as an intermediate in leucine breakdown to HMG-CoA (e.g, dimethylcrotonyl-CoA) could be directly reduced to produce an isoprene alcohol followed by phosphorylation to enter the isoprenoid pathway post-MVA.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Edinburgh	Goad, LJ (corresponding author), Univ Liverpool, Sch Biol Sci, Life Sci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	ljgo@liv.ac.uk		Ginger, Michael/0000-0002-9643-8482				ANASTASIS P, 1985, J CHEM SOC CHEM COMM, P148, DOI 10.1039/c39850000148; ANASTASIS P, 1987, J CHEM SOC PERK T 1, P2427, DOI 10.1039/p19870002427; Anderson MD, 1998, PLANT PHYSIOL, V118, P1127, DOI 10.1104/pp.118.4.1127; BATES PA, 1993, PARASITOL TODAY, V9, P143, DOI 10.1016/0169-4758(93)90181-E; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; BERMAN JD, 1984, MOL BIOCHEM PARASIT, V12, P1, DOI 10.1016/0166-6851(84)90039-2; Bloch K, 1944, J BIOL CHEM, V155, P255; BLUM JJ, 1993, PARASITOL TODAY, V9, P118, DOI 10.1016/0169-4758(93)90168-F; BLUM JJ, 1991, J PROTOZOOL, V38, P527, DOI 10.1111/j.1550-7408.1991.tb06075.x; BLUM JJ, 1994, J BIOENERG BIOMEMBR, V26, P147, DOI 10.1007/BF00763063; Chance Michael L., 1997, P163; CHICHESTER CO, 1959, J BIOL CHEM, V234, P598; Concepcion JL, 1998, ARCH BIOCHEM BIOPHYS, V352, P114, DOI 10.1006/abbi.1998.0577; COPPENS I, 1995, MOL BIOCHEM PARASIT, V69, P29, DOI 10.1016/0166-6851(94)00192-P; Croft Simon L., 1997, P245; Domenech CE, 1996, EUR J BIOCHEM, V239, P720, DOI 10.1111/j.1432-1033.1996.0720u.x; EDMOND J, 1974, J BIOL CHEM, V249, P66; Ginger ML, 1999, BIOCHEM J, V342, P397, DOI 10.1042/0264-6021:3420397; Ginger ML, 2000, EUR J BIOCHEM, V267, P2555, DOI 10.1046/j.1432-1327.2000.01261.x; GOAD LJ, 1989, MOL BIOCHEM PARASIT, V32, P179, DOI 10.1016/0166-6851(89)90069-8; GOAD LJ, 1985, MOL BIOCHEM PARASIT, V15, P257, DOI 10.1016/0166-6851(85)90089-1; GOAD LJ, 1985, BIOCHEM PHARMACOL, V34, P3785, DOI 10.1016/0006-2952(85)90250-3; Goad LJ., 1997, ANAL STEROLS; Gonzalez-Pacanowska D., 1999, Memorias do Instituto Oswaldo Cruz, V94, P18; GREENSPAN MD, 1987, P NATL ACAD SCI USA, V84, P7488, DOI 10.1073/pnas.84.21.7488; GREENSPAN MD, 1993, BIOCHEM J, V289, P889, DOI 10.1042/bj2890889; Haughan P.A., 1991, P312; HAUGHAN PA, 1992, BIOCHEM PHARMACOL, V44, P2199, DOI 10.1016/0006-2952(92)90347-L; HAUGHAN PA, 1995, BIOCHEM J, V308, P31, DOI 10.1042/bj3080031; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Heise N, 2000, Z NATURFORSCH C, V55, P473; Hida A, 1998, J BIOCHEM-TOKYO, V124, P648, DOI 10.1093/oxfordjournals.jbchem.a022161; MIETTINEN TA, 1971, ANN MED EXP BIOL FEN, V49, P20; Montalvetti A, 2000, BIOCHEM J, V349, P27, DOI 10.1042/0264-6021:3490027; MONTAMAT EE, 1987, MOL BIOCHEM PARASIT, V22, P185, DOI 10.1016/0166-6851(87)90049-1; PenaDiaz J, 1997, BIOCHEM J, V324, P619, DOI 10.1042/bj3240619; RIGHETTI M, 1976, J BIOL CHEM, V251, P2716; ROSENTHA.J, 1974, AM J PHYSIOL, V226, P411, DOI 10.1152/ajplegacy.1974.226.2.411; STEIGER RF, 1977, T ROY SOC TROP MED H, V71, P441, DOI 10.1016/0035-9203(77)90049-9; STILLWAY LW, 1977, LIPIDS, V12, P1012, DOI 10.1007/BF02533327; SUGA T, 1980, PHYTOCHEMISTRY, V19, P67, DOI 10.1016/0031-9422(80)85014-X; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969; URBINA JA, 1994, PARASITOL TODAY, V10, P107, DOI 10.1016/0169-4758(94)90010-8; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; VANDENBOSSCHE H, 1993, MICROBIOL EUR    NOV, P20; VANDENBOSSCHE H, 1988, STEROL BIOSYNTHESIS, P79; WEINSTOCK SB, 1984, J BIOL CHEM, V259, P8939; Wilson WK, 1996, J LIPID RES, V37, P1529	51	57	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11674	11682		10.1074/jbc.M006850200	http://dx.doi.org/10.1074/jbc.M006850200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11148203	hybrid			2022-12-27	WOS:000168081800035
J	Sato, Y; Takahashi, M; Shibukawa, Y; Jain, SK; Hamaoka, R; Miyagawa, J; Yaginuma, Y; Honke, K; Ishikawa, M; Taniguchi, N				Sato, Y; Takahashi, M; Shibukawa, Y; Jain, SK; Hamaoka, R; Miyagawa, J; Yaginuma, Y; Honke, K; Ishikawa, M; Taniguchi, N			Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIVATED PROTEIN-KINASE; HIGH-AFFINITY BINDING; SIGNAL-TRANSDUCTION; EGF RECEPTOR; GENE TRANSFECTION; GLYCOSYLATION; DOMAIN; OLIGOSACCHARIDES; PROGRESSION	N-Acetylglucosaminyltransferase III (GnT-III) is a key enzyme that inhibits the extension of N-glycans by introducing a bisecting N-acetylglucosamine residue. In this study we investigated the effect of GnT-III on epidermal growth factor (EGF) signaling in HeLaS3 cells. Although the binding of EGF to the epidermal growth factor receptor (EGFR) was decreased in GnT-III transfectants to a level of about 60% of control cells, the EGF-induced activation of extracellular signal-regulated kinase (ERR) in GnT-III transfectants was enhanced to similar to1.4-fold that of the control cells. A binding analysis revealed that only low affinity binding of EGF was decreased in the GnT-III transfectants, whereas high affinity binding, which is considered to be responsible for the downstream signaling, was not altered, EGF-induced autophosphorylation and dimerization of the EGFR in the GnT-III transfectants were the same levels as found in the controls. The internalization rate of EGFR was, however, enhanced in the GnT-III transfectants as judged by the uptake of I-125-EGF and Oregon Green-labeled EGF. Then the EGFR internalization was delayed by dansylcadaverine, the up-regulation of ERK phosphorylation in GnT-III transfectants was completely suppressed to the same level as control cells. These results suggest that GnT-III overexpression in HeLaS3 cells resulted in an enhancement of EGF-induced ERR phosphorylation at least in part by the upregulation of the endocytosis of EGFR.	Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; Asahikawa Med Coll, Dept Obstet & Gynecol, Asahikawa, Hokkaido 0788510, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan	Osaka University; Asahikawa Medical College; Osaka University	Taniguchi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem, B1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016; Takahashi, Motoko/I-3154-2013	Taniguchi, Naoyuki/0000-0001-5889-5968; Takahashi, Motoko/0000-0002-2112-6142				Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; Bhaumik M, 1998, CANCER RES, V58, P2881; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569; GAMOU S, 1988, J BIOCHEM-TOKYO, V104, P388, DOI 10.1093/oxfordjournals.jbchem.a122478; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; HENEGOUWEN PMP, 1992, EXP CELL RES, V199, P90; Hobert ME, 1997, J BIOL CHEM, V272, P32901, DOI 10.1074/jbc.272.52.32901; Ihara Y, 1997, J BIOL CHEM, V272, P9629; KING AC, 1982, J BIOL CHEM, V257, P3053; LANDRETH GE, 1985, J CELL BIOL, V101, P1341, DOI 10.1083/jcb.101.4.1341; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; MIYOSHI E, 1995, J BIOL CHEM, V270, P28311; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; NISHIKAWA A, 1988, ANAL BIOCHEM, V170, P349, DOI 10.1016/0003-2697(88)90641-0; Oksvold MP, 2000, J HISTOCHEM CYTOCHEM, V48, P21, DOI 10.1177/002215540004800103; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; Ringerike T, 1998, J BIOL CHEM, V273, P16639, DOI 10.1074/jbc.273.27.16639; ROY LM, 1989, J CELL PHYSIOL, V140, P295, DOI 10.1002/jcp.1041400215; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Sheng Y, 1997, INT J CANCER, V73, P850, DOI 10.1002/(SICI)1097-0215(19971210)73:6<850::AID-IJC15>3.0.CO;2-8; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; SORKIN A, 1993, ONCOGENE, V8, P3021; Sorkina T, 1999, J CELL SCI, V112, P317; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; TANIGUCHI N, 1995, GLYCOCONJUGATE J, V12, P733, DOI 10.1007/BF00731232; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; VanderHeyden MAG, 1997, FEBS LETT, V410, P265, DOI 10.1016/S0014-5793(97)00599-1; WIEGANT FAC, 1986, J CELL BIOL, V103, P87, DOI 10.1083/jcb.103.1.87; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yang XP, 2000, CANCER RES, V60, P3313; Yoshimura M, 1996, CANCER RES, V56, P412; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754	48	77	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11956	11962		10.1074/jbc.M008551200	http://dx.doi.org/10.1074/jbc.M008551200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134020	hybrid			2022-12-27	WOS:000168081800070
J	Kang, HG; Evers, MR; Xia, GQ; Baenziger, U; Schachner, M				Kang, HG; Evers, MR; Xia, GQ; Baenziger, U; Schachner, M			Molecular cloning and expression of an N-acetylgalactosamine-4-O-sulfotransferase that transfers sulfate to terminal and non-terminal beta 1,4-linked N-acetylgalactosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; SIALYLATED OLIGOSACCHARIDES; CRYSTAL-STRUCTURE; HEPARAN-SULFATE; MONOCLONAL IGM; SULFOTRANSFERASE; CHONDROITIN; LUTROPIN; BOVINE; RECOGNITION	We have identified and characterized an N-acetyl-galaetosamine-4-O-sulfotransferase designated GalNAc-4-ST2 (GenBank(TM) accession number AF332472) based on its homology to HNK-1 sulfotransferase (HNK-1 ST). The cDNA predicts an open reading frame encoding a type II membrane protein of 443 amino acids with a 12-amino acid cytoplasmic domain, a 23-amino acid transmembrane domain, and a 408-amino acid luminal domain containing four potential N-linked glycosylation sites. GalNAc-4-ST2 displays a high degree of amino acid sequence identity with GalNAc-4-ST1 (46%), HNK-1 ST (23%), chondroitin 4-O-sulfotransferase-1 (C4ST-1) (27%), and chondroitin 4-O-sulfotransferase-2 (C4ST-2) (24%), GalNAc-4-ST2 transfers sulfate to the C-4 hydroxyl of terminal beta1,4-linked GalNAc in the sequence GalNAc beta1,4GlcNAc beta -R found on N-linked oligosaccharides and nonterminal beta1,4-linked GalNAc in chondroitin and dermatan. The translated region of GalNAc-4-ST2 is encoded by five exons located on human chromosome 18q11.2, Northern blot analysis reveals a 2.1-kilobase transcript. GalNAc-4-ST2 message is most highly expressed in trachea and to a lesser extent in heart, liver, pancreas, salivary gland, and testis. The I.M.A.G.E. cDNA clone 49547 contains a putative GalNAc-4-ST2 splice form with an open reading frame encoding a protein of 358 amino acids that lacks the transmembrane domain and the stem region. This form of GalNAc-4-ST2 is not retained by transfected cells and is active against chondroitin but not terminal beta1,4-linked GalNAc. Thus, as with GalNAc-4-ST1, sequences N-terminal to the catalytic domain contribute to the specificity of GalNAc-4-ST2 toward terminal beta1,4-linked GalNAc.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Washington University (WUSTL)	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Xia, Guoqing/C-2365-2015	Xia, Guoqing/0000-0003-4492-9156	NIDDK NIH HHS [R01-DK41738] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1991, BIOL CARBOHYDRATES, V3, P1; BAJT ML, 1990, J NEUROSCI RES, V27, P276, DOI 10.1002/jnr.490270306; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; CHOU KH, 1985, BIOCHEM BIOPH RES CO, V128, P383, DOI 10.1016/0006-291X(85)91690-0; COLES P, 1997, CAMB LECT N PHYS, V7, P1; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1986, ANAL BIOCHEM, V158, P42, DOI 10.1016/0003-2697(86)90585-3; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hooper LV, 1996, FASEB J, V10, P1137, DOI 10.1096/fasebj.10.10.8751716; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; HOOPER LV, 1995, J BIOL CHEM, V270, P16327, DOI 10.1074/jbc.270.27.16327; JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; Okuda T, 2000, J BIOL CHEM, V275, P40605, DOI 10.1074/jbc.M007983200; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Rosen SD, 1996, CURR BIOL, V6, P261, DOI 10.1016/S0960-9822(02)00473-6; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; SKELTON TP, 1991, J BIOL CHEM, V266, P17142; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STECK AJ, 1983, NEUROLOGY, V33, P19, DOI 10.1212/WNL.33.1.19; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Xia GQ, 2000, J BIOL CHEM, V275, P38402, DOI 10.1074/jbc.M007821200; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975	41	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10861	10869		10.1074/jbc.M011560200	http://dx.doi.org/10.1074/jbc.M011560200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139592	Green Published, hybrid			2022-12-27	WOS:000167980900042
J	Bonacchi, A; Romagnani, P; Romanelli, RG; Efsen, E; Annunziato, F; Lasagni, L; Francalanci, M; Serio, M; Laffi, G; Pinzani, M; Gentilini, P; Marra, F				Bonacchi, A; Romagnani, P; Romanelli, RG; Efsen, E; Annunziato, F; Lasagni, L; Francalanci, M; Serio, M; Laffi, G; Pinzani, M; Gentilini, P; Marra, F			Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; PROTEIN-COUPLED RECEPTORS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERFERON-INDUCIBLE PROTEIN-10; GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE CELLS; FAT-STORING CELLS; TYROSINE KINASE; T-LYMPHOCYTES; CHEMOTACTIC PROTEIN-1	Hepatic stellate cells (HSC) and glomerular mesangial cells (MC) are tissue-specific pericytes involved in tissue repair, a process that is regulated by members of the chemokine family. In this study, we explored the signal transduction pathways activated by the chemokine receptor CXCR3 in vascular pericytes, In HSC, interaction of CXCR3 with its ligands resulted in increased chemotaxis and activation of the Ras/ERK cascade. Activation of CXCR3 also stimulated Src phosphorylation and kinase activity and increased the activity of phosphatidylinositol 3-kinase and its downstream pathway, Akt. The increase in ERK activity was inhibited by genistein and PP1, but not by wortmannin, indicating that Src activation is necessary for the activation of the Ras/ERK pathway by CXCR3. Inhibition of ERI( activation resulted in a decreased chemotactic and mitogenic effect of CXCR3 ligands. In MC, which respond to CXCR3 ligands with increased DNA synthesis, CXCR3 activation resulted in a biphasic stimulation of ERK activation, a pattern similar to the one observed in HSC exposed to platelet-derived growth factor, indicating that this type of response is related to the stimulation of cell proliferation. These data characterize CXCR3 signaling in pericytes and clarify the relevance of downstream pathways in the modulation of different biologic responses.	Univ Florence, Dipartimento Med Interna, I-50134 Florence, Italy; Univ Florence, Dipartimento Fisiopatol Clin, I-50134 Florence, Italy	University of Florence; University of Florence	Marra, F (corresponding author), Univ Florence, Dipartimento Med Interna, Viale Morgagni 85, I-50134 Florence, Italy.		Marra, Fabio/K-7263-2016; Lasagni, Laura/J-6856-2018; Romagnani, Paola/A-4309-2008; Annunziato, Francesco/C-1155-2013; ROMANELLI, Roberto Giulio/K-4406-2018	Marra, Fabio/0000-0001-8629-0878; Lasagni, Laura/0000-0001-6553-9160; Romagnani, Paola/0000-0002-1774-8088; ROMANELLI, Roberto Giulio/0000-0001-9219-8189; Laffi, Giacomo/0000-0001-6916-1134; Annunziato, Francesco/0000-0001-8798-7589; Bonacchi, Andrea/0000-0003-4703-4067				ABBOUD HE, 1995, ANNU REV PHYSIOL, V57, P297; Aronica SM, 1997, BLOOD, V89, P3582, DOI 10.1182/blood.V89.10.3582.3582_3582_3595; Banas B, 1999, J AM SOC NEPHROL, V10, P2314; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; CASINI A, 1993, GASTROENTEROLOGY, V105, P245, DOI 10.1016/0016-5085(93)90033-9; CHOUDHURY GG, 1991, J BIOL CHEM, V266, P8068; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COLLINS T, 1999, ROBBINS PATHOLOGICAL; Cunnick JM, 1998, J BIOL CHEM, V273, P14468, DOI 10.1074/jbc.273.23.14468; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Marra F, 1999, HEPATOLOGY, V30, P951, DOI 10.1002/hep.510300406; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Marra F, 1998, AM J PATHOL, V152, P423; Marra F, 1996, J CLIN INVEST, V98, P1218, DOI 10.1172/JCI118905; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pupilli C, 1999, J AM SOC NEPHROL, V10, P245; Robino G, 2000, J BIOL CHEM, V275, P40561, DOI 10.1074/jbc.M007694200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Schecter AD, 2000, J BIOL CHEM, V275, P5466, DOI 10.1074/jbc.275.8.5466; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Shields PL, 1999, J IMMUNOL, V163, P6236; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	51	256	264	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9945	9954		10.1074/jbc.M010303200	http://dx.doi.org/10.1074/jbc.M010303200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136732	hybrid			2022-12-27	WOS:000167996400051
J	Gampala, SSL; Hagenbeek, D; Rock, CD				Gampala, SSL; Hagenbeek, D; Rock, CD			Functional interactions of lanthanum and phospholipase D with the abscisic acid signaling effecters VP1 and ABI1-1 in rice protoplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2C; DNA-BINDING ACTIVITY; CONSERVED B3 DOMAIN; GENE-EXPRESSION; EM GENE; RESPONSIVE ELEMENT; VIVIPAROUS1 VP1; ANION CHANNELS; BZIP PROTEIN; GUARD-CELLS	cis,trans-Abscisic acid (ABA) plays an important role in plant growth and development, regulation of seed maturation, germination, and adaptation to environmental stresses. Knowledge of ABA mechanisms of action and the interactions of components required for ABA signal transduction is far from complete. Using transient gene expression in rice protoplasts, we observed additive and inhibitory effects between maize VP1 Viviparous-1, a transcriptional activator) and a dominant-negative mutant protein phosphatase, ABI1-1 (ABA-insensitive-1-1), from Arabidopsis. Lanthanide ions were shown to be specific agonists of ABA-inducible gene expression and to interact synergistically with ABA and overexpressed VP1, Both VP1 and lanthanum activities could be antagonized by coexpression of ABI1-1, which demonstrates the specific ABA dependence of these effecters on ABA-regulated gene expression. We obtained pharmacological evidence that phospholipase D (PLD) functions in ABA-inducible gene expression in rice, Antagonism of ABA, VP1, and lanthanum synergy by 1-butanol, a specific inhibitor of PLD, was similar to the inhibition by coexpression of ABI1-1, These results demonstrate that ABA,VP1, lanthanum, PLD, and ABI1 are all involved in ABA-regulated gene expression and are consistent with an integrated model whereby La3+ acts upstream of PLD.	Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Rock, CD (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	borock@ust.hk		, Christopher/0000-0002-2090-0650				Albinsky D, 1999, PLANT J, V17, P73, DOI 10.1046/j.1365-313X.1999.00354.x; Bobb AJ, 1997, NUCLEIC ACIDS RES, V25, P641, DOI 10.1093/nar/25.3.641; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; Busk PK, 1999, PLANT MOL BIOL, V41, P529, DOI 10.1023/A:1006345113637; Carson CB, 1997, PLANT J, V12, P1231, DOI 10.1046/j.1365-313x.1997.12061231.x; Chak RKF, 2000, PLANTA, V210, P875, DOI 10.1007/s004250050692; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Desikan R, 1999, FEBS LETT, V456, P257, DOI 10.1016/S0014-5793(99)00972-2; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hagenbeek D, 2000, PLANT PHYSIOL, V123, P1553, DOI 10.1104/pp.123.4.1553; HEUSER J, 1971, PROC R SOC SER B-BIO, V179, P247, DOI 10.1098/rspb.1971.0096; Hill A, 1996, J BIOL CHEM, V271, P3366, DOI 10.1074/jbc.271.7.3366; HIRAYAMA T, 1995, P NATL ACAD SCI USA, V92, P3903, DOI 10.1073/pnas.92.9.3903; Hobo T, 1999, PLANT J, V19, P679, DOI 10.1046/j.1365-313x.1999.00565.x; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; HOECKER U, 1995, GENE DEV, V9, P2459, DOI 10.1101/gad.9.20.2459; Hoecker U, 1999, PLANT J, V19, P371, DOI 10.1046/j.1365-313X.1999.00521.x; HORNBERG C, 1984, NATURE, V310, P321, DOI 10.1038/310321a0; HUANG JWW, 1994, P NATL ACAD SCI USA, V91, P3473, DOI 10.1073/pnas.91.8.3473; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Jones HD, 2000, PLANT J, V21, P133, DOI 10.1046/j.1365-313x.2000.00662.x; Kim SY, 1998, J PLANT PHYSIOL, V152, P607, DOI 10.1016/S0176-1617(98)80019-9; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kurup S, 2000, PLANT J, V21, P143, DOI 10.1046/j.1365-313x.2000.00663.x; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li GF, 1999, P NATL ACAD SCI USA, V96, P7104, DOI 10.1073/pnas.96.12.7104; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; LU GH, 1992, P NATL ACAD SCI USA, V89, P11490, DOI 10.1073/pnas.89.23.11490; MARCOTTE WR, 1988, NATURE, V335, P454, DOI 10.1038/335454a0; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1995, ANNU REV PLANT PHYS, V46, P71, DOI 10.1146/annurev.pp.46.060195.000443; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa H, 1996, PLANT J, V9, P217, DOI 10.1046/j.1365-313X.1996.09020217.x; Nantel A, 1996, J BIOL CHEM, V271, P31296, DOI 10.1074/jbc.271.49.31296; OEDA K, 1991, EMBO J, V10, P1793, DOI 10.1002/j.1460-2075.1991.tb07704.x; Pappan K, 1997, J BIOL CHEM, V272, P7048, DOI 10.1074/jbc.272.11.7048; Parcy F, 1997, PLANT J, V11, P693, DOI 10.1046/j.1365-313X.1997.11040693.x; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Razik MA, 1997, PLANT CELL, V9, P1791, DOI 10.1105/tpc.9.10.1791; RICHIE S, 2000, PLANT PHYSIOL, V124, P693; RICHIE SM, 1998, P NATL ACAD SCI USA, V95, P2697; ROBERTSON M, 1995, PHYSIOL PLANTARUM, V94, P470, DOI 10.1111/j.1399-3054.1995.tb00956.x; ROCK CD, 1994, CURR BIOL, V4, P1013, DOI 10.1016/S0960-9822(00)00229-3; Rock CD, 1996, PLANT CELL REP, V15, P371, DOI 10.1007/BF00232374; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Rohde A, 1999, PLANT CELL ENVIRON, V22, P261, DOI 10.1046/j.1365-3040.1999.00428.x; Rohde A, 2000, PLANT CELL, V12, P35, DOI 10.1105/tpc.12.1.35; Rojas A, 1999, PLANT J, V20, P601, DOI 10.1046/j.1365-313X.1999.00635.x; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Schultz TF, 1998, PLANT CELL, V10, P837, DOI 10.1105/tpc.10.5.837; Schultz TF, 1996, J BIOL CHEM, V271, P25742, DOI 10.1074/jbc.271.42.25742; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Shen QX, 1997, PHYSIOL PLANTARUM, V101, P653, DOI 10.1111/j.1399-3054.1997.tb01050.x; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Svetek J, 1999, J BIOL CHEM, V274, P14724, DOI 10.1074/jbc.274.21.14724; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; VANSTEVENINCK RFM, 1976, PROTOPLASMA, V90, P89, DOI 10.1007/BF01276481; VASIL V, 1995, PLANT CELL, V7, P1511, DOI 10.1105/tpc.7.9.1511; WANG M, 1995, PLANTA, V196, P271, DOI 10.1007/BF00201384; Wang XM, 1999, PLANT PHYSIOL, V120, P645, DOI 10.1104/pp.120.3.645; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xu LW, 1997, PLANT PHYSIOL, V115, P387, DOI 10.1104/pp.115.2.387; YANG SF, 1967, J BIOL CHEM, V242, P477; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439	77	43	44	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9855	9860		10.1074/jbc.M009168200	http://dx.doi.org/10.1074/jbc.M009168200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139577	hybrid			2022-12-27	WOS:000167996400038
J	Nugent, C; Prins, JB; Whitehead, JP; Wentworth, JM; Chatterjee, VKK; O'Rahilly, S				Nugent, C; Prins, JB; Whitehead, JP; Wentworth, JM; Chatterjee, VKK; O'Rahilly, S			Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane - Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; INSULIN-RESISTANCE; PPAR-GAMMA; GENE-EXPRESSION; DIFFERENTIAL INHIBITION; MUSCLE; TRANSPORT; LIGAND; EICOSANOIDS; ALPHA	Exposure of insulin-sensitive tissues to free fatty acids can impair glucose disposal through inhibition of carbohydrate oxidation and glucose transport. However, certain fatty acids and their derivatives can also act as endogenous ligands for peroxisome proliferator-activated receptor gamma (PPAR gamma), a nuclear receptor that positively modulates insulin sensitivity. To clarify the effects of externally delivered fatty acids on glucose uptake in an insulin-responsive cell type, we systematically examined the effects of a range of fatty acids on glucose uptake in 3T3-L1 adipocytes. Of the fatty acids examined, arachidonic acid (AA) had the greatest positive effects, significantly increasing basal and insulin-stimulated glucose uptake by 1.8- and 2-fold, respectively, with effects being maximal at 4 h at which time membrane phospholipid content of AA was markedly increased. The effects of AA were sensitive to the inhibition of protein synthesis but were unrelated to changes in membrane fluidity. AA had no effect on total cellular levels of glucose transporters, but significantly increased levels of GLUT1 and GLUT4 at the plasma membrane. While the effects of AA were insensitive to cyclooxygenase inhibition, the lipoxygenase inhibitor, nordihydroguaiaretic acid, substantially blocked the AA effect on basal glucose uptake. Furthermore, adenoviral expression of a dominant-negative PPAR gamma mutant attenuated the AA potentiation of basal glucose uptake. Thus, AA potentiates basal and insulin-stimulated glucose uptake in 3T3-L1 adipocytes by a cyclooxygenase-independent mechanism that increases the levels of both GLUT1 and GLUT4 at the plasma membrane. These effects are at least partly dependent on de novo protein synthesis, an intact lipoxygenase pathway and the activation of PPAR gamma with these pathways having a greater role in the absence than in the presence of insulin.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QR, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 2QR, England.	sorahill@hgmp.mrc.ac.uk	Whitehead, Jonathan/F-5022-2014; O'Rahilly, Stephen/ABF-6509-2020; Prins, Johannes/I-3610-2019; Prins, Johannes B/M-5884-2013	O'Rahilly, Stephen/0000-0003-2199-4449; Prins, Johannes/0000-0001-9497-927X; Prins, Johannes B/0000-0001-9497-927X; Wentworth, John/0000-0002-5197-3529; Whitehead, Jonathan/0000-0003-3978-3148; Chatterjee, Vengalil Krishna/0000-0002-2654-8854				Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; CLANCY BM, 1991, J BIOL CHEM, V266, P10122; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; ELKEBBI IM, 1994, METABOLISM, V43, P953, DOI 10.1016/0026-0495(94)90173-2; Fong JC, 1999, CELL SIGNAL, V11, P53, DOI 10.1016/S0898-6568(98)00031-X; Fong JC, 1996, CELL SIGNAL, V8, P179, DOI 10.1016/0898-6568(95)02052-7; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GRUNFELD C, 1981, BIOCHEM BIOPH RES CO, V103, P219, DOI 10.1016/0006-291X(81)91682-X; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hansen PA, 1998, J BIOL CHEM, V273, P26157, DOI 10.1074/jbc.273.40.26157; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KNODELL RG, 1990, GASTROENTEROLOGY, V98, P1320, DOI 10.1016/0016-5085(90)90351-Z; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Ma HW, 1998, J BIOL CHEM, V273, P30131, DOI 10.1074/jbc.273.46.30131; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; PAN DA, 1993, J NUTR, V123, P512, DOI 10.1093/jn/123.3.512; RANDLE PJ, 1963, LANCET, V1, P785; RICHELSEN B, 1987, BIOCHEM J, V247, P389, DOI 10.1042/bj2470389; Roden M, 1999, DIABETES, V48, P358, DOI 10.2337/diabetes.48.2.358; Shimaya A, 1998, HORM METAB RES, V30, P543, DOI 10.1055/s-2007-978929; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Storlien LH, 1996, DIABETOLOGIA, V39, P621, DOI 10.1007/BF00418533; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Stouthard JML, 1996, BIOCHEM BIOPH RES CO, V220, P241, DOI 10.1006/bbrc.1996.0389; STUBBS CD, 1990, BIOCHEM SOC T, V18, P779, DOI 10.1042/bst0180779; Tafuri SR, 1996, ENDOCRINOLOGY, V137, P4706, DOI 10.1210/en.137.11.4706; TEBBEY PW, 1994, J BIOL CHEM, V269, P639; TOBIAS LD, 1979, LIPIDS, V14, P181, DOI 10.1007/BF02533870; Urso B, 1999, J BIOL CHEM, V274, P30864, DOI 10.1074/jbc.274.43.30864; Wang T, 1999, ANAL BIOCHEM, V269, P198, DOI 10.1006/abio.1999.4022; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	47	90	97	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9149	9157		10.1074/jbc.M009817200	http://dx.doi.org/10.1074/jbc.M009817200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11124961	hybrid			2022-12-27	WOS:000167607700072
J	Zhang, BL; Gao, Y; Moon, SY; Zhang, YQ; Zheng, Y				Zhang, BL; Gao, Y; Moon, SY; Zhang, YQ; Zheng, Y			Oligomerization of Rac1 GTPase mediated by the carboxyl-terminal polybasic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; INORGANIC-PHOSPHATE; ACTIVATING PROTEINS; CRYSTAL-STRUCTURE; CELL-ADHESION; BINDING; CDC42; RAS; EXPRESSION; ASSEMBLES	The Rho family GTPase Rad mediates a variety of signal transduction processes leading to activation of NADPH oxidase, actin cytoskeleton reorganization, transcription activation, and stimulation of DNA synthesis, In this study, Rad was found to form a reversible monomer and oligomer in both the GDP- and GTP-bound states in vitro and in cells. Mutational analysis and peptide competition experiments showed that the unique C-terminal domain of Rad consisting of six consecutive basic residues (amino acids 183-188) is required for the homophilic interaction. Oligomerization of Rac1-GTP led to a self-stimulatory GTPase-activating protein (GAP) activity, resulting in a significantly enhanced intrinsic GTP hydrolysis rate of Rac1-GTP, Deletion or mutation of the polybasic residues drastically decreased its intrinsic GTPase activity and resulted in a loss of the self-stimulatory GAP activity, In the oligomeric state, Rad became insensitive to the RhoGAP stimulation, albeit maintaining the responsiveness to the guanine nucleotide exchange factor. The ability of the Rad C-terminal mutants to activate the effector p21(cdc42/rac)-activated kinase-1 correlated with their oligomerization states, suggesting that oligomer formation potentiates effector activation. Furthermore, the oligomer-to-monomer transition of Rac1-GDP could be driven effectively by interaction with the Rho guanine nucleotide dissociation inhibitor. Building on previous characterizations of Rac1 interaction with regulatory proteins and effectors, these results suggest that Rad may employ yet another means of regulation by cycling between the monomeric and oligomeric states to effectively generate a transient and augmented signal.	Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Zhang, BL (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA.		Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIGMS NIH HHS [GM 60523] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060523] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; JOSEPH G, 1995, J BIOL CHEM, V270, P29079, DOI 10.1074/jbc.270.49.29079; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kasper B, 2000, BLOOD, V95, P2947, DOI 10.1182/blood.V95.9.2947.009k10_2947_2953; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; KRECK ML, 1994, J BIOL CHEM, V269, P4161; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MOLL J, 1991, ONCOGENE, V6, P863; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; NOELJP, 1997, NAT STRUCT BIOL, V277, P677; PAOLO C, 1999, J BIOL CHEM, V274, P32071; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sander EE, 1999, EUR J CANCER, V35, P1302, DOI 10.1016/S0959-8049(99)00145-8; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; Symons M, 2000, CURR BIOL, V10, pR535, DOI 10.1016/S0960-9822(00)00588-1; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WARNOCK DE, 1995, EMBO J, V14, P1322, DOI 10.1002/j.1460-2075.1995.tb07118.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WEBB MR, 1992, BIOCHEM J, V287, P555, DOI 10.1042/bj2870555; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169; ZHENG Y, 1993, J BIOL CHEM, V268, P24629; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	46	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8958	8967		10.1074/jbc.M008720200	http://dx.doi.org/10.1074/jbc.M008720200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134022	hybrid			2022-12-27	WOS:000167607700048
J	Grichtchenko, II; Choi, IY; Zhong, XB; Bray-Ward, P; Russell, JM; Boron, WF				Grichtchenko, II; Choi, IY; Zhong, XB; Bray-Ward, P; Russell, JM; Boron, WF			Cloning, characterization, and chromosomal mapping of a human electroneutral Na+-driven Cl-NCO3 exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH REGULATION; SODIUM-BICARBONATE COTRANSPORTER; PIG HIPPOCAMPAL SLICES; BARNACLE MUSCLE-FIBERS; SQUID GIANT-AXONS; TISSUE DISTRIBUTION; FUNCTIONAL-CHARACTERIZATION; NA+/HCO3 COTRANSPORTER; PYRAMIDAL NEURONS; CL-/HCO3 EXCHANGE	The electroneutral Na+-driven Cl-HCO3 exchanger is a key mechanism for regulating intracellular pH (pH(i)) in neurons, glia, and other cells, Here we report the cloning, tissue distribution, chromosomal location, and functional characterization of the cDNA of such a transporter (NDCBE1) from human brain (GenBank(TM) accession number AF069512). NDCBE1, which encodes 1044 amino acids, is 34% identical to the mammalian anion exchanger (AF2); similar to 50% to the electrogenic Na/HCO3 co-transporter (NBCe1) from salamander, rat, and humans; similar to 73% to mammalian electroneutral Na/HCO3 cotransporters (NBCn1); 71% to mouse NCBE; and 47% to a Na+-driven anion exchanger (NDAE1) from Drosophila, Northern blot analysis of NDCBE1 shows a robust similar to 12-kilobase signal in all major regions of human brain and in testis, and weaker signals in kidney and ovary. This human gene (SLC4A8) maps to chromosome 12q13. When expressed in Xenopus oocytes and running in the forward direction, NDCBE1 is electroneutral and mediates increases in both pH(i) and [Na+](i) (monitored with microelectrodes) that require HCO3- and are blocked by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS). The pH(i) increase also requires extracellular Na+. The Na+:HCO3- stoichiometry is 1:2. Forward-running NDCBE1 mediates a Cl-36 efflux that requires extracellular Na+ and HCO3- and is blocked by DIDS. Running in reverse, NDCBE1 requires extracellular Cl-. Thus, NDCBE1 encodes a human, electroneutral Na+-driven ClHCO3 exchanger.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Yale University; Yale University; Syracuse University	Grichtchenko, II (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.		Boron, Walter/ABI-1564-2020; choi, inyeong/AAM-4826-2021	Boron, Walter/0000-0003-4741-7287; Grichtchenko, Irina/0000-0002-6708-6916	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18400] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AALKJAER C, 1991, J PHYSIOL-LONDON, V436, P57, DOI 10.1113/jphysiol.1991.sp018539; Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Amlal H, 1999, AM J PHYSIOL-RENAL, V276, pF903, DOI 10.1152/ajprenal.1999.276.6.F903; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Bonnet U, 2000, BRAIN RES, V872, P116, DOI 10.1016/S0006-8993(00)02350-7; Bonnet U, 1999, BRAIN RES, V840, P16, DOI 10.1016/S0006-8993(99)01687-X; BORON WF, 1976, NATURE, V259, P240, DOI 10.1038/259240a0; BORON WF, 1985, J GEN PHYSIOL, V85, P325, DOI 10.1085/jgp.85.3.325; BORON WF, 1978, NATURE, V276, P511, DOI 10.1038/276511a0; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BORON WF, 1977, AM J PHYSIOL, V233, pC61, DOI 10.1152/ajpcell.1977.233.3.C61; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BORON WF, 1983, J GEN PHYSIOL, V81, P373, DOI 10.1085/jgp.81.3.373; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CHAO P, 1988, PFLUG ARCH EUR J PHY, V411, P216, DOI 10.1007/BF00582318; Choi I, 1999, AM J PHYSIOL-CELL PH, V276, pC576, DOI 10.1152/ajpcell.1999.276.3.C576; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; CHURCH J, 1992, J PHYSIOL-LONDON, V455, P51, DOI 10.1113/jphysiol.1992.sp019290; Church J, 1998, J PHYSIOL-LONDON, V511, P119, DOI 10.1111/j.1469-7793.1998.119bi.x; DAUMAS P, 1993, J GEN PHYSIOL, V101, P27, DOI 10.1085/jgp.101.1.27; DIXON DB, 1993, NEURON, V11, P267, DOI 10.1016/0896-6273(93)90183-R; Faber S, 1998, CELL PHYSIOL BIOCHEM, V8, P202, DOI 10.1159/000016283; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; FREY G, 1993, J MEMBRANE BIOL, V134, P131; Grichtchenko II, 2000, J GEN PHYSIOL, V115, P533, DOI 10.1085/jgp.115.5.533; Kiss L, 1999, J NEUROPHYSIOL, V81, P1839, DOI 10.1152/jn.1999.81.4.1839; Ko YP, 1999, CHINESE J PHYSIOL, V42, P237; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KOSTENKO MA, 1983, BRAIN RES, V276, P43, DOI 10.1016/0006-8993(83)90546-2; KOTTGEN M, 1994, PFLUG ARCH EUR J PHY, V428, P179, DOI 10.1007/BF00374856; LADOUX A, 1987, EUR J BIOCHEM, V170, P43, DOI 10.1111/j.1432-1033.1987.tb13665.x; Lane J, 2000, BIOPHYS J, V78, P2493, DOI 10.1016/S0006-3495(00)76794-4; Meyer TM, 2000, NEUROREPORT, V11, P33, DOI 10.1097/00001756-200001170-00007; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Pedersen KA, 2000, PFLUG ARCH EUR J PHY, V440, P153, DOI 10.1007/s004240051033; Pushkin A, 1999, GENOMICS, V57, P321, DOI 10.1006/geno.1999.5781; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Romero M. F., 1998, Journal of the American Society of Nephrology, V9, p11A; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; RUSSELL JM, 1976, NATURE, V264, P73, DOI 10.1038/264073a0; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; SHRODE LD, 1994, GLIA, V12, P196, DOI 10.1002/glia.440120305; SIEBENS AW, 1987, J GEN PHYSIOL, V90, P799, DOI 10.1085/jgp.90.6.799; Smith GAM, 1998, J PHYSIOL-LONDON, V512, P487, DOI 10.1111/j.1469-7793.1998.487be.x; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; Strazzabosco M, 1997, HEPATOLOGY, V25, P976, DOI 10.1002/hep.510250431; THOMAS RC, 1976, J PHYSIOL-LONDON, V255, P715, DOI 10.1113/jphysiol.1976.sp011305; THOMAS RC, 1976, NATURE, V262, P54, DOI 10.1038/262054a0; THOMAS RC, 1977, J PHYSIOL-LONDON, V273, P317, DOI 10.1113/jphysiol.1977.sp012096; Tombaugh GC, 1997, J NEUROPHYSIOL, V77, P639, DOI 10.1152/jn.1997.77.2.639; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wang XG, 1998, AM J PHYSIOL-CELL PH, V275, pC1384, DOI 10.1152/ajpcell.1998.275.5.C1384; Xiong ZQ, 2000, J NEUROSCI, V20, P1290; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; Zhu GY, 2000, J CELL PHYSIOL, V183, P53, DOI 10.1002/(SICI)1097-4652(200004)183:1<53::AID-JCP7>3.3.CO;2-I	64	126	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					8358	8363		10.1074/jbc.C000716200	http://dx.doi.org/10.1074/jbc.C000716200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11133997	hybrid			2022-12-27	WOS:000167474900093
J	Ostedgaard, LS; Baldursson, O; Welsh, MJ				Ostedgaard, LS; Baldursson, O; Welsh, MJ			Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by its R domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CFTR CHLORIDE CHANNEL; BINDING PROTEIN; CONFORMATIONAL PREFERENCES; TRANSACTIVATION DOMAIN; CRYSTAL-STRUCTURE; ABC TRANSPORTER; PHOSPHORYLATION; CREB; SUBUNIT; ACTIVATION		Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, 500 EMRB, Iowa City, IA 52242 USA.			Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442	NHLBI NIH HHS [HL42385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042385] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Baldursson O, 2000, AM J PHYSIOL-LUNG C, V279, pL835, DOI 10.1152/ajplung.2000.279.5.L835; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; COHN JA, 1992, P NATL ACAD SCI USA, V89, P2340, DOI 10.1073/pnas.89.6.2340; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; DULHANTY AM, 1994, FEBS LETT, V343, P109, DOI 10.1016/0014-5793(94)80300-5; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; King SA, 2000, BIOCHEMISTRY-US, V39, P9868, DOI 10.1021/bi992807d; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Neville DCA, 1998, BIOCHEMISTRY-US, V37, P2401, DOI 10.1021/bi972021k; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1996, MOL CELL BIOL, V16, P694; Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Plaxco KW, 1997, NATURE, V386, P657, DOI 10.1038/386657a0; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; RICH DP, 1993, J BIOL CHEM, V268, P20259; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; RIORDAN JR, 1989, SCIENCE, V245, P1066; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; Vankeerberghen A, 1999, BIOCHEMISTRY-US, V38, P14988, DOI 10.1021/bi991520d; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie JX, 2000, BIOPHYS J, V78, P1293, DOI 10.1016/S0006-3495(00)76685-9	45	89	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7689	7692		10.1074/jbc.R100001200	http://dx.doi.org/10.1074/jbc.R100001200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244086	hybrid			2022-12-27	WOS:000167474900001
J	Vainshtein, I; Kovacina, KS; Roth, RA				Vainshtein, I; Kovacina, KS; Roth, RA			The insulin receptor substrate (IRS)-1 pleckstrin homology domain functions in downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; IN-VIVO; PROTEIN; BINDING; KINASE; IRS-1; REGION; AKT; LOCALIZATION; ADIPOCYTES	The pleckstrin homology (PH) domain of the insulin receptor substrate-1 (IRS-1) plays a role in directing this molecule to the insulin receptor, thereby regulating its tyrosine phosphorylation. In this work, the role of the PH domain in subsequent signaling was studied by constructing constitutively active forms of IRS-1 in which the inter-SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase was fused to portions of the IRS-1 molecule. Chimeric molecules containing the PH domain were found to activate the downstream response of stimulating the Ser/Thr kinase Akt, A chimera containing point mutations in the PH domain that abolished the ability of this domain to bind phosphatidylinositol 4,5-bisphosphate prevented these molecules from activating Akt. These mutations also decreased by about 70% the amount of the constructs present in a particulate fraction of the cells. These results indicate that the PH domain of IRS-1, in addition to directing this protein to the receptor for tyrosine phosphorylation, functions in the ability of this molecule to stimulate subsequent responses. Thus, compromising the function of the PH domain, e.g. in insulin-resistant states, could decrease both the ability of IRS-1 to be tyrosine phosphorylated by the insulin receptor and to link to subsequent downstream targets.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Roth, RA (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA.				NIDDK NIH HHS [DK 34926] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034926, R01DK034926] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Burks DJ, 1997, J BIOL CHEM, V272, P27716, DOI 10.1074/jbc.272.44.27716; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Margolis B, 1996, J LAB CLIN MED, V128, P235, DOI 10.1016/S0022-2143(96)90022-0; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Paz K, 1996, J BIOL CHEM, V271, P6998, DOI 10.1074/jbc.271.12.6998; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Razzini G, 2000, MOL ENDOCRINOL, V14, P823, DOI 10.1210/me.14.6.823; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Takeuchi H, 1998, BIOCHEM J, V334, P211, DOI 10.1042/bj3340211; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; White MF, 1998, CURR TOP MICROBIOL, V228, P179; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300	29	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					8073	8078		10.1074/jbc.M008436200	http://dx.doi.org/10.1074/jbc.M008436200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11145958	hybrid			2022-12-27	WOS:000167474900057
J	Koch, M; Foley, JE; Hahn, R; Zhou, PH; Burgeson, RE; Gerecke, DR; Gordon, MK				Koch, M; Foley, JE; Hahn, R; Zhou, PH; Burgeson, RE; Gerecke, DR; Gordon, MK			alpha 1(XX) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; XII; EXPRESSION; MEMBRANE; DOMAIN; CHAIN	Chick cDNA clones for a new member of the FACIT (fibril-associated collagens with interrupted triple helices) subfamily have been isolated and sequenced. The collagen chain encoded by these cDNAs was assigned the next consecutive number, making it the alpha1(XX) collagen chain. Assignment of type XX collagen to the FACIT family was based on sequence similarities to types XII and XIV collagen. Type XX collagen mRNA is not abundant in the chick embryo. It is most prevalent in corneal epithelium. It is also detectable by reverse transcription polymerase chain reaction in embryonic skin, sternal cartilage, and tendon, but is barely detectable in calvaria, notochord, or neural retina at select stages of development, suggesting that it is not expressed in these tissues. The cDNA predicts that the alpha1(XX) collagen polypeptide is smaller than the short forms of collagen XII and XIV. A polyclonal antibody against a synthetic alpha1(XX) peptide reacts with polypeptide bands of 185, 170, and 135 kDa by Western blot analysis. From its similarity to types XII and XIV collagen, type XX is expected to bind to collagen fibrils, projecting the amino-terminal domains away from the fibrillar surface. The projecting NC 3 domains are predicted to be about half the length of those of collagen XIV.	Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, EOHSI, Piscataway, NJ 08854 USA; Harvard Univ, Massachusetts Gen Hosp E, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Rutgers State Univ, Dept Pharmacol & Toxicol, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Harvard University; University of Pennsylvania; Rutgers State University New Brunswick	Gordon, MK (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, EOHSI, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	magordon@eohsi.rutgers.edu	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814	NATIONAL EYE INSTITUTE [R01EY009056] Funding Source: NIH RePORTER; NEI NIH HHS [EY09056] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; FITCH JM, 1988, INVEST OPHTH VIS SCI, V29, P1125; Gordon MK, 1996, DEV DYNAM, V206, P49, DOI 10.1002/(SICI)1097-0177(199605)206:1<49::AID-AJA5>3.3.CO;2-T; Gordon MK, 1997, INVEST OPHTH VIS SCI, V38, P153; GORDON MK, 1994, J BIOL CHEM, V269, P24959; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kania AM, 1999, J BIOL CHEM, V274, P22053, DOI 10.1074/jbc.274.31.22053; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p; LINSENMAYER TF, 1986, J CELL BIOL, V103, P1587, DOI 10.1083/jcb.103.4.1587; LUNSTRUM GP, 1991, J CELL BIOL, V113, P963, DOI 10.1083/jcb.113.4.963; MORADIAMELI M, 1994, MATRIX BIOL, V14, P233, DOI 10.1016/0945-053X(94)90187-2; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALCHLI C, 1993, EUR J BIOCHEM, V212, P1125; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	21	62	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23120	23126		10.1074/jbc.M009912200	http://dx.doi.org/10.1074/jbc.M009912200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11274142	hybrid			2022-12-27	WOS:000169412700152
J	Lambert, G; Becker, B; Schreiber, R; Boucherot, A; Reth, M; Kunzelmann, K				Lambert, G; Becker, B; Schreiber, R; Boucherot, A; Reth, M; Kunzelmann, K			Control of cystic fibrosis transmembrane conductance regulator expression by BAP31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; CHLORIDE CHANNEL; RETRIEVAL SIGNAL; EPITHELIAL-CELLS; CL SECRETION; PROTEINS; DEGRADATION; MATURATION; ER	Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) is stringently controlled by molecular chaperones participating in formation of the quality control system. it has been shown that about 75% of all CFTR protein and close to 100% of the [Delta Phe(508)] CFTR variant are rapidly degraded before leaving the endoplasmic reticulum (ER). B cell antigen receptor-associated proteins (BAPs) are ubiquitously expressed integral membrane proteins that may control association with the cytoskeleton, vesicular transport, or retrograde transport from the cis Golgi to the ER. The present study delivers evidence for cytosolic co-localization of both BAP31 and CFTR and for the control of expression of recombinant CFTR in Chinese hamster ovary (CHO) cells and Xenopus oocytes by BAP31. Antisense inhibition of BAP31 in various cell types increased expression of both wild-type CFTR and [Delta Phe(508)]CFTR and enabled cAMP-activated CI- currents in [Delta Phe(508)]CFTR-expressing CHO cells. Coexpression of CFTR together with BAP31 attenuated cAMP-activated CI- currents in Xenopus oocytes. These data therefore suggest association of BAP31 with CFTR that may control maturation or trafficking of CFTR and thus expression in the plasma membrane.	Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia; Univ Zurich Irchel, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Klin Regensburg, Dept Dermatol, D-93052 Regensburg, Germany; Univ Freiburg, Dept Mol Immunol, Freiburg, Germany; Max Planck Inst Immunobiol, Freiburg, Germany	University of Queensland; University of Zurich; University of Regensburg; University of Freiburg; Max Planck Society	Kunzelmann, K (corresponding author), Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia.		Schreiber, Robert/Q-7550-2019	Kunzelmann, Karl/0000-0002-4583-7037				Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Goepfert PA, 1999, J VIROL, V73, P7210, DOI 10.1128/JVI.73.9.7210-7217.1999; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JENSEN TJ, 1995, CELL, V83, P13; Jiang XS, 1997, AM J PHYSIOL-LUNG C, V273, pL913, DOI 10.1152/ajplung.1997.273.5.L913; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; KOTTGEN M, 1996, PLFUGERS ARCH, V431, P499; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; KUNZELMANN K, 1994, PFLUG ARCH EUR J PHY, V428, P590, DOI 10.1007/BF00374582; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LETZ B, 1996, PFLUGERS ARCH S, V431, pO56; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 2000, AM J PHYSIOL-GASTR L, V278, pG617, DOI 10.1152/ajpgi.2000.278.4.G617; MORRIS AP, 1993, AM J PHYSIOL, V265, pC688, DOI 10.1152/ajpcell.1993.265.3.C688; Ng FWH, 1998, J BIOL CHEM, V273, P3140, DOI 10.1074/jbc.273.6.3140; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pahl HL, 1996, J CELL BIOL, V132, P511, DOI 10.1083/jcb.132.4.511; PIND S, 1994, J BIOL CHEM, V269, P12784; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480	37	50	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20340	20345		10.1074/jbc.M011209200	http://dx.doi.org/10.1074/jbc.M011209200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274174	hybrid			2022-12-27	WOS:000169135100091
J	Franch, HA; Sooparb, S; Du, J				Franch, HA; Sooparb, S; Du, J			A mechanism regulating proteolysis of specific proteins during renal tubular cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE PATHWAY; LYSOSOMAL PROTEOLYSIS; TRANSCRIPTION FACTOR; RAT-LIVER; DEGRADATION; HYPERTROPHY; EXPRESSION; GENE; KIDNEY; INHIBITION	Growth factors suppress the degradation of cellular proteins in lysosomes in renal epithelial cells, Whether this process also involves specific classes of proteins that influence growth processes is unknown. We investigated chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal import consensus sequence (KFERQ motif), Epidermal growth factor (EGF) or ammonia, but not transforming growth factor beta1, suppresses total protein breakdown in cultured NRK-52E renal epithelial cells, EGF or ammonia prolonged the half-life of glyceraldehyde-3-phosphate dehydrogenase, a classic substrate for chaperone-mediated autophagy, by more than 90%, whereas transforming growth factor pi did not. EGF caused a similar increase in the half-life of the KFERQ-containing paired box-related transcription factor, Pax2. The increase in half-life was accompanied by an increased accumulation of proteins with a KFERQ motif including glyceraldehyde-3-phosphate dehydrogenase and Pax2. Ammonia also increased the level of the Pax2 protein. Lysosomal import of KFERQ proteins depends on the abundance of the 96-kDa lysosomal glycoprotein protein (lgp96), and we found that EGF caused a significant decrease in lgp96 in cellular homogenates and associated with lysosomes, We conclude that EGF in cultured renal cells regulates the breakdown of proteins targeted for destruction by chaperone-mediated autophagy, Because suppression of this pathway results in an increase in Pax2, these results suggest a novel mechanism for the regulation of cell growth.	Emory Univ, Sch Med, Div Renal, WBM, Atlanta, GA 30322 USA; Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Franch, HA (corresponding author), Emory Univ, Sch Med, Div Renal, WBM, Rm 338,1639 Pierce Dr,NE, Atlanta, GA 30322 USA.	hfranch@emory.edu		Franch, Harold/0000-0003-1392-3798	NIDDK NIH HHS [K08 DK02496] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002496] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; BALLARD FJ, 1980, FEBS LETT, V114, P209, DOI 10.1016/0014-5793(80)81116-1; BALLARD FJ, 1980, J CELL PHYSIOL, V105, P335, DOI 10.1002/jcp.1041050216; Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018; BRINCK U, 1994, VIRCHOWS ARCH, V424, P177; Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; DICE JF, 1989, BIOCHEM SOC SYMP, V55, P45; DICE JF, 1994, CELLULAR PROTEOLYTIC, P134; ECCLES MR, 1992, CELL GROWTH DIFFER, V3, P279; FRANCH HA, 1995, J CELL BIOL, V129, P245, DOI 10.1083/jcb.129.1.245; Franch HA, 2000, J AM SOC NEPHROL, V11, P1631, DOI 10.1681/ASN.V1191631; Franch HA, 1997, AM J PHYSIOL-CELL PH, V273, pC843, DOI 10.1152/ajpcell.1997.273.3.C843; Franch HA, 1996, AM J PHYSIOL-CELL PH, V270, pC932, DOI 10.1152/ajpcell.1996.270.3.C932; FUKUHARA Y, 1991, CONTRIB NEPHROL, V95, P222; GOLCHINI K, 1989, J CLIN INVEST, V84, P1767, DOI 10.1172/JCI114361; HALPERIN ML, 1992, KIDNEY PHYSL PATHOPH, P2645; JURKOVITZ CT, 1992, KIDNEY INT, V42, P595, DOI 10.1038/ki.1992.323; KALAMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; LEE HK, 1994, INT REV EXP PATHOL, V35, P39; Liu SG, 1997, EXP NEPHROL, V5, P295; MERCER RW, 1986, MOL CELL BIOL, V6, P3884, DOI 10.1128/MCB.6.11.3884; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POLEEV A, 1992, DEVELOPMENT, V116, P611; PROUD CG, 1994, NATURE, V371, P747, DOI 10.1038/371747a0; Spizz G, 1997, J BIOL CHEM, V272, P23833, DOI 10.1074/jbc.272.38.23833; TANG MJ, 1989, AM J PHYSIOL, V256, pC532, DOI 10.1152/ajpcell.1989.256.3.C532; TERLECKY SR, 1993, J BIOL CHEM, V268, P23490; WING SS, 1991, BIOCHEM J, V275, P165, DOI 10.1042/bj2750165; Winyard PJD, 1996, J CLIN INVEST, V98, P451, DOI 10.1172/JCI118811	38	79	79	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19126	19131		10.1074/jbc.M101777200	http://dx.doi.org/10.1074/jbc.M101777200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262416	hybrid			2022-12-27	WOS:000169091000067
J	Kataoka, T; Holler, N; Micheau, O; Martinon, F; Tinel, A; Hofmann, K; Tschopp, J				Kataoka, T; Holler, N; Micheau, O; Martinon, F; Tinel, A; Hofmann, K; Tschopp, J			Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; INHIBITION; PROTEINS; FAMILY; BAX; BCL-X(L)	The Bcl-2 family of proteins plays a central regulatory role in apoptosis, We have identified a novel, widely expressed Bcl-2 member which we have named Bcl-rambo. Bcl-rambo shows overall structural homology to the anti-apoptotic Bcl-2 members containing conserved Bcl-2 homology (BH) motifs 1, 2, 3, and 4, Unlike Bcl-2, however, the C-terminal membrane anchor region is preceded by a unique 250 amino acid insertion containing two tandem repeats. No interaction of Bcl-rambo with either anti-apoptotic (Bcl-2, Bcl-x(L), Bcl-w, A1, MCL-1, E1B-1SK, and BHRF1) or pro-apoptotic (Bax, Bak, Bik, Bid, Bim, and Bad) members of the Bcl-2 family was observed. In mammalian cells, Bcl-rambo was localized to mitochondria, and its overexpression induces apoptosis that is specifically blocked by the caspase inhibitors, IAPs, whereas inhibitors controlling upstream events of either the 'death receptor' (FLIP, FADD-DN) or the 'mitochondrial' pro-apoptotic pathway (Bcl-x(L)) had no effect. Surprisingly, the Bcl-rambo cell death activity was induced by its membrane-anchored C-terminal domain and not by the Bcl-2 homology region. Thus, Bcl-rambo constitutes a novel type of pro-apoptotic Bcl-2 member that triggers cell death independently of its BH motifs.	Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; MEMOREC Stoffel GmbH, D-50829 Cologne, Germany	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	Jurg.tschopp@ib.unil.ch	Hofmann, Kay/D-6714-2011; Martinon, Fabio/A-5575-2009; micheau, olivier/C-3574-2011	Hofmann, Kay/0000-0002-2289-9083; Martinon, Fabio/0000-0002-6969-822X; micheau, olivier/0000-0001-8499-7984				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AUSUBEL FM, 1999, CURRENT PROTOCOLS MO, V2; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	19	100	111	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19548	19554		10.1074/jbc.M010520200	http://dx.doi.org/10.1074/jbc.M010520200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262395	hybrid			2022-12-27	WOS:000169091000118
J	Kim, J; Yoon, MY; Choi, SL; Kang, I; Kim, SS; Kim, YS; Choi, YK; Ha, J				Kim, J; Yoon, MY; Choi, SL; Kang, I; Kim, SS; Kim, YS; Choi, YK; Ha, J			Effects of stimulation of AMP-activated protein kinase on insulinlike growth factor 1-and epidermal growth factor-dependent extracellular signal-regulated kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FATTY-ACID; RAT HEPATOCYTES; RAF-1 KINASE; CELLS; PHOSPHORYLATION; GLUCOSE; IDENTIFICATION; METABOLISM; INHIBITION	AMP-activated protein kinase (AMPK) is tightly regulated by the cellular AMP:ATP ratio and plays a central role in the regulation of energy homeostasis. Previously, AMPK was reported to phosphorylate serine 621 of Raf-l in vitro, In the present study, we investigated a possible role of AMPK in extracellular signal-regulated kinase (Erk) cascades, using 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside (AICAR), a cell-permeable activator of AMPK and antisense RNA experiments. Activation of AMPK by AICAR in NIH-3T3 cells resulted in drastic inhibitions of Ras, Raf-l, and Erk activation induced by insulin-like growth factor 1 (IGF-1), Expression of an antisense RNA for the AMPK catalytic subunit decreased the AMPK activity and significantly diminished the AICAR effect on IGF-l-induced Ras activation and the subsequent Erk activation, indicating that its effect is indeed mediated by AMPK. Phosphorylation of Raf-l serine 621, however, was not involved in AMPK-mediated inhibition of Erk cascades. In contrast to IGF-1, AICAR did not block epidermal growth factor (EGF)-dependent Raf-l and Erk activation, but our results demonstrated that multiple Raf-l upstream pathways induced by EGF were differentially affected by AICAR: inhibition of Ras activation and simultaneous induction of Ras-independent Raf activation. The activities of IGF-1 and EGF receptor were not affected by AICAR, Taken together, our results suggest that AMPK differentially regulate Erk cascades by inhibiting Ras activation or stimulating the Ras-independent pathway in response to the varying energy status of the cell.	Kyrung Hee Univ, Coll Med, EW Med Res Ctr, Dept Mol Biol,Tongdarmun Gu, Seoul 130701, South Korea; Kyrung Hee Univ, Coll Med, Dept Internal Med, Seoul 130701, South Korea; Hanyang Univ, Dept Chem, Seoul 133791, South Korea	Kyung Hee University; Kyung Hee University; Hanyang University	Ha, J (corresponding author), Kyrung Hee Univ, Coll Med, EW Med Res Ctr, Dept Mol Biol,Tongdarmun Gu, Hoegi Dong 1, Seoul 130701, South Korea.		Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668				BELSCHES AP, 1997, FRONT BIOSCI, V2, pD501; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CARLING D, 1994, J BIOL CHEM, V269, P11442; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DENT P, 1995, MOL CELL BIOL, V15, P4125; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Eguchi Y, 1997, CANCER RES, V57, P1835; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Kasi VS, 1999, MOL CELL BIOL, V19, P6858; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Leclerc I, 1998, FEBS LETT, V431, P180, DOI 10.1016/S0014-5793(98)00745-5; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Sakatsume M, 1998, J BIOL CHEM, V273, P3021, DOI 10.1074/jbc.273.5.3021; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sprenkle AB, 1997, FEBS LETT, V403, P254, DOI 10.1016/S0014-5793(97)00062-8; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; THOMAS CB, 1981, J CELL PHYSIOL, V107, P335, DOI 10.1002/jcp.1041070305; THOMPSON PA, 1991, CELL GROWTH DIFFER, V2, P609; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Ziogas A, 1998, J BIOL CHEM, V273, P24108, DOI 10.1074/jbc.273.37.24108	50	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19102	19110		10.1074/jbc.M011579200	http://dx.doi.org/10.1074/jbc.M011579200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262401	hybrid			2022-12-27	WOS:000169091000064
J	Lee, HJ; Chun, M; Kandror, KV				Lee, HJ; Chun, M; Kandror, KV			Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RAT MESANGIAL CELLS; TYROSINE KINASE; TRANSCRIPTION FACTOR; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; BETA-ARRESTIN; A RECEPTOR; ACETYLATION; ACTIVATION	Endothelins exert their biological effects through G; protein-coupled receptors. However, the precise mechanism of downstream signaling and trafficking of the receptors is largely unknown. Here we report that the histone acetyltransferase Tip60 and the histone deacetylase HDAC7 interact with one of the ET receptors, ETA, as determined by yeast two-hybrid analysis, glutathione S-transferase pull-down assays, and co-immunoprecipitation from transfected COS-7 cells. In the absence of ET-1, Tip60 and HDAC7 were localized mainly in the cell nucleus while ETA was predominantly confined to the plasma membrane. Stimulation with ET-1 resulted in the internalization of ETA to the perinuclear compartment and simultaneously ill the efflux of Tip60 and HDAC7 from the nucleus to the same perinuclear compartment where each protein co-localized with the receptor. Upon co-transfection with ETA into COS-7 cells, Tip60 strongly increased ET-l-induced ERK1/2 phosphorylation, whereas HDAC7 had no significant effect. We thus suggest that protein acetylase and deacetylase interact with ETA in a ligand-dependent fashion and may participate in ET signal transduction.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), 715 Albany St, Boston, MA 02118 USA.			Kandror, Konstantin/0000-0002-8601-9313	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK052057, R01DK056736] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56736, DK52057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bannister AJ, 2000, CURR BIOL, V10, P467, DOI 10.1016/S0960-9822(00)00445-0; BATTISTINI B, 1993, LAB INVEST, V68, P600; BAYNASH AG, 1969, CELL, V79; Bhowmick N, 1998, ENDOCRINOLOGY, V139, P3185, DOI 10.1210/en.139.7.3185; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; CHUN MY, 1995, J BIOL CHEM, V270, P10855, DOI 10.1074/jbc.270.18.10855; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Horstmeyer A, 1996, J BIOL CHEM, V271, P20811, DOI 10.1074/jbc.271.34.20811; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; HOSODA K, 1992, J BIOL CHEM, V267, P18797; Husain S, 1999, BIOCHEM J, V342, P87, DOI 10.1042/0264-6021:3420087; IIJIMA K, 1991, AM J PHYSIOL, V260, pC982, DOI 10.1152/ajpcell.1991.260.5.C982; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kao HY, 2000, GENE DEV, V14, P55; KOSHIMIZU T, 1995, BIOCHEM BIOPH RES CO, V217, P354, DOI 10.1006/bbrc.1995.2784; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KRSMANOVIC LZ, 1991, P NATL ACAD SCI USA, V88, P11124, DOI 10.1073/pnas.88.24.11124; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVIN ER, 1991, ENDOCRINOLOGY, V128, P2925, DOI 10.1210/endo-128-6-2925; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maggi M, 2000, J CLIN ENDOCR METAB, V85, P1658, DOI 10.1210/jc.85.4.1658; MARSAULT R, 1993, AM J PHYSIOL, V264, pC687, DOI 10.1152/ajpcell.1993.264.3.C687; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; MASAKI T, 1993, ENDOCR REV, V14, P256, DOI 10.1210/er.14.3.256; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; MULDOON LL, 1990, CELL REGUL, V1, P379, DOI 10.1091/mbc.1.4.379; NISHIMURA T, 1991, BRIT J PHARMACOL, V103, P1242, DOI 10.1111/j.1476-5381.1991.tb12331.x; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; REYNOLDS EE, 1990, J PHARMACOL EXP THER, V252, P915; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Schlaepfer DD, 1996, CELL STRUCT FUNCT, V21, P445, DOI 10.1247/csf.21.445; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; SIMONSON MS, 1993, PHYSIOL REV, V73, P375, DOI 10.1152/physrev.1993.73.2.375; SIMONSON MS, 1992, J AM SOC NEPHROL, V2, pS116; TAKEMURA R, 1992, J CELL SCI, V103, P953; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; WANG YZ, 1993, J CARDIOVASC PHARM, V22, pS164, DOI 10.1097/00005344-199322008-00044; WANG YZ, 1992, BIOCHEM J, V287, P589, DOI 10.1042/bj2870589; Wu-Wong JSR, 1999, J BIOL CHEM, V274, P8103, DOI 10.1074/jbc.274.12.8103; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	64	48	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 18	2001	276	20					16597	16600		10.1074/jbc.C000909200	http://dx.doi.org/10.1074/jbc.C000909200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	432ZG	11262386	hybrid			2022-12-27	WOS:000168730400002
J	Mok, YK; Lo, KWH; Zhang, MJ				Mok, YK; Lo, KWH; Zhang, MJ			Structure of Tctex-1 and its interaction with cytoplasmic dynein intermediate chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN; NMR-SPECTROSCOPY; LARGE PROTEINS; TRANSPORT; DYNACTIN; ASSIGNMENT; COMPLEXES; KINASE; FAMILY; MOUSE	The minus-ended microtubule motor cytoplasmic dynein contains a number of low molecular weight light chains including the 14-kDa Tctex-1. The assembly of Tctex-1 in the dynein complex and its function are largely unknown. Using partially deuterated, N-15,C-13-labeled protein samples and transverse relaxation-optimized NMR spectroscopic techniques, the secondary structure and overall topology of Tctex-1 were determined based on the backbone nuclear Overhauser effect pattern and the chemical shift values of the protein. The data showed that Tctex-1 adopts a structure remarkably similar to that of the 8-kDa light chain of the motor complex (DLC8), although the two light chains share no amino acid sequence homology, We further demonstrated that Tctex-1 binds directly to the intermediate chain (DIC) of dynein, The Tctex-1 binding site on DIC was mapped to a 19-residue fragment immediately following the second alternative splicing site of DIG. Titration of Tctex-1 with a peptide derived from DIG, which contains a consensus sequence R/KR/KXYR/K found in various Tctex-1 target proteins, indicated that Tctex-1 binds to its targets in a manner similar to that of DLC8. The experimental results presented in this study suggest that Tctex-1 is likely to be a specific cargo adaptor for the dynein motor complex.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.		Mok, Yu Keung/H-8019-2012	Mok, Yu Keung/0000-0002-2829-4878; Zhang, Mingjie/0000-0001-9404-0190				Bauch A, 1998, EUR J IMMUNOL, V28, P2167, DOI 10.1002/(SICI)1521-4141(199807)28:07<2167::AID-IMMU2167>3.0.CO;2-L; Campbell KS, 1998, J IMMUNOL, V161, P1728; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; LADER E, 1989, CELL, V58, P969, DOI 10.1016/0092-8674(89)90948-3; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Pervushin K, 2000, J BIOMOL NMR, V17, P195, DOI 10.1023/A:1008399320576; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Zhang OW, 1997, J BIOMOL NMR, V9, P181, DOI 10.1023/A:1018658305040	31	96	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14067	14074		10.1074/jbc.M011358200	http://dx.doi.org/10.1074/jbc.M011358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11148215	hybrid			2022-12-27	WOS:000168356600077
J	Selmi, B; Boretto, J; Navarro, JM; Sire, J; Longhi, S; Guerreiro, C; Mulard, L; Sarfati, S; Canard, B				Selmi, B; Boretto, J; Navarro, JM; Sire, J; Longhi, S; Guerreiro, C; Mulard, L; Sarfati, S; Canard, B			The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-STEADY-STATE; MECHANISM; 3'-AZIDO-3'-DEOXYTHYMIDINE; INHIBITION; MUTANTS; AZT; 2,3-DIDEHYDRO-2,3-DIDEOXYTHYMIDINE; 5'-TRIPHOSPHATE; PHOSPHORYLATION; PYROPHOSPHATE	The amino acid change V75T in human immunodeficiency virus type 1 reverse transcriptase confers a low level of 2',3'-didehydro-2',3'-dideoxythymidine (stavudine, d4T) resistance in vivo and in vitro, Valine 75 is located at the basis of the fingers subdomain of reverse transcriptase between the template contact point and the nucleotide-binding pocket. V75T reverse transcriptase discriminates 3.6-fold d4T 5'-triphosphate relative to dTTP, as judged by pre-steady state kinetics of incorporation of a single nucleotide into DNA, In addition, V75T increases the DNA polymerization rate up to 5-fold by facilitating translocation along nucleic acid single-stranded templates. V75T also increases the reverse transcriptase-mediated repair of the d4TMP-terminated DNA by pyrophosphate but not by ATP. The V75T/Y146F double substitution partially suppressed both increases in rate of polymerization and pyrophosphorolysis, indicating that the hydroxyl group of Thr-75 interacts with that of Tyr-146. V75T recombinant virus was 3-4-fold d4T-resistant and 3-fold resistant to phosphonoformic acid relative to wild type, confirming that the pyrophosphate traffic is affected in V75T reverse transcriptase. Thus, in addition to nucleotide selectivity V75T defines a type of amino acid change conferring resistance to nucleoside analogues that links translocation rate to the traffic of pyrophosphate at the reverse transcriptase active site.	CNRS, F-13288 Marseille 9, France; Univ Aix Marseille 1, UMR 6098, F-13288 Marseille 9, France; Univ Aix Marseille 2, UMR 6098, F-13288 Marseille 9, France; INSERM, U372, F-13288 Marseille 9, France; Inst Pasteur, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Canard, B (corresponding author), CNRS, ESIL Case 925,163 Ave Luminy, F-13288 Marseille 9, France.	bruno@esil.univ-mrs.fr	LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771; Canard, Bruno/0000-0003-4924-1991				Ahluwalia GS, 1996, MOL PHARMACOL, V50, P160; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; BALZARINI J, 1989, J BIOL CHEM, V264, P6127; Balzarini J, 1999, BIOCHEM PHARMACOL, V58, P1; BARSHOP BA, 1991, ANAL BIOCHEM, V197, P266, DOI 10.1016/0003-2697(91)90387-9; BRUNVEZINET F, 2000, ANTIVIR THER S, V5, P78; Canard B, 1999, J BIOL CHEM, V274, P35768, DOI 10.1074/jbc.274.50.35768; Canard B, 1998, J BIOL CHEM, V273, P14596, DOI 10.1074/jbc.273.23.14596; CARROLL SS, 1994, BIOCHEMISTRY-US, V33, P2113, DOI 10.1021/bi00174a018; Coakley EP, 2000, AIDS, V14, pF9, DOI 10.1097/00002030-200001280-00002; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Hashimoto K, 1997, AIDS RES HUM RETROV, V13, P193, DOI 10.1089/aid.1997.13.193; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUANG P, 1992, J BIOL CHEM, V267, P2817; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LACEY SF, 1994, ANTIMICROB AGENTS CH, V38, P1428, DOI 10.1128/AAC.38.6.1428; LARDER B, 1992, REVERSE TRANSCRIPTAS, P205; Lavie A, 1997, NAT STRUCT BIOL, V4, P601, DOI 10.1038/nsb0897-601; LENNERSTRAND J, 2000, ANTIVIR THER S, V5, P14; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Lin PF, 1999, ANTIVIR THER, V4, P21; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MORENO S, 2000, ANTIVIR THER S3, V5, P19; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Rigourd M, 2000, J BIOL CHEM, V275, P26944; ROSS LL, 2000, ANTIVIR THER S, V5, P38; ROUSSEL A, 1991, SILICON GRAPHICS DIR, P97; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Schinazi R.F., 2000, INT ANTIVIRAL NEWS, V8, P65; Schneider B, 1998, J BIOL CHEM, V273, P11491, DOI 10.1074/jbc.273.19.11491; Schneider B, 2000, MOL PHARMACOL, V57, P948; Soriano V, 1997, AIDS, V11, P696; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Vaccaro JA, 2000, ANTIMICROB AGENTS CH, V44, P217, DOI 10.1128/AAC.44.1.217-221.2000; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057	40	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13965	13974		10.1074/jbc.M009837200	http://dx.doi.org/10.1074/jbc.M009837200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11134027	hybrid			2022-12-27	WOS:000168356600064
J	Paik, JH; Chae, SS; Lee, MJ; Thangada, S; Hla, T				Paik, JH; Chae, SS; Lee, MJ; Thangada, S; Hla, T			Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha(v)beta(3)- and beta(1)-containing integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; ALPHA(5)BETA(1) INTEGRINS; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS; GROWTH-FACTORS; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; ADHESION; DIFFERENTIATION	Sphingosine 1-phosphate (SPP), a platelet-derived bioactive lysophospholipid, is a regulator of angiogenesis. However, molecular mechanisms involved in SPP-induced angiogenic responses are not fully defined. Here we report the molecular mechanisms involved in SPP-induced human umbilical vein endothelial cell (HUVEC) adhesion and migration. SPP-induced HUVEC migration is potently inhibited by antisense phosphothioate oligonucleotides against EDG-1 as well as EDG-3 receptors, In addition, C3 exotoxin blocked SPP-induced cell attachment, spreading and migration on fibronectin-, vitronectin- and Matrigel-coated surfaces, suggesting that endothelial differentiation gene receptor signaling via the Rho pathway is critical for SPP-induced cell migration. Indeed, SPP induced Rho activation in an adherence-independent manner, whereas Rac activation was dispensible for cell attachment and focal contact formation. Interestingly, both EDG-1 and -3 receptors were required for Rho activation. Since integrins are critical for cell adhesion, migration, and angiogenesis, we examined the effects of blocking antibodies against alpha (v)beta (3), beta (1), or beta (3) integrins. SPP induced Rho-dependent integrin clustering into focal contact sites, which was essential for cell adhesion, spreading and migration. Blockage of alpha (v)beta (3)- or beta (1)-containing integrins inhibited SPP-induced HUVEC migration. Together our results suggest that endothelial differentiation gene receptor-mediated Rho signaling is required for the activation of integrin alpha (v)beta (3) as well as beta (1)-containing integrins, leading to the formation of initial focal contacts and endothelial cell migration.	Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, Farmington, CT 06030 USA	University of Connecticut	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, 263 Farmington Ave, Farmington, CT 06030 USA.		Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045659] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-45659] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672; Kanda S, 1999, EXP CELL RES, V248, P203, DOI 10.1006/excr.1999.4400; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang F, 1999, CANCER RES, V59, P6185; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351	48	248	254	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11830	11837		10.1074/jbc.M009422200	http://dx.doi.org/10.1074/jbc.M009422200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11150298	hybrid			2022-12-27	WOS:000168081800055
J	Shui, Z; Khan, IA; Haga, T; Benovic, JL; Boyett, MR				Shui, Z; Khan, IA; Haga, T; Benovic, JL; Boyett, MR			Control of the cardiac muscarinic K+ channel by beta-arrestin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DEPENDENT DESENSITIZATION; ACETYLCHOLINE-RECEPTOR; IONIC BASIS; RAT; ARRESTIN; KINASE; PHOSPHORYLATION; HYDROLYSIS; ACTIVATION	Control of the cardiac muscarinic K+ current (i(K,ACh)) by beta -arrestin 2 has been studied. In Chinese hamster ovary cells transfected with m2 muscarinic receptor, muscarinic K+ channel, receptor kinase (GRK2), and beta -arrestin 2, desensitization of i(K,ACh) during a 3-min application of 10 muM ACh was significantly increased as compared with that in cells transfected with receptor, channel, and GRK2 only (fade in current increased from 45 to 78%). The effect of beta -arrestin 2 was lost if cells were not co-transfected with GRK2, Resensitization (recovery from desensitization) of i(K,ACh) in cells transfected with beta -arrestin 2 was significantly slowed (time constant increased from 34 to 232 s), Activation and deactivation of i(K,ACh) on application and wash-off of ACh in cells transfected with beta -arrestin 2 were significantly slowed from 0.9 to 3.1 s (time to half peak i(K,ACh)) and from 6.2 to 13.8 s (time to half-deactivation), respectively. In cells transfected with a constitutively active beta -arrestin 2 mutant, desensitization occurred in the absence of agonist (peak current significantly decreased from 0.4 +/- 0.05 to 0.1 +/- 0.01 nA), We conclude that beta -arrestin 2 has the potential to play a major role in desensitization and other aspects of the functioning of the muscarinic K+ channel.	Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Tokyo, Fac Med, Dept Neurochem, Tokyo 1130033, Japan; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA	University of Leeds; University of Tokyo; Jefferson University	Boyett, MR (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.	m.r.boyett@leeds.ac.uk		Boyett, Mark/0000-0003-3931-2020				Appleyard SM, 1999, J BIOL CHEM, V274, P23802, DOI 10.1074/jbc.274.34.23802; BOYETT MR, 1995, CARDIOVASC RES, V29, P867, DOI 10.1016/S0008-6363(96)88625-1; BOYETT MR, 1987, J PHYSIOL-LONDON, V393, P171, DOI 10.1113/jphysiol.1987.sp016818; BOYETT MR, 1988, J PHYSIOL-LONDON, V404, P613, DOI 10.1113/jphysiol.1988.sp017309; BOYETT MR, 1999, J PHYSL, V521, P23; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; HAGA T, 1994, J NEUROCHEM, V63, P400; HARRISON SM, 1992, J PHYSIOL-LONDON, V449, P517, DOI 10.1113/jphysiol.1992.sp019100; Hong SG, 1996, AM J PHYSIOL-HEART C, V270, pH526, DOI 10.1152/ajpheart.1996.270.2.H526; HONJO H, 1992, AM J PHYSIOL, V263, pH1779, DOI 10.1152/ajpheart.1992.263.6.H1779; KAMEYAMA K, 1993, J BIOL CHEM, V268, P7753; KIM D, 1991, J PHYSIOL-LONDON, V437, P133, DOI 10.1113/jphysiol.1991.sp018588; KIM DH, 1993, CIRC RES, V73, P89, DOI 10.1161/01.RES.73.1.89; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KWATRA MM, 1987, J BIOL CHEM, V262, P16314; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LOHSE MJ, 1995, TRENDS CARDIOVAS MED, V5, P63, DOI 10.1016/1050-1738(94)00034-4; MARTIN P, 1982, AM J PHYSIOL, V243, pH219, DOI 10.1152/ajpheart.1982.243.2.H219; MARTIN P, 1983, AM J PHYSIOL, V245, pH584, DOI 10.1152/ajpheart.1983.245.4.H584; NISHIMURA M, 1988, AM J PHYSIOL, V255, pH7, DOI 10.1152/ajpheart.1988.255.1.H7; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Santini F, 2000, J CELL SCI, V113, P2463; Shui Z, 1997, J PHYSIOL-LONDON, V505, P77, DOI 10.1111/j.1469-7793.1997.077bc.x; Shui Z, 1998, J PHYSIOL-LONDON, V507, P325, DOI 10.1111/j.1469-7793.1998.325bt.x; SHUI Z, 1995, J PHYSIOL-LONDON, V487, P359, DOI 10.1113/jphysiol.1995.sp020885; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TSUGA H, 1994, J BIOL CHEM, V269, P32522; ZANG WJ, 1993, J PHYSIOL-LONDON, V464, P649, DOI 10.1113/jphysiol.1993.sp019656	36	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11691	11697		10.1074/jbc.M011007200	http://dx.doi.org/10.1074/jbc.M011007200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152693	hybrid			2022-12-27	WOS:000168081800037
J	Zhao, KH; Chai, XM; Johnston, K; Clements, A; Marmorstein, R				Zhao, KH; Chai, XM; Johnston, K; Clements, A; Marmorstein, R			Crystal structure of the mouse p53 core DNA-binding domain at 2.7 angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMERIZATION DOMAIN; TUMOR-SUPPRESSOR; PROTEIN; OLIGOMERIZATION; REFINEMENT; PATHWAY; REGIONS	The p53 tumor suppressor is a sequence-specific DNA-binding protein that activates transcription in response to DNA damage to promote cell cycle arrest or apoptosis, The p53 protein functions in a tetrameric form in vivo and contains four domains including an N-terminal transcriptional activation domain, a C-terminal regulatory domain, a tetramerization domain, and a central core DNA-binding domain that is the site of the majority of tumor-derived mutations. Here we report the 2.7-Angstrom crystal structure of the mouse p53 core domain. Like the human p53 core domain in complex with DNA, the mouse p53 core domain adopts an immunoglobulin-like beta sandwich architecture with a series of loops and short helices at opposite ends of the beta sandwich. Comparison of the DNA-bound and DNA-free p53 core domains reveals that while the central beta sandwich architecture remains largely unchanged, a loop region important for DNA binding undergoes significant rearrangement. Although this loop region mediates major groove DNA contacts in the DNA-bound structure, it adopts a conformation that is incompatible with DNA binding in the DNA-free structure. Interestingly, crystals of the DNA-free core domain contain a noncrystallographic trimer with three nearly identical subunit-subunit (dimer) contacts. These dimer contacts align the p53 core domains in a way that is incompatible with simultaneous DNA binding by both protomers of the dimer. Surprisingly, similar dimer contacts are observed in crystals of the human p53 core domain with DNA in which only one of the three p53 protomers in the asymmetric unit cell is specifically bound to DNA. We propose that the p53 core domain dimer that: is seen in the crystals described here represents a physiologically relevant inactive form of p53 that must undergo structural rearrangement for sequence-specific DNA binding.	Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.							BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLORE GM, 1995, NAT STRUCT BIOL, V2, P253; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Leslie A.G.W., 1992, CCP4 ESF EACMB NEWSL; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Prives C, 1999, J PATHOL, V187, P112; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; STENGER JE, 1994, EMBO J, V13, P6011, DOI 10.1002/j.1460-2075.1994.tb06947.x; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; WANG Y, 1993, GENE DEV, V7, P2575, DOI 10.1101/gad.7.12b.2575; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	27	70	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12120	12127		10.1074/jbc.M011644200	http://dx.doi.org/10.1074/jbc.M011644200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152481	hybrid			2022-12-27	WOS:000168081800092
J	Ame, JC; Schreiber, V; Fraulob, V; Dolle, P; de Murcia, G; Niedergang, CP				Ame, JC; Schreiber, V; Fraulob, V; Dolle, P; de Murcia, G; Niedergang, CP			Bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA - Structure and expression of the mouse PARP-2 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; SERINE PROTEASE GENES; CIS-ACTING ELEMENTS; ALPHA-CHAIN; TRANSCRIPTION FACTORS; III TRANSCRIPTION; DNA-POLYMERASE; H1 RNA; REGION; SEQUENCES	Poly(ADP-ribose) polymerase 2 (PARP-2) is a DNA damage-dependent enzyme that belongs to a growing family of enzymes seemingly involved in genome protection. To gain insight into the physiological role of PARP-2 and to investigate mechanisms of PARP-2 gene regulation, we cloned and characterized the murine PARP-2 gene. The PARP-2 gene consists of 16 exons and 15 introns spanning about 13 kilobase pairs. Interestingly, the PARP-2 gene lies head to head with the gene encoding the mouse RNase P RNA subunit. The distance between the transcription start sites of the PARP-2 and RNase P RNA genes is 114 base pairs. This suggested that regulation of the expression of both genes may be coordinated through a bi-directional promoter. The PARP-2/RNase P RNA gene organization is conserved in the human. To our knowledge, this is the first report of a RNA polymerase II gene and an RNA polymerase III gene sharing the same promoter region and potentially the same transcriptional control elements. Reporter gene constructs showed that the 113-base pair intergenic region was indeed sufficient for the expression of both genes and revealed the importance of both the TATA and the DSE/Oct-1 expression control elements for the PARP-2 gene transcription. The expression of both genes is clearly independently regulated. PARP-2 is expressed only in certain tissues, and RNase P RNA is ex pressed in all tissues, This suggests that both genes may be subjected to multiple levels of control and may be regulated by different factors in different cellular contexts.	ULP, Ecole Super Biotechnol Strasbourg, CNRS,UPR 9003, Lab Conventionne Commissariat Energie Atom, F-67400 Illkirch, France; ULP, CNRS,INSERM, Coll France, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de Murcia, G (corresponding author), ULP, Ecole Super Biotechnol Strasbourg, CNRS,UPR 9003, Lab Conventionne Commissariat Energie Atom, Blvd Sebastien Brant, F-67400 Illkirch, France.		Schreiber, Valérie/M-5007-2016; Dolle, Pascal/A-8037-2010	Schreiber, Valérie/0000-0003-0507-639X; Dolle, Pascal/0000-0002-9294-9090				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Berghammer H, 1999, FEBS LETT, V449, P259, DOI 10.1016/S0014-5793(99)00448-2; BERGHAMMER H, 1992, ADP RIBOSYLATION REA, P69; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; COLLINS MKL, 1985, NATURE, V314, P273, DOI 10.1038/314273a0; CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442; CROSBY JL, 1990, GENOMICS, V6, P252, DOI 10.1016/0888-7543(90)90564-B; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; DeMurcia G., 2000, DNA DAMAGE STRESS SI; EDELHOFF S, 1995, MAMM GENOME, V6, P111, DOI 10.1007/BF00303253; Gibson L, 1996, ONCOGENE, V13, P665; HANNON GJ, 1991, J BIOL CHEM, V266, P22796; HANSON RD, 1990, P NATL ACAD SCI USA, V87, P960, DOI 10.1073/pnas.87.3.960; HERNANDEZ N, 1990, MOL BIOL REP, V14, P167, DOI 10.1007/BF00360460; HUPPI K, 1989, NUCLEIC ACIDS RES, V17, P3387, DOI 10.1093/nar/17.9.3387; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; LOBO SM, 1990, NUCLEIC ACIDS RES, V18, P2891, DOI 10.1093/nar/18.10.2891; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MCCAW BK, 1975, P NATL ACAD SCI USA, V72, P2071, DOI 10.1073/pnas.72.6.2071; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURPHY S, 1989, CELL, V59, P1071, DOI 10.1016/0092-8674(89)90763-0; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; Niederreither K, 1998, METH MOL B, V89, P247; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; OGURA T, 1990, BIOCHEM BIOPH RES CO, V167, P701, DOI 10.1016/0006-291X(90)92082-B; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; ROBSON CN, 1992, NUCLEIC ACIDS RES, V20, P4417, DOI 10.1093/nar/20.17.4417; Saito T, 1997, GENOMICS, V46, P46, DOI 10.1006/geno.1997.5005; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SHALL S, 1999, MUTAT RES, V460, P1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P1954, DOI 10.1093/nar/19.8.1954; TOPPER JN, 1990, NUCLEIC ACIDS RES, V18, P793, DOI 10.1093/nar/18.4.793; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V	48	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11092	11099		10.1074/jbc.M007870200	http://dx.doi.org/10.1074/jbc.M007870200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11133988	hybrid			2022-12-27	WOS:000167980900071
J	Chen, F; Lu, YJ; Zhang, Z; Vallyathan, V; Ding, M; Castranova, V; Shi, XL				Chen, F; Lu, YJ; Zhang, Z; Vallyathan, V; Ding, M; Castranova, V; Shi, XL			Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; GENE-EXPRESSION; IKK-BETA; ACTIVATION; JNK; P53; ALPHA	Cell cycle checkpoint, a major genomic surveillance mechanism,is an important step in maintaining genomic stability and integrity in response to environmental stresses. Using cells derived from human bronchial epithelial cells, we demonstrate that NF-kappaB and c-Jun N-terminal kinase (JNK) reciprocally regulate arsenic trioxide (arsenite)-induced, p53-independent expression of GADD45 protein, a cell cycle checkpoint protein that arrests cells at the G(2)/M phase transition. Inhibition of NF-kappaB activation by stable expression of a kinase-mutated form of I kappaB kinase caused increased and prolonged induction of GADD45 by arsenite. In contrast, the induction of GADD45 by arsenite was transient and less potent in cells where the NF-kappaB activation pathway was normal. Analysis of the cell cycle profile by flow cytometry indicated that NF-kappaB inhibition potentiates arsenite-induced G(2)/M cell cycle arrest. Abrogation of JNK activation, on the other hand, decreased GADD45 expression induced by arsenite, suggesting a role for JNK activation in GADD45 induction. These results indicate a molecular mechanism by which NF-kappaB and JNK may differentially contribute to cell cycle regulation in response to arsenite.	NIOSH, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Shi, XL (corresponding author), NIOSH, Pathol & Physiol Res Branch, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	lfd3@cdc.gov; Xshi@cdc.gov	Shi, Xianglin/B-8588-2012; Zhang, Zhuo/B-8601-2012					Akao Y, 2000, LEUKEMIA LYMPHOMA, V37, P53, DOI 10.3109/10428190009057628; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen F, 1999, CLIN CHEM, V45, P7; Chen F, 1999, J BIOL CHEM, V274, P20307, DOI 10.1074/jbc.274.29.20307; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Estrov Z, 1999, BLOOD, V94, P2844, DOI 10.1182/blood.V94.8.2844.420k43_2844_2853; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gebel T, 2000, TOXICOLOGY, V144, P155, DOI 10.1016/S0300-483X(99)00202-4; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hayes RB, 1997, CANCER CAUSE CONTROL, V8, P371, DOI 10.1023/A:1018457305212; Huang CS, 1999, CANCER RES, V59, P3053; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jin SQ, 2000, ONCOGENE, V19, P4050, DOI 10.1038/sj.onc.1203759; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kayajanian GM, 2000, ECOTOX ENVIRON SAFE, V45, P195, DOI 10.1006/eesa.1999.1865; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lubin JH, 2000, AM J EPIDEMIOL, V151, P554, DOI 10.1093/oxfordjournals.aje.a010243; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; O'Reilly MA, 2000, AM J PHYSIOL-LUNG C, V278, pL552, DOI 10.1152/ajplung.2000.278.3.L552; Piwnica-Worms H, 1999, NATURE, V401, P535, DOI 10.1038/44029; Porter AC, 1999, ONCOGENE, V18, P7794, DOI 10.1038/sj.onc.1203214; Roussel RR, 2000, ARCH BIOCHEM BIOPHYS, V377, P204, DOI 10.1006/abbi.2000.1770; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; Simeonova PP, 2000, CANCER RES, V60, P3445; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Wang XT, 1999, J BIOL CHEM, V274, P29599, DOI 10.1074/jbc.274.42.29599; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhao RB, 2000, GENE DEV, V14, P981; Zhu XH, 1999, J NATL CANCER I, V91, P772, DOI 10.1093/jnci/91.9.772	44	88	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11414	11419		10.1074/jbc.M011682200	http://dx.doi.org/10.1074/jbc.M011682200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150309	hybrid			2022-12-27	WOS:000167980900114
J	Hoch, U; de Montellano, PRO				Hoch, U; de Montellano, PRO			Covalently linked heme in cytochrome P4504A fatty acid hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; LAURIC ACID; OMEGA-HYDROXYLATION; CATALYTIC SITE; RAT; PROTEINS; (OMEGA-1)-HYDROXYLATION; CYP4A11; BINDING	Three independent experimental methods, liquid chromatography, denaturing gel electrophoresis with heme staining, and mass spectrometry, establish that the CYP4A class of enzymes has a covalently bound heme group even though the heme is not cross-linked to the protein in other P450 enzymes. Covalent binding has been demonstrated for CYP4A1, -4A2, -4A3, -4A8, and -4A11 heterologously expressed in Escherichia coli. However, the covalent link is also present in CYP4A1 isolated from rat liver and is not an artifact of heterologous expression. The extent of heme covalent binding in the proteins as isolated varies and is substoichiometric. In CYP4A3, the heme is attached to the protein via an ester link to glutamic acid residue 318, which is on the I-helix, and is predicted to be within the active site. This is the first demonstration that a class of cytochrome P450 enzymes covalently binds their prosthetic heme group.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ortiz@cgl.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMET Y, 1994, BIOCHEM BIOPH RES CO, V203, P1168, DOI 10.1006/bbrc.1994.2305; Barker PD, 1999, STRUCTURE, V7, pR281, DOI 10.1016/S0969-2126(00)88334-3; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; BASILE G, 1980, J BIOL CHEM, V255, P7181; BONFILS C, 1995, ANAL BIOCHEM, V226, P302, DOI 10.1006/abio.1995.1229; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; CASTLE PJ, 1995, DRUG METAB DISPOS, V23, P1037; Chang YT, 1999, PROTEINS, V34, P403, DOI 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Dierks EA, 1998, J BIOL CHEM, V273, P23055, DOI 10.1074/jbc.273.36.23055; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; DORWARD DW, 1993, ANAL BIOCHEM, V209, P219, DOI 10.1006/abio.1993.1110; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; Helvig C, 1998, BIOCHEMISTRY-US, V37, P12546, DOI 10.1021/bi981048g; Hoch U, 2000, ARCH BIOCHEM BIOPHYS, V373, P63, DOI 10.1006/abbi.1999.1504; Hoch U, 2000, J BIOL CHEM, V275, P26952; IMAOKA S, 1989, BIOCHEM INT, V18, P731; Koenigs LL, 1999, BIOCHEMISTRY-US, V38, P2312, DOI 10.1021/bi9823030; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P13184, DOI 10.1021/bi981198r; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OMURA T, 1964, J BIOL CHEM, V239, P2370; Orrenius S, 1972, Biochem Soc Symp, V34, P55; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Rae TD, 1996, J AM CHEM SOC, V118, P2103, DOI 10.1021/ja952650m; Rae TD, 1998, J BIOL CHEM, V273, P27968, DOI 10.1074/jbc.273.43.27968; Regal KA, 2000, CHEM RES TOXICOL, V13, P262, DOI 10.1021/tx990195s; TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083; THONYMEYER L, 1994, BBA-BIOENERGETICS, V1187, P260, DOI 10.1016/0005-2728(94)90123-6; VISCO C, 1985, J BIOL CHEM, V260, P6133; Vuletich JL, 1998, ANAL BIOCHEM, V265, P375, DOI 10.1006/abio.1998.2926; Xie ZY, 1996, J BIOL CHEM, V271, P4632; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	35	61	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11339	11346		10.1074/jbc.M009969200	http://dx.doi.org/10.1074/jbc.M009969200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139583	hybrid			2022-12-27	WOS:000167980900103
J	Hirase, T; Kawashima, S; Wong, EYM; Ueyama, T; Rikitake, Y; Tsukita, S; Yokoyama, M; Staddon, JM				Hirase, T; Kawashima, S; Wong, EYM; Ueyama, T; Rikitake, Y; Tsukita, S; Yokoyama, M; Staddon, JM			Regulation of tight junction permeability and occludin phosphorylation by RhoA-p160ROCK-dependent and -independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; RHO-ASSOCIATED KINASE; ENDOTHELIAL-CELLS; LYSOPHOSPHATIDIC ACID; ACTIN CYTOSKELETON; POSSIBLE INVOLVEMENT; EPITHELIAL-CELLS; BINDING PROTEIN; ZO-1; IDENTIFICATION	In epithelial and endothelial cells, tight junctions regulate the paracellular permeability of ions and proteins. Disruption of tight junctions by inflammation is often associated with tissue edema, but regulatory mechanisms are not fully understood. Using ECV304 cells as a model system, lysophosphatidic acid and histamine were found to increase the paracellular permeability of the tracer horseradish peroxidase. Cytoskeletal changes induced by these agents included stimulation of stress fiber formation and myosin light chain phosphorylation, Additionally, occludin, a tight junction protein, was a target for signaling events triggered by lysophosphatidic acid and histamine, events that resulted in its phosphorylation, A dominant-negative mutant of RhoA, RhoA T19N, or a specific inhibitor of Rho-activated kinases, Y-27632, prevented stress fiber formation, myosin light chain phosphorylation, occludin phosphorylation, and the increase in tracer flux in response to lysophosphatidic acid. In contrast, although RhoA T19N and Y-27632 blocked the cytoskeletal events induced by histamine, they had no effect on the stimulation of occludin phosphorylation or increased tracer flux, indicating that occludin phosphorylation may regulate tight junction permeability independently of cytoskeletal events. Thus, occludin is a target for receptor-initiated signaling events regulating its phosphorylation, and this phosphorylation may be a key regulator of tight junction permeability.	Kobe Univ, Sch Med, Dept Internal Med 1, Chuo Ku, Kobe, Hyogo 6500017, Japan; Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; UCL, Eisai London Res Labs Ltd, London WC1E 6BT, England	Kobe University; Kyoto University; Eisai Co Ltd; University of London; University College London	Hirase, T (corresponding author), Kobe Univ, Sch Med, Dept Internal Med 1, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hirase@med.kobe-u.ac.jp						ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Cordenonsi M, 1997, J CELL SCI, V110, P3131; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Essler M, 1998, J IMMUNOL, V161, P5640; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hirase T, 1997, J CELL SCI, V110, P1603; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kranenburg O, 1997, J CELL SCI, V110, P2417; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McDonald DM, 1999, MICROCIRCULATION, V6, P7; MEISENHELDER J, 1991, METHOD ENZYMOL, V197, P288; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Ratcliffe MJ, 1999, BIOCHEM J, V338, P471, DOI 10.1042/0264-6021:3380471; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Schulze C, 1997, J NEUROCHEM, V68, P991; SELDEN SC, 1981, J CELL PHYSIOL, V108, P195, DOI 10.1002/jcp.1041080210; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; STADDON JM, 1995, J CELL SCI, V108, P609; Staddon JM, 1996, CURR OPIN NEUROBIOL, V6, P622, DOI 10.1016/S0959-4388(96)80094-8; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; ZHONG Y, 1993, J CELL BIOL, V120, P477, DOI 10.1083/jcb.120.2.477	51	243	261	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10423	10431		10.1074/jbc.M007136200	http://dx.doi.org/10.1074/jbc.M007136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139571	hybrid			2022-12-27	WOS:000167996400109
J	Miyadera, H; Amino, H; Hiraishi, A; Taka, H; Murayama, K; Miyoshi, H; Sakamoto, K; Ishii, N; Hekimi, S; Kita, K				Miyadera, H; Amino, H; Hiraishi, A; Taka, H; Murayama, K; Miyoshi, H; Sakamoto, K; Ishii, N; Hekimi, S; Kita, K			Altered quinone biosynthesis in the long-lived clk-1 mutants of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIFE-SPAN; COQ7 GENE; MITOCHONDRIA; COMPLEX; NEMATODE; RESPIRATION; PROTEIN; MOUSE	Mutations in the clk-1 gene of Caenorhabditis elegans result in an extended life span and an average slowing down of developmental and behavioral rates. However, it has not been possible to identify biochemical changes that might underlie the extension of life span observed in clk-1 mutants, and therefore the function of CLK-1 in C. elegans remains unknown. In this report, we analyzed the effect of clk-1 mutation on ubiquinone (UQ(9)) biosynthesis and show that clk-1 mutants mitochondria do not contain detectable levels of UQ(9). Instead, the UQ(9) biosynthesis intermediate, demethoxyubiquinone (DMQ(9)), is present at high levels. This result demonstrates that CLK-1 is absolutely required for the biosynthesis of UQ(9) in C. elegans. Interestingly, the activity levels of NADH-cytochrome c reductase and succinate-cytochrome c reductase in mutant mitochondria are very similar to those in the wild-type, suggesting that DMQ(9) can function as an electron carrier in the respiratory chain. To test this possibility, the short side chain derivative DMQ(2) was chemically synthesized. We find that DMQ(2) can act as an electron acceptor for both complex I and complex II in clk-1 mutant mitochondria, while another ubiquinone biosynthesis precursor, 3-hydroxy-UQ(2), cannot. The accumulation of DMQ(9) and its use in mutant mitochondria indicate, for the first time in any organism, a link between the alteration in the quinone species used in respiration and life span.	Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; Toyohashi Univ Technol, Dept Ecol Engn, Toyohashi, Aichi 4418580, Japan; Juntendo Univ, Sch Med, Cent Lab Med Sci, Tokyo 1138421, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Tokyo; Toyohashi University of Technology; Juntendo University; Kyoto University; Tokai University; McGill University	Kita, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kitak@m.u-tokyo.ac.jp	Sakamoto, Kimitoshi/G-4539-2014	Hiraishi, Akira/0000-0001-5556-344X; Kita, Kiyoshi/0000-0002-0426-4308				Asaumi S, 1999, GENOMICS, V58, P293, DOI 10.1006/geno.1999.5838; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gems D, 1999, CURR BIOL, V9, pR614, DOI 10.1016/S0960-9822(99)80387-X; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; HEKIMI S, 2000, MOL GENETICS AGING, P81; HIRAISHI A, 1984, J GEN APPL MICROBIOL, V30, P435, DOI 10.2323/jgam.30.435; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Jonassen T, 1996, ARCH BIOCHEM BIOPHYS, V330, P285, DOI 10.1006/abbi.1996.0255; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; KITA K, 1989, J BIOL CHEM, V264, P2672; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LESTER RL, 1959, BIOCHIM BIOPHYS ACTA, V33, P169, DOI 10.1016/0006-3002(59)90511-6; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; MURFITT RR, 1976, COMP BIOCHEM PHYS B, V53, P423, DOI 10.1016/0305-0491(76)90191-7; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Ohshima M, 1998, BIOCHEMISTRY-US, V37, P6436, DOI 10.1021/bi9800202; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; SCHEFFLER IE, 1999, MITOCHONDRIA, P235; TAKAMIYA S, 1984, MOL BIOCHEM PARASIT, V13, P121, DOI 10.1016/0166-6851(84)90107-5; TRUMPOWER BL, 1974, CHEM PHYS LIPIDS, V13, P123, DOI 10.1016/0009-3084(74)90027-9; Vajo Z, 1999, MAMM GENOME, V10, P1000, DOI 10.1007/s003359901147; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; WONG A, 1995, GENETICS, V139, P1247	31	164	174	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7713	7716		10.1074/jbc.C000889200	http://dx.doi.org/10.1074/jbc.C000889200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244089	hybrid			2022-12-27	WOS:000167474900007
J	Hu, JX; Reyes-Cruz, G; Goldsmith, PK; Spiegel, AM				Hu, JX; Reyes-Cruz, G; Goldsmith, PK; Spiegel, AM			The venus's-flytrap and cysteine-rich domains of the human Ca2+ receptor are not linked by disulfide bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CALCIUM-SENSING RECEPTOR; CELL-SURFACE EXPRESSION; SIGNAL-TRANSDUCTION; EXTRACELLULAR DOMAIN; IDENTIFICATION; DIMERIZATION; CLONING	The extracellular N-terminal domain of the human Ca2+ receptor (hCaR) consists of a Venus's-flytrap (VFT) domain and a cysteine-rich (Cys-rich) domain. We have shown earlier that the Cys-rich domain is critical for signal transmission from the VFT domain to the seven-transmembrane domain. The VFT domain contains 10 cysteines: two of them (Cys(129) and Cys(131)) were identified as involved in intermolecular disulfide bonds necessary for homodimerization, and six others (Cys(60)- Cys(101), Cys(358)-Cys(395), and Cys(437)-Cys(449)) are predicted to form three intramolecular disulfide bonds. The Cys-rich domain contains nine cysteines, the involvement of which in disulfide bond formation has not been defined. In this work, we asked whether the remaining cysteines in the hCaR VFT, namely Cys(236) and Cys(482), form disulfide bond(s) with cysteines in the Cys-rich domain. We constructed mutant hCaRs with a unique tobacco etch virus (TEV) protease recognition site inserted between the VFT domain and the Cys-rich domain. These mutant hCaRs remain fully functional compared with the wild type hCaR. After TEV protease digestion of the mutant hCaR proteins, dimers of the VFT were identified on Western blot under nonreducing conditions. We concluded that there is no disulfide bond between the VFT and the Cys-rich domains in the hCaR.	NIDCD, Mol Pathophysiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hu, JX (corresponding author), NIDCD, Mol Pathophysiol Sect, NIH, Bldg 10,Rm 8C-101,9000 Rockville Pike, Bethesda, MD 20892 USA.		Centeno, Patricia Pacios/O-8368-2016		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000061] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brown EM, 1999, AM J MED, V106, P238, DOI 10.1016/S0002-9343(98)00418-5; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Hu JX, 2000, J BIOL CHEM, V275, P16382, DOI 10.1074/jbc.M000277200; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Tsuji Y, 2000, J BIOL CHEM, V275, P28144	19	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6901	6904		10.1074/jbc.C000865200	http://dx.doi.org/10.1074/jbc.C000865200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11238442	hybrid			2022-12-27	WOS:000167442900006
J	Kornberg, A				Kornberg, A			Remembering our teachers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item									Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Kornberg, A (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.								0	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	2001	276	1					3	11						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	390DP	11134064				2022-12-27	WOS:000166280700001
J	Hutchins, MU; Klionsky, DJ				Hutchins, MU; Klionsky, DJ			Vacuolar localization of oligomeric alpha-mannosidase requires the cytoplasm to vacuole targeting and autophagy pathway components in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CONJUGATION SYSTEM; PEROXISOME DEGRADATION; AMINOPEPTIDASE-I; YEAST VACUOLE; MARKER ENZYME; MEMBRANE; IMPORT; MACHINERY; TRANSPORT; MUTANTS	One challenge facing eukaryotic cells is the posttranslational import of proteins into organelles. This problem is exacerbated when the proteins assemble into large complexes. Aminopeptidase I (API) is a resident hydrolase of the vacuole/lysosome in the yeast Saccharomyces cerevisiae. The precursor form of API assembles into a dodecamer in the cytosol and maintains this oligomeric form during the import process. Vacuolar delivery of the precursor form of API requires a vesicular mechanism termed the cytoplasm to vacuole targeting (Cvt) pathway. Many components of the Cvt pathway are also used in the degradative autophagy pathway. alpha -Mannosidase (Ams1) is another resident hydrolase that enters the vacuole independent of the secretory pathway; however, its mechanism of vacuolar delivery has not been established. We show vacuolar localization of Ams1 is blocked in mutants that are defective in the Cvt and autophagy pathways. We have found that Ams1 forms an oligomer in the cytoplasm. The oligomeric form of Ams1 is also detected in subvacuolar vesicles in strains that are blocked in vesicle breakdown, indicating that it retains its oligomeric form during the import process. These results identify Ams1 as a second biosynthetic cargo protein of the Cvt and autophagy pathways.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Dept Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53396, R01 GM053396-12, R01 GM053396, R01 GM053396-11] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; Eades CJ, 1998, GLYCOBIOLOGY, V8, P17, DOI 10.1093/glycob/8.1.17; Gonzalez DS, 2000, MOL BIOL EVOL, V17, P292, DOI 10.1093/oxfordjournals.molbev.a026309; Grard T, 1996, BIOCHEM J, V316, P787, DOI 10.1042/bj3160787; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 1999, J CELL SCI, V112, P4079; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Keegstra K, 1999, CURR OPIN PLANT BIOL, V2, P471, DOI 10.1016/S1369-5266(99)00021-7; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KURANDA MJ, 1987, P NATL ACAD SCI USA, V84, P2585, DOI 10.1073/pnas.84.9.2585; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Rassow J, 2000, TRAFFIC, V1, P457, DOI 10.1034/j.1600-0854.2000.010603.x; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; SIKORSKI RS, 1989, GENETICS, V122, P19; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Teter SA, 1999, TRENDS CELL BIOL, V9, P428, DOI 10.1016/S0962-8924(99)01652-9; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; VANDERWILDEN W, 1973, Z NATURFORSCH C, VC 28, P416; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; YOSHIHISA T, 1988, J BIOL CHEM, V263, P5158	48	133	139	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20491	20498		10.1074/jbc.M101150200	http://dx.doi.org/10.1074/jbc.M101150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264288	hybrid, Green Accepted			2022-12-27	WOS:000169135100110
J	Maklashina, E; Rothery, RA; Weiner, JH; Cecchini, G				Maklashina, E; Rothery, RA; Weiner, JH; Cecchini, G			Retention of heme in axial ligand mutants of succinate-ubiquinone oxidoreductase (complex II) from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS SUCCINATE; MEMBRANE-INTEGRAL DOMAIN; FUMARATE REDUCTASE; MENAQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASES; HYDROPHOBIC SUBUNITS; CATALYTIC ACTIVITY; ELECTRON-TRANSFER; BINDING-SITE; DEHYDROGENASE	Succinate-ubiquinone oxidoreductase (SdhCDAB, complex II) from Escherichia coli is a four-subunit membrane-bound respiratory complex that catalyzes ubiquinone reduction by succinate, In the E. coli enzyme, heme b(556) is ligated between SdhC His(84) and SdhD His(71). Contrary to a previous report (Vibat, C. R. T., Cecchini, G., Nakamura, K., Kita, K,, and Gennis, R, B, (1998) Biochemistry 37, 4148-4159), we demonstrate the presence of heme in both SdhC H84L and SdhD H71Q mutants of SdhCDAB. EPR spectroscopy reveals the presence of low spin heme in the SdhC H84L, (g(Z) = 2.92) mutant and high spin heme in the SdhD H71Q mutant (g = 6.0), The presence of low spin heme in the SdhC H84L mutant suggests that the heme b(556) is able to pick up another ligand from the protein. CO binds to the reduced form of the mutants, indicating that it is able to displace one of the ligands to the low spin heme of the SdhC H84L, mutant. The g = 2.92 signal of the SdhC H84L mutant titrates with a redox potential at pH 7.0 (E-m,E-7) of approximately +15 mV, whereas the g 6.0 signal of the SdhD H71Q mutant titrates with an E-m,E-7 of approximately -100 mV, The quinone site inhibitor pentachlorophenol perturbs the heme optical spectrum of the wild-type and SdhD H71Q mutant enzymes but not the SdhC H84L mutant. This finding suggests that the latter residue also plays an important role in defining the quinone binding site of the enzyme. The SdhC H84L mutation also results in a significant increase in the K, and a decrease in the k(cat) for ubiquinone-1, whereas the SdhD H71Q mutant has little effect on these parameters. Overall, these data indicate that SdhC His(84) has an important role in defining the interaction of SdhCDAB with both quinones and heme b(556).	Vet Affairs Med Ctr, Mol Biol Div 151S, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Alberta, Dept Biochem, CIHR, Grp Mol Biol Membrane Prot, Edmonton, AB T6G 2H7, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Alberta	Cecchini, G (corresponding author), Vet Affairs Med Ctr, Mol Biol Div 151S, 4150 Clement St, San Francisco, CA 94121 USA.	ceccini@itsa.ucsf.edu		Rothery, Richard/0000-0003-3265-1783	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016251] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-16251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKRELL BAC, 1980, J BIOL CHEM, V255, P2761; ACKRELL BAC, 1992, CHEM BIOCH FLAVOENZY, V3, P220; BABCOCK GT, 1985, BIOCHEMISTRY-US, V24, P3638, DOI 10.1021/bi00335a036; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; COLE ST, 1980, MOL GEN GENET, V178, P409, DOI 10.1007/BF00270492; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; CROUSE BR, 1995, FEBS LETT, V367, P1, DOI 10.1016/0014-5793(95)00522-B; DARLISON MG, 1984, BIOCHEM J, V223, P507, DOI 10.1042/bj2230507; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; FRIDEN H, 1990, BIOCHIM BIOPHYS ACTA, V1041, P207, DOI 10.1016/0167-4838(90)90067-P; GRIVENNIKOVA VG, 1993, BIOCHIM BIOPHYS ACTA, V1140, P282, DOI 10.1016/0005-2728(93)90067-P; HAGERHALL C, 1992, BIOCHEMISTRY-US, V31, P7411, DOI 10.1021/bi00147a028; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1996, FEBS LETT, V389, P25, DOI 10.1016/0014-5793(96)00529-7; Hederstedt L, 1998, BIOCHEM SOC T, V26, P408, DOI 10.1042/bst0260408; HEDERSTEDT L, 1980, J BACTERIOL, V144, P941, DOI 10.1128/JB.144.3.941-951.1980; HEDERSTEDT L, 1992, MOL MECHANISMS BIOEN, V23, P163; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; KAMENSKY Y, 1985, FEBS LETT, V181, P95, DOI 10.1016/0014-5793(85)81120-0; KITA K, 1989, J BIOL CHEM, V264, P2672; KROGER A, 1978, BIOCHIM BIOPHYS ACTA, V505, P129, DOI 10.1016/0304-4173(78)90010-1; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LEMIRE BD, 1982, J BACTERIOL, V152, P1126; LOHMEIER E, 1981, CAN J BIOCHEM CELL B, V59, P158, DOI 10.1139/o81-023; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; MCINTIRE W, 1981, BIOCHEMISTRY-US, V20, P3068, DOI 10.1021/bi00514a013; MEINHARDT SW, 1989, BIOCHIM BIOPHYS ACTA, V975, P175, DOI 10.1016/S0005-2728(89)80216-6; Nakamura K, 1996, J BIOL CHEM, V271, P521, DOI 10.1074/jbc.271.1.521; PARK SJ, 1995, MOL MICROBIOL, V15, P473, DOI 10.1111/j.1365-2958.1995.tb02261.x; PETERSON J, 1994, FEBS LETT, V355, P155, DOI 10.1016/0014-5793(94)01189-3; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; ROTHERY RA, 1989, BIOCHEM J, V261, P437, DOI 10.1042/bj2610437; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; SALERNO JC, 1990, J BIOL CHEM, V265, P4364; SALERNO JC, 1991, BIOCHEM SOC T, V19, P599, DOI 10.1042/bst0190599; SASARMAN S, 1968, J BACTERIOL, V96, P570; Shenoy SK, 1999, J BIOL CHEM, V274, P8717, DOI 10.1074/jbc.274.13.8717; SMIRNOVA IA, 1995, FEBS LETT, V359, P23, DOI 10.1016/0014-5793(94)01442-4; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; WOOD D, 1984, BIOCHEM J, V222, P519, DOI 10.1042/bj2220519; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yang XD, 1997, J BIOL CHEM, V272, P9683; YU L, 1987, J BIOL CHEM, V262, P1137	48	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18968	18976		10.1074/jbc.M011270200	http://dx.doi.org/10.1074/jbc.M011270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259408	hybrid			2022-12-27	WOS:000169091000044
J	Pitkanen, J; Vahamurto, P; Krohn, K; Peterson, P				Pitkanen, J; Vahamurto, P; Krohn, K; Peterson, P			Subcellular localization of the autoimmune regulator protein - Characterization of nuclear targeting and transcriptional activation domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRE GENE; TRANSPORT; CRM1; EXPRESSION; INTERACTS; TOLERANCE; SIGNAL; EXPORT; MOUSE; CELLS	The autoimmune regulator (AIRE) gene, defective in the hereditary autoimmune disease APECED, encodes a transcriptional regulator protein. AIRE is expressed in the medullary epithelial cells and monocyte-dendritic cells of the thymus with lower expression in the spleen, fetal liver, and lymph nodes. At the cellular level, AIRE is located in microtubular structures of the cytoskeleton and in discrete nuclear dots resembling ND10 nuclear bodies. We studied the determinants of the targeting of AIRE into these structures. We report here that the N-terminal HSR domain confers localization to the microtubular network whereas the C-terminal region contains a second nuclear localization signal. We also demonstrate that the consensus nuclear localization signal of AIRE is functional and that the HSR domain harbors a nuclear export signal. Accordingly, the nuclear export inhibitor leptomycin B partially inhibits the nuclear export of AIRE, From a functional standpoint, we show that AIRE can activate the interferon P minimal promoter in a transfection assay and demonstrate that the transcriptional activating function of AIRE is mediated by its two plant homeodomain (PHD) zinc fingers.	Tampere Univ, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Pathol, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Pitkanen, J (corresponding author), Tampere Univ, Inst Med Technol, Lenkkeilijankatu 6, FIN-33101 Tampere, Finland.		Peterson, Pärt/A-5788-2009	Peterson, Pärt/0000-0001-6755-791X				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Adam SA, 1999, CURR OPIN CELL BIOL, V11, P402, DOI 10.1016/S0955-0674(99)80056-8; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; DOUCAS V, 1996, BIOCHIM BIOPHYS ACTA, V1288, P25; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; NISHI K, 1994, J BIOL CHEM, V269, P6320; Peterson P, 1998, IMMUNOL TODAY, V19, P384, DOI 10.1016/S0167-5699(98)01293-6; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Rinderle C, 1999, HUM MOL GENET, V8, P277, DOI 10.1093/hmg/8.2.277; Shi JD, 1999, AUTOIMMUNITY, V31, P47, DOI 10.3109/08916939908993859; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4	23	106	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19597	19602		10.1074/jbc.M008322200	http://dx.doi.org/10.1074/jbc.M008322200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11274163	hybrid			2022-12-27	WOS:000169091000124
J	Dalgleish, G; Veyrune, JL; Blanchard, JM; Hesketh, J				Dalgleish, G; Veyrune, JL; Blanchard, JM; Hesketh, J			mRNA localization by a 145-nucleotide region of the c-fos 3 '-untranslated region - Links to translation but not stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL-BOUND POLYSOMES; MESSENGER-RNA DEGRADATION; 3' UNTRANSLATED REGION; INTRACELLULAR-LOCALIZATION; SEQUENCES; GENE; MYC; EXPRESSION; PROTEIN; CELLS	The presence of a localization signal in the 3'-untranslated region of c-fos mRNA was investigated by in situ hybridization and cell fractionation techniques. Cells were transfected with chimeric gene constructs in which the beta -globin coding region was used as a reporter and linked to either its own 3'-untranslated region, the c-fos 3'-untranslated region, or the c-fos 3'-untranslated region containing different deletions. Replacement of the endogenous beta -globin 3'-untranslated region by that from c-fos caused a redistribution of the transcripts so that they were recovered in cytoskeletal-bound polysomes and seen localized in the perinuclear cytoplasm, Deletion of the AU-rich instability region did not affect transcript localization, but removal of a distinct 145-nucleotide region of the 3'-untranslated region abolished it. The prevention of transcript translation by desferrioxamine led to a marked loss of transcript localization, independent of mRNA instability. The data show that the 3'-untranslated region of c-fos mRNA, as c-myc, contains a localization signal, which targets the mRNA to the perinuclear cytoskeleton. We propose that this is important to ensure efficient nuclear import of these key regulatory proteins. mRNA localization by the fos 3'-untranslated region is independent of mRNA instability, and the two are determined by different regulatory elements.	Rowett Res Inst, Aberdeen AB21 9SB, Scotland; Inst Genet Mol, CNRS, UMR 5535, F-34293 Montpellier 5, France; Univ Newcastle Upon Tyne, Dept Biol & Nutr Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Newcastle University - UK	Hesketh, J (corresponding author), Rowett Res Inst, Aberdeen AB21 9SB, Scotland.							Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; BIRD RC, 1986, BIOCHIM BIOPHYS ACTA, V868, P215, DOI 10.1016/0167-4781(86)90057-6; BONNIEU A, 1989, ONCOGENE, V4, P881; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARILLO S, 1994, ONCOGENE, V9, P1679; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; Gavis ER, 1997, TRENDS CELL BIOL, V7, P485, DOI 10.1016/S0962-8924(97)01162-8; HESKETH J, 1994, BIOCHEM J, V298, P143, DOI 10.1042/bj2980143; Hesketh JE, 1996, EXP CELL RES, V225, P219, DOI 10.1006/excr.1996.0172; HESKETH JE, 1991, BIOCHEM J, V274, P607, DOI 10.1042/bj2740607; HOVLAND R, 1995, BIOCHEM J, V310, P193, DOI 10.1042/bj3100193; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; Levadoux M, 1999, J BIOL CHEM, V274, P34961, DOI 10.1074/jbc.274.49.34961; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Sambrook J., 2002, MOL CLONING LAB MANU; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; Veyrune JL, 1996, J CELL SCI, V109, P1185; VEYRUNE JL, 1995, ONCOGENE, V11, P2127; WILSON IA, 1995, BIOCHEM J, V308, P599, DOI 10.1042/bj3080599; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; WINSTALL E, 1995, MOL CELL BIOL, V15, P3796; ZAMBETTI G, 1990, EXP CELL RES, V191, P246, DOI 10.1016/0014-4827(90)90011-X	34	28	28	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					13593	13599		10.1074/jbc.M001141200	http://dx.doi.org/10.1074/jbc.M001141200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11139568	hybrid, Green Published			2022-12-27	WOS:000168356600014
J	Becamel, C; Figge, A; Poliak, S; Dumuis, A; Peles, E; Bockaert, J; Lubbert, H; Ullmer, C				Becamel, C; Figge, A; Poliak, S; Dumuis, A; Peles, E; Bockaert, J; Lubbert, H; Ullmer, C			Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; CHOROID-PLEXUS; BETA(2)-ADRENERGIC RECEPTOR; 5-HT2C RECEPTORS; IMMUNOHISTOCHEMICAL LOCALIZATION; MOLECULAR CHARACTERIZATION; SYNAPTIC PROTEINS; MESSENGER-RNAS; FAMILY; RAT	By using the yeast two-hybrid system, we previously isolated a cDNA clone encoding a novel member of the multivalent PDZ protein family called MUPP1 containing 13 PDZ domains. Here we report that the C terminus of the Fi-hydroxytryptamine type 2C (5-HT2C) receptor selectively interacts with the 10th PDZ domain of MUPP1. Mutations in the extreme C terminal SSV sequence of the 5-HT2C receptor confirmed that the SXV motif is critical for the interaction, Co-immunoprecipitations of MUPP1 and 5-HT2C receptors from transfected COS-7 cells and from rat choroid plexus verified this interaction in vivo. Immunocytochemistry revealed an SXV motif-dependent co-clustering of both proteins in transfected COS-7 cells as well as a colocalization in rat choroid plexus. A 5-HT2C receptor-dependent unmasking of a C-terminal vesicular stomatitis virus epitope of MUPP1 suggests that the interaction triggers a conformational change within the MUPP1 protein. Moreover, 5-HT2A and 5-HT2B, sharing the C-terminal EX(V/I)SXV sequence with 5-HT2C receptors, also bind MUPP1 PDZ domains in vitro. The highest MUPP1 mRNA levels were found in all cerebral cortical layers, the hippocampus, the granular layer of the dentate gyrus, as well as the choroid plexus, where 5-HT2C receptors are highly enriched. We propose that MUPP1 may serve as a multivalent scaffold protein that selectively assembles and targets signaling complexes.	Biofrontera Pharmaceut AG, D-51377 Leverkusen, Germany; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; CNRS UPR 9023, INSERM, F-34094 Montpellier 05, France; Ruhr Univ Bochum, Dept Anim Physiol, D-44780 Bochum, Germany	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ruhr University Bochum	Ullmer, C (corresponding author), Biofrontera Pharmaceut AG, Hemmelratherweg 201, D-51377 Leverkusen, Germany.	ullmer@biofrontera.de		Peles, Elior/0000-0002-3325-0597; Luebbert, Herrmann/0000-0003-3429-5233				Abramowski D, 1995, NEUROPHARMACOLOGY, V34, P1635, DOI 10.1016/0028-3908(95)00138-7; ABRAMOWSKI D, 1995, J NEUROCHEM, V65, P782; ANNWEILER A, 1991, NUCLEIC ACIDS RES, V19, P3750, DOI 10.1093/nar/19.13.3750; Backstrom JR, 2000, J BIOL CHEM, V275, P23620, DOI 10.1074/jbc.M000922200; BARTSCH S, 1992, J NEUROSCI, V12, P736; Berg KA, 1996, MOL PHARMACOL, V50, P1017; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Choi DS, 1996, FEBS LETT, V391, P45, DOI 10.1016/0014-5793(96)00695-3; Claeysen S, 1996, FEBS LETT, V398, P19, DOI 10.1016/S0014-5793(96)01132-5; Clemett DA, 2000, NEUROPHARMACOLOGY, V39, P123, DOI 10.1016/S0028-3908(99)00086-6; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; Fone KCF, 1998, BRIT J PHARMACOL, V123, P1707, DOI 10.1038/sj.bjp.0701798; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; HARTIG PR, 1989, SEROTONIN ACTIONS RE, P180; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kaufman MJ, 1996, NEUROSCI LETT, V206, P153, DOI 10.1016/S0304-3940(96)12461-7; KAUFMAN MJ, 1995, J NEUROCHEM, V64, P199; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KLUXEN FW, 1992, P NATL ACAD SCI USA, V89, P4618, DOI 10.1073/pnas.89.10.4618; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurschner C, 1998, MOL CELL NEUROSCI, V11, P161, DOI 10.1006/mcne.1998.0679; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; LUCKI I, 1989, J PHARMACOL EXP THER, V249, P155; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Marcoli M, 1998, J PHARMACOL EXP THER, V285, P983; Millan MJ, 1997, NEUROPHARMACOLOGY, V36, P743, DOI 10.1016/S0028-3908(97)00071-3; MURPHY DL, 1991, PHARMACOL REV, V43, P527; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; PAZOS A, 1984, EUR J PHARMACOL, V106, P539, DOI 10.1016/0014-2999(84)90057-8; Philipp S, 1997, FEBS LETT, V413, P243, DOI 10.1016/S0014-5793(97)00877-6; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; SCHMUCK K, 1994, FEBS LETT, V342, P85, DOI 10.1016/0014-5793(94)80590-3; Schmuck K, 1996, EUR J NEUROSCI, V8, P959, DOI 10.1111/j.1460-9568.1996.tb01583.x; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Simpson EH, 1999, GENOMICS, V59, P102, DOI 10.1006/geno.1999.5853; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; ULLMER C, 1995, FEBS LETT, V370, P215, DOI 10.1016/0014-5793(95)00828-W; YAGALOFF KA, 1985, J NEUROSCI, V5, P3178; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	54	121	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12974	12982		10.1074/jbc.M008089200	http://dx.doi.org/10.1074/jbc.M008089200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11150294	hybrid			2022-12-27	WOS:000168198600074
J	Ciesielski-Treska, J; Ulrich, G; Chasserot-Golaz, S; Zwiller, J; Revel, MO; Aunis, D; Bader, MF				Ciesielski-Treska, J; Ulrich, G; Chasserot-Golaz, S; Zwiller, J; Revel, MO; Aunis, D; Bader, MF			Mechanisms underlying neuronal death induced by chromogranin A-activated microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALZHEIMERS-DISEASE; CYTOCHROME-C; FAS LIGAND; CELL-DEATH; NEUROLOGICAL DISEASES; CEREBROSPINAL-FLUID; DYSTROPHIC NEURITES; INDUCED APOPTOSIS; SECRETOGRANIN-II	The neurotoxic effects of activated microglia in neurodegenerative diseases are well established. We recently provided evidence that chromogranin A (CGA), a multifunctional protein localized in dystrophic neurites and in senile plaques, induces an activated phenotype and secretion of neurotoxins by rat microglia in culture. In the present study, we focused on the mechanisms underlying neuronal degeneration triggered by CGA-activated microglia, We found that neuronal death exhibits apoptotic features, characterized by the externalization of phosphatidylserine and the fragmentation of DNA. Microglial neurotoxins markedly stimulate the phosphorylation and activity of neuronal p38 mitogen-activated protein kinase and provoke the release of mitochondrial cytochrome c, which precedes apoptosis. Inhibition of p38 kinase with SE 203580 partially protects neurons from death induced by CGA-activated microglia. Furthermore, neurons are also protected by Fas-Fc, which antagonizes the interactions between the death receptor Fas and its ligand Fast and by cell-permeable peptides that inhibit caspases 8 and 3. Thus, CGA triggers the release of microglial neurotoxins that mobilize several death-signaling pathways in neurons. Our results further support the idea that CGA, which is upregulated in many neuropathologies, represents a potent endogeneous inflammatory factor possibly responsible for neuronal degeneration.	Unite INSERM U338 Biol Commun Cellulaire, Ctr Neurochim, F-67084 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Ciesielski-Treska, J (corresponding author), CNRS UPR 2356, 5 Rue Blaise Pascal, F-67084 Strasbourg, France.		Dominique, Aunis/W-1419-2019; Bader, Marie-France/O-2098-2016; Chasserot-Golaz, Sylvette/K-7625-2017	Chasserot-Golaz, Sylvette/0000-0002-7437-2558				BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406; BANATI RB, 1994, DEV NEUROSCI-BASEL, V16, P114, DOI 10.1159/000112098; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; CETIN Y, 1993, P NATL ACAD SCI USA, V90, P2360, DOI 10.1073/pnas.90.6.2360; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Ciesielski-Treska J, 1998, J BIOL CHEM, V273, P14339, DOI 10.1074/jbc.273.23.14339; CIESIELSKITRESKA J, 1991, J NEUROSCI RES, V29, P362, DOI 10.1002/jnr.490290312; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Crain BJ, 1996, AM J PATHOL, V149, P1087; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; DICKSON DW, 1997, J NEUROPATHOL EXP NE, V56, P521; Du YS, 1997, J NEUROCHEM, V69, P1382; Eder U, 1998, J NEURAL TRANSM, V105, P39, DOI 10.1007/s007020050036; FASCIOTTO BH, 1993, ENDOCRINOLOGY, V133, P461, DOI 10.1210/en.133.2.461; Ferrer I, 1998, J NEUROPATH EXP NEUR, V57, P218, DOI 10.1097/00005072-199803000-00002; Gasparri A, 1997, J BIOL CHEM, V272, P20835, DOI 10.1074/jbc.272.33.20835; Giulian D, 1996, J NEUROSCI, V16, P6021; GIULIAN D, 1993, P NATL ACAD SCI USA, V90, P2769, DOI 10.1073/pnas.90.7.2769; Gottfries CG, 1998, J NEURAL TRANSM, V105, P773, DOI 10.1007/s007020050094; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Joashi UC, 1999, EUR J NEUROSCI, V11, P91, DOI 10.1046/j.1460-9568.1999.00409.x; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; Kingham PJ, 2000, J NEUROCHEM, V74, P1452, DOI 10.1046/j.1471-4159.2000.0741452.x; KIRCHMAIR R, 1994, NEUROSCIENCE, V63, P1179, DOI 10.1016/0306-4522(94)90582-7; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lannuzel A, 1997, ANN NEUROL, V42, P847, DOI 10.1002/ana.410420605; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; MUNOZ DG, 1991, LAB INVEST, V64, P826; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; RAUL C, 1999, J CELL BIOL K, V29, P1049; SIMON JP, 1988, P NATL ACAD SCI USA, V85, P1712, DOI 10.1073/pnas.85.5.1712; SIMON JP, 1989, BIOCHEM J, V262, P1; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 1996, NEUROSCIENCE, V72, P377, DOI 10.1016/0306-4522(96)83172-1; Thal DR, 1998, J BRAIN RES, V39, P175; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Virdee K, 1997, J NEUROCHEM, V69, P550; Walton M, 1999, BRAIN RES REV, V29, P137, DOI 10.1016/S0165-0173(98)00053-8; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YASUHARA O, 1994, NEUROSCI LETT, V170, P13, DOI 10.1016/0304-3940(94)90227-5	56	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13113	13120		10.1074/jbc.M009711200	http://dx.doi.org/10.1074/jbc.M009711200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11124958	hybrid			2022-12-27	WOS:000168198600091
J	Daoud, R; Julien, M; Gros, P; Georges, E				Daoud, R; Julien, M; Gros, P; Georges, E			Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; CONJUGATE EXPORT PUMP; QUINOLINE-BASED DRUG; LEUKOTRIENE C-4; VINCRISTINE TRANSPORT; INCREASED SENSITIVITY; DEPENDENT TRANSPORT; EPITOPE INSERTION; TUMOR-CELLS; GLUTATHIONE	MRP1 is an ABC (or ATP binding cassette) membrane transport protein shown to confer resistance to structurally dissimilar drugs, Studies of MRP1 topology suggested the presence of a hydrophobic N-domain with five potential membrane-spanning domains linked to an MDR1-like core (MSD1-NBD1-L1-MSD2-NBD2) by an intracellular linker domain (LO). MRP1-mediated multidrug resistance is thought to be due to enhanced drug efflux. However, little is known about MRP1-drug interaction and its drug binding site(s). We previously developed several photoreactive probes to study MRP1-drug interactions. In this report, we have used eight MRP1-HA variants that were modified to have hemagglutinin A (HA) epitopes inserted at different sites in MRP1 sequence. Exhaustive in-gel digestion of all IAARh123 photoaffinity-labeled MRP1-HA variants revealed the same profile of photolabeled peptides as seen for wild type MRP1. Photolabeling of the different MRP1-HA variants followed by digestion with increasing concentrations of trypsin or Staphylococcus aureus V8 protease (1:800 to 1:5 w/w) and immunoprecipitation with anti-HA mAb identified two small photolabeled peptides (similar to6-7 kDa) from MRP1-HA(574) and MRP1-HA(1222). Based on the location of the HA epitopes in the latter variants together with molecular masses of the two peptides, the photolabeled amino acid residues were localized to MRP1 sequences encoding transmembranes 10 and 11 of MSD1 (Ser(542)-Arg(593)) and transmembranes 16 and 17 of MSD2 (Cys(1205)-Glu(1253)). Interestingly, the same sequences in MRP1 were also photolabeled with a structurally different photoreactive drug, IACI, confirming the significance of transmembranes 10, 11, 16 and 17 in MRP1 drug binding. Taken together, the results in this study provide the first delineation of the drug binding site(s) of MRP1. Furthermore, our findings suggest the presence of common drug binding site(s) for structurally dissimilar drugs.	McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; McGill Univ, Dept Biochem, Ste Anne De Bellevue, PQ H9X 3V9, Canada	McGill University; McGill University	Georges, E (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	Elias.Georges@McGill.CA						Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; BRADLEY G, 1994, CANCER METAST REV, V13, P223, DOI 10.1007/BF00689638; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; Daoud R, 2000, BIOCHEMISTRY-US, V39, P6094, DOI 10.1021/bi9922188; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Draper MP, 1997, EUR J BIOCHEM, V243, P219, DOI 10.1111/j.1432-1033.1997.0219a.x; Evers R, 1997, FEBS LETT, V419, P112, DOI 10.1016/S0014-5793(97)01442-7; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FELLER N, 1995, BRIT J CANCER, V72, P543, DOI 10.1038/bjc.1995.371; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; GEORGES E, 1991, J CELL PHYSIOL, V148, P479, DOI 10.1002/jcp.1041480321; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1996, CANCER RES, V56, P3307; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Jedlitschky G, 1996, CANCER RES, V56, P988; KAJIJI S, 1993, BIOCHEMISTRY-US, V32, P4185, DOI 10.1021/bi00067a005; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1997, MOL PHARMACOL, V51, P1034, DOI 10.1124/mol.51.6.1034; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 1999, BIOCHEMISTRY-US, V38, P5124, DOI 10.1021/bi982525y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; RAO US, 1994, MOL PHARMACOL, V45, P773; Rappa G, 1997, CANCER RES, V57, P5232; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Shen HX, 1996, BIOCHEMISTRY-US, V35, P5719, DOI 10.1021/bi960098n; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERSANTVOORT CHM, 1995, BRIT J CANCER, V72, P82, DOI 10.1038/bjc.1995.281; Vezmar M, 1998, BIOCHEM PHARMACOL, V56, P733, DOI 10.1016/S0006-2952(98)00217-2; Vezmar M, 2000, BIOCHEM PHARMACOL, V59, P1245, DOI 10.1016/S0006-2952(00)00270-7; Vezmar M, 1997, BIOCHEM BIOPH RES CO, V241, P104, DOI 10.1006/bbrc.1997.7634; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; ZAMAN GJR, 1996, MULTIDRUG RESISTANCE, P95	48	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12324	12330		10.1074/jbc.M009782200	http://dx.doi.org/10.1074/jbc.M009782200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152467	hybrid			2022-12-27	WOS:000168081800118
J	An, J; Li, YZ; van de Werve, G; Newgard, CB				An, J; Li, YZ; van de Werve, G; Newgard, CB			Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS-MEDIATED TRANSFER; STORAGE-DISEASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; MICROSOMAL GLUCOSE-6-PHOSPHATASE; LIVER GLUCOSE-6-PHOSPHATASE; INSULIN; GLUCOKINASE; TRANSPORT; PROTEIN	The final step of gluconeogenesis and glycogenolysis is catalyzed by the glucose-6-phosphatase (Glc-6-Pase) enzyme complex, located in the endoplasmic reticulum, The complex consists of a 36-kDa catalytic subunit (P36), a 46-kDa glucose 6-phosphate translocase (P46), and putative glucose and inorganic phosphate transporters. Mutations in the genes encoding P36 or P46 have been linked:to glycogen storage diseases type Ia and type Tb, respectively. However, the relative roles of these two proteins in control of the rate of glucose 6-phosphate hydrolysis have not been defined. To gain insight into this area, we have constructed a recombinant adenovirus containing the cDNA encoding human P46 (AdCMV-P46) and treated rat hepatocytes with this virus, or a virus encoding P36 (AdCMV-P36), or the combination of both viruses, resulting in large and equivalent increases in expression of the transgenes within 8-24 h of viral treatment. The overexpressed P46 protein was appropriately targeted to hepatocyte microsomes and caused a 58% increase in glucose 6-phosphate hydrolysis in nondetergent-treated (intact) microsomal preparations relative to controls, whereas overexpression of P36 caused a 3.6-fold increase. Overexpression of P46 caused a 50% inhibition of glycogen accumulation in hepatocytes from fasted rats incubated at 25 mM glucose relative to cells treated with a control virus (AdCMV-beta GAL), Furthermore, in hepatocytes from fed rats cultured at 25 mM glucose and then exposed to 15 nM glucose, AdCMV-P46 treatment activated glycogenolysis, as indicated by a 50% reduction in glycogen content relative to AdCMV-beta GAL-treated controls. In contrast, overexpression of P46 had only small effects on glycolysis, whereas overexpression of P36 had large effects on both glycogen metabolism and glycolysis, even in the presence of co-overexpressed glucokinase, Finally, P46 overexpression enhanced glucose 1-phosphate but not fructose 6-phosphhate hydrolysis in intact microsomes, providing a mechanism by which P46 overexpression may exert its preferential effects on glycogen metabolism.	Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Montreal, Dept Nutr, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H2L 4M1, Canada; CHUM, Ctr Rech, Lab Endocrinol Metab, Montreal, PQ H2L 4M1, Canada	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Universite de Montreal; Universite de Montreal; Universite de Montreal	Newgard, CB (corresponding author), Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	newgard@utsw.swmed.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 58398] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; ARION WJ, 1980, J BIOL CHEM, V255, P396; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Becker TC, 1996, J BIOL CHEM, V271, P390, DOI 10.1074/jbc.271.1.390; BERTELOOT A, 1991, J BIOL CHEM, V266, P5497; Brown KS, 1997, DIABETES, V46, P179, DOI 10.2337/diabetes.46.2.179; Burchell A, 1998, BIOCHEM J, V331, P973, DOI 10.1042/bj3310973; CLINE GW, 1994, J CLIN INVEST, V94, P2369, DOI 10.1172/JCI117602; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; FernandezNovell JM, 1996, EUR J BIOCHEM, V238, P570, DOI 10.1111/j.1432-1033.1996.0570z.x; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; GOMEZFOIX AM, 1992, J BIOL CHEM, V267, P25129; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Li YZ, 1999, J BIOL CHEM, V274, P33866, DOI 10.1074/jbc.274.48.33866; Li YZ, 2000, BIOCHEM BIOPH RES CO, V272, P41, DOI 10.1006/bbrc.2000.2734; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MASSAGUE J, 1978, BIOCHIM BIOPHYS ACTA, V543, P269, DOI 10.1016/0304-4165(78)90073-9; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Massillon D, 1996, J BIOL CHEM, V271, P9871, DOI 10.1074/jbc.271.17.9871; Mechin MC, 2000, METABOLISM, V49, P1200, DOI 10.1053/meta.2000.7714; Mevorach M, 1998, J CLIN INVEST, V102, P744, DOI 10.1172/JCI2720; NARISAWA K, 1987, ENZYME, V38, P177, DOI 10.1159/000469203; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Nordlie R C, 1974, Curr Top Cell Regul, V8, P33; Scott DK, 1998, J BIOL CHEM, V273, P24145, DOI 10.1074/jbc.273.37.24145; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Trinh K, 1997, J BIOL CHEM, V272, P24837, DOI 10.1074/jbc.272.40.24837; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; van de Werve G, 2000, EUR J BIOCHEM, V267, P1533, DOI 10.1046/j.1432-1327.2000.01160.x; Van Schaftingen E, 2000, FRONT DIABETES, V15, P136; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Veiga-da-Cunha M, 1998, AM J HUM GENET, V63, P976, DOI 10.1086/302068; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; WADDELL ID, 1992, BIOCHEM J, V286, P173, DOI 10.1042/bj2860173; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1	46	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10722	10729		10.1074/jbc.M009525200	http://dx.doi.org/10.1074/jbc.M009525200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148207	hybrid			2022-12-27	WOS:000167980900023
J	Kwon, YG; Min, JK; Kim, KM; Lee, DJ; Billiar, TR; Kim, YM				Kwon, YG; Min, JK; Kim, KM; Lee, DJ; Billiar, TR; Kim, YM			Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INHIBITS APOPTOSIS; CYTOCHROME-C; TYROSINE PHOSPHORYLATION; SUPPRESSES APOPTOSIS; MEDIATED APOPTOSIS; CASPASE ACTIVATION; RAT HEPATOCYTES; SYNTHASE GENE; SHEAR-STRESS	Sphingosine 1-phosphate (S1P) can prevent endothelial cell apoptosis. We investigated the molecular mechanisms and signaling pathways by which S1P protects endothelial cells from serum deprivation-induced apoptosis. We show here that human umbilical vein endothelial cells (HUVECs) undergo apoptosis associated with increased DEVDase activity, caspase-3 activation, cytochrome c release, and DNA fragmentation after 24 h of serum deprivation. These apoptotic markers were suppressed by the addition of S1P, the NO donor S-nitroso-N-acetylpenicillamine (100 muM), or caspase-3 inhibitor z-VAD-fmk. The protective effects of S1P were reversed by the nitric-oxide synthase (NOS) inhibitor N-monomethyl-L-arginine, but not by the soluble guanylyl cyclase inhibitor 1H-(1,2,4)oxadiazolo[4,3-a]-quanoxaline-1-one, suggesting that NO, but not cGMP, is responsible for S1P protection from apoptosis. Furthermore, S1P increased NO production by enhancing Ca2+ sensitive NOS activity without changes in the eNOS protein level. S1P-mediated cell survival and NO production were suppressed significantly by pretreatment with antisense oligonucleotide of EDG-1 and partially by EDG-3 antisense. S1P-mediated NO production was suppressed by the addition of pertussis toxin, an inhibitor of G(i) proteins, the specific inhibitor of phospholipase C (PLC), U73122, and the Ca2+ chelator BAPTA-AM. These findings indicate that S1P protects HUVECs from apoptosis through the activation of eNOS activity mainly through an EDG-1 and -3/G(i)/PLC/Ca2+ signaling pathway.	Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Kangwon Do 200701, South Korea; Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwon Do 200701, South Korea; Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Kangwon National University; Kangwon National University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwon, YG (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Kangwon Do 200701, South Korea.			Min, Jeong-Ki/0000-0003-4924-8739				An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; BUCKLEY BJ, 1995, AM J PHYSIOL-CELL PH, V269, pC757, DOI 10.1152/ajpcell.1995.269.3.C757; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Ceneviva GD, 1998, AM J PHYSIOL-LUNG C, V275, pL717, DOI 10.1152/ajplung.1998.275.4.L717; CHUN SY, 1995, ENDOCRINOLOGY, V136, P3120, DOI 10.1210/en.136.7.3120; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Estevez AG, 1998, J NEUROSCI, V18, P3708; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; GRANGER DL, 1980, J CLIN INVEST, V65, P357, DOI 10.1172/JCI109679; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hebestreit H, 1998, J EXP MED, V187, P415, DOI 10.1084/jem.187.3.415; Heneka MT, 1998, J NEUROCHEM, V71, P88; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; JAMES NL, 1995, FASEB J, V9, P968, DOI 10.1096/fasebj.9.10.7615166; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; KIM YM, 1995, FEBS LETT, V374, P228, DOI 10.1016/0014-5793(95)01115-U; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li JR, 1999, J BIOL CHEM, V274, P17325, DOI 10.1074/jbc.274.24.17325; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Okada S, 1998, J IMMUNOL, V160, P2590; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Ozes ON, 1999, NATURE, V401, P82; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sato K, 1998, BIOCHEM BIOPH RES CO, V253, P253, DOI 10.1006/bbrc.1998.9745; Shears LL, 1997, J CLIN INVEST, V100, P2035, DOI 10.1172/JCI119736; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xiao ZS, 1997, J CELL PHYSIOL, V171, P205, DOI 10.1002/(SICI)1097-4652(199705)171:2<205::AID-JCP11>3.3.CO;2-3	67	175	190	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10627	10633		10.1074/jbc.M011449200	http://dx.doi.org/10.1074/jbc.M011449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134047	hybrid			2022-12-27	WOS:000167980900010
J	Pirneskoski, A; Ruddock, LW; Klappa, P; Freedman, RB; Kivirikko, KI; Koivunen, P				Pirneskoski, A; Ruddock, LW; Klappa, P; Freedman, RB; Kivirikko, KI; Koivunen, P			Domains b ' and a ' of protein disulfide isomerase fulfill the minimum requirement for function as a subunit of prolyl 4-hydroxylase - The N-terminal domains a and b enhance this function and can be substituted in part by those of ERp57	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BINDING-SITE; BETA-SUBUNIT; ALPHA-SUBUNIT; BACULOVIRUS EXPRESSION; CHAPERONE ACTIVITIES; TETRAMER; CLONING; COLLAGEN; LYSOZYME; ISOFORM	Protein disulfide isomerase (PDI) is a modular polypeptide consisting of four domains, a, b, b' and a', plus an acidic C-terminal extension, c. PDI carries out multiple functions, acting as the beta subunit in the animal prolyl 4-hydroxylases and in the microsomal triglyceride transfer protein and independently acting as a protein folding catalyst. We report here that the minimum sequence requirement for the assembly of an active prolyl 4-hydroxylase alpha (2)beta (2) tetramer in insect cell coexpression experiments is fulfilled by the PDI domain construct b'a' but that the sequential addition of the b and a domains greatly increases the level of enzyme activity obtained. In the assembly of active prolyl 4-hydroxylase tetramers, the a and b domains of PDI, but not b' and a', can in part be substituted by the corresponding domains of ERp57, a PDI isoform that functions naturally in association with the lectins calnexin and calreticulin. The a' domain of PDI could not be substituted by the PDI a domain, suggesting that both b' and a' domains contain regions critical for prolyl 4-hydroxylase assembly. All PDI domain constructs and PDI/ERp57 hybrids that contain the b' domain can bind the 14-amino acid peptide Delta -somatostatin, as measured by cross-linking; however, binding of the misfolded protein "scrambled" RNase required the addition of domains ab or a' of PDI. The human prolyl 4-hydroxylase alpha subunit has at least two isoforms, alpha (I) and alpha (II), which form with the PDI polypeptide the (alpha (I))(2)beta (2) and (alpha (II))(2)beta (2) tetramers. We report here that all the PDI domain constructs and PDI/ERp57 hybrid polypeptides tested were more effectively associated with the alpha (II) subunit than the alpha (I) subunit.	Univ Oulu, Bioctr, Collagen Res Unit, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem, FIN-90014 Oulu, Finland; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of Oulu; University of Oulu; University of Kent	Koivunen, P (corresponding author), Univ Oulu, Bioctr, Collagen Res Unit, POB 5000, FIN-90014 Oulu, Finland.			Ruddock, Lloyd/0000-0002-6247-686X				Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; CAI H, 1994, J BIOL CHEM, V269, P24550; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Dijkstra K, 1999, J BIOMOL NMR, V14, P195, DOI 10.1023/A:1008331225208; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; FREEDMAN RB, 1999, MOL CHAPERONES PROTE, P437; GRUENWALD S, 1994, BACULOVIRUS EXPRESSI; Hayano T, 1995, FEBS LETT, V377, P505, DOI 10.1016/0014-5793(95)01410-1; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Kemmink J, 1999, J BIOMOL NMR, V13, P357, DOI 10.1023/A:1008341820489; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Klappa P, 2000, J BIOL CHEM, V275, P13213, DOI 10.1074/jbc.275.18.13213; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KLAPPA P, 1991, EMBO J, V10, P2795, DOI 10.1002/j.1460-2075.1991.tb07828.x; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Koivunen P, 1996, BIOCHEM J, V316, P599, DOI 10.1042/bj3160599; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; OTSU M, 1994, J BIOL CHEM, V269, P6874; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PUIG A, 1994, J BIOL CHEM, V269, P7764; PUIG A, 1994, J BIOL CHEM, V269, P19128; RUPP K, 1994, J BIOL CHEM, V269, P2501; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; WETTERAU JR, 1990, J BIOL CHEM, V265, P9801; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	38	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11287	11293		10.1074/jbc.M010656200	http://dx.doi.org/10.1074/jbc.M010656200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134056	hybrid			2022-12-27	WOS:000167980900096
J	Slotboom, DJ; Konings, WN; Lolkema, JS				Slotboom, DJ; Konings, WN; Lolkema, JS			Cysteine-scanning mutagenesis reveals a highly amphipathic, pore-lining membrane-spanning helix in the glutamate transporter GltT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REENTRANT LOOP; RAT-BRAIN; BACILLUS-STEAROTHERMOPHILUS; SUBSTRATE-BINDING; HIGH-AFFINITY; TOPOLOGY; ACCESSIBILITY; FAMILY; SELECTIVITY; PROTEINS	The carboxyl terminal membrane-spanning segment 8 of the glutamate transporter GltT of Bacillus stearothermophilus was studied by cysteine-scanning mutagenesis. 21 single cysteine mutants were constructed in a stretch ranging from Gly-574 to Gln-404, Two mutants were not expressed, four were inactive, and two showed severely reduced glutamate transport activity. Cysteine mutations at the other positions were well tolerated. Only the two most amino- and carboxyl-terminal mutants (G374C, I375C, S399C, and Q404C) could be labeled with the large thiol reagent fluorescein maleimide, indicating unrestricted access and a location in a loop structure outside the membrane. The labeling pattern of these mutants using membrane- permeable and -impermeable thiol reagents showed that the N and C termini of the mutated stretch are located extra- and intracellularly, respectively. Thus, the location of the membrane-spanning segment was confined to a stretch of 23 residues between Gly-374 and Ser-399. Cysteine residues in three mutants in the central part of the segment (M381C, V388C, and N391C) could be labeled with the small and flexible reagent a-aminoethyl methanethiosulfonate hydrobromide only, suggesting accessibility via a narrow aqueous pore. When the region was modeled as an cu-helix, all positions at which cysteine mutations lead to inactive or severely impaired transporters cluster on one face of this helix, The inactive mutants showed neither proton motive force-driven uptake activity nor exchange activity nor glutamate binding. The results indicate that transmembrane segment 8 forms an amphipathic alpha -helix, The hydrophilic face of the helix lines an aqueous pore and contains many residues that are important for activity.	Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Groningen	Lolkema, JS (corresponding author), Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, Kerklaan 30, NL-9751 NN Haren, Netherlands.		Konings, Wilhelmus N./C-7063-2013					AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; Eskandari S, 2000, P NATL ACAD SCI USA, V97, P8641, DOI 10.1073/pnas.97.15.8641; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Sambrook J., 2002, MOL CLONING LAB MANU; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TOLNER B, 1995, MOL MICROBIOL, V18, P123, DOI 10.1111/j.1365-2958.1995.mmi_18010123.x; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	31	50	50	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10775	10781		10.1074/jbc.M011064200	http://dx.doi.org/10.1074/jbc.M011064200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148213	Green Published, hybrid			2022-12-27	WOS:000167980900030
J	Walter, W; Scheuer, C; Loos, M; Reichert, TE; Maeurer, MJ				Walter, W; Scheuer, C; Loos, M; Reichert, TE; Maeurer, MJ			H2-M beta 1 and H2-M beta 2 heterodimers equally promote CLIP removal in I-A(q) molecules from autoimmune-prone DBA/1 mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; COLLAGEN-INDUCED ARTHRITIS; ANTIGEN PRESENTATION; INVARIANT CHAIN; DENDRITIC CELLS; HLA-DM; PEPTIDE; H2-M; EXPRESSION; POLYMORPHISM	Antigen-presenting cells degrade endocytosed antigens, e.g. collagen type II, into peptides that are bound and presented to arthritogenic CD4(+) helper T cells by major histocompatibility complex (MHC) class II molecules. Efficient loading of many MHC class II alleles with peptides requires the assistance of H2-M (HLA-DM in humans), a heterodimeric MHC class II-like molecule that facilitates CLIP removal from MHC class II molecules and aids to shape the peptide repertoire presented by MHC class II to CD4(+) T cells. In contrast to the KLA-DM region in humans, the beta -chain locus is duplicated in mice, with the H2-Mb1 beta-chain distal to H2-Mb2 and the H2-Ma alpha-chain gene. H2-M alleles appear to be associated with the development of autoimmune diseases. Recent data showed that M beta1 and M beta2 isoforms are differentially expressed in isolated macrophages and B cells, respectively. The tissue expression and functional role of these heterodimers in promoting CLIP removal and peptide selection have not been addressed. We utilized the human T2 cell line, which lacks part of chromosome 6 encompassing the MHC class II and DM genes, to construct transgenic cell lines expressing the MHC class II heterodimer I-A(q) alone or in the presence of H2-M alpha beta1 or H2-M alpha beta2 heterodimers, Both H2-M isoforms facilitate the exchange of CLIP for cognate peptides on I-Aq molecules from arthritis-susceptible DBA/1 mice and induce a conformational change in I-A(q) molecules. Moreover, I-A(q) cell-surface expression is not absolutely dependent on H2-M molecules. These data suggest that I-A(q) exhibits a high affinity for CLIP since virtually all I-A(q) molecules on T2 cells were found to be associated with CLIP in the absence of both H2-M isoforms.	Johannes Gutenberg Univ Mainz, Dept Med Microbiol, D-55101 Mainz, Germany; Johannes Gutenberg Univ Mainz, Dept Oral & Maxillofacial Surg, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Maeurer, MJ (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med Microbiol, D-55101 Mainz, Germany.	maeurer@mail.uni-mainz.de		Maeurer, Markus/0000-0002-8436-8077				Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; BRICKELL PM, 1981, IMMUNOLOGY, V43, P493; CHIOCCHIA G, 1993, EUR J IMMUNOL, V23, P327, DOI 10.1002/eji.1830230204; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; CHO SG, 1991, P NATL ACAD SCI USA, V88, P5197, DOI 10.1073/pnas.88.12.5197; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Germain RN, 1996, IMMUNOL REV, V151, P5, DOI 10.1111/j.1600-065X.1996.tb00701.x; HASENKRUG KJ, 1987, IMMUNOGENETICS, V25, P136, DOI 10.1007/BF00364282; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; HOLMDAHL R, 1986, AGENTS ACTIONS, V19, P295, DOI 10.1007/BF01971231; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KERWAR SS, 1983, ARTHRITIS RHEUM, V26, P1120, DOI 10.1002/art.1780260910; Kim KJ, 1996, MOL CELLS, V6, P684; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; ManourySchwartz B, 1995, EUR J IMMUNOL, V25, P3235, DOI 10.1002/eji.1830251206; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MICHAELSSON E, 1995, EUR J IMMUNOL, V25, P2234, DOI 10.1002/eji.1830250818; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; MYERS LK, 1992, J IMMUNOL, V149, P1439; NIJMAN HW, 1995, J EXP MED, V182, P163, DOI 10.1084/jem.182.1.163; Osman GE, 1998, INT IMMUNOL, V10, P1613, DOI 10.1093/intimm/10.11.1613; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SEKI N, 1988, J IMMUNOL, V140, P1477; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SLOAN JH, 1992, J IMMUNOL, V148, P2591; Stebbins CC, 1996, J IMMUNOL, V157, P4892; TERATO K, 1985, J EXP MED, V162, P637, DOI 10.1084/jem.162.2.637; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Walter W, 2000, BRIT J CANCER, V83, P1192, DOI 10.1054/bjoc.2000.1415; Walter W, 1996, IMMUNOGENETICS, V44, P19, DOI 10.1007/s002510050085; Walter W, 2000, IMMUNOGENETICS, V51, P794, DOI 10.1007/s002510000210; Walter W, 1999, MOL IMMUNOL, V36, P733, DOI 10.1016/S0161-5890(99)00089-9; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	48	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11086	11091		10.1074/jbc.M006521200	http://dx.doi.org/10.1074/jbc.M006521200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148202				2022-12-27	WOS:000167980900070
J	Yoshikawa, DM; Bresciano, K; Hatwar, M; Smrcka, AV				Yoshikawa, DM; Bresciano, K; Hatwar, M; Smrcka, AV			Characterization of a phospholipase C beta 2-binding site near the amino-terminal coiled-coil of G protein beta gamma subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST G-PROTEIN; ADENYLYL-CYCLASE; ACTIVATION; BINDING	In previous work (Sankaran, B., Osterhout, J., Wu, D., and Smrcka, A. V. (1998) J. Biol. Chem. 273, 7148-7154), we showed that overlapping peptides, N20K (Asn(564)- Lys(583)) and E20K (Glu(574)-Lys(593)), from the catalytic domain of phospholipase C (PLC) beta2 block G beta gamma -dependent activation of PLC beta2, The peptides could also be directly cross-linked to beta gamma subunits with a heterobifunctional cross-linker succinimidyl 4-[N-maleimidomethyl]-cyclohexane-1-carboxylate. Cross-linking of peptides to G beta (1) was inhibited by PLC beta2 but not by alpha (i1)(GDP), indicating that the peptide-binding site on beta (1) represents a binding site for PLC beta2 that does not overlap with the alpha (i1)-binding site. Here we identify the site of peptide cross-linking and thereby define a site for PLC beta2 interaction with beta subunits. Each of the 14 cysteine residues in beta (1) were altered to alanine. The ability of the PLC beta2-derived peptide to cross-link to each beta gamma mutant was then analyzed to identify the reactive sulfhydryl moiety on the beta subunit required for the cross-linking reaction. We find that C25A was the only mutation that significantly affected peptide cross-linking. This indicates that the peptide is specifically binding to a region near cysteine 25 of beta (1) which is located in the amino-terminal coiled-coil region of beta (1), and identifies a PLC-binding site distinct from the alpha subunit interaction site.	Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.				NIGMS NIH HHS [GM 53536] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buck E, 1999, SCIENCE, V283, P1332, DOI 10.1126/science.283.5406.1332; Dowell SJ, 1998, GENETICS, V150, P1407; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GarciaHiguera I, 1996, J BIOL CHEM, V271, P528, DOI 10.1074/jbc.271.1.528; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Means GE, 1990, BIOCONJUGATE CHEM, V1, P2, DOI 10.1021/bc00001a001; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Pellegrino S, 1997, J BIOL CHEM, V272, P25360, DOI 10.1074/jbc.272.40.25360; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; THOMAS TC, 1993, BIOCHEMISTRY-US, V32, P8628, DOI 10.1021/bi00084a034; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	20	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11246	11251		10.1074/jbc.M006073200	http://dx.doi.org/10.1074/jbc.M006073200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145956	hybrid			2022-12-27	WOS:000167980900090
J	Zhao, RB; Russell, RG; Wang, YH; Liu, LB; Gao, F; Kneitz, B; Edelmann, W; Goldman, ID				Zhao, RB; Russell, RG; Wang, YH; Liu, LB; Gao, F; Kneitz, B; Edelmann, W; Goldman, ID			Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L1210 LEUKEMIA-CELLS; NEURAL-TUBE DEFECTS; MEDIATED TRANSPORT; MEMBRANE-TRANSPORT; RECEPTOR-ALPHA; EXPRESSION; GENE; LOCALIZATION; METHOTREXATE; ORGANIZATION	The reduced folate carrier (RFC1) is an important route by which the major blood folate, B-methyltetrahydrofolate, is transported into mammalian cells. In this study we determined the consequences of inactivation of RFC1 in mice by homologous recombination. While RFC1-null embryos died in utero before embryonic day 9.5 (E9.5), near-normal development could be sustained in RFC1(-/-) embryos examined at E18.5 by supplementation of pregnant RFC1(+/-) darns with l-mg daily subcutaneous doses of folic acid. About 10% of these animals went on to live birth but died within 12 days. These RFC1(-/-) mice showed a marked absence of erythropoiesis in bone marrow, spleen, and liver along with lymphoid depletion in the splenic white pulp and thymus, In addition, there was some impairment of renal and seminiferous tubule development. These data indicate that in the absence of RFC1 function, neonatal animals die due to failure of hematopoietic organs.	Albert Einstein Coll Med, Ctr Comprehens Canc, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Goldman, ID (corresponding author), Albert Einstein Coll Med, Ctr Comprehens Canc, Dept Med & Mol Pharmacol, Chanin 2,1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu			NATIONAL CANCER INSTITUTE [R35CA039807, R01CA082621] Funding Source: NIH RePORTER; NCI NIH HHS [CA-39807, CA82621] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRANDA RF, 1978, J CLIN INVEST, V61, P1270, DOI 10.1172/JCI109043; BRIGLE KE, 1994, BIOCHEM PHARMACOL, V47, P337, DOI 10.1016/0006-2952(94)90025-6; Brigle KE, 1997, BBA-GENE STRUCT EXPR, V1353, P191, DOI 10.1016/S0167-4781(97)00082-1; Chancy CD, 2000, J BIOL CHEM, V275, P20676, DOI 10.1074/jbc.M002328200; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen L, 1996, J BIOL CHEM, V271, P13077, DOI 10.1074/jbc.271.22.13077; Chiao JH, 1997, J BIOL CHEM, V272, P11165, DOI 10.1074/jbc.272.17.11165; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; HENDERSON GB, 1990, CANCER RES, V50, P1709; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; IOFFE E, 1995, P NATL ACAD SCI USA, V92, P7357, DOI 10.1073/pnas.92.16.7357; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Kumar CK, 1998, AM J PHYSIOL-CELL PH, V274, pC289, DOI 10.1152/ajpcell.1998.274.1.C289; MORAN RG, 1989, J BIOL CHEM, V264, P21047; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; PRASAD PD, 1995, BIOCHEM BIOPH RES CO, V206, P681, DOI 10.1006/bbrc.1995.1096; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Said HM, 1997, AM J PHYSIOL-CELL PH, V272, pC729, DOI 10.1152/ajpcell.1997.272.2.C729; SELHUB J, 1983, PHARMACOL THERAPEUT, V20, P397, DOI 10.1016/0163-7258(83)90034-7; Sharif KA, 2000, BIOTECHNIQUES, V28, P926, DOI 10.2144/00285st06; Sierra EE, 1999, SEMIN ONCOL, V26, P11; Sierra EE, 1998, BIOCHEM PHARMACOL, V55, P1505, DOI 10.1016/S0006-2952(97)00673-4; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; SPINELLA MJ, 1995, J BIOL CHEM, V270, P7842, DOI 10.1074/jbc.270.14.7842; WANG X, 1992, BIOCHEM PHARMACOL, V44, P1898; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; WHITE JC, 1978, J BIOL CHEM, V253, P242; Wickramasinghe SN, 1999, SEMIN HEMATOL, V36, P3; YANG CH, 1983, J MEMBRANE BIOL, V75, P11, DOI 10.1007/BF01870795; Zhao RB, 2000, BBA-BIOMEMBRANES, V1466, P7, DOI 10.1016/S0005-2736(00)00190-5	38	97	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10224	10228		10.1074/jbc.C000905200	http://dx.doi.org/10.1074/jbc.C000905200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11266438	hybrid			2022-12-27	WOS:000167996400086
J	Rodicio, R; Strauss, A; Heinisch, JJ				Rodicio, R; Strauss, A; Heinisch, JJ			Single point mutations in either gene encoding the subunits of the heterooctameric yeast phosphofructokinase abolish allosteric inhibition by ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FRUCTOSE 2,6-BISPHOSPHATE; ESCHERICHIA-COLI; MUTANTS; SITES; DUPLICATION; ACTIVATION; DISRUPTION	Yeast phosphofructokinase is a heterooctameric enzyme subject to a complex allosteric regulation. A mutation in the PFK1 gene, encoding the larger cy-subunits, rendering the enzyme insensitive to allosteric inhibition by ATP was found to be caused by an exchange of proline 728 for a leucine residue. By in vitro mutagenesis, we introduced this mutation in either PFK1 or PFK2 and found that the exchange in either subunit drastically reduced the sensitivity of the holoenzyme to ATP inhibition. This was accompanied by a lack of allosteric activation by AMP, fructose a,6-bisphosphate, or ammonium and an increased resistance to heat inactivation. Yeast cells carrying either one mutation or both in conjunction did not display a strong phenotype when grown on fermentable carbon sources and did not show any significant changes in intermediary metabolites. Growth on non-fermentable carbon sources was clearly impaired. The strain carrying both mutant alleles was more sensitive to Congo Red than the wildtype strain or the single mutants indicating differences in cell wall composition. In addition, we found single pfk null mutants to be less viable than wild type at different storage temperatures and a pfk2 null mutant to be temperature-sensitive for growth at 37 degreesC. The latter mutant was shown to be respiration-dependent for growth on glucose.	Univ Dusseldorf, Inst Mikrobiol, D-40225 Dusseldorf, Germany; Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	Heinrich Heine University Dusseldorf; University of Oviedo	Heinisch, JJ (corresponding author), Univ Dusseldorf, Inst Mikrobiol, Univ Str 1,Gebaude 26-12, D-40225 Dusseldorf, Germany.		Heinisch, Juergen J./G-3801-2017	Rodicio Rodicio, Rosaura/0000-0002-3862-9619				ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; AVIGAD G, 1981, BIOCHEM BIOPH RES CO, V102, P985, DOI 10.1016/0006-291X(81)91635-1; BANUELOS M, 1977, J BIOL CHEM, V252, P6394; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; CLIFTON D, 1982, BIOCHEMISTRY-US, V21, P1935, DOI 10.1021/bi00537a037; CLIFTON D, 1978, GENETICS, V88, P1; EBERHARDT I, 1995, CURR GENET, V27, P306, DOI 10.1007/BF00352097; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; FRENZEL J, 1984, BIOMED BIOCHIM ACTA, V43, P413; GALAZZO JL, 1990, ENZYME MICROB TECH, V12, P162, DOI 10.1016/0141-0229(90)90033-M; GANCEDO JM, 1973, BIOCHIMIE, V55, P205, DOI 10.1016/S0300-9084(73)80393-1; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; HEINISCH J, 1989, GENE, V78, P309; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HEINISCH JJ, 1993, YEAST, V9, P1103, DOI 10.1002/yea.320091010; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; Kirchberger J, 1999, BIOCHEM J, V341, P15, DOI 10.1042/0264-6021:3410015; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; KOPPERSCHLAGER G, 1993, EUR J BIOCHEM, V217, P527, DOI 10.1111/j.1432-1033.1993.tb18273.x; KOPPERSCHLAGER G, 1977, EUR J BIOCHEM, V81, P317, DOI 10.1111/j.1432-1033.1977.tb11954.x; KOPPERSCHLAGER G, 1982, ANAL BIOCHEM, V124, P117, DOI 10.1016/0003-2697(82)90228-7; Kopperschlager G, 1997, YEAST SUGAR METABOLI, P97; KRETSCHMER M, 1991, EUR J BIOCHEM, V197, P367, DOI 10.1111/j.1432-1033.1991.tb15920.x; LAURENT M, 1978, BIOCHEM BIOPH RES CO, V80, P646, DOI 10.1016/0006-291X(78)91617-0; LISOWSKY T, 1988, MOL GEN GENET, V214, P218, DOI 10.1007/BF00337714; LLOYD D, 1992, YEAST, V8, P291, DOI 10.1002/yea.320080406; LOBO Z, 1982, FEBS LETT, V139, P93, DOI 10.1016/0014-5793(82)80494-8; LOBO Z, 1983, J BIOL CHEM, V258, P1444; NADKARNI M, 1984, FEBS LETT, V175, P294, DOI 10.1016/0014-5793(84)80754-1; NISSLER K, 1983, BIOCHEM BIOPH RES CO, V111, P294, DOI 10.1016/S0006-291X(83)80150-8; Obmolova G, 1998, ACTA CRYSTALLOGR D, V54, P96, DOI 10.1107/S0907444997007555; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1995, AM J HUM GENET, V56, P131; RILEY BB, 1990, P NATL ACAD SCI USA, V87, P4746, DOI 10.1073/pnas.87.12.4746; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Sherman F., 1983, LAB MANUAL; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; SOLS A, 1981, CURR TOP CELL REGUL, V19, P77; Varon M, 2000, J BACTERIOL, V182, P3877, DOI 10.1128/JB.182.13.3877-3880.2000; WESTERHOFF HV, 1995, TRENDS BIOTECHNOL, V13, P242, DOI 10.1016/S0167-7799(00)88955-6; ZIMMERMANN FK, 1977, MOL GEN GENET, V154, P75, DOI 10.1007/BF00265579	45	27	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 29	2000	275	52					40952	40960		10.1074/jbc.M007131200	http://dx.doi.org/10.1074/jbc.M007131200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387GJ	11221662	hybrid			2022-12-27	WOS:000166114600040
J	Orsomando, G; Lorenzi, M; Raffaelli, N; Dalla Rizza, M; Mezzetti, B; Ruggieri, S				Orsomando, G; Lorenzi, M; Raffaelli, N; Dalla Rizza, M; Mezzetti, B; Ruggieri, S			Phytotoxic protein PcF, purification, characterization, and cDNA sequencing of a novel hydroxyproline-containing factor secreted by the strawberry pathogen Phytophthora cactorum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MOLECULAR CHARACTERIZATION; ELICITOR; RESISTANCE; CYSTEINE; BINDING; TOBACCO; TOMATO; DERIVATIZATION; PREDICTION	A novel protein factor, named PcF, has been isolated from the culture filtrate of Phytophthora cactorum strain P381 using a highly sensitive leaf necrosis bioassay with tomato seedlings. Isolated PcF protein alone induced leaf necrosis on its host strawberry plant. The primary structure and cDNA sequence of this novel phytotoxic protein was determined, and BLAST searches of Swiss-Prot, EMBL, and GenBank(TM)/EBI data banks showed that PcF shared no significant homology with other known sequences. The 52-residue PcF protein, which contains a 4-hydroxyproline residue along with three S-S bridges, exhibits a high content of acidic sidechains, accounting for its isoelectric point of 4.4. The molecular mass of isolated PcF is 5,622 +/- 0.5 Da as determined by mass spectrometry and matches that calculated from the deduced amino acid sequence with cDNA sequencing. The cDNA sequence indicates that PcF is first produced as a larger precursor, comprising an additional N-terminal, 21-residue secretory signal peptide. Maturation of this protein involves the hydroxylation of proline 49, a feature that is unique among other known secreted fungal phytopathogenic proteins.	Univ Ancona, Fac Agr, Dipartimento Biotecnol Agr & Ambientali, I-60131 Ancona, Italy; Univ Ancona, Fac Med & Chirurg, Ist Biochim, I-60131 Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Ruggieri, S (corresponding author), Univ Ancona, Fac Agr, Dipartimento Biotecnol Agr & Ambientali, Via Brecce Bianche, I-60131 Ancona, Italy.		Orsomando, Giuseppe/L-2120-2015; Mezzetti, Bruno/AAB-8500-2019; Mezzetti, Bruno/AAE-7696-2019	Mezzetti, Bruno/0000-0001-9307-812X; Orsomando, Giuseppe/0000-0001-6640-097X; Dalla-Rizza, Marco/0000-0003-4065-0940				BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bourque S, 1998, PLANT PHYSIOL, V118, P1317, DOI 10.1104/pp.118.4.1317; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Capasso R, 1999, PHYTOCHEMISTRY, V50, P703, DOI 10.1016/S0031-9422(98)00539-1; Capasso R., 1997, Phytopathologia Mediterranea, V36, P67; DALLARIZZA M, 1998, THESIS U ANCONA ITAL; DUBERY IA, 1994, PHYTOCHEMISTRY, V35, P307, DOI 10.1016/S0031-9422(00)94753-8; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GRANITI A, 1991, EXPERIENTIA, V47, P751, DOI 10.1007/BF01922453; HALL R, 1969, PHYTOPATHOLOGY, V59, P770; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; HUET JC, 1993, PHYTOCHEMISTRY, V34, P1261, DOI 10.1016/0031-9422(91)80012-P; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; KOHMOTO K, 1991, EXPERIENTIA, V47, P756; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE KS, 1979, J BIOL CHEM, V254, P6248; LLOYD MY, 1995, P NATL ACAD SCI USA, V92, P4088; MEZZETTI B, 1994, J PHYTOPATHOL, V142, P219, DOI 10.1111/j.1439-0434.1994.tb04532.x; MOLOT P. M., 1970, Annales de Phytopathologie, V2, P117; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NURNBERGER T, 1994, CELL, V78, P449, DOI 10.1016/0092-8674(94)90423-5; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Perez V, 1999, PHYTOCHEMISTRY, V50, P961, DOI 10.1016/S0031-9422(98)00640-2; PERNOLLET JC, 1993, PHYSIOL MOL PLANT P, V42, P53, DOI 10.1006/pmpp.1993.1005; PLICH M, 1979, PHYTOPATHOL Z, V94, P270; RICCI P, 1989, EUR J BIOCHEM, V183, P555, DOI 10.1111/j.1432-1033.1989.tb21084.x; ROHE M, 1995, EMBO J, V14, P4168, DOI 10.1002/j.1460-2075.1995.tb00090.x; ROSATI P, 1989, ACTA HORTIC, V265, P123; Ruggieri S, 1999, FASEB J, V13, pA1408; SACKS W, 1995, MOL GEN GENET, V246, P45, DOI 10.1007/BF00290132; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAGURI M, 1988, BIOCHEM BIOPH RES CO, V157, P210, DOI 10.1016/S0006-291X(88)80034-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHOTTENSTOMA IMJ, 1988, PHYSIOL MOL PLANT P, V33, P59, DOI 10.1016/0885-5765(88)90043-4; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; TEMPLETON MD, 1994, MOL PLANT MICROBE IN, V7, P320, DOI 10.1094/MPMI-7-0320; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; VARNER JE, 1989, CELL, V56, P231, DOI 10.1016/0092-8674(89)90896-9; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wilhelm S., 1980, STRAWBERRY CULTIVARS, P245; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681	48	56	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21578	21584		10.1074/jbc.M101377200	http://dx.doi.org/10.1074/jbc.M101377200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262411	hybrid, Green Published			2022-12-27	WOS:000169297900104
J	Casola, A; Burger, N; Liu, TS; Jamaluddin, M; Brasier, AR; Garofalo, RP				Casola, A; Burger, N; Liu, TS; Jamaluddin, M; Brasier, AR; Garofalo, RP			Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus - Role in viral-induced interferon regulatory factor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; INTERLEUKIN-8 GENE; HUMAN EOSINOPHILS; CHEMOKINE RANTES; INFLUENZA-VIRUS; CHILDREN; SECRETIONS; MECHANISM	Respiratory syncytial virus (RSV) produces intense pulmonary inflammation, in part, through its ability to induce chemokine synthesis in infected airway epithelial cells. RANTES (regulated upon activation, normal T-cells expressed and secreted) is a CC chemokine which recruits and activates monocytes, lymphocytes, and eosinophils, all cell types present in the lung inflammatory infiltrate induced by RSV infection. In this study we investigated the role of reactive oxygen species in the induction of RANTES gene expression in human type II alveolar epithelial cells (A549), following RSV infection. Our results indicate that RSV infection of airway epithelial cells rapidly induces reactive oxygen species production, prior to RANTES expression, as measured by oxidation of 2',7' dichlorofluorescein. Pretreatment of airway epithelial cells with the antioxidant butylated hydroxyanisol (BHA), as well a panel of chemically unrelated antioxidants, blocks RSV-induced RANTES gene expression and protein secretion. This effect is mediated through the ability of BHA to inhibit RSV-induced interferon regulatory factor binding to the RANTES promoter interferon-stimulated responsive element, that is absolutely required for inducible RANTES promoter activation. BHA inhibits de novo interferon regulator factor (IRF)-1 and -7 gene expression and protein synthesis, and IRF-3 nuclear translocation. Together, these data indicates that a redox-sensitive pathway is involved in RSV-induced IRF activation, an event necessary for RANTES gene expression.	Univ Texas, Med Branch, Dept Pediat, Div Child Hlth,Res Ctr, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Casola, A (corresponding author), Univ Texas, Med Branch, Dept Pediat, Div Child Hlth,Res Ctr, 301 Univ Blvd, Galveston, TX 77555 USA.		Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Brasier, Allan/0000-0002-5012-4090	NIAID NIH HHS [AI 40218, AI 15939] Funding Source: Medline; NIEHS NIH HHS [P30ES06676] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040218, R01AI015939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; ALAM R, 1993, J IMMUNOL, V150, P3442; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Boehlk S, 2000, EUR J IMMUNOL, V30, P1102, DOI 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Faure V, 1999, J BIOL CHEM, V274, P4794, DOI 10.1074/jbc.274.8.4794; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Gabbita SP, 2000, ARCH BIOCHEM BIOPHYS, V376, P1, DOI 10.1006/abbi.1999.1685; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; GAROFALO R, 1992, J PEDIATR-US, V120, P28, DOI 10.1016/S0022-3476(05)80592-X; Garofalo RP, 1991, PEDIATR ALLERGY IMMU, V2, P30; HALL CB, 1995, PRINCIPLES PRACTICES; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; KIMPEN JLL, 1992, PEDIATR RES, V32, P160, DOI 10.1203/00006450-199208000-00007; Koga T, 1999, P NATL ACAD SCI USA, V96, P5680, DOI 10.1073/pnas.96.10.5680; Kooy NW, 1997, FREE RADICAL RES, V27, P245, DOI 10.3109/10715769709065763; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; MASTRONARDE JG, 1995, AM J RESP CELL MOL, V13, P237, DOI 10.1165/ajrcmb.13.2.7626291; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; NELSON PJ, 1993, J IMMUNOL, V151, P2601; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; PATEL JA, 1995, AM J RESP CELL MOL, V13, P602, DOI 10.1165/ajrcmb.13.5.7576697; Saito T, 1997, J INFECT DIS, V175, P497, DOI 10.1093/infdis/175.3.497; SALKIND AR, 1991, J CLIN INVEST, V88, P505, DOI 10.1172/JCI115332; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Satriano JA, 1997, J AM SOC NEPHROL, V8, P596; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Simeonova PP, 1999, LAB INVEST, V79, P1027; Teran LM, 1999, J INFECT DIS, V179, P677, DOI 10.1086/314618; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; WEBB MSC, 1985, ARCH DIS CHILD, V60, P1064, DOI 10.1136/adc.60.11.1064	41	102	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19715	19722		10.1074/jbc.M101526200	http://dx.doi.org/10.1074/jbc.M101526200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259439	hybrid			2022-12-27	WOS:000169135100007
J	Li, Y; Dowbenko, D; Lasky, LA				Li, Y; Dowbenko, D; Lasky, LA			Caenorhabditis elegans PIAK, a phospholipid-independent kinase that activates the AKT/PKB survival kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-1 PI3 KINASE; PROTEIN-KINASE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; FAMILY MEMBER; AKT; INSULIN; SIGNALS; CELLS; PDK1	Phospholipid-dependent kinase 1 (PDK 1) is a 3'-phospholipid-responsive serine/threonine kinase that plays a critical role in cell survival by phosphorylating and activating the anti-apoptotic AKT/PKB kinase, While PDK 1 is clearly an important component of the cell survival machinery, the potential for phospholipid-independent activation of the AKT/PKB survival pathway has not been extensively examined at the molecular level. We have identified a second form of PDK 1 in the nematode Caenorhabditis elegans that we have termed PIAK. (phospholipid-independent AKT/PKB kinase). PIAK is highly homologous to C. elegans and mammalian PDK 1 with the exception that the novel kinase lacks a phospholipid binding pleckstrin homology domain. The domain structure of PIAK suggests that it might be a phospholipid-independent kinase, and PIAK phosphorylates mammalian AKT/PKB at the activating Thr(308) residue in the presence of the phosphatidylinositol (PI) 3-kinase inhibitors as well as in the absence of growth factors. In addition, PIAK is capable of inducing the phospholipid-independent, AKT/PKB-induced phosphorylation of the AFX-type forkhead transcription factor, resulting in its cytoplasmic localization. Because the nuclear localization of this transcription factor induces an apoptotic state, this PIAK-mediated cytoplasmic sequestration allows for cell survival. Finally, PIAK activity appears to be induced by various inhibitors of cell cycle G(1) progression. These data suggest an alternate, phosphatidylinositol 3-kinase-independent mechanism for the activation of the AKT/PKB survival pathway that may be utilized during periods of cellular quiescence.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lasky, LA (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	lal@gene.com						Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Casagrande F, 1998, FEBS LETT, V422, P385, DOI 10.1016/S0014-5793(98)00043-X; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Huang H, 1999, DEVELOPMENT, V126, P5365; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	33	5	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20323	20329		10.1074/jbc.M101309200	http://dx.doi.org/10.1074/jbc.M101309200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274160	hybrid			2022-12-27	WOS:000169135100089
J	Wiberg, C; Hedbom, E; Khairullina, A; Lamande, SR; Oldberg, A; Timpl, R; Morgelin, M; Heinegard, D				Wiberg, C; Hedbom, E; Khairullina, A; Lamande, SR; Oldberg, A; Timpl, R; Morgelin, M; Heinegard, D			Biglycan and decorin bind close to the N-terminal region of the collagen VI triple helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; ELECTRON-MICROSCOPY; ALPHA-3 CHAIN; TARGETED DISRUPTION; CONNECTIVE TISSUES; BETHLEM MYOPATHY; INTIMA COLLAGEN; COLLOIDAL GOLD; HUMAN-PLACENTA	The binding of native biglycan and decorin to pepsin-extracted collagen VT from human placenta was examined by solid phase assay and by measurement of surface plasmon resonance in the BIAcore (TM) 2000 system. Both proteoglycans exhibited a strong affinity for collagen VI with dissociation constants (K-D) of similar to 30 nM. Removal of the glycosaminoglycan chains by chondroitinase ABC digestion did not significantly affect binding. In coprecipitation experiments, biglycan and decorin bound to collagen VT and equally competed with the other, suggesting that biglycan and decorin bind to the same binding site on collagen VI. This was confirmed by electron microscopy after negative staining of complexes between gold-labeled proteoglycans and collagen VI, demonstrating that both biglycan and decorin bound exclusively to a domain close to the interface between the N terminus of the triple helical region and the following globular domain. In solid phase assay using recombinant collagen VI fragments, it was shown that the alpha2(VI) chain probably plays a role in the interaction.	Univ Lund, Dept Mol & Cell Biol, BMC, S-22184 Lund, Sweden; Ctr Rheumatol & Bone Dis, Lab Expt Cartilage Res, CH-8038 Zurich, Switzerland; Univ Melbourne, Dept Pediat, Cell & Matrix Biol Res Unit, Royal Childrens Hosp, Parkville, Vic 3052, Australia; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Lund University; Royal Children's Hospital Melbourne; University of Melbourne; Max Planck Society	Heinegard, D (corresponding author), Univ Lund, Dept Mol & Cell Biol, BMC, Plan C12, S-22184 Lund, Sweden.			Lamande, Shireen/0000-0003-2938-2711				ANTONOPO.CA, 1967, BIOCHIM BIOPHYS ACTA, V148, P158, DOI 10.1016/0304-4165(67)90291-7; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bilezikian, 1999, DYNAMICS BONE CARTIL, P3; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHOI HU, 1989, J BIOL CHEM, V264, P2876; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; Dziadek M, 1996, EXP CELL RES, V226, P302, DOI 10.1006/excr.1996.0231; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEINEGARD D, 1985, BIOCHEM J, V230, P181, DOI 10.1042/bj2300181; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hocking AM, 1996, J BIOL CHEM, V271, P19571, DOI 10.1074/jbc.271.32.19571; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; MCDEVITT CA, 1991, FEBS LETT, V294, P167, DOI 10.1016/0014-5793(91)80660-U; MIOSGE N, 1994, HISTOCHEM J, V26, P939; ODERMATT E, 1983, BIOCHEM J, V211, P295, DOI 10.1042/bj2110295; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TAKAHASHI T, 1993, J HISTOCHEM CYTOCHEM, V41, P1447, DOI 10.1177/41.10.8245404; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; TIMPL R, 1994, EXTRACELLULAR MATRIX, P208; Timpl R., 1987, STRUCTURE FUNCTION C, P105, DOI [10.1016/B978--0--12--481280-2.50008---8, DOI 10.1016/B978--0--12--481280-2.50008---8]; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746	56	164	168	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18947	18952		10.1074/jbc.M100625200	http://dx.doi.org/10.1074/jbc.M100625200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259413	hybrid			2022-12-27	WOS:000169091000041
J	Farrant, RD; Walker, V; Mills, GA; Mellor, JM; Langley, GJ				Farrant, RD; Walker, V; Mills, GA; Mellor, JM; Langley, GJ			Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid - Increased risk of vitamin B-6 deficiency and seizures in hyperprolinemia type II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMIC GAMMA-SEMIALDEHYDE; DELTA-1-PYRROLINE-5-CARBOXYLIC ACID; 5-CARBOXYLATE DEHYDROGENASE; PYRROLINE 5-CARBOXYLATE; DIFFUSION; IDENTIFICATION; SPECTROSCOPY; PURIFICATION; PROLINE; LIVER	We previously identified vitamin B-6 deficiency in a child presenting with seizures whose primary diagnosis was the inherited disorder hyperprolinemia type II. This is an unrecognized association, which was not explained by diet or medication. We hypothesized that pyridoxal phosphate (vitamin B-6 coenzyme) was de-activated by L-Delta (1)-pyrroline-5-carboxylic acid, the major intermediate that accumulates endogenously in hyperprolinemia type II. The proposed interaction has now been investigated in vitro with high resolution H-1 nuclear magnetic resonance spectroscopy and mass spectrometry at a pH of 7.4 and temperature of 310 K. Three novel adducts were identified. These were the result of a Claisen condensation (or Knoevenagel type of reaction) of the activated C-4 carbon of the pyrroline ring with the aldehyde carbon of pyridoxal phosphate. The structures of the adducts were confirmed by a combination of high performance liquid chromatography, nuclear magnetic resonance, and mass spectrometry. This interaction has not been reported before. From preliminary observations, pyrroline-5-carboxylic acid also condenses with other aromatic and aliphatic aldehydes and ketones, and this may be a previously unsuspected generic addition reaction. Pyrroline-5 carboxylic acid is thus found to be a unique endogenous vitamin antagonist. Vitamin B-6 de-activation may contribute to seizures in hyperprolinemia type II, which are so far unexplained, but they may be preventable with long term vitamin B-6 supplementation.	Glaxo Wellcome Med Res Ctr, Stevenage SG1 2NY, Herts, England; Southampton Gen Hosp, Dept Chem Pathol, Southampton SO16 6YD, Hants, England; Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England	GlaxoSmithKline; University of Southampton; University of Portsmouth; University of Southampton	Farrant, RD (corresponding author), Glaxo Wellcome Med Res Ctr, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	rdf17079@glaxowellcome.co.uk	Langley, Graham J/B-5320-2008	Langley, Graham J/0000-0002-8323-7235				ALVAREZ FG, 1995, INTENS CARE MED, V21, P641, DOI 10.1007/BF01711541; BARJAT H, 1995, J MAGN RESON SER B, V108, P170, DOI 10.1006/jmrb.1995.1118; Bates CJ, 1997, ANN CLIN BIOCHEM, V34, P599, DOI 10.1177/000456329703400604; BOSRON WF, 1978, J BIOL CHEM, V253, P1488; Coburn S P, 1996, Adv Food Nutr Res, V40, P107, DOI 10.1016/S1043-4526(08)60023-6; COBURN SP, 1981, J NUTR, V111, P391, DOI 10.1093/jn/111.2.391; DARNELL J, 1986, MOL CELL BIOL, P32; EBADI M, 1986, COENZYMES COFACTOR B, V1, P449; Emery F A, 1968, J Ment Defic Res, V12, P187; FLEMING GA, 1984, METABOLISM, V33, P739, DOI 10.1016/0026-0495(84)90215-4; FLYNN MP, 1989, ARCH DIS CHILD, V64, P1699, DOI 10.1136/adc.64.12.1699; FORTEMCROBBIE CM, 1986, J BIOL CHEM, V261, P2154; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; GYORGY P, 1968, VITAMINS, V2, P90; HAGEDORN CH, 1986, ARCH BIOCHEM BIOPHYS, V248, P166, DOI 10.1016/0003-9861(86)90413-3; HOLTZ P, 1964, PHARMACOL REV, V16, P113; INK SL, 1984, ANNU REV NUTR, V4, P455, DOI 10.1146/annurev.nu.04.070184.002323; KLOSTERMAN HJ, 1986, COENZYMES COFACTORS, V1, P392; KLOSTERMAN HJ, 1979, METHOD ENZYMOL, V72, P483; MCCOY EE, 1986, COENZYMES COFACTORS, V1, P573; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; MINNS R, 1980, DEV MED CHILD NEUROL, V22, P795; Nabbout R, 1999, ARCH DIS CHILD-FETAL, V81, pF125, DOI 10.1136/fn.81.2.F125; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; RICHTER W, 1967, HELV CHIM ACTA, V50, P364, DOI 10.1002/hlca.19670500204; SAUBERLICH HE, 1968, VITAMINS, V2, P33; SIMILA S, 1970, Annals of Clinical Research, V2, P143; SMALL WC, 1990, J BIOL CHEM, V265, P18668; SNELL EE, 1968, PYRIDOXAL CATALYSIS, P770; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stott K, 1997, J MAGN RESON, V125, P302, DOI 10.1006/jmre.1997.1110; STRECKER HJ, 1960, J BIOL CHEM, V235, P3218; Stryer L., 1988, BIOCHEMISTRY-US, P496; TRYFIATES GP, 1986, COENZYMES COFACTOR B, V1, P421; Valle, 1995, METABOLIC MOL BASES, P1125; VOGEL HJ, 1952, J AM CHEM SOC, V74, P109, DOI 10.1021/ja01121a025; WAJNER M, 1990, CLIN GENET, V37, P485; Walker V, 2000, ARCH DIS CHILD, V82, P236, DOI 10.1136/adc.82.3.236; YEH GC, 1988, J BIOL CHEM, V263, P13083	40	77	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15107	15116		10.1074/jbc.M010860200	http://dx.doi.org/10.1074/jbc.M010860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11134058	hybrid			2022-12-27	WOS:000168528800078
J	Huang, LM; Chao, MF; Chen, MY; Shih, HM; Chiang, YP; Chuang, CY; Lee, CY				Huang, LM; Chao, MF; Chen, MY; Shih, HM; Chiang, YP; Chuang, CY; Lee, CY			Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; DNA-SEQUENCES; TAT PROTEIN; T-CELLS; HIV-1; AIDS; IDENTIFICATION; EPIDEMIOLOGY	Human herpesvirus 8 (HHV8) is the primary viral etiologic agent in Kaposi's sarcoma (KS). However, individuals dually infected with both HHV8 and human immunodeficiency virus type 1 (HIV-1) show an enhanced prevalence of KS when compared with those singularly infected with HHV8. Host immune suppression conferred by HIV infection cannot wholly explain this increased presentation of KS. To better understand how HHV8 and HIV 1 might interact directly in the pathogenesis of KS, we queried for potential regulatory interactions between the two viruses. Here, we report that HHV8 and HIV-1 reciprocally up-regulate the gene expression of each other. We found that the KIE2 immediate-early gene product of HHV8 interacted synergistically with Tat in activating expression from the HIV-1 long terminal repeat. On the other hand, HIV-1 encoded Tat and Vpr proteins increased intracellular HHV8-specific expression. These results provide molecular insights correlating coinfection with HHV8 and HIV-1 with an unusually high incidence of KS.	Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Huang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan S Rd, Taipei 100, Taiwan.	lmhuang@ha.mc.ntu.edu.tw	Shih, Hsiu-Ming/S-7023-2018	LEE, CHIN-YUN/0000-0002-3938-377X; HUANG, LI-MIN/0000-0002-9291-260X				Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Biggar RJ, 1996, HEMATOL ONCOL CLIN N, V10, P997, DOI 10.1016/S0889-8588(05)70380-4; Blauvelt A, 1999, Adv Dermatol, V14, P167; Boccuni MC, 1998, AIDS, V12, P365, DOI 10.1097/00002030-199804000-00004; Buonaguro FM, 1996, INT J CANCER, V65, P25, DOI 10.1002/(SICI)1097-0215(19960103)65:1&lt;25::AID-IJC5&gt;3.0.CO;2-3; BUONAGURO L, 1994, ANTIBIOT CHEMOTHER, V46, P62; CARRIGAN DR, 1990, J INFECT DIS, V162, P844, DOI 10.1093/infdis/162.4.844; Cathomas G, 2000, VIRCHOWS ARCH, V436, P195, DOI 10.1007/s004280050031; Cathomas G, 1996, J CLIN PATHOL, V49, P631, DOI 10.1136/jcp.49.8.631; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Conti L, 2000, J VIROL, V74, P10207, DOI 10.1128/JVI.74.21.10207-10211.2000; Crowley RW, 1996, J IMMUNOL, V156, P2004; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1991, HEMATOL ONCOL CLIN N, V5, P281, DOI 10.1016/S0889-8588(18)30441-6; Flore O, 1997, AIDS RES HUM RETROV, V13, P1229, DOI 10.1089/aid.1997.13.1229; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Foreman K, 1999, J INVEST DERMATOL, V112, P603; GENG YQ, 1992, J VIROL, V66, P1564, DOI 10.1128/JVI.66.3.1564-1570.1992; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guan MX, 1996, J VIROL, V70, P7341, DOI 10.1128/JVI.70.10.7341-7346.1996; Harrington W, 1997, LANCET, V349, P774; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; Iscovich J, 2000, CANCER-AM CANCER SOC, V88, P500, DOI 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0; Jacobson LP, 2000, J INFECT DIS, V181, P1940, DOI 10.1086/315503; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JEANG KT, 1988, J VIROL, V62, P3874, DOI 10.1128/JVI.62.10.3874-3878.1988; Kelly GO, 1998, AIDS, V12, P1753, DOI 10.1097/00002030-199814000-00006; Kim JM, 2000, J GEN VIROL, V81, P37, DOI 10.1099/0022-1317-81-1-37; Li LH, 1999, GENE THER, V6, P364, DOI 10.1038/sj.gt.3300828; Martin JC, 1999, J ACQ IMMUN DEF SYND, V22, P413; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Moir S, 1999, J VIROL, V73, P7972, DOI 10.1128/JVI.73.10.7972-7980.1999; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Morini M, 2000, BIOCHEM BIOPH RES CO, V273, P267, DOI 10.1006/bbrc.2000.2941; MOSES SV, 1999, J ACQ IMMUN DEF SYND, V21, pA28; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; NAKAMURA S, 1988, SCIENCE, V242, P426, DOI 10.1126/science.3262925; Noel JC, 1996, CANCER, V77, P2132, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2132::AID-CNCR26>3.0.CO;2-V; NOORE PS, 1996, J VIROL, V70, P549; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; Renne R, 1996, J VIROL, V70, P8151, DOI 10.1128/JVI.70.11.8151-8154.1996; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Romano G, 1997, VIROLOGY, V237, P23, DOI 10.1006/viro.1997.8764; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sarid R, 1999, ADV VIRUS RES, V52, P139, DOI 10.1016/S0065-3527(08)60299-7; Secchiero P, 1998, BLOOD, V92, P4521, DOI 10.1182/blood.V92.12.4521.424k38_4521_4528; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Weiss RA, 2000, TROP MED INT HEALTH, V5, pA10, DOI 10.1046/j.1365-3156.2000.00591.x; Yurochko AD, 1999, J HUMAN VIROL, V2, P81; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	56	67	81	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13427	13432		10.1074/jbc.M011314200	http://dx.doi.org/10.1074/jbc.M011314200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11154704	hybrid			2022-12-27	WOS:000168198600131
J	Egawa, K; Maegawa, H; Shimizu, S; Morino, K; Nishio, Y; Bryer-Ash, M; Cheung, AT; Kolls, JK; Kikkawa, R; Kashiwagi, A				Egawa, K; Maegawa, H; Shimizu, S; Morino, K; Nishio, Y; Bryer-Ash, M; Cheung, AT; Kolls, JK; Kikkawa, R; Kashiwagi, A			Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in L6 myocytes and Fao hepatoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1; INCREASED ABUNDANCE; GLUCOSE-TRANSPORT; ADIPOSE-TISSUE; RESISTANT; MICE; SENSITIVITY; ADIPOCYTES; OBESITY	Insulin signaling is regulated by tyrosine phosphorylation of the signaling molecules, such as the insulin receptor and insulin receptor substrates (IRSs), Therefore, the balance between protein-tyrosine kinases and protein-tyrosine phosphatase activities is thought to be important in the modulation of insulin signaling in insulin-resistant states. We thus employed the adenovirus-mediated gene transfer technique, and we analyzed the effect of overexpression of a wild-type protein-tyrosine phosphatase-1B (PTP1B) on insulin signaling in both L6 myocytes and Fao cells. In both cells, PTP1B overexpression blocked insulin-stimulated tyrosine phosphorylation of the insulin receptor and IRS-1 by more than 70% and resulted in a significant inhibition of the association between IRS-1 and the p85 subunit of phosphatidylinositol 3-kinase and Akt phosphorylation as well as mitogen-activated protein kinase phosphorylation, Moreover, insulin-stimulated glycogen synthesis was also inhibited by PTP1B overexpression in both cells. These effects were specific for insulin signaling, because platelet-derived growth factor (PDGF)-stimulated PDGF receptor tyrosine phosphorylation and Akt phosphorylation were not inhibited by PTP1B overexpression. The present findings demonstrate that PTP1B negatively regulates insulin signaling in L6 and Fao cells, suggesting that PTP1B plays an important role in insulin resistance in muscle and liver.	Shiga Univ Med Sci, Dept Med 3, Otsu, Shiga 5202192, Japan; Univ Tennessee, Dept Med, Memphis, TN 38104 USA; Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; Tulane Univ, Dept Physiol, New Orleans, LA 70112 USA; Louisiana State Univ, Dept Med, New Orleans, LA 70112 USA	Shiga University of Medical Science; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Tulane University; Louisiana State University System	Maegawa, H (corresponding author), Shiga Univ Med Sci, Dept Med 3, Otsu, Shiga 5202192, Japan.		Kolls, Jay/AAH-1829-2019; Kashiwagi, Atsunori/H-8712-2019; MORINO, KATSUTARO/I-3207-2019	Kolls, Jay/0000-0001-5151-6304; MORINO, KATSUTARO/0000-0003-2420-3817; Maegawa, Hiroshi/0000-0002-4611-8149	NCRR NIH HHS [RR-00211] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ahmad F, 1997, METABOLISM, V46, P1140, DOI 10.1016/S0026-0495(97)90206-7; Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; Chen H, 1997, J BIOL CHEM, V272, P8026, DOI 10.1074/jbc.272.12.8026; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gluzman Y., 1982, EUKARYOTIC VIRAL VEC, P187; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215; MAEGAWA H, 1986, AM J PHYSIOL, V251, pE616, DOI 10.1152/ajpendo.1986.251.5.E616; MAEGAWA H, 1995, J BIOL CHEM, V270, P7724, DOI 10.1074/jbc.270.13.7724; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MCGUIRE MC, 1991, DIABETES, V40, P939, DOI 10.2337/diabetes.40.7.939; MEYEROVITCH J, 1989, J CLIN INVEST, V84, P976, DOI 10.1172/JCI114261; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Wang H, 1999, TALANTA, V48, P1, DOI 10.1016/S0039-9140(97)00360-3; WHITE MF, 1994, J BIOL CHEM, V269, P1; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	25	126	134	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10207	10211		10.1074/jbc.M009489200	http://dx.doi.org/10.1074/jbc.M009489200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136729	hybrid			2022-12-27	WOS:000167996400083
J	Hildebrand, D; Tiefenbach, J; Heinzel, T; Grez, M; Maurer, AB				Hildebrand, D; Tiefenbach, J; Heinzel, T; Grez, M; Maurer, AB			Multiple regions of ETO cooperate in transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE ACTIVITY; N-COR; SIGNALING PATHWAYS; FUSION TRANSCRIPT; COREPRESSOR; T(8-21); COMPLEX; AML1; PROTEIN	In acute myeloid leukemias (AMLs) with t(8;21), the transcription factor AML1 is juxtaposed to the zinc finger nuclear protein ETO (Eight-Twenty-One), resulting in transcriptional repression of AML1 target genes. ETO has been shown to interact with corepressors, such as N-CoR and mSin3A to form complexes containing histone deacetylases. To define regions of ETO required for maximal repressor activity, we analyzed amino-terminal deletions in a transcriptional repression assay. We found that ETO mutants lacking the first 236 amino acids were not affected in their repressor activity, whereas a further deletion of 85 amino acids drastically reduced repressor function and high molecular weight complex formation. This latter mutant can still homodimerize and bind to N-CoR but shows only weak binding to mSin3A. Furthermore, we could show that a "core repressor domain" comprising nervy homology region 2 and its amino- and carboxyl-terminal flanking sequences recruits mSin3A and induces transcriptional repression. These results suggest that mSin3A and N-CoR bind to ETO independently and that both binding sites cooperate to maximize ETO-mediated transcriptional repression. Thus, ETO has a modular structure, and the interaction between the individual elements is essential for the formation of a stable repressor complex and efficient transcriptional repression.	Inst Biomed Res, D-60596 Frankfurt, Germany		Maurer, AB (corresponding author), Inst Biomed Res, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.		Heinzel, Thorsten/B-1013-2015					Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Behre G, 1999, METHODS, V17, P231, DOI 10.1006/meth.1998.0733; Davie JR, 1999, BIOCHEM CELL BIOL, V77, P265, DOI 10.1139/bcb-77-4-265; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; ERICKSON P, 1992, BLOOD, V80, P1825; ERICKSON PF, 1994, CANCER RES, V54, P1782; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Glass CK, 2000, GENE DEV, V14, P121; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Morohoshi F, 2000, GENE, V241, P287, DOI 10.1016/S0378-1119(99)00481-3; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NUCIFORA G, 1994, LEUKEMIA LYMPHOMA, V14, P353, DOI 10.3109/10428199409049690; NUCIFORA G, 1995, BLOOD, V86, P1; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Zhang JS, 2001, MOL CELL BIOL, V21, P156, DOI 10.1128/MCB.21.1.156-163.2001	32	76	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9889	9895		10.1074/jbc.M010582200	http://dx.doi.org/10.1074/jbc.M010582200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11150306	hybrid			2022-12-27	WOS:000167996400043
J	Kim, SW; Muise, AM; Lyons, PJ; Ro, HS				Kim, SW; Muise, AM; Lyons, PJ; Ro, HS			Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; KINASE-MEDIATED PHOSPHORYLATION; ADIPOCYTIC DIFFERENTIATION; RECEPTOR-GAMMA; GROWTH-FACTOR; CATALYTIC ACTIVATION; SIGNAL-TRANSDUCTION; RAF-1 KINASE; 3T3-L1 CELLS; PPAR-GAMMA	Mitogen-activated protein kinase (MAPK) is required for cell growth and cell differentiation. In adipogenesis, MAPK activation opposes the differentiation process. The regulatory mechanisms or the cellular factors that regulate the switch between growth and differentiation in the adipogenic lineage have been largely unelucidated. We show here that AEBP1, a transcriptional repressor that is down-regulated during adipogenesis, complexes and protects MAPK from its specific phosphatase in mammalian cells. We further show evidence that the modulation of MAPK activation by AEBP1 is a biologically relevant process in adipogenesis. Our results suggest that modulation of MAPK activation by the protective effect of AEBP1 may constitute a critical part in the determination between cell growth and differentiation in the adipogenic lineage. The proposed mode of action by which a transcription factor regulates MAPK activation is novel.	Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Halifax, NS B3H 4H7, Canada	Dalhousie University	Ro, HS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Sir Charles Tupper Med Bldg, Halifax, NS B3H 4H7, Canada.			Ro, Hyo-Sung/0000-0003-4411-0386; Lyons, Peter/0000-0001-5214-5445				Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; CAMP HS, 1997, J BIOL CHEM, V272, P13452; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; Elion EA, 1998, SCIENCE, V281, P1625, DOI 10.1126/science.281.5383.1625; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; He GP, 1999, J BIOL CHEM, V274, P14678, DOI 10.1074/jbc.274.21.14678; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ito T, 1996, MOL CELL BIOL, V16, P943; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Muise AM, 1999, BIOCHEM J, V343, P341, DOI 10.1042/0264-6021:3430341; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; NAVRE M, 1989, J CELL BIOL, V109, P1857, DOI 10.1083/jcb.109.4.1857; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PORRAS A, 1994, J BIOL CHEM, V269, P12741; Porras A, 1996, INT J OBESITY, V20, pS43; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SELLS MA, 1995, GENE, V152, P187, DOI 10.1016/0378-1119(94)00685-L; SERRERO G, 1991, P NATL ACAD SCI USA, V88, P3912, DOI 10.1073/pnas.88.9.3912; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	47	99	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10199	10206		10.1074/jbc.M010640200	http://dx.doi.org/10.1074/jbc.M010640200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152475	hybrid			2022-12-27	WOS:000167996400082
J	Luo, X; Choi, JY; Ko, SBH; Pushkin, A; Kurtz, I; Ahn, W; Lee, MG; Muallem, S				Luo, X; Choi, JY; Ko, SBH; Pushkin, A; Kurtz, I; Ahn, W; Lee, MG; Muallem, S			HCO3- salvage mechanisms in the submandibular gland acinar and duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BICARBONATE COTRANSPORTER; PH-REGULATORY MECHANISMS; VASCULAR SMOOTH-MUSCLE; GUINEA-PIG PANCREAS; INTRACELLULAR PH; MEMBRANE LOCALIZATION; TARGETED DISRUPTION; TISSUE DISTRIBUTION; INTERLOBULAR DUCTS; NA+/H+ EXCHANGER	In the present work, we characterized H+ and HCO3- transport mechanisms in the submandibular salivary gland (SMG) ducts of wild type, NHE2-/-, NHE3-/-, and NHE2-/-;NHES-/- double knock-out mice. The bulk of recovery from an acid load across the luminal membrane (LM) of the duct was mediated by a Na+-dependent HOE and ethyl-isopropyl-amiloride (EIPA)-inhibitable and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)-insensitive mechanism. HCO3- increased the rate of luminal Na+-dependent pH(i) recovery but did not change inhibition by HOE and EIPA or the insensitivity to DIDS. Despite expression of NHE2 and NHE3 in the LM of the duct, the same activity was observed in ducts from wild type and all mutant mice. Measurements of Na+-dependent OH- and/or HCO3- cotransport (NBC) activities in SMG acinar and duct cells showed separate DIDS-sensitive/EIPA-insensitive and DIDS-insensitive/ EIPA-sensitive NBC activities in both cell types. Functional and immunocytochemical localization of these activities in the perfused duct indicated that pNBC1 probably mediates the DIDS-sensitive/EIPA-insensitive transport in the basolateral membrane, and splice variants of NBC3 probably mediate the DIDS-insensitive/ EIPA-sensitive NBC activity in the LM of duct and acinar cells. Notably, the acinar cell NBCS variants transported HCO, but not OH-. By contrast, duct cell NBC3 transported both OH- and HCO3-. Accordingly, reverse transcription-polymerase chain reaction analysis revealed that both cell types expressed mRNA for pNBC1, However, the acini expressed mRNA for the NBC3 splice variants NBCn1C and NBCn1D, whereas the ducts expressed mRNA for NCBn1B, Based on these findings we propose that the luminal NBCs in the HCO3- secreting SMG acinar and duct cells function as HCO3- salvage mechanisms at the resting state, These studies emphasize the complexity but also begin to clarify the mechanism of HCO3- homeostasis in secretory epithelia.	Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA; Univ Calif Los Angeles, Dept Med, Div Nephrol, Los Angeles, CA 90024 USA; Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; Yonsei University; Yonsei University Health System	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.		Ko, Shigeru/H-3450-2012; Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012	Ko, Shigeru/0000-0003-1913-6357; Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X	NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK46976, DK38938] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046976, R01DK038938] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; ARGENT BE, 1994, PHYSL GASTROINTESTIN, P1478; BOBIK A, 1990, CLIN EXP PHARMACOL P, V17, P297, DOI 10.1111/j.1440-1681.1990.tb01324.x; Chaturapanich G, 1997, J PHYSIOL-LONDON, V503, P583, DOI 10.1111/j.1469-7793.1997.583bg.x; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2000, J CLIN INVEST, V105, P1141, DOI 10.1172/JCI9260; Cook D. I., 1994, P1061; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P169, DOI 10.1113/jphysiol.1996.sp021582; JOHANSEN PG, 1968, LANCET, V1, P455; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 2000, J CLIN INVEST, V105, P1651, DOI 10.1172/JCI9207; Lee MG, 1998, J PHYSIOL-LONDON, V513, P341, DOI 10.1111/j.1469-7793.1998.341bb.x; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; LITTLE PJ, 1995, CARDIOVASC RES, V29, P239, DOI 10.1016/0008-6363(96)88576-2; MARINO GR, 1999, AM J PHYSIOL, V277, pG487; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Park K, 1999, AM J PHYSIOL-GASTR L, V276, pG470, DOI 10.1152/ajpgi.1999.276.2.G470; PAULAIS M, 1994, AM J PHYSIOL, V266, pC1594, DOI 10.1152/ajpcell.1994.266.6.C1594; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Romero MF, 1999, ANNU REV PHYSIOL, V61, P699, DOI 10.1146/annurev.physiol.61.1.699; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Thevenod F, 1999, BIOCHEM BIOPH RES CO, V264, P291, DOI 10.1006/bbrc.1999.1484; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57; ZHAO H, 1995, J BIOL CHEM, V270, P19599, DOI 10.1074/jbc.270.33.19599	34	69	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9808	9816		10.1074/jbc.M008548200	http://dx.doi.org/10.1074/jbc.M008548200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139574	hybrid			2022-12-27	WOS:000167996400032
J	Kimura, K; Cuvier, O; Hirano, T				Kimura, K; Cuvier, O; Hirano, T			Chromosome condensation by a human condensin complex in Xenopus egg extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							13S CONDENSIN; PROTEIN COMPLEXES; HEAT REPEATS; IN-VITRO; HOMOLOG; DNA; PHOSPHORYLATION; IDENTIFICATION; SEGREGATION; SEPARATION	13S condensin is a five-subunit protein complex that plays a central role in mitotic chromosome condensation. The condensin complex was originally identified and purified from Xenopus egg extracts and shown to have an ATP-dependent positive supercoiling activity in vitro. We report here the characterization of a human condensin complex purified from HeLa cell nuclear extracts. The human 13S complex has exactly the same composition as its Xenopus counterpart, being composed of two structural maintenance of chromosomes (human chromosome-associated polypeptide (hCAP)-C and hCAP-E) subunits and three non-structural maintenance of chromosomes (hCAP-D2/CNAP1, hCAP-G, and hCAP-H/BRRN) subunits. Human condensin purified from asynchronous HeLa cell cultures fails to reconfigure DNA structure in vitro. When phosphorylated by purified cdc2-cyclin B, however, it gains the ability to introduce positive supercoils into DNA in the presence of ATP and topoisomerase I. Strikingly, human condensin can induce chromosome condensation when added back into a Xenopus egg extract that has been immunodepleted of endogenous condensin. Thus, the structure and function of the condensin complex are highly conserved between Xenopus and humans, underscoring its fundamental importance in mitotic chromosome dynamics in eukaryotic cells.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Hirano, T (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd,POB 100, Cold Spring Harbor, NY 11724 USA.		CUVIER, Olivier/AAC-4693-2019; Hirano, Tatsuya/F-6008-2011; Cuvier, Olivier/ADO-0657-2022	CUVIER, Olivier/0000-0003-0644-2734; Hirano, Tatsuya/0000-0002-4219-6473; 	NIGMS NIH HHS [R01-GM153926] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Cabello OA, 1997, GENOMICS, V46, P311, DOI 10.1006/geno.1997.5021; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Jager D, 2000, CANCER RES, V60, P3584; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271	21	143	152	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 23	2001	276	8					5417	5420		10.1074/jbc.C000873200	http://dx.doi.org/10.1074/jbc.C000873200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404RU	11136719	hybrid			2022-12-27	WOS:000167115100002
J	Huber, HE; Robinson, RG; Watkins, A; Nahas, DD; Abrams, MT; Buser, CA; Lobell, RB; Patrick, D; Anthony, NJ; Dinsmore, CJ; Graham, SL; Hartman, GD; Lumma, WC; Williams, TM; Heimbrook, DC				Huber, HE; Robinson, RG; Watkins, A; Nahas, DD; Abrams, MT; Buser, CA; Lobell, RB; Patrick, D; Anthony, NJ; Dinsmore, CJ; Graham, SL; Hartman, GD; Lumma, WC; Williams, TM; Heimbrook, DC			Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOGS; FARNESYLTRANSFERASE INHIBITORS; SUBSTRATE-BINDING; STEADY-STATE; FARNESYL TRANSFERASE; KINETIC MECHANISM; TRANSGENIC MICE; TUMOR-CELLS; K-RAS; N-RAS	We have identified and characterized potent and specific inhibitors of geranylgeranyl-protein transferase type I (GGPTase I), as well as dual inhibitors of GGPTase I and farnesyl-protein transferase. Many of these inhibitors require the presence of phosphate anions for maximum activity against GGPTase I in vitro, Inhibitors with a strong anion dependence were competitive with geranylgeranyl pyrophosphate (GGPP), rather than with the peptide substrate, which had served as the original template for inhibitor design. One of the most effective anions was ATP, which at low millimolar concentrations increased the potency of GGPTase I inhibitors up to several hundred-fold. In the case of clinical candidate L-778,123, this increase in potency was shown to result from two major interactions: competitive binding of inhibitor and GGPP, and competitive binding of ATP and GGPP, At 5 mM, ATP caused an increase in the apparent K-d for the GGPP-GGPTase I interaction from 20 pM to 4 nM, resulting in correspondingly tighter inhibitor binding. A subset of very potent GGPP-competitive inhibitors displayed slow tight binding to GGPTase I with apparent on and off rates on the order of 10(6) M-1 s(-1) and 10(-3) s(-1) respectively, Slow binding and the anion requirement suggest that these inhibitors may act as transition state analogs. After accounting for anion requirement, slow binding, and mechanism of competition, the structure-activity relationship determined in vitro correlated well with the inhibition of processing of GGPTase I substrate Rap1a in vivo.	Merck Res Labs, Dept Canc Res, West Point, PA 19486 USA; Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company	Huber, HE (corresponding author), Merck Res Labs, Dept Canc Res, 770 Sumneytown Pike, West Point, PA 19486 USA.	hans_huber@merck.com	Patrick, Donald/Y-2460-2019	Patrick, Donald/0000-0003-0756-0492				Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; BUKHTIYAROV YE, 1995, J BIOL CHEM, V270, P19035, DOI 10.1074/jbc.270.32.19035; COX AD, 1994, J BIOL CHEM, V269, P19203; DOLENCE JM, 1995, P NATL ACAD SCI USA, V92, P5008, DOI 10.1073/pnas.92.11.5008; Dolence JM, 1995, BIOCHEMISTRY-US, V34, P16687, DOI 10.1021/bi00051a017; Du W, 1999, CANCER RES, V59, P5492; Heimbrook DC, 1998, CURR OPIN CELL BIOL, V10, P284, DOI 10.1016/S0955-0674(98)80152-X; Huang CC, 2000, BIOCHEMISTRY-US, V39, P2593, DOI 10.1021/bi992356x; James G, 1996, P NATL ACAD SCI USA, V93, P4454, DOI 10.1073/pnas.93.9.4454; Kapus A, 1999, J BIOL CHEM, V274, P8093, DOI 10.1074/jbc.274.12.8093; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Martin MB, 1999, BIOCHEM BIOPH RES CO, V263, P754, DOI 10.1006/bbrc.1999.1404; Mazet JL, 1999, FEBS LETT, V460, P235, DOI 10.1016/S0014-5793(99)01355-1; Miquel K, 1997, CANCER RES, V57, P1846; Mu YQ, 1996, J AM CHEM SOC, V118, P1817; MUEHLBACHER M, 1988, BIOCHEMISTRY-US, V27, P7315, DOI 10.1021/bi00419a021; OMER CA, 1995, METHOD ENZYMOL, V250, P3; Omer CA, 2000, CANCER RES, V60, P2680; PICKETT WC, 1995, ANAL BIOCHEM, V225, P60, DOI 10.1006/abio.1995.1108; POMPLIANO DL, 1993, BIOCHEMISTRY-US, V32, P8341, DOI 10.1021/bi00083a038; POULTER CD, 1978, ACCOUNTS CHEM RES, V11, P307, DOI 10.1021/ar50128a004; Prendergast GC, 2000, CURR OPIN CELL BIOL, V12, P166, DOI 10.1016/S0955-0674(99)00072-1; Qian YM, 1998, BIOORGAN MED CHEM, V6, P293, DOI 10.1016/S0968-0896(97)10040-2; Radisky ES, 2000, BIOCHEMISTRY-US, V39, P1748, DOI 10.1021/bi9915014; REARDON JE, 1986, BIOCHEMISTRY-US, V25, P5609, DOI 10.1021/bi00367a040; Roskoski R, 1998, ARCH BIOCHEM BIOPHYS, V356, P167, DOI 10.1006/abbi.1998.0768; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Scholten JD, 1997, J BIOL CHEM, V272, P18077, DOI 10.1074/jbc.272.29.18077; Sepp-Lorenzino L, 1998, J BIOL CHEM, V273, P20243, DOI 10.1074/jbc.273.32.20243; Stirtan WG, 1997, BIOCHEMISTRY-US, V36, P4552, DOI 10.1021/bi962579c; Sun JZ, 1999, CANCER RES, V59, P4919; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Unlu S, 2000, J CARDIOVASC PHARM, V35, P341, DOI 10.1097/00005344-200002000-00025; Vasudevan A, 1999, J MED CHEM, V42, P1333, DOI 10.1021/jm9900873; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yokoyama K, 1997, J BIOL CHEM, V272, P3944, DOI 10.1074/jbc.272.7.3944; YOKOYAMA K, 1995, BIOCHEMISTRY-US, V34, P1344, DOI 10.1021/bi00004a029; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; ZHANG FL, 1994, J BIOL CHEM, V269, P3175; Zhang FL, 1996, BIOCHEM J, V320, P925, DOI 10.1042/bj3200925; Zhang FL, 1997, J BIOL CHEM, V272, P10232; ZHANG FL, 1994, J BIOL CHEM, V269, P23465	45	27	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					24457	24465		10.1074/jbc.M100325200	http://dx.doi.org/10.1074/jbc.M100325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11274181	hybrid			2022-12-27	WOS:000169800700007
J	Grizot, S; Fieschi, F; Dagher, MC; Pebay-Peyroula, E				Grizot, S; Fieschi, F; Dagher, MC; Pebay-Peyroula, E			The active N-terminal region of p67(phox) - Structure at 1.8 angstrom resolution and biochemical characterizations of the A128V mutant implicated in chronic granulomatous disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; ACTIVATION DOMAIN; TPR DOMAIN; RAC; COMPONENT; IDENTIFICATION; COMPLEX; SYSTEM	Upon activation, the NADPH oxidase from neutrophils produces superoxide anions in response to microbial infection. This enzymatic complex is activated by association of its cytosolic factors p67(phox), p47(phox), and the small G protein Rac with a membrane-associated flavocytochrome b(558). Here we report the crystal structure of the active N-terminal fragment of p67(phox) at 1.8 Angstrom resolution, as well as functional studies of p67(phox) mutants. This N-terminal region (residues 1-213) consists mainly of four TPR (tetratricopeptide repeat) motifs in which the C terminus folds back into a hydrophobic groove formed by the TPR domain. The structure is very similar to that of the inactive truncated form of p67(phox) bound to the small C: protein Rac previously reported, but differs by the presence of a short C-terminal helix (residues 187-193) that might be part of the activation domain. All p67(phox) mutants responsible for Chronic Granulomatous Disease (CGD), a severe defect of NADPH oxidase function, are localized in the N-terminal region. We investigated two CGD mutations, G78E and A128V, Surprisingly, the A128V CGD mutant is able to fully activate the NADPH oxidase in vitro at 25 degreesC, However, this point mutation represents a temperature-sensitive defect in p67(phox) that explains its phenotype at physiological temperature.	UJF, CEA, Inst Biol Struct, CNRS,UMR 5075, F-38027 Grenoble 1, France; UJF, CEA Grenoble, Dept Biol Mol & Struct, Lab Biochim & Biophys Syst Integres,CNRS,UMR 5092, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pebay-Peyroula, E (corresponding author), UJF, CEA, Inst Biol Struct, CNRS,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	pebay@ibs.fr	Fieschi, Franck/W-2748-2019	GRIZOT, Sylvestre/0000-0002-0670-0687; DAGHER, Marie-Claire/0000-0001-6878-3169; FIESCHI, Franck/0000-0003-1194-8107				Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP N4, 1994, ACTA CRYSTALLOGR D, V50, P905; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DEBOER M, 1994, BLOOD, V83, P531, DOI 10.1182/blood.V83.2.531.bloodjournal832531; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; FUCHS A, 1995, J BIOL CHEM, V270, P5695, DOI 10.1074/jbc.270.11.5695; FUCHS A, 1994, EUR J BIOCHEM, V226, P587, DOI 10.1111/j.1432-1033.1994.tb20084.x; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Leusen JHW, 1996, J EXP MED, V184, P1243, DOI 10.1084/jem.184.4.1243; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Noack D, 1999, HUM GENET, V105, P460, DOI 10.1007/s004390051131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patino PJ, 1999, BLOOD, V94, P2505, DOI 10.1182/blood.V94.7.2505.419k10_2505_2514; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	31	65	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21627	21631		10.1074/jbc.M100893200	http://dx.doi.org/10.1074/jbc.M100893200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262407	hybrid			2022-12-27	WOS:000169297900110
J	Sampson, DA; Wang, M; Matunis, MJ				Sampson, DA; Wang, M; Matunis, MJ			The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SURIO-1 modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; CONJUGATING ENZYME; COVALENT MODIFICATION; MOLECULAR-CLONING; C-JUN; RANGAP1; COMPLEX; P53; LOCALIZATION; MODULATION	SUMO-1 is an ubiquitin-related protein that is covalently conjugated to a diverse assortment of proteins. The consequences of SUMO-1 modification include the regulation of protein-protein interactions, protein-DNA interactions, and protein subcellular localization. At present, very little is understood about the specific mechanisms that govern the recognition of proteins as substrates for SUMO-1 modification. However, many of the proteins that are modified by SUMO-1 interact directly with the SUMO-1 conjugating enzyme, Ubc9, These interactions suggest that Ubc9 binding may play an important role in substrate recognition as well as in substrate modification. The SUMO-1 consensus sequence (SUMO-1-CS) is a motif of conserved residues surrounding the modified lysine residue of most SUMO-1 substrates. This motif conforms to the sequence "Psi KXE," where Psi is a large hydrophobic residue, K is the lysine to which SUMO-1 is conjugated, X is any amino acid, and E is glutamic acid. In this study, we demonstrate that the SUMO-1-CS is a major determinant of Ubc9 binding and SUMO-1 modification. Mutating residues in the SUMO-1-CS abolishes both Ubc9 binding and substrate modification. These findings have important implications for how SUMO-1 substrates are recognized and for how SUMO-1 is ultimately transferred to specific lysine residues on these substrates.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, MJ (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	mmatunis@jhsph.edu		Matunis, Michael/0000-0002-9350-6611	NIGMS NIH HHS [GM60980] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chakrabarti SR, 1999, P NATL ACAD SCI USA, V96, P7467, DOI 10.1073/pnas.96.13.7467; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Duprez E, 1999, J CELL SCI, V112, P381; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; GOODSON ML, 2001, IN PRESS J BIOL CHEM, V276; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Gottlicher M, 1996, STEROIDS, V61, P257, DOI 10.1016/0039-128X(96)00032-3; Hahn SL, 1997, ONCOGENE, V15, P1489, DOI 10.1038/sj.onc.1201301; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Masson M, 1997, GENE, V190, P287, DOI 10.1016/S0378-1119(97)00015-2; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; RECHSTEINER M, 1989, RBC-CELL BIOL REV, V20, P235; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tashiro K, 1997, P NATL ACAD SCI USA, V94, P7862, DOI 10.1073/pnas.94.15.7862; Wang ZY, 1996, J BIOL CHEM, V271, P24811, DOI 10.1074/jbc.271.40.24811; Yamao F, 1999, J BIOCHEM-TOKYO, V125, P223, DOI 10.1093/oxfordjournals.jbchem.a022277; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	45	392	405	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21664	21669		10.1074/jbc.M100006200	http://dx.doi.org/10.1074/jbc.M100006200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259410	hybrid			2022-12-27	WOS:000169297900115
J	Suzuki, T; Park, H; Kwofie, MA; Lennarz, WJ				Suzuki, T; Park, H; Kwofie, MA; Lennarz, WJ			Rad23 provides a link between the Png1 deglycosylating enzyme and the 26 S proteasome in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR TFIIH; UBIQUITIN-LIKE DOMAIN; PEPTIDE-N-GLYCANASE; I HEAVY-CHAINS; ENDOPLASMIC-RETICULUM; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; QUALITY-CONTROL	In addition to a role in DNA repair events in yeast, several lines of evidence indicate that the Rad23 protein (Rad23p) may regulate the activity of the 26 S proteasome. We report evidence that a de-N-glycosylating enzyme, Png1p, may be involved in the proteasomal degradation pathway via its binding to Rad23p. Interaction of Rad23p and Png1p was first detected by two-hybrid screening, and this interaction in vivo was confirmed by biochemical analyses. The Png1p-Rad23p complex was shown to be distinct from the well established DNA repair complex, Rad4p-Rad23p. We propose a model in which Rad23p functions as an escort protein to link the 26 S proteasome with proteins such as Rad4p or Png1p to regulate their cellular activities.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lennarz, WJ (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	wlennarz@notes.cc.sunysb.edu	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631; Kwofie, Michael/0000-0003-4632-5436	NIGMS NIH HHS [GM33184] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033184] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; de Laat WL, 1993, GENE DEV, V13, P768; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Guzder SN, 1996, J BIOL CHEM, V271, P8903, DOI 10.1074/jbc.271.15.8903; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Guzder SN, 1998, J BIOL CHEM, V273, P31541, DOI 10.1074/jbc.273.47.31541; GUZDER SN, 1995, J BIOL CHEM, V270, P8385, DOI 10.1074/jbc.270.15.8385; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HOFFMAN K, 1996, TRENDS BIOCHEM SCI, V21, P172; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; James P, 1996, GENETICS, V144, P1425; Jansen LET, 1998, J BIOL CHEM, V273, P33111, DOI 10.1074/jbc.273.50.33111; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lambertson D, 1999, GENETICS, V153, P69; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lord JM, 2000, SEMIN CELL DEV BIOL, V11, P159; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park H, 1998, CHROMOSOMA, V107, P211, DOI 10.1007/s004120050299; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Romisch K, 1999, J CELL SCI, V112, P4185; Rose MD., 1990, METHODS YEAST GENETI; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 1996, MOL CELL BIOL, V16, P4852; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; VERLAGE RA, 1996, MUTAT RES, V362, P155; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Weng S, 1997, BIOCHEM J, V322, P655, DOI 10.1042/bj3220655; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	56	97	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21601	21607		10.1074/jbc.M100826200	http://dx.doi.org/10.1074/jbc.M100826200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259433	hybrid			2022-12-27	WOS:000169297900107
J	Marshall, P; Chartrand, N; Worton, RG				Marshall, P; Chartrand, N; Worton, RG			The mouse dystrophin enhancer is regulated by MyoD, E-box-binding factors, and by the serum response factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED DILATED CARDIOMYOPATHY; MUSCLE-SPECIFIC ENHANCER; BECKER MUSCULAR-DYSTROPHY; CREATINE-KINASE GENE; CARDIAC ACTIN GENE; GEL-ELECTROPHORESIS; TRANSGENIC MICE; PROMOTER REGION; BASIC REGION; DNA-BINDING	In vivo studies in the mouse have revealed that the muscle promoter of the mouse dystrophin gene can target the right ventricle of the heart only, suggesting the need for other regulatory elements to target the skeletal muscle as well as other compartments of the heart. In this study we report the identification of the mouse dystrophin gene enhancer that is located similar to8.5 kilobases downstream from the mouse dystrophin gene muscle promoter. The enhancer was tested in myogenic G8, H9-C2, and nonmyogenic 3T3 cell lines and is mostly active in G8 myotubes. Sequence analysis of the mouse dystrophin gene enhancer revealed the presence of four E-boxes numbered E1-E4, a putative mef-2 binding site, and a serum response element. Site-directed mutagenesis studies have shown that E-boxes 1, 2, and 3 as well as the serum response element are required for enhancer activity. Gel shift analysis revealed two binding activities at binding sites E1 and E3 which were specific to myotubes, and supershift assays confirmed that myoD binds at both these sites. Our study also shows that werum response factor binds the serum response element but in myoblasts and fibroblasts only, suggesting that serum response factor may repress enhancer function.	Ottawa Gen Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Worton, RG (corresponding author), Ottawa Gen Hosp, Res Inst, 501 Smyth, Ottawa, ON K1H 8L6, Canada.							AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; APONE S, 1995, J BIOL CHEM, V270, P21420, DOI 10.1074/jbc.270.36.21420; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHAKRABORTY T, 1992, J BIOL CHEM, V267, P17498; CHRISTIAN CN, 1977, SCIENCE, V196, P995, DOI 10.1126/science.193191; CROTHERS DM, 1991, METHOD ENZYMOL, V208, P118; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diagana TT, 1997, J MOL BIOL, V265, P480, DOI 10.1006/jmbi.1996.0752; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708; Galvagni F, 1997, MOL CELL BIOL, V17, P1731, DOI 10.1128/MCB.17.3.1731; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; HOFFMAN EP, 1987, SCIENCE, V238, P347, DOI 10.1126/science.3659917; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JAYNES RB, 1989, MOL CELL BIOL, V8, P62; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kimura S, 1997, DEV GROWTH DIFFER, V39, P257, DOI 10.1046/j.1440-169X.1997.t01-2-00001.x; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; Klamut HJ, 1997, NUCLEIC ACIDS RES, V25, P1618, DOI 10.1093/nar/25.8.1618; Klamut HJ, 1996, HUM MOL GENET, V5, P1599, DOI 10.1093/hmg/5.10.1599; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; LIN H, 1992, J BIOL CHEM, V267, P4773; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nakamura A, 1997, AM J HUM GENET, V60, P1555; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Strauss EC, 1999, METHOD ENZYMOL, V304, P572; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242	57	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20719	20726		10.1074/jbc.M102100200	http://dx.doi.org/10.1074/jbc.M102100200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259421	hybrid			2022-12-27	WOS:000169135100139
J	Myers, FA; Evans, DR; Clayton, AL; Thorne, AW; Crane-Robinson, C				Myers, FA; Evans, DR; Clayton, AL; Thorne, AW; Crane-Robinson, C			Targeted and extended acetylation of histones H4 and H3 at active and inactive genes in chicken embryo erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; TRANSCRIPTIONAL REPRESSION; ACETYLTRANSFERASE ACTIVITY; CHROMATIN STRUCTURE; NUCLEOSOMAL DNA; YEAST GCN5P; IN-VIVO; N-COR; DEACETYLASE	Affinity-purified polyclonal antibodies recognizing the most highly acetylated forms of histones H3 and H4 were used in immunoprecipitation assays with chromatin fragments derived from 15-day chicken embryo erythrocytes by micrococcal nuclease digestion. The distribution of hyperacetylated H4 and H3 was mapped at the housekeeping gene, glyceraldehyde S-phosphate dehydrogenase (GAPDH), and the tissue-specific gene, carbonic anhydrase (CA), H3 and H4 acetylation was found targeted to the CpG island region at the 5' end of both these genes, falling off in the downstream direction. In contrast, at the beta (A)-globin gene, both H3 and H4 are highly acetylated throughout the gene and at the downstream enhancer, with a maximum at the promoter. Low level acetylation was observed at the 5' end of the inactive ovalbumin gene. Run-on assays to measure ongoing transcription showed that the GAPDH and CA genes are transcribed at a much lower rate than the adult beta (A)-globin gene. The extensive high level acetylation at the beta (A)-globin gene correlates most simply with its high rate of transcription. The targeted acetylation of histones H3 and H4 at the GAPDH and CA genes is consistent with a role in transcriptional initiation and implies that transcriptional elongation does not necessarily require hyperacetylation.	Univ Portsmouth, Fac Sci, Biophys Lab, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England	University of Portsmouth	Crane-Robinson, C (corresponding author), Univ Portsmouth, Fac Sci, Biophys Lab, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England.		, thorne/AAC-4984-2020	, thorne/0000-0002-8670-2358; Myers, Fiona/0000-0001-5568-1817				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BONNER WM, 1980, EUR J BIOCHEM, V109, P17, DOI 10.1111/j.1432-1033.1980.tb04762.x; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; CLAYTON AL, 1993, FEBS LETT, V336, P23, DOI 10.1016/0014-5793(93)81601-U; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; CraneRobinson C, 1997, METHODS, V12, P48, DOI 10.1006/meth.1997.0446; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HEBBES TR, 1989, MOL IMMUNOL, V26, P865, DOI 10.1016/0161-5890(89)90143-0; HEBBES TR, 1992, NUCLEIC ACIDS RES, V20, P1017, DOI 10.1093/nar/20.5.1017; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Ito T, 2000, GENE DEV, V14, P1899; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LANDES GM, 1982, J BIOL CHEM, V257, P1002; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; ORGYZKO VV, 1996, CELL, V87, P953; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; RODAWAY ARF, 1990, MOL CELL BIOL, V10, P5388, DOI 10.1128/MCB.10.10.5388; Schubeler D, 2000, GENE DEV, V14, P940; STONE EM, 1985, P NATL ACAD SCI USA, V82, P1628, DOI 10.1073/pnas.82.6.1628; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Vitolo JM, 2000, MOL CELL BIOL, V20, P2167, DOI 10.1128/MCB.20.6.2167-2175.2000; Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; YOSHIHARA CM, 1987, NUCLEIC ACIDS RES, V15, P753, DOI 10.1093/nar/15.2.753; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	52	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20197	20205		10.1074/jbc.M009472200	http://dx.doi.org/10.1074/jbc.M009472200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274167	hybrid			2022-12-27	WOS:000169135100072
J	Pringa, E; Martinez-Noel, G; Muller, U; Harbers, K				Pringa, E; Martinez-Noel, G; Muller, U; Harbers, K			Interaction of the RING finger-related U-box motif of a nuclear dot protein with ubiquitin-conjugating enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; LIGASES; SYSTEM; E2; DEGRADATION; EFFICIENT; LOCATION; DOMAINS; COMPLEX; DEFECT	The U-box domain has been suggested to be a modified RING finger motif where the metal-coordinating cysteines and histidines have been replaced with other amino acids. Known U-box-containing proteins have been implicated in the ubiquitin/proteasome system. In a search for proteins interacting with the ubiquitin-conjugating enzyme UbcM4/UbcH7, we have identified a novel U-box containing protein, termed UIP5, that is exclusively found in the nucleus as part of a nuclear dot-like structure. Interaction between UbcM4 and UIP5 was observed in vivo and in vitro with bacterially expressed proteins. In addition to UbcM4, several other ubiquitin-conjugating enzymes (E2s) that share the same sequence within the L1 loop bind to UIP5. Mutational analysis showed that the U-box, like the RING finger in other proteins, forms the physical basis for the interaction with E2 enzymes. Further support for the structural similarity between U-box and RING finger comes from the observation that, in both cases, the same regions within the UbcM4 molecule are required for interaction, Our results establish at the molecular level a link between the U-box and the ubiquitin conjugating system and strongly suggest that proteins containing U-box domains are functionally closely related to RING finger proteins.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Harbers, K (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.							Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Hateboer G, 1996, J BIOL CHEM, V271, P25906, DOI 10.1074/jbc.271.42.25906; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; Muller U, 1998, GENE, V224, P109, DOI 10.1016/S0378-1119(98)00515-0; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Ruthardt M, 1998, ONCOGENE, V16, P1945, DOI 10.1038/sj.onc.1201722; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	39	36	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19617	19623		10.1074/jbc.M100192200	http://dx.doi.org/10.1074/jbc.M100192200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11274149	hybrid			2022-12-27	WOS:000169091000127
J	Onodera, Y; Suzuki, A; Wu, CY; Washida, H; Takaiwa, F				Onodera, Y; Suzuki, A; Wu, CY; Washida, H; Takaiwa, F			A rice functional transcriptional activator, RISBZ1, responsible for endosperm-specific expression of storage protein genes through GCN4 motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; GLUTELIN GENE; BZIP PROTEIN; PLANT EMBRYOGENESIS; BARLEY ENDOSPERM; GCN4-LIKE MOTIF; ZIPPER PROTEIN; LEUCINE ZIPPER; PROLAMIN-BOX; OPAQUE-2	The GCN4 motif, a cis-element that is highly conserved in the promoters of cereal seed storage protein genes, plays a central role in controlling endosperm-specific expression. This motif is the recognition site for a basic leucine zipper transcriptional factor that belongs to the group of maize Opaque-2 (O2)-like proteins. Five different basic leucine zipper cDNA clones, designated RISBZ1-5, have been isolated from a rice seed cDNA library. The predicted gene products can be divided into two groups based on their amino acid sequences. Although all the RISBZ proteins are able to interact with the GCN4 motif, only RISBZ1 is capable of activating (more than 100-fold expression) the expression of a reporter gene under a minimal promoter fused to a pentamer of the GCN4 motif, Loss-of-function and gain-of-function experiments using the yeast GAL4 DNA binding domain revealed that the proline-rich N-terminal domain (27 amino acids in length) is responsible for transactivation, The RISBZ1 protein is capable of forming homodimers as well as heterodimers with other RISBZ subunit proteins. RISBZ1 gene expression is restricted to the seed, where it precedes the expression of storage protein genes. When the RISBZ1 promoter was transcriptionally fused to the beta -glucuronidase reporter gene and the chimeric gene was introduced into rice, the beta -glucuronidase gene is specifically expressed in aleurone and subaleurone layer of the developing endosperm, These findings suggest that the specific expression of transcriptional activator RISBZ1 gene may determine the endosperm specificity of the storage protein genes.	Natl Inst Agrobiol Resources, Dept Biotechnol, Tsukuba, Ibaraki 3058602, Japan; Chiba Univ, Fac Hort, Matsudo, Chiba 2718510, Japan	National Institute of Agrobiological Sciences - Japan; Chiba University	Takaiwa, F (corresponding author), Natl Inst Agrobiol Resources, Dept Biotechnol, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.			Washida, Haruhiko/0000-0001-7372-9503				Albani D, 1997, PLANT CELL, V9, P171, DOI 10.1105/tpc.9.2.171; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Ciceri P, 1997, PLANT CELL, V9, P97, DOI 10.1105/tpc.9.1.97; Conlan RS, 1999, PLANT J, V19, P173, DOI 10.1046/j.1365-313X.1999.00522.x; DAPATER S, 1993, PLANT CELL, V5, P877; DEPATER S, 1994, PLANT J, V6, P133, DOI 10.1046/j.1365-313X.1994.6020133.x; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; HAMMONDKOSACK MCU, 1993, EMBO J, V12, P545, DOI 10.1002/j.1460-2075.1993.tb05686.x; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Holdsworth MJ, 1995, PLANT MOL BIOL, V29, P711, DOI 10.1007/BF00041162; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IZAWA T, 1994, PLANT CELL, V6, P1277, DOI 10.1105/tpc.6.9.1277; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KIM SY, 1990, NUCLEIC ACIDS RES, V18, P6845, DOI 10.1093/nar/18.23.6845; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LOHMER S, 1991, EMBO J, V10, P617, DOI 10.1002/j.1460-2075.1991.tb07989.x; LOHMER S, 1993, PLANT CELL, V5, P65, DOI 10.1105/tpc.5.1.65; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; Marzabal P, 1998, PLANT J, V16, P41, DOI 10.1046/j.1365-313x.1998.00272.x; Mena M, 1998, PLANT J, V16, P53, DOI 10.1046/j.1365-313x.1998.00275.x; MENKENS AE, 1994, P NATL ACAD SCI USA, V91, P2522, DOI 10.1073/pnas.91.7.2522; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORTON RL, 1995, SEED DEV GERMINATION, P103; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Nakase M, 1997, PLANT MOL BIOL, V33, P513, DOI 10.1023/A:1005784717782; Nakayama T, 1997, MOL GEN GENET, V253, P553, DOI 10.1007/s004380050357; NETO GC, 1995, PLANT MOL BIOL, V27, P1015, DOI 10.1007/BF00037028; Onate L, 1999, J BIOL CHEM, V274, P9175, DOI 10.1074/jbc.274.14.9175; PIROVANO L, 1994, PLANT MOL BIOL, V24, P515, DOI 10.1007/BF00024119; PYSH LD, 1993, PLANT CELL, V5, P227, DOI 10.1105/tpc.5.2.227; Sambrook J., 2002, MOL CLONING LAB MANU; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Schmitz D, 1997, NUCLEIC ACIDS RES, V25, P756, DOI 10.1093/nar/25.4.756; Suzuki A, 1998, PLANT CELL PHYSIOL, V39, P555, DOI 10.1093/oxfordjournals.pcp.a029404; TAKAIWA F, 1987, MOL GEN GENET, V208, P15, DOI 10.1007/BF00330416; Takaiwa F, 1996, PLANT MOL BIOL, V30, P1207, DOI 10.1007/BF00019553; THOMAS TL, 1993, PLANT CELL, V5, P1401, DOI 10.1105/tpc.5.10.1401; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Vettore AL, 1998, PLANT MOL BIOL, V36, P249, DOI 10.1023/A:1005995806897; Vicente-Carbajosa J, 1998, PLANT J, V13, P629, DOI 10.1111/j.1365-313X.1998.00068.x; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; WEINBERGER J, 1986, NATURE, V322, P846, DOI 10.1038/322846a0; Wu CY, 1998, PLANT J, V14, P673, DOI 10.1046/j.1365-313x.1998.00167.x; Wu CY, 2000, PLANT J, V23, P415, DOI 10.1046/j.1365-313x.2000.00797.x; Yoshihara T, 1996, FEBS LETT, V383, P213, DOI 10.1016/0014-5793(96)00233-5; ZHENG ZW, 1993, PLANT J, V4, P357, DOI 10.1046/j.1365-313X.1993.04020357.x	53	125	143	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14139	14152		10.1074/jbc.M007405200	http://dx.doi.org/10.1074/jbc.M007405200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11133985	hybrid			2022-12-27	WOS:000168356600086
J	Kieschnick, H; Wakefield, T; Narducci, CA; Beckers, C				Kieschnick, H; Wakefield, T; Narducci, CA; Beckers, C			Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROPERTIES; PLASMODIUM-FALCIPARUM; PARAMECIUM-TETRAURELIA; INTRACELLULAR CALCIUM; INVASION; EXPRESSION; MOBILIZATION; PURIFICATION; FAMILY; CA2+	The role of calcium-dependent protein kinases in the invasion of Toxoplasma gondii into its animal host cells was analyzed. KT5926, an inhibitor of calcium-dependent protein kinases in other systems, is known to block. the motility of Toxoplasma tachyzoites and their attachment to host cells. lit vivo, KT5926 blocks the phosphorylation of only three parasite proteins, and in parasite extracts only a single KT5926-sensitive protein kinase activity was detected. This activity was calcium-dependent but did not require calmodulin, In a search for calcium-dependent protein kinases in Toxoplasma, two members of the class of calmodulin-like domain protein kinases (CDPKs) were detected. TgCDPK2 was only expressed at the mRNA level in tachyzoites, but no protein was detected, TgCDPK1 protein was expressed in Toxoplasma tachyzoites and cofractionated precisely with the peak of KT5926-sensitive protein kinase activity. TgCDPK1 kinase activity was calcium-dependent but did not require calmodulin or phospholipids. TgCDPK1 was found to be inhibited effectively by KT5926 at concentrations that block parasite attachment to host cells. In vitro, TgCDPK1 phosphorylated three parasite proteins that migrated identical to the three KT5926-sensitive phosphoproteins detected in vivo, Based on these observations, a central role is suggested for TgCDPK1 in regulating Toxoplasma motility and host cell invasion.	Univ Alabama Birmingham, Div Geog Med, BBRB 206, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beckers, C (corresponding author), Univ Alabama Birmingham, Div Geog Med, BBRB 206, 845 19th St S, Birmingham, AL 35294 USA.	cbeckers@uab.edu			NIAID NIH HHS [AI41765] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041765, R01AI041765] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Bohne W, 1999, IMMUNOBIOLOGY, V201, P248, DOI 10.1016/S0171-2985(99)80065-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dunn PPJ, 1996, PARASITOLOGY, V113, P439, DOI 10.1017/S0031182000081506; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FRENKEL JK, 1988, PARASITOL TODAY, V4, P273, DOI 10.1016/0169-4758(88)90018-X; GUNDERSEN RE, 1987, J BIOL CHEM, V262, P4602; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARMON AC, 1987, PLANT PHYSIOL, V83, P830, DOI 10.1104/pp.83.4.830; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; HASHIMOTO Y, 1991, BIOCHEM BIOPH RES CO, V181, P423, DOI 10.1016/S0006-291X(05)81436-6; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Kim K, 1998, EUR J BIOCHEM, V251, P605, DOI 10.1046/j.1432-1327.1998.2510605.x; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Lee JY, 1998, BIOCHEMISTRY-US, V37, P6801, DOI 10.1021/bi980062q; Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; MCCURDY DW, 1992, PLANTA, V188, P54, DOI 10.1007/BF00198939; Pei ZM, 1996, EMBO J, V15, P6564, DOI 10.1002/j.1460-2075.1996.tb01047.x; Pezzella N, 1997, EUR J CELL BIOL, V74, P92; Pfefferkorn E.R., 1990, P26; PUTNAMEVANS CL, 1990, BIOCHEMISTRY-US, V29, P2488, DOI 10.1021/bi00462a008; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; SHAW MK, 1995, EUR J CELL BIOL, V68, P78; SON M, 1993, J BIOL CHEM, V268, P5940; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Vieira MCF, 2000, MOL BIOCHEM PARASIT, V106, P157, DOI 10.1016/S0166-6851(99)00182-6; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; YUASA T, 1992, ARCH BIOCHEM BIOPHYS, V296, P175, DOI 10.1016/0003-9861(92)90560-J; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; ZHAO Y, 1993, J BIOL CHEM, V268, P4347	36	119	133	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12369	12377		10.1074/jbc.M011045200	http://dx.doi.org/10.1074/jbc.M011045200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11154702	hybrid			2022-12-27	WOS:000168081800124
J	Kominami, S; Owaki, A; Iwanaga, T; Tagashira-Ikushiro, H; Yamazaki, T				Kominami, S; Owaki, A; Iwanaga, T; Tagashira-Ikushiro, H; Yamazaki, T			The rate-determining step in P450C21-catalyzing reactions in a membrane-reconstituted system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P-450 REDUCTASE; PIG ADRENAL MICROSOMES; NADPH-CYTOCHROME-P-450 REDUCTASE; ADRENOCORTICAL MICROSOMES; PHOSPHOLIPID-VESICLES; SUCCESSIVE REACTIONS; YEAST MICROSOMES; P450 REDUCTASE; ENZYME SYSTEM; ROTATION	Adrenal cytochrome P450 C21 in a membrane-reconstituted system catalyzed 21-hydroxylation of 17 alpha -hydroxyprogesterone at a rate higher than that for progesterone in the steady state at 37 degreesC, The rate of product formation in the steady state increased with the concentration of the complex between P450 C21 and the reductase in the membranes. The complex formation was independent of the volume of the reaction, showing that the effective concentrations of the membrane proteins should be defined with the volume of the lipid phase. The rates of conversion of progesterone and 17 alpha -hydroxyprogesterone to the product in a single cycle of the P450 C21 reaction were measured with a reaction rapid quenching device. The first-order rate constant for the conversion of progesterone by P450 C21 was 4.3 +/- 0.7 s(-1), and that for 17 alpha -hydroxyprogesterone was 1.8 +/- 0.5 s(-1) at 37 degreesC, It was found from the analysis of kinetic data that the rate-determining step in 21-hydroxylation of progesterone in the steady state was the dissociation of product from P450 C21, whereas the conversion to deoxycortisol was the rate-determining step in the reaction of 17 alpha -hydroxyprogesterone. The difference in the rate-determining steps in the reactions for the two substrates was clearly demonstrated in the pre-steady-state kinetics.	Hiroshima Univ, Fac Integrated Arts & Sci, Higashihiroshima 7398521, Japan	Hiroshima University	Kominami, S (corresponding author), Hiroshima Univ, Fac Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashihiroshima 7398521, Japan.							ALGAILANY KAS, 1978, BIOCHEM PHARMACOL, V27, P783, DOI 10.1016/0006-2952(78)90521-X; BACKES WL, 1989, J BIOL CHEM, V264, P6252; BACKES WL, 1981, J BIOL CHEM, V256, P7213; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; BENDER ML, 1966, J AM CHEM SOC, V88, P5890, DOI 10.1021/ja00976a034; ETTER HU, 1991, J BIOL CHEM, V266, P18600; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; FRIEDEN C, 1993, TRENDS BIOCHEM SCI, V18, P58, DOI 10.1016/0968-0004(93)90056-S; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUT J, 1982, J BIOL CHEM, V257, P7030; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Iwanaga T, 1999, BIOCHEMISTRY-US, V38, P16629, DOI 10.1021/bi991277i; IWASE T, 1991, BIOCHEMISTRY-US, V30, P8347, DOI 10.1021/bi00098a010; KAWATO S, 1982, J BIOL CHEM, V257, P7023; KOMINAMI S, 1982, BIOCHEM BIOPH RES CO, V109, P916, DOI 10.1016/0006-291X(82)92027-7; KOMINAMI S, 1989, BIOCHIM BIOPHYS ACTA, V985, P293, DOI 10.1016/0005-2736(89)90415-X; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; KOMINAMI S, 1987, BIOCHIM BIOPHYS ACTA, V905, P143, DOI 10.1016/0005-2736(87)90018-6; KOMINAMI S, 1982, BIOCHIM BIOPHYS ACTA, V709, P147, DOI 10.1016/0167-4838(82)90454-X; KOMINAMI S, 1986, J BIOL CHEM, V261, P2077; KOMINAMI S, 1984, J BIOL CHEM, V259, P2991; MIWA GT, 1984, ARCH BIOCHEM BIOPHYS, V234, P161, DOI 10.1016/0003-9861(84)90337-0; MIWA GT, 1979, J BIOL CHEM, V254, P5695; MULLERENOCH D, 1984, J BIOL CHEM, V259, P8174; OHTA Y, 1992, BIOCHEMISTRY-US, V31, P12680, DOI 10.1021/bi00165a019; OMURA T, 1964, J BIOL CHEM, V239, P2370; OPRIAN DD, 1979, J BIOL CHEM, V254, P8895; ROBERTS DV, 1977, ENZYME KINETICS, P35; SCHEN S, 1994, BIOCHEMISTRY-US, V33, P8807; SEVRUKOVA IF, 1994, ARCH BIOCHEM BIOPHYS, V311, P133, DOI 10.1006/abbi.1994.1218; SHINZAWA K, 1985, BIOCHIM BIOPHYS ACTA, V833, P151; TAGASHIRA H, 1995, BIOCHEMISTRY-US, V34, P10939, DOI 10.1021/bi00034a028; TAKEMORI S, 1984, TRENDS BIOCHEM SCI, V9, P393, DOI 10.1016/0968-0004(84)90223-8; TAKEMORI S, 1982, OXYGENASES OXYGEN ME, P403; VOZNESENSKY AI, 1992, J BIOL CHEM, V267, P14669; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; Yamada M, 1999, BIOCHEMISTRY-US, V38, P9465, DOI 10.1021/bi990648s; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YOSHIOKA H, 1986, J BIOL CHEM, V261, P4106	43	9	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10753	10758		10.1074/jbc.M006043200	http://dx.doi.org/10.1074/jbc.M006043200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154687	hybrid			2022-12-27	WOS:000167980900027
J	Nadler, LS; Kumar, G; Nathanson, NM				Nadler, LS; Kumar, G; Nathanson, NM			Identification of a basolateral sorting signal for the m(3) muscarinic acetylcholine receptor in Madin-Darby canine kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; MDCK CELLS; STRUCTURAL REQUIREMENTS; CYTOPLASMIC TAIL; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; XENOPUS OOCYTES; ACINAR-CELLS	Muscarinic acetylcholine receptors (mAChRs) can be differentially localized in polarized cells. To identify potential sorting signals that mediate mAChR targeting, we examined the sorting of mAChRs in Madin-Darby canine kidney cells, a widely used model system. Expression of FLAG-tagged mAChRs in polarized Madin-Darby canine kidney cells demonstrated that the M-2 subtype is sorted apically, whereas M-3 is targeted basolaterally, Expression of M-2/M-3 receptor chimeras revealed that a al-residue sequence, Ser(271)-Ser(291), from the M-3 third intracellular loop contains a basolateral sorting signal. Substitution of sequences containing the M-3 sorting signal into the homologous regions of M-2 was sufficient to confer basolateral localization to this apical receptor. Sequences containing the M-3 sorting signal also conferred basolateral targeting to M-2 when added to either the third intracellular loop or the C-terminal cytoplasmic tail. Furthermore, addition of a sequence containing the M-3 basolateral sorting signal to the cytoplasmic tail of the interleukin-2 receptor alpha -chain caused significant basolateral targeting of this heterologous apical protein. The results indicate that the M-3 basolateral sorting signal is dominant over apical signals in M-2 and acts in a position-independent manner. The M-3 sorting signal represents a novel basolateral targeting motif for G protein-coupled receptors.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nathanson, NM (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, POB 357750, Seattle, WA 98195 USA.				NINDS NIH HHS [NS26920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026920] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beau I, 1998, J BIOL CHEM, V273, P18610, DOI 10.1074/jbc.273.29.18610; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; DAVIDSON A, 1991, FEBS LETT, V284, P252, DOI 10.1016/0014-5793(91)80697-2; Distel B, 1998, J BIOL CHEM, V273, P186, DOI 10.1074/jbc.273.1.186; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Ghavami A, 1999, J CELL SCI, V112, P967; Goldman PS, 1996, J BIOL CHEM, V271, P4215; Hajos N, 1998, NEUROSCIENCE, V82, P355; Hobert ME, 1997, J BIOL CHEM, V272, P32901, DOI 10.1074/jbc.272.52.32901; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Jacob R, 1999, J BIOL CHEM, V274, P8061, DOI 10.1074/jbc.274.12.8061; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; JONES DT, 1987, J BIOL CHEM, V262, P14241; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; Kostenis E, 1997, J BIOL CHEM, V272, P23675, DOI 10.1074/jbc.272.38.23675; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LeGall AH, 1997, J BIOL CHEM, V272, P4559, DOI 10.1074/jbc.272.7.4559; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVEY AI, 1994, NEUROSCIENCE, V63, P207, DOI 10.1016/0306-4522(94)90017-5; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maisner A, 1996, J BIOL CHEM, V271, P18853, DOI 10.1074/jbc.271.31.18853; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MATUSLEIBOVITCH N, 1990, PFLUG ARCH EUR J PHY, V417, P194, DOI 10.1007/BF00370699; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MIGEON JC, 1995, J BIOL CHEM, V270, P16070, DOI 10.1074/jbc.270.27.16070; MIGEON JC, 1994, J BIOL CHEM, V269, P9767; MONLAUZEUR L, 1995, J BIOL CHEM, V270, P12219, DOI 10.1074/jbc.270.20.12219; MORO O, 1994, J BIOL CHEM, V269, P6651; MORO O, 1993, J BIOL CHEM, V268, P6862; Muth TR, 1998, J BIOL CHEM, V273, P25616, DOI 10.1074/jbc.273.40.25616; Nadler LS, 1999, AM J PHYSIOL-CELL PH, V277, pC1220, DOI 10.1152/ajpcell.1999.277.6.C1220; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; Odorizzi G, 1997, J BIOL CHEM, V272, P11757, DOI 10.1074/jbc.272.18.11757; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; Renold A, 2000, J BIOL CHEM, V275, P9290, DOI 10.1074/jbc.275.13.9290; Rodionov DG, 2000, J BIOL CHEM, V275, P8279, DOI 10.1074/jbc.275.12.8279; Rouse ST, 1997, LIFE SCI, V60, P1031, DOI 10.1016/S0024-3205(97)00044-1; Rouse ST, 1998, NEUROSCIENCE, V86, P221, DOI 10.1016/S0306-4522(97)00681-7; Sambrook J., 2002, MOL CLONING LAB MANU; Saunders C, 1998, J BIOL CHEM, V273, P24196, DOI 10.1074/jbc.273.37.24196; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schlador ML, 2000, J BIOL CHEM, V275, P23295, DOI 10.1074/jbc.M002380200; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; Simmen T, 1999, MOL CELL BIOL, V19, P3136; SIMON SA, 1992, ARCH ORAL BIOL, V37, P685, DOI 10.1016/0003-9969(92)90072-G; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; TAN YP, 1992, P NATL ACAD SCI USA, V89, P11229, DOI 10.1073/pnas.89.23.11229; TOESCU EC, 1992, EMBO J, V11, P1623, DOI 10.1002/j.1460-2075.1992.tb05208.x; Tugizov S, 1998, J VIROL, V72, P7374, DOI 10.1128/JVI.72.9.7374-7386.1998; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wozniak M, 1998, BRAIN RES, V780, P311, DOI 10.1016/S0006-8993(97)01216-X; Yeaman C, 1996, AM J PHYSIOL-CELL PH, V270, pC753, DOI 10.1152/ajpcell.1996.270.3.C753; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	64	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10539	10547		10.1074/jbc.M007190200	http://dx.doi.org/10.1074/jbc.M007190200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136723	hybrid			2022-12-27	WOS:000167996400123
J	Osman, A; Niles, EG; LoVerde, PT				Osman, A; Niles, EG; LoVerde, PT			Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAD-RELATED PROTEIN; FAMILY MEDIATOR SMAD1; TUMOR-SUPPRESSOR; RECEPTOR HOMOLOG; MOUSE EMBRYO; PHOSPHORYLATION; KINASE; SMAD4/DPC4; ACTIVATION; PATHWAYS	Smad proteins are essential intracellular signal transducers of the transforming growth factor-beta (TGF-beta) superfamily, The TGF-beta superfamily signals through phosphorylation and activation of R-Smad proteins, receptor-regulated Smads, by heteromeric complexes of ligand-specific type I and type II serine/threonine kinase receptors, R-Smads receive a signal from the activated receptor complex and transmit it to the nucleus. A cDNA was isolated that encodes a 649-amino acid protein found to be homologous to members of R-Smad subfamily with highest homology scored to clawed African frog and human Smads, The Schistosoma mansoni homologue (SmSmad2) was overexpressed in bacteria as a Sj26-GST fusion protein and used to raise specific antibodies. The IgG fraction of the immunized rabbit serum identified 70- and 72-kDa protein bands in Western analysis of schistosome extracts. Treatment with alkaline phosphatase removed the 72-kDa band, which indicates that this band represents the phosphorylated form of schistosome Smad2, SmSmad2 was localized in the subtegument, parenchymal cells, and sex organs in both male and female worm cryosections. Similar results were also obtained from the analysis of the Smad2 mRNA distribution pattern revealed by in situ hybridization of adult worm pair paraffin sections, SmSmad2 mRNA levels were determined by reverse transcriptase-polymerase chain reaction in different mammalian host developmental stages and found to be constitutively expressed, SmSmad2 was also found to interact with a previously identified SmT betaR-I, a serine/threonine type I kinase receptor. Furthermore, SmSmad2 was shown to undergo phosphorylation by constitutively active forms of SmT betaR-I in uitro, In addition, SmSmad2 localized in the nuclei of mink lung epithelial cells upon treatment with TGF-beta (1), These data indicate that the SmSmad2 responds to the TGF-beta signals by interaction with receptor I, which phosphorylates it, whereupon it translocates into the nucleus presumably to regulate target gene transcription and consequently elicit a specific TGF-beta effect.	SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med & Biomed Sci, Ctr Microbial Pathogenesis, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	LoVerde, PT (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, 138 Farber Hall, Buffalo, NY 14214 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046762] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46762] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; BOBEK L, 1986, P NATL ACAD SCI USA, V83, P5544, DOI 10.1073/pnas.83.15.5544; BOROS DL, 1989, CLIN MICROBIOL REV, V2, P250, DOI 10.1128/CMR.2.3.250-269.1989; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen TP, 1998, CANCER RES, V58, P4805; Chen Y, 1996, P NATL ACAD SCI USA, V93, P12992, DOI 10.1073/pnas.93.23.12992; Davies SJ, 1998, J BIOL CHEM, V273, P11234, DOI 10.1074/jbc.273.18.11234; Derynck R, 1998, NATURE, V393, P737, DOI 10.1038/31593; Engers HD, 1996, DEV BIOL STAND, V87, P73; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Freebern WJ, 1999, J BIOL CHEM, V274, P4577, DOI 10.1074/jbc.274.8.4577; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; LOVERDE PT, 1991, PARASITOL TODAY, V7, P303, DOI 10.1016/0169-4758(91)90263-N; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meersseman G, 1997, MECH DEVELOP, V61, P127, DOI 10.1016/S0925-4773(96)00629-6; Nakao A, 1997, J BIOL CHEM, V272, P2896, DOI 10.1074/jbc.272.5.2896; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Osman A, 1999, MOL BIOCHEM PARASIT, V100, P27, DOI 10.1016/S0166-6851(99)00029-8; Ramachandran H, 1996, MOL BIOCHEM PARASIT, V83, P1, DOI 10.1016/S0166-6851(96)02731-4; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; SILVA EE, 1993, J IMMUNOL, V151, P7057; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Smithers S. R., 1982, Immunology of parasitic infections.  2nd edition., P527; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	51	62	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10072	10082		10.1074/jbc.M005933200	http://dx.doi.org/10.1074/jbc.M005933200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152451	hybrid			2022-12-27	WOS:000167996400067
J	Pedarzani, P; Mosbacher, J; Rivard, A; Cingolani, LA; Oliver, D; Stocker, M; Adelman, JP; Fakler, B				Pedarzani, P; Mosbacher, J; Rivard, A; Cingolani, LA; Oliver, D; Stocker, M; Adelman, JP; Fakler, B			Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; CA1 PYRAMIDAL NEURONS; INTERMEDIATE-CONDUCTANCE; CALCIUM CHANNELS; EPILEPTIFORM ACTIVITY; HIPPOCAMPAL-NEURONS; EPITHELIAL-CELLS; CALMODULIN; INACTIVATION; RECEPTORS	In most central neurons, action potentials are followed by an afterhyperpolarization (AHP) that controls firing pattern and excitability, The medium and slow components of the AHP have been ascribed to the activation of small conductance Ca2+-activated potassium (SK) channels. Cloned SK channels are heteromeric complexes of SK alpha -subunits and calmodulin, The channels are activated by Ca2+ binding to calmodulin that induces conformational changes resulting in channel opening, and channel deactivation is the reverse process brought about by dissociation of Ca2+ Rom calmodulin, Here we show that SK channel gating is effectively modulated by 1-ethyl-2-benzimidazolinone (EBIO). Application of EBIO to cloned SK channels shifts the Ca2+ concentration-response relation into the lower nanomolar range and slows channel deactivation by almost 10-fold. In hippocampal CA1 neurons, EBIO increased both the medium and slow AHP, strongly reducing electrical activity. Moreover, EBIO suppressed the hyperexcitability induced by low Mg2+ in cultured cortical neurons. These results underscore the importance of SK channels for shaping the electrical response patterns of central neurons and suggest that modulating SK channel gating is a potent mechanism for controlling excitability in the central nervous system.	Univ Tubingen, Dept Physiol 2, D-72074 Tubingen, Germany; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Novartis Pharma AG, TA Nervous Syst, CH-4002 Basel, Switzerland; Max Planck Inst Expt Med, D-37075 Gottingen, Germany	Eberhard Karls University of Tubingen; Oregon Health & Science University; Novartis; Max Planck Society	Fakler, B (corresponding author), Univ Tubingen, Dept Physiol 2, Ob Himmelreich 7, D-72074 Tubingen, Germany.	bernd.fakler@uni-tuebingen.de	Oliver, Dominik/F-5845-2013; Cingolani, Lorenzo A/ABH-1364-2021; Cingolani, Lorenzo/J-1530-2012; Stocker, Martin/C-1844-2008	Oliver, Dominik/0000-0002-8368-0923; Cingolani, Lorenzo A/0000-0001-9538-1659; 				Adeagbo ASO, 1999, EUR J PHARMACOL, V379, P151, DOI 10.1016/S0014-2999(99)00489-6; Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRUGNARA C, 1995, J MEMBRANE BIOL, V147, P71, DOI 10.1007/BF00235398; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Gardener MJ, 1999, BRIT J PHARMACOL, V128, P1064, DOI 10.1038/sj.bjp.0702916; HAIECH J, 1991, J BIOL CHEM, V266, P3427; Hamilton KL, 1999, PFLUG ARCH EUR J PHY, V439, P158, DOI 10.1007/s004240051140; Hille B., 1992, IONIC CHANNELS EXCIT; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hirschberg B, 1999, BIOPHYS J, V77, P1905, DOI 10.1016/S0006-3495(99)77032-3; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15, DOI 10.1113/jphysiol.1995.sp020644; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P14117, DOI 10.1021/bi9950894; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; OLWIN BB, 1984, J BIOL CHEM, V259, P949; OZAWA T, 1999, BIOCHIM BIOPHYS ACTA, V1432, P254; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; SCHWINDT PC, 1992, J NEUROPHYSIOL, V67, P216, DOI 10.1152/jn.1992.67.1.216; STANTON PK, 1987, EPILEPSY RES, V1, P53, DOI 10.1016/0920-1211(87)90051-9; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; STORM JF, 1990, PROG BRAIN RES, V83, P161; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; Trost C, 1999, FEBS LETT, V451, P257, DOI 10.1016/S0014-5793(99)00588-8; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WOLFART J, 2000, SOC NEUR ABSTR, V26, P1401; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	55	191	199	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9762	9769		10.1074/jbc.M010001200	http://dx.doi.org/10.1074/jbc.M010001200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134030	hybrid			2022-12-27	WOS:000167996400026
J	Tretter, V; Hauer, B; Nusser, Z; Mihalek, RM; Hoger, H; Homanics, GE; Somogyi, P; Sieghart, W				Tretter, V; Hauer, B; Nusser, Z; Mihalek, RM; Hoger, H; Homanics, GE; Somogyi, P; Sieghart, W			Targeted disruption of the GABA(A) receptor delta subunit gene leads to an up-regulation of gamma(2) subunit-containing receptors in cerebellar granule cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; A RECEPTOR; RAT-BRAIN; ALPHA-6 SUBUNIT; ALCOHOL ANTAGONIST; SUBTYPES; MICE; PHARMACOLOGY; EXPRESSION; BINDING	GABA(A) receptors are chloride channels composed of five subunits. Cerebellar granule cells express abundantly six subunits belonging to four subunit classes. These are assembled into a number of distinct receptors, but the regulation of their relative proportions is yet unknown. Here, we studied the composition of cerebellar GABA(A) receptors after targeted disruption of the delta subunit gene, In membranes and extracts of delta-/- cerebellum, [H-3]muscimol binding was not significantly changed, whereas [H-3]Ro15-4513 binding was increased by 52% due to an increase in diazepam-insensitive binding. Immunocytochemical and Western blot analysis revealed no change in alpha (6) subunits but an increased expression of gamma (2) subunits in delta-/- cerebellum. Immunoaffinity chromatography of cerebellar extracts indicated there was an increased coassembly of alpha (6) and gamma (2) subunits and that 24% of all receptors in delta-/- cerebellum did not contain a gamma subunit, Because 97% of delta subunits are coassembled with alpha (6) subunits in the cerebellum of wild-type mice, these results indicated that, in delta-/- mice, alpha (6)beta gamma (2) and alpha beta receptors replaced delta subunit-containing receptors, The availability of the delta subunit, thus, influences the level of expression or the extent of assembly of the gamma (2) subunit, although these two subunits do not occur in the same receptor.	Univ Vienna, Brain Res Inst, A-1090 Vienna, Austria; Univ Vienna, Sect Biochem Psychiat, Psychiat Clin, A-1090 Vienna, Austria; MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Pittsburgh, Sch Med, Dept Anesthesiol Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; Res Inst Lab Anim Breeding, A-2325 Himberg, Austria	University of Vienna; University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sieghart, W (corresponding author), Univ Vienna, Brain Res Inst, Spitalgasse 4, A-1090 Vienna, Austria.		Sieghart, Werner/A-4877-2013; Nusser, Zoltan/K-8587-2014	Sieghart, Werner/0000-0002-0443-0302; Nusser, Zoltan/0000-0001-7004-4111; Homanics, Gregg/0000-0003-3641-8153	NIAAA NIH HHS [AA10422] Funding Source: Medline; NIGMS NIH HHS [GM52035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010422, R37AA010422] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1418; Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Barnard EA, 1998, PHARMACOL REV, V50, P291; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; BENKE D, 1991, FEBS LETT, V283, P145, DOI 10.1016/0014-5793(91)80573-L; BENKE D, 1991, J BIOL CHEM, V266, P4478; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jones A, 1997, J NEUROSCI, V17, P1350; Khan ZU, 1996, J NEUROCHEM, V66, P685; KORPI ER, 1993, NEUROSCIENCE, V53, P483, DOI 10.1016/0306-4522(93)90212-X; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mohler H, 1998, LIFE SCI, V62, P1611, DOI 10.1016/S0024-3205(98)00116-7; MOSSIER B, 1994, J BIOL CHEM, V269, P25777; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; POLLARD S, 1995, J BIOL CHEM, V270, P21285, DOI 10.1074/jbc.270.36.21285; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SIEGHART W, 1987, J NEUROCHEM, V48, P46, DOI 10.1111/j.1471-4159.1987.tb13125.x; STEPHENSON FA, 1995, BIOCHEM J, V310, P1; THOMPSON CL, 1994, J NEUROCHEM, V62, P2037; Tretter V, 1997, J NEUROSCI, V17, P2728; TURNER DM, 1991, J PHARMACOL EXP THER, V257, P1236; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7; WISDEN W, 1992, J NEUROSCI, V12, P1040; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G; Zezula J, 1996, EUR J PHARMACOL, V301, P207, DOI 10.1016/0014-2999(96)00066-0	41	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10532	10538		10.1074/jbc.M011054200	http://dx.doi.org/10.1074/jbc.M011054200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136737	hybrid			2022-12-27	WOS:000167996400122
J	Grivennikova, VG; Kapustin, AN; Vinogradov, AD				Grivennikova, VG; Kapustin, AN; Vinogradov, AD			Catalytic activity of NADH-ubiquinone oxidoreductase (Complex I) in intact mitochondria - Evidence for the slow active/inactive transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOLEMMAL VESICLES; IRON-SULFUR CLUSTERS; RESPIRATORY-CHAIN; HEART-MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; INACTIVE TRANSITION; ADENYLATE-CYCLASE; ALAMETHICIN; REDUCTASE; DEHYDROGENASE	The mammalian purified dispersed NADH-ubiquinone oxidoreductase (Complex I) and the enzyme in inside-out submitochondrial particles are known to be the slowly equilibrating mixture of the active and de-activated forms (Vinogradov, A. D. (1998) Biochim. Biophys. Acta 1364, 169-185). We report here the phenomenon of slow active/de-active transition in intact mitochondria where the enzyme is located within its natural environment being exposed to numerous mitochondrial matrix proteins. A simple procedure for permeabilization of intact mitochondria by channel-forming antibiotic alamethicin was worked out for the "in situ" assay of Complex I activity. Alamethicin-treated mitochondria catalyzed the rotenone-sensitive NADH-quinone reductase reaction with exogenousely added NADH and quinone-acceptor at the rates expected if the enzyme active sites would be freely accessible for the substrates. The matrix proteins were retained in alamethicin-treated mitochondria as judged by their high rotenone-sensitive malate-cytochrome c reductase activity in the presence of added NAD(+). The sensitivity of Complex I to N-ethylmaleimide and to the presence of Mg2+ was used as the diagnostic tools to detect the presence of the de-activated enzyme. The NADH-quinone reductase activity of alamethicin-treated mitochondria was sensitive to neither N-ethylmaleimide nor Mg2+. After exposure to elevated temperature (37 degreesC, the conditions known to induce de-activation of Complex 1) the enzyme activity became sensitive to the sulfhydryl reagent and/or Mg2+. The sensitivity to both inhibitors disappeared after brief exposure of the thermally de-activated mitochondria with malate/glutamate, NAD(+), and cytochrome c (the conditions known for the turnover-induced reactivation of the enzyme). We conclude that the slow active/de-active Complex I transition is a characteristic feature of the enzyme in intact mitochondria and discuss its possible physiological significance.	Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119899, Russia	Lomonosov Moscow State University	Vinogradov, AD (corresponding author), Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119899, Russia.		Grivennikova, Vera/AAM-3319-2021	Grivennikova, Vera/0000-0002-9132-7169				BATAYNEH N, 1986, ARCH BIOCHEM BIOPHYS, V250, P476, DOI 10.1016/0003-9861(86)90752-6; BESCH HR, 1977, J BIOL CHEM, V252, P7905; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; BURBAEV DS, 1989, FEBS LETT, V254, P47, DOI 10.1016/0014-5793(89)81007-5; BURNELL JN, 1975, BIOCHEM J, V150, P527, DOI 10.1042/bj1500527; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; DAS MK, 1985, BIOCHEM INT, V11, P357; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; FOX RO, 1982, NATURE, V300, P325, DOI 10.1038/300325a0; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gomall A. G, 1949, J BIOL CHEM, V177, P751; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HALL C, 1966, BIOCHEM BIOPH RES CO, V25, P373, DOI 10.1016/0006-291X(66)90214-2; HANKE W, 1980, BIOCHIM BIOPHYS ACTA, V596, P456, DOI 10.1016/0005-2736(80)90134-0; Hatefi Y, 1978, Methods Enzymol, V53, P11; HORGAN DJ, 1968, J BIOL CHEM, V243, P5967; JACOBUS WE, 1982, ARCH BIOCHEM BIOPHYS, V219, P167, DOI 10.1016/0003-9861(82)90146-1; JONES LR, 1980, J BIOL CHEM, V255, P9971; Jung DW, 1997, BBA-BIOENERGETICS, V1320, P310, DOI 10.1016/S0005-2728(97)00036-4; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; MAKLASHINA EO, 1994, BIOCHEMISTRY-MOSCOW+, V59, P1221; Marsh D, 1996, BIOCHEM J, V315, P345, DOI 10.1042/bj3150345; MINAKAMI S, 1964, J BIOL CHEM, V239, P2049; Ohnishi T, 1998, BBA-BIOENERGETICS, V1365, P301, DOI 10.1016/S0005-2728(98)00082-6; Okun JG, 1999, BIOCHEM SOC T, V27, P596, DOI 10.1042/bst0270596; RAMSAY RR, 1992, BIOCHEM BIOPH RES CO, V189, P47, DOI 10.1016/0006-291X(92)91523-S; RITOV VB, 1992, GEN PHYSIOL BIOPHYS, V11, P49; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SLED VD, 1993, J BIOENERG BIOMEMBR, V25, P347, DOI 10.1007/BF00762460; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Ushakova AV, 1999, BBA-BIOENERGETICS, V1409, P143, DOI 10.1016/S0005-2728(98)00156-X; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; VINOGRADOV AD, 1993, J BIOENERG BIOMEMBR, V25, P367, DOI 10.1007/BF00762462; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1	42	94	95	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9038	9044		10.1074/jbc.M009661200	http://dx.doi.org/10.1074/jbc.M009661200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11124957	hybrid			2022-12-27	WOS:000167607700057
J	Nardai, G; Braun, L; Csala, M; Mile, V; Csermely, P; Benedetti, A; Mandl, J; Banhegyi, G				Nardai, G; Braun, L; Csala, M; Mile, V; Csermely, P; Benedetti, A; Mandl, J; Banhegyi, G			Protein-disulfide isomerase- and protein thiol-dependent dehydroascorbate reduction and ascorbate accumulation in the lumen of the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL VESICLES; GLUTATHIONE-INSULIN TRANSHYDROGENASE; RIBONUCLEASE-REACTIVATING ENZYME; RAT-LIVER; TISSUE DISTRIBUTION; INTERCHANGE ENZYME; SECRETION GRANULES; PAROTID-GLAND; GLUCOSE-6-PHOSPHATASE; DEGRADATION	The transport and intraluminal reduction of dehydroascorbate was investigated in microsomal vesicles from various tissues. The highest rates of transport and intraluminal isotope accumulation (using radiolabeled compound and a rapid filtration technique) were found in hepatic microsomes. These microsomes contain the highest amount of protein-disulfide isomerase, which is known to have a dehydroascorbate reductase activity, The steady-state level of intraluminal isotope accumulation was more than a-fold higher in hepatic microsomes prepared from spontaneously diabetic BioBreeding/Worcester rats and was very low in fetal hepatic microsomes although the initial rate of transport was not changed. In these microsomes, the amount of protein-disulfide isomerase was similar, but the availability of protein thiols was different and correlated with dehydroascorbate uptake. The increased isotope accumulation was accompanied by a higher rate of dehydroascorbate reduction and increased protein thiol oxidation in microsomes from diabetic animals, The results suggest that both the activity of protein-disulfide isomerase and the availability of protein thiols as reducing equivalents can play a crucial role in the accumulation of ascorbate in the lumen of the endoplasmic reticulum, These findings also support the fact that dehydroascorbate can act as an oxidant in the protein-disulfide isomerase-catalyzed protein disulfide formation.	Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary; Univ Siena, Dipartimento Fisiopatol & Med Sperimentale, I-53100 Siena, Italy	Semmelweis University; University of Siena	Banhegyi, G (corresponding author), Semmelweis Univ, Dept Med Chem, POB 260, H-1444 Budapest, Hungary.	banhegyi@puskin.sote.hu	Csermely, Peter/J-2067-2017; Csala, Miklos/H-5369-2011; Bánhegyi, Gábor/A-1476-2014	Csermely, Peter/0000-0001-9234-0659; Csala, Miklos/0000-0002-3829-4361; 				Banhegyi G, 1998, J BIOL CHEM, V273, P2758, DOI 10.1074/jbc.273.5.2758; Banhegyi G, 1999, J BIOL CHEM, V274, P12213, DOI 10.1074/jbc.274.18.12213; BJELLAND S, 1987, COMP BIOCHEM PHYS B, V87, P907, DOI 10.1016/0305-0491(87)90411-1; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Csala M, 1999, FEBS LETT, V460, P539, DOI 10.1016/S0014-5793(99)01412-X; Csala M, 2000, BIOCHEM J, V349, P413, DOI 10.1042/0264-6021:3490413; DANIELS AJ, 1982, SCIENCE, V216, P737, DOI 10.1126/science.7079733; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FULCERI R, 1994, ARCH BIOCHEM BIOPHYS, V309, P43, DOI 10.1006/abbi.1994.1081; FULCERI R, 1993, BIOCHEM J, V289, P299, DOI 10.1042/bj2890299; Gamberucci A, 1996, MOL MEMBR BIOL, V13, P103, DOI 10.3109/09687689609160583; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HENNE V, 1986, FEBS LETT, V202, P267, DOI 10.1016/0014-5793(86)80699-8; HERN EP, 1980, J BIOL CHEM, V255, P697; Heuck AP, 1997, ANAL BIOCHEM, V248, P94, DOI 10.1006/abio.1997.2123; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Marcus N, 1996, BBA-GENE STRUCT EXPR, V1309, P253, DOI 10.1016/S0167-4781(96)00133-9; Ngkeekwong FC, 1997, BIOCHEM J, V324, P225, DOI 10.1042/bj3240225; NIETO A, 1990, BIOCHEM J, V267, P317, DOI 10.1042/bj2670317; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Puskas F, 1999, J BIOL CHEM, V274, P117, DOI 10.1074/jbc.274.1.117; SOM S, 1981, METABOLISM, V30, P572, DOI 10.1016/0026-0495(81)90133-5; THOMAS JH, 1979, BIOCHIM BIOPHYS ACTA, V567, P88, DOI 10.1016/0005-2744(79)90175-X; VARANDANI PT, 1985, DIABETOLOGIA, V28, P379; VENETIAN.P, 1965, ACTA PHYSIOL HUNG, V27, P303; VENETIANER P, 1964, BIOCHIM BIOPHYS ACTA, V89, P189, DOI 10.1016/0926-6569(64)90123-3; VONZASTROW M, 1986, P NATL ACAD SCI USA, V83, P3297; VONZASTROW M, 1984, J BIOL CHEM, V259, P1746; WELLS WW, 1994, J BIOENERG BIOMEMBR, V26, P369, DOI 10.1007/BF00762777; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WHITEHEAD TP, 1979, CLIN CHEM, V25, P1531; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801	34	49	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8825	8828		10.1074/jbc.M010563200	http://dx.doi.org/10.1074/jbc.M010563200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11136734	hybrid			2022-12-27	WOS:000167607700030
J	Yart, A; Laffargue, M; Mayeux, P; Chretien, S; Peres, C; Tonks, N; Roche, S; Payrastre, B; Chap, H; Raynal, P				Yart, A; Laffargue, M; Mayeux, P; Chretien, S; Peres, C; Tonks, N; Roche, S; Payrastre, B; Chap, H; Raynal, P			A critical pole for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of Ras and mitogen-activated protein kinases by epidermal growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; LYSOPHOSPHATIDIC ACID; DOCKING PROTEIN; RECEPTOR; DOMAIN; PHOSPHORYLATION; PHOSPHATASE; INHIBITION; BINDING	Although the mechanisms involved in the activation of mitogen-activated protein kinases (MAPK) by receptor tyrosine kinases do not display an obvious role for phosphoinositide 3-kinases (PI3Ks), we have observed in the nontransformed cell line Vero stimulated with epidermal growth factor (EGF) that wortmannin and LY294002 nearly abolished MAPK activation. The effect was observed under strong stimulation and was independent of EGF concentration. In addition, three mutants of class Is PI3Ks were found to inhibit MAPK activation to an extent similar to their effect on Akt/protein kinase B activation. To determine the importance of PI3K lipid kinase activity in MAPK activation, we have used the phosphatase PTEN and the pleckstrin homology domain of Tec kinase, Overexpression of these proteins, but not control mutants, was found to inhibit MAPK activation, suggesting that the lipid products of class Ia PI3K are necessary for MAPK signaling. We next investigated the location of PI3K in the MAPK cascade. Pharmacological inhibitors and dominant negative forms of PI3K were found to block the activation of Pas induced by EGF, Upstream from Pas, although association of Grb2 with its conventional effectors was independent of PI3K we have observed that the recruitment of the tyrosine phosphatase SHP2 required PI3K, Because SHP2 was also essential for Ras activation, this suggested the:existence of a PI3K/SHP2 pathway leading to the activation of Pas. In addition, we have observed that the docking protein Gab1, which is involved in PI3K activation during EGF stimulation, is also implicated in this pathway downstream of PI3K, Indeed, the association of Gab1 with SHP2 was blocked by PI3K inhibitors, and expression of Gab1 mutant deficient for binding to SHPS was found to inhibit Ras stimulation without interfering with PI3K activation. These results show that, in addition to Shc and Grb2, a PI3K-dependent pathway involving Gab1 and SHP2 is essential for Ras activation under EGF stimulation.	Hop Purpan, IFR 30, INSERM, U326, F-31059 Toulouse, France; Hop Cochin, INSERM, U363, F-75014 Paris, France; CNRS, UPR 1086, F-34293 Montpellier, France; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Cold Spring Harbor Laboratory	Raynal, P (corresponding author), Hop Purpan, IFR 30, INSERM, U326, F-31059 Toulouse, France.	raynal@purpan.inserm.fr	Laffargue, Muriel/AAE-7849-2021; Peres, Carlos A./B-1276-2013; Chretien, Stany/M-5166-2018; Raynal, Patrick/O-1926-2018; Peres, Carlos A./ABE-8361-2020; YART, Armelle/A-5656-2016; Peres, Carlos Augusto/N-8275-2019	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; YART, Armelle/0000-0002-2412-9840; Laffargue, Muriel/0000-0003-1833-639X; Raynal, Patrick/0000-0002-6731-3007; roche, serge/0000-0003-3413-3859; , Bernard/0000-0002-8693-0190	NATIONAL CANCER INSTITUTE [R01CA053840] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HU P, 1994, MOL CELL BIOL, V14, P2577, DOI 10.1128/MCB.14.4.2577; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TOKER A, 1994, J BIOL CHEM, V269, P32358; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279	44	122	126	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8856	8864		10.1074/jbc.M006966200	http://dx.doi.org/10.1074/jbc.M006966200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134009	hybrid			2022-12-27	WOS:000167607700035
J	Harvey, KF; Dinudom, A; Cook, DI; Kumar, S				Harvey, KF; Dinudom, A; Cook, DI; Kumar, S			The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE EXPRESSION SYSTEM; NA+-CHANNEL; LIDDLES-SYNDROME; LIGASE NEDD4; BETA-SUBUNIT; WW DOMAINS; SUBCELLULAR-LOCALIZATION; MISSENSE MUTATION; XENOPUS-LAEVIS; C2 DOMAIN	The amiloride-sensitive epithelial sodium channel (ENaC) plays a critical role in fluid and electrolyte homeostasis and consists of alpha, beta, and gamma subunits. The carboxyl terminus of each ENaC subunit contains a PPxY, motif which is believed to be important for interaction with the WW domains of the ubiquitin-protein ligase, Nedd4, Disruption of this interaction, as in Liddle's syndrome, where mutations delete or alter the PPxY motif of either the beta or gamma subunits, has been proposed to result in increased ENaC activity, Here we present evidence that KIAA0439 protein, a close relative of Nedd4, is also a potential regulator of ENaC, We demonstrate that KTAA0439 WW domains bind all three ENaC subunits. We show that a recombinant KIAA0439 WW domain protein acts as a dominant negative mutant that can interfere with the Na+-dependent feedback inhibition of ENaC in whole-cell patch clamp experiments. We propose that KIAA0439 and Nedd4 proteins either play a redundant role in ENaC regulation or function in a tissue- and/or signal-specific manner to down-regulate ENaC.	Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia; Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia	Institute Medical & Veterinary Science Australia; University of Sydney	Kumar, S (corresponding author), Inst Med & Vet Sci, Hanson Ctr Canc Res, POB 14,Rundle Mall,Frome Rd, Adelaide, SA 5000, Australia.		Harvey, Kieran/AAD-5268-2022; Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814; Harvey, Kieran/0000-0001-7845-369X				Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Awayda MS, 1997, AM J PHYSIOL-CELL PH, V273, pC1889; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DINUDOM A, 1993, PFLUG ARCH EUR J PHY, V344, P33; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farman N, 1997, AM J PHYSIOL-CELL PH, V272, pC131, DOI 10.1152/ajpcell.1997.272.1.C131; Farr TJ, 2000, BIOCHEM J, V345, P503, DOI 10.1042/0264-6021:3450503; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Jeunemaitre X, 1997, J HYPERTENS, V15, P1091, DOI 10.1097/00004872-199715100-00007; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Matsushita K, 1996, AM J PHYSIOL-LUNG C, V271, pL332, DOI 10.1152/ajplung.1996.271.2.L332; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Rebhun JF, 1998, DNA SEQUENCE, V9, P295, DOI 10.3109/10425179809008468; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606	39	126	137	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					8597	8601		10.1074/jbc.C000906200	http://dx.doi.org/10.1074/jbc.C000906200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244092	hybrid			2022-12-27	WOS:000167474900123
J	Panka, DJ; Mano, T; Suhara, T; Walsh, K; Mier, JW				Panka, DJ; Mano, T; Suhara, T; Walsh, K; Mier, JW			Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; ANTIGEN RECEPTOR; GROWTH-FACTOR; LIGAND TRAIL; DEATH DOMAIN; FAS; INHIBITION	The caspase-8 homologue FLICE-inhibitory protein (FLIP) functions as a caspase-8 dominant negative, blocking apoptosis induced by the oligomerization of the adapter protein FADD/MORT-1. FLIP expression correlates with resistance to apoptosis induced by various members of the tumor necrosis factor family such as TRAIL. Furthermore, forced expression of FLIP renders cells resistant to Fas-mediated apoptosis. Although FLIP expression is regulated primarily by MEK1 activity in activated T cells, the oncogenic signaling pathways that regulate FLIP expression in tumor cells are largely unknown. In this report, we examined the roles of the MAP kinase and phosphatidylinositol (PI) 3-kinase signaling pathways in the regulation of FLIP expression in tumor cells. We observed that the MEK1 inhibitor PD98059 reduced FLIP levels in only 2 of 11 tumor cell lines tested. In contrast, disruption of the PI 3-kinase pathway with the specific inhibitor LY294002 reduced Akt (protein kinase B) phosphorylation and the levels of FLIP protein and mRNA in all cell lines evaluated. The introduction of a dominant negative Akt adenoviral construct also consistently reduced FLIP expression as well as the phosphorylation of the Akt target glycogen synthase kinase-3. In addition, infection of the same cell lines with a constitutively active Akt adenovirus increased FLIP expression and the phosphorylation of GSK-5, These data add FLIP to the growing list of apoptosis inhibitors in which expression or function is regulated by the PI 3-kinase-Akt pathway.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Hematol & Oncol, Boston, MA 02115 USA; St Elizabeth Hosp, Boston, MA 02135 USA	Harvard University; Beth Israel Deaconess Medical Center	Mier, JW (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Hematol & Oncol, Rm 309,4 Blackfan Cr, Boston, MA 02115 USA.	jmier@caregroup.harvard.edu			NCI NIH HHS [CA74401] Funding Source: Medline; NIA NIH HHS [AG15051] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Capodici C, 1998, J IMMUNOL, V160, P1901; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Ebert AD, 1999, CANCER RES, V59, P4502; ETTINGER R, 1995, J IMMUNOL, V154, P4302; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gibbs BF, 1999, J LEUKOCYTE BIOL, V65, P883, DOI 10.1002/jlb.65.6.883; Griffith TS, 1998, J IMMUNOL, V161, P2833; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Houghton JA, 1997, CLIN CANCER RES, V3, P2205; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kataoka T, 1998, J IMMUNOL, V161, P3936; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 1998, CANCER RES, V58, P5315; THORNE M, 1997, NATURE, V386, P517; Tschopp J, 1999, CURR BIOL, V9, pR381, DOI 10.1016/S0960-9822(99)80233-4; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhang XD, 1999, CANCER RES, V59, P2747	50	233	237	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6893	6896		10.1074/jbc.C000569200	http://dx.doi.org/10.1074/jbc.C000569200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11145953	hybrid			2022-12-27	WOS:000167442900004
J	Galietta, LJV; Springsteel, MF; Eda, M; Niedzinski, EJ; By, K; Haddadin, MJ; Kurth, MJ; Nantz, MH; Verkman, AS				Galietta, LJV; Springsteel, MF; Eda, M; Niedzinski, EJ; By, K; Haddadin, MJ; Kurth, MJ; Nantz, MH; Verkman, AS			Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; FIBROSIS; GENISTEIN	The flavonoid genistein and the benzo[c]quinolizinium MPB-07 have been shown to activate the cystic fibrosis transmembrane conductance regulator (CFTR), the protein that is defective in cystic fibrosis, Lead-based combinatorial and parallel synthesis yielded 223 flavonoid, quinolizinium, and related heterocyclic compounds. The compounds were screened for their ability to activate CFTR at 50 muM concentration by measurement of the kinetics of iodide influx in Fisher rat thyroid cells expressing wild-type or G551D CFTR together with the green fluorescent protein-based halide indicator YFP-H148Q, Duplicate screenings revealed that 204 compounds did not significantly affect CFTR function. Compounds of the 7,8-benzoflavone class, which are structurally intermediate between flavones and benzo[c]quinoliziniums, were effective CFTR activators with the most potent being 2-(4-pyridinium)benzo[h]4H-chromen-4-one bisulfate (UCCF-029). Compounds of the novel structural class of fused pyrazolo heterocycles were also strong CFTR activators with the most potent being 3-(3-butynyl) -5-methoxy-l -phenylpyrazole-4-carbaldehyde (UCCF-180). A CFTR inhibitor was also identified. The active compounds did not induce iodide influx in null cells deficient in CFTR, Short-circuit current measurements showed that the CFTR activators identified by screening induced strong anion currents in the transfected cell monolayers grown on porous supports. Compared with genistein, the most active compounds had up to 10 times greater potency in activating wildtype and/or G551D-CFTR. The activators had low cellular toxicity and did not elevate cellular cAMP concentration or inhibit phosphatase activity, suggesting that CFTR activation may involve a direct interaction. These results establish an efficient screening procedure to identify CFTR activators and inhibitors and have identified 7,8-benzoflavones and pyrazolo derivatives as novel classes of CFTR activators.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Galietta, LJV (corresponding author), Inst Gaslini, Genoa, Italy.		Galietta, Luis JV/HCG-8692-2022	Galietta, Luis/0000-0001-8686-3461	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060288, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043840, R01DK035124, R37DK035124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60288, HL59198] Funding Source: Medline; NIDDK NIH HHS [DK43840, DK35124] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARES JJ, 1995, J MED CHEM, V38, P4937, DOI 10.1021/jm00025a011; Arispe N, 1998, J BIOL CHEM, V273, P5727, DOI 10.1074/jbc.273.10.5727; Baker W, 1933, J CHEM SOC, P1381, DOI 10.1039/jr9330001381; Baldursson O, 2000, AM J PHYSIOL-LUNG C, V279, pL835, DOI 10.1152/ajplung.2000.279.5.L835; BANERJI A, 1980, SYNTHESIS-STUTTGART, P874; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Bulteau L, 2000, AM J PHYSIOL-CELL PH, V279, pC1925, DOI 10.1152/ajpcell.2000.279.6.C1925; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; Eda M, 2000, J ORG CHEM, V65, P5131, DOI 10.1021/jo0001636; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; GRIBKOFF VK, 1994, J BIOL CHEM, V269, P10983; Haddadin MJ, 2000, TETRAHEDRON LETT, V41, P5613, DOI 10.1016/S0040-4039(00)00908-4; HALVELKOVA M, 1999, SYNLETT, V7, P1145; ILLEK B, 1995, AM J PHYSIOL-CELL PH, V268, pC886, DOI 10.1152/ajpcell.1995.268.4.C886; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; Illek B, 1998, AM J PHYSIOL-LUNG C, V275, pL902, DOI 10.1152/ajplung.1998.275.5.L902; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Kizer DE, 1999, TETRAHEDRON LETT, V40, P3535, DOI 10.1016/S0040-4039(99)00559-6; Mahal HS, 1934, J CHEM SOC, P1767, DOI 10.1039/jr9340001767; Mall M, 2000, BRIT J PHARMACOL, V130, P1884, DOI 10.1038/sj.bjp.0703520; NIEDZINSKI EJ, 2001, IN PRESS HETEROCYCLE, V55; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Sammelson RE, 2000, J ORG CHEM, V65, P9265, DOI 10.1021/jo001363k; Sammelson RE, 2000, J ORG CHEM, V65, P2225, DOI 10.1021/jo991551e; Schultz B. D., 1999, Physiological Reviews, V79, pS109; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEPPARD DN, 1994, AM J PHYSIOL, V266, pL405, DOI 10.1152/ajplung.1994.266.4.L405; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477	30	190	211	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19723	19728		10.1074/jbc.M101892200	http://dx.doi.org/10.1074/jbc.M101892200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262417	hybrid			2022-12-27	WOS:000169135100008
J	Okamoto, OK; Robertson, DL; Fagan, TF; Hastings, JW; Colepicolo, P				Okamoto, OK; Robertson, DL; Fagan, TF; Hastings, JW; Colepicolo, P			Different regulatory mechanisms modulate the expression of a dinoflagellate iron-superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGA GONYAULAX-POLYEDRA; RESPONSIVE ELEMENT; OXIDATIVE STRESS; GENE; PROTEINS; BIOLUMINESCENCE; ACTIVATION; REGION; LIGHT; RNA	Regulation of antioxidant enzymes is critical to control the levels of reactive oxygen species in cell compartments highly susceptible to oxidative stress. In this work, we studied the regulation of a chloroplastic iron superoxide dismutase (Fe-SOD) from Lingulodinium polyedrum (formerly Gonyaulax polyedra) under different physiological conditions, A cDNA-encoding Fe-SOD was isolated from this dinoflagellate, showing high sequence similarity to cyanobacterial, algal, and plant Fe-SODs, Under standard growth conditions, on a 12:12-h light-dark cycle, Lingulodinium polyedrum Fe-SOD exhibited a daily rhythm of activity and cellular abundance with the maximum occurring during the middle of the light phase. Northern analyses showed that this rhythmicity is not related to changes in Fe-SOD mRNA levels, indicative of translational regulation. By contrast, conditions of metal induced oxidative stress resulted in higher levels of Fe-SOD transcripts, suggesting that transcriptional control is responsible for increased protein and activity levels. Daily (circadian) and metal-induced up-regulation of Fe-SOD expression in L. polyedrum are thus mediated by different regulatory pathways, allowing biochemically distinct changes appropriate to oxidative challenges.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05599970 Sao Paulo, Brazil	Harvard University; Universidade de Sao Paulo	Hastings, JW (corresponding author), 16 Divin Ave, Cambridge, MA 02138 USA.		Robertson, Deborah/AAF-2512-2020; Colepicolo, Pio/C-1349-2013; Okamoto, Oswaldo Keith/C-5593-2013	Okamoto, Oswaldo Keith/0000-0002-8528-6225				ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Burkhardt Susanne, 1997, P34; Chung DJ, 1998, BIOCHEMISTRY-US, V37, P16298, DOI 10.1021/bi980935g; COLEPICOLO P, 1992, CHRONOBIOL INT, V9, P266, DOI 10.3109/07420529209064536; DESJARDINS M, 1993, BIOCHEM CELL BIOL, V71, P176, DOI 10.1139/o93-028; DEVOS CHR, 1992, PLANT PHYSIOL, V98, P853, DOI 10.1104/pp.98.3.853; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Duttaroy A, 1997, DNA CELL BIOL, V16, P391, DOI 10.1089/dna.1997.16.391; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Foyer CH, 1996, BIOCHEM SOC T, V24, P427, DOI 10.1042/bst0240427; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; GABBIANELLI R, 1995, BIOCHEM BIOPH RES CO, V216, P841, DOI 10.1006/bbrc.1995.2698; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hollnagel HC, 1996, BRAZ J MED BIOL RES, V29, P105; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; KHAN AU, 1995, CHEM BIOL, V2, P437; Kim JS, 2000, BBA-GENE STRUCT EXPR, V1493, P200, DOI 10.1016/S0167-4781(00)00178-0; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Knirsch L, 2000, BIOCHEM BIOPH RES CO, V272, P164, DOI 10.1006/bbrc.2000.2754; Li LM, 1998, PLANT MOL BIOL, V36, P275, DOI 10.1023/A:1005941421474; Markovic P, 1996, J BIOL RHYTHM, V11, P57, DOI 10.1177/074873049601100106; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MILOS P, 1990, NATURWISSENSCHAFTEN, V77, P87, DOI 10.1007/BF01131782; MITTAG M, 1994, P NATL ACAD SCI USA, V91, P5257, DOI 10.1073/pnas.91.12.5257; Mittag M, 1998, CHRONOBIOL INT, V15, P93, DOI 10.3109/07420529808998673; MORSE D, 1989, P NATL ACAD SCI USA, V86, P172, DOI 10.1073/pnas.86.1.172; Okamoto OK, 1999, COMP BIOCHEM PHYS C, V123, P75, DOI 10.1016/S0742-8413(99)00013-4; Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18; Okamoto OK, 1998, COMP BIOCHEM PHYS C, V119, P67, DOI 10.1016/S0742-8413(97)00192-8; Okamoto OK, 1996, J PHYCOL, V32, P74, DOI 10.1111/j.0022-3646.1996.00074.x; RIZZO PJ, 1981, BIOSYSTEMS, V14, P433, DOI 10.1016/0303-2647(81)90048-4; SEHN AP, 1994, BIOCHEM J, V304, P803, DOI 10.1042/bj3040803; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; ten Lohuis MR, 1998, PLANT PHYSIOL, V117, P189, DOI 10.1104/pp.117.1.189; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Weckx JEJ, 1996, PHYSIOL PLANTARUM, V96, P506, DOI 10.1111/j.1399-3054.1996.tb00465.x; WINTERBOURN CC, 1982, BIOCH J LETT, V205, P461; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Yoo HY, 1999, MOL GEN GENET, V262, P310, DOI 10.1007/s004380051088; [No title captured]	46	92	96	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19989	19993		10.1074/jbc.M101169200	http://dx.doi.org/10.1074/jbc.M101169200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264289	hybrid			2022-12-27	WOS:000169135100042
J	Kamradt, MC; Chen, F; Cryns, VL				Kamradt, MC; Chen, F; Cryns, VL			The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; DEPENDENT ACTIVATION; PROTECTIVE ACTIVITY; APAF-1 APOPTOSOME; 2-STEP MECHANISM; HSP27; OLIGOMERIZATION; PROCASPASE-9; PROTEASES; COMPLEX	Caspases are universal effecters of apoptosis. The mitochondrial and death receptor pathways activate distinct apical caspases (caspase-9 and -8, respectively) that converge on the proteolytic activation of the downstream executioner caspase-3. Caspase-9 and -8 cleave procaspase-3 to produce a p24 processing intermediate (composed of its prodomain and large subunit), which then undergoes autoproteolytic cleavage to remove the prodomain from the active protease. Recently, several heat shock proteins have been shown to selectively inhibit the mitochondrial apoptotic pathway by disrupting the activation of caspase-9 downstream of cytochrome c release. We report here that the small heat shock protein alphaB-crystallin inhibits both the mitochondrial and death receptor pathways. In S-100 cytosolic extracts treated with cytochrome c/dATP or caspase-8, alphaB-crystallin inhibits the autoproteolytic maturation of the p24 partially processed caspase-3 intermediate. In contrast, neither the closely related small heat shock protein family member Hsp27 nor Hsp70 inhibited the maturation of the p24 intermediate. We also demonstrate that alphaB-crystallin co-immunoprecipitates with the p24 partially processed caspase-3 in vivo. Taken together, our results demonstrate that alphaB-crystallin is a novel negative regulator of apoptosis that acts distally in the conserved cell death machinery by inhibiting the autocatalytic maturation of caspase-3.	Northwestern Univ, Sch Med, Div Endocrinol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Cryns, VL (corresponding author), Northwestern Univ, Sch Med, Div Endocrinol, Tarry 15-755,303 E Chicago Ave, Chicago, IL 60611 USA.				NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NCI NIH HHS [5T32-CA70085] Funding Source: Medline; ONDIEH CDC HHS [ND42967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ONDIEH CDC HHS		Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; BYUN Y, 2001, IN PRESS CELL DEATH; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liossis SNC, 1997, J IMMUNOL, V158, P5668; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	33	317	340	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					16059	16063		10.1074/jbc.C100107200	http://dx.doi.org/10.1074/jbc.C100107200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11274139	hybrid			2022-12-27	WOS:000168623100067
J	Rezaie, AR				Rezaie, AR			Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1 - Implications for the mechanism of profibrinolytic action of activated protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; FACTOR VA; FIBRINOLYTIC-ACTIVITY; HUMAN-PLATELETS; ALPHA-THROMBIN; CLOT LYSIS; INACTIVATION; BINDING; SPECIFICITY; HEPARIN	Activated protein C (APC) is a natural anticoagulant in plasma that down-regulates the coagulation cascade by degrading factors Va and VIIIa. In addition to its anticoagulant function, APC is also known to possess a profibrinolytic property. This property of APC has been attributed to its ability to neutralize PAI-1, thereby increasing the concentration of tissue plasminogen activator in plasma leading to up-regulation of the fibrinolytic cascade. This hypothesis, however, has not been well established, since the concentration of PAI-1 in plasma is low, and its reactivity with APC is very slow in a purified system. Here we demonstrate that vitronectin enhances the reactivity of PAI-1 with APC similar to 300-fold making PAI-1 the most efficient inhibitor of APC thus far reported (k(2) = 1.8 x 10(5) M-1 s(-1)). We further show that PAI-1 inhibition of the Glu(192) --> Gln mutant of APC is enhanced similar to 40-fold, independent of vitronectin, suggesting that vitronectin partially overcomes the inhibitory interaction of PAI-1 with Glu(192). Additionally, we show that PAI-1 inhibition of the Lys(37)-Lys(38)-Lys(39) --> Pro-Gln-Glu mutant of APC is severely impaired, suggesting that, similar to tissue plasminogen activator, the basic 39-loop of APC plays a critical role in the reaction. Together, these results suggest that vitronectin functions as a cofactor to promote the profibrinolytic activity of APC.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 62565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aznar J, 1996, THROMB HAEMOSTASIS, V76, P983; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; Camire RM, 1998, BLOOD, V91, P2818, DOI 10.1182/blood.V91.8.2818.2818_2818_2829; COMP PC, 1981, J CLIN INVEST, V68, P1221, DOI 10.1172/JCI110368; DEFOUW NJ, 1988, THROMB HAEMOSTASIS, V60, P328; DEFOUW NJ, 1987, THROMB HAEMOSTASIS, V57, P176; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; Elisen MGLM, 1996, THROMB HAEMOSTASIS, V75, P760; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; GRUBER A, 1992, BLOOD, V79, P2340; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; JANE SM, 1989, J CLIN INVEST, V83, P222, DOI 10.1172/JCI113862; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; NASKI MC, 1993, J BIOL CHEM, V268, P12367; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Rezaie AR, 1996, EUR J BIOCHEM, V242, P477, DOI 10.1111/j.1432-1033.1996.477rr.x; Rezaie AR, 1998, BIOCHEMISTRY-US, V37, P13138, DOI 10.1021/bi9808518; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; Rezaie AR, 1999, BIOCHEMISTRY-US, V38, P14592, DOI 10.1021/bi9913303; SAKATA Y, 1986, BLOOD, V68, P1218; SAKATA Y, 1985, P NATL ACAD SCI USA, V82, P1121, DOI 10.1073/pnas.82.4.1121; Shen L, 1999, THROMB HAEMOSTASIS, V82, P1078, DOI 10.1055/s-0037-1614332; SHIZUKA R, 1995, THROMB RES, V78, P189, DOI 10.1016/0049-3848(95)00046-1; SIDELMANN J, 1995, THROMB HAEMOSTASIS, V74, P993; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; THIAGARAJAN P, 1988, J BIOL CHEM, V263, P3035; vanMeijer M, 1997, BLOOD, V90, P1874, DOI 10.1182/blood.V90.5.1874; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308	42	102	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15567	15570		10.1074/jbc.C100123200	http://dx.doi.org/10.1074/jbc.C100123200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11264280	hybrid			2022-12-27	WOS:000168623100002
J	Zheng, YM; Liu, CD; Chen, H; Locke, D; Ryan, JC; Kahn, ML				Zheng, YM; Liu, CD; Chen, H; Locke, D; Ryan, JC; Kahn, ML			Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma-chain in response to the snake venom convulxin but not to collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-RI-GAMMA; GLYCOPROTEIN-VI; IMMUNOGLOBULIN SUPERFAMILY; FUNCTIONAL ASSOCIATION; I COLLAGEN; ACTIVATION; ADHESION; IGE; INTEGRIN; PROTEIN	The mechanism of signal transduction underlying the activation of platelets by collagen has been actively investigated for over 30 years, but the receptors involved remain incompletely understood. Studies of human platelets, which are unresponsive to collagen, mouse knockout models, and platelet biochemical studies support the hypothesis that the recently cloned platelet surface protein GPVI functions as a signaling receptor for collagen. To directly test this hypothesis, we have expressed wild-type and mutant forms of GPVI in RBL-2H3 cells, which express the Fee receptor gamma -chain (Fc R gamma), the putative signaling co-receptor for GPVI in platelets, but lack GPVI itself. Expression of GPVI in RBL-2H3 cells confers strong adhesive and signaling responses to convulxin (a snake venom protein that directly binds GPVI) and weak responsiveness to collagen-related peptide but no responsiveness to collagen, To elucidate the mechanism of GPVI intracellular signaling, mutations were introduced in the receptor's transmembrane domain and C-terminal tail. Unlike reported studies of other Fc R gamma partners, these studies reveal that both the GPVI transmembrane arginine and intracellular C-tail are necessary for coupling to Fc R gamma and for signal transduction. To our knowledge, these studies are the first to demonstrate a direct signaling role for GPVI and the first to directly test the role of GPVI as a collagen receptor. Our results suggest that GPVI may be necessary but not sufficient for collagen signaling and that a distinct ligand-binding collagen receptor such as the alpha (2)beta (1) integrin is likely to play a necessary role for collagen signaling as well as adhesion in platelets.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kahn, ML (corresponding author), Univ Penn, Dept Med, 421 Curie Blvd,BRB 2-3,Rm 952, Philadelphia, PA 19104 USA.							ALBER G, 1991, J BIOL CHEM, V266, P22613; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; CLEMETSON KJ, 1982, J CLIN INVEST, V70, P304, DOI 10.1172/JCI110618; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; DU XP, 1994, J BIOL CHEM, V269, P18287; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Hamawy MM, 1997, J BIOL CHEM, V272, P30498, DOI 10.1074/jbc.272.48.30498; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; LANIER LL, 1991, J IMMUNOL, V146, P1571; LECONIAT M, 1990, IMMUNOGENETICS, V32, P183, DOI 10.1007/BF02114971; Monnet E, 2000, THROMB RES, V98, P423, DOI 10.1016/S0049-3848(00)00199-7; MOROI M, 1992, BIOCHIM BIOPHYS ACTA, V1137, P1, DOI 10.1016/0167-4889(92)90092-P; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON HC, 1995, J BIOL CHEM, V270, P29781; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; POSNER RG, 1995, J IMMUNOL, V155, P3601; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; Strouse RJ, 1996, THROMB RES, V82, P485, DOI 10.1016/0049-3848(96)00099-0; SUGIYAMA T, 1987, BLOOD, V69, P1712; Taylor LS, 1999, BLOOD, V94, P1790, DOI 10.1182/blood.V94.5.1790.417k16_1790_1796; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365; WILNER GD, 1968, J CLIN INVEST, V47, P2616, DOI 10.1172/JCI105944	36	64	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12999	13006		10.1074/jbc.M009344200	http://dx.doi.org/10.1074/jbc.M009344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152687	hybrid			2022-12-27	WOS:000168198600077
J	Sauna, ZE; Ambudkar, SV				Sauna, ZE; Ambudkar, SV			Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein - The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; HAMSTER OVARY CELLS; CRYSTAL-STRUCTURE; TRANSITION-STATE; WALKER-A; NUCLEOTIDE; SITES; BINDING; PURIFICATION; TRANSPORTER	P-glycoprotein (Pgp) is a plasma membrane protein whose overexpression confers multidrug resistance to tumor cells by extruding amphipathic natural product cytotoxic drugs using the energy of ATP, An elucidation of the catalytic cycle of Pgp would help design rational strategies to combat multidrug resistance and to further our understanding of the mechanism of ATP-binding cassette transporters. We have recently reported (Sauna, Z, E,, and Ambudkar, S, V. (2000) Proc. Natl, Acad Sci, U.S.A. 97, 2515-2520) that there are two independent ATP hydrolysis events in a single catalytic cycle of Pgp, In this study we exploit the vanadate (Vi)induced transition state conformation of Pgp (Pgp ADP Vi) to address the question of what are the effects of ATP hydrolysis on the nucleotide-binding site, We find that at the end of the first hydrolysis event there is a drastic decrease in the affinity of nucleotide for Pgp coincident with decreased substrate binding. Release of occluded dinucleotide is adequate for the next hydrolysis event to occur but is not sufficient for the recovery of substrate binding. Whereas the two hydrolysis events have different functional outcomes vis a vis the substrate, they show comparable t(1/2), for both incorporation and release of nucleotide, and the affinities for [alpha-P-32]8-azido-ATP during Vi induced trapping are identical. In addition, the incorporation of [alpha-P-32]8-azido-ADP in two ATP sites during both hydrolysis events is also similar. These data demonstrate that during individual hydrolysis events, the ATP sites are recruited in a random manner, and only one site is utilized at any given time because of the conformational change in the catalytic site that drastically reduces the affinity of the second ATP site for nucleotide binding. In aggregate, these findings provide an explanation for the alternate catalysis of ATP hydrolysis and offer a mechanistic framework to elucidate events at both the substrate- and nucleotide-binding sites in the catalytic cycle of Pgp.	NCI, Cell Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Div Basic Sci, NIH, Bldg 37,Rm 1B-22,37 Convent Dr, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Ambudkar, Suresh V/B-5964-2008; Ambudkar, Suresh V/L-1317-2016; Sauna, Zuben E./AAA-7149-2019					ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; FORD JM, 1990, PHARMACOL REV, V42, P155; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; HIRATSUKA T, 1973, BIOCHIM BIOPHYS ACTA, V320, P635, DOI 10.1016/0304-4165(73)90143-8; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1997, BIOCHEMISTRY-US, V36, P2836, DOI 10.1021/bi9627119; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Muller M, 1996, J BIOL CHEM, V271, P1877; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SENIOR AE, 1995, J BIOENERG BIOMEMBR, V27, P31, DOI 10.1007/BF02110328; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; Shapiro AB, 1998, EUR J BIOCHEM, V254, P189, DOI 10.1046/j.1432-1327.1998.2540189.x; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	41	147	148	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11653	11661		10.1074/jbc.M011294200	http://dx.doi.org/10.1074/jbc.M011294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11154703	hybrid			2022-12-27	WOS:000168081800033
J	Sharkov, NA; Davis, RM; Reidhaar-Olson, JF; Navre, M; Cai, D				Sharkov, NA; Davis, RM; Reidhaar-Olson, JF; Navre, M; Cai, D			Reaction kinetics of protease with substrate phage - Kinetic model developed using stromelysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; PLASMINOGEN-ACTIVATOR; DISPLAY; SPECIFICITY; SELECTION; IDENTIFICATION; STABILITY; PROTEINS; LIGANDS	Peptide libraries generated using phage display have been widely applied to proteolytic enzymes for substrate selection and optimization, but the reaction kinetics between the enzyme and substrate phage are not well understood. Using a quantitative ELISA assay to monitor the disappearance of substrate, we have been able to follow the course of reaction between stromelysin, a metalloprotease, and its substrate phage, We found that under the proteolytic conditions where the enzyme was present in nanomolar concentration or higher, in excess over the substrate, the proteolysis of substrate phage was a single exponential event and the observed rate linear with respect to enzyme concentration. The enzyme concentration dependence could be described by pseudo first-order kinetic equations. Our data suggest that substrate binding is slow relative to the subsequent hydrolysis step, implying that the phage display selection process enriches clones that have high binding affinity to the protease, and the selection may not discriminate those of different chemical reactivity toward the enzyme. Considering that multiple substrate molecules may be present on a single phage particle, we regard the substrate phage reaction kinetic model as empirical. The validity of the model was ascertained when we successfully applied it to determine the binding affinity of a competitive inhibitor of stromelysin.	Affymax Res Inst, Santa Clara, CA 95051 USA		Cai, D (corresponding author), 3410 Cent Expressway, Santa Clara, CA 95051 USA.							Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11604, DOI 10.1021/bi990765n; Gram H, 1999, COMB CHEM HIGH T SCR, V2, P19; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hervio LS, 2000, CHEM BIOL, V7, P443, DOI 10.1016/S1074-5521(00)00125-3; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MATTHEWS DJ, 1994, PROTEIN SCI, V3, P1197, DOI 10.1002/pro.5560030805; OBoyle DR, 1997, VIROLOGY, V236, P338, DOI 10.1006/viro.1997.8746; Ruan B, 1998, PROTEIN SCI, V7, P2345, DOI 10.1002/pro.5560071111; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Webster Robert E., 1996, P1, DOI 10.1016/B978-012402380-2/50003-4; Zwick MB, 1998, CURR OPIN BIOTECH, V9, P427, DOI 10.1016/S0958-1669(98)80017-7	25	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10788	10793		10.1074/jbc.M011772200	http://dx.doi.org/10.1074/jbc.M011772200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152696	hybrid			2022-12-27	WOS:000167980900032
J	Han, GS; Johnston, CN; Chen, XM; Athenstaedt, K; Daum, G; Carman, GM				Han, GS; Johnston, CN; Chen, XM; Athenstaedt, K; Daum, G; Carman, GM			Regulation of the Saccharomyces cerevisiae DPP1-encoded diacylglycerol pyrophosphate phosphatase by zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; GENE ENCODES; SHUTTLE VECTORS; SEQUENCE MOTIF; H+-ATPASE; YEAST; IDENTIFICATION; TRANSPORTER; PROTEIN; PURIFICATION	The DPP1 gene, encoding diacylglycerol pyrophosphate (DGPP) phosphatase from Saccharomyces cerevisiae, has recently been identified as a zinc-regulated gene, and it contains a putative zinc-responsive element (UAS(ZRE)) in its promoter. In this work we examined the hypothesis that expression of DGPP phosphatase was regulated by zinc availability. The deprivation of zinc from the growth medium resulted in a time- and dose-dependent induction of beta -galactosidase activity driven by a P-DPP1-lacZ reporter gene, This regulation was dependent on the UAS(ZRE) in the DPP1 promoter and was mediated by the Zap1p transcriptional activator. Induction of the DGPP phosphatase protein and activity by zinc deprivation was demonstrated by immunoblot analysis and measurement of the dephosphorylation of DGPP, The regulation pattern of DGPP phosphatase in mutants defective in plasma membrane (Zrt1p and Zrt2p) and vacuolar membrane (Zrt3p) zinc transporters indicated that enzyme expression was sensitive to the cytoplasmic levels of zinc. DGPP phosphatase activity was inhibited by zinc by a mechanism that involved formation of DGPP-zinc complexes, Studies with well characterized subcellular fractions and by indirect immunofluorescence microscopy revealed that the DGPP phosphatase enzyme was localized to the vacuolar membrane.	Rutgers State Univ, Dept Food Sci, Cook Coll, New Jersey Agr Expt Stn, New Brunswick, NJ 08901 USA; Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Rutgers State University New Brunswick; Graz University of Technology	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, Cook Coll, New Jersey Agr Expt Stn, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Athenstaedt, Karin/0000-0001-7198-3989	NIGMS NIH HHS [GM-28140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balboa MA, 1999, J BIOL CHEM, V274, P522, DOI 10.1074/jbc.274.1.522; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Chen HM, 1996, J AGR FOOD CHEM, V44, P2619, DOI 10.1021/jf950833m; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; HAID A, 1983, METHOD ENZYMOL, V96, P192; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Riedel B, 1997, PLANT SCI, V128, P1, DOI 10.1016/S0168-9452(97)00120-9; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SIKORSKI RS, 1989, GENETICS, V122, P19; Stukey J, 1997, PROTEIN SCI, V6, P469; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; UCHIDA E, 1988, METHOD ENZYMOL, V157, P544; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WISSING JB, 1993, PLANT PHYSIOL, V102, P1243, DOI 10.1104/pp.102.4.1243; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Yuan DS, 2000, GENETICS, V156, P45; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	67	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10126	10133		10.1074/jbc.M011421200	http://dx.doi.org/10.1074/jbc.M011421200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139591	hybrid			2022-12-27	WOS:000167996400073
J	Rohde, J; Heitman, J; Cardenas, ME				Rohde, J; Heitman, J; Cardenas, ME			The TOR kinases link nutrient sensing to cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							P70 S6 KINASE; MESSENGER-RNA TRANSLATION; RIBOSOMAL-PROTEIN GENES; SIGNALING PATHWAY; MAMMALIAN TARGET; SACCHAROMYCES-CEREVISIAE; PHAS-I; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; AMINO-ACIDS; EIF-4E BP1	Rapamycin is an immunosuppressive natural product that inhibits the proliferation of T-cells in response to nutrients and growth factors. Rapamycin binds to the peptidyl-prolyl isomerase FKBP12 and forms protein-drug complexes that inhibit signal transduction by the TOR kinases. The FKBP12 and TOR proteins are conserved from fungi to humans, and in both organisms the TOR signaling pathway plays a role in nutrient sensing. In response to nitrogen sources or amino acids, TOR regulates both transcription and translation, enabling cells to appropriately respond to growth-promoting signals. Rapamycin is having a profound impact on clinical medicine and was approved as an immunosuppressant for transplant recipients in 1999. Ongoing clinical studies address new clinical applications for rapamycin as an antiproliferative drug for chemotherapy and invasive cardiology.	Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Cardenas, ME (corresponding author), Duke Univ, Med Ctr, Dept Genet, Box 3546,322 CARL Bldg,Res Dr, Durham, NC 27710 USA.	carde004@mc.duke.edu	Rohde, John/F-1479-2013; Heitman, Joseph/ABC-6006-2021		NATIONAL CANCER INSTITUTE [K01CA077075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041937] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CARDENAS ME, 1995, EMBO J, V14, P5892, DOI 10.1002/j.1460-2075.1995.tb00277.x; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KILBERG MS, 1994, FASEB J, V8, P13, DOI 10.1096/fasebj.8.1.8299885; Klasson H, 1999, MOL CELL BIOL, V19, P5405; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MAHAJAN PB, 1994, INT J IMMUNOPHARMACO, V16, P711, DOI 10.1016/0192-0561(94)90091-4; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Sekulic A, 2000, CANCER RES, V60, P3504; STAN R, 1994, J BIOL CHEM, V269, P32027; STETTLER S, 1993, MOL GEN GENET, V239, P169, DOI 10.1007/BF00281615; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	74	285	296	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9583	9586		10.1074/jbc.R000034200	http://dx.doi.org/10.1074/jbc.R000034200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11266435	hybrid			2022-12-27	WOS:000167996400001
J	Elmendorf, BJ; Shilatifard, A; Yan, Q; Conaway, JW; Conaway, RC				Elmendorf, BJ; Shilatifard, A; Yan, Q; Conaway, JW; Conaway, RC			Transcription factors TFIIF, ELL, and elongin negatively regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEXES; CHAIN ELONGATION; FUNCTIONAL-PROPERTIES; FACTOR-EPSILON; FACTOR-DELTA; RAT-LIVER; INITIATION; IDENTIFICATION; TERMINATION; MECHANISM	TFIIF, ELL, and Elongin belong to a class of RNA polymerase II transcription factors that function similarly to activate the rate of elongation by suppressing transient pausing by polymerase at many sites along DNA templates, SII is a functionally distinct RNA polymerase II elongation factor that promotes elongation by reactivating arrested polymerase, Studies of the mechanism of SII action have shown (i) that arrest of RNA polymerase II results from irreversible displacement of the 3'-end of the nascent transcript from the polymerase catalytic site and (ii) that SII reactivates arrested polymerase by inducing endonucleolytic cleavage of the nascent transcript by the polymerase catalytic site thereby creating a new transcript 3'-end that is properly aligned with the catalytic site and can be extended. SII also induces nascent transcript cleavage by paused but non-arrested RNA polymerase H elongation intermediates, leading to the proposal that pausing may result from reversible displacement of the 3'-end of nascent transcripts from the polymerase catalytic site. On the basis of evidence consistent with the model that TFIIF, ELL, and Elongin suppress pausing by preventing displacement of the 3'-end of the nascent transcript from the polymerase catalytic site, we investigated the possibility of cross-talk between SII and transcription factors TFIIF, ELL, and Elongin, These studies led to the discovery that TFIIF, ELL, and Elongin are all capable of inhibiting SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates, Here we present these findings, which bring to light a novel activity associated with TFIIF, ELL, and Elongin and suggest that these transcription factors may expedite elongation not only by increasing the forward rate of nucleotide addition by RNA polymerase II, but also by inhibiting SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.	Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; St Louis Univ, Sch Med, Edward A Doisey Dept Biochem, St Louis, MO 63104 USA; Oklahoma Med Res Fdn, Howard Hughes Med Inst, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Saint Louis University; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Conaway, RC (corresponding author), Oklahoma Med Res Fdn, Program Mol & Cell Biol, 825 Ne 13Th St, Oklahoma City, OK 73104 USA.		Yan, Qin/E-8893-2012	Yan, Qin/0000-0003-4077-453X; Conaway, Joan/0000-0002-2786-0663	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37-GM41628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; CHAMBERLIN MJ, 1995, HARVEY LECT, V88, P1; CONAWAY JW, 1992, J BIOL CHEM, V267, P10142; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; KRUMMEL B, 1992, J MOL BIOL, V225, P221, DOI 10.1016/0022-2836(92)90917-9; LAVIALLE C, 1982, J BIOL CHEM, V257, P2458; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Moreland RJ, 1998, J BIOL CHEM, V273, P26610, DOI 10.1074/jbc.273.41.26610; PETERSON MG, 1991, NATURE, V354, P369; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; RHODES G, 1974, J BIOL CHEM, V249, P6675; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; TAKAGI Y, 1995, J BIOL CHEM, V270, P24300, DOI 10.1074/jbc.270.41.24300; TAN SY, 1994, J BIOL CHEM, V269, P25684; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; YOO OJ, 1991, NUCLEIC ACIDS RES, V19, P1073, DOI 10.1093/nar/19.5.1073	37	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					23109	23114		10.1074/jbc.M101445200	http://dx.doi.org/10.1074/jbc.M101445200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11259417	hybrid			2022-12-27	WOS:000169412700150
J	Pastorelli, C; Veiga, J; Charles, N; Voignier, E; Moussu, H; Monteiro, RC; Benhamou, M				Pastorelli, C; Veiga, J; Charles, N; Voignier, E; Moussu, H; Monteiro, RC; Benhamou, M			IgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PHOSPHOLIPIDS; KINASE C-DELTA; TRANSBILAYER MOVEMENT; SCOTT-SYNDROME; HISTAMINE-RELEASE; GAMMA-CHAIN; MAST-CELLS; PROTEIN; PHOSPHATIDYLSERINE; EXPRESSION	To identify new effecters of IgE receptor (Fc epsilon RI) signaling, we purified proteins from Fc epsilon RI-stimulated RBL-2H3 rat mast cells on anti-phosphotyrosine beads and generated mouse monoclonal antibodies (mAb) against these proteins. Two mAbs bound to a protein that was identified as a new isoform of phospholipid scramblase (PLSCR) after screening an RBL-2H3 cDNA expression library. This isoform differed from PLSCR1 by the absence of an exon 3-encoded sequence and by an insert coding six QGPY(P/A)GP repeats. The PLSCR family of proteins is responsible for a redistribution of phospholipids across the plasma membrane, Although rat PLSCR is a 37-kDa protein, anti-phosphotyrosine immunoblots revealed the presence of 37-49 kDa phosphoproteins in the material immunoprecipitated with either anti-PLSCR mAb but not with unrelated monoclonal or polyclonal antibodies. Depletion of PLSCR resulted in the absence of these phosphoproteins. Additional experiments led to the identification of these phosphoproteins as phospho-PLSCR itself. Stimulation of RBL-2H3 cells upon Fc epsilon RI engagement resulted in a dramatic increase in PLSCR tyrosine phosphorylation. A comparison of the relative amounts of phospho-PLSCR and nonphosphorylated PLSCR demonstrated that only a tiny fraction was thus modified, indicating a finely targeted involvement of PLSCR in Fc epsilon RI signaling. Thus, this study reports the cloning of a new isoform of PLSCR, as well as the first observation that a member of the PLSCR family is a target for tyrosine kinases and is involved in signaling by an immune receptor. These findings open new perspectives on the role of phospholipid scramblases and to the mechanisms involved in their regulation.	Inst Pasteur, INSERM, U485, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U25, F-75743 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benhamou, M (corresponding author), Inst Pasteur, INSERM, U485, 25 Rue Dr Roux, F-75015 Paris, France.		CHARLES, Nicolas/P-5430-2014; Monteiro, Renato C/U-8633-2017; CHARLES, Nicolas/S-2214-2019	CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; CHARLES, Nicolas/0000-0002-5416-5834; Benhamou, Marc/0000-0001-7763-3795				BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bevers EM, 1998, BIOL CHEM, V379, P973; Comfurius P, 1996, BIOCHEMISTRY-US, V35, P7631, DOI 10.1021/bi9606859; Dachary-Prigent J, 1997, BRIT J HAEMATOL, V99, P959, DOI 10.1046/j.1365-2141.1997.5003302.x; Dekkers DWC, 1998, BLOOD, V91, P2133, DOI 10.1182/blood.V91.6.2133; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; GERMANO P, 1994, J BIOL CHEM, V269, P23102; Janel N, 1999, THROMB HAEMOSTASIS, V81, P322, DOI 10.1055/s-0037-1614469; Kasukabe T, 1998, BIOCHEM BIOPH RES CO, V249, P449, DOI 10.1006/bbrc.1998.9190; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; MONTEIRO RC, 1992, J IMMUNOL, V148, P1764; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; OZAWA K, 1993, J BIOL CHEM, V268, P1749; ROSING J, 1985, BLOOD, V65, P1557, DOI 10.1182/blood.V65.6.1557.bloodjournal6561557; SIRAGANIAN RP, 1993, ALLERGY PRINCIPLES P, V1, P105; Stout JG, 1997, J CLIN INVEST, V99, P2232, DOI 10.1172/JCI119397; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; WELLS E, 1983, BIOCHEM PHARMACOL, V32, P837, DOI 10.1016/0006-2952(83)90585-3; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhao J, 1998, BIOCHEMISTRY-US, V37, P6361, DOI 10.1021/bi980218m; Zhou QS, 1998, BIOCHEMISTRY-US, V37, P2356, DOI 10.1021/bi972625o; Zhou QS, 1998, BLOOD, V92, P1707, DOI 10.1182/blood.V92.5.1707; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	33	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20407	20412		10.1074/jbc.M100790200	http://dx.doi.org/10.1074/jbc.M100790200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259432	hybrid			2022-12-27	WOS:000169135100099
J	Tottey, S; Rich, PR; Rondet, SAM; Robinson, NJ				Tottey, S; Rich, PR; Rondet, SAM; Robinson, NJ			Two Menkes-type ATPases supply copper for photosynthesis in Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-BF COMPLEX; P-TYPE ATPASES; GENE-PRODUCTS; PHOTOSYSTEM-I; CYANOBACTERIUM; RESISTANCE; MEMBRANE; MUTANTS; PROTEIN; ALGAE	Synechocystis PCC 6803 contains four genes encoding polypeptides with sequence features of CPx-type ATPases, two of which are now designated pacS and ctaA, We show that CtaA and PacS (but not the related transporters, ZiaA or CoaT) facilitate switching to the use of copper (in plastocyanin) as an alternative to iron (in cytochrome c(6)) for the carriage of electrons within the thylakoid lumen. Disruption of pacS reduced copper tolerance but enhanced silver tolerance, and pacS-mediated restoration of copper tolerance was used to select transformants, Disruption of ctaA caused no change in copper tolerance but reduced the amount of copper cell(-1). In cultures supplemented with 0.2 muM copper, photooxidation of cytochrome c(6) (PetJ) was depressed in wild-type cells but remained elevated in both Synechocystis PCC 6803(ctaA) and Synechocystis PCC 6803(pacS), Conversely, plastocyanin transcripts (petE) were less abundant in both mutants at this [copper]. Synechocystis PCC 6803(ctaA) and Synechocystis PCC 6803(pacS) showed increased iron dependence with impaired growth in deferoxamine mesylate (iron chelator)containing media. Double mutants also deficient in cytochrome c(6), Synechocystis PCC 6803(petJ,ctaA) and Synechocystis PCC 6803(petJ,pacS), were viable, but the former had increased copper dependence with severely impaired growth in the presence of bathocuproinedisulfonic acid (copper chelator), Analogous transporters are likely to supply copper to plastocyanin in chloroplasts.	Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; UCL, Dept Biol, Glynn Res Lab Bioenerget, London WC1E 6BT, England	Newcastle University - UK; University of London; University College London	Robinson, NJ (corresponding author), Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@newcastle.ac.uk	Robinson, Nigel J/J-6363-2012	Robinson, Nigel J/0000-0001-5586-1092				Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Kaneko T, 1996, DNA Res, V3, P109; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; KRATZ WA, 1955, AM J BOT, V42, P282, DOI 10.2307/2438564; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PESCHEK GA, 1981, BIOCHIM BIOPHYS ACTA, V635, P470, DOI 10.1016/0005-2728(81)90106-7; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; REDDY KJ, 1990, BIOTECHNIQUES, V8, P250; RICH PR, 1987, BIOCHIM BIOPHYS ACTA, V892, P138, DOI 10.1016/0005-2728(87)90256-8; RICH PR, 1991, BIOCHIM BIOPHYS ACTA, V1058, P312, DOI 10.1016/S0005-2728(05)80252-X; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; TURNER JS, 1993, J BIOL CHEM, V268, P4494; ZHANG L, 1992, J BIOL CHEM, V267, P19054	28	125	128	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19999	20004		10.1074/jbc.M011243200	http://dx.doi.org/10.1074/jbc.M011243200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264284	hybrid			2022-12-27	WOS:000169135100044
J	Gogvadze, V; Robertson, JD; Zhivotovsky, B; Orrenius, S				Gogvadze, V; Robertson, JD; Zhivotovsky, B; Orrenius, S			Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCATOR; RAT-LIVER MITOCHONDRIA; CELL-DEATH; OUTER-MEMBRANE; BCL-2 FAMILY; APOPTOSIS; OLIGOMERIZATION; HYDROPEROXIDE; CARDIOLIPIN	Release of cytochrome c from mitochondria is a key initiative step in the apoptotic process, although the mechanisms regulating this event remain elusive. In the present study, using isolated liver mitochondria, we demonstrate that cytochrome c release occurs via distinct mechanisms that are either Ca2+-dependent or Ca2+-independent, An increase in mitochondrial matrix Ca2+ promotes the opening of the permeability transition (PT) pore and the release of cytochrome c, an effect that is significantly enhanced when these organelles are incubated in a reaction buffer that is based on a physiologically relevant concentration of K+ (150 mM KCI) versus a buffer composed of mannitol/sucrose/Hepes. Moreover, low concentrations of Ca2+ are sufficient to induce mitochondrial cytochrome c release without measurable manifestations of PT, though inhibitors of PT effectively prevent this release, indicating that the critical threshold for PT varies among mitochondria within a single population of these organelles. In contrast, Ca2+-independent cytochrome c release is induced by oligomeric Bax protein and occurs without mitochondrial swelling or the release of matrix proteins, although our data also indicate that Pax enhances permeability transition-induced cytochrome c release. Taken together, our results suggest that the intramitochondrial Ca2+ concentration, as well as the reaction buffer composition, are key factors in determining the mode and amount of cytochrome c release. Finally, oligomeric Bax appears to be capable of stimulating cytochrome c release via both Ca2+-dependent and Ca2+-independent mechanisms.	Karolinska Inst, Inst Environm Med, Div Toxicol, SE-17177 Stockholm, Sweden; Inst Theoret & Expt Biophys, Pushchino 142290, Russia	Karolinska Institutet; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Orrenius, S (corresponding author), Karolinska Inst, Inst Environm Med, Div Toxicol, Box 210, SE-17177 Stockholm, Sweden.		Gogvadze, Vladimir/A-4392-2014; Zhivotovsky, Boris/A-4346-2014	Zhivotovsky, Boris/0000-0002-2238-3482				Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; BEATRICE MC, 1982, J BIOL CHEM, V257, P7161; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cortese JD, 1998, BIOCHEMISTRY-US, V37, P6402, DOI 10.1021/bi9730543; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hampton MB, 1998, BIOCHEM J, V329, P95; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LEMESHKO VV, 1993, MECH AGEING DEV, V68, P221, DOI 10.1016/0047-6374(93)90153-I; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Montessuit S, 1999, PROTEIN EXPRES PURIF, V15, P202, DOI 10.1006/prep.1998.1010; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Robertson JD, 2000, J BIOL CHEM, V275, P32438, DOI 10.1074/jbc.C000518200; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Skulachev Vladimir P., 1999, Molecular Aspects of Medicine, V20, P139, DOI 10.1016/S0098-2997(99)00008-4; Thress K, 1999, J BIOENERG BIOMEMBR, V31, P321, DOI 10.1023/A:1005471701441; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang JC, 1998, FREE RADICAL BIO MED, V24, P624, DOI 10.1016/S0891-5849(97)00367-5; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030	39	172	184	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19066	19071		10.1074/jbc.M100614200	http://dx.doi.org/10.1074/jbc.M100614200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11264286	hybrid			2022-12-27	WOS:000169091000058
J	Madrid, LV; Mayo, MW; Reuther, JY; Baldwin, AS				Madrid, LV; Mayo, MW; Reuther, JY; Baldwin, AS			Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the I kappa B kinase and activation of the mitogen-activated protein kinase p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FORKHEAD TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; CELL-SURVIVAL; FACTOR-ALPHA; P65 SUBUNIT; DEPENDENT TRANSCRIPTION; GENE-EXPRESSION; ONCOGENIC RAS	The serine/threonine kinase Akt/PKB is a potent regulator of cell survival and has oncogenic transformation potential. Previously, it has been shown that Akt can activate the transcription factor NF-kappaB and that this functions to block apoptosis induced by certain stimuli. The mechanism whereby Akt activates NF-kappaB has been controversial, with evidence supporting induction of nuclear translocation of NF-kappaB via activation of I kappaB kinase activity and/or the stimulation of the transcription function of NF-kappaB. Here we demonstrate that Akt targets the transactivation function of NF-kappaB by stimulating the transactivation domain of RelA/p65 in a manner that is dependent on I kappaB kinase beta activity and on the mitogen-activated protein kinase p38 (p38), Activation of RelA/ p65 transactivation function requires serines 529 and 536, sites shown previously to be inducibly phosphorylated. Consistent with the requirement of p38 in the activation of NF-kappaB transcriptional function, expression of activated Akt induces p38 activity. Furthermore, the ability of IL-I beta to activate NF-kappaB is known to involve Akt, and we show here that IL-1 beta induces p38 activity in manner dependent on Akt and I kappaB kinase activation. Interestingly, activated Akt and the transcriptional coactivators CBP/p300 synergize in the activation of the RelA/p65 transactivation domain, and this synergy is blocked by p38 inhibitors. These studies demonstrate that Akt, functioning through I kappaB kinase and p38, induces the transcription function of NF-kappaB by stimulating the RelA/p65 transactivation subunit of NF-kappaB.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.				NCI NIH HHS [CA73756, CA75080, CA72771] Funding Source: Medline; NIAID NIH HHS [AI35098] Funding Source: Medline; NIGMS NIH HHS [T32GM07092] Funding Source: Medline; PHS HHS [K01 78595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073756, R01CA072771, R01CA075080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delhase M, 2000, NATURE, V406, P367, DOI 10.1038/35019154; delPeso L, 1997, SCIENCE, V278, P687; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; Ozes ON, 1999, NATURE, V401, P82; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	51	680	695	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18934	18940		10.1074/jbc.M101103200	http://dx.doi.org/10.1074/jbc.M101103200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259436	hybrid, Green Published			2022-12-27	WOS:000169091000039
J	Saaf, A; Baars, L; von Heijne, G				Saaf, A; Baars, L; von Heijne, G			The internal repeats in the Na+/Ca2+ exchanger-related Escherichia coli protein YrbG have opposite membrane topologies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVELY CHARGED RESIDUES; ALKALINE-PHOSPHATASE; NA+-CA2+ EXCHANGER; GENE; TRANSLOCATION; SEQUENCE; FUSIONS; REGION; EXPORT; SIGNAL	We have determined the topology of the Escherichia coli inner membrane protein YrbG, a putative Na+/Ca2+ exchanger with homology to a family of eukaryotic ion exchangers. Our results show that the two homologous halves of YrbG both have five transmembrane segments but opposite membrane orientations. This has implications for our understanding of the function of Na+/Ca2+ exchangers and provides an example of "divergent" evolution of membrane protein topology.	Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; DUNLOP J, 1995, EMBO J, V14, P3609, DOI 10.1002/j.1460-2075.1995.tb00030.x; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEE E, 1994, J BIOL CHEM, V269, P28822; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VONHEIJNE G, 1984, EMBO J, V3, P2315, DOI 10.1002/j.1460-2075.1984.tb02132.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WHITLEY P, 1995, J BIOL CHEM, V270, P29831; WHITLEY P, 1994, NAT STRUCT BIOL, V1, P858, DOI 10.1038/nsb1294-858	24	40	42	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18905	18907		10.1074/jbc.M101716200	http://dx.doi.org/10.1074/jbc.M101716200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259419	hybrid			2022-12-27	WOS:000169091000035
J	Vaisman, A; Warren, MW; Chaney, SG				Vaisman, A; Warren, MW; Chaney, SG			The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTICANCER DRUG CISPLATIN; INTRASTRAND CROSS-LINK; TRANSLESION SYNTHESIS; SEQUENCE-SPECIFICITY; INSERTION FIDELITY; CRYSTAL-STRUCTURES; MAJOR ADDUCT; GPG ADDUCTS; GAPPED DNA; DUPLEX	DNA adducts formed by platinum-based anticancer drugs interfere with DNA replication. The carrier ligand of the platinum compound is likely to affect the conformation of the Pt DNA adducts. In addition, the conformation of the adduct can also change upon binding of damaged DNA to the active site of DNA polymerase. From the crystal structures of pol P ternary complexes it is evident that undamaged gapped and primed single-stranded (non-gapped) DNA templates exist in very different conformations when bound to pol beta. Therefore, one might expect that the constraints imposed on the damaged templates by binding to the polymerase active site should also affect the conformation of the Pt-DNA adducts and their ability to inhibit DNA replication. In support of this hypothesis we have found that the efficiency, carrier ligand specificity, site of discrimination (3 ' -G: versus 5 ' -G of the Pt-GG adducts), and fidelity of translesion synthesis past Pt-DNA adducts by pol beta are strongly affected by the structure of the DNA template. Previous studies have suggested that the conformation of Pt-DNA adducts may be affected by the sequence context of the adduct, In support of this hypothesis, our data show that sequence context affects the efficiency, fidelity, and pattern of misincorporation by pol beta.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chaney, SG (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Vaisman, Alexandra/C-3766-2013	Vaisman, Alexandra/0000-0002-2521-1467				Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BUBLEY GJ, 1991, MOL CARCINOGEN, V4, P397, DOI 10.1002/mc.2940040512; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; COSMAN M, 1995, BIOCHEMISTRY-US, V34, P15334, DOI 10.1021/bi00046a043; Creighton S, 1995, METHOD ENZYMOL, V262, P232; DEBOER JG, 1989, CARCINOGENESIS, V10, P1363, DOI 10.1093/carcin/10.8.1363; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Efrati E, 1997, J BIOL CHEM, V272, P2559; Feng BB, 1997, BIOCHEMISTRY-US, V36, P13780, DOI 10.1021/bi970070r; Fink D, 1996, CANCER RES, V56, P4881; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; HERMAN F, 1990, EUR J BIOCHEM, V194, P119, DOI 10.1111/j.1432-1033.1990.tb19435.x; Kunkel TA, 1998, NAT STRUCT BIOL, V5, P95, DOI 10.1038/nsb0298-95; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pilch DS, 2000, J MOL BIOL, V296, P803, DOI 10.1006/jmbi.2000.3496; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Woynarowski JM, 1998, MOL PHARMACOL, V54, P770, DOI 10.1124/mol.54.5.770; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054	27	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18999	19005		10.1074/jbc.M007805200	http://dx.doi.org/10.1074/jbc.M007805200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259423	Green Published, hybrid			2022-12-27	WOS:000169091000048
J	Cortajarena, AL; Goni, FM; Ostolaza, H				Cortajarena, AL; Goni, FM; Ostolaza, H			Glycophorin as a Receptor for Escherichia coli alpha-hemolysin in erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TOXIN; FATTY ACYLATION; SINGLE-HIT; RTX TOXINS; MEMBRANE; VESICLES; CELLS; MECHANISM; RELEASE; BINDING	Escherichia coli cu-hemolysin (HlyA) can lyse both red blood cells (RBC) and liposomes, However, the cells are lysed at HlyA concentrations 1-2 orders of magnitude lower than liposomes (large unilamellar vesicles). Treatment of RBC with trypsin, but not with chymotrypsin, reduces the sensitivity of RBC toward HlyA to the level of the liposomes, Since glycophorin, one of the main proteins in the RBC surface, can be hydrolyzed by trypsin much more readily than by chymotrypsin, the possibility was tested of a specific binding of HlyA to glycophorin, With this purpose, a number of experiments were performed. (a) HlyA was preincubated with purified glycophorin, after which it was found to be inactive against both RBC and liposomes, (b) Treatment of RBC with an anti-glycophorin antibody protected the cells against HlyA lysis, (c) Immobilized HlyA was able to bind glycophorin present in a detergent lysate of RBC ghosts. (d) Incorporation of glycophorin into pure phosphatidylcholine liposomes increased notoriously the sensitivity of the vesicles toward HlyA (e) Treatment of the glycophorin-containing liposomes with trypsin reverted the vesicles to their original low sensitivity, The above results are interpreted in terms of glycophorin acting as a receptor for HlyA in RBC. The binding constant of HlyA for glycophorin was estimated, in RBC at sublytic HlyA concentrations, to be 1.5 x 10(-9) M.	Univ Basque Country, Unidad Biofis, Consejo Super Invest Cient, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, Unidad Biofis, Consejo Super Invest Cient, Aptdo 644, E-48080 Bilbao, Spain.	gbzoseth@lg.ehu.es	Goni, Felix M/M-5425-2015; Cortajarena, Aitziber L/J-6202-2012; Fu, Lixia/B-7429-2009	Goni, Felix M/0000-0001-6270-9216; Cortajarena, Aitziber L/0000-0002-5331-114X; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975				Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1991, INFECT IMMUN, V59, P2955, DOI 10.1128/IAI.59.9.2955-2962.1991; BHAKDI S, 1990, J CLIN INVEST, V85, P1746, DOI 10.1172/JCI114631; Blumenfeld OO, 1997, TRANSFUS CLIN BIOL, V4, P357, DOI 10.1016/S1246-7820(97)80041-9; BRETSCHER MS, 1973, SCIENCE, V181, P622, DOI 10.1126/science.181.4100.622; CABANTCHIK ZI, 1974, J MEMBRANE BIOL, V15, P227, DOI 10.1007/BF01870089; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; CHALLOU N, 1994, BIOCHEMISTRY-US, V33, P6902, DOI 10.1021/bi00188a020; CHASIS JA, 1992, BLOOD, V80, P1869; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; COOTE JG, 1996, REV MED MICROBIOL, V7, P53, DOI [10.1097/00013542-199601000-00006, DOI 10.1097/00013542-199601000-00006]; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Duk M, 2000, ARCH BIOCHEM BIOPHYS, V375, P111, DOI 10.1006/abbi.1999.1637; EBERSPACHER B, 1989, INFECT IMMUN, V57, P983; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; GARLAND WJ, 1988, INFECT IMMUN, V56, P1249, DOI 10.1128/IAI.56.5.1249-1253.1988; Goni FM, 1998, BRAZ J MED BIOL RES, V31, P1019, DOI 10.1590/S0100-879X1998000800002; GRIMMINGER F, 1990, INFECT IMMUN, V58, P2659, DOI 10.1128/IAI.58.8.2659-2663.1990; GUTFREUND H, 1972, ENZYMES PHYSICAL PRI, P71; HAMAGUCHI H, 1972, BIOCHIM BIOPHYS ACTA, V278, P271, DOI 10.1016/0005-2795(72)90232-2; HOWARD SP, 1982, BIOCHEMISTRY-US, V21, P1662, DOI 10.1021/bi00536a029; Huang Pearl S., 1997, Current Opinion in Oncology, V9, P94; JORGENSEN SE, 1980, INFECT IMMUN, V27, P988, DOI 10.1128/IAI.27.3.988-994.1980; KEANE WF, 1987, AM J PATHOL, V126, P350; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Li J, 1999, VET MICROBIOL, V67, P91, DOI 10.1016/S0378-1135(99)00040-1; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; MACDONALD RI, 1975, J BIOL CHEM, V250, P9206; MARCHESI VT, 1976, ANNU REV BIOCHEM, V45, P667, DOI 10.1146/annurev.bi.45.070176.003315; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MENESTRINA G, 1988, FEBS LETT, V232, P217, DOI 10.1016/0014-5793(88)80420-4; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; OSTOLAZA H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P81, DOI 10.1016/0005-2736(93)90318-T; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; SCHEFFER J, 1985, INFECT IMMUN, V50, P271, DOI 10.1128/IAI.50.1.271-278.1985; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SMITH SO, 1995, P NATL ACAD SCI USA, V92, P488, DOI 10.1073/pnas.92.2.488; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; SPRINGER GF, 1966, BIOCHEMISTRY-US, V5, P3254, DOI 10.1021/bi00874a028; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; STECK TL, 1976, BIOCHEMISTRY-US, V15, P1154, DOI 10.1021/bi00650a030; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANZOELEN EJJ, 1978, EUR J BIOCHEM, V86, P539; WELCH RA, 1992, FEMS MICROBIOL IMMUN, V105, P29; Zhang DY, 1999, INFECT IMMUN, V67, P5332, DOI 10.1128/IAI.67.10.5332-5337.1999	51	61	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12513	12519		10.1074/jbc.M006792200	http://dx.doi.org/10.1074/jbc.M006792200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11134007	hybrid			2022-12-27	WOS:000168198600009
J	Bodendorf, U; Fischer, F; Bodian, D; Multhaup, G; Paganetti, P				Bodendorf, U; Fischer, F; Bodian, D; Multhaup, G; Paganetti, P			A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GENERATION; PEPTIDE; PURIFICATION; ENDOCYTOSIS; MATURATION; CLEAVAGE; BACE	beta -Secretase (BACE) initiates the amyloidogenic processing of the amyloid precursor protein leading to the generation of the beta -amyloid, the main component of Alzheimer's disease senile plaques. BACE is a type I transmembrane aspartyl protease of 501 amino acids. Here we describe a novel BACE mRNA lacking 132 base pairs that is expressed in the pancreas but not in the brain. Sequence alignment indicates that the deleted fragment matches the terminal two-thirds of exon 3. The new BACE variant is short of a 44-amino acid region located between the two catalytic aspartyl residues. Accordingly, a 50-kDa form of BACE (BACE457) is detected in the human pancreas. When expressed in cells, BACE457 colocalizes with the marker for the endoplasmic reticulum BiP. Moreover, BACE457 remains in a proenzymatic and endoglycosidase H-sensitive state, suggesting that its transport along the secretory pathway is blocked at the level of the endoplasmic reticulum. Notably, this novel form of BACE does not contribute to the processing of the amyloid precursor protein. Our findings suggest that tissue-specific splicing of the BACE mRNA may explain the observation that in the human pancreas robust transcription of the BACE gene does not translate into recovered enzymatic activity.	Novartis Pharma AG, Nervous Syst, CH-4002 Basel, Switzerland; Novartis Pharmaceut Corp, Funct Gen, Summit, NJ 07901 USA; Univ Heidelberg, Ctr Mol Biol, D-69120 Heidelberg, Germany	Novartis; Novartis; Ruprecht Karls University Heidelberg	Paganetti, P (corresponding author), Novartis Pharma AG, Nervous Syst, WSJ-386-8-28, CH-4002 Basel, Switzerland.		Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324				CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cescato R, 2000, J NEUROCHEM, V74, P1131; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; FAN W, 1999, SCIENCE, V286, P1255; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; SAUDNERS AJ, 1999, SCIENCE, V286, P1255; SchraderFischer G, 1996, BRAIN RES, V716, P91, DOI 10.1016/0006-8993(96)00002-9; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	22	66	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12019	12023		10.1074/jbc.M008861200	http://dx.doi.org/10.1074/jbc.M008861200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152683	hybrid			2022-12-27	WOS:000168081800078
J	Mannering, DE; Sharma, S; Davidson, AL				Mannering, DE; Sharma, S; Davidson, AL			Demonstration of conformational changes associated with activation of the maltose transport complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; SITE-DIRECTED FLUORESCENCE; ESCHERICHIA-COLI; ABC TRANSPORTER; NUCLEOTIDE-BINDING; P-GLYCOPROTEIN; ADENOSINE-TRIPHOSPHATASE; SALMONELLA-TYPHIMURIUM; MEMBRANE-COMPONENTS; CRYSTAL-STRUCTURE	In Escherichia coli, interaction of a periplasmic maltose-binding protein with a membrane-associated ATP-binding cassette transporter stimulates ATP hydrolysis, resulting in translocation of maltose into the cell. The maltose transporter contains two transmembrane subunits, MalF and MalG, and two copies of a nucleotide-hydrolyzing subunit, MalK. Mutant transport complexes that function in the absence of binding protein are thought to be stabilized in an ATPase-active conformation. To probe the conformation of the nucleotide-binding site and to gain an understanding of the nature of the conformational changes that lead to activation, cysteine 40 within the Walker A motif of the MalK subunit was modified by the fluorophore 2-(4'-maleimidoanilino)naphthalene-6-sulfonic acid. Fluorescence differences indicated that residues involved in nucleotide binding were less accessible to aqueous solvent in the binding protein independent transporter than in the wild-type transporter, Similar differences in fluorescence were seen when a vanadate-trapped transition state conformation was compared with the ground state in the wild-type transporter. Our results and recent crystal structures are consistent with a model in which activation of ATPase activity is associated with conformational changes that bring the two MalK subunits closer together, completing the nucleotide-binding sites and burying ATP in the interface.	Baylor Coll Med, Dept Mol Virol & Microbiol, MS BCM 280, Houston, TX 77030 USA	Baylor College of Medicine	Davidson, AL (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, MS BCM 280, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049261, R29GM049261] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49261, GM08231] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOOS W, 1996, ESCHERICHIA COLI SAL, P1197; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHEN J, 2001, IN PRESS P NATL ACAD; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; DAHL MK, 1989, MOL GEN GENET, V218, P199, DOI 10.1007/BF00331269; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DEAN DA, 1992, MOL MICROBIOL, V6, P2033, DOI 10.1111/j.1365-2958.1992.tb01376.x; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; FERSHT A, 1985, ENZYME STRUCTURE MEC, P311; FROSHAUER S, 1984, J BIOL CHEM, V259, P896; GRANA D, 1988, GENETICS, V120, P319; GUPTE SS, 1979, J BIOL CHEM, V254, P362; HAUGLAND RP, 1983, EXCITED STATES BIOPO, P41; HIGGINS CF, 1990, RES MICROBIOL, V141, P353, DOI 10.1016/0923-2508(90)90011-E; HIRATSUKA T, 1992, J BIOL CHEM, V267, P14941; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 1999, FEBS LETT, V448, P131, DOI 10.1016/S0014-5793(99)00356-7; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; KSENZENKO MY, 1993, BIOCHEMISTRY-US, V32, P13362, DOI 10.1021/bi00211a051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 1983, PRINCIPLES FLUORESCE, P260; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Liu RH, 1997, BIOCHEMISTRY-US, V36, P2836, DOI 10.1021/bi9627119; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; MANSON MD, 1985, J BIOL CHEM, V260, P9727; MORBACH S, 1993, J BIOL CHEM, V268, P18617; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WU JH, 1995, BIOCHEMISTRY-US, V34, P8257, DOI 10.1021/bi00026a007; WU JH, 1994, BIOCHEMISTRY-US, V33, P12166, DOI 10.1021/bi00206a020	45	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12362	12368		10.1074/jbc.M011686200	http://dx.doi.org/10.1074/jbc.M011686200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11150310	hybrid			2022-12-27	WOS:000168081800123
J	Chu, SY; Tordova, M; Gilliland, GL; Gorshkova, I; Shi, Y; Wang, SL; Schwarz, FP				Chu, SY; Tordova, M; Gilliland, GL; Gorshkova, I; Shi, Y; Wang, SL; Schwarz, FP			The structure of the T127L/S128A mutant of cAMP receptor protein facilitates promoter site binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DNA COMPLEX; CYCLIC-NUCLEOTIDE BINDING; GENE ACTIVATOR PROTEIN; ESCHERICHIA-COLI; REGULATORY PROTEIN; RESOLUTION; CONFORMATIONS; MUTAGENESIS; TRANSITION; MUTATIONS	The x-ray crystal structure of the cAMP-ligated T127L/ S128A double mutant of cAMP receptor protein (CRP) was determined to a resolution of 2.2 Angstrom Although this structure is close to that of the x-ray crystal structure of cAMP-ligated CRP with one subunit in the open form and one subunit in the closed form, a bound syn-cAMP is clearly observed in the closed subunit in a third binding site in the C-terminal domain. In addition, water-mediated interactions replace the hydrogen bonding interactions between the N-6 of anti-cAMP bound in the N-terminal domains of each subunit and the OH groups of the Thr(127) and Ser(128) residues in the C alpha -helix of wild type CRP, This replacement induces flexibility in the C alpha -helix at Ala(128), which swings the C-terminal domain of the open subunit more toward the N-terminal domain in the T127L/S128A double mutant of CRP (CRP*) than is observed in the open subunit of cAMP-ligated CRP, Isothermal titration calorimetry measurements on the binding of cAMP to CRP* show that the binding mechanism changes from an exothermic independent two-site binding mechanism at pH 7.0 to an endothermic interacting two-site mechanism at pH 5.2, similar to that observed for CRP at both pH levels. Differential scanning calorimetry measurements exhibit a broadening of the thermal denaturation transition of CRP*; relative to that of CRP at pH 7.0 but similar to the multipeak transitions observed for cAMP-ligated CRP. These properties and the bound syn-cAMP ligand, which has only been previously observed in the DNA bound x-ray crystal structure of cAMP-ligated CRP by Passner and Steitz (Passner, J. M., and Steitz, T. A. (1997) Proc. Nafl. Acad. Sci. U.S. A. 94, 2843-2847), imply that the cAMP-ligated CRP* structure is closer to the conformation of the allosterically activated structure than cAMP-ligated CRP. This may be induced by the unique flexibility at Ala128 and/or by the bound syn-cAMP in the hinge region of CRP*.	NIST, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ Maryland, Inst Biotechnol, Rockville, MD 20850 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland Baltimore	Gilliland, GL (corresponding author), NIST, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	gary.gilliland@nist.gov; frederick.schwarz@nist.gov						AIBA H, 1985, EMBO J, V4, P3329, DOI 10.1002/j.1460-2075.1985.tb04084.x; ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROWN AM, 1989, P NATL ACAD SCI USA, V86, P7387, DOI 10.1073/pnas.86.19.7387; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG X, 1998, BIOCHEMISTRY-US, V37, P50; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Garcia AE, 1996, PROTEIN SCI, V5, P62; GHOSAINI LR, 1988, BIOCHEMISTRY-US, V27, P5257, DOI 10.1021/bi00414a046; GORSHKOVA I, 1995, J BIOL CHEM, V270, P21679, DOI 10.1074/jbc.270.37.21679; GRONENBORN AM, 1982, BIOCHEMISTRY-US, V21, P4040, DOI 10.1021/bi00260a020; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; Kirchhoff W. H., 1993, 1401 NIST, P1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krueger S, 1998, J BIOL CHEM, V273, P20001, DOI 10.1074/jbc.273.32.20001; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE FJ, 1994, NUCLEIC ACIDS RES, V22, P2894; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOORE JL, 1993, THESIS G WASHINGTON; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; ROUSSEL A, 1996, TURBOFRODO SOFTWARE; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHWARZ FP, 1988, THERMOCHIM ACTA, V128, P267, DOI 10.1016/0040-6031(88)85371-1; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shi Y, 2000, BIOCHEMISTRY-US, V39, P7300, DOI 10.1021/bi000225m; Shi Y, 1999, J BIOL CHEM, V274, P6946, DOI 10.1074/jbc.274.11.6946; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; Wang SL, 2000, J BIOL CHEM, V275, P33457, DOI 10.1074/jbc.M004877200; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YANG CP, 1990, OMEGA DATA ORIGIN, P66; YSERN X, 1994, J MOL BIOL, V238, P496; ZHANG XP, 1992, J BIOL CHEM, V267, P8136	38	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11230	11236		10.1074/jbc.M010428200	http://dx.doi.org/10.1074/jbc.M010428200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11124966	hybrid			2022-12-27	WOS:000167980900088
J	Mironneau, J; Coussin, F; Jeyakumar, LH; Fleischer, S; Mironneau, C; Macrez, N				Mironneau, J; Coussin, F; Jeyakumar, LH; Fleischer, S; Mironneau, C; Macrez, N			Contribution of ryanodine receptor subtype 3 to Ca2+ responses in Ca2+-overloaded cultured rat portal vein myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; SKELETAL-MUSCLE; CALCIUM SPARKS; SMOOTH-MUSCLE; MICE LACKING; VASCULAR MYOCYTES; LUMINAL CA2+; ELEMENTARY EVENTS; CARDIAC MYOCYTES	Using an antisense strategy, we have previously shown that in vascular myocytes, subtypes 1 and 2 of ryanodine receptors (RYRs) are required for Ca2+ release during Ca2+ sparks and global Ca2+ responses, evoked by activation of voltage-gated Ca2+ channels, whereas RYR subtype 3 (RYR3) has no contribution. Here, we investigated the effects of increased Ca2+ loading of the sarcoplasmic reticulum (SR) on the RYR-mediated Ca2+ responses and the role of the RYR3 by injecting antisense oligonucleotides targeting the RYR subtypes, RYR3 expression was demonstrated by immunodetection in both freshly dissociated and cultured rat portal vein myocytes, Confocal Ca2+ measurements revealed that the number of cells showing spontaneous Ca2+ sparks was strongly increased by superfusing the vascular myocytes in 10 mM Ca2+-containing solution. These Ca2+ sparks were blocked after inhibition of RYR1 or RYR2 by treatment with antisense oligolucleotides but not after inhibition of RYR3, In contrast, inhibition of RYR3 reduced the global Ca2+ responses induced by caffeine and phenylephrine, indicating that RYR3 participated together with RYR1 and RYR2 to these Ca2+ responses in Ca2+-overloaded myocytes. Ca2+ transients evoked by photolysis of caged Ca2+ with increasing flash intensities were also reduced after inhibition of RYR3 and revealed that the [Ca2+](i) sensitivity of RYR3 would be similar to that of RYR1 and RYR2. Our results show that, under conditions of increased SR Ca2+ loading, the RYR3 becomes activable by caffeine and local increases in [Ca2+](i).	Univ Bordeaux 2, Lab Signalisat & Interact Cellulaires, CNRS, UMR 5017, F-33076 Bordeaux, France; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University	Mironneau, J (corresponding author), Univ Bordeaux 2, Lab Signalisat & Interact Cellulaires, CNRS, UMR 5017, 146 Rue Leo Saignat, F-33076 Bordeaux, France.			MACREZ, Nathalie/0000-0002-3844-4403				Arnaudeau S, 1997, CELL CALCIUM, V22, P399, DOI 10.1016/S0143-4160(97)90024-5; Arnaudeau S, 1996, BIOCHEM BIOPH RES CO, V222, P809, DOI 10.1006/bbrc.1996.0808; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; Boittin FX, 1999, AM J PHYSIOL-CELL PH, V277, pC139, DOI 10.1152/ajpcell.1999.277.1.C139; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Chen W, 1996, J BIOL CHEM, V271, P7398, DOI 10.1074/jbc.271.13.7398; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CHU A, 1993, J MEMBRANE BIOL, V135, P49; Conklin MW, 1999, BIOPHYS J, V77, P1394, DOI 10.1016/S0006-3495(99)76988-2; Conklin MW, 2000, BIOPHYS J, V78, P1777, DOI 10.1016/S0006-3495(00)76728-2; Coussin F, 2000, J BIOL CHEM, V275, P9596, DOI 10.1074/jbc.275.13.9596; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; Jeyakumar LH, 1998, J BIOL CHEM, V273, P16011, DOI 10.1074/jbc.273.26.16011; Lesh RE, 1998, CIRC RES, V82, P175; Lukyanenko V, 1999, J PHYSIOL-LONDON, V518, P173, DOI 10.1111/j.1469-7793.1999.0173r.x; Manunta M, 2000, FEBS LETT, V471, P256, DOI 10.1016/S0014-5793(00)01385-5; Mironneau J, 1996, CELL CALCIUM, V20, P153, DOI 10.1016/S0143-4160(96)90104-9; Miyatake R, 1996, FEBS LETT, V395, P123, DOI 10.1016/0014-5793(96)01022-8; Morel JL, 1996, BRIT J PHARMACOL, V118, P73, DOI 10.1111/j.1476-5381.1996.tb15368.x; Murayama T, 1999, J BIOL CHEM, V274, P17297, DOI 10.1074/jbc.274.24.17297; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NEYLON CB, 1995, BIOCHEM BIOPH RES CO, V215, P814, DOI 10.1006/bbrc.1995.2536; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Satoh H, 1997, AM J PHYSIOL-HEART C, V272, pH657, DOI 10.1152/ajpheart.1997.272.2.H657; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Sonnleitner A, 1998, EMBO J, V17, P2790, DOI 10.1093/emboj/17.10.2790; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; TAKESHIMA H, 1995, EMBO J, V14, P2999, DOI 10.1002/j.1460-2075.1995.tb07302.x; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; TSUGORKA A, 1995, SCIENCE, V269, P1723, DOI 10.1126/science.7569901; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; WIER WG, 1987, SCIENCE, V235, P325, DOI 10.1126/science.3798114; Yamazawa T, 1996, EMBO J, V15, P6172, DOI 10.1002/j.1460-2075.1996.tb01005.x; ZhuGe RH, 1999, J GEN PHYSIOL, V113, P215, DOI 10.1085/jgp.113.2.215	42	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11257	11264		10.1074/jbc.M005994200	http://dx.doi.org/10.1074/jbc.M005994200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150292	hybrid			2022-12-27	WOS:000167980900092
J	Napoli, A; Kvaratskelia, M; White, MF; Rossi, M; Ciaramella, M				Napoli, A; Kvaratskelia, M; White, MF; Rossi, M; Ciaramella, M			A novel member of the bacterial-archaeal regulator family is a nonspecific DNA-binding protein and induces positive supercoiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-LIKE PROTEIN; SULFOLOBUS-SHIBATAE; TRANSCRIPTIONAL REGULATOR; SMC PROTEINS; LRP; PURIFICATION; GENE; REPLICATION; COMPLEX; SOLFATARICUS	In hyperthermophilic Archaea genomic DNA is from relaxed to positively supercoiled in vivo because of the action of the enzyme reverse gyrase, and this peculiarity is believed to be related to stabilization of DNA against denaturation. We report the identification and characterization of Smj12, a novel protein of Sulfolobus solfataricus, which is homologous to members of the so-called Bacterial-Archaeal family of regulators, found in multiple copies in Eubacteria and Archaea. Whereas other members of the family are sequence-specific DNA-binding proteins and have been implicated in transcriptional regulation, Smj12 is a nonspecific DNA-binding protein that stabilizes the double helix and induces positive supercoiling. Smj12 is not abundant, suggesting that it is not a general architectural protein, but rather has a specialized function and/or localization. Smj12 is the first protein with the described features identified in Archaea and might participate in control of superhelicity during DNA transactions.	CNR, Inst Prot Biochem & Enzymol, I-80125 Naples, Italy; Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of St Andrews	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem & Enzymol, Via Marconi 10, I-80125 Naples, Italy.	ciaramel@dafne.ibpe.na.cnr.it	White, Malcolm F/A-6055-2010; Ciaramella, Maria/O-1152-2015	White, Malcolm F/0000-0003-1543-9342; Ciaramella, Maria/0000-0003-1583-1694				Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BATES AD, 1993, DNA TOPOLOGY; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Bell SD, 2000, J BIOL CHEM, V275, P31624, DOI 10.1074/jbc.M005422200; Bell SD, 1999, MOL CELL, V4, P971, DOI 10.1016/S1097-2765(00)80226-9; Bell SD, 1998, TRENDS MICROBIOL, V6, P222, DOI 10.1016/S0966-842X(98)01281-5; Bell SD, 1999, P NATL ACAD SCI USA, V96, P13662, DOI 10.1073/pnas.96.24.13662; Beloin C, 1997, MOL GEN GENET, V256, P63, DOI 10.1007/s004380050546; BERGERAT A, 1994, J BIOL CHEM, V269, P27663; Brinkman AB, 2000, J BIOL CHEM, V275, P38160, DOI 10.1074/jbc.M005916200; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; CHOLI T, 1988, J BIOL CHEM, V263, P7087; Dennis PP, 1997, CELL, V89, P1007, DOI 10.1016/S0092-8674(00)80288-3; Enoru-Eta J, 2000, J BACTERIOL, V182, P3661, DOI 10.1128/JB.182.13.3661-3672.2000; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Forterre P, 1996, FEMS MICROBIOL REV, V18, P237; GOULET I, 1987, NUCLEIC ACIDS RES, V15, P2803, DOI 10.1093/nar/15.7.2803; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Jones KA, 2000, GENE DEV, V14, P1992; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kulms D, 1997, BIOL CHEM, V378, P545, DOI 10.1515/bchm.1997.378.6.545; Kvaratskhelia M, 2000, J BIOL CHEM, V275, P25540, DOI 10.1074/jbc.M003420200; Kvaratskhelia M, 2000, J MOL BIOL, V297, P923, DOI 10.1006/jmbi.2000.3624; Landgraf JR, 1996, J BACTERIOL, V178, P6930, DOI 10.1128/jb.178.23.6930-6936.1996; Lilley DMJ., 1995, NUCL ACIDS MOL BIOL, P84; Lopez-Delgado A, 1997, RRD MET MAT SCI, V1, P23; Lopez-Garcia P, 1999, J MOL EVOL, V49, P439, DOI 10.1007/PL00006567; Lopez-Garcia P, 1998, NUCLEIC ACIDS RES, V26, P2322, DOI 10.1093/nar/26.10.2322; Mai VQ, 1998, J BACTERIOL, V180, P2560, DOI 10.1128/JB.180.9.2560-2563.1998; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; Napoli A, 1999, J BACTERIOL, V181, P1474, DOI 10.1128/JB.181.5.1474-1480.1999; Newlon CS, 1997, CELL, V91, P717, DOI 10.1016/S0092-8674(00)80459-6; Pisani FM, 1998, EXTREMOPHILES, V2, P171, DOI 10.1007/s007920050057; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; REDDY TR, 1989, J BIOL CHEM, V264, P17298; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Ridgway P, 2000, J CELL SCI, V113, P2647; Ritzi M, 2000, GENE, V245, P13, DOI 10.1016/S0378-1119(00)00020-2; Ronimus RS, 1996, MOL MICROBIOL, V20, P77, DOI 10.1111/j.1365-2958.1996.tb02490.x; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sandman K, 2000, ARCH MICROBIOL, V173, P165, DOI 10.1007/s002039900122; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; Soppa J, 1999, MOL MICROBIOL, V31, P1295, DOI 10.1046/j.1365-2958.1999.01273.x; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Tapias A, 2000, NUCLEIC ACIDS RES, V28, P552, DOI 10.1093/nar/28.2.552; TOULME F, 1995, J BIOL CHEM, V270, P6286, DOI 10.1074/jbc.270.11.6286; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	59	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10745	10752		10.1074/jbc.M010611200	http://dx.doi.org/10.1074/jbc.M010611200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148211	hybrid			2022-12-27	WOS:000167980900026
J	Aragones, J; Jones, DR; Martin, S; San Juan, MA; Alfranca, A; Vidal, F; Vara, A; Merida, I; Landazuri, MO				Aragones, J; Jones, DR; Martin, S; San Juan, MA; Alfranca, A; Vidal, F; Vara, A; Merida, I; Landazuri, MO			Evidence for the involvement of diacylglycerol. kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 1-ALPHA HIF-1-ALPHA; PHOSPHOLIPASE-D ACTIVITY; PHOSPHATIDIC-ACID; PROTEIN-KINASE; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ERYTHROPOIETIN PRODUCTION; MOLECULAR MECHANISMS; O-2 HOMEOSTASIS; ALPHA-SUBUNIT	Hypoxia-inducible factor 1 (HIF-1) induces a gene expression program essential for the cellular adaptation to lowered oxygen environments. The intracellular mechanisms by which hypoxia induces HIF-1 remain poorly understood. Here we show that exposure of various cell types to hypoxia raises the intracellular level of phosphatidic acid primarily through the action of diacylglycerol kinase (DGK), Pharmacological inhibition of DGK activity through use of the specific DGK inhibitors R59949 and R59022 abrogated specifically HIF-1-dependent transcription analyzed with a HIF-1-responsive reporter plasmid. A more detailed analysis revealed that pharmacological inhibition of DGK activity prevented the hypoxia-dependent accumulation of the HIF-1 alpha subunit and the subsequent HIF-1-DNA complex formation as well as hypoxia-induced activity of the HIF-1 transactivation domains localized to amino acids 530-582 and 775-826 of the HIF-1-alpha subunit. Our results demonstrate for the first time that accumulation of phosphatidic acid through DGK underlines oxygen sensing and provide evidence for the involvement of this lipid kinase in the intracellular signaling that leads to HIF-1 activation.	Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid 28006, Spain; CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid 28049, Spain	Autonomous University of Madrid; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Landazuri, MO (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Diego Leon 62, Madrid 28006, Spain.	mortiz@hlpr.insalud.es	Merida, Isabel/A-9713-2014; Alfranca, Arantzazu/E-8804-2018; Sanjuán, Miguel AF/B-7709-2011	Merida, Isabel/0000-0003-2762-6241; Sanjuán, Miguel AF/0000-0003-3515-0837; Martin-Puig, Silvia/0000-0003-3048-6729; Aragones Lopez, Julian/0000-0002-0193-4679				AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; EDWARDS JS, 1995, BIOCHEM J, V308, P473, DOI 10.1042/bj3080473; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Erickson RW, 1999, J BIOL CHEM, V274, P22243, DOI 10.1074/jbc.274.32.22243; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Flores I, 1999, J IMMUNOL, V163, P708; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Flores I, 1998, J IMMUNOL, V160, P3528; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gleadle JM, 1998, MOL MED TODAY, V4, P122, DOI 10.1016/S1357-4310(97)01198-2; Goldberg M, 1997, J CLIN INVEST, V99, P55, DOI 10.1172/JCI119133; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Gozal E, 1999, J NEUROCHEM, V73, P665, DOI 10.1046/j.1471-4159.1999.0730665.x; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Jones DR, 1999, J BIOL CHEM, V274, P16846, DOI 10.1074/jbc.274.24.16846; Jones DR, 1998, FEBS LETT, V433, P23, DOI 10.1016/S0014-5793(98)00875-8; Kishikawa K, 1999, J BIOL CHEM, V274, P21335, DOI 10.1074/jbc.274.30.21335; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Michell RH, 1997, ESSAYS BIOCHEM, V32, P31; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OLSON EN, 1993, CELL GROWTH DIFFER, V4, P699; PLEVIN R, 1994, BRIT J PHARMACOL, V112, P311, DOI 10.1111/j.1476-5381.1994.tb13070.x; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Raymond R, 1997, KIDNEY INT, V51, P536, DOI 10.1038/ki.1997.74; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Salceda S, 1997, KIDNEY INT, V51, P556, DOI 10.1038/ki.1997.78; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Scott PH, 1998, AM J RESP CRIT CARE, V158, P958, DOI 10.1164/ajrccm.158.3.9712130; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; SEMENZA GL, 1994, HEMATOL ONCOL CLIN N, V8, P863, DOI 10.1016/S0889-8588(18)30134-5; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; van Blitterswijk WJ, 1999, CHEM PHYS LIPIDS, V98, P95, DOI 10.1016/S0009-3084(99)00022-5; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yoshioka K, 1998, LIFE SCI, V63, P523, DOI 10.1016/S0024-3205(98)00303-8; Zundel W, 2000, GENE DEV, V14, P391	76	91	92	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10548	10555		10.1074/jbc.M006180200	http://dx.doi.org/10.1074/jbc.M006180200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136721	hybrid			2022-12-27	WOS:000167996400124
J	Bergum, PW; Cruikshank, A; Maki, SL; Kelly, CR; Ruf, W; Vlasuk, GP				Bergum, PW; Cruikshank, A; Maki, SL; Kelly, CR; Ruf, W; Vlasuk, GP			Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE PEPTIDE-BOND; SLOW-BINDING; RECOGNITION; HYDROLYSIS; THROMBOSIS; AFFINITY; SURFACE	Recombinant nematode anticoagulant protein c2 (rNAPc2) is a potent, factor Xa (Ma)-dependent small protein inhibitor of factor VIIa-tissue factor (fVIIa.TF), which binds to a site on fXa that is distinct from the catalytic center (exo-site), In the present study, the role of other M derivatives in presenting rNAPc2 to fVIIa.TF is investigated. Catalytically active and active site blocked fXa, as well as a plasma-derived and an activation-resistant mutant of zymogen M bound to rNAPc2 with comparable affinities (K-D = 1-10 nM), and similarly supported the inhibition of fVIIa.TF (K-i* = similar to 10 pM), The roles of phospholipid membrane composition in the inhibition of fVIIa TF by rNAPc2 were investigated using TF that was either detergent-solubilized (TFS), or reconstituted into membranes, containing phosphatidylcholine (TFPC) or a mixture of phosphatidylcholine and phosphatidylserine (TFPCPS). In the absence of the M derivative, inhibition of fVIIa TF was similar for all three conditions (K-i similar to1 muM), whereas the addition of the M derivative increased the respective inhibition by 35-, 150-, or 100,000-fold for TFS, TFPC, and TFPCPS. The removal of the gamma -carboxyglutamic acid-containing domain from the M derivative did not affect the binding to rNAPc2, but abolished the effect of factor Xa as a scaffold for the inhibition of fVIIa.TF by rNAPcQ, The overall. anticoagulant potency of rNAPc2, therefore, results from a coordinated recognition of an exo-site on fX/fXa and of the active site of fVIIa, both of which are properly positioned in the ternary fVIIa.TF.M(a) complex assembled on an appropriate phospholipid surface.	Corvas Int Inc, Epping, NSW 2121, Australia; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Bergum, PW (corresponding author), Corvas Int Inc, 3030 Sci Pk Rd, Epping, NSW 2121, Australia.	peter_bergum@corvas.com						ARDELT W, 1991, J MOL BIOL, V220, P1041, DOI 10.1016/0022-2836(91)90370-L; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1991, BIOMED BIOCHIM ACTA, V50, P437; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUNWIDDIE CT, 1992, ARCH BIOCHEM BIOPHYS, V294, P647, DOI 10.1016/0003-9861(92)90737-H; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GIRARD TJ, 1990, SCIENCE, V248, P1421, DOI 10.1126/science.1972598; HAKANSSON K, 1995, BIOORGAN MED CHEM, V3, P1009, DOI 10.1016/0968-0896(95)00096-Y; Hirsh J, 1999, SEMIN HEMATOL, V36, P118; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; JACKSON CM, 1984, PROG HEMOST THROMB, V7, P55; Jenny NS, 1998, THROMBOSIS HEMORRHAG, P3; Kelly CR, 1997, J BIOL CHEM, V272, P17467, DOI 10.1074/jbc.272.28.17467; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lee A, 2000, BLOOD, V96, p491A; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; MANN KG, 1992, SEMIN HEMATOL, V29, P213; Martin DMA, 1998, THROMB RES, V90, P1, DOI 10.1016/S0049-3848(98)00015-2; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; RUF W, 1994, BIOCHEMISTRY-US, V33, P11631, DOI 10.1021/bi00204a026; RUF W, 1992, J BIOL CHEM, V267, P6375; Ruf W, 1999, BIOCHEMISTRY-US, V38, P1957, DOI 10.1021/bi982254r; RUF W, 1993, METHOD ENZYMOL, V222, P209; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shobe J, 1999, J BIOL CHEM, V274, P24171, DOI 10.1074/jbc.274.34.24171; Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149; Vlasuk GP, 1998, BLOOD, V92, p361A; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Williams J W, 1979, Methods Enzymol, V63, P437	41	78	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10063	10071		10.1074/jbc.M009116200	http://dx.doi.org/10.1074/jbc.M009116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139576	hybrid			2022-12-27	WOS:000167996400066
J	Mechaly, A; Fierobe, HP; Belaich, A; Belaich, JP; Lamed, R; Shoham, Y; Bayer, EA				Mechaly, A; Fierobe, HP; Belaich, A; Belaich, JP; Lamed, R; Shoham, Y; Bayer, EA			Cohesin-dockerin interaction in cellulosome assembly - A single hydroxyl group of a dockerin domain distinguishes between nonrecognition and high affinity recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CLOSTRIDIUM-THERMOCELLUM CELLULOSOME; PROTEIN SECONDARY STRUCTURE; SCAFFOLDING PROTEIN; DUPLICATED SEGMENT; CRYSTAL-STRUCTURE; NEURAL NETWORKS; CELLULOLYTICUM; CELLULASES; BINDING	The assembly of enzyme components into the cellulosome complex is dictated by the cohesin-dockerin interaction. In a recent article (Mechaly, A, Yaron, S,, Lamed, R., Fierobe, H.-P., Belaich, A., Belaich, J.-P., Shoham, Y., and Bayer, E. A. (2000) Proteins 39, 170-177), we provided experimental evidence that four previously predicted dockerin residues play a decisive role in the specificity of this high affinity interaction, although additional residues were also implicated. In the present communication, we examine further the contributing factors for the recognition of a dockerin by a cohesin domain between the respective cellulosomal systems of Clostridium thermocellum and Clostridium cellulolyticum, In this context, the four confirmed residues were analyzed for their individual effect on selectivity, In addition, other dockerin residues were discerned that could conceivably contribute to the interaction, and the suspected residues were similarly modified by site-directed mutagenesis, The results indicate that mutation of a single residue from threonine to leucine at a given position of the C. thermocellum dockerin differentiates between its nonrecognition and high affinity recognition (K-a similar to 10(9) M-1) by a cohesin from C. cellulolyticum, This suggests that the presence or absence of a single decisive hydroxyl group is critical to the observed biorecognition, This study further implicates additional residues as secondary determinants in the specificity of interaction, because interconversion of selected residues reduced intraspecies self-recognition by at least three orders of magnitude. Nevertheless, as the latter mutageneses served to reduce but not annul the cohesin-dockerin interaction within this species, it follows that other subtle alterations play a comparatively minor role in the recognition between these two modules.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; CNRS, IBSM, IFR1, F-13402 Marseille, France; Univ Aix Marseille 1, F-13331 Marseille, France; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Tel Aviv University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		FIEROBE, Henri-Pierre/P-4372-2019; Shoham, Yuval/M-4409-2013					Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1990, METHOD ENZYMOL, V184, P138; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; BAYER EA, 1998, CARBOHYDRASES TRICHO, P39; Beguin P, 1996, CRIT REV BIOCHEM MOL, V31, P201, DOI 10.3109/10409239609106584; Belaich JP, 1997, J BIOTECHNOL, V57, P3, DOI 10.1016/S0168-1656(97)00085-0; CHAUVAUX S, 1990, BIOCHEM J, V265, P261, DOI 10.1042/bj2650261; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Ding SY, 1999, J BACTERIOL, V181, P6720, DOI 10.1128/JB.181.21.6720-6729.1999; DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548; FANUTTI C, 1995, J BIOL CHEM, V270, P29314, DOI 10.1074/jbc.270.49.29314; FELIX CR, 1993, ANNU REV MICROBIOL, V47, P791, DOI 10.1146/annurev.micro.47.1.791; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lamed R, 1983, BIOTECHNOL BIOENG S, V13, P163; Li XL, 1997, APPL ENVIRON MICROB, V63, P4721, DOI 10.1128/AEM.63.12.4721-4728.1997; Lytle B, 1996, J BACTERIOL, V178, P1200, DOI 10.1128/jb.178.4.1200-1203.1996; Lytle B, 1998, J BACTERIOL, V180, P6581, DOI 10.1128/JB.180.24.6581-6585.1998; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; Mechaly A, 2000, PROTEINS, V39, P170, DOI 10.1002/(SICI)1097-0134(20000501)39:2<170::AID-PROT7>3.0.CO;2-H; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pages S, 1996, J BACTERIOL, V178, P2279, DOI 10.1128/jb.178.8.2279-2286.1996; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sambrook J., 2002, MOL CLONING LAB MANU; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; TOKATLIDIS K, 1993, PROTEIN ENG, V6, P947, DOI 10.1093/protein/6.8.947; Wilchek M, 1999, BIOMOL ENG, V16, P1; Wu J. H. D., 1988, Biochemistry and genetics of cellulose degradation, P117; WU JHD, 1988, BIOCHEMISTRY-US, V27, P1703, DOI 10.1021/bi00405a048; YARON S, 1995, FEBS LETT, V360, P121, DOI 10.1016/0014-5793(95)00074-J	40	85	87	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9883	9888		10.1074/jbc.M009237200	http://dx.doi.org/10.1074/jbc.M009237200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11148206	hybrid			2022-12-27	WOS:000167996400042
J	Koyabu, Y; Nakata, K; Mizugishi, K; Aruga, J; Mikoshiba, K				Koyabu, Y; Nakata, K; Mizugishi, K; Aruga, J; Mikoshiba, K			Physical and functional interactions between Zic and Gli proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE CUBITUS-INTERRUPTUS; NEURAL CREST DEVELOPMENT; SONIC HEDGEHOG; FLOOR PLATE; MOUSE ZIC1; IN-VITRO; DROSOPHILA; EXPRESSION; ACTIVATION; FAMILY	Zic and Gli family proteins are transcription factors that share similar zinc finger domains. Recent studies indicate that Zic and Gli collaborate in neural and skeletal development. We provide evidence that the Zic and Gli proteins physically and functionally interact through their zinc finger domains. Moreover, Gli proteins were translocated to cell nuclei by coexpressed Zic proteins, and both proteins regulated each other's transcriptional activity. Our result suggests that the physical interaction between Zic and Gli is the molecular basis of their antagonistic or synergistic features in developmental contexts and that Zic proteins are potential modulators of the hedgehog-mediated signaling pathway.	RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol,Minato Ku, Tokyo 1088639, Japan	RIKEN; University of Tokyo	Aruga, J (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Mikoshiba, Katsuhiko/N-7943-2015; Aruga, Jun/H-5837-2011	Aruga, Jun/0000-0001-7936-1375				Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Aruga J, 1999, MECH DEVELOP, V89, P141, DOI 10.1016/S0925-4773(99)00220-8; Aruga J, 1998, J NEUROSCI, V18, P284; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee J, 1997, DEVELOPMENT, V124, P2537; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mo R, 1997, DEVELOPMENT, V124, P113; Nagai T, 2000, P NATL ACAD SCI USA, V97, P1618, DOI 10.1073/pnas.97.4.1618; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; Park HL, 2000, DEVELOPMENT, V127, P1593; Sasaki H, 1997, DEVELOPMENT, V124, P1313; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9	35	154	163	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6889	6892		10.1074/jbc.C000773200	http://dx.doi.org/10.1074/jbc.C000773200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11238441	hybrid			2022-12-27	WOS:000167442900003
J	Wolfe, MS; Haass, C				Wolfe, MS; Haass, C			The role of presenilins in gamma-secretase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID PRECURSOR PROTEIN; DISEASE-ASSOCIATED PRESENILIN-1; BETA-PEPTIDE PRODUCTION; C-TERMINAL FRAGMENTS; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; CAENORHABDITIS-ELEGANS; ASPARTYL PROTEASE; SENILE PLAQUES; CLEAVAGE		Univ Munich, Adolf Butenandt Inst, Dept Biochem, D-80336 Munich, Germany; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	University of Munich; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wolfe, MS (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Schillerstr 44, D-80336 Munich, Germany.	wolfe@cnd.bwh.harvard.edu; chaass@pbm.med.uni-muenchen.de						Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dewji NN, 1997, P NATL ACAD SCI USA, V94, P14025, DOI 10.1073/pnas.94.25.14025; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; ELSER WP, 2000, NATURE CELL BIOL, V2, P428; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lehmann S, 1997, J BIOL CHEM, V272, P12047, DOI 10.1074/jbc.272.18.12047; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Maruyama K, 1996, BIOCHEM BIOPH RES CO, V227, P730, DOI 10.1006/bbrc.1996.1577; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Okochi M, 2000, J BIOL CHEM, V275, P40925, DOI 10.1074/jbc.M005254200; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; STEINER H, 2001, IN PRESS NAT REV MOL; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tischer E, 1996, J BIOL CHEM, V271, P21914, DOI 10.1074/jbc.271.36.21914; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu G, 2000, J BIOL CHEM, V275, P27348; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	88	108	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2001	276	8					5413	5416		10.1074/jbc.R000026200	http://dx.doi.org/10.1074/jbc.R000026200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404RU	11134059	hybrid			2022-12-27	WOS:000167115100001
J	Born, TL; Smith, DE; Garka, KE; Renshaw, BR; Bertles, JS; Sims, JE				Born, TL; Smith, DE; Garka, KE; Renshaw, BR; Bertles, JS; Sims, JE			Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. (vol 275, pg 29954, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Sims, John/0000-0002-5667-9185				Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200	1	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2000	275	52					41529	41529						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387GJ	11134060				2022-12-27	WOS:000166114600113
J	Fontaine, T; Sinenel, C; Dubreucq, G; Adam, O; Delepierre, M; Lemoine, J; Vorgias, CE; Diaquin, M; Latge, JP				Fontaine, T; Sinenel, C; Dubreucq, G; Adam, O; Delepierre, M; Lemoine, J; Vorgias, CE; Diaquin, M; Latge, JP			Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. (vol 275, pg 27603, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Fontaine, thierry/Q-2201-2018; Fontaine, Thierry/F-8227-2011; Latge, Jean Paul/C-9846-2014	Fontaine, thierry/0000-0002-8184-789X; 				Fontaine T, 2000, J BIOL CHEM, V275, P27594	1	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 29	2000	275	52					41528	41529						2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387GJ	11134062				2022-12-27	WOS:000166114600112
J	Bezhani, S; Sherameti, I; Pfannschmidt, T; Oelmuller, R				Bezhani, S; Sherameti, I; Pfannschmidt, T; Oelmuller, R			A repressor with similarities to prokaryotic and eukaryotic DNA helicases controls the assembly of the CAAT box binding complex at a photosynthesis gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-Y; NUCLEAR GENES; TRANSCRIPTION; ELEMENTS; LIGHT; EXPRESSION; ACTIVATION; PROTEINS	A single nucleotide exchange in a promoter region located immediately upstream of the CAAT box of the spinach photosynthesis gene AtpC (gene product is subunit gamma of the chloroplast ATP synthase) prevents the formation of a secondary structure and causes an unregulated, constitutive high level of expression (Kusnetsov, V,, Landsberger, M,, Oelmuller, R, (1999) J, Biol, Chem, 274, 36009-36014). We have isolated cDNAs for ATPC-2, a new polypeptide with homologies to pro- and eukaryotic helicases, which specifically binds to this promoter region. Binding of ATPC-2 competes strongly with that of a CAAT box binding factor (CBF), consistent with the idea that both complexes cannot be formed simultaneously because of sterical reasons, In gel mobility shift assays, high binding activities of ATPC-2 and low binding activities of CBF were observed with nuclear extracts from tissue with low AtpC expression levels, and the opposite was observed with extracts from tissues with high AtpC expression levels. Binding of ATPC-2 to the mutant sequence, which directs a constitutively high level expression in vivo and prevents the formation of a secondary structure in vitro, is significantly weaker than binding to the wild-type sequence. Again, the opposite results were obtained for the CBF, Thus, we conclude that the assembly of the CBF DNA complex stimulates transcription of AtpC and that CBF binding is prevented if ATPC-2 is bound to the promoter region. The novel mechanism of gene regulation and the role of the helicase-like protein ATPC-2 as a potential transcriptional repressor is discussed in relation to its modular structure.	Univ Jena, Lehrstuhl Pflanzenphysiol, Inst Allgemeine Bot, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Oelmuller, R (corresponding author), Univ Jena, Lehrstuhl Pflanzenphysiol, Inst Allgemeine Bot, Dornburger Str 159, D-07743 Jena, Germany.	Ralf.Oelmueller@rz.uni-jena.de	Pfannschmidt, Thomas/AAH-5916-2021					Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; BOLLE C, 1994, PLANT PHYSIOL, V105, P1355, DOI 10.1104/pp.105.4.1355; Bolle C, 1996, PLANT J, V9, P21, DOI 10.1046/j.1365-313X.1996.09010021.x; BROWN AM, 1993, J BIOL CHEM, V268, P26328; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; FUKITA Y, 1993, J BIOL CHEM, V268, P17463; GOLDSMITH ME, 1993, J BIOL CHEM, V268, P5856; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hasegawa T, 1996, NUCLEIC ACIDS RES, V24, P3253, DOI 10.1093/nar/24.16.3253; HATAMOCHI A, 1988, J BIOL CHEM, V263, P5940; Herrmann R. G., 1991, Plant molecular biology 2. Proceedings of a NATO Advanced Study Institute, 14-23 May 1990, Elmau, Germany., P411; Hung HL, 1996, J BIOL CHEM, V271, P2323, DOI 10.1074/jbc.271.4.2323; JACKSON SM, 1995, J BIOL CHEM, V270, P21445, DOI 10.1074/jbc.270.37.21445; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kusnetsov V, 1996, MOL GEN GENET, V252, P631, DOI 10.1007/BF02173968; KUSNETSOV VV, 1994, PLANTA, V194, P318, DOI 10.1007/BF00197531; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; LIWEBER M, 1994, J IMMUNOL, V153, P4122; LUBBERSTEDT T, 1994, MOL GEN GENET, V242, P602, DOI 10.1007/BF00285284; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Marians KJ, 1997, STRUCTURE, V5, P1129, DOI 10.1016/S0969-2126(97)00263-3; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; OELMULLER R, 1995, MOL GEN GENET, V246, P478, DOI 10.1007/BF00290451; OELMULLER R, 1993, MOL GEN GENET, V237, P261, DOI 10.1007/BF00282808; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x	38	8	15	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23785	23789		10.1074/jbc.M010945200	http://dx.doi.org/10.1074/jbc.M010945200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11274172	hybrid			2022-12-27	WOS:000169531100076
J	Dartigalongue, C; Missiakas, D; Raina, S				Dartigalongue, C; Missiakas, D; Raina, S			Characterization of the Escherichia coli sigma(E) regulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; GRAM-NEGATIVE BACTERIA; HEAT-SHOCK GENE; PERIPLASMIC PROTEIN; EXTRACYTOPLASMIC COMPARTMENTS; ELEVATED-TEMPERATURES; OPERON FUSIONS; RNA-POLYMERASE; TRIGGER FACTOR; STRESS	Escherichia coli responds to the accumulation of misfolded proteins by inducing the transcription of heat shock genes. E sigma (E) RNA polymerase controls one of the two heat shock regulons off. coli, This regulon is activated upon accumulation of misfolded polypeptides in the double membrane envelope off. coli. sigma (E) (RpoE) is a member of the extracytoplasmic function subfamily of sigma factors. Here we asked how many genes are activated by E sigma (E) RNA polymerase and what is the identity of these genes. Using two independent genetic approaches, 20 E. coli promoters were identified which activate reporter gene transcription in a sigma (E)-dependent manner. In all cases examined, a canonical sigma (E) binding site could be revealed upon mapping transcriptional start sites. 10 identified promoters activated the transcription of previously identified genes with four genes acting directly on the folding off. coli envelope proteins (dsbC, fkpA, skp, and surA), The remaining promoters transcribed genes that are presumed to encode hitherto unknown extracytoplasmic functions and were named ecf (ecfA-ecfM). Two of these ecf genes were found to be essential for E. coli growth.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Geneva, Ctr Med Univ, Dept Biochim Med, CH-1211 Geneva 4, Switzerland	University of California System; University of California Los Angeles; University of Geneva	Missiakas, D (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 609 Charles Young Dr, Los Angeles, CA 90095 USA.	missiaka@microbio.ucla.edu	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932	NIGMS NIH HHS [GM58266] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058266] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BREMER E, 1985, J BACTERIOL, V162, P1092, DOI 10.1128/JB.162.3.1092-1099.1985; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Collinet B, 2000, J BIOL CHEM, V275, P33898, DOI 10.1074/jbc.M006214200; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; KOOP AH, 1987, GENE, V52, P245, DOI 10.1016/0378-1119(87)90051-5; KUSUKAWA N, 1988, GENE DEV, V2, P874, DOI 10.1101/gad.2.7.874; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; MISSIAKAS D, 1993, J BACTERIOL, V175, P2613, DOI 10.1128/JB.175.9.2613-2624.1993; Missiakas Dominique, 1996, P481; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, P1334; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J	43	301	310	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20866	20875		10.1074/jbc.M100464200	http://dx.doi.org/10.1074/jbc.M100464200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274153	hybrid			2022-12-27	WOS:000169297900012
J	Beismann-Driemeyer, S; Sterner, R				Beismann-Driemeyer, S; Sterner, R			Imidazole glycerol phosphate synthase from Thermotoga maritima - Quaternary structure, steady-state kinetics, and reaction mechanism of the bienzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; GLUTAMINE AMIDOTRANSFERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SYNTHETASE; PROTEINS; PURIFICATION; ENZYME; EXPRESSION; SUBSTRATE	Imidazole glycerol phosphate synthase, which links histidine and de novo purine biosynthesis, is a member of the glutamine amidotransferase family. In bacteria, imidazole glycerol phosphate synthase constitutes a bienzyme complex of the glutaminase subunit HisH and the synthase subunit HisF. Nascent ammonia produced by HisH reacts at the active site of HisF with N'-((5'-phosphoribulosyl)formimino)-5-aminoimidazole-4-carboxamide-ribonucleotide to yield the products imidazole glycerol phosphate and 5-aminoimidazole-4-carboxamide ribotide. In order to elucidate the interactions between HisH and HisF and the catalytic mechanism of the HisF reaction, the enzymes tHisH and tHisF from Thermotoga maritima were produced in Escherichia coli, purified, and characterized. Isolated tHisH showed no detectable glutaminase activity but was stimulated by complex formation with tHisF to which either the product imidazole glycerol phosphate or a substrate analogue were bound. Eight conserved amino acids at the putative active site of tHisF were exchanged by site-directed mutagenesis, and the purified variants were investigated by steady-state kinetics. Aspartate 11 appeared to be essential for the synthase activity both in vitro and in vivo, and aspartate 130 could be partially replaced only by glutamate. The carboxylate groups of these residues could provide general acid/base catalysis in the proposed catalytic mechanism of the synthase reaction.	Univ Cologne, Inst Biochem, D-50674 Cologne, Germany	University of Cologne	Sterner, R (corresponding author), Univ Cologne, Inst Biochem, Otto-Fischer-Str 12-14, D-50674 Cologne, Germany.	Reinhard.Sterner@Uni-Koeln.de		Sterner, Reinhard/0000-0001-8177-8460				Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Chittur SV, 2000, PROTEIN EXPRES PURIF, V18, P366, DOI 10.1006/prep.2000.1207; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; DAVISSON VJ, 1994, J ORG CHEM, V59, P137, DOI 10.1021/jo00080a022; GOLDSCHMIDT EP, 1970, GENETICS, V66, P219; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; KLEM TJ, 1993, BIOCHEMISTRY-US, V32, P5177, DOI 10.1021/bi00070a029; Klem TJ, 2001, J BACTERIOL, V183, P989, DOI 10.1128/JB.182.3.989-996.2001; Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479; Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114; KUENZLER M, 1993, J BACTERIOL, V175, P5548, DOI 10.1128/JB.175.17.5548-5558.1993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Martin R. G., 1971, METHODS ENZYMOL    B, V17, P3; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pujadas G, 1999, BIOLOGIA, V54, P231; Rishavy MA, 2000, BIOCHEMISTRY-US, V39, P7309, DOI 10.1021/bi000435z; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P8825, DOI 10.1021/bi9807761; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Thoma R, 1998, EXTREMOPHILES, V2, P379, DOI 10.1007/s007920050082; Thoma R, 1999, FEBS LETT, V454, P1, DOI 10.1016/S0014-5793(99)00757-7; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	43	75	77	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20387	20396		10.1074/jbc.M102012200	http://dx.doi.org/10.1074/jbc.M102012200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264293	hybrid			2022-12-27	WOS:000169135100097
J	Kenjo, A; Takahashi, M; Matsushita, M; Endo, Y; Nakata, M; Mizuochi, T; Fujita, T				Kenjo, A; Takahashi, M; Matsushita, M; Endo, Y; Nakata, M; Mizuochi, T; Fujita, T			Cloning and characterization of novel ficolins from the solitary ascidian, Halocynthia roretzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; COMPLEMENT COMPONENT C3; SERINE-PROTEASE; MOLECULAR-CLONING; FIBRINOGEN-LIKE; ACTIVATES COMPLEMENT; CARBOHYDRATE MOIETY; INNATE IMMUNITY; MANNAN-BINDING; COLLAGEN-LIKE	Ficolins are animal lectins with collagen-like and fibrinogen-like domains. They are involved in the first line of host defense against pathogens. Human ficolin/P35 as well as mannose-binding lectin (MBL) activates the complement lectin pathway in association with MEL-associated serine proteases. To elucidate the origin and evolution of ficolins, we separated similar to 40 kDa (p40) and similar to 50 kDa (p50) N-acetylglucosamine-binding lectins from hemolymph plasma of the solitary ascidian. Binding assays revealed that p40 recognizes N-acetyl groups in association with a pyranose ring and that p50 recognizes N-acetylglucosamine alone. Based on the amino acid sequences of the proteins, we isolated two clones each of p40 and p50 from the ascidian hepatopancreas cDNA and determined the entire coding sequences of these clones. Because all of the clones contained both collagen-like and fibrinogen-like domains, we concluded that these were homologs of the mammalian ficolin family and designated ascidian ficolins (AsFCNs), The fibrinogen-like domain of the AsFCNs shows 45.4-52.4% amino acid sequence identity with the mammalian ficolin family. A phylogenetic tree of the fibrinogen-like sequences shows that all the fibrinogen-like domains may have evolved from a common ancestor that branched off an authentic fibrinogen. These results suggest that AsFCNs play an important role with respect to ascidian hemolymph lectin activity and the correlation of different functions with binding specificity.	Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan; Tokai Univ, Dept Appl Chem, Lab Biomed Chem, Kanagawa 2591292, Japan	Fukushima Medical University; Tokai University	Fujita, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Biochem, 1 Hikariga Oka, Fukushima 9601295, Japan.		Takahashi, Minoru/G-4748-2011					Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; Endo Y, 1996, GENOMICS, V36, P515, DOI 10.1006/geno.1996.0497; Endo Y, 1998, J IMMUNOL, V161, P4924; Fujimori Y, 1998, BIOCHEM BIOPH RES CO, V244, P796, DOI 10.1006/bbrc.1998.8344; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; ICHIJO H, 1993, J BIOL CHEM, V268, P14505; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JENSENIUS JC, 1994, BIOCHEM SOC T, V22, P95, DOI 10.1042/bst0220095; Ji X, 1997, P NATL ACAD SCI USA, V94, P6340, DOI 10.1073/pnas.94.12.6340; Ji X., 2000, Immunopharmacology, V49, P43, DOI 10.1016/S0162-3109(00)80122-8; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; LIANG CJ, 1980, J BIOCHEM-TOKYO, V88, P51; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; MIZUOCHI T, 1989, J BIOL CHEM, V264, P13834; Nair SV, 2000, COMP BIOCHEM PHYS B, V125, P279, DOI 10.1016/S0305-0491(99)00180-7; NILSSON B, 1979, J BIOL CHEM, V254, P4545; Nonaka M, 1999, J IMMUNOL, V162, P387; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; Omori-Satoh T, 2000, TOXICON, V38, P1561, DOI 10.1016/S0041-0101(00)00090-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; Sekine H, 1998, MOL IMMUNOL, V35, P349, DOI 10.1016/S0161-5890(98)90605-8; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; TAI T, 1977, J BIOL CHEM, V252, P6687; TAI T, 1975, J BIOL CHEM, V250, P8569; TAKASAKI S, 1986, BIOCHEMISTRY-US, V25, P5709, DOI 10.1021/bi00367a054; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1	38	112	127	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19959	19965		10.1074/jbc.M011723200	http://dx.doi.org/10.1074/jbc.M011723200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259430	hybrid			2022-12-27	WOS:000169135100038
J	Vogt, A; Adachi, T; Ducruet, AP; Chesebrough, J; Nemoto, K; Carr, BI; Lazo, JS				Vogt, A; Adachi, T; Ducruet, AP; Chesebrough, J; Nemoto, K; Carr, BI; Lazo, JS			Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual-specificity phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; VITAMIN-K; TYROSINE PHOSPHORYLATION; GROWTH-INHIBITION; NUCLEAR TRANSLOCATION; CYCLE ARREST; MAP KINASES; IN-VIVO; ACTIVATION	Protein phosphorylation frequently results in the subcellular redistribution of key signaling molecules, and this spatial change is critical for their activity. Here we have probed the effects of a Cdc25 inhibitor, 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone or Compound 5, on the spatial regulation and activation kinetics of tyrosine phosphorylation-dependent signaling events using two methods: (i) high-content, automated, fluorescence-based, solid-phase cytometry and (ii) a novel cellular assay for Cdc25A activity in intact cells. Immunofluorescence studies demonstrated that Compound 5 produced a concentration-dependent nuclear accumulation of phospho-Erk and phospho-p38, but not nuclear factor kappaB, Immunoblot analysis confirmed Erk phosphorylation and nuclear accumulation, and in vitro kinase assays showed that Compound 5-activated Erk. was competent to phosphorylate its physiological substrate, the transcription factor Elk-1. Pretreatment of cells with the MEK inhibitor U-0126 prevented the induction by Compound 5 of phospho-Erk (but not phospho-p38) nuclear accumulation and protected cells from the antiproliferative effects of Compound 5. Overexpression of Cdc25A in whole cells caused dephosphorylation of Erk that was reversed by Compound 5, The data show that an inhibitor of Cdc25 increases Erk phosphorylation and nuclear accumulation and support the hypothesis that Cdc25A regulates Erk phosphorylation status.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Pittsburgh, Dept Pharmacol, Biomed Sci Tower E-3140, Pittsburgh, PA 15261 USA.			Carr, Brian/0000-0002-6111-5077	NCI NIH HHS [CA 78039, CA 82723, CA 52995] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA052995, R01CA082723, U01CA052995, P01CA078039] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chen F, 1999, J BIOL CHEM, V274, P20307, DOI 10.1074/jbc.274.29.20307; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Kar S, 2000, J CELL PHYSIOL, V185, P386, DOI 10.1002/1097-4652(200012)185:3<386::AID-JCP8>3.0.CO;2-X; KERNS J, 1995, BIOORG CHEM, V23, P101, DOI 10.1006/bioo.1995.1008; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu RY, 2000, J BIOL CHEM, V275, P21086, DOI 10.1074/jbc.M001281200; Ludwig S, 1998, J BIOL CHEM, V273, P1917, DOI 10.1074/jbc.273.4.1917; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; NISHIKAWA Y, 1995, J BIOL CHEM, V270, P28304, DOI 10.1074/jbc.270.47.28304; Nishikawa Y, 1999, J BIOL CHEM, V274, P34803, DOI 10.1074/jbc.274.49.34803; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RAGO R, 1990, ANAL BIOCHEM, V191, P31; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Tamura K, 2000, CANCER RES, V60, P1317; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang ZQ, 2000, J CELL PHYSIOL, V183, P338, DOI 10.1002/(SICI)1097-4652(200006)183:3<338::AID-JCP6>3.0.CO;2-X; Xia K, 1999, MOL CELL BIOL, V19, P4819; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	37	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20544	20550		10.1074/jbc.M100078200	http://dx.doi.org/10.1074/jbc.M100078200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274178	hybrid			2022-12-27	WOS:000169135100117
J	Ma, HT; Venkatachalam, K; Li, HS; Montell, C; Kurosaki, T; Patterson, RL; Gill, DL				Ma, HT; Venkatachalam, K; Li, HS; Montell, C; Kurosaki, T; Patterson, RL; Gill, DL			Assessment of the role of the inositol 1,4,5-trisphosphate receptor in the activation of transient receptor potential channels and store-operated Ca2+ entry channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; THAPSIGARGIN-RESISTANT CELLS; INTRACELLULAR CALCIUM; HTRP3 CHANNELS; DROSOPHILA TRP; 2-AMINOETHOXYDIPHENYL BORATE; FUNCTIONAL-CHARACTERIZATION; ENDOTHELIAL-CELLS; INSP(3) RECEPTOR; CATION CHANNELS	The mechanism for coupling between Ca2+ stores and store-operated channels (SOCs) is an important but unresolved question. Although SOCs have not been molecularly identified, transient receptor potential (TRP) channels share a number of operational parameters with SOCs. The question of whether activation of SOCs and TRP channels is mediated by the inositol 1,4,5-trisphosphate receptor (InsP(3)R) was examined using the permeant InsP(3)R antagonist, 2-aminoethoxy-diphenyl borate (2-APB) in both mammalian and invertebrate systems. In HEK293 cells stably transfected with human TRPC3 channels, the actions of 8-APB to block carbachol-induced InsP(3)R-mediated store release and carbachol-induced Sr2+ entry through TRPC3 channels were both reversed at high agonist levels, suggesting InsP(3)Rs mediate TRPC3 activation. However, electroretinogram recordings of the light induced current in Drosophila revealed that the TRP channel-mediated responses in wild-type as well as trp and trp1 mutant flies were all inhibited by 2-APB, This action of 2-APB is likely InsP(3)R-independent since InsP(3)Rs are dispensable for the light response. We used triple InsP(3)R knockout DT40 chicken B-cells to further assess the role of InsP(3)Rs in SOC activation. Ca-45(2+) flux analysis revealed that although DT40 wildtype cells retained normal InsP(3)Rs mediating 2-APB-sensitive Ca2+ release, the DT40InsP(3)R-k/o cells were devoid of functional InsP(3)Rs. Using intact cells, all parameters of Ca2+ store function and SOC activation were identical in DT40wt and DT40InsP(3)R-k/o cells. Moreover, in both cell lines SOC activation was completely blocked by 2-APB, and the kinetics of action of 2-APB on SOCs (time dependence and IC50) were identical. The results indicate that (a) the action of 2-APB on Ca2+ entry is not mediated by the InsP(3)R and (b) the effects of 2-APB provide evidence for an important similarity in the function of invertebrate TRP channels, mammalian TRP channels, and mammalian store-operated channels.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Kansai Med Univ, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Kansai Medical University	Gill, DL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.		Kurosaki, Tomohiro/D-1306-2009; Montell, Craig/AAH-3357-2021; Venkatachalam, Kaliyamurthi/GXM-4890-2022	Kurosaki, Tomohiro/0000-0002-6352-304X; Montell, Craig/0000-0001-5637-1482; 	NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NEI NIH HHS [EY10852] Funding Source: Medline; NHLBI NIH HHS [HL55426] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; Gill DL, 1996, BIOSCIENCE REP, V16, P139, DOI 10.1007/BF01206203; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MULLANEY JM, 1987, J BIOL CHEM, V262, P13865; MULLANEY JM, 1988, P NATL ACAD SCI USA, V85, P2499, DOI 10.1073/pnas.85.8.2499; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Putney JW, 2000, CELL MOL LIFE SCI, V57, P1272, DOI 10.1007/PL00000765; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rys-Sikora KE, 1998, J BIOL CHEM, V273, P32627, DOI 10.1074/jbc.273.49.32627; RYSSIKORA KE, 1994, J BIOL CHEM, V269, P31607; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; WALDRON RT, 1995, J BIOL CHEM, V270, P11955, DOI 10.1074/jbc.270.20.11955; Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440; WILLARS GB, 1995, MOL PHARMACOL, V47, P509; Wu J, 2000, MOL PHARMACOL, V58, P1368, DOI 10.1124/mol.58.6.1368; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	66	138	145	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18888	18896		10.1074/jbc.M100944200	http://dx.doi.org/10.1074/jbc.M100944200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259416	hybrid			2022-12-27	WOS:000169091000033
J	Melnikova, IN; Gardner, PD				Melnikova, IN; Gardner, PD			The signal transduction pathway underlying ion channel gene regulation by Sp1-c-Jun interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NICOTINIC ACETYLCHOLINE-RECEPTORS; BETA-4 SUBUNIT GENE; MAP KINASE KINASE; PC12 CELLS; PROTEIN-KINASE; C-JUN; TRANSCRIPTIONAL ACTIVATION; PHEOCHROMOCYTOMA CELLS; FACTOR INCREASES	During neuronal differentiation, an exquisitely controlled program of signal transduction events takes place, leading to the temporally and spatially regulated expression of genes associated with the differentiated phenotype. A critical class of genes involved in this phenomenon is that made up of genes encoding neurotransmitter-gated ion channels that play a central role in signal generation and propagation within the nervous system. We used the well established PC12 cell line to investigate the molecular details underlying the expression of the neuronal nicotinic acetylcholine receptor class of ion channels. Neuronal differentiation of PC12 cells can be induced by nerve growth factor, leading to an increase in neuronal nicotinic acetylcholine receptor gene expression, Nerve growth factor initiates several signal transduction cascades. Here, we show that the Pas-dependent mitogen-activated protein kinase and phosphoinositide 3-kinase pathways are critical for the nerve growth factor-mediated increase in the transcriptional activity of a neuronal nicotinic acetylcholine receptor gene promoter. In addition, we show that a component of the Ras-dependent mitogen-activated protein kinase pathway, nerve growth factor-inducible c-Jun, exerts its effects on receptor gene promoter activity most likely through protein-protein interactions with Spl. Finally, we demonstrate that the target for nerve growth factor signaling is an Spl-binding site within the neuronal nicotinic acetylcholine receptor gene promoter.	Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01613 USA	University of Massachusetts System; University of Massachusetts Worcester	Gardner, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 55 Lake Ave N,POB 2795, Worcester, MA 01613 USA.	paul.gardner@umassmed.edu			NINDS NIH HHS [R01 NS030243] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030243] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Boyd RT, 1996, NEUROSCI LETT, V208, P73, DOI 10.1016/0304-3940(96)12561-1; Boyd RT, 1997, CRIT REV TOXICOL, V27, P299, DOI 10.3109/10408449709089897; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; CHIN LS, 1994, J BIOL CHEM, V269, P18507; Cibelli G, 1996, EUR J BIOCHEM, V237, P311, DOI 10.1111/j.1432-1033.1996.0311n.x; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, P743; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CURRAN P, 1992, TRANSCRIPTIONAL REGU, P1123; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; FARAONIO R, 1994, NUCLEIC ACIDS RES, V22, P4876, DOI 10.1093/nar/22.23.4876; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; HENDERSON LP, 1994, J NEUROSCI, V14, P1153, DOI 10.1523/JNEUROSCI.14-03-01153.1994; HU MJ, 1994, J NEUROCHEM, V62, P392; IFUNE CK, 1990, P NATL ACAD SCI USA, V87, P4794, DOI 10.1073/pnas.87.12.4794; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; Kaplan D, 2000, NEURON, V25, P253, DOI 10.1016/S0896-6273(00)80887-9; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Kolkova K, 2000, J NEUROSCI, V20, P2238; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu Q, 1999, J NEUROSCI, V19, P9747; MADHOK TC, 1992, ENDOCRINOLOGY, V130, P825, DOI 10.1210/en.130.2.825; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; Melikian HE, 1999, J NEUROSCI, V19, P7699; Melnikova IN, 1996, CELL GROWTH DIFFER, V7, P1067; Nakayama H, 2000, J NEUROCHEM, V74, P1346, DOI 10.1046/j.1471-4159.2000.0741346.x; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; REEBEN M, 1995, J NEUROSCI RES, V40, P177, DOI 10.1002/jnr.490400206; Ruberti F, 2000, J NEUROSCI, V20, P2589; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WHITING PJ, 1987, NATURE, V327, P515, DOI 10.1038/327515a0; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Yan GZ, 1997, J NEUROSCI, V17, P6122; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	65	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19040	19045		10.1074/jbc.M010735200	http://dx.doi.org/10.1074/jbc.M010735200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262397	hybrid			2022-12-27	WOS:000169091000054
J	Kogan, I; Ramjeesingh, M; Huan, LJ; Wang, YC; Bear, CE				Kogan, I; Ramjeesingh, M; Huan, LJ; Wang, YC; Bear, CE			Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; NUCLEOTIDE-BINDING DOMAINS; CHLORIDE CHANNEL; CL CHANNEL; CELL-LINE; HYDROLYSIS; PERMEATION; MUTATIONS; ANION; GENE	Mutations in the cystic fibrosis gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) lead to altered chloride (Cl-) flux in affected epithelial tissues. CFTR is a Cl- channel that is regulated by phosphorylation, nucleotide binding, and hydrolysis, However, the molecular basis for the functional regulation of wild type and mutant CFTR remains poorly understood. CFTR possesses two nucleotide binding domains, a phosphorylation-dependent regulatory domain, and two transmembrane domains that comprise the pore through which Cl- permeates. Mutations of residues lining the channel pore (e.g. R347D) are typically thought to cause disease by altering the interaction of Cl- with the pore. However, in the present study we show that the R347D mutation and diphenylamine-2-carboxylate (an open pore inhibitor) also inhibit CFTR ATPase activity, revealing a novel mechanism for cross-talk from the pore to the catalytic domains. In both cases, the reduction in ATPase correlates with a decrease in nucleotide turnover rather than affinity. Finally, we demonstrate that glutathione (GSH) inhibits CFTR ATPase and that this inhibition is altered in the CFTR-R347D variant. These findings suggest that cross-talk between the pore and nucleotide binding domains of CFTR may be important in the in vivo regulation of CFTR in health and disease.	Hosp Sick Children, Res Inst, Toronto, ON M5G 1XB, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1XB, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1XB, Canada.							AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Arsalane K, 1997, AM J RESP CELL MOL, V17, P599, DOI 10.1165/ajrcmb.17.5.2833; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Harrington MA, 1999, J BIOL CHEM, V274, P27536, DOI 10.1074/jbc.274.39.27536; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KO YH, 1995, J BIOL CHEM, V270, P22093, DOI 10.1074/jbc.270.38.22093; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; MCCARTY NA, 1993, J GEN PHYSIOL, V102, P1, DOI 10.1085/jgp.102.1.1; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; Pilewski JM, 1999, PHYSIOL REV, V79, P215; POOT M, 1995, J CELL PHYSIOL, V163, P555, DOI 10.1002/jcp.1041630316; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Pusch M, 1999, J PHYSIOL-LONDON, V515, P341, DOI 10.1111/j.1469-7793.1999.341ac.x; RAHMAN I, 1995, AM J PHYSIOL-LUNG C, V269, pL285, DOI 10.1152/ajplung.1995.269.3.L285; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Ramjeesingh M, 1997, BIOCHEM J, V327, P17, DOI 10.1042/bj3270017; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Ramjeesingh M, 1999, Methods Enzymol, V294, P227; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1996, J MEMBRANE BIOL, V151, P63, DOI 10.1007/s002329900058; Schultz BD, 1996, AM J PHYSIOL-LUNG C, V271, pL192, DOI 10.1152/ajplung.1996.271.2.L192; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; SUN JD, 1988, EXP MOL PATHOL, V49, P254, DOI 10.1016/0014-4800(88)90038-X; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; Tabcharani JA, 1997, J GEN PHYSIOL, V110, P341, DOI 10.1085/jgp.110.4.341; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; WANGEMANN P, 1986, PFLUG ARCH        S2, V407, P128; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zhang ZR, 2000, BIOPHYS J, V79, P298, DOI 10.1016/S0006-3495(00)76292-8	57	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11575	11581		10.1074/jbc.M010403200	http://dx.doi.org/10.1074/jbc.M010403200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11124965	hybrid			2022-12-27	WOS:000168081800023
J	Barth, H; Pfeifer, G; Hofmann, F; Maier, E; Benz, R; Aktories, K				Barth, H; Pfeifer, G; Hofmann, F; Maier, E; Benz, R; Aktories, K			Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM C2 TOXIN; RHO-PROTEINS; RETROGRADE TRANSPORT; PROTECTIVE ANTIGEN; ESCHERICHIA-COLI; MAMMALIAN-CELLS; MEMBRANES; OLIGOMERIZATION; LOCALIZATION; INFECTION	Clostridium difficile toxin B (269 kDa), which is one of the causative agents of antibiotic-associated diarrhea and pseudomembranous colitis, inactivates Rho GTPase by glucosylation, Here we studied the uptake and membrane interaction of the toxin with eukaryotic target cells. Bafilomycin A1, which prevents acidification of endosomal compartments, blocked the cellular uptake of toxin B in Chinese hamster ovary cells cells. Extracellular acidification (pH less than or equal to 5.2) induced uptake of toxin B into the cytosol even in the presence of bafilomycin A1. Toxin B increased Rb-86(+) release when preloaded Chinese hamster ovary cells were exposed to low pH (pH less than or equal to 5.6) for 5 min. Release of Rb-86(+) depended on the concentration of toxin B and on the pH of the extracellular medium. An antibody directed against the holotoxin prevented channel formation, whereas an antibody against the N-terminal enzyme domain was without effect. The N-terminally truncated toxin B fragment consisting of amino acids 547-2366 increased Rb-86(+) efflux when cells were exposed to low pH, Toxin B also induced pH-dependent channel formation in artificial lipid bilayer membranes. Clostridium sordellii lethal toxin, another member of the family of large clostridial cytotoxins, also induced increased Rb-86(+) release at low pH, The results suggest that large clostridial cytotoxins including C. difficile toxin B and C, sordellii lethal toxin undergo structural changes at low pH of endosomes that are accompanied by membrane insertion and channel formation.	Univ Freiburg, Inst Expt & Klin Phamrakol & Toxikol, D-79104 Freiburg, Germany; Univ Wurzburg, Biozentrum, Theodor Boveri Inst, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany	University of Freiburg; University of Wurzburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Phamrakol & Toxikol, Hermann Herder Str 5, D-79104 Freiburg, Germany.		Barth, Holger/E-7920-2013; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Benz, Roland/0000-0002-9510-9265				Aktories K, 1997, J CLIN INVEST, V99, P827, DOI 10.1172/JCI119245; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; FREY SM, 1992, INFECT IMMUN, V60, P2488, DOI 10.1128/IAI.60.6.2488-2492.1992; Genth H, 2000, INFECT IMMUN, V68, P1094, DOI 10.1128/IAI.68.3.1094-1101.2000; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hofmann F, 1997, J BIOL CHEM, V272, P11074; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Just I., 1997, BACTERIAL TOXINS TOO, P159; Kelly CP, 1998, ANNU REV MED, V49, P375; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyerly David M., 1995, P867; MADSHUS IH, 1991, J BIOL CHEM, V266, P17446; Maier E, 1996, INFECT IMMUN, V64, P4415, DOI 10.1128/IAI.64.11.4415-4423.1996; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Singh Y, 1999, INFECT IMMUN, V67, P1853; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992	29	123	128	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10670	10676		10.1074/jbc.M009445200	http://dx.doi.org/10.1074/jbc.M009445200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152463	hybrid			2022-12-27	WOS:000167980900016
J	Ceresa, BP; Lotscher, M; Schmid, SL				Ceresa, BP; Lotscher, M; Schmid, SL			Receptor and membrane recycling can occur with unaltered efficiency despite dramatic Rab5(Q79L)-induced changes in endosome geometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAB5; GTPASE; FUSION; TRANSFERRIN; PATHWAY	Current models for sorting in the endosomal compartment suggest that endosomal geometry plays a significant role as membrane-bound proteins accumulate in tubular regions for recycling, and lumenal markers accumulate in large vacuolar portions for delivery to lysosomes, Rab5, a small molecular weight GTPase, functions in the formation and maintenance of the early/sorting endosome, Overexpression of the constitutively active form, Rab5(Q79L), leads to enhanced endosome fusion resulting in the enlargement of early endosomes, Using an adenoviral expression system to regulate the time and level of Rab5(Q79L) overexpression in HeLa cells, we find that although endosomes are dramatically enlarged, the rates of transferrin receptor-mediated endocytosis and recycling are unaffected. Moreover, despite the enlarged endosome phenotype, neither the rate of internalization of a fluid phase marker nor the rate of recycling of a bulk lipid marker were affected. These results suggest that GTP hydrolysis by Rab5 is rate-limiting for endosome fusion but not for endocytic trafficking and that early endosome geometry may be a less critical determinant of sorting efficiencies than previously thought.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu		Schmid, Sandra/0000-0002-1690-7024	NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; GHOSH RN, 1995, J CELL BIOL, V128, P549, DOI 10.1083/jcb.128.4.549; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; LI GP, 1993, J BIOL CHEM, V268, P24475; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Roberts RL, 1999, J CELL SCI, V112, P3667; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553	25	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9649	9654		10.1074/jbc.M010387200	http://dx.doi.org/10.1074/jbc.M010387200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136733	hybrid			2022-12-27	WOS:000167996400011
J	Maruyama, M; Kumagai, T; Matoba, Y; Hayashida, M; Fujii, T; Hata, Y; Sugiyama, M				Maruyama, M; Kumagai, T; Matoba, Y; Hayashida, M; Fujii, T; Hata, Y; Sugiyama, M			Crystal structures of the transposon Tn5-carried bleomycin resistance determinant uncomplexed and complexed with bleomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTANCE GEOMETRY CALCULATIONS; X-RAY-DIFFRACTION; ESCHERICHIA-COLI; STREPTOMYCES-VERTICILLUS; STAPHYLOCOCCUS-AUREUS; ACTIVATED BLEOMYCIN; MOLECULAR-CLONING; FACTOR REFINEMENT; NMR-SPECTROSCOPY; BINDING PROTEIN	The transposon Tn5 carries a gene designated ble that confers resistance to bleomycin (Bm), In this study, we determined the x-ray crystal structures of the ble gene product, designated BLMT, uncomplexed and complexed with Bm at 1.7 and 2.5 Angstrom resolution, respectively. The structure of BLMT is a dimer with two Bm-binding pockets composed of two large concavities and two long grooves, This crystal structure of BLMT complexed with Bm gives a precise mode for binding of the antibiotic to BLMT. The conformational change of BLMT generated by binding to Bm occurs at a beta -turn composed of the residues from Gln(97) to Thr(102). Crystallographic analysis of Bm bound to BLMT shows that two thiazolium rings of the bithiazole moiety are in the trans conformation. The axial ligand, which binds a metal ion, seems to be the primary amine in the beta -aminoalanine moiety. This report, which is the first with regard to the x-ray crystal structure of Bm, shows that the bithiazole moiety of Bm is far from the metal-binding domain. That is, Bm complexed with BLMT takes a more extended form than the drug complexed with DNA.	Hiroshima Univ, Fac Med, Inst Pharmaceut Sci, Minami Ku, Hiroshima 7348551, Japan; Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Hiroshima University; Kyoto University	Sugiyama, M (corresponding author), Hiroshima Univ, Fac Med, Inst Pharmaceut Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.							Adam E, 1998, MOL MICROBIOL, V28, P15, DOI 10.1046/j.1365-2958.1998.00755.x; AKKERMAN MAJ, 1990, J AM CHEM SOC, V112, P7462, DOI 10.1021/ja00177a003; AKKERMAN MAJ, 1988, EUR J BIOCHEM, V173, P211, DOI 10.1111/j.1432-1033.1988.tb13987.x; BERG DE, 1975, P NATL ACAD SCI USA, V72, P3628, DOI 10.1073/pnas.72.9.3628; BHUIYAN MZA, 1995, APPL MICROBIOL BIOT, V43, P65; BLOT M, 1991, P NATL ACAD SCI USA, V88, P9112, DOI 10.1073/pnas.88.20.9112; BLOT M, 1994, MOL GEN GENET, V242, P595, DOI 10.1007/BF00285283; BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BURGER RM, 1981, J BIOL CHEM, V256, P1636; CaceresCortes J, 1997, EUR J BIOCHEM, V244, P818, DOI 10.1111/j.1432-1033.1997.00818.x; CARTER BJ, 1990, P NATL ACAD SCI USA, V87, P9373, DOI 10.1073/pnas.87.23.9373; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; FOX GC, 1966, ACTA CRYSTALLOGR, V20, P886, DOI 10.1107/S0365110X66002007; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; GENILLOUD O, 1984, GENE, V32, P225, DOI 10.1016/0378-1119(84)90050-7; HIGASHI T, 1989, J APPL CRYSTALLOGR, V16, P542; HOLMES CE, 1993, BIOCHEMISTRY-US, V32, P4293, DOI 10.1021/bi00067a019; IITAKA Y, 1978, J ANTIBIOT, V31, P1070, DOI 10.7164/antibiotics.31.1070; JAMES MN, 1996, J CHEM SOC, V16, P1361; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; Kawano Y, 2000, J MOL BIOL, V295, P915, DOI 10.1006/jmbi.1999.3404; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; Kumagai T, 1999, FEBS LETT, V442, P34, DOI 10.1016/S0014-5793(98)01613-5; Kumagai T, 1999, ACTA CRYSTALLOGR D, V55, P1095, DOI 10.1107/S0907444999002875; KURODA R, 1982, NUCLEIC ACIDS RES, V10, P4753, DOI 10.1093/nar/10.15.4753; Lehmann TE, 1997, BIOCHEMISTRY-US, V36, P2807, DOI 10.1021/bi962748t; LIN SY, 1981, BIOCHEMISTRY-US, V20, P7589, DOI 10.1021/bi00529a038; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MAGLIOZZO RS, 1989, MOL PHARMACOL, V35, P428; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MAZODIER P, 1985, NUCLEIC ACIDS RES, V13, P195, DOI 10.1093/nar/13.1.195; MCPHERSON A, 1982, PREPARATION ANAL PRO, P96; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SAKABE N, 1995, REV SCI INSTRUM, V66, P1276, DOI 10.1063/1.1146021; SAKAI TT, 1981, J MED CHEM, V24, P279, DOI 10.1021/jm00135a008; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; STUBBE J, 1987, CHEM REV, V87, P1107, DOI 10.1021/cr00081a011; SUGIYAMA M, 1994, GENE, V151, P11; SUGIYAMA M, 1995, FEBS LETT, V362, P80, DOI 10.1016/0014-5793(95)00218-X; UMEZAWA H, 1974, FED PROC, V33, P2296; Vanderwall DE, 1997, CHEM BIOL, V4, P373, DOI 10.1016/S1074-5521(97)90128-9; Wilson A. J. C., 1942, NATURE, V150, P152; Wu W, 1996, J AM CHEM SOC, V118, P1268, DOI 10.1021/ja9524964; Wu W, 1996, J AM CHEM SOC, V118, P1281, DOI 10.1021/ja952497w; XU RX, 1994, BIOCHEMISTRY-US, V33, P907, DOI 10.1021/bi00170a009	50	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9992	9999		10.1074/jbc.M009874200	http://dx.doi.org/10.1074/jbc.M009874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134052	hybrid			2022-12-27	WOS:000167996400057
J	Wilde, C; Chhatwal, GS; Schmalzing, G; Aktories, K; Just, I				Wilde, C; Chhatwal, GS; Schmalzing, G; Aktories, K; Just, I			A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ESCHERICHIA-COLI; GENE-PRODUCT; IDENTIFICATION; PROTEINS; PURIFICATION; TOXIN; EXOENZYME; FAMILY; ENZYME	Clostridium botulinum C3 is the prototype of the family of the C3-like transferases that ADP-ribosylate exclusively RhoA, -B and -C, The ADP-ribose at Asn-41 results in functional inactivation of Rho reflected by disaggregation of the actin cytoskeleton. We report on a new C3-like transferase produced by a pathogenic Staphylococcus aureus strain, The transferase designated C3(Stau) was cloned from the genomic DNA, At the amino acid level, C3(Stau) revealed an identity of 35% to C3 from C. botulinum and Clostridium limosum exoenzyme, respectively, and of 78% to EDIN from S, aureus, In addition to RhoA, which is the target of the other C3-like transferases, C3(Stau) modified RhoE and Rnd3. RhoE was ADP-ribosylated at Asn-44, which is equivalent to Asn-41 of RhoA, RhoE and Rnd3 are members of the Rho subfamily, which are deficient in intrinsic GTPase activity and possess a RhoA antagonistic cell function, The protein substrate specificity found with recombinant Rho proteins was corroborated by expression of RhoE in Xenopus laevis oocytes showing that RhoE was also modified in vivo by C3(Stau) but not by C3 from C. botulinum. The poor cell accessibility of C3(Stau) was overcome by generation of a chimeric toxin recruiting the cell entry machinery of C, botulinum C2 toxin, The chimeric C3(Stau) caused the same morphological and cytoskeletal changes as the chimeric C. botulinum C3. C3(Stau) is a new member of the family of the C3-like transferases but is also the prototype of a subfamily of RhoE/Rnd modifying transferases.	Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany	University of Freiburg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Just, I (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Hermann Herder Str 5, D-79104 Freiburg, Germany.	just.ingo@mh-hannover.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436				Aktories K, 2000, HANDB EXP PHARM, V145, P207; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P115; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; Barth H, 1999, J BIOL CHEM, V274, P27407, DOI 10.1074/jbc.274.39.27407; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Foster R, 1996, MOL CELL BIOL, V16, P2689; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; JUST I, 1992, J BIOL CHEM, V267, P10274; JUST I, 1994, J CELL SCI, V107, P1653; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; MORII N, 1995, METHOD ENZYMOL, V256, P196; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SUGAI M, 1992, J BIOL CHEM, V267, P2600; VAN AL, 1997, GENE DEV, V11, P2295; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	27	82	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9537	9542		10.1074/jbc.M011035200	http://dx.doi.org/10.1074/jbc.M011035200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11124969	hybrid			2022-12-27	WOS:000167607700121
J	Balaban, N; Goldkorn, T; Gov, Y; Hirshberg, M; Koyfman, N; Matthews, HR; Nhan, RT; Singh, B; Uziel, O				Balaban, N; Goldkorn, T; Gov, Y; Hirshberg, M; Koyfman, N; Matthews, HR; Nhan, RT; Singh, B; Uziel, O			Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGR; VIRULENCE; SYSTEMS; LOCUS; GENE; SAR; MOLECULE; TOXIN	Staphylococcus aureus can cause disease through the production of toxins. Toxin production is autoinduced by the protein RNAIII-activating protein (RAP) and by the autoinducing peptide (AIP), and is inhibited by RNAIII-inhibiting peptide (RIP) and by inhibitory AIPs. RAP has been shown to be a useful vaccine target site, and RIP and inhibitory AIPs as therapeutic molecules to prevent and suppress S. aureus infections. Development of therapeutic strategies based on these molecules has been hindered by a lack of knowledge of the molecular mechanisms by which they activate or inhibit virulence. Here, we show that RAP specifically induces the phosphorylation of a novel 21-kDa protein, whereas RIP inhibits its phosphorylation. This protein was termed target of RAP (TRAP). The synthesis of the virulence regulatory molecule, RNAIII, is not activated by RAP in the trap mutant strain, suggesting that RAP activates RNAIII synthesis via TRAP. Phosphoamino acid analysis shows that TRAP is histidine-phosphorylated, suggesting that TRAP may be a sensor of RAP. AIPs upregulate the synthesis of RNAIII also in trap mutant strains, suggesting that TRAP and AIPs activate RNAIII synthesis via distinct signal transduction pathways. Furthermore, TRAP phosphorylation is down-regulated in the presence of AIP, suggesting that a network of signal transduction pathways regulate S. aureus pathogenesis.	Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA; Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, IL-69978 Tel Aviv, Israel; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Tel Aviv University; Sackler Faculty of Medicine; University of Cambridge	Balaban, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol, Res Bldg 3, Sacramento, CA 95817 USA.	nbalaban@ucdavis.edu						ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Balaban N, 2000, PEPTIDES, V21, P1301, DOI 10.1016/S0196-9781(00)00272-2; BALABAN N, 1995, FEMS MICROBIOL LETT, V133, P155, DOI 10.1016/0378-1097(95)00356-A; BALABAN N, 1995, P NATL ACAD SCI USA, V92, P1619, DOI 10.1073/pnas.92.5.1619; Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438; BALABAN N, 2000, SCIENCE, V287, pA391; Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996; Cheung AL, 1997, J BACTERIOL, V179, P3963, DOI 10.1128/jb.179.12.3963-3971.1997; Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Lina G, 1998, MOL MICROBIOL, V28, P655, DOI 10.1046/j.1365-2958.1998.00830.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; MOERFELDT E, 1995, EMBO J, V14, P4569; Moreau JM, 1997, CURR EYE RES, V16, P1221, DOI 10.1076/ceyr.16.12.1221.5022; Morfeldt E, 1996, FEMS MICROBIOL LETT, V143, P195, DOI 10.1016/0378-1097(96)00310-2; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 2000, SCIENCE, V287, pA391; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; POPHAM DL, 1993, J BACTERIOL, V175, P4870, DOI 10.1128/JB.175.15.4870-4876.1993; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schmitt CK, 1999, EMERG INFECT DIS, V5, P224, DOI 10.3201/eid0502.990206; WEI YF, 1991, METHOD ENZYMOL, V200, P388	32	122	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2001	276	4					2658	2667		10.1074/jbc.M005446200	http://dx.doi.org/10.1074/jbc.M005446200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	398YV	11160124	hybrid			2022-12-27	WOS:000166784800051
J	Jang, MK; Goo, YH; Sohn, YC; Kim, YS; Lee, SK; Kang, HJ; Cheong, JH; Lee, JW				Jang, MK; Goo, YH; Sohn, YC; Kim, YS; Lee, SK; Kang, HJ; Cheong, JH; Lee, JW			Ca2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-kappa B transactivation via phosphorylation of the p65 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; RECEPTOR COREPRESSORS; ACTIVATING PROTEIN-1; SMRT COREPRESSOR; N-COR; COMPLEX; COACTIVATOR; CANCER	Calmodulin-dependent protein kinase TV (CaMKIV) is a key mediator of Ca2+-induced gene expression. In this study, CaMKIV was found to directly associate with and phosphorylate the nuclear factor-kappaB (NF kappaB) component p65 both in vitro and in vivo. The phosphorylation of p65 by CaMKIV resulted in recruitment of transcription coactivator cAMP-response element-binding protein-binding protein and concomitant release of corepressor silencing mediator for retinoid and thyroid hormone receptors, as demonstrated by the glutathione S-transferase pull down and mammalian two hybrid assays. In addition, cotransfection of CaMKIV resulted in cytosolic translocation of the silencing mediator for retinoid and thyroid hormone receptors. Consistent with these results, cotransfected CaMKIV dramatically stimulated the NF kappaB transactivation in mammalian cells. From these results, NF kappaB is suggested to be a novel downstream effector molecule of CaMKIV.	Chonnam Natl Univ, Ctr Ligand & Transcript, Kwangju 500757, South Korea; Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 151742, South Korea	Chonnam National University; Seoul National University (SNU)	Lee, JW (corresponding author), Chonnam Natl Univ, Ctr Ligand & Transcript, Kwangju 500757, South Korea.	jlee@chonnam.chonnam.ac.kr		Jang, Moon Kyoo/0000-0002-1657-2877				Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Huang EY, 2000, GENE DEV, V14, P45; Kao HY, 2000, GENE DEV, V14, P55; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kawamura KI, 1996, BIOCHEM PHARMACOL, V52, P1903, DOI 10.1016/S0006-2952(96)00692-2; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Means AR, 1997, RECENT PROG HORM RES, V52, P389; Moore DD, 1995, GLOB MOB SURV; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Westin S, 2000, ADV PHARMACOL, V47, P89; Williams CL, 1996, BIOCHEM PHARMACOL, V51, P707, DOI 10.1016/S0006-2952(95)02393-3; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	35	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20005	20010		10.1074/jbc.M010211200	http://dx.doi.org/10.1074/jbc.M010211200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274168	hybrid			2022-12-27	WOS:000169135100045
J	Moller, A; Dienz, O; Hehner, SP; Droge, W; Schmitz, ML				Moller, A; Dienz, O; Hehner, SP; Droge, W; Schmitz, ML			Protein kinase C theta cooperates with Vav1 to induce JNK activity in T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAYS; IL-2 PROMOTER; PKC-THETA; LYMPHOCYTE DEVELOPMENT; PROTOONCOGENE PRODUCT; DEPENDENT ACTIVATION; NEGATIVE REGULATOR; MAP KINASES; CD28	Here we show that in human T-cell leukemia cells Vav1 and protein kinase C theta (PKC theta) synergize for the activation of c-Jun N-terminal kinase (JNK) but not p38 MAP kinase. Vav1 and PKC theta also cooperated to induce transcription of reporter genes controlled either by AP-1 binding sites or the CD28RE/AP composite element contained in the IL-2 promoter by stimulating the binding of transcription factors to these two elements. Dominant negative versions of Vav1 and PKC theta inhibited CD3/CD28-induced activation of JNK revealing their relative importance for this activation pathway, Gel filtration experiments revealed the existence of constitutively associated Vav1/PKC theta heterodimers in extracts from unstimulated T-cells, whereas T-cell costimulation induced the recruitment of Vav1 into high molecular weight, complexes. Several experimental approaches showed that Vav1 is located upstream from PKC theta in the control of the pathway leading to synergistic JNK activation. Vav1-derived signals lead to the activation of JNK by at least two different pathways. The major contribution of Vav1 for the activation of JNK relies on the PKC theta -mediated CA(2+)-independent synergistic activation pathway, whereas JNK is also activated by a separate Ca2+-dependent signaling route.	German Canc Res Ctr, Div Immunochem G0200, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Schmitz, ML (corresponding author), German Canc Res Ctr, Div Immunochem G0200, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Schmitz, M. Lienhard/D-9328-2017; Möller, Andreas/O-1063-2015	Schmitz, M. Lienhard/0000-0002-6984-7192; Möller, Andreas/0000-0002-8618-6998				Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Avraham A, 1998, EUR J IMMUNOL, V28, P2320, DOI 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO;2-K; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dienz O, 2000, J BIOL CHEM, V275, P24547, DOI 10.1074/jbc.C000177200; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hehner SP, 2000, J IMMUNOL, V164, P3829, DOI 10.4049/jimmunol.164.7.3829; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Jung S, 1995, ANN NY ACAD SCI, V766, P245, DOI 10.1111/j.1749-6632.1995.tb26672.x; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; McGuire KL, 1997, J IMMUNOL, V159, P1319; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Pacini S, 2000, EUR J IMMUNOL, V30, P2620, DOI 10.1002/1521-4141(200009)30:9<2620::AID-IMMU2620>3.0.CO;2-Q; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Salojin KV, 1999, J IMMUNOL, V163, P844; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Song JS, 1999, J IMMUNOL, V163, P802; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	42	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20022	20028		10.1074/jbc.M011139200	http://dx.doi.org/10.1074/jbc.M011139200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274147	hybrid			2022-12-27	WOS:000169135100048
J	Nishida, CR; de Montellano, PRO				Nishida, CR; de Montellano, PRO			Control of electron transfer in nitric-oxide synthases - Swapping of autoinhibitory elements among nitric-oxide synthase isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED INSECT CELLS; ESCHERICHIA-COLI; CALMODULIN-BINDING; EXPRESSION; PURIFICATION; INHIBITION; DOMAIN; IDENTIFICATION; PROTEIN; TETRAHYDROBIOPTERIN	To clarify the role of the autoinhibitory insert in the endothelial (eNOS) and neuronal (nNOS) nitric-oxide synthases, the insert was excised from nNOS and chimeras with its reductase domain; the eNOS and nNOS inserts were swapped and put into the normally insertless inducible (iNOS) isoform and chimeras with the iNOS reductase domain; and an RRKRK sequence in the insert suggested by earlier peptide studies to be important (Salerno, J. C., Harris, D. E., Irizarry, K., Patel, B., Morales, A. J., Smith, S. M., Martasek, P., Roman, L. J., Masters, B. S., Jones, C. L., Weissman, B. A., Lane, P., Liu, Q., and Gross, S. S. (1997) J. Biol. Chem. 272, 29769-29777) was mutated. Insertless nNOS required calmodulin (CaM) for normal NOS activity, but the Ca2+ requirement for this activity was relaxed. Furthermore, insert deletion enhanced CaM-free electron transfer within nNOS and chimeras with the nNOS reductase, emphasizing the involvement of the insert in modulating electron transfer. Swapping the nNOS and eNOS inserts gave proteins with normal NOS activities, and the nNOS insert acted normally in raising the Ca2+ dependence when placed in eNOS. insertion of the eNOS insert into iNOS and chimeras with the iNOS reductase domain significantly lowered NOS activity, consistent with inhibition of electron transfer by the insert. Mutation of the eNOS RRKRK to an AAAAA sequence did not alter the eNOS Ca2+ dependence but marginally inhibited electron transfer The salt dependence suggests that the insert modulates electron transfer within the reductase domain prior to the heme/reductase interface. The results clarify the role of the reductase insert in modulating the Ca2+ requirement, electron transfer rate, and overall activity of nNOS and eNOS.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ortiz@cgl.ucsf.edu			NIGMS NIH HHS [GM25515] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025515, R37GM025515] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; CHEN PF, 1994, J BIOL CHEM, V269, P25062; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; FORSTERMANN U, 1991, BIOCHEM PHARMACOL, V42, P1849, DOI 10.1016/0006-2952(91)90581-O; Fossetta JD, 1996, FEBS LETT, V379, P135, DOI 10.1016/0014-5793(95)01496-9; GARVEY EP, 1994, ARCH BIOCHEM BIOPHYS, V311, P235, DOI 10.1006/abbi.1994.1232; Gerber NC, 1997, ARCH BIOCHEM BIOPHYS, V343, P249, DOI 10.1006/abbi.1997.0187; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Huhmer AFR, 1997, CHEM RES TOXICOL, V10, P618, DOI 10.1021/tx960188t; JANSSENS SP, 1992, J BIOL CHEM, V267, P22694; JANSSENS SP, 1992, J BIOL CHEM, V267, P14519; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Komeima K, 2000, J BIOL CHEM, V275, P28139; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; MAYER B, 1990, FEBS LETT, V277, P215, DOI 10.1016/0014-5793(90)80848-D; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; Menshikova EB, 2000, BIOCHEMISTRY-MOSCOW+, V65, P409; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; NAKANE M, 1995, BIOCHEM BIOPH RES CO, V206, P511, DOI 10.1006/bbrc.1995.1073; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; Nishimura JS, 1999, J BIOL CHEM, V274, P5399, DOI 10.1074/jbc.274.9.5399; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Rafferty S, 1996, BIOCHEM BIOPH RES CO, V220, P1002, DOI 10.1006/bbrc.1996.0522; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; RIVEROSMORENO V, 1995, EUR J BIOCHEM, V230, P52; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Ruan J, 1996, J BIOL CHEM, V271, P22679, DOI 10.1074/jbc.271.37.22679; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Schrammel A, 1998, BBA-PROTEIN STRUCT M, V1387, P257, DOI 10.1016/S0167-4838(98)00138-1; SEO HG, 1995, BIOCHEM BIOPH RES CO, V208, P10, DOI 10.1006/bbrc.1995.1298; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; WOLFF DJ, 1994, ARCH BIOCHEM BIOPHYS, V314, P360, DOI 10.1006/abbi.1994.1454; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	50	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20116	20124		10.1074/jbc.M101548200	http://dx.doi.org/10.1074/jbc.M101548200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11264292	hybrid			2022-12-27	WOS:000169135100060
J	Cluzel, C; Lethias, C; Humbert, F; Garrone, R; Exposito, JY				Cluzel, C; Lethias, C; Humbert, F; Garrone, R; Exposito, JY			Characterization of fibrosurfin, an interfibrillar component of sea urchin catch connective tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL PROPEPTIDE; FIBRILLAR COLLAGEN; CUCUMBER DERMIS; EMBRYO; GENES; IDENTIFICATION; FIBROPELLINS; PROCOLLAGEN; TRANSLATION; EXPRESSION	The Sea URchin Fibrillar (SURF) domain is a four-cysteine module present in the amino-propeptide of the sea urchin 2 alpha fibrillar collagen chain. Despite numerous international genome and expressed sequence tag projects, computer searches have so far failed to identify similar domains in other species. Here, we have characterized a new sea urchin protein of 2656 amino acids made up of a series of epidermal growth factor-like and SURF modules. From its striking similarity to the modular organization of fibropellins, we called this new protein fibrosurfin. This protein is acidic with a calculated pi of 4.12, Eleven of the 17 epidermal growth factor-like domains correspond to the consensus sequence of calcium-binding type. By Western blot and immunofluorescence analyses, this protein is not detectable during embryogenesis, In adult tissues, fibrosurfin is colocalized with the amino-propeptide of the 2 alpha fibrillar collagen chain in several collagenous ligaments, i.e., test sutures, spine ligaments, peristomial membrane, and to a lesser extent, tube feet. Finally, immunogold labeling indicates that fibrosurfin is an interfibrillar component of collagenous tissues. Taken together, the data suggest that proteins possessing SURF modules are localized in the vicinity of mineralized tissues and could be responsible for the unique properties of sea urchin mutable collagenous tissues.	Univ Lyon 1, Inst Biol & Chim Prot, CNRS, UMR 5086, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Exposito, JY (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, CNRS, UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.			Cluzel, Caroline/0000-0001-8946-3439; Exposito, Jean-Yves/0000-0002-4926-4942				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY AJ, 1985, BIOL INVERTEBRATE LO, P369; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BISGROVE BW, 1993, DEV BIOL, V157, P526, DOI 10.1006/dbio.1993.1155; BISGROVE BW, 1991, DEV BIOL, V146, P89, DOI 10.1016/0012-1606(91)90449-D; BURKE RD, 1989, COMP BIOCHEM PHYS B, V94, P41, DOI 10.1016/0305-0491(89)90007-2; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; DALESSIO M, 1990, J BIOL CHEM, V265, P7050; DARDEL F, 1988, COMPUT APPL BIOSCI, V4, P483; Ellers O, 1996, P ROY SOC B-BIOL SCI, V263, P39, DOI 10.1098/rspb.1996.0007; Ellers O, 1998, BIOL BULL, V195, P136, DOI 10.2307/1542821; EXPOSITO JY, 1992, J BIOL CHEM, V267, P17404; EXPOSITO JY, 1995, EUR J BIOCHEM, V234, P59, DOI 10.1111/j.1432-1033.1995.059_c.x; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Kadler KE, 1996, BIOCHEM J, V316, P1; Koob TJ, 1999, J EXP BIOL, V202, P2291; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE B, 1991, CRIT REV EUKAR GENE, V1, P172; Lethias C, 1997, EUR J BIOCHEM, V245, P434, DOI 10.1111/j.1432-1033.1997.t01-2-00434.x; LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433; MORLE F, 1986, NUCLEIC ACIDS RES, V14, P3279, DOI 10.1093/nar/14.8.3279; Patthy L, 1996, MATRIX BIOL, V15, P301, DOI 10.1016/S0945-053X(96)90131-6; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PUCCIMINAFRA I, 1978, J SUBMICR CYTOL PATH, V10, P53; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Sambrook J., 2002, MOL CLONING LAB MANU; Sherwood DR, 1997, DEVELOPMENT, V124, P3363; SHIMIZU K, 1990, BIOCHIM BIOPHYS ACTA, V1038, P39, DOI 10.1016/0167-4838(90)90007-3; SMITH DS, 1981, TISSUE CELL, V13, P299, DOI 10.1016/0040-8166(81)90007-0; SU MW, 1991, J CELL BIOL, V115, P565, DOI 10.1083/jcb.115.2.565; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5; Wilkie I.C., 1996, Echinoderm Studies, V5, P61; Wilkie IC, 1996, BIOL BULL, V190, P237, DOI 10.2307/1542544; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	2001	276	21					18108	18114		10.1074/jbc.M009597200	http://dx.doi.org/10.1074/jbc.M009597200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	435FJ	11259425	hybrid			2022-12-27	WOS:000168866500067
J	Leonidas, DD; Boix, E; Prill, R; Suzuki, M; Turton, R; Minson, K; Swaminathan, GJ; Youle, RJ; Acharya, KR				Leonidas, DD; Boix, E; Prill, R; Suzuki, M; Turton, R; Minson, K; Swaminathan, GJ; Youle, RJ; Acharya, KR			Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN) - High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CATIONIC PROTEIN; SUBSTRATE; BINDING; RIBONUCLEASES; MECHANISM; HYDRATION; SUBSITE; RESIDUE; LINKAGE	Eosinophil-derived neurotoxin (EDN), a basic ribonuclease found in the large specific granules of eosinophils, belongs to the pancreatic RNase A family. Although its physiological function is still unclear, it has been shown that EDN is a neurotoxin capable of inducing the Gordon phenomenon in rabbits. EDN is also a potent helminthotoxin and can mediate antiviral activity of eosinophils against isolated virions of the respiratory syncytial virus. EDN is a catalytically efficient RNase sharing similar substrate specificity with pancreatic RNase A with its ribonucleolytic activity being absolutely essential for its neurotoxic, helminthotoxic, and antiviral activities. The crystal structure of recombinant human EDN in the unliganded form has been determined previously (Mosimann, S. C., Newton, D. L., Youle, R. J., and James, M. N. G. (1996) J. Mol. Biol. 260, 540-552). We have now determined high resolution (1.8 Angstrom) crystal structures for EDN in complex with adenosine-3',5'-diphosphate (3',5'-ADP), adenosine-2',5'-diphosphate (2',5'-ADP), adenosine-5'-diphosphate (5'-ADP) as well as for a native structure in the presence of sulfate refined at 1.6 Angstrom. The inhibition constant of these mononucleotides for EDN has been determined. The structures present the first detailed picture of differences between EDN and RNase A in substrate recognition at the ribonucleolytic active site. They also provide a starting point for the design of tight-binding inhibitors, which may be used to restrain the RNase activity of EDN.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	University of Bath; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk	Boix, Ester/B-9038-2012; Leonidas, Demetres/F-7228-2013; Leonidas, Demetres/AAE-9296-2021	Boix, Ester/0000-0003-1790-2142; Leonidas, Demetres/0000-0002-3874-2523; Leonidas, Demetres/0000-0002-3874-2523; Swaminathan, Jawahar/0000-0002-0215-4084; Turton, Kathryn/0000-0002-1421-3504; Acharya, K. Ravi/0000-0002-3009-4058	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002674, ZIANS002674] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERMAN SJ, 1983, J IMMUNOL, V52, P611; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEINTEMA JJ, 1988, PROG BIOPHYS MOL BIO, V51, P165, DOI 10.1016/0079-6107(88)90001-6; Berisio R, 1999, J MOL BIOL, V292, P845, DOI 10.1006/jmbi.1999.3093; BIRDSALL DL, 1992, J BIOL CHEM, V267, P22230; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 1999, J BIOL CHEM, V274, P15605, DOI 10.1074/jbc.274.22.15605; BOIX E, 1994, J BIOL CHEM, V269, P2529; BORKAKOTI N, 1983, EUR J BIOCHEM, V132, P89, DOI 10.1111/j.1432-1033.1983.tb07329.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Cuchillo C. M., 1997, RIBONUCLEASES STRUCT, P271; DEMEL VSJ, 1992, J BIOL CHEM, V267, P247; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; EFTINK MR, 1987, HYDROLYTIC ENZYMES, V7, P333; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; Fedorov AA, 1996, BIOCHEMISTRY-US, V35, P15962, DOI 10.1021/bi961533g; Fisher BM, 1998, J BIOL CHEM, V273, P34134, DOI 10.1074/jbc.273.51.34134; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GILLILAND GL, 1997, RIBONUCLEASES STRUCT, P305; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; IMAZAWA M, 1968, J BIOCHEM-TOKYO, V64, P595, DOI 10.1093/oxfordjournals.jbchem.a128936; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonidas DD, 1997, BIOCHEMISTRY-US, V36, P5578, DOI 10.1021/bi9700330; Leonidas DD, 1999, BIOCHEMISTRY-US, V38, P10287, DOI 10.1021/bi990900w; LOFFLER A, 1998, BIOCHEMISTRY-US, V35, P12005; MATTOS C, 1994, NAT STRUCT BIOL, V1, P55, DOI 10.1038/nsb0194-55; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCPHERSON A, 1986, SCIENCE, V232, P765, DOI 10.1126/science.3961503; MOISEEV GP, 1982, BIOORG KHIM+, V8, P1197; MOODIE SL, 1993, NUCLEIC ACIDS RES, V21, P1369, DOI 10.1093/nar/21.6.1369; Mosimann SC, 1996, J MOL BIOL, V260, P540, DOI 10.1006/jmbi.1996.0420; NEWTON DL, 1994, J BIOL CHEM, V269, P26739; NEWTON DL, 1994, J NEUROSCI, V14, P538; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nogues MV, 1998, CELL MOL LIFE SCI, V54, P766, DOI 10.1007/s000180050205; OIKONOMAKOS NG, 1995, J MOL BIOL, V254, P900, DOI 10.1006/jmbi.1995.0665; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RICHARDS FM, 1971, ENZYMES, V4, P647; Rosenberg HF, 1998, CELL MOL LIFE SCI, V54, P795, DOI 10.1007/s000180050208; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; Russo N, 1999, J BIOL CHEM, V274, P14902, DOI 10.1074/jbc.274.21.14902; Russo N, 1997, BIOCHEM BIOPH RES CO, V231, P671, DOI 10.1006/bbrc.1997.6167; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; SNYDER MR, 1997, RIBONUCLEASES STRUCT, P425; SORRENTINO S, 1992, J BIOL CHEM, V267, P14859; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Toiron C, 1996, PROTEIN SCI, V5, P1633, DOI 10.1002/pro.5560050817; ZEGERS I, 1994, PROTEIN SCI, V3, P2322, DOI 10.1002/pro.5560031217	61	39	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15009	15017		10.1074/jbc.M010585200	http://dx.doi.org/10.1074/jbc.M010585200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11154698	hybrid			2022-12-27	WOS:000168528800066
J	Medina, M; Luquita, A; Tejero, J; Hermoso, J; Mayoral, T; Sanz-Aparicio, J; Grever, K; Gomez-Moreno, C				Medina, M; Luquita, A; Tejero, J; Hermoso, J; Mayoral, T; Sanz-Aparicio, J; Grever, K; Gomez-Moreno, C			Probing the determinants of coenzyme specificity in ferredoxin-NADP(+) reductase by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PHTHALATE DIOXYGENASE REDUCTASE; ANABAENA SP PCC-7119; NADP+ REDUCTASE; ELECTRON-TRANSFER; SPINACH FERREDOXIN; ISOCITRATE DEHYDROGENASE; LACTATE-DEHYDROGENASE; COFACTOR SPECIFICITY; CATALYTIC MECHANISM	On the basis of sequence and three-dimensional structure comparison between Anabaena PCC7119 ferredoxin-NADP(+) reductase (FNR) and other reductases from its structurally related family that bind either NADP(+)/H or NAD(+)/H, a set of amino acid residues that might determine the FNR coenzyme specificity can be assigned, These residues include Thr-155, Ser-223, Arg-224, Arg-233 and Tyr-285. Systematic replacement of these amino acids was done to identify which of them are the main determinants of coenzyme specificity. Our data indicate that all of the residues interacting with the 2'-phosphate of NADP(+)/H in Anabaena FNR are not involved to the same extent in determining coenzyme specificity and affinity. Thus, it is found that Ser-223 and Tyr-235 are important for determining NADP(+)/H specificity and orientation with respect to the protein, whereas Arg-224 and Arg-233 provide only secondary interactions in Anabaena FNR. The analysis of the T155G FNR form also indicates that the determinants of coenzyme specificity are not only situated in the 2'-phosphate NADP(+)/H interacting region but that other regions of the protein must be involved. These regions, although not interacting directly with the coenzyme, must produce specific structural arrangements of the backbone chain that determine coenzyme specificity. The loop formed by residues 261-268 in Anabaena FNR must be one of these regions.	Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, E-28006 Madrid, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Medina, M (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.	mmedina@posta.unizar.es	Medina, Milagros/F-8310-2012; Tejero, Jesus/G-3953-2017; Hermoso, Juan/J-3433-2012; Sanz-Aparicio, Julia/F-6201-2013	Medina, Milagros/0000-0001-8743-0182; Tejero, Jesus/0000-0003-3245-9978; Hermoso, Juan/0000-0002-1862-8950; Sanz-Aparicio, Julia/0000-0002-6849-8621				Aliverti A, 1998, J BIOL CHEM, V273, P34008, DOI 10.1074/jbc.273.51.34008; ALIVERTI A, 1991, J BIOL CHEM, V266, P17760; ALIVERTI A, 1995, BIOCHEMISTRY-US, V34, P8371, DOI 10.1021/bi00026a019; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATIE CJ, 1984, J BIOL CHEM, V259, P1976; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; Brunger A. T., 1993, XPLOR SYSTEM XRAY CR; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; CASTELLANO EE, 1992, J APPL CRYSTALLOGR, V25, P281, DOI 10.1107/S0021889891012773; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; CHEN Z, 1991, EUR J BIOCHEM, V202, P263, DOI 10.1111/j.1432-1033.1991.tb16371.x; CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P101, DOI 10.1016/0968-0004(89)90131-X; CORRELL CC, 1992, SCIENCE, V258, P1604, DOI 10.1126/science.1280857; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; Didierjean C, 1997, J MOL BIOL, V268, P739, DOI 10.1006/jmbi.1997.0998; FAN F, 1991, BIOCHEMISTRY-US, V30, P6397, DOI 10.1021/bi00240a008; FILLAT MF, 1990, NUCLEIC ACIDS RES, V18, P7161, DOI 10.1093/nar/18.23.7161; Friesen JA, 1996, BIOCHEMISTRY-US, V35, P11945, DOI 10.1021/bi9609937; GOMEZMORENO C, 1995, PHOT LIGHT BIOSPH, P627; HALL AV, 1994, J BIOL CHEM, V269, P33082; HEDSTROM L, 1994, CURR OPIN STRUC BIOL, V4, P608, DOI 10.1016/S0959-440X(94)90225-9; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; Hurley JK, 1996, J AM CHEM SOC, V118, P5526, DOI 10.1021/ja953662a; HYDE GE, 1990, BIOCHEM BIOPH RES CO, V168, P1285, DOI 10.1016/0006-291X(90)91168-R; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KARPLUS PA, 1984, BIOCHEMISTRY-US, V23, P6576, DOI 10.1021/bi00321a046; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1987, P CCP4 STUD WEEK SER, P39; LONG DM, 1992, PHYSIOL PLANTARUM, V85, P561, DOI 10.1111/j.1399-3054.1992.tb04755.x; Madoz-Gurpide J, 2000, J AM CHEM SOC, V122, P9808, DOI 10.1021/ja001365m; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P17680, DOI 10.1021/bi981718i; Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y; MEDINA M, 1992, FEBS LETT, V298, P25, DOI 10.1016/0014-5793(92)80014-8; MEDINA M, 1992, ARCH BIOCHEM BIOPHYS, V299, P281, DOI 10.1016/0003-9861(92)90276-3; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Nakanishi M, 1997, J BIOL CHEM, V272, P2218, DOI 10.1074/jbc.272.4.2218; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEWMAN BJ, 1988, PLANT MOL BIOL, V10, P511, DOI 10.1007/BF00033606; NISHIDA H, 1995, BIOCHEMISTRY-US, V34, P2763, DOI 10.1021/bi00009a004; ORELLANO EG, 1993, J BIOL CHEM, V268, P19267; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; OZOLS J, 1985, J BIOL CHEM, V260, P1953; Piubelli L, 2000, J BIOL CHEM, V275, P10472, DOI 10.1074/jbc.275.14.10472; PORTER TD, 1985, P NATL ACAD SCI USA, V82, P973, DOI 10.1073/pnas.82.4.973; PUEYO JJ, 1991, PREP BIOCHEM, V21, P191, DOI 10.1080/10826069108018571; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SANCHO J, 1991, ARCH BIOCHEM BIOPHYS, V288, P231, DOI 10.1016/0003-9861(91)90189-P; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SEM DS, 1993, BIOCHEMISTRY-US, V32, P11548, DOI 10.1021/bi00094a011; Serre L, 1996, J MOL BIOL, V263, P20, DOI 10.1006/jmbi.1996.0553; WALKER MC, 1991, ARCH BIOCHEM BIOPHYS, V287, P351, DOI 10.1016/0003-9861(91)90489-6; YAOI T, 1994, FEBS LETT, V355, P171, DOI 10.1016/0014-5793(94)01191-5; ZANETTI G, 1979, BIOCHIM BIOPHYS ACTA, V568, P127, DOI 10.1016/0005-2744(79)90280-8; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1; Zubay G, 1998, BIOCHEMISTRY	62	54	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11902	11912		10.1074/jbc.M009287200	http://dx.doi.org/10.1074/jbc.M009287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152461	hybrid			2022-12-27	WOS:000168081800064
J	Tamar, S; Papadopoulou, B				Tamar, S; Papadopoulou, B			A telomere-mediated chromosome fragmentation approach to assess mitotic stability and ploidy alterations of Leishmania chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; MAMMALIAN ARTIFICIAL CHROMOSOMES; CHAIN DEHYDROGENASE GENE; HOMOLOGOUS RECOMBINATION; TRYPANOSOMA-BRUCEI; SACCHAROMYCES-CEREVISIAE; METHOTREXATE RESISTANCE; TRYPANOTHIONE REDUCTASE; PARASITIC PROTOZOA; DNA-SEQUENCE	We have used a telomere-associated chromosome fragmentation strategy to induce internal chromosome-specific breakage of Leishmania chromosomes. The integration of telomeric repeats from the kinetoplastid Trypanosoma brucei into defined positions of the Leishmania genome by homologous recombination can induce chromosome breakage accompanied by the deletion of the chromosomal part that is distal to the site of the break. The cloned telomeric DNA at the end of the truncated chromosomes is functional and it can seed the formation of new telomeric repeats. We found that genome ploidy is often altered upon telomere-mediated chromosome fragmentation events resulting in large chromosomal deletions. In most cases diploidy is either preserved, or partial trisomic cells are observed, but interestingly we report here the generation of partial haploid mutants in this diploid organism. Partial haploid Leishmania mutants should facilitate studies on the function of chromosome-assigned genes. We also present several lines of evidence for the presence of sequences involved in chromosome mitotic stability and segregation during cell cycle in this parasitic protozoan. Telomere-directed chromosome fragmentation studies in Leishmania may constitute a useful tool to assay for centromere function.	CHU Laval, CHUQ, Ctr Rech, Ctr Rech Infectiol, Ste Foy, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Dept Med Biol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Papadopoulou, B (corresponding author), CHU Laval, CHUQ, Ctr Rech, Ctr Rech Infectiol, 2705 Blvd Laurier, Ste Foy, PQ G1V 4G2, Canada.	Papadopoulou@crchul.ulaval.ca						BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; BELMAAZA A, 1994, MUTAT RES, V314, P199, DOI 10.1016/0921-8777(94)90065-5; BERINSTEIN N, 1992, MOL CELL BIOL, V12, P360, DOI 10.1128/MCB.12.1.360; BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Brown W, 1996, CURR OPIN GENET DEV, V6, P281, DOI 10.1016/S0959-437X(96)80003-7; Brown WRA, 1992, CURR OPIN GENET DEV, V2, P479, DOI 10.1016/S0959-437X(05)80161-3; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165; Cano MIN, 1999, P NATL ACAD SCI USA, V96, P3616, DOI 10.1073/pnas.96.7.3616; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chiurillo MA, 2000, EXP PARASITOL, V94, P248, DOI 10.1006/expr.2000.4499; CROSS S, 1990, NUCLEIC ACIDS RES, V18, P6649, DOI 10.1093/nar/18.22.6649; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; ELLIS J, 1988, MOL BIOCHEM PARASIT, V29, P9, DOI 10.1016/0166-6851(88)90114-4; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FARR CJ, 1992, NAT GENET, V2, P275, DOI 10.1038/ng1292-275; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; Farr CJ, 1996, SEMIN CELL DEV BIOL, V7, P41, DOI 10.1006/scdb.1996.0007; FLINT J, 1994, AM J HUM GENET, V55, P505; Fu GL, 1998, NUCLEIC ACIDS RES, V26, P2161, DOI 10.1093/nar/26.9.2161; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; Ivens AC, 1998, GENOME RES, V8, P135, DOI 10.1101/gr.8.2.135; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; LABAN A, 1990, NATURE, V343, P572, DOI 10.1038/343572a0; Lamontagne J, 1999, J BIOL CHEM, V274, P6602, DOI 10.1074/jbc.274.10.6602; LANZER M, 1995, MOL BIOCHEM PARASIT, V70, P1, DOI 10.1016/0166-6851(95)00021-R; LARSON DD, 1987, CELL, V50, P477, DOI 10.1016/0092-8674(87)90501-0; Lee MGS, 1995, NUCLEIC ACIDS RES, V23, P4893, DOI 10.1093/nar/23.23.4893; LEGARE D, 1994, MOL BIOCHEM PARASIT, V68, P81, DOI 10.1016/0166-6851(94)00156-1; MA DP, 1992, GENE, V119, P253, DOI 10.1016/0378-1119(92)90279-X; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; Morrow DM, 1997, GENETICS, V147, P371; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; Muyombwe A, 1997, EXP PARASITOL, V85, P35, DOI 10.1006/expr.1996.4115; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Papadopoulou B, 1996, BIOCHEM BIOPH RES CO, V224, P772, DOI 10.1006/bbrc.1996.1098; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P7310; Patnaik PK, 1996, NUCLEIC ACIDS RES, V24, P668, DOI 10.1093/nar/24.4.668; PATNAIK PK, 1993, EMBO J, V12, P2529, DOI 10.1002/j.1460-2075.1993.tb05908.x; PAYS E, 1983, NUCLEIC ACIDS RES, V11, P8137, DOI 10.1093/nar/11.23.8137; PENNINGTON SL, 1991, P NATL ACAD SCI USA, V88, P9498, DOI 10.1073/pnas.88.21.9498; PLASTERK RHA, 1992, EMBO J, V11, P287, DOI 10.1002/j.1460-2075.1992.tb05051.x; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Ravel C, 1995, MOL BIOCHEM PARASIT, V74, P31, DOI 10.1016/0166-6851(95)02480-8; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sambrook J., 2002, MOL CLONING LAB MANU; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SMITH DR, 1992, METHOD ENZYMOL, V216, P603; SUROSKY RT, 1985, P NATL ACAD SCI USA, V82, P2106, DOI 10.1073/pnas.82.7.2106; Tamar S, 2000, MOL BIOCHEM PARASIT, V111, P401, DOI 10.1016/S0166-6851(00)00337-6; TOBIN JF, 1991, P NATL ACAD SCI USA, V88, P864, DOI 10.1073/pnas.88.3.864; VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; WHITE TC, 1988, J BIOL CHEM, V263, P16977; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0	80	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11662	11673		10.1074/jbc.M009006200	http://dx.doi.org/10.1074/jbc.M009006200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152684	hybrid			2022-12-27	WOS:000168081800034
J	Darling, RJ; Wilken, JA; Miller-Lindbolm, AK; Urlacher, TM; Ruddon, RW; Sherman, SA; Bedows, E				Darling, RJ; Wilken, JA; Miller-Lindbolm, AK; Urlacher, TM; Ruddon, RW; Sherman, SA; Bedows, E			Functional contributions of noncysteine residues within the cystine knots of human chorionic gonadotropin subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HAMSTER OVARY CELLS; ALPHA-BETA-DIMER; DISULFIDE FOLDING PATHWAY; CYSTEINE RESIDUES; GROWTH-FACTOR; BIOLOGICAL-ACTIVITY; SECRETORY PATHWAY; CRYSTAL-STRUCTURE; MUTATIONS AFFECT	Human chorionic gonadotropin (hCG) is a heterodimeric member of a family of cystine knot-containing proteins that contain the consensus sequences Cys-X-1-Gly-X-2-Cys and Cys-X-3-Cys. Previously, we characterized the contributions that cystine residues of the hCG subunit cystine knots make in folding, assembly, and bioactivity. Here, we determined the contributions that noncysteine residues make in hCG folding, secretion, and assembly. When the X-1, X-2, and X-3 residues of hGC-alpha and -beta were substituted by swapping their respective cystine knot moths, the resulting chimeras appeared to fold correctly and were efficiently secreted. However, assembly of the chimeras with their wild type partner was almost completely abrogated. No single amino acid substitution completely accounted for the assembly inhibition, although the X-2 residue made the greatest individual contribution. Analysis by tryptic mapping, high performance liquid chromatography, and SDS-polyacrylamide gel electrophoresis revealed that substitution of the central Gly in the Cys-X-1-Gly-X-2-Cys sequence of either the alpha- or beta -subunit cystine knot resulted in non-native disulfide bond formation and subunit misfolding. This occurred even when the most conservative change possible (Gly --> Ala) was made. From these studies we conclude that all three "X" residues within the hCG cystine knots are collectively, but not individually, required for the formation of assembly-competent hCG subunits and that the invariant Gly residue is required for efficient cystine knot formation and subunit folding.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Bedows, E (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.			Lindholm-Perry, Amanda/0000-0002-5555-118X	NATIONAL CANCER INSTITUTE [P30CA036727, R01CA032949] Funding Source: NIH RePORTER; NCI NIH HHS [CA32949, P30 CA36727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AZUMA C, 1990, J MOL ENDOCRINOL, V5, P97, DOI 10.1677/jme.0.0050097; BEDOWS E, 1992, J BIOL CHEM, V267, P8880; BEDOWS E, 1994, J BIOL CHEM, V269, P10574; BEDOWS E, 1993, J BIOL CHEM, V268, P11655; BEEBE JS, 1990, J BIOL CHEM, V265, P312; Brewer JW, 1996, J CELL SCI, V109, P2383; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; CHANG JY, 1995, J BIOL CHEM, V270, P9207, DOI 10.1074/jbc.270.16.9207; CHANG JY, 1994, J BIOL CHEM, V269, P22087; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; CORLESS CL, 1987, J BIOL CHEM, V262, P14197; Darling RJ, 2000, J BIOL CHEM, V275, P15413, DOI 10.1074/jbc.275.20.15413; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Erbel PJA, 1999, EUR J BIOCHEM, V260, P490, DOI 10.1046/j.1432-1327.1999.00188.x; FARLING RJ, 2001, BIOCHEMISTRY-US, V40, P577; FURUHASHI M, 1994, J BIOL CHEM, V269, P25543; GIESE NA, 1987, SCIENCE, V236, P1315, DOI 10.1126/science.3035718; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; HUTH JR, 1992, J BIOL CHEM, V267, P8870; HUTH JR, 1993, J BIOL CHEM, V268, P16472; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Jackson AM, 1999, MOL ENDOCRINOL, V13, P2175, DOI 10.1210/me.13.12.2175; KIKUCHI T, 1994, MOL CELL ENDOCRINOL, V102, P1, DOI 10.1016/0303-7207(94)90090-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Miyai K, 1998, ENDOCR J, V45, P467, DOI 10.1507/endocrj.45.467; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PETERS BP, 1989, ENDOCRINOLOGY, V124, P1602, DOI 10.1210/endo-124-4-1602; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sato A, 1997, J BIOL CHEM, V272, P18098, DOI 10.1074/jbc.272.29.18098; SUGANUMA N, 1989, J BIOL CHEM, V264, P19302; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	39	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10692	10699		10.1074/jbc.M010168200	http://dx.doi.org/10.1074/jbc.M010168200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134053	hybrid			2022-12-27	WOS:000167980900019
J	Krishna, S; Woodrow, C; Webb, R; Penny, J; Takeyasu, K; Kimura, M; East, JM				Krishna, S; Woodrow, C; Webb, R; Penny, J; Takeyasu, K; Kimura, M; East, JM			Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; MEMBRANE CA2+ PUMP; P-TYPE ATPASE; CALCIUM PUMPS; INFECTED ERYTHROCYTES; TRANSMEMBRANE DOMAIN; CYCLOPIAZONIC ACID; CATION ATPASE; AMINO-ACIDS; THAPSIGARGIN	We have obtained a full-length P type ATPase sequence (PfATP4) encoded by Plasmodium falciparum and expressed PfATP4 in Xenopus laevis oocytes to study its function. Comparison of the hitherto incomplete open reading frame with other Ca2+-ATPase sequences reveals that PfATP4 differs significantly from previously defined categories. The Ca2+-dependent ATPase activity of PfATP4 is stimulated by a much broader: range of [Ca2+](free) (3.2-320 muM) than are an avian SERCA1 pump or rabbit SERCA 1a (maximal activity < 10 <mu>M). The activity of PfATP4 is resistant to inhibition by ouabain (200 muM) or thapsigargin (0.8 muM) but is inhibited by vanadate (1 mM) or cyclopiazonic acid (1 muM). We used a quantitative polymerase chain reaction to assay expression of mRNA encoding PfATP4 relative to that for beta -tubulin in synchronized asexual stages and found variable expression throughout the life cycle with a maximal 5-fold increase in meronts compared with ring stages. This analysis suggests that PfATP4 defines a novel subclass of Ca2+-ATPases unique to apicomplexan organisms and therefore offers potential as a drug target.	St George Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England; Kyoto Univ, Fac Integrated Human Studies, Sakyo Ku, Kyoto 606, Japan; Osaka City Univ, Sch Med, Biophys Lab, Abeno Ku, Osaka 5458585, Japan; Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton S016 7PX, Hants, England	St Georges University London; Kyoto University; Osaka Metropolitan University; University of Southampton	Krishna, S (corresponding author), St George Hosp, Sch Med, Dept Infect Dis, Cranmer Terrace, London SW17 0RE, England.	s.krishna@sghms.ac.uk		Woodrow, Charles/0000-0002-5134-7165; Krishna, Sanjeev/0000-0003-0066-0634				ADOVELANDE J, 1993, EXP PARASITOL, V76, P247, DOI 10.1006/expr.1993.1030; ALLEVA LM, 2000, MOL APPROACHES MALAR, P54; ANSAH TA, 1984, J BIOL CHEM, V259, P3442; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Dyer M, 1996, MOL BIOCHEM PARASIT, V78, P1, DOI 10.1016/S0166-6851(96)02593-5; East J M, 1994, Methods Mol Biol, V27, P87; Garcia CRS, 1996, EUR J CELL BIOL, V71, P409; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Guerini D, 1996, BIOCHEMISTRY-US, V35, P3290, DOI 10.1021/bi952572f; ISHII T, 1993, P NATL ACAD SCI USA, V90, P8881, DOI 10.1073/pnas.90.19.8881; ISHII T, 1994, P NATL ACAD SCI USA, V91, P6103, DOI 10.1073/pnas.91.13.6103; KIMURA M, 1993, J CELL SCI, V104, P1129; KRISHNA S, 1990, PARASITOL TODAY, V6, P196, DOI 10.1016/0169-4758(90)90356-9; KRISHNA S, 1994, EXP PARASITOL, V78, P113, DOI 10.1006/expr.1994.1011; Krishna S, 1997, BMJ-BRIT MED J, V315, P730, DOI 10.1136/bmj.315.7110.730; KRISHNA S, 1993, J CELL BIOL, V120, P385, DOI 10.1083/jcb.120.2.385; KRISHNA S, 1999, TRANSPORT TRAFFICKIN, V226, P126; LAFAIRE AV, 1986, J MEMBRANE BIOL, V91, P43, DOI 10.1007/BF01870213; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; NORREGAARD A, 1994, J BIOL CHEM, V269, P26598; Pittman JK, 1999, GENE, V236, P137, DOI 10.1016/S0378-1119(99)00242-5; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sorin A, 1997, J BIOL CHEM, V272, P9895; Staines HM, 1999, J MEMBRANE BIOL, V172, P13, DOI 10.1007/s002329900579; Tiffert T, 2000, J PHYSIOL-LONDON, V525, P125, DOI 10.1111/j.1469-7793.2000.00125.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TROTTEIN F, 1995, GENE, V158, P133, DOI 10.1016/0378-1119(95)00158-3; TROTTEIN F, 1995, EUR J BIOCHEM, V227, P214, DOI 10.1111/j.1432-1033.1995.tb20379.x; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Zhu G, 1997, MOL BIOCHEM PARASIT, V90, P307, DOI 10.1016/S0166-6851(97)00168-0	38	76	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10782	10787		10.1074/jbc.M010554200	http://dx.doi.org/10.1074/jbc.M010554200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145964	hybrid			2022-12-27	WOS:000167980900031
J	Gangar, A; Karande, AA; Rajasekharan, R				Gangar, A; Karande, AA; Rajasekharan, R			Isolation and localization of a cytosolic 10 S triacylglycerol biosynthetic multienzyme complex from oleaginous yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; SACCHAROMYCES-CEREVISIAE; DIHYDROXYACETONE PHOSPHATE; ACID-PHOSPHATASE; ESCHERICHIA-COLI; RAT-LIVER; ACYLTRANSFERASE; PURIFICATION; METABOLISM; MEMBRANES	Triacylglycerol is one of the major storage forms of metabolic energy in eukaryotic cells. Biosynthesis of triacylglycerol is known to occur in membranes. We report here the isolation, purification, and characterization of a catalytically active cytosolic 10 S multienzyme complex for triacylglycerol biosynthesis from Rhodotorula glutinis during exponential growth. The complex was characterized and was found to contain lysophosphatidic acid acyltransferase, phosphatidic acid phosphatase, diacylglycerol acyltransferase, acyl-acyl carrier protein synthetase, and acyl carrier protein. The 10 S triacylglycerol biosynthetic complex rapidly incorporates free fatty acids as well as fatty acyl-coenzyme A into triacylglycerol and its biosynthetic intermediates, Lysophosphatidic acid acyltransferase, phosphatidic acid phosphatase, and diacylglycerol acyltransferase from the complex were microsequenced. Antibodies were raised against the synthetic peptides corresponding to lysophosphatidic acid acyltransferase and phosphatidic acid phosphatase sequences. Immunoprecipitation and immunolocalization studies show the presence of a cytosolic multienzyme complex for triacylglycerol biosynthesis, Chemical cross-linking studies revealed that the 10 S multienzyme complex was held together by protein-protein interactions. These results demonstrate that the cytosol is one of the sites for triacylglycerol biosynthesis in oleaginous yeast.	Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.		R, Rajasekharan/D-3420-2009; Rajasekharan, Ram/R-2257-2019	Rajasekharan, Ram/0000-0002-2124-6013				AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; BERGFELD R, 1978, PLANTA, V143, P297, DOI 10.1007/BF00392002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Engvall E, 1980, Methods Enzymol, V70, P419; FRITZ PJ, 1986, J BIOL CHEM, V261, P194; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Hiroyama R, 1999, J BIOL CHEM, V274, P29172, DOI 10.1074/jbc.274.41.29172; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; ICHIHARA K, 1990, BIOCHIM BIOPHYS ACTA, V1043, P227, DOI 10.1016/0005-2760(90)90021-O; JACKOWSKI S, 1992, METHOD ENZYMOL, V209, P111; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; KANOH H, 1983, J BIOL CHEM, V258, P1767; Kates M., 1986, TECHNIQUES LIPIDOLOG, P100; KENNEDY EP, 1961, FED PROC, V20, P934; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KENT C, 1991, FASEB J, V5, P2258, DOI 10.1096/fasebj.5.9.1860617; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPETINA EG, 1971, BIOCHEM J, V122, P171; MURPHY DJ, 1988, LIPIDS, V23, P157, DOI 10.1007/BF02535452; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NOVICK D, 1987, J BIOL CHEM, V262, P8483; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; PALTAUF F, 1992, MOL CELLULAR BIOL YE, V2, P415; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; Pillai MG, 1998, BBA-LIPID LIPID MET, V1393, P128, DOI 10.1016/S0005-2760(98)00069-1; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; ROCK CO, 1980, ANAL BIOCHEM, V102, P362, DOI 10.1016/0003-2697(80)90168-2; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Stymne S., 1987, Biochemistry of Plants, V9, P175; SUNDLER R, 1975, J BIOL CHEM, V250, P8585; SUZUKI O, 1988, P WORLD C BIOT FATS, P110; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WEBBER KO, 1992, METHOD ENZYMOL, V209, P92; WEETE JD, 1980, LIPID BIOCH FUNGI OT, P16; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	41	35	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10290	10298		10.1074/jbc.M009550200	http://dx.doi.org/10.1074/jbc.M009550200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139581	hybrid			2022-12-27	WOS:000167996400094
J	Padovani, D; Mulliez, E; Fontecave, M				Padovani, D; Mulliez, E; Fontecave, M			Activation of class III ribonucleotide reductase by thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CENTER; ESCHERICHIA-COLI; S-ADENOSYLMETHIONINE; PROTEIN; CATALYSIS	Anaerobic ribonucleotide reductase provides facultative and obligate anaerobic microorganisms with the deoxyribonucleoside triphosphates used for DNA chain elongation and repair. In Escherichia coli, the dimeric alpha2 enzyme contains, in its active form, a glycyl radical essential for the reduction of the substrate, The introduction of the glycyl radical results from the reductive cleavage of S-adenosylmethionine catalyzed by the reduced (4Fe-4S) center of a small activating protein called beta. This activation reaction has long been known to have an absolute requirement for dithiothreitol, Here, we report that thioredoxin, along with NADPH and NADPH:thioredoxin oxidoreductase, efficiently replaces dithiothreitol and reduces an unsuspected critical disulfide bond probably located on the C terminus of the alpha protein, Activation of reduced alpha protein does not require dithiothreitol or thioredoxin anymore, and activation rates are much faster than previously reported. Thus, in E, coli, thioredoxin has very different roles for class I ribonucleotide reductase where it is required for the substrate turnover and class III ribonucleotide reductase where it acts only for the activation of the enzyme.	Univ Grenoble 1, CNRS, CEA,Lab Chim & Biochim, Dept Biol Mol & Struct Chim Biol,Ctr Redox Biol, F-38054 Grenoble 09, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mulliez, E (corresponding author), Univ Grenoble 1, CNRS, CEA,Lab Chim & Biochim, Dept Biol Mol & Struct Chim Biol,Ctr Redox Biol, 17 Ave Martyrs, F-38054 Grenoble 09, France.		Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801				Andersson J, 2000, J BIOL CHEM, V275, P19449, DOI 10.1074/jbc.M001278200; ANDERSSON J, 2000, THESIS STOCKHOLM U E; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ELIASSON R, 1992, J BIOL CHEM, V267, P25541; FONTECAVE M, 1999, B12, P731; HARDER J, 1992, J BIOL CHEM, V267, P25548; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Lawrence CC, 1999, P NATL ACAD SCI USA, V96, P8979, DOI 10.1073/pnas.96.16.8979; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; MULLIEZ E, 2001, IN PRESS BIOCHEMISTR; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Ollagnier S, 1999, J AM CHEM SOC, V121, P6344, DOI 10.1021/ja990073m; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291	21	20	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9587	9589		10.1074/jbc.C000895200	http://dx.doi.org/10.1074/jbc.C000895200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11266436	hybrid			2022-12-27	WOS:000167996400002
J	Pak, J; Pu, YB; Zhang, ZT; Hasty, DL; Wu, XR				Pak, J; Pu, YB; Zhang, ZT; Hasty, DL; Wu, XR			Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY-TRACT INFECTION; ASYMMETRIC UNIT MEMBRANE; UROTHELIAL DIFFERENTIATION; FUNCTIONAL-HETEROGENEITY; UROEPITHELIAL CELLS; STRUCTURAL-ANALYSIS; MUCOSAL DEFENSE; MOLECULAR-BASIS; FIMH-ADHESIN; GLYCOPROTEIN	The adherence of uropathogenic Escherichia coli to the urothelial surface, a critical first step in the pathogenesis of urinary tract infection (UTI), is controlled by three key elements: E, coli adhesins, host receptors, and host defense mechanisms. Although much has been learned about E. coli adhesins and their urothelial receptors, little is known about the role of host defense in the adherence process, Here we show that Tamm-Horsfall protein (THP) is the principal urinary protein that binds specifically to type 1 fimbriated E. coli, the main cause of UTI, The binding was highly specific and saturable and could be inhibited by D-mannose and abolished by endoglycosidase H treatment of THP, suggesting that the binding is mediated by the high-mannose moieties of THP, It is species-conserved, occurring in both human and mouse THPs. In addition, the binding to THP was much greater with an E, coli strain bearing a phenotypic variant of the type 1 fimbrial FimH adhesin characteristic of those prevalent in UTI isolates compared with the one prevalent in isolates from the large intestine of healthy individuals, Finally, a physiological concentration of THP completely abolished the binding of type 1 fimbriated E. coli to uroplakins Ia and Ib, two putative urothelial receptors for type 1 fimbriae, These results establish, on a functional level, that THP contains conserved high-mannose moieties capable of specific interaction with type 1 fimbriae and strongly suggest that this major urinary glycoprotein is a key urinary anti-adherence factor serving to prevent type 1 fimbriated E, coli from binding to the urothelial receptors.	NYU, Sch Med, Kaplan Comprehens Canc Ctr, Dept Urol, New York, NY 10016 USA; Vet Affairs Med Ctr, New York, NY 10010 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, Dept Microbiol, New York, NY 10016 USA; Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Vet Affairs Med Ctr, Memphis, TN 38104 USA	New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); New York University; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Wu, XR (corresponding author), NYU, Sch Med, Kaplan Comprehens Canc Ctr, Dept Urol, 550 1st Ave,Rm Skirball 10U, New York, NY 10016 USA.	xue-ru.wu@med.ny.edu		Wu, Xue-Ru/0000-0001-6058-6291	NIAID NIH HHS [1R01AI42886-01A1] Funding Source: Medline; NIDDK NIH HHS [1R01DK56903-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFONSO AMM, 1981, CARBOHYD RES, V89, P309, DOI 10.1016/S0008-6215(00)85256-8; CLEGG S, 1982, INFECT IMMUN, V38, P739, DOI 10.1128/IAI.38.2.739-744.1982; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; DALLOLIO F, 1988, CARBOHYD RES, V178, P327, DOI 10.1016/0008-6215(88)80123-X; EISENSTEIN BI, 1988, REV INFECT DIS, V10, pS341; FLETCHER AP, 1970, BIOCHEM J, V120, P417, DOI 10.1042/bj1200417; FOXMAN B, 1995, J INFECT DIS, V171, P1514, DOI 10.1093/infdis/171.6.1514; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; FUJITA K, 1989, INFECT IMMUN, V57, P2574, DOI 10.1128/IAI.57.8.2574-2579.1989; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HICKS RM, 1969, NATURE, V224, P1304, DOI 10.1038/2241304a0; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; HULL RA, 1981, INFECT IMMUN, V33, P933, DOI 10.1128/IAI.33.3.933-938.1981; IWAHI T, 1983, INFECT IMMUN, V39, P1307, DOI 10.1128/IAI.39.3.1307-1315.1983; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; KEITH BR, 1986, INFECT IMMUN, V53, P693, DOI 10.1128/IAI.53.3.693-696.1986; KLEMM P, 1996, ANTIADHESIN THERAPY, P81; KOSS LG, 1969, LAB INVEST, V21, P154; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; LAMONT JT, 1992, ANN NY ACAD SCI, V664, P190, DOI 10.1111/j.1749-6632.1992.tb39760.x; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Leeker A, 1997, EXP NEPHROL, V5, P38; LIN JH, 1994, J BIOL CHEM, V269, P1775; MEASLEY RE, 1991, MED CLIN N AM, V75, P275, DOI 10.1016/S0025-7125(16)30453-9; MOBLEY HLT, 1995, METHOD ENZYMOL, V253, P360; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; OHANLEY P, 1985, J CLIN INVEST, V75, P347, DOI 10.1172/JCI111707; ORSKOV I, 1980, LANCET, V1, P887; PARKKINEN J, 1988, INFECT IMMUN, V56, P2623, DOI 10.1128/IAI.56.10.2623-2630.1988; PAULI BU, 1983, PATHOLOGY BLADDER CA, P42; PORTER KR, 1963, INTRO FINE STRUCTURE; REINHART HH, 1990, J INFECT DIS, V162, P1335, DOI 10.1093/infdis/162.6.1335; ROBERTS JA, 1996, ADV EXP MED BIOL, V462, P325; SCHAEFFER AJ, 1991, INFECTION, V19, pS144, DOI 10.1007/BF01643685; Schoolnik G K, 1987, Adv Exp Med Biol, V224, P53; SERAFINICESSI F, 1993, BIOCHEM BIOPH RES CO, V194, P784, DOI 10.1006/bbrc.1993.1890; SERAFINICESSI F, 1984, BIOSCIENCE REP, V4, P269, DOI 10.1007/BF01119663; Slomiany B L, 1991, J Physiol Pharmacol, V42, P147; SMAGULA RM, 1997, INFECT DIS CLIN N AM, V11, P531; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1994, J BACTERIOL, V176, P748, DOI 10.1128/jb.176.3.748-755.1994; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; SOKURENKO EV, 1992, INFECT IMMUN, V60, P4709, DOI 10.1128/IAI.60.11.4709-4719.1992; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; STAMM WE, 1989, J INFECT DIS, V159, P400, DOI 10.1093/infdis/159.3.400; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; van Rooijen JJM, 1999, GLYCOBIOLOGY, V9, P21, DOI 10.1093/glycob/9.1.21; VERGARA J, 1969, J MOL BIOL, V46, P593, DOI 10.1016/0022-2836(69)90200-9; Wallace JL, 1996, FASEB J, V10, P731, DOI 10.1096/fasebj.10.7.8635690; WILLIAMS J, 1984, CARBOHYD RES, V134, P141, DOI 10.1016/0008-6215(84)85029-6; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1995, J BIOL CHEM, V270, P29752; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171	59	206	216	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9924	9930		10.1074/jbc.M008610200	http://dx.doi.org/10.1074/jbc.M008610200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134021	hybrid			2022-12-27	WOS:000167996400048
J	Kawai, H; Allende, ML; Wada, R; Kono, M; Sango, K; Deng, CX; Miyakawa, T; Crawley, JN; Werth, N; Bierfreund, U; Sandhoff, K; Proia, RL				Kawai, H; Allende, ML; Wada, R; Kono, M; Sango, K; Deng, CX; Miyakawa, T; Crawley, JN; Werth, N; Bierfreund, U; Sandhoff, K; Proia, RL			Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-SERIES GANGLIOSIDES; COMPLEX GANGLIOSIDES; NEURONAL DIFFERENTIATION; SYNTHASE; GENE; GLYCOSPHINGOLIPIDS; MODULATORS; METABOLISM; LACKING; DEFECTS	Gangliosides are a family of glycosphingolipids that contain sialic acid. Although they are abundant on neuronal cell membranes, their precise functions and importance in the central nervous system (CNS) remain largely undefined. We have disrupted the gene encoding GD3 synthase (GD3S), a sialyltransferase expressed in the CNS that is responsible for the synthesis of b-series gangliosides. GD3S-/- mice, even with an absence of b-series gangliosides, appear to undergo normal development and have a normal life span. To further restrict the expression of gangliosides, the GD3S mutant mice were crossbred with mice carrying a disrupted GalNAcT gene encoding beta1,4-N-acetylgalactosaminyltransferase. These double mutant mice expressed GM3 as their major ganglioside. In contrast to the single mutant mice, the double mutants displayed a sudden death phenotype and were extremely susceptible to induction of lethal seizures by sound stimulus. These results demonstrate unequivocally that gangliosides play an essential role in the proper functioning of the CNS.	NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; NIMH, Sect Behav Neuropharmacol, Expt Therapeut Branch, Bethesda, MD 20892 USA; Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Bonn	Proia, RL (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, Bldg 10,Rm 9N-314, Bethesda, MD 20892 USA.		Miyakawa, Tsuyoshi/A-7741-2008; deng, chuxia/N-6713-2016; Proia, Richard L/A-7908-2012	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Kono, Mari/0000-0003-2447-4350; Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, ZIADK056001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002177] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Futerman AH, 1998, ACTA BIOCHIM POL, V45, P469, DOI 10.18388/abp.1998_4240; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; IBER H, 1992, GLYCOBIOLOGY, V2, P137, DOI 10.1093/glycob/2.2.137; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Kawai H, 1998, J BIOL CHEM, V273, P19634, DOI 10.1074/jbc.273.31.19634; Kono M, 1998, BIOCHEM BIOPH RES CO, V253, P170, DOI 10.1006/bbrc.1998.9768; Ledeen RW, 1998, ANN NY ACAD SCI, V845, P161, DOI 10.1111/j.1749-6632.1998.tb09669.x; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Matsuda Y, 1996, GENOMICS, V32, P137, DOI 10.1006/geno.1996.0090; MIETTINEN T, 1959, ACTA CHEM SCAND, V13, P856, DOI 10.3891/acta.chem.scand.13-0856; MIYAKAWA T, 1995, MOL BRAIN RES, V28, P349, DOI 10.1016/0169-328X(94)00251-9; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Puranam RS, 1999, CURR OPIN NEUROBIOL, V9, P281, DOI 10.1016/S0959-4388(99)80041-5; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, GENOMICS, V27, P362, DOI 10.1006/geno.1995.1058; Schnaar RL, 1998, ANN NY ACAD SCI, V845, P92, DOI 10.1111/j.1749-6632.1998.tb09664.x; Seyfried T N, 1999, Adv Neurol, V79, P279; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR10; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Takashima S, 2000, J BIOCHEM-TOKYO, V128, P1033, DOI 10.1093/oxfordjournals.jbchem.a022831; Walkley SU, 2000, CEREB CORTEX, V10, P1028, DOI 10.1093/cercor/10.10.1028; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6; YU RK, 1994, PROG BRAIN RES, V101, P31	33	189	191	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6885	6888		10.1074/jbc.C000847200	http://dx.doi.org/10.1074/jbc.C000847200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11133999	hybrid			2022-12-27	WOS:000167442900002
J	Ohtsuki, T; Watanabe, Y; Takemoto, C; Kawai, G; Ueda, T; Kita, K; Kojima, S; Kaziro, Y; Nyborg, J; Watanabe, K				Ohtsuki, T; Watanabe, Y; Takemoto, C; Kawai, G; Ueda, T; Kita, K; Kojima, S; Kaziro, Y; Nyborg, J; Watanabe, K			An "elongated" translation elongation factor Tu for truncated tRNAs in nematode mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TV-REPLACEMENT LOOP; FACTOR-EF-TU; AMINOACYL-TRANSFER-RNA; ASCARIS-SUUM; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PARASITIC NEMATODE; TERNARY COMPLEX; CDNA SEQUENCE	We have found the gene for a translation elongation factor Tu (EF-Tu) homologue in the genome of the nematode Caenorhabditis elegans, Because the corresponding protein was detected immunologically in a nematode mitochondrial (mt) extract, it could be regarded as a nematode mt EF-Tu. The protein possesses an extension of about 57 amino acids (we call this domain 3') at the C terminus, which is not found in any other known EF-Tu, Because most nematode mt tRNAs lack a T stem, domain 3' may be related to this feature. The nematode EF-Tu bound to nematode T stem-lacking tRNA, but bacterial EF-Tu was unable to do so. A series of domain exchange experiments strongly suggested that domains 3 and 3' are essential for binding to T stem-lacking tRNAs, This finding may constitute a novel example of the co-evolution of a structurally simplified RNA and the cognate RNA-binding protein, the latter having apparently acquired an additional domain to compensate for the lack of a binding site(s) on the RNA.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Inst Med Sci, Dept Parasitol, Minato Ku, Tokyo 1080071, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Lab Mol Life Sci Schering Plough, Yokohama, Kanagawa 2278501, Japan; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus C, Denmark	University of Tokyo; University of Tokyo; Tokyo Institute of Technology; Aarhus University	Watanabe, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138656, Japan.		Ueda, Takuya/K-5217-2014; OHTSUKI, Takashi/B-1471-2011	Ueda, Takuya/0000-0002-7760-8271; OHTSUKI, Takashi/0000-0002-3183-5305; Kita, Kiyoshi/0000-0002-0426-4308				AHMADIAN MR, 1991, BIOCHIMIE, V73, P1037, DOI 10.1016/0300-9084(91)90145-Q; Andersen GR, 2000, J MOL BIOL, V297, P421, DOI 10.1006/jmbi.2000.3564; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Bullard JM, 1999, BBA-GENE STRUCT EXPR, V1446, P102, DOI 10.1016/S0167-4781(99)00077-9; Clark Brian F. C., 1995, P423; Dreher TW, 1999, J BIOL CHEM, V274, P666, DOI 10.1074/jbc.274.2.666; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FORSTER C, 1993, NUCLEIC ACIDS RES, V21, P5679; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JACOBSON GR, 1977, FEBS LETT, V79, P8, DOI 10.1016/0014-5793(77)80338-4; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; Keddie EM, 1998, MOL BIOCHEM PARASIT, V95, P111, DOI 10.1016/S0166-6851(98)00102-9; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Kromayer M, 1996, J MOL BIOL, V262, P413, DOI 10.1006/jmbi.1996.0525; Kuhlman P, 1995, PLANT MOL BIOL, V29, P1057, DOI 10.1007/BF00014977; KUMAZAWA Y, 1991, BIOCHIM BIOPHYS ACTA, V1090, P167, DOI 10.1016/0167-4781(91)90097-6; KURAMOCHI T, 1994, MOL BIOCHEM PARASIT, V68, P177, DOI 10.1016/0166-6851(94)90163-5; Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ohtsuki T, 1996, NUCLEIC ACIDS RES, V24, P662, DOI 10.1093/nar/24.4.662; Ohtsuki T, 1998, J BIOCHEM-TOKYO, V124, P28, DOI 10.1093/oxfordjournals.jbchem.a022092; OKIMOTO R, 1990, EMBO J, V9, P3405, DOI 10.1002/j.1460-2075.1990.tb07542.x; OKIMOTO R, 1992, GENETICS, V130, P471; Palmer JD, 1997, NATURE, V387, P454, DOI 10.1038/387454a0; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; ROTH J, 1985, J CELL BIOL, V100, P113; RUDINGER J, 1994, BIOCHEMISTRY-US, V33, P5682, DOI 10.1021/bi00185a003; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARUTA F, 1995, J BIOL CHEM, V270, P928, DOI 10.1074/jbc.270.2.928; SPRINZL M, 1994, TRENDS BIOCHEM SCI, V19, P245, DOI 10.1016/0968-0004(94)90149-X; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; TABOR S, 1989, J BIOL CHEM, V264, P6447; TAKEMOTO C, 1995, BIOCHIMIE, V77, P104, DOI 10.1016/0300-9084(96)88112-0; TARTOF KD, 1987, FOCUS, V9, P12; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; Watanabe Y, 1997, BBA-GENE STRUCT EXPR, V1353, P7, DOI 10.1016/S0167-4781(97)00075-4; Watanabe Y, 1997, BBA-GENE STRUCT EXPR, V1350, P119, DOI 10.1016/S0167-4781(96)00211-4; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WOLSTENHOLME DR, 1994, NUCLEIC ACIDS RES, V22, P4300, DOI 10.1093/nar/22.20.4300; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	54	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21571	21577		10.1074/jbc.M011118200	http://dx.doi.org/10.1074/jbc.M011118200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262399	hybrid			2022-12-27	WOS:000169297900103
J	Sulpizi, M; Schelling, P; Folkers, G; Carloni, P; Scapozza, L				Sulpizi, M; Schelling, P; Folkers, G; Carloni, P; Scapozza, L			The rational of catalytic activity of herpes simplex virus thymidine kinase - A combined biochemical and quantum chemical study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WANNIER FUNCTIONS; GENE-TRANSFER; AB-INITIO; TYPE-1; COMPLEX; BINDING; PHOSPHORYLATION; ACYCLOVIR; EXCHANGE; ENZYMES	Most antiherpes therapies exploit the large substrate acceptance of herpes simplex virus type 1 thymidine kinase (TKHSV1) relative to the human isoenzyme, The enzyme selectively phosphorylates nucleoside analogs that can either inhibit viral DNA polymerase or cause toxic effects when incorporated into viral DNA. To relate structural properties of TKHSV1 ligands to their chemical reactivity we have carried out ab initio quantum chemistry calculations within the density functional theory framework in combination with biochemical studies. Calculations have focused on a set of ligands carrying a representative set of the large spectrum of sugar-mimicking moieties and for which structural information of the TKHSV1-ligand complex is available. The k(cat) values of these ligands have been measured under the same experimental conditions using an UV spectrophotometric assay. The calculations point to the crucial role of electric dipole moment of ligands and its interaction with the negatively charged residue Glu(225). A striking correlation is found between the energetics associated with this interaction and the k(cat) values measured under homogeneous conditions. This finding uncovers a fundamental aspect of the mechanism governing substrate diversity and catalytic turnover and thus represents a significant step toward the rational design of novel and powerful prodrugs for antiviral and TKHSV1-linked suicide gene therapies.	Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Appl Biosci, CH-8057 Zurich, Switzerland; SISSA, Int Sch Adv Studies, I-34013 Trieste, Italy; Int Ctr Genet Engn & Biotechnol, Area Sci Pk, I-34012 Trieste, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; International School for Advanced Studies (SISSA); International Center for Genetic Engineering & Biotechnology (ICGEB)	Carloni, P (corresponding author), SISSA, Int Sch Adv Studies, Via beirut 2-4, I-34013 Trieste, Italy.	carloni@sissa.it; scapozza@pharma.anbi.ethz.ch	Sulpizi, Marialore/C-9772-2016	Sulpizi, Marialore/0000-0002-7810-3224; Scapozza, Leonardo/0000-0003-1079-648X; Folkers, Gerd/0000-0002-3620-705X				Alber F, 1999, J PHYS CHEM B, V103, P6121, DOI 10.1021/jp9901038; Alber F, 1998, PROTEINS, V31, P453, DOI 10.1002/(SICI)1097-0134(19980601)31:4<453::AID-PROT11>3.0.CO;2-E; BARNETT RN, 1993, PHYS REV B, V48, P2081, DOI 10.1103/PhysRevB.48.2081; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bennett MS, 1999, FEBS LETT, V443, P121, DOI 10.1016/S0014-5793(98)01619-6; BLACK ME, 1993, BIOCHEMISTRY-US, V32, P11618, DOI 10.1021/bi00094a019; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; BROWN DG, 1995, NAT STRUCT BIOL, V2, P876, DOI 10.1038/nsb1095-876; CASE D, 1997, AMBER 5 0; Champness JN, 1998, PROTEINS, V32, P350, DOI 10.1002/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8; CHEN MS, 1978, J BIOL CHEM, V253, P1325; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; De Santis L, 1999, PROTEINS, V37, P611, DOI 10.1002/(SICI)1097-0134(19991201)37:4<611::AID-PROT11>3.3.CO;2-Z; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Encell LP, 1999, NAT BIOTECHNOL, V17, P143, DOI 10.1038/6142; HEHRE WJ, 1986, AB INITIO MOL ORBITA, P140; HODGE RAV, 1993, ANTIVIR CHEM CHEMOTH, V4, P67, DOI 10.1177/095632029300400201; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; HUTTER J, 1996, CPMD VERSION 3 0H; KELLER PM, 1981, BIOCHEM PHARMACOL, V30, P3071, DOI 10.1016/0006-2952(81)90495-0; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kokoris MS, 1999, GENE THER, V6, P1415, DOI 10.1038/sj.gt.3300966; Kussmann-Gerber S, 1998, EUR J BIOCHEM, V255, P472, DOI 10.1046/j.1432-1327.1998.2550472.x; Kussmann-Gerber S, 1999, NUCLEOS NUCLEOT, V18, P311, DOI 10.1080/15257779908043078; Leach A.R., 1996, MOL MODELLING PRINCI; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Molteni C, 1999, J AM CHEM SOC, V121, P12177, DOI 10.1021/ja983708a; Perozzo R, 2000, J BIOL CHEM, V275, P16139, DOI 10.1074/jbc.M000509200; Piana S, 2000, PROTEINS, V39, P26, DOI 10.1002/(SICI)1097-0134(20000401)39:1<26::AID-PROT3>3.0.CO;2-N; Pilger BD, 1999, J BIOL CHEM, V274, P31967, DOI 10.1074/jbc.274.45.31967; Prota A, 2000, BIOCHEMISTRY-US, V39, P9597, DOI 10.1021/bi000668q; PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4; ROETHLISBERGER U, 2000, J BIOL INORG CHEM; Rothlisberger U, 1999, INT J QUANTUM CHEM, V73, P209, DOI 10.1002/(SICI)1097-461X(1999)73:2<209::AID-QUA14>3.0.CO;2-B; Silvestrelli PL, 1999, PHYS REV LETT, V82, P3308, DOI 10.1103/PhysRevLett.82.3308; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; WILD K, 1995, FEBS LETT, V368, P289, DOI 10.1016/0014-5793(95)00680-8; Wild K, 1997, PROTEIN SCI, V6, P2097; XU HY, 1995, J MED CHEM, V38, P49, DOI 10.1021/jm00001a010	43	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21692	21697		10.1074/jbc.M010223200	http://dx.doi.org/10.1074/jbc.M010223200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262392	hybrid			2022-12-27	WOS:000169297900119
J	Baena-Gonzalez, E; Gray, JC; Tyystjarvi, E; Aro, EM; Maenpaa, P				Baena-Gonzalez, E; Gray, JC; Tyystjarvi, E; Aro, EM; Maenpaa, P			Abnormal regulation of photosynthetic electron transport in a chloroplast ycf9 inactivation mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC PHOTOPHOSPHORYLATION; BARLEY THYLAKOIDS; STATE TRANSITIONS; PHOTOSYSTEM-II; IN-VIVO; PROTEIN; GENE; TOBACCO; TRANSFORMATION; CHLAMYDOMONAS	The ycf9 (orf62) gene of the plastid genome encodes a 6.6-kDa protein (ORF62) of thylakoid membranes. To elucidate the role of the ORF62 protein, the coding region of the gene was disrupted with an aadA cassette. yielding mutant plants that were nearly (more than 95%) homoplasmic for ycf9 inactivation. The ycf9 mutant had no altered phenotype under standard growth conditions, but its growth rate was severely reduced under suboptimal irradiances. On the other hand, it was less susceptible to photodamage than the wild type. ycf9 inactivation resulted in a clear reduction in protein amounts of CP26, the NAD(P)H dehydrogenase complex, and the plastid terminal oxidase. Furthermore, depletion of ORF62 led to a faster flow of electrons to photosystem I without a change in the maximum electron transfer capacity of photosystem II. Despite the reduction of CP26 in the mutant thylakoids, no differences in PSII oxygen evolution rates were evident even at low light intensities. On the other hand, the ycf9 mutant presented deficiencies in the capacity for PSII-independent electron transport (ferredoxin-dependent cyclic electron transport and NAD(P)H dehydrogenase-mediated plastoquinone reduction). Altogether, it is shown that depletion of ORF62 leads to anomalies in the photosynthetic electron transfer chain and in the regulation of electron partitioning among the different routes of electron transport.	Univ Turku, Dept Biol, FIN-20014 Turku, Finland; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Turku; University of Cambridge	Aro, EM (corresponding author), Univ Turku, Dept Biol, FIN-20014 Turku, Finland.	evaaro@utu.fi	Baena-González, Elena/G-5811-2013; Tyystjärvi, Esa/B-2360-2015; Aro, Eva-Mari/Q-8664-2017; Baena-González, Elena/AAI-4051-2020	Baena-González, Elena/0000-0001-6598-3579; Tyystjärvi, Esa/0000-0001-6808-7470; Aro, Eva-Mari/0000-0002-2922-1435; Baena-González, Elena/0000-0001-6598-3579				ANDERSON JM, 1992, PHOTOSYNTH RES, V34, P341, DOI 10.1007/BF00029810; Anderson JM, 1995, PHOTOSYNTH RES, V46, P129, DOI 10.1007/BF00020423; ANDERSSON J, 2001, IN PRESS PLANT CELL; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BERENDS T, 1987, NUCLEIC ACIDS RES, V15, P5217, DOI 10.1093/nar/15.13.5217; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Casano LM, 2000, J BIOL CHEM, V275, P942, DOI 10.1074/jbc.275.2.942; CHEN SCG, 1994, PLANT SCI, V99, P171, DOI 10.1016/0168-9452(94)90174-0; Cournac L, 2000, J BIOL CHEM, V275, P17256, DOI 10.1074/jbc.M908732199; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; FOYER C, 1990, PHOTOSYNTH RES, V25, P83, DOI 10.1007/BF00035457; Fryer MJ, 1998, PLANT PHYSIOL, V116, P571, DOI 10.1104/pp.116.2.571; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; GARAB G, 1989, PLANTA, V179, P349, DOI 10.1007/BF00391080; GILLHAM DJ, 1986, PLANTA, V167, P246, DOI 10.1007/BF00391422; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; Hager M, 1999, EMBO J, V18, P5834, DOI 10.1093/emboj/18.21.5834; HALLICK RB, 1994, PLANT MOL BIOL REP, V12, P29; HOSLER JP, 1985, BIOCHIM BIOPHYS ACTA, V808, P21, DOI 10.1016/0005-2728(85)90023-4; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Keranen M, 1999, PHOTOSYNTHETICA, V37, P225, DOI 10.1023/A:1007187105205; KUONEN DR, 1986, ANAL BIOCHEM, V153, P221, DOI 10.1016/0003-2697(86)90084-9; MAENPAA P, 1988, PLANT PHYSIOL, V87, P762, DOI 10.1104/pp.87.3.762; Maenpaa P, 2000, J EXP BOT, V51, P375, DOI 10.1093/jexbot/51.suppl_1.375; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; NIXON P, 2001, ADV PHOTOSYNTHESIS R; Ott T, 1999, PLANTA, V209, P250, DOI 10.1007/s004250050629; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rochaix JD, 1997, TRENDS PLANT SCI, V2, P419, DOI 10.1016/S1360-1385(97)90025-X; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rolland N, 1997, EMBO J, V16, P6713, DOI 10.1093/emboj/16.22.6713; Ruf S, 2000, J CELL BIOL, V149, P369, DOI 10.1083/jcb.149.2.369; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheller HV, 1996, PLANT PHYSIOL, V110, P187, DOI 10.1104/pp.110.1.187; SCHLUCHTER WM, 1993, J BACTERIOL, V175, P3343, DOI 10.1128/jb.175.11.3343-3352.1993; SILVERSTEIN T, 1993, BIOCHIM BIOPHYS ACTA, V1183, P215, DOI 10.1016/0005-2728(93)90022-8; STIEHL HH, 1969, Z NATURFORSCH PT B, VB 24, P1588; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Teicher HB, 1998, PLANT PHYSIOL, V117, P525, DOI 10.1104/pp.117.2.525; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; YAO WB, 1989, NUCLEIC ACIDS RES, V17, P9583, DOI 10.1093/nar/17.23.9583; ZHAO J, 1993, MOL MICROBIOL, V9, P183, DOI 10.1111/j.1365-2958.1993.tb01680.x	58	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20795	20802		10.1074/jbc.M101255200	http://dx.doi.org/10.1074/jbc.M101255200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259438	hybrid			2022-12-27	WOS:000169135100149
J	Burhop, J; Rosol, M; Craig, R; Tobacman, LS; Lehman, W				Burhop, J; Rosol, M; Craig, R; Tobacman, LS; Lehman, W			Effects of a cardiomyopathy-causing troponin T mutation on thin filament function and structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; BETA-CARDIAC MYOSIN; 3-DIMENSIONAL RECONSTRUCTION; MUSCLE-CONTRACTION; F-ACTIN; CRYOELECTRON MICROSCOPY; REGULATORY PROPERTIES; COOPERATIVE BINDING; TROPOMYOSIN BINDING; SKELETAL-MUSCLE	Familial hypertrophic cardiomyopathy (FHC) is caused by missense or premature truncation mutations in proteins of the cardiac contractile apparatus. Mutant proteins are incorporated into the thin filament or thick filament and eventually produce cardiomyopathy, However, it has been unclear how the several, genetically identified defects in protein structure translate into impaired protein and muscle function. We have studied the basis of FHC caused by premature truncation of the most frequently implicated thin filament target, troponin T, Electron microscope observations showed that the thin filament undergoes normal structural changes in response to Ca(2+) binding. On the other hand, solution studies showed that the mutation alters and destabilizes troponin binding to the thin filament to different extents in different regulatory states, thereby affecting the transitions among states that regulate myosin binding and muscle contraction, Development of hypertrophic cardiomyopathy can thus be traced to a defect in the primary mechanism controlling cardiac contraction, switching between different conformations of the thin filament.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Iowa; University of Iowa; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Tobacman, LS (corresponding author), Univ Iowa, Dept Internal Med, 200 Hawkins Dr SE,610-GH, Iowa City, IA 52242 USA.	larry-tobacman@uiowa.edu		Lehman, William/0000-0002-9430-9521	NCRR NIH HHS [RR08426] Funding Source: Medline; NHLBI NIH HHS [HL-36153, R01 HL063774, HL-63774] Funding Source: Medline; NIAMS NIH HHS [AR-34711] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036153, R01HL063774, R55HL036153, R01HL036153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR034711] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EGELMAN EH, 1986, ULTRAMICROSCOPY, V19, P367, DOI 10.1016/0304-3991(86)90096-3; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; GEEVES MA, 1986, PROC R SOC SER B-BIO, V229, P85, DOI 10.1098/rspb.1986.0076; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; HILL LE, 1992, J BIOL CHEM, V267, P16106; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hodgkinson JL, 1997, J MOL BIOL, V273, P150, DOI 10.1006/jmbi.1997.1307; HOLMES KC, 1995, BIOPHYS J, V68, pS2; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Korman VL, 2000, J BIOL CHEM, V275, P22470, DOI 10.1074/jbc.M002939200; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Michele DE, 1999, NAT MED, V5, P1413; MILLIGAN RA, 1987, J CELL BIOL, V105, P29, DOI 10.1083/jcb.105.1.29; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; MOODY C, 1990, J MUSCLE RES CELL M, V11, P176, DOI 10.1007/BF01766496; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Mukherjea P, 1999, BIOCHEMISTRY-US, V38, P13296, DOI 10.1021/bi9906120; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; OWEN C, 1993, J CELL BIOL, V123, P337, DOI 10.1083/jcb.123.2.337; Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; Redwood C, 2000, CIRC RES, V86, P1146; Rosol M, 2000, BIOPHYS J, V78, P908, DOI 10.1016/S0006-3495(00)76648-3; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Saeki K, 2000, BIOCHEMISTRY-US, V39, P1324, DOI 10.1021/bi991297k; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TRACHTENBURG S, 1987, J MOL BIOL, V195, P571; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WILLIAMS DL, 1983, BIOCHEMISTRY-US, V22, P2770, DOI 10.1021/bi00280a027; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	55	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20788	20794		10.1074/jbc.M101110200	http://dx.doi.org/10.1074/jbc.M101110200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262409	hybrid			2022-12-27	WOS:000169135100148
J	Ribeiro, RCJ; Feng, WJ; Wagner, RL; Costa, CHRM; Pereira, AC; Apriletti, JW; Fletterick, RJ; Baxter, JD				Ribeiro, RCJ; Feng, WJ; Wagner, RL; Costa, CHRM; Pereira, AC; Apriletti, JW; Fletterick, RJ; Baxter, JD			Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CRYSTAL-STRUCTURE; DIMERIZATION ACTIVITIES; NUCLEAR RECEPTORS; MOLECULAR-BASIS; RXR; ESTROGEN; RAR; RECOGNITION; INTERFACES	Thyroid hormone receptors (TRs) bind as homodimers or heterodimers with retinoid X receptors (RXRs) to DNA elements with diverse orientations of AGGTCA half-sites. We performed a comprehensive x-ray crystal structure-guided mutation analysis of the TR ligand binding domain (TR LED) surface to map the functional interface for TR homodimers and heterodimers with RXR in the absence and/or in the presence of DNA. We also identified the molecular contacts in TR LBDs crystallized as dimers. The results show that crystal dimer contacts differ from those found in the functional studies. We found that identical TR LED residues found in helices 10 and 11 are involved in TR homodimerization and heterodimerization with RXR. Moreover, the same TR LED surface is operative for dimerization with direct repeats spaced by 4 base pairs (DR-4) and with the inverted palindrome spaced by 6 base pairs (F2), but not with TREpal (unspaced palindrome), where homodimers appear to be simply two monomers binding independently to DNA. We also demonstrate that interactions between the TR and RXR DNA binding domains stabilize TR-RXR heterodimers on DR-4. The dimer interface can be functional in the cell, because disruption of key residues impairs transcriptional activity of TRs mediated through association with RXR LED linked to GAL4 DNA-binding domain.	Univ Calif San Francisco, Dept Med, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Brasilia, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Brasilia	Ribeiro, RCJ (corresponding author), Univ Brasilia, Fac Hlth Sci, Mol Pharmacol Lab, BR-70910900 Brasilia, DF, Brazil.	ralff@unb.br	Wood, David W/B-2992-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009516, R01DK041842] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41842, DK09516] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen SC, 1999, J BIOL CHEM, V274, P11260, DOI 10.1074/jbc.274.16.11260; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Glass CK, 2000, GENE DEV, V14, P121; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; KITAJIMA K, 1995, THYROID, V5, P343, DOI 10.1089/thy.1995.5.343; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lee SK, 1998, MOL ENDOCRINOL, V12, P325, DOI 10.1210/me.12.3.325; Leitman DC, 1996, J BIOL CHEM, V271, P21950, DOI 10.1074/jbc.271.36.21950; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; MITCHELL JBO, 1994, J MOL BIOL, V239, P315, DOI 10.1006/jmbi.1994.1370; NAGAYA T, 1993, J BIOL CHEM, V268, P24278; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; RIBEIRO RCJ, 1994, ENDOCRINOLOGY, V135, P2076, DOI 10.1210/en.135.5.2076; Ribeiro RCJ, 1998, RECENT PROG HORM RES, V53, P351; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; YEN PM, 1992, J BIOL CHEM, V267, P3565; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311	47	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					14987	14995		10.1074/jbc.M010195200	http://dx.doi.org/10.1074/jbc.M010195200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11145963	hybrid			2022-12-27	WOS:000168528800063
J	Gerlach, LO; Skerlj, RT; Bridger, GJ; Schwartz, TW				Gerlach, LO; Skerlj, RT; Bridger, GJ; Schwartz, TW			Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHENYLENEBIS(METHYLENE)-LINKED BIS-TETRAAZAMACROCYCLES; SELECTIVE-INHIBITION; HIGHLY POTENT; REPLICATION; CORECEPTOR; BINDING; HIV-1; SITE; DERIVATIVES	The non-peptide CXCR4 receptor antagonist AMD3100, which is a potent blocker of human immunodeficiency virus cell entry, is a symmetrical bicyclam composed of two identical 1,4,8,11-tetraazacyclotetradecane (cyclam) moieties connected by a relatively rigid phenylenebismethylene linker. Based on the known strong propensity of the cyclam moiety to bind carboxylic acid groups, receptor mutagenesis identified Asp(171) and Asp(262), located in transmembrane domain (TM) TV and TM-VI, respectively, at each end of the main ligand-binding crevice of the CXCR4 receptor, as being essential for the ability of AMD3100 to block the binding of the chemokine ligand stromal cell-derived factor (SDF)-1 alpha as well as the binding of the receptor antibody 12G5. The free cyclam moiety had no effect on 12G5 binding, but blocked SDF-1 alpha binding with an affinity of 3 muM through interaction with Asp(171). The effect on SDF-1 alpha binding of a series of bicyclam analogs with variable chemical linkers was found to rely either only on Asp(171), i.e. the bicyclams acted as the isolated cyclam, or on both Asp(171) and Asp(262), i.e, they acted as AMD3100, depending on the length and the chemical nature of the linker between the two cyclam moieties. A positive correlation was found between the dependence of these compounds on Asp(262) for binding and their potency as anti-human immunodeficiency virus agents, It is concluded that AMD3100 acts on the CXCR4 receptor through binding to Asp(171), TM-IV and Asp(262) in TM-VI with each of its cyclam moieties, and it is suggested that part of its function is associated with a conformational constraint imposed upon the receptor by the connecting phenylenebismethylene linker.	Univ Copenhagen, Panum Inst 18 6 12, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; AnorMED Inc, Langley, BC V2Y 1N5, Canada; 7TM Pharmaceut AS, DK-2100 Copenhagen, Denmark	University of Copenhagen; AnorMED Inc	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst 18 6 12, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.			Schwartz, Thue W./0000-0002-0261-6904				ADAM KR, 1994, J CHEM SOC CHEM COMM, P1539, DOI 10.1039/c39940001539; Brelot A, 1997, J VIROL, V71, P4744, DOI 10.1128/JVI.71.6.4744-4751.1997; Bridger GJ, 1996, J MED CHEM, V39, P109, DOI 10.1021/jm950584t; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; BRIDGER GJ, 1999, ADV ANTIV D, V3, P161; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Clercq E, 1999, Drugs R D, V2, P321, DOI 10.2165/00126839-199902050-00010; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; De Clercq E, 2000, MOL PHARMACOL, V57, P833; DECLERCO E, 1992, P NATL ACAD SCI USA, V89, P5286, DOI 10.1073/pnas.89.12.5286; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Este JA, 1999, MOL PHARMACOL, V55, P67, DOI 10.1124/mol.55.1.67; GETHER U, 1993, J BIOL CHEM, V268, P7893; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003; JOAO HC, 1995, J MED CHEM, V38, P3865, DOI 10.1021/jm00019a017; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; MCAULEY A, 1987, J CHEM SOC CHEM COMM, P539, DOI 10.1039/c39870000539; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Signoret N, 1998, J CELL SCI, V111, P2819; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; TROUTNER DE, 1980, J NUCL MED, V21, P443	30	240	256	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14153	14160		10.1074/jbc.M010429200	http://dx.doi.org/10.1074/jbc.M010429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11154697	hybrid			2022-12-27	WOS:000168356600087
J	Mowla, SJ; Farhadi, HF; Pareek, S; Atwal, JK; Morris, SJ; Seidah, NG; Murphy, RA				Mowla, SJ; Farhadi, HF; Pareek, S; Atwal, JK; Morris, SJ; Seidah, NG; Murphy, RA			Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; REGULATED SECRETORY PATHWAY; HIPPOCAMPAL-NEURONS; PROTEIN SULFATION; PROPROTEIN; CELLS; SPECIFICITY; CONVERTASES; EXPRESSION; TRANSPORT	We examined the biosynthesis and post-translational processing of the brain-derived neurotrophic factor precursor (pro-BDNF) in cells infected with a pro-BDNF-encoding vaccinia virus. Metabolic labeling, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis reveal that pro-BDNF is generated as a 32-kDa precursor that is N-glycosylated and glycosulfated on a site, within the pro-domain. Some pro-BDNF is released extracellularly and is biologically active as demonstrated by its ability to mediate TrkB phosphorylation, The precursor undergoes N-terminal cleavage within the trans-Golgi network and/or immature secretory vesicles to generate mature BDNF (14 kDa), Small amounts of a 28-kDa protein that is immunoprecipitated with BDNF antibodies is also evident. This protein is generated in the endoplasmic reticulum through N-terminal cleavage of pro-BDNF at the Arg-Gly-Leu-Thr(57)- down arrow -Ser-Leu site. Cleavage is abolished when Arg(54) is changed to Ala (R54A) by in vitro mutagenesis. Blocking generation of 28-kDa BDNF has no effect on the level of mature BDNF and blocking generation of mature BDNF with alpha (1)-PDX, an inhibitor of furin-like enzymes, does not lead to accumulation of the 28-kDa form. These data suggest that 28-kDa pro-BDNF is not an obligatory intermediate in the formation of the 14-kDa form in the constitutive secretory pathway.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Salk Institute; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Murphy, RA (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Farhadi, H. Francis/E-3051-2011; Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Mowla, Seyed Javad/0000-0002-3300-6332; Farhadi, H Francis/0000-0002-4668-8512				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; KAPLAN DR, 1991, SCIENCE, V252, P545; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P5543; MAISONOPIERRE PC, 1990, SCIENCE, V247, P1373; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Mowla SJ, 1999, J NEUROSCI, V19, P2069; MOWLA SJ, 1999, SOC NEUR ABSTR, V709, P6; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SEIDAH NG, 1996, FEBS LETT, V379, P248; SNIDER DW, 1994, CELL, V77, P625; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; van Kuppeveld FJM, 1997, MOL CELL ENDOCRINOL, V136, P29, DOI 10.1016/S0303-7207(97)00211-6; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6	30	412	438	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12660	12666		10.1074/jbc.M008104200	http://dx.doi.org/10.1074/jbc.M008104200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11152678	hybrid			2022-12-27	WOS:000168198600027
J	Chaturvedi, K; Bandari, P; Chinen, N; Howells, RD				Chaturvedi, K; Bandari, P; Chinen, N; Howells, RD			Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE-INDUCED ANALGESIA; FUNCTIONAL EXPRESSION; PROTEIN; UBIQUITIN; KINASE; PATHWAY; INTERNALIZATION; MICE; PHOSPHORYLATION; DEGRADATION	This study investigated the mechanism of agonist-induced opioid receptor down-regulation. Incubation of HEK 293 cells expressing FLAG-tagged delta and mu receptors with agonists caused a time-dependent decrease in opioid receptor levels assayed by immunoblotting. Pulse-chase experiments using [S-35]methionine metabolic labeling indicated that the turnover rate of delta receptors was accelerated 5-fold following agonist stimulation. Inactivation of functional G(i) and G(o) proteins by pertussis toxin-attenuated down-regulation of the mu opioid receptor, while down-regulation of the delta opioid receptor was unaffected. Pretreatment of cells with inhibitors of lysosomal proteases, calpain, and caspases had little effect on mu and delta opioid receptor down-regulation. In marked contrast, pretreatment with proteasome inhibitors attenuated agonist-induced mu and delta receptor down-regulation. In addition, incubation of cells with proteasome inhibitors in the absence of agonists increased steady-state mu and delta opioid receptor levels. Immunoprecipitation of mu and delta opioid receptors followed by immunoblotting with ubiquitin antibodies suggested that preincubation with proteasome inhibitors promoted accumulation of polyubiquitinated receptors. These data provide evidence that the ubiquitin/proteasome pathway plays a role in agonist-induced down-regulation and basal turnover of opioid receptors.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Howells, RD (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	howells@umdnj.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009113] Funding Source: NIH RePORTER; NIDA NIH HHS [DA09113] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Breuer P, 1998, J BIOL CHEM, V273, P33254, DOI 10.1074/jbc.273.50.33254; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; CARTER BD, 1993, P NATL ACAD SCI USA, V90, P4062, DOI 10.1073/pnas.90.9.4062; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Chaturvedi K, 2000, MOL BRAIN RES, V80, P166, DOI 10.1016/S0169-328X(00)00134-0; Chaturvedi K, 2000, MOL BRAIN RES, V76, P64, DOI 10.1016/S0169-328X(99)00332-0; Chaturvedi K, 2000, BIOPOLYMERS, V55, P334, DOI 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S; CHEN Y, 1993, MOL PHARMACOL, V44, P8; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jockers R, 1999, J BIOL CHEM, V274, P28900, DOI 10.1074/jbc.274.41.28900; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Kramer HK, 2000, BIOCHEM PHARMACOL, V60, P781, DOI 10.1016/S0006-2952(00)00400-7; LAUGWITZ KL, 1993, NEURON, V10, P233, DOI 10.1016/0896-6273(93)90314-H; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Law SF, 1997, J PHARMACOL EXP THER, V281, P1476; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Miura H, 1996, BIOCHEM BIOPH RES CO, V227, P684, DOI 10.1006/bbrc.1996.1569; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEI G, 1995, MOL PHARMACOL, V48, P173; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; PRATHER PL, 1994, J BIOL CHEM, V269, P21293; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Shahrestanifar MS, 1996, NEUROCHEM RES, V21, P1295, DOI 10.1007/BF02532370; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Singh VK, 1997, NEUROIMMUNOMODULAT, V4, P285, DOI 10.1159/000097349; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; VINITSKY A, 1994, J BIOL CHEM, V269, P29860; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yabaluri N, 1997, MOL PHARMACOL, V52, P896, DOI 10.1124/mol.52.5.896; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	63	110	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12345	12355		10.1074/jbc.M008054200	http://dx.doi.org/10.1074/jbc.M008054200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152677	hybrid			2022-12-27	WOS:000168081800121
J	Henry, SP; Takanosu, M; Boyd, TC; Mayne, PM; Eberspaecher, H; Zhou, W; de Crombrugghe, B; Hook, M; Mayne, R				Henry, SP; Takanosu, M; Boyd, TC; Mayne, PM; Eberspaecher, H; Zhou, W; de Crombrugghe, B; Hook, M; Mayne, R			Expression pattern and gene characterization of asporin - A newly discovered member of the leucine-rich repeat protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; STATIONARY NIGHT BLINDNESS; COMPLETE CDNA CLONING; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; DERMATAN SULFATE; COLLAGEN FIBRILLOGENESIS; CHROMOSOMAL LOCALIZATION; OSTEOINDUCTIVE FACTOR	We have discovered a new member of the class I small leucine-rich repeat proteoglycan (SLRP) family which is distinct from the other class I SLRPs since it possesses a unique stretch of aspartate residues at its N terminus. For this reason, we called the molecule asporin. The deduced amino acid sequence is about 50% identical (and 70% similar) to decorin and biglycan. However, asporin does not contain a serine/glycine dipeptide sequence required for the assembly of O-linked glycosaminoglycans and is probably not a proteoglycan. The tissue expression of asporin partially overlaps with the expression of decorin and biglycan. During mouse embryonic development, asporin mRNA expression was detected primarily in the skeleton and other specialized connective tissues; very little asporin message was detected in the major parenchymal organs. The mouse asporin gene structure is similar to that of biglycan and decorin with 8 exons. The asporin gene is localized to human chromosome 9q22-9q21.3 where asporin is part of a SLRP gene cluster that includes extracellular matrix protein 2, osteoadherin, and osteoglycin. Further analysis shows that, with the exception of biglycan, all known SLRP genes reside in three gene clusters.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Mayne, R (corresponding author), Univ Alabama, Dept Cell Biol, Box 302,Volker Hall, Birmingham, AL 35294 USA.				NIAMS NIH HHS [P01 AR42919-05, R37 AR30481] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR030481, P01AR042919] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; BORDER WA, 1990, CELL DIFFER DEV, V32, P425, DOI 10.1016/0922-3371(90)90059-6; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Danielson KG, 1999, MAMM GENOME, V10, P201, DOI 10.1007/s003359900971; Deere M, 1996, GENOMICS, V38, P399, DOI 10.1006/geno.1996.0643; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Friedman JS, 2000, INVEST OPHTH VIS SCI, V41, P2059; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; GALLAGHER JT, 1983, BIOCHEM J, V215, P107, DOI 10.1042/bj2150107; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Grover J, 1997, GENOMICS, V45, P379, DOI 10.1006/geno.1997.4951; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hobby P, 2000, MOL VIS, V6, P72; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Kurita K, 1996, BIOCHEM J, V318, P909, DOI 10.1042/bj3180909; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishiu J, 1998, GENOMICS, V52, P378, DOI 10.1006/geno.1998.5455; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; SHINOMURA T, 1992, J BIOL CHEM, V267, P1265; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; SZTROLOVICS R, 1994, GENOMICS, V23, P715, DOI 10.1006/geno.1994.1567; TRAUPE H, 1992, GENOMICS, V13, P481, DOI 10.1016/0888-7543(92)90279-2; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WEGROWSKI Y, 1995, GENOMICS, V30, P8, DOI 10.1006/geno.1995.0002; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; WHINNA HC, 1993, J BIOL CHEM, V268, P3920; Wilda M, 2000, J BONE MINER RES, V15, P2187, DOI 10.1359/jbmr.2000.15.11.2187; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	58	129	140	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12212	12221		10.1074/jbc.M011290200	http://dx.doi.org/10.1074/jbc.M011290200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152695	hybrid			2022-12-27	WOS:000168081800104
J	Ashizawa, S; Nishizawa, H; Yamada, M; Higashi, H; Kondo, T; Ozawa, H; Kakita, A; Hatakeyama, M				Ashizawa, S; Nishizawa, H; Yamada, M; Higashi, H; Kondo, T; Ozawa, H; Kakita, A; Hatakeyama, M			Collective inhibition of pRB family proteins by phosphorylation in cells with p16(INK4a) loss or cyclin E overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; TUMOR-SUPPRESSOR PROTEIN; E2F TRANSCRIPTION FACTOR; GROWTH SUPPRESSION; S-PHASE; DISTINCT MECHANISMS; P107; P130; RB; EXPRESSION	The activity of the retinoblastoma protein pRB is regulated by phosphorylation that is mediated by G(1) cyclin-associated cyclin-dependent kinases (CDKs). Since the pRB-related pocket proteins p107 and p130 share general structures and biological functions with pRB, their activity is also considered to be regulated by phosphorylation. In this work, we generated phosphorylation-resistant p107 and p130 molecules by replacing potential cyclin CDK phosphorylation sites with non-phosphorylatable alanine residues. These phosphorylation-resistant mutants retained the ability to bind E2F and cyclin. Upon introduction into p16(INK4a)-deficient U2-OS osteosarcoma cells, in which cyclin D-CDK4/6 is dysregulated, the phosphorylation-resistant mutants, but not wild-type p107 or p130, were capable of inhibiting cell proliferation. Furthermore, when ectopically expressed in pRB-deficient SAOS-8 osteosarcoma cells, the wild-type as well as the phosphorylation-resistant pRB family proteins were capable of inducing large flat cells. The flat cell-inducing activity of the wild-type proteins, but not that of the phosphorylation-resistant mutants; was:abolished by coexpressing cyclin E. Our results indicate that the elevated cyclin D- or cyclin E-associated kinase leads to systemic inactivation of the pRB family proteins and suggest that dysregulation of the pRB kinase provokes an aberrant cell cycle in a broader range of cell types than those induced by genetic inactivation of the RB gene.	Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Viral Oncol, Toshima Ku, Tokyo 1708455, Japan; Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228555, Japan	Hokkaido University; Japanese Foundation for Cancer Research; Kitasato University	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@imm.hokudai.ac.jp	Higashi, Hideaki/F-6872-2012					BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Claudio PP, 1996, CANCER RES, V56, P2003; CLAUDIO PP, 1994, CANCER RES, V54, P5556; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; DELMER A, 1995, LEUKEMIA, V9, P1240; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; HAMEL PA, 1992, ONCOGENE, V7, P693; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hoshikawa Y, 1998, P NATL ACAD SCI USA, V95, P8574, DOI 10.1073/pnas.95.15.8574; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen KE, 1999, ONCOGENE, V18, P5239, DOI 10.1038/sj.onc.1202910; Lacy S, 1997, ONCOGENE, V14, P2395, DOI 10.1038/sj.onc.1201085; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MAYOL X, 1993, ONCOGENE, V8, P2561; Mayol X, 1996, ONCOGENE, V13, P237; MAYOL X, 1995, ONCOGENE, V11, P801; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Moberg K, 1996, MOL CELL BIOL, V16, P1436; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mori A, 1999, ONCOGENE, V18, P6209, DOI 10.1038/sj.onc.1203044; NEVINS JR, 1992, SCIENCE, V258, P424; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OTTERSON GA, 1995, ONCOGENE, V11, P1211; Parreno M, 2000, J VIROL, V74, P3166, DOI 10.1128/JVI.74.7.3166-3176.2000; QIN XQ, 1995, MOL CELL BIOL, V15, P742; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SELLERS WR, 1996, BIOCHIM BIOPHYS ACTA, V1288, P1; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Steeg PS, 1998, BREAST CANCER RES TR, V52, P17, DOI 10.1023/A:1006102916060; SuzukiTakahashi I, 1997, BIOCHEM BIOPH RES CO, V234, P386, DOI 10.1006/bbrc.1997.6654; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAM SW, 1994, ONCOGENE, V9, P2663; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; ZHU L, 1995, GENE DEV, V9, P1740, DOI 10.1101/gad.9.14.1740; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	71	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11362	11370		10.1074/jbc.M007992200	http://dx.doi.org/10.1074/jbc.M007992200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152455	hybrid			2022-12-27	WOS:000167980900106
J	Nappi, AJ; Vass, E				Nappi, AJ; Vass, E			The effects of nitric oxide on the oxidations of L-dopa and dopamine mediated by tyrosinase and peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SUBSTANTIA-NIGRA; SIGNAL-TRANSDUCTION PATHWAY; HYDROXYL RADICAL FORMATION; PARKINSONS-DISEASE; HYDROGEN-PEROXIDE; 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID; GLUTATHIONE-PEROXIDASE; NEURONAL DEGENERATION; SEPIA-OFFICINALIS; MELANIN SYNTHESIS	The effects of nitric oxide (NO) on both tyrosinase/O(2)- and horseradish peroxidase/H(2)O(2)-mediated oxidations of dopamine and its o-dihydric phenol precursor L-dopa were compared with autoxidative processes and quantitatively assessed by oxidative and reductive electrochemical detection systems. In peroxidase/H(2)O(2)/NO-catalyzed reactions, significantly more substrate was oxidized than in the corresponding control incubations lacking NO. In tyrosinase/O(2)/NO-promoted reactions the total amounts of L-dopa and dopamine oxidized were significantly less than the amounts of the substrates oxidized by enzyme alone. These data indicate that the activity of the heme protein peroxidase was enhanced by NO, whereas tyrosinase, a copper-containing monoxygenase, was inhibited. The NO-mediated reduction of tyrosinase/O(2) activity may be attributed to the formation of an inhibitory copper nitrosyl complex. An oxidized nitrodopamine derivative, considered to be either the quinone or semiquinone of 6-nitrosodopamine, was generated in peroxidase/H(2)O(2)/NO-mediated reactions with dopamine along with two oxidized melanin precursors, dopamine quinone and dopaminechrome. No corresponding nitroso compound was formed in reactions involving L-dopa or in any of the tyrosinase-mediated reactions, The formation of such a noncyclized nitrosodopamine represents an important alternative pathway in catecholamine metabolism, one that by-passes the formation of cytoprotective indole precursors of melanin. The results of this investigation suggest that cellular integrity and function can be adversely affected by NO-promoted oxidations of dopamine and other catechols, reactions that not only accelerate their conversion to reactive quinones but also form potentially cytotoxic noncyclized nitroso derivatives. Reduced levels of dopamine in the brain through NO-enhanced oxidation of the catecholamine will almost certainly be manifested by diminished levels of the dopamine-derived brain pigment neuromelanin.	Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Nappi, AJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	anappi@orion.it.luc.edu			NIGMS NIH HHS [GM 59774] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059774] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; Asahi M, 1997, J BIOL CHEM, V272, P19152, DOI 10.1074/jbc.272.31.19152; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; BECKMAN JS, 1996, NITRIC OXIDE PRINCIP, P1, DOI DOI 10.1016/B978-012435555-2/50002-4; Bridelli MG, 1999, FEBS LETT, V457, P18, DOI 10.1016/S0014-5793(99)01001-7; Brus R, 1997, ACTA NEUROBIOL EXP, V57, P283; BUGNON O, 1994, NEUROREPORT, V5, P401, DOI 10.1097/00001756-199401120-00007; Buyukuysal RL, 1997, FUNDAM CLIN PHARM, V11, P528; CARSTAM R, 1991, BIOCHIM BIOPHYS ACTA, V1097, P152, DOI 10.1016/0925-4439(91)90100-N; Cook JA, 1996, NEUROCHEM INT, V28, P609, DOI 10.1016/0197-0186(95)00125-5; Daveu C, 1997, NITRIC OXIDE-BIOL CH, V1, P234, DOI 10.1006/niox.1997.0123; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; Decker H, 2000, J EXP BIOL, V203, P1777; dIschia M, 1997, PIGM CELL RES, V10, P370, DOI 10.1111/j.1600-0749.1997.tb00694.x; DISCHIA M, 1995, BIOORGAN MED CHEM, V3, P923, DOI 10.1016/0968-0896(95)00083-S; ENOCHS WS, 1994, J NEURAL TRANSM-PARK, V7, P83, DOI 10.1007/BF02260963; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; FEHER J, 1987, FREE RADICAL REACTIO, P8; Ikemoto K, 1998, NEUROSCI LETT, V253, P198, DOI 10.1016/S0304-3940(98)00649-1; Jimenez M, 2000, ARCH BIOCHEM BIOPHYS, V373, P255, DOI 10.1006/abbi.1999.1519; JOLLEY RL, 1974, J BIOL CHEM, V249, P200; KANNER J, 1992, LIPIDS, V27, P46, DOI 10.1007/BF02537058; LaVoie MJ, 1999, J NEUROCHEM, V73, P2546, DOI 10.1046/j.1471-4159.1999.0732546.x; Liang LP, 1998, BRAIN RES, V800, P181, DOI 10.1016/S0006-8993(98)00452-1; Lin AMY, 1999, NEUROSCI RES, V34, P133; Lorrain DS, 1996, NEUROREPORT, V8, P31, DOI 10.1097/00001756-199612200-00007; Mohanakumar KP, 1998, J CHEM NEUROANAT, V14, P195, DOI 10.1016/S0891-0618(98)00032-5; NAKAHARA K, 1995, NEUROSCIENCES, V21, P185; Nakahara Kimihiro, 1994, Brain and Nerve (Tokyo), V46, P1147; Nappi AJ, 1998, BBA-GEN SUBJECTS, V1380, P55, DOI 10.1016/S0304-4165(97)00125-6; NAPPI AJ, 1994, J LIQ CHROMATOGR, V17, P793, DOI 10.1080/10826079408013369; Novellino L, 1998, BBA-GEN SUBJECTS, V1425, P27, DOI 10.1016/S0304-4165(98)00060-9; ODH G, 1994, J NEUROCHEM, V62, P2030; Padmaja S, 1999, RES CHEM INTERMEDIAT, V25, P441, DOI 10.1163/156856799X00040; Palumbo A, 2000, J BIOL CHEM, V275, P16885, DOI 10.1074/jbc.M909509199; Palumbo A, 1999, CHEM RES TOXICOL, V12, P1213, DOI 10.1021/tx990121g; Palumbo A, 1997, BIOCHEM BIOPH RES CO, V235, P429, DOI 10.1006/bbrc.1997.6734; Pavel S, 1996, INT CONGR SER, V1096, P161; POGUN S, 1994, BRAIN RES, V641, P83, DOI 10.1016/0006-8993(94)91818-X; PROTA G, 1993, PIGM CELL RES, V6, P333, DOI 10.1111/j.1600-0749.1993.tb00610.x; Prota G, 1997, PIGM CELL RES, V10, P5, DOI 10.1111/j.1600-0749.1997.tb00460.x; Prota G, 1996, INT CONGR SER, V1096, P49; Reszka KJ, 1998, FREE RADICAL BIO MED, V25, P208, DOI 10.1016/S0891-5849(98)00058-6; Riley PA, 2000, J THEOR BIOL, V203, P1, DOI 10.1006/jtbi.1999.1061; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Sasaki M, 2000, PIGM CELL RES, V13, P248, DOI 10.1034/j.1600-0749.2000.130406.x; SCHOOTUI.AJ, 1973, P NATL ACAD SCI USA, V70, P993; Schopfer Francisco, 2000, Nitric Oxide, V4, P315; Smith CS, 1998, NEUROSCI LETT, V241, P71, DOI 10.1016/S0304-3940(97)00961-0; SMITH TS, 1994, NEUROREPORT, V5, P2598, DOI 10.1097/00001756-199412000-00048; Tief K, 1996, EUR J BIOCHEM, V241, P12, DOI 10.1111/j.1432-1033.1996.0012t.x; Tief K, 1998, MOL BRAIN RES, V53, P307, DOI 10.1016/S0169-328X(97)00301-X; van Gastel M, 2000, FEBS LETT, V474, P228, DOI 10.1016/S0014-5793(00)01609-4; Wink David A., 1999, P245; Xu YM, 1997, MOL BRAIN RES, V45, P159, DOI 10.1016/S0169-328X(96)00308-7; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F	61	43	44	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11214	11222		10.1074/jbc.M009872200	http://dx.doi.org/10.1074/jbc.M009872200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11136730	hybrid			2022-12-27	WOS:000167980900085
J	Preston, TJ; Muller, WJ; Singh, G				Preston, TJ; Muller, WJ; Singh, G			Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; HYDROGEN-PEROXIDE; C-JUN; TYROSINE PHOSPHORYLATION; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; CELL-SURVIVAL; HUMAN BREAST; RECEPTOR	High levels of reactive oxygen species (ROS) are associated with cytotoxicity, Alternatively, nontoxic levels of ROS like hydrogen peroxide (H2O2) can mediate the transmission of many intracellular signals, including those invoked in growth and transformation. To identify pathways downstream of endogenous cellular H2O2 production, the response of Rat-1 fibroblasts exhibiting differential HER-2/Neu receptor tyrosine kinase activity to removal of physiological H2O2 concentrations was investigated. The proliferation of all cells was abolished by addition of the H2O2 scavenger catalase to the culture medium; HER-2/Neu activity was not significantly affected by catalase treatment, suggesting that the target(s) of the H2O2 signal lie downstream of the receptor in our model, ERK1/2 phosphorylation was blocked by catalase in fibroblasts expressing wild type Neu, however such a response did not occur in cells possessing activated mutant Neu, This indicates that the ERK1/2 response contributes little to the growth inhibition observed. By contrast, JNK1 activity increased following the addition of catalase or H2O2, regardless of Neu activity or level of cell transformation. Phosphorylation of p38 MAPK was induced by H2O2 but not by catalase. These observations suggest that scavenging of H2O2 from the cellular environment blocks Rat-1 proliferation primarily through the activation of stress pathways.	Hamilton Reg Canc Ctr, Hamilton, ON L8V 5C2, Canada; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON L8V 5C2, Canada	McMaster University; McMaster University	Singh, G (corresponding author), Hamilton Reg Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada.		Singh, Gurmit/C-6744-2014					Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Del Bello B, 1999, FASEB J, V13, P69; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hansen LL, 1999, J BIOL CHEM, V274, P25078, DOI 10.1074/jbc.274.35.25078; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V264, P696, DOI 10.1006/bbrc.1999.1542; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; LI JJ, 1995, ONCOGENE, V10, P1989; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Nilakantan V, 1998, CARCINOGENESIS, V19, P631, DOI 10.1093/carcin/19.4.631; Oberley TD, 1997, HISTOL HISTOPATHOL, V12, P525; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; QUIN MT, 1993, J BIOL CHEM, V268, P20988; Rao GN, 1996, ONCOGENE, V13, P713; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; Sattler M, 1999, BLOOD, V93, P2928; Schmid E, 1999, FASEB J, V13, P1491, DOI 10.1096/fasebj.13.12.1491; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zhang JH, 1998, AM J RESP CELL MOL, V19, P324, DOI 10.1165/ajrcmb.19.2.3209	39	123	128	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9558	9564		10.1074/jbc.M004617200	http://dx.doi.org/10.1074/jbc.M004617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134000	hybrid			2022-12-27	WOS:000167607700124
J	Alfalah, M; Parkin, ET; Jacob, R; Sturrock, ED; Mentele, R; Turner, AJ; Hooper, NM; Naim, HY				Alfalah, M; Parkin, ET; Jacob, R; Sturrock, ED; Mentele, R; Turner, AJ; Hooper, NM; Naim, HY			A point mutation in the juxtamembrane stalk of human angiotensin I-converting enzyme invokes the action of a distinct secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ZINC METALLOPROTEASE INHIBITORS; COLONY-STIMULATING FACTOR; CELL-SURFACE; INFLUENZA HEMAGGLUTININ; ECTODOMAIN CLEAVAGE; CYTOPLASMIC DOMAINS; MEMBRANE-PROTEIN; QUALITY-CONTROL; FORMS	Angiotensin I-converting enzyme (ACE) is one of a number of integral membrane proteins that is proteolytically shed from the cell surface by a zinc metallosecretase, Mutagenesis of Asn(631) to Gin in the juxtamembrane stalk region of ACE resulted in more efficient secretion of the mutant protein (ACE(NQ)) as determined by pulse-chase analysis. In contrast to the wild-type ACE, the cleavage of ACE(NQ) was not blocked by the metallosecretase inhibitor batimastat but by the serine protease inhibitor, 1,3-dichloroisocoumarin. Incubation of the cells at 15 degreesC revealed that ACE(NQ) was cleaved in the endoplasmic reticulum, and mass spectrometric analysis of the secreted form of the protein indicated that it had been cleaved at the Asn(635)-Ser(636) bond, three residues N-terminal to the normal secretase cleavage site at Arg(638)-Ser(639). These data clearly show that a point mutation in the juxtamembrane region of an integral membrane protein can invoke the action of a mechanistically and spatially distinct secretase, In light of this observation, previous data on the effect of mutations in the juxtamembrane stalk of shed proteins being accommodated by a single secretase having a relaxed specificity need to be re-evaluated.	Univ Leeds, Sch Biochem & Mol Biol, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England; Sch Vet Med, Dept Physiol Chem, D-30559 Hannover, Germany; Univ Cape Town, Dept Med Biochem, ZA-7700 Rondebosch, South Africa; Univ Munich, Klin Chem & Klin Biochem Abt, D-80336 Munich, Germany	University of Leeds; University of Veterinary Medicine Hannover, Foundation; University of Cape Town; University of Munich	Hooper, NM (corresponding author), Univ Leeds, Sch Biochem & Mol Biol, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk	Al Falah, Dr. Marwan/C-6281-2011; Jacob, Ralf/B-8163-2011	Parkin, Edward/0000-0003-3270-3184; Hooper, Nigel/0000-0002-5811-3484				Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; BOULAY F, 1988, J CELL BIOL, V106, P629, DOI 10.1083/jcb.106.3.629; Christie G, 1999, J NEUROCHEM, V73, P195, DOI 10.1046/j.1471-4159.1999.0730195.x; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Deng P, 1996, J BIOL CHEM, V271, P16338, DOI 10.1074/jbc.271.27.16338; Deng P, 1998, BIOCHEMISTRY-US, V37, P17898, DOI 10.1021/bi9817313; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V179, P1670, DOI 10.1016/0006-291X(91)91767-7; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; NAIM HY, 1992, BIOCHEM J, V286, P451, DOI 10.1042/bj2860451; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; Naim HY, 1996, EUR J CELL BIOL, V70, P198; OPPONG SY, 1993, BIOCHEM J, V292, P597, DOI 10.1042/bj2920597; Parvathy S, 1997, BIOCHEM J, V327, P37, DOI 10.1042/bj3270037; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; RAMCHANDRAN R, 1995, BIOCHEMISTRY-US, V34, P12645, DOI 10.1021/bi00039a021; RAMCHANDRAN R, 1994, J BIOL CHEM, V269, P2125; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schwager SLU, 1999, BIOCHEMISTRY-US, V38, P10388, DOI 10.1021/bi990357j; Schwager SLU, 1998, BIOCHEMISTRY-US, V37, P15449, DOI 10.1021/bi981260k; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; SEN I, 1991, J BIOL CHEM, V266, P21985; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; WEI L, 1991, J BIOL CHEM, V266, P9002; WILLIAMS TA, 1992, BIOCHEM J, V288, P875, DOI 10.1042/bj2880875; WILSON JM, 1987, J CELL BIOL, V105, P691, DOI 10.1083/jcb.105.2.691; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	47	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21105	21109		10.1074/jbc.M100339200	http://dx.doi.org/10.1074/jbc.M100339200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274151	Green Published, hybrid			2022-12-27	WOS:000169297900043
J	Galbiati, F; Engelman, JA; Volonte, D; Zhang, XL; Minetti, C; Li, MM; Hou, H; Kneitz, B; Edelmann, W; Lisanti, MP				Galbiati, F; Engelman, JA; Volonte, D; Zhang, XL; Minetti, C; Li, MM; Hou, H; Kneitz, B; Edelmann, W; Lisanti, MP			Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; RICH MEMBRANE DOMAINS; ONCOGENICALLY TRANSFORMED-CELLS; NITRIC-OXIDE SYNTHASE; ROUS-SARCOMA VIRUS; GENE FAMILY; MUSCLE DIFFERENTIATION; BIOLOGICAL-MEMBRANES; TRANSPORT VESICLES; PROTEIN-COMPONENT	Caveolin-3, a muscle-specific caveolin-related protein, is the principal structural protein of caveolae membrane domains in striated muscle cells. Recently, we identified a novel autosomal dominant form of limb-girdle muscular dystrophy (LGMD-1C) in humans that is due to mutations within the coding sequence of the human caveolin-3 gene (3p25), These LGMD-1C mutations lead to an similar to 95% reduction in caveolin-3 protein expression, i.e. a caveolin-3 deficiency. Here, we created a caveolin-3 null (CAV3 -/-) mouse model, using standard homologous recombination techniques, to mimic a caveolin-3 deficiency. We show that these mice lack caveolin-3 protein expression and sarcolemmal caveolae membranes. In addition, analysis of skeletal muscle tissue from these caveolin-3 null mice reveals: (i) mild myopathic changes; (ii) an exclusion of the dystrophin-glycoprotein complex from lipid raft domains; and (iii) abnormalities in the organization of the T-tubule system, with dilated and longitudinally oriented T-tubules. These results have clear mechanistic implications for understanding the pathogenesis of LGMD-1C at a molecular level.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Univ Genoa, Ist Gaslini, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Genoa; IRCCS Istituto Giannina Gaslini	Lisanti, MP (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lisanti@aecom.yu.edu	Lisanti, Michael/B-6131-2018; Galbiati, Ferruccio/AAF-3527-2020; Lisanti, Michael P/C-6866-2013; Minetti, Carlo/K-4666-2018	Lisanti, Michael/0000-0003-2034-1382; Minetti, Carlo/0000-0002-0640-1804	NCI NIH HHS [R01-CA-76329] Funding Source: Medline; Telethon [470/BI] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; CORLEYMASTICK C, 1995, J CELL BIOL, V129, P1523; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Doyle DD, 2000, CIRC RES, V87, P480; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; FRA AM, 1994, J BIOL CHEM, V269, P30745; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; IOFFE E, 1995, P NATL ACAD SCI USA, V92, P7357, DOI 10.1073/pnas.92.16.7357; ISHIKAWA H, 1968, J CELL BIOL, V38, P51, DOI 10.1083/jcb.38.1.51; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1995, METHOD ENZYMOL, V250, P655; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Mikel U. V., 1994, ADV LAB METHODS HIST; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SARGIACOMO M, 1994, ONCOGENE, V9, P2589; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255	55	347	355	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21425	21433		10.1074/jbc.M100828200	http://dx.doi.org/10.1074/jbc.M100828200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259414	hybrid			2022-12-27	WOS:000169297900085
J	Wang, L; Guo, Y; Huang, WJ; Ke, XL; Poyet, JL; Manji, GA; Merriam, S; Glucksmann, MA; DiStefano, PS; Alnemri, ES; Bertin, J				Wang, L; Guo, Y; Huang, WJ; Ke, XL; Poyet, JL; Manji, GA; Merriam, S; Glucksmann, MA; DiStefano, PS; Alnemri, ES; Bertin, J			CARD10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; COILED COILS; CYTOCHROME-C; APOPTOSIS; PATHWAY; GENE; RIP	BCL10 belongs to the caspase recruitment domain (CARD) family of proteins that regulate apoptosis and NF-kappaB signaling pathways. Analysis of BCL10-deficcient mice has revealed that BCL10 mediates NF-kappaB activation by antigen receptors in B and T cells. We recently identified a subclass of CARD proteins (CARD9, CARD11, and CARD14) that may function to connect BCL10 to multiple upstream signaling pathways. We report here that CARD10 is a novel BCL10 interactor that belongs to the membrane-associated guanylate kinase family, a class of proteins that function to organize signaling complexes at plasma membranes. When expressed in cells, CARD10 binds to BCL10 and signals the activation of NF-kappaB through its N-terminal effector CARD domain. We propose that CARD10 functions as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB.	Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Jefferson University; Jefferson University	Bertin, J (corresponding author), Millennium Pharmaceut Inc, 640 Mem Dr, Cambridge, MA 02139 USA.	bertin@mpi.com	Poyet, Jean-Luc/G-7114-2017; Alnemri, Emad S/B-4526-2010	Poyet, Jean-Luc/0000-0002-3747-255X; 	NATIONAL CANCER INSTITUTE [R01CA085421] Funding Source: NIH RePORTER; NCI NIH HHS [CA85421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad M, 1997, CANCER RES, V57, P615; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pawson T, 2000, GENE DEV, V14, P1027; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Staub E, 2001, TRENDS BIOCHEM SCI, V26, P83, DOI 10.1016/S0968-0004(00)01717-5; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Ye HT, 2000, AM J PATHOL, V157, P1147, DOI 10.1016/S0002-9440(10)64630-5; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	30	114	121	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21405	21409		10.1074/jbc.M102488200	http://dx.doi.org/10.1074/jbc.M102488200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259443	hybrid			2022-12-27	WOS:000169297900082
J	Pitts, RL; Wang, SB; Jones, EA; Symes, AJ				Pitts, RL; Wang, SB; Jones, EA; Symes, AJ			Transforming growth factor-beta and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAYS; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATION; TYROSINE PHOSPHORYLATION; DNA-BINDING; INTERLEUKIN-6; CNTF; SURVIVAL	The cytokine ciliary neurotrophic factor (CNTF) and transforming growth factor-beta (TGF-beta) both induce transcription of the vasoactive intestinal peptide (VIP) gene through a 180-base pair cytokine response element (CyRE) in the VIP promoter. While CNTF induces STAT and AP-1 proteins to bind to cognate sites in the VIIP CS;RE, the mechanism through which TGF-beta acts to induce VIP gene transcription is not known. Here we show that Smad3 and Smad4 proteins can bind to two distinct sites within the VIP CyRE. These sites are absolutely required for the induction of VIP CyRE transcription, by TGF-beta. TGF-beta induces endogenous Smad;containing complexes to bind to these sites in human neuroblastoma cells. CNTF and TGF-beta synergize to induce VIP mRNA expression and transcription through the VIP CyRE. This synergy is dependent on the Smad, STAT, and AP-1 sites, suggesting that these two independent cytokine pathways synergize through the cooperation of pathway-specific transcription factors binding to distinct sites within the VIP CyRE.	Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Asymes@usuhs.mil	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035839] Funding Source: NIH RePORTER; NINDS NIH HHS [R29 NS035839, R29 NS-35839] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Blottner D, 1996, EUR J NEUROSCI, V8, P202, DOI 10.1111/j.1460-9568.1996.tb01181.x; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Carpenter LR, 1999, ADV PROTEIN CHEM, V52, P109; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Giordano V, 1997, J IMMUNOL, V158, P4097; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Jones EA, 2000, J BIOL CHEM, V275, P36013, DOI 10.1074/jbc.M007373200; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Krieglstein K, 1998, EUR J NEUROSCI, V10, P2746, DOI 10.1046/j.1460-9568.1998.00324.x; Krieglstein K, 1998, J NEUROBIOL, V37, P563, DOI 10.1002/(SICI)1097-4695(199812)37:4<563::AID-NEU5>3.3.CO;2-1; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MAGAL E, 1993, NEUROREPORT, V4, P779, DOI 10.1097/00001756-199306000-00046; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; Ren RF, 1996, BRAIN RES, V732, P16, DOI 10.1016/0006-8993(96)00458-1; RICHARDSON PM, 1994, PHARMACOL THERAPEUT, V63, P187, DOI 10.1016/0163-7258(94)90045-0; SCHIEMANN WP, 1994, J BIOL CHEM, V269, P6376; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; SCHWARZSCHILD MA, 1994, J NEUROCHEM, V63, P1246; SENDTNER M, 1991, J CELL SCI, P103; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SYMES A, 1994, MOL ENDOCRINOL, V8, P1750, DOI 10.1210/me.8.12.1750; Symes A, 1997, J BIOL CHEM, V272, P9648; SYMES AJ, 1993, P NATL ACAD SCI USA, V90, P572, DOI 10.1073/pnas.90.2.572; SYMES AJ, 1995, J BIOL CHEM, V270, P8068, DOI 10.1074/jbc.270.14.8068; Symes AJ, 2000, MOL ENDOCRINOL, V14, P429, DOI 10.1210/me.14.3.429; TSUKADA T, 1985, DNA-J MOLEC CELL BIO, V4, P293, DOI 10.1089/dna.1985.4.293; WANG Y, 1995, GENE, V162, P285, DOI 10.1016/0378-1119(95)00295-H; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	58	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19966	19973		10.1074/jbc.M011759200	http://dx.doi.org/10.1074/jbc.M011759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259431	hybrid			2022-12-27	WOS:000169135100039
J	Takeuchi, N; Vial, L; Panvert, M; Schmitt, E; Watanabe, K; Mechulam, Y; Blanquet, S				Takeuchi, N; Vial, L; Panvert, M; Schmitt, E; Watanabe, K; Mechulam, Y; Blanquet, S			Recognition of tRNAs by methionyl-tRNA transformylase from mammalian mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA TRANSFORMYLASE; ESCHERICHIA-COLI; FORMYLTRANSFERASE; SYNTHETASE; PROTEIN; GENE; PURIFICATION; SPECIFICITY; SEQUENCE; INVIVO	Protein synthesis involves two methionine-isoaccepting tRNAs, an initiator and an elongator, In eubacteria, mitochondria, and chloroplasts, the addition of a formyl group gives its full functional identity to initiator Met-tRNA(Met). In Escherichia coli, it has been shown that the specific action of methionyl-tRNA transformylase on Met-tRNA(f)(Met) mainly involves a set of nucleotides in the acceptor stem, particularly a C(1)A(72) mismatch. In animal mitochondria, only one tRNA(Met) species has yet been described. It is admitted that this species can engage itself either in initiation or elongation of translation, depending on the presence or absence of a formyl group. In the present study, we searched for the identity elements of tRNA(Met) that govern its formylation by bovine mitochondrial transformylase, The main conclusion is that the mitochondrial formylase preferentially recognizes the methionyl moiety of its tRNA substrate. Moreover, the relatively small importance of the tRNA acceptor stem in the recognition process accounts for the protection against formylation of the mitochondrial tRNAs that share with tRNA(Met) an A(1)U(72) motif.	Ecole Polytech, CNRS, Unite Mixte Rech 7654, Biochim Lab, F-91128 Palaiseau, France; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138654, Japan	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Tokyo	Mechulam, Y (corresponding author), Ecole Polytech, CNRS, Unite Mixte Rech 7654, Biochim Lab, F-91128 Palaiseau, France.		Mechulam, Yves/F-3313-2019; SCHMITT, Emmanuelle/F-2605-2019; Emmanuelle, SCHMITT/ABF-8658-2020	Mechulam, Yves/0000-0003-3586-3554; SCHMITT, Emmanuelle/0000-0001-7532-338X; Emmanuelle, SCHMITT/0000-0001-7532-338X; VIAL, Lionel/0000-0002-2786-842X				ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BLANQUET S, 1984, METHOD ENZYMOL, V106, P141; Blanquet S, 2000, CURR OPIN STRUC BIOL, V10, P95, DOI 10.1016/S0959-440X(99)00055-X; BREVET A, 1989, P NATL ACAD SCI USA, V86, P8275, DOI 10.1073/pnas.86.21.8275; GIEGE R, 1973, FEBS LETT, V30, P291, DOI 10.1016/0014-5793(73)80672-6; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; GUILLON JM, 1992, J MOL BIOL, V224, P359, DOI 10.1016/0022-2836(92)91000-F; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HIREL PH, 1988, BIOCHIMIE, V70, P773, DOI 10.1016/0300-9084(88)90107-1; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; LEE CP, 1991, J BIOL CHEM, V266, P18012; Li SH, 1996, J BIOL CHEM, V271, P1022, DOI 10.1074/jbc.271.2.1022; MEINNEL T, 1988, NUCLEIC ACIDS RES, V16, P8095, DOI 10.1093/nar/16.16.8095; MEINNEL T, 1995, J BIOL CHEM, V270, P15906; MELLOT P, 1989, J MOL BIOL, V208, P429, DOI 10.1016/0022-2836(89)90507-X; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; ROE BA, 1981, P 3 CLEV S MACR, P167; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schmitt E, 1996, EMBO J, V15, P4749, DOI 10.1002/j.1460-2075.1996.tb00852.x; SCHMITT E, 1993, J MOL BIOL, V233, P615, DOI 10.1006/jmbi.1993.1540; SOURGOUTCHOV A, 1974, EUR J BIOCHEM, V46, P431, DOI 10.1111/j.1432-1033.1974.tb03636.x; Takeuchi N, 1998, J BIOCHEM-TOKYO, V124, P1069, DOI 10.1093/oxfordjournals.jbchem.a022222; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085	23	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20064	20068		10.1074/jbc.M101007200	http://dx.doi.org/10.1074/jbc.M101007200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274157	hybrid			2022-12-27	WOS:000169135100053
J	Forsythe, HL; Jarvis, JL; Turner, JW; Elmore, LW; Holt, SE				Forsythe, HL; Jarvis, JL; Turner, JW; Elmore, LW; Holt, SE			Stable association of hsp90 and p23, but not hsp70, with active human telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGESTERONE-RECEPTOR COMPLEXES; NORMAL HUMAN-CELLS; RNA COMPONENT; REVERSE-TRANSCRIPTASE; IMMORTAL CELLS; HUMAN CANCER; LIFE-SPAN; IN-VITRO; RECONSTITUTION; INHIBITION	The ribonucleoprotein telomerase holoenzyme is minimally composed of a catalytic subunit, hTERT, and its associated template RNA component, hTR. We have previously found two additional components of the telomerase holoenzyme, the chaperones p23 and heat shock protein (hsp) 90, both of which are required for efficient telomerase assembly in vitro and in vivo. Both hsp90 and p23 bind specifically to hTERT and influence its proper assembly with the template RNA, hTR. We report here that the hsp70 chaperone also associates with hTERT in the absence of hTR and dissociates when telomerase is folded into its active state, similar to what occurs with other chaperone targets. Our data also indicate that hsp90 and p23 remain associated with functional telomerase complexes, which differs from other hsp90-folded enzymes that require only a transient hsp90 p23 binding. Our data suggest that components of the hsp90 chaperone complex, while required for telomerase assembly, remain associated with active enzyme, which may ultimately provide critical insight into the biochemical properties of telomerase assembly.	Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Dept Pathol & Human Genet, Richmond, VA 23298 USA	Virginia Commonwealth University	Holt, SE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Dept Pathol & Human Genet, 1101 E Marshall St, Richmond, VA 23298 USA.							Bachand F, 1999, J BIOL CHEM, V274, P38027, DOI 10.1074/jbc.274.53.38027; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Holt Shawn E., 1996, Methods in Cell Science, V18, P237, DOI 10.1007/BF00132889; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Licht JD, 1999, GENE DEV, V13, P1116, DOI 10.1101/gad.13.9.1116; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Toft DO, 1998, TRENDS ENDOCRIN MET, V9, P238, DOI 10.1016/S1043-2760(98)00060-5; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Zheng FF, 2000, CANCER RES, V60, P2090	27	177	199	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 11	2001	276	19					15571	15574		10.1074/jbc.C100055200	http://dx.doi.org/10.1074/jbc.C100055200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431GH	11274138	hybrid			2022-12-27	WOS:000168623100003
J	Kim, JB; Sharp, PA				Kim, JB; Sharp, PA			Positive transcription elongation factor b phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT-ACTIVATION; FACTOR P-TEFB; MESSENGER-RNA; IN-VITRO; HIGH-AFFINITY; HELA-CELLS; PROTEIN; COMPLEX; SPT5; TFIIH	The CDK9-cyclin T kinase complex, positive transcription elongation factor b (P-TEFb), stimulates the process of elongation of RNA polymerase (Pol) II during transcription of human immunodeficiency virus. P-TEFb associates with the human immunodeficiency virus Tat protein and with the transactivation response element to form a specific complex, thereby mediating efficient elongation. Here, we show that P-TEFb preferentially phosphorylates hSPT5 as compared with the carboxyl-terminal domain of RNA Pol II in vitro. Phosphorylation of hSPT5 by P-TEFb occurred on threonine and serine residues in its carboxyl-terminal repeat domains. In addition, we provide several lines of evidence that P-TEFb is a CDK-activating kinase (CAK)-independent kinase. For example, CDK9 was not phosphorylated by CAK, whereas CDK2-cyclin A kinase activity was dramatically enhanced by CAR. Therefore, it is likely that P-TEFb participates in regulation of elongation by RNA Pol II by phosphorylation of its substrates, hSPT5 and the CTD of RNA Pol II, in a CAK-independent manner.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Massachusetts Institute of Technology (MIT); Seoul National University (SNU)	Sharp, PA (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu		KIM, Jae Bum/0000-0003-2337-6935	NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032486] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA42063, P30-CA14051] Funding Source: Medline; NIAID NIH HHS [R01-AI32486] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Chen D, 1999, MOL CELL BIOL, V19, P2863; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; EGYHAZI E, 1974, J MOL BIOL, V84, P173, DOI 10.1016/0022-2836(74)90220-4; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Garber ME, 2000, MOL CELL BIOL, V20, P6958, DOI 10.1128/MCB.20.18.6958-6969.2000; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GarciaMartinez LF, 1997, EMBO J, V16, P2836, DOI 10.1093/emboj/16.10.2836; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hirose Y, 2000, GENE DEV, V14, P1415; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; Holstege FCP, 1999, P NATL ACAD SCI USA, V96, P2, DOI 10.1073/pnas.96.1.2; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Kwak YT, 1999, J MOL BIOL, V288, P57, DOI 10.1006/jmbi.1999.2664; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Parada CA, 1996, NATURE, V384, P375, DOI 10.1038/384375a0; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; RATNASABAPATHY R, 1990, GENE DEV, V4, P2061, DOI 10.1101/gad.4.12a.2061; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TAMM I, 1976, J CELL BIOL, V69, P229, DOI 10.1083/jcb.69.2.229; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; VANDERGEER P, 1994, ELECTROPHORESIS, V15, P544, DOI 10.1002/elps.1150150173; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu-Baer F, 1998, J MOL BIOL, V277, P179, DOI 10.1006/jmbi.1997.1601; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	60	152	157	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12317	12323		10.1074/jbc.M010908200	http://dx.doi.org/10.1074/jbc.M010908200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11145967	hybrid			2022-12-27	WOS:000168081800117
J	Diana, F; Sgarra, R; Manfioletti, G; Rustighi, A; Poletto, D; Sciortino, MT; Mastino, A; Giancotti, V				Diana, F; Sgarra, R; Manfioletti, G; Rustighi, A; Poletto, D; Sciortino, MT; Mastino, A; Giancotti, V			A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H1; IN-VIVO; CHROMATIN CONDENSATION; DNA FRAGMENTATION; NUCLEAR PROTEINS; CDC2 KINASE; HMG-I; BINDING; EXPRESSION; ACTIVATION	Nuclear phosphoprotein HMGA1a, high mobility group A1a, (previously HMGI) has been investigated during apoptosis. A change in the degree of phosphorylation of HMGA1a has been observed during apoptosis induced in four leukemic cell lines (HL60, K562, NB4, and U937) by drugs (etoposide, camptothecin) or herpes simplex virus type-1. Both hyper-phosphorylation and de-phosphorylation of HMGA1a have been ascertained by liquid chromatography-mass spectrometry. Hyperphosphorylation (at least five phosphate groups/ HMGA1a molecule) occurs at the early apoptotic stages and is probably related to HMGA1a displacement from DNA and chromatin release from the nuclear scaffold. De-phosphorylation (one phosphate or no phosphate groups/HMGA1a molecule) accompanies the later formation of highly condensed chromatin in the apoptotic bodies. We report for the first time a direct link between the degree of phosphorylation of HMGA1a protein and apoptosis according to a process that involves the entire amount of HMGA1a present in the cells and, consequently, whole chromatin. At the same time we report that variously phosphorylated forms of HMGA1a protein are also mono-methylated.	Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy; Ctr Riferimento Oncol, I-33081 Aviano, Italy; Univ Messina, Dipartimento Sci Microbiol Genet & Mol, I-98100 Messina, Italy	University of Trieste; IRCCS Aviano (CRO); University of Messina	Giancotti, V (corresponding author), Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, Via Licio Giorgieri, I-34127 Trieste, Italy.	giancot@bbcm.univ.trieste.it	Sciortino, Maria Teresa/B-9425-2012; Mastino, Antonio/A-4686-2008	Sciortino, Maria Teresa/0000-0002-8519-7724; Mastino, Antonio/0000-0002-0338-6450; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601; Sgarra, Riccardo/0000-0002-4496-2856				Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Bandiera A, 1998, CANCER RES, V58, P426; Banks GC, 2000, BIOCHEMISTRY-US, V39, P8333, DOI 10.1021/bi000378+; Bosman FT, 1999, VIRCHOWS ARCH, V435, P391, DOI 10.1007/s004280050416; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Bustin M, 1999, MOL CELL BIOL, V19, P5237; BUSTIN M, 1996, PROG NUCL ACIDS RES, V84, pS35; Chiappetta G, 1998, CANCER RES, V58, P4193; Chiappetta G, 1996, ONCOGENE, V13, P2439; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; DELBINO G, 1991, EXP CELL RES, V193, P27, DOI 10.1016/0014-4827(91)90534-2; FERRANTI P, 1992, J BIOL CHEM, V267, P22486; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; GIANCOTTI V, 1993, EUR J BIOCHEM, V213, P825, DOI 10.1111/j.1432-1033.1993.tb17825.x; GIANCOTTI V, 1991, EUR J BIOCHEM, V198, P211, DOI 10.1111/j.1432-1033.1991.tb16003.x; GIANCOTTI V, 1985, CANCER RES, V45, P6051; GIANCOTTI V, 1989, EXP CELL RES, V184, P538, DOI 10.1016/0014-4827(89)90352-2; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; Giancotti V, 1996, BIOCHEM J, V317, P865, DOI 10.1042/bj3170865; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Hill DA, 1999, NUCLEIC ACIDS RES, V27, P2135, DOI 10.1093/nar/27.10.2135; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JANSEN E, 1999, GENE THER MOL BIOL, V3, P387; Johns EW, 1982, HMG CHROMOSOMAL PROT; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Liu WM, 1999, CANCER RES, V59, P5695; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; Mantovani F, 1998, NUCLEIC ACIDS RES, V26, P1433, DOI 10.1093/nar/26.6.1433; Martelli AM, 1998, J HISTOCHEM CYTOCHEM, V46, P863, DOI 10.1177/002215549804600710; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Martins LM, 1998, BLOOD, V92, P3042, DOI 10.1182/blood.V92.9.3042.421k55_3042_3049; MARUSHIGE Y, 1995, ANTICANCER RES, V15, P267; Mastino A, 1997, CELL DEATH DIFFER, V4, P629, DOI 10.1038/sj.cdd.4400289; Morana SJ, 1996, J BIOL CHEM, V271, P18263, DOI 10.1074/jbc.271.30.18263; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; PALVIMO J, 1989, FEBS LETT, V257, P101, DOI 10.1016/0014-5793(89)81796-X; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Schwanbeck R, 1997, J BIOL CHEM, V272, P27476, DOI 10.1074/jbc.272.43.27476; Shao RG, 1997, J BIOL CHEM, V272, P31321, DOI 10.1074/jbc.272.50.31321; SHIBATA K, 1993, J BIOL CHEM, V268, P18431; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; WANG DZ, 1995, J BIOL CHEM, V270, P22924, DOI 10.1074/jbc.270.39.22924; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Wolffe A., 1998, CHROMATIN STRUCTURE; Xiao DM, 2000, J NEUROCHEM, V74, P392, DOI 10.1046/j.1471-4159.2000.0740392.x; Yoshida M, 1997, EXP CELL RES, V232, P225, DOI 10.1006/excr.1997.3538; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; Zhou X, 1998, Keio J Med, V47, P73; Zhu N, 1997, ANAL BIOCHEM, V246, P155, DOI 10.1006/abio.1997.2018	57	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11354	11361		10.1074/jbc.M009521200	http://dx.doi.org/10.1074/jbc.M009521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145960	hybrid			2022-12-27	WOS:000167980900105
J	Linderoth, NA; Simon, MN; Hainfeld, JF; Sastry, S				Linderoth, NA; Simon, MN; Hainfeld, JF; Sastry, S			Binding of antigenic peptide to the endoplasmic reticulum-resident protein gp96/GRP94 heat shock chaperone occurs in higher order complexes - Essential role of some aromatic amino acid residues in the peptide-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; SH2 DOMAIN; GP96 GRP94; HSP90; RECEPTOR; FAMILY; FORMS; DNA	Vaccination with heat shock protein gp96-antigenic peptide complexes produces a powerful specific immune response against cancers and infectious diseases in some experimental animal models, and gp96-peptide complexes are now being tested in human clinical trials. gp96 appears to serve as a natural adjuvant for chaperoning antigenic peptides into the immune surveillance pathways. A fundamental issue that needs to be addressed is the mechanism of binding of antigenic peptide to gp96, Here, we show using scanning transmission electron microscopy that recombinant gp96 binds peptide in stable multimeric complexes, which may have biological significance. To open the possibility for genetically engineering gp96 for improved immunogenicity and to understand if molecular recognition plays a role in the binding of antigenic peptide, we mutagenized some specific aromatic amino acids in the presumed peptide-binding pocket. Replacement of Tyr-667 or Tyr-678 to Ala reduced affinity for peptide whereas conversion of Trp-654 to Tyr increased peptide binding. Similarly, changing Trp-621 to Phe or Leu or Ala or lie negatively affected peptide binding whereas changing Trp-621 to Tyr or Val positively affected peptide binding, Probing the peptide microenvironment in gp86-peptide complexes, suggested that hydrophobic interactions land perhaps hydrogen bonding/stacking interactions) may play a role in peptide loading by gp96.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Rockefeller University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sastry, S (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	sastrys@rockvax.rockefeller.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001777] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR01777] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Gregori L, 1997, J BIOL CHEM, V272, P58; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Ishii T, 1999, J IMMUNOL, V162, P1303; KOCH G, 1986, J CELL SCI, V86, P217; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, V10, P128; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; Linderoth NA, 2000, J BIOL CHEM, V275, P5472, DOI 10.1074/jbc.275.8.5472; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; MINAMI Y, 1993, J BIOL CHEM, V268, P9604; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Sastry S, 1999, J BIOL CHEM, V274, P12023, DOI 10.1074/jbc.274.17.12023; Soti C, 1998, Pathol Oncol Res, V4, P316; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; WACHSMAN JT, 1987, GENETICS, V115, P405; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wall JS, 1998, METHOD CELL BIOL, V53, P139; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Wassenberg JJ, 1999, J CELL SCI, V112, P2167; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	33	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11049	11054		10.1074/jbc.M010059200	http://dx.doi.org/10.1074/jbc.M010059200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148208	hybrid			2022-12-27	WOS:000167980900065
J	Campbell, RA; Bhat-Nakshatri, P; Patel, NM; Constantinidou, D; Ali, S; Nakshatri, H				Campbell, RA; Bhat-Nakshatri, P; Patel, NM; Constantinidou, D; Ali, S; Nakshatri, H			Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha - A new model for anti-estrogen resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; BCL-2 EXPRESSION; GENE-EXPRESSION; BINDING PROTEIN; KINASE-B; PHOSPHORYLATION; TAMOXIFEN; 3-KINASE	Estrogen receptors (ERs) mediate most of the biological effects of estrogen in mammary and uterine epithelial cells by binding to estrogen response elements in the promoter region of target genes or through protein-protein interactions. Anti-estrogens such as tamoxifen inhibit the growth of ER-positive breast cancers by reducing the expression of estrogen-regulated genes. However, anti-estrogen-resistant growth of ER-positive tumors remains a significant clinical problem. Here we show that phosphatidylinositol (PI) 3-kinase and AKT activate ER alpha in the absence of estrogen. Although PI 3-kinase increased the activity of both estrogen-independent activation function 1 (AF-1) and estrogen-dependent activation function 2 (AF-2) of ER alpha, AKT increased the activity of only AF-1, PTEN and a catalytically inactive AKT decreased PI 3-kinase-induced AF-1 activity, suggesting that PI I-kinase utilizes AKT-dependent and AKT-independent pathways in activating ER alpha. The consensus AKT phosphorylation site Ser-167 of ER alpha is required for phosphorylation and activation by AKT, In addition, LY294002, a specific inhibitor of the PI 3-kinase/AKT pathway, reduced phosphorylation of ER alpha in vivo, Moreover, AKT overexpression led to up-regulation of estrogen-regulated pS2 gene, Bcl-2, and macrophage inhibitory cytokine 1. We demonstrate that AKT protects breast cancer cells from tamoxifen-induced apoptosis. Taken together, these results define a molecular link between activation of the PI3-kinase/AKT survival pathways, hormone-independent activation of ER alpha, and inhibition of tamoxifen-induced apoptotic regression.	Indiana Univ, Sch Med, Dept Surg, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Hammersmith Hosp, Dept Canc Med, Imperial Coll Sch Med, London W12 0NN, England	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Imperial College London	Nakshatri, H (corresponding author), Indiana Canc Res Inst, R4-202,1044 W Walnut St, Indianapolis, IN 46202 USA.		Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Nakshatri, Harikrishna/0000-0001-8876-0052; Coombes, Raoul Charles/0000-0002-4811-1100				Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; ARNOLD SF, 1994, MOL ENDOCRINOL, V8, P1208, DOI 10.1210/me.8.9.1208; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chien PY, 1999, MOL ENDOCRINOL, V13, P2122, DOI 10.1210/me.13.12.2122; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAUVOIS S, 1993, J CELL SCI, V106, P1377; de Haan G, 2000, J BIOL CHEM, V275, P13493, DOI 10.1074/jbc.275.18.13493; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Elledge RM, 1997, J CLIN ONCOL, V15, P1916, DOI 10.1200/JCO.1997.15.5.1916; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Glass CK, 2000, GENE DEV, V14, P121; Hyder SM, 1999, BIOCHEM PHARMACOL, V57, P597, DOI 10.1016/S0006-2952(98)00355-4; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kumar R, 1996, CLIN CANCER RES, V2, P1215; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee AV, 1995, BIOMED PHARMACOTHER, V49, P415, DOI 10.1016/0753-3322(96)82678-3; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Skov S, 1998, TISSUE ANTIGENS, V51, P215; Tonks NK, 1999, SCIENCE, V286, P2096, DOI 10.1126/science.286.5447.2096; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	47	743	775	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9817	9824		10.1074/jbc.M010840200	http://dx.doi.org/10.1074/jbc.M010840200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139588	hybrid, Green Published			2022-12-27	WOS:000167996400033
J	Jones, PL; Sachs, LM; Rouse, N; Wade, PA; Shi, YB				Jones, PL; Sachs, LM; Rouse, N; Wade, PA; Shi, YB			Multiple N-CoR complexes contain distinct histone deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; YEAST; GENE; SMRT; INTERACTS; COMPONENT; MSIN3	N-CoR (nuclear receptor corepressor) is a corepressor for multiple transcription factors including unliganded thyroid hormone receptors (TRs). In vitro, N-CoR can interact with the Sin3 corepressor, which in turn binds to the histone deacetylase Rpd3 (HDAC1), predicting the existence of a corepressor complex containing N-CoR, Sin3, and histone deacetylase. However, previous biochemical studies of endogenous Sin3 complexes have failed to find an N CoR association. Xenopus laevis eggs and oocytes contain all of the necessary components for transcriptional repression by unliganded TRs. In this study, we report the biochemical fractionation of three novel macromolecular complexes containing N-CoR, two of which possess histone deacetylase activity, from Xenopus egg extract. One complex contains Sin3, Rpd3, and RbAp48; the second complex contains a Sin3-independent histone deacetylase; and the third complex lacks histone deacetylase activity. This study describes the first biochemical isolation of endogenous N-CoR-containing HDAC complexes and illustrates that N-CoR associates with distinct histone deacetylases that are both dependent and independent of Sin3. Immunoprecipitation studies show that N-CoR binds to unliganded TR expressed in the frog oocyte, confirming that N-CoR complexes are involved in repression by unliganded TR. These results suggest that N-CoR targets transcriptional repression of specific promoters through at least two distinct histone deacetylase pathways.	NICHD, UMM, LME, NIH, Bethesda, MD 20892 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University	Shi, YB (corresponding author), NICHD, UMM, LME, NIH, Bldg 18T,Rm 106, Bethesda, MD 20892 USA.	Shi@helix.nih.gov	Sachs, Laurent/AAE-1504-2020; Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X; Shi, Yun-Bo/0000-0002-6330-0639	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001901] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Glass CK, 2000, GENE DEV, V14, P121; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guenther MG, 2000, GENE DEV, V14, P1048; Harlow E, 1999, USING ANTIBODIES LAB, P321; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang EY, 2000, GENE DEV, V14, P45; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kao HY, 2000, GENE DEV, V14, P55; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Vermaak D, 1999, MOL CELL BIOL, V19, P5847; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; WADE PA, 1998, METHODS ENZYMOL; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1998, EMBO J, V17, P520, DOI 10.1093/emboj/17.2.520; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	34	80	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8807	8811		10.1074/jbc.C000879200	http://dx.doi.org/10.1074/jbc.C000879200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254656	hybrid			2022-12-27	WOS:000167607700027
J	Johnson, CA; Padget, K; Austin, CA; Turner, BM				Johnson, CA; Padget, K; Austin, CA; Turner, BM			Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; COMPLEX; CHROMATIN; BETA; CONDENSATION; ACETYLATION; EXPRESSION; MECHANISM; INTERACTS	DNA topoisomerase II (topo II) is a ubiquitous nuclear enzyme that is involved in DNA replication, transcription, chromosome segregation, and apoptosis, Here we show by immunoprecipitation, pull down with glutathione S-transferase fusion proteins, and yeast two-hybrid analysis that both topo II alpha and -beta physically interact with the histone deacetylase HDAC1. The in vitro DNA decatenation activity of recombinant topo II alpha and -beta is inhibited by association with catalytically inactive, recombinant HDAC1. We provide evidence for the in vivo significance of the topo II-HDAC1 association, showing that inhibition of HDAC activity with trichostatin A suppresses apoptosis induced by the topo II poison etoposide, but not by the topoisomerase I inhibitor camptothecin, We suggest that chromatin remodeling by an HDAC-containing complex facilitates both topo II-catalyzed DNA rearrangement and etoposide-induced DNA damage in vivo.	Univ Birmingham, Dept Anat, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England; Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Birmingham; Newcastle University - UK	Turner, BM (corresponding author), Univ Birmingham, Dept Anat, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England.			Johnson, Colin/0000-0002-2979-8234; Austin, Caroline/0000-0002-1921-5947				Allera C, 1997, J BIOL CHEM, V272, P10817; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Cowell IG, 2000, EXP CELL RES, V255, P86, DOI 10.1006/excr.1999.4772; Cowell IG, 1998, EXP CELL RES, V243, P232, DOI 10.1006/excr.1998.4150; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WHITE DA, 1999, METHODS COMPANION ME, V10, P417; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	77	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 16	2001	276	7					4539	4542		10.1074/jbc.C000824200	http://dx.doi.org/10.1074/jbc.C000824200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	428WH	11136718	hybrid			2022-12-27	WOS:000168484300004
J	Collin-Osdoby, P; Rothe, L; Anderson, F; Nelson, M; Maloney, W; Osdoby, P				Collin-Osdoby, P; Rothe, L; Anderson, F; Nelson, M; Maloney, W; Osdoby, P			Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; DIFFERENTIATION FACTOR ODF; INHIBITORY FACTOR; BONE-RESORPTION; MESSENGER-RNA; IN-VITRO; RHEUMATOID-ARTHRITIS; PARATHYROID-HORMONE; OSTEOBLASTIC CELLS; PROSTAGLANDIN E-2	The receptor activator of NF-kappaB (RANKL) is the essen tial signal required for full osteoclast (OC) development, activation, and survival. RANKL is highly expressed in areas of trabecular bone remodeling and inflammatory bone loss, is increased on marrow stromal cells or osteoblasts by osteotropic hormones or cytokines, and is neutralized by osteoprotegerin (OPG), a soluble decoy receptor also crucial for preventing arterial calcification. Vascular endothelial cells (VEC) are critically involved in bone development and remodeling and influence OC recruitment, formation, and activity. Although OCs develop and function in close association with bone VEC and sinusoids, signals mediating their interactions are not well known. Here, we show for the first time that human microvascular endothelial cells (HMVEC) express transcripts for both RANKL and OPG; inflammatory cytokines tumor necrosis factor-alpha and interleukin-1 alpha elevate RANKL and OPG expression 5-40-fold in HMVEC (with an early OPG peak that declines as RANKL rises), and RANKL protein increases on the surface of tumor necrosis factor-alpha -activated HMVEC. Cytokine-activated HMVEC promoted the formation, fusion, and bone resorption of OCs formed in co-cultures with circulating human monocytic precursors via a RANKL-mediated mechanism fully antagonized by exogenous OPG. Furthermore, paraffin sections of human osteoporotic fractured bone exhibited increased RANKL immunostaining in vivo on VEC located near resorbing OCs in regions undergoing active bone turnover. Therefore, cytokine-activated VEC may contribute to inflammatory-mediated bone loss via regulated production of RANKL and OPG. VEC-derived OPG may also serve as an autocrine signal to inhibit blood vessel calcification.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Div Bone & Mineral Metab, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Collin-Osdoby, P (corresponding author), Washington Univ, Dept Biol, Box 1229, St Louis, MO 63130 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046547, R29DK046547] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR32927] Funding Source: Medline; NIDDK NIH HHS [DK46547] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V248, P454, DOI 10.1006/bbrc.1998.8993; BROWN RA, 1990, BONE MINER, V9, P35, DOI 10.1016/0169-6009(90)90098-Z; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Chaudhary LR, 1996, MOL CELL BIOCHEM, V156, P69; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Cines DB, 1998, BLOOD, V91, P3527; Collin-Osdoby P, 2000, J BONE MINER RES, V15, P474, DOI 10.1359/jbmr.2000.15.3.474; COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306; COLLINOSDOBY P, 1995, J BONE MINER RES, V10, P45; CRUTCHLEY DJ, 1985, J PHARMACOL EXP THER, V233, P650; Faust J, 1999, J CELL BIOCHEM, V72, P67, DOI 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A; Filvaroff E, 1998, CURR BIOL, V8, pR679, DOI 10.1016/S0960-9822(98)70434-8; Firestein GS, 1999, J CLIN INVEST, V103, P3, DOI 10.1172/JCI5929; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Mbalaviele G, 1999, ENDOCRINOLOGY, V140, P3736, DOI 10.1210/endo.140.8.6880; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nagai M, 1999, BIOCHEM BIOPH RES CO, V257, P719, DOI 10.1006/bbrc.1999.0524; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Parfitt AM, 1998, BONE, V23, P491, DOI 10.1016/S8756-3282(98)00140-9; Rothe L, 1998, ENDOCRINOLOGY, V139, P4353, DOI 10.1210/en.139.10.4353; Shalhoub V, 1999, J CELL BIOCHEM, V72, P251; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SOSKOLNE WA, 1979, CELL TISSUE RES, V203, P487; STREETEN EA, 1989, P NATL ACAD SCI USA, V86, P916, DOI 10.1073/pnas.86.3.916; STREETEN EA, 1990, BONE MINER, V10, P85, DOI 10.1016/0169-6009(90)90084-S; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sunyer T, 1999, J CLIN INVEST, V103, P1409, DOI 10.1172/JCI4682; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402, DOI 10.1302/0301-620X.45B2.402; Tsukii K, 1998, BIOCHEM BIOPH RES CO, V246, P337, DOI 10.1006/bbrc.1998.8610; Vidal ONA, 1998, BIOCHEM BIOPH RES CO, V248, P696, DOI 10.1006/bbrc.1998.9035; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZAIDI M, 1993, BONE, V14, P97, DOI 10.1016/8756-3282(93)90234-2	56	321	332	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20659	20672		10.1074/jbc.M010153200	http://dx.doi.org/10.1074/jbc.M010153200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274143	hybrid			2022-12-27	WOS:000169135100132
J	Nishimura, Y; Tanaka, T				Nishimura, Y; Tanaka, T			Calcium-dependent activation of nuclear factor regulated by interleukin 3/adenovirus E4 promoter-binding protein gene expression by calcineurin/nuclear factor of activated T cells and calcium/calmodulin-dependent protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; LEUCINE ZIPPER; CYCLOSPORINE-A; K+ CHANNELS; BZIP FAMILY; NFAT; E4BP4; REPRESSION; HYPERTROPHY; INHIBITION	An increase in the intracellular Ca2+ concentration controls a diverse range of cell functions, including gene expression, apoptosis, adhesion, motility, and proliferation. We have investigated Ca2+ regulation of gene expression in rat aortic smooth muscle cells. We found that the expression of nuclear factor regulated by interleukin 3 (NFIL3)/adenovirus E4 promoter-binding protein (E4BP4)/basic region/leucine zipper (bZIP) type of a transcription factor that has a very important function in cell survival, was activated by thapsigargin (TG). This activation was inhibited by chelation of extra- or intracellular Ca2+, suggesting that the induction by TG was dependent on the elevation of [Ca2+](i). Specific inhibition of calcineurin or calcium/calmodulin-dependent protein kinase (CaM kinase) by chemical means impaired the TG-induced NFIL3/E4BP4 expression. Expression of dominant negative forms of calcineurin or nuclear factor of activated T cells (NFAT) inhibited the induction of NFIL3/E4BP4 mRNA by TG. These results suggest that intracellular Ca2+ plays a critical role in regulating gene expression of NFIL3/E4BP4 by calcineurin\NFAT and CaM kinase signaling in vascular smooth muscle cells.	Mie Univ, Sch Med, Dept Mol & Cellular Pharmacol, Tsu, Mie 5148507, Japan	Mie University	Tanaka, T (corresponding author), Mie Univ, Sch Med, Dept Mol & Cellular Pharmacol, Tsu, Mie 5148507, Japan.	tanaka@doc.medic.mie-u.ac.jp		Nishimura, Yuhei/0000-0003-1901-8799				Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Chen WJ, 1995, BBA-GENE STRUCT EXPR, V1264, P388, DOI 10.1016/0167-4781(95)00182-4; Chow CW, 1999, MOL CELL BIOL, V19, P2300; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; DEL CEM, 1998, GENE, V211, P151; Duncliffe KN, 1997, IMMUNITY, V6, P175, DOI 10.1016/S1074-7613(00)80424-0; Ehring GR, 1998, J EXP MED, V188, P1593, DOI 10.1084/jem.188.9.1593; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hulme DJ, 2000, HUM GENET, V106, P594, DOI 10.1007/s004390050030; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; ITO T, 1994, FEBS LETT, V351, P231, DOI 10.1016/0014-5793(94)00867-1; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Lai CK, 1999, J VIROL, V73, P3197, DOI 10.1128/JVI.73.4.3197-3209.1999; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; ROSEN LB, 1995, ADV SEC MESS PHOSPH, V30, P225; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsai EY, 1996, MOL CELL BIOL, V16, P459; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wallace AD, 1997, BIOCHEM BIOPH RES CO, V232, P403, DOI 10.1006/bbrc.1997.6206; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	46	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19921	19928		10.1074/jbc.M010332200	http://dx.doi.org/10.1074/jbc.M010332200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262393	hybrid			2022-12-27	WOS:000169135100033
J	Shankavaram, UT; Lai, WC; Netzel-Arnett, S; Mangan, PR; Ardans, JA; Caterina, N; Stetler-Stevenson, WG; Birkedal-Hansen, H; Wahl, LM				Shankavaram, UT; Lai, WC; Netzel-Arnett, S; Mangan, PR; Ardans, JA; Caterina, N; Stetler-Stevenson, WG; Birkedal-Hansen, H; Wahl, LM			Monocyte membrane type 1-matrix metalloproteinase - Prostaglandin-dependent regulation and role in metalloproteinase-2 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE COLLAGENASE PRODUCTION; HUMAN MONONUCLEAR PHAGOCYTES; IV COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; GELATINASE-A; H SYNTHASE-2; TUMOR-CELLS; IN-VITRO	Membrane type 1-matrix metalloproteinase (MT1-MMP)-mediated activation of MMP-2 is thought to be important in the proteolysis of extracellular matrix in pathological events in which monocytes/macrophages are found. Here we report on the induction and regulation of human monocyte MT1-MMP and its role in MMP-2 activation. Activation of monocytes by lipopolysaccharide resulted in the induction of MT1-MMP mRNA and protein that was suppressed by inhibitors of prostaglandin synthesis (indomethacin), adenylyl cyclase (SQ 22536), and protein kinase A (Rp-cAMPs). Suppression of MT1-MMP by indomethacin and SQ 22536 was reversed by prostaglandin E, and dibutyryl cyclic AMP, respectively, demonstrating that induction of monocyte MT1-MMP is regulated through a prostaglandin-cAMP pathway. Functional analysis revealed that pro-MMP-2 in the supernatants from human bone marrow stromal fibroblasts, normal male-derived fibroblasts and melanoma cells (A2058) was converted to active MMP-2 when cultured with activated but not control monocytes, Antibodies against MT1-MMP blocked the activation of MMP-2. Tissue inhibitor of metalloproteinase-2 regulation of MMP-2 activation was shown through the addition of varying amounts of recombinant tissue inhibitor of metalloproteinase-2 with pro-MMP-2 to MT1-MMP-expressing monocytes, These findings demonstrate that activated monocytes express functionally active MT1-MMP that may play a significant role in the activation of MMP-2 produced by other cells and as such influence developmental and pathological conditions.	NIDCR, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; NIDCR, Matrix Metalloprot Unit, NIH, Bethesda, MD 20892 USA; NCI, Extracellular Matrix Pathol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wahl, LM (corresponding author), NIDCR, Immunopathol Sect, NIH, 30 Convent Dr,Bldg 30,Rm 325, Bethesda, MD 20892 USA.		Stetler-Stevenson, William/AAE-3501-2020; Stetler-Stevenson, William G/H-6956-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Stetler-Stevenson, William G/0000-0002-5500-5808	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000456] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BAKER T, 1994, BRIT J CANCER, V70, P506, DOI 10.1038/bjc.1994.336; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BRINCKERHOFF C E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P145; BROWN PD, 1990, CANCER RES, V50, P6184; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; CORCORAN ML, 1994, ARCH BIOCHEM BIOPHYS, V310, P481, DOI 10.1006/abbi.1994.1196; COTTAM DW, 1992, INVEST OPHTH VIS SCI, V33, P1923; Deryugina EI, 1998, CANCER RES, V58, P3743; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; KLEINER DE, 1993, BIOCHEMISTRY-US, V32, P1583, DOI 10.1021/bi00057a024; Kuranami Masaru, 1994, Surgical Forum, V45, P551; Li L, 1997, EXP CELL RES, V232, P322, DOI 10.1006/excr.1997.3510; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MCCARTHY JB, 1980, J IMMUNOL, V124, P2405; Mertz PM, 1996, CELL IMMUNOL, V173, P252, DOI 10.1006/cimm.1996.0275; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; MURPHY G, 1989, INT J CANCER, V44, P757, DOI 10.1002/ijc.2910440434; Nagase H, 1998, Cell Res, V8, P179; NAKAJIMA M, 1987, CANCER RES, V47, P4869; PYKE C, 1993, AM J PATHOL, V142, P359; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shankavaram UT, 1997, J CELL PHYSIOL, V173, P327, DOI 10.1002/(SICI)1097-4652(199712)173:3<327::AID-JCP4>3.3.CO;2-R; Shankavaram UT, 1998, J LEUKOCYTE BIOL, V64, P221, DOI 10.1002/jlb.64.2.221; SHAPIRO SD, 1993, J BIOL CHEM, V268, P8170; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Swallow CJ, 1996, CLIN EXP METASTAS, V14, P3, DOI 10.1007/BF00157680; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wahl LM, 1997, TRANSPL IMMUNOL, V5, P173, DOI 10.1016/S0966-3274(97)80033-0; WAHL LM, 1974, P NATL ACAD SCI USA, V71, P3598, DOI 10.1073/pnas.71.9.3598; WAHL LM, 1987, CELL IMMUNOL, V105, P411, DOI 10.1016/0008-8749(87)90088-8; WAHL LM, 1977, P NATL ACAD SCI USA, V74, P4955, DOI 10.1073/pnas.74.11.4955; WAHL LM, 1991, CURRENT PROTOCOLS IM; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WATANABE H, 1993, J CELL SCI, V104, P991; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Werb Z, 1996, BRAZ J MED BIOL RES, V29, P1087; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Yamamoto M, 1996, CANCER RES, V56, P384; Zhang YH, 1998, J IMMUNOL, V161, P3071	50	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19027	19032		10.1074/jbc.M009562200	http://dx.doi.org/10.1074/jbc.M009562200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259424	hybrid			2022-12-27	WOS:000169091000052
J	Bateman, RL; Bhanumoorthy, P; Witte, JF; McClard, RW; Grompe, M; Timm, DE				Bateman, RL; Bhanumoorthy, P; Witte, JF; McClard, RW; Grompe, M; Timm, DE			Mechanistic inferences from the crystal structure of fumarylacetoacetate hydrolase with a bound phosphorus-based inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINEMIA TYPE-I; STATE ANALOG INHIBITORS; LETHAL ALBINO MICE; HEREDITARY TYROSINEMIA; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; HEPATIC-DYSFUNCTION; MURINE MODEL; GENE-THERAPY; ENZYME; HEPATOCYTES	Fumarylacetoacetate hydrolase (FAH) catalyzes the hydrolytic cleavage of a carbon-carbon bond in fumarylacetoacetate to yield fumarate and acetoacetate as the final step of Phe and Tyr degradation. This unusual reaction is an essential human metabolic function, with loss of FAH activity causing the fatal metabolic disease hereditary tyrosinemia type I (HT1), An enzymatic mechanism involving a catalytic metal ion, a Glu/His catalytic dyed, and a charged oxyanion hole was previously proposed based on recently determined FAH crystal structures. Here we report the development and characterization of an FAH inhibitor, 4-(hydroxymethylphosphinoyl)-3-oxo-butanoic acid (HMPOBA), that competes with the physiological substrate with a K-i of 85 muM. The crystal structure of FAH complexed with HMPOBA refined at 1.3-Angstrom resolution reveals the molecular basis for the competitive inhibition, supports the proposed formation of a tetrahedral alkoxy transition state intermediate during the FAH catalyzed reaction, and reveals a Mg2+ bound in the enzyme's active site. The analysis of FAH structures corresponding to different catalytic states reveals significant active site sidechain motions that may also be related to catalytic function. Thus, these results advance the understanding of an essential catabolic reaction associated with a fatal metabolic disease and provide insight into the structure-based development of FAH inhibitors.	Indiana Univ, Dept Biochem, Indianapolis, IN 46202 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Reed Coll, Dept Chem, Portland, OR 97202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; Reed College - Oregon	Timm, DE (corresponding author), Indiana Univ, Dept Biochem, Indianapolis, IN 46202 USA.			Grompe, Markus/0000-0002-6616-4345				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BARTLETT PA, 1983, BIOCHEMISTRY-US, V22, P4618, DOI 10.1021/bi00289a002; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; *CCP4, 1979, SERC UK COLL COMP PR; DIAZ E, 1995, J BIOL CHEM, V270, P6403, DOI 10.1074/jbc.270.11.6403; Endo F, 1997, J BIOL CHEM, V272, P24426, DOI 10.1074/jbc.272.39.24426; FRASER ME, 1992, BIOCHEMISTRY-US, V31, P5201, DOI 10.1021/bi00137a016; GILBERT-BARNESS E, 1990, Pediatric Pathology, V10, P243; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; HANSON JE, 1989, BIOCHEMISTRY-US, V28, P6294, DOI 10.1021/bi00441a022; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorquera R, 1999, FASEB J, V13, P2284, DOI 10.1096/fasebj.13.15.2284; Jorquera R, 1997, BIOCHEM BIOPH RES CO, V232, P42, DOI 10.1006/bbrc.1997.6220; KNOX WE, 1955, J BIOL CHEM, V216, P479; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P27; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; MAHURAN DJ, 1997, CAN J BIOCHEM, V55, P1; MANNE V, 1995, ONCOGENE, V10, P1763; MITCHELL G, 1990, NEW ENGL J MED, V322, P432, DOI 10.1056/NEJM199002153220704; Nandhagopal N, 1997, P JPN ACAD B-PHYS, V73, P154, DOI 10.2183/pjab.73.154; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overturf K, 1997, HUM GENE THER, V8, P513, DOI 10.1089/hum.1997.8.5-513; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PARADIS K, 1990, AM J HUM GENET, V47, P338; PHILLIPS MA, 1992, BIOCHEMISTRY-US, V31, P959, DOI 10.1021/bi00119a003; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; StLouis M, 1997, HUM MUTAT, V9, P291, DOI 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9; STONER E, 1984, PEDIATR RES, V18, P1332, DOI 10.1203/00006450-198412000-00023; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; TIMMIS KN, 1994, ANNU REV MICROBIOL, V48, P525, DOI 10.1146/annurev.mi.48.100194.002521; WEILER L, 1970, J AM CHEM SOC, V92, P6702, DOI 10.1021/ja00725a088	36	49	51	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 4	2001	276	18					15284	15291		10.1074/jbc.M007621200	http://dx.doi.org/10.1074/jbc.M007621200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429QQ	11154690	hybrid			2022-12-27	WOS:000168528800101
J	Campeau, E; Gravel, RA				Campeau, E; Gravel, RA			Expression in Escherichia coli of N- and C-terminally deleted human holocarboxylase synthetase - Influence of the N-terminus on biotinyilation and identification of a minimum functional protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE CARBOXYLASE DEFICIENCY; ACETYL-COA CARBOXYLASE; BIOTIN HOLOENZYME SYNTHETASE; COENZYME-A CARBOXYLASE; CARRIER PROTEIN; DNA-BINDING; POSTTRANSLATIONAL MODIFICATION; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA	Biotin functions as a covalently bound cofactor of biotindependent carboxylases. Biotin attachment is catalyzed by biotin protein ligases, called holocarboxylase synthetase in mammals and BirA in prokaryotes. These enzymes show a high degree of sequence similarity in their biotinylation domains but differ markedly in the length and sequence of their N terminus. BirA is also the repressor of the biotin operon, and its DNA attachment site is located in its N terminus. The function of the eukaryotic N terminus is unknown. Holocarboxylase synthetase with N- and C-terminal deletions were evaluated for the ability to catalyze biotinylation after expression in Escherichia coli using bacterial and human acceptor substrates. We showed that the minimum functional protein is comprised of the last 349 of the 726-residue protein, which includes the biotinylation domain. Significantly, enzyme containing intermediate length, N-terminal deletions interfered with biotin transfer and interaction with different peptide acceptor substrates. We propose that the N terminus of holocarboxylase synthetase contributes to biotinylation through N- and C-terminal interactions and may affect acceptor substrate recognition. Our findings provide a rationale for the biotin responsiveness of patients with point mutations in the N-terminal sequence of holocarboxylase synthetase, Such mutant enzyme may respond to biotin-mediated stabilization of the substrate-bound complex.	McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Res Inst,Dept Biol, Montreal, PQ H3Z 2Z3, Canada; McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Res Inst,Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Res Inst,Dept Pediat, Montreal, PQ H3Z 2Z3, Canada	McGill University; McGill University; McGill University	Gravel, RA (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Room 250 Heritage Med Res Bldg,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.							Aoki Y, 1999, HUM GENET, V104, P143, DOI 10.1007/s004390050927; Aoki Y, 1995, BBA-MOL BASIS DIS, V1272, P168, DOI 10.1016/0925-4439(95)00082-8; Aoki Y, 1997, PEDIATR RES, V42, P849, DOI 10.1203/00006450-199712000-00021; Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; Baumgartner ER, 1997, INT J VITAM NUTR RES, V67, P377; BOWER S, 1995, J BACTERIOL, V177, P2572, DOI 10.1128/jb.177.9.2572-2575.1995; BUONCRISTIANI MR, 1986, GENE, V44, P255, DOI 10.1016/0378-1119(86)90189-7; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CHAPMANSMITH A, 1999, J NUTR, V477, pS484; CHAUHAN J, 1991, J BIOL CHEM, V266, P10035; CRONAN JE, 1995, FEMS MICROBIOL LETT, V130, P221, DOI 10.1016/0378-1097(95)00210-V; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DAKSHINAMURTI K, 1994, MOL CELL BIOCHEM, V132, P127, DOI 10.1007/BF00926921; Dupuis L, 1996, HUM MOL GENET, V5, P1011, DOI 10.1093/hmg/5.7.1011; Dupuis L, 1999, MOL GENET METAB, V66, P80, DOI 10.1006/mgme.1998.2785; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; LI SJ, 1992, J BIOL CHEM, V267, P855; Lindqvist Y, 1996, CURR OPIN STRUC BIOL, V6, P798, DOI 10.1016/S0959-440X(96)80010-8; MCALLISTER HC, 1966, J BIOL CHEM, V241, P2855; MURTIF VL, 1987, J BIOL CHEM, V262, P11813; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; Reddy DV, 2000, BIOCHEMISTRY-US, V39, P2509, DOI 10.1021/bi9925367; REED KE, 1991, J BIOL CHEM, V266, P11425; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; Sakamoto O, 1999, PEDIATR RES, V46, P671, DOI 10.1203/00006450-199912000-00006; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SINGH IN, 1988, MOL CELL BIOCHEM, V79, P47, DOI 10.1007/BF00229397; SPENCE JT, 1984, J BIOL CHEM, V259, P6393; Stockert RJ, 1997, J BIOL CHEM, V272, P9161; Streaker ED, 1998, BIOCHEMISTRY-US, V37, P3210, DOI 10.1021/bi9715019; Suormala T, 1997, PEDIATR RES, V41, P666, DOI 10.1203/00006450-199705000-00011; Suzuki Y, 1996, CLIN CHIM ACTA, V251, P41, DOI 10.1016/0009-8981(96)06291-2; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; Tissot G, 1998, EUR J BIOCHEM, V258, P586, DOI 10.1046/j.1432-1327.1998.2580586.x; Tissot G, 1997, BIOCHEM J, V323, P179, DOI 10.1042/bj3230179; Val DL, 1995, BIOCHEM J, V312, P817, DOI 10.1042/bj3120817; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wolfe BE, 1995, IN SESSION-PSYCHOTH, V1, P1; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f	52	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12310	12316		10.1074/jbc.M009717200	http://dx.doi.org/10.1074/jbc.M009717200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11124959	hybrid			2022-12-27	WOS:000168081800116
J	Kumar, R; Grammatikakis, N; Chinkers, M				Kumar, R; Grammatikakis, N; Chinkers, M			Regulation of the atrial natriuretic peptide receptor by heat shock protein 90 complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE MUTANT; GUANYLYL CYCLASES; IMMUNOPHILIN FKBP51; SQUIRREL-MONKEY; HSP90; KINASE; DOMAIN; PHOSPHATASE-5; DEGRADATION; ACTIVATION	Heat shock protein 90 (hsp90) is a chaperone required for the proper folding and trafficking of many proteins involved in signal transduction. We tested whether hsp90 plays a role as a chaperone for GC-A, the membrane guanylate cyclase that acts as a receptor for atrial natriuretic peptide (ANP). When cultured cells expressing recombinant GC-A were treated with geldanamycin, an inhibitor of hsp90 function, the ANP-stimulated production of cyclic GMP was inhibited. This suggested that hsp90 was required for GC-A processing and/or stability. A physical association between hsp90 and GC-A was demonstrated in coimmunoprecipitation experiments. Treatment with geldanamycin disrupted this association and led to the accumulation of complexes containing GC-A and heat shock protein 70 (hsp70). Protein folding pathways involving hsp70 and hsp90 include several pathway-specific co-chaperones. Complexes between GC-A and hsp90 contained the co-chaperone p50(cdc37), typically found associated with protein. kinase hsp(90) heterocomplexes, GC-A immunoprecipitates did not contain detectable amounts of Hop, FKBP51, FKBP52, PP5, or p23, all co-chaperones found in hsp90 complexes with other signaling proteins. The association of hsp90 and p50(cdc37) with GC-A was dependent on the kinase homology domain of this receptor but not on its ANP-binding, transmembrane, or guanylate cyclase domains. The data suggest that GC-A is regulated by hsp90 complexes similar to those involved in the maturation of protein kinases.	Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA	University of South Alabama; Lankenau Medical Center; Lankenau Institute for Medical Research	Chinkers, M (corresponding author), Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA.				NHLBI NIH HHS [HL 47063] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047063] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birnby DA, 2000, GENETICS, V155, P85; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Busconi L, 2000, J BIOL CHEM, V275, P1565, DOI 10.1074/jbc.275.3.1565; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hartson SD, 1998, J BIOL CHEM, V273, P8475, DOI 10.1074/jbc.273.14.8475; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; KOLLER KJ, 1992, MOL CELL BIOL, V12, P2581, DOI 10.1128/MCB.12.6.2581; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lucas KA, 2000, PHARMACOL REV, V52, P375; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0	25	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11371	11375		10.1074/jbc.M010480200	http://dx.doi.org/10.1074/jbc.M010480200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152473	hybrid			2022-12-27	WOS:000167980900107
J	Van Baelen, K; Vanoevelen, J; Missiaen, L; Raeymaekers, L; Wuytack, F				Van Baelen, K; Vanoevelen, J; Missiaen, L; Raeymaekers, L; Wuytack, F			The Golgi PMR1 P-type ATPase of Caenorhabditis elegans - Identification of the gene and demonstration of calcium and manganese transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; PROPERTIES DISTINCT; MOLECULAR-CLONING; CA2+ PUMP; ION-PUMP; EF-HAND; CA2+-ATPASE; MUTATIONS	In recent years, it has been well established that the Ca2+ concentration in the lumen of intracellular organelles is a key determinant of cell function. Despite the fact that essential functions of the Golgi apparatus depend on the Ca2+ and Mn2+ concentration in its lumen, little is known on the transport system responsible for ion accumulation. The Golgis ion pump PMR1 has been functionally studied only in yeast. In humans, mutations in the orthologous gene ATP2C1 cause Hailey-Hailey disease. We report here the identification of the PMR1 homologue in the model organism Caenorhabditis elegans and after ectopic expression the direct study of its ion transport in permeabilized COS-1 cells. The C. elegans genome is predicted to contain a single PMR1 orthologue on chromosome I. We found evidence for alternative splicing in the 5'-untranslated region, but no indication for the generation of different protein isoforms. C. elegans PMR1 overexpressed in COS-1 cells transports Ca2+ and Mn2+ with high affinity into the Golgi apparatus in a thapsigargin-insensitive manner. Part of the accumulated Ca2+ can be released by inositol 1,4,5-trisphosphate, in agreement with the idea that the Golgis apparatus is an inositol 1,4,5-trisphosphate-sensitive Ca2+ store.	Katholieke Univ Leuven, Physiol Lab, B-3000 Louvain, Belgium	KU Leuven	Van Baelen, K (corresponding author), Katholieke Univ Leuven, Physiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	Kurt.Vanbaelen@med.kuleuven.ac.be	Vanoevelen, Jo M/F-2686-2013	Vanoevelen, Jo M/0000-0003-1830-8858				ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Baylis HA, 1999, J MOL BIOL, V294, P467, DOI 10.1006/jmbi.1999.3229; Benito B, 2000, MOL MICROBIOL, V35, P1079, DOI 10.1046/j.1365-2958.2000.01776.x; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BLUMENTHAL T, 1988, TRENDS GENET, V4, P305, DOI 10.1016/0168-9525(88)90107-2; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cools J, 1999, BLOOD, V94, P1820, DOI 10.1182/blood.V94.5.1820.417k09_1820_1824; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Degand I, 1999, MOL MICROBIOL, V31, P545, DOI 10.1046/j.1365-2958.1999.01195.x; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GUNTESKIHAMBLIN AM, 1992, BIOCHEMISTRY-US, V31, P7600, DOI 10.1021/bi00148a023; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; IVESSA NE, 1995, J BIOL CHEM, V270, P25960, DOI 10.1074/jbc.270.43.25960; Kraev A, 1999, J BIOL CHEM, V274, P4254, DOI 10.1074/jbc.274.7.4254; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Martell A. E., 1974, CRITICAL STABILITY C; MISSIAEN L, 1994, J BIOL CHEM, V269, P7238; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Sorin A, 1997, J BIOL CHEM, V272, P9895; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Taylor RS, 1997, MOL BIOL CELL, V8, P1911, DOI 10.1091/mbc.8.10.1911; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wei Y, 2000, J BIOL CHEM, V275, P23927, DOI 10.1074/jbc.M002618200; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; WUYTACK F, 1982, BIOCHIM BIOPHYS ACTA, V693, P45, DOI 10.1016/0005-2736(82)90469-2; Yagodin S, 1999, CELL CALCIUM, V25, P429, DOI 10.1054/ceca.1999.0043; ZHA XH, 1995, AM J PHYSIOL-CELL PH, V268, pC1133, DOI 10.1152/ajpcell.1995.268.5.C1133	41	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10683	10691		10.1074/jbc.M010553200	http://dx.doi.org/10.1074/jbc.M010553200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134055	hybrid			2022-12-27	WOS:000167980900018
J	Zimmermann, J; Lamerant, N; Grossenbacher, R; Furst, P				Zimmermann, J; Lamerant, N; Grossenbacher, R; Furst, P			Proteasome- and p38-dependent regulation of ERK3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; HUMAN HOMOLOG; CHOP GADD153; P53; APOPTOSIS; GENES; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; INHIBITORS	Proteasome inhibition leads to accumulation of transcription factors, heat shock proteins, cyclins, and other proteasome substrate proteins by blocking their proteolytic degradation. An increase in gene transcription upon proteasome inhibition was found for a group of proteins, including p21(WAF1/CIP1), ubiquitin, and transcription factors, In this study, we have demonstrated selective up-regulation of extracellular signal-regulated kinase 3 (ERK3) mRNA and protein expression upon treatment with peptide based proteasome inhibitors or lactacystin. ERK3 is a family member of the mitogen-activated protein kinases (also called ERK) that are key mediators of signal transduction from the cell surface to the nucleus. ERK3 up-regulation is independent of the p53, Bcl2, and caspase 3 status of cells. p38 pathway kinase inhibitors prevent proteasome-dependent ERK3 induction and enhance the antiproliferative effect of proteasome inhibitors. MCF-7 cells expressing ERK3 ectopically show increased resistance toward proteasome inhibition. The results indicate that ERK3 expression is a consequence of p38 pathway activation and most probably represents an intracellular defense or rescue mechanism against cell stress and damage induced by proteasome inhibition.	Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland	Novartis	Furst, P (corresponding author), Novartis Pharma AG, Oncol Res, WKL-125-13-14, CH-4002 Basel, Switzerland.	peter.fuerst@pharma.novartis.com						Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Camarillo IG, 1997, P SOC EXP BIOL MED, V215, P198, DOI 10.3181/00379727-215-44129; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chang DD, 1998, ONCOGENE, V16, P1921, DOI 10.1038/sj.onc.1201715; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Eymin B, 1997, CANCER RES, V57, P686; He HL, 1998, J BIOL CHEM, V273, P25015, DOI 10.1074/jbc.273.39.25015; ISAACS WB, 1991, CANCER RES, V51, P4716; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kleines M, 2000, BBA-GENE STRUCT EXPR, V1492, P139, DOI 10.1016/S0167-4781(00)00098-1; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Meloche S, 1996, ONCOGENE, V13, P1575; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; *PE APPL BIOS, 1997, US B PE APPL BIOS, V2; Qi XM, 1997, ONCOGENE, V15, P1207, DOI 10.1038/sj.onc.1201290; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Tchernitsa OI, 1999, ONCOGENE, V18, P5448, DOI 10.1038/sj.onc.1202987; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; VanLint C, 1996, GENE EXPRESSION, V5, P245; WANG NP, 1993, ONCOGENE, V8, P279; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; YOSHIDA H, 1992, JPN J CANCER RES, V83, P324, DOI 10.1111/j.1349-7006.1992.tb00109.x; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; ZHU AX, 1994, MOL CELL BIOL, V14, P8202, DOI 10.1128/MCB.14.12.8202; Zimmermann J, 2000, ONCOGENE, V19, P2913, DOI 10.1038/sj.onc.1203606	37	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10759	10766		10.1074/jbc.M008567200	http://dx.doi.org/10.1074/jbc.M008567200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148204	hybrid			2022-12-27	WOS:000167980900028
J	Bebenek, A; Dressman, HK; Carver, GT; Ng, SS; Petrov, V; Yang, GW; Konigsberg, WH; Karam, JD; Drake, JW				Bebenek, A; Dressman, HK; Carver, GT; Ng, SS; Petrov, V; Yang, GW; Konigsberg, WH; Karam, JD; Drake, JW			Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-EVEN BACTERIOPHAGES; SPONTANEOUS MUTATION; CRYSTAL-STRUCTURE; BIOCHEMICAL BASIS; ESCHERICHIA-COLI; KLENOW FRAGMENT; MISMATCH REPAIR; MUTANTS; RATES; GENE	The DNA polymerases (gp43s) of the related bacteriophages T4 and RB69 are B family (polymerase alpha class) enzymes that determine the fidelity of phage DNA replication. A T4 whose gene 43 has been mutationally inactivated can be replicated by a cognate RB69 gp43 encoded by a recombinant plasmid in T l-infected Escherichia coli. We used this phage-plasmid complementation assay to obtain rapid and sensitive measurements of the mutational specificities of mutator derivatives of the RB69 enzyme, RB69 gp43s lacking proofreading function (Exo(-) enzymes) and/or substituted with alanine, serine, or threonine at the conserved polymerase function residue Tyr(567) (Pol(Y567(A/S/T)) enzymes) were examined for their effects on the reversion of specific mutations in the T4 rII gene and on forward mutation in the T4 rI gene. The results reveal that Tyr567 is a key determinant of the fidelity of base selection and that the Pol and fro functions are strongly coupled in this B family enzyme, In vitro assays show that the Pol(Y567A) EXO- enzyme generates mispairs more frequently but extends them less efficiently than does a pol(+) Exo- enzyme. Other replicative DNA polymerases may control fidelity by strategies similar to those used by RB69 gp43.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tulane University; Yale University	Drake, JW (corresponding author), NIEHS, Mol Genet Lab, NIH, E3-01,Rm E-344,111 S Alexander Dr, Res Triangle Pk, NC 27709 USA.			Bebenek, Anna/0000-0001-5374-8205	NIDDK NIH HHS [DK09070] Funding Source: Medline; NIGMS NIH HHS [GM54627, GM18842] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK009070, R01DK009070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES061054, ZIAES061054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054627] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bebenek A, 1999, J BACTERIOL, V181, P3123, DOI 10.1128/JB.181.10.3123-3128.1999; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; BESSMAN MJ, 1977, J MOL BIOL, V116, P115, DOI 10.1016/0022-2836(77)90122-X; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; CONKLING MA, 1980, J MOL BIOL, V143, P303, DOI 10.1016/0022-2836(80)90192-8; CONKLING MA, 1984, GENETICS, V107, P505; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DRAKE JW, 1963, J MOL BIOL, V6, P268, DOI 10.1016/S0022-2836(63)80088-1; DRAKE JW, 1994, MOL BIOL BACTERIOP T, V4, P98; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KARAM JD, 1973, J VIROL, V11, P933, DOI 10.1128/JVI.11.6.933-945.1973; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Morales JC, 2000, BIOCHEMISTRY-US, V39, P2626, DOI 10.1021/bi992173a; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; NELSON MA, 1982, MOL GEN GENET, V188, P60, DOI 10.1007/BF00332996; Nossal NG, 1998, GENETICS, V148, P1535; Paddison P, 1998, GENETICS, V148, P1539; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PRIBNOW D, 1981, J MOL BIOL, V149, P337, DOI 10.1016/0022-2836(81)90477-0; Reha-Krantz LJ, 1998, GENETICS, V148, P1551; REHAKRANTZ LJ, 1991, P NATL ACAD SCI USA, V88, P2417, DOI 10.1073/pnas.88.6.2417; REHAKRANTZ LJ, 1994, MOL BIOL BACTERIOP T, V4, P307; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Russell R.L., 1967, SPECIATION T EVEN BA; RUSSELL RL, 1974, GENETICS, V78, P989; SANTOS ME, 1994, GENETICS, V138, P553; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SINGER BS, 1984, MOL GEN GENET, V193, P104, DOI 10.1007/BF00327422; Smith LA, 1998, GENETICS, V148, P1611; SNUSTAD DP, 1968, VIROLOGY, V35, P550, DOI 10.1016/0042-6822(68)90285-7; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUGINO A, 1984, J MOL BIOL, V176, P239, DOI 10.1016/0022-2836(84)90422-4; Wang CC, 1997, J BIOL CHEM, V272, P17703, DOI 10.1074/jbc.272.28.17703; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; Wang FJ, 1998, GENETICS, V148, P1655; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Yeh LS, 1998, J BACTERIOL, V180, P2005, DOI 10.1128/JB.180.8.2005-2013.1998; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2	53	53	54	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10387	10397		10.1074/jbc.M007707200	http://dx.doi.org/10.1074/jbc.M007707200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133987	hybrid			2022-12-27	WOS:000167996400105
J	Sato, H; Kuriyama-Matsumura, K; Hashimoto, T; Sasaki, H; Wang, HY; Ishii, T; Mann, GE; Bannai, S				Sato, H; Kuriyama-Matsumura, K; Hashimoto, T; Sasaki, H; Wang, HY; Ishii, T; Mann, GE; Bannai, S			Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; NF-KAPPA-B; TRANSCRIPTION FACTOR; ARGININE TRANSPORT; MEMBRANE-PROTEIN; NITRIC-OXIDE; HEAVY-CHAIN; GLUTATHIONE; METABOLISM	Amino acid transport in mouse peritoneal macrophages is mediated by several membrane carriers with different substrate specificity and sensitivity to environmental stimuli. We reported previously that transport activities of cystine and arginine in the macrophages were induced markedly by low concentrations of bacterial lipopolysaccharide (LPS), It is known that a variety of macrophage functions are affected by ambient oxygen tension. In this study, we have investigated the effects of oxygen on the induction of amino acid transport activity by LPS and found that the induction of cystine, but not arginine, transport activity was dependent on the ambient oxygen tension. When the macrophages were cultured with 2% O-2 in the presence of 1 ng/ml LPS, induction of cystine transport activity was reduced by similar to 70% compared with cells cultured under normoxic conditions. In macrophages, transport of cystine is mediated by a Na+-independent anionic amino acid transporter named system x(c)(-). System x(c)(-) is composed of two protein components, xCT and 4F2hc, and the expression of xCT was closely correlated with system x(c)(-) activity. A putative NF-kappaB binding site was found in the 5 ' -flanking region of the xCT gene, but the enhanced expression of xCT by LPS and oxygen was not mediated by NF-KB binding. An increase in intracellular GSH in macrophages paralleled induction of xCT, but not gamma -glutamylcysteine synthetase, These results suggest the importance of system x(c)(-) in antioxidant defense in macrophages exposed to LPS and oxidative stress.	Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 3058575, Japan; Kings Coll London, Guys Kings & St Thomas Sch Biomed Sci, Ctr Cardiovasc Biol & Med, London SE1 1UL, England	University of Tsukuba; University of London; King's College London	Sato, H (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 3058575, Japan.	hideyo-s@md.tsukuba.ac.jp		Mann, Giovanni/0000-0001-7311-2044				BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BOGLE RG, 1992, BIOCHEM J, V284, P15, DOI 10.1042/bj2840015; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CLOSS EI, 1993, J BIOL CHEM, V268, P20796; COTGREAVE IA, 1986, J BIOCHEM BIOPH METH, V13, P231, DOI 10.1016/0165-022X(86)90102-8; Deves R, 2000, J MEMBRANE BIOL, V173, P165, DOI 10.1007/s002320001017; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaul N, 1998, FREE RADICAL BIO MED, V24, P202, DOI 10.1016/S0891-5849(97)00209-8; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Li HF, 1999, AM J PHYSIOL-CELL PH, V276, pC803, DOI 10.1152/ajpcell.1999.276.4.C803; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Monick MM, 1999, J BIOL CHEM, V274, P18075, DOI 10.1074/jbc.274.25.18075; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; SAGARA J, 1993, J NEUROCHEM, V61, P1667, DOI 10.1111/j.1471-4159.1993.tb09801.x; Sagara JI, 1996, J NEUROCHEM, V66, P1876; SATO H, 1991, BIOCHIM BIOPHYS ACTA, V1069, P46, DOI 10.1016/0005-2736(91)90102-E; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; SATO H, 1987, J BIOL CHEM, V262, P13015; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SATO H, 1992, J LEUKOCYTE BIOL, V52, P161, DOI 10.1002/jlb.52.2.161; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Sekhar KR, 1997, RADIAT RES, V147, P592, DOI 10.2307/3579626; Shibazaki T, 1996, BBA-MOL CELL RES, V1311, P150, DOI 10.1016/0167-4889(95)00198-0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; TOWELL ME, 1976, J APPL PHYSIOL, V41, P245, DOI 10.1152/jappl.1976.41.2.245; WATANABE H, 1987, J EXP MED, V165, P628, DOI 10.1084/jem.165.3.628	33	76	77	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10407	10412		10.1074/jbc.M007216200	http://dx.doi.org/10.1074/jbc.M007216200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11136724	hybrid			2022-12-27	WOS:000167996400107
J	Hayashi, M; Tapping, RI; Chao, TH; Lo, JF; King, CC; Yang, Y; Lee, JD				Hayashi, M; Tapping, RI; Chao, TH; Lo, JF; King, CC; Yang, Y; Lee, JD			BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THREONINE PROTEIN-KINASE; MAP KINASE; PROTEIN-KINASE-1 BMK1; SIGNALING PATHWAYS; CYCLE; SGK; BMK1/ERK5; FAMILY	Activation of the mammalian mitogen-activated protein kinase known as BMK1 is required for growth factor-induced cell proliferation. To understand the mechanism by which BMK1 mediates this cellular response, this kinase was used as bait in a yeast two-hybrid-based library screening. Here, we report the identification of serum and glucocorticoid-inducible kinase (SGK) as a cellular protein that physically interacts with BMK1. During growth factor-induced cell stimulation, BMK1 activates SGK by phosphorylation at serine 78. This BMK1-mediated phosphorylation event is necessary for the activation of SGK and, more importantly, for cell proliferation induced by growth factors.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.		King, Cecile/Q-9794-2019; Lo, Jeng-Fan/AAE-9626-2020; Lo, Jeng-Fan/ABB-2820-2020	King, Cecile/0000-0003-2193-2563; Lo, Jeng-Fan/0000-0001-7188-9140; Lo, Jeng-Fan/0000-0001-7188-9140	NATIONAL CANCER INSTITUTE [R01CA079871] Funding Source: NIH RePORTER; NCI NIH HHS [CA79871] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Fiddes RJ, 1998, ONCOGENE, V16, P2803, DOI 10.1038/sj.onc.1201815; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pelech S L, 1995, Prog Cell Cycle Res, V1, P33; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	27	100	108	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8631	8634		10.1074/jbc.C000838200	http://dx.doi.org/10.1074/jbc.C000838200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11254654	hybrid			2022-12-27	WOS:000167607700003
J	Suzuki, Y; Yoda, T; Ruhul, A; Sugiura, W				Suzuki, Y; Yoda, T; Ruhul, A; Sugiura, W			Molecular cloning and characterization of the gene coding for azoreductase from Bacillus sp OY1-2 isolated from soil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZO DYES; MINERALIZATION; DEHYDROGENASE; STREPTOMYCES	Azo dyes are regarded as pollutants because they are not readily reduced under aerobic conditions. Bacillus sp, OY1-2 transforms azo dyes into colorless compounds, and this reduction is mediated by a reductase activity for the azo group in the presence of NADPH, A 1.2-kbp EcoRI fragment containing the gene that encodes azoreductase was cloned by screening the genomic library of Bacillus sp, OY1-2 with digoxigenin-labeled probe designed from the N-terminal amino acid sequence of the purified enzyme. An open reading frame encoding the azoreductase, consisting of 178 amino acids, was predicted from the nucleotide sequence. In addition, because only a Bacillus subtillis hypothetical protein was discovered in the public databases (with an amino acid identity of 52.8%), the gene encoding the azoreductase cloned in this study was predicted to be a member of a novel family of reductases. Southern blot analysis revealed that the azoreductase gene exists as a single copy gene on a chromosome. Escherichia coli-expressing recombinant azoreductase gave a ten times greater reducing activity toward azo dyes than the original Bacillus sp, OY1-2, In addition, the expressed azoreductase purified from the recombinant E. coli lysate by Red-Sepharose affinity chromatography showed a similar activity and specificity as the native enzyme. This is the first report describing the sequencing and characterization of a gene encoding the azo dye-reducing enzyme, azoreductase, from aerobic bacteria and its expression in E. coli.	Osaka Prefectural Inst Publ Hlth, Dept Pathol, Higashinari Ku, Osaka 5370025, Japan; Osaka Prefectural Inst Publ Hlth, Dept Food Microbiol, Higashinari Ku, Osaka 5370025, Japan; Osaka Prefectural Inst Publ Hlth, Dept Environm Sanitat, Higashinari Ku, Osaka 5370025, Japan	Osaka Prefectural Institute of Public Health; Osaka Prefectural Institute of Public Health; Osaka Prefectural Institute of Public Health	Suzuki, Y (corresponding author), Osaka Prefectural Inst Publ Hlth, Dept Pathol, Higashinari Ku, 1-3-69 Nakamichi, Osaka 5370025, Japan.	suzuki@iph.pref.osaka.jp	Suzuki, Yasuhiko/F-6890-2012					AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bragg PD, 1997, ARCH BIOCHEM BIOPHYS, V338, P57, DOI 10.1006/abbi.1996.9797; HAUG W, 1991, APPL ENVIRON MICROB, V57, P3144, DOI 10.1128/AEM.57.11.3144-3149.1991; HEISS GS, 1992, FEMS MICROBIOL LETT, V99, P221, DOI 10.1111/j.1574-6968.1992.tb05571.x; KIM SMF, 1991, APPL ENVIRON MICROB, V57, P2413, DOI 10.1128/AEM.57.8.2413-2417.1991; Kulla H. G., 1981, MICROBIAL DEGRADATIO, V12, P387; LEVINE WG, 1991, DRUG METAB REV, V23, P253, DOI 10.3109/03602539109029761; MCKIE JH, 1993, BIOCHIM BIOPHYS ACTA, V1202, P61, DOI 10.1016/0167-4838(93)90063-W; Meyer U., 1981, MICROBIAL DEGRADATIO, P371; PASTIGRIGSBY MB, 1992, APPL ENVIRON MICROB, V58, P3605, DOI 10.1128/AEM.58.11.3605-3613.1992; PASZCZYNSKI A, 1992, APPL ENVIRON MICROB, V58, P3598, DOI 10.1128/AEM.58.11.3598-3604.1992; Rafii F, 1999, J BASIC MICROB, V39, P29, DOI 10.1002/(SICI)1521-4028(199903)39:1<29::AID-JOBM29>3.0.CO;2-W; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZERETTMER R, 1996, TEXTILVEREDLUNG, V31, P13; Shimada T, 2000, PROTEIN EXPRES PURIF, V20, P73, DOI 10.1006/prep.2000.1302; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sugiura W, 1999, J BIOSCI BIOENG, V88, P577, DOI 10.1016/S1389-1723(00)87680-X; Suzuki Y, 1995, Kansenshogaku Zasshi, V69, P413; Tan NCG, 1999, APPL MICROBIOL BIOT, V51, P865, DOI 10.1007/s002530051475; Zolinger H., 1987, COLOR CHEM SYNTHESES, V1	21	120	142	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					9059	9065		10.1074/jbc.M008083200	http://dx.doi.org/10.1074/jbc.M008083200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134015	hybrid			2022-12-27	WOS:000167607700060
J	Frohlich, RF; Hansen, SG; Lisby, M; Grainge, I; Westergaard, O; Jayaram, M; Knudsen, BR				Frohlich, RF; Hansen, SG; Lisby, M; Grainge, I; Westergaard, O; Jayaram, M; Knudsen, BR			Inhibition of Flp recombinase by the topoisomerase I-targeting drugs, camptothecin and NSC-314622	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; DNA CLEAVAGE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MUTATIONS; MECHANISM; SEQUENCE; COMPLEX; IDENTIFICATION; RESISTANCE	Recombinases of the h-Int family and type IB topoisomerases act by introducing transient single strand breaks in DNA using chemically identical reaction schemes. Recent structural data have supported the relationship between the two enzyme groups by revealing considerable similarities in the architecture of their catalytic pockets. In this study we show that the Int-type recombinase Flp is inhibited by the two structurally unrelated topoisomerase I-directed anti-cancer drugs, camptothecin (CPT) and NSC-314622. The interaction of these drugs with topoisomerase I is very specific with several single amino acid substitutions conferring drug resistance to the enzyme. Thus, the observed interaction of CPT and NSC-314622 with Flp, which is comparable to their interaction with the cleavage complex formed by topoisomerase I, strongly supports a close mechanistic and evolutionary relationship between the two enzymes. The results suggest that Flp and other Int family recombinases may provide model systems for dissecting the molecular mechanisms of topoisomerase I-directed anti-cancer therapeutic agents.	Aarhus Univ, Dept Mol & Struct Biol, DK-8000 Aarhus C, Denmark; Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	Aarhus University; University of Texas System; University of Texas Austin	Knudsen, BR (corresponding author), Aarhus Univ, Dept Mol & Struct Biol, Bldg 130,CF Mollers ALle, DK-8000 Aarhus C, Denmark.		Grainge, Ian RF/A-9031-2010; Lisby, Michael/K-9814-2014	Grainge, Ian RF/0000-0001-8268-583X; Lisby, Michael/0000-0002-4830-5247; Knudsen, Birgitta Ruth/0000-0002-3484-3802				ABREMSKI K, 1986, J BIOL CHEM, V261, P391; BENEDETTI P, 1993, CANCER RES, V53, P4343; Caruthers M H, 1983, Gene Amplif Anal, V3, P1; CHEN JW, 1992, MOL CELL BIOL, V12, P3757, DOI 10.1128/MCB.12.9.3757; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; CHRISTIANSEN K, 1993, J BIOL CHEM, V268, P9690; Christiansen K, 1996, ANN NY ACAD SCI, V803, P50, DOI 10.1111/j.1749-6632.1996.tb26376.x; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; GUPTA M, 1992, J BIOL CHEM, V267, P24177; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; JAXEL C, 1991, J BIOL CHEM, V266, P20418; JAYARAM M, 1994, TRENDS BIOCHEM SCI, V19, P78, DOI 10.1016/0968-0004(94)90039-6; KIKUCHI Y, 1979, P NATL ACAD SCI USA, V76, P3760, DOI 10.1073/pnas.76.8.3760; KJELDSEN E, 1988, J MOL BIOL, V202, P333, DOI 10.1016/0022-2836(88)90462-7; Knudsen BR, 1997, J MOL BIOL, V266, P93, DOI 10.1006/jmbi.1996.0767; Kohlhagen G, 1998, MOL PHARMACOL, V54, P50, DOI 10.1124/mol.54.1.50; LEE J, 1993, J BIOL CHEM, V268, P17564; LEE J, 1995, J BIOL CHEM, V270, P23203, DOI 10.1074/jbc.270.39.23203; Lee J, 1999, EMBO J, V18, P784, DOI 10.1093/emboj/18.3.784; Li XG, 1996, ANN NY ACAD SCI, V803, P111, DOI 10.1111/j.1749-6632.1996.tb26381.x; Lisby M, 1998, BIOCHEMISTRY-US, V37, P10815, DOI 10.1021/bi980757r; POMMIER Y, 1995, P NATL ACAD SCI USA, V92, P8861, DOI 10.1073/pnas.92.19.8861; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pond CD, 1999, ANTI-CANCER DRUG, V10, P647, DOI 10.1097/00001813-199908000-00004; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; Sekiguchi JA, 1996, P NATL ACAD SCI USA, V93, P785, DOI 10.1073/pnas.93.2.785; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; SHUMAN S, 1991, P NATL ACAD SCI USA, V88, P10104, DOI 10.1073/pnas.88.22.10104; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Straub T, 1997, BIOCHEMISTRY-US, V36, P10777, DOI 10.1021/bi970417q; TANIZAWA A, 1993, J BIOL CHEM, V268, P25463; THOMSEN B, 1987, EMBO J, V6, P1817, DOI 10.1002/j.1460-2075.1987.tb02436.x; Wang LF, 1997, CANCER RES, V57, P1516; Xu CJ, 1998, MOL CELL, V1, P729, DOI 10.1016/S1097-2765(00)80072-6	41	1	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6993	6997		10.1074/jbc.C000901200	http://dx.doi.org/10.1074/jbc.C000901200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11152668	hybrid			2022-12-27	WOS:000167442900019
J	Overgaard, MT; Boldt, HB; Laursen, LS; Sottrup-Jensen, L; Conover, CA; Oxvig, C				Overgaard, MT; Boldt, HB; Laursen, LS; Sottrup-Jensen, L; Conover, CA; Oxvig, C			Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BASIC-PROTEIN; HUMAN FIBROBLASTS; IDENTIFICATION; EXPRESSION; SEQUENCE; PROFORM; PROTEOLYSIS; SUPERFAMILY; INHIBITOR; SERUM	A novel metalloproteinase with similarity to]pregnancy-associated plasma protein-A (PAPP-A), which we denoted PAPP-A2, has been identified. Through expression in mammalian cells we showed that recombinant PAPP-A2 polypeptide of 1558 residues resulted from processing of a 1791-residue prepro-protein, Unlike PAPP-A, PAPP-A2 migrated as a monomer (of 220 kDa) in non-reducing SDS-polyacrylamide gel electrophoresis. The prepro-parts of PAPP-A2 and PAPP-A are not homologous, but mature PAPP-A2 shares 45% of its residues with PAPP-A, Because PAPP-A specifically cleaves insulin-like growth factor-binding protein (IGFBP)-4, one of six known modulators of IGF-I and -II, we looked for a possible PAPP-A2 substrate among the members of this family. We showed that PAPP-A2 specifically cleaved IGFBP-5 at one site, between Ser-143 and Lys-144, In contrast to the cleavage of IGFBF-4 by PAPP-A that strictly requires the presence of IGF, the cleavage of IGFBP-5 by PAPP-A2 was IGF-independent. Recent data firmly establish PAPP-A and IGFBPP-4 as an important functional pair in several systems. Because of its close relationship with PAPP-A, both structurally and functionally, PAPP-A2 is a likely candidate IGFBP-5 proteinase in many tissues and conditioned media where IGFBP-5 proteolysis has been reported.	Aarhus Univ, Dept Biol Mol & Struct, DK-8000 Aarhus C, Denmark; Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA	Aarhus University; Mayo Clinic	Oxvig, C (corresponding author), Aarhus Univ, Dept Biol Mol & Struct, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	co@mbio.aau.dk	Overgaard, Michael Toft/E-1354-2011	Overgaard, Michael Toft/0000-0002-1423-2481; Oxvig, Claus/0000-0002-4715-9719; Laursen, Lisbeth Schmidt/0000-0002-8676-5869				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; BUSBY WH, 2000, J BIOL CHEM; CLAUSSEN M, 1994, ENDOCRINOLOGY, V134, P1964, DOI 10.1210/en.134.4.1964; Conover CA, 1999, J CLIN ENDOCR METAB, V84, P4742, DOI 10.1210/jc.84.12.4742; CONOVER CA, 1993, J CLIN INVEST, V91, P1129, DOI 10.1172/JCI116272; CONOVER CA, 1993, J CLIN ENDOCR METAB, V76, P1153, DOI 10.1210/jc.76.5.1153; Fowlkes JL, 1997, TRENDS ENDOCRIN MET, V8, P299, DOI 10.1016/S1043-2760(97)00112-4; Haaning J, 1996, EUR J BIOCHEM, V237, P159, DOI 10.1111/j.1432-1033.1996.0159n.x; HINTZ RL, 1977, J CLIN ENDOCR METAB, V45, P988, DOI 10.1210/jcem-45-5-988; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Imai Y, 1997, J CLIN INVEST, V100, P2596, DOI 10.1172/JCI119803; KRISTENSEN T, 1994, BIOCHEMISTRY-US, V33, P1592, DOI 10.1021/bi00172a040; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LEE KO, 1994, J CLIN ENDOCR METAB, V79, P1367, DOI 10.1210/jc.79.5.1367; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; OXVIG C, 1993, J BIOL CHEM, V268, P12243; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; Qin XZ, 2000, ARCH BIOCHEM BIOPHYS, V379, P209, DOI 10.1006/abbi.2000.1872; Resnick CE, 1998, ENDOCRINOLOGY, V139, P1249, DOI 10.1210/en.139.3.1249; SOTTRUPJENSEN L, 1993, BIOCHEM MOL BIOL INT, V30, P789; STOCKER W, 1995, PROTEIN SCI, V4, P823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THRAILKILL KM, 1995, ENDOCRINOLOGY, V136, P3527, DOI 10.1210/en.136.8.3527	29	194	202	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21849	21853		10.1074/jbc.M102191200	http://dx.doi.org/10.1074/jbc.M102191200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11264294	hybrid			2022-12-27	WOS:000169297900136
J	Nanda, N; Iismaa, SE; Owens, WA; Husain, A; Mackay, F; Graham, RM				Nanda, N; Iismaa, SE; Owens, WA; Husain, A; Mackay, F; Graham, RM			Targeted inactivation of G(h)/tissue transglutaminase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING ENZYMES; GTP-BINDING PROTEIN; C 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; ALPHA(1B)-ADRENERGIC RECEPTOR; CELLULAR TRANSGLUTAMINASE; DIFFERENTIAL EXPRESSION; TRANSGENIC MICE; PHOSPHOLIPASE-C; HUMAN HEART	The novel G-protein, G(h)/tissue transglutaminase (TGase II), has both guanosine triphosphatase and Ca2+-activated transglutaminase activity and has been implicated in a number of processes including signal transduction, apoptosis, bone ossification, wound healing, and cell adhesion and spreading. To determine the role of G(h) in vivo, the Cre/loxP site-specific recombinase system was used to develop a mouse line in which its expression was ubiquitously inactivated. Despite the absence of G(h) expression and a lack of intracellular TGase activity that was not compensated by other TGases, the Tgm2(-/-) mice were viable, phenotypically normal, and were born with the expected Mendelian frequency. Absence of G(h) coupling to alpha (1)-adrenergic receptor signaling in Tgm2(-/-) mice was demonstrated by the lack of agonist-stimulated [alpha-P-32]GTP photolabeling of a 74-kDa protein in liver membranes. Annexin-V positivity observed with dexamethasone-induced apoptosis was not different in Tgm2-/- thymocytes compared with Tgm2(+/+) thymocytes. However, with this treatment there was a highly significant decrease in the viability (propidium iodide negativity) of Tgm2(-/-) thymocytes, Primary fibroblasts isolated from Tgm2(-/-) mice also showed decreased adherence with culture. These results indicate that G(h) may be importantly involved in stabilizing apoptotic cells before clearance, and in responses such as wound healing that require fibroblast adhesion mediated by extracellular matrix cross-linking.	Garvan Inst Med Res, Arthrit & Inflammat Res Program, Darlinghurst, NSW 2010, Australia; Victor Chang Cardiac Res Inst, Mol Cardiol Unit, Darlinghurst, NSW 2010, Australia; Victor Chang Cardiac Res Inst, Enzyme Res Unit, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2054, Australia	Garvan Institute of Medical Research; Victor Chang Cardiac Research Institute; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Graham, RM (corresponding author), 384 Victoria St, Darlinghurst, NSW 2010, Australia.		Iismaa, Siiri/A-9924-2008; Mackay, Fabienne/B-7440-2008; Husain, Ahsan/J-6861-2012; Owens, Andrew/K-4776-2012; Iismaa, Siiri/C-9300-2013	Mackay, Fabienne/0000-0002-6074-2693; Husain, Ahsan/0000-0003-3426-3469; Owens, Andrew/0000-0001-9836-9209; Iismaa, Siiri/0000-0003-2409-7356				Aeschlimann D, 1998, J BIOL CHEM, V273, P3452, DOI 10.1074/jbc.273.6.3452; AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Akhter SA, 1997, J BIOL CHEM, V272, P21253, DOI 10.1074/jbc.272.34.21253; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; BAEK KJ, 1993, J BIOL CHEM, V268, P27390; Baek KJ, 1996, BIOCHEM J, V315, P739; BARSIGIAN C, 1991, J BIOL CHEM, V266, P22501; Brodde OE, 1999, PHARMACOL REV, V51, P651; Cavalli A, 1997, P NATL ACAD SCI USA, V94, P11589, DOI 10.1073/pnas.94.21.11589; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; FESUS L, 1986, J IMMUNOL METHODS, V94, P131, DOI 10.1016/0022-1759(86)90225-5; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Gentile V, 1997, BBA-MOL CELL RES, V1357, P115, DOI 10.1016/S0167-4889(97)00024-4; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hitomi K, 1999, J BIOCHEM-TOKYO, V125, P1048, DOI 10.1093/oxfordjournals.jbchem.a022385; Hunter I, 1998, FEBS LETT, V425, P141, DOI 10.1016/S0014-5793(98)00223-3; Hwang KC, 1996, CIRCULATION, V94, P718, DOI 10.1161/01.CIR.94.4.718; Iismaa SE, 2000, J BIOL CHEM, V275, P18259, DOI 10.1074/jbc.M000583200; IM MJ, 1990, J BIOL CHEM, V265, P18944; Jones RA, 1997, J CELL SCI, V110, P2461; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; KLENMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768; Lee MY, 1997, PFLUG ARCH EUR J PHY, V433, P671, DOI 10.1007/s004240050330; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nanda N, 1999, ARCH BIOCHEM BIOPHYS, V366, P151, DOI 10.1006/abbi.1999.1189; Oliverio S, 1999, J BIOL CHEM, V274, P34123, DOI 10.1074/jbc.274.48.34123; PIACENTINI M, 1994, DIFFERENTIATION, V57, P51, DOI 10.1046/j.1432-0436.1994.5710051.x; Piredda L, 1997, CELL DEATH DIFFER, V4, P463, DOI 10.1038/sj.cdd.4400267; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; PRPIC V, 1984, J BIOL CHEM, V259, P1382; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Stevens HY, 2000, J ANAT, V196, P181, DOI 10.1046/j.1469-7580.2000.19620181.x; Szondy Z, 1997, FEBS LETT, V404, P307, DOI 10.1016/S0014-5793(97)00140-3; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; Thomazy VA, 1999, CELL DEATH DIFFER, V6, P146, DOI 10.1038/sj.cdd.4400464; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Vezza R, 1999, J BIOL CHEM, V274, P12774, DOI 10.1074/jbc.274.18.12774	48	228	232	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20673	20678		10.1074/jbc.M010846200	http://dx.doi.org/10.1074/jbc.M010846200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274171	hybrid			2022-12-27	WOS:000169135100133
J	Young, SH; Ye, JP; Frazer, DG; Shi, XL; Castranova, V				Young, SH; Ye, JP; Frazer, DG; Shi, XL; Castranova, V			Molecular mechanism of tumor necrosis factor-alpha production in 1 -> 3-beta-glucan (Zymosan)-activated macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; POLYMORPHONUCLEAR LEUKOCYTES; TRANSCRIPTION FACTORS; GLUCAN RECEPTOR; TNF-ALPHA; ACTIVATION; CYTOKINE; CELLS; (1->3)-BETA-D-GLUCAN; STIMULATION	The molecular details of 1 -->3-beta -glucans, a fungal cell wall component, induced inflammatory responses are not well understood. In the present study, we conducted a systematic analysis of the molecular events leading to tumor necrosis factor (TNF)-alpha production after glucan stimulation of macrophages. We demonstrated that activation of nuclear factor kappaB (NF-kappaB) is essential in zymosan A (a source of 1 -->3-beta -glucans)-induced TNF-alpha production in macrophages (RAW264.7 cells). Zymosan A-induced TNF-alpha protein production was associated with an increase in the TNF-alpha gene promoter activity. Activation of the TNF-alpha gene promoter was dependent on activation of NF-kappaB. Time course studies indicated that DNA binding activity of NF-kappaB preceded TNF-alpha promoter activity. Inhibition of NF-kappaB activation led to a dramatic reduction in both TNF-alpha promoter activity and TNF-alpha protein production in the response to zymosan A Mutation of a major NF-kappaB binding site (kappa3) in the gene promoter resulted in a significant decrease in the induction of the gene promoter by zymosan A, while mutation of Egr or CRE sites failed to inhibit the response to zymosan. Together, these results strongly suggest that NF-kappaB is involved in signal transduction of 1 -->3-beta -glucans-induced TNF-alpha expression.	NIOSH, ECTB, HELD, NIH, Morgantown, WV 26505 USA; NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, NIH, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); National Institutes of Health (NIH) - USA	Young, SH (corresponding author), NIOSH, ECTB, HELD, NIH, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	syoung@cdc.gov	Ye, Jianping/N-1998-2017; Shi, Xianglin/B-8588-2012	Ye, Jianping/0000-0003-3875-365X; 				ABEL G, 1992, INT J IMMUNOPHARMACO, V14, P1363, DOI 10.1016/0192-0561(92)90007-8; Adachi Y, 1997, MEDIAT INFLAMM, V6, P251, DOI 10.1080/09629359791569; Adachi Y, 1998, BIOL PHARM BULL, V21, P278, DOI 10.1248/bpb.21.278; Adams DS, 2000, J CELL BIOCHEM, V77, P221, DOI 10.1002/(SICI)1097-4644(20000501)77:2<221::AID-JCB6>3.0.CO;2-V; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Battle J, 1998, BIOCHEM BIOPH RES CO, V249, P499, DOI 10.1006/bbrc.1998.9175; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Bondeson J, 1999, J IMMUNOL, V162, P2939; Carpentier I, 1998, FEBS LETT, V425, P195, DOI 10.1016/S0014-5793(98)00226-9; Chiba Norihisa, 1996, Pharmaceutical and Pharmacological Letters, V6, P12; DAUM T, 1992, FEBS LETT, V309, P119, DOI 10.1016/0014-5793(92)81077-Y; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; DOITA M, 1991, J LEUKOCYTE BIOL, V49, P342, DOI 10.1002/jlb.49.4.342; Driscoll KE, 1997, ENVIRON HEALTH PERSP, V105, P1159, DOI 10.2307/3433526; DUAN XC, 1994, CELL IMMUNOL, V157, P393, DOI 10.1006/cimm.1994.1236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HUMBERT JR, 1990, AM J MED SCI, V300, P209, DOI 10.1097/00000441-199010000-00002; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; KONDO Y, 1992, J PHARMACOBIO-DYNAM, V15, P617, DOI 10.1248/bpb1978.15.617; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MING WJ, 1987, J IMMUNOL, V138, P1469; MORIKAWA K, 1985, CANCER RES, V45, P1496; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; NOBLE PW, 1993, J IMMUNOL, V151, P979; Ohno N, 1996, IMMUNOL LETT, V52, P1, DOI 10.1016/0165-2478(96)02538-2; OHNO N, 1995, BIOL PHARM BULL, V18, P1242; RIGGI SJ, 1961, AM J PHYSIOL, V200, P297, DOI 10.1152/ajplegacy.1961.200.2.297; ROBINSON VA, 1996, P 20 COTT ORG DUST R, P356; Sakurai T, 1997, EUR J PHARMACOL, V334, P255, DOI 10.1016/S0014-2999(97)01191-6; Sorenson WG, 1998, ANN AGR ENV MED, V5, P65; Suzuki T, 1996, J PHARM PHARMACOL, V48, P1243, DOI 10.1111/j.2042-7158.1996.tb03930.x; TAPPER H, 1995, BIOCHEM J, V306, P829, DOI 10.1042/bj3060829; TENNENT RJ, 1976, J RETICULOENDOTH SOC, V19, P269; TRANTHI TA, 1995, HEPATOLOGY, V22, P613, DOI 10.1016/0270-9139(95)90587-1; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; YE JP, 1994, J BIOL CHEM, V269, P25728	41	123	133	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20781	20787		10.1074/jbc.M101111200	http://dx.doi.org/10.1074/jbc.M101111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259437	hybrid			2022-12-27	WOS:000169135100147
J	Sugihara, T; Kaul, SC; Kato, J; Reddel, RR; Nomura, H; Wadhwa, R				Sugihara, T; Kaul, SC; Kato, J; Reddel, RR; Nomura, H; Wadhwa, R			Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INK4A LOCUS; PEROXISOME BIOGENESIS; FARNESYLATED PROTEIN; STABILIZES P53; MDM2; P19(ARF); P16(INK4A); SENESCENCE; FIBROBLASTS; P14(ARF)	We isolated a 33-kDa protein, Pex19p/HK33/HsPXF, as a p19ARF-binding protein in a yeast two-hybrid screen, We demonstrate here that Pex19p interacts with p19ARF in the cell cytoplasm and excludes p19ARF from the nucleus, leading to a concurrent inactivation of p53 function. Down-regulation of Pex19p by its antisense expression resulted in increased levels of p19ARF, increased p53 function, and a p53/p21WAF1-mediated senescence-like cell cycle arrest. The data demonstrated a novel mechanism of down-regulation of the p19ARF-p53 pathway.	Chugai Res Inst Mol Med, Niihari, Ibaraki 30041, Japan; Natl Inst Adv Ind Sci & Technol, AIST, Inst Mol & Cell Biol, Tsukuba, Ibaraki 3058566, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Childrens Med Res Inst, Westmead, NSW 2145, Australia	National Institute of Advanced Industrial Science & Technology (AIST); Nara Institute of Science & Technology; Children's Medical Research Institute - Australia	Wadhwa, R (corresponding author), Chugai Res Inst Mol Med, 153-2 Nagai, Niihari, Ibaraki 30041, Japan.		Wadhwa, Renu/L-8898-2018; Reddel, Roger R/A-6635-2014; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Reddel, Roger R/0000-0002-6302-6107; Kaul, Sunil C/0000-0002-0046-3916				BRAUN A, 1994, GENE, V146, P291, DOI 10.1016/0378-1119(94)90308-5; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Gotte K, 1998, MOL CELL BIOL, V18, P616; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huschtscha LI, 1999, CARCINOGENESIS, V20, P921, DOI 10.1093/carcin/20.6.921; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kammerer S, 1997, GENOMICS, V45, P200, DOI 10.1006/geno.1997.4914; Kurokawa K, 1999, ONCOGENE, V18, P2718, DOI 10.1038/sj.onc.1202628; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Louvet O, 1997, BIOTECHNIQUES, V23, P816, DOI 10.2144/97235bm11; QUELLE DE, 1995, CELL, V83, P993; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Vogt M, 1998, CELL GROWTH DIFFER, V9, P139; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	25	40	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					18649	18652		10.1074/jbc.C100011200	http://dx.doi.org/10.1074/jbc.C100011200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259404	hybrid			2022-12-27	WOS:000169091000001
J	Lorenzo, P; Aspberg, A; Onnerfjord, P; Bayliss, MT; Neame, PJ; Heinegard, D				Lorenzo, P; Aspberg, A; Onnerfjord, P; Bayliss, MT; Neame, PJ; Heinegard, D			Identification and characterization of asporin - A novel member of the leucine-rich repeat protein family closely related to decorin and biglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; STATIONARY NIGHT BLINDNESS; EXTRACELLULAR-MATRIX; BONE SIALOPROTEIN; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; CORE PROTEIN; OSTEOINDUCTIVE FACTOR; CRYSTAL-FORMATION; COLLAGEN FIBRILS	Asporin, a novel member of the leucine-rich repeat family of proteins, was partially purified from human articular cartilage and meniscus. Cloning of human and mouse asporin cDNAs revealed that the protein is closely related to decorin and biglycan. It contains a putative propeptide, 4 amino-terminal cysteines, 10 leucine-rich repeats, and 2 C-terminal cysteines. In contrast to decorin and biglycan, asporin is not a proteoglycan. Instead, asporin contains a unique stretch of aspartic acid residues in its amino-terminal region. A polymorphism was identified in that the number of consecutive aspartate residues varied from 11 to 15. The 8 exons of the human asporin gene span 26 kilobases on chromosome 9q31.1-32, and the putative promoter region lacks TATA consensus sequences. The asporin mRNA is expressed in a variety of human tissues with higher levels in osteoarthritic articular cartilage, aorta, uterus, heart, and liver. The deduced amino acid sequence of asporin was confirmed by mass spectrometry of the isolated protein resulting in 84% sequence coverage. The protein contains an N-glycosylation site at Asn(281) with a heterogeneous oligosaccharide structure and a potential O-glycosylation site at Ser(54). The name asporin reflects the aspartate-rich amino terminus and the overall similarity to decorin.	Univ Lund, Dept Cell & Mol Biol, Sect Connect Tissue Biol, SE-22184 Lund, Sweden; Shriners Hosp Children, Tampa, FL 33612 USA; Univ London Royal Vet Coll, London NW1 0TU, England	Lund University; University of London; University of London Royal Veterinary College	Heinegard, D (corresponding author), Univ Lund, Dept Cell & Mol Biol, Sect Connect Tissue Biol, BMC Plan C12, SE-22184 Lund, Sweden.		Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Aspberg, Anders/0000-0002-6588-6944				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Deere M, 1996, GENOMICS, V38, P399, DOI 10.1006/geno.1996.0643; Ehring H, 1997, RAPID COMMUN MASS SP, V11, P1867; FISHER LW, 1991, J BIOL CHEM, V266, P14371; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Friedman JS, 2000, INVEST OPHTH VIS SCI, V41, P2059; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hobby P, 2000, MOL VIS, V6, P72; Hocking AM, 1996, J BIOL CHEM, V271, P19571, DOI 10.1074/jbc.271.32.19571; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jimenez SA, 1998, OSTEOARTHRITIS, P31; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Nishiu J, 1998, GENOMICS, V52, P378, DOI 10.1006/geno.1998.5455; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Oldberg A, 1996, FEBS LETT, V386, P29, DOI 10.1016/0014-5793(96)00407-3; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; PAULSSON M, 1983, BIOCHEM J, V212, P659, DOI 10.1042/bj2120659; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Sambrook J., 2002, MOL CLONING LAB MANU; Sarioglu H, 2000, ELECTROPHORESIS, V21, P2209, DOI 10.1002/1522-2683(20000601)21:11<2209::AID-ELPS2209>3.0.CO;2-T; Schuerenbeg M, 2000, ANAL CHEM, V72, P3436, DOI 10.1021/ac000092a; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SHINOMURA T, 1992, J BIOL CHEM, V267, P1265; Shintani S, 2000, J MOL EVOL, V51, P363, DOI 10.1007/s002390010098; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	52	163	177	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					12201	12211		10.1074/jbc.M010932200	http://dx.doi.org/10.1074/jbc.M010932200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152692	hybrid			2022-12-27	WOS:000168081800103
J	Fujino, T; Kondo, J; Ishikawa, M; Morikawa, K; Yamamoto, TT				Fujino, T; Kondo, J; Ishikawa, M; Morikawa, K; Yamamoto, TT			Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINERGIC NERVE-TERMINALS; MOLECULAR CHARACTERIZATION; RAT; CELLS; EXPRESSION; PROTEINS; LIVER	Using peptide sequences derived from bovine cardiac acetyl-CoA synthetase (AceCS), we isolated and characterized cDNAs for a bovine and murine cardiac enzyme designated AceCS2. We also isolated a murine cDNA encoding a hepatic type enzyme, designated AceCS1, identical one reported recently (Luong, A., Hannah, V. C., Brown, M. S., and Goldstein, J. L. (2000) J. Biol. Chem. 275, 26458-26466). Murine AceCS1 and AceCS2 were purified to:homogeneity and characterized. Among C2-C5 short and medium chain fatty acids, both enzymes preferentially utilize acetate with similar affinity. The AceCS2 transcripts are expressed in a wide range of tissues, with the highest levels in heart, and are apparently absent from the liver. The levels of AceCS2 mRNA in skeletal muscle were increased markedly under ketogenic conditions. Subcellular fractionation revealed that AceCS2 is a mitochondrial matrix enzyme. [C-14]Acetate incorporation indicated that acetyl-CoAs produced by AceCS2 are utilized mainly for oxidation.	Tohoku Univ, Gene Res Ctr, Aoba Ku, Sendai, Miyagi 9818555, Japan; Mitsubishi Tokyo Pharmaceut Inc, Yokohama Res Ctr, Yokohama, Kanagawa 2270033, Japan; Biomed Engn Res Inst, Suita, Osaka 5650874, Japan	Tohoku University	Yamamoto, TT (corresponding author), Tohoku Univ, Gene Res Ctr, Aoba Ku, 1 1 Tsutsumidori Amamiya, Sendai, Miyagi 9818555, Japan.	yama@biochem.tohoku.ac.jp						AKANJI AO, 1989, CLIN CHIM ACTA, V185, P25, DOI 10.1016/0009-8981(89)90127-7; BREMER J, 1984, FATTY ACID METABOLIS, P113; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Carroll PT, 1997, BRAIN RES, V753, P47, DOI 10.1016/S0006-8993(96)01485-0; CRABTREE B, 1989, BIOCHEM J, V257, P673, DOI 10.1042/bj2570673; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197, DOI 10.1093/oxfordjournals.jbchem.a123737; Harlow E., 1988, ANTIBODIES LAB MANUA; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; ISHIKAWA M, 1995, TOHOKU J EXP MED, V175, P55, DOI 10.1620/tjem.175.55; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; MATSUNAGA T, 1985, EUR J BIOCHEM, V152, P331, DOI 10.1111/j.1432-1033.1985.tb09202.x; MIYAZAWA S, 1985, J BIOCHEM, V98, P723, DOI 10.1093/oxfordjournals.jbchem.a135330; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEUFERT CD, 1974, BIOCHEM BIOPH RES CO, V57, P901, DOI 10.1016/0006-291X(74)90631-7; STERRI SH, 1980, J NEUROCHEM, V35, P249, DOI 10.1111/j.1471-4159.1980.tb12511.x; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TAKAI T, 1990, BIOCHIM BIOPHYS ACTA, V1048, P105, DOI 10.1016/0167-4781(90)90029-2; Tanaka T, 1981, Methods Enzymol, V71 Pt C, P334; TOH H, 1991, Protein Sequences and Data Analysis, V4, P111; TOH H, 1990, Protein Sequences and Data Analysis, V3, P517; WEBSTER LT, 1963, J BIOL CHEM, V238, P4010	29	212	219	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11420	11426		10.1074/jbc.M008782200	http://dx.doi.org/10.1074/jbc.M008782200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150295	hybrid			2022-12-27	WOS:000167980900115
J	Riehman, K; Crews, C; Fridovich-Keil, JL				Riehman, K; Crews, C; Fridovich-Keil, JL			Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDYLTRANSFERASE GENE; MOLECULAR CHARACTERIZATION; URIDYL TRANSFERASE; SACCHAROMYCES-CEREVISIAE; CLASSICAL GALACTOSEMIA; MILD GALACTOSEMIA; BIOCHEMICAL BASIS; Q188R MUTATION; MOUSE MODEL; GALT GENE	Impairment of the human enzyme galactose-1-phosphate uridylyltransferase (GALT) results in the potentially lethal disorder galactosemia; the biochemical basis of pathophysiology in galactosemia remains unknown, We have applied a yeast expression system for human GALT to test the hypothesis that genotype will correlate with GALT activity measured in, vitro and with metabolite levels and galactose sensitivity measured in vivo. In particular, we have determined the relative degree of functional impairment associated with each of 16 patient-derived hGALT alleles; activities ranged from null to essentially normal. Next, we utilized strains expressing these alleles to demonstrate a clear inverse relationship between GALT activity and galactose sensitivity. Finally, we monitored accumulation of galactose-1-P, :UDP-gal, and UDP-glc in yeast expressing a subset of these alleles, As reported for humans, yeast deficient in GALT, but not their wild type counterparts, demonstrated elevated levels of galactose l-phosphate and diminished UDP-gal upon exposure to galactose, These results present the first clear evidence in a genetically and biochemically amenable model system of a relationship between GALT genotype, enzyme activity, sensitivity to galactose, and aberrant metabolite accumulation. As such, these data lay a foundation for future studies into the underlying mechanism(s) of galactose sensitivity in yeast and perhaps other eukaryotes, including humans.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Fridovich-Keil, JL (corresponding author), Emory Univ, Sch Med, Dept Genet, Rm 431C Dent Bldg,1462 Clifton Rd NE, Atlanta, GA 30322 USA.				NIDDK NIH HHS [DK46403] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046403, R29DK046403] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ai YJ, 2000, HUM MOL GENET, V9, P1821, DOI 10.1093/hmg/9.12.1821; ANDERSEN MW, 1984, HUM GENET, V65, P287, DOI 10.1007/BF00286519; ASHINO J, 1995, HUM MUTAT, V6, P36, DOI 10.1002/humu.1380060108; BERGMEYER H, 1974, METHOD ENZYMAT AN, P1291; Christacos NC, 2000, MOL GENET METAB, V70, P272, DOI 10.1006/mgme.2000.3019; Crews C, 2000, J BIOL CHEM, V275, P22847, DOI 10.1074/jbc.M001053200; DOUGLAS HC, 1964, GENETICS, V49, P837; ELSAS LJ, 1995, AM J HUM GENET, V56, P630; ELSAS LJ, 1995, EUR J PEDIATR, V154, pS21, DOI 10.1007/BF02143798; Elsevier JP, 1996, P NATL ACAD SCI USA, V93, P7166, DOI 10.1073/pnas.93.14.7166; Elsevier JP, 1996, J BIOL CHEM, V271, P32002, DOI 10.1074/jbc.271.50.32002; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; FRIDOVICHKEIL JL, 1995, AM J HUM GENET, V56, P640; FRIDOVICHKEIL JL, 1993, P NATL ACAD SCI USA, V90, P398, DOI 10.1073/pnas.90.2.398; FridovichKeil JL, 1995, BIOCHEM MOL MED, V56, P121, DOI 10.1006/bmme.1995.1067; Geeganage S, 1998, BIOCHEMISTRY-US, V37, P14500, DOI 10.1021/bi9815546; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P281; Henderson JM, 2000, J BIOL CHEM, V275, P30088, DOI 10.1074/jbc.M005259200; Hirokawa H, 1999, EUR J HUM GENET, V7, P757, DOI 10.1038/sj.ejhg.5200368; Holton J. B., 2000, METABOLIC MOL BASES, P1553; Kabir MA, 2000, MOL GEN GENET, V262, P1113, DOI 10.1007/PL00008654; KAUFMAN FR, 1994, J PEDIATR-US, V125, P225, DOI 10.1016/S0022-3476(94)70197-0; Lai K, 1999, J BIOL CHEM, V274, P6559, DOI 10.1074/jbc.274.10.6559; Lai K, 1996, J PEDIATR-US, V128, P89, DOI 10.1016/S0022-3476(96)70432-8; Lai K, 2000, BIOCHEM BIOPH RES CO, V271, P392, DOI 10.1006/bbrc.2000.2629; LESLIE ND, 1992, GENOMICS, V14, P474, DOI 10.1016/S0888-7543(05)80244-7; Leslie ND, 1996, BIOCHEM MOL MED, V59, P7, DOI 10.1006/bmme.1996.0057; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; Mehta DV, 1999, BBA-MOL BASIS DIS, V1454, P217, DOI 10.1016/S0925-4439(99)00037-X; NG WG, 1991, NEONATAL SCREENING 9, P181; Ninfali P, 1996, J NEUROL, V243, P102; Ning C, 2000, PEDIATR RES, V48, P211, DOI 10.1203/00006450-200008000-00015; Quimby BB, 1996, J BIOL CHEM, V271, P26835, DOI 10.1074/jbc.271.43.26835; REICHARDT JKV, 1992, BIOCHEMISTRY-US, V31, P5430, DOI 10.1021/bi00139a002; REICHARDT JKV, 1991, AM J HUM GENET, V49, P860; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; Segal S, 1995, METABOLIC MOL BASIS, P967; Shield JPH, 2000, ARCH DIS CHILD, V83, P248, DOI 10.1136/adc.83.3.248; Shin YS, 1999, J INHERIT METAB DIS, V22, P327, DOI 10.1023/A:1005516523196; Shin YS, 1998, J INHERIT METAB DIS, V21, P232, DOI 10.1023/A:1005303818858; Shin YS, 1996, EUR J PEDIATR, V155, P393, DOI 10.1007/s004310050425; SOMMER M, 1995, J INHERIT METAB DIS, V18, P567, DOI 10.1007/BF02436001; Tyfield L, 1999, HUM MUTAT, V13, P417, DOI 10.1002/(SICI)1098-1004(1999)13:6<417::AID-HUMU1>3.0.CO;2-0; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Wang BBT, 1998, MOL GENET METAB, V63, P263, DOI 10.1006/mgme.1998.2678; Wedekind JE, 1996, BIOCHEMISTRY-US, V35, P11560, DOI 10.1021/bi9612677; Wells L, 1997, J INHERIT METAB DIS, V20, P633, DOI 10.1023/A:1005314207513; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784; XU YK, 1995, CLIN CHIM ACTA, V235, P125, DOI 10.1016/0009-8981(95)06013-X; Zekanowski C, 1999, J INHERIT METAB DIS, V22, P679; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P961, DOI 10.1002/pro.5560010801	51	44	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10634	10640		10.1074/jbc.M009583200	http://dx.doi.org/10.1074/jbc.M009583200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152465	hybrid			2022-12-27	WOS:000167980900011
J	Shah, AM; Li, SX; Anderson, KS; Sweasy, JB				Shah, AM; Li, SX; Anderson, KS; Sweasy, JB			Y265H mutator mutant of DNA polymerase beta - Proper geometric alignment is critical for fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; CRYSTAL-STRUCTURES; GAPPED DNA; MECHANISM; REPLICATION; EXCISION; REPAIR; PROCESSIVITY; SUBSTITUTE; DOMAIN	DNA polymerases have the unique ability to select a specific deoxynucleoside triphosphate from a pool of similarly structured substrates. One of these enzymes, DNA polymerase beta, offers a simple system to relate polymerase structure to the fidelity of DNA synthesis. In this study, a mutator DNA polymerase beta, Y265H, was identified using an in vivo genetic screen. Purified Y265H produced errors at a 40-fold higher frequency than the wild-type protein in a forward mutation assay. At 37 degreesC, transient kinetic analysis demonstrated that the alteration:caused a 111-fold decrease in the maximum rate of polymerization and a 117-fold loss in fidelity for G misincorporation opposite template A. Our data suggest that the maximum rate of polymerization was reduced, because Y265H was dramatically impaired in its ability to perform nucleotidyl transfer in the presence of the correct nucleotide substrate. In contrast, at 20 degreesC, the mutant protein had a fidelity similar to wildtype enzyme. Both proteins at 20 degreesC demonstrate a rapid change in protein conformation, followed by a slow chemical step. These data suggest that proper geometric alignment of template, 3'-OH of the primer, magnesium ions, dNTP substrates, and the active site residues of DNA polymerase beta are important factors in polymerase fidelity and provide the first evidence that Tyr-265 is important for this alignment to occur properly in DNA polymerase beta.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St,POB 208240, New Haven, CT 06520 USA.				NATIONAL CANCER INSTITUTE [T32CA009259, F32CA083250, R01CA080830, T32CA009159] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09259, F32-CA83250, CA80830, T32-CA09159] Funding Source: Medline; NIGMS NIH HHS [GM49551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Eckert KA, 1997, NUCLEIC ACIDS RES, V25, P1450, DOI 10.1093/nar/25.7.1450; Feng JA, 1998, BIOCHEMISTRY-US, V37, P9605, DOI 10.1021/bi9808619; JOHNSONKA, 1993, ANN REV BIOCH, V62, P686; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kosa JL, 1999, J BIOL CHEM, V274, P3851, DOI 10.1074/jbc.274.6.3851; Kosa JL, 1999, J BIOL CHEM, V274, P35866, DOI 10.1074/jbc.274.50.35866; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Opresko PL, 2000, BIOCHEMISTRY-US, V39, P11399, DOI 10.1021/bi000698t; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Plug AW, 1997, P NATL ACAD SCI USA, V94, P1327, DOI 10.1073/pnas.94.4.1327; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; SOWERS LC, 1986, P NATL ACAD SCI USA, V83, P5434, DOI 10.1073/pnas.83.15.5434; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; SWEASY JB, 1992, J BIOL CHEM, V267, P1407; SWEASY JB, 1995, J BACTERIOL, V177, P2923, DOI 10.1128/jb.177.10.2923-2925.1995; Washington SL, 1997, P NATL ACAD SCI USA, V94, P1321, DOI 10.1073/pnas.94.4.1321; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Zhong XJ, 1998, J AM CHEM SOC, V120, P235, DOI 10.1021/ja973507r; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	30	63	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10824	10831		10.1074/jbc.M008680200	http://dx.doi.org/10.1074/jbc.M008680200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154692	hybrid			2022-12-27	WOS:000167980900037
J	Shpak, E; Barbar, E; Leykam, JF; Kieliszewski, MJ				Shpak, E; Barbar, E; Leykam, JF; Kieliszewski, MJ			Contiguous hydroxyproline residues direct hydroxyproline arabinosylation in Nicotiana tabacum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL GLYCOPROTEIN; SUSPENSION-CULTURED-CELLS; ARABINOGALACTAN-PROTEINS; MASS-SPECTROMETRY; RICH EXTENSIN; PROLINE; GENE; GLYCOPEPTIDES; BIOSYNTHESIS; ARABINOSIDES	Hydroxyproline (Hyp) O-glycosylation characterizes the hydroxyproline-rich glycoprotein (HRGP) superfamily of the plant extracellular matrix. Hyp glycosylation occurs in two modes: Arabinosylation adds short oligoarabinosides (Hyp-arabinosides) while galactosylation leads to the addition of larger arabinogalactan polysaccharides (Hyp-polysaccharides). We hypothesize that sequence-dependent glycosylation of small peptide motifs results in glycomodules. These small functional units in combination with other repetitive peptide modules define the properties of HRGPs. The Hyp contiguity hypothesis predicts arabinosylation of contiguous Hyp residues and galactosylation of clustered noncontiguous Hyp residues. To determine the minimum level of Hyp contiguity that directs arabinosylation, we designed a series of synthetic genes encoding repetitive (Ser-Pro(2))(n), (Ser-Pro(3))(n), and (Ser-Pro(4))(n). A signal sequence targeted these endogenous substrates to the endoplasmic reticulum/Golgi for post-translational proline hydroxylation and glycosylation in transformed Nicotiana tabacum cells. The fusion glycoproteins also contained green fluorescence protein, facilitating their detection and isolation. The (Ser-Pro(2))(n) and (Ser-Hyp(4))(n) fusion glycoproteins yielded Hyp-arabinosides but no Hyp-polysaccharide. The motif (Ser-Pro(3))(n) was incompletely hydroxylated, yielding mixed contiguous/noncontiguous Hyp and a corresponding mixture of Hyparabinosides and Hyp-polysaccharides, These results plus circular dichroic spectra of the glycosylated and deglycosylated (Ser-Pro(2))(n), (Ser-Pro(3))(n), and (Ser-Pro(4))(n) modules corroborate the Hyp contiguity hypothesis and indicate that Hyp O-glycosylation is indeed sequence-driven.	Ohio Univ, Dept Chem & Biochem, Clippinger Labs, Athens, OH 45701 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	University System of Ohio; Ohio University; Michigan State University	Kieliszewski, MJ (corresponding author), Ohio Univ, Dept Chem & Biochem, Clippinger Labs, Athens, OH 45701 USA.	kielisze@helios.phy.ohiou.edu		Shpak, Elena/0000-0002-5702-7517; Barbar, Elisar/0000-0003-4892-5259				AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; AN G, 1988, PLANT MOL BIOL MANUA, V1, P1; ASPINALL GO, 1969, CAN J BIOCHEM, V47, P1070; BACIC A, 1987, CARBOHYD RES, V162, P85, DOI 10.1016/0008-6215(87)80203-3; BALDWIN TC, 1993, PLANT PHYSIOL, V103, P115, DOI 10.1104/pp.103.1.115; BHATTI T, 1970, BIOCHIM BIOPHYS ACTA, V222, P339, DOI 10.1016/0304-4165(70)90122-4; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOWN DP, 1993, GENE, V134, P229, DOI 10.1016/0378-1119(93)90098-N; CHO YP, 1976, PHYTOCHEMISTRY, V15, P165, DOI 10.1016/S0031-9422(00)89077-9; Choi SB, 2000, NATURE, V407, P765, DOI 10.1038/35037633; DEFAYE J, 1986, CARBOHYD RES, V150, P221, DOI 10.1016/0008-6215(86)80018-0; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; FONG C, 1992, PLANT PHYSIOL, V99, P548, DOI 10.1104/pp.99.2.548; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; HILLESTAD A, 1977, PHYTOCHEMISTRY, V16, P1953, DOI 10.1016/0031-9422(77)80103-9; HOMER RB, 1979, PLANTA, V146, P217, DOI 10.1007/BF00388235; Karacsonyi S, 1998, CARBOHYD RES, V307, P271, DOI 10.1016/S0008-6215(98)00052-4; KIELISZEWSKI M, 1987, PLANT PHYSIOL, V85, P823, DOI 10.1104/pp.85.3.823; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; KIELISZEWSKI MJ, 1992, PLANT PHYSIOL, V99, P538, DOI 10.1104/pp.99.2.538; KIELISZEWSKI MJ, 1995, J BIOL CHEM, V270, P2541, DOI 10.1074/jbc.270.6.2541; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 1997, PHYTOCHEMISTRY, V45, P9, DOI 10.1016/S0031-9422(96)00794-7; Lamport D. T. A., 1980, The biochemistry of plants. A comprehensive treatise. Volume 3. Carbohydrates: structure and function., P501; LAMPORT DTA, 1967, NATURE, V216, P1322, DOI 10.1038/2161322a0; LAMPORT DTA, 1973, BIOCHEM J, V133, P125, DOI 10.1042/bj1330125; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Lamport DTA, 1977, RECENT ADV PHYTOCHEM, V11, P79; MARCUS A, 1991, PHYSIOL PLANTARUM, V81, P273; MAZAU D, 1988, PLANT PHYSIOL, V86, P540, DOI 10.1104/pp.86.2.540; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; MCGRATH KP, 1990, BIOTECHNOL PROGR, V6, P188, DOI 10.1021/bp00003a004; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; PARMENTIER Y, 1995, PLANT MOL BIOL, V29, P279, DOI 10.1007/BF00043652; RABANAL F, 1993, BIOPOLYMERS, V33, P1019, DOI 10.1002/bip.360330704; REES DA, 1977, POLYSACCHARIDE SHAPE, P41; RUBINSTEIN AL, 1995, P NATL ACAD SCI USA, V92, P3086, DOI 10.1073/pnas.92.8.3086; Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X; SADAVA D, 1971, BIOCHIM BIOPHYS ACTA, V227, P278, DOI 10.1016/0005-2744(71)90060-X; SAULNIER L, 1992, CARBOHYD RES, V224, P219, DOI 10.1016/0008-6215(92)84108-5; SERPE MD, 1994, PLANTA, V193, P542, DOI 10.1007/BF02411560; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; SMITH JJ, 1986, PHYTOCHEMISTRY, V25, P1021, DOI 10.1016/S0031-9422(00)81547-2; TANAKA M, 1980, BIOCHIM BIOPHYS ACTA, V616, P188, DOI 10.1016/0005-2744(80)90137-0; VANHOLST GJ, 1984, PLANT PHYSIOL, V74, P247, DOI 10.1104/pp.74.2.247; ZHU JK, 1993, PLANTA, V190, P221	50	107	112	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11272	11278		10.1074/jbc.M011323200	http://dx.doi.org/10.1074/jbc.M011323200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154705	hybrid			2022-12-27	WOS:000167980900094
J	Usui, Y; Nakase, M; Hotta, H; Urisu, A; Aoki, N; Kitajima, K; Matsuda, T				Usui, Y; Nakase, M; Hotta, H; Urisu, A; Aoki, N; Kitajima, K; Matsuda, T			A 33-kDa allergen from rice (Oryza sativa L. Japonica) - cDNA cloning, expression, and identification as a novel glyoxalase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPSIN-INHIBITOR FAMILY; ESCHERICHIA-COLI; 14-16 KDA; PROTEINS; GENE; SEQUENCE; PURIFICATION; PLANTS; RNA	Cereal proteins are known to cause allergic reactions such as Baker's asthma and severe atopic dermatitis to certain populations. In rice allergy, proteins with molecular masses of 14-16, 26, 33, and 56 kDa have been demonstrated to be potentially allergenic. In this study, to identify and characterize the 33-kDa allergen, designated Glb33, this protein was first purified to homogeneity, and its cDNA clone was isolated. When expressed in Escherichia coli, the recombinant Glb33 was shown to be as reactive as the native Glb33 with mouse IgG and patients' IgE antibodies to Glb33. The Glb33 cDNA coded for a protein of 291 amino acids with two 120-amino acid residue repeats, and the amino acid sequence showed similarity to glyoxalase I from various organisms, including human, plant, yeast, and bacterium. As expected, both native Glb33 purified from rice seeds and the recombinant protein had glyoxalase I activity that catalyzes condensation of methylglyoxal and glutathione into S-lactoylglutathione. However, Glb33 had a higher sequence identity to the bacterial glyoxalase I rather than to known plant and yeast enzymes. Both the Glb33 transcript and the protein were detected not only in maturing seeds of rice but also in its stem and leaf. Taken all together, the rice allergen, Glb33, was identified to be a novel type of plant glyoxalase I that is expressed in various plant tissues, including maturing seeds.	Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701101, Japan	Nagoya University; Fujita Health University	Matsuda, T (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	tmatsuda@agr.nagoya-u.ac.jp						ADACHI T, 1993, PLANT MOL BIOL, V21, P239, DOI 10.1007/BF00019940; Arai T, 1998, INTERNAL MED, V37, P98, DOI 10.2169/internalmedicine.37.98; Baldo B. A., 1984, Advances in Cereal Science and Technology, V6, P289; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; CARBONERO P, 1993, INNOVATIONS PROTEASE, P333; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Clugston SL, 1998, J MOL EVOL, V47, P230, DOI 10.1007/PL00006380; De Rocher EJ, 1998, PLANT PHYSIOL, V117, P1445, DOI 10.1104/pp.117.4.1445; ENGVALL E, 1972, J IMMUNOL, V109, P129; Espartero J, 1995, PLANT MOL BIOL, V29, P1223, DOI 10.1007/BF00020464; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; IKEZAWA Z, 1992, ACTA DERM-VENEREOL, P103; INOUE Y, 1987, J BIOCHEM-TOKYO, V102, P583, DOI 10.1093/oxfordjournals.jbchem.a122091; Inoue Y, 1996, J BIOL CHEM, V271, P25958, DOI 10.1074/jbc.271.42.25958; IZUMI H, 1992, FEBS LETT, V302, P213, DOI 10.1016/0014-5793(92)80443-K; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIMAS GG, 1990, PLANTA, V181, P1, DOI 10.1007/BF00202318; Maruyama N, 1998, EUR J BIOCHEM, V255, P739, DOI 10.1046/j.1432-1327.1998.2550739.x; MCKENDREE W, 1997, PLANT PHYSIOL, V115, P314; Nakase M, 1996, J AGR FOOD CHEM, V44, P2624, DOI 10.1021/jf9508099; RACKER E, 1951, J BIOL CHEM, V190, P685; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; SHIBASAKI M, 1979, J ALLERGY CLIN IMMUN, V64, P259, DOI 10.1016/0091-6749(79)90141-6; Tada Y, 1996, FEBS LETT, V391, P341, DOI 10.1016/0014-5793(96)00773-9; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URISU A, 1991, INT ARCH ALLER A IMM, V96, P244, DOI 10.1159/000235502; Veena, 1999, PLANT J, V17, P385, DOI 10.1046/j.1365-313X.1999.00390.x	31	81	86	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11376	11381		10.1074/jbc.M010337200	http://dx.doi.org/10.1074/jbc.M010337200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139585	hybrid			2022-12-27	WOS:000167980900108
J	Geha, RM; Rebrin, I; Chen, K; Shih, JC				Geha, RM; Rebrin, I; Chen, K; Shih, JC			Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BEHAVIOR; GENES; SELECTIVITY; FORMS; RAT	Monoamine oxidase (MAO) is responsible for the oxidation of biogenic and dietary amines, It exists as two isoforms, A and B, which have a 70% amino acid identity and different substrate and inhibitor specificities. This study reports the identification of residues responsible for conferring this specificity in human MAO A and B, Using site-directed mutagenesis we reciprocally interchanged three pairs of corresponding nonconserved amino acids within the central portion of human MAO. Mutant MAO A-I335Y became like MAO B, which exhibits a higher preference for beta -phenylethylamine than for the MAO A preferred substrate serotonin (5-hydroxytryptamine), and became more sensitive to deprenyl (MAO B-specific inhibitor) than to clorgyline (MAO A-specific inhibitor). The reciprocal mutant MAO B-Y326I exhibited an increased preference for 5-hydroxytryptamine, a decreased preference for beta -phenylethylamine, and, similar to MAO A, was more sensitive to clorgyline than to deprenyl, These mutants also showed a distinct shift in sensitivity for the MAO A- and B-selective inhibitors Ro 41-1049 and Ro 16-6491. Mutant pair MAO A-T245I and MAO B-I236T and mutant pair MAO A-D328G and MAO B-G319D reduced catalytic activity but did not alter specificity. Our results indicate that Ile-335 in MAO A and Tyr-326 in MAO B play a critical role in determining substrate and inhibitor specificities in human MAO A and B.	Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA; Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Shih, JC (corresponding author), 1985 Zonal Ave, Los Angeles, CA 90089 USA.				NIMH NIH HHS [K05 MH00796, R01 MH37020, R37 MH39085] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039085, K05MH000796, R01MH037020] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CESURA A M, 1988, Pharmacological Research Communications, V20, P51, DOI 10.1016/S0031-6989(88)80547-2; Cesura AM, 1996, EUR J BIOCHEM, V236, P996, DOI 10.1111/j.1432-1033.1996.00996.x; CESURA AM, 1989, MOL PHARMACOL, V37, P358; Chen K, 1996, J NEUROCHEM, V66, P797; CHEN K, 1994, MOL PHARMACOL, V46, P1226; Crossen R., 1996, BACULOVIRUS EXPRESSI; Egashira T, 1999, JPN J PHARMACOL, V81, P115, DOI 10.1254/jjp.81.115; Geha RM, 2000, J NEUROCHEM, V75, P1304, DOI 10.1046/j.1471-4159.2000.751304.x; GLOVER V, 1977, NATURE, V265, P80, DOI 10.1038/265080a0; GOTTOWIK J, 1993, FEBS LETT, V317, P152, DOI 10.1016/0014-5793(93)81512-X; GOTTOWIK J, 1995, EUR J BIOCHEM, V230, P934, DOI 10.1111/j.1432-1033.1995.tb20639.x; GREENAWALT JW, 1970, J CELL BIOL, V46, P173, DOI 10.1083/jcb.46.1.173; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Grimsby J, 1996, LIFE SCI, V58, P777, DOI 10.1016/0024-3205(95)02356-9; GRIMSBY J, 1997, NAT GENET, V17, P1; Inoue H, 1999, J PHARMACOL EXP THER, V291, P856; Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393; KRUEGER MJ, 1995, BIOCHEM BIOPH RES CO, V206, P556, DOI 10.1006/bbrc.1995.1079; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; OCARROLL A, 1983, N-S ARCH PHARMACOL, V312, P51; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Tsugeno Y, 1997, J BIOL CHEM, V272, P14033, DOI 10.1074/jbc.272.22.14033; TSUGENO Y, 1995, J BIOCHEM-TOKYO, V118, P974, DOI 10.1093/jb/118.5.974; Veselovsky AV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1441; WU HF, 1993, MOL PHARMACOL, V43, P888	30	139	142	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9877	9882		10.1074/jbc.M006972200	http://dx.doi.org/10.1074/jbc.M006972200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134050	hybrid			2022-12-27	WOS:000167996400041
J	Geminard, C; Nault, F; Johnstone, RM; Vidal, M				Geminard, C; Nault, F; Johnstone, RM; Vidal, M			Characteristics of the interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSC70; CELL-DERIVED EXOSOMES; HEAT-SHOCK-PROTEIN; IMMUNOSUPPRESSANT DEOXYSPERGUALIN; UNCOATING ATPASE; SELECTIVE EXTERNALIZATION; SHEEP RETICULOCYTES; HSP70; DOMAIN; ACCUMULATION	The transferrin receptor (TfR) of reticulocytes is released in vesicular form (exosomes) during their maturation to erythrocytes, The heat shock cognate 70-kDa protein (Hsc70) has been demonstrated to interact with the cytosolic domain of the TfR and could thus trigger the receptor toward this secretion pathway. We investigated the characteristics of the interaction between Hsc70 and the TfR in exosomes with an in vitro binding assay using TfR immobilized on Sepharose beads and purified Hsc70. The results show that Hsc70 binds to exosomal TfR with characteristics expected of a chaperone/peptide interaction. We demonstrated that heat-denatured luciferase competed for in vitro binding, dependent on the nucleotide bound to Hsc70, and that this interaction activates the ATPase activity of Hsc70. Moreover, we used immunosuppressive agents that interact with Hsc70, thus decreasing Hsc70 binding to TfR in our in vitro binding assay and enabling us to assess the role of this interaction in vivo during reticulocyte maturation.	Univ Montpellier 2, UMR 5539, CNRS, F-34095 Montpellier, France; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; McGill University	Vidal, M (corresponding author), Univ Montpellier 2, UMR 5539, CNRS, CC107, F-34095 Montpellier, France.		Geminard, Charles/O-8035-2018	GEMINARD, Charles/0000-0002-0018-9566				ADAM MA, 1987, BIOCHEM J, V242, P151, DOI 10.1042/bj2420151; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BAYNES RD, 1994, J LAB CLIN MED, V123, P407; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHIANG HL, 1989, SCIENCE, V246, P282; CLEAVELAND JS, 1993, BIOCHEM BIOPH RES CO, V195, P455, DOI 10.1006/bbrc.1993.2065; DAVIS JQ, 1986, J BIOL CHEM, V261, P5368; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUCHS H, 1995, BIOCHEMISTRY-US, V34, P6196, DOI 10.1021/bi00018a024; GAO BC, 1993, J BIOL CHEM, V268, P8507; HOEGER PH, 1994, J IMMUNOL, V153, P3908; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Johnstone RM, 1996, J CELL PHYSIOL, V168, P333, DOI 10.1002/(SICI)1097-4652(199608)168:2<333::AID-JCP12>3.0.CO;2-4; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Komesli S, 1999, INT J IMMUNOPHARMACO, V21, P349, DOI 10.1016/S0192-0561(99)00017-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu QL, 1996, J BIOL CHEM, V271, P29937, DOI 10.1074/jbc.271.47.29937; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; RAPOSO G, 1996, J EXP MED, V183, P1; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vidal M, 1997, J CELL SCI, V110, P1867; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412; ZIEMIENOWICZ A, 1995, J BIOL CHEM, V270, P15479, DOI 10.1074/jbc.270.26.15479; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	41	60	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9910	9916		10.1074/jbc.M009641200	http://dx.doi.org/10.1074/jbc.M009641200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133993	hybrid			2022-12-27	WOS:000167996400046
J	Sawamura, N; Gong, JS; Garver, WS; Heidenreich, RA; Ninomiya, H; Ohno, K; Yanagisawa, K; Michikawa, M				Sawamura, N; Gong, JS; Garver, WS; Heidenreich, RA; Ninomiya, H; Ohno, K; Yanagisawa, K; Michikawa, M			Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; DISEASE TYPE-C; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; APOLIPOPROTEIN-E; INTRACELLULAR TRAFFICKING; ABNORMAL PHOSPHORYLATION; ANTIGENIC DETERMINANTS; CHOLESTEROL; ALLELE	Niemann-Pick type C (NPC) disease is characterized by an accumulation of cholesterol in most tissues and progressive neurodegeneration with the formation of neurofibrillary tangles. Neurofibrillary tangles are composed of paired helical filaments (PHF), a major component of which is the hyperphosphorylated tau. In this study we used NPC heterozygous and NPC homozygous mouse brains to investigate the molecular mechanism responsible for tauopathy in NPC, Immunoblot analysis using anti-tau antibodies (Tau-1, PHF-1, AT-180, and AT-100) revealed site-specific phosphorylation of tau at Ser-396 and Ser-404 in the brains of NPC homozygous mice. Mitogen-activated protein kinase, a potential serine kinase known to phosphorylate tau, was activated, whereas other serine kinases such as glycogen synthase kinase-3 beta and cyclin-dependent kinase 5 were inactive. Morphological examination demonstrated that a number of neurons the perikarya of which strongly immunostained with PHF-1, exhibited polymorphorous cytoplasmic inclusion bodies and multi-concentric lamellar-like bodies. Importantly, the accumulation of intracellular cholesterol in NPC mouse brains was determined to be a function of age. From these results we conclude that abnormal cholesterol metabolism due to the genetic mutation in NPC1 may be responsible for activation of the mitogen-activated protein kinase-signaling pathway and site-specific phosphorylation of tau in vivo, leading to tauopathy in NPC.	Natl Inst Longev Sci, Dept Dementia Res, Aichi 4748522, Japan; Univ Arizona, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; Tottori Univ, Fac Med, Dept Neurobiol, Yonago, Tottori 683, Japan	University of Arizona; Tottori University	Michikawa, M (corresponding author), Natl Inst Longev Sci, Dept Dementia Res, 36-3 Gengo, Aichi 4748522, Japan.		Sawamura, Naoya/K-1663-2018	Sawamura, Naoya/0000-0003-4753-1119	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056732] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56732] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARENDT T, 1995, NEUROSCIENCE, V68, P5, DOI 10.1016/0306-4522(95)00146-A; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; ELFENBEIN IB, 1968, JOHNS HOPKINS MED J, V123, P205; Fan QW, 2001, J NEUROCHEM, V76, P391, DOI 10.1046/j.1471-4159.2001.00063.x; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Garver WS, 2000, J LIPID RES, V41, P673; Garver WS, 1999, BBA-MOL BASIS DIS, V1453, P193, DOI 10.1016/S0925-4439(98)00101-X; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Goedert M., 1996, MOL GENETIC BASIS NE, P613; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Henderson LP, 2000, J BIOL CHEM, V275, P20179, DOI 10.1074/jbc.M001793200; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LOVE S, 1995, BRAIN, V118, P119, DOI 10.1093/brain/118.1.119; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; MORRIS MD, 1982, AM J PATHOL, V108, P140; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1995, METABOLIC BASIS INHE, P2624; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shea TB, 1999, CELL MOL NEUROBIOL, V19, P223, DOI 10.1023/A:1006977127422; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; Xie CL, 1999, AM J PHYSIOL-ENDOC M, V276, pE336, DOI 10.1152/ajpendo.1999.276.2.E336; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992	39	92	98	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10314	10319		10.1074/jbc.M009733200	http://dx.doi.org/10.1074/jbc.M009733200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152466	hybrid			2022-12-27	WOS:000167996400097
J	Cohen, B; Barkan, D; Levy, Y; Goldberg, I; Fridman, E; Kopolovic, J; Rubinstein, M				Cohen, B; Barkan, D; Levy, Y; Goldberg, I; Fridman, E; Kopolovic, J; Rubinstein, M			Leptin induces angiopoietin-2 expression in adipose tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ANGIOGENIC FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; OBESE GENE; FAT PADS; TIE2; RECEPTOR; DIFFERENTIATION; ADIPOCYTES	Adipose tissues consisting of adipocytes, microvasculature, and stroma are completely ablated upon overexpression of leptin in rats. This tissue regression is mediated by enhanced lipid beta-oxidation, adipocyte dedifferentiation, and apoptosis. To further characterize this phenomenon, we studied the possible effect of leptin on the adipose microvasculature. Tissue microvasculature is maintained by the interplay between positive and negative signals mediated by factors including vascular endothelial growth factor (VEGF), basic fibroblast growth factor, angiopoletin-1 (Ang-1), and Ang-2. Expression of the negative signal Ang-2 was reported in fetal tissues and in the adult ovary, which undergoes vascular remodeling or regression. We demonstrate that leptin induces the expression of Ang-a in adipose tissue without a concomitant increase in VEGF. Induction of Ang-2 occurred in an autocrine manner, as demonstrated in cultured adipocytes but not in several other cell types. This tissue-specific induction of Ang-2 coincided with initiation of apoptosis in adipose endothelial cells. We propose that induction of Ang-2 by leptin in adipose cells is one of the events leading to adipose tissue regression.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Ramat Gan, Israel	Weizmann Institute of Science; Chaim Sheba Medical Center	Rubinstein, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.			Rubinstein, Menachem/0000-0002-3472-6614; Barkan, Dalit/0000-0003-4714-0580				Barkan D, 1999, ENDOCRINOLOGY, V140, P1731, DOI 10.1210/en.140.4.1731; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Considine RV, 1997, INT J BIOCHEM CELL B, V29, P1255, DOI 10.1016/S1357-2725(97)00050-2; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Flier JS, 1997, P NATL ACAD SCI USA, V94, P4242, DOI 10.1073/pnas.94.9.4242; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goede V, 1998, LAB INVEST, V78, P1385; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Otani A, 1999, INVEST OPHTH VIS SCI, V40, P1912; Qian H, 1998, ENDOCRINOLOGY, V139, P791, DOI 10.1210/en.139.2.791; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4; Soukas A, 2000, GENE DEV, V14, P963; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; TARGAGLIA LA, 1995, CELL, V83, P1263; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wang ZW, 1999, P NATL ACAD SCI USA, V96, P10373, DOI 10.1073/pnas.96.18.10373; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P6386, DOI 10.1073/pnas.94.12.6386	36	75	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7697	7700		10.1074/jbc.C000634200	http://dx.doi.org/10.1074/jbc.C000634200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11152449	hybrid			2022-12-27	WOS:000167474900003
J	Zhuo, LS; Yoneda, M; Zhao, M; Yingsung, W; Yoshida, N; Kitagawa, Y; Kawamura, K; Suzuki, T; Kimata, K				Zhuo, LS; Yoneda, M; Zhao, M; Yingsung, W; Yoshida, N; Kitagawa, Y; Kawamura, K; Suzuki, T; Kimata, K			Defect in SHAP-hyaluronan complex causes severe female infertility - A study by inactivation of the bikunin gene in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; CUMULUS EXTRACELLULAR-MATRIX; CELL-OOCYTE COMPLEXES; HUMAN PLASMA; HEAVY-CHAIN; CODING SEQUENCE; MOUSE; PROTEIN; ACID; FAMILY	Hyaluronan (HA) associates with proteins and proteoglycans to form the extracellular HA-rich matrices that significantly affect cellular behaviors. So far, only the heavy chains of the plasma inter-alpha -trypsin inhibitor (ITI) family, designated as SHAPs (serum-derived hyaluronan-associated proteins), have been shown to bind covalently to HA. The physiological significance of such a unique covalent complex has been unknown but is of great interest, because HA and the ITI family are abundant in tissues and in plasma, respectively, and the SHAP-HA complex is formed wherever HA meets plasma. We abolished the formation of the SHAP-HA complex in mice by targeting the gene of bikunin, the light chain of the ITI family members, which is essential for their biosynthesis. As a consequence, the cumulus oophorus, an investing structure unique to the oocyte of higher mammals, had a defect in forming the extracellular HA-rich matrix during expansion. The ovulated oocytes were completely devoid of matrix and were unfertilized, leading to severe female infertility. Intraperitoneal administration of ITI, accompanied by the formation of the SHAP-HA complex, fully rescued the defects. We conclude that the SHAP-HA complex Is a major component of the HA-rich matrix of the cumulus oophorus and is essential for fertilization in vivo.	Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Grad Program Regulat Biol Signals, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Japan SLC Inc, Hamamatsu, Shizuoka 4338114, Japan	Aichi Medical University; Nagoya University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	kimata@amugw.aichi-med-u.ac.jp						ATMANI F, 1993, UROL RES, V21, P61, DOI 10.1007/BF00295195; Berggard T, 1997, EUR J BIOCHEM, V245, P676, DOI 10.1111/j.1432-1033.1997.00676.x; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; Camaioni A, 1996, ARCH BIOCHEM BIOPHYS, V325, P190, DOI 10.1006/abbi.1996.0024; CASTILLO GM, 1993, FEBS LETT, V318, P292, DOI 10.1016/0014-5793(93)80531-X; CHAN P, 1995, BIOCHEM J, V306, P505, DOI 10.1042/bj3060505; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Fulop C, 1997, ARCH BIOCHEM BIOPHYS, V337, P261, DOI 10.1006/abbi.1996.9793; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; HOCHSTRASSER K, 1981, H-S Z PHYSIOL CHEM, V362, P1357, DOI 10.1515/bchm2.1981.362.2.1357; HUANG L, 1993, J BIOL CHEM, V268, P26725; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; Kida D, 1999, J RHEUMATOL, V26, P1230; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kobayashi H, 1999, ENDOCRINOLOGY, V140, P3835, DOI 10.1210/en.140.8.3835; KOBAYASHI H, 1995, INT J CANCER, V63, P455, DOI 10.1002/ijc.2910630326; LARSEN WJ, 1986, DEV BIOL, V113, P517, DOI 10.1016/0012-1606(86)90187-9; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lindqvist A, 1999, GENE, V234, P329, DOI 10.1016/S0378-1119(99)00191-2; Mizon C, 1996, J IMMUNOL METHODS, V190, P61, DOI 10.1016/0022-1759(95)00257-X; Nakayashiki N, 1997, JPN J HUM GENET, V42, P363, DOI 10.1007/BF02766960; POWERS RW, 1995, AM J PHYSIOL-ENDOC M, V269, pE290, DOI 10.1152/ajpendo.1995.269.2.E290; PROKSCH GJ, 1973, CLIN BIOCHEM, V6, P200, DOI 10.1016/S0009-9120(73)80027-X; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SUGIKI M, 1989, ENZYME, V42, P31, DOI 10.1159/000469004; TALBOT P, 1984, DEV BIOL, V103, P159, DOI 10.1016/0012-1606(84)90017-4; Thuveson M, 1999, J BIOL CHEM, V274, P6741, DOI 10.1074/jbc.274.10.6741; Toole B. P., 1991, CELL BIOL EXTRACELLU, P305; Yamamoto T, 1996, J BIOCHEM-TOKYO, V120, P145; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoneda M, 2000, INT CONGR SER, V1196, P21; YONEDA M, 1998, CONNECT TISSUE, V30, P69; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	41	206	215	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7693	7696		10.1074/jbc.C000899200	http://dx.doi.org/10.1074/jbc.C000899200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11145954	hybrid			2022-12-27	WOS:000167474900002
J	Filosa, A; English, AM				Filosa, A; English, AM			Mass spectral analysis of protein-based radicals using DBNBS - Nonradical adduct formation versus spin trapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; ACID; IDENTIFICATION; CHROMATOGRAPHY; METMYOGLOBIN; SPECTROMETRY; MYOGLOBIN; OXIDATION	Protein-based radicals generated in the reaction of ferricytochrome c (cyt c) with H2O2 were investigated by electrospray mass spectrometry (ESI-MS) using 3,5-dibromo-4-nitrosobenzenesulfonate (DBNBS). Up to four DBNBS-cyt c adducts were observed in the mass spectra, However, by varying the reaction conditions (0-5 molar equivalents of H2O2 and substituting cyt c with its cyanide adduct which is resistant to peroxidation), noncovalent DBNBS adduct formation was inferred. Nonetheless, optical difference spectra revealed the presence of a small fraction of covalently trapped DBNBS. To probe the nature of the noncovalent DBNBS adducts, the less basic proteins, metmyoglobin (Mb) and alpha -lactalbumin, were substituted for cyt c in the cyt c/H2O2/DBNBS reaction. A maximum of two DBNBS adducts were observed in the mass spectra of the products of the Rib! H2O2/DBNBS reactions, whereas no adducts were detected following alpha -lactalbumin/H2O2/DBNBS incubation, which is consistent with adduct formation via spin trapping only. Titration with DBNBS at pH 2.0 yielded noncovalent DBNBS-cyt c adducts and induced folding of acid-denatured cyt c, as monitored by ESI-MS and optical spectroscopy, respectively. Thus, the noncovalent DBNBS-cyt c mass adducts observed are assigned to ion pair formation occurring between the negatively charged sulfonate group on DBNBS and positively charged surface residues on cyt c, The results reveal the pitfalls inherent in using mass spectral data with negatively charged spin traps such as DBNBS to identify sites of radical formation on basic proteins such as cyt c.	Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	English, AM (corresponding author), Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada.							Ali V, 1999, BIOCHEMISTRY-US, V38, P13635, DOI 10.1021/bi9907835; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; BLUMENTHAL DC, 1980, J BIOL CHEM, V255, P5859; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; Chen YR, 1999, J BIOL CHEM, V274, P3308, DOI 10.1074/jbc.274.6.3308; Deterding LJ, 1998, J BIOL CHEM, V273, P12863, DOI 10.1074/jbc.273.21.12863; DYER C, 1979, BIOCHIM BIOPHYS ACTA, V579, P253, DOI 10.1016/0005-2795(79)90053-9; Eberson L, 1998, ADV PHYS ORG CHEM, V31, P91; Fenwick CW, 1996, J AM CHEM SOC, V118, P12236, DOI 10.1021/ja962764d; FENWICK CW, 1997, THESIS CONCORDIA U M; FILOSA A, 2000, P 48 ASMS C MASS SPE; FILOSA A, 1999, P 47 ASMS C MASS SPE; GEORGE P, 1952, BIOCHEM J, V52, P511, DOI 10.1042/bj0520511; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GUNTHER MR, 1995, J BIOL CHEM, V270, P16075, DOI 10.1074/jbc.270.27.16075; Gunther MR, 1998, BIOCHEM J, V330, P1293; HIRAMOTO K, 1994, FREE RADICAL RES, V21, P341, DOI 10.3109/10715769409056586; IWAHASHI H, 1991, BIOCHEM J, V276, P447, DOI 10.1042/bj2760447; IWAHASHI H, 1990, RAPID COMMUN MASS SP, V4, P352, DOI 10.1002/rcm.1290040912; JANZEN EG, 1990, FREE RADICAL RES COM, V9, P353, DOI 10.3109/10715769009145694; KALYANARAMAN B, 1992, BIOCHIM BIOPHYS ACTA, V1126, P309, DOI 10.1016/0005-2760(92)90245-Q; KAUR H, 1981, J CHEM SOC CHEM COMM, P142, DOI 10.1039/c39810000142; KIM YM, 1995, FREE RADICAL RES, V22, P11, DOI 10.3109/10715769509147524; KOHNO M, 1991, B CHEM SOC JPN, V64, P1447, DOI 10.1246/bcsj.64.1447; MASON RP, 1980, J BIOL CHEM, V255, P5019; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MOORE GR, 1987, CYTOCHROMES C BIOL A, P83; Nazhat NB, 1999, BBA-GEN SUBJECTS, V1427, P276, DOI 10.1016/S0304-4165(99)00026-4; OZAWA T, 1991, B CHEM SOC JPN, V64, P1976, DOI 10.1246/bcsj.64.1976; PERKINS MJ, 1980, ADV PHYS ORG CHEM, V17, P1; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; RADI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P409, DOI 10.1006/abbi.1993.1055; RIGHETTI PG, 1976, J CHROMATOGR, V127, P1, DOI 10.1016/S0021-9673(00)98537-6; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; TSAPRAILLIS G, 1997, THESIS CONCORDIA U M; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200	36	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21022	21027		10.1074/jbc.M100644200	http://dx.doi.org/10.1074/jbc.M100644200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262405	Green Accepted, hybrid			2022-12-27	WOS:000169297900032
J	Lo, KWH; Naisbitt, S; Fan, JS; Sheng, M; Zhang, MJ				Lo, KWH; Naisbitt, S; Fan, JS; Sheng, M; Zhang, MJ			The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; INTERMEDIATE-CHAIN; HEAVY-CHAIN; PROTEIN INHIBITOR; MYOSIN-V; DIMERIZATION; PURIFICATION; INTERACTS; TRANSPORT; FLAGELLA	Cytoplasmic dynein is a large, multisubunit molecular motor that translocates cargoes toward the minus ends of microtubules. Proper functioning of the dynein motor requires precise assembly of its various subunits. Using purified recombinant proteins, we show that the highly conserved 8-kDa light chain (DLC8) binds to the intermediate chain of the dynein complex. The DLC8-binding region was mapped to a highly conserved 10-residue fragment (amino acid sequence SYSKETQTPL) C-terminal to the second alternative splicing site of dynein intermediate chain. Yeast two-hybrid screening using DLC8 as bait identified numerous additional DLC8-binding proteins. Biochemical and mutational analysis of selected DLC8 binding proteins revealed that DLC8 binds to a consensus sequence containing a (K/R)XTQT motif. The (K/R)XTQT motif interacts with the common target-accepting grooves of DLC8 dimer. The role of each conserved amino acid residue in this pentapeptide motif in supporting complex formation with DLC8 was systematically studied using site-directed mutagenesis.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Hong Kong University of Science & Technology; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.			Zhang, Mingjie/0000-0001-9404-0190; Sheng, Morgan/0000-0002-8703-5366				Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Liang J, 1999, NAT STRUCT BIOL, V6, P735; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507	28	159	162	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14059	14066		10.1074/jbc.M010320200	http://dx.doi.org/10.1074/jbc.M010320200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11148209	hybrid			2022-12-27	WOS:000168356600076
J	Pare, JF; Roy, S; Galarneau, L; Belanger, L				Pare, JF; Roy, S; Galarneau, L; Belanger, L			The mouse fetoprotein transcription factor (FTF) gene promoter is regulated by three GATA elements with tandem E box and Nkx motifs, and FTF in turn activates the Hnf3 beta, Hnf4 alpha, and Hnf1 alpha gene promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; BILE-ACID; ALPHA-1-FETOPROTEIN GENE; DEFINITIVE ENDODERM; MOLECULAR-CLONING; ORPHAN RECEPTORS; GUT ENDODERM; FTZ-F1 GENE; FACTOR LFB1; LIVER	Fetoprotein transcription factor (FTF) is an orphan nuclear receptor that activates the alpha (1)-fetoprotein gene during early liver developmental growth. Here we sought to define better the position of FTF in transcriptional cascades leading to hepatic differentiation. The mouse FTF gene was isolated and assigned to chromosome 1 band E4 (one mFTF pseudogene was also found). Exon/intron mapping shows an mFTF gene structure similar to that of its close homologue SF1, with two more N-terminal exons in the mFTF gene; exon mapping also delimits several FTF mRNA 5 '- and 3 ' -splice variants. The mFTF transcription initiation site was located in adult liver at 238 nucleotides from the first translation initiator codon, with six canonical GATA, E box, and Nkx motifs clustered between -50/-140 base pairs (bp) from the cap site; DNA/protein binding assays also pinpointed an HNF4-binding element at +36 bp and an FTF-binding element at -257 bp. Transfection assays and point mutations showed that the mFTF promoter is activated by GATA, HNF4 alpha, FTF, Nkx, and basic helix-loop-helix factors, with marked cooperativity between GATA and HNF4 alpha, A tandem GATA/E box activatory motif in the proximal mFTF promoter is strikingly similar to a composite motif coactivated by differentiation inducers in the hematopoietic lineage; a tandem GATA-Nkx motif in the distal mFTF promoter is also similar to a composite motif transducing differentiation signals from transforming growth factor-a-like receptors in the cardiogenic lineage. Three genes encoding transcription factors critical to early hepatic differentiation, Hnf3 beta, Hnf4 alpha, and Hnf1 alpha, each contain dual FTF-binding elements in their proximal promoters, and all three promoters are activated by FTF in transfection assays. Direct DNA binding action and cooperativity was demonstrated between FTF and HNF3 beta on the Hnf3 beta promoter and between FTF and HNF4 alpha on the Hnf1 alpha promoter. These combined results suggest that FTF is an early intermediary between endodermal specification signals and downstream genes that establish and amplify the hepatic phenotype.	Univ Laval, Hotel Dieu, Ctr Rech Cancerol, Dept Biol Med,Fac Med, Quebec City, PQ G1R 2J6, Canada	Laval University	Belanger, L (corresponding author), Hop Hotel Dieu, Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada.	luc.belanger@crhdq.ulaval.ca						ANG SL, 1993, DEVELOPMENT, V119, P1301; Apergis GA, 1998, J BIOL CHEM, V273, P2917, DOI 10.1074/jbc.273.5.2917; BARTKOWSKI S, 1993, MOL CELL BIOL, V13, P421, DOI 10.1128/MCB.13.1.421; BELANGER L, 1994, J BIOL CHEM, V269, P5481; BELANGER L, 1975, NATURE, V256, P657, DOI 10.1038/256657a0; BERNIER D, 1993, MOL CELL BIOL, V13, P1619, DOI 10.1128/MCB.13.3.1619; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Bossard P, 1998, DEVELOPMENT, V125, P4909; Chai C, 2000, MECH DEVELOP, V91, P421, DOI 10.1016/S0925-4773(99)00312-3; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; del Castillo-Olivares A, 2000, J BIOL CHEM, V275, P17793, DOI 10.1074/jbc.M000996200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; ELLINGERZIEGELBAUER H, 1995, MOL ENDOCRINOL, V9, P872, DOI 10.1210/me.9.7.872; ELLINGERZIEGELBAUER H, 1994, MOL CELL BIOL, V14, P2786, DOI 10.1128/MCB.14.4.2786; Galarneau L, 1998, CYTOGENET CELL GENET, V82, P269, DOI 10.1159/000015116; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Gilbert S, 2000, J VIROL, V74, P5032, DOI 10.1128/JVI.74.11.5032-5039.2000; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Ktistaki E, 1997, MOL CELL BIOL, V17, P2790, DOI 10.1128/MCB.17.5.2790; Kudo T, 1997, GENE, V197, P261, DOI 10.1016/S0378-1119(97)00270-9; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; LEDOUARIN NM, 1975, MED BIOL, V53, P427; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Li JX, 2000, GENE DEV, V14, P464; Li M, 1998, J BIOL CHEM, V273, P29022, DOI 10.1074/jbc.273.44.29022; Lin WW, 2000, BIOCHEM J, V348, P439, DOI 10.1042/0264-6021:3480439; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Nakajima T, 2000, GENE, V248, P203, DOI 10.1016/S0378-1119(00)00119-0; Nawata H, 1999, J STEROID BIOCHEM, V69, P323, DOI 10.1016/S0960-0760(99)00081-3; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; *NUCL REC NOM COMM, 1909, CELL, V97, P161; PANI L, 1992, MOL CELL BIOL, V12, P552, DOI 10.1128/MCB.12.2.552; Rausa FM, 1999, MECH DEVELOP, V89, P185, DOI 10.1016/S0925-4773(99)00209-9; Ryffel GU, 2000, MECH DEVELOP, V90, P65, DOI 10.1016/S0925-4773(99)00230-0; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; TAKETO M, 1995, GENOMICS, V25, P565, DOI 10.1016/0888-7543(95)80059-U; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weber H, 1996, DEVELOPMENT, V122, P1975; ZAPP D, 1993, MOL CELL BIOL, V13, P6416, DOI 10.1128/MCB.13.10.6416; Zaret K, 1998, CURR OPIN GENET DEV, V8, P526, DOI 10.1016/S0959-437X(98)80006-3; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; ZHONG WM, 1994, MOL CELL BIOL, V14, P7276, DOI 10.1128/MCB.14.11.7276	53	80	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13136	13144		10.1074/jbc.M010737200	http://dx.doi.org/10.1074/jbc.M010737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11145965	hybrid			2022-12-27	WOS:000168198600094
J	Ruvolo, PP; Gao, FQ; Blalock, WL; Deng, XM; May, WS				Ruvolo, PP; Gao, FQ; Blalock, WL; Deng, XM; May, WS			Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PKR; INDUCED APOPTOSIS; STRESS; RNA; INITIATION; INHIBITION; PHOSPHORYLATION; DEATH; CELLS; DEPHOSPHORYLATION	The sphingolipid ceramide is an important second signal molecule and potent apoptotic agent. The production of ceramide is associated with virtually every known stress stimulus, and thus, generation of this sphingolipid has been suggested as a universal feature of apoptosis. Recent studies suggest that an important component of cell death following diverse stress stimuli (e.g. interleukin-3 withdrawal, sodium arsenite treatment, and peroxide treatment) is the activation of the double-stranded RNA-activable protein kinase, PKR, resulting in the inhibition of protein synthesis (Ito, T., Jagus, R., and May, W. S. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 7455-7459). The recently discovered cellular PKR activator, RAX, is phosphorylated in association with PKR activation (Ito, T., Yang, M., and May, W. S. (1999) J. Biol. Chem. 274, 15427-15432). Since RAX is phosphorylated by an as yet undetermined SAPK and ceramide is a potent activator of SAPKs such as JNK, a role for ceramide in the activation of RAX might be possible. Results indicate that overexpression of exogenous RAX potentiates ceramide-induced killing. Furthermore, ceramide can potently inhibit protein synthesis. Since ceramide potently promotes RAX and eukaryotic initiation factor-2 alpha phosphorylation, a possible role for ceramide in this process may involve the activation of PKR by RAX. Since 2-aminopurine, a serine/threonine kinase inhibitor that has previously been shown to inhibit PKR, blocks both the potentiation of ceramide killing by RAX and ceramide-induced inhibition of protein synthesis, ceramide appears to promote PKR activation, at least indirectly. Collectively, these findings suggest a novel role for ceramide in the regulation of protein synthesis and apoptosis.	Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ruvolo, PP (corresponding author), Univ Florida, Shands Canc Ctr, POB 100232, Gainesville, FL 32610 USA.		Blalock, William L/C-6959-2019	Blalock, William L/0000-0002-8045-4840	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054083] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; Basu S, 1998, ONCOGENE, V17, P3277, DOI 10.1038/sj.onc.1202570; Bielawska AE, 1997, AM J PATHOL, V151, P1257; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; DEBENEDETTI A, 1983, J BIOL CHEM, V258, P4556; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HERSHEY JWB, 1993, SEMIN VIROL, V4, P201, DOI 10.1006/smvy.1993.1016; HOVANESSIAN AG, 1993, SEMIN VIROL, V4, P237, DOI 10.1006/smvy.1993.1020; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Ito T, 1999, BIOCHEM BIOPH RES CO, V265, P589, DOI 10.1006/bbrc.1999.1727; ITO T, 1994, P NATL ACAD SCI USA, V91, P7455, DOI 10.1073/pnas.91.16.7455; Jarvis WD, 1997, MOL PHARMACOL, V52, P935, DOI 10.1124/mol.52.6.935; Jarvis WD, 1996, CLIN CANCER RES, V2, P1; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; MATTHEWS MB, 1993, SEMIN VIROL, V4, P247; MERRICK WC, 1992, MICROBIOL REV, V56, P241; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; QUINTANS J, 1994, BIOCHEM BIOPH RES CO, V202, P710, DOI 10.1006/bbrc.1994.1988; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Sheikh MS, 1999, ONCOGENE, V18, P6121, DOI 10.1038/sj.onc.1203131; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wu SY, 1998, BIOCHEMISTRY-US, V37, P13816, DOI 10.1021/bi981472h; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451; Zamanian-Daryoush M, 1999, ONCOGENE, V18, P315, DOI 10.1038/sj.onc.1202293; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434; Zundel W, 1998, GENE DEV, V12, P1941, DOI 10.1101/gad.12.13.1941	46	65	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11754	11758		10.1074/jbc.M011400200	http://dx.doi.org/10.1074/jbc.M011400200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11148216	hybrid			2022-12-27	WOS:000168081800045
J	dos Santos, CMA; van Kerkhof, P; Strous, GJ				dos Santos, CMA; van Kerkhof, P; Strous, GJ			The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; CLATHRIN-MEDIATED ENDOCYTOSIS; PROTEIN-TYROSINE PHOSPHATASES; ERYTHROPOIETIN RECEPTOR; CYTOPLASMIC DOMAIN; JAK/STAT PATHWAY; UBIQUITIN SYSTEM; JAK2; KINASE; SHP-2	The growth hormone receptor (GHR) intracellular domain contains all of the information required for signal transduction as well as for endocytosis. Previously, we showed that the proteasome mediates the clathrin-mediated endocytosis of the GHR. Here, we present evidence that the proteasomal inhibitor MG132 prolongs the GH-induced activity of both GHR and JAK2, presumably through stabilization of GHR and JAK2 tyrosine phosphorylation, If proteasomal inhibitor was combined with ligand in an endocytosis-deficient GHR mutant, the same phenomenon occurred indicating that proteasomal action on tyrosine dephosphorylation is independent of endocytosis. Experiments with a GHR-truncated tail mutant (GHR-(1-369)) led to a prolonged JAK2 phosphorylation caused by the loss of a phosphatase-binding site. This raised the question of what happens to the signal transduction of the GHR after its internalization. Co-immunoprecipitation of GH . GHR complexes before and after endocytosis showed that JAK2 as well as other activated proteins are bound to the GHR not only at the cell surface but also intracellularly, suggesting that the GHR signal transduction continues in endosomes. Additionally, these results provide evidence that GHR is present in endosomes both in its full-length and truncated form, indicating that the receptor is down-regulated by the proteasome.	Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	Utrecht University	Strous, GJ (corresponding author), Univ Utrecht, Med Ctr, Dept Cell Biol, Heidelberglaan 100,AZU-G02-525, NL-3584 CX Utrecht, Netherlands.			van Kerkhof, Peter/0000-0002-8954-2230				Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; ALLEVATO G, 1995, J BIOL CHEM, V270, P17210, DOI 10.1074/jbc.270.29.17210; Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; Callus BA, 1998, BLOOD, V91, P3182, DOI 10.1182/blood.V91.9.3182.3182_3182_3192; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Hackett RH, 1997, J BIOL CHEM, V272, P11128; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Mellado M, 1997, J BIOL CHEM, V272, P9189; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; Strous GJ, 1999, J CELL SCI, V112, P1417; Strous GJ, 1997, J BIOL CHEM, V272, P40; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Thirone ACP, 1999, ENDOCRINOLOGY, V140, P55, DOI 10.1210/en.140.1.55; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yu CL, 1997, J BIOL CHEM, V272, P14017, DOI 10.1074/jbc.272.22.14017; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	43	34	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10839	10846		10.1074/jbc.M003635200	http://dx.doi.org/10.1074/jbc.M003635200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152671	hybrid			2022-12-27	WOS:000167980900039
J	Mischel, PS; Smith, SG; Vining, ER; Valletta, JS; Mobley, WC; Reichardt, LF				Mischel, PS; Smith, SG; Vining, ER; Valletta, JS; Mobley, WC; Reichardt, LF			The extracellular domain of p75(NTR) is necessary to inhibit neurotrophin-3 signaling through TrkA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; XENOPUS-LAEVIS OOCYTES; AFFINITY NGF RECEPTOR; SYMPATHETIC NEURONS; FUNCTIONAL INTERACTIONS; SENSORY NEURONS; FACTOR-BINDING; PC12 CELLS; IN-VIVO; P75	The TrkA receptor is activated primarily by nerve growth factor (NGF), but it can also be activated by high concentrations of neurotrophin 3 (NT-3). The pan-neurotrophin receptor p75(NTR) strongly inhibits activation of TrbA by NT-3 but not by NGF. To examine the role of p75(NTR) in regulating the specificity of TrkA signaling, we expressed both receptors in Xenopus oocytes. Application of NGF or NT-3 to oocytes expressing TrkA alone resulted in efflux of Ca-45(2+) by a phospholipase C-gamma -dependent pathway. Coexpression of p75(NTR) with TrkA inhibited Ca-45(2+) efflux in response to NT-3 but not NGF. The inhibitory effect on NT-3 activation of TrkA increased with increasing expression of p75(NTR). Coexpression of a truncated p75(NTR) receptor lacking all but the first 9 amino acids of the cytoplasmic domain inhibited NT-3 stimulation of Ca-45(2+) efflux, whereas coexpression of an epidermal growth factor receptor/p75(NTR) chimera (extracellular domain of epidermal growth factor receptor with transmembrane and cytoplasmic domains of p75(NTR)) did not inhibit NT-3 signaling through TrkA. These studies demonstrated that the extracellular domain of p75(NTR) was necessary to inhibit NT-3 signaling through TrkA. Remarkably, p75(NTR) binding to NT-3 was not required to prevent signaling through TrkA, since occupying p75(NTR) with brain-derived neurotrophic factor or anti-p75 antibody (REX) did not rescue the ability of NT-3 to activate Ca-45(2+) efflux. These data suggested a physical association between TrkA and p75(NTR). Documenting this physical interaction, we showed that p75(NTR) and TrkA could be coimmunoprecipitated from Xenopus oocytes. Our results suggest that the interaction of these two receptors on the cell surface mediated the inhibition of NT-3-activated signaling through TrkA.	Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University	Mischel, PS (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.				NIMH NIH HHS [P50 MH048200-070005, MH48200] Funding Source: Medline; NINDS NIH HHS [NS10301, F32 NS010301, NS24054, R01 NS024054] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010301, R01NS024054] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARKER PA, 1994, J BIOL CHEM, V269, P30645; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BATTLEMAN DS, 1993, J NEUROSCI, V13, P941; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; Davey F, 1998, CURR BIOL, V8, P915, DOI 10.1016/S0960-9822(07)00371-5; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Eide FF, 1996, J NEUROSCI, V16, P3123; EMFORS P, 1994, CELL, V77, P503; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Filtz TM, 1996, J BIOL CHEM, V271, P31121, DOI 10.1074/jbc.271.49.31121; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Gargano N, 1997, J NEUROSCI RES, V50, P1; GILLO B, 1987, J PHYSIOL-LONDON, V392, P349, DOI 10.1113/jphysiol.1987.sp016784; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Hartzell HC, 1996, J GEN PHYSIOL, V108, P157, DOI 10.1085/jgp.108.3.157; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Huang EJ, 1999, DEVELOPMENT, V126, P2191; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; Kimpinski K, 1999, NEUROSCIENCE, V93, P253, DOI 10.1016/S0306-4522(99)00156-6; Kohn J, 1999, J NEUROSCI, V19, P5393; LEE KF, 1994, DEVELOPMENT, V120, P1027; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; RICHTER JD, 1981, CELL, V27, P183, DOI 10.1016/0092-8674(81)90372-X; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; SCHULTZ P, 1992, CELL SIGNAL, V4, P153, DOI 10.1016/0898-6568(92)90079-N; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; UENO H, 1993, J BIOL CHEM, V268, P22814; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; Vesa J, 2000, J BIOL CHEM, V275, P24414, DOI 10.1074/jbc.M001641200; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WOLF DE, 1995, J BIOL CHEM, V270, P2133, DOI 10.1074/jbc.270.5.2133; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; Yoon SO, 1998, J NEUROSCI, V18, P3273; ZHOU J, 1995, J NEUROCHEM, V65, P1146	53	70	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11294	11301		10.1074/jbc.M005132200	http://dx.doi.org/10.1074/jbc.M005132200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11150291	Green Accepted, hybrid			2022-12-27	WOS:000167980900097
J	Chen, LM; Skinner, ML; Kauffman, SW; Chao, J; Chao, L; Thaler, CD; Chai, KX				Chen, LM; Skinner, ML; Kauffman, SW; Chao, J; Chao, L; Thaler, CD; Chai, KX			Prostasin is a glycosylphosphatidylinositol-anchored active serine protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLANDULAR KALLIKREIN; HUMAN TISSUE KALLIKREIN; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; NUCLEAR-ENVELOPE; SODIUM-CHANNEL; ANTIGEN; PROTEINASE; ALPHA-1-ANTITRYPSIN; PURIFICATION	A recombinant human prostasin serine protease was expressed in several human cell lines. Subcellular fractionation showed that this serine protease is synthesized as a membrane-bound protein while a free-form prostasin is secreted into the culture medium, Prostasin was identified in nuclear and membrane fractions. Membrane-bound prostasin can be released by phosphatidylinositol-specific phospholipase C treatment, or labeled by [H-3]ethanolamine, indicating a glycosylphosphatidylinositol anchorage. A prostasin-binding protein was identified in mouse and human seminal vesicle fluid. Both the secreted and the membrane-bound prostasin were able to form a covalently linked 82-kDa complex when incubated with seminal vesicle fluid. The complex formation between prostasin and the prostasin-binding protein was inhibited by a prostasin antibody, heparin, and serine protease inhibitors. Prostasin's serine protease activity was inhibited when bound to the prostasin-binding protein in mouse seminal vesicle fluid. This study indicates that prostasin is an active serine protease in its membrane-bound form.	Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Medical University of South Carolina	Chai, KX (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.							Ali BRS, 2000, J BIOL CHEM, V275, P33222, DOI 10.1074/jbc.M003845200; BEALS DF, 1969, CLIN CHEM, V15, P1210; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CHEN LM, 1990, BIOCHEM J, V267, P79, DOI 10.1042/bj2670079; CHEN LM, 2001, IN PRESS PROSTATE, V48; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Frenette G, 1997, BBA-GEN SUBJECTS, V1334, P109, DOI 10.1016/S0304-4165(96)00080-3; GUINAN P, 1987, J UROLOGY, V137, P686, DOI 10.1016/S0022-5347(17)44175-9; HIROSE S, 1995, METHOD ENZYMOL, V250, P582; HIROSHI T, 1998, BIOCHEM BIOPH RES CO, V251, P737; Hooper JD, 1999, CANCER RES, V59, P3199; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NIEMANN MA, 1992, MATRIX, V12, P233, DOI 10.1016/S0934-8832(11)80066-1; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Recker F, 1998, CANCER, V83, P2540, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2540::AID-CNCR20>3.0.CO;2-V; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; ROSENBERG IM, 1996, PROTEIN ANAL PURIFIC, P254; SHIMAMOTO K, 1980, J CLIN ENDOCR METAB, V51, P840, DOI 10.1210/jcem-51-4-840; SOOLE KL, 1995, J CELL SCI, V108, P369; STAMEY TA, 1989, J UROLOGY, V141, P1076, DOI 10.1016/S0022-5347(17)41175-X; Stenman UH, 1999, CLIN CHEM, V45, P753; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843; ZHOU GX, 1992, J BIOL CHEM, V267, P25873	36	90	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21434	21442		10.1074/jbc.M011423200	http://dx.doi.org/10.1074/jbc.M011423200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274175	hybrid, Green Published			2022-12-27	WOS:000169297900086
J	Hess, J; Porte, D; Munz, C; Angel, P				Hess, J; Porte, D; Munz, C; Angel, P			AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT COLLAGENASE-3 PROMOTER; TRANSCRIPTION FACTOR; C-JUN; INTERSTITIAL COLLAGENASE; BONE-FORMATION; MESSENGER-RNA; FACTOR CBFA1; GRANULOCYTIC DIFFERENTIATION; HYPERTROPHIC CHONDROCYTES; CLEIDOCRANIAL DYSPLASIA	The expression of MMP13 (collagenase-3), a member of the matrix metalloproteinase family, is increased in vivo as well as in cultured osteosarcoma cell lines by parathyroid hormone (PTH), a major regulator of calcium homeostasis, Binding sites for AP-1 and Cbfa/Runt transcription factors in close proximity have been identified as cis-acting elements in the murine and rat mmp13 promoter required for PTH-induced expression. The cooperative function of these factors in response to PTH in osteoblastic cells suggests a direct interaction between AP-1 and Cbfa/Runt transcription factors. Here, we demonstrate interaction between c-Jun and c-Fos with Cbfa/Runt proteins. This interaction depends on the leucine zipper of c-Jun or c-Fos and the Bunt domain of Cbfa/Runt proteins, respectively. Moreover, c-Fos interacts with the C-terminal part of Cbfa1 and Cbfa2, sharing a conserved transcriptional repression domain. In addition to the distal osteoblast-specific element 2 (OSE2) element in the murine and rat mmp13 promoter, we identified a new proximal OSE2 site overlapping with the TRE motif, Both interaction of Cbfa/Runt proteins with AP-1 and the presence of a functional proximal OSE2 site are required for enhanced transcriptional activity of the mmp13 promoter in transient transfected fibroblasts and in PTH-treated osteosarcoma cells.	Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control B0800, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Angel, P (corresponding author), Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control B0800, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.angel@dkfz.de	Hess, Jochen/ABE-1144-2021; Münz, Christian/W-4881-2017	Hess, Jochen/0000-0003-3493-1711; Munz, Christian/0000-0001-6419-1940				Ahn MY, 1998, P NATL ACAD SCI USA, V95, P1812, DOI 10.1073/pnas.95.4.1812; ANGEL P, 1989, New Biologist, V1, P35; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANNWEILER A, 1994, NUCLEIC ACIDS RES, V22, P4250, DOI 10.1093/nar/22.20.4250; Bannister AJ, 1995, ONCOGENE, V11, P2509; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; CANALIS E, 1995, ENDOCRINOLOGY, V136, P1348, DOI 10.1210/en.136.4.1348; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; CLOHISY JC, 1992, MOL ENDOCRINOL, V6, P1834, DOI 10.1210/me.6.11.1834; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Evans DB, 1996, J BONE MINER RES, V11, P1066; Franchimont N, 1997, J BIOL CHEM, V272, P12144, DOI 10.1074/jbc.272.18.12144; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; GACK S, 1995, CELL GROWTH DIFFER, V6, P759; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRIGORIADIS AE, 1995, TRENDS GENET, V11, P436, DOI 10.1016/S0168-9525(00)89142-8; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Javed A, 2000, J CELL SCI, V113, P2221; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lenny N, 1997, MOL BIOL REP, V24, P157, DOI 10.1023/A:1006859700409; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nishitani J, 1999, J BIOL CHEM, V274, P5454, DOI 10.1074/jbc.274.9.5454; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; PFISTERER P, 1994, EMBO J, V13, P1654, DOI 10.1002/j.1460-2075.1994.tb06429.x; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Rajakumar RA, 1996, MOL ENDOCRINOL, V10, P867, DOI 10.1210/me.10.7.867; SCHORPP M, 1995, BIOCHEM J, V308, P211, DOI 10.1042/bj3080211; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; UHLER MD, 1987, J BIOL CHEM, V262, P15202; van Dam H, 1998, GENE DEV, V12, P1227, DOI 10.1101/gad.12.8.1227; VARGHESE S, 1995, ENDOCRINOLOGY, V136, P2156, DOI 10.1210/en.136.5.2156; Verheijen MHG, 1997, J BIOL CHEM, V272, P3423, DOI 10.1074/jbc.272.6.3423; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang RJ, 1996, J BIOL CHEM, V271, P29839, DOI 10.1074/jbc.271.47.29839; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	69	155	165	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20029	20038		10.1074/jbc.M010601200	http://dx.doi.org/10.1074/jbc.M010601200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274169	hybrid			2022-12-27	WOS:000169135100049
J	Lee, JM; Hanson, JM; Chu, WA; Johnson, JA				Lee, JM; Hanson, JM; Chu, WA; Johnson, JA			Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DRUG-METABOLIZING-ENZYMES; TRANSCRIPTION FACTOR NRF2; THREONINE PROTEIN-KINASE; PHOSPHOLIPASE C-GAMMA; HEME OXYGENASE-1 GENE; NERVE GROWTH-FACTOR; PHOSPHOINOSITIDE 3-KINASE; NF-E2-RELATED FACTOR-2; DETOXIFY CARCINOGENS	The antioxidant-responsive element (ARE) plays an important role in the induction of phase II detoxifying enzymes including NADPH:quinone oxidoreductase (NQO1). We report herein that activation of the human NQO1-ARE (hNQO1-ARE) by tert-butylhydroquinone (tBHQ) is mediated by phosphatidylinositol 3-kinase (PI3-kinase), not extracellular signal-regulated kinase (Erk1/2), in IMR-32 human neuroblastoma cells. Treatment with tBHQ significantly increased NQO1 protein without activation of Erk1/2, In addition, PD 98059 (a selective mitogen activated kinase/Erk kinase inhibitor) did not inhibit hNQO1-ARE-luciferase expression or NQO1 protein induction by tBHQ. Pretreatment with LY 294002 (a selective PI3-kinase inhibitor), however, inhibited both hNQO1-ARE-luciferase expression and endogenous NQO1 protein induction. In support of a role for PI3-kinase in ARE activation we show that: 1) transfection of IMR-32 cells with constitutively active PI3-kinase selectively activated the ARE in a dose-dependent manner that was completely inhibited by treatment with LY 294002; 2) pretreatment of cells with the PI3-kinase inhibitors, LY 294002 and wortmannin, significantly decreased NF-Ea-related factor 2 (Nrf2) nuclear translocation induced by tBHQ; and 3) ARE activation by constitutively active PI3-kinase was blocked completely by dominant negative Nrf2. Taken together, these data clearly show that ARE activation by tBHQ depends on PI3-kinase, which lies upstream of Nrf2.	Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Univ Wisconsin, Ctr Environm Toxicol, Madison, WI 53706 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA; Univ Wisconsin, Ctr Neurosci, Madison, WI 53706 USA; Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Kansas; University of Kansas Medical Center	Johnson, JA (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.	jajohnson@pharmacy.wisc.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008089, R01ES008089] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES08089] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duffy S, 1998, J NEUROCHEM, V71, P69; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hayes JD, 1999, BIOCHEM SOC SYMP, P141; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itho K, 1999, GENE DEV, V13, P76; ITHO K, 1997, BIOCH BIOPHYSIC RES, V236, P313; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kang KW, 2000, MOL PHARMACOL, V58, P1017, DOI 10.1124/mol.58.5.1017; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Takata M, 1999, J BIOL CHEM, V274, P20611, DOI 10.1074/jbc.274.29.20611; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; VOLENTE C, 1993, J BIOL CHEM, V268, P21410; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	49	195	201	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20011	20016		10.1074/jbc.M100734200	http://dx.doi.org/10.1074/jbc.M100734200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274155	hybrid			2022-12-27	WOS:000169135100046
J	She, YM; Haber, S; Seifers, DL; Loboda, A; Chernushevich, I; Perreault, H; Ens, W; Standing, KG				She, YM; Haber, S; Seifers, DL; Loboda, A; Chernushevich, I; Perreault, H; Ens, W; Standing, KG			Determination of the complete amino acid sequence for the coat protein of brome mosaic virus by time-of-flight mass spectrometry - Evidence for mutations associated with change of propagation host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; DISULFIDE BOND ARRANGEMENT; POSTTRANSLATIONAL MODIFICATIONS; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; GLYCOPROTEINS; EPITOPES; STRAIN	Time-of-flight mass spectrometry (TOFMS) has been applied to determine the complete coat protein amino acid sequences of a number of distinct brome mosaic virus (BMV) isolates. Ionization was carried out by both electrospray ionization and matrix-assisted laser desorption/ionization (MALDI), After determining overall coat protein masses, the proteins were digested with trypsin or Lys-C proteinases, and the digestion products were analyzed in a MALDI QqTOF mass spectrometer. The N terminus of the coat protein was found to be acetylated in each BMV isolate analyzed. In one isolate (BMV-Valverde), the amino acid sequence was identical to that predicted from the cDNA sequence of the "type" isolate, but deviations from the predicted amino acid sequence were observed for all the other isolates analyzed, When isolates were propagated in different host taxa, modified coat protein sequences were observed in some cases, along with the original sequence. Sequencing by TOFMS may therefore provide a basis for monitoring the effects of host passaging on a virus at the molecular level. Such TOFMS-based analyses assess the complete profiles of coat protein sequences actually present in infected tissues. They are therefore not subject to the selection biases inherent in deducing such sequences from reverse-transcribed viral RNA and cloning the resulting cDNA.	Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB R3T 2M9, Canada; Kansas State Univ, Agr Res Ctr, Hays, KS 67601 USA; Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; MDS Sciex, Concord, ON L4K 4V8, Canada	University of Manitoba; Agriculture & Agri Food Canada; Kansas State University; University of Manitoba; SCIEX	Standing, KG (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada.	standin@cc.umanitoba.ca	Standing, Kenneth/E-2416-2011	She, Yi-Min/0000-0002-0571-4630	NIGMS NIH HHS [GM59240] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059240] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLQUIST P, 1981, J MOL BIOL, V153, P23, DOI 10.1016/0022-2836(81)90524-6; Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; Brunt AA, 1996, VIRUSES PLANTS DESCR, P1484; CARR SA, 1993, PROTEIN SCI, V2, P183; Chernushevich IV, 1998, NATO ADV SCI I C-MAT, V510, P101; Chernushevich IV, 1999, ANAL CHEM, V71, p452A, DOI 10.1021/ac990524l; CHERNUSHEVICH IV, 1996, P 44 ASMS C MASS SPE, P751; CHERNUSHEVICH IV, 1997, P 45 ASMS C MASS SPE, P17; DASGUPTA R, 1975, NATURE, V256, P624, DOI 10.1038/256624a0; DASGUPTA R, 1982, NUCLEIC ACIDS RES, V10, P703, DOI 10.1093/nar/10.2.703; Despeyroux D, 1996, RAPID COMMUN MASS SP, V10, P937, DOI 10.1002/(SICI)1097-0231(19960610)10:8<937::AID-RCM598>3.0.CO;2-9; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Gorman JJ, 1997, PROTEIN SCI, V6, P1308, DOI 10.1002/pro.5560060619; GORMAN JJ, 1990, BIOMED ENVIRON MASS, V19, P646, DOI 10.1002/bms.1200191104; HABER S, 1989, PLANT DIS, V73, P195, DOI 10.1094/PD-73-0195; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; Jeyarajah S, 1998, J AM SOC MASS SPECTR, V9, P157, DOI 10.1016/S1044-0305(97)00247-X; Jonscher KR, 1997, J BIOL CHEM, V272, P1735, DOI 10.1074/jbc.272.3.1735; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; Krutchinsky AN, 1998, RAPID COMMUN MASS SP, V12, P508, DOI 10.1002/(SICI)1097-0231(19980515)12:9<508::AID-RCM197>3.0.CO;2-L; Lane L C, 1974, Adv Virus Res, V19, P151, DOI 10.1016/S0065-3527(08)60660-0; LANE LC, 1971, NATURE-NEW BIOL, V232, P40, DOI 10.1038/newbio232040a0; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P8596, DOI 10.1073/pnas.95.15.8596; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; Lopaticki S, 1998, J MASS SPECTROM, V33, P950, DOI 10.1002/(SICI)1096-9888(199810)33:10<950::AID-JMS704>3.3.CO;2-1; PATTHY L, 1999, PROTEIN EVOLUTION, P33; Pitt JJ, 2000, J BIOL CHEM, V275, P6469, DOI 10.1074/jbc.275.9.6469; Seifers DL, 1999, PLANT DIS, V83, P905, DOI 10.1094/PDIS.1999.83.10.905; Seifers DL, 2000, PHYTOPATHOLOGY, V90, P505, DOI 10.1094/PHYTO.2000.90.5.505; SHE YM, 1999, P 47 ASMS C MASS SPE, P1089; SHE YM, 1999, P 47 ASMS C MASS SPE, P1952; SHE YM, 1998, P 46 ASMS C MASS SPE, P1329; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Siuzdak G, 1996, CHEM BIOL, V3, P45, DOI 10.1016/S1074-5521(96)90083-6; Siuzdak G, 1998, J MASS SPECTROM, V33, P203, DOI 10.1002/(SICI)1096-9888(199803)33:3<203::AID-JMS653>3.0.CO;2-Q; TANG X, 1988, INT J MASS SPECTROM, V85, P43, DOI 10.1016/0168-1176(88)83004-0; Thomas JJ, 1998, ANAL CHEM, V70, P3863, DOI 10.1021/ac9802372; Thomas JJ, 2000, ACCOUNTS CHEM RES, V33, P179; VALVERDE RA, 1983, PLANT DIS, V67, P1194, DOI 10.1094/PD-67-1194; VERENTCHIKOV AN, 1994, ANAL CHEM, V66, P126, DOI 10.1021/ac00073a022; WAN GL, 1999, P 47 ASMS C MASS SPE, P2723; WANG L, 1998, P 46 ASMS C MASS SPE, P607; Wilm M, 1996, ANAL CHEM, V68, P527, DOI 10.1021/ac950875+	43	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20039	20047		10.1074/jbc.M100189200	http://dx.doi.org/10.1074/jbc.M100189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274180	hybrid			2022-12-27	WOS:000169135100050
J	Song, J; Ugai, H; Kanazawa, I; Sun, K; Yokoyama, KK				Song, J; Ugai, H; Kanazawa, I; Sun, K; Yokoyama, KK			Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR SP1; C-MYC GENE; HISTONE DEACETYLASE; MOLECULAR-CLONING; CDNA CLONE; PROMOTER; BINDING; DNA; EXPRESSION	The transcription factors Spl and MAZ ((M) under bar yc-(a) under bar ssociated (z) under bar inc finger protein) contain several zinc finger motifs, and each functions as both a positive and a negative regulator of gene expression. In this study, we characterized the extremely GC-rich promoter of the human gene for MAZ, which is known as a housekeeping gene. Unique symmetrical motifs in the promoter region (nucleotides -383 to -334) were essential for the expression of the gene for MAZ, whereas an upstream silencer element (nucleotides -784 to -612) was found to act in a position-dependent but orientation-independent manner. Spl and MAZ bound to the same cis-elements in the GC-rich promoter, apparently sharing DNA-binding sites. The relative extent of binding of Spl and MAZ to these cis-elements corresponded to the extent of negative regulation of the expression of the gene for MAZ in various lines of cells. Furthermore, novel repressive do mains in both Spl (amino acids 622-788) and MAZ (amino acids 127-292) were identified. Suppression by Spl and suppression by MAZ were independent phenomena; histone deacetylases were involved in the autorepression by MAZ itself, whereas DNA methyltransferase 1 was associated with suppression by Spl. Our results indicate that both deacetylation and methylation might be involved in the regulation of expression of a single gene via the actions of different zinc finger proteins that bind to the same cis-elements.	RIKEN, Inst Phys & Chem Res, Tsukuba Inst, Tsukuba, Ibaraki 3050074, Japan; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol, Tokyo 1130033, Japan; China Med Univ, Dept Med Genet, Shenyang 110001, Peoples R China	RIKEN; University of Tokyo; China Medical University	Yokoyama, KK (corresponding author), RIKEN, Inst Phys & Chem Res, Tsukuba Inst, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.		Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480				ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CIAO H, 2000, J BIOL CHEM, V275, P1371; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, P743; Davies IJ, 1996, MICROBIOL-UK, V142, P2429, DOI 10.1099/00221287-142-9-2429; DELUCA NA, 1987, NUCLEIC ACIDS RES, V15, P4491, DOI 10.1093/nar/15.11.4491; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Dhar M, 1997, J BIOL CHEM, V272, P18490, DOI 10.1074/jbc.272.29.18490; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; Gupta M, 1998, MOL CELL BIOL, V18, P7243, DOI 10.1128/MCB.18.12.7243; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; Komatsu M, 1997, ONCOGENE, V15, P1123, DOI 10.1038/sj.onc.1201283; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Lee SJ, 1997, DNA CELL BIOL, V16, P485, DOI 10.1089/dna.1997.16.485; LI BY, 1994, J BIOL CHEM, V269, P7756; LI SJ, 1993, J BACTERIOL, V175, P332, DOI 10.1128/JB.175.2.332-340.1993; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Parks CL, 1996, J BIOL CHEM, V271, P4417; PYRC JJ, 1992, BIOCHEMISTRY-US, V31, P4102, DOI 10.1021/bi00131a029; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 1998, GENOMICS, V52, P374, DOI 10.1006/geno.1998.5452; Song J, 1999, BIOTECHNIQUES, V26, P1056, DOI 10.2144/99266bm11; SONG J, 2000, CURR GENOMICS, V1, P23; Spelsberg TC, 1996, RECENT PROG HORM RES, V51, P63; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; TENG CT, 1992, MOL ENDOCRINOL, V6, P1969, DOI 10.1210/me.6.11.1969; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; YOO HW, 1993, GENOMICS, V15, P21, DOI 10.1006/geno.1993.1005	55	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19897	19904		10.1074/jbc.M010658200	http://dx.doi.org/10.1074/jbc.M010658200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259406	hybrid			2022-12-27	WOS:000169135100030
J	Yamada, H; Vijayachandra, K; Penner, C; Glick, A				Yamada, H; Vijayachandra, K; Penner, C; Glick, A			Increased sensitivity of transforming growth factor (TGF) beta 1 null cells to alkylating agents reveals a novel link between TGF beta signaling and O-6-methylguanine methyltransferase promoter hypermethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN TUMORS; MICROSATELLITE INSTABILITY; MALIGNANT CONVERSION; CARCINOMA-CELLS; HUMAN-CANCERS; II RECEPTOR; CPG ISLAND; HIGH-RISK; GENE; DNA	Inactivation of the transforming growth factor P (TGF beta)-signaling pathway and gene silencing through hypermethylation of promoter CpG islands are two frequent alterations in human and experimental cancers. Here we report that nonneoplastic TGF beta1-/- keratinocyte cell lines exhibit increased sensitivity to cell killing by alkylating agents, and this is due to lack of expression of the DNA repair enzyme O-6-methylguanine DNA methyltransferase (MGMT), In TGF beta1-/- but not TGF beta1+/- cell lines, the CpG dinucleotides in the MGMT promoter are hypermethylated, as measured by restriction enzyme analysis and methylation specific polymerase chain reaction. In one unstable TGF beta1+/- cell line, loss of the wild type TGF beta1 allele correlates with the appearance of methylation in the MGMT promoter. Bisulfite sequencing shows that in the KO3 TGF beta1-/-cell line nearly all of the 28 CpG: sites in the MGMT promoter 475 base pairs upstream of the start site of transcription are methylated, whereas most are unmethylated in the H1 TGF beta1+/- line. Treatment of the TGF beta1-/- cell lines with 5-azacytidine causes reexpression of MGMT mRNA and demethylation of CpG islands in the promoter. Analysis of the time course of methylation using methylation-specific polymerase chain reaction shows a lack of methylation in primary TGF beta1-/-keratinocytes and increasing methylation with passage number of immortalized clones. Subcloning of early passage clones reveals a remarkable heterogeneity and instability of the methylation state in the TGF beta1-/- keratinocytes, Thus, the TGF beta1-/- genotype does not directly regulate MGMT methylation but predisposes cells to immortalization-associated MGMT hypermethylation.	NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bethesda, MD 20892 USA; Taisho Pharmaceut Co Ltd, Toxicol Lab, Pharmaceut Res Labs, Tokyo 1708633, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Taisho Pharmaceutical Holdings Co Ltd	Glick, A (corresponding author), NCI, Cellular Carcinogenesis & Tumor Promot Lab, NIH, Bldg 37 3B19, Bethesda, MD 20892 USA.							Amendt C, 1998, ONCOGENE, V17, P25, DOI 10.1038/sj.onc.1202161; Azzoli CG, 1998, MOL CARCINOGEN, V21, P50, DOI 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T; Bachman KE, 1999, CANCER RES, V59, P798; Becker K, 1996, CANCER RES, V56, P3244; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; CHEN JM, 1992, CARCINOGENESIS, V13, P1503; CUI W, 1994, CANCER RES, V54, P5831; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; DEMPLE B, 1983, DNA REPAIR LAB MANUA, P41; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 1999, CANCER RES, V59, P793; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; GARRIGUEANTAR L, 1995, CANCER RES, V55, P3982; Glick A, 1999, P NATL ACAD SCI USA, V96, P14949, DOI 10.1073/pnas.96.26.14949; GLICK AB, 1994, GENE DEV, V8, P2429, DOI 10.1101/gad.8.20.2429; GLICK AB, 1993, P NATL ACAD SCI USA, V90, P6076, DOI 10.1073/pnas.90.13.6076; Glick AB, 1996, CANCER RES, V56, P3645; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Iwakuma T, 1996, DNA CELL BIOL, V15, P863, DOI 10.1089/dna.1996.15.863; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Li JM, 1998, NUCLEIC ACIDS RES, V26, P2449, DOI 10.1093/nar/26.10.2449; MANNING AM, 1991, ONCOGENE, V6, P1471; MARGISON GP, 1985, CARCINOGENESIS, V6, P1699, DOI 10.1093/carcin/6.12.1699; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; PARSONS R, 1995, CANCER RES, V55, P5548; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Qian XLC, 1997, CANCER RES, V57, P3672; Riggins GJ, 1997, CANCER RES, V57, P2578; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; Sakumi K, 1997, CANCER RES, V57, P2415; Sambrook J, 1989, MOL CLONING LAB MANU, P280; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; TANO K, 1990, P NATL ACAD SCI USA, V87, P686, DOI 10.1073/pnas.87.2.686; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAROSH DB, 1983, CARCINOGENESIS, V4, P199, DOI 10.1093/carcin/4.2.199	45	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19052	19058		10.1074/jbc.M100615200	http://dx.doi.org/10.1074/jbc.M100615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262404	hybrid			2022-12-27	WOS:000169091000056
J	Kallberg, Y; Gustafsson, M; Persson, B; Thyberg, J; Johansson, J				Kallberg, Y; Gustafsson, M; Persson, B; Thyberg, J; Johansson, J			Prediction of amyloid fibril-forming proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE SP-C; SECONDARY-STRUCTURE; THERMODYNAMIC STABILITY; 3-DIMENSIONAL STRUCTURE; NMR STRUCTURE; BETA-PEPTIDE; PRION; CONFORMATIONS; RECOGNITION; EVOLUTION	In Alzheimer's disease and spongiform encephalopathies proteins transform from their native states into fibrils, We find that several amyloid-forming proteins harbor an a-helix in a polypeptide segment that should form a beta -strand according to secondary structure predictions. In 1324 nonredundant protein structures, 37 beta -strands with greater than or equal to7 residues were predicted in segments where the experimentally determined structures show helices, These discordances include the prion protein (helix 2, positions 179-191), the Alzheimer amyloid beta -peptide (alpha beta, positions 16-23), and lung surfactant protein C (SP-C, positions 12-27), In addition, human coagulation factor XIII (positions 258-266), triacylglycerol lipase from Candida antarctica (positions 256-266), and D-alanyl-D-alanine transpeptidase from Streptomyces R61 (positions 92-106) contain a discordant helix, These proteins have not been reported to form fibrils hut in this study were found to form fibrils in buffered saline at pH 7.4. By replacing valines in the discordant helical part of SP-C with leucines, an alpha -helix is found experimentally and by secondary structure predictions. This analogue does not form fibrils under conditions where SP-C forms abundant fibrils, Likewise, when alpha beta residues 14-23 are removed or changed to a nondiscordant sequence, fibrils are no longer formed. We propose that alpha -helix/beta -strand-discordant stretches are associated with amyloid fibril formation.	Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Johansson, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jan.johansson@mbb.ki.se		Johansson, Jan/0000-0002-8719-4703				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BARSUKOV IL, 1992, EUR J BIOCHEM, V206, P665, DOI 10.1111/j.1432-1033.1992.tb16972.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; GAUSTAFSSON M, UNPUB; Glockshuber R, 1998, FEBS LETT, V426, P291, DOI 10.1016/S0014-5793(98)00372-X; Gomis-Ruth FX, 1998, PROTEIN SCI, V7, P283; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; HOBOHM U, 1992, PROTEIN SCI, V1, P409; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; JOHANSSON J, 1995, FEBS LETT, V362, P261, DOI 10.1016/0014-5793(95)00216-V; JOHANSSON J, 1995, BIOCHEM J, V307, P535, DOI 10.1042/bj3070535; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KELLY JA, 1985, J BIOL CHEM, V260, P6449; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kelly JW, 1998, P NATL ACAD SCI USA, V95, P930, DOI 10.1073/pnas.95.3.930; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nilsson G, 1998, EUR J BIOCHEM, V255, P116, DOI 10.1046/j.1432-1327.1998.2550116.x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Szyperski T, 1998, PROTEIN SCI, V7, P2533, DOI 10.1002/pro.5560071206; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Wetzel R, 1996, CELL, V86, P699, DOI 10.1016/S0092-8674(00)80143-9; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	50	261	274	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					12945	12950		10.1074/jbc.M010402200	http://dx.doi.org/10.1074/jbc.M010402200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11134035	hybrid			2022-12-27	WOS:000168198600070
J	Ionescu, AM; Schwarz, EM; Vinson, C; Puzas, JE; Rosier, R; Reynolds, PR; O'Keefe, RJ				Ionescu, AM; Schwarz, EM; Vinson, C; Puzas, JE; Rosier, R; Reynolds, PR; O'Keefe, RJ			PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; DEPENDENT PROTEIN-KINASE; C-FOS EXPRESSION; PARATHYROID-HORMONE; GROWTH-PLATE; X COLLAGEN; TERMINAL DIFFERENTIATION; OSTEOBLASTIC CELLS; TRANSGENIC MICE; INDIAN HEDGEHOG	During the process of differentiation, chondrocytes integrate a complex array of signals from local or systemic factors like parathyroid hormone-related peptide (PTHrP), Indian hedgehog, bone morphogenetic proteins and transforming growth factor beta, While PTHrP is known to be a critical regulator of chondrocyte proliferation and differentiation, the signaling pathways through which this factor acts remain to be elucidated. Here we show that both cAMP response element-binding protein (CREB) and AP-1 activation are critical to PTHrP signaling in chondrocytes. PTHrP treatment leads to rapid CREB phosphorylation and activation, while CREB DNA binding activity is constitutive, In contrast, PTHrP induces AP-1 DNA binding activity through induction of c-Fos protein expression. PTHrP activates CRE and TRE reporter constructs primarily through PKA-mediated signaling events. Both signaling pathways were found to be important mediators of PTHrP effects on chondrocyte phenotype, Alone, PTHrP suppresses maturation and stimulates proliferation of the chondrocyte cultures, However, in the presence of dominant negative inhibitors of CREB and c-Fos, these PTHrP effects were suppressed, and chondrocyte maturation was accelerated. Moreover, in combination, the effects of dominant negative c-Fos and CREB are synergistic, suggesting interaction between these signaling pathways during chondrocyte differentiation.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Orthopaed, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; NCI, NIH, Bethesda, MD 20892 USA	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Keefe, RJ (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Dept Orthopaed, Box 665,601 Elmwood Ave, Rochester, NY 14642 USA.	regis_okeefe@urmc.rochester.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038945] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR 38945] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Anouar Y, 1999, MOL PHARMACOL, V56, P162, DOI 10.1124/mol.56.1.162; Ausubel F, 1997, SHORT PROTOCOLS MOL; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Chung U, 2000, J BONE MINER RES, V15, pS175; CLOHISY JC, 1992, MOL ENDOCRINOL, V6, P1834, DOI 10.1210/me.6.11.1834; Eggers A, 2000, BIOCHEM J, V345, P201, DOI 10.1042/0264-6021:3450201; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimsrud CD, 1999, J BONE MINER RES, V14, P475, DOI 10.1359/jbmr.1999.14.4.475; Guo J, 2000, J BONE MINER RES, V15, pS152; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; Hata R, 1998, J CEREBR BLOOD F MET, V18, P1325, DOI 10.1097/00004647-199812000-00007; HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216; Ishikawa Y, 1997, J BONE MINER RES, V12, P356, DOI 10.1359/jbmr.1997.12.3.356; Kameda T, 1997, CELL GROWTH DIFFER, V8, P495; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Klaus G, 1997, KIDNEY INT, V52, P45, DOI 10.1038/ki.1997.302; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; LEWINSON D, 1992, ANAT REC, V233, P504, DOI 10.1002/ar.1092330403; LINSENMAYER TF, 1991, DEVELOPMENT, V111, P191; McCauley LK, 1997, ENDOCRINOLOGY, V138, P5427, DOI 10.1210/en.138.12.5427; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; OKEEFE RJ, 1989, J BONE JOINT SURG AM, V71A, P607, DOI 10.2106/00004623-198971040-00017; Pateder DB, 2000, EXP CELL RES, V256, P555, DOI 10.1006/excr.2000.4860; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; SCHWARZ EM, 1993, P NATL ACAD SCI USA, V90, P7734, DOI 10.1073/pnas.90.16.7734; Segre G V, 1992, J Endocrinol Invest, V15, P11; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Suda N, 1999, J BONE MINER RES, V14, P1838, DOI 10.1359/jbmr.1999.14.11.1838; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WANG ZQ, 1995, CANCER RES, V55, P6244; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; White BR, 1999, MOL ENDOCRINOL, V13, P566, DOI 10.1210/me.13.4.566; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Zerega B, 1999, J BONE MINER RES, V14, P1281, DOI 10.1359/jbmr.1999.14.8.1281; ZUSCIK MJ, 1994, CELL CALCIUM, V16, P112, DOI 10.1016/0143-4160(94)90006-X; ZUSCIK MJ, 1994, ARCH BIOCHEM BIOPHYS, V315, P352, DOI 10.1006/abbi.1994.1511	60	93	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11639	11647		10.1074/jbc.M006564200	http://dx.doi.org/10.1074/jbc.M006564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11136722	hybrid			2022-12-27	WOS:000168081800031
J	Shiseki, K; Murai, N; Motojima, F; Hisabori, T; Yoshida, M; Taguchi, H				Shiseki, K; Murai, N; Motojima, F; Hisabori, T; Yoshida, M; Taguchi, H			Synchronized domain-opening motion of GroEL is essential for communication between the two rings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHAPERONIN GROEL; CRYSTAL-STRUCTURE; POLYPEPTIDE BINDING; ATPASE CYCLE; COOPERATIVITY; HYDROLYSIS; MECHANISM; RESIDUES	Escherichia coli chaperonin GroEL consists of two stacked rings of seven identical subunits each. Accompanying binding of ATP and GroES to one ring of GroEL, that ring undergoes a large en bloc domain movement, in which the apical domain twists upward and outward. A mutant GroEL(AEX) (C138S,C458S,C519S,D83C,K327C) in the oxidized form is locked in a closed conformation by an interdomain disulfide cross-link and cannot hydrolyze ATP (Murai, N., Makino, Y., and Yoshida, M. (1996) J. Biol. Chem. 271, 28229-28234). By reconstitution of GroEL complex from subunits of both wild-type GroEL and oxidized GroEL(AEX), hybrid GroEL complexes containing various numbers of oxidized GroELAEX subunits were prepared. ATPase activity of the hybrid GroEL containing one or two oxidized GroEL(AEX) subunits per ring was about 70% higher than that of wild-type GroEL. Based on the detailed analysis of the ATPase activity, we concluded that inter-ring negative cooperativity was lost in the hybrid GroEL, indicating that synchronized opening of the subunits in one ring is necessary for the negative cooperativity. Indeed, hybrid GroEL complex reconstituted from subunits of wild-type and GroEL mutant (D398A), which is ATPase-deficient but can undergo domain opening motion, retained the negative cooperativity of ATPase. In contrast, the ability of GroEL to assist protein folding was impaired by the presence of a single oxidized GroEL(AEX) subunit in a ring. Taken together, cooperative conformational transitions in GroEL rings ensure the functional communication between the two rings of GroEL.	Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Taguchi, H (corresponding author), Tokyo Inst Technol, Chem Resources Lab, R-1,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.		Motojima, Fumihiro/J-2389-2014; taguchi, hideki/AAM-2663-2021; MURAI, NORIYUKI/V-5747-2018; Taguchi, Hideki/B-6946-2009; Hisabori, Toru/E-5205-2014	Motojima, Fumihiro/0000-0003-4461-8673; taguchi, hideki/0000-0002-6612-9339; MURAI, NORIYUKI/0000-0002-1552-5104; Taguchi, Hideki/0000-0002-6612-9339; Hisabori, Toru/0000-0003-2046-0277				Aharoni A, 1996, J MOL BIOL, V258, P732, DOI 10.1006/jmbi.1996.0282; BOCHKAREVA ES, 1994, J BIOL CHEM, V269, P23869; BOCHKAREVA ES, 1992, J BIOL CHEM, V267, P6796; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; KIRINO H, 1991, J BIOCHEM-TOKYO, V109, P852, DOI 10.1093/oxfordjournals.jbchem.a123470; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; TAGUCHI H, 1991, J BIOL CHEM, V266, P22411; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YBARRA J, 1995, J BIOL CHEM, V270, P22113, DOI 10.1074/jbc.270.38.22113; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	24	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11335	11338		10.1074/jbc.M010348200	http://dx.doi.org/10.1074/jbc.M010348200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11139586	hybrid			2022-12-27	WOS:000167980900102
J	Cheng, XG; Hart, GW				Cheng, XG; Hart, GW			Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta - Post-translational regulation of turnover and transactivation activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; NUCLEAR-PORE; TETRATRICOPEPTIDE REPEATS; GLCNAC TRANSFERASE; PROTEIN-PHOSPHORYLATION; CYTOPLASMIC PROTEINS; CELLULAR-REGULATION; CYTOSOLIC PROTEINS	O-Linked N-acetylglucosamine (O-GlcNAc) is a dynamic post-translational modification abundant on nuclear and cytoplasmic proteins. Recently, we demonstrated that the murine estrogen receptor-beta (mER-beta) is alternatively O-GlcNAcylated or O-phosphorylated at Ser(16). Analyses of mER-betas containing mutations in the three adjacent hydroxyl amino acids at this locus confirmed that Ser(16) is the major site of O-GlcNAc modification on mER-beta and that mutants lacking hydoxyl amino acids at this locus are glycosylation-deficient. Pulse-chase studies in transfected Cos-1 cells demonstrate that the turnover rate of the mutant containing a glutamic acid moiety at Ser(16), which mimics constitutive phosphorylation at this locus, is faster than that of the wild type receptor. Whereas, the mutant without hydroxyl amino acids at this locus is degraded at a slower rate, indicating that O-GlcNAc/O-phosphate at Ser(16) modulates mER-beta protein stability. Luciferase reporter assays also show that the Ser(16) locus mutants have abnormal transactivation activities, suggesting that the two alternative modifications at Ser(16) on mER-beta may also be involved in transcriptional regulation. DNA mobility shift assays show that the mutants do not have altered DNA binding. Green fluorescence protein constructs of both wild type and mutant forms of mER-beta show that the receptor is nearly exclusively localized within the nucleus. It appears that reciprocal occupancy of Ser(16) by either O-phosphate or O-GlcNAc modulates the degradation and activity of mER-beta.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Alabama, Grad Program, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Hart, Gerald/0000-0001-7812-4351	NCI NIH HHS [R01 CA42486] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU CF, 1994, J CELL SCI, V107, P1833; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; DATTA B, 1989, J BIOL CHEM, V264, P20620; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Edwards DP, 1999, VITAM HORM, V55, P165; FISCHER EH, 1993, ANGEW CHEM INT EDIT, V32, P1130, DOI 10.1002/anie.199311301; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; HANOVER JA, 1992, FASEB J, V6, P2288, DOI 10.1096/fasebj.6.6.1312045; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HECHT SM, 1978, J BIOL CHEM, V253, P4517; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; Jiang MS, 1997, J BIOL CHEM, V272, P2421; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KRAMER MF, 1999, CURR PROT MOL BIOL, V3; KREBS EG, 1993, ANGEW CHEM INT EDIT, V32, P1122, DOI 10.1002/anie.199311221; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Liu DR, 1997, P NATL ACAD SCI USA, V94, P10092, DOI 10.1073/pnas.94.19.10092; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Muramatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P1, DOI 10.1006/bbrc.2000.2214; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; PAKDEL F, 1993, J STEROID BIOCHEM, V46, P663, DOI 10.1016/0960-0760(93)90307-I; Parker MG, 1995, VITAM HORM, V51, P267, DOI 10.1016/S0083-6729(08)61041-9; REASON AJ, 1992, J BIOL CHEM, V267, P16911; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; SCHINDLER M, 1987, J BIOL CHEM, V262, P1254; Shaw P, 1996, ONCOGENE, V12, P921; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353	60	149	167	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10570	10575		10.1074/jbc.M010411200	http://dx.doi.org/10.1074/jbc.M010411200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11150304	hybrid			2022-12-27	WOS:000167996400127
J	Sado, K; Ayusawa, D; Enomoto, A; Suganuma, T; Oshimura, M; Sato, K; Koyama, H				Sado, K; Ayusawa, D; Enomoto, A; Suganuma, T; Oshimura, M; Sato, K; Koyama, H			Identification of a mutated DNA ligase IV gene in the X-ray-hypersensitive mutant SX10 of mouse FM3A cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; V(D)J RECOMBINATION; MAMMALIAN-CELLS; COMPLEMENTATION GROUP; IONIZING-RADIATION; SENSITIVE MUTANTS; MOLECULAR-CLONING; DIVERSE MUTAGENS; DEFECT	The mouse carcinoma cell line SX10 is a hypersensitive mutant to x-rays and bleomycin, An earlier complementation test suggests that SX10 would belong to x-ray-cross complementing group (XRCC) 4, However, in this study, a human XRCC4 expression vector failed to complement the SX10 phenotype, Consistent with the previous report, SX10 showed the same level of DNA-dependent protein kinase activity as the wild-type SR-l, We isolated and analyzed hybrids between SX10 and human diploid fibroblast cells and found that human chromosome 13 conferred the x-ray resistance to the hybrids, suggesting that a candidate gene would be located on this chromosome, Polymerase chain reaction analysis with these hybrids and x-ray-resistant transformants obtained by introducing human chromosomes into SX10 indicated that the mutant was likely to be defective in DNA ligase IV Sequence analysis of the DNA ligase N gene confirmed that a defect in SX10 was attributed to a transition of G to A at nucleotide position 1413 of the gene, leading to an amino acid substitution from Trp at residue 471 to a stop codon, Revertant clones (Rev1-3) derived from SX10 showed a restored x-ray resistance; Rev1 reverted to the original nucleotide G at position 1413, whereas Revs and Rev3 to C, Transfection of a mouse DNA ligase N cDNA vector into SX10 restored the resistance to both x-rays and bleomycin, SX10 showed a reduced frequency of chromosomal integration of transfected DNA, but the revertants restored the frequency found in the wild-type cells. These results suggest a possible involvement of DNA ligase IV in the integration event of foreign DNA as well as a crucial role in DNA double-strand break repair.	Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet, Yonago, Tottori 6838504, Japan; Univ Tokyo, Grad Sch Med, Dept Radiat Oncol, Tokyo 1130033, Japan	Yokohama City University; Yokohama City University; Kindai University (Kinki University); Tottori University; University of Tokyo	Koyama, H (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Maioka Cho, Yokohama, Kanagawa 2440813, Japan.							Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Busch DB, 1996, MUTAT RES-DNA REPAIR, V363, P209, DOI 10.1016/0921-8777(96)00014-6; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Danska JS, 1996, MOL CELL BIOL, V16, P5507; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fujimaki K, 1996, SOMAT CELL MOLEC GEN, V22, P279, DOI 10.1007/BF02369567; Fukumura R, 1998, J BIOL CHEM, V273, P13058, DOI 10.1074/jbc.273.21.13058; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; GU Y, 1997, P NATL ACAD SCI USA, V94, P8067; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; JEGGO PA, 1991, MUTAT RES, V254, P125, DOI 10.1016/0921-8777(91)90003-8; JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; KANAAR P, 1988, TRENDS CELL BIOL, V8, P483; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kobayashi M, 1998, GENE, V215, P329, DOI 10.1016/S0378-1119(98)00283-2; KOYAMA H, 1982, CANCER RES, V42, P4210; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liu N, 1997, P NATL ACAD SCI USA, V94, P9232, DOI 10.1073/pnas.94.17.9232; MCBRIDE OW, 1973, P NATL ACAD SCI USA, V70, P1258, DOI 10.1073/pnas.70.4.1258; Merrihew RV, 1996, MOL CELL BIOL, V16, P10; Peterson SR, 1997, J BIOL CHEM, V272, P10227; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; ROTH DB, 1988, ILLEGITIMATE RECOMBI, P621; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; SAMEC S, 1994, GENOMICS, V21, P283, DOI 10.1006/geno.1994.1261; SATO K, 1979, RADIAT RES, V78, P167, DOI 10.2307/3575014; SATO K, 1986, JPN J CANCER RES, V77, P456; STACKHOUSE MA, 1994, MUTAT RES, V323, P47, DOI 10.1016/0165-7992(94)90044-2; TACCIOLI GE, 1994, J BIOL CHEM, V269, P7439; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; THACKER J, 1995, HUM MOL GENET, V4, P113, DOI 10.1093/hmg/4.1.113; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WATERS RL, 1995, MUTAT RES, P1; WEI YF, 1995, MOL CELL BIOL, V15, P3206; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	53	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9742	9748		10.1074/jbc.M010530200	http://dx.doi.org/10.1074/jbc.M010530200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133995	hybrid			2022-12-27	WOS:000167996400023
J	Heredia, J; Crooks, M; Zhu, ZW				Heredia, J; Crooks, M; Zhu, ZW			Phosphorylation and Cu+ coordination-dependent DNA binding of the transcription factor Mac1p in the regulation of copper transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUP2 GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; YEAST; EXPRESSION; PROTEIN; ACTIVATION; DOMAIN; DEGRADATION; REPRESSION	Copper ions are essential at a proper level yet toxic when present in excess. To maintain a proper intracellular level, cells must be able to sense the changes in copper ion concentrations. The yeast transcription factor Mac1p plays a critical role in the transcriptional regulation of CTR1 and CTR3, both encoding high affinity copper ion transporters. Here we report that the Mac1p binding of the copper ion-responsive elements (CuREs) in the promoters of CTR1 and CTR3 is affected by copper ions. On one hand, the Mac1p DNA binding is Cu+ coordination dependent, and on the other hand, exogenous Cu+ and isoelectronic Ag+ ions disrupt the DNA binding of Mac1p, These results suggest that the Mac1p is able to sense two different levels of copper ions. These two levels are probably the physiological and toxic copper levels in yeast cells. Furthermore, we found that Mac1p undergoes posttranslational phosphorylation modification in yeast and that the phosphorylation is required for the Mac1p to become DNA-binding active. Nonphosphorylated Mac1p is unable to bind the CTR1 promoter DNA, The data support the model of intradomain interactions and indicate further that the phosphorylation probably prevents the inhibition of DNA-binding domain activity by the activation domain of Mac1p, Taken together, these findings demonstrate that Mac1p functions critically in maintaining a proper intracellular concentration of copper ions.	Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Zhu, ZW (corresponding author), Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA.	zhu@biology.ucsc.edu			NIGMS NIH HHS [GM58082-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058082] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BUCHMAN C, 1989, MOL CELL BIOL, V9, P4091, DOI 10.1128/MCB.9.9.4091; Casas C, 1997, YEAST, V13, P621, DOI 10.1002/(SICI)1097-0061(19970615)13:7<621::AID-YEA121>3.0.CO;2-U; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; EVANS CF, 1990, MOL CELL BIOL, V10, P426, DOI 10.1128/MCB.10.1.426; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Harris ZL, 1996, AM J CLIN NUTR, V63, P836; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KARIN KD, 1993, BIOINORGANIC CHEM CO; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Linder M, 1991, BIOCH COPPER; Liu HD, 1996, GENE DEV, V10, P592; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; SZCZYPKA MS, 1989, MOL CELL BIOL, V9, P421, DOI 10.1128/MCB.9.2.421; THIELE DJ, 1992, NUCLEIC ACIDS RES, V20, P1183, DOI 10.1093/nar/20.6.1183; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; THORVALDSEN JL, 1994, BIOCHEMISTRY-US, V33, P9566, DOI 10.1021/bi00198a024; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; WELCH J, 1989, EMBO J, V8, P255, DOI 10.1002/j.1460-2075.1989.tb03371.x; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zhu ZW, 1996, CELL, V87, P459, DOI 10.1016/S0092-8674(00)81366-5; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	33	27	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8793	8797		10.1074/jbc.M008179200	http://dx.doi.org/10.1074/jbc.M008179200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11134042	hybrid, Green Submitted			2022-12-27	WOS:000167607700025
J	Barylko, B; Gerber, SH; Binns, DD; Grichine, N; Khvotchev, M; Sudhof, TC; Albanesi, JP				Barylko, B; Gerber, SH; Binns, DD; Grichine, N; Khvotchev, M; Sudhof, TC; Albanesi, JP			A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; KINASE; PHOSPHOINOSITIDES; REGULATORS; PROTEINS	Phosphatidylinositolpolyphosphates (PIPs) are centrally involved in many biological processes, ranging from cell growth and organization of the actin cytoskeleton to endo- and exocytosis. Phosphorylation of phosphatidylinositol at the D-4 position, an essential step in the biosynthesis of PIPs, appears to be catalyzed by two biochemically distinct enzymes. However, only one of these two enzymes has been molecularly characterized. We now describe a novel class of phosphatidylinositol 4-kinases that probably corresponds to the missing element in phosphatidylinositol metabolism. These kinases are highly conserved evolutionarily, but unrelated to previously characterized phosphatidylinositol kinases, and thus represent the founding members of a new family. The novel phosphatidylinositol 4-kinases, which are widely expressed in cells, only phosphorylate phosphatidylinositol, are potently inhibited by adenosine, but are insensitive to wortmannin or phenylarsine oxide. Although they lack an obvious transmembrane domain, they are strongly attached to membranes by palmitoylation. Our data suggest that independent pathways for phosphatidylinositol 4-phosphate synthesis emerged during evolution, possibly to allow tight temporal and spatial control over the production of this key signaling molecule.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Albanesi, JP (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jalban@mednet.swmed.edu	Khvotchev, Mikhail/G-5411-2013	Khvotchev, Mikhail/0000-0001-9328-8549	NIGMS NIH HHS [GM55562] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; Carpenter CL, 1998, NAT STRUCT BIOL, V5, P843, DOI 10.1038/2283; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; ENDEMANN G, 1987, BIOCHEMISTRY-US, V26, P6845, DOI 10.1021/bi00395a039; ENDEMANN GC, 1991, BIOCHEM J, V273, P63, DOI 10.1042/bj2730063; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; HUSEBYE ES, 1990, BIOCHIM BIOPHYS ACTA, V1042, P330, DOI 10.1016/0005-2760(90)90161-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDER ME, 1995, METHOD ENZYMOL, V250, P314; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; MICHELL RH, 1967, BIOCHIM BIOPHYS ACTA, V144, P649, DOI 10.1016/0005-2760(67)90053-7; NICKELS JT, 1992, J BIOL CHEM, V267, P16297; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; PIKE LJ, 1992, ENDOCR REV, V13, P692, DOI 10.1210/er.13.4.692; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwartz JJ, 1998, CULT SP CEL, P179; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANCE DE, 1991, BIOCH LIPIDS LIPOPRO, P205; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WALKER DH, 1988, BIOCHEMISTRY-US, V27, P6504, DOI 10.1021/bi00417a046; WETZKER R, 1991, EUR J BIOCHEM, V200, P179, DOI 10.1111/j.1432-1033.1991.tb21065.x; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	33	133	138	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7705	7708		10.1074/jbc.C000861200	http://dx.doi.org/10.1074/jbc.C000861200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244087	hybrid			2022-12-27	WOS:000167474900005
J	Zhang, H; Shi, XQ; Hampong, M; Blanis, L; Pelech, S				Zhang, H; Shi, XQ; Hampong, M; Blanis, L; Pelech, S			Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASE; EXPRESSION; P38(MAPK)	We have identified a direct physical interaction between the stress signaling p38 alpha MAP kinase and the mitogen-activated protein kinases ERK1 and ERK2 by affinity chromatography and coimmunoprecipitation studies. Phosphorylation and activation of p38 alpha enhanced its interaction with ERK1/2, and this correlated with inhibition of ERK1/2 phosphotransferase activity. The loss of epidermal growth factor-induced activation and phosphorylation of ERK1/2 but not of their direct activator MEK1 in HeLa cells transfected with the p38 alpha activator MKK6(E) indicated that activated p38 alpha may sequester ERK1/2 and sterically block their phosphorylation by MEK1.	Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; Kinexus Bioinformat Corp, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Pelech, S (corresponding author), Univ British Columbia, Dept Med, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Ludwig S, 1998, J BIOL CHEM, V273, P1917, DOI 10.1074/jbc.273.4.1917; Morrison DL, 2000, J BIOL CHEM, V275, P34236, DOI 10.1074/jbc.M004656200; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sambrook J., 2002, MOL CLONING LAB MANU; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4	13	150	152	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2001	276	10					6905	6908		10.1074/jbc.C000917200	http://dx.doi.org/10.1074/jbc.C000917200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410MC	11238443	hybrid			2022-12-27	WOS:000167442900007
J	Peng, YH; Chen, LH; Li, CG; Lu, WG; Agrawal, S; Chen, JD				Peng, YH; Chen, LH; Li, CG; Lu, WG; Agrawal, S; Chen, JD			Stabilization of the MDM2 oncoprotein by mutant p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-INDEPENDENT ROLE; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; FUNCTION MUTATIONS; TERMINAL DOMAIN; TUMOR-CELLS; PROTEIN; GAIN; EXPRESSION; OVEREXPRESSION	MDM2 is a short-lived protein that regulates p53 degradation. We report here that transient coexpression of MDM2 and several p53 hotspot mutants resulted in stabilization and increased expression of MDM2. Ectopic expression of the mutant p53(175H) allele by recombinant adenovirus infection or stable transfection also stabilized endogenous MDM2 in p53-null cells. A panel of human tumor cell lines expressing different endogenous mutant p53 alleles also contained stabilized nuclear MDM2 at elevated levels when compared with p53 null cells. MDM2 was present in complexes with mutant p53 in tumor cells, and stabilization of MDM2 required direct binding to mutant p53. These results reveal a novel property of mutant p53 and a unique feature of tumors with p53 missense mutations. Accumulation of stable MDM2 may contribute to tumorigenesis through its p53-independent transforming functions.	H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; Hybridon Inc, Cambridge, MA 02139 USA	H Lee Moffitt Cancer Center & Research Institute	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	JCHEN@Moffitt.usf.edu		Agrawal, Sudhir/0000-0003-4275-2510				BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Blattner C, 1999, MOL CELL BIOL, V19, P3704; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CORDONCARDO C, 1994, CANCER RES, V54, P794; CRIPPS KJ, 1994, ONCOGENE, V9, P2739; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Endo K, 2000, LIVER, V20, P209, DOI 10.1034/j.1600-0676.2000.020003209.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HSIAO M, 1994, AM J PATHOL, V145, P702; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Juven-Gershon T, 1999, MOL MED, V5, P71, DOI 10.1007/BF03402141; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; LIN JY, 1995, ONCOGENE, V10, P2387; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OLSON DC, 1993, ONCOGENE, V8, P2353; Pan Y, 1999, CANCER RES, V59, P2064; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Soong R, 1996, HUM PATHOL, V27, P1050, DOI 10.1016/S0046-8177(96)90282-8; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	36	54	57	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6874	6878		10.1074/jbc.C000781200	http://dx.doi.org/10.1074/jbc.C000781200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11152666	hybrid			2022-12-27	WOS:000167261000103
J	Ulens, C; Tytgat, J				Ulens, C; Tytgat, J			Functional heteromerization of HCN1 and HCN2 pacemaker channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC K+ CHANNELS; BETA-GAMMA-SUBUNITS; MU-OPIOID RECEPTOR; ADENYLYL-CYCLASE; MOLECULAR CHARACTERIZATION; POTASSIUM CHANNELS; XENOPUS-OOCYTES; CATION CHANNELS; MESSENGER-RNA; BRAIN	An important step toward understanding the molecular basis of the functional diversity of pacemaker currents in spontaneously active cells has been the identification of a gene family encoding hyperpolarization-activated cyclic nucleotide-sensitive cation nonselective (HCN) channels. Three of the four gene products that have been expressed so far give rise to pacemaker channels with distinct activation kinetics and are differentially distributed among the brain, with considerable overlap between some isoforms. This raises the possibility that HCN channels may coassemble to form heteromeric channels in some areas, similar to other K+ channels. In this study, we have provided evidence for functional heteromerization of HCN1 and HCN2 channels using a concatenated cDNA construct encoding two connected subunits. We have observed that heteromeric channels activate several-fold faster than HCN2 and only a little slower than HCN1. Furthermore, the voltage dependence of activation is more similar to HCN2, whereas the cAMP sensitivity is intermediate between HCN1 and HCN2. This phenotype shows marked similarity to the current arising from coexpressed HCN1 and HCN2 subunits in oocytes and the native pacemaker current in CA1 pyramidal neurons. We suggest that heteromerization may increase the functional diversity beyond the levels expected from the number of HCN channel genes and their differential distribution.	Catholic Univ Louvain, Toxicol Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain	Tytgat, J (corresponding author), Catholic Univ Louvain, Toxicol Lab, Van Evenstr 4, B-3000 Louvain, Belgium.		Tytgat, Jan/F-1560-2010	Tytgat, Jan/0000-0003-1778-6022				CHAN JSC, 1995, J NEUROCHEM, V65, P2682; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Clapham DE, 1998, NEURON, V21, P5, DOI 10.1016/S0896-6273(00)80508-5; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Ulens C, 2000, J PHARMACOL EXP THER, V294, P1024; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0	28	167	171	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 2	2001	276	9					6069	6072		10.1074/jbc.C000738200	http://dx.doi.org/10.1074/jbc.C000738200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	407FF	11133998	hybrid			2022-12-27	WOS:000167261000004
J	Correia, JD; Soldau, K; Christen, U; Tobias, PS; Ulevitch, RJ				Correia, JD; Soldau, K; Christen, U; Tobias, PS; Ulevitch, RJ			Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex - Transfer from CD14 to TLR4 and MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; LPS-BINDING-PROTEIN; CELL WALL COMPONENTS; SOLUBLE CD14; BACTERIAL LIPOPOLYSACCHARIDE; DROSOPHILA TOLL; CUTTING EDGE; ACTIVATION; RESPONSIVENESS; RECOGNITION	The structural features of some proteins of the innate immune system involved in mediating responses to microbial pathogens are highly conserved throughout evolution. Examples include members of the Drosophila Toll (dToll) and the mammalian Toll-like receptor (TLR) protein families. Activation of Drosophila Toll is believed to occur via an endogenous peptide rather than through direct binding of microbial products to the Toll protein. In mammals there is a growing consensus that lipopolysaccharide (LPS) initiates its biological activities through a heteromeric receptor complex containing CD14, TLR4, and at least one other protein, MD-2, LPS binds directly to CD14 but whether LPS then binds to TLR4 and/or MD-2 is not known. We have used transient transfection to express human TLRs, MD-2, or CD14 alone or in different combinations in HEK 293 cells, Interactions between LPS and these proteins were studied using a chemically modified, radioiodinated LPS containing a covalently linked, UV light-activated crosslinking group (I-125-ASD-Re595 LPS), Here we show that LPS is cross-linked specifically to TLR4 and MD-2 only when co-expressed with CD14, These data support the contention that LPS is in close proximity to the three known proteins of its membrane receptor complex. Thus, LPS binds directly to each of the members of the tripartite LPS receptor complex.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.		Christen, Urs/A-7338-2009; Ulevitch, Richard J/Q-3393-2017	Christen, Urs/0000-0003-4165-7976; 	NHLBI NIH HHS [HL23584] Funding Source: Medline; NIAID NIH HHS [AI32021, AI15136] Funding Source: Medline; NIGMS NIH HHS [GM28485, GM37696] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL023584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015136, R01AI032021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696, R37GM028485, R01GM028485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Hailman E, 1996, J IMMUNOL, V156, P4384; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Miyake K, 1998, J IMMUNOL, V161, P1348; Mokuno Y, 2000, J IMMUNOL, V165, P931, DOI 10.4049/jimmunol.165.2.931; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Seydel U, 2000, CHEM IMMUNOL, V74, P5; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; THEOFAN G, 1994, J IMMUNOL, V152, P3623; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	41	498	519	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21129	21135		10.1074/jbc.M009164200	http://dx.doi.org/10.1074/jbc.M009164200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274165	hybrid			2022-12-27	WOS:000169297900046
J	Martynov, VI; Savitsky, AP; Martynova, NY; Savitsky, PA; Lukyanov, KA; Lukyanov, SA				Martynov, VI; Savitsky, AP; Martynova, NY; Savitsky, PA; Lukyanov, KA; Lukyanov, SA			Alternative cyclization in GFP-like proteins family - The formation and structure of the chromophore of a purple chromoprotein from Anemonia sulcata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; LOCALIZATION; ANTHOZOA; CORAL	Anemonia sulcata purple protein (asFP595) belongs to a family of green fluorescent protein (GFP)-like proteins from the Anthozoa species. Similar to GFP, asFP595 apparently forms its chromophore by modifying amino acids within its polypeptide chain. Until now, the GFP-like proteins from Anthozoa were thought to contain chromophores with the same imidazolidinone core as GFP. Mass spectral analysis of a chromophore-containing tryptic pentapeptide from asFP595 demonstrates that chromophore formation in asFP595 is stoichiometrically the same as that in GFP: one H2O and two H+ are released while a Schiff base and dehydrotyrosine are formed. However, structural studies of this asFP595 chromopeptide show that in contrast to GFP, the other peptide bond nitrogen and carbonyl carbon are required for chromophore cyclization, a reaction that yields the six-membered heterocycle 2-(4-hydroxybenzylidene) -6-hydroxy-2,5-dihydropyrazine. Spectrophotometric titration reveals three pH-dependent forms of the asFP595 chromopeptide: yellow (absorption maximum = 430 nm) at pH 3.0; red (absorption maximum = 535 nm) at pH 8.0; and colorless (absorption maximum = 380 nm) at pH 14.0. The pK(a) values for these spectral transitions (6.8 and 10.9) are consistent with the ionization of the phenolic group of dehydrotyrosine and deprotonation of the amidinium cation in the chromophore heterocycle, respectively. The amidinium group in asFP595 accounts for the unique absorption spectrum of the protein, which is substantially red-shifted relative to that of GFP, When the asFP595 chromophore cyclizes, the Cys-Met bond adjacent to the chromophore hydrolyzes, splitting the chromoprotein into 8- and 20-kDa fragments. High performance liquid chromatography analysis of a tryptic digest of denatured asFP595 shows that a pentapeptide with the cleaved Cys-Met bond is the only fragment associated with the red-shifted absorbance. These results imply that fragmentation of asFP595 is a critical step in protein maturation.	RAS, Shemiakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia; Russian Acad Sci, Inst Biochem, Moscow 117071, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Lukyanov, SA (corresponding author), RAS, Shemiakin & Ovchinnikov Inst Bioorgan Chem, Miklukho Maklaya 16-10, Moscow 117997, Russia.	luk@ibch.ru	Martynov, Vladimir I./S-3483-2016; Savitsky, Alexander P/O-9799-2015; Lukyanov, Sergey/F-9140-2014; Lukyanov, Sergey/HIU-0305-2022; Lukyanov, Konstantin A/D-4030-2013; Martynova, Natalia Y/U-4520-2018	Martynov, Vladimir I./0000-0003-4923-6842; Savitsky, Alexander P/0000-0002-6820-2341; Lukyanov, Konstantin A/0000-0001-9845-2088; Savitsky, Pavel/0000-0001-8584-7750	NATIONAL CANCER INSTITUTE [R01CA077882] Funding Source: NIH RePORTER; NCI NIH HHS [CA77882] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bajno L, 1999, J IMMUNOL METHODS, V232, P67, DOI 10.1016/S0022-1759(99)00155-6; CHUA SO, 1974, J CHEM SOC P1, V5, P546; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Fradkov AF, 2000, FEBS LETT, V479, P127, DOI 10.1016/S0014-5793(00)01895-0; FREEMAN HS, 1991, DYES PIGMENTS, V16, P317, DOI 10.1016/0143-7208(91)85021-Y; GAUTIER JA, 1975, CHEM AMIDINES IMIDAT, P89; Gonzalez C, 2000, TRENDS CELL BIOL, V10, P162, DOI 10.1016/S0962-8924(00)01726-8; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Kendall JM, 1998, TRENDS BIOTECHNOL, V16, P216, DOI 10.1016/S0167-7799(98)01184-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Margolin W, 2000, METHODS, V20, P62, DOI 10.1006/meth.1999.0906; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; *PERK LIF SCI, 1993, US B, V58; PETRA PH, 1970, METHOD ENZYMOL, V25, P460; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Remington SJ, 2000, METHOD ENZYMOL, V305, P196; SHIMOMURA O, 1979, FEBS LETT, V104, P220, DOI 10.1016/0014-5793(79)80818-2; Stark G R, 1972, Methods Enzymol, V25, P103, DOI 10.1016/S0076-6879(72)25009-1; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; vanBreemen RB, 1996, J MASS SPECTROM, V31, P975, DOI 10.1002/(SICI)1096-9888(199609)31:9<975::AID-JMS380>3.0.CO;2-S; VANBREEMEN RB, 1988, BIOMED ENVIRON MASS, V17, P97, DOI 10.1002/bms.1200170205; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; WARD WW, 1980, PHOTOCHEM PHOTOBIOL, V31, P611, DOI 10.1111/j.1751-1097.1980.tb03755.x; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; Wiedenmann J, 2000, P NATL ACAD SCI USA, V97, P14091, DOI 10.1073/pnas.97.26.14091; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	32	45	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21012	21016		10.1074/jbc.M100500200	http://dx.doi.org/10.1074/jbc.M100500200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259412	hybrid			2022-12-27	WOS:000169297900030
J	Braun, IC; Herold, A; Rode, M; Conti, E; Izaurralde, E				Braun, IC; Herold, A; Rode, M; Conti, E; Izaurralde, E			Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE TRANSPORT ELEMENT; BINDING PROTEIN; HUMAN TAP; MEX67P; CTE; INTERACTS; REV; IDENTIFICATION; COMPLEX; BEARING	Human TAP and its yeast orthologue Mex67p are members of the multigene family of NXF proteins. A conserved feature of NXFs is a leucine-rich repeat domain (LRR) followed by a region related to the nuclear transport factor 2 (the NTF2-like domain). The NTF2-like domain of metazoan NXFs heterodimerizes with a protein known as p15 or NXT. A C-terminal region related to ubiquitin-associated domains (the UBA-like domain) is present in most, but not all NXF proteins. Saccharomyces cerevisiae Mex67p and Caenorhabditis elegans NXF1 are essential for the export of messenger RNA from the nucleus. Human TAP mediates the export of simian type D retroviral RNAs bearing the constitutive transport element, but the precise role of TAP and p15 in mRNA nuclear export has not yet been established. Here we show that overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates the export of mRNAs that are otherwise exported inefficiently. This stimulation of mRNA export is strongly reduced by removing the UBA-like domain of TAP and abolished by deleting the LRR domain or the NTF2-like domain. Similar results are obtained when TAP/p15 heterodimers are directly tethered to the RNA export cargo. Our data indicate that formation of TAP/pl5 heterodimers is required for TAP-mediated export of mRNA and show that the LRR domain of TAP plays an essential role in this process.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Izaurralde, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	izaurralde@embl-heidelberg.de	/C-3697-2019; Izaurralde, Elisa/G-3239-2012	Kos-Braun, Isabelle/0000-0002-2380-5720; Conti, Elena/0000-0003-1254-5588; Izaurralde, Elisa/0000-0001-7365-2649				Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bear J, 1999, MOL CELL BIOL, V19, P6306; Black BE, 1999, MOL CELL BIOL, V19, P8616; Black BE, 2001, J CELL BIOL, V152, P141, DOI 10.1083/jcb.152.1.141; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Cullen BR, 1998, VIROLOGY, V249, P203, DOI 10.1006/viro.1998.9331; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; HUANG XJ, 1991, J VIROL, V65, P2131, DOI 10.1128/JVI.65.4.2131-2134.1991; Kang YB, 2000, J VIROL, V74, P5863, DOI 10.1128/JVI.74.13.5863-5871.2000; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MCDONALD D, 1992, J VIROL, V66, P7232, DOI 10.1128/JVI.66.12.7232-7238.1992; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; Ossareh-Nazari B, 2000, MOL CELL BIOL, V20, P4562, DOI 10.1128/MCB.20.13.4562-4571.2000; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; STRAWN LA, 2000, J BIOL CHEM; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Suyama M, 2000, EMBO REP, V1, P53, DOI 10.1093/embo-reports/kvd009; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; VANKAN P, 1992, EMBO J, V11, P335, DOI 10.1002/j.1460-2075.1992.tb05056.x; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	40	110	112	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20536	20543		10.1074/jbc.M100400200	http://dx.doi.org/10.1074/jbc.M100400200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259411	hybrid			2022-12-27	WOS:000169135100116
J	Barnes, H; Larsen, B; Tyers, M; van der Geer, P				Barnes, H; Larsen, B; Tyers, M; van der Geer, P			Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (LRP1) associates with the adaptor protein SHC in SRC-transformed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; ROUS-SARCOMA VIRUS; PTB DOMAIN; C-SRC; SIGNAL-TRANSDUCTION; V-SRC; RAS; KINASES; MOUSE; PATHWAY	v-Src transforms fibroblasts in vitro and causes tumor formation in the animal by tyrosine phosphorylation of critical cellular substrates. Exactly how v-Src interacts with these substrates remains unknown. One of its substrates, the adaptor protein She, is thought to play a crucial role during cellular transformation by v-Src by linking v-Src to has, We used She proteins with mutations in either the phosphotyrosine binding (PTB) or Src homology 2 domain to determine that phosphorylation of She in v-Src-expressing cells depends on the presence of a functional PTB domain. We purified a 100-kDa She PTB-binding protein from Src-transformed cells that was identified as the beta chain of the low density lipoprotein receptor-related protein LRP1. LRP1 acts as an import receptor for a variety of proteins and is involved in clearance of the beta -amyloid precursor protein. This study shows that LRP1 is tyrosine-phosphorylated in v-Src-transformed cells and that tyrosine-phosphorylated LRP1 binds in vivo and in vitro to She. The association between She and LRP1 may provide a mechanism for recruitment of She to the plasma membrane where it is phosphorylated by v-Src. It is at the membrane that She is thought to be involved in Ras activation, These observations further suggest that LRP1 could function as a signaling receptor and may provide new avenues to investigate its possible role during embryonal development and the onset of Alzheimer's disease.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	van der Geer, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Tyers, Michael/ABE-3194-2021		NCI NIH HHS [1R29 CA78629] Funding Source: Medline; NIDDK NIH HHS [DK 07233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA078629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; BROOKSWILSON AR, 1989, MOL CELL BIOL, V9, P2214, DOI 10.1128/MCB.9.5.2214; Bubeck-Wardenburg J, 1999, PROG BIOPHYS MOL BIO, V71, P373, DOI 10.1016/S0079-6107(98)00060-1; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Djordjevic JT, 2000, CELL BIOL INT, V24, P599, DOI 10.1006/cbir.2000.0561; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Heldin CH, 1996, CANCER SURV, V27, P7; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; Kolibaba KS, 1997, BBA-REV CANCER, V1333, pF217, DOI 10.1016/S0304-419X(97)00022-X; LEVINSON AD, 1978, CELL, V15, P561, DOI 10.1016/0092-8674(78)90024-7; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; NEET K, 1995, MOL CELL BIOL, V15, P4908; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; van der Geer P, 1999, ONCOGENE, V18, P3071, DOI 10.1038/sj.onc.1202879; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; vanderGeer P, 1996, P NATL ACAD SCI USA, V93, P963, DOI 10.1073/pnas.93.3.963; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	50	97	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19119	19125		10.1074/jbc.M011437200	http://dx.doi.org/10.1074/jbc.M011437200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11259429	hybrid			2022-12-27	WOS:000169091000066
J	Lucas, PC; Yonezumi, M; Inohara, N; McAllister-Lucas, LM; Abazeed, ME; Chen, FF; Yamaoka, S; Seto, M; Nunez, G				Lucas, PC; Yonezumi, M; Inohara, N; McAllister-Lucas, LM; Abazeed, ME; Chen, FF; Yamaoka, S; Seto, M; Nunez, G			Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappa B signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE RECRUITMENT DOMAIN; CELL LYMPHOMA; TRANSCRIPTION FACTOR; CONTAINING PROTEIN; KINASE COMPLEX; BIR MOTIFS; ACTIVATION; APOPTOSIS; DEATH; IKK	At least two distinct recurrent chromosomal translocations have been implicated in the pathogenesis of MALT lymphoma. The first, t(1;14), results in the transfer of the entire Bcl10 gene to chromosome 14 wherein Bcl10 expression is inappropriately stimulated by the neighboring Ig enhancer. The second, t(11;18), results in the synthesis of a novel fusion protein, API2-MALT1. Until now, no common mechanism of action has been proposed to explain how the products of these seemingly unrelated translocations may contribute to the same malignant process. We show here that Bcl10 and MALT1 form a strong and specific complex within the cell, and that these proteins synergize in the activation of NF-kappaB. The data support a mechanism of action whereby Bcl10 mediates the oligomerization and activation of the MALT1 caspase-like domain. This subsequently activates the IKK complex through an unknown mechanism, setting in motion a cascade of events leading to NF-kappaB induction. Furthermore, the API2-MALT1 fusion protein also strongly activates NF-kappaB and shows dependence upon the same downstream signaling factors. We propose a model whereby both the Bcl10.MALT1 complex and the API2-MALT1 fusion protein activate a common downstream signaling pathway that originates with the oligomerization-dependent activation of the MALT1 caspase-like domain.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; Tokyo Med & Dent Univ, Sch Med, Dept Microbiol, Bunkyo Ku, Tokyo 1138519, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Aichi Cancer Center; Tokyo Medical & Dental University (TMDU)	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Abazeed, Mohamed/AAN-2376-2020; Nuñez, Gabriel/A-7160-2014	Abazeed, Mohamed/0000-0002-6614-4440; Lucas, Peter/0000-0003-4880-7172	NCI NIH HHS [CA84064, F32-CA88470-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA088470, R01CA084064] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Hozak RR, 2000, MOL CELL BIOL, V20, P1877, DOI 10.1128/MCB.20.5.1877-1885.2000; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; ISAACSON P, 1983, CANCER, V52, P1410, DOI 10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3; ISAACSON PG, 1995, J CLIN PATHOL, V48, P395, DOI 10.1136/jcp.48.5.395; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Morgan JA, 1999, CANCER RES, V59, P6205; OBRIEN RM, 1994, J BIOL CHEM, V269, P30419; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; WOTHERSPOON AC, 1992, CANCER GENET CYTOGEN, V58, P35, DOI 10.1016/0165-4608(92)90130-Z; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	37	343	368	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 1	2001	276	22					19012	19019		10.1074/jbc.M009984200	http://dx.doi.org/10.1074/jbc.M009984200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439BM	11262391	hybrid			2022-12-27	WOS:000169091000050
J	Schmidt, K; Schrader, M; Kern, HF; Kleene, R				Schmidt, K; Schrader, M; Kern, HF; Kleene, R			Regulated apical secretion of zymogens in rat pancreas - Involvement of the glycosylphosphatidylinositol-anchored glycoprotein GP-2, the lectin ZG16p, and cholesterol-glycosphingolipid-enriched microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; TRANS-GOLGI NETWORK; MDCK EPITHELIAL-CELLS; ACINAR-CELLS; TRANSMEMBRANE DOMAIN; GRANULE FORMATION; ENZYME PROTEINS; PLASMA-MEMBRANE; SORTING SIGNAL; BIOGENESIS	We examined the role of glycosphingolipid- and cholesterol-enriched microdomains, or rafts, in the sorting of digestive enzymes into zymogen granules destined for apical secretion and in granule formation. Isolated membranes of zymogen granules from pancreatic acinar cells showed an enrichment in cholesterol and sphingomyelin and formed detergent-insoluble glycolipid-enriched complexes. These complexes floated to the lighter fractions of sucrose density gradients and contained the glycosylphosphatidylinositol (GPI)-anchored glycoprotein GP-2, the lectin ZG16p, and sulfated matrix proteoglycans. Morphological and pulse-chase studies with isolated pancreatic lobules revealed that after inhibition of GPI-anchor biosynthesis by mannosamine or the fungal metabolite YW 3548, granule formation was impaired leading to an accumulation of newly synthesized proteins in the Golgi apparatus and the rough endoplasmic reticulum. Furthermore, the membrane attachment of matrix proteoglycans was diminished. After cholesterol depletion or inhibition of glycosphingolipid synthesis by fumonisin B1, the formation of zymogen granules as well as the formation of detergent-insoluble complexes was reduced. In addition, cholesterol depletion led to constitutive secretion of newly synthesized proteins, e.g. amylase, indicating that zymogens were missorted. Together, these data provide first evidence that in polarized acinar cells of the exocrine pancreas GPI-anchored proteins, e.g, GP-2, and cholesterol-sphingolipid-enriched microdomains are required for granule formation as well as for regulated secretion of zymogens and may function as sorting platforms for secretory proteins destined for apical delivery.	Univ Marburg, Dept Cell Biol & Cell Pathol, D-35033 Marburg, Germany	Philipps University Marburg	Schrader, M (corresponding author), Univ Marburg, Dept Cell Biol & Cell Pathol, Robert Koch Str 5, D-35033 Marburg, Germany.							Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Baldoni E, 1995, EUR J HISTOCHEM, V39, P253; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; CRONSHAGEN U, 1994, EUR J CELL BIOL, V65, P366; DANIELSEN EM, 1995, BIOCHEMISTRY-US, V34, P1596, DOI 10.1021/bi00005a016; DANIELSEN EM, 1995, J CELL BIOL, V131, P939, DOI 10.1083/jcb.131.4.939; Dartsch H, 1998, EUR J CELL BIOL, V75, P211, DOI 10.1016/S0171-9335(98)80115-5; Dhanvantari S, 2000, J BIOL CHEM, V275, P29887, DOI 10.1074/jbc.M005364200; DITTIE A, 1992, EUR J CELL BIOL, V58, P243; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Freedman SD, 1998, EUR J CELL BIOL, V75, P163, DOI 10.1016/S0171-9335(98)80058-7; FREEDMAN SD, 1993, BIOCHEM BIOPH RES CO, V197, P992, DOI 10.1006/bbrc.1993.2577; GORELICK FS, 1981, PHYSL GASTROINTESTIN, V2, P773; HANSEN LJ, 1983, P NATL ACAD SCI-BIOL, V80, P4379, DOI 10.1073/pnas.80.14.4379; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HEMPELMANN E, 1986, ELECTROPHORESIS, V7, P481, DOI 10.1002/elps.1150071011; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; Huttner WB, 1995, COLD SPRING HARB SYM, V60, P315, DOI 10.1101/SQB.1995.060.01.036; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kleene R, 1999, EUR J CELL BIOL, V78, P79, DOI 10.1016/S0171-9335(99)80009-0; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laine J, 1996, J HISTOCHEM CYTOCHEM, V44, P481, DOI 10.1177/44.5.8627005; LEBLOND FA, 1993, BIOCHEM J, V291, P289, DOI 10.1042/bj2910289; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1991, EMBO J, V10, P1969, DOI 10.1002/j.1460-2075.1991.tb07726.x; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; New R.R., 1990, LIPOSOMES PRACTICAL; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; RALTON JE, 1993, J BIOL CHEM, V268, P24183; RAUSCH U, 1987, CELL TISSUE RES, V247, P187, DOI 10.1007/BF00216561; RICK W, 1974, METHOD ENZYMAT AN, V1, P149; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; SCHEELE GA, 1994, PANCREAS, V9, P139, DOI 10.1097/00006676-199403000-00001; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schmidt K, 2000, J CELL SCI, V113, P2233; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045, DOI 10.1152/ajpgi.1998.275.5.G1045; Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374; Thiele C, 1998, SEMIN CELL DEV BIOL, V9, P511, DOI 10.1006/scdb.1998.0259; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	50	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14315	14323		10.1074/jbc.M006221200	http://dx.doi.org/10.1074/jbc.M006221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11152672	hybrid			2022-12-27	WOS:000168356600106
J	Shaked, GM; Meiner, Z; Avraham, I; Taraboulos, A; Gabizon, R				Shaked, GM; Meiner, Z; Avraham, I; Taraboulos, A; Gabizon, R			Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCUBATION PERIOD; SCRAPIE INFECTIVITY; MASS-SPECTROMETRY; CULTURED-CELLS; PROTEINS; ISOFORM; AGENT; CONFORMATIONS; ACCUMULATION; MOLECULES	The scrapie isoform of the prion protein, PrPSc, is the only identified component of the infectious prion, an agent causing neurodegenerative diseases such as Creutzfeldt-Jakob disease and bovine spongiform encephalopathy, Following proteolysis, PrPSc is trimmed to a fragment designated PrP 27-30, Both PrPSc and PrP 27-30 molecules tend to aggregate and precipitate as amyloid rods when membranes from prion-infected brain are extracted with detergents. Although prion rods mere also shown to contain lipids and sugar polymers, no physiological role has yet been attributed, to these molecules. In this work, we show that prion infectivity can be reconstituted by combining Me2SO-solubilized PrP 27-30, which at best contained low prion infectivity, with nonprotein components of prion rods (heavy fraction after deproteination, originating from a scrapie-infected hamster brain), which did not present any infectivity. Whereas heparanase digestion of the heavy fraction after deproteination (originating from a scrapie-infected hamster brain), before its combination with solubilized PrP 27-30, considerably reduced the reconstitution of infectivity, preliminary results suggest that infectivity can be greatly increased by combining nonaggregated protease-resistant PrP with heparan sulfate, a known component of amyloid plaques in the brain. We submit that whereas PrP 27-30 is probably the obligatory template for the conversion of Pr-Pc to PrPSc, sulfated sugar polymers may play an important role in the pathogenesis of prion diseases.	Hadassah Univ Hosp, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Gabizon, R (corresponding author), Hadassah Univ Hosp, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91120 Jerusalem, Israel.							Appel TR, 1999, BIOL CHEM, V380, P1295, DOI 10.1515/BC.1999.165; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; FARQUHAR CF, 1986, J GEN VIROL, V67, P463, DOI 10.1099/0022-1317-67-3-463; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; JEFFREY M, 1992, NEUROSCI LETT, V147, P106, DOI 10.1016/0304-3940(92)90785-6; KANEKO K, 1995, P NATL ACAD SCI USA, V92, P11160, DOI 10.1073/pnas.92.24.11160; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KELLINGS K, 1992, J GEN VIROL, V73, P1025, DOI 10.1099/0022-1317-73-4-1025; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MICHEL B, 1987, REV NEUROL, V143, P526; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Shaked GM, 1999, J BIOL CHEM, V274, P17981, DOI 10.1074/jbc.274.25.17981; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1988, AM J PATHOL, V133, P456; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079	35	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14324	14328		10.1074/jbc.M007815200	http://dx.doi.org/10.1074/jbc.M007815200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11152454	hybrid			2022-12-27	WOS:000168356600107
J	Denisov, IG; Makris, TM; Sligar, SG				Denisov, IG; Makris, TM; Sligar, SG			Cryotrapped reaction intermediates of cytochrome P450 studied by radiolytic reduction with phosphorus-32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON REDUCTION; SPECTROSCOPY; EPR; HEMOGLOBIN; MECHANISM; PORPHYRIN; MOSSBAUER; COMPOUND; P-450CAM; PROTEIN	Unstable reaction intermediates of the cytochrome P450 catalytic cycle have been prepared at cryogenic temperatures using radiolytic one-electron reduction of the oxy-P450 CYP101 complex. Since a rate-limiting step in the catalytic cycle of the enzyme is the reduction of the ferrous oxygenated heme protein, subsequent reaction intermediates do not normally accumulate. Using Co-60 gamma -irradiation, the primary reduced oxy-P450 species at 77 K has been identified as a superoxo- or hydroperoxo-Fe3+-heme complex (Davydov, R., Macdonald, I. D, G,, Makris, T, M., Sligar, S. G., and Hoffman, B, M. (1999) J, Am. Chem. Sec. 121, 10654-10655). The electronic absorption spectroscopy is an essential tool to characterize cytochrome P450 intermediates and complements paramagnetic methods, which are blind to important diamagnetic or antiferromagnetically coupled states. We report a method of trapping unstable states of redox enzymes using phosphorus-32 as an internal source of electrons. me determine the W-visible optical spectra of the reduced oxygenated state of CYP101 and show that the primary intermediate, a hydroperoxo-P450, is stable below 180 K and converts smoothly to the product complex at similar to 195 K, In the course of the thermal annealing, no spectral changes indicating the presence of oxoferryl species (the so-called compound I type spectrum) was observed.	Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, 405 N Mathews Ave, Urbana, IL 61801 USA.	s-sligar@uiuc.edu	Denisov, Ilia G/J-6590-2013; Denisov, Gleb S/J-6549-2013; Makris, Thomas/W-9965-2019	Denisov, Ilia G/0000-0002-7878-2626; Denisov, Gleb S/0000-0002-1246-0552; Makris, Thomas/0000-0001-7927-620X	NIGMS NIH HHS [GM33773, GM31756] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031756, R01GM031756] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEREZIN IV, 1964, RUSS J PHYS CHEM, V38, P1468; BLUMENFELD LA, 1979, BIOCHIM BIOPHYS ACTA, V549, P255, DOI 10.1016/0304-4173(79)90002-8; Brugna M, 2000, P NATL ACAD SCI USA, V97, P2069, DOI 10.1073/pnas.030539897; CHAMPION PM, 1989, J AM CHEM SOC, V111, P3433, DOI 10.1021/ja00191a053; Cunningham ID, 1999, J CHEM SOC PERK T 2, P2133, DOI 10.1039/a903511g; Davydov R, 1999, J AM CHEM SOC, V121, P10654, DOI 10.1021/ja9918829; DAVYDOV R, 1994, J AM CHEM SOC, V116, P11120, DOI 10.1021/ja00103a029; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; DAVYDOV R, 1991, FEBS LETT, V295, P113, DOI 10.1016/0014-5793(91)81398-R; Davydov RM, 1999, J AM CHEM SOC, V121, P10656, DOI 10.1021/ja992425v; DAVYDOV RM, 1978, MOL BIOL+, V12, P1037; de Montellano Ortiz, CYTOCHROME P450 STRU; DEMONTELLANO O, 1995, PR; DIPRIMO C, 1992, FEBS LETT, V312, P252, DOI 10.1016/0014-5793(92)80946-E; FESSENDEN RW, 1970, ADV RADIAT CHEM, V7, P1; GASYNA Z, 1979, BIOCHIM BIOPHYS ACTA, V577, P207, DOI 10.1016/0005-2795(79)90022-9; GASYNA Z, 1979, FEBS LETT, V106, P213, DOI 10.1016/0014-5793(79)80730-9; Green MT, 1999, J AM CHEM SOC, V121, P7939, DOI 10.1021/ja991541v; GRESCHNER S, 1979, ACTA BIOL MED GER, V38, P443; Groves John T., 1995, P3; HARDWICK TJ, 1952, CAN J CHEM, V30, P39, DOI 10.1139/v52-005; Harris D, 1998, J AM CHEM SOC, V120, P4308, DOI 10.1021/ja974110q; Karlsson A, 2000, J INORG BIOCHEM, V78, P83, DOI 10.1016/S0162-0134(99)00213-5; Khriachtchev L, 2000, NATURE, V406, P874, DOI 10.1038/35022551; KOBAYASHI K, 1987, J BIOL CHEM, V262, P5445; Kolodziejski M, 1997, J MOL STRUCT, V437, P543, DOI 10.1016/S0022-2860(97)00221-4; MAGONOV SN, 1978, MOL BIOL+, V12, P913; MAGONOV SN, 1978, MOL BIOL+, V12, P919; MAGONOV SN, 1978, MOL BIOL+, V12, P725; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Oshtrakh MI, 1999, RADIAT PHYS CHEM, V55, P549, DOI 10.1016/S0969-806X(99)00300-X; PEISACH M, 1960, NATURE, V187, P58, DOI 10.1038/187058a0; PRUSAKOV VE, 1985, FEBS LETT, V186, P158, DOI 10.1016/0014-5793(85)80700-6; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; SCHULER RH, 1956, J CHEM PHYS, V24, P56, DOI 10.1063/1.1700854; Shibata Y, 1999, BIOCHEMISTRY-US, V38, P1789, DOI 10.1021/bi9815694; Spinks J. W. T., 1990, INTRO RAD CHEM, P364; SYMONS MCR, 1978, PROC R SOC SER B-BIO, V201, P285, DOI 10.1098/rspb.1978.0046; SYMONS MCR, 1989, J CHEM SOC FARAD T 1, V85, P2427, DOI 10.1039/f19898502427; TURNER JJ, 1963, SCIENCE, V140, P974, DOI 10.1126/science.140.3570.974-a; UNGER BP, 1986, J BIOL CHEM, V261, P1158; Urano Y, 1997, J AM CHEM SOC, V119, P12008, DOI 10.1021/ja972892h; WATANABE Y, 2000, PORPHYRIN HDB, V4, P97; YAMAMOTO O, 1982, INT J RADIAT BIOL, V42, P661, DOI 10.1080/09553008214551631	44	92	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11648	11652		10.1074/jbc.M010219200	http://dx.doi.org/10.1074/jbc.M010219200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152470	hybrid			2022-12-27	WOS:000168081800032
J	Kim, YS; Min, JK; Kim, D; Jung, J				Kim, YS; Min, JK; Kim, D; Jung, J			A soluble auxin-binding protein, ABP(57) - Purification with anti-bovine serum albumin antibody and characterization of its mechanistic role in the auxin effect on plant plasma membrane H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL ELONGATION; C-TERMINAL REGION; PHOSPHORYLATION; IDENTIFICATION; RECEPTORS; KINASE; GROWTH; SIGNAL	ABP(57) is an aurin-binding protein that possesses receptor function. In this study, a protocol for ABP(57) purification was developed on the basis of cross-reactivity shown between ABP(57) and antisera raised against bovine serum albumin, which enabled us to purify ABP(57) with a high yield and to further characterize it. ABP(57) activates plant plasma membrane H+-ATPase (PM H+- ATPase) via direct interaction. The binding of indole-3-acetic acid (IAA) to the primary binding site on ABP(57) caused a marked increase in the affinity of ABP(57) for PM H+-ATPase, which was accompanied by a change in ABP(57) conformation. Meanwhile, additional IAA binding to the secondary site on ABP(57) nullified the initial effect without inducing further conformational change. When ABP(57) with IAA occupying only the primary site interacted with PM H+-ATPase, no IAA could access the secondary site. These results suggest that IAA induced biphasic alteration in the affinity of ABP(57) for PM H+-ATPase correlates with a bell-shaped dose response of the enzyme to IAA, There is also a possibility that, whereas the stimulation phase of the response is associated with a conformational change of ABP` the de-stimulation phase probably results from hindrance arising directly from the presence of IAA at the secondary site.	Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea; Natl Inst Agr Sci & Technol, Div Biochem, Suwon 441100, South Korea	Seoul National University (SNU)	Jung, J (corresponding author), Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea.	jinjung@snu.ac.kr		Min, Jungki/0000-0003-1860-3064				BARBIERBRYGOO H, 1995, CRIT REV PLANT SCI, V14, P1, DOI 10.1080/713608067; BARBIERBRYGOO H, 1991, PLANT J, V1, P83, DOI 10.1111/j.1365-313X.1991.00083.x; BARRIERBRYGOO H, 1989, P NATL ACAD SCI USA, V86, P891, DOI 10.1073/pnas.86.3.891; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; Bertuzzi A, 1997, CLIN CHIM ACTA, V265, P183, DOI 10.1016/S0009-8981(97)00117-4; BRAHMS S, 1977, P NATL ACAD SCI USA, V74, P3208, DOI 10.1073/pnas.74.8.3208; CLELAND R, 1972, PLANTA, V104, P1, DOI 10.1007/BF00387679; CROSS JW, 1991, NEW BIOL, V3, P813; DUFOUR JP, 1988, METHOD ENZYMOL, V157, P513; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; HARLOW E, 1988, ANTIBODIES; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; JOHNSON WC, 1972, J AM CHEM SOC, V94, P4389, DOI 10.1021/ja00767a084; JONES AM, 1992, BIOESSAYS, V14, P43, DOI 10.1002/bies.950140109; KARZ W, 1990, PHYSIOL PLANTARUM, V80, P257; Kim YS, 1998, FEBS LETT, V438, P241, DOI 10.1016/S0014-5793(98)01307-6; KIM YS, 2000, IN PRESS PLANT GROWT; KLAMBT D, 1990, PLANT MOL BIOL, V14, P1045, DOI 10.1007/BF00019401; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Oecking C, 1997, PLANT J, V12, P441, DOI 10.1046/j.1365-313X.1997.12020441.x; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; PALMGREN MG, 1990, PLANT PHYSIOL, V94, P882, DOI 10.1104/pp.94.3.882; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, P76, DOI DOI 10.1016/B978-012552110-9/50005-2; Pittz E P, 1973, Methods Enzymol, V27, P209; RADERMACHER E, 1993, J PLANT PHYSIOL, V141, P698, DOI 10.1016/S0176-1617(11)81577-4; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; SANTONI V, 1991, PLANTA, V185, P227, DOI 10.1007/BF00194065; SCHERER GFE, 1993, PLANTA, V191, P515, DOI 10.1007/BF00195753; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SHEN WH, 1988, P NATL ACAD SCI USA, V85, P3417, DOI 10.1073/pnas.85.10.3417; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; VENIS MA, 1995, CRIT REV PLANT SCI, V14, P27, DOI 10.1080/713608065; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; Yi HJ, 1996, PHYSIOL PLANTARUM, V96, P359, DOI 10.1111/j.1399-3054.1996.tb00445.x	39	49	57	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10730	10736		10.1074/jbc.M009416200	http://dx.doi.org/10.1074/jbc.M009416200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11154693	hybrid			2022-12-27	WOS:000167980900024
J	Savinainen, A; Garcia, EP; Dorow, D; Marshall, J; Liu, YF				Savinainen, A; Garcia, EP; Dorow, D; Marshall, J; Liu, YF			Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; PSD-95; HIPPOCAMPUS; HUNTINGTON; EXPRESSION; SEIZURES; FAMILY; MEMBER; MICE	Kainate receptor glutamate receptor 6 (GluR6) subunit-deficient and c-Jun N-terminal kinase 3 (JNK3)-null mice share similar phenotypes including resistance to kainite-induced epileptic seizures and neuronal toxicity (Yang, D. D., Kuan, C-Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., Davis, R. J., Rakis, P., and Flavell, R. (1997) Nature 389, 865-869; Mulle, C., Seiler, A. Perez-Otano, I., Dickinson-Anson, H., Castillo, P. E., Bureau, I., Maron, C., Gage, F. H., Mann, J. R., Bettler, B., and Heinemmann, S.F. (1998) Nature 392, 601-605). This suggests that JNK activation may be involved in GluR6-mediated excitotoxicity. We provide evidence that postsynaptic density protein (PSD-95) links GluR6 to JNK activation by anchoring mixed lineage kinase (MLK) 2 or MLK3, upstream activators of JNKs, to the receptor complex. Association of MLK2 and MLK3 with PSD-95 in HN33 cells and rat brain preparations is dependent upon the SH3 domain of PSD-95, and expression of GluR6 in HN33 cells activated JNKs and induced neuronal apoptosis. Deletion of the PSD-BB-binding site of GluR6 reduced both JNK activation and neuronal toxicity. Co-expression of dominant negative MLK2, MLK3, or mitogen-activated kinase kinase (MKK) 4 and MKK7 also significantly attenuated JNK activation and neuronal toxicity mediated by GluR6, and co-expression of PSD-95 with a deficient Src homology 3 domain also inhibited GluR6-induced JNK activation and neuronal toxicity. Our results suggest that PSD-95 plays a critical role in GluR6-mediated JNK activation and excitotoxicity by anchoring MLK to the receptor complex.	Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI USA; Peter MacCallum Canc Inst, Trecowthick Res Ctr, Melbourne, Vic 3000, Australia	Northeastern University; Brown University; Peter Maccallum Cancer Center	Liu, YF (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, 312 Mugar Hall,360 Huntington Ave, Boston, MA 02115 USA.	yafliu@lynx.neu.edu						BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Liu YF, 1998, J BIOL CHEM, V273, P28873, DOI 10.1074/jbc.273.44.28873; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Liu YF, 2000, J BIOL CHEM, V275, P19035, DOI 10.1074/jbc.C000180200; MacDonald ME, 1999, NEUROLOGY, V53, P1330, DOI 10.1212/WNL.53.6.1330; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; NIETHAMMER M, 1997, NEURON, V16, P2157; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schauwecker PE, 2000, BRAIN RES, V884, P116, DOI 10.1016/S0006-8993(00)02888-2; Telfeian AE, 2000, NEUROBIOL DIS, V7, P362, DOI 10.1006/nbdi.2000.0294; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; WAGSTER MV, 1994, EXP NEUROL, V127, P70, DOI 10.1006/exnr.1994.1081; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	29	98	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11382	11386		10.1074/jbc.M100190200	http://dx.doi.org/10.1074/jbc.M100190200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152698	hybrid			2022-12-27	WOS:000167980900109
J	Russell, SJ; Johnston, SA				Russell, SJ; Johnston, SA			Evidence that proteolysis of Ga14 cannot explain the transcriptional effects of proteasome ATPase mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEDIATED DEGRADATION; REGULATORY PARTICLE; ACTIVATION DOMAIN; YEAST PROTEASOME; 26-S PROTEASE; 26S PROTEASE; SUBUNIT; FAMILY; CODES	The Gal system of Saccharomyces cerevisiae is a paradigm for eukaryotic gene regulation. Expression of genes required for growth on galactose is regulated by the transcriptional activator Ga14. The activation function of Ga14 has been localized to 34 amino acids near the C terminus of the protein. The gal4D allele of GAL4 encodes a truncated protein in which only 14 amino acids of the activation domain remain. Expression of GAL genes is dramatically reduced in gal4D strains and these strains are unable to grow on galactose as the sole carbon source. Overexpression of gal4D partially relieves the defect in GAL gene expression and allows growth on galactose. A search for extragenic suppressors of gal4D identified recessive mutations in the SUG1 and SUG2 genes, which encode ATPases of the 19S regulatory complex of the proteasome. The proteasome is responsible for the ATP-dependent degradation of proteins marked for destruction by the ubiquitin system. It has been commonly assumed that effects of SUGI and SUG2 mutations on transcription are explained by alterations in the proteolysis of gal4D protein. We have investigated this assumption. Surprisingly, we find that SUGI and SUG2 alleles that are unable to suppress gal4D cause a larger increase in gal4D protein levels than do suppressing alleles. in addition, mutations in genes encoding subunits of the proteolytic 20S sub-complex of the proteasome increase the levels of gal4D protein but do not rescue its transcriptional activity, Therefore, an alteration in the proteolysis of gal4D by the proteasome cannot explain the effects of mutations in SUGI and SUG2 on expression of GAL genes. These findings suggest that the 19S regulatory complex may play a more direct role in transcription.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Biochem & Mol Biol Grad Program, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Johnston, SA (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.johnston@utsouthwestern.edu						Beyer A, 1997, PROTEIN SCI, V6, P2043; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DUBIEL W, 1994, BIOL CHEM H-S, V375, P237, DOI 10.1515/bchm3.1994.375.4.237; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Guthrie C., 1991, GUIDE YEAST GENETICS, P194; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; HILT W, 1993, J BIOL CHEM, V268, P3479; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; MCCUSKER JH, 1988, GENETICS, V119, P303; MCCUSKER JH, 1988, GENETICS, V119, P317; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1996, J BIOL CHEM, V271, P32810, DOI 10.1074/jbc.271.51.32810; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; RUSSELL SJ, 1999, THESIS U TEXAS SW ME; St-Arnaud R, 1999, J CELL BIOCHEM, P32; Swaffield JC, 1996, NATURE, V379, P658, DOI 10.1038/379658a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEISSMAN JS, 1995, SCIENCE, V268, P523, DOI 10.1126/science.7725096; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; XU QL, 1995, MOL CELL BIOL, V15, P6025	32	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9825	9831		10.1074/jbc.M010889200	http://dx.doi.org/10.1074/jbc.M010889200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152478	hybrid			2022-12-27	WOS:000167996400034
J	Wan, M; Shi, XM; Feng, X; Cao, X				Wan, M; Shi, XM; Feng, X; Cao, X			Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLASTOGENESIS-INHIBITORY FACTOR; MESSENGER-RNA LEVELS; TRANSFORMING GROWTH-FACTOR-BETA-1; SMAD PROTEINS; FACTOR OCIF; CELL-LINE; DIFFERENTIATION; MARROW; ACTIVATION; C3H10T1/2	Osteoprotegerin (OPG), an osteoblast-secreted decoy receptor, specifically binds to osteoclast differentiation factor and inhibits osteoclast maturation. Members of the transforming growth factor-beta superfamily including bone morphogenetic proteins (SMPs) stimulate OPG mRNA expression. In this study, we have characterized the transcription mechanism of BMP-induced OPG gene expression. Transfection of Smadl and a constitutively active BMP type IA receptor ALK3 (Q233) stimulated the OPG promoter. Deletion analysis of the OPG promoter identified two Hoxc-8 binding sites that respond to BMP stimulation. Glutathione S-transferase-Hoxc-8 protein binds to these two Hox sites specifically. Consistent with the transfection results of the native promoter, ALK3 or Smadl linker region, which interacts with Hoxc-8, stimulated the activation of the reporter construct with the two Hox sites. Overexpression of Hoxc-8 inhibited the induced promoter activity. When the two Hox binding sites were mutated, ALK3 or Smadl linker region no longer activated the transcription. Importantly, Smadl linker region induced both OPG promoter activity and endogenous OPG protein expression in 2T3 osteoblastic cells. The medium from cells transfected with Smadl linker region expression plasmid effectively inhibited osteoclastogenesis. Collectively, our data indicate that Hox sites mediate both OPG promoter construct activity and endogenous OPG gene expression in response to BMP stimulation.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Cao, X (corresponding author), 1670 Univ Blvd,VH G002, Birmingham, AL 35294 USA.	Cao@path.uab.edu			NIDDK NIH HHS [DK 53757] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053757] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; BIZZARRI C, 1994, J BIOL CHEM, V269, P13817; Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V247, P338, DOI 10.1006/bbrc.1998.8783; Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V248, P454, DOI 10.1006/bbrc.1998.8993; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; Hakeda Y, 1998, BIOCHEM BIOPH RES CO, V251, P796, DOI 10.1006/bbrc.1998.9523; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kwon BS, 1998, FASEB J, V12, P845, DOI 10.1096/fasebj.12.10.845; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; STERNER JM, 1995, J BIOL CHEM, V270, P9281, DOI 10.1074/jbc.270.16.9281; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vidal ONA, 1998, BIOCHEM BIOPH RES CO, V248, P696, DOI 10.1006/bbrc.1998.9035; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZHOU H, 1993, J CELL PHYSIOL, V155, P112, DOI 10.1002/jcp.1041550115	40	80	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10119	10125		10.1074/jbc.M006918200	http://dx.doi.org/10.1074/jbc.M006918200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11139569	hybrid			2022-12-27	WOS:000167996400072
J	Zhang, LH; Wu, SL; Rubin, CS				Zhang, LH; Wu, SL; Rubin, CS			Structural properties and mechanisms that govern association of C kinase adapter 1 with protein kinase C3 and the cell periphery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; PTB DOMAIN; REGULATED EXPRESSION; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; IN-VITRO; II-BETA; POLARITY; ZETA; GENE	Association of an atypical protein kinase C (aPKC) with an adapter protein can affect the location, activity, substrate specificity, and physiological role of the phosphotransferase, Knowledge of mechanisms that govern formation and intracellular targeting of aPKC adapter protein complexes is limited. Caenorhabditis elegans protein kinase C adapter proteins (CKA1 and CKA1S) bind and target aPKCs and provide prototypes for mechanistic analysis. CKA1 binds an aPKC (PKC3) via a phosphotyrosine binding (PTB) domain. A distinct, Arg/Lys-rich N-terminal region targets CKA1 to the cell periphery. We discovered that a short segment ((212)GGIDNGAFHEHEI(224)) of the V-2 (linker) region of PKC3 creates a binding surface that interacts with the PTB domain of CKA1/CKA1S. The docking domain of PKC3 differs from classical PTB ligands by the absence of Tyr and Pro. Substitution of Ile(214), Asn(216), or Phe(219) with Ala abrogates binding of PKC3 with CKA1; these residues cooperatively configure a docking site that complements an apolar surface of the CKA1 PTB domain. Phosphorylation site domains (PSD1, residues 11-25; PSD2, residues 61-77) in CKA1 route the adapter land tethered PKC3) to the cell periphery, Phosphorylation of Ser(17) and Ser(65) in PSDs 1 and 2 elicits translocation of CKA1 from the cell surface to cytoplasm, Activities of DAG-stimulated PKCs and opposing protein Ser/Thr phosphatases can dynamically regulate the distribution of adapter protein between the cell periphery and cytoplasm.	Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rubin, CS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, Forch 229,1300 Morris Pk Ave, Bronx, NY 10461 USA.				NIGMS NIH HHS [GM22792] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022792] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Diaz-Meco MT, 1999, J BIOL CHEM, V274, P19606, DOI 10.1074/jbc.274.28.19606; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; Gong JP, 1999, SCIENCE, V285, P1565, DOI 10.1126/science.285.5433.1565; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; Hung TJ, 1999, DEVELOPMENT, V126, P127; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; LAND M, 1994, J BIOL CHEM, V269, P9234; LAND M, 1994, J BIOL CHEM, V269, P14820; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Margolis B, 1999, TRENDS ENDOCRIN MET, V10, P262, DOI 10.1016/S1043-2760(99)00168-X; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; Zhang LH, 2001, J BIOL CHEM, V276, P10463, DOI 10.1074/jbc.M008990200; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	45	6	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10476	10484		10.1074/jbc.M008991200	http://dx.doi.org/10.1074/jbc.M008991200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134025	hybrid			2022-12-27	WOS:000167996400115
J	Tian, LJ; Duncan, RR; Hammond, MSL; Coghill, LS; Wen, H; Rusinova, R; Clark, AG; Levitan, IB; Shipston, MJ				Tian, LJ; Duncan, RR; Hammond, MSL; Coghill, LS; Wen, H; Rusinova, R; Clark, AG; Levitan, IB; Shipston, MJ			Alternative splicing switches potassium channel sensitivity to protein phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CONDUCTANCE; KINASE-A; MODULATION; RAT; SLOWPOKE; BRAIN; DEPHOSPHORYLATION; MYOMETRIUM; INHIBITION; SUBUNIT	Alternative exon splicing and reversible protein phosphorylation of large conductance calcium-activated potassium (BK) channels represent fundamental control mechanisms for the regulation of cellular excitability. BK channels are encoded by a single gene that undergoes extensive, hormonally regulated exon splicing. In native tissues BK channels display considerable diversity and plasticity in their regulation by cAMP-dependent protein kinase (PKA). Differential regulation of alternatively spliced BK channels by PKA may provide a molecular basis for the diversity and plasticity of BK channel sensitivities to PKA. Here we demonstrate that PKA activates BK channels lacking splice inserts (ZERO) but inhibits channels expressing a 59-amino acid exon at splice site 2 (STREX-1). Channel activation is dependent upon a conserved C-terminal PKA consensus motif (S869), whereas inhibition is mediated via a STREX-1 exon-specific PKA consensus site. Thus, alternative splicing acts as a molecular switch to determine the sensitivity of potassium channels to protein phosphorylation.	Univ Edinburgh, Membrane Biol Grp, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Edinburgh, MRC, Sch Med, Membrane & Adapter Prot Cooperat Grp, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Edinburgh; University of Edinburgh; University of Pennsylvania	Shipston, MJ (corresponding author), Univ Edinburgh, Membrane Biol Grp, Sch Med, Reviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.		Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Duncan, Rory/0000-0003-0693-910X				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Clark AG, 1999, J PHYSIOL-LONDON, V516, P45, DOI 10.1111/j.1469-7793.1999.045aa.x; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LEE K, 1995, J PHYSIOL-LONDON, V488, P319, DOI 10.1113/jphysiol.1995.sp020969; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PEREZ G, 1994, AM J PHYSIOL, V266, pC1459, DOI 10.1152/ajpcell.1994.266.5.C1459; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1995, J NEUROSCI, V15, P4572; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Shipston MJ, 1996, J BIOL CHEM, V271, P9197, DOI 10.1074/jbc.271.16.9197; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; WANG J, 1999, J NEUROSCI, V19, P1; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; Xia XM, 1998, J NEUROSCI, V18, P2360; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	27	167	172	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 16	2001	276	11					7717	7720		10.1074/jbc.C000741200	http://dx.doi.org/10.1074/jbc.C000741200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	411AA	11244090	hybrid			2022-12-27	WOS:000167474900008
J	Ravanat, JL; Di Mascio, P; Martinez, GR; Medeiros, MHG; Cadet, J				Ravanat, JL; Di Mascio, P; Martinez, GR; Medeiros, MHG; Cadet, J			Singlet oxygen induces oxidation of cellular DNA (vol 275, pg 40601, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction							PERFORMANCE LIQUID-CHROMATOGRAPHY; BASE DAMAGE; NAPHTHALENE ENDOPEROXIDE; BIOLOGICAL MEDIA; VISIBLE-LIGHT; RADIATION; 8-HYDROXY-2'-DEOXYGUANOSINE; PRODUCTS; ASSAY; THERMOLYSIS	The aim of the present work was to evaluate the potential for O-1(2) to induce oxidation of cellular DNA. For this purpose cells were incubated in the presence of a water-soluble endoperoxide whose thermal decomposition leads to the formation of singlet oxygen. Thereafter, DNA was extracted and the level of several modified DNA bases was determined by HPLC analysis coupled to a tandem mass spectrometric detection. A significant increase in the level of 8 oxo-7,8-dihydro-2'-deoxyguanosine was observed upon incubation of the cells with the chemical generator of O-1(2), whereas the level of the other DNA bases measured remained unchanged. To demonstrate that singlet oxygen is directly involved in the formation of 8 oxo-7,8-dihydro-2'-deoxyguanosine, the corresponding O-18-labeled endoperoxide was used. Incubation of the cells with such a generator of O-18-labeled singlet oxygen results in the formation of O-18. labeled 8 oxo-7,8-dihydro-2'-deoxyguanosine in the nuclear DNA. This result clearly demonstrates that singlet oxygen, when released within cells, is able to directly oxidize cellular DNA.	CEA Grenoble, SCIB, DRFMC, Lab Les Acides Nucle,CNRS,UMR 5046, F-38054 Grenoble 9, France; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil	CEA; Centre National de la Recherche Scientifique (CNRS); Universidade de Sao Paulo	Ravanat, JL (corresponding author), CEA Grenoble, SCIB, DRFMC, Lab Les Acides Nucle,CNRS,UMR 5046, 17 Ave Martyrs, F-38054 Grenoble 9, France.		Ravanat, Jean-Luc/E-3452-2018; Di Mascio, Paolo/D-1264-2014; de Medeiros, Marisa Helena Gennari/AAA-8015-2019; Medeiros, Marisa H. G./A-5212-2008; Martinez, Glaucia Regina/I-3110-2016	Ravanat, Jean-Luc/0000-0002-7123-6358; Di Mascio, Paolo/0000-0003-4125-8350; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Medeiros, Marisa H. G./0000-0002-5438-1174; Martinez, Glaucia Regina/0000-0002-2628-4406				Alapetite C, 1996, INT J RADIAT BIOL, V69, P359, DOI 10.1080/095530096145922; BASUMODAK S, 1993, CANCER RES, V53, P4505; BUCHKO GW, 1992, NUCLEIC ACIDS RES, V20, P4847, DOI 10.1093/nar/20.18.4847; CADENAS E, 1983, HOPPESEYLERS Z PHYSL, V364, P515; CADET J, 1994, METHOD ENZYMOL, V234, P79; Cadet J, 1998, FREE RADICAL RES, V29, P541, DOI 10.1080/10715769800300581; Cadet J, 1997, BIOL CHEM, V378, P1275; CADET J, 1978, PHOTOCHEM PHOTOBIOL, V28, P661, DOI 10.1111/j.1751-1097.1978.tb06991.x; Cadet J, 2000, METHOD ENZYMOL, V319, P143; CLAYCAMP HG, 1993, INT J RADIAT BIOL, V63, P597, DOI 10.1080/09553009314450781; Dewilde A, 1996, J PHOTOCH PHOTOBIO B, V36, P23, DOI 10.1016/S1011-1344(96)07323-X; Dewilde A, 1998, BIOL CHEM, V379, P1377; DI MASCIO P, 1989, J AM CHEM SOC, V111, P2909, DOI 10.1021/ja00190a027; Douki T., 1995, P213; EPE B, 1991, CHEM-BIOL INTERACT, V80, P239, DOI 10.1016/0009-2797(91)90086-M; Frelon S, 2000, CHEM RES TOXICOL, V13, P1002, DOI 10.1021/tx000085h; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KASAI H, 1992, J AM CHEM SOC, V114, P9692, DOI 10.1021/ja00050a078; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Lafleur M V, 1987, Free Radic Res Commun, V2, P343, DOI 10.3109/10715768709065301; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391, DOI 10.1080/15287399309531806; Martinez GR, 2000, J AM CHEM SOC, V122, P10212, DOI 10.1021/ja0016452; Pierlot C, 1996, J PHOTOCH PHOTOBIO B, V36, P31, DOI 10.1016/S1011-1344(96)07324-1; Pierlot C, 2000, METHOD ENZYMOL, V319, P3; PIETTE J, 1991, J PHOTOCH PHOTOBIO B, V11, P241, DOI 10.1016/1011-1344(91)80030-L; PIETTE J, 1990, J PHOTOCH PHOTOBIO B, V4, P335, DOI 10.1016/1011-1344(90)85039-Y; Pouget JP, 1999, INT J RADIAT BIOL, V75, P51, DOI 10.1080/095530099140807; Ravanat JL, 2000, J BIOL CHEM, V275, P40601, DOI 10.1074/jbc.M006681200; Ravanat JL, 1998, J CHROMATOGR B, V715, P349, DOI 10.1016/S0378-4347(98)00259-X; RAVANAT JL, 1995, CHEM RES TOXICOL, V8, P379, DOI 10.1021/tx00045a009; SHEU C, 1993, J AM CHEM SOC, V115, P10446, DOI 10.1021/ja00075a105; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; STEINBECK MJ, 1992, J BIOL CHEM, V267, P13425	38	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 23	2001	276	8					6056	40604						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404RU	11246639				2022-12-27	WOS:000167115100086
J	Estevez, JM; Cantero, A; Reindl, A; Reichler, S; Leon, P				Estevez, JM; Cantero, A; Reindl, A; Reichler, S; Leon, P			1-deoxy-D-xylulose-5-phosphate synthase, a limiting enzyme for plastidic isoprenoid biosynthesis in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXYXYLULOSE 5-PHOSPHATE SYNTHASE; MEVALONATE-INDEPENDENT PATHWAY; SYNECHOCOCCUS-LEOPOLIENSIS; GIBBERELLIN BIOSYNTHESIS; HETEROLOGOUS EXPRESSION; CAROTENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; NONMEVALONATE PATHWAY; PHYTOENE SYNTHASE; GENE	The initial step of the plastidic 2C-methyl-D-erythritol 4-phosphate (MEP) pathway that produces isopentenyl diphosphate is catalyzed by 1-deoxy-D-xylulose-5-phosphate synthase. To investigate whether or not 1-deoxy-D-xylulose-5-phosphate synthase catalyzes a limiting step in the MEP pathway in plants, we produced transgenic Arabidopsis plants that over- or underexpress this enzyme. Compared with non-transgenic wild-type plants, the transgenic plants accumulate different levels of various isoprenoids such as chlorophylls, tocopherols, carotenoids, abscisic acid, and gibberellins. Phenotypically, the transgenic plants had slight alterations in growth and germination rates. Because the levels of several plastidic isoprenoids correlate with changes in 1-deoxy-D-xylulose-5-phosphate synthase levels, we conclude that this enzyme catalyzes one of the rate-limiting steps of the MEP biosynthetic pathway. Furthermore, since the product of the MEP pathway is isopentenyl diphosphate, our results suggest that in plastids the pool of isopentenyl diphosphate is limiting to isprenoid production.	Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Cuernavaca 62271, Morelos, Mexico; BASF AG, Crop Prot Res, D-67056 Ludwigshafen, Germany	Universidad Nacional Autonoma de Mexico; BASF	Leon, P (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Avenida Univ 2001 Chamilpa,Apartado Postal 510-3, Cuernavaca 62271, Morelos, Mexico.	patricia@ibt.unam.mx	Estevez, Jose Manuel/AAZ-9261-2020	Estevez, Jose Manuel/0000-0001-6332-7738				Arango Y, 1998, BIOCHEM J, V336, P531, DOI 10.1042/bj3360531; Bach TJ, 1999, CRIT REV BIOCHEM MOL, V34, P107, DOI 10.1080/10409239991209237; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Bouvier F, 1998, PLANT PHYSIOL, V117, P1423, DOI 10.1104/pp.117.4.1423; BRAMLEY P, 1992, PLANT J, V2, P343, DOI 10.1111/j.1365-313X.1992.00343.x; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Disch A, 1998, BIOCHEM J, V333, P381, DOI 10.1042/bj3330381; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; FRAY RG, 1995, PLANT J, V8, P693, DOI 10.1046/j.1365-313X.1995.08050693.x; Frey A, 1999, PLANT MOL BIOL, V39, P1267, DOI 10.1023/A:1006145025631; FURBANK RT, 1995, PLANT CELL, V7, P797, DOI 10.2307/3870037; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; Hirschberg J, 1999, CURR OPIN BIOTECH, V10, P186, DOI 10.1016/S0958-1669(99)80033-0; Huang SS, 1998, PLANT PHYSIOL, V118, P773, DOI 10.1104/pp.118.3.773; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; JULLIARD JH, 1992, CR ACAD SCI III-VIE, V314, P285; Kinney AJ, 1998, CURR OPIN PLANT BIOL, V1, P173, DOI 10.1016/S1369-5266(98)80021-6; KOORNNEEF M, 1994, SEED DORMANCY GERMIN, P313; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lange BM, 1999, CURR OPIN PLANT BIOL, V2, P139; Lange BM, 1999, ARCH BIOCHEM BIOPHYS, V365, P170, DOI 10.1006/abbi.1999.1168; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; MACROBBIE EAC, 1991, ABSCISIC ACID PHYSL, P23; Mandel MA, 1996, PLANT J, V9, P649, DOI 10.1046/j.1365-313X.1996.9050649.x; Miller B, 2000, FEBS LETT, V481, P221, DOI 10.1016/S0014-5793(00)02014-7; Miller B, 1999, FEBS LETT, V460, P485, DOI 10.1016/S0014-5793(99)01397-6; Newman JD, 1999, CRIT REV BIOCHEM MOL, V34, P95, DOI 10.1080/10409239991209228; PENACORTES H, 1989, P NATL ACAD SCI USA, V86, P9851, DOI 10.1073/pnas.86.24.9851; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P8251, DOI 10.1073/pnas.140209197; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P6451, DOI 10.1073/pnas.97.12.6451; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Schwender J, 1996, BIOCHEM J, V316, P73, DOI 10.1042/bj3160073; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Totte N, 2000, TETRAHEDRON LETT, V41, P6407, DOI 10.1016/S0040-4039(00)01094-7; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zeidler JG, 1997, Z NATURFORSCH C, V52, P15	67	449	520	4	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22901	22909		10.1074/jbc.M100854200	http://dx.doi.org/10.1074/jbc.M100854200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11264287	hybrid			2022-12-27	WOS:000169412700123
J	Ramirez-Carrozzi, VR; Kerppola, TK				Ramirez-Carrozzi, VR; Kerppola, TK			Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIENTED HETERODIMER BINDING; DNA; DOMAINS; ACTIVATION; SYNERGISM; PROMOTER; ELEMENTS; SEQUENCE; POLARITY; INVITRO	Heterodimeric transcription regulatory proteins can bind to palindromic recognition elements in two opposite orientations. We have developed a gel-based fluorescence resonance energy transfer assay for quantifying heterodimer orientation preferences. Fos-Jun heterodimers bind in opposite orientations to, AP-1 sites with different flanking sequences. The effects of individual amino acid and base pair substitutions on heterodimer binding orientation were quantified. Base pairs at positions +/-6 and +/-10 relative to the center of the AP-1 site were the principal determinants of Fos-Jun binding orientation. Amino acid residues of opposite charge adjacent to the basic regions of Fos and Jun had independent effects on heterodimer orientation. Exchange of these amino acid residues between the basic region-leucine zipper domains of Fos and Jun reversed the binding orientation. Heterodimers formed by full-length Fos and Jun exhibited the same changes in binding orientation in response to amino acid and base pair substitutions. The preferred orientation of heterodimer binding affected the stability of Fos-Jun-NFAT1 complexes at composite regulatory elements. Changes in heterodimer orientation preference altered the transcriptional activity and the promoter selectivity of Fos-Jun-NFAT1 complexes. Consequently, the orientation of Fos-Jun binding can influence transcriptional activity by altering cooperative interactions with other transcription regulatory proteins.	Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kerppola, TK (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.		Kerppola, Tom/AFK-6155-2022; Kerppola, Tom/AAG-4457-2022	Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446				ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; CHEN L, 1995, CURR BIOL, V5, P882, DOI 10.1016/S0960-9822(95)00178-3; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Chytil M, 1998, P NATL ACAD SCI USA, V95, P14076, DOI 10.1073/pnas.95.24.14076; Diebold RJ, 1998, P NATL ACAD SCI USA, V95, P7915, DOI 10.1073/pnas.95.14.7915; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583; Kerppola TK, 1997, EMBO J, V16, P2907, DOI 10.1093/emboj/16.10.2907; Kerppola TK, 1998, STRUCT FOLD DES, V6, P549, DOI 10.1016/S0969-2126(98)00057-4; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Leonard DA, 1998, NAT STRUCT BIOL, V5, P877, DOI 10.1038/2316; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Rajaram N, 1997, EMBO J, V16, P2917, DOI 10.1093/emboj/16.10.2917; Ramirez-Carrozzi VR, 2001, P NATL ACAD SCI USA, V98, P4893, DOI 10.1073/pnas.091095998; Ramirez-Carrozzi VR, 2001, J MOL BIOL, V305, P411, DOI 10.1006/jmbi.2000.4286; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	33	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21797	21808		10.1074/jbc.M101494200	http://dx.doi.org/10.1074/jbc.M101494200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11259418	hybrid			2022-12-27	WOS:000169297900131
J	Kito, K; Yeh, ETH; Kamitani, T				Kito, K; Yeh, ETH; Kamitani, T			NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; KAPPA-B-ALPHA; SENTRIN FAMILY; HUMAN CUL-1; UBIQUITIN; IDENTIFICATION; DEGRADATION; PATHWAY; COMPLEX	NEDD8, a ubiquitin-like protein, covalently conjugates to cullin family members. It appears to control vital biological events through its conjugation to cullins. To study how this conjugation pathway is regulated, we performed yeast two hybrid screening by using NEDD8 as a bait and isolated a cDNA fragment encoding a potent down-regulator of the NEDD8 expression. Here, we report this novel regulator, NUB1 (NEDD8 Ultimate Buster-1). NUB1 is composed of 601 residues with a calculated 69.1-kDa molecular mass. It is an interferon-inducible protein and predominantly localized in the nucleus. The NUB1 message is specifically expressed in adult human testis, ovary, heart, and skeletal muscle tissues and is developmentally down-regulated in mouse embryos. In biochemical analysis, we found that NUB1 overexpression leads to severe reduction of NEDD8 monomer and NEDD8 conjugates in cells. This reduction is not due to down-regulation of NEDD8 transcription, but due to post-transcriptional mechanism. As expected from this activity, overexpression of NUB1 had a profound growth-inhibitory effect on U20S cells. Thus, NUB1 is a strong down-regulator of the NEDD8 expression and appears to play critical roles in regulating biological events, including cell growth.	Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Div Mol Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kamitani, T (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd,Box 449, Houston, TX 77030 USA.	tkamitani@mdanderson.org	Kamitani, Tetsu/GSI-7613-2022	Kamitani, Tetsu/0000-0002-3257-9630	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056298] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK56298-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; KAMITANI T, 1991, CLIN IMMUNOL IMMUNOP, V58, P217, DOI 10.1016/0090-1229(91)90138-Z; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Okura T, 1996, J IMMUNOL, V157, P4277; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	36	78	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20603	20609		10.1074/jbc.M100920200	http://dx.doi.org/10.1074/jbc.M100920200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259415	hybrid			2022-12-27	WOS:000169135100125
J	Kontrogianni-Konstantopoulos, A; Frye, CS; Benz, EJ; Huang, SC				Kontrogianni-Konstantopoulos, A; Frye, CS; Benz, EJ; Huang, SC			The prototypical 4.1R-10-kDa domain and the 4.1G-10-kDa paralog mediate fodrin-actin complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANE; BRAIN SPECTRIN FODRIN; PRE-MESSENGER-RNA; PROTEIN-4.1 FAMILY; BETA-SPECTRIN; CYTOSKELETAL PROTEIN-4.1; ERYTHROCYTE SPECTRIN; SKELETAL PROTEIN-4.1; NONERYTHROID CELLS; PC12 CELLS	A complex family of 4.1R isoforms has been identified in non-erythroid tissues. In this study we characterized the exonic composition of brain 4.1R-10-kDa or spectrin/actin binding (SAB) domain and identified the minimal sequences required to stimulate fodrin/F-actin association. Adult rat brain expresses predominantly 4.1R mRNAs that carry an extended SAB, consisting of the alternative exons 14/15/16 and part of the constitutive exon 17. Exon 16 along with sequences carried by exon 17 is necessary and sufficient to induce formation of fodrin-actin-4.1R ternary complexes. The ability of the respective SAB domains of 4.1 homologs to sediment fodrin/actin was also investigated. 4.1G-SAB stimulates association of fodrin/actin, although with an similar to2-fold reduced efficiency compared with 4.1R-10-kDa, whereas 4.1N and 4.1B do not. Sequencing of the corresponding domains revealed that 4.1G-SAB carries a cassette that shares significant homology with 4.1R exon 16, whereas the respective sequence is divergent in 4.1N and absent from brain 4.1B. An similar to 150-kDa 4.1R and an similar to 160-kDa 4.1G isoforms are present in PC12 lysates that occur in vivo in a supramolecular complex with fodrin and F-actin. Moreover, proteins 4.1R and 4.1G are distributed underneath the plasma membrane in PC12 cells. Collectively, these observations suggest that brain 4.1R and 4.1G may modulate the membrane mechanical properties of neuronal cells by promoting fodrin/actin association.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huang, SC (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, D1420B,44 Binney St, Boston, MA 02115 USA.	Shu-Ching_Huang@dfci.harvard.edu			NHLBI NIH HHS [HL 44985] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044985] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; Baklouti F, 1997, GENOMICS, V39, P289, DOI 10.1006/geno.1996.4512; Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; BECKER PS, 1990, EUR J BIOCHEM, V193, P827, DOI 10.1111/j.1432-1033.1990.tb19406.x; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; BENZ EJ, 1994, MOL BASIS BLOOD DIS, P257; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BURNS NR, 1983, FEBS LETT, V153, P165, DOI 10.1016/0014-5793(83)80140-9; CHENEY R, 1986, METHOD ENZYMOL, V134, P42; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CORREAS I, 1986, J BIOL CHEM, V261, P3310; DAVIS J, 1983, J BIOL CHEM, V258, P7757; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; DELAUNAY J, 1995, CRIT REV ONCOL HEMAT, V19, P79, DOI 10.1016/1040-8428(94)00139-K; DISCHER D, 1993, J BIOL CHEM, V268, P7186; DUBREUIL RR, 1990, J CELL BIOL, V111, P1849, DOI 10.1083/jcb.111.5.1849; EDER PS, 1986, BIOCHEMISTRY-US, V25, P1764, DOI 10.1021/bi00355a047; Gascard P, 2000, CURR OPIN HEMATOL, V7, P123, DOI 10.1097/00062752-200003000-00009; GLENNEY JR, 1983, CELL, V34, P503, DOI 10.1016/0092-8674(83)90383-5; GOODMAN SR, 1981, P NATL ACAD SCI-BIOL, V78, P7570, DOI 10.1073/pnas.78.12.7570; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HORNE WC, 1993, BLOOD, V82, P2558; HUANG JP, 1993, J BIOL CHEM, V268, P3758; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LORENZO F, 1994, J CLIN INVEST, V94, P1651, DOI 10.1172/JCI117508; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Ohara R, 1999, DEV BRAIN RES, V117, P127, DOI 10.1016/S0165-3806(99)00110-8; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Peters LL, 1998, GENOMICS, V54, P348, DOI 10.1006/geno.1998.5537; PODGORSKI A, 1985, BIOCHEMISTRY-US, V24, P7871, DOI 10.1021/bi00348a004; Porter GA, 1997, CELL MOTIL CYTOSKEL, V37, P7, DOI 10.1002/(SICI)1097-0169(1997)37:1<7::AID-CM2>3.0.CO;2-7; Reid M E, 1989, Prog Clin Biol Res, V319, P553; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Shimizu T, 1996, BIOL CELL, V86, P19, DOI 10.1016/0248-4900(96)89520-7; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; TAKEMURA R, 1993, NEUROSCIENCE, V52, P381, DOI 10.1016/0306-4522(93)90165-C; TANG TK, 1990, J CELL BIOL, V110, P617, DOI 10.1083/jcb.110.3.617; TYLER JM, 1980, J BIOL CHEM, V255, P7034; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; Walensky LD, 1998, CURR BIOL, V8, P1269, DOI 10.1016/S0960-9822(07)00536-2; Walensky LD, 1999, J NEUROSCI, V19, P6457; Yamakawa H, 2000, GENE, V248, P137, DOI 10.1016/S0378-1119(00)00130-X; Yamakawa H, 1999, MOL BRAIN RES, V70, P197, DOI 10.1016/S0169-328X(99)00139-4; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999	53	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20679	20687		10.1074/jbc.M010581200	http://dx.doi.org/10.1074/jbc.M010581200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11274145	hybrid			2022-12-27	WOS:000169135100134
J	Walters, RW; Yi, SMP; Keshavjee, S; Brown, KE; Welsh, MJ; Chiorini, JA; Zabner, J				Walters, RW; Yi, SMP; Keshavjee, S; Brown, KE; Welsh, MJ; Chiorini, JA; Zabner, J			Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIATED AIRWAY EPITHELIA; INFLUENZA-C VIRUS; CANINE PARVOVIRUS; FACTOR-IX; RECEPTOR; VECTORS; EXPRESSION; CELLS; TRANSDUCTION; PERSISTENT	Recombinant adeno-associated viruses (AAV) are promising gene therapy vectors. Whereas AAV serotype 2-mediated gene transfer to muscle has partially replaced factor IX deficiency in hemophilia patients, its ability to mediate gene transfer to the lungs for cystic fibrosis is hindered by lack of apical receptors. However, AAV serotype 5 infects human airway epithelia from the lumenal surface. We found that in contrast to AAV2, the apical membrane of airway epithelia contains abundant high affinity receptors for AAV5. Binding and gene transfer with AAV5 was abolished by genetic or enzymatic removal of sialic acid from the cell surface. Furthermore, binding and gene transfer to airway epithelia was competed by lectins that specifically bind 2,3-linked sialic acid. These observations suggest that 2,3-linked sialic acid is either a receptor for AAV5 or it is a necessary component of a receptor complex. Further elucidation of the receptor for this virus should enhance understanding of parvovirus biology and expand the therapeutic targets for AAV vectors.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Toronto, Toronto Lung Transplant Program, Toronto, ON M5G 2C4, Canada; NIDCR, Gene Therapeut Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zabner, J (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, 500 EMRB, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu		Zabner, Joseph/0000-0002-9606-1339; Keshavjee, Shaf/0000-0003-4547-8094; Welsh, Michael/0000-0002-1646-6206	NIDDK NIH HHS [T30DK54759] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; Bais R, 1999, J VIROL, V73, P6085, DOI 10.1128/JVI.73.7.6085-6088.1999; Bantel-Schaal U, 1999, J VIROL, V73, P939, DOI 10.1128/JVI.73.2.939-947.1999; BARBIS DP, 1992, VIROLOGY, V191, P301, DOI 10.1016/0042-6822(92)90192-R; Beck SE, 1999, J VIROL, V73, P9446, DOI 10.1128/JVI.73.11.9446-9455.1999; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; Chao HJ, 2000, MOL THER, V2, P619, DOI 10.1006/mthe.2000.0219; Chiorini JA, 1997, J VIROL, V71, P6823, DOI 10.1128/JVI.71.9.6823-6833.1997; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; COTMORE SF, 1989, J VIROL, V63, P3902, DOI 10.1128/JVI.63.9.3902-3911.1989; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; FINNE J, 1982, J BIOL CHEM, V257, P1966; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; FLOTTE TR, 1995, GENE THER, V2, P357; GOTO H, 1974, JPN J VET SCI, V36, P203; GOTO H, 1975, JPN J VET SCI, V37, P239; Guy J, 1999, ARCH OPHTHALMOL-CHIC, V117, P929; HALBERT CL, 1995, J VIROL, V69, P1473, DOI 10.1128/JVI.69.3.1473-1479.1995; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; Handa A, 2000, J GEN VIROL, V81, P2077, DOI 10.1099/0022-1317-81-8-2077; HERRLER G, 1985, VIROLOGY, V141, P144, DOI 10.1016/0042-6822(85)90190-4; HIRST GK, 1950, J EXP MED, V91, P161, DOI 10.1084/jem.91.2.161; KARP PP, 2001, IN PRESS EPITHELIAL; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; Kurpad C, 1999, J HEMATOTH STEM CELL, V8, P585, DOI 10.1089/152581699319740; LIMBIRD LE, 1996, CELL SURFACE RECEPTO, P73; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; Muramatsu S, 1996, VIROLOGY, V221, P208, DOI 10.1006/viro.1996.0367; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; PAULSON JC, 1987, METHOD ENZYMOL, V138, P162; PERSSON R, 1985, J VIROL, V54, P92, DOI 10.1128/JVI.54.1.92-97.1985; Pickles RJ, 2000, J VIROL, V74, P6050, DOI 10.1128/JVI.74.13.6050-6057.2000; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Qiu JM, 2000, VIROLOGY, V269, P137, DOI 10.1006/viro.2000.0205; Qiu JM, 1999, NAT MED, V5, P467, DOI 10.1038/8328; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Rutledge EA, 1998, J VIROL, V72, P309, DOI 10.1128/JVI.72.1.309-319.1998; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; TARDIEU M, 1982, INT REV CYTOL, V80, P27, DOI 10.1016/S0074-7696(08)60366-6; Teramoto S, 1998, J VIROL, V72, P8904, DOI 10.1128/JVI.72.11.8904-8912.1998; TSUCHIYA E, 1989, FEBS LETT, V250, P285, DOI 10.1016/0014-5793(89)80739-2; Varki A., 1999, ESSENTIALS GLYCOBIOL; VIERBUCHEN MJ, 1995, CANCER, V76, P727, DOI 10.1002/1097-0142(19950901)76:5<727::AID-CNCR2820760504>3.0.CO;2-R; Wagner JA, 1998, LANCET, V351, P1702, DOI 10.1016/S0140-6736(05)77740-0; Walters RW, 2000, J VIROL, V74, P535, DOI 10.1128/JVI.74.1.535-540.2000; Xiao WD, 1999, J VIROL, V73, P3994, DOI 10.1128/JVI.73.5.3994-4003.1999; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996; ZUBER C, 1992, J BIOL CHEM, V267, P9965	61	250	264	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20610	20616		10.1074/jbc.M101559200	http://dx.doi.org/10.1074/jbc.M101559200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262413	hybrid			2022-12-27	WOS:000169135100126
J	Wong, GW; Lin, LX; Madhusudhan, MS; Krilis, SA; Gurish, MF; Rothenberg, ME; Sali, A; Stevens, RL				Wong, GW; Lin, LX; Madhusudhan, MS; Krilis, SA; Gurish, MF; Rothenberg, ME; Sali, A; Stevens, RL			Tryptase 4, a new member of the chromosome 17 family of mouse serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL PROTEASE-7; TISSUE-SPECIFIC EXPRESSION; PANCREATIC TRYPSIN; COMPLEMENTARY-DNA; DISULFIDE BONDS; APPLE DOMAINS; CLONING; MICE; GENE; BINDING	Genomic blot analysis raised the possibility that uncharacterized tryptase genes reside on chromosome 17 at the complex containing the three genes that encode mouse mast cell protease (mMCP) 6, mMCP-7, and transmembrane tryptase (mTMT). Probing of GenBank's expressed sequence tag data base with these three tryptase cDNAs resulted in the identification of an expressed sequence tag that encodes a portion of a novel mouse serine protease (now designated mouse tryptase 4 (mT4) because it is the fourth member of this family). 5'- and 3'-rapid amplification of cDNA ends approaches were carried out to deduce the nucleotide sequence of the full-length mT4 transcript. This information was then used to clone its similar to5.0-kilobase pair gene. Chromosome mapping analysis of its gene, sequence analysis of its transcript, and comparative protein structure modeling of its translated product revealed that mT4 is a new member of the chromosome 17 family of mouse tryptases. mT4 is 40-44% identical to mMCP-6, mMCP-7, and mTMT, and this new serine protease has all of the structural features of a functional tryptase. Moreover, mT4 is enzymatically active when expressed in insect cells. Due to its 17-mer hydrophobic domain at its C terminus, mT4 is a membrane-anchored tryptase more analogous to mTMT than the other members of its family, As assessed by RNA blot, reverse transcriptase-polymerase chain reaction, and/or in situ hybridization analysis, mT4 is expressed in interleukin-5-dependent mouse eosinophils, as well as in ovaries and testes. The observation that recombinant mT4 is preferentially retained in the endoplasmic reticulum of transiently transfected COS-7 cells suggests a convertase-like role for this integral membrane serine protease.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; St George Hosp, Dept Immunol Allergy & Infect Dis, Kogarah, NSW 2217, Australia; Univ New S Wales, Dept Med, Kogarah, NSW 2217, Australia; Rockefeller Univ, New York, NY 10021 USA; Childrens Hosp, Med Ctr, Childrens Hosp, Dept Pediat,Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; St George Hospital; University of New South Wales Sydney; Rockefeller University; Cincinnati Children's Hospital Medical Center	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.			Wong, G. William/0000-0002-5286-6506	NHLBI NIH HHS [HL-36110, HL-63284] Funding Source: Medline; NIAID NIH HHS [AI-23483] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110, R01HL063284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023483] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA T, 1994, J BIOL CHEM, V269, P31845; BABA T, 1989, FEBS LETT, V244, P296, DOI 10.1016/0014-5793(89)80549-6; BENYON RC, 1993, J IMMUNOL, V151, P2699; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 2000, J IMMUNOL, V165, P344, DOI 10.4049/jimmunol.165.1.344; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GURISH MF, 1994, MAMM GENOME, V5, P656, DOI 10.1007/BF00411467; GURISH MF, 1993, J BIOL CHEM, V268, P11372; HAUNG C, 1997, J BIOL CHEM, V272, P31885; Hooper JD, 1999, CANCER RES, V59, P3199; Huang C, 2000, J BIOL CHEM, V275, P351, DOI 10.1074/jbc.275.1.351; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; JOHNSON AR, 1975, IMMUNOLOGY, V28, P1067; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; Kohno N, 1998, BIOCHEM BIOPH RES CO, V245, P658, DOI 10.1006/bbrc.1998.8501; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2050, DOI 10.1021/bi00222a007; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; Ohmura K, 1999, J BIOL CHEM, V274, P29426, DOI 10.1074/jbc.274.41.29426; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; SALI A, 1993, J BIOL CHEM, V268, P9023; SALING PM, 1981, P NATL ACAD SCI-BIOL, V78, P6231, DOI 10.1073/pnas.78.10.6231; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; TOPFERPETERSEN E, 1990, FEBS LETT, V275, P139, DOI 10.1016/0014-5793(90)81458-Z; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; WEI L, 1991, J BIOL CHEM, V266, P5540; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	51	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					20648	20658		10.1074/jbc.M010422200	http://dx.doi.org/10.1074/jbc.M010422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11259427	hybrid			2022-12-27	WOS:000169135100131
J	Pfeiffer, M; Koch, T; Schroder, H; Klutzny, M; Kirscht, S; Kreienkamp, HJ; Hollt, V; Schulz, S				Pfeiffer, M; Koch, T; Schroder, H; Klutzny, M; Kirscht, S; Kreienkamp, HJ; Hollt, V; Schulz, S			Homo- and heterodimerization of somatostatin receptor subtypes - Inactivation of sst(3) receptor function by heterodimerization with sst(2A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SPINAL-CORD; GABA(B) RECEPTOR; DIMERIZATION; IDENTIFICATION; DOPAMINE; DOMAIN; OLIGOMERIZATION; LOCALIZATION; ACTIVATION; ASSEMBLE	Several recent studies suggest that G protein-coupled receptors can assemble as heterodimers or hetero-oligomers with enhanced functional activity. However, inactivation of a fully functional receptor by heterodimerization has not been documented. Here we show that the somatostatin receptor (sst) subtypes sst(2A) and sst(3) exist as homodimers at the plasma membrane when expressed in human embryonic kidney 293 cells. Moreover, in coimmunoprecipitation studies using differentially epitope tagged receptors, we provide direct evidence for heterodimerization of sst(2A) and sst(3). The sst(2A)-sst(3) heterodimer exhibited high affinity binding to somatostatin-14 and the sst(2)-selective ligand L-779,976 but not to the sst(3)-selective ligand L-796,778, Like the sst(2A) homodimer, the sst(2A)-sst(3) heterodimer stimulated guanosine 5'-3-O-(thio)triphosphate (GTP gammaS) binding, inhibition of adenylyl cyclase, and activation of extracellular signal-regulated kinases after exposure to the sst(2)-selective ligand L-779,976, However, unlike the sst(3) homodimer, the sst(2A)-sst(3) heterodimer did not promote GTP gammaS binding, adenylyl cyclase inhibition, or extracellular signal-regulated kinase activation in the presence of the sst(3)-selective ligand L-796,778, Interestingly, during prolonged somatostatin-14 exposure, the sst(2A)-sst(3) heterodimer desensitized at a slower rate than the sst(2A) and sst(3) homodimers. Both sst(2A) and sst(3) homodimers underwent agonist-induced endocytosis in the presence of somatostatin-14, In contrast, the sst(2A)-sst(3) heterodimer separated at the plasma membrane, and only sst, but not sst, underwent agonist induced endocytosis after exposure to somatostatin-14, Together, heterodimerization of sst(2A) and sst(3) results in a new receptor with a pharmacological and functional profile resembling that of the sst(2A) receptor, however with a greater resistance to agonist-induced desensitization. Thus, inactivation of sst(3) receptor function by heterodimerization with sst(2A) or possibly other G protein-coupled receptors may explain some of the difficulties in detecting sst(3)-specific binding and signaling in mammalian tissues.	Otto von Guericke Univ, Dept Pharmacol & Toxicol, Inst Pharmakol & Toxikol, D-39120 Magdeburg, Germany; Univ Hamburg, Hosp Eppendorf, Inst Zellbiochem & Klin Neurobiol, D-20246 Hamburg, Germany	Otto von Guericke University; University of Hamburg	Schulz, S (corresponding author), Otto von Guericke Univ, Dept Pharmacol & Toxicol, Inst Pharmakol & Toxikol, Leipziger Str 44, D-39120 Magdeburg, Germany.		Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885				AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AGNERS S, 2000, P NATL ACAD SCI USA, V97, P3684; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KAUPMANN K, 1993, FEBS LETT, V331, P53, DOI 10.1016/0014-5793(93)80296-7; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Meyerhof W, 1998, Rev Physiol Biochem Pharmacol, V133, P55; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Ng GYK, 1999, J BIOL CHEM, V274, P7607, DOI 10.1074/jbc.274.12.7607; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PEREZ J, 1994, N-S ARCH PHARMACOL, V349, P145; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; Schulz S, 1998, CLIN CANCER RES, V4, P2047; Schulz S, 1998, EUR J NEUROSCI, V10, P3700, DOI 10.1046/j.1460-9568.1998.00386.x; Schulz S, 2000, CLIN CANCER RES, V6, P1865; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	31	271	278	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2001	276	17					14027	14036		10.1074/jbc.M006084200	http://dx.doi.org/10.1074/jbc.M006084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	426PB	11134004	hybrid			2022-12-27	WOS:000168356600072
J	Shimojo, M; Lee, JH; Hersh, LB				Shimojo, M; Lee, JH; Hersh, LB			Role of zinc finger domains of the transcription factor neuron-restrictive silencer factor/repressor element-1 silencing transcription factor in DNA binding and nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; SODIUM-CHANNEL GENE; HISTONE DEACETYLASE; TARGET GENES; EXPRESSION; PROTEIN; REST; IDENTIFICATION; TRANSLOCATION; REPRESSION	The transcription factor neuron-restrictive silencer factor/repressor element-1 (RE-1) silencing transcription factor (NRSF/REST) contains nine zinc finger domains and binds to the DNA element, neuron-restrictive silencer element/repressor element-1. REST4, a C-terminally truncated form of NRSF/REST, contains the five N-terminal zinc fingers and binds weakly to DNA yet is transported into the nucleus. To study the contribution of zinc fingers 6-8 to DNA binding, each was mutated. A mutation in zinc finger 6 or 8 had little effect; however, mutation of zinc finger 7 diminished DNA binding. Mutations in any two of these zinc fingers eliminated DNA binding. The contribution of zinc fingers 2-5 to nuclear targeting was studied. Deletion of zinc finger 5 prevented nuclear targeting. Mutations in zinc finger 2, 4, or 5 did not abolish nuclear targeting. However, a zinc finger 3 mutation together with a zinc finger 2 mutation localized to the nuclear envelope. A zinc finger 3 mutation alone or in combination with a zinc finger 4 or 5 mutation produced a punctate nuclear distribution. These results suggest the presence of signals for nuclear targeting, for nuclear entry, and for release from the translocation machinery within zinc fingers 2-5 of REST 4.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, Lexington, KY 40536 USA	University of Kentucky	Hersh, LB (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, 800 Roe St, Lexington, KY 40536 USA.	lhersh@pop.uky.edu	Shimojo, Masahito/T-8086-2019	Shimojo, Masahito/0000-0003-1859-4444	NATIONAL INSTITUTE ON AGING [R01AG005893, R55AG005893] Funding Source: NIH RePORTER; NIA NIH HHS [AG05893] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai G, 1998, J BIOL CHEM, V273, P1086, DOI 10.1074/jbc.273.2.1086; Bruening W, 1996, FEBS LETT, V393, P41, DOI 10.1016/0014-5793(96)00853-8; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Lee JH, 2000, MOL BRAIN RES, V80, P88, DOI 10.1016/S0169-328X(00)00129-7; LEE JH, 2000, J MOL NEUROSCI, V80, P88; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; Lonnerberg P, 1996, J BIOL CHEM, V271, P33358, DOI 10.1074/jbc.271.52.33358; MATHENY C, 1994, J BIOL CHEM, V269, P8176; MILNE CA, 1993, J BIOL CHEM, V268, P11364; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Palm K, 1998, J NEUROSCI, V18, P1280; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	25	51	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2001	276	16					13121	13126		10.1074/jbc.M011193200	http://dx.doi.org/10.1074/jbc.M011193200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	423VN	11145971	hybrid			2022-12-27	WOS:000168198600092
J	Antonsson, B; Montessuit, S; Sanchez, B; Martinou, JC				Antonsson, B; Montessuit, S; Sanchez, B; Martinou, JC			Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ADENINE-NUCLEOTIDE TRANSLOCASE; PERMEABILITY TRANSITION PORE; CHANNEL-FORMING ACTIVITY; BCL-X-L; BH3 DOMAIN; CASPASE ACTIVATION; MONOMERIC PROTEIN; CYCLOPHILIN-D; ION-CHANNEL	Bax is a Bcl-2 family protein with proapoptotic activity, which has been shown to trigger cytochrome c release from mitochondria both in vitro and in vivo. In control HeLa cells, Bax is present in the cytosol and weakly associated with mitochondria as a monomer with an apparent molecular mass of 20,000 Da. After treatment of the HeLa cells with the apoptosis inducer staurosporine or UV irradiation, Bax associated with mitochondria is present as two large molecular weight oligomers/complexes of 96,000 and 260,000 Da, which are integrated into the mitochondrial membrane. Bcl-2 prevents Bax oligomerization and insertion into the mitochondrial membrane. The outer mitochondrial membrane protein voltage-dependent anion channel and the inner mitochondrial membrane protein adenosine nucleotide translocator do not coelute with the large molecular weight Bax oligomers/complexes on gel filtration. Bax oligomerization appears to be required for its proapoptotic activity, and the Bax oligomer/complex might constitute the structural entirety of the cytochrome c-conducting channel in the outer mitochondrial membrane.	Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	Merck & Company; Serono International S.A.	Antonsson, B (corresponding author), Serono Int SA, Serono Pharmaceut Res Inst, 14 Chemin Aulx, CH-1228 Geneva, Switzerland.			martinou, Jean-claude/0000-0002-9847-2051				Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; CHITTENDEN T, 1995, EMBO J, V14, P733; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Conus S, 2000, EMBO J, V19, P1534, DOI 10.1093/emboj/19.7.1534; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Estoppey S, 1997, CELL DEATH DIFFER, V4, P34, DOI 10.1038/sj.cdd.4400205; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Hunter JJ, 1996, J BIOL CHEM, V271, P8521, DOI 10.1074/jbc.271.15.8521; JACOBSON MD, 1997, CURR BIOL, V7, P277; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kohler C, 1999, FEBS LETT, V447, P10, DOI 10.1016/S0014-5793(99)00251-3; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Montessuit S, 1999, PROTEIN EXPRES PURIF, V15, P202, DOI 10.1006/prep.1998.1010; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NEWBY AC, 1982, TECHNIQUES LIPID MEM, P1; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; ROJO M, 1994, BBA-BIOENERGETICS, V1187, P360, DOI 10.1016/0005-2728(94)90010-8; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	64	579	597	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11615	11623		10.1074/jbc.M010810200	http://dx.doi.org/10.1074/jbc.M010810200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11136736	hybrid			2022-12-27	WOS:000168081800028
J	Bishop, N; Woodman, P				Bishop, N; Woodman, P			TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; STRUCTURE PREDICTION; TSG101 PROTEIN; PREVACUOLAR COMPARTMENT; YEAST; SEQUENCE; ATPASE; VACUOLAR; DOMAIN; IDENTIFICATION	Class E vacuolar protein sorting (vps) proteins are required for appropriate sorting of receptors within the yeast endocytic pathway, and most probably function in the biogenesis of multivesicular bodies. We have identified the mammalian orthologue of Vps28p as a 221-amino acid cytosolic protein that interacts with TSG101/ mammalian VPS23 to form part of a multiprotein complex. Co-immunoprecipitation and cross-linking experiments demonstrated that hVPS28 and TSG101 interact directly and that binding requires structural information within the conserved C-terminal portion of TSG101. TSG101 and hVPS28 are predominantly cytosolic. However, when endosomal vacuolization was induced by the expression of a dominant-negative mutant of another class E vps protein, human VPS4, a portion of both TSG101 and hVPS28 translocated to the surface of these vacuoles. We conclude that TSG101 and its interacting components are directly involved in endosomal sorting.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Woodman, P (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	pwoodman@fs1.scg.man.ac.uk						Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Blanchet C, 2000, BIOINFORMATICS, V16, P286, DOI 10.1093/bioinformatics/16.3.286; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Ferrer M, 1999, ONCOGENE, V18, P2253, DOI 10.1038/sj.onc.1202551; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; GORLICH D, 1991, METHOD CELL BIOL, V34, P241; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hampl M, 1998, BIOCHEM BIOPH RES CO, V248, P753, DOI 10.1006/bbrc.1998.9038; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; LEVIN JM, 1986, FEBS LETT, V205, P303, DOI 10.1016/0014-5793(86)80917-6; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li Y, 1999, MOL CELL BIOL, V19, P3588; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PERIER F, 1994, FEBS LETT, V351, P286, DOI 10.1016/0014-5793(94)00879-5; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Ponting CP, 1997, J MOL MED-JMM, V75, P467; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shu W, 1999, BIOCHEMISTRY-US, V38, P5378, DOI 10.1021/bi990199w; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steiner P, 1997, NAT GENET, V16, P332, DOI 10.1038/ng0897-332; Strous GJ, 1999, J CELL SCI, V112, P1417; Swanton E, 1998, MOL BIOL CELL, V9, P1633, DOI 10.1091/mbc.9.7.1633; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; Zhong Q, 1998, CANCER RES, V58, P2699	59	162	168	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11735	11742		10.1074/jbc.M009863200	http://dx.doi.org/10.1074/jbc.M009863200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11134028	hybrid			2022-12-27	WOS:000168081800043
J	Corey, S; Clapham, DE				Corey, S; Clapham, DE			The stoichiometry of G beta gamma binding to G-protein-regulated inwardly rectifying K(+) channels (GIRKs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNELS; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; I-KACH; SUBUNITS; ACTIVATION; BRAIN; IDENTIFICATION; MEMBRANE; MICE	G-protein-coupled inwardly rectifying K(+) (GIRK; Kir3.x) channels are the primary effecters of numerous G-protein-coupled receptors, GIRK channels decrease cellular excitability by hyperpolarizing the membrane potential in cardiac cells, neurons, and secretory cells. Although direct regulation of GIRKs by the heterotrimeric G-protein subunit G beta gamma has been extensively studied, little is known about the number of G beta gamma binding sites per channel. Here we demonstrate that purified GIRK (Kir 3.x) tetramers can be chemically cross-linked to exogenously purified G beta gamma subunits. The observed laddering pattern of G beta gamma attachment to GIRK4 homotetramers was consistent with the binding of one, two, three, or four G beta gamma molecules per channel tetramer. The fraction of channels chemically cross-linked to four G beta gamma molecules increased with increasing G beta gamma concentrations and approached saturation. These results suggest that GIRK tetrameric channels have four G beta gamma binding sites. Thus, GIRK (Kir 3.x) channels, like the distantly related cyclic nucleotide-gated channels, are tetramers and exhibit a 1:1 subunit/ligand binding stoichiometry.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Neurosci Program, Rochester, MN 55905 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Mayo Clinic	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, 1309 Enders,320 Longwood Ave, Boston, MA 02115 USA.	clapham@rascal.med.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CHENJ, 1995, SCIENCE, V268, P1166; CHOU H, 1991, RES COMMUN CHEM PATH, V74, P117; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CLARK KL, 1993, MOL CELL BIOL, V13, P1; Corey S, 1998, J BIOL CHEM, V273, P5271, DOI 10.1074/jbc.273.9.5271; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Doupnik CA, 1996, NEUROPHARMACOLOGY, V35, P923, DOI 10.1016/0028-3908(96)00125-6; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; HASSON MS, 1994, MOL CELL BIOL, V14, P1054, DOI 10.1128/MCB.14.2.1054; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; ITO H, 1991, J GEN PHYSIOL, V98, P517, DOI 10.1085/jgp.98.3.517; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; JELACIC TM, 2000, J BIOL CHEM; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOTERSZTAJN S, 1992, J BIOL CHEM, V267, P2375; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; Nakajima Y, 1996, FEBS LETT, V390, P217, DOI 10.1016/0014-5793(96)00661-8; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PRIVAT A, 1978, ACTA NEUROPATHOL, V42, P137, DOI 10.1007/BF00690980; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; SLAUGHTER RS, 1983, J BIOL CHEM, V258, P3183; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tucker SJ, 1996, AM J PHYSIOL-HEART C, V271, pH379, DOI 10.1152/ajpheart.1996.271.1.H379; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yan K, 1997, J BIOL CHEM, V272, P2056; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597	61	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11409	11413		10.1074/jbc.M100058200	http://dx.doi.org/10.1074/jbc.M100058200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11148218	hybrid			2022-12-27	WOS:000167980900113
J	Koike, M; Shiomi, T; Koike, A				Koike, M; Shiomi, T; Koike, A			Dimerization and nuclear localization of Ku proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; DNA-BINDING; SUBCELLULAR-LOCALIZATION; INTERACTION REGIONS; KINASE; GROWTH; GENE; EXPRESSION; COMPONENTS	Ku, a heterodimer of Ku70 and Ku80, plays a key role in multiple nuclear processes, e.g. DNA repair, chromosome maintenance, and transcription regulation. Heterodimerization is essential for Ku-dependent DNA repair in vivo although its role is poorly understood. Some lines of evidence suggest that heterodimerization is required for the stabilization of Ku70 and Ku80. Here we show that the heterodimerization of these Ku subunits is important for their nuclear entry. When transfected into Ku-deficient xrs-6 cells, exogenous Ku70 and Ku80 tagged with green fluorescent protein accumulated into the nucleus, whereas each nuclear localization signal (NLS)-dysfunctional mutant was undetectable in the nucleus, supporting the idea that each Ku can translocate to the nucleus through its own NLS. On the other hand, the nuclear accumulation of each NLS-dysfunctional mutant was markedly enhanced by the presence of an exogenous wild-type counterpart. In Ku-expressing HeLa cells, each NLS-dysfunctional mutant, as well as wild-type Ku70 and Ku80, was still detectable in the nucleus, whereas the double mutant of each Ku subunit with decreased functions of both nuclear targeting and dimerization was undetectable in the nucleus. Our results indicate that each Ku subunit can translocate to the nucleus not only through its own NLS but also through heterodimerization with each other.	Natl Inst Radiol Sci, Genome Res Grp, Inage Ku, Chiba 2638555, Japan	National Institutes for Quantum Science & Technology	Koike, M (corresponding author), Natl Inst Radiol Sci, Genome Res Grp, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.		Koike, Manabu/AAP-3107-2021					ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Brown KD, 2000, J BIOL CHEM, V275, P6651, DOI 10.1074/jbc.275.9.6651; Cary RB, 1998, NUCLEIC ACIDS RES, V26, P974, DOI 10.1093/nar/26.4.974; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DANZIEL RG, 1992, AUTOIMMUNITY, V13, P265; Errami A, 1996, MOL CELL BIOL, V16, P1519; Fewell JW, 1996, J CELL SCI, V109, P1937; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Koike M, 1998, BIOCHEM BIOPH RES CO, V252, P679, DOI 10.1006/bbrc.1998.9368; Koike M, 1999, ONCOGENE, V18, P7495, DOI 10.1038/sj.onc.1203247; Koike M, 1999, EXP CELL RES, V250, P401, DOI 10.1006/excr.1999.4507; KOIKE M, 1995, ONCOGENE, V10, P117; Koike M, 2000, BIOCHEM BIOPH RES CO, V276, P1105, DOI 10.1006/bbrc.2000.3567; Koike M, 1999, J CELL SCI, V112, P4031; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Morio T, 1999, IMMUNITY, V11, P339, DOI 10.1016/S1074-7613(00)80109-0; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Osipovich O, 1997, J BIOL CHEM, V272, P27259, DOI 10.1074/jbc.272.43.27259; PRABHAKAR BS, 1990, J CLIN INVEST, V86, P1301, DOI 10.1172/JCI114838; REEVES WH, 1992, RHEUM DIS CLIN N AM, V18, P391; SATOH M, 1995, EUR J CELL BIOL, V66, P127; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Teoh G, 1998, J CLIN INVEST, V101, P1379; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; WEAVER DT, 1995, ADV IMMUNOL, V58, P29, DOI 10.1016/S0065-2776(08)60619-7; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	34	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11167	11173		10.1074/jbc.M010902200	http://dx.doi.org/10.1074/jbc.M010902200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152690	hybrid			2022-12-27	WOS:000167980900079
J	Liu, PQ; Rebar, EJ; Zhang, L; Liu, Q; Jamieson, AC; Liang, YX; Qi, H; Li, PX; Chen, BL; Mendel, MC; Zhong, XH; Lee, YL; Eisenberg, SP; Spratt, SK; Case, CC; Wolffe, AP				Liu, PQ; Rebar, EJ; Zhang, L; Liu, Q; Jamieson, AC; Liang, YX; Qi, H; Li, PX; Chen, BL; Mendel, MC; Zhong, XH; Lee, YL; Eisenberg, SP; Spratt, SK; Case, CC; Wolffe, AP			Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions - Activation of vascular endothelial growth factor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TRANSCRIPTIONAL ACTIVATION; DNA-BINDING SPECIFICITIES; CORONARY-ARTERY DISEASE; C6 GLIOMA-CELLS; FACTOR GENE; FACTOR EXPRESSION; CRYSTAL-STRUCTURE; MESSENGER-RNA; VEGF121 CDNA; HYPOXIA	We have mapped conserved regions of enhanced DNase I accessibility within the endogenous chromosomal locus of vascular endothelial growth factor A (VEGF-A). Synthetic zinc finger protein (ZFP) transcription factors were designed to target DNA sequences contained within the DNase I-hypersensitive regions. These ZFPs, when fused to either VP16 or p65 transcriptional activation domains, were able to activate expression of the VEGF-A gene as assayed by mRNA accumulation and VEGF-A protein secretion through a range exceeding that induced by hypoxic stress. Importantly, multiple splice variants of VEGF-A mRNA with defined physiological functions were induced by a single engineered ZFP transcription factor. We present evidence for an enhanced activation of VEGF-A gene transcription by ZFP transcription factors fused to VP16 and p65 targeted to two distinct chromosomal sites >500 base pairs upstream or downstream of the transcription start site. Our strategy provides a novel approach for dissecting the requirements for gene regulation at a distance without altering the DNA sequence of the endogenous target locus.	Sangamo BioSci Inc, Point Richmond Tech Ctr, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Wolffe, AP (corresponding author), Sangamo BioSci Inc, Point Richmond Tech Ctr, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA.							Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Bartsevich VV, 2000, MOL PHARMACOL, V58, P1; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; DESJARLAIS JR, 1992, PROTEINS, V12, P101, DOI 10.1002/prot.340120202; DESJARLAIS JR, 1993, P NATL ACAD SCI USA, V90, P2256, DOI 10.1073/pnas.90.6.2256; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; DESJARLAIS JR, 1992, PROTEINS, V13, P272; Diaz BV, 2000, J BIOL CHEM, V275, P642, DOI 10.1074/jbc.275.1.642; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Esakof DD, 1999, HUM GENE THER, V10, P2307, DOI 10.1089/10430349950016951; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grant RA, 2000, BIOCHEMISTRY-US, V39, P8187, DOI 10.1021/bi000071a; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Hendel RC, 2000, CIRCULATION, V101, P118, DOI 10.1161/01.CIR.101.2.118; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Isner JM, 1998, J VASC SURG, V28, P964, DOI 10.1016/S0741-5214(98)70022-9; Jamieson AC, 1996, P NATL ACAD SCI USA, V93, P12834, DOI 10.1073/pnas.93.23.12834; JAMIESON AC, 1994, BIOCHEMISTRY-US, V33, P5689, DOI 10.1021/bi00185a004; Kim JS, 1997, P NATL ACAD SCI USA, V94, P3616, DOI 10.1073/pnas.94.8.3616; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; LADOUX A, 1994, BIOCHEM BIOPH RES CO, V204, P794, DOI 10.1006/bbrc.1994.2529; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rebar EJ, 1996, METHOD ENZYMOL, V267, P129; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Rosengart TK, 1999, ANN SURG, V230, P466, DOI 10.1097/00000658-199910000-00002; Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Salimath B, 2000, ONCOGENE, V19, P3470, DOI 10.1038/sj.onc.1203672; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	61	200	257	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11323	11334		10.1074/jbc.M011172200	http://dx.doi.org/10.1074/jbc.M011172200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11145970	hybrid			2022-12-27	WOS:000167980900101
J	Uversky, VN; Li, J; Fink, AL				Uversky, VN; Li, J; Fink, AL			Evidence for a partially folded intermediate in alpha-synuclein fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FAMILIAL PARKINSONS-DISEASE; X-RAY-SCATTERING; ALZHEIMERS-DISEASE; LEWY BODIES; SECONDARY STRUCTURE; FIBER DIFFRACTION; AMYLOID FIBRILS; MOLTEN GLOBULE; THIOFLAVINE-T	Intracellular proteinaceous aggregates (Lewy bodies and Lewy neurites) of alpha -synuclein are hallmarks of neurodegenerative diseases such as Parkinson's disease, dementia with Lewy bodies, and multiple systemic atrophy. However, the molecular mechanisms underlying alpha -synuclein aggregation into such filamentous inclusions remain unknown. An intriguing aspect of this problem is that: alpha -synuclein is a natively unfolded protein, with little or no ordered structure under physiological conditions. This raises the question of how an essentially disordered protein is transformed into highly organized fibrils. In the search for an answer to this question, we have investigated the effects of pH and temperature on the structural properties and fibrillation kinetics of human recombinant alpha -synuclein. Either a decrease in pH or an increase in temperature transformed alpha -synuclein into a partially folded conformation, The presence of this intermediate is strongly correlated with the enhanced formation of alpha -synuclein fibrils. We propose a model for the fibrillation of alpha -synuclein in which the first step is the conformational transformation of the natively unfolded protein into the aggregation-competent partially folded intermediate.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Fink, AL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	enzyme@cats.ucsc.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857				Arawaka S, 1998, NEUROLOGY, V51, P887, DOI 10.1212/WNL.51.3.887; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BARTL F, 1995, BIOPHYS J, V68, P104, DOI 10.1016/S0006-3495(95)80164-5; BUCHET R, 1991, BIOCHIM BIOPHYS ACTA, V1068, P201, DOI 10.1016/0005-2736(91)90211-P; Creighton T. E., 1993, PROTEINS STRUCTURES; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; DAMASCHUN G, 1991, BIOCHIM BIOPHYS ACTA, V1078, P289, DOI 10.1016/0167-4838(91)90571-G; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DUFFY PE, 1965, J NEUROPATH EXP NEUR, V24, P398, DOI 10.1097/00005072-196507000-00003; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; FINK AL, 1999, ENCY MOL BIOL, P140; Galvin J E, 1999, Adv Neurol, V80, P313; GAST K, 1995, BIOCHEMISTRY-US, V34, P13211, DOI 10.1021/bi00040a037; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Glatter O., 1982, SMALL ANGLE XRAY SCA; Goedert M, 1997, NATURE, V388, P232, DOI 10.1038/40767; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kay MS, 1999, P NATL ACAD SCI USA, V96, P2007, DOI 10.1073/pnas.96.5.2007; KHURANA R, 2001, IN PRESS BIOCHEMISTR, V39; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NAIKI H, 1990, LAB INVEST, V62, P768; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; Oberg KA, 1998, ANAL BIOCHEM, V256, P92, DOI 10.1006/abio.1997.2486; OKAZAKI H, 1961, J NEUROPATHOL EXP NE, V21, P422; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RODIONOVA NA, 1989, MOL BIOL+, V23, P528; SCHMID FX, 1995, CURR BIOL, V5, P993, DOI 10.1016/S0960-9822(95)00197-7; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Tsuruta H, 1998, J APPL CRYSTALLOGR, V31, P672, DOI 10.1107/S0021889898002702; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; WAKATSUKI S, 1992, REV SCI INSTRUM, V63, P1736, DOI 10.1063/1.1143332; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	51	875	891	1	124	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					10737	10744		10.1074/jbc.M010907200	http://dx.doi.org/10.1074/jbc.M010907200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11152691	hybrid			2022-12-27	WOS:000167980900025
J	Larson, ED; Drummond, JT				Larson, ED; Drummond, JT			Human mismatch repair and G center dot T mismatch binding by hMutS alpha in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE-II; HUMAN CELL-LINE; TUMOR-CELLS; DEOXYRIBONUCLEIC-ACID; MICROSATELLITE INSTABILITY; REPLICATION FIDELITY; EQUILIBRIUM BINDING; GENOME INSTABILITY; ANTICANCER AGENTS; NUCLEAR EXTRACTS	Loss of the human DNA mismatch repair pathway confers cross-resistance to structurally unrelated anticancer drugs. Examples include cisplatin, doxorubicin (adriamycin), and specific alkylating agents. We focused on defining the molecular events that link adriamycin to mismatch repair-dependent drug resistance because adriamycin, unlike drugs that covalently modify DNA can interact reversibly with DNA. We found that adriamycin, nogalamycin, and actinomycin D comprise a class of drugs that reversibly inhibits human mismatch repair in vitro at low micromolar concentrations. The substrate DNA was not covalently modified by adriamycin treatment in a way that prevents repair, and the inhibition was independent of the number of intercalation sites separating the mismatch and the DNA nick used to direct repair, from 10 to 808 base pairs. Over the broad concentration range tested, there was no evidence for recognition of intercalated adriamycin by MutS alpha as if it were an insertion mismatch. Inhibition apparently results from the ability of the intercalated drug to prevent mismatch binding, shown using a defined mobility shift assay, which occurs at drug concentrations that inhibit repair. These data suggest that adriamycin interacts with the mismatch repair pathway through a mechanism distinct from the manner by which covalent DNA lesions are processed.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Drummond, JT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.				NIGMS NIH HHS [GM 07757-21] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Anthoney DA, 1996, CANCER RES, V56, P1374; Arcamone F., 1981, DOXORUBICIN; BACHUR NR, 1992, MOL PHARMACOL, V41, P993; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; BARCELO F, 1988, BIOCHEM PHARMACOL, V37, P2133, DOI 10.1016/0006-2952(88)90571-0; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; BRESLOFF JL, 1981, BIOCHEMISTRY-US, V20, P3547, DOI 10.1021/bi00515a038; Brown R, 1997, ONCOGENE, V15, P45, DOI 10.1038/sj.onc.1201167; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CUMMINGS J, 1992, BIOCHEM PHARMACOL, V44, P2165, DOI 10.1016/0006-2952(92)90343-H; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; EGORIN MJ, 1974, CANCER RES, V34, P2243; FANG WH, 1993, J BIOL CHEM, V268, P11838; Fink D, 1998, CLIN CANCER RES, V4, P1; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; FOX KR, 1992, EUR J BIOCHEM, V209, P31, DOI 10.1111/j.1432-1033.1992.tb17257.x; GAO YG, 1990, BIOCHEMISTRY-US, V29, P10307, DOI 10.1021/bi00497a004; GIGLI M, 1988, BIOCHIM BIOPHYS ACTA, V950, P13, DOI 10.1016/0167-4781(88)90068-1; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Gong JG, 1999, NATURE, V399, P806; GOODMAN MF, 1974, P NATL ACAD SCI USA, V71, P1193, DOI 10.1073/pnas.71.4.1193; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; GRAVES DE, 1983, BIOCHEMISTRY-US, V22, P3941, DOI 10.1021/bi00285a033; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; HOLDEN JA, 1985, J BIOL CHEM, V260, P4491; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hu T, 1998, J BIOL CHEM, V273, P9586, DOI 10.1074/jbc.273.16.9586; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lage H, 1999, J CANCER RES CLIN, V125, P156, DOI 10.1007/s004320050258; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; MACGREGOR RB, 1987, BIOCHEMISTRY-US, V26, P4008, DOI 10.1021/bi00387a040; MACGREGOR RB, 1985, BIOCHEMISTRY-US, V24, P5503, DOI 10.1021/bi00341a034; Mello JA, 1996, CHEM BIOL, V3, P579, DOI 10.1016/S1074-5521(96)90149-0; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; MONACO RR, 1993, BIOCHEM BIOPH RES CO, V196, P975, DOI 10.1006/bbrc.1993.2345; MULLER W, 1968, J MOL BIOL, V35, P251, DOI 10.1016/S0022-2836(68)80024-5; O'Driscoll M, 1999, CARCINOGENESIS, V20, P799, DOI 10.1093/carcin/20.5.799; PACHTER JA, 1982, BIOCHEMISTRY-US, V21, P1541, DOI 10.1021/bi00536a012; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PIERSON V, 1989, BIOCHEM PHARMACOL, V38, P1395, DOI 10.1016/0006-2952(89)90178-0; RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038; SENTENAC A, 1968, BIOCHIM BIOPHYS ACTA, V161, P299, DOI 10.1016/0005-2787(68)90108-1; SHEARMAN CW, 1983, J BIOL CHEM, V258, P4477; SHERMAN SE, 1987, CHEM REV, V87, P1153, DOI 10.1021/cr00081a013; SINGH B, 1983, ENVIRON MUTAGEN, V5, P871, DOI 10.1002/em.2860050611; SKLADANOWSKI A, 1994, BIOCHEM PHARMACOL, V47, P2279, DOI 10.1016/0006-2952(94)90266-6; SKLADANOWSKI A, 1994, BIOCHEM PHARMACOL, V47, P2269, DOI 10.1016/0006-2952(94)90265-8; SU SS, 1988, J BIOL CHEM, V263, P6829; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; VIGEVANI A, 1980, DOXORUBICIN ANAL PRO, V9; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; WANG JC, 1974, J MOL BIOL, V89, P783, DOI 10.1016/0022-2836(74)90053-9; Yamada M, 1997, NUCLEIC ACIDS RES, V25, P491, DOI 10.1093/nar/25.3.491; YU YJ, 1994, MUTAT RES LETT, V325, P91, DOI 10.1016/0165-7992(94)90007-8; ZUNINO F, 1975, CANCER RES, V35, P754	71	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9775	9783		10.1074/jbc.M006390200	http://dx.doi.org/10.1074/jbc.M006390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134041	hybrid			2022-12-27	WOS:000167996400028
J	Majima, E; Ishida, M; Miki, S; Shinohara, Y; Terada, H				Majima, E; Ishida, M; Miki, S; Shinohara, Y; Terada, H			Specific labeling of the bovine heart mitochondrial phosphate carrier with fluorescein 5-isothiocyanate - Roles of Lys(185) and putative adenine nucleotide recognition site in phosphate transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP/ATP CARRIER; ACTIVE-SITE; UNCOUPLING PROTEIN; CYSTEINE RESIDUES; BINDING-SITE; EOSIN; LOOPS; EOSIN-5-MALEIMIDE; BACTERIORHODOPSIN; TRANSLOCATION	The amine/SH-modifying fluorescein 5-isothiocyanate (FITC) specifically labeled Lys(185) in the putative membrane-spanning region of the phosphate carrier from both the cytosolic and matrix sides of bovine heart mitochondria at 0 degreesC and pH 7.2, and the labeling inhibited the phosphate transport. Nonmodifying fluorescein derivatives having similar structural features to those of ADP and ATP (Majima, E., Yamaguchi, N., Chuman, H,, Shinohara, Y., Ishida, M., Goto, S., and Terada, H, (1998) Biochemistry 37, 424-432) inhibited the specific FITC labeling and phosphate transport, but the nonfluorescein phenylisothiocyanate did not inhibit FITC labeling, suggesting that there is a region recognizing the adenine nucleotides in the phosphate carrier and that this region is closely associated with the transport activity. The phosphate transport inhibitor pyridoxal 5 ' -phosphate inhibited the specific FITC labeling, possibly due to competitive modification of Lys(185), In addition, FITC inhibited the ADP transport and specific labeling of the ADP/ATP carrier with the fluorescein SH reagent eosin 5-maleimide, Based on these results, we discuss the structural features of the phosphate carrier in relation to its transport activity.	Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708506, Japan; APRO Life Sci Inst, Naruto 7720001, Japan	Tokushima University	Terada, H (corresponding author), Univ Tokushima, Fac Pharmaceut Sci, Shomachi 1, Tokushima 7708506, Japan.							AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; BRAND L, 1967, BIOCHEMISTRY-US, V6, P3510, DOI 10.1021/bi00863a024; Briggs C, 1999, BIOCHEMISTRY-US, V38, P5096, DOI 10.1021/bi982945n; CAPOBIANCO L, 1991, BIOCHEMISTRY-US, V30, P4963, DOI 10.1021/bi00234a018; CARILLI CT, 1982, J BIOL CHEM, V257, P5601; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P10; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; FLETTERICK RJ, 1975, P NATL ACAD SCI USA, V72, P38, DOI 10.1073/pnas.72.1.38; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; GENCHI G, 1988, BIOCHIM BIOPHYS ACTA, V936, P413, DOI 10.1016/0005-2728(88)90018-7; HOUSTEK J, 1985, J BIOL CHEM, V260, P6288; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; KLINGENBERG M, 1993, J BIOENERG BIOMEMBR, V25, P447, DOI 10.1007/BF01108402; KOLVE HVD, 1985, J BIOL CHEM, V260, P15889; Kramer R, 1996, KIDNEY INT, V49, P947, DOI 10.1038/ki.1996.133; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; LIGETI E, 1987, EUR J BIOCHEM, V167, P167, DOI 10.1111/j.1432-1033.1987.tb13319.x; MAJIMA E, 1994, BIOCHEMISTRY-US, V33, P9530, DOI 10.1021/bi00198a019; Majima E, 1998, BIOCHEMISTRY-US, V37, P424, DOI 10.1021/bi9710683; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; MAJIMA E, 1995, J BIOL CHEM, V270, P29548, DOI 10.1074/jbc.270.49.29548; MCKINLEYMCKEE JS, 1972, EUR J BIOCHEM, V28, P1, DOI 10.1111/j.1432-1033.1972.tb01877.x; MEANS GE, 1971, J BIOL CHEM, V246, P5532; Nakamura S, 1997, J BIOL CHEM, V272, P6232, DOI 10.1074/jbc.272.10.6232; PARDO JP, 1988, J BIOL CHEM, V263, P18664; Phelps A, 1996, BIOCHEMISTRY-US, V35, P10757, DOI 10.1021/bi961052x; PODHRADSKY D, 1979, EXPERIENTIA, V35, P154, DOI 10.1007/BF01920581; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V727, P101, DOI 10.1016/0005-2736(83)90373-5; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SOMERVILLE LL, 1977, BIOCHIM BIOPHYS ACTA, V481, P493, DOI 10.1016/0005-2744(77)90282-0; STAPPEN R, 1993, BIOCHIM BIOPHYS ACTA, V1149, P40, DOI 10.1016/0005-2736(93)90022-R; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; Terada H, 1997, PROG COLL POL SCI S, V106, P192, DOI 10.1007/BF01189519; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; WASSARMAN PM, 1971, J MOL BIOL, V60, P509, DOI 10.1016/0022-2836(71)90185-9	40	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					9792	9799		10.1074/jbc.M007222200	http://dx.doi.org/10.1074/jbc.M007222200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11133984	hybrid			2022-12-27	WOS:000167996400030
J	Zhang, JH; Barr, VA; Mo, YY; Rojkova, AM; Liu, SH; Simonds, WF				Zhang, JH; Barr, VA; Mo, YY; Rojkova, AM; Liu, SH; Simonds, WF			Nuclear localization of G protein beta(5) and regulator of G protein signaling 7 in neurons and brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; RGS PROTEINS; P115 RHOGEF; COMPLEX; G-BETA-5; DNA; TRANSLOCATION; ACTIVATION; EXPRESSION; RECEPTORS	The role that G beta (5) regulator of G protein signaling (RGS) complexes play in signal transduction in brain remains unknown. The subcellular localization of G beta (5) and RGS7 was examined in rat PC12 pheochromocytoma cells and mouse brain. Both nuclear and cytosolic localization of G beta (5) and RGS7 was evident in PC12 cells by immunocytochemical staining. Subcellular fractionation of PC12 cells demonstrated G beta (5) immunoreactivity in the membrane, cytosolic, and nuclear fractions. Analysis by limited proteolysis confirmed the identity of G beta (5) in the nuclear fraction, Subcellular fractionation of mouse brain demonstrated G beta (5) and RGS7 but not G gamma (2/3) immunoreactivity in the nuclear fraction. RGS7 and G beta (5) were tightly complexed in the brain nuclear extract as evidenced by their coimmunoprecipitation with anti-RGS7 antibodies. Chimeric protein constructs containing green fluorescent protein fused to wild-type G beta (5) but not green fluorescent fusion proteins with G beta (1) or a mutant G beta (5) impaired in its ability to bind to RGS7 demonstrated nuclear localization in transfected PC12 cells, These findings suggest that G beta (5) undergoes nuclear translocation in neurons via an RGS-dependent mechanism. The novel intracellular distribution of G beta (5). RGS protein complexes suggests a potential role in neurons communicating between classical heterotrimeric G protein subunits and/or their effecters at the plasma membrane and the cell nucleus.	NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Simonds, WF (corresponding author), NIDDK, Metab Dis Branch, NIH, Bldg 10,Rm 8C-101,10 Ctr Dr,MSC 1752, Bethesda, MD 20892 USA.	wfs@helix.nih.gov	Mo, Yin-Yuan/B-6141-2011; Rozhkova, Alexandra/E-5607-2014; Mo, Yin-Yuan/R-8255-2019	Rozhkova, Alexandra/0000-0003-4901-4705; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043304, Z01DK043304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Benzing T, 2000, J BIOL CHEM, V275, P28167; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Crouch MF, 1997, FASEB J, V11, P189, DOI 10.1096/fasebj.11.2.9039962; Dessauer CW, 1996, CLIN SCI, V91, P527, DOI 10.1042/cs0910527; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Liang JJ, 2000, J NEUROSCI RES, V60, P58, DOI 10.1002/(SICI)1097-4547(20000401)60:1<58::AID-JNR6>3.0.CO;2-L; Liang JJ, 1998, J NEUROCHEM, V71, P345; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; MURAKAMI T, 1992, BIOCHEMISTRY-US, V31, P2905, DOI 10.1021/bi00126a009; Obrdlik P, 2000, FEBS LETT, V476, P208, DOI 10.1016/S0014-5793(00)01706-3; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Willard FS, 2000, IMMUNOL CELL BIOL, V78, P387, DOI 10.1046/j.1440-1711.2000.00927.x; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zhang JH, 2000, J NEUROCHEM, V75, P393, DOI 10.1046/j.1471-4159.2000.0750393.x; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575	39	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10284	10289		10.1074/jbc.M009247200	http://dx.doi.org/10.1074/jbc.M009247200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11152459	hybrid			2022-12-27	WOS:000167996400093
J	Zhang, LH; Wu, SL; Rubin, CS				Zhang, LH; Wu, SL; Rubin, CS			A novel adapter protein employs a phosphotyrosine binding domain and exceptionally basic N-terminal domains to capture and localize an atypical protein kinase C - Characterization of Caenorhabditis elegans C kinase adapter 1, a protein that avidly binds protein kinase C3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHOR PROTEIN; PTB DOMAIN; SIGNAL-TRANSDUCTION; REGULATORY SUBUNIT; TIGHT JUNCTION; MESSENGER-RNA; RAT-BRAIN; CELL FATE; ZETA; EXPRESSION	Atypical protein kinase C isoforms (aPKCs) transmit regulatory signals to effector proteins located in the cytoplasm, nucleus, cytoskeleton, and membranes. Mechanisms by which aPKCs encounter and control effector proteins in various microenvironments are poorly understood. By using a protein interaction screen, we discovered two novel proteins that adapt a Caenorhabditis elegans aPKC (PKC3) for specialized (localized) functions; protein kinase C adapter 1 (CKA1, 593 amino acids) and CKA1S (549 amino acids) are derived from a unique mRNA by alternative utilization of two translation initiation codons. CKA1S and CKA1 are routed to the cell periphery by exceptionally basic N-terminal regions that include classical phosphorylation site domains (PSDs). Tethering of PKC3 is mediated by a segment of CKA1 that constitutes a phosphotyrosine binding (PTB) domain. Two aromatic amino acids (Phe(175) and Phe(221)) are indispensable for creation of a PKC3-binding surface and/or stabilization of CKA1 aPKC complexes. Patterns of CKA1 gene promoter activity and CKA1/CKA1S protein localization in vivo overlap with patterns established for PKC3 expression and distribution. Transfection experiments demonstrated that CKA1/CKA1S sequesters PKC3 in intact cells. Structural information in CKA1/CKA1S enables delivery of adapters to the lateral plasma membrane surface (near tight junctions) in polarized epithelial cells. Thus, a PTB domain and PSDs collaborate in a novel fashion in CKA1/CKA1S to enable tethering and targeting of PKC3. Avid ligation of a PKC isoform is a previously unappreciated function for a PTB module.	Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rubin, CS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, Forch 229,1300 Morris Pk Ave, Bronx, NY 10461 USA.	rubin@aecom.yu.edu			NIGMS NIH HHS [GM22792] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022792] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Balda MS, 1998, J CELL SCI, V111, P541; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BLUMENTHAL T, 1988, TRENDS GENET, V4, P305, DOI 10.1016/0168-9525(88)90107-2; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Diaz-Meco MT, 1999, J BIOL CHEM, V274, P19606, DOI 10.1074/jbc.274.28.19606; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Fields Stanley, 1993, Methods (Orlando), V5, P116, DOI 10.1006/meth.1993.1016; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; Gong JP, 1999, SCIENCE, V285, P1565, DOI 10.1126/science.285.5433.1565; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HU ED, 1990, J BIOL CHEM, V265, P5072; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Hung TJ, 1999, DEVELOPMENT, V126, P127; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LAND M, 1994, J BIOL CHEM, V269, P14820; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; Margolis B, 1999, TRENDS ENDOCRIN MET, V10, P262, DOI 10.1016/S1043-2760(99)00168-X; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Rossi EA, 1999, J BIOL CHEM, V274, P27201, DOI 10.1074/jbc.274.38.27201; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Stevenson BR, 1998, ANNU REV CELL DEV BI, V14, P89, DOI 10.1146/annurev.cellbio.14.1.89; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Toker A., 1998, FRONT BIOSCI-LANDMRK, V3, P1134, DOI 10.2741/A350; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VINIEGRA S, 1988, J BIOL CHEM, V263, P7099; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; WAYS DK, 1992, J BIOL CHEM, V267, P4799; White J., 1988, NEMATODE CAENORHABDI, V17, P81; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Zhang LH, 2001, J BIOL CHEM, V276, P10476, DOI 10.1074/jbc.M008991200; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	68	9	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10463	10475		10.1074/jbc.M008990200	http://dx.doi.org/10.1074/jbc.M008990200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134024	hybrid			2022-12-27	WOS:000167996400114
J	Van Oosten, MV; Rensen, PCN; Van Amersfoort, ES; Van Eck, M; Van Dam, AM; Breve, JJP; Vogel, T; Panet, A; Van Berkel, TJC; Kuiper, J				Van Oosten, MV; Rensen, PCN; Van Amersfoort, ES; Van Eck, M; Van Dam, AM; Breve, JJP; Vogel, T; Panet, A; Van Berkel, TJC; Kuiper, J			Apolipoprotein E protects against-bacterial lipopolysaccharide-induced lethality - A new therapeutic approach to treat Gram-negative sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; E-DEFICIENT MICE; BONE-MARROW TRANSPLANTATION; HIGH-DENSITY-LIPOPROTEINS; SEPTIC SHOCK; MONOCLONAL-ANTIBODY; CHYLOMICRONS ALTER; ENDOTOXEMIC SHOCK; CONTROLLED TRIAL; BINDING-PROTEIN	Septic shock is the most common cause of death in intensive care units and no effective treatment is available at present. Lipopolysaccharide (LPS) is the primary mediator of Gram-negative sepsis by inducing the production of macrophage-derived cytokines. Previously, we showed that apolipoprotein E (apoE), an established modulator of lipid metabolism, can bind LPS, thereby redirecting LPS from macrophages to hepatocytes in vivo. We now report that intravenously administered LPS strongly increases the serum levels of apoE. In addition, apoE can prevent the LPS-induced production of cytokines and subsequent death in rodents. Finally, apoE-deficient mice show a significantly higher sensitivity toward LPS than control wild-type mice. These findings indicate that apoE may have a physiological role in the protection against sepsis, and recombinant apoE may be used therapeutically to protect against LPS-induced endotoxemia.	Leiden Univ, Sylvius Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; Free Univ Amsterdam, Fac Med, Dept Pharmacol, Neurosci Res Inst, NL-1081 BT Amsterdam, Netherlands; Biotechnol Gen Ltd, IL-76326 Rehovot, Israel	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Kuiper, J (corresponding author), Leiden Univ, Sylvius Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, POB 9503, NL-2300 RA Leiden, Netherlands.	j.kuiper@lacdr.leidenuniv.nl	Rensen, Patrick C.N./D-7176-2018; van Amersfoort, Edwin S/J-9944-2018; Van Berkel, Theo/ABD-7677-2021	Rensen, Patrick C.N./0000-0002-8455-4988; 				AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; AUERBACH BJ, 1989, J BIOL CHEM, V264, P10264; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; CHENSUE SW, 1991, AM J PATHOL, V138, P395; de Bont N, 1999, J LIPID RES, V40, P680; Dinarello C A, 1994, Adv Pharmacol, V25, P21, DOI 10.1016/S1054-3589(08)60429-9; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; FIEDLER VB, 1992, J LAB CLIN MED, V120, P574; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FLEGEL WA, 1993, INFECT IMMUN, V61, P5140, DOI 10.1128/IAI.61.12.5140-5146.1993; Fraunberger P, 1997, ATHEROSCLEROSIS, V134, P349, DOI 10.1016/S0021-9150(97)89781-X; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; GALLAY P, 1993, P NATL ACAD SCI USA, V90, P9935, DOI 10.1073/pnas.90.21.9935; Giroir BP, 1997, LANCET, V350, P1439, DOI 10.1016/S0140-6736(97)06468-4; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Harris HW, 1998, HEPATOLOGY, V27, P1341, DOI 10.1002/hep.510270521; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Heumann D, 1996, J ENDOTOXIN RES, V3, P87, DOI 10.1177/096805199600300201; HINSHAW LB, 1990, CIRC SHOCK, V30, P279; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; MISTRY MJ, 1995, CELL IMMUNOL, V160, P14, DOI 10.1016/0008-8749(95)80004-3; Netea MG, 1998, INFECT IMMUN, V66, P2365, DOI 10.1128/IAI.66.5.2365-2367.1998; PARKER TS, 1995, INFECT IMMUN, V63, P253, DOI 10.1128/IAI.63.1.253-258.1995; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; READ TE, 1993, INFECT IMMUN, V61, P3496, DOI 10.1128/IAI.61.8.3496-3502.1993; RENSEN PCN, 1995, NAT MED, V1, P221, DOI 10.1038/nm0395-221; Rensen PCN, 1997, J CLIN INVEST, V99, P2438, DOI 10.1172/JCI119427; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Roselaar SE, 1997, CIRCULATION, V96, P1937; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; VANLENTEN BJ, 1986, P NATL ACAD SCI USA, V83, P2704; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; VanVelzen AG, 1997, BIOCHEM J, V322, P411; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333	51	140	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2001	276	12					8820	8824		10.1074/jbc.M009915200	http://dx.doi.org/10.1074/jbc.M009915200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	413HV	11136731	hybrid			2022-12-27	WOS:000167607700029
J	Schweickart, VL; Epp, A; Raport, CJ; Gray, PW				Schweickart, VL; Epp, A; Raport, CJ; Gray, PW			CCR11 is a functional receptor for the monocyte chemoaattractant protein family of chemokines. (vol 275, pg 9550, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Schweickart VL, 2000, J BIOL CHEM, V275, P9550, DOI 10.1074/jbc.275.13.9550	2	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	2001	276	1					856	856						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	390DP	11134065				2022-12-27	WOS:000166280700115
J	Bushell, M; Wood, W; Carpenter, G; Pain, VM; Morley, SJ; Clemens, MJ				Bushell, M; Wood, W; Carpenter, G; Pain, VM; Morley, SJ; Clemens, MJ			Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HELICASE ACTIVITY; POLY(A) BINDING-PROTEIN; FACTOR 4G EIF4G; TRANSLATION INITIATION; MESSENGER-RNA; IN-VITRO; CAP-POLY(A) SYNERGY; RECOGNITION MOTIF; APOPTOTIC CELLS; FACTOR 4F	Eukaryotic initiation factor (eIF) 4B interacts with several components of the initiation pathway and is targeted for cleavage during apoptosis. In a cell-free system, cleavage of eIF4B by caspase-3 coincides with a general inhibition of protein synthetic activity. Affinity chromatography demonstrates that mammalian eIF4B interacts with the poly(A)-binding protein and that a region consisting of the N-terminal 80 amino acids of eIF4B is both necessary and sufficient for such binding. This interaction is lost when eIF4B is cleaved by caspase-3, which removes the N-terminal 45 amino acids. Similarly, the association of eIF4B with the poly(a)binding protein in vivo is reduced when cells are induced to undergo apoptosis. Cleavage of the poly(A)binding protein itself, using human rhinovirus 3C protease, also eliminates the interaction with eIF4B. Thus, disruption of the association between mammalian eIF4B and the poly(A)-binding protein can occur during both apoptosis and picornaviral infection and is Likely to contribute to the inhibition of translation observed under these conditions.	St George Hosp, Sch Med, Dept Biochem & Immunol, Cellular & Mol Sci Grp, London SW17 0RE, England; Univ Sussex, Sch Biol Sci, Dept Biochem, Brighton BN1 9QG, E Sussex, England	St Georges University London; University of Sussex	Clemens, MJ (corresponding author), St George Hosp, Sch Med, Dept Biochem & Immunol, Cellular & Mol Sci Grp, Cranmer Terrace, London SW17 0RE, England.							ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; Asano K, 1997, J BIOL CHEM, V272, P1101, DOI 10.1074/jbc.272.2.1101; Barco A, 2000, VIROLOGY, V266, P352, DOI 10.1006/viro.1999.0043; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Belsham GJ, 1996, MICROBIOL REV, V60, P499, DOI 10.1128/MMBR.60.3.499-511.1996; BENNE R, 1978, J BIOL CHEM, V253, P3078; Bi XP, 2000, J BIOL CHEM, V275, P17740, DOI 10.1074/jbc.M909464199; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Bushell M, 2000, CELL DEATH DIFFER, V7, P628, DOI 10.1038/sj.cdd.4400699; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Bushell M, 1999, FEBS LETT, V451, P332, DOI 10.1016/S0014-5793(99)00614-6; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Clemens MJ, 1998, ONCOGENE, V17, P2921, DOI 10.1038/sj.onc.1202227; EDERY I, 1983, J BIOL CHEM, V258, P1398; Fraser CS, 1999, J BIOL CHEM, V274, P196, DOI 10.1074/jbc.274.1.196; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; KIRCHWEGER R, 1994, J VIROL, V68, P5677, DOI 10.1128/JVI.68.9.5677-5684.1994; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; LLOYD RE, 1987, J VIROL, V61, P2480, DOI 10.1128/JVI.61.8.2480-2488.1987; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Marissen WE, 2000, CELL DEATH DIFFER, V7, P1234, DOI 10.1038/sj.cdd.4400750; MERRICK WC, 1994, BIOCHIMIE, V76, P822, DOI 10.1016/0300-9084(94)90183-X; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; MILBURN SC, 1990, EMBO J, V9, P2783, DOI 10.1002/j.1460-2075.1990.tb07466.x; Morley SJ, 1998, FEBS LETT, V438, P41, DOI 10.1016/S0014-5793(98)01269-1; Morley SJ, 1997, RNA, V3, P1085; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; Morley SJ, 2000, FEBS LETT, V477, P229, DOI 10.1016/S0014-5793(00)01805-6; MORLEY SJ, 1996, PROTEIN PHOSPHORYLAT, P197; Niederberger N, 1998, RNA, V4, P1259, DOI 10.1017/S1355838298980487; NIETFELD W, 1990, EMBO J, V9, P3699, DOI 10.1002/j.1460-2075.1990.tb07582.x; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PAUSE A, 1993, CURR OPIN STRUC BIOL, V3, P953, DOI 10.1016/0959-440X(93)90161-D; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Satoh S, 1999, BIOCHEM J, V342, P65, DOI 10.1042/0264-6021:3420065; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; WEI CL, 1995, J BIOL CHEM, V270, P5764, DOI 10.1074/jbc.270.11.5764; YODERHILL J, 1993, J BIOL CHEM, V268, P5566	64	80	83	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					23922	23928		10.1074/jbc.M100384200	http://dx.doi.org/10.1074/jbc.M100384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11274152	hybrid			2022-12-27	WOS:000169531100093
J	Costanzi, C; Pehrson, JR				Costanzi, C; Pehrson, JR			MACROH2A2, a new member of the MACROH2A core histone family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INACTIVE X-CHROMOSOME; EXPRESSED SEQUENCE TAGS; MESSENGER-RNAS; XIST GENE; INITIATION; POSITION; SUBTYPES; NUCLEUS; REGION; CELLS	MACROH2As are core histones that have a unique hybrid structure consisting of an amino-terminal domain that closely resembles a full-length histone H2A followed by a large nonhistone region. The human MACROH2A1 gene, on chromosome 5, encodes two MACROH2A subtypes, MACROH2A1.1 and MACROH2A1.2, produced by alternate splicing. Here we report the identification of MACROH2A2, a new MACROH2A subtype encoded by a separate gene on human chromosome 10, MACROR2A2. The amino acid sequence of human MACROH2A2 is 68% identical to human MACROH2A1.2, We show by immunofluorescence on mouse tissue sections that MACROH2A2, like MACROH2A1.2, is concentrated in the inactive X chromosome. However, MACROH2A2 has a very different pattern of expression in the cell types present in the liver and kidney. When MACROH2A2 and MACROH2A1.2 are present in the same nucleus, they have a similar, though nonidentical, pattern of localization, with both subtypes present in the inactive X chromosome. Our results suggest a developmental role for MACROH2A subtypes.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Pehrson, JR (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.				NIGMS NIH HHS [GM49351] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee YH, 1998, BBA-GENE STRUCT EXPR, V1399, P73, DOI 10.1016/S0167-4781(98)00098-0; Mao M, 1998, P NATL ACAD SCI USA, V95, P8175, DOI 10.1073/pnas.95.14.8175; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; MOORE KL, 1953, J COMP NEUROL, V98, P213, DOI 10.1002/cne.900980203; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; SAINIO K, 1992, DEVELOPMENT, V115, P827; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	28	120	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21776	21784		10.1074/jbc.M010919200	http://dx.doi.org/10.1074/jbc.M010919200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11262398	hybrid			2022-12-27	WOS:000169297900128
J	Routhier, EL; Burn, TC; Abbaszade, I; Summers, M; Albright, CF; Prendergast, GC				Routhier, EL; Burn, TC; Abbaszade, I; Summers, M; Albright, CF; Prendergast, GC			Human BIN3 complements the F-actin localization defects caused by loss of Hob3p, the fission yeast homolog of Rvs161p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR BIN1; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PROTEIN INTERACTIONS; AMPHIPHYSIN ISOFORM; CELL-SEPARATION; SPLICE VARIANTS; ARP2/3 COMPLEX; GENE ENCODES; IN-VIVO	The BAR adaptor proteins encoded by the RVS167 and RVS161 genes from Saccharomyces cerevisiae form a complex that regulates actin, endocytosis, and viability following starvation or osmotic stress. In this study, we identified a human homolog of RVS161, termed BIN3 ((b) under bar ridging (i) under bar ntegrator-3), and a Schizosaccharomyces pombe homolog of RVS161, termed hob3+ (homolog of (B) under bar in3), In human tissues, the BIN3 gene was expressed ubiquitously except for brain, S. pombe cells lacking Hob3p were often multinucleate and characterized by increased amounts of calcofluor-stained material and mislocalized F-actin. For example, while wild-type cells localized F-actin to cell ends during interphase, hob3 Delta mutants had F-actin patches distributed randomly around the cell. In addition, medial F-actin rings were rarely found in hob3 Delta mutants. Notably, in contrast to S. cerevisiae rvs161 Delta mutants, hob3 Delta mutants showed no measurable defects in endocytosis or response to osmotic stress, yet hob3+ complemented the osmosensitivity of a rus161 Delta mutant. BIN3 failed to rescue the osmosensitivity of rvs161 Delta, but the actin localization defects of hob3 Delta mutants were completely rescued by BIN3 and partially rescued by RVS161, These findings suggest that hob3+ and BIN3 regulate F-actin localization, like RVS161, but that other roles for this gene have diverged somewhat during evolution.	DuPont Pharmaceut Co, Canc Res Grp, Glenolden Lab, Glenolden, PA 19036 USA; DuPont Pharmaceut Co, Appl Biotechnol Grp, Wilmington, DE 19803 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	DuPont; DuPont; The Wistar Institute	Prendergast, GC (corresponding author), DuPont Pharmaceut Co, Canc Res Grp, Glenolden Lab, Glenolden, PA 19036 USA.	george.c.prendergast@dupontpharma.com		Burn, Timothy/0000-0001-6648-4333				Alfa C., 1993, EXPT FISSION YEAST; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Balguerie A, 1999, J CELL SCI, V112, P2529; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Breton AM, 1998, CURR GENET, V34, P280, DOI 10.1007/s002940050397; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chang F, 1996, J CELL SCI, V109, P131; Colwill K, 1999, GENETICS, V152, P881; CROUZET M, 1991, YEAST, V7, P727, DOI 10.1002/yea.320070708; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Feoktistova A, 1999, GENETICS, V152, P895; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Grallert A, 1997, PROTOPLASMA, V198, P218, DOI 10.1007/BF01287571; Grallert A, 1999, YEAST, V15, P669, DOI 10.1002/(SICI)1097-0061(19990615)15:8<669::AID-YEA411>3.0.CO;2-K; Guthrie C, 1991, METHODS ENZYMOL; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kadlec L, 1997, P NATL ACAD SCI USA, V94, P12390, DOI 10.1073/pnas.94.23.12390; Le Goff X, 2000, J CELL SCI, V113, P4157; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mao NC, 1999, GENOMICS, V56, P51, DOI 10.1006/geno.1998.5709; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; McCollum D, 1999, FEBS LETT, V451, P321, DOI 10.1016/S0014-5793(99)00619-5; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sivadon P, 1997, FEBS LETT, V417, P21, DOI 10.1016/S0014-5793(97)01248-9; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Tsutsui K, 1997, BIOCHEM BIOPH RES CO, V236, P178, DOI 10.1006/bbrc.1997.6927; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	58	22	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21670	21677		10.1074/jbc.M101096200	http://dx.doi.org/10.1074/jbc.M101096200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11274158	hybrid			2022-12-27	WOS:000169297900116
J	Chi, AS; Deng, ZH; Albach, RA; Kemp, RG				Chi, AS; Deng, ZH; Albach, RA; Kemp, RG			The two phosphofructokinase gene products of Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROPHOSPHATE-DEPENDENT PHOSPHOFRUCTOKINASE; ESCHERICHIA-COLI; TRYPANOSOMA-BRUCEI; EXPRESSION; CLONING; ATP; PHOSPHOFRUCTO-1-KINASE; INHIBITION; PROTEINS; BINDING	Two phosphofructokinase genes have been described previously in Entamoeba histolytica. The product of the larger of the two genes codes for a 60-kDa protein that has been described previously as a pyrophosphate (PPi)-dependent enzyme, and the product of the second, coding for a 48-kDa protein, has been previously reported to be a PPi-dependent enzyme with extremely low specific activity, Here it is found that the 48-kDa protein is not a PPi-dependent enzyme but a highly active ATP-requiring enzyme (k(cat) = 250 s(-1)) that binds the cosubstrate fructose 6-phosphate (Fru-6-P) with relatively low affinity. This enzyme exists in concentration- and ATP-dependent tetrameric active and dimeric inactive states. Activation is achieved in the presence of nucleoside triphosphates, ADP, and PPi but not by AMP, P-i, or the second substrate Fru-6-P, Activation by ATP is facilitated by conditions of molecular crowding. Divalent cations are not required, and no phosphoryl transfer occurs during activation. Kinetics of the activated enzyme show cooperativity with Fru-6-P (Fru-6-P-0.5 = 3.8 mM) and inhibition by high ATP and phosphoenolpyruvate, The enzyme is active without prior activation in extracts off. histolytica. The level of mRNA, the amount of enzyme protein, and the enzyme activity of the 48-kDa enzyme are about one-tenth that of the 60-kDa enzyme in extracts off. histolytica trophozoites.	Finch Univ Hlth Sci Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; Finch Univ Hlth Sci Chicago Med Sch, Dept Microbiol & Immunol, N Chicago, IL 60064 USA	Chicago Medical School; Chicago Medical School	Kemp, RG (corresponding author), Finch Univ Hlth Sci Chicago Med Sch, Dept Biol Chem, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kempr@finchems.edu			NIAID NIH HHS [AI34527] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034527] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANAS T, 1988, BIOCHIM BIOPHYS ACTA, V957, P178, DOI 10.1016/0167-4838(88)90270-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchhaus I, 1996, BIOCHEM J, V316, P57, DOI 10.1042/bj3160057; CARLISLE SM, 1990, J BIOL CHEM, V265, P18366; Chi A, 2000, J BIOL CHEM, V275, P35677, DOI 10.1074/jbc.C000581200; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Deng ZH, 1998, BIOCHEM J, V329, P659, DOI 10.1042/bj3290659; Deng ZH, 1999, ARCH BIOCHEM BIOPHYS, V371, P326, DOI 10.1006/abbi.1999.1446; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; HUANG M, 1995, BBA-GENE STRUCT EXPR, V1260, P215, DOI 10.1016/0167-4781(94)00216-P; KEMP RG, 1967, BIOCHEMISTRY-US, V6, P423, DOI 10.1021/bi00854a009; KOTLARZ D, 1982, METHOD ENZYMOL, V90, P60; LADROR US, 1991, J BIOL CHEM, V266, P16550; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JC, 1979, BIOCHEMISTRY-US, V18, P5518, DOI 10.1021/bi00591a040; LINDBERG M, 1975, EUR J BIOCHEM, V53, P481, DOI 10.1111/j.1432-1033.1975.tb04089.x; Mertens E, 1998, J MOL EVOL, V47, P739, DOI 10.1007/PL00006433; Michels PAM, 1997, EUR J BIOCHEM, V250, P698, DOI 10.1111/j.1432-1033.1997.00698.x; MIEKKA SI, 1980, ARCH BIOCHEM BIOPHYS, V203, P630, DOI 10.1016/0003-9861(80)90220-9; NWAGWU M, 1982, ACTA TROP, V39, P61; RAMADOSS CS, 1976, ARCH BIOCHEM BIOPHYS, V175, P487, DOI 10.1016/0003-9861(76)90536-1; REEVES RE, 1984, ADV PARASIT, V23, P105, DOI 10.1016/S0065-308X(08)60286-9; REEVES RE, 1974, J BIOL CHEM, V249, P7737; VALDEZ BC, 1988, BIOCHEM BIOPH RES CO, V156, P537, DOI 10.1016/S0006-291X(88)80875-1; Wang XJ, 1999, BIOCHEMISTRY-US, V38, P4313, DOI 10.1021/bi982940q; ZHENG RL, 1992, J BIOL CHEM, V267, P23640	26	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2001	276	23					19974	19981		10.1074/jbc.M011584200	http://dx.doi.org/10.1074/jbc.M011584200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	439UC	11262402	hybrid			2022-12-27	WOS:000169135100040
J	Schulbach, MC; Mahapatra, S; Macchia, M; Barontini, S; Papi, C; Minutolo, F; Bertini, S; Brennan, PJ; Crick, DC				Schulbach, MC; Mahapatra, S; Macchia, M; Barontini, S; Papi, C; Minutolo, F; Bertini, S; Brennan, PJ; Crick, DC			Purification, enzymatic characterization, and inhibition of the Z-farnesyl diphosphate synthase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNDECAPRENYL PYROPHOSPHATE SYNTHETASE; CIS-ISOPRENYLTRANSFERASE ACTIVITY; SUBSTRATE-SPECIFICITY; LACTOBACILLUS-PLANTARUM; BIOSYNTHESIS; PRENYLTRANSFERASE; IDENTIFICATION; INTERMEDIATE; TRANSFERASE; MUTAGENESIS	We have recently shown that open reading frame Rv1086 of the Mycobacterium tuberculosis H37Rv genome sequence encodes a unique isoprenyl diphosphate synthase. The product of this enzyme, omega ,E,Z-farnesyl diphosphate, is an intermediate for the synthesis of decaprenyl phosphate, which has a central role in the biosynthesis of most features of the mycobacterial cell wall, including peptidoglycan, arabinan, linker unit galactan, and lipoarabinomannan. We have now purified Z-farnesyl diphosphate synthase to near homogeneity using a novel mycobacterial expression system. Z-Farnesyl diphosphate synthase catalyzed the addition of isopentenyl diphosphate to omega ,E-geranyl diphosphate or omega ,Z-neryl diphosphate yielding omega ,E,Z-farnesyl diphosphate and omega ,Z,Z-farnesyl diphosphate, respectively. The enzyme has an absolute requirement for a divalent cation, an optimal pH range of 7-8, and K-m values of 124 muM for isopentenyl diphosphate, 38 muM for geranyl diphosphate, and 16 muM for neryl diphosphate. Inhibitors of the Z-farnesyl diphosphate synthase were designed and chemically synthesized as stable analogs of omega ,E-geranyl diphosphate in which the labile diphosphate moiety was replaced with stable moieties. Studies with these compounds revealed that the active site of Z-farnesyl diphosphate synthase differs substantially from E-farnesyl diphosphate synthase from pig brain (Sus scrofa).	Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy	Colorado State University; University of Pisa	Crick, DC (corresponding author), Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA.		Minutolo, Filippo/A-7480-2011; Mahapatra, Sebabrata/D-6033-2017; Crick, Dean/H-8251-2017	Minutolo, Filippo/0000-0002-3312-104X; Crick, Dean/0000-0001-9281-7058; BERTINI, SIMONE/0000-0001-8832-8075; MACCHIA, MARCO/0000-0002-5565-2044	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018357, R37AI018357, R22AI018357] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46393, AI18357] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN CM, 1976, ARCH BIOCHEM BIOPHYS, V175, P236, DOI 10.1016/0003-9861(76)90504-X; ANDERSON RG, 1972, BIOCHEM J, V127, P11, DOI 10.1042/bj1270011; Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; BABA T, 1985, J BIOL CHEM, V260, P467; BABA T, 1978, BIOCHEMISTRY-US, V17, P5598, DOI 10.1021/bi00619a003; Baddiley J, 1972, Essays Biochem, V8, P35; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COOKE MP, 1981, SYNTHESIS STUTTGART, V4, P283; CRICK DC, 1991, J NEUROCHEM, V57, P1354, DOI 10.1111/j.1471-4159.1991.tb08301.x; CRICK DC, 1994, J BIOL CHEM, V269, P10559; CRICK DC, 1994, J NEUROCHEM, V62, P247; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DEWICK PM, 1995, NAT PROD REP, V12, P507, DOI 10.1039/np9951200507; DORSEY JK, 1966, J BIOL CHEM, V241, P5353; ERICSSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1991, EUR J BIOCHEM, V202, P789, DOI 10.1111/j.1432-1033.1991.tb16434.x; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; GREEN TR, 1974, BIOCHEMISTRY-US, V13, P4720, DOI 10.1021/bi00720a007; HIGASHI Y, 1970, J BIOL CHEM, V245, P3683; HOLLOWAY PW, 1967, BIOCHEM J, V104, P57, DOI 10.1042/bj1040057; ISHII K, 1986, BIOCHEM J, V233, P773, DOI 10.1042/bj2330773; KEENAN MV, 1974, ARCH BIOCHEM BIOPHYS, V161, P375, DOI 10.1016/0003-9861(74)90318-X; Kellogg BA, 1997, CURR OPIN CHEM BIOL, V1, P570, DOI 10.1016/S1367-5931(97)80054-3; KOYAMA T, 1977, J BIOCHEM-TOKYO, V82, P1585, DOI 10.1093/oxfordjournals.jbchem.a131853; Koyama T, 2000, BIOCHEMISTRY-US, V39, P463, DOI 10.1021/bi991621b; Macchia M, 1996, J MED CHEM, V39, P1352, DOI 10.1021/jm960127s; MACCHIA M, 1997, Patent No. 9719091; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Narita K, 1999, J BIOCHEM-TOKYO, V126, P566, DOI 10.1093/oxfordjournals.jbchem.a022487; OGURA K, 1969, J BIOCHEM-TOKYO, V66, P117, DOI 10.1093/oxfordjournals.jbchem.a129113; Ohnuma S, 1996, J BIOL CHEM, V271, P18831, DOI 10.1074/jbc.271.31.18831; Ohnuma S, 1997, J BIOCHEM-TOKYO, V121, P696; Ohnuma SI, 1996, J BIOL CHEM, V271, P10087, DOI 10.1074/jbc.271.17.10087; PATEL DV, 1995, J MED CHEM, V38, P2906, DOI 10.1021/jm00015a013; POPJAK G, 1969, BIOCHEM J, V111, P333, DOI 10.1042/bj1110333; PRASHAD M, 1993, EUR J MED CHEM, V28, P527, DOI 10.1016/0223-5234(93)90022-7; REED BC, 1975, BIOCHEMISTRY-US, V14, P50, DOI 10.1021/bi00672a009; RIEBER M, 1969, J GEN MICROBIOL, V55, P155, DOI 10.1099/00221287-55-1-155; Schulbach MC, 2000, J BIOL CHEM, V275, P22876, DOI 10.1074/jbc.M003194200; Shimizu N, 1998, J BIOL CHEM, V273, P19476, DOI 10.1074/jbc.273.31.19476; STORM DR, 1973, J BIOL CHEM, V248, P3940; TAKAYAMA K, 1973, BIOCHIM BIOPHYS ACTA, V316, P212, DOI 10.1016/0005-2760(73)90011-8; TAKAYAMA K, 1970, J BIOL CHEM, V245, P6251; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; VANHEIJENOORT J, 1996, ESCHERICHIA COLI SAL, P1025; Wolucka BA, 1998, GLYCOBIOLOGY, V8, P955, DOI 10.1093/glycob/8.10.955; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328	49	46	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 13	2001	276	15					11624	11630		10.1074/jbc.M007168200	http://dx.doi.org/10.1074/jbc.M007168200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421UK	11152452	hybrid			2022-12-27	WOS:000168081800029
J	Shimizu, A; Tada, K; Shukunami, C; Hiraki, Y; Kurokawa, T; Magane, N; Kurokawa-Seo, M				Shimizu, A; Tada, K; Shukunami, C; Hiraki, Y; Kurokawa, T; Magane, N; Kurokawa-Seo, M			A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINE LIGAND-BINDING; THANATOPHORIC DYSPLASIA; FGF RECEPTOR; HEPARAN-SULFATE; KINASE DOMAIN; FACTOR FAMILY; LINE ATDC5; SPECIFICITY; ACTIVATION; GENE	To determine the role of fibroblast growth factor (FGF).FGF receptor (FGFR) signaling in chondrogenesis, we analyzed the gene expression of alternatively spliced FGFRs during chondrogenic differentiation of ATDC5 cells in vitro. Two isoforms of FGFR3 were expressed in these cells. One was the complete form of FGFR3 (FGFR3) already reported, and the other was a novel one that lacks the acid box domain (FGFR3 Delta AB). The gene of FGFR3 Delta AB was expressed in undifferentiated ATDC5 cells. In contrast, the transcripts of FGFR3 were not detectable in undifferentiated cells but increased during cellular condensation, which is an obligatory step for chondrogenic differentiation. FGFR1 and FGFR2 expression was higher than that of FGFR3 in undifferentiated cells. The gene expression of cell cycle inhibitor p21 was induced during cell condensation and correlated best with the expression of FGFR3 among the FGFR isoforms expressed. The differential expression of FGFR3 isoforms during chondrogenesis suggests that these isoforms may play different roles in the regulation of growth and differentiation in chondrocytes. To define the mitogenic response of FGFR3 Delta AB and FGFR3 to FGFs, their cDNAs were stably transfected into mouse BaF3 pro-B cells. FGFR3 preferentially mediates the mitogenic response to FGF1 and poor response to FGF2, In contrast, FGFR3 Delta AB mediated a higher mitogenic response to FGF2 as well as to FGF1, In addition, FGFR3 Delta AB responds to FGF1 at lower concentrations of heparin than FGFR3 does. These results suggest that the acid box plays an important role in the regulation of FGFR3 to mediate biological activities in response to FGFs.	Kyoto Sangyo Univ, Dept Biotechnol, Fac Engn, Kita Ku, Kyoto 6038555, Japan; Kyoto Univ, Dept Mol Interact & Tissue Engn, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; Takeda Chem Ind Ltd, Discovery Res Labs 3, Pharmaceut Discovery Res Div, Yodogawa Ku, Osaka 5328686, Japan	Kyoto Sangyo University; Kyoto University; Takeda Chemical Industries	Kurokawa-Seo, M (corresponding author), Kyoto Sangyo Univ, Dept Biotechnol, Fac Engn, Kita Ku, Kyoto 6038555, Japan.	mseo@cc.kyoto-su.ac.jp	Shukunami, Chisa/G-2887-2019	Shukunami, Chisa/0000-0001-5616-6761				ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; Bansal R, 1996, MOL CELL NEUROSCI, V7, P263, DOI 10.1006/mcne.1996.0020; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; CHAMPIONARNAUD P, 1991, ONCOGENE, V6, P979; CHAUDHURI MM, 1993, J CELL PHYSIOL, V157, P209, DOI 10.1002/jcp.1041570202; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; EISEMANN A, 1991, ONCOGENE, V6, P1195; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KEEGAN K, 1991, ONCOGENE, V6, P2229; Kemler R, 1989, CURR OPIN CELL BIOL, V1, P892, DOI 10.1016/0955-0674(89)90055-0; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; KLAGSBRUN M, 1977, EXP CELL RES, V105, P99, DOI 10.1016/0014-4827(77)90155-0; KUROKAWA T, 1987, FEBS LETT, V213, P189, DOI 10.1016/0014-5793(87)81489-8; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PETERCASTRO AV, 1997, GENOMICS, V41, P10; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; SAVAGE MP, 1995, DEV DYNAM, V202, P343, DOI 10.1002/aja.1002020404; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Webster MK, 1997, MOL CELL BIOL, V17, P5739, DOI 10.1128/MCB.17.10.5739; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; Xu XL, 1999, DEV BIOL, V208, P293, DOI 10.1006/dbio.1999.9227; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; YAMAGUCHI F, 1994, P NATL ACAD SCI USA, V91, P484, DOI 10.1073/pnas.91.2.484; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZIMMER Y, 1993, J BIOL CHEM, V268, P7899	59	43	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2001	276	14					11031	11040		10.1074/jbc.M003535200	http://dx.doi.org/10.1074/jbc.M003535200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420AC	11134040	hybrid			2022-12-27	WOS:000167980900063
J	Blanc, V; Navaratnam, N; Henderson, JO; Anant, S; Kennedy, S; Jarmuz, A; Scott, J; Davidson, NO				Blanc, V; Navaratnam, N; Henderson, JO; Anant, S; Kennedy, S; Jarmuz, A; Scott, J; Davidson, NO			(O)over-cap vertical bar identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CYTIDINE DEAMINASE; CATALYTIC SUBUNIT; MOLECULAR-CLONING; SEQUENCE REQUIREMENTS; EVOLUTIONARY ORIGINS; SECONDARY STRUCTURE; ENZYME-COMPLEX; SITE; INVITRO	C to U editing of apolipoprotein B (apoB) mRNA involves the interaction of a multicomponent editing enzyme complex with a requisite RNA sequence embedded within an AU-rich context. This enzyme complex includes apobec-1, an RNA-specific cytidine deaminase, and apobec-1 complementation factor (ACF), a novel 65-kDa RNA-binding protein, that together represent the minimal core of the editing enzyme complex. The precise composition of the hole-enzyme, however, remains unknown. We have previously isolated an enriched fraction of S100 extracts, prepared from chicken intestinal cells, that displays apoB RNA binding and which, following supplementation with apobec-1, permits efficient C to U editing. Peptide sequencing of this most active fraction reveals the presence of ACF as well as GRY-RBP, an RNA-binding protein with similar to 50% homology to ACF, GRY-RBP was independently isolated from a two-hybrid screen of chicken intestinal cDNA. GRY-RBP binds to ACF, to apobec-1, and also binds apoB RNA. Experiments using recombinant proteins demonstrate that GRY-RBP binds to ACF and inhibits both the binding of ACF to apoB RNA and C to U RNA editing. This competitive inhibition is rescued by addition of ACF, suggesting that GRY-RBP binds to and sequesters ACF, As further evidence of the role of GRY-RBP, rat hepatoma cells treated with an antisense oligonucleotide to GRY-RBP demonstrated an increase in C to U editing of endogenous apoB RNA. ACF and GRY-RBP colocalize in the nucleus of transfected cells and, in cotransfection experiments with apobec-1, each appears to colocalize in a predominantly nuclear distribution. Taken together, the results indicate that GRY-RBP is a member of the ACF gene family that may function to modulate C to U RNA editing through binding either to ACF or to apobec-1 or, alternatively, to the target RNA itself.	Washington Univ, Sch Med, Div Gastroenterol, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Hammersmith Hosp, Imperial Coll, Sch Med, Clin Sci Ctr,MRC,Mol Med Grp, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Sch Med, Div Natl Heart & Lung Inst, London W12 0NN, England	Washington University (WUSTL); Washington University (WUSTL); Imperial College London; Imperial College London	Davidson, NO (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Dept Internal Med, Box 8124,660 S Euclid Ave, St Louis, MO 63110 USA.		Anant, Shrikant/AAF-8020-2020		NHLBI NIH HHS [HL-38180] Funding Source: Medline; NIDDK NIH HHS [DK-52574, DK-56260] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180, R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Anant S, 1998, BIOL CHEM, V379, P1075, DOI 10.1515/bchm.1998.379.8-9.1075; ANANT S, 1997, NUCL ACIDS S SER, V36, P115; BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; CHEN SH, 1990, J BIOL CHEM, V265, P6811; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DAVIES MS, 1989, J BIOL CHEM, V264, P13395; DRISCOLL DM, 1993, MOL CELL BIOL, V13, P7288, DOI 10.1128/MCB.13.12.7288; GREEVE J, 1993, J LIPID RES, V34, P1367; Greeve J, 1998, BIOL CHEM, V379, P1063, DOI 10.1515/bchm.1998.379.8-9.1063; HARRIS SG, 1993, J BIOL CHEM, V268, P7382; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Hersberger M, 1999, J BIOL CHEM, V274, P34590, DOI 10.1074/jbc.274.49.34590; Hersberger M, 1998, J BIOL CHEM, V273, P9435, DOI 10.1074/jbc.273.16.9435; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; Lau PP, 1997, J BIOL CHEM, V272, P1452, DOI 10.1074/jbc.272.3.1452; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mehta A, 1998, MOL CELL BIOL, V18, P4426, DOI 10.1128/MCB.18.8.4426; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Richardson N, 1998, J BIOL CHEM, V273, P31707, DOI 10.1074/jbc.273.48.31707; Schock D, 1996, P NATL ACAD SCI USA, V93, P1097, DOI 10.1073/pnas.93.3.1097; SHAH RR, 1991, J BIOL CHEM, V266, P16301; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; TENG BB, 1992, J BIOL CHEM, V267, P21265; Yang Y, 1997, J BIOL CHEM, V272, P27700, DOI 10.1074/jbc.272.44.27700; Yang Y, 2000, J BIOL CHEM, V275, P22663, DOI 10.1074/jbc.M910406199; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574	40	82	91	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10272	10283		10.1074/jbc.M006435200	http://dx.doi.org/10.1074/jbc.M006435200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11134005	hybrid			2022-12-27	WOS:000167996400092
J	Deszo, EL; Brake, DK; Cengel, KA; Kelley, KW; Freund, GG				Deszo, EL; Brake, DK; Cengel, KA; Kelley, KW; Freund, GG			CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMATURE B-CELLS; MAP KINASE; SIGNAL TRANSDUCTION; ESTER; IDENTIFICATION; DIACYLGLYCEROL; PHOSPHATASE; SERINE; LYN; SRC	The protein-tyrosine phosphatase CD45 is expressed on all monocytic cells, but its function in these cells is not well defined. Here we report that CD45 negatively regulates monocyte differentiation by inhibiting phorbol 12-myristate 13-acetate (PMA)-dependent activation of protein kinase C (PKC) delta. We found that antisense reduction of CD45 in U937 monocytic cells (CD45as cells) increased by 100% the ability of PMA to enlarge cell size, increase cell cytoplasmic process width and length, and induce surface expression of CD11b. In addition, reduction in CD45 expression caused the duration of peak PMA-induced MEK and extracellular signal-regulated kinase (ERK) 1/2 activity to increase from 5 min to 30 min while leading to a 4-fold increase in PMA-dependent PKC delta activation. Importantly, PMA-dependent tyrosine phosphorylation of PKC delta was also increased 4-fold in CD45as cells. Finally, inhibitors of MEK (PD98059) and PKC delta (rottlerin) completely blocked PMA-induced monocytic cell differentiation. Taken together, these data indicate that CD45 inhibits PMA-dependent PKC delta activation by impeding PMA-dependent PKC delta tyrosine phosphorylation, Furthermore, this blunting of PKC delta activation leads to an inhibition of PKC delta -dependent activation of ERK1/2 and ERK1/2-dependent monocyte differentiation. These findings suggest that CD45 is a critical regulator of monocytic cell development.	Univ Illinois, Coll Med, Dept Pathol, Urbana, IL 61801 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Freund, GG (corresponding author), Univ Illinois, Coll Med, Dept Pathol, 506 S Mathews Ave, Urbana, IL 61801 USA.	freun@ux1.cso.uiuc.edu			NCI NIH HHS [CA-61931] Funding Source: Medline; NIA NIH HHS [AG06246] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA061931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006246] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BARENDSEN N, 1990, LEUKEMIA RES, V14, P467, DOI 10.1016/0145-2126(90)90034-7; Bhatia M, 1996, EXP CELL RES, V222, P61, DOI 10.1006/excr.1996.0008; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cengel KA, 1999, J BIOL CHEM, V274, P27969, DOI 10.1074/jbc.274.39.27969; Cengel KA, 1998, BIOCHEM J, V335, P397, DOI 10.1042/bj3350397; D'Oro U, 1999, J IMMUNOL, V162, P1879; DONOVAN JA, 1993, J AM SOC NEPHROL, V4, P976; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hayes AL, 1999, J BIOL CHEM, V274, P33455, DOI 10.1074/jbc.274.47.33455; He HC, 1999, CELL GROWTH DIFFER, V10, P307; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KATAGIRI T, 1995, J BIOL CHEM, V270, P27987; Katagiri T, 1999, J IMMUNOL, V163, P1321; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kontny E, 2000, J LEUKOCYTE BIOL, V67, P249, DOI 10.1002/jlb.67.2.249; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Kulas DT, 1996, J BIOL CHEM, V271, P755, DOI 10.1074/jbc.271.2.755; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LI WQ, 1994, J BIOL CHEM, V269, P2349; Li WQ, 1996, J BIOL CHEM, V271, P26404, DOI 10.1074/jbc.271.42.26404; LILES WC, 1995, J IMMUNOL, V155, P2175; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; ORR JW, 1992, J BIOL CHEM, V267, P15263; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEDRINACI S, 1990, INT J CANCER, V45, P294, DOI 10.1002/ijc.2910450215; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Schacher DH, 2000, J IMMUNOL, V164, P113, DOI 10.4049/jimmunol.164.1.113; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; SOZERI O, 1992, ONCOGENE, V7, P2259; TAOKA T, 1992, BLOOD, V80, P46; TONKS NK, 1988, BIOCHEMISTRY-US, V27, P8696; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Wang WJ, 1997, J BIOL CHEM, V272, P76; Woodford-Thomas T, 1993, Semin Cell Biol, V4, P409, DOI 10.1006/scel.1993.1049; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	49	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10212	10217		10.1074/jbc.M010589200	http://dx.doi.org/10.1074/jbc.M010589200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11124968	hybrid			2022-12-27	WOS:000167996400084
J	Okamura, Y; Watari, M; Jerud, ES; Young, DW; Ishizaka, ST; Rose, J; Chow, JC; Strauss, JF				Okamura, Y; Watari, M; Jerud, ES; Young, DW; Ishizaka, ST; Rose, J; Chow, JC; Strauss, JF			The extra domain A of fibronectin activates toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FRAGMENTS MODULATE; PROTEIN; FAMILY; INDUCTION; LIGAND; MMP-9	Cellular fibronectin, which contains an alternatively spliced exon encoding type III repeat extra domain A (EDA), is produced in response to tissue injury, Fragments of fibronectin have been implicated in physiological and pathological processes, especially tissue remodeling associated with inflammation. Because EDA-containing fibronectin fragments produce cellular responses similar to those provoked by bacterial lipopolysaccharide (LPS), we examined the ability of recombinant EDA to activate Toll-like receptor 4 (TLR4), the signaling receptor stimulated by LPS. We found that recombinant EDA, but not other recombinant fibronectin domains, activates human TLR4 expressed in a cell type (HEK 293 cells) that normally lacks this Toll-like receptor. EDA stimulation of TLR4 was dependent upon co-expression of MD-2, a TLR4 accessory protein. Unlike LPS, the activity of EDA was heat-sensitive and persisted in the presence of the LPS-binding antibiotic polymyxin B and a potent LPS antagonist, E5564, which completely suppressed LPS activation of TLR4, These observations provided a mechanism by which EDA-containing fibronectin fragments promote expression of genes involved in the inflammatory response.	Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Eisai Res Inst, Dept Mol Biol & Biochem & Signal Transduct, Wilmington, MA USA	University of Pennsylvania; Pennsylvania Medicine; Eisai Co Ltd	Strauss, JF (corresponding author), Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, 1354 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	jfs3@mail.med.upenn.edu			NICHD NIH HHS [HD-34612] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034612] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1991, CELL BIOL EXTRACELLU; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; George J, 2000, AM J PATHOL, V156, P115, DOI 10.1016/S0002-9440(10)64711-6; Grant MB, 1998, DIABETES, V47, P1335, DOI 10.2337/diabetes.47.8.1335; HINO K, 1995, ARTHRITIS RHEUM-US, V38, P678, DOI 10.1002/art.1780380516; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kapila YL, 1996, MATRIX BIOL, V15, P251, DOI 10.1016/S0945-053X(96)90116-X; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; SATO H, 1993, ONCOGENE, V8, P395; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tremble P M, 1992, Matrix Suppl, V1, P212; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	28	900	964	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2001	276	13					10229	10233		10.1074/jbc.M100099200	http://dx.doi.org/10.1074/jbc.M100099200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	420GC	11150311	hybrid			2022-12-27	WOS:000167996400087
J	Trott, RL; Kalive, M; Paroush, Z; Bidwai, AP				Trott, RL; Kalive, M; Paroush, Z; Bidwai, AP			Drosophila melanogaster casein kinase II interacts with and phosphorylates the basic helix-loop-helix proteins m5, m7, and m8 derived from the Enhancer of split complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; BETA-SUBUNIT; TYROSINE PHOSPHORYLATION; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; REGULATORY SUBUNIT; SYNTHETIC PEPTIDES	Drosophila melanogaster casein kinase II (DmCKII) is composed of catalytic (alpha) and regulatory (beta) subunits associated as an alpha (2)beta (2) heterotetramer. Using the two-hybrid system, we have screened a D. melanogaster embryo cDNA library for proteins that interact with DmCKII alpha. One of the cDNAs isolated in this screen encodes m7, a basic helix-loop-helix (bHLH)-type transcription factor encoded by the Enhancer of split complex (E(spl)C), which regulates neurogenesis. m7 interacts with DmCKII alpha but not with DmCKII beta, suggesting that this interaction is specific for the catalytic subunit of DmCKII. In addition to m7, we demonstrate that DmCKII alpha also interacts with two other E(spl)C-derived bHLH proteins, m5 and m8, but not with other members, such as m3 and mC. Consistent with the specificity observed for the interaction of DmCKII alpha with these bHLH proteins, sequence alignment suggests that only m5, m7, and m8 contain a consensus site for phosphorylation by CKII within a subdomain unique to these three proteins. Accordingly, these three proteins are phosphorylated by DmCKII alpha, as well as by the alpha (2)beta (2), holoenzyme purified from Drosophila embryos. In line with the prediction of a single consensus site for CKII, replacement of Ser(159) of m8 with either Ala or Asp abolishes phosphorylation, identifying this residue as the site of phosphorylation. We also demonstrate that m8 forms a direct physical complex with purified DmCKII, corroborating the observed two-hybrid interaction between these proteins. Finally, substitution of Ser(159) of m8 with Ala attenuates interaction with DmCKII alpha, whereas substitution with Asp abolishes the interaction. These studies constitute the first demonstration that DmCKII interacts with and phosphorylates m5, m7, and m8 and suggest a biochemical and/or structural basis for the functional equivalency of these bHLH proteins that is observed in the context of neurogenesis.	W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	West Virginia University; Hebrew University of Jerusalem	Bidwai, AP (corresponding author), W Virginia Univ, Dept Biol, POB 6057,Brooks Hall, Morgantown, WV 26506 USA.			Bidwai, Ashok/0000-0002-4297-5629				Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Ausubel FM, 1988, MOL REPROD DEV; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bidwai A P, 1999, Mol Cell Biol Res Commun, V1, P21, DOI 10.1006/mcbr.1999.0103; BIDWAI AP, 1994, ARCH BIOCHEM BIOPHYS, V309, P348, DOI 10.1006/abbi.1994.1123; BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; BIDWAI AP, 1992, J BIOL CHEM, V267, P18790; Bidwai Ashok P., 2000, Molecular Cell Biology Research Communications, V3, P283, DOI 10.1006/mcbr.2000.0223; Blaumueller CM, 1997, PERSPECT DEV NEUROBI, V4, P325; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray S, 1998, CELL, V93, P499, DOI 10.1016/S0092-8674(00)81180-0; CamposOrtega JA, 1997, PERSPECT DEV NEUROBI, V4, P267; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COLLINGE MA, 1994, PLANT MOL BIOL, V25, P649, DOI 10.1007/BF00029603; DAHMUS GK, 1984, J BIOL CHEM, V259, P9001; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; FISHER AL, 1996, MOL CELL BIOL, V16, P257; FUJITAYAMAGUCHI Y, 1989, P NATL ACAD SCI USA, V86, P7306, DOI 10.1073/pnas.86.19.7306; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gigliani F, 1996, MOL GEN GENET, V251, P628, DOI 10.1007/BF02174111; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; HU E, 1990, J BIOL CHEM, V265, P20609; HU ED, 1990, J BIOL CHEM, V265, P5072; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Israel A, 1997, NATURE, V388, P519, DOI 10.1038/41433; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1992, GENETICS, V132, P505; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; LIN WJ, 1991, J BIOL CHEM, V266, P5664; MAIER D, 1993, P NATL ACAD SCI USA, V90, P5464, DOI 10.1073/pnas.90.12.5464; Marin O, 1999, J BIOL CHEM, V274, P29260, DOI 10.1074/jbc.274.41.29260; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; MEGGIO F, 1983, FEBS LETT, V162, P235, DOI 10.1016/0014-5793(83)80762-5; MEGGIO F, 1984, J BIOL CHEM, V259, P4576; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Miller J. H, 1972, EXPT MOL GENETICS; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Packman LC, 1997, FEBS LETT, V400, P45, DOI 10.1016/S0014-5793(96)01324-5; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PINNA LA, 1994, CELL MOL BIOL RES, V40, P383; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rethinaswamy A, 1998, J BIOL CHEM, V273, P5869, DOI 10.1074/jbc.273.10.5869; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; YANG XL, 1994, EMBO J, V13, P5878, DOI 10.1002/j.1460-2075.1994.tb06933.x; YANG XO, 1992, SCIENCE, V257, P680, DOI 10.1126/science.1496382; YASUKAWA T, 1995, J BIOL CHEM, V270, P25328, DOI 10.1074/jbc.270.43.25328; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095	76	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 19	2001	276	3					2159	2167		10.1074/jbc.M005996200	http://dx.doi.org/10.1074/jbc.M005996200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	394MN	11208814	hybrid			2022-12-27	WOS:000166528000069
